FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Witzel, I
   Laakmann, E
   Fehm, T
   Mobus, V
   vonMinckwitz, G
   Kaiser, J
   Loibl, S
   Muller, V
AF Witzel, Isabell
   Laakmann, Elena
   Fehm, Tanja
   Moebus, Volker
   vonMinckwitz, Gunter
   Kaiser, Julia
   Loibl, Sibylle
   Mueller, Volkmar
TI Brain metastases in breast cancer network Germany (BMBC, GBG 79):
   Multicentric, retro- and prospective collection of patient data and
   biomaterial from breast cancer patients with brain metastases
SO CANCER RESEARCH
LA English
DT Meeting Abstract
CT 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium
CY DEC 09-13, 2014
CL San Antonio, TX
SP Canc Therapy Res Ctr, Amer Assoc Canc Res
C1 [Witzel, Isabell; Laakmann, Elena; Mueller, Volkmar] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   [Fehm, Tanja] Arbeitsgemeinschaft Gynakol Onkol AGO Trafo, Translat Res Board, Hamburg, Germany.
   [Moebus, Volker] Arbeitsgemeinschaft Gynakol Onkol AGO B, Breast Study Grp, Hamburg, Germany.
   [vonMinckwitz, Gunter; Kaiser, Julia; Loibl, Sibylle] German Breast Grp, Berlin, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 2015
VL 75
SU 9
MA OT2-5-01
DI 10.1158/1538-7445.SABCS14-OT2-5-01
PG 2
WC Oncology
SC Oncology
GA CL1UK
UT WOS:000356730200116
DA 2018-10-20
ER

PT J
AU Hussein, MA
   Mohammed, AS
   Al-Aqeeli, N
AF Hussein, Mohamed A.
   Mohammed, Abdul Samad
   Al-Aqeeli, Naser
TI Wear Characteristics of Metallic Biomaterials: A Review
SO MATERIALS
LA English
DT Review
DE metallic biomaterial; tribology; wear; friction
ID CO-CR ALLOY; BIOMEDICAL APPLICATIONS; POWDER-METALLURGY; SURGICAL
   IMPLANTS; TITANIUM-ALLOYS; COCRMO-ALLOYS; BEHAVIOR; OSSEOINTEGRATION;
   INDENTATION; COEFFICIENT
AB Metals are extensively used in a variety of applications in the medical field for internal support and biological tissue replacements, such as joint replacements, dental roots, orthopedic fixation, and stents. The metals and alloys that are primarily used in biomedical applications are stainless steels, Co alloys, and Ti alloys. The service period of a metallic biomaterial is determined by its abrasion and wear resistance. A reduction in the wear resistance of the implant results in the release of incompatible metal ions into the body that loosen the implant. In addition, several reactions may occur because of the deposition of wear debris in tissue. Therefore, developing biomaterials with high wear resistance is critical to ensuring a long life for the biomaterial. The aim of this work is to review the current state of knowledge of the wear of metallic biomaterials and how wear is affected by the material properties and conditions in terms of the type of alloys developed and fabrication processes. We also present a brief evaluation of various experimental test techniques and wear characterization techniques that are used to determine the tribological performance of metallic biomaterials.
C1 [Hussein, Mohamed A.; Mohammed, Abdul Samad; Al-Aqeeli, Naser] King Fahd Univ Petr & Minerals, Dept Mech Engn, Dhahran 31261, Saudi Arabia.
   [Hussein, Mohamed A.] Kafrelsheikh Univ, Dept Mech Engn, Kafrelsheikh 33516, Egypt.
RP Mohammed, AS (reprint author), King Fahd Univ Petr & Minerals, Dept Mech Engn, Dhahran 31261, Saudi Arabia.
EM mahussein@kfupm.edu.sa; samad@kfupm.edu.sa; naqeeli@kfupm.edu.sa
RI Hussein, Mohamed/F-4120-2015
OI Hussein, Mohamed/0000-0002-6720-7618
FU King Abdulaziz City for Science and Technology (KACST) through the
   Science & Technology Unit at King Fahd University of Petroleum &
   Minerals (KFUPM) as part of the National Science, Technology and
   Innovation Plan [12-ADV3036-04]; King Fahd University of Petroleum &
   Minerals (KFUPM) [IN131020]
FX The authors would like to acknowledge the support provided by King
   Abdulaziz City for Science and Technology (KACST) through the Science &
   Technology Unit at King Fahd University of Petroleum & Minerals (KFUPM)
   for funding this work through project No. 12-ADV3036-04 as part of the
   National Science, Technology and Innovation Plan and King Fahd
   University of Petroleum & Minerals (KFUPM) through Project No. IN131020.
CR Alam M.d. Ohidul, 2002, TRIBOL INT, V35, P357, DOI DOI 10.1016/S0301-679X(02)00015-4
   Alvarado J, 2003, APPL ENG MECH MED GE, V6, P22
   Alvarez-Vera M, 2013, WEAR, V301, P175, DOI 10.1016/j.wear.2013.01.085
   Attar H, 2015, MATER LETT, V142, P38, DOI 10.1016/j.matlet.2014.11.156
   Barfeie A, 2015, BRIT DENT J, V218, DOI 10.1038/sj.bdj.2015.171
   Beake BD, 2013, TRIBOL INT, V63, P123, DOI 10.1016/j.triboint.2012.08.007
   Bhushan B., 2013, INTRO TRIBOLOGY, V621, P621
   Bhushan B, 2008, PHILOS T R SOC A, V366, P1351, DOI 10.1098/rsta.2007.2163
   Black J, 1998, HDB BIOMATERIALS PRO
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Chan SMT, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4004760
   Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005
   Choubey A, 2005, TRENDS BIOMATER ARTI, V18, P141, DOI DOI 10.1016/J.MSEA.2004.02.027
   Cvijovic A. I., 2010, TRIBOL LETT, V40, P59, DOI [10.1007/s11249-010-9639-8, DOI 10.1007/S11249-010-9639-8]
   Diaz C, 2009, NUCL INSTRUM METH B, V267, P1630, DOI 10.1016/j.nimb.2009.01.118
   Dowson D., 1995, BIOENGINEERING SKIN, P159
   Fellah M., 2014, TMS, V237, P237
   Fischer A, 2012, J MECH BEHAV BIOMED, V9, P50, DOI 10.1016/j.jmbbm.2012.01.007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gialanella S, 2008, J MATER SCI, V43, P1701, DOI 10.1007/s10853-007-2358-3
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Henriques VAR, 2010, J MATER SCI, V45, P5844, DOI 10.1007/s10853-010-4660-8
   Hou XD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/7/074006
   Hou XD, 2012, ACTA MATER, V60, P4128, DOI 10.1016/j.actamat.2012.03.054
   Munoz AI, 2011, J MATER SCI-MATER M, V22, P437, DOI 10.1007/s10856-010-4224-0
   Iwabuchi A, 2007, WEAR, V263, P492, DOI 10.1016/j.wear.2007.01.102
   Karanjai M, 2007, MAT SCI ENG A-STRUCT, V447, P19, DOI 10.1016/j.msea.2006.10.154
   Latysh V, 2006, CURR APPL PHYS, V6, P262, DOI 10.1016/j.cap.2005.07.053
   Lawrence K., 1980, NATURE, V283, P106, DOI DOI 10.1038/283106A07350519
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Liang P. G., 1967, J BIOMED MATER RES, V1, P135, DOI 10.1002/jbm.8200101135605609
   Litonjua LA, 2003, QUINTESSENCE INT, V34, P435
   Luo X, 2013, WEAR, V302, P1615, DOI 10.1016/j.wear.2013.01.023
   Manhabosco TM, 2011, CORROS SCI, V53, P1786, DOI 10.1016/j.corsci.2011.01.057
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Mohan L, 2013, APPL SURF SCI, V282, P281, DOI 10.1016/j.apsusc.2013.05.120
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Niespodziana K, 2008, REV ADV MATER SCI, V18, P236
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Park J., 2007, BIOMATERIALS INTRO
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Pilliar R. M., 2009, METALLIC BIOMATERIAL
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Ratner J. B. B. D., 1996, BIOMATERIALS SCI, V37, P50
   Reul H, 2002, J HEART VALVE DIS, V11, P409
   Ribeiro ALR, 2009, J MATER SCI-MATER M, V20, P1629, DOI 10.1007/s10856-009-3737-x
   Sathish S, 2010, MAT SCI ENG C-MATER, V30, P376, DOI 10.1016/j.msec.2009.12.004
   Shahgaldi BF, 2000, INJURY, V31, P85, DOI 10.1016/S0020-1383(99)00241-7
   Sivamani RK, 2003, SKIN RES TECHNOL, V9, P227, DOI 10.1034/j.1600-0846.2003.02366.x
   Spary IJ, 2006, PHILOS MAG, V86, P5581, DOI 10.1080/14786430600854988
   Stolyarov VV, 2004, MAT SCI ENG A-STRUCT, V371, P313, DOI 10.1016/j.msea.2003.12.026
   Sun D, 2009, WEAR, V267, P1845, DOI 10.1016/j.wear.2009.03.005
   Suresh KS, 2012, MAT SCI ENG C-MATER, V32, P763, DOI 10.1016/j.msec.2012.01.022
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Turssi CP, 2003, J BIOMED MATER RES B, V65B, P280, DOI 10.1002/jbm.b.10563
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Walowit JA, 1997, ASAIO J, V43, pM556
   Wennerberg A., 2015, IMPLANT SURFACES THE, V1st, P168
   Williams D., 1990, CONCISE ENCY MED DEN, pxvii
   Xu LJ, 2013, T NONFERR METAL SOC, V23, P692, DOI 10.1016/S1003-6326(13)62518-2
   YOSHIMITSU O, 2005, BIOMATERIALS, V26, P11, DOI DOI 10.1016/J.BIOMATERIALS.2004.02.005
NR 64
TC 31
Z9 31
U1 7
U2 101
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2015
VL 8
IS 5
BP 2749
EP 2768
DI 10.3390/ma8052749
PG 20
WC Materials Science, Multidisciplinary
SC Materials Science
GA CL3VK
UT WOS:000356879100045
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Choudhary, R
   Raj, R
   Swamiappan, S
AF Choudhary, Rajan
   Raj, Rishabh
   Swamiappan, Sasikumar
TI Synthesis and characterization of diopside by sol-gel combustion method
   by using L-alanine as a fuel for biomedical applications
SO JOURNAL OF THE INDIAN CHEMICAL SOCIETY
LA English
DT Article
DE Bioceramic; bioactivity; diopside; bio-waste; powder-XRD
ID BIOMATERIALS; BIOCERAMICS; BIOACTIVITY; ABILITY
AB Bioceramic calcium silicates have evolved as a potential biomaterial for artificial bone and dental root implants due to its excellent bioactivity and improved mechanical strength hence in the present work we aimed to convert the bio-waste into a useful biomaterial. In this study diopside (CaMgSi2O6) has been successfully prepared by sol-gel combustion method by using L-alanine as a fuel, nitrate ions as an oxidiser and egg shell (chicken) as a calcium source. Optimization of calcination temperature resulted in a well crystalline diopside powders with high phase purity. Synthesized powders were characterized by powder-XRD for phase identification, FT-IR spectroscopy for functional group analysis and scanning electron microscope for the measurement of particle size and surface morphology.
C1 [Choudhary, Rajan; Raj, Rishabh; Swamiappan, Sasikumar] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
RP Swamiappan, S (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM ssasikumar@vit.ac.in
RI Swamiappan, Sasikumar/M-9921-2016; Choudhary, Rajan/R-7998-2018
OI Swamiappan, Sasikumar/0000-0003-2533-4923; 
FU VIT University through Research Grants for Engineeiing, Management and
   Science (RGEMS) scheme
FX Authors are greatly thankful to the management of VIT University for
   providing the necessary facility for present study. The authors express
   their sincere gratitude. to Dr. V. Raju, Vice Chancellor, VIT University
   for funding this work through Research Grants for Engineeiing,
   Management and Science (RGEMS) scheme.
CR Bhatkar VB, 2011, B MATER SCI, V34, P1281, DOI 10.1007/s12034-011-0166-5
   Bozadjiev L, 2006, J U CHEM TECHNOLOGY, V41, P125
   Ghorbanian L, 2012, J NANOSTRUCT, V2, P357, DOI 10.7508/jns.2012.03.011
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iwata NY, 2004, COLLOID SURFACE B, V33, P1, DOI 10.1016/j.colsurfb.2003.07.004
   Kokubo T., 1997, AN QUIM, V93, P49
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Padilla S, 2006, ACTA BIOMATER, V2, P331, DOI 10.1016/j.actbio.2006.01.006
   Sainz MA, 2010, ACTA BIOMATER, V6, P2797, DOI 10.1016/j.actbio.2010.01.003
   Yamamoto S, 2012, J AUST CERAM SOC, V48, P180
NR 10
TC 1
Z9 1
U1 0
U2 4
PU SCIENTIFIC PUBL-INDIA
PI JODHPUR
PA 5-A, NEW PALI RD, PO BOX 91, NEAR HOTEL TAJ HARI MAHAL, JODHPUR, 342
   003, INDIA
SN 0019-4522
J9 J INDIAN CHEM SOC
JI J. Indian Chem. Soc.
PD MAY
PY 2015
VL 92
IS 5
BP 773
EP 776
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA CK7GA
UT WOS:000356399600041
DA 2018-10-20
ER

PT J
AU Sych, EE
   Pinchuk, ND
   Klimenko, VP
   Uvarova, IV
   Tovstonog, AB
   Tomila, TV
   Evich, YI
AF Sych, E. E.
   Pinchuk, N. D.
   Klimenko, V. P.
   Uvarova, I. V.
   Tovstonog, A. B.
   Tomila, T. V.
   Evich, Ya. I.
TI Synthesis and Properties of Si-Modified Biogenic Hydroxyapatite Ceramics
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE hydroxyapatite; silica; biomaterial; specific surface area; structure
ID IN-VITRO; COMPOSITES; PHOSPHATE; SILICON
AB The paper examines the production of Si-modified biogenic hydroxyapatite ceramics. The introduction of methylsilicic acid hydrogel in amounts converted to 2 and 5 wt.% Si and subsequent sintering at 600A degrees C increase the specific surface area by 10 times, from 6.1 to 59.8 m(2)/g. The porosity of ceramics increases from 43.0 to 62.3% when the modifying addition reaches up to 5 wt.%, the compressive strength being equal to 27-33 MPa. The modifying addition also influences the structure and reduces the minimum grain size of the material from 0.65 to 0.1 mu m.
C1 [Sych, E. E.; Pinchuk, N. D.; Klimenko, V. P.; Uvarova, I. V.; Tovstonog, A. B.; Tomila, T. V.; Evich, Ya. I.] Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
RP Sych, EE (reprint author), Natl Acad Sci Ukraine, Frantsevich Inst Problems Mat Sci, Kiev, Ukraine.
EM lena_sych@ukr.net
RI Sych, Olena/T-3111-2017
OI Sych, Olena/0000-0001-9902-7833
CR [Anonymous], [No title captured], Patent No. 61938
   Atta-ur-Rahman, 2008, STUDIES NATURAL PROD, P954
   Emanuel E., 1999, ANNU REV PLANT PHYS, V50, P641
   Exley C, 1998, J INORG BIOCHEM, V69, P139, DOI 10.1016/S0162-0134(97)10010-1
   Goldstein SA, 1987, BIOMECHANICS, V20, P1055, DOI DOI 10.1016/0021-9290(87)90023-6
   Ivanchenko LA, 1999, POWDER METALL MET C+, V38, P448, DOI 10.1007/BF02676058
   Ivchenko D. V., 2006, ORTOPED TRAVMATOL PR, P12
   Li XW, 2006, J MATER SCI-MATER M, V17, P573, DOI 10.1007/s10856-006-8942-2
   Loeper J., 1978, PHYSL ROLE SILICON I, P589
   Luzin V. I., 2011, UKRAIN MORFOL ALMANA, V9, P116
   Luzin V. I., 2009, TRAVMA, V10, P346
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   Ning CQ, 2005, J MATER SCI-MATER M, V16, P355, DOI 10.1007/s10856-005-0635-8
   Podrushnyak E. P., Ukrainian Patent, Patent No. [61938, 61K3300]
   Podrushnyak E. P., 1998, PROBL OSTEOLOGII, V1, P98
   Podrushnyak E. P., Ukrainian Patent, Patent No. [A61K6/ 02, 61P1900]
   Podrushnyak E. P., Patent No. [Ukrainian Patent, A61K33/ 00, 61K602]
   Sych EE, 2010, POWDER METALL MET C+, V49, P153
   Sych O., 2007, FUNCT MAT, V14, P430
   Zaman QHMS, 2008, J CERAM SOC JPN, V116, P88, DOI 10.2109/jcersj2.116.88
NR 20
TC 3
Z9 3
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
EI 1573-9066
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD MAY
PY 2015
VL 54
IS 1-2
BP 67
EP 73
DI 10.1007/s11106-015-9681-z
PG 7
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CK6RO
UT WOS:000356355600010
DA 2018-10-20
ER

PT J
AU Kokorev, OV
   Khodorenko, VN
   Anikeev, SG
   Gunther, VE
AF Kokorev, O. V.
   Khodorenko, V. N.
   Anikeev, S. G.
   Gunther, V. E.
TI Biocompatibility of Textile Titanium Nickel Implants with Fibroblast
   Culture
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE biomaterial; biocompatibility; fibroblasts; textile implant; titanium
   nickel alloy
AB The parameters of biocompatibility of titanium nickel implants of different design with fibroblast culture are studied. Colonization of textile and mesh implants with fibroblasts and tissue development depend on the size of mesh cells and thread diameter. Titanium nickel implants of different constructions do not inhibit the growth of fibroblast culture.
C1 [Kokorev, O. V.; Khodorenko, V. N.; Anikeev, S. G.; Gunther, V. E.] Tomsk State Univ, Res Inst Med Mat & Shape Memory Implants, Siberian Phys Technol Inst, Tomsk 634050, Russia.
RP Kokorev, OV (reprint author), Tomsk State Univ, Res Inst Med Mat & Shape Memory Implants, Siberian Phys Technol Inst, Tomsk 634050, Russia.
EM kokorevov@yandex.ru
RI Anikeev, Sergey/E-1449-2017; Hodorenko, Valentina/P-2247-2016; Gunther,
   Viktor/O-6678-2014
OI Anikeev, Sergey/0000-0001-9323-5973; Kokorev, Oleg/0000-0003-3690-0177
CR Dambaev G. Ts., 2000, Implant for Surgical Treatment of Visceral Diseases, Patent No. 2143867
   Dambaev G. Ts, 2012, MED MAT SHAPE MEMORY, V11, P19
   Gunter VE, 2011, MED MAT SHAPE MEMORY, V1, P96
   Gunther V. E., 2002, Artificial Visceral Cell Culture Carrier, Patent No. 2191607
   Gunther V. E., 2010, SHAPE MEMORY IMPLANT
   Gunther VE, 2000, DELAY LAW NEW CLASS
   Ivchenko O. A., 2012, MED MAT SHAPE MEMORY, V10, P25
   Kainer K.U., 2006, METAL MATRIX COMPOSI
   Kokorev O. V., 2012, VESTN NOV MEDITS TEK, V19, P32
   Kokorev O. V., 2012, SIB MEDITS ZH, V27, P130
   KOKOREV OV, 2010, KLET TRANSPLANTOL TK, V5, P31
   Schawaller D., 2006, ADV SCI TECHNOL, V50, P1
   Sigmund W, 2006, J AM CERAM SOC, V89, P395, DOI 10.1111/j.1551-2916.2005.00807.x
   Volova T. G., 2003, POLYOXYALKANOATES PO
NR 14
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD MAY
PY 2015
VL 159
IS 1
BP 87
EP 91
DI 10.1007/s10517-015-2897-6
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CK0VX
UT WOS:000355924500024
PM 26028231
DA 2018-10-20
ER

PT J
AU Paliwal, SR
   Paliwal, R
   Vyas, SP
AF Paliwal, Shivani Rai
   Paliwal, Rishi
   Vyas, Suresh P.
TI A review of mechanistic insight and application of pH-sensitive
   liposomes in drug delivery
SO DRUG DELIVERY
LA English
DT Review
DE Chemotherapy; drug/gene delivery; fusogenicity; intracellular delivery;
   pH-sensitive lipid
ID TUMOR-BEARING MICE; BREAST-CANCER THERAPY; GENE DELIVERY; INTRACELLULAR
   DELIVERY; IN-VIVO; PHOSPHATIDYLETHANOLAMINE LIPOSOMES; PROLONGED
   CIRCULATION; CATIONIC LIPOSOMES; TRIGGERED RELEASE; HYBRID COMPLEXES
AB The pH-sensitive liposomes have been extensively used as an alternative to conventional liposomes in effective intracellular delivery of therapeutics/antigen/DNA/diagnostics to various compartments of the target cell. Such liposomes are destabilized under acidic conditions of the endocytotic pathway as they usually contain pH-sensitive lipid components. Therefore, the encapsulated content is delivered into the intracellular bio-environment through destabilization or its fusion with the endosomal membrane. The therapeutic efficacy of pH-sensitive liposomes enables them as biomaterial with commercial utility especially in cancer treatment. In addition, targeting ligands including antibodies can be anchored on the surface of pH-sensitive liposomes to target specific cell surface receptors/antigen present on tumor cells. These vesicles have also been widely explored for antigen delivery and serve as immunological adjuvant to enhance the immune response to antigens. The present review deals with recent research updates on application of pH-sensitive liposomes in chemotherapy/diagnostics/ antigen/gene delivery etc.
C1 [Paliwal, Shivani Rai] Guru Ghasidas Vishwavidyalaya Bilaspur, SLT Inst Pharmaceut Sci, Dept Pharmaceut, Bilaspur, Chattisgarh, India.
   [Paliwal, Rishi] Columbia Inst Pharm, Dept Pharmaceut, Raipur, Chhattisgarh, India.
   [Vyas, Suresh P.] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, Madhya Pradesh, India.
RP Paliwal, SR (reprint author), Guru Ghasidas Vishwavidyalaya A Cent Univ, SLT Inst Pharmaceut Sci, Bilaspur 495009, Chattisgarh, India.
EM srai2k@gmail.com
CR Abra RM, 2002, J LIPOSOME RES, V12, P1, DOI 10.1081/LPR-120004770
   Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001
   Andrews CD, 2012, MOL PHARMACEUT, V9, P1118, DOI 10.1021/mp2003835
   Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008
   Bertrand N, 2010, METHODS MOL BIOL, V605, P545, DOI 10.1007/978-1-60327-360-2_36
   de Barros ALB, 2011, BIOORG MED CHEM LETT, V21, P7373, DOI 10.1016/j.bmcl.2011.10.016
   Chang JS, 1999, VACCINE, V17, P1540, DOI 10.1016/S0264-410X(98)00353-3
   Chang JS, 2001, VACCINE, V19, P3608, DOI 10.1016/S0264-410X(01)00104-9
   Chen DQ, 2011, INT J NANOMED, V6, P2053, DOI 10.2147/IJN.S24344
   Chen HG, 2012, EUR J MED CHEM, V52, P159, DOI 10.1016/j.ejmech.2012.03.013
   Chen Y, 2013, INT J NANOMED, V8, P1573, DOI 10.2147/IJN.S42800
   Araujo JGC, 2011, EXP BIOL MED, V236, P808, DOI 10.1258/ebm.2011.011038
   COLLINS D, 1995, LIPOSOMES TOOLS BASI, P201
   CONNOR J, 1986, CANCER RES, V46, P3431
   CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715
   de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277
   Di Marzio L, 2008, BBA-BIOMEMBRANES, V1778, P2749, DOI 10.1016/j.bbamem.2008.07.029
   Drummond DC, 2000, PROG LIPID RES, V39, P409, DOI 10.1016/S0163-7827(00)00011-4
   Ducat E, 2011, INT J PHARMACEUT, V420, P319, DOI 10.1016/j.ijpharm.2011.08.034
   DUZGUNES N, 1985, BIOCHEMISTRY-US, V24, P3091, DOI 10.1021/bi00334a004
   Fattal E, 2004, ADV DRUG DELIVER REV, V56, P931, DOI 10.1016/j.addr.2003.10.037
   Soares DCF, 2012, EUR J PHARM SCI, V45, P58, DOI 10.1016/j.ejps.2011.10.018
   Gerasimov OV, 1999, ADV DRUG DELIVER REV, V38, P317, DOI 10.1016/S0169-409X(99)00035-6
   Giuberti CD, 2011, J LIPOSOME RES, V21, P60, DOI 10.3109/08982101003754377
   Guo WJ, 2002, J CONTROL RELEASE, V83, P121, DOI 10.1016/S0168-3659(02)00167-0
   Hong MS, 2002, J PHARM PHARMACOL, V54, P51, DOI 10.1211/0022357021771913
   HUANG A, 1982, BIOCHIM BIOPHYS ACTA, V716, P140, DOI 10.1016/0304-4165(82)90262-8
   Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027
   Junior ADC, 2007, LIFE SCI, V80, P659, DOI 10.1016/j.lfs.2006.10.011
   Kale AA, 2007, J LIPOSOME RES, V17, P197, DOI 10.1080/08982100701525035
   Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001
   Khalil IA, 2011, J CONTROL RELEASE, V156, P374, DOI 10.1016/j.jconrel.2011.08.012
   Kim IY, 2009, J CONTROL RELEASE, V140, P55, DOI 10.1016/j.jconrel.2009.07.005
   Kim MJ, 2008, ARCH PHARM RES, V31, P539, DOI 10.1007/s12272-001-1190-9
   KONO K, 1994, BBA-BIOMEMBRANES, V1193, P1, DOI 10.1016/0005-2736(94)90325-5
   Koren E, 2012, J CONTROL RELEASE, V160, P264, DOI 10.1016/j.jconrel.2011.12.002
   Koynova R, 2006, P NATL ACAD SCI USA, V103, P14373, DOI 10.1073/pnas.0603085103
   LAI MZ, 1985, BIOCHEMISTRY-US, V24, P1646, DOI 10.1021/bi00328a012
   Lee KY, 2002, BIOCHEM BIOPH RES CO, V292, P682, DOI 10.1006/bbrc.2002.6711
   Leite EA, 2009, LIFE SCI, V84, P641, DOI 10.1016/j.lfs.2009.02.002
   Leroux JC, 2001, J CONTROL RELEASE, V72, P71, DOI 10.1016/S0168-3659(01)00263-2
   LESERMAN L, 1990, PROG CLIN BIOL RES, V343, P95
   Li P, 2012, INT J NANOMED, V7, P925, DOI 10.2147/IJN.S26955
   LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D
   Lutwyche P, 1998, ANTIMICROB AGENTS CH, V42, P2511, DOI 10.1128/AAC.42.10.2511
   Ferreira SMZMD, 2012, BIOORG MED CHEM LETT, V22, P4605, DOI 10.1016/j.bmcl.2012.05.105
   Mo R, 2013, BIOMATERIALS, V34, P2773, DOI 10.1016/j.biomaterials.2013.01.030
   Momekova D, 2010, METHODS MOL BIOL, V605, P527, DOI 10.1007/978-1-60327-360-2_35
   Moore NM, 2008, MOL PHARM, V5, P140, DOI 10.1021/mp700072n
   Nakamura K, 2009, BIOL PHARM BULL, V32, P1628, DOI 10.1248/bpb.32.1628
   NAYAR R, 1985, BIOCHEMISTRY-US, V24, P5967, DOI 10.1021/bi00342a042
   Paliwal SR, 2012, MOL PHARMACEUT, V9, P176, DOI 10.1021/mp200439z
   Paliwal SR, 2013, RSC SMART MATER, P80, DOI 10.1039/9781849736800-00080
   Paliwal SR, 2011, NANOMEDICINE-UK, V6, P1085, DOI [10.2217/NNM.11.72, 10.2217/nnm.11.72]
   Pichon Chantal, 2013, Methods Mol Biol, V969, P247, DOI 10.1007/978-1-62703-260-5_16
   Rodrigues PCA, 1999, BIOORGAN MED CHEM, V7, P2517, DOI 10.1016/S0968-0896(99)00209-6
   Rosa M, 2008, MOL MEMBR BIOL, V25, P23, DOI 10.1080/09687680701499451
   Roux E, 2004, J CONTROL RELEASE, V94, P447, DOI 10.1016/j.jconrel.2003.10.024
   Roux E, 2003, BIOMACROMOLECULES, V4, P240, DOI 10.1021/bm025651x
   Roux E, 2002, INT J PHARM, V242, P25, DOI 10.1016/S0378-5173(02)00183-7
   Roux E, 2002, J PHARM SCI, V91, P1795, DOI 10.1002/jps.10172
   Sakaguchi N, 2008, BIOMATERIALS, V29, P4029, DOI 10.1016/j.biomaterials.2008.06.006
   Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1588, DOI 10.1021/bc800126s
   Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1040, DOI 10.1021/bc7004736
   Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h
   SEDDON JM, 1983, BIOCHEMISTRY-US, V22, P1280, DOI 10.1021/bi00274a045
   Shi GF, 2002, J CONTROL RELEASE, V80, P309, DOI 10.1016/S0168-3659(02)00017-2
   Shigeta K, 2007, J CONTROL RELEASE, V118, P262, DOI 10.1016/j.jconrel.2006.12.019
   Simard P, 2010, MOL PHARMACEUT, V7, P1098, DOI 10.1021/mp900261m
   Simard P, 2009, INT J PHARMACEUT, V381, P86, DOI 10.1016/j.ijpharm.2009.05.013
   Simoes S, 2004, ADV DRUG DELIVER REV, V56, P947, DOI 10.1016/j.addr.2003.10.038
   Simoes S, 2001, BBA-BIOMEMBRANES, V1515, P23, DOI 10.1016/S0005-2736(01)00389-3
   Slepushkin VA, 1997, J BIOL CHEM, V272, P2382
   Soenen SJH, 2009, BIOMATERIALS, V30, P3691, DOI 10.1016/j.biomaterials.2009.03.040
   SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002
   Sudimack JJ, 2002, BBA-BIOMEMBRANES, V1564, P31, DOI 10.1016/S0005-2736(02)00399-1
   Tachibana R, 1998, BIOCHEM BIOPH RES CO, V251, P538, DOI 10.1006/bbrc.1998.9460
   Torchilin V P, 1985, Crit Rev Ther Drug Carrier Syst, V2, P65
   Torchilin V. P., 1993, J LIPOSOME RES, V3, P201, DOI DOI 10.3109/08982109309148213]
   Torres E, 2011, J CONTROL RELEASE, V154, P196, DOI 10.1016/j.jconrel.2011.05.017
   Venugopalan P, 2002, PHARMAZIE, V57, P659
   WANG CY, 1987, P NATL ACAD SCI USA, V84, P7851, DOI 10.1073/pnas.84.22.7851
   Watabe S, 2001, VACCINE, V19, P4434, DOI 10.1016/S0264-410X(01)00194-3
   Watarai S, 2013, SCI WORLD J, V2013, P1
   WEBB MS, 1995, BBA-BIOMEMBRANES, V1238, P147, DOI 10.1016/0005-2736(95)00121-I
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1105, P193, DOI 10.1016/0005-2736(92)90194-Q
   Xia GM, 2013, CHEM PHARM BULL, V61, P390
   YATVIN MB, 1980, BIOPHYS STRUCT MECH, V6, P233, DOI 10.1007/BF00537296
   YATVIN MB, 1980, SCIENCE, V210, P1253, DOI 10.1126/science.7434025
   Yoshikawa T, 2008, BIOCHEM BIOPH RES CO, V366, P408, DOI 10.1016/j.bbre.2007.11.153
   Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200
   Yuba E, 2013, BIOMATERIALS, V34, P3042, DOI 10.1016/j.biomaterials.2012.12.031
   Yuba E, 2010, BIOMATERIALS, V31, P943, DOI 10.1016/j.biomaterials.2009.10.006
   ZHOU F, 1995, J DRUG TARGET, V3, P91, DOI 10.3109/10611869509059210
   Zignani M, 2000, BBA-BIOMEMBRANES, V1463, P383, DOI 10.1016/S0005-2736(99)00234-5
NR 95
TC 26
Z9 27
U1 5
U2 76
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD MAY
PY 2015
VL 22
IS 3
BP 231
EP 242
DI 10.3109/10717544.2014.882469
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ8PH
UT WOS:000355764900001
PM 24524308
OA Bronze
DA 2018-10-20
ER

PT J
AU Tsintou, M
   Dalamagkas, K
   Seifalian, AM
AF Tsintou, Magdalini
   Dalamagkas, Kyriakos
   Seifalian, Alexander Marcus
TI Advances in regenerative therapies for spinal cord injury: a
   biomaterials approach
SO NEURAL REGENERATION RESEARCH
LA English
DT Review
DE tissue engineering; neuroregeneration; repair; central nervous system;
   biomaterial; regenerative medicine; nanotechnology; spinal cord injury
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; TEMPLATED AGAROSE SCAFFOLDS;
   HYALURONAN-BASED HYDROGEL; COLONY-STIMULATING FACTOR; BONE-MARROW;
   AXONAL REGENERATION; FUNCTIONAL RECOVERY; COLLAGEN SCAFFOLDS;
   SCHWANN-CELLS
AB Spinal cord injury results in the permanent loss of function, causing enormous personal, social and economic problems. Even though neural regeneration has been proven to be a natural mechanism, central nervous system repair mechanisms are ineffective due to the imbalance of the inhibitory and excitatory factors implicated in neuroregeneration. Therefore, there is growing research interest on discovering a novel therapeutic strategy for effective spinal cord injury repair. To this direction, cell-based delivery strategies, biomolecule delivery strategies as well as scaffold-based therapeutic strategies have been developed with a tendency to seek for the answer to a combinatorial approach of all the above. Here we review the recent advances on regenerative/neural engineering therapies for spinal cord injury, aiming at providing an insight to the most promising repair strategies, in order to facilitate future research conduction.
C1 [Tsintou, Magdalini; Dalamagkas, Kyriakos; Seifalian, Alexander Marcus] UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
   [Seifalian, Alexander Marcus] Royal Free London NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
EM a.seifalian@gmail.com
FU Program "IKY (Greek State Scholarships Foundation) Scholarships" from
   funds of the Operational Program "Education and Lifelong Learning", of
   the European Social Fund (ESF) of the National Strategic Reference
   Framework (NSRF); A.G. Leventis Foundation; John S. Latsis Public
   Benefit Foundation; Faculty of Medicine of the University of Thessaly
   (Greece)
FX This work was partially funded by the Program "IKY (Greek State
   Scholarships Foundation) Scholarships" from funds of the Operational
   Program "Education and Lifelong Learning", of the European Social Fund
   (ESF) of the National Strategic Reference Framework (NSRF), 2007-2013.
   It was also partially funded by Scholarships from the A.G. Leventis
   Foundation, by a Scholarship from John S. Latsis Public Benefit
   Foundation and by a special Scholarship from the Faculty of Medicine of
   the University of Thessaly (Greece).
CR Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003
   Akdemir HU, 2013, ULUS TRAVMA ACIL CER, V19, P441, DOI 10.5505/tjtes.2013.21456
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004
   Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008
   Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003
   Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5
   Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2006-0393
   Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010
   Caicco MJ, 2013, J BIOMED MATER RES A, V101, P1472, DOI 10.1002/jbm.a.34454
   Callera F, 2006, EXP HEMATOL, V34, P130, DOI 10.1016/j.exphem.2005.11.006
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011
   Chen NC, 2012, BIOMATERIALS, V33, P1353, DOI 10.1016/j.biomaterials.2011.10.062
   Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Donoghue PS, 2013, TISSUE ENG PT A, V19, P497, DOI [10.1089/ten.tea.2012.0382, 10.1089/ten.TEA.2012.0382]
   English D, 2013, J CELL BIOCHEM, V114, P764, DOI 10.1002/jcb.24436
   Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB
   Fan JA, 2010, J NEUROTRAUM, V27, P1671, DOI 10.1089/neu.2010.1281
   Fan Z., 2013, CELL TRANSPLANT S1, V22, P39
   Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7
   Forgione N, 2013, WORLD NEUROSURG
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297
   Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007
   Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hansmann F, 2012, CELL TRANSPLANT, V21, P1161, DOI 10.3727/096368911X627444
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242
   Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247
   He L, 2013, NEUROSCI BULL, V29, P129, DOI 10.1007/s12264-013-1318-y
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Ibarretxe G, 2012, STEM CELLS INT, V2012
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670
   Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589
   Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163
   Kozlowska H, 2007, STEM CELLS DEV, V16, P481, DOI 10.1089/scd.2007.9993
   Kubinova S, 2015, J TISSUE ENG REGEN M, V9, P1298, DOI 10.1002/term.1694
   Kubinova S, 2012, REGEN MED, V7, P207, DOI [10.2217/RME.11.121, 10.2217/rme.11.121]
   Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149
   Lanfer B, 2010, TISSUE ENG PT A, V16, P1103, DOI [10.1089/ten.tea.2009.0282, 10.1089/ten.TEA.2009.0282]
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047
   Li XR, 2013, BIOMATERIALS, V34, P5107, DOI 10.1016/j.biomaterials.2013.03.062
   Lis Anna, 2013, Polim Med, V43, P59
   Liu JB, 2013, CELLS TISSUES ORGANS, V198, P35, DOI 10.1159/000351665
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lo V, 2013, J NEUROSURG SCI, V57, P281
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008
   Mitra T, 2013, MATER RES-IBERO-AM J, V16, P755, DOI [10.1590/S1516-14392013000400009, 10.1590/S1516-14392013005000059]
   Moon LDF, 2006, RESTOR NEUROL NEUROS, V24, P147
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   National Spinal Cord Injury Statistical Center, 2013, FACTS FIG GLANC
   Nomura H, 2008, NEUROSURGERY, P141
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580
   Ovechkin AV, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00174
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020
   Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5
   Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Raad M, 2012, ELECTROPHORESIS, V33, P3659, DOI 10.1002/elps.201200470
   Ribeiro-Samy S, 2013, MACROMOL BIOSCI, V13, P1576, DOI 10.1002/mabi.201300178
   Rochkind S, 2006, EUR SPINE J, V15, P234, DOI 10.1007/s00586-005-0981-8
   Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c
   Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114
   Sebastia-Alcacer V, 2014, SPINAL CORD, V52, P29, DOI 10.1038/sc.2013.128
   Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098
   Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002
   Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Tan A, 2012, J CONTROL RELEASE, V163, P342, DOI 10.1016/j.jconrel.2012.08.009
   Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116
   Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomas KE, 2011, BRIT MED BULL, V98, P127, DOI 10.1093/bmb/ldr013
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   White RE, 2008, RESTOR NEUROL NEUROS, V26, P197
   Wilcox JT, 2012, NEUROSCI LETT, V519, P93, DOI 10.1016/j.neulet.2012.02.028
   Willerth SM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt58
   Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   Wu BQ, 2013, CHINESE MED J-PEKING, V126, P3723, DOI 10.3760/cma.j.issn.0366-6999.20111068
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Yarygin V N, 2006, Neurosci Behav Physiol, V36, P483, DOI 10.1007/s11055-006-0044-6
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807
   Zhang HT, 2012, CYTOTHERAPY, V14, P1203, DOI 10.3109/14653249.2012.711470
   Zhang XB, 2007, J NEUROTRAUM, V24, P1863, DOI 10.1089/neu.2007.0334
   Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276
   Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 150
TC 27
Z9 31
U1 8
U2 95
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD MAY
PY 2015
VL 10
IS 5
BP 726
EP 742
DI 10.4103/1673-5374.156966
PG 17
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA CK1JU
UT WOS:000355964400018
PM 26109946
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, LP
   Ren, J
   Zhang, XY
   Yang, XC
   Yang, W
AF Wang, Liping
   Ren, Jie
   Zhang, Xiaoyan
   Yang, Xiaoci
   Yang, Wu
TI Synthesis and Characterization of pH-sensitive and Self-oscillating IPN
   Hydrogel in a pH Oscillator
SO POLYMER-KOREA
LA English
DT Article
DE PAA/PEG IPN hydrogel; reversibility; self-oscillation; pH-responsiveness
ID BELOUSOV-ZHABOTINSKII REACTION; PERISTALTIC MOTION; GEL; DRIVEN
AB A self-oscillating interpenetrating polymer network (IPN) poly(acrylic acid)/poly(ethylene glycol) (PAA/PEG) hydrogel was prepared by using radical polymerization with a two-step method. The IPN hydrogel was characterized by FUR spectroscopy and morphological analysis. The results indicated that the chains of PEG and PAA twined to form porous structure which is beneficial to water molecules entering inside of the hydrogel. In addition, the pH-responsive behavior, salt sensitivity, swelling/de-swelling oscillatory behaviors and self-oscillation in a closed pH oscillator were also studied. The results showed that the prepared hydrogel exhibited pH-sensitivity, good swelling/de-swelling reversibility and excellent salt sensitivity. The self-oscillating behavior of swelling/de-swelling for the prepared hydrogel was caused by pH alteration coupled with the external media. This study may create a new possibility as biomaterial including new self-walking actuators and other related devices.
C1 [Wang, Liping; Ren, Jie; Zhang, Xiaoyan; Yang, Xiaoci; Yang, Wu] Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhon 730070, Peoples R China.
RP Ren, J (reprint author), Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhon 730070, Peoples R China.
EM jieren@nwnu.edu.cn
FU Basic Project of Science and Research of Colleges and Universities of
   Gansu Province [5001-109]; Natural Science Foundation of Gansu Province
   [1010 RJZA015, 096RJZA120]
FX This work was supported in part by the Basic Project of Science and
   Research of Colleges and Universities of Gansu Province (5001-109), the
   Natural Science Foundation of Gansu Province (1010 RJZA015; 096RJZA120).
CR Alzari V, 2009, BIOMACROMOLECULES, V10, P2672, DOI 10.1021/bm900605y
   Bilici C, 2010, J APPL POLYM SCI, V118, P2981, DOI 10.1002/app.32693
   Dogu Y, 2006, J APPL POLYM SCI, V99, P37, DOI 10.1002/app.22140
   Edblom E. C., 1989, J PHYS CHEM-US, V93, P2122
   FIELD RJ, 1974, J AM CHEM SOC, V96, P2001, DOI 10.1021/ja00814a003
   Gou B. L., 2007, CARBOHYD RES, V342, P2416
   GYORGYI L, 1990, J PHYS CHEM-US, V94, P7162, DOI 10.1021/j100381a039
   Kim SJ, 2003, SENSOR ACTUAT B-CHEM, V88, P286, DOI 10.1016/S0925-4005(02)00371-4
   Liu MM, 2012, CARBOHYD POLYM, V87, P2425, DOI 10.1016/j.carbpol.2011.11.010
   Motornov M, 2010, PROG POLYM SCI, V35, P174, DOI 10.1016/j.progpolymsci.2009.10.004
   Murase Y, 2010, SENSOR ACTUAT B-CHEM, V149, P272, DOI 10.1016/j.snb.2010.06.017
   Murase Y, 2009, LANGMUIR, V25, P483, DOI 10.1021/la8029006
   Okazaki N, 1999, J PHYS CHEM A, V103, P10915, DOI 10.1021/jp992626l
   Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tamashiro MN, 1998, EUR PHYS J B, V1, P337, DOI 10.1007/s100510050192
   Taniguchi H, 2010, J PHYS CHEM B, V114, P2405, DOI 10.1021/jp911779j
   Tokarev I., 2009, ACS APPL MATER INTER, V3, P532
   Wang J, 2004, MACROMOLECULES, V37, P670, DOI 10.1021/ma035453d
   Yoshida R, 2005, BIOMACROMOLECULES, V6, P2923, DOI 10.1021/bm050398x
   Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511
   Yoshida R, 2010, ADV MATER, V22, P3463, DOI 10.1002/adma.200904075
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
   Zhao SP, 2010, CARBOHYD RES, V345, P425, DOI 10.1016/j.carres.2009.11.014
NR 25
TC 3
Z9 3
U1 5
U2 33
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAY
PY 2015
VL 39
IS 3
BP 359
EP 364
DI 10.7317/pk.2015.39.3.359
PG 6
WC Polymer Science
SC Polymer Science
GA CJ7VK
UT WOS:000355708300001
OA Bronze
DA 2018-10-20
ER

PT J
AU Hu, CC
   Chaw, JR
   Chen, YC
   Chen, CF
   Liu, HW
AF Hu, Chao-Chien
   Chaw, Jen-Ray
   Chen, Yu-Chih
   Chen, Chin-Fu
   Liu, Hsia-Wei
TI A Novel Thermo-Responsive Nanogel for Intraocular Drug Delivery
SO JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE
LA English
DT Article
DE Amphiphilic Polymer; Thermo-Responsive; Nanogels; Bevacizumab; Drug
   Delivery
ID POLY(ETHYLENE GLYCOL); MACULAR DEGENERATION; COPOLYMERS; HYDROGELS
AB The novel amphiphilic hydrophilic hydrophobic block copolymers of methoxy-poly(ethylene glycol)block-poly(lactic-co-glycolic acid) (mPEG-PLGA) were synthesized by the ring-opening polymerization, cross-linked with 2,2-bis(2-oxazoline) (BOX) and the chemical structures were characterized by H-1 nuclear magnetic resonance (H-1-NMR). Cross-linked mPEG-PLGA-BOX block copolymers formed a core shell micellar structure with a critical micelle concentration of 9.21 x 10(-4) mg/mL. The mPEG-PLGA-BOX micelles were spherical with a hydrodynamic diameter of between 26.10 nm to 39.70 nm. A solution containing mPEG-PLGA-BOX micelles exhibited a fast and reversible sol gel phase transition behavior that could convert into nanogels at body temperature. The pharmacokinetic release rate of anti-vascular endothelial growth factor (VEGF) entrapped in nanogels were examined in vitro. Release profiles of the anti-VEGF agents (bevacizumab) showed that there was sustained release for approximately 30 days. Released bevacizumab inhibited the RF6A cells growth, which showed drug delivery system may provide localized and sustained release of bevacizumab over an extended period. The mPEG-PLGA-BOX nanogel has been successfully synthesized and determined as thermosensitive and biocompatible. This suggests that the nanogel may be considered as a novel biomaterial with potential as the form of injectable dilute dispersions or as in situ gelling carrier for extended anti-VEGF drug release to treat intraocular neovascular diseases.
C1 [Hu, Chao-Chien] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei 111101, Taiwan.
   [Hu, Chao-Chien] Fu Jen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan.
   [Chaw, Jen-Ray] Fu Jen Catholic Univ, Grad Inst Appl Sci & Engn, New Taipei City 24205, Taiwan.
   [Chen, Yu-Chih; Liu, Hsia-Wei] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
   [Chen, Chin-Fu] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu 31040, Taiwan.
RP Liu, HW (reprint author), Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
FU National Science Foundation [101-2221-E-030-002]; Shin Kong Wu Ho-Su
   Memorial Hospital [SKH-8302-101-DR-21]
FX This research was financially supported by the National Science
   Foundation (101-2221-E-030-002) and Shin Kong Wu Ho-Su Memorial Hospital
   (SKH-8302-101-DR-21).
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Bakri SJ, 2006, RETINA-J RET VIT DIS, V26, P519, DOI 10.1097/01.iae.0000225354.92444.7a
   CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kiss E, 2010, LANGMUIR, V26, P1440, DOI 10.1021/la903373g
   Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053
   Meletis E. I., 2014, QUANTUM MATTER, V3, P287
   Michels S, 2005, OPHTHALMOLOGY, V112, P1035, DOI 10.1016/j.ophtha.2005.02.007
   Nagahama K, 2009, LANGMUIR, V25, P9734, DOI 10.1021/la901092x
   Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001
   Paolo D. S., 2014, REV THEOR SCI, V2, P146
   Peng KT, 2010, BIOMATERIALS, V31, P5227, DOI 10.1016/j.biomaterials.2010.03.027
   Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017
   Sidorov L. A., 2006, J COMPUT THEOR NANOS, V3, P405
   Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001
NR 17
TC 1
Z9 1
U1 1
U2 33
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-1955
EI 1546-1963
J9 J COMPUT THEOR NANOS
JI J. Comput. Theor. Nanosci.
PD MAY
PY 2015
VL 12
IS 5
SI SI
BP 762
EP 768
DI 10.1166/jctn.2015.3799
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CJ6AI
UT WOS:000355575000012
DA 2018-10-20
ER

PT J
AU Muller, V
   Laakmann, E
   Fehm, T
   Mobus, V
   von Minckwitz, G
   Kaiser, J
   Loibl, S
   Witzel, I
AF Mueller, V.
   Laakmann, E.
   Fehm, T.
   Moebus, V.
   von Minckwitz, G.
   Kaiser, J.
   Loibl, S.
   Witzel, I.
TI Brain Metastases in Breast Cancer Network Germany (BMBC, GBG 79):
   Multicentric, retrospective and prospective collection of patient data
   and biomaterial from breast cancer patients as platform for
   translational research
SO ANNALS OF ONCOLOGY
LA English
DT Meeting Abstract
CT IMPAKT Breast Cancer Conference
CY MAY 07-09, 2015
CL Brussels, BELGIUM
SP European Soc Med Oncol
C1 [Mueller, V.; Laakmann, E.; Witzel, I.] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany.
   [Fehm, T.] Univ Klinikum Dusseldorf, Dept Obstet & Gynecol, Dusseldorf, Germany.
   [Moebus, V.] Klinikum Frankfurt Hoechst, Dept Obstet & Gynecol, Frankfurt, Germany.
   [von Minckwitz, G.; Kaiser, J.; Loibl, S.] GBG Forsch GmbH, German Breast Grp, Med & Res, Neu Isenburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0923-7534
EI 1569-8041
J9 ANN ONCOL
JI Ann. Oncol.
PD MAY
PY 2015
VL 26
SU 3
MA 18P
DI 10.1093/annonc/mdv115.6
PG 1
WC Oncology
SC Oncology
GA CI6SE
UT WOS:000354890600010
DA 2018-10-20
ER

PT J
AU Trindade, R
   Albrektsson, T
   Wennerberg, A
AF Trindade, Ricardo
   Albrektsson, Tomas
   Wennerberg, Ann
TI Current Concepts for the Biological Basis of Dental Implants Foreign
   Body Equilibrium and Osseointegration Dynamics
SO ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Implants; Osseointegration; Foreign body reaction
ID MARGINAL BONE LOSS; BIOMATERIAL-INDUCED INFLAMMATION; CELLS IN-VITRO;
   GIANT-CELLS; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; LANGERHANS CELLS;
   ORAL IMPLANTS; TITANIUM; SKIN
AB To understand the biological basis of osseointegration, one has to understand the 2 main sides of the implant host interaction: tissue and biomaterial characteristics. This article addresses osseous tissue characteristics and the potential role of soft tissues in the osseointegration of dental implants. Successful integration is driven by an inflammatory process. Protein adsorption is key for tissue integration with biomaterials. Osseointegration dynamics relate to the in vivo lifetime of the implant. Understanding this biology is important; it opens the door to putting aside heuristic methods and replaces them by methods that produce solutions to achieve a specific biological goal.
C1 [Trindade, Ricardo; Albrektsson, Tomas; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, S-21421 Malmo, Sweden.
   [Albrektsson, Tomas] Gothenburg Univ, Dept Biomat, Sahlgrenska Acad, S-41346 Gothenburg, Sweden.
RP Wennerberg, A (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, Carl Gustavsvag 34, S-21421 Malmo, Sweden.
EM ann.wennerberg@mah.se
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365
   Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Barrett AW, 1996, CRIT REV ORAL BIOL M, V7, P36, DOI 10.1177/10454411960070010301
   Bougas K, 2012, THESIS MALMO U SWEDE
   Boyd AR, 2011, J MATER SCI-MATER M, V22, P71, DOI 10.1007/s10856-010-4180-8
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
   Crotti TN, 2004, BIOMATERIALS, V25, P565, DOI 10.1016/S0142-9612(03)00556-8
   Cutler CW, 2006, J DENT RES, V85, P678, DOI 10.1177/154405910608500801
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   Du Z, 2014, CLIN IMPLANT DENT RE
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Frost H M, 1998, J Orthop Sci, V3, P272, DOI 10.1007/s007760050053
   Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001
   Hasseus B, 2004, CLIN EXP IMMUNOL, V136, P483, DOI 10.1111/j.1365-2249.2004.02469.x
   Hasseus B, 2004, EUR J ORAL SCI, V112, P48, DOI 10.1111/j.0909-8836.2004.00097.x
   Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Khan UA, 2014, J CELL BIOCHEM, V115, P1290, DOI 10.1002/jcb.24781
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021
   Lin YH, 2007, J ORAL MAXIL SURG, V65, P2340, DOI 10.1016/j.joms.2007.06.673
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mozumder MS, 2012, J BIOMED MATER RES A, V100A, P2695, DOI 10.1002/jbm.a.34199
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Shimpuku H, 2003, CLIN ORAL IMPLAN RES, V14, P423, DOI 10.1034/j.1600-0501.2003.110823.x
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Tamaki Y, 2008, J BIOMED MATER RES B, V84B, P191, DOI 10.1002/jbm.b.30861
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Trindade R., 2014, CLIN IMPLANT DENT RE
   Ujiie Y, 2012, INT J DENT, DOI 10.1155/2012/742439
   Wang TW, 2006, BIOMATERIALS, V27, P5059, DOI 10.1016/j.biomaterials.2006.05.004
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018
   Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47
NR 52
TC 17
Z9 19
U1 4
U2 15
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1042-3699
EI 1558-1365
J9 ORAL MAXIL SURG CLIN
JI Oral Maxillofac. Surg. Clin. N. Am.
PD MAY
PY 2015
VL 27
IS 2
BP 175
EP +
DI 10.1016/j.coms.2015.01.004
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CJ4ZH
UT WOS:000355496700002
PM 25753575
DA 2018-10-20
ER

PT J
AU Booms, P
   Ghanaati, S
   Sader, R
AF Booms, P.
   Ghanaati, S.
   Sader, R.
TI Biomaterial-based tissue-like constructs for assessing effects of
   vismodegib on soft and hard tissue
SO ORAL ONCOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
EI 1879-0593
J9 ORAL ONCOL
JI Oral Oncol.
PD MAY
PY 2015
VL 51
IS 5
MA P24
BP E49
EP E50
DI 10.1016/j.oraloncology.2015.02.072
PG 2
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA CH4TZ
UT WOS:000354027100072
DA 2018-10-20
ER

PT J
AU Zhang, PF
   Li, GQ
AF Zhang, Pengfei
   Li, Guoqiang
TI Healing-on-demand composites based on polymer artificial muscle
SO POLYMER
LA English
DT Article
DE Healing-on-demand; Artificial muscle; Biomaterial
ID SYNTACTIC FOAM; THERMOMECHANICAL CHARACTERIZATION; FIBERS; HYDROGELS;
   GELS; CYCLODEXTRIN; REPTATION; ORGANOGEL; BEHAVIOR; RUBBER
AB In this study, a new polymer artificial muscle based healing-on-demand composite was prepared and characterized. The composite consists of polymer artificial muscle made of commercial fishing line, thermoset host, and thermoplastic particle. Three-point bending damage to the beam sample can be healed even at a constrained boundary condition upon local heating, undergoing a close-then-heal procedure. The fractured beams were heated locally by a heat gun for 10 min. The healing efficiency was investigated at both free boundary condition and fixed boundary condition. The fast contraction of artificial muscle brings the fractured surfaces in spatial proximity; simultaneously, the melting thermoplastic agent fills the crack via capillary action and bonds the two fracture surfaces. With 60% pre-strain of the reinforcing polymer artificial muscles (8% volume fraction), over 60% of healing efficiency was achieved at free boundary condition and 54% at fixed boundary condition after repeated damage-healing events. Due to its low cost, high healing efficiency, good compatibility, and excellent flexibility, we envision that the polymer artificial muscle will be a new device in designing next generation healing-on-demand polymer composite. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhang, Pengfei; Li, Guoqiang] Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA.
   [Li, Guoqiang] Southern Univ, Dept Mech Engn, Baton Rouge, LA 70813 USA.
RP Li, GQ (reprint author), Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA.
EM lguoqi1@lsu.edu
FU National Science Foundation [CMMI 1333997]; NASA [NNX11AM17A]; Louisiana
   Board of Regents [NNX11AM17A, NASA/LEQSF(2011-14)-Phase3-05]; Army
   Research Office [W911NF-13-1-0145]
FX This study was financially supported by National Science Foundation
   under grant number CMMI 1333997, the Cooperative Agreement NNX11AM17A
   between NASA and the Louisiana Board of Regents under contract
   NASA/LEQSF(2011-14)-Phase3-05, and Army Research Office under grant
   number W911NF-13-1-0145. Mr. Zhen Zhang at Louisiana State University
   helped run the rheological test of CIA powders. His assistance is
   greatly appreciated.
CR Amamoto Y, 2011, ANGEW CHEM INT EDIT, V50, P1660, DOI 10.1002/anie.201003888
   Bleay SM, 2001, COMPOS PART A-APPL S, V32, P1767, DOI 10.1016/S1359-835X(01)00020-3
   Bousmina M, 1998, MACROMOLECULES, V31, P8273, DOI 10.1021/ma980562r
   Canadell J, 2011, MACROMOLECULES, V44, P2536, DOI 10.1021/ma2001492
   CHOY CL, 1981, J POLYM SCI POL PHYS, V19, P335, DOI 10.1002/pol.1981.180190213
   Chuo TW, 2013, J POLYM SCI POL CHEM, V51, P3395, DOI 10.1002/pola.26736
   Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669
   DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789
   Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197
   FOX TG, 1964, J CHEM PHYS, V41, P344, DOI 10.1063/1.1725872
   Froimowicz P, 2011, MACROMOL RAPID COMM, V32, P468, DOI 10.1002/marc.201000643
   Hager MD, 2010, ADV MATER, V22, P5424, DOI 10.1002/adma.201003036
   Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906
   Hamilton AR, 2010, ADV MATER, V22, P5159, DOI 10.1002/adma.201002561
   Harada A, 2014, ACCOUNTS CHEM RES, V47, P2128, DOI 10.1021/ar500109h
   Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248
   He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a
   Herbst F, 2013, SELF-HEALING POLYMERS: FROM PRINCIPLES TO APPLICATIONS, P275
   Hu JL, 2012, PROG POLYM SCI, V37, P1720, DOI 10.1016/j.progpolymsci.2012.06.001
   Imato K, 2012, ANGEW CHEM INT EDIT, V51, P1138, DOI 10.1002/anie.201104069
   Ji GF, 2010, INT J SOLIDS STRUCT, V47, P2445, DOI 10.1016/j.ijsolstr.2010.05.006
   Kakuta T, 2013, ADV MATER, V25, P2849, DOI 10.1002/adma.201205321
   Kalista SJ, 2007, MECH ADV MATER STRUC, V14, P391, DOI 10.1080/15376490701298819
   Kirkby EL, 2009, POLYMER, V50, P5533, DOI 10.1016/j.polymer.2009.05.014
   Kirkby EL, 2008, ADV FUNCT MATER, V18, P2253, DOI 10.1002/adfm.200701208
   KLEIN J, 1978, NATURE, V271, P143, DOI 10.1038/271143a0
   KLEIN J, 1978, MACROMOLECULES, V11, P852, DOI 10.1021/ma60065a002
   Kolmakov GV, 2009, ACS NANO, V3, P885, DOI 10.1021/nn900052h
   Li G, 2015, SELF-HEALING COMPOSITES: SHAPE MEMORY POLYMER-BASED STRUCTURES, P1
   Li GG, 2010, COMPOS SCI TECHNOL, V70, P1419, DOI 10.1016/j.compscitech.2010.04.026
   Li GQ, 2013, POLYMER, V54, P5075, DOI 10.1016/j.polymer.2013.07.010
   Li GQ, 2013, POLYMER, V54, P920, DOI 10.1016/j.polymer.2012.12.046
   Li GQ, 2012, P ROY SOC A-MATH PHY, V468, P2319, DOI 10.1098/rspa.2011.0628
   Li GQ, 2010, POLYMER, V51, P755, DOI 10.1016/j.polymer.2009.12.002
   Li GQ, 2008, COMPOS SCI TECHNOL, V68, P3337, DOI 10.1016/j.compscitech.2008.09.009
   Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762
   Love A. E. H., 1944, TREATISE MATH THEORY
   Lu J, 2011, J CONTROL RELEASE, V152, pE229, DOI 10.1016/j.jconrel.2011.09.028
   Meng H, 2013, POLYMER, V54, P2199, DOI 10.1016/j.polymer.2013.02.023
   Mukhopadhyay P, 2010, ANGEW CHEM INT EDIT, V49, P6338, DOI 10.1002/anie.201001382
   Park JS, 2008, J COMPOS MATER, V42, P2869, DOI 10.1177/0021998308097280
   Rahman MA, 2013, ACS APPL MATER INTER, V5, P1494, DOI 10.1021/am303015e
   Sottos NR, 2011, NATURE, V472, P299, DOI 10.1038/472299a
   South A. B., 2010, ANGEW CHEM, V122, P779, DOI DOI 10.1002/ANGE.200906040
   Sun L, 2012, MATER DESIGN, V33, P577, DOI 10.1016/j.matdes.2011.04.065
   Terech P, 2013, PHYS CHEM CHEM PHYS, V15, P7338, DOI 10.1039/c3cp50671a
   Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v
   Urban MW, 2014, ANGEW CHEM INT EDIT, V53, P3775
   van Gemert GML, 2012, MACROMOL CHEM PHYS, V213, P234, DOI 10.1002/macp.201100559
   Vidyasagar A, 2011, ANGEW CHEM INT EDIT, V50, P8021, DOI 10.1002/anie.201103584
   Wang X, 2011, ANGEW CHEM INT EDIT, V50, P11378, DOI 10.1002/anie.201105822
   White SR, 2014, SCIENCE, V344, P620, DOI 10.1126/science.1251135
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Williams KA, 2007, J R SOC INTERFACE, V4, P359, DOI 10.1098/rsif.2006.0202
   Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g
   WOOL RP, 1981, J APPL PHYS, V52, P5953, DOI 10.1063/1.328526
   Yin T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/7/074001
   Yoon JA, 2012, MACROMOLECULES, V45, P142, DOI 10.1021/ma2015134
   Yu XD, 2012, SOFT MATTER, V8, P3329, DOI 10.1039/c2sm07309a
   Zhang PF, 2013, J POLYM SCI POL PHYS, V51, P966, DOI 10.1002/polb.23295
NR 60
TC 22
Z9 22
U1 3
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD MAY 1
PY 2015
VL 64
BP 29
EP 38
DI 10.1016/j.polymer.2015.03.022
PG 10
WC Polymer Science
SC Polymer Science
GA CJ1KB
UT WOS:000355241400005
DA 2018-10-20
ER

PT J
AU Petreus, T
   Holicov, AM
   Balan, GG
   Mitrica, DE
AF Petreus, Tudor
   Holicov, Ana Maria
   Balan, Gheorghe Gh.
   Mitrica, Dana Elena
TI Comparative Evaluation of Biocompatibility Assays used in Polymer
   Biomaterials Assessment
SO REVISTA DE CHIMIE
LA English
DT Article
DE biocompatibility; biomaterials; metabolic/membrane integrity/DNA
   quantitation assays; chitosan film; normal phenotype cells
ID ENDODONTIC TREATMENT; BACTERIAL VIABILITY; IMPLANTATION; STAIN
AB Most of the biocompatibility assays - metabolic, DNA quantitation and membrane permeability - are commonly used to evaluate biomaterials with medical and dental applications. Comparing the results and efficacy among these various protocols may lead to a faster and more accurate choice for a specific assay according to the evaluated biomaterial and its physical/chemical features. The aim of the present work was to perform a reliability comparison between metabolic, membrane integrity and DNA content assays, with respect to biocompatibility of biomaterials with biomedical use. Using chitosan films as polymer support we have observed a good correlation (0.7<R2<1) between cell proliferation evaluated by MTT assay and the DNA quantitation for both tumor and normal phenotype cell lines. For all investigated cell lines grown on chitosan films, less epithelial phenotype MCF10A, there was a good correlation for the two metabolic assays, MTT and CellTiterBlue. Same good correlation was noticed for SytoxGreen (membrane integrity assay) and CyQuant (DNA quantitation). Correlation study performed for metabolic/membrane integrity/DNA quantitation assays demonstrated the usefulness of a permanent adaptation of the cytotoxicity assay for biomaterial evaluation according to physical/chemical and mechanical sample features. For the polymer films used in the present study (chitosan), metabolic assays and DNA quantitation assays showed well correlated results for both tumor and normal phenotype cells. Both assay types may be used, but the final choice will respect potential interferences of the reagents in the assays with biomaterial compounds.
C1 [Petreus, Tudor; Holicov, Ana Maria] Gr T Popa Univ Med & Pharm, Fac Med, Dept Cell & Mol Biol, Iasi 700115, Romania.
   [Balan, Gheorghe Gh.; Mitrica, Dana Elena] Gr T Popa Univ Med & Pharm, Fac Med, Dept Med Semiol & Gastroenterol, Iasi 700115, Romania.
RP Balan, GG (reprint author), Gr T Popa Univ Med & Pharm, Fac Med, Dept Med Semiol & Gastroenterol, 16 Univ Str, Iasi 700115, Romania.
EM balan.gheo@yahoo.com
CR Aminov L, 2014, MATER PLAST, V51, P417
   Aminov L, 2014, MATER PLAST, V51, P246
   BARILE F.A., 2008, PRINCIPLES TOXICOLOG, P231
   Cardiff RD, 2014, J CLIN INVEST, V124, P478, DOI 10.1172/JCI73910
   Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697
   Lin GJ, 2013, J BIOL INORG CHEM, V18, P873, DOI 10.1007/s00775-013-1032-2
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421
   Simion D, 2013, MATER PLAST, V50, P323
   Strober W., 2001, CURRENT PROTOCOLS IM
   Voicu G, 2012, REV CHIM-BUCHAREST, V63, P1031
   Zaharia C, 2014, MATER PLAST, V51, P1
   Zuang V, 2001, ATLA-ALTERN LAB ANIM, V29, P575
NR 15
TC 2
Z9 2
U1 0
U2 5
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD MAY
PY 2015
VL 66
IS 5
BP 707
EP 709
PG 3
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CI9YF
UT WOS:000355126000022
DA 2018-10-20
ER

PT J
AU Iyer, KA
   Torkelson, JM
AF Iyer, Krishnan A.
   Torkelson, John M.
TI Sustainable Green Hybrids of Polyolefins and Lignin Yield Major
   Improvements in Mechanical Properties When Prepared via Solid-State
   Shear Pulverization
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Lignin; Composites; Polypropylene; Polyethylene; Extrusion; Antioxidant;
   Tensile properties; Rheology
ID POLYPROPYLENE/WOOD-FLOUR COMPOSITES; POLYMER BLEND COMPATIBILIZATION;
   THERMAL-PROPERTIES; ANTIOXIDANT PROPERTIES; PHYSICAL-PROPERTIES; FLAME
   RETARDANTS; POLYETHYLENE; DISPERSION; NANOCOMPOSITES; POLYSTYRENE
AB Lignin, a byproduct of paper and pulp industries, is a sustainable, inexpensive biomaterial with potential as composite filler. Past research on polyolefin/lignin composites made by melt processing has led to modest increases in Youngs modulus and drastic reductions in tensile strength and elongation at break relative to neat polymer. Here, green hybrids of low density polyethylene (LDPE) and polypropylene (PP) with 5-30 wt % lignin are made by solid-state shear pulverization (SSSP). Microscopy shows that SSSP leads to superior lignin dispersion and suppressed degradation when compared to melt-mixed composites reported in the literature. Composites made by SSSP exhibit major improvements in Youngs modulus (81% and 62% increases for 30 wt % lignin in LDPE and PP, respectively, relative to neat polymer), tensile strength equal to or better than that of neat LDPE and near that of neat PP, and much better strain at break than reported in the literature for polyolefin/lignin composites. The SSSP-produced hybrids exhibit major increases in hardness, with 70/30 wt % PP/lignin hybrids reaching values near that of polycarbonate. Well-dispersed lignin improves LDPE and PP thermo-oxidative stability as shown by thermogravimetric analysis (similar to 35 degrees C increase in 20% mass loss temperature in air with 20 wt % lignin addition) and isothermal shear flow rheology. Lastly, SSSP-processed composites exhibit slightly improved crystallizability and melt viscosities at moderate to high shear rates that differ relatively little from those of neat LDPE and PP.
C1 [Iyer, Krishnan A.; Torkelson, John M.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Torkelson, John M.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Torkelson, JM (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM j-torkelson@northwestern.edu
RI Torkelson, John/B-7616-2009
OI Iyer, krishnan/0000-0002-8302-714X
FU Initiative for Sustainability and Energy at Northwestern University
   (ISEN); Northwestern University; Northwestern University Terminal Year
   Fellowship; NSF-MRSEC program at Northwestern University [DMR-1121262]
FX We thank Total Petrochemicals and ExxonMobil for providing PP and LDPE,
   respectively. We acknowledge support from the Initiative for
   Sustainability and Energy at Northwestern University (ISEN),
   Northwestern University, and a Northwestern University Terminal Year
   Fellowship (to K.A.I.). This study made use of Central Facilities
   supported by the NSF-MRSEC program (Grant Number DMR-1121262) at
   Northwestern University.
CR Alexy P, 2000, POLYMER, V41, P4901, DOI 10.1016/S0032-3861(99)00714-4
   Bahl K, 2014, POLYMER, V55, P3825, DOI 10.1016/j.polymer.2014.06.061
   Barzegari MR, 2012, POLYM COMPOSITE, V33, P353, DOI 10.1002/pc.22154
   Bourmaud A, 2013, IND CROP PROD, V43, P225, DOI 10.1016/j.indcrop.2012.07.030
   Brunner PJ, 2012, POLYM ENG SCI, V52, P1555, DOI 10.1002/pen.23115
   BU HS, 1988, MAKROMOL CHEM-RAPID, V9, P75
   Canetti M, 2006, POLYM DEGRAD STABIL, V91, P494, DOI 10.1016/j.polymdegradstab.2005.01.052
   Canetti M, 2004, J APPL POLYM SCI, V91, P1435, DOI 10.1002/app.13311
   Chen F, 2011, POLYM COMPOSITE, V32, P1019, DOI 10.1002/pc.21087
   Chen Z, 2001, POLYM INT, V50, P966, DOI 10.1002/pi.723
   Chibani N, 2016, J VINYL ADDIT TECHN, V22, P231, DOI 10.1002/vnl.21437
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   De Chirico A, 2003, POLYM DEGRAD STABIL, V79, P139, DOI 10.1016/S0141-3910(02)00266-5
   de Menezes AJ, 2009, POLYMER, V50, P4552, DOI 10.1016/j.polymer.2009.07.038
   Diop MF, 2015, POLYMER, V60, P77, DOI 10.1016/j.polymer.2015.01.016
   Diop MF, 2014, POLYMER, V55, P4948, DOI 10.1016/j.polymer.2014.07.050
   Diop MF, 2013, MACROMOLECULES, V46, P7834, DOI 10.1021/ma401628u
   Diop MF, 2013, POLYMER, V54, P4143, DOI 10.1016/j.polymer.2013.06.003
   Doan TTL, 2006, COMPOS SCI TECHNOL, V66, P952, DOI 10.1016/j.compscitech.2005.08.009
   Doherty WOS, 2011, IND CROP PROD, V33, P259, DOI 10.1016/j.indcrop.2010.10.022
   Fetecau C., 2011, P ASME 2011 INT MECH, V8, P599
   Furgiuele N, 2000, MACROMOLECULES, V33, P225, DOI 10.1021/ma990434i
   Ganglani M, 2001, J APPL POLYM SCI, V80, P671
   Gregorova A, 2007, J APPL POLYM SCI, V106, P1626, DOI 10.1002/app.26687
   Haque MM, 2009, BIORESOURCE TECHNOL, V100, P4903, DOI 10.1016/j.biortech.2009.04.072
   Hu L, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41484
   Hu L, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41040
   Ichazo MN, 2001, COMPOS STRUCT, V54, P207, DOI 10.1016/S0263-8223(01)00089-7
   Iwamoto S, 2014, CELLULOSE, V21, P1573, DOI 10.1007/s10570-014-0195-5
   Iyer KA, 2015, MACROMOL MATER ENG, V300, P772, DOI 10.1002/mame.201500019
   Iyer KA, 2015, POLYMER, V56, P464, DOI 10.1016/j.polymer.2014.11.017
   Iyer KA, 2014, COMPOS SCI TECHNOL, V102, P152, DOI 10.1016/j.compscitech.2014.07.029
   Iyer KA, 2013, POLYM COMPOSITE, V34, P1211, DOI 10.1002/pc.22534
   Jairam S, 2013, ACS SUSTAIN CHEM ENG, V1, P1630, DOI 10.1021/sc4003196
   Jeencham R, 2014, COMPOS PART B-ENG, V56, P249, DOI 10.1016/j.compositesb.2013.08.012
   Jiang X, 2012, J APPL POLYM SCI, V124, P525, DOI 10.1002/app.34891
   Joseph PV, 1999, COMPOS SCI TECHNOL, V59, P1625, DOI 10.1016/S0266-3538(99)00024-X
   Kadla JF, 2004, COMPOS PART A-APPL S, V35, P395, DOI 10.1016/j.compositesa.2003.09.019
   KOSIKOVA B, 1995, EUR POLYM J, V31, P953, DOI 10.1016/0014-3057(95)00052-6
   La Mantia FP, 2011, COMPOS PART A-APPL S, V42, P579, DOI 10.1016/j.compositesa.2011.01.017
   Lebovitz AH, 2002, MACROMOLECULES, V35, P8672, DOI 10.1021/ma021182f
   Lu H, 2014, ACS SUSTAIN CHEM ENG, V2, P2699, DOI 10.1021/sc500440q
   Maldhure AV, 2011, J THERM ANAL CALORIM, V103, P625, DOI 10.1007/s10973-010-1048-6
   Maldhure AV, 2012, J APPL POLYM SCI, V125, P1701, DOI 10.1002/app.35633
   Masuda J, 2008, MACROMOLECULES, V41, P5974, DOI 10.1021/ma801321j
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Morandim-Giannetti AA, 2012, CARBOHYD POLYM, V87, P2563, DOI 10.1016/j.carbpol.2011.11.041
   Ndiaye D, 2011, J APPL POLYM SCI, V119, P3321, DOI 10.1002/app.32985
   Pandey JK, 2010, MACROMOL MATER ENG, V295, P975, DOI 10.1002/mame.201000095
   Park JM, 2006, COMPOS SCI TECHNOL, V66, P2686, DOI 10.1016/j.compscitech.2006.03.014
   Peterson JD, 2001, MACROMOL CHEM PHYSIC, V202, P775, DOI 10.1002/1521-3935(20010301)202:6<775::AID-MACP775>3.0.CO;2-G
   Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0
   Pracella M, 2006, COMPOS SCI TECHNOL, V66, P2218, DOI 10.1016/j.compscitech.2005.12.006
   Premalal HGB, 2002, POLYM TEST, V21, P833, DOI 10.1016/S0142-9418(02)00018-1
   Pucciariello R, 2010, J POLYM ENVIRON, V18, P326, DOI 10.1007/s10924-010-0212-1
   Rusu M, 1999, J POLYM ENG, V19, P355
   Sadeghifar H, 2015, ACS SUSTAIN CHEM ENG, V3, P349, DOI 10.1021/sc500756n
   Sahoo S, 2011, COMPOS PART A-APPL S, V42, P1710, DOI 10.1016/j.compositesa.2011.07.025
   Sailaja RRN, 2010, MATER DESIGN, V31, P4369, DOI 10.1016/j.matdes.2010.03.046
   Sailaja RRN, 2005, POLYM INT, V54, P1589, DOI 10.1002/pi.1864
   Samal SK, 2014, J POLYM ENVIRON, V22, P58, DOI 10.1007/s10924-013-0620-0
   Schartel B, 2003, POLYMER, V44, P6241, DOI 10.1016/S0032-3861(03)00692-X
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Tao Y, 2006, POLYMER, V47, P6773, DOI 10.1016/j.polymer.2006.07.041
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Toriz G, 2002, POLYM COMPOSITE, V23, P806, DOI 10.1002/pc.10478
   Wakabayashi K, 2008, MACROMOLECULES, V41, P1905, DOI 10.1021/ma071687b
   Wakabayashi K, 2010, POLYMER, V51, P5525, DOI 10.1016/j.polymer.2010.09.007
   Walker AM, 2007, POLYMER, V48, P1066, DOI 10.1016/j.polymer.2006.12.038
   WUNDERLICH B, 1967, J POLYM SCI A2, V5, P987, DOI 10.1002/pol.1967.160050514
   Xia HS, 2004, J APPL POLYM SCI, V93, P378, DOI 10.1002/app.20435
   Xu X, 2014, MACROMOL RES, V22, P1084, DOI 10.1007/s13233-014-2161-3
NR 72
TC 12
Z9 12
U1 6
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAY
PY 2015
VL 3
IS 5
BP 959
EP 968
DI 10.1021/acssuschemeng.5b00099
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA CH5JU
UT WOS:000354072700019
DA 2018-10-20
ER

PT J
AU Li, XD
   Hong, ATL
   Naskar, N
   Chung, HJ
AF Li, Xinda
   Hong, Albert T. -L.
   Naskar, Nilanjon
   Chung, Hyun-Joong
TI Criteria for Quick and Consistent Synthesis of Poly(glycerol sebacate)
   for Tailored Mechanical Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE-ENGINEERING SCAFFOLDS; BIODEGRADABLE ELASTOMER; POLYMER;
   BIOMATERIALS; DEGRADATION
AB Poly(glycerol sebatate) (PGS) and its derivatives make up an attractive class of biomaterial, owing to their tunable,mechanical properties With programmable biodegradability. In practice, however, the application of PGS is often hampered by frequent inconsistency in reproducing process conditions. The inconsistency stems from the volatile nature of glycerol during the esterification process. In this study, we suggest that the degree of esterification (DE). can be used to predict precisely the physical status, the mechanical properties, and the degradation of the PGS materials. Young's modulus is shown to linearly increase with DE, which is in agreement with an entropic spring theory of rubbers. To provide a processing guideline for researchers, we also provide a physical status map as a function of curing temperature and time. The amount of glycerol loss, obtainable by monitoring the evolution of the total mass loss and the DE during synthesis, is shown to make the predictions even more precise. We expect that these strategies cart be applicable to different categories of polymers that involve condensation polymerization with the volatility of the reactants. In addition, we demonstrate that microwave-assisted prepolymerization is a time- and energy-efficient pathway to obtain PGS. For example, 15 min of microwave time is shown to be as efficient as prepolymerization in nitrogen atmosphere for 6 h at 130 degrees C. The quick synthesis method, however, causes a severe evaporation of glycerol, resulting in a large distortion in the monomer ratio between glycerol and sebacic acid. Consequently, more rigid PGS is produced under a similar curing condition compared to the conventional prepolymerizatton method. Finally, we demonstrate that the addition of molecularly rigid cross-linking agents and network-Structured inorganic nanoparticles are also effective in enhancing the mechanical properties of the PGS-derived materials.
C1 [Li, Xinda; Hong, Albert T. -L.; Naskar, Nilanjon; Chung, Hyun-Joong] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
RP Chung, HJ (reprint author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
EM chung.hj13@ualberta.ca
RI Chung, Hyun-Joong/D-5383-2013; Naskar, Nilanjon/C-3891-2018
OI Chung, Hyun-Joong/0000-0003-0569-6951; Naskar,
   Nilanjon/0000-0003-4620-8213
FU NSERC RGPIN [435914]; University of Alberta
FX We thank Mr. T. Ng and Prof. A. Elias for help with mechanical testing
   and Prof. J. Choi (Chungnam National University) and Prof. R. Composto
   (University of Pennsylvania) for electron microscopy of nanoparticles.
   We acknowledge NSERC RGPIN 435914 and a startup grant from University of
   Alberta for financial support. A.T.H. and N.N. thank the URI and
   Globalink programs from University of Alberta and MITACS, respectively,
   for their internship supports.
CR [Anonymous], 1998, D41298A ASTM, DOI [10.1520/D0412-98A, DOI 10.1520/D0412-98A]
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cheng H, 2011, ADV MATER, V23, pH95, DOI 10.1002/adma.201003482
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Jaafar IH, 2010, J MATER SCI, V45, P2525, DOI 10.1007/s10853-010-4259-0
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Kharaziha M, 2013, BIOMATERIALS, V34, P6355, DOI 10.1016/j.biomaterials.2013.04.045
   Li Y, 2013, POLYM INT, V62, P534, DOI 10.1002/pi.4419
   Liang SL, 2012, POLYM INT, V61, P17, DOI 10.1002/pi.3165
   Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Maliger R, 2013, J APPL POLYM SCI, V127, P3980, DOI 10.1002/app.37719
   Pereira MJN, 2013, ADV MATER, V25, P1209, DOI 10.1002/adma.201203824
   Petsonk EL, 2000, CHEST, V118, P1183, DOI 10.1378/chest.118.4.1183
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   RICHARDS RB, 1951, J APPL CHEM, V1, P370, DOI 10.1002/jbt.2570010812
   Sperling L. H., 1992, INTRO PHYS POLYM SCI
   Walls HJ, 2000, J POWER SOURCES, V89, P156, DOI 10.1016/S0378-7753(00)00424-9
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wu Y, 2012, J APPL POLYM SCI, V123, P1612, DOI 10.1002/app.34556
   Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yuan L., 2013, BIOMED MATER, V8
   Zhang H, 2014, MACROMOL RAPID COMM, V35, P1906, DOI 10.1002/marc.201400389
NR 37
TC 21
Z9 21
U1 5
U2 53
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2015
VL 16
IS 5
BP 1525
EP 1533
DI 10.1021/acs.biomac.5b00018
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CI1KS
UT WOS:000354503700009
PM 25857651
DA 2018-10-20
ER

PT J
AU Fermor, HL
   Russell, SL
   Williams, S
   Fisher, J
   Ingham, E
AF Fermor, Hazel L.
   Russell, Serena L.
   Williams, Sophie
   Fisher, John
   Ingham, Eileen
TI Development and characterisation of a decellularised bovine
   osteochondral biomaterial for cartilage repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; FOLLOW-UP;
   MATRIX SCAFFOLD; KNEE; DEFECTS; OSTEOARTHRITIS; COLLAGEN; CELLS;
   REGENERATION
AB It is proposed that an acellular natural osteochondral scaffold will provide a successful repair material for the early intervention treatment of cartilage lesions, to prevent or slow the progression of cartilage deterioration to osteoarthritis. Here, we investigated the efficacy of methods for the decellularisation of bovine osteochondral plugs. The plugs were subject to four freeze/thaw cycles followed by two cycles of washes in hypotonic solution and low concentration (0.1 % w/v) sodium dodecyl sulphate with protease inhibitors. Plugs were treated with nuclease (DNase and RNase) treatment followed by sterilization in peracetic acid. Full tissue decellularisation was achieved as confirmed by histological analysis and DNA quantification, however the resultant acellular matrix had reduced glycosaminoglycan content which led to an increased percent deformation of cartilage. Furthermore, the acellular scaffold was not reproducibly biocompatible. Additional terminal washes were included in the process to improve biocompatibility, however, this led to visible structural damage to the cartilage. This damage was found to be minimised by reducing the cut edge to cartilage area ratio through decellularisation of larger cuts of osteochondral tissue.
C1 [Fermor, Hazel L.; Ingham, Eileen] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.
   [Russell, Serena L.; Williams, Sophie; Fisher, John] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England.
RP Fermor, HL (reprint author), Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.
EM h.l.fermor@leeds.ac.uk
FU EPSRC; WELMEC, a Centre of Excellence in Medical Engineering by Wellcome
   Trust; EPSRC [WT 088908/Z/09/Z]; NIHR LMBRU Leeds Musculoskeletal
   Biomedical Research Unit; ERC; Engineering and Physical Sciences
   Research Council [EP/N00941X/1, EP/K029592/1, EP/J017620/1,
   EP/G012172/1]; National Institute for Health Research [NF-SI-0611-10096]
FX This work was funded by EPSRC and partially through WELMEC, a Centre of
   Excellence in Medical Engineering funded by the Wellcome Trust and
   EPSRC, under Grant Number WT 088908/Z/09/Z. J Fisher is an NIHR senior
   investigator. Additionally the principle investigators J Fisher and E
   Ingham are supported in part by the NIHR LMBRU Leeds Musculoskeletal
   Biomedical Research Unit and the ERC. E Ingham and J Fisher are academic
   founders of Tissue Regenix and are shareholders and advisers to Tissue
   Regenix Group PLC.
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Arthritis Research UK, 2013, OST GEN PRACT DAT PE
   Bae DK, 2013, ARTHROSCOPY, V29, P244, DOI 10.1016/j.arthro.2012.09.006
   Bauer S, 2012, KNEE, V19, P431, DOI 10.1016/j.knee.2011.06.005
   Bayrak A, 2013, TISSUE ENG PT A, V19, P1592, DOI [10.1089/ten.tea.2012.0394, 10.1089/ten.TEA.2012.0394]
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Chaing H, 2009, J FORMOS MED ASSOC, V108, P87
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   da Costa FDA, 2010, ANN THORAC SURG, V90, P1854, DOI 10.1016/j.athoracsur.2010.08.022
   Ding CH, 2005, OSTEOARTHR CARTILAGE, V13, P198, DOI 10.1016/j.joca.2004.11.007
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Fermor HL, BIO MED MAT IN PRESS
   Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669
   Greaves NS, 2013, WOUND REPAIR REGEN, V21, P813, DOI 10.1111/wrr.12113
   Hogg P, 2013, CELL TISSUE BANK, V14, P465, DOI 10.1007/s10561-012-9333-1
   JEFFERY AK, 1991, J BONE JOINT SURG BR, V73, P795
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Knight R, 2006, WILEY ENCY BIOMEDICA
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   McGonagle D, 2010, J ANAT, V216, P279, DOI 10.1111/j.1469-7580.2009.01186.x
   Moradi B, 2012, ARTHROSCOPY, V28, P1851, DOI 10.1016/j.arthro.2012.05.883
   MOW VC, 2005, BASIC ORTHOPAEDIC BI, P181
   Oshima Y, 2009, TISSUE ENG PART C-ME, V15, P595, DOI [10.1089/ten.tec.2008.0487, 10.1089/ten.TEC.2008.0487]
   Pawaskar SS, 2010, J BIOMECH ENG, V132, P1
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   SOKAL RR, 1995, BIOMETRY PRINCIPALS
   Solheim E, 2013, KNEE, V20, P287, DOI 10.1016/j.knee.2013.01.001
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Taylor SD, 2012, P I MECH ENG H, V226, P55, DOI 10.1177/0954411911428717
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
NR 39
TC 8
Z9 8
U1 2
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR 186
DI 10.1007/s10856-015-5517-0
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500011
PM 25893393
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Gabbai-Armelin, PR
   Souza, MT
   Kido, HW
   Tim, CR
   Bossini, PS
   Magri, AMP
   Fernandes, KR
   Pastor, FAC
   Zanotto, ED
   Parizotto, NA
   Peitl, O
   Renno, ACM
AF Gabbai-Armelin, P. R.
   Souza, M. T.
   Kido, H. W.
   Tim, C. R.
   Bossini, P. S.
   Magri, A. M. P.
   Fernandes, K. R.
   Pastor, F. A. C.
   Zanotto, E. D.
   Parizotto, N. A.
   Peitl, O.
   Renno, A. C. M.
TI Effect of a new bioactive fibrous glassy scaffold on bone repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; IN-VITRO; HUMAN OSTEOBLASTS; IONIC PRODUCTS;
   DEFECT; MODEL; BIOSILICATE(R); PROLIFERATION; MICROSPHERES; REGENERATION
AB Researchers have investigated several therapeutic approaches to treat non-union fractures. Among these, bioactive glasses and glass ceramics have been widely used as grafts. This class of biomaterial has the ability to integrate with living bone. Nevertheless, bioglass and bioactive materials have been used mainly as powder and blocks, compromising the filling of irregular bone defects. Considering this matter, our research group has developed a new bioactive glass composition that can originate malleable fibers, which can offer a more suitable material to be used as bone graft substitutes. Thus, the aim of this study was to assess the morphological structure (via scanning electron microscope) of these fibers upon incubation in phosphate buffered saline (PBS) after 1, 7 and 14 days and, also, evaluate the in vivo tissue response to the new biomaterial using implantation in rat tibial defects. The histopathological, immunohistochemistry and biomechanical analyzes after 15, 30 and 60 days of implantation were performed to investigate the effects of the material on bone repair. The PBS incubation indicated that the fibers of the glassy scaffold degraded over time. The histological analysis revealed a progressive degradation of the material with increasing implantation time and also its substitution by granulation tissue and woven bone. Histomorphometry showed a higher amount of newly formed bone area in the control group (CG) compared to the biomaterial group (BG) 15 days post-surgery. After 30 and 60 days, CG and BG showed a similar amount of newly formed bone. The novel biomaterial enhanced the expression of RUNX-2 and RANK-L, and also improved the mechanical properties of the tibial callus at day 15 after surgery. These results indicated a promising use of the new biomaterial for bone engineering. However, further long-term studies should be carried out to provide additional information concerning the material degradation in the later stages and the bone regeneration induced by the fibrous material.
C1 [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil.
   [Souza, M. T.; Zanotto, E. D.; Peitl, O.] Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab LaMaV, Dept Mat Engn, Sao Carlos, SP, Brazil.
   [Bossini, P. S.; Magri, A. M. P.; Fernandes, K. R.; Renno, A. C. M.] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [Pastor, F. A. C.] Fed Univ Sao Carlos UFSCar, Dept Physiol Sci, Sao Carlos, SP, Brazil.
   [Gabbai-Armelin, P. R.; Kido, H. W.; Tim, C. R.; Parizotto, N. A.] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Sao Carlos, SP, Brazil.
RP Gabbai-Armelin, PR (reprint author), Fed Univ Sao Carlos UFSCar, Rodovia Washington Luis SP 310,Km 235, Sao Carlos, SP, Brazil.
EM paulogabbai@gmail.com
RI Zanotto, Edgar/A-7992-2011; CerTEV, CeRTEV/J-6817-2015; Gabbai-Armelin,
   Paulo/L-5984-2016; Bossini, Paulo/G-2333-2014; Kido,
   Hueliton/O-9970-2015
OI Zanotto, Edgar/0000-0003-4931-4505; Kido, Hueliton/0000-0001-8554-432X;
   Tim, Carla/0000-0002-4745-9375
FU CAPES; CNPq; FAPESP; Sao Paulo Research Funding Agency [2013/07793-6];
   PhD students Grant [2011/22937-9]
FX The authors are indebted to CAPES, CNPq and FAPESP, Sao Paulo Research
   Funding Agency, Grant Number 2013/07793-6 (CeRTEV - Center for
   Technology, Research and Education in Glass) for funding this research
   work and PhD students Grant 2011/22937-9.
CR Abiraman S, 2002, B MATER SCI, V25, P419, DOI 10.1007/BF02708021
   Afzal F, 2004, J PATHOL, V202, P503, DOI 10.1002/path.1536
   Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007
   Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Dias AG, 2006, J BIOMATER APPL, V20, P253, DOI 10.1177/0885328206052466
   Dorozhkin S, 2009, P I MECH ENG H, V223, P459, DOI 10.1243/09544119JEIM513
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Gu Y, 2011, J BIOMED MATER RES A, V97A, P177, DOI 10.1002/jbm.a.33018
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 2002, J INORG MATER, V17, P897
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023
   Lin YN, 2014, J BIOMED MATER RES A, V102, P4491, DOI 10.1002/jbm.a.35120
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matsumoto MA, 2012, J MATER SCI-MATER M, V23, P1447, DOI 10.1007/s10856-012-4612-8
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Pedrosa WF, 2009, CLIN ORAL IMPLAN RES, V20, P1254, DOI 10.1111/j.1600-0501.2009.01747.x
   Poologasundarampillai G, 2014, ACTA BIOMATER, V10, P3733, DOI 10.1016/j.actbio.2014.05.020
   Qi XP, 2008, ACTA BIOMATER, V4, P1837, DOI 10.1016/j.actbio.2008.05.009
   Renno ACM, 2013, ACTA BIOMATER, V9, P5728, DOI 10.1016/j.actbio.2012.11.009
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Saino E, 2011, EUR CELLS MATER, V21, P59, DOI 10.22203/eCM.v021a05
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Souza MT, 2013, Patent Application, Patent No. [BR 10 2013 020961 9, 1020130209619]
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Valimaki VV, 2005, BIOMATERIALS, V26, P6693, DOI 10.1016/j.biomaterials.2005.04.033
   van de Watering FCJ, 2012, CLIN ORAL IMPLAN RES, V23, P151, DOI 10.1111/j.1600-0501.2011.02218.x
   Virk MS, 2013, J BONE JOINT SURG AM, V95A, P694, DOI 10.2106/JBJS.L.00285
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Pinto KNZ, 2013, PHOTOMED LASER SURG, V31, P252, DOI 10.1089/pho.2012.3435
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 45
TC 10
Z9 10
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR UNSP 177
DI 10.1007/s10856-015-5516-1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500002
PM 25893392
DA 2018-10-20
ER

PT J
AU Hutmacher, DW
   Little, JP
   Pettet, GJ
   Loessner, D
AF Hutmacher, Dietmar W.
   Little, J. Paige
   Pettet, Graeme J.
   Loessner, Daniela
TI Biomaterial science meets computational biology
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CANCER PROGRESSION; CELL; OVARIAN
AB There is a pressing need for a predictive tool capable of revealing a holistic understanding of fundamental elements in the normal and pathological cell physiology of organoids in order to decipher the mechanoresponse of cells. Therefore, the integration of a systems bioengineering approach into a validated mathematical model is necessary to develop a new simulation tool. This tool can only be innovative by combining biomaterials science with computational biology. Systems-level and multi-scale experimental data are incorporated into a single framework, thus representing both single cells and collective cell behaviour. Such a computational platform needs to be validated in order to discover key mechano-biological factors associated with cell-cell and cell-niche interactions.
C1 [Hutmacher, Dietmar W.; Little, J. Paige; Pettet, Graeme J.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Hutmacher, Dietmar W.; Loessner, Daniela] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia.
   [Hutmacher, Dietmar W.; Little, J. Paige; Pettet, Graeme J.; Loessner, Daniela] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Hutmacher, Dietmar W.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany.
   [Pettet, Graeme J.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.
   [Loessner, Daniela] Translat Res Inst, Brisbane, Qld, Australia.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
EM dietmar.hutmacher@qut.edu.au; daniela.lossner@qut.edu.au
RI Loessner, Daniela/L-2265-2017
OI Loessner, Daniela/0000-0001-5891-3441; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Little, J Paige/0000-0001-8377-5343
CR Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Gilbert PM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt44
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001
   Loessner D, 2013, J CELL SCI, V126, P2761, DOI 10.1242/jcs.123836
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Werner HMJ, 2014, NAT REV CLIN ONCOL, V11, P167, DOI 10.1038/nrclinonc.2014.6
NR 8
TC 0
Z9 0
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2015
VL 26
IS 5
AR 185
DI 10.1007/s10856-015-5518-z
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CI5UO
UT WOS:000354825500010
PM 25893394
DA 2018-10-20
ER

PT J
AU Peres, GL
   Leite, DC
   da Silveira, NP
AF Peres, Gisele Louro
   Leite, Daiani Canabarro
   da Silveira, Nadya Pesce
TI Ultrasound effect on molecular weight reduction of amylopectin
SO STARCH-STARKE
LA English
DT Article
DE amylopectin; molecular weight; ultrasound; viscosity
ID POLYMER-SOLUTIONS; LIGHT-SCATTERING; RHEOLOGICAL PROPERTIES;
   HIGH-AMYLOSE; STARCH; DEGRADATION; MACROMOLECULES; TEMPERATURE;
   PURIFICATION; DISPERSIONS
AB Amylopectin is a major polymer found in native starch granules and presents wide applicability as a biomaterial because of its low cost and biocompatibility. However, in many cases, the use of polysaccharides with low molecular weight is needed, mainly due to the possibility to produce functionalized nanomaterials, as well as to increase their diffusion quality. An effective technique for reducing the molecular weight of polysaccharides without chemical structure alteration is the ultrasound technique. In this paper, amylopectin solubilized in DMSO 90% (v/v) was submitted to ultrasound treatment under various conditions. For the evaluation before and after ultrasound treatment, laser light scattering (LLS) techniques, and viscosity measurements accompanied by pH, conductivity and temperature observations were carried out. As a result of the ultrasound treatment a decrease in the size of the polymer chains and solution viscosity were observed in all the conditions analyzed, demonstrating a low-cost method for reducing the molecular weight of amylopectin.
C1 [Peres, Gisele Louro; Leite, Daiani Canabarro; da Silveira, Nadya Pesce] Univ Fed Rio Grande do Sul, Lab Mol Dynam & Instrumentat, Inst Chem, Bio & Macromol, Porto Alegre, RS, Brazil.
RP Peres, GL (reprint author), Inst Chem, E-116,Ave Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM glperes@yahoo.com.br
RI silveira, nadya/G-9970-2016
OI silveira, nadya/0000-0002-1556-7304; LEITE, DAIANI/0000-0003-1197-8437
FU FAPERGS; CAPES; CNPq
FX The authors would like to thank FAPERGS, CAPES, and CNPq for their
   financial support of this study.
CR Albano KM, 2014, FOOD HYDROCOLLOID, V40, P30, DOI 10.1016/j.foodhyd.2014.02.003
   Aliyu M, 2000, ULTRASON SONOCHEM, V7, P265, DOI 10.1016/S1350-4177(00)00052-3
   Bello-Perez LA, 1998, CARBOHYD POLYM, V37, P383, DOI 10.1016/S0144-8617(97)00139-2
   Berry G. C., 1971, J POLYM SCI POLY PHY, V9
   Blomfeldt TOJ, 2012, RSC ADV, V2, P6617, DOI 10.1039/c2ra20946b
   BURCHARD W, 1983, ADV POLYM SCI, V48, P1
   Burgalassi S, 2000, J OCUL PHARMACOL TH, V16, P497, DOI 10.1089/jop.2000.16.497
   Czechowska-Biskup R, 2005, CARBOHYD POLYM, V60, P175, DOI 10.1016/j.carbpol.2004.12.001
   DAVIS H, 1994, J POLYM SCI POL CHEM, V32, P2267, DOI 10.1002/pola.1994.080321208
   Farzi M, 2011, INT J FOOD SCI TECH, V46, P849, DOI 10.1111/j.1365-2621.2011.02558.x
   Freudig B, 2003, ENG LIFE SCI, V3, P266, DOI 10.1002/elsc.200390042
   GALINSKY G, 1995, MACROMOLECULES, V28, P2363, DOI 10.1021/ma00111a033
   HAWORTH WN, 1946, NATURE, V157, P19, DOI 10.1038/157019a0
   Herrero-Martinez JM, 2004, J CHROMATOGR A, V1053, P227, DOI 10.1016/j.chroma.2004.06.048
   Hosseini SMH, 2013, FOOD HYDROCOLLOID, V32, P235, DOI 10.1016/j.foodhyd.2013.01.002
   Hu T, 2014, STARCH-STARKE, V66, P841, DOI 10.1002/star.201400013
   Iida Y, 2008, INNOV FOOD SCI EMERG, V9, P140, DOI 10.1016/j.ifset.2007.03.029
   Karaman S, 2012, ULTRASON SONOCHEM, V19, P928, DOI 10.1016/j.ultsonch.2011.12.009
   Koda S, 2011, ULTRASON SONOCHEM, V18, P276, DOI 10.1016/j.ultsonch.2010.06.007
   Kolawole AO, 2011, PROCESS BIOCHEM, V46, P2178, DOI 10.1016/j.procbio.2011.08.021
   LANGTON NH, 1969, J SOUND VIB, V10, P22, DOI 10.1016/0022-460X(69)90126-6
   Liu HS, 2009, PROG POLYM SCI, V34, P1348, DOI 10.1016/j.progpolymsci.2009.07.001
   Liu S., 2013, ENV HLTH PERSPECT, V121, P6
   Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545
   PECORA R, 1968, J CHEM PHYS, V49, P1032, DOI 10.1063/1.1670188
   Peroni FHG, 2006, FOOD SCI TECHNOL INT, V12, P505, DOI 10.1177/1082013206073045
   PRICE GJ, 1993, EUR POLYM J, V29, P419, DOI 10.1016/0014-3057(93)90114-U
   PRICE GJ, 1993, POLYMER, V34, P4111, DOI 10.1016/0032-3861(93)90675-Z
   Rao A., 1999, RHEOLOGY FLUID SEMIS
   Rolland-Sabate A, 2012, FOOD HYDROCOLLOID, V27, P161, DOI 10.1016/j.foodhyd.2011.07.008
   Steffe J. F., 1996, RHEOLOGICAL METHODS
   Sujka M, 2013, FOOD HYDROCOLLOID, V31, P413, DOI 10.1016/j.foodhyd.2012.11.027
   Sun JP, 2008, J FOOD QUALITY, V31, P250, DOI 10.1111/j.1745-4557.2008.00192.x
   Szymonska J., 2008, 2 NAT C NAN NANO 200
   Tan ZJ, 2012, DESALINATION, V286, P389, DOI 10.1016/j.desal.2011.11.053
   Vendamme R., 2014, J APPL POLYM SCI, V131, P16
   Wang YH, 2012, CARBOHYD POLYM, V90, P696, DOI 10.1016/j.carbpol.2012.05.099
   Wolf M. J., 1970, CEREAL CHEM, V47
   WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S
   Zhang LF, 2013, ULTRASON SONOCHEM, V20, P222, DOI 10.1016/j.ultsonch.2012.07.021
   Zhu J, 2012, FOOD HYDROCOLLOID, V29, P116, DOI 10.1016/j.foodhyd.2012.02.004
NR 41
TC 7
Z9 8
U1 1
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0038-9056
EI 1521-379X
J9 STARCH-STARKE
JI Starch-Starke
PD MAY
PY 2015
VL 67
IS 5-6
BP 407
EP 414
DI 10.1002/star.201400230
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA CH7KL
UT WOS:000354215000004
DA 2018-10-20
ER

PT J
AU Hogan, MV
   Kawakami, Y
   Murawski, CD
   Fu, FH
AF Hogan, MaCalus V.
   Kawakami, Yohei
   Murawski, Christopher D.
   Fu, Freddie H.
TI Tissue Engineering of Ligaments for Reconstructive Surgery
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Review
ID ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; INTENSITY PULSED
   ULTRASOUND; PLATELET-RICH PLASMA; PATELLAR TENDON AUTOGRAFT; BONE
   MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; FOLLOW-UP EVALUATION;
   STEM-CELLS; ARTIFICIAL LIGAMENTS
AB Purpose: The use of musculoskeletal bioengineering and regenerative medicine applications in orthopaedic surgery has continued to evolve. The aim of this systematic review was to address tissue-engineering strategies for knee ligament reconstruction. Methods: A systematic review of PubMed/Medline using the terms "knee AND ligament" AND "tissue engineering" OR "regenerative medicine" was performed. Two authors performed the search, independently assessed the studies for inclusion, and extracted the data for inclusion in the review. Both preclinical and clinical studies were reviewed, and the articles deemed most relevant were included in this article to provide relevant basic science and recent clinical translational knowledge concerning "tissue-engineering" strategies currently used in knee ligament reconstruction. Results: A total of 224 articles were reviewed in our initial PubMed search. Non-nglish-language studies were excluded. Clinical and preclinical studies were identified, and those with a focus on knee ligament tissue-engineering strategies including stem cell-based therapies, growth factor administration, hybrid biomaterial, and scaffold development, as well as mechanical stimulation modalities, were reviewed. Conclusions: The body of knowledge surrounding tissue-engineering strategies for ligament reconstruction continues to expand. Presently, various tissue-engineering techniques have some potential advantages, including faster recovery, better ligamentization, and possibly, a reduction of recurrence. Preclinical research of these novel therapies continues to provide promising results. There remains a need for well-designed, high-powered comparative clinical studies to serve as a foundation for successful translation into the clinical setting going forward.
C1 [Hogan, MaCalus V.; Kawakami, Yohei; Murawski, Christopher D.; Fu, Freddie H.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA.
RP Fu, FH (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Kaufmann Med Bldg,Ste 1011,3471 Fifth Ave, Pittsburgh, PA 15213 USA.
EM ffu@upmc.edu
RI Hogan, MaCalus/N-5484-2017
OI Hogan, MaCalus/0000-0002-6598-1095
CR Anderson K, 2001, AM J SPORT MED, V29, P689, DOI 10.1177/03635465010290060301
   ARAGONA J, 1983, AM J SPORT MED, V11, P228, DOI 10.1177/036354658301100409
   Bach BR, 1998, AM J SPORT MED, V26, P30, DOI 10.1177/03635465980260012201
   Bach BR, 1998, AM J SPORT MED, V26, P20, DOI 10.1177/03635465980260012101
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   Brophy RH, 2011, J BONE JOINT SURG AM, V93A, P381, DOI [10.2106/JBJS.I.00933, 10.2106/JBJSJ.00933]
   Cervellin M, 2012, KNEE SURG SPORT TR A, V20, P114, DOI 10.1007/s00167-011-1570-5
   Chang Chih-Hsiang, 2012, Biomed J, V35, P473, DOI 10.4103/2319-4170.104412
   Chow DHK, 2014, J ORTHOP RES, V32, P507, DOI 10.1002/jor.22566
   Cook SD, 2001, CLIN ORTHOP RELAT R, pS231
   COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1
   Crawford C, 2005, CLIN INFECT DIS, V41, P195, DOI 10.1086/430911
   Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1
   Doan N, 1999, J ORAL MAXILLOFAC SU, V57, P420
   Eagan MJ, 2012, J TISSUE ENG REGEN M, V6, P702, DOI 10.1002/term.474
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Emond CE, 2011, J BONE JOINT SURG AM, V93A, P572, DOI 10.2106/JBJS.J.00269
   Ersen A, 2014, ARCH ORTHOP TRAUM SU, V134, P405, DOI 10.1007/s00402-013-1914-3
   Farraro KE, 2014, J BIOMECH, V47, P1979, DOI 10.1016/j.jbiomech.2013.12.003
   GRANA WA, 1994, AM J SPORT MED, V22, P344, DOI 10.1177/036354659402200309
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Gulotta LV, 2008, AM J SPORT MED, V36, P1290, DOI 10.1177/0363546508314396
   Hildebrand KA, 1998, AM J SPORT MED, V26, P549, DOI 10.1177/03635465980260041401
   Hoher J, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P231, DOI 10.1007/s001670050105
   Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005
   Ishibashi Y, 2001, AM J SPORT MED, V29, P473, DOI 10.1177/03635465010290041601
   Jadeja H, 2007, KNEE, V14, P439, DOI 10.1016/j.knee.2007.08.006
   Jarvela T, 2007, KNEE SURG SPORT TR A, V15, P500, DOI 10.1007/s00167-006-0254-z
   Kim HM, 2011, CONNECT TISSUE RES, V52, P87, DOI 10.3109/03008207.2010.483026
   Kohno T, 2007, J ORTHOP SCI, V12, P67, DOI 10.1007/s00776-006-1088-8
   Leung KS, 2004, ULTRASOUND MED BIOL, V30, P389, DOI 10.1016/j.ultrasmedbio.2003.11.008
   Li H, 2012, ACTA BIOMATER, V8, P4007, DOI 10.1016/j.actbio.2012.07.008
   Li H, 2012, ARTHROSCOPY, V28, P583, DOI 10.1016/j.arthro.2011.12.008
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Liang R, 2008, J ORTHOP RES, V26, P1098, DOI 10.1002/jor.20616
   Lind M, 2009, ARTHROSCOPY, V25, P1275, DOI 10.1016/j.arthro.2009.06.003
   Liu ZT, 2010, INT ORTHOP, V34, P45, DOI 10.1007/s00264-009-0768-3
   Lovric V, 2013, KNEE SURG SPORT TR A, V21, P466, DOI 10.1007/s00167-012-1972-z
   Lu H, 2008, ULTRASOUND MED BIOL, V34, P1248, DOI 10.1016/j.ultrasmedbio.2008.01.009
   Lui Pauline Po Yee, 2012, Muscles Ligaments Tendons J, V2, P163
   Lui PPY, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-59
   Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312
   Marumo K, 2005, AM J SPORT MED, V33, P1166, DOI 10.1177/0363546504271973
   Matsumoto T, 2012, AM J SPORT MED, V40, P1296, DOI 10.1177/0363546512439026
   Matsumoto T, 2012, STEM CELLS DEV, V21, P859, DOI 10.1089/scd.2010.0528
   Mazzocca AD, 2012, AM J SPORT MED, V40, P1742, DOI 10.1177/0363546512452713
   Mifune Y, 2013, BIOMATERIALS, V34, P5476, DOI 10.1016/j.biomaterials.2013.04.013
   Mifune Y, 2012, CELL TRANSPLANT, V21, P1651, DOI 10.3727/096368912X647234
   Moraes VY, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD010071.PUB2
   Murray AW, 2004, KNEE, V11, P9, DOI 10.1016/S0968-0160(03)00076-0
   Murray MM, 2013, AM J SPORT MED, V41, P1762, DOI 10.1177/0363546513483446
   Murray MM, 2013, J ORTHOP RES, V31, P1501, DOI 10.1002/jor.22420
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Mutsuzaki H, 2004, J BIOMED MATER RES A, V70A, P319, DOI 10.1002/jbm.a.30084
   Mutsuzaki H, 2012, AM J SPORT MED, V40, P1772, DOI 10.1177/0363546512449618
   Nau T, 2002, J BONE JOINT SURG BR, V84B, P356, DOI 10.1302/0301-620X.84B3.12400
   Pereira HMD, 2013, KNEE SURG SPORT TR A, V21, P986, DOI 10.1007/s00167-013-2414-2
   Petersen W, 2000, KNEE SURG SPORT TR A, V8, P26, DOI 10.1007/s001670050006
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Qin L, 2006, ULTRASOUND MED BIOL, V32, P1905, DOI 10.1016/j.ultrasmedbio.2006.06.028
   Ranger P, 2011, INT ORTHOP, V35, P1477, DOI 10.1007/s00264-010-1154-x
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Salmon L, 2005, ARTHROSCOPY, V21, P948, DOI 10.1016/j.arthro.2005.04.110
   Sasaki K, 2008, AM J SPORT MED, V36, P1519, DOI 10.1177/0363546508316282
   Seijas R, 2015, KNEE SURG SPORT TR A, V23, P991, DOI 10.1007/s00167-013-2787-2
   Shah AA, 2010, ARTHROSCOPY, V26, P667, DOI 10.1016/j.arthro.2010.02.031
   Shen GS, 2012, J SURG RES, V173, P75, DOI 10.1016/j.jss.2010.08.015
   Silva A, 2009, KNEE SURG SPORT TR A, V17, P676, DOI 10.1007/s00167-009-0762-8
   Snow M, 2010, KNEE SURG SPORT TR A, V18, P1374, DOI 10.1007/s00167-009-0997-4
   Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745
   Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0
   Suzuki Akito, 2009, J Oral Sci, V51, P29
   Takakura Y, 2002, J ULTRAS MED, V21, P283, DOI 10.7863/jum.2002.21.3.283
   Taylor DW, 2011, CLIN J SPORT MED, V21, P344, DOI 10.1097/JSM.0b013e31821d0f65
   Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059
   Tucker B A, 2010, J Stem Cells, V5, P155, DOI jsc.2010.5.4.155
   van Eck CF, 2012, AM J SPORT MED, V40, P800, DOI 10.1177/0363546511432545
   Wadhwa M, 1996, BRIT J HAEMATOL, V93, P225, DOI 10.1046/j.1365-2141.1996.4611002.x
   Walsh WR, 2007, ARTHROSCOPY, V23, P197, DOI 10.1016/j.arthro.2006.09.003
   Widuchowski W, 2012, BMC MUSCULOSKEL DIS, V27, P115, DOI DOI 10.1186/1471-2474-13-115
   Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049
   Woodall James Jr, 2008, Biomed Sci Instrum, V44, P489
   Xie XX, 2013, J SURG RES, V183, P214, DOI 10.1016/j.jss.2013.01.020
   Yoshikawa T, 2006, AM J SPORT MED, V34, P1918, DOI 10.1177/0363546506294469
   Yoshioka T, 2013, KNEE SURG SPORT TR A, V21, P1763, DOI 10.1007/s00167-012-2002-x
   Yu Y, 2007, ARTHROSCOPY, V23, P205, DOI 10.1016/j.arthro.2006.08.023
   Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315
   Zhai WL, 2012, ORTHOPEDICS, V35, pE520, DOI 10.3928/01477447-20120327-22
NR 89
TC 14
Z9 14
U1 3
U2 53
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
EI 1526-3231
J9 ARTHROSCOPY
JI Arthroscopy
PD MAY
PY 2015
VL 31
IS 5
BP 971
EP 979
DI 10.1016/j.arthro.2014.11.026
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA CH2YN
UT WOS:000353891600027
PM 25618491
DA 2018-10-20
ER

PT J
AU Zustiak, SP
AF Zustiak, Silviya Petrova
TI The Role of Matrix Compliance on Cell Responses to Drugs and Toxins:
   Towards Predictive Drug Screening Platforms
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE compliance; drug screening; matrix; substrate stiffness; therapeutics
ID ORGANS-ON-CHIPS; IN-VITRO; HIGH-THROUGHPUT; MOLECULAR-MECHANISMS;
   SUBSTRATE STIFFNESS; TISSUE STIFFNESS; STEM-CELLS; CANCER; RESISTANCE;
   DISCOVERY
AB Since the birth of tissue engineering, it has been redefined to include not only the development of tissues for clinical use, but also in vitro models for the study of tissue physiology and pathology. Great strides have been accomplished in the design of in vitro tissue models, yet one area in which they are underrepresented, but where they can have an immediate impact, is the development of platforms for drug screening. By providing more in vivo-like cell environments, such models could address the growing concerns about drug failures due to lack of efficacy or unexpected side effects. This review aims to address the interface between substrate compliance and cell responsiveness to toxins and drugs since compliance has been established as a major determinate of overall cell fate. Here, results from 2D substrates and 3D matrices are discussed. Additionally, examples of biomaterial-based high-throughput stiffness assays in drug screening are presented.
C1 St Louis Univ, Dept Biomed Engn, Pk Coll Engn Aviat & Technol, St Louis, MO 63103 USA.
RP Zustiak, SP (reprint author), St Louis Univ, Dept Biomed Engn, Pk Coll Engn Aviat & Technol, 3507 Lindell Blvd, St Louis, MO 63103 USA.
EM szustiak@slu.edu
FU Saint Louis University; President's Research Fund (PRF)
FX This work was funded by start-up funds provided to Dr. Silviya Zustiak
   by Saint Louis University, as well as, by the President's Research Fund
   (PRF) and the Stroble Award in the Health Sciences awarded to Dr.
   Silviya Zustiak by Saint Louis University.
CR Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967
   Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g
   Chang RC, 2011, METHODS MOL BIOL, V671, P219, DOI 10.1007/978-1-59745-551-0_13
   Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004
   Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003
   Feng JT, 2013, CLIN HEMORHEOL MICRO, V55, P121, DOI 10.3233/CH-131696
   Fernandez-Fuente G, 2014, MOL CANCER THER, V13, P1664, DOI 10.1158/1535-7163.MCT-13-0854
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029
   Ghassemi S, 2008, J VAC SCI TECHNOL B, V26, P2549, DOI 10.1116/1.3013424
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grimm S, 2010, J MATER CHEM, V20, P3171, DOI 10.1039/b926432a
   Gupta K, 2010, LAB CHIP, V10, P2019, DOI 10.1039/c004689b
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603
   Herrick WG, 2013, BIOMACROMOLECULES, V14, P2294, DOI 10.1021/bm400418g
   Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599
   Horwitz S., 1993, ANN ONCOL, V5, pS3
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Huh D., 2011, TRENDS CELL BIOL, P745
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x
   Ivanov M, 2014, TRENDS PHARMACOL SCI, V35, P384, DOI 10.1016/j.tips.2014.05.004
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Justin R. T., 2011, PLOS ONE, V6
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201
   Kumachev A, 2011, BIOMATERIALS, V32, P1477, DOI 10.1016/j.biomaterials.2010.10.033
   Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q
   Lam J, 2015, ADV HEALTHC MATER, V4, P534, DOI 10.1002/adhm.201400410
   Lan SF, 2011, TOXICOL APPL PHARM, V256, P62, DOI 10.1016/j.taap.2011.07.013
   Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320
   Lemmon Christopher A, 2005, Mech Chem Biosyst, V2, P1
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045
   Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9
   Liu C, 2015, BIOTECHNOL APPL BIOC, V62, P556, DOI 10.1002/bab.1302
   Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082
   Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706
   Maltman D., 2010, BIOCHEM SOC T, P1072
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Mckee CT, 2011, BIOMATERIALS, V32, P2417, DOI 10.1016/j.biomaterials.2010.11.071
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Nguyen TV, 2014, BIOMATERIALS, V35, P5749, DOI 10.1016/j.biomaterials.2014.03.058
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Ozben T, 2006, FEBS LETT, V580, P2903, DOI 10.1016/j.febslet.2006.02.020
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Patel DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036594
   Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Ramamoorthi K., 2014, AICHE ANN M C P ATL, V112b
   Ramamoorthi K, 2014, CELL MOL BIOENG, V7, P278, DOI 10.1007/s12195-014-0326-y
   Rossow T, 2012, J AM CHEM SOC, V134, P4983, DOI 10.1021/ja300460p
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215
   Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084
   SORENSON CM, 1990, J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749
   Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469
   Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347
   Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0
   Syed S., J VIS EXPT IN PRESS
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tse JR, 2010, CURR PROTOC CELL BIO, V47
   Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   Wood JA, 2011, INVEST OPHTH VIS SCI, V52, P9298, DOI 10.1167/iovs.11-7857
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zustiak S. P., 2010, BIOMACROMOLECULES, P1348
   Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097
NR 98
TC 4
Z9 4
U1 2
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY
PY 2015
VL 15
IS 5
BP 589
EP 599
DI 10.1002/mabi.201400507
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CI0AB
UT WOS:000354396800001
PM 25654999
DA 2018-10-20
ER

PT J
AU Cross, D
   Jiang, XZ
   Ji, WH
   Han, WQ
   Wang, C
AF Cross, Daisy
   Jiang, Xiaoze
   Ji, Weihang
   Han, Wenqing
   Wang, Chun
TI Injectable Hybrid Hydrogels of Hyaluronic Acid Crosslinked by
   Well-Defined Synthetic Polycations: Preparation and Characterization In
   Vitro and In Vivo
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE hyaluronic acid; hybrid hydrogel; physical hydrogel; polyelectrolyte
   hydrogel; star block copolymer
ID BLOCK-COPOLYMERS; CELL TRANSPLANTATION; TRIBLOCK COPOLYMER; DENDRITIC
   CELLS; CHAIN-LENGTH; STEM-CELLS; DELIVERY; MICROSPHERES; THERAPY; DESIGN
AB An injectable hybrid hydrogel system was developed consisting of hyaluronic acid (HA) crosslinked by well-defined block copolymers of the cationic poly(2-aminoethyl methacrylate) (PAEM) and polyethylene glycol (PEG). Robust, shear-thinning hybrid hydrogel was produced by mixing HA and 4-arm star PEG-PAEM block copolymer at 1:1 charge ratio. The encapsulation and release of highly viable human mesenchymal stem cells in physiological media was demonstrated. After subcutaneous injection of the hybrid gel in mice, mild but resolvable inflammatory response was observed. This hybrid gel could serve as a model system for studying structure-function relationship of polyelectrolyte hydrogels and as a practical injectable biomaterial for medical applications.
C1 [Cross, Daisy; Jiang, Xiaoze; Ji, Weihang; Han, Wenqing; Wang, Chun] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
RP Wang, C (reprint author), Univ Minnesota, Dept Biomed Engn, 7-105 Hasselmo Hall,312 Church St SE, Minneapolis, MN 55455 USA.
EM wangx504@umn.edu
RI Ji, Weihang/I-7265-2012
OI Ji, Weihang/0000-0002-1054-6280
FU University of Minnesota's Institute for Engineering in Medicine (IEM);
   NSF CAREER grant [BES0547613]; NIH Biotechnology Training Grant [T32
   GM008347]; University of Minnesota Doctoral Dissertation Fellowship
FX This work is supported in part by the University of Minnesota's
   Institute for Engineering in Medicine (IEM), an NSF CAREER grant
   (BES0547613), a NIH Biotechnology Training Grant (Grant Number T32
   GM008347) fellowship (to DC), and a University of Minnesota Doctoral
   Dissertation Fellowship (to DC). Special thanks to Dr. Robert T.
   Tranquillo (Department of Biomedical Engineering, University of
   Minnesota) for kindly providing human MSCs, and to David Giles
   (University of Minnesota Polymer Characterization Facility) for advice
   regarding rheological characterization.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDRIANOV AK, 1994, J APPL POLYM SCI, V53, P1573, DOI 10.1002/app.1994.070531203
   Angot B, 2000, MACROMOLECULES, V33, P5418, DOI 10.1021/ma000079s
   Arimura H, 2005, J BIOMAT SCI-POLYM E, V16, P1347, DOI 10.1163/156856205774472353
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Cerritelli S, 2005, MACROMOLECULES, V38, P7845, DOI 10.1021/ma051176u
   CLARK AH, 1987, ADV POLYM SCI, V83, P57
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hornof M, 2008, J GENE MED, V10, P70, DOI 10.1002/jgm.1125
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Jankova K, 1998, MACROMOLECULES, V31, P538, DOI 10.1021/ma9710186
   Ji WH, 2011, BIOMACROMOLECULES, V12, P4373, DOI 10.1021/bm201360v
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Kim JI, 2012, BIOMATERIALS, V33, P2823, DOI 10.1016/j.biomaterials.2012.01.004
   KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235
   Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+
   Liu B, 2009, BIOMACROMOLECULES, V10, P3182, DOI 10.1021/bm900908g
   Liu KL, 2011, SOFT MATTER, V7, P11290, DOI 10.1039/c1sm06340e
   Liu Y, 2011, MACROMOL BIOSCI, V11, P1325, DOI 10.1002/mabi.201100119
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523
   Schmalz A, 2012, SOFT MATTER, V8, P9436, DOI 10.1039/c2sm25686j
   Segura T, 2007, BIOCONJUGATE CHEM, V18, P736, DOI 10.1021/bc060284y
   Tang RP, 2010, J CONTROL RELEASE, V142, P229, DOI 10.1016/j.jconrel.2009.10.021
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Wu J, 2007, J BIOMED MATER RES A, V80A, P800, DOI 10.1002/jbm.a.30972
   Xu J, 2006, MACROMOLECULES, V39, P8178, DOI 10.1021/ma061934w
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yannas I. V., 2004, BIOMATERIALS SCI, P728
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang JJ, 2011, ADV MATER, V23, P5098, DOI 10.1002/adma.201103349
NR 45
TC 6
Z9 6
U1 5
U2 46
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY
PY 2015
VL 15
IS 5
BP 668
EP 681
DI 10.1002/mabi.201400491
PG 14
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CI0AB
UT WOS:000354396800008
PM 25630277
DA 2018-10-20
ER

PT J
AU Chlanda, A
   Rebis, J
   Kijenska, E
   Wozniak, MJ
   Rozniatowski, K
   Swieszkowski, W
   Kurzydlowski, KJ
AF Chlanda, Adrian
   Rebis, Janusz
   Kijenska, Ewa
   Wozniak, Michal J.
   Rozniatowski, Krzysztof
   Swieszkowski, Wojciech
   Kurzydlowski, Krzysztof J.
TI Quantitative imaging of electrospun fibers by PeakForce Quantitative
   NanoMechanics atomic force microscopy using etched scanning probes
SO MICRON
LA English
DT Article
DE Atomic force microscopy; PeakForce Quantitative NanoMechanics;
   Electrospun fibers; Focused ion beam; Mechanical properties
ID MECHANICAL-PROPERTIES; FIBRINOGEN FIBERS; NANOFIBERS; CHONDROCYTES;
   FABRICATION; MORPHOLOGY; SCAFFOLDS; SILICON; PROTEIN
AB Electrospun polymeric submicron and nanofibers can be used as tissue engineering scaffolds in regenerative medicine. In physiological conditions fibers are subjected to stresses and strains from the surrounding biological environment. Such stresses can cause permanent deformation or even failure to their structure. Therefore, there is a growing necessity to characterize their mechanical properties, especially at the nanoscale.
   Atomic force microscopy is a powerful tool for the visualization and probing of selected mechanical properties of materials in biomedical sciences. Image resolution of atomic force microscopy techniques depends on the equipment quality and shape of the scanning probe. The probe radius and aspect ratio has huge impact on the quality of measurement.
   In the presented work the nanomechanical properties of four different polymer based electros pun fibers were tested using PeakForce Quantitative NanoMechanics atomic force microscopy, with standard and modified scanning probes. Standard, commercially available probes have been modified by etching using focused ion beam (FIB). Results have shown that modified probes can be used for mechanical properties mapping of biomaterial in the nanoscale, and generate nanomechanical information where conventional tips fail. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Chlanda, Adrian; Rebis, Janusz; Kijenska, Ewa; Wozniak, Michal J.; Rozniatowski, Krzysztof; Swieszkowski, Wojciech; Kurzydlowski, Krzysztof J.] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
   [Wozniak, Michal J.] Warsaw Univ Technol, Univ Res Ctr Funct Mat, PL-02507 Warsaw, Poland.
RP Chlanda, A (reprint author), Warsaw Univ Technol, Fac Mat Sci & Engn, 141 Woloska Str, PL-02507 Warsaw, Poland.
EM adrian.chlanda@inmat.pw.edu.pl
OI Kijenska-Gawronska, Ewa/0000-0002-2614-2838; Chlanda,
   Adrian/0000-0002-8795-7563
FU National Science Center of Poland (NCN) [UMO-2011/01/B/ST8/07559,
   DEC-2011/01/M/ST8/07742]; Ministry of Science and Higher Education,
   Republic of Poland (MNiSW) [0616/IP2/2011/71]
FX This study is financially supported by: (1) National Science Center of
   Poland (NCN) under grant: "Three-dimensional composite scaffold based on
   biodegradable polymers and bioceramic with incorporated growth factors
   for bone tissue engineering. Research on the manufacturing process and
   the material influence on living cells function", number:
   UMO-2011/01/B/ST8/07559. (2) Ministry of Science and Higher Education,
   Republic of Poland (MNiSW) under grant: "Polymer-ceramic composite,
   extracellular matrix mimicking biomaterials for tissue engineering
   needs: processes of degradation of the structure and mechanical
   properties", number: 0616/IP2/2011/71. (3) National Science Center of
   Poland (NCN) under grant: "Hybrid growth factors delivery system
   supporting bone tissue regeneration", number DEC-2011/01/M/ST8/07742.
CR Adamcik J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589369
   [Anonymous], 2011, PEAKFORCE QNM US GUI
   Baker S, 2012, MAT SCI ENG C-MATER, V32, P215, DOI 10.1016/j.msec.2011.10.021
   Bale M, 2002, J VAC SCI TECHNOL B, V20, P364, DOI 10.1116/1.1447242
   Bosworth LA, 2013, NANOMED-NANOTECHNOL, V9, P322, DOI 10.1016/j.nano.2012.10.008
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   Chattopadhyray S, 2006, CRIT REV SOLID STATE, V31, P15, DOI 10.1080/10408430600689299
   Chen Y, 2000, J CRYST GROWTH, V210, P527, DOI 10.1016/S0022-0248(99)00728-9
   Chew SY, 2006, NANOTECHNOLOGY, V17, P3880, DOI 10.1088/0957-4484/17/15/045
   Croisier F, 2012, ACTA BIOMATER, V8, P218, DOI 10.1016/j.actbio.2011.08.015
   Elsabee MZ, 2012, MAT SCI ENG C-MATER, V32, P1711, DOI 10.1016/j.msec.2012.05.009
   Fischer H., 2013, J MICROSC
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030
   Lee JH, 2008, ULTRAMICROSCOPY, V108, P1163, DOI 10.1016/j.ultramic.2008.04.073
   Liu H, 2012, MACROMOLECULES, V45, P8770, DOI 10.1021/ma301961h
   Pittenger B., 2010, QUANTITATIVE MECH PR
   Raghavan P, 2012, REACT FUNCT POLYM, V72, P915, DOI 10.1016/j.reactfunctpolym.2012.08.018
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rozniatowski K., 2013, TOWAROZNAWCZE PROBLE, V34
   Sencadas V, 2012, CARBOHYD POLYM, V87, P1295, DOI 10.1016/j.carbpol.2011.09.017
   Sun B., 2013, PROG POLYM SCI
   Wang Y, 2010, APPL SURF SCI, V256, P6107, DOI 10.1016/j.apsusc.2010.03.127
   Wozniak MJ, 2010, SOFT MATTER, V6, P2462, DOI 10.1039/b926890a
   Wozniak MJ, 2009, MICRON, V40, P870, DOI 10.1016/j.micron.2009.06.002
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Zanden C, 2012, EUR POLYM J, V48, P472, DOI 10.1016/j.eurpolymj.2012.01.004
   Zhang J., 2011, APPL PHYS LETT, V99
NR 31
TC 12
Z9 12
U1 0
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD MAY
PY 2015
VL 72
BP 1
EP 7
DI 10.1016/j.micron.2015.01.005
PG 7
WC Microscopy
SC Microscopy
GA CI1ME
UT WOS:000354507500001
PM 25710786
DA 2018-10-20
ER

PT J
AU Rytlewski, JA
   Aldon, MA
   Lewis, EW
   Suggs, LJ
AF Rytlewski, Julie A.
   Aldon, M. Alejandra
   Lewis, Evan W.
   Suggs, Laura J.
TI Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs
SO MICROVASCULAR RESEARCH
LA English
DT Article
DE Mesenchymal stem cells; Tubulogenesis; Vasculogenic mimicry; Fibrin;
   Hypoxia; Neovascularization
ID MESENCHYMAL STEM-CELLS; 3-DIMENSIONAL EXTRACELLULAR MATRICES;
   HUMAN-MELANOMA CELLS; VASCULOGENIC MIMICRY; IN-VITRO; CAPILLARY LUMEN;
   GROWTH-FACTOR; VE-CADHERIN; MORPHOGENESIS; VIVO
AB Stem cell-based therapies are a promising new avenue for treating ischemic disease and chronic wounds. Mesenchymal stem cells (MSCs) have a proven ability to augment the neovascularization processes necessary for wound healing and are widely popular as an autologous source of progenitor cells. Our lab has previously reported on PEGylated fibrin as a unique hydrogel that promotes spontaneous tubulogenesis of encapsulated MSCs without exogenous factors. However, the mechanisms underlying this process have remained unknown. To better understand the therapeutic value of PEGylated fibrin delivery of MSCs, we sought to clarify the relationship between biomaterial properties and cell behavior. Here we find that fibrin PEGylation does not dramatically alter the macroscopic mechanical properties of the fibrin-based matrix (less than 10% difference). It does, however, dramatically reduce the rate of diffusion through the gel matrix. PEGylated fibrin enhances the tubulogenic growth of encapsulated MSCs demonstrating fluid-filled lumens by interconnected MSCs. Image analysis gave a value of 4320 +/- 1770 pm total network length versus 618 +/- 443 gm for unmodified fibrin. PEGylation promotes the endothelial phenotype of encapsulated MSCs compared to unmodified fibrin as evidenced by higher levels of endothelial markers (von Willebrand factor, 2.2-fold; vascular endothelial cadherin, 1.8-fold) and vascular endothelial growth factor (VEGF, up to 1.8-fold). Prospective analysis of underlying molecular pathways demonstrated that this endothelial-like MSC behavior is sensitively modulated by hypoxic stress, but not VEGF supplementation as evidenced by a significant increase in VEGF and MMP-2 secretion per cell under hypoxia. Further gain-of-function studies under hypoxic stress demonstrated that hypoxia culture of MSCs in unmodified fibrin could increase both vWF and VE-cadherin levels to values that were not significantly different than cells cultured in PEGylated fibrin. This result corroborated our hypothesis that the diffusion-limited environment of PEGylated fibrin is augmenting endothelial differentiation cues provided by unmodified fibrin. However, MSC networks lack platelet endothelial cell adhesion molecule-1 (PECAM-1) expression, which indicates incomplete differentiation towards an endothelial cell type. Collectively, the data here supports a revised understanding of MSC-derived neovascularization that contextualizes their behavior and utility as a hybrid endothelial-stromal cell type, with mixed characteristics of both populations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rytlewski, Julie A.; Aldon, M. Alejandra; Lewis, Evan W.; Suggs, Laura J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Suggs, LJ (reprint author), Univ Texas Austin, Dept Biomed Engn, 107 W Dean Keeton,Stop C0800, Austin, TX 78712 USA.
EM julie.rytlewski@utexas.edu; alejandra.aldon@utexas.edu;
   evan.lewis@utexas.edu; laura.suggs@engr.utexas.edu
FU American Heart Association [11GRNT7080002]; Department of Defense (NDSEG
   fellowship); Cockrell School of Engineering; National Center for
   Research Resources [S10RR027950]
FX We gratefully acknowledge our sources of funding: the American Heart
   Association (11GRNT7080002) for funding this project; the Department of
   Defense (NDSEG fellowship) and Cockrell School of Engineering (Thrust
   2000 fellowship) for funding JR We also would like to thank the ICMB
   Microscopy and Imaging Facility (UT Austin) for access to cryo-SEM and
   confocal microscopes and Award Number S10RR027950 from the National
   Center for Research Resources for providing access to two-photon
   microscopy. The content here is solely the responsibility of the authors
   and does not necessarily represent the official views of the National
   Center for Research Resources or the National Institutes of Health.
CR Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117
   Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019
   Bayless KJ, 2002, J CELL SCI, V115, P1123
   Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x
   Galas RJ, 2014, J CELL PHYSIOL, V229, P90, DOI 10.1002/jcp.24421
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI 10.1089/ten.TEA.2010.0189
   Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798
   Hess AR, 2003, CANCER RES, V63, P4757
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Karlsson LK, 2009, ANN VASC SURG, V23, P663, DOI 10.1016/j.avsg.2009.03.007
   Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Majumdar D, 2013, PLACENTA, V34, P642, DOI 10.1016/j.placenta.2013.04.021
   Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5
   Nagle RB, 2011, PROSTATE CANCER, DOI 10.1155/2011/249290
   Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1
   Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116
   Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Razban V, 2012, BIORESEARCH OPEN ACC, V1, P174, DOI 10.1089/biores.2012.9905
   Rytlewski JA, 2012, TISSUE ENG PART C-ME, V18, P507, DOI [10.1089/ten.tec.2011.0417, 10.1089/ten.TEC.2011.0417]
   Sahai S, 2012, TISSUE ENG PART C-ME, V18, P557, DOI [10.1089/ten.tec.2011.0518, 10.1089/ten.TEC.2011.0518]
   Simionescu DT, 2012, J HEALTHC ENG, V3, P179, DOI 10.1260/2040-2295.3.2.179
   Vartanian AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1044, DOI 10.1134/S000629791209012X
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zhao N, 2012, MED ONCOL, V29, P3599, DOI 10.1007/s12032-012-0245-5
NR 37
TC 6
Z9 7
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD MAY
PY 2015
VL 99
BP 26
EP 35
DI 10.1016/j.mvr.2015.02.005
PG 10
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA CI0IL
UT WOS:000354420200004
PM 25711526
OA Green Accepted
DA 2018-10-20
ER

PT J
AU An, SF
   Gao, Y
   Huang, XY
   Ling, JQ
   Liu, ZH
   Xiao, Y
AF An, Shaofeng
   Gao, Yan
   Huang, Xiangya
   Ling, Junqi
   Liu, Zhaohui
   Xiao, Yin
TI A comparative study of the proliferation and osteogenic differentiation
   of human periodontal ligament cells cultured on beta-TCP ceramics and
   demineralized bone matrix with or without osteogenic inducers in vitro
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE human periodontal ligament cells; osteogenic differentiation; tricalcium
   phosphate; demineralized bone matrix
ID MARROW STROMAL CELLS; TRICALCIUM PHOSPHATE; MORPHOGENETIC PROTEINS;
   GRAFT SUBSTITUTES; CALCIUM; REGENERATION; BIOCERAMICS; REPAIR;
   MINERALIZATION; BIOMATERIAL
AB The repair of bone defects that result from periodontal diseases remains a clinical challenge for periodontal therapy. beta-tricalcium phosphate (beta-TCP) ceramics are biodegradable inorganic bone substitutes with inorganic components that are similar to those of bone. Demineralized bone matrix (DBM) is an acid-extracted organic matrix derived from bone sources that consists of the collagen and matrix proteins of bone. A few studies have documented the effects of DBM on the proliferation and osteogenic differentiation of human periodontal ligament cells (hPDLCs). The aim of the present study was to investigate the effects of inorganic and organic elements of bone on the proliferation and osteogenic differentiation of hPDLCs using three-dimensional porous beta-TCP ceramics and DBM with or without osteogenic inducers. Primary hPDLCs were isolated from human periodontal ligaments. The proliferation of the hPDLCs on the scaffolds in the growth culture medium was examined using a Cell-Counting kit-8 (CCK-8) and scanning electron microscopy (SEM). Alkaline phosphatase (ALP) activity and the osteogenic differentiation of the hPDLCs cultured on the beta-TCP ceramics and DBM were examined in both the growth culture medium and osteogenic culture medium. Specific osteogenic differentiation markers were examined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). SEM images revealed that the cells on the beta-TCP were spindle-shaped and much more spread out compared with the cells on the DBM surfaces. There were no significant differences observed in cell proliferation between the beta-TCP ceramics and the DBM scaffolds. Compared with the cells that were cultured on beta-TCP ceramics, the ALP activity, as well as the Runx2 and osteocalcin (OCN) mRNA levels in the hPDLCs cultured on DBM were significantly enhanced both in the growth culture medium and the osteogenic culture medium. The organic elements of bone may exhibit greater osteogenic differentiation effects on hPDLCs than the inorganic elements.
C1 [An, Shaofeng; Gao, Yan; Huang, Xiangya; Ling, Junqi; Liu, Zhaohui] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510055, Guangdong, Peoples R China.
   [An, Shaofeng; Gao, Yan; Huang, Xiangya; Ling, Junqi; Liu, Zhaohui] Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China.
   [Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Ling, JQ (reprint author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, 56 Ling Yuan Xi Rd, Guangzhou 510055, Guangdong, Peoples R China.
EM lingjq@mail.sysu.edu.cn; yin.xiao@qut.edu.au
OI Xiao, Yin/0000-0003-1785-3491; An, Shaofeng/0000-0002-5183-9530
FU Guangdong Natural Science Foundation [S2012040007041]
FX This study was supported by the Guangdong Natural Science Foundation
   (grant no. S2012040007041).
CR An S, 2012, J PERIODONTAL RES, V47, P374, DOI 10.1111/j.1600-0765.2011.01443.x
   Anzai J, 2010, BIOCHEM BIOPH RES CO, V403, P345, DOI 10.1016/j.bbrc.2010.11.032
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Bernstein A, 2008, J BIOMED MATER RES B, V84B, P452, DOI 10.1002/jbm.b.30891
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Dori F, 2005, J PERIODONTOL, V76, P2236, DOI 10.1902/jop.2005.76.12.2236
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Elahi MM, 2004, J CRANIOFAC SURG, V15, P967, DOI 10.1097/00001665-200411000-00015
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   GUIZZARDI S, 1992, SPINE, V17, P701, DOI 10.1097/00007632-199206000-00010
   Hu ZM, 2011, J BIOMED MATER RES A, V98A, P473, DOI 10.1002/jbm.a.33119
   Hughes FJ, 2010, P I MECH ENG H, V224, P1345, DOI 10.1243/09544119JEIM820
   Ishikawa I, 2009, PERIODONTOL 2000, V51, P220, DOI 10.1111/j.1600-0757.2009.00312.x
   Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032
   Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   Mahr MA, 2000, OPHTHALMIC PLAST REC, V16, P393, DOI 10.1097/00002341-200009000-00014
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Miron RJ, 2013, J PERIODONTOL, V84, P1646, DOI 10.1902/jop.2013.120574
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Orimo H, 2008, MOL CELL BIOCHEM, V315, P51, DOI 10.1007/s11010-008-9788-3
   Papadopoulos CE, 2003, J PERIODONTOL, V74, P451, DOI 10.1902/jop.2003.74.4.451
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Urist MR, 2002, CLIN ORTHOP RELAT R, P5
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 41
TC 3
Z9 4
U1 1
U2 19
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD MAY
PY 2015
VL 35
IS 5
BP 1341
EP 1346
DI 10.3892/ijmm.2015.2122
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CH2IQ
UT WOS:000353849300021
PM 25738431
OA Bronze
DA 2018-10-20
ER

PT J
AU Jambhekar, S
   Kernen, F
   Bidra, AS
AF Jambhekar, Shantanu
   Kernen, Florian
   Bidra, Avinash S.
TI Clinical and histologic outcomes of socket grafting after flapless tooth
   extraction: A systematic review of randomized controlled clinical trials
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID ALVEOLAR RIDGE PRESERVATION; DRIED BONE ALLOGRAFT; MAGNESIUM-ENRICHED
   HYDROXYAPATITE; PLATELET-RICH FIBRIN; HISTOMORPHOMETRIC EVALUATION;
   DIMENSIONAL CHANGES; CALCIUM-SULFATE; AESTHETIC ZONE; SINUS
   AUGMENTATION; COLLAGEN SPONGE
AB Statement of problem. Several biomaterials and techniques have been reported for socket grafting and alveolar ridge preservation. However, the evidence for clinical and histologic outcomes for socket grafting with different types of materials in flapless extraction is not clear.
   Purpose. The purpose of this systematic review was to analyze the outcomes of a socket grafting procedure performed with flapless extraction of teeth in order to determine which graft material results in the least loss of socket dimensions, the maximum amount of vital bone, the least remnant graft material, and the least amount of connective tissue after a minimum of 12 weeks of healing. Secondary outcomes, including the predictability of regenerating deficient buccal bone, necessity of barrier membranes, and coverage with autogenous soft tissue graft, were also evaluated.
   Material and methods. An electronic search for articles in the English-language literature was performed independently by multiple investigators using a systematic search process with the PubMed search engine. After applying predetermined inclusion and exclusion criteria, the final list of randomized controlled clinical trials (RCTs) for flapless extraction and socket grafting was analyzed to derive results for the various objectives of the study.
   Results. The initial electronic search resulted in 2898 titles. The systematic application of inclusion and exclusion criteria resulted in 32 RCTs studying 1354 sockets, which addressed the clinical and histologic outcomes of flapless extraction with socket grafting and provided dimensional and histologic information at or beyond the 12-week reentry period. From these RCTs, the mean loss of buccolingual width at the ridge crest was lowest for xenografts (1.3 mm), followed by allografts (1.63 mm), alloplasts (2.13 mm), and sockets without any socket grafting (2.79 mm). Only 3 studies reported on loss of width at 3 mm below the ridge crest. The mean loss of buccal wall height from the ridge crest was lowest for xenografts (0.57 mm) and allografts (0.58 mm), followed by alloplasts (0.77 mm) and sockets without any grafting (1.74 mm). The mean histologic outcomes at or beyond the 12-week reentry period revealed the highest vital bone content for sockets grafted with alloplasts (45.53%), followed by sockets with no graft material (41.07%), xenografts (35.72%), and allografts (29.93%). The amount of remnant graft material was highest for sockets grafted with allografts (21.75%), followed by xenografts (19.3%) and alloplasts (13.67%). The highest connective tissue content at the time of reentry was seen for sockets with no grafting (52.53%), followed by allografts (51.03%), xenografts (44.42%), and alloplast (38.39%). Data for new and emerging biomaterials such as cell therapy and tissue regenerative materials were not amenable to calculations because of biomaterial heterogeneity and small sample sizes.
   Conclusions. After flapless extraction of teeth, and using a minimum healing period of 12 weeks as a temporal measure, xenografts and allografts resulted in the least loss of socket dimensions compared to alloplasts or sockets with no grafting. Histologic outcomes after a minimum of 12 weeks of healing showed that sockets grafted with alloplasts had the maximum amount of vital bone and the least amount of remnant graft material and remnant connective tissue. There is a limited but emerging body of evidence for the predictable regeneration of deficient buccal bone with socket grafting materials, need for barrier membranes, use of tissue engineering, and use of autogenous soft tissue grafts from the palate to cover the socket.
C1 [Jambhekar, Shantanu] Terna Dent Coll Nerul, Bombay, Maharashtra, India.
   [Jambhekar, Shantanu; Kernen, Florian] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA.
   [Bidra, Avinash S.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Postgrad Prosthodont, Farmington, CT 06030 USA.
RP Bidra, AS (reprint author), Univ Connecticut, Ctr Hlth, 263 Farmington Ave,L6078, Farmington, CT 06030 USA.
EM avinashbidra@yahoo.com
CR Aimetti M, 2009, INT J ORAL MAX IMPL, V24, P901
   Alkan EA, 2013, INT J ORAL MAX SURG, V42, P1522, DOI 10.1016/j.ijom.2013.06.002
   AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2014, CLIN ORAL IMPLAN RES, P1
   Avila-Ortiz G, 2014, J DENT RES, V93, P950, DOI 10.1177/0022034514541127
   Barone A., 2014, CLIN ORAL IMPLANTS R
   Barone A, 2014, CLIN ORAL IMPLANTS R
   Barone A, 2014, J PERIODONTOL, V85, P14, DOI 10.1902/jop.2013.120711
   Barone A, 2013, CLIN ORAL IMPLAN RES, V24, P1231, DOI 10.1111/j.1600-0501.2012.02535.x
   Bartee B K, 2001, J Oral Implantol, V27, P187, DOI 10.1563/1548-1336(2001)027<0187:ESRFAR>2.3.CO;2
   Bidra Avinash S, 2014, Dent Clin North Am, V58, P1, DOI 10.1016/j.cden.2013.09.001
   Brkovic BMB, 2012, CLIN ORAL INVEST, V16, P581, DOI 10.1007/s00784-011-0531-1
   Brownfield LA, 2012, J PERIODONTOL, V83, P581, DOI 10.1902/jop.2011.110365
   Calasans-Maia M, 2014, CLIN ORAL IMPLAN RES, V25, P1125, DOI 10.1111/clr.12237
   Cardaropoli D, 2008, INT J PERIODONT REST, V28, P469
   Cardaropoli D, 2012, INT J PERIODONT REST, V32, P421
   Chan HL, 2013, INT J ORAL MAX IMPL, V28, P710, DOI 10.11607/jomi.2913
   Chappuis V, 2013, J DENT RES, V92, p195S, DOI 10.1177/0022034513506713
   Checchi V, 2011, INT J ORAL MAX SURG, V40, P526, DOI 10.1016/j.ijom.2010.12.005
   Coomes AM, 2014, J PERIODONTOL, V85, P525, DOI 10.1902/jop.2013.130207
   Crespi R, 2014, INT J ORAL MAX IMPL, V29, P699, DOI 10.11607/jomi.3535
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P1057
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P866
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Darby I, 2009, INT J ORAL MAX IMPL, V24, P260
   Engler-Hamm D, 2011, J PERIODONTOL, V82, P377, DOI 10.1902/jop.2010.090342
   Eskow AJ, 2014, J PERIODONTOL, V85, P514, DOI 10.1902/jop.2013.130178
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Festa VM, 2013, CLIN IMPLANT DENT R, V15, P707, DOI 10.1111/j.1708-8208.2011.00398.x
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P906, DOI 10.1111/j.1600-051X.2008.01305.x
   Fotek PD, 2009, J PERIODONTOL, V80, P776, DOI 10.1902/jop.2009.080514
   Geurs N, 2014, INT J ORAL MAX IMPL, V29, P485, DOI 10.11607/jomi.3408
   Hammerle CHF, 2012, CLIN ORAL IMPLAN RES, V23, P80, DOI 10.1111/j.1600-0501.2011.02370.x
   Hanser T, 2014, INT J PERIODONT REST, V34, P305, DOI 10.11607/prd.1749
   Hauser F, 2013, IMPLANT DENT, V22, P295, DOI 10.1097/ID.0b013e3182906eb3
   Heberer S, 2012, CLIN ORAL IMPLAN RES, V23, P19, DOI 10.1111/j.1600-0501.2010.02148.x
   Heberer S, 2011, INT J ORAL MAX IMPL, V26, P385
   Hoang TN, 2012, J PERIODONTOL, V83, P174, DOI 10.1902/jop.2011.110209
   Horowitz Robert, 2012, J Evid Based Dent Pract, V12, P149, DOI 10.1016/S1532-3382(12)70029-5
   Horvath A, 2013, CLIN ORAL INVEST, V17, P341, DOI 10.1007/s00784-012-0758-5
   Huh JB, 2011, J ADV PROSTHODONT, V3, P161, DOI 10.4047/jap.2011.3.3.161
   Jung RE, 2013, J CLIN PERIODONTOL, V40, P90, DOI 10.1111/jcpe.12027
   Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098
   Kim YK, 2011, IMPLANT DENT, V20, P267, DOI 10.1097/ID.0b013e3182166afc
   Kutkut A, 2012, J PERIODONTOL, V83, P401, DOI 10.1902/jop.2011.110237
   Laney WR, 2007, GLOSSARY ORAL MAXILL, p[4, 175]
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Lindhe J, 2014, CLIN ORAL IMPLAN RES, V25, P786, DOI 10.1111/clr.12170
   Mah J, 2004, EUR J ORTHODONT, V26, P475, DOI 10.1093/ejo/26.5.475
   MAHESH L, 2013, J ORAL IMPLANTOL
   Moghaddas Hamid, 2012, Dent Res J (Isfahan), V9, P758
   Morjaria KR, 2014, CLIN IMPLANT DENT R, V16, P1, DOI 10.1111/j.1708-8208.2012.00450.x
   Nahles S, 2013, CLIN ORAL IMPLAN RES, V24, P812, DOI 10.1111/j.1600-0501.2012.02462.x
   Neiva R, 2011, INT J PERIODONT REST, V31, P457
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Oghli AA, 2010, QUINTESSENCE INT, V41, P605
   Orgeas GV, 2013, INT J ORAL MAX IMPL, V28, P1049, DOI 10.11607/jomi.2670
   Pelegrine AA, 2010, CLIN ORAL IMPLAN RES, V21, P535, DOI 10.1111/j.1600-0501.2009.01891.x
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rasperini G, 2010, INT J PERIODONT REST, V30, P265
   Sbordone L, 2011, CLIN ORAL IMPLAN RES, V22, P485, DOI 10.1111/j.1600-0501.2010.02030.x
   Schneider D, 2014, J CLIN PERIODONTOL, V41, P612, DOI 10.1111/jcpe.12246
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Sclar AG, 2004, J ORAL MAXIL SURG, V62, P90, DOI 10.1016/j.joms.2004.06.041
   Shakibaie B, 2013, INT J PERIODONT REST, V33, P223, DOI 10.11607/prd.0734
   Sisti A, 2012, CLIN ORAL IMPLAN RES, V23, P526, DOI 10.1111/j.1600-0501.2011.02386.x
   Smukler H, 1999, INT J ORAL MAX IMPL, V14, P407
   Suttapreyasri S, 2013, J CRANIOFAC SURG, V24, P1088, DOI 10.1097/SCS.0b013e31828b6dc3
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Tarnow DP, 2014, INT J PERIODONT REST, V34, P323, DOI 10.11607/prd.1821
   Tarnow DP, 1996, PERIODONTOL 2000, V11, P85, DOI 10.1111/j.1600-0757.1996.tb00186.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Thalmair T, 2013, J CLIN PERIODONTOL, V40, P721, DOI 10.1111/jcpe.12111
   Toloue SM, 2012, J PERIODONTOL, V83, P847, DOI 10.1902/jop.2011.110470
   Tomlin Elizabeth M, 2014, Open Dent J, V8, P66, DOI 10.2174/1874210601408010066
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Weng D, 2011, EUR J ORAL IMPLANTOL, V4, P59
   Wood RA, 2012, J PERIODONTOL, V83, P329, DOI 10.1902/jop.2011.110270
NR 84
TC 26
Z9 27
U1 0
U2 23
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD MAY
PY 2015
VL 113
IS 5
BP 371
EP 382
DI 10.1016/j.prosdent.2014.12.009
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CH9GM
UT WOS:000354344000004
PM 25749077
DA 2018-10-20
ER

PT J
AU Wu, QQ
   Gong, P
   Wang, TL
   Gong, T
   Man, Y
AF Wu, Qingqing
   Gong, Ping
   Wang, Tianlu
   Gong, Ting
   Man, Yi
TI Evaluation of the efficacy of keratinized mucosa augmentation techniques
   around dental implants: A systematic review
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID CONNECTIVE-TISSUE GRAFT; INCREASED ATTACHED GINGIVA; DERMAL MATRIX
   ALLOGRAFTS; IMMEDIATE IMPLANT; MUCOGINGIVAL SURGERY; PERIODONTAL
   APPLICATIONS; LONGITUDINAL EVALUATION; CLINICAL-EVALUATION; SUBMERGED
   IMPLANTS; AESTHETIC OUTCOMES
AB Statement of problem. The absence of periimplant keratinized mucosa is considered risky in patients with a predisposition to periodontitis or recession. Although various soft tissue augmentation techniques exist, dentists are seeking for more efficient approaches to augment periimplant keratinized mucosa.
   Purpose. The purpose of this systematic review was to evaluate the efficacy of the various techniques and biomaterials adopted in periimplant keratinized mucosa augmentation and whether one technique or biomaterial is superior.
   Material and methods. A search in Medline-PubMed and the Cochrane Central Register of controlled trials was conducted. Randomized clinical trials, prospective cohort studies, clinical control studies, and case series from January 1, 1980, to December 31, 2013, with a follow-up of at least 6 months reporting changes on keratinized mucosa width were included. Several Journals were hand-searched for related articles. The bibliographies of all publications selected for inclusion were also scanned.
   Results. The screening of titles and abstracts resulted in 60 relevant publications. Six of them were finally included. Free gingival graft, connective tissue graft, acellular dermal matrix, and collagen matrix were used for keratinized mucosa augmentation. Because of heterogeneity of the studies, only descriptive analysis was performed. Improvements in keratinized mucosa width were reported in all studies.
   Conclusions. A definitive conclusion could not be achieved owing to the lack of well-designed studies and appropriate methods of studying soft tissue. The establishment of universal surgical guidelines and measurement systems is imperative in the future.
C1 [Wu, Qingqing; Wang, Tianlu; Gong, Ting] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Wu, Qingqing; Wang, Tianlu; Gong, Ting] Sichuan Univ, Dept Oral Implantol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Gong, Ping; Man, Yi] Sichuan Univ, Dept Prosthodont, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.
   [Gong, Ping] Sichuan Univ, Dept Oral Implantol, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.
RP Man, Y (reprint author), 14,3rd Sect Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.
EM manyi780203@gmail.com
FU National Key Clinical Speciality on Oral Implantology; National Science
   Foundation [81101347]; ITI small grant [2009660]
FX Supported by National Key Clinical Speciality on Oral Implantology,
   National Science Foundation (81101347) and an ITI small grant (2009660).
CR Allen Edward P, 2006, Dent Today, V25, P50
   Barone R, 1998, INT J PERIODONT REST, V18, P377
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Bianchi AE, 2004, CLIN ORAL IMPLAN RES, V15, P269, DOI 10.1111/j.1600-0501.2004.01020.x
   BRANEMARK P, 1985, INTRO OSSEOINTEGRATI
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BRANEMARK PI, 1977, SCAND J PLAST RECONS, P7
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P163, DOI 10.1111/j.1600-051X.2008.01266.x
   Camargo PM, 2001, PERIODONTOL 2000, V27, P72, DOI 10.1034/j.1600-0757.2001.027001072.x
   Caneva M, 2013, CLIN ORAL IMPLAN RES, V24, P50, DOI 10.1111/j.1600-0501.2012.02450.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Covani U, 2007, J PERIODONTOL, V78, P1644, DOI 10.1902/jop.2007.060461
   DORFMAN HS, 1980, J CLIN PERIODONTOL, V7, P316, DOI 10.1111/j.1600-051X.1980.tb01974.x
   Edel A, 1974, J Clin Periodontol, V1, P185, DOI 10.1111/j.1600-051X.1974.tb01257.x
   ERICSSON I, 1984, J CLIN PERIODONTOL, V11, P95, DOI 10.1111/j.1600-051X.1984.tb00837.x
   Esposito M, 2001, INT J ORAL MAX IMPL, V16, P783
   Esposito M, 2007, COCHRANE DB SYST REV, V18
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   FRIEDMAN N, 1962, J PERIODONTOL, V33, P328, DOI 10.1902/jop.1962.33.4.328
   Greenstein G, 2011, COMPEND CONTIN ED DE, V32, P32
   Griffin TJ, 2006, J PERIODONTOL, V77, P2070, DOI 10.1092/jop.2006.050296
   HAN TJ, 1995, INT J PERIODONT REST, V15, P405
   Higgins J, 2011, COCHRANE HDB SYSTEMA
   Hoelscher D C, 1996, J Mich Dent Assoc, V78, P56
   KARRING T, 1975, J PERIODONTOL, V46, P577, DOI 10.1902/jop.1975.46.10.577
   Keceli HG, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2007.01181.x
   KENNEDY JE, 1985, J CLIN PERIODONTOL, V12, P667, DOI 10.1111/j.1600-051X.1985.tb00938.x
   Khoury F, 2000, QUINTESSENCE INT, V31, P483
   LANG NP, 1972, J PERIODONTOL, V43, P623, DOI 10.1902/jop.1972.43.10.623
   Lee YM, 2012, INT J PERIODONT REST, V32, P213
   Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x
   Lorenzo R, 2012, CLIN ORAL IMPLAN RES, V23, P316, DOI 10.1111/j.1600-0501.2011.02260.x
   Maksoud Mohamed A, 2003, J Oral Implantol, V29, P120, DOI 10.1563/1548-1336(2003)029<0120:MOTPIT>2.3.CO;2
   McGuire MK, 2005, J PERIODONTOL, V76, P867, DOI 10.1902/jop.2005.76.6.867
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Nemcovsky CE, 2002, INT J PERIODONT REST, V22, P607
   Nemcovsky CE, 1999, INT J PERIODONT REST, V19, P387
   Orsini M, 2004, J PERIODONTOL, V75, P470, DOI 10.1902/jop.2004.75.3.470
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Prato GP, 1995, PERIODONTOL 2000, V9, P90, DOI 10.1111/j.1600-0757.1995.tb00058.x
   Quirynen M, 1991, CLIN ORAL IMPLAN RES, V2, P186, DOI 10.1034/j.1600-0501.1991.020405.x
   Rapley J W, 1992, Int J Periodontics Restorative Dent, V12, P373
   Rhee PH, 1998, ARCH OTOLARYNGOL, V124, P1201, DOI 10.1001/archotol.124.11.1201
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   Schrott AR, 2009, CLIN ORAL IMPLAN RES, V20, P1170, DOI 10.1111/j.1600-0501.2009.01795.x
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Seibert J S, 1983, Compend Contin Educ Dent, V4, P437
   Silverstein L H, 1994, Implant Dent, V3, P231, DOI 10.1097/00008505-199412000-00003
   Simons A M, 1994, Implant Dent, V3, P235, DOI 10.1097/00008505-199412000-00004
   Simons A M, 1993, Implant Dent, V2, P27, DOI 10.1097/00008505-199304000-00006
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   SULLIVAN HC, 1969, DENT CLIN N AM, V13, P133
   Ten Cate A, 1985, GINGIVAL JUNCTION TI, P145
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   TENBRUGGENKATE CM, 1991, ORAL SURG ORAL MED O, V72, P154, DOI 10.1016/0030-4220(91)90155-6
   von Elm E, 2007, PREV MED, V45, P247, DOI [10.1016/j.ypmed.2007.08.012, 10.7326/0003-4819-147-8-200710160-00010]
   WARRER K, 1995, CLIN ORAL IMPLAN RES, V6, P131, DOI 10.1034/j.1600-0501.1995.060301.x
   Wei PC, 2002, J PERIODONTOL, V73, P257, DOI 10.1902/jop.2002.73.3.257
   Wei PC, 2000, J PERIODONTOL, V71, P1297, DOI 10.1902/jop.2000.71.8.1297
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Yan JJ, 2006, INT J PERIODONT REST, V26, P287
   Yilmaz S, 1994, J Marmara Univ Dent Fac, V2, P383
   YUKNA RA, 1978, J PERIODONTAL RES, V13, P177, DOI 10.1111/j.1600-0765.1978.tb00167.x
   Zigdon H, 2008, CLIN ORAL IMPLAN RES, V19, P387, DOI 10.1111/j.1600-0501.2007.01492.x
   Zitzmann NU, 2001, J CLIN PERIODONTOL, V28, P517, DOI 10.1034/j.1600-051x.2001.028006517.x
NR 71
TC 4
Z9 6
U1 4
U2 28
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD MAY
PY 2015
VL 113
IS 5
BP 383
EP 390
DI 10.1016/j.prosdent.2014.10.001
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CH9GM
UT WOS:000354344000005
PM 25681355
DA 2018-10-20
ER

PT J
AU Shah, SV
   Chakravarthy, D
AF Shah, Shishir V.
   Chakravarthy, Debashish
TI Evaluation of a Bovine 100% Native Collagen for the Treatment of Chronic
   Wounds A Case Series
SO JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING
LA English
DT Article
DE Bovine; Chronic wounds; Collagen; Decubitus ulcers; Diabetic ulcers;
   Microscaffold; Native; Nonhealing wounds; Pressure ulcers; Vasculitis;
   Venous ulcers; Wound closure
ID FIBROBLASTS; MECHANISMS; DISEASE
AB PURPOSE: The roles of debridement, infection control, and moisture balance in wound healing are familiar to wound care clinicians, but these measures may not be sufficient for wound closure in all patients. In these cases, adjuvant therapies such as collagen dressings may be needed. Collagen dressings are thought to encourage wound healing by laying down a provisional biomaterial matrix that captures wound exudates because of its absorbent nature, and thus creates an environment necessary for healing. This case series describes our experience with a bovine-derived, 100% native, type I collagen in patients with chronic and persistent wounds.
   CASES: This case series included 20 patients with 21 chronic wounds ranging from 0.6 to 101.4 cm(2) that had been recalcitrant to prior conservative treatment and/or the use of submucosal intestinal matrix, oxidized regenerated cellulose/collagen matrix, or skin substitute. In addition to the bovine-derived 100% native collagen, standard wound care included the use of any systemic or topical antimicrobial treatments needed to specifically address wound infections. The total duration of treatment with the bovine-derived 100% native collagen was up to 12 weeks. Complete wound healing was achieved for 15 of the patients in this series; wound healing times varied from 13 to 68 days. Two additional patients achieved wound healing, using a combination of the bovine-derived 100% native collagen and other therapies, at 114 days and 107 days, respectively, after starting the wound healing process with solely the bovine-derived 100% native collagen treatment. One patient did not respond to treatment. The collagen treatment was well tolerated by the patients, with 3 incidences of dermatitis that resolved after treatment with corticosteroids.
   CONCLUSION: Following a change in their chronic wound care regimen to include a bovine-derived, 100% native, type I collagen, we achieved an 83.3% (15 out of 18 patients) wound closure rate. Two patients were excluded from the data set analysis because they received additional intervention outside the parameters described in this multiple-case series.
C1 [Shah, Shishir V.] St Josephs Hosp Wound Ctr, Phoenix, AZ USA.
   [Chakravarthy, Debashish] Medline Ind Inc, Mundelein, IL USA.
RP Shah, SV (reprint author), 15029 N Thompson Pk,Ste B111-611, Scottsdale, AZ 85260 USA.
EM woundexpert@gmail.com
FU Medline Industries (Mundelein, Illinois)
FX Medline Industries (Mundelein, Illinois) contributed funding for this
   case series and publication assistance. Editorial assistance in
   preparing this manuscript was provided by Magellan Medical Technology
   Consultants, Inc (Minneapolis, Minnesota). This article was adapted from
   a poster presentation at the Symposium of Advanced Wound Care, April
   2008, San Diego, California. At this conference, the lead author
   received reimbursement of costs associated with the poster presentation
   from Medline Industries.
CR Ayello EA, 2003, WOUND CARE ESSENTIAL, P138
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289
   CALLAM M, 1992, PHLEBOLOGY S1, V7, pS6
   Clerici G, 2010, INT WOUND J, V7, P176, DOI 10.1111/j.1742-481X.2010.00670.x
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   FALANGA V, 1993, J INVEST DERMATOL, V100, P721, DOI 10.1111/1523-1747.ep12472373
   Fleischli JG, 2009, J AM PODIAT MED ASSN, V99, P301, DOI 10.7547/0980301
   Fowler E, 1990, CHRONIC WOUND CARE C, P12
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Hansen SL, 2003, WOUND REPAIR REGEN, V11, P474, DOI 10.1046/j.1524-475X.2003.11615.x
   Herrick SE, 1996, J INVEST DERMATOL, V106, P187, DOI 10.1111/1523-1747.ep12329920
   Lazaro-Martinez JL, 2010, OSTOMY WOUND MA S11A, V56, pS4
   Nelzen O, 1996, BRIT J SURG, V83, P255, DOI 10.1002/bjs.1800830235
   Rees RS, 1999, ADV WOUND CARE, V12, P4
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Singh Aparajita, 2004, Asian J Surg, V27, P326, DOI 10.1016/S1015-9584(09)60061-0
   Snyder RJ, 2010, OSTOMY WOUND MA S11A, V56, pS9
   Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200
   Walmsley S, 2002, CLIN REPORTS
   Woo K, 2007, ADV SKIN WOUND CARE, V20, P99
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
NR 23
TC 2
Z9 2
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1071-5754
EI 1528-3976
J9 J WOUND OSTOMY CONT
JI J. Wound Ostomy Cont. Nurs.
PD MAY-JUN
PY 2015
VL 42
IS 3
BP 226
EP 234
DI 10.1097/WON.0000000000000124
PG 9
WC Nursing
SC Nursing
GA CH7LK
UT WOS:000354217700003
PM 25945821
DA 2018-10-20
ER

PT J
AU Hashim, N
   Yusoh, K
AF Hashim, Norazlina
   Yusoh, Kamal
TI Supercritical carbon dioxide-assisted process in synthesis of
   polymer/clay melt
SO MACROMOLECULAR RESEARCH
LA English
DT Review
DE supercritical carbon dioxide; melt processing; clay nanocomposites;
   nanofiller dispersion; foaming
ID SOLUTION-ENHANCED DISPERSION; SOLVENT-EXTRACTION SYSTEM; RAPID
   EXPANSION; ANTISOLVENT PRECIPITATION; BIODIESEL PRODUCTION;
   NANOCOMPOSITE FOAMS; SEDS TECHNIQUE; ASES PROCESS; SILICATE
   NANOCOMPOSITES; PARTICLE FORMATION
AB Nanocomposites are currently being used in a number of fields, and new applications are continuously being developed including mechanical and biomaterial devices, as well as various in solar and fuel cells applications. Generally, the synthesis of polymer nanocomposites are done using solution chemistry, and this may raise serious concerns regarding air and water pollutions. Immediately, the 'green' method using supercritical carbon dioxide (scCO(2)) has grabbed the attention of researchers who are responsible to synthesize polymer composites by non-hazardous routes. Extrusion processes would benefit from the use of scCO(2) since the rationale of the extrusion process is to formulate, provide texture and shape molten polymers by forcing them through a die. ScCO2 has been used in several studies as a medium of clay dispersion in polymer matrix by providing a solvent-free fabrication route for nanocomposites. Furthermore, it has more favorable interactions with polymers compared to other inert gases and has the ability to be dissolve in large quantities. It acts as a plasticizer, which modifies viscosity and interfacial properties of the polymer drastically. In this paper, experimental and theoretical studies of solubility and viscosity of several polymer melts in clay are discussed in detail. The assistance of scCO(2) in clay dispersion and as a foaming agent has been reviewed extensively.
C1 [Hashim, Norazlina] TATI Univ Coll, Fac Chem Engn Technol, Kemaman 24000, Terengganu, Malaysia.
   [Yusoh, Kamal] Univ Malaysia Pahang, Fac Chem & Nat Resources Engn, Gambang 26300, Pahang, Malaysia.
RP Hashim, N (reprint author), TATI Univ Coll, Fac Chem Engn Technol, Kemaman 24000, Terengganu, Malaysia.
EM norazlinatatiuc@gmail.com
RI Yusoh, Kamal/L-8761-2018
OI Yusoh, Kamal/0000-0003-2663-344X
CR Adachi H, 2009, J SUPERCRIT FLUID, V49, P265, DOI 10.1016/j.supflu.2008.12.010
   Aguiar AC, 2012, J SUPERCRIT FLUID, V71, P1, DOI 10.1016/j.supflu.2012.07.005
   Amiguet VT, 2012, FOOD CHEM, V130, P853, DOI 10.1016/j.foodchem.2011.07.098
   ARANDA P, 1992, CHEM MATER, V4, P1395, DOI 10.1021/cm00024a048
   Baker KC, 2011, ACTA BIOMATER, V7, P3382, DOI 10.1016/j.actbio.2011.05.014
   Bakhbakhi Y, 2013, EUR J PHARM SCI, V48, P30, DOI 10.1016/j.ejps.2012.10.013
   Baldwin DF, 1996, POLYM ENG SCI, V36, P1437, DOI 10.1002/pen.10538
   Baldwin DF, 1996, POLYM ENG SCI, V36, P1446, DOI 10.1002/pen.10539
   Balsiger C, 2005, CHEMOSPHERE, V61, P361, DOI 10.1016/j.chemosphere.2005.02.087
   Bernardo-Gil MG, 2007, J SUPERCRIT FLUID, V40, P344, DOI 10.1016/j.supflu.2006.07.026
   Bhatti HN, 2008, FUEL, V87, P2961, DOI 10.1016/j.fuel.2008.04.016
   Bilotti E, 2008, J APPL POLYM SCI, V107, P1116, DOI 10.1002/app.25395
   Blasig A, 2002, IND ENG CHEM RES, V41, P4976, DOI 10.1021/ie0201819
   BLEICH J, 1993, INT J PHARM, V97, P111, DOI 10.1016/0378-5173(93)90131-X
   BLEICH J, 1994, INT J PHARM, V106, P77, DOI 10.1016/0378-5173(94)90278-X
   Bordes P, 2009, POLYM DEGRAD STABIL, V94, P789, DOI 10.1016/j.polymdegradstab.2009.01.027
   Boschetto DL, 2013, IND CROP PROD, V50, P352, DOI 10.1016/j.indcrop.2013.07.044
   Brion M, 2009, J SUPERCRIT FLUID, V51, P50, DOI 10.1016/j.supflu.2009.06.021
   Broekaert C, 2007, EUR POLYM J, V43, P4160, DOI 10.1016/j.eurpolymj.2007.08.003
   Byrappa K, 2008, ADV DRUG DELIVER REV, V60, P299, DOI 10.1016/j.addr.2007.09.001
   Cabedo L, 2009, J APPL POLYM SCI, V112, P3669, DOI 10.1002/app.29945
   Cao K, 2010, CHEM ENG SCI, V65, P1621, DOI 10.1016/j.ces.2009.11.004
   Cardoso LC, 2013, MOLECULES, V18, P3137, DOI 10.3390/molecules18033137
   Castro-Vargas HI, 2013, J SUPERCRIT FLUID, V76, P17, DOI 10.1016/j.supflu.2012.10.006
   Chang SC, 2007, J SUPERCRIT FLUID, V40, P420, DOI 10.1016/j.supflu.2006.07.025
   Chen AZ, 2012, J SUPERCRIT FLUID, V67, P7, DOI 10.1016/j.supflu.2012.03.004
   Chen AZ, 2009, J SUPERCRIT FLUID, V49, P394, DOI 10.1016/j.supflu.2009.02.004
   Chen C, 2012, POLYMER, V53, P1373, DOI 10.1016/j.polymer.2012.01.049
   Chen JE, 2013, J SUPERCRIT FLUID, V77, P33, DOI 10.1016/j.supflu.2013.02.007
   Chen KX, 2005, POWDER TECHNOL, V152, P127, DOI 10.1016/j.powtec.2005.01.009
   Chernyak Y, 2001, IND ENG CHEM RES, V40, P6118, DOI 10.1021/ie010267m
   Chong GH, 2011, J SUPERCRIT FLUID, V60, P69, DOI 10.1016/j.supflu.2011.04.020
   COLTON JS, 1987, POLYM ENG SCI, V27, P500, DOI 10.1002/pen.760270704
   da Silva MS, 2012, CHEM ENG SCI, V68, P94, DOI 10.1016/j.ces.2011.09.015
   de Paz E, 2012, J SUPERCRIT FLUID, V72, P125, DOI 10.1016/j.supflu.2012.08.007
   Di YW, 2005, MACROMOL MATER ENG, V290, P1083, DOI 10.1002/mame.200500115
   Dong ZX, 2004, J SUPERCRIT FLUID, V31, P67, DOI 10.1016/j.supflu.2003.09.020
   Doroudiani S, 1996, POLYM ENG SCI, V36, P2645, DOI 10.1002/pen.10664
   Drobek M, 2013, J MEMBRANE SCI, V429, P428, DOI 10.1016/j.memsci.2012.11.058
   Ekinci MS, 2014, J SUPERCRIT FLUID, V92, P319, DOI 10.1016/j.supflu.2014.06.004
   Elizondo E, 2010, J SUPERCRIT FLUID, V53, P108, DOI 10.1016/j.supflu.2010.02.018
   Engwicht A, 1999, INT J PHARM, V185, P61, DOI 10.1016/S0378-5173(99)00127-1
   Farias-Campomanes AM, 2013, J SUPERCRIT FLUID, V77, P70, DOI 10.1016/j.supflu.2013.02.006
   Foster N, 2003, IND ENG CHEM RES, V42, P6476, DOI 10.1021/ie030219x
   Fraile M, 2013, J SUPERCRIT FLUID, V81, P226, DOI 10.1016/j.supflu.2013.06.010
   Franceschi E, 2009, J FOOD ENG, V95, P656, DOI 10.1016/j.jfoodeng.2009.06.034
   Franceschi E, 2008, J SUPERCRIT FLUID, V47, P259, DOI 10.1016/j.supflu.2008.08.002
   Fujimoto Y, 2003, MACROMOL RAPID COMM, V24, P457, DOI 10.1002/marc.200390068
   Ganapathy HS, 2007, EUR POLYM J, V43, P119, DOI 10.1016/j.eurpolymj.2006.10.009
   Garcia-Gonzalez CA, 2009, ACTA BIOMATER, V5, P1094, DOI 10.1016/j.actbio.2008.10.018
   Garcia-Leiner M., 2003, ANTEC C P, V2, P1528
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   Gogolewski S., 1993, POLYM DEGRAD STABIL, V40, P13
   Goren K, 2012, J SUPERCRIT FLUID, V67, P108, DOI 10.1016/j.supflu.2012.03.013
   Hakuta Y, 2003, CURR OPIN SOLID ST M, V7, P341, DOI 10.1016/j.cossms.2003.12.005
   Haldorai Y, 2012, J SUPERCRIT FLUID, V71, P45, DOI 10.1016/j.supflu.2012.07.007
   Han XM, 2003, POLYM ENG SCI, V43, P1261, DOI 10.1002/pen.10107
   Horsch S, 2006, POLYMER, V47, P7485, DOI 10.1016/j.polymer.2006.08.048
   Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025
   Hwang HS, 2007, J SUPERCRIT FLUID, V39, P409, DOI 10.1016/j.supflu.2006.02.011
   Jarmer DJ, 2003, J SUPERCRIT FLUID, V27, P317, DOI 10.1016/S0896-8446(02)00245-0
   Javadi A, 2012, J MATER RES, V27, P1506, DOI 10.1557/jmr.2012.74
   Jeong HH, 2008, J IND ENG CHEM, V14, P77, DOI 10.1016/j.jiec.2007.08.002
   Jiang XL, 2009, J SUPERCRIT FLUID, V48, P167, DOI 10.1016/j.supflu.2008.10.006
   Jin HY, 2012, POWDER TECHNOL, V227, P17, DOI 10.1016/j.powtec.2012.04.050
   Kang YQ, 2008, J COLLOID INTERF SCI, V322, P87, DOI 10.1016/j.jcis.2008.02.031
   Keshtkar M, 2014, POLYMER, V55, P4077, DOI 10.1016/j.polymer.2014.06.059
   Kikic I, 1998, IND ENG CHEM RES, V37, P1577, DOI 10.1021/ie980838j
   Kikuchi E, 2011, J CLEAN PROD, V19, P414, DOI 10.1016/j.jclepro.2010.05.021
   Kim KH, 2011, ATMOS ENVIRON, V45, P1369, DOI 10.1016/j.atmosenv.2010.12.029
   Kiran E, 2010, J SUPERCRIT FLUID, V54, P308, DOI 10.1016/j.supflu.2010.05.004
   Kongsombut B, 2009, IND ENG CHEM RES, V48, P11230, DOI 10.1021/ie900690v
   Kunastitchai S, 2006, INT J PHARM, V316, P93, DOI 10.1016/j.ijpharm.2006.02.051
   Kusdiana D, 2004, BIORESOURCE TECHNOL, V91, P289, DOI 10.1016/S0960-8524(03)00201-3
   Lay E. N., 2009, J CHEM ENG DATA, V55, P223
   Le Moigne N, 2014, EUR POLYM J, V61, P157, DOI 10.1016/j.eurpolymj.2014.10.008
   Lee KT, 2014, PROG ENERG COMBUST, V45, P54, DOI 10.1016/j.pecs.2014.07.001
   Lee ST, 2008, J CELL PLAST, V44, P293, DOI 10.1177/0021955X08088859
   Lee SM, 2008, MACROMOL RES, V16, P6, DOI 10.1007/BF03218954
   LELE AK, 1994, IND ENG CHEM RES, V33, P1476, DOI 10.1021/ie00030a007
   Lepoittevin B, 2003, POLYMER, V44, P2033, DOI 10.1016/S0032-3861(03)00076-4
   Li DC, 2011, J SUPERCRIT FLUID, V60, P89, DOI 10.1016/j.supflu.2011.07.015
   Li DC, 2011, IND ENG CHEM RES, V50, P1997, DOI 10.1021/ie101723g
   Lin IH, 2010, J SUPERCRIT FLUID, V51, P384, DOI 10.1016/j.supflu.2009.10.008
   Liu GT, 1996, IND ENG CHEM RES, V35, P4626, DOI 10.1021/ie960142v
   Liu T, 2005, IND ENG CHEM RES, V44, P4292, DOI 10.1021/ie0501428
   Liu W, 2013, J CELL PLAST, V49, P535, DOI 10.1177/0021955X13503845
   Liu WW, 2014, APPL SURF SCI, V292, P142, DOI 10.1016/j.apsusc.2013.11.102
   Liu ZM, 2002, CHEM MATER, V14, P4619, DOI 10.1021/cm0203215
   Liu ZM, 2002, POLYMER, V43, P1183, DOI 10.1016/S0032-3861(01)00703-0
   Lu HS, 2013, CHINESE J CHEM ENG, V21, P551, DOI 10.1016/S1004-9541(13)60508-X
   Ma J, 2007, EUR POLYM J, V43, P4931, DOI 10.1016/j.eurpolymj.2007.09.010
   Machado FRS, 2014, IND CROP PROD, V54, P17, DOI 10.1016/j.indcrop.2014.01.007
   Manke C. W., 2002, U. S. Patent, Patent No. [6,469,073, 6469073]
   Martin A, 2008, ADV DRUG DELIVER REV, V60, P339, DOI 10.1016/j.addr.2007.06.019
   Marulanda VF, 2010, J SUPERCRIT FLUID, V54, P53, DOI 10.1016/j.supflu.2010.04.001
   Mauricio MR, 2011, COMPOS PART A-APPL S, V42, P757, DOI 10.1016/j.compositesa.2011.03.002
   Mawson S, 1997, POLYMER, V38, P2957, DOI 10.1016/S0032-3861(96)00852-X
   Meziani MJ, 2005, IND ENG CHEM RES, V44, P4594, DOI 10.1021/ie048796o
   Mezzomo N, 2013, J SUPERCRIT FLUID, V74, P22, DOI 10.1016/j.supflu.2012.11.020
   Mezzomo N, 2012, J SUPERCRIT FLUID, V66, P342, DOI 10.1016/j.supflu.2011.08.006
   Mielewski D. F., 2004, INT GEOPHYS, Patent No. 6,753,360 B2
   Mielewski D.F., 2004, US Patent, Patent No. 6753360
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Montes A., 2013, IND ENG CHEM RES, V53, P474
   Moribe K, 2009, INT J PHARMACEUT, V380, P201, DOI 10.1016/j.ijpharm.2009.06.030
   Muth O, 2000, J SUPERCRIT FLUID, V17, P65, DOI 10.1016/S0896-8446(99)00042-X
   Nalawade SP, 2006, PROG POLYM SCI, V31, P19, DOI 10.1016/j.progpolymsci.2005.08.002
   Nguyen QT, 2007, POLYMER, V48, P6923, DOI 10.1016/j.polymer.2007.09.015
   Niza NM, 2013, J SUPERCRIT FLUID, V79, P73, DOI 10.1016/j.supflu.2013.02.021
   Nofar M, 2012, J CELL PLAST, V48, P271, DOI 10.1177/0021955X12440271
   O'Connor P, 2012, EUR POLYM J, V48, P1279, DOI 10.1016/j.eurpolymj.2012.04.011
   Oh K. S., 2008, EUR POLYM J, V44, P415
   Okamoto H, 2008, ADV DRUG DELIVER REV, V60, P433, DOI 10.1016/j.addr.2007.02.002
   Omar J, 2013, FOOD ANAL METHOD, V6, P1244, DOI 10.1007/s12161-012-9536-x
   Park CB, 1996, POLYM ENG SCI, V36, P34, DOI 10.1002/pen.10382
   Park EJ, 2011, POLYMER, V52, P5403, DOI 10.1016/j.polymer.2011.09.038
   Park MW, 2012, CHEM ENG RES DES, V90, P2202, DOI 10.1016/j.cherd.2012.05.001
   Park SJ, 2008, J SUPERCRIT FLUID, V47, P85, DOI 10.1016/j.supflu.2008.05.010
   Pasquali I, 2008, INT J PHARMACEUT, V364, P176, DOI 10.1016/j.ijpharm.2008.05.014
   Reategui JLP, 2014, J SUPERCRIT FLUID, V94, P223, DOI 10.1016/j.supflu.2014.07.019
   Pereira VJ, 2013, J SUPERCRIT FLUID, V81, P128, DOI 10.1016/j.supflu.2013.05.010
   Pilla S, 2009, POLYM ENG SCI, V49, P1653, DOI 10.1002/pen.21385
   Plaza M, 2013, J AGR FOOD CHEM, V61, P5500, DOI 10.1021/jf400584f
   Pourmortazavi SM, 2005, IND ENG CHEM RES, V44, P6523, DOI 10.1021/ie0503242
   Prado JM, 2014, J SUPERCRIT FLUID, V86, P15, DOI 10.1016/j.supflu.2013.11.018
   Rajaei H, 2012, J SUPERCRIT FLUID, V67, P1, DOI 10.1016/j.supflu.2012.02.005
   Ramkumar DHS, 1998, POLYM ENG SCI, V38, P1426, DOI 10.1002/pen.10313
   Ratzsch M, 1996, J MACROMOL SCI PURE, VA33, P913, DOI 10.1080/10601329608014641
   Ray SS, 2003, MACROMOLECULES, V36, P2355, DOI 10.1021/ma021728y
   Reverchon E, 1999, J SUPERCRIT FLUID, V15, P1, DOI 10.1016/S0896-8446(98)00129-6
   Rizvi S. S. H., 1995, TRENDS FOOD SCI TECH, V6, P209
   Roseiro LB, 2013, IND CROP PROD, V47, P132, DOI 10.1016/j.indcrop.2013.02.026
   Rossmann M, 2012, J SUPERCRIT FLUID, V66, P350, DOI 10.1016/j.supflu.2011.11.023
   Saka S, 2001, FUEL, V80, P225, DOI 10.1016/S0016-2361(00)00083-1
   Salinas-Hernandez R., 2008, IND ENG CHEM RES, V48, P769
   Sane A, 2005, J PHYS CHEM B, V109, P19688, DOI 10.1021/jp0581072
   Santos DT, 2012, J FOOD ENG, V108, P444, DOI [10.1016/j.jfoodeng.2011.08.022, 10.1016/jjfoodeng.2011.08.022]
   Shariati A, 2003, CURR OPIN SOLID ST M, V7, P371, DOI 10.1016/j.cossms.2003.12.001
   Shekunov BY, 2001, CHEM ENG SCI, V56, P2421
   Shin HY, 2012, J SUPERCRIT FLUID, V61, P134, DOI 10.1016/j.supflu.2011.09.009
   STAHL E, 1980, J AGR FOOD CHEM, V28, P1153, DOI 10.1021/jf60232a023
   Steckel H, 2004, EUR J PHARM BIOPHARM, V57, P507, DOI 10.1016/j.ejph.2004.01.002
   Su FH, 2011, J SUPERCRIT FLUID, V56, P114, DOI 10.1016/j.supflu.2010.12.001
   Sun Y.-P., 1998, CHEM MATER, V11, P7
   Sun YP, 2000, IND ENG CHEM RES, V39, P4663, DOI 10.1021/ie000114j
   Suo QL, 2005, POWDER TECHNOL, V154, P110, DOI 10.1016/j.powtec.2005.05.001
   Suwito Supriyono, 2012, Frontiers of Chemical Science and Engineering, V6, P210, DOI 10.1007/s11705-012-1282-5
   Svoboda P, 2012, POLYM TEST, V31, P444, DOI 10.1016/j.polymertesting.2012.01.004
   Tabernero A, 2012, CHEM ENG PROCESS, V60, P9, DOI 10.1016/j.cep.2012.06.004
   Tabernero A, 2012, POWDER TECHNOL, V217, P177, DOI 10.1016/j.powtec.2011.10.025
   Thakur R, 2005, IND ENG CHEM RES, V44, P7380, DOI 10.1021/ie050417j
   Tomasko DL, 2003, CURR OPIN SOLID ST M, V7, P407, DOI 10.1016/j.cossms.2003.10.005
   Treece MA, 2007, J APPL POLYM SCI, V103, P884, DOI 10.1002/app.25226
   Tsimpliaraki A, 2013, J SUPERCRIT FLUID, V81, P86, DOI 10.1016/j.supflu.2013.05.003
   Tsimpliaraki A, 2011, J SUPERCRIT FLUID, V57, P278, DOI 10.1016/j.supflu.2011.03.010
   Tsivintzelis I, 2007, J SUPERCRIT FLUID, V42, P265, DOI 10.1016/j.supflu.2007.02.009
   Urbanczyk L, 2008, POLYMER, V49, P3979, DOI 10.1016/j.polymer.2008.06.052
   Urbanczyk L, 2009, EUR POLYM J, V45, P643, DOI 10.1016/j.eurpolymj.2008.11.033
   Van Ngo TT, 2010, POLYMER, V51, P3436, DOI 10.1016/j.polymer.2010.05.039
   Vasapollo G, 2004, J SUPERCRIT FLUID, V29, P87, DOI 10.1016/S0896-8446(03)00039-1
   Ventosa N, 2003, J SUPERCRIT FLUID, V26, P33, DOI 10.1016/S0896-8446(02)00189-4
   de Melo SABV, 2014, J SUPERCRIT FLUID, V93, P112, DOI 10.1016/j.supflu.2013.11.019
   Vigano J., 2014, J SUPERCRIT FLUID, V96, P272
   Wang YM, 2008, J SUPERCRIT FLUID, V44, P62, DOI 10.1016/j.supflu.2007.09.018
   Wang YS, 2007, EUR POLYM J, V43, P43, DOI 10.1016/j.eurpolymj.2006.09.007
   Wang Z, 2006, POLYMER, V47, P7670, DOI 10.1016/j.polymer.2006.09.011
   Wijngaard H, 2012, FOOD RES INT, V46, P505, DOI 10.1016/j.foodres.2011.09.027
   Wijngaard H, 2009, J AGR FOOD CHEM, V57, P10625, DOI 10.1021/jf902498y
   Wong A, 2007, IND ENG CHEM RES, V46, P7107, DOI 10.1021/ie070551z
   Wu K, 2008, J SUPERCRIT FLUID, V46, P211, DOI 10.1016/j.supflu.2008.02.007
   Xu LQ, 2014, IND ENG CHEM RES, V53, P2277, DOI 10.1021/ie403594t
   Yang JT, 2013, IND ENG CHEM RES, V52, P14169, DOI 10.1021/ie4018447
   Yang K, 2008, J SUPERCRIT FLUID, V43, P515, DOI 10.1016/j.supflu.2007.07.022
   Yeo SD, 2005, J SUPERCRIT FLUID, V34, P287, DOI 10.1016/j.supflu.2004.10.006
   Yu WL, 2008, CHINESE J CHEM ENG, V16, P956, DOI 10.1016/S1004-9541(09)60023-9
   Yun JH, 2012, APCBEE PROC, V2, P22, DOI 10.1016/j.apcbee.2012.06.005
   Yun JH, 2013, J IND ENG CHEM, V19, P686, DOI 10.1016/j.jiec.2012.10.005
   Yuvaraj H, 2008, EUR POLYM J, V44, P2253, DOI 10.1016/j.eurpolymj.2008.04.040
   Zhai WT, 2006, POLYMER, V47, P7580, DOI 10.1016/j.polymer.2006.08.034
   Zhai WT, 2010, IND ENG CHEM RES, V49, P9834, DOI 10.1021/ie101225f
   Zhang YZ, 2012, POWDER TECHNOL, V221, P343, DOI 10.1016/j.powtec.2012.01.023
   Zhao HB, 2013, COMPOS PART B-ENG, V51, P79, DOI 10.1016/j.compositesb.2013.02.034
   Zhao HB, 2013, IND ENG CHEM RES, V52, P2569, DOI 10.1021/ie301573y
NR 184
TC 2
Z9 2
U1 6
U2 58
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAY
PY 2015
VL 23
IS 5
BP 403
EP 417
DI 10.1007/s13233-015-3067-4
PG 15
WC Polymer Science
SC Polymer Science
GA CH9YV
UT WOS:000354393500001
DA 2018-10-20
ER

PT J
AU Domingues, JFD
   Roest, S
   Wang, Y
   van der Mei, HC
   Libera, M
   van Kooten, TG
   Busscher, HJ
AF Domingues, Joana F. da Silva
   Roest, Steven
   Wang, Yi
   van der Mei, Henny C.
   Libera, Matthew
   van Kooten, Theo G.
   Busscher, Henk J.
TI Macrophage phagocytic activity toward adhering staphylococci on cationic
   and patterned hydrogel coatings versus common biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial-associated infection; Poly(ethylene)glycol coatings;
   Cationic coatings; Water contact angles; Phagocytosis
ID GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; TISSUE INTEGRATION; MICROBIAL
   ADHESION; BIOFILM FORMATION; J774 MACROPHAGES; STAINLESS-STEEL;
   CELL-ADHESION; NITRIC-OXIDE; SURFACES
AB Biomaterial-associated-infection causes failure of biomaterial implants. Many new biomaterials have been evaluated for their ability to inhibit bacterial colonization and stimulate tissue-cell-integration, but neglect the role of immune cells. This paper compares macrophage phagocytosis of adhering Staphylococcus aureus on cationic-coatings and patterned poly(ethylene)glycol-hydrogels versus common biomaterials and stainless steel in order to identify surface conditions that promote clearance of adhering bacteria. Staphylococci were allowed to adhere and grow on the materials in a parallel-plate-flow-chamber, after which murine macrophages were introduced. From the decrease in the number of adhering staphylococci, phagocytosis-rates were calculated, and total macrophage displacements during an experiment determined. Hydrophilic surfaces had the lowest phagocytosis-rates, while common biomaterials had intermediate phagocytosis-rates. Patterning of poly(ethylene)glycol-hydrogel coatings increased phagocytosis-rates to the level of common biomaterials, while on cationic-coatings phagocytosis-rates remained relatively low. Likely, phagocytosis-rates on cationic coatings are hampered relative to common biomaterials through strong electrostatic binding of negatively-charged macrophages and staphylococci. On polymeric biomaterials and glass, phagocytosis-rates increased with macrophage displacement, while both parameters increased with biomaterial surface hydrophobicity. Thus hydrophobicity is a necessary surface condition for effective phagocytosis. Concluding, next-generation biomaterials should account for surface effects on phagocytosis in order to enhance the ability of these materials to resist biomaterial-associated-infection. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Domingues, Joana F. da Silva; Roest, Steven; van der Mei, Henny C.; van Kooten, Theo G.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Wang, Yi; Libera, Matthew] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
RP van der Mei, HC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1,FB-40, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
OI Wang, Yi/0000-0001-5495-5839
FU UMCG; U.S. Army Research Office [W911NF-12-1-0331]
FX This project was funded by the UMCG and partially supported by the U.S.
   Army Research Office via Grant #W911NF-12-1-0331.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/nchembio.264, 10.1038/NCHEMBIO.264]
   Chiang WC, 2009, APPL ENVIRON MICROB, V75, P1674, DOI 10.1128/AEM.02274-08
   Costerton J, 2007, INT J ARTIF ORGANS, V30, P757
   Dai XG, 2014, ANALYST, V139, P5568, DOI 10.1039/c4an01220h
   Dai XG, 2012, SOFT MATTER, V8, P3067, DOI 10.1039/c1sm06702h
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   Dinjaski N, 2014, BIOMATERIALS, V35, P14, DOI 10.1016/j.biomaterials.2013.09.059
   Domingues JFD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070046
   Draing C, 2008, IMMUNOBIOLOGY, V213, P285, DOI 10.1016/j.imbio.2007.12.001
   Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hattor Y, 1997, BIOCHEM BIOPH RES CO, V233, P375, DOI 10.1006/bbrc.1997.6462
   Hedberg Y, 2014, COLLOID SURFACE B, V122, P216, DOI 10.1016/j.colsurfb.2014.06.066
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hucknall A, 2009, BIOINTERPHASES, V4, pFA50, DOI 10.1116/1.3151968
   Jones KJ, 2005, J MED MICROBIOL, V54, P315, DOI 10.1099/jmm.0.45872-0
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x
   Kimbrell MR, 2008, IMMUNOL LETT, V118, P132, DOI 10.1016/j.imlet.2008.03.009
   Krsko P, 2003, LANGMUIR, V19, P5618, DOI 10.1021/la034157r
   Krsko P, 2005, NANOFABRICATION TECH
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Lee JH, 2012, BIOMATERIALS, V33, P999, DOI 10.1016/j.biomaterials.2011.10.036
   Lichter JA, 2009, LANGMUIR, V25, P7686, DOI 10.1021/la900349c
   Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138
   Magin CM, 2010, BIOFOULING, V26, P719, DOI 10.1080/08927014.2010.511198
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Mintzer MA, 2012, MOL PHARMACEUT, V9, P342, DOI 10.1021/mp2005033
   Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Nguyen F, 1998, ELECTROCHIM ACTA, V44, P239, DOI 10.1016/S0013-4686(98)00111-X
   Peltroche-Llacsahuanga H, 2000, FEMS MICROBIOL LETT, V191, P151, DOI 10.1016/S0378-1097(00)00384-0
   Rochford ET, 2014, J BIOMED MAT RES A
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Scislowska-Czarnecka A, 2012, J BIOMAT SCI-POLYM E, V23, P715, DOI 10.1163/092050611X559421
   Seral C, 2003, ANTIMICROB AGENTS CH, V47, P2283, DOI 10.1128/AAC.47.7.2283-2292.2003
   Song Z, 2013, ORTHOP REV, V5, P65, DOI 10.4081/or.2013.e14
   Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   SUNDERLAND J, 1995, J BIOLUM CHEMILUM, V10, P291, DOI 10.1002/bio.1170100506
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
   Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744
   VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315
   Vincent ME, 2010, CHEM SOC REV, V39, P974, DOI 10.1039/b917851a
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   Wang Y, 2014, BIOMATERIALS, V35, P5446, DOI 10.1016/j.biomaterials.2014.03.057
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wiles JA, 2004, J PHYS CHEM B, V108, P20296, DOI 10.1021/jp0457904
   Yue CX, 2014, BIOMATERIALS, V35, P2580, DOI 10.1016/j.biomaterials.2013.12.036
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 68
TC 8
Z9 8
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 1
EP 8
DI 10.1016/j.actbio.2015.02.028
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300001
DA 2018-10-20
ER

PT J
AU Levato, R
   Planell, JA
   Mateos-Timoneda, MA
   Engel, E
AF Levato, Riccardo
   Planell, Josep A.
   Mateos-Timoneda, Miguel A.
   Engel, Elisabeth
TI Role of ECM/peptide coatings on SDF-1 alpha triggered mesenchymal
   stromal cell migration from microcarriers for cell therapy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Chemotaxis; ECM (extracellular matrix); Mesenchymal stromal cells;
   Surface modification; Cell therapy
ID STEM-CELLS; BONE-MARROW; ENDOTHELIAL-CELLS; ADHESION; CXCR4; CULTURE;
   DIFFERENTIATION; EXPRESSION; CARTILAGE; DELIVERY
AB Many cell therapies rely on the ability of mesenchymal stromal cells (MSCs) to diffuse and localize throughout the target tissue - such as tumoral and ischemic tissues-, in response to specific cytokine signals, rather than being concentrated at the site of implantation. Therefore, it is fundamental to engineer biomaterial carriers as reservoirs, from which cells can migrate, possibly in a controlled manner. In this work, microcarriers (mu Cs) made of polylactic acid are characterized as MSC delivery vehicles capable of modulating key chemotactic pathways. The effect of different functionalization strategies on MSC migratory behavior from the mu Cs is studied in vitro in relation to SDF-1 alpha/CXCR4 axis, - a major actor in MSC recruitment, chemotaxis and homing. Collagen and arginine-glycine-aspartic acid (RGD) peptides were either covalently grafted or physisorbed on mu C surface. While stable covalent modifications promoted better cell adhesion and higher proliferation compared to physisorption, the functionalization method of the mu Cs also affected the cells migratory behavior in response to SDF-1 alpha (CXCL12) stimulation. Less stable coatings (physisorbed) showed sensibly higher number of migrating cells than covalent collagen/RGD coatings. The combination of physic-chemical cues provided by protein/peptide functionalization and stimuli induced by 3D culture on mu Cs improved MSC expression of CXCR4, and exerted a control over cell migration, a condition suitable to promote cell homing after transplantation in vivo. These are key findings to highlight the impact of surface modification approaches on chemokine-triggered cell release, and allow designing biomaterials for efficient and controlled cell delivery to damaged tissues. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Levato, Riccardo; Planell, Josep A.; Mateos-Timoneda, Miguel A.; Engel, Elisabeth] Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies Grp, Barcelona, Spain.
   [Levato, Riccardo; Mateos-Timoneda, Miguel A.; Engel, Elisabeth] CIBER Biomat Bioingn & Nanomed CIBER BBN, Zaragoza, Spain.
   [Engel, Elisabeth] Tech Univ Catalonia, Dept Mat Sci & Met, Barcelona, Spain.
RP Mateos-Timoneda, MA (reprint author), Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies Grp, Barcelona, Spain.
EM mamateos@ibecbarcelona.eu
OI Levato, Riccardo/0000-0002-3795-3804
FU Spanish Ministry of Education, Culture and Sport (MECD) [AP2010-4827];
   Spanish Ministry of Economy and Competitiveness [MAT2012-38793]
FX RL acknowledges the Spanish Ministry of Education, Culture and Sport
   (MECD) for its financial support through the FPU programme (Grant
   reference AP2010-4827) and the Spanish Ministry of Economy and
   Competitiveness (Project MAT2012-38793).
CR Alieva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035148
   Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Chang J, 2012, CELL PROLIFERAT, V45, P430, DOI 10.1111/j.1365-2184.2012.00836.x
   Chen W, 2013, CELL BIOCHEM BIOPHYS, V67, P1181, DOI 10.1007/s12013-013-9632-6
   Chung HJ, 2009, TISSUE ENG PT A, V15, P1391, DOI 10.1089/ten.tea.2008.0344
   Das Madhurima, 2013, J Stem Cells, V8, P1
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Egea V, 2011, CELL DEATH DIFFER, V18, P853, DOI 10.1038/cdd.2010.154
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Filova E, 2014, J BIOMED MATER RES A, V102, P698, DOI 10.1002/jbm.a.34733
   Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769
   Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   Herklotz M, 2009, BIOMATERIALS, V30, P35, DOI 10.1016/j.biomaterials.2008.09.023
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Levato R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035020
   Levato R, 2012, MACROMOL BIOSCI, V12, P557, DOI 10.1002/mabi.201100383
   Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Madhavan NK, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI DOI 10.1016/J.BI0RTECH.2010.05.092
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Pompe T, 2004, TISSUE ENG, V10, P841, DOI 10.1089/1076327041348356
   Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200
   Punet X, 2013, BIOMACROMOLECULES, V14, P2690, DOI 10.1021/bm4005436
   Rafiq QA, 2013, BIOTECHNOL LETT, V35, P1233, DOI 10.1007/s10529-013-1211-9
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Sart S, 2013, J TISSUE ENG REGEN M, V7, P537, DOI 10.1002/term.545
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Wiehe JM, 2013, INT J CARDIOL, V167, P2073, DOI 10.1016/j.ijcard.2012.05.065
   Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526
   Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796
   Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
NR 43
TC 12
Z9 12
U1 3
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 59
EP 67
DI 10.1016/j.actbio.2015.02.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300007
PM 25702533
DA 2018-10-20
ER

PT J
AU Kasputis, T
   Pieper, A
   Rodenhausen, KB
   Schmidt, D
   Sekora, D
   Rice, C
   Schubert, E
   Schubert, M
   Pannier, AK
AF Kasputis, Tadas
   Pieper, Alex
   Rodenhausen, Keith Brian
   Schmidt, Daniel
   Sekora, Derek
   Rice, Charles
   Schubert, Eva
   Schubert, Mathias
   Pannier, Angela K.
TI Use of precisely sculptured thin film (STF) substrates with generalized
   ellipsometry to determine spatial distribution of adsorbed fibronectin
   to nanostructured columnar topographies and effect on cell adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotopography; Surface analysis; Protein adsorption; Biocompatibility;
   Cell adhesion
ID PROTEIN ADSORPTION; SURFACE-CHEMISTRY; NANOSCALE ROUGHNESS; INTEGRIN
   BINDING; STEM-CELLS; TITANIUM; PROLIFERATION; OSTEOBLASTS; ATTACHMENT;
   INTERPLAY
AB Sculptured thin film (STF) substrates consist of nanocolumns with precise orientation, intercolumnar spacing, and optical anisotropy, which can be used as model biomaterial substrates to study the effect of homogenous nanotopogrophies on the three-dimensional distribution of adsorbed proteins. Generalized ellipsometry was used to discriminate between the distributions of adsorbed FN either on top of or within the intercolumnar void spaces of STFs, afforded by the optical properties of these precisely crafted substrates. Generalized ellipsometry indicated that STFs with vertical nanocolumns enhanced total FN adsorption two-fold relative to flat control substrates and the FN adsorption studies demonstrate different STF characteristics influence the degree of FN immobilization both on top and within intercolumnar spaces, with increasing spacing and surface area enhancing total protein adsorption. Mouse fibroblasts or mouse mesenchymal stem cells were subsequently cultured on STFs, to investigate the effect of highly ordered and defined nanotopographies on cell adhesion, spreading, and proliferation. All STF nanotopographies investigated in the absence of adsorbed FN were found to significantly enhance cell adhesion relative to flat substrates; and the addition of FN to STFs was found to have cell-dependent effects on enhancing cell material interactions. Furthermore, the amount of FN adsorbed to the STFs did not correlate with comparative enhancements of cell material interactions, suggesting that nanotopography predominantly contributes to the biocompatibility of homogenous nanocolumnar surfaces. This is the first study to correlate precisely defined nanostructured features with protein distribution and cell nanomaterial interactions. STFs demonstrate immense potential as biomaterial surfaces for applications in tissue engineering, drug delivery, and biosensing. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kasputis, Tadas; Pieper, Alex; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.
   [Rodenhausen, Keith Brian; Schmidt, Daniel; Sekora, Derek; Rice, Charles; Schubert, Eva; Schubert, Mathias] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
   [Schmidt, Daniel] Natl Univ Singapore, Singapore Synchotron Light Source, Singapore 119077, Singapore.
   [Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.
   [Kasputis, Tadas; Pieper, Alex; Rodenhausen, Keith Brian; Schmidt, Daniel; Sekora, Derek; Rice, Charles; Schubert, Eva; Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska Med Ctr, Maly & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA.
RP Pannier, AK (reprint author), 231 LW Chase Hall, Lincoln, NE 68583 USA.
EM apannier2@unl.edu
RI Schmidt, Daniel/F-2694-2010; Schubert, Mathias/B-2676-2017
OI Schubert, Mathias/0000-0001-6238-663X
FU National Science Foundation (CAREER) [CBET-1254415]; Center for
   Nanohybrid Functional Materials [NSF EPS-1004094]; American Heart
   Association [10SDG2640217]; University of Nebraska Foundation; J.A.
   Woollam Company; USDA CSREES-Nebraska [NEB-21-146]
FX Support for this research was provided in part by funds from the
   National Science Foundation (CAREER to AKP, CBET-1254415), Center for
   Nanohybrid Functional Materials (NSF EPS-1004094), American Heart
   Association (#10SDG2640217), the University of Nebraska Foundation
   (Layman Funds), the J.A. Woollam Company, and USDA CSREES-Nebraska
   (NEB-21-146).
CR Akasaka T, 2010, MAT SCI ENG C-MATER, V30, P391, DOI 10.1016/j.msec.2009.12.006
   Albuschies J., 2013, SCI REP, V3
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bazaka K, 2011, BIOTECHNOL J, V6, P1103, DOI 10.1002/biot.201100027
   Bittrich E, 2010, BIOINTERPHASES, V5, P1, DOI 10.1116/1.3530841
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cheng Q, 2009, BIOMATERIALS, V30, P4203, DOI 10.1016/j.biomaterials.2009.04.023
   Depan D, 2013, ACTA BIOMATER, V9, P6084, DOI 10.1016/j.actbio.2012.12.019
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dolatshahi-Pirouz A, 2011, COLLOID SURFACE B, V84, P18, DOI 10.1016/j.colsurfb.2010.12.004
   Dolatshahi-Pirouz A, 2009, NANOTECHNOLOGY, P20
   Elias AL, 2005, J MICROMECH MICROENG, V15, P49, DOI 10.1088/0960-1317/15/1/008
   Elter P, 2011, LANGMUIR, V27, P8767, DOI 10.1021/la201358c
   Emohare O, 2013, J MATER SCI-MATER M, V24, P1543, DOI 10.1007/s10856-013-4904-7
   Garcia AJ, 2000, MOL BIOL CELL, V11, p393A
   Gerein NJ, 2010, SOL ENERG MAT SOL C, V94, P2343, DOI 10.1016/j.solmat.2010.08.010
   Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233
   Harris KD, 2000, J ELECTROCHEM SOC, V147, P2002, DOI 10.1149/1.1393475
   He YP, 2011, NANOSCALE, V3, P2361, DOI 10.1039/c1nr10103j
   Heydarkhan-Hagvall S, 2007, CELL COMMUN ADHES, V14, P181, DOI 10.1080/15419060701755594
   Joos U, 2006, EUR J CELL BIOL, V85, P225, DOI 10.1016/j.ejcb.2005.08.007
   Kasputis T, 2013, J PHYS CHEM C, V117, P13971, DOI 10.1021/jp402055h
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Koenig M, 2014, ANAL BIOANAL CHEM, V406, P7233, DOI 10.1007/s00216-014-8154-4
   KOTELIANSKY VE, 1981, EUR J BIOCHEM, V119, P619, DOI 10.1111/j.1432-1033.1981.tb05652.x
   Lai M, 2012, COLLOID SURFACE B, V97, P211, DOI 10.1016/j.colsurfb.2012.04.029
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee BH, 2012, ACTA BIOMATER, V8, P1693, DOI 10.1016/j.actbio.2012.01.012
   Li JA, 2013, NUCL INSTRUM METH B, V307, P575, DOI 10.1016/j.nimb.2012.11.055
   Liang D, 2013, APPL PHYS LETT, P103
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lisfi A, 2001, PHYS REV B, P63
   Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, P24
   Lovejoy KS, 2011, MOL CANCER THER, V10, P1709, DOI 10.1158/1535-7163.MCT-11-0250
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Misra RDK, 2013, J BIOMED MATER RES A, V101, P1, DOI 10.1002/jbm.a.34105
   More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010
   Novin M, 2013, SURF INTERFACE ANAL, V45, P619, DOI 10.1002/sia.5101
   Pareta RA, 2009, BIOTECHNOL BIOENG, V103, P459, DOI 10.1002/bit.22276
   Pennisi C. P., 2009, NANOTECHNOLOGY, V20
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z
   Pompe T, 2005, BIOPHYS J, V88, P527, DOI [10.1529/biophysj.104.048074, 10.1529/biophysj.104.049074]
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656
   Rider DA, 2011, NANOTECHNOLOGY, P22
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Robbie K, 1996, NATURE, V384, P616, DOI 10.1038/384616a0
   Rodenhausen KB, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3653880
   Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2817, DOI 10.1016/j.tsf.2010.11.081
   Rodenhausen KB, 2012, OPT EXPRESS, V20, P5419, DOI 10.1364/OE.20.005419
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Sabirianov RF, 2011, PHYS CHEM CHEM PHYS, V13, P6597, DOI 10.1039/c0cp02389b
   Salakhutdinov I, 2008, J NANOMATER
   Schmidt D, 2008, PHYS STATUS SOLIDI A, V205, P748, DOI 10.1002/pssa.200777906
   Schmidt D, 2009, J APPL PHYS, P105
   Schmidt D, 2012, APPL PHYS LETT, P100
   Schmidt D, 2011, THIN SOLID FILMS, V519, P2645, DOI 10.1016/j.tsf.2010.12.111
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Shi HQ, 1999, NATURE, V398, P593
   Steele JJ, 2007, J MATER SCI-MATER EL, V18, P367, DOI 10.1007/s10854-006-9049-8
   Sweetman MJ, 2012, ADV FUNCT MATER, V22, P1158, DOI 10.1002/adfm.201102000
   Tajima S, 2008, J BIOMED MATER RES A, V84A, P828, DOI 10.1002/jbm.a.31539
   Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088
   Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074
   Thomas M, 2011, ACS APPL MATER INTER, V3, P1887, DOI 10.1021/am200076m
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Venkatsurya PKC, 2012, MAT SCI ENG C-MATER, V32, P330, DOI 10.1016/j.msec.2011.10.036
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yonezawa A, 2011, BIOCHEM PHARMACOL, V81, P563, DOI 10.1016/j.bcp.2010.11.016
   Zhang J, 2009, ADV MATER, V21, P790, DOI 10.1002/adma.200801586
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao YP, 2003, P SOC PHOTO-OPT INS, V5219, P59, DOI 10.1117/12.505253
NR 78
TC 8
Z9 8
U1 1
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2015
VL 18
BP 88
EP 99
DI 10.1016/j.actbio.2015.02.016
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG8ZX
UT WOS:000353605300010
PM 25712389
DA 2018-10-20
ER

PT J
AU Chamberlain, MD
   West, MED
   Lam, GC
   Sefton, MV
AF Chamberlain, M. Dean
   West, Michael E. D.
   Lam, Gabrielle C.
   Sefton, Michael V.
TI In Vivo Remodelling of Vascularizing Engineered Tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Hypoxia; HIF-1 alpha; Angiogenesis; Mesenchymal stromal cells; Myeloid
   cells; Macrophages; M1; M2; Host response
ID ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; HUMAN-MELANOMA
   XENOGRAFTS; BONE-MARROW; MACROPHAGE ACTIVATION; STROMAL CELLS; TUMOR
   ANGIOGENESIS; OXYGEN GRADIENTS; HOST VASCULATURE; MYELOID CELLS
AB A critical aspect of creating vascularized tissues is the remodelling that occurs in vivo, driven in large part by the host response to the tissue construct. Rather than a simple inflammatory response, a beneficial tissue remodelling response results in the formation of vascularised tissue. The characteristics and dynamics of this response are slowly being elucidated, especially as they are modulated by the complex interaction between the biomaterial and cellular components of the tissue constructs and the host. This process has elements that are similar to both wound healing and tumour development, and its features are illustrated by reference to the bottom-up generation of a tissue using modular constructs. These modular constructs consist of mesenchymal stromal cells (MSC) embedded in endothelial cell (EC)-covered collagen gel rods that are a few hundred microns in size. Particular attention is paid to the role of hypoxia and macrophage recruitment, as well as the paracrine effects of the MSC and EC in this host response.
C1 [Chamberlain, M. Dean; West, Michael E. D.; Lam, Gabrielle C.; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Chamberlain, M. Dean; West, Michael E. D.; Lam, Gabrielle C.; Sefton, Michael V.] Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.
   [Chamberlain, M. Dean; Sefton, Michael V.] Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
RI Chamberlain, Michael/A-9107-2016
OI Chamberlain, Michael/0000-0003-1813-8545
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR); Ontario Research
   Excellence Fund; CIHR; NSERC
FX We thank the Natural Sciences and Engineering Research Council of Canada
   (NSERC), Canadian Institutes of Health Research (CIHR) and the Ontario
   Research Excellence Fund for financial support. M. D. C. thanks CIHR for
   a Post-doctoral Fellowship, M. E. D. W. thanks NSERC for a CREATE
   Graduate Scholarship and G. C. L. thanks CIHR for a Frederick Banting
   and Charles Best Canada Graduate Scholarship (CGS) Doctoral Award and a
   Training Program in Regenerative Medicine Award.
CR Aguilera KY, 2014, CELL MOL LIFE SCI, V71, P299, DOI 10.1007/s00018-013-1432-z
   Akman HO, 2001, BLOOD, V98, P3324, DOI 10.1182/blood.V98.12.3324
   Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f
   Balaji S, 2013, ADV WOUND CARE, V2, P283, DOI 10.1089/wound.2012.0398
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423
   Benelli R, 2001, FASEB J, V15, P267, DOI 10.1096/fj.01-0651fje
   Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Butler MJ, 2012, TISSUE ENG PT A, V18, P1628, DOI [10.1089/ten.tea.2011.0467, 10.1089/ten.TEA.2011.0467]
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI 10.1089/ten.TEA.2010.0293
   Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1222, DOI [10.1089/ten.tea.2013.0241, 10.1089/ten.TEA.2013.0241]
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1235, DOI [10.1089/ten.tea.2013.0242, 10.1089/ten.TEA.2013.0242]
   Ciucurel EC, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P119
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877
   Debels H, 2013, TISSUE ENG PT A, V19, P2615, DOI [10.1089/ten.tea.2013.0071, 10.1089/ten.TEA.2013.0071]
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Fitzpatrick L. E., 2014, SCAFFOLDS TISSUE ENG, P173
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31
   Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003
   Gulliksrud K, 2008, RADIAT RES, V170, P638, DOI 10.1667/RR1400.1
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960
   Hu M, 2014, LARYNGOSCOPE, V124, P642, DOI 10.1002/lary.24293
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086
   Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kang KT, 2011, BLOOD, V118, P6718, DOI 10.1182/blood-2011-08-375188
   Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602
   Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004
   Kolaczkowska E, 2012, BLOOD, V120, P4455, DOI 10.1182/blood-2012-09-457226
   Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278
   Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Martins-Green M, 2013, ADV WOUND CARE, V2, P327, DOI 10.1089/wound.2012.0380
   Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3
   Mehrad B, 2007, THROMB HAEMOSTASIS, V97, P755, DOI 10.1160/TH07-01-0040
   MEININGER CJ, 1988, AM J PHYSIOL, V255, pH554
   Melero-Martin JM, 2010, TISSUE ENG PT A, V16, P2457, DOI [10.1089/ten.tea.2010.0024, 10.1089/ten.TEA.2010.0024]
   Menon C, 2003, CANCER RES, V63, P7232
   Mikami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067739
   Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109
   Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444
   Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347
   Peng LH, 2013, CELL TISSUE RES, V352, P573, DOI 10.1007/s00441-013-1609-7
   Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603
   Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528
   Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931
   Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167
   Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012
   Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186
   Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176
   Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001
   Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021
   Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Stockmann C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00069
   Sun CJ, 2014, J RADIAT RES, V55, P183, DOI 10.1093/jrr/rrt092
   Takahashi T, 1999, NAT MED, V5, P434
   Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x
   Tura O, 2013, STEM CELLS, V31, P338, DOI 10.1002/stem.1280
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   Van Belle E, 1998, CIRCULATION, V97, P381
   Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240
   Zhu HT, 2012, ONCOL REP, V28, P1217, DOI 10.3892/or.2012.1944
NR 106
TC 3
Z9 3
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2015
VL 43
IS 5
BP 1189
EP 1200
DI 10.1007/s10439-014-1146-x
PG 12
WC Engineering, Biomedical
SC Engineering
GA CH1KM
UT WOS:000353780300012
PM 25297985
DA 2018-10-20
ER

PT J
AU Teimouri, A
   Ebrahimi, R
   Emadi, R
   Beni, BH
   Chermahini, AN
AF Teimouri, Abbas
   Ebrahimi, Raheleh
   Emadi, Rahmatollah
   Beni, Batool Hashemi
   Chermahini, Alireza Najafi
TI Nano-composite of silk fibroin-chitosan/Nano ZrO2 for tissue engineering
   applications: Fabrication and morphology
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Chitosan; Tissue engineering; Microporous materials
ID POROUS SCAFFOLDS; PORE-SIZE; HYDROXYAPATITE; BIOMATERIAL; ZIRCONIA;
   PROLIFERATION; MIGRATION; NANOFIBER; MEMBRANE; MATRICES
AB A scaffold possessing certain desired features such as biodegradation, biocompatibility, and porous structure could serve as a template for tissue engineering. In the present study, silk fibroin (SF), chitosan (CS) and zirconia (Nano ZrO2) were all combined using the freeze drying technique to fabricate a bio-composite scaffold. The composite scaffold (SF/CS/Nano ZrO2) was characterized by SEM, XRD, TGA, BET and FT-IR studies. The scaffold was found to possess a porous nature with pore dimensions suitable for cell infiltration and colonization. The presence of zirconia in the SF/CS/Nano ZrO2 scaffold led to an increase in compressive strength and water uptake capacity while at the same time decreasing the porosity. Cytocompatibility of the SF/CS/Nano ZrO2 scaffold, assessed by MU assay, revealed non-toxicity to the Human Gingival Fibroblast (HGF, NCBI: C-131). Thus, we suggest that SF/CS/Nano ZrO2 composite scaffold is a potential candidate to be used for tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Teimouri, Abbas; Ebrahimi, Raheleh] Payame Noor Univ, Dept Chem, Tehran 193953697, Iran.
   [Emadi, Rahmatollah] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
   [Beni, Batool Hashemi] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci, Esfahan, Iran.
   [Chermahini, Alireza Najafi] Isfahan Univ Technol, Dept Chem, Esfahan 8415683111, Iran.
RP Teimouri, A (reprint author), Payame Noor Univ, Dept Chem, POB 81395-671, Esfahan, Iran.
EM a_teimouri@pnu.ac.ir
RI Najafi Chermahini, Alireza/F-8271-2017
OI Najafi Chermahini, Alireza/0000-0001-9803-7837
FU Payame Noor University in Isfahan Research council [62370]
FX Supports from the Payame Noor University in Isfahan Research council
   (Grant # 62370) and contribution from Isfahan University of Technology
   are gratefully acknowledged. The authors would like to thank Dr. L.
   Ghorbanian for critical reading of the manuscript. We thank Mrs. Hydari
   for providing cell culture facilities.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bahrami SB, 2003, IRAN POLYM J, V12, P139
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bhardwaj N, 2011, INT J BIOL MACROMOL, V49, P260, DOI 10.1016/j.ijbiomac.2011.04.013
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cao H, 2013, J MATER SCI, V48, P150, DOI 10.1007/s10853-012-6722-6
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Chung TW, 2010, J MATER SCI-MATER M, V21, P1343, DOI 10.1007/s10856-009-3876-0
   Eberli D., 2011, REGENERATIVE MED TIS
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Gibson L., 1999, CAMBRIDGE SOLID STAT
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang XJ, 2007, EUR POLYM J, V43, P3710, DOI 10.1016/j.eurpolymj.2007.06.010
   Jao WC, 2012, POLYM ADVAN TECHNOL, V23, P1066, DOI 10.1002/pat.2014
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004
   Pattnaik S, 2011, INT J BIOL MACROMOL, V49, P1167, DOI 10.1016/j.ijbiomac.2011.09.016
   Peon E, 2004, LAT AM APPL RES, V34, P225
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Silva R. M., 2004, J MATER SCI-MATER M, V15, P1105
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Singh M, 1999, J MATER SCI, V34, P5315, DOI 10.1023/A:1004796921503
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Teimouri A, 2014, CERAM INT, V40, P6405, DOI 10.1016/j.ceramint.2013.12.051
   Thomas JM, 1997, PRINCIPLES PRACTICE
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vacanti JP, 2000, PRINCIPLES TISSUE EN, V3, P3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhensheng L., 2006, BIOMATERIALS, V26, P3919
   Zhou YS, 2013, INT J BIOL MACROMOL, V53, P88, DOI 10.1016/j.ijbiomac.2012.11.013
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 60
TC 19
Z9 19
U1 2
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAY
PY 2015
VL 76
BP 292
EP 302
DI 10.1016/j.ijbiomac.2015.02.023
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CG8ZK
UT WOS:000353604000038
PM 25709014
DA 2018-10-20
ER

PT J
AU Vergroesen, PPA
   Bochynska, AI
   Emanuel, KS
   Sharifi, S
   Kingma, I
   Grijpma, DW
   Smit, TH
AF Vergroesen, Pieter-Paul A.
   Bochynska, Agnieszka I.
   Emanuel, Kaj S.
   Sharifi, Shahriar
   Kingma, Idsart
   Grijpma, Dirk W.
   Smit, Theodoor H.
TI A Biodegradable Glue for Annulus Closure Evaluation of Strength and
   Endurance
SO SPINE
LA English
DT Article
DE intervertebral disc; annulus fibrosus repair; nucleus pulposus;
   biomechanics; ex vivo; ultimate strength testing; biodegradable
   polymers; adhesive biomaterial; discectomy; herniation; motion segment
   testing; organ culture; bioreactor
ID BIOMECHANICAL EVALUATION; NUCLEUS REPLACEMENT; DISC DEGENERATION; MODEL;
   PUNCTURE
AB Study Design. A biodegradable glue was biomechanically tested for annulus closure using nondegenerated goat intervertebral discs. Ultimate strength and endurance tests were performed using native and punctured discs as positive and negative controls, respectively.
   Objective. The aim of this study was to investigate the feasibility and biomechanical properties of a biodegradable glue for annulus closure.
   Summary of Background Data. There is an unmet clinical need for annulus closure techniques. Isocyanate-terminated tissue glues show potential because they adhere to annulus tissue, have an elastic modulus similar to the annulus, and show limited cytotoxicity to human annulus fibrosus cells.
   Methods. Three biomechanical tests were performed divided in 2 parts: part 1: ultimate strength tests comparing native, punctured (2.4-mm needle), and glued caprine intervertebral discs (n = 11 per group); part 2: 10 discs per group were subjected to a 10-day ex vivo endurance test of 864,000 load cycles, followed by ultimate strength tests. Outcome parameters include the restoration of strength after puncture, reduction of herniation in the endurance test, and conservation of glue strength after endurance testing.
   Results. Part 1: The glue partially restored subsidence to failure and yield strength/ultimate strength ratio of intervertebral discs. Part 2: During endurance testing, 40% of punctured discs failed compared with none of the glued discs. Endurance testing did not affect glue strength, and pooling of ultimate strength tests showed that the glue restored ultimate strength, work to failure, and yield strength/ultimate strength to 79%, 75%, and 119% of native values, respectively.
   Conclusion. A biodegradable isocyanate-terminated glue increases the force at which nucleus protrusion occurs, and it limits herniations during endurance or ultimate strength tests. Biomechanical tests in a bioreactor provide a low-cost assessment for annulus repair strategies; however, the clinical efficacy needs to be further addressed using long-term in vivo studies.
C1 [Vergroesen, Pieter-Paul A.; Emanuel, Kaj S.; Smit, Theodoor H.] Vrije Univ Amsterdam, Dept Orthoped Surg, Med Ctr, NL-1007 MB Amsterdam, Netherlands.
   [Vergroesen, Pieter-Paul A.; Emanuel, Kaj S.; Kingma, Idsart; Smit, Theodoor H.] MOVE Res Inst Amsterdam, Amsterdam, Netherlands.
   [Bochynska, Agnieszka I.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Bochynska, Agnieszka I.] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, Orthoped Res Lab,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.
   [Sharifi, Shahriar; Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, Groningen, Netherlands.
   [Kingma, Idsart] Vrije Univ Amsterdam, Dept Human Movement Sci, NL-1007 MB Amsterdam, Netherlands.
RP Smit, TH (reprint author), Vrije Univ Amsterdam, Dept Orthoped Surg, Med Ctr, De Boelelaan 1117,Room 3F-045,POB 7057, NL-1007 MB Amsterdam, Netherlands.
EM Th.smit@vumc.nl
OI Bochynska, Agnieszka/0000-0001-9423-0023; Emanuel,
   Kaj/0000-0002-4970-4303; Vergroesen, Pieter-Paul/0000-0001-7769-2197
FU government-led consortium for the development of BioMedical Materials,
   BMM [P2.01 IDiDAS]; ZonMW-VICI grant [918.11.635]
FX The government-led consortium for the development of BioMedical
   Materials, BMM (grant number P2.01 IDiDAS), and ZonMW-VICI grant
   918.11.635 funds were received to support this work.
CR ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002
   Akhtar R, 2011, MATER TODAY, V14, P96, DOI 10.1016/S1369-7021(11)70059-1
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bochynska AI, 2013, MACROMOL SYMP, V334, P40, DOI 10.1002/masy.201300101
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468
   Kang JD, 2010, SPINE J, V10, P1106, DOI 10.1016/j.spinee.2010.10.014
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610
   Smit TH, 1997, SPINE, V22, P2823, DOI 10.1097/00007632-199712150-00005
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Smit TH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-38
   van Dijk M, 2003, EUR SPINE J, V12, P34, DOI 10.1007/s00586-002-0458-y
   Vergroesen PPA, 2014, EUR SPINE J, V23, P2359, DOI 10.1007/s00586-014-3450-4
   Wilke HJ, 2013, SPINE, V38, pE587, DOI 10.1097/BRS.0b013e31828ca4bc
NR 20
TC 10
Z9 10
U1 1
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD MAY 1
PY 2015
VL 40
IS 9
BP 622
EP 628
DI 10.1097/BRS.0000000000000792
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA CH2CX
UT WOS:000353833700012
PM 25608249
DA 2018-10-20
ER

PT J
AU Simon-Yarza, T
   Rossi, A
   Heffels, KH
   Prosper, F
   Groll, J
   Blanco-Prieto, MJ
AF Simon-Yarza, Teresa
   Rossi, Angela
   Heffels, Karl-Heinz
   Prosper, Felipe
   Groll, Juergen
   Blanco-Prieto, Maria J.
TI Polymeric Electrospun Scaffolds: Neuregulin Encapsulation and
   Biocompatibility Studies in a Model of Myocardial Ischemia
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CARDIAC REGENERATION; MACROPHAGE PHENOTYPE; DRUG-DELIVERY;
   HEART-FAILURE; INFARCTION; BIOMATERIALS; CARRIER; PATCH
AB Cardiovascular disease represents one of the major health challenges in modern times and is the number one cause of death globally. Thus, numerous studies are under way to identify effective cell- and/or growth factor (GF)-based therapies for repairing damaged cardiac tissue. In this regard, improving the engraftment or survival of regenerative cells and prolonging GF exposure have become fundamental goals in advancing these therapeutic approaches. Biomaterials have emerged as innovative scaffolds for the delivery of both cells and proteins in tissue engineering applications. In the present study, electrospinning was used to generate smooth homogenous polymeric fibers, which consisted of a poly(lactic-co-glycolic acid) (PLGA)/NCO-sP(EO-stat-PO) polymer blend encapsulating the cardioactive GF, Neuregulin-1 (Nrg). We evaluated the biocompatibility and degradation of this Nrg-containing biomaterial in a rat model of myocardial ischemia. Histological analysis revealed the presence of an initial acute inflammatory response after implantation, which was followed by a chronic inflammatory phase, characterized by the presence of giant cells. Notably, the scaffold remained in the heart after 3 months. Furthermore, an increase in the M2:M1 macrophage ratio following implantation suggested the induction of constructive tissue remodeling. Taken together, the combination of Nrg-encapsulating scaffolds with cells capable of inducing cardiac regeneration could represent an ambitious and promising therapeutic strategy for repairing diseased or damaged myocardial tissue.
C1 [Simon-Yarza, Teresa; Blanco-Prieto, Maria J.] Univ Navarra, Dept Pharm & Pharmaceut Technol, Sch Pharm, E-31080 Pamplona, Spain.
   [Rossi, Angela; Heffels, Karl-Heinz; Groll, Juergen] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Prosper, Felipe] Univ Navarra, Hematol Serv & Area Cell Therapy, Clin Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, Dept Pharm & Pharmaceut Technol, Sch Pharm, Irunlarrea 1, E-31080 Pamplona, Spain.
EM juergen.groll@fmz.uni-wuerzburg.de; mjblanco@unav.es
RI Groll, Jurgen/F-4202-2012; Prosper, Felipe/H-6859-2017
OI Groll, Jurgen/0000-0003-3167-8466; Prosper, Felipe/0000-0001-6115-8790;
   Blanco-prieto, Maria J/0000-0003-0710-899X
FU ISCIII-RETIC [RD12/0019/0031]; MINECO [PLE2009-0116 CARDIOBIO]; Program
   INNPACTO (PROCARDIO); European Union FPVII (INELPY); FUN (University of
   Navarra) Caja de Ahorros de Navarra (Programa Tu Eliges: Tu Decides);
   Spanish Ministerio de Educacion (programa FPU);  [SAF2013-42528-R]
FX This work was partially supported by ISCIII-RETIC RD12/0019/0031, MINECO
   PLE2009-0116 CARDIOBIO, SAF2013-42528-R, Program INNPACTO (PROCARDIO),
   European Union FPVII (INELPY), FUN (University of Navarra) Caja de
   Ahorros de Navarra (Programa Tu Eliges: Tu Decides). T.S.-Y. thanks the
   Spanish Ministerio de Educacion (programa FPU) for the fellowship grant.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arana M, 2013, ACTA BIOMATER, V9, P6075, DOI 10.1016/j.actbio.2012.12.014
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Freytes DO, 2012, CELLS TISSUES ORGANS, V195, P171, DOI 10.1159/000331392
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304
   Lakshmanan R, 2012, EXPERT OPIN BIOL TH, V12, P1623, DOI 10.1517/14712598.2012.721770
   Lundberg MS, 2013, CIRC RES, V112, P1097, DOI 10.1161/CIRCRESAHA.112.300638
   Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450
   Mendes-Ferreira P, 2013, DRUG DISCOV TODAY, V18, P836, DOI 10.1016/j.drudis.2013.01.010
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rim N. G., 2013, BIOMED MAT, V8
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   SIMONYARZA T, 2012, RSC DRUG DISCOV, P501
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   World Health Organization, 2012, WORLD HLTH STAT
   World Health Organization (WHO), 2013, CARD DIS CVDS FACT S
NR 31
TC 6
Z9 6
U1 5
U2 37
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY 1
PY 2015
VL 21
IS 9-10
BP 1654
EP 1661
DI 10.1089/ten.tea.2014.0523
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CH3TD
UT WOS:000353952300017
PM 25707939
DA 2018-10-20
ER

PT J
AU Omran, AM
   Do Woo, K
   Kang, DS
   Abdel-Gaber, GT
   Fouad, H
   Abdo, HS
   Khalil, KA
AF Omran, A. M.
   Do Woo, Kee
   Kang, Duck Soo
   Abdel-Gaber, G. T.
   Fouad, H.
   Abdo, Hany S.
   Khalil, Abdelrazek Khalil
TI Fabrication and evaluation of porous Ti-HA bio-nanomaterial by leaching
   process
SO ARABIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Ti-HA composite; Biomaterial; Leaching solution; PCAS; Porosity; Powder
   metallurgy
ID HYDROXYAPATITE; TITANIUM; ALLOYS
AB A porous surface of Ti-HA composite was successfully fabricated by pulsed current activated sintering (PCAS), followed by leaching using diluted H3PO4. The Ti and HA powders were mixed at different contents of the HA, Ti-5, 10, 30 and 40 wt% HA powders. The mixed powders were pressed in a coated graphite die using pulsed current activated sintering (PCAS) under pressure of 60 MPa at temperature of 1000 degrees C for 5 min. The sintered Ti-HA specimens were immersed in the eight kinds of leaching solutions at room temperature for 24 h. The leached specimen's surfaces were characterized using XRD, SEM, EDX and Rockwell hardness. The XRD patterns after sintering show that many phases were detected at the sintered specimen surfaces such as; Ti2O, CaO, CaTiO3, TixPy in addition to the remaining Ti and HA. Furthermore, the high concentration H3PO4 leaching solution is more efficient than the low concentration. Also the produced porous surfaces of Ti-HA materials containing more than 30% HA have a low relative density and hardness than the commercial Ti-6Al-4V ELI alloy. In a word, the presence of porous surface coated by HA will promote the nucleation of the biological apatite created with the human tissue and increase the bonding between them. So, the produced porous materials are considered so easy for the muscle cells to permeate after transplanted with high coherence. (C) 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Omran, A. M.] Al Azhar Univ, Fac Engn, Dept Min & Met, Qena 83513, Egypt.
   [Do Woo, Kee; Kang, Duck Soo] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
   [Do Woo, Kee; Kang, Duck Soo] Chonbuk Natl Univ, RCIT, Jeonju 561756, South Korea.
   [Abdel-Gaber, G. T.] South Valley Univ, Fac Engn, Qena, Egypt.
   [Fouad, H.] King Saud Univ, Riyadh Community Coll, Riyadh 11437, Saudi Arabia.
   [Fouad, H.] Helwan Univ, Fac Engn, Dept Biomed Engn, Helwan, Egypt.
   [Khalil, Abdelrazek Khalil] King Saud Univ, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
   [Abdo, Hany S.; Khalil, Abdelrazek Khalil] Aswan Univ, Fac Energy Engn, Aswan, Egypt.
   [Abdo, Hany S.] King Saud Univ, CEREM, Adv Mfg Inst, Riyadh 11421, Saudi Arabia.
RP Khalil, KA (reprint author), King Saud Univ, Dept Mech Engn, POB 800, Riyadh 11421, Saudi Arabia.
EM kabdelmawgoud@ksu.edu.sa
RI Abdo, Hany/D-3646-2014
OI Abdo, Hany/0000-0002-7260-639X; Abdelmawgoud, Khalil/0000-0001-7965-5779
FU Deanship of Scientific Research at king Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at king Saud University for funding this
   Research Group No. (RG 1435-001).
CR Ahmed T., 1995, SCI TECHNOL, V2
   Jakubowicz J, 2009, ELECTROCHEM COMMUN, V11, P461, DOI 10.1016/j.elecom.2008.12.024
   Khor KA, 2003, SURF COAT TECH, V168, P195, DOI 10.1016/S0257-8972(03)00238-X
   Kumar R. R., 2002, BIOMATER, V23, P1679
   Langsberg J. P., 1992, NATURE, V360, P65
   Long Marc, 1998, BIOMATER, V19, P1921
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Ning CQ, 2004, BIOMATERIALS, V25, P3379, DOI 10.1016/j.biomaterials.2003.10.017
   OKAZAKI Y, 1995, J JPN I MET, V59, P229, DOI 10.2320/jinstmet1952.59.2_229
   Omran AM, 2008, MET MATER-INT, V14, P321, DOI 10.3365/met.mat.2008.06.321
   Sun RX, 2006, MAT SCI ENG C-BIO S, V26, P28, DOI 10.1016/j.msec.2005.05.003
   Thian ES, 2001, BIOMATERIALS, V22, P1225, DOI 10.1016/S0142-9612(00)00272-6
   Turkan U, 2006, SURF COAT TECH, V200, P5020, DOI 10.1016/j.surfcoat.2005.05.005
   Woo K. D., 2009, J KOREAN INST MET MA, V47, P8
   Woo K. D., 2010, CER INT, V36, P1
   Yumoto S., 1992, INT J PIXE, V2, P493, DOI 10.1142/S0129083592000531
NR 16
TC 6
Z9 6
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1878-5352
EI 1878-5379
J9 ARAB J CHEM
JI Arab. J. Chem.
PD MAY
PY 2015
VL 8
IS 3
BP 372
EP 379
DI 10.1016/j.arabjc.2014.11.052
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG4PT
UT WOS:000353269300012
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Paliwal, R
   Uniyal, S
   Rai, JPN
AF Paliwal, Rashmi
   Uniyal, Shivani
   Rai, J. P. N.
TI Evaluating the potential of immobilized bacterial consortium for black
   liquor biodegradation
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biodegradation; Bacterial consortium; Immobilization; Corncob; GC/MS;
   SEM
ID PAPER-MILL EFFLUENT; KRAFT LIGNIN DEGRADATION; CYANIDE WASTE-WATER;
   PHANEROCHAETE-CHRYSOSPORIUM; MANGANESE PEROXIDASE; CELL IMMOBILIZATION;
   ENHANCED PRODUCTION; GAS-CHROMATOGRAPHY; ETHANOL-PRODUCTION; BLEACH
   PLANT
AB Two indigenous bacterial strains, Bacillus megaterium ETLB-1 (accession no. KC767548) and Pseudomonas plecoglossicida ETLB-3 (accession no. KC767547), isolated from soil contaminated with paper mill effluent, were co-immobilized on corncob cubes to investigate their biodegradation potential against black liquor (BL). Results exhibit conspicuous reduction in color and lignin of BL upto 913.46 Co-Pt and 531.45 mg l(-1), respectively. Reduction in chlorophenols up to 12 mg l(-1) was recorded with highest release of chloride ions, i.e., 1290 mg l(-1). Maximum enzyme activity for lignin peroxidase (LiP), manganese peroxidase (MnP), and laccase (LAC) was recorded as 5.06, 8.13, and 8.23 U ml(-1), respectively, during the treatment. Scanning electron microscopy (SEM) revealed successful immobilization of bacterial strains in porous structures of biomaterial. Gas chromatography/mass spectroscopy (GC/MS) showed formation of certain low molecular weight metabolites such as 4-hydroxy-benzoic acid, 3-hydroxy-4-methoxybenzaldehyde, ferulic acid, and t-cinnamic acid and removal of majority of the compounds (such as teratogenic phthalate derivatives) during the period of treatment. Results demonstrated that the indigenous bacterial consortium possesses excellent decolorization and lignin degradation capability which enables its commercial utilization in effluents treatment system.
C1 [Paliwal, Rashmi; Uniyal, Shivani; Rai, J. P. N.] GB Pant Univ Agr & Technol, Ecotechnol Lab, Dept Environm Sci, Pantnagar 263145, Uttar Pradesh, India.
RP Paliwal, R (reprint author), GB Pant Univ Agr & Technol, Ecotechnol Lab, Dept Environm Sci, Pantnagar 263145, Uttar Pradesh, India.
EM paliwal39561@gmail.com
OI Paliwal, Rashmi/0000-0002-0948-7834
CR Arora DS, 2002, INT BIODETER BIODEGR, V50, P115, DOI 10.1016/S0964-8305(02)00064-1
   BAJPAI P, 1993, PROCESS BIOCHEM, V28, P377, DOI 10.1016/0032-9592(93)80024-B
   Belem A, 2008, GLOBAL NEST J, V10, P426
   BERGMANN JG, 1957, ANAL CHEM, V29, P241, DOI 10.1021/ac60122a018
   Branyik T, 2004, BIOTECHNOL BIOENG, V88, P84, DOI 10.1002/bit.20217
   Brenner D. J., 2005, BERGEYS MANUAL SYSTE, V2
   BUSWELL JA, 1987, CRIT REV BIOTECHNOL, V6, P1, DOI 10.3109/07388558709086984
   Chandra R, 2012, BIOCHEM ENG J, V61, P49, DOI 10.1016/j.bej.2011.12.004
   Chandra R, 2011, BIORESOURCE TECHNOL, V102, P6429, DOI 10.1016/j.biortech.2011.03.048
   Chen CY, 2008, CHEMOSPHERE, V71, P133, DOI 10.1016/j.chemosphere.2007.10.058
   Chen CY, 2007, WATER SCI TECHNOL, V56, P99, DOI 10.2166/wst.2007.699
   Chen YH, 2012, J APPL MICROBIOL, V112, P900, DOI 10.1111/j.1365-2672.2012.05275.x
   Chung E, 2005, BIOTECHNOL LETT, V27, P477, DOI 10.1007/s10529-005-2224-9
   D'Souza DT, 2006, ENZYME MICROB TECH, V38, P504, DOI 10.1016/j.enzmictec.2005.07.005
   Franzetti L, 2007, ANN MICROBIOL, V57, P39, DOI 10.1007/BF03175048
   Genisheva Z, 2013, FOOD CHEM, V138, P1510, DOI 10.1016/j.foodchem.2012.11.058
   Genisheva Z, 2011, IND CROP PROD, V34, P979, DOI 10.1016/j.indcrop.2011.03.006
   Greenberg A., 1995, STANDARD METHODS EXA
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Ko JJ, 2009, BIORESOURCE TECHNOL, V100, P1622, DOI 10.1016/j.biortech.2008.09.029
   KUWAHARA M, 1984, FEBS LETT, V169, P247, DOI 10.1016/0014-5793(84)80327-0
   Lee SE, 2012, J MICROBIOL BIOTECHN, V22, P1673, DOI 10.4014/jmb.1202.02049
   Linger JG, 2014, P NATL ACAD SCI USA, V111, P12013, DOI 10.1073/pnas.1410657111
   LUNDQUIST K, 1971, ACTA CHEM SCAND, V25, P889, DOI 10.3891/acta.chem.scand.25-0889
   Malaviya P, 2007, BIORESOURCE TECHNOL, V98, P3647, DOI 10.1016/j.biortech.2006.11.021
   Mishra M, 2010, BIODEGRADATION, V21, P967, DOI 10.1007/s10532-010-9356-x
   Oliveira LPD, 2009, BRAZ J MICROBIOL, V40, P818
   Pakshirajan K, 2009, APPL BIOCHEM BIOTECH, V157, P159, DOI 10.1007/s12010-008-8283-3
   Paliwal R, 2012, APPL BIOCHEM BIOTECH, V167, P1865, DOI 10.1007/s12010-012-9735-3
   Pang Y, 2011, BIORESOURCE TECHNOL, V102, P10733, DOI 10.1016/j.biortech.2011.08.078
   Pathak C, 2013, ENVIRON MONIT ASSESS, V185, P7343, DOI 10.1007/s10661-013-3104-8
   Pearl A, 1940, PAP TRADE J, V111, P35
   Philp JC, 2003, ANAL CHIM ACTA, V487, P61, DOI 10.1016/S0003-2670(03)00358-1
   Raghukumar C, 2001, APPL MICROBIOL BIOT, V55, P510, DOI 10.1007/s002530000579
   Raj A, 2007, INT BIODETER BIODEGR, V59, P292, DOI 10.1016/j.ibiod.2006.09.006
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   SALTER GJ, 1991, CURR OPIN BIOTECH, V2, P385, DOI 10.1016/S0958-1669(05)80143-0
   Shi K, 2013, BIOTECHNOL BIOFUELS, V6, P1
   Shi Y, 2013, BIOPROC BIOSYST ENG, V36, P1957, DOI 10.1007/s00449-013-0972-9
   Singh A, 2002, J ENVIRON BIOL, V23, P283
   Singhal V, 2005, J ENVIRON BIOL, V26, P525
   Sipsas V, 2009, J FOOD ENG, V90, P495, DOI 10.1016/j.jfoodeng.2008.07.016
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tayal AK, 1999, BIOMED CHROMATOGR, V13, P220, DOI 10.1002/(SICI)1099-0801(199905)13:3<220::AID-BMC823>3.0.CO;2-E
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Vos P, 2009, BERGEYS MANUAL SYSTE, V3
   Xu PA, 2012, CHEM ENG J, V203, P423, DOI 10.1016/j.cej.2012.07.048
   Yang C-F, 2007, J ENV ENG MANAG, V17, P157
   Yu JL, 2010, RENEW ENERG, V35, P1130, DOI 10.1016/j.renene.2009.11.045
NR 49
TC 11
Z9 12
U1 2
U2 27
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD MAY
PY 2015
VL 22
IS 9
BP 6842
EP 6853
DI 10.1007/s11356-014-3872-x
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA CG1PX
UT WOS:000353046600042
PM 25433900
DA 2018-10-20
ER

PT J
AU Huang, WW
   Rollett, A
   Kaplan, DL
AF Huang, Wenwen
   Rollett, Alexandra
   Kaplan, David L.
TI Silk-elastin-like protein biomaterials for the controlled delivery of
   therapeutics
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE drug delivery; gene delivery; hydrogel; nanoparticle; protein;
   self-assembly; silk-elastin; stimuli responsive
ID STIMULI-RESPONSIVE NANOCARRIERS; INVERSE TEMPERATURE TRANSITION;
   CONTROLLED DRUG-DELIVERY; ENZYME-PRODRUG THERAPY; GENE DELIVERY;
   CONTROLLED-RELEASE; BLOCK-COPOLYMERS; ESCHERICHIA-COLI; CANCER-THERAPY;
   SOLID TUMORS
AB Introduction: Genetically engineered biomaterials are useful for controlled delivery owing to their rational design, tunable structure-function, biocompatibility, degradability and target specificity. Silk-elastin-like proteins (SELPs), a family of genetically engineered recombinant protein polymers, possess these properties. Additionally, given the benefits of combining semi-crystalline silk-blocks and elastomeric elastin-blocks, SELPs possess multi-stimuli-responsive properties and tunability, thereby becoming promising candidates for targeted cancer therapeutics delivery and controlled gene release.
   Areas covered: An overview of SELP biomaterials for drug delivery and gene release is provided. Biosynthetic strategies used for SELP production, fundamental physicochemical properties and self-assembly mechanisms are discussed. The review focuses on sequence-structure-function relationships, stimuli-responsive features and current and potential drug delivery applications.
   Expert opinion: The tunable material properties allow SELPs to be pursued as promising biomaterials for nanocarriers and injectable drug release systems. Current applications of SELPs have focused on thermally-triggered biomaterial formats for the delivery of therapeutics, based on local hyperthermia in tumors or infections. Other prominent controlled release applications of SELPs as injectable hydrogels for gene release have also been pursued. Further biomedical applications that utilize other stimuli to trigger the reversible material responses of SELPs for targeted delivery, including pH, ionic strength, redox, enzymatic stimuli and electric field, are in progress. Exploiting these additional stimuli-responsive features will provide a broader range of functional biomaterials for controlled therapeutics release and tissue regeneration.
C1 [Huang, Wenwen; Rollett, Alexandra; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU NIH [P41 EB002520]
FX This work is supported by NIH Grant no. P41 EB002520. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript. This includes employment, consultancies, honoraria, stock
   ownership or options, expert testimony, grants or patents received or
   pending or royalties.
CR Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Anderson JP, 1998, BIOPOLYMERS, V45, P307
   ANDERSON JP, 1994, BIOPOLYMERS, V34, P1049, DOI 10.1002/bip.360340808
   Bikram M, 2008, EXPERT OPIN DRUG DEL, V5, P1077, DOI [10.1517/17425247.5.10.1077, 10.1517/17425247.5.10.1077 ]
   Boddy AV, 2005, CLIN CANCER RES, V11, P7834, DOI 10.1158/1078-0432.CCR-05-0803
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Brigger I, 2012, ADV DRUG DELIVER REV, V64, P24, DOI 10.1016/j.addr.2012.09.006
   Calejo MT, 2013, EXPERT OPIN DRUG DEL, V10, P1669, DOI 10.1517/17425247.2013.846906
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Chang J, 2011, J AM CHEM SOC, V133, P1745, DOI 10.1021/ja110191f
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Ciofani G, 2014, MACROMOL BIOSCI, V14, P632, DOI 10.1002/mabi.201300361
   Collins T, 2013, MICROB CELL FACT, V12, P1
   Collins T, 2014, BIOMACROMOLECULES, V15, P2701, DOI 10.1021/bm5005564
   COX BA, 1974, J BIOL CHEM, V249, P997
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dandu R, 2006, ACS SYM SER, V924, P150
   Dandu R, 2008, J BIOACT COMPAT POL, V23, P5, DOI 10.1177/0883911507085278
   Dandu R, 2007, PROG POLYM SCI, V32, P1008, DOI 10.1016/j.progpolymsci.2007.05.015
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   DOEL MT, 1980, NUCLEIC ACIDS RES, V8, P4575, DOI 10.1093/nar/8.20.4575
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Ferrari FA, 1986, EP0293443A1, Patent No. 0293443
   Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020
   Florczak A, 2014, BIOMACROMOLECULES, V15, P2971, DOI 10.1021/bm500591p
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Frandsen JL, 2012, CHEM SOC REV, V41, P2696, DOI 10.1039/c2cs15303c
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gao HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02534
   Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001
   Ge ZS, 2013, CHEM SOC REV, V42, P7289, DOI 10.1039/c3cs60048c
   Ghandehari H, 2002, AM CHEM SOC, V224, P308
   Golinska MD, 2013, BIOMACROMOLECULES, V14, P48, DOI 10.1021/bm3011775
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Gustafson JA, 2010, MOL PHARMACEUT, V7, P1050, DOI 10.1021/mp100161u
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hart DS, 2007, J PHARM SCI-US, V96, P484, DOI 10.1002/jps.20755
   Hatefi A, 2007, PHARM RES, V24, P773, DOI 10.1007/s11095-006-9200-5
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Huang J, 2004, AM CHEM SOC, V227, P188
   Huang WW, 2014, MACROMOLECULES, V47, P8107, DOI 10.1021/ma5016227
   Huang WW, 2014, MACROMOLECULES, V47, P8098, DOI 10.1021/ma5016215
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Hwang D, 2009, INT J PHARM, V368, P215, DOI 10.1016/j.ijpharm.2008.10.021
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Johnson S, 2012, CHEM COMMUN, V48, P10654, DOI 10.1039/c2cc35384a
   Kim W, 2007, POLYM REV, V47, P93, DOI 10.1080/15583720601109586
   Krishnaji ST, 2011, LANGMUIR, V27, P1000, DOI 10.1021/la102638j
   Krishnaji ST, 2013, ADV FUNCT MATER, V23, P241, DOI 10.1002/adfm.201200510
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Li LQ, 2010, POLYM CHEM-UK, V1, P1160, DOI 10.1039/b9py00346k
   Liu YM, 2014, P NATL ACAD SCI USA, V111, pE2780, DOI 10.1073/pnas.1402909111
   Machado R., 2013, BIOMED MATER, V8, P1
   Machado R, 2013, AMB EXPRESS, V3, P1
   Mackay JA, 2008, INT J HYPERTHER, V24, P483, DOI 10.1080/02656730802149570
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/nmat2569, 10.1038/NMAT2569]
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Meyer DE, 2001, CANCER RES, V61, P1548
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Nagarsekar A, 2003, BIOMACROMOLECULES, V4, P602, DOI 10.1021/bm0201082
   Nakayama M, 2006, J CONTROL RELEASE, V115, P46, DOI 10.1016/j.jconrel.2006.07.007
   Ner Y, 2009, POLYMER, V50, P5828, DOI 10.1016/j.polymer.2009.09.017
   Nerini IF, 2014, CLIN PHARMACOL THER, V96, P224, DOI 10.1038/clpt.2014.105
   Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Ozaki C, 2014, J BIOMAT SCI-POLYM E, V25, P1266, DOI 10.1080/09205063.2014.926580
   Pei Y, 2004, J BIOMAT SCI-POLYM E, V15, P585, DOI 10.1163/156856204323046852
   Portney NG, 2006, ANAL BIOANAL CHEM, V384, P620, DOI 10.1007/s00216-005-0247-7
   Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561
   Pray L, 2008, NAT ED, V1, P51
   Price R, 2014, J CONTROL RELEASE, V190, P304, DOI 10.1016/j.jconrel.2014.06.016
   Price R, 2012, INT J PHARMACEUT, V427, P97, DOI 10.1016/j.ijpharm.2011.09.037
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Qiu WG, 2009, BIOMACROMOLECULES, V10, P602, DOI 10.1021/bm801296r
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Raucher D, 2008, EXPERT OPIN DRUG DEL, V5, P353, DOI 10.1517/17425247.5.3.353 
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702
   Rodriguez-Cabello JC, 2007, J BIOMAT SCI-POLYM E, V18, P269, DOI 10.1163/156856207779996904
   Ryu JS, 2014, EUR J PHARM BIOPHARM, V88, P382, DOI 10.1016/j.ejpb.2014.05.016
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shen W, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P243, DOI 10.1007/978-3-7091-0385-2_9
   Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Somamoto S, 2012, J BIOTECHNOL BIOMATE, V2, P139
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun ZY, 2013, J AM CHEM SOC, V135, P3675, DOI 10.1021/ja312647n
   Tjin MS, 2014, POLYM J, V46, P444, DOI 10.1038/pj.2014.65
   Urry DW, 2010, ADV DRUG DELIVER REV, V62, P1404, DOI 10.1016/j.addr.2010.07.001
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   URRY DW, 1985, BIOPOLYMERS, V24, P2345, DOI 10.1002/bip.360241212
   URRY DW, 1992, BIOPOLYMERS, V32, P373, DOI 10.1002/bip.360320413
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Wlodarczyk-Biegun MK, 2014, ACTA BIOMATER, V10, P3620, DOI 10.1016/j.actbio.2014.05.006
   Xia XX, 2014, BIOMACROMOLECULES, V15, P908, DOI 10.1021/bm4017594
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   You YZ, 2008, CHEM MATER, V20, P3354, DOI 10.1021/cm703363w
   Yuan F, 1998, SEMIN RADIAT ONCOL, V8, P164, DOI 10.1016/S1053-4296(98)80042-8
   Zeng LK, 2014, MACROMOL RAPID COMM, V35, P1273, DOI 10.1002/marc.201400058
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 128
TC 28
Z9 28
U1 8
U2 97
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2015
VL 12
IS 5
BP 779
EP 791
DI 10.1517/17425247.2015.989830
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CG3WA
UT WOS:000353209100007
PM 25476201
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Laird, D
   El-Baba, MD
   Charpin-El Hamri, G
   Eberwein, P
   Nelson, K
   Tomakidi, P
   Steinberg, T
AF Laird, Dougal
   El-Baba, Marie Daoud
   Charpin-El Hamri, Ghislaine
   Eberwein, Philipp
   Nelson, Katja
   Tomakidi, Pascal
   Steinberg, Thorsten
TI In vitro and in vivo biocompatibility evaluation of a novobiocin
   stimulus-responsive poly(ethylene glycol)-based hydrogel designed for
   soft tissue regeneration
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Poly(ethylene glycol) (PEG)-based hydrogel; stimulus responsive;
   impedance measurement; cytotoxicity; novobiocin; coumermycin;
   biocompatibility
ID PROTEIN; RGD; BIOMATERIALS; COMBINATION; EXPRESSION; SURFACES; CELLS
AB In vitro and in vivo biocompatibility evaluation of medical devices designed for soft tissue healing and regeneration is mandatory for new biomaterials targeted toward human application. To this end, a novel stimulus-responsive eight-arm poly(ethylene glycol) (PEG)-based hydrogel for soft tissue regeneration was subjected to preclinical safety evaluation. While in vitro safety testing included determination of half-maximal inhibitory concentrations by cell index impedance measurements, an in vivo pilot rat study focused on detectable signs of oral mucosal inflammation. In a hydrogel with a total volume of 40 mu L, the following concentrations of the constituents were released upon hydrogel dissolution in 1mL body fluid: PEG, 19 mu M; gyrase B, 152 mu M; and coumermycin, 76 mu M, while the dissolving agent novobiocin was effective in a range from 50 to 100 mu M. Concerning the components' biological effects, half-maximal inhibitory concentrations of 806 and 95 mu M for human oral mucosal gingival fibroblasts and gingival keratinocytes were calculated for novobiocin, proving gingival keratinocytes more susceptible to substance effects. Furthermore, with respect to coumermycin concentrations, half-maximal inhibitory concentrations of 10 and 3 mu M for gingival fibroblasts and gingival keratinocytes, respectively, were obtained, and thereby revealed coumermycin to be toxic in vitro. In vivo, submucosal hard palatal implantation of standard hydrogels showed no evidence of inflammation at any time point under study, which was supported by immunohistochemistry analysis. In order to realize the potential of such a promising stimulus-responsive hydrogel biomaterial concept for soft tissue wound healing and/or regenerative applications, the crosslinker coumermycin and its competitor novobiocin should be replaced by more innocuous alternative protein-ligand pairs.
C1 [Laird, Dougal; Tomakidi, Pascal; Steinberg, Thorsten] Univ Med Ctr Freiburg, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
   [El-Baba, Marie Daoud; Charpin-El Hamri, Ghislaine] Univ Lyon, Dept Genie Biol, IUT, Lyon, France.
   [Eberwein, Philipp] Univ Eye Hosp Freiburg, Dept Ophthalmol, Freiburg, Germany.
   [Nelson, Katja] Univ Med Ctr Freiburg, Dept Craniomaxillofacial Surg, Freiburg, Germany.
RP Steinberg, T (reprint author), Univ Med Ctr Freiburg, Dept Oral Biotechnol, Hugstetterstr 55, D-79106 Freiburg, Germany.
EM thorsten.steinberg@uniklinik-freiburg.de
FU Deutsche Forschungsgemeinschaft/DFG [EB-478/2-1, TO-198/10-1]; Medical
   Faculty of the University of Freiburg
FX This study was supported by a grant of the Deutsche
   Forschungsgemeinschaft/DFG to Philipp Eberwein (EB-478/2-1) and Pascal
   Tomakidi (TO-198/10-1). Moreover, this work is part of the Research
   Consortium ProTissueMat funded by the Medical Faculty of the University
   of Freiburg.
CR Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Buban T, 2004, CANCER GENET CYTOGEN, V149, P81, DOI 10.1016/S0165-4608(03)00297-8
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   DRUSANO GL, 1986, ANTIMICROB AGENTS CH, V30, P42, DOI 10.1128/AAC.30.1.42
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Eustaquio AS, 2003, ARCH MICROBIOL, V180, P25, DOI 10.1007/s00203-003-0555-2
   FEDORKO J, 1969, APPL MICROBIOL, V18, P869
   Fleischmajer R, 1998, ANN NY ACAD SCI, V857, P212, DOI 10.1111/j.1749-6632.1998.tb10118.x
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474
   Guebeli RJ, 2013, ACTA BIOMATER, V9, P8272, DOI 10.1016/j.actbio.2013.05.008
   KENNEDY MJ, 1995, J CLIN ONCOL, V13, P1136, DOI 10.1200/JCO.1995.13.5.1136
   Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030
   Krishnan S, 2008, J MATER CHEM, V18, P3405, DOI 10.1039/b801491d
   KUTUZOV H, 1952, ANAT REC, V114, P67, DOI 10.1002/ar.1091140106
   Luhrmann A, 1998, ANTIMICROB AGENTS CH, V42, P1911, DOI 10.1128/AAC.42.8.1911
   Luong E, 2009, ADV BIOCHEM ENG BIOT, V114, P129, DOI 10.1007/10_2008_8
   Mahajan A, 2012, E J DENT, V2, P193
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Moodley K, 2011, J NEUROSCI METH, V200, P173, DOI 10.1016/j.jneumeth.2011.07.005
   Mussig E, 2010, EUR J CELL BIOL, V89, P315, DOI 10.1016/j.ejcb.2009.08.004
   NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5
   NORDENBERG J, 1992, BRIT J CANCER, V65, P183, DOI 10.1038/bjc.1992.38
   PALU G, 1984, BIOCHEM PHARMACOL, V33, P147, DOI 10.1016/0006-2952(84)90382-4
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054
   Pivodova V, 2011, BIOMED PAP, V155, P109, DOI 10.5507/bp.2011.021
   Ratliff BB, 2010, AM J PHYSIOL-RENAL, V299, pF178, DOI 10.1152/ajprenal.00102.2010
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SMITH RD, 1990, J AM SOC MASS SPECTR, V1, P53, DOI 10.1016/1044-0305(90)80006-9
   Tomakidi P, 2000, J OROFAC ORTHOP, V61, P2
   Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007
   Venault A, 2013, J NANOSCI NANOTECHNO, V13, P2656, DOI 10.1166/jnn.2013.7359
   Wang TW, 2006, J BIOMED MATER RES B, V79B, P379, DOI 10.1002/jbm.b.30552
   Wu LX, 2008, LEUKEMIA, V22, P1402, DOI 10.1038/leu.2008.89
   Zhang W, 2014, IEJSME, V14, P89
   Zhao HF, 2003, HUM GENE THER, V14, P1619, DOI 10.1089/104303403322542266
NR 37
TC 1
Z9 1
U1 0
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2015
VL 30
IS 3
BP 319
EP 339
DI 10.1177/0883911515570370
PG 21
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA CG6ZC
UT WOS:000353450600006
DA 2018-10-20
ER

PT J
AU Dawlee, S
   Jayabalan, M
AF Dawlee, S.
   Jayabalan, M.
TI Intrinsically radiopaque polyurethanes with chain extender 4,4
   '-isopropylidenebis [2-( 2,6-diiodophenoxy)ethanol] for biomedical
   applications
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biocompatibility; cytotoxicity; iodinated polyurethanes; radiopacity;
   X-ray
ID METHACRYLATE COPOLYMER; BIOCOMPATIBILITY; ELASTOMERS; POLYMERIZATION;
   POLYMERS; UREA)
AB Radiopaque polyurethanes are used for medical applications as it allows post-operative assessment of the biomaterial devices using X-ray. Inherently, radiopaque polyurethanes based on polytetramethylene glycol (PTMG), polypropylene glycol, 4,4-methylenebis(phenyl isocyanate), and a new iodinated chain extender 4,4-isopropylidenebis[2-(2,6-diiodophenoxy)ethanol] with flexible spacers were synthesized and characterized. The iodinated polyurethanes were clear, optically transparent, and had high molecular weights. The polyurethanes also possessed excellent radiopacity and high thermal stability. The biocompatibility of the most promising iodinated polyurethane was evaluated both in vitro (cytotoxicity evaluation by direct contact and MTT assay, using L929 mouse fibroblast cells) and in vivo (toxicology studies in rabbits and subcutaneous implantation in rats). The material was nontoxic and well tolerated by the animals. Thus, these radiopaque and transparent polyurethanes are expected to have potential for various biomedical applications.
C1 [Dawlee, S.; Jayabalan, M.] Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Sci Div, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
RP Jayabalan, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Sci Div, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
EM muthujayabalan@rediffmail.com
FU Council for Scientific and Industrial Research, New Delhi; Kerala State
   Council for Science, Technology and Environment, Trivandrum
FX S. D. acknowledges the financial support from Council for Scientific and
   Industrial Research, New Delhi and Kerala State Council for Science,
   Technology and Environment, Trivandrum.
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   [Anonymous], 2002, ISO1099310
   Aviv H, 2009, BIOMATERIALS, V30, P5610, DOI 10.1016/j.biomaterials.2009.06.038
   Boelen EJH, 2008, J BIOMED MATER RES A, V86A, P76, DOI 10.1002/jbm.a.31601
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   Dawlee S, 2013, J BIOMATER APPL, V28, P28, DOI 10.1177/0885328211434090
   Dawlee S, 2012, J APPL POLYM SCI, V125, P2252, DOI 10.1002/app.36457
   Dawlee S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055002
   Dawlee S, 2009, J MATER SCI-MATER M, V20, P243, DOI 10.1007/s10856-008-3557-4
   EDGAR KJ, 1990, J ORG CHEM, V55, P5287, DOI 10.1021/jo00305a026
   Gogolewski S., 1996, DESK REFERENCE FUNCT, P657
   Ihova B, 1996, ADV DRUG DELIV REV, V21, P157
   ISO10993-6, 2007, ISO109936
   James NR, 2007, BIOMATERIALS, V28, P3182, DOI 10.1016/j.biomaterials.2007.03.025
   James NR, 2006, BIOMATERIALS, V27, P160, DOI 10.1016/j.biomaterials.2005.05.099
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   Kiran S, 2014, J BIOMED MATER RES A, V102, P3207, DOI 10.1002/jbm.a.34997
   Kiran S, 2012, J BIOMED MATER RES A, V100A, P3472, DOI 10.1002/jbm.a.34295
   Kiran S, 2009, BIOMATERIALS, V30, P5552, DOI 10.1016/j.biomaterials.2009.06.049
   Kwok CS, 2000, BIOMACROMOLECULES, V1, P139, DOI 10.1021/bm000292w
   Lakshmi S, 2003, J APPL POLYM SCI, V88, P2580, DOI 10.1002/app.12187
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Liaw DJ, 1997, J APPL POLYM SCI, V66, P1251, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1251::AID-APP5>3.0.CO;2-F
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Pereira IHL, 2010, ACTA BIOMATER, V6, P3056, DOI 10.1016/j.actbio.2010.02.036
   Qu WQ, 2011, J POLYM SCI POL CHEM, V49, P2191, DOI 10.1002/pola.24649
   Sang L, 2014, J BIOMED MATER RES A, V102, P1121, DOI 10.1002/jbm.a.34777
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Velayudhan S, 2005, ACTA BIOMATER, V1, P201, DOI 10.1016/j.actbio.2004.11.005
   Zaharia C, 2008, ACTA BIOMATER, V4, P1762, DOI 10.1016/j.actbio.2008.06.009
   Zhao Jonathon Z, 2008, Biocompatible polymeric contrast agents and radiopaque materials for medical devices, Patent No. [8,197,796, 8197796]
   Zhao O H, 1992, J Biomed Mater Res, V26, P1019
NR 33
TC 0
Z9 0
U1 0
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2015
VL 29
IS 10
BP 1329
EP 1342
DI 10.1177/0885328214565221
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG3DB
UT WOS:000353156600001
PM 25542732
DA 2018-10-20
ER

PT J
AU Hong, JY
   Yon, J
   Lee, JS
   Lee, IK
   Yang, C
   Kim, MS
   Choi, SH
   Jung, UW
AF Hong, Ji-Youn
   Yon, Jeyoung
   Lee, Jung-Seok
   Lee, In-Kyeong
   Yang, Cheryl
   Kim, Min-Soo
   Choi, Seong-Ho
   Jung, Ui-Won
TI Effects of epigallocatechin-3-gallate on the healing of extraction
   sockets with a periapical lesion: A pilot study in dogs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bio-oss collagen; epigallocatechin gallate; histology; periapical
   periodontitis; tooth extraction
ID POLYPHENOL (-)-EPIGALLOCATECHIN GALLATE; RETROGRADE PERI-IMPLANTITIS;
   RIDGE PRESERVATION; TOOTH EXTRACTION; IMMEDIATE PLACEMENT; BIO-OSS(R)
   COLLAGEN; TISSUE ALTERATIONS; SITES; APICOECTOMY; OSTEOCLASTS
AB The aim of this study was to characterize the healing process of extraction sockets with a periapical lesion following immediate graft with collagenated bovine bone mineral (CBBM) soaked with epigallocatechin-3-gallate (EGCG). Following induction of periapical lesions in premolars in five dogs, treatment of extraction sockets was divided into three groups: control (no treatment) and two test groups, CBBM with or without EGCG. 3D reconstruction and superimposition of the digital images were used to measure the dimensional changes in alveolar ridge. Histologic specimen was evaluated in all groups. The horizontal ridge widths at 4-mm level were wider in both test groups (3.3 +/- 1.7 mm in CBBM; 3.0 +/- 1.7 mm in CBBM+EGCG) than in the control group (1.7 +/- 2.4 mm). Fibrosis and limited new bone formation were observed in the apical regions of test groups; however, the extent of fibrosis was less in the CBBM+EGCG group. Within the limitations of this study, it was conjectured that adjunctive use of EGCG with CBBM can be a candidate biomaterial in grafting of extraction socket with periapical lesion. Bone regeneration at the coronal region of the CBBM grafted socket might not be influenced by the presence of a periapical lesion. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 727-734, 2015.
C1 [Hong, Ji-Youn] Kyung Hee Univ, Dept Periodontol, Sch Dent, Seoul 134727, South Korea.
   [Yon, Jeyoung; Lee, Jung-Seok; Lee, In-Kyeong; Yang, Cheryl; Kim, Min-Soo; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, Seoul 120752, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, Seoul 120752, South Korea.
EM drjew@yuhs.ac
OI Hong, Ji-Youn/0000-0003-1040-7077
FU Korea Health technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX Contract grant sponsor: Korea Health technology R&D Project, Ministry of
   Health & Welfare, Republic of Korea; contract grant number: A120822
CR Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Ayangco L, 2001, INT J ORAL MAX IMPL, V16, P412
   Becker W, 1990, Int J Periodontics Restorative Dent, V10, P376
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Del Fabbro M, 2009, J ORAL MAXIL SURG, V67, P2476, DOI 10.1016/j.joms.2009.04.063
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Hosokawa Y, 2010, MOL NUTR FOOD RES, V54, pS151, DOI 10.1002/mnfr.200900549
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Kamon M, 2010, CELL BIOL INT, V34, P109, DOI 10.1042/CBI20090011
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Lin SK, 2002, EUR J ORAL SCI, V110, P246, DOI 10.1034/j.1600-0447.2002.11227.x
   Maruyama T, 2011, ARCH ORAL BIOL, V56, P48, DOI 10.1016/j.archoralbio.2010.08.015
   Quirynen M, 2005, CLIN ORAL IMPLAN RES, V16, P599, DOI 10.1111/j.1600-0501.2005.01147.x
   Quirynen M, 2003, PERIODONTOL 2000, V33, P129, DOI 10.1046/j.0906-6713.2002.03311.x
   Rodd HD, 2007, DENT TRAUMATOL, V23, P328, DOI 10.1111/j.1600-9657.2006.00466.x
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   Siegenthaler DW, 2007, CLIN ORAL IMPLAN RES, V18, P727, DOI 10.1111/j.1600-0501.2007.01411.x
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Trope M, 1996, ORAL SURG ORAL MED O, V81, P221, DOI 10.1016/S1079-2104(96)80419-7
   Vier FV, 2002, INT ENDOD J, V35, P710, DOI 10.1046/j.1365-2591.2002.00554.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Waasdorp JA, 2010, J PERIODONTOL, V81, P801, DOI 10.1902/jop.2010.090706
   Wang CY, 1997, ORAL MICROBIOL IMMUN, V12, P65, DOI 10.1111/j.1399-302X.1997.tb00619.x
   Yang FJ, 1998, J NUTR, V128, P2334
   Yun JH, 2007, J PERIODONTAL RES, V42, P212, DOI 10.1111/j.1600-0765.2006.00935.x
   Yun JH, 2004, J PERIODONTAL RES, V39, P300, DOI 10.1111/j.1600-0765.2004.00743.x
NR 34
TC 1
Z9 1
U1 1
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 727
EP 734
DI 10.1002/jbm.b.33238
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800001
PM 25045081
DA 2018-10-20
ER

PT J
AU Lin, WJ
   Zhang, G
   Cao, P
   Zhang, DY
   Zheng, YF
   Wu, RX
   Qin, L
   Wang, GQ
   Wen, TY
AF Lin, Wenjiao
   Zhang, Gui
   Cao, Ping
   Zhang, Deyuan
   Zheng, Yufeng
   Wu, Rangxiu
   Qin, Li
   Wang, Geqi
   Wen, Taoyuan
TI Cytotoxicity and its test methodology for a bioabsorbable nitrided iron
   stent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioabsorbable; nitrided iron stent; cytotoxicity; size effect; test
   methodology
ID IN-VITRO CORROSION; FE-BASED ALLOYS; CORONARY-ARTERIES; PURE IRON;
   BIOCOMPATIBILITY; IMPLANTATION; BIOMATERIAL; DEGRADATION; RESISTANCE;
   MORPHOLOGY
AB Comprehensive assessments of the cytotoxicity of nitrided iron, a promising bioabsorbable metallic material, were conducted using in vitro methods. Extracting and standing experiments were conducted to determine the factors influencing the precipitation of the extract during extraction and incubation. The MTT method, fluorescent staining, and direct contact method were used to explore the in vitro cytotoxicity of nitrided iron stent extracts, nitrided iron foils, and their bulk corrosion products. The extracting and standing experiments confirmed that the extraction medium and available oxygen are crucial for precipitation during the extraction and incubation processes. In the MTT test, the extract of nitrided iron stents with a high iron ion concentration (124.11 +/- 7.55 g/mL) was not cytotoxic to L929 fibroblasts. Thus, the in vitro cytotoxicity of nitrided iron stents was actually caused by the size effect of corrosion particles and not the material itself. Test methodology for in vitro cytotoxicity of biodegradable iron-based materials was analyzed, and the results demonstrate that multiple methods should be combined for comprehensive evaluation of the cytocompatibility of bioabsorbable iron-based materials to get an impartial conclusion. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 764-776, 2015.
C1 [Lin, Wenjiao; Zhang, Gui; Zhang, Deyuan; Wu, Rangxiu; Qin, Li; Wang, Geqi; Wen, Taoyuan] Lifetech Sci Shenzhen Co Ltd, R&D Ctr, Shenzhen 518057, Peoples R China.
   [Cao, Ping] Shenzhen Testing Ctr Med Devices, Shenzhen 518057, Peoples R China.
   [Zheng, Yufeng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
RP Zhang, DY (reprint author), Lifetech Sci Shenzhen Co Ltd, R&D Ctr, Shenzhen 518057, Peoples R China.
EM zhangdeyuan_2012@163.com
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National 863 Program [2011AA030103]; Provincial Science and Technology
   Plan Program of Guangdong [2008A030102006]; Municipal Key Technologies
   R&D Program of Shenzhen [ZD200904300071A]; Municipal Special Funds for
   Industry-University-Research Institute Collaboration [SY200806270124A];
   Municipal Science and Technology Plan of Shenzhen-General Program
   [JSA201006010138A]
FX Contract grant sponsor: National 863 Program; contract grant number:
   2011AA030103; Contract grant sponsor: Provincial Science and Technology
   Plan Program of Guangdong; contract grant number: 2008A030102006;
   Contract grant sponsor: Municipal Key Technologies R&D Program of
   Shenzhen; contract grant number: ZD200904300071A; Contract grant
   sponsor: Municipal Special Funds for Industry-University-Research
   Institute Collaboration; contract grant number: SY200806270124A;
   Contract grant sponsor: Municipal Science and Technology Plan of
   Shenzhen-General Program; contract grant number: JSA201006010138A
CR ANSI/AAMI, 2007, ISO1099312 ANSIAAMI
   ANSI/AAMI, 2009, 109935 ISO
   Baek HS, 2005, YONSEI MED J, V46, P579, DOI 10.3349/ymj.2005.46.4.579
   Brien BO, 2009, ACTA BIOMATER, V5, P945
   Brown DA, 2009, J VASC INTERV RADIOL, V20, P315, DOI 10.1016/j.jvir.2008.11.007
   Chen CZ, 2010, SURF COAT TECH, V204, P3082, DOI 10.1016/j.surfcoat.2010.03.017
   Ciedlik M, 2011, CORROS SCI, V53, P296
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Feng QM, 2012, J MATER SCI-MATER M, V24, P713
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Gastaldi D, 2011, J MECH BEHAV BIOMED, V4, P352, DOI 10.1016/j.jmbbm.2010.11.003
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   Peuster M, 2006, CARDIOL YOUNG, V16, P107, DOI 10.1017/S1047951106000011
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pierson D, 2012, J BIOMED MATER RES B, V100B, P58, DOI 10.1002/jbm.b.31922
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Slottow TLP, 2008, CARDIOVASC REVASCULA, V9, P248, DOI 10.1016/j.carrev.2008.04.001
   Song MM, 2010, BIOMATERIALS, V31, P1509, DOI 10.1016/j.biomaterials.2009.11.034
   Speight JG, 2004, LANGES HDB CHEM, P1335
   Staiger MP, 2011, MATER SCI ENG B-ADV, V176, P1596, DOI 10.1016/j.mseb.2011.09.032
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Tamura K, 2002, MATER TRANS, V43, P3052, DOI 10.2320/matertrans.43.3052
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wang YB, 2012, MAT SCI ENG C-MATER, V32, P599, DOI 10.1016/j.msec.2011.12.018
   Wegener B, 2011, MATER SCI ENG B-ADV, V176, P1789, DOI 10.1016/j.mseb.2011.04.017
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu C, 2013, CHINESE MED J-PEKING, V126, P4752, DOI 10.3760/cma.j.issn.0366-6999.20131120
   Ying EB, 2010, SCI TOTAL ENVIRON, V408, P4475, DOI 10.1016/j.scitotenv.2010.07.025
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhang X, 2011, ENG FAIL ANAL, V18, P1981, DOI 10.1016/j.engfailanal.2011.03.007
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 45
TC 8
Z9 9
U1 4
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 764
EP 776
DI 10.1002/jbm.b.33246
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800005
PM 25065998
DA 2018-10-20
ER

PT J
AU Yan, LP
   Oliveira, JM
   Oliveira, AL
   Reis, RL
AF Yan, L-P.
   Oliveira, J. M.
   Oliveira, A. L.
   Reis, R. L.
TI In vitro evaluation of the biological performance of macro/micro-porous
   silk fibroin and silk-nano calcium phosphate scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE silk fibroin; nano calcium phosphate; scaffold; cytocompatibility;
   biomechanical property
ID TISSUE-ENGINEERING APPLICATIONS; OF-THE-ART; BIOMATERIAL SCAFFOLDS;
   COMPOSITE SCAFFOLDS; ARTICULAR-CARTILAGE; BONE-FORMATION; 3-D SCAFFOLDS;
   STEM-CELLS; DELIVERY
AB This study evaluates the biological performance of salt-leached macro/microporous silk scaffolds (S16) and silk-nano calcium phosphate scaffolds (SC16), both deriving from a 16 wt % aqueous SF solution. Enzymatic degradation results showed that the silk-based scaffolds presented desirable biostability, and the incorporation of calcium phosphate further improved the scaffolds' biostability. Human adipose tissue derived stromal cells (hASCs) were cultured onto the scaffolds in vitro. The Alamar blue assay and DNA content revealed that both scaffolds were non-cytotoxic and can support the viability and proliferation of the hASCs. Scanning electron microscopy observation demonstrated that the microporous structure was beneficial for the cell adhesion while the macroporous structure favored the cell migration and proliferation. The histological analysis displayed abundant extracellular matrix formed inside the scaffolds, leading to the significant increase of scaffolds' modulus. These results revealed that S16 and SC16 could be promising alternatives for cartilage and bone tissue engineering scaffolding applications, respectively. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 888-898, 2015.
C1 [Yan, L-P.; Oliveira, J. M.; Oliveira, A. L.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Yan, L-P.; Oliveira, J. M.; Oliveira, A. L.; Reis, R. L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Oliveira, A. L.] Portuguese Catholic Univ, Sch Biotechnol, CBQF Ctr Biotechnol & Fine Chem, P-4200072 Oporto, Portugal.
RP Oliveira, JM (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Oliveira, Ana/J-3404-2013; Reis, Rui
   L./A-8938-2008; Oliveira, Joaquim Miguel/H-8636-2012
OI Group, 3Bs/0000-0002-5195-3456; Oliveira, Ana/0000-0001-8012-4203; Reis,
   Rui L./0000-0002-4295-6129; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Yan, Leping/0000-0002-4806-5052
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/105703/2008]; OsteoCart [PTDC/CTM-BPC/115977/2009]; European
   Union's FP7 Programme [REGPOT-CT2012-316331-POLARIS]; FCT
   [SFRH/BD/64717/2009, IF/00423/2012, IF/00411/2013]
FX Contract grant sponsor: Portuguese Foundation for Science and Technology
   (FCT); contract grant number: PTDC/CTM/105703/2008; Contract grant
   sponsor: OsteoCart; contract grant number: PTDC/CTM-BPC/115977/2009;
   Contract grant sponsor: European Union's FP7 Programme; contract grant
   number: REGPOT-CT2012-316331-POLARIS; Contract grant sponsor: FCT;
   contract grant numbers: SFRH/BD/64717/2009, IF/00423/2012, IF/00411/2013
CR Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Duarte ARC, 2009, INT MATER REV, V54, P214, DOI 10.1179/174328009X411181
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim H. J., 2012, J TISSUE ENG, V3
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Oliveira AL, 2006, 20 EUR C BIOM NANT F
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JM, 2009, J BIOMED MATER RES A, V91A, P175, DOI 10.1002/jbm.a.32213
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yan LP, 2013, J BIOACT COMPAT POL, V28, P439, DOI 10.1177/0883911513503538
   Yan LP, 2013, NANOMEDICINE-UK, V8, P359, DOI [10.2217/NNM.12.118, 10.2217/nnm.12.118]
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 43
TC 9
Z9 9
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2015
VL 103
IS 4
BP 888
EP 898
DI 10.1002/jbm.b.33267
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5MU
UT WOS:000353336800019
PM 25164158
DA 2018-10-20
ER

PT J
AU Rokutanda, S
   Yanamoto, S
   Yamada, S
   Naruse, T
   Inokuchi, S
   Umeda, M
AF Rokutanda, Satoshi
   Yanamoto, Souichi
   Yamada, Shin-ichi
   Naruse, Tomofumi
   Inokuchi, Satoshi
   Umeda, Masahiro
TI Application of Polyglycolic Acid Sheets and Fibrin Glue Spray to Bone
   Surfaces During Oral Surgery: A Case Series
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID SKIN-GRAFTS; SEALANT; FELT
AB Purpose: Previous studies have described the use of a combination of polyglycolic acid (PGA) sheets (a resorbable biomaterial) and fibrin glue spray to treat open soft tissue wounds during oral surgery, which have produced good results. However, there have not been any detailed investigations of the use of these materials to treat exposed hard tissue wounds. This study investigated the combination of PGA sheets and fibrin glue spray to treat exposed bone surfaces during oral surgery.
   Materials and Methods: PGA sheets and fibrin glue spray were applied to exposed bone surfaces after lesion resection in 8 patients (10 sites) who had been diagnosed with malignant tumors. The sheets were cut into pieces (width, 5 to 10 mm) and applied to the exposed bone surface.
   Results: PGA adhesion was confirmed for the final time on postoperative days 28 to 56 (mean, 35.8 days), and there were no cases in which the PGA sheets fell off the wound prematurely. Epithelialization of the wound surface occurred gradually and was complete by postoperative weeks 4 to 5, regardless of the size of the wound.
   Conclusion: This method was considered very effective at preventing postoperative bleeding, alleviating postoperative pain, and promoting epithelialization during the reconstruction of bone surfaces after tumor resection in the oral cavity. (c) 2015 American Association of Oral and Maxillofacial Surgeons
C1 [Rokutanda, Satoshi; Yanamoto, Souichi; Yamada, Shin-ichi; Naruse, Tomofumi; Inokuchi, Satoshi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki 8528588, Japan.
RP Rokutanda, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.
EM satoshi6@nagasaki-u.ac.jp
CR Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5
   Doyama N, 2014, DIGEST ENDOSC, V26, P41
   HALL HD, 1970, J ORAL SURG, V28, P565
   Kobayashi S, 2011, SURG ENDOSC, V25, P3590, DOI 10.1007/s00464-011-1764-4
   Maniwa Tomohiro, 2009, Interact Cardiovasc Thorac Surg, V8, P697, DOI 10.1510/icvts.2008.201814
   Ochiai T, 2010, J GASTROINTEST SURG, V14, P884, DOI 10.1007/s11605-009-1149-3
   Qureshi SS, 2005, J SURG ONCOL, V89, P102, DOI 10.1002/jso.20192
   SCHRAMM VL, 1980, ARCH OTOLARYNGOL, V106, P528
   Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186
   Takeuchi J, 2013, J ORAL MAXIL SURG, V71, pE126, DOI 10.1016/j.joms.2012.08.012
   Takimoto K, 2014, DIGEST ENDOSC, V26, P46, DOI 10.1111/den.12280
   Yonezawa H, 2012, BR J ORAL MAXILLOFAC, V50, P43
NR 12
TC 4
Z9 4
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD MAY
PY 2015
VL 73
IS 5
BP 1017E1
EP 1017E6
DI 10.1016/j.joms.2015.01.014
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CG3AL
UT WOS:000353148700036
PM 25883005
DA 2018-10-20
ER

PT J
AU Francic, N
   Lyagin, IV
   Efremenko, EN
   Lobnik, A
AF Francic, Nina
   Lyagin, Ilya V.
   Efremenko, Elena N.
   Lobnik, Aleksandra
TI Hybrid sol-gel bio-films: influence of synthetic parameters on behaviour
   and performance of entrapped His(6)-tagged organophosphorus hydrolase
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Solid State Physics (ICSSP)
CY DEC 01-06, 2013
CL Univ Punjab, Lahore, PAKISTAN
SP Ctr Excellence Solid State Phys, Biotroll Pvt Ltd, Dawn Sci, Sanco, Bana Int, Comp Engn Serv
HO Univ Punjab
DE Sol-gel; Silica thin film; Enzyme encapsulation; His(6)-tagged
   organophosphorus hydrolase; Organophosphate detoxification
ID INFRARED-SPECTROSCOPY; SILICA; IMMOBILIZATION; STABILIZATION;
   ENCAPSULATION; PESTICIDES; STRATEGIES; ENZYMES; SPECTRA; LIPASE
AB The presented work describes the optimising of sol-gel process parameters including the aging time of the sol, the water/silane ratios, type of precursor [tetramethoxysilane (TMOS) or tetraethoxysilane (TEOS)], and the precursor ratios using organically modified silanes [methyltrimethoxysilane (MTMOS) and 3-glycidoxypropyltrimethoxysilane (GPTMS)], for the successful entrapment of hexahistidine-tagged organophosphorus hydrolase (His(6)-OPH) and its applicability during organophosphate detoxification processes. The prepared bio-composite films retained enzyme activity by up to 90 % with expected differences between the starting sols' compositions. The obtained values of K-M and V-max for TMOS/MTMOS and TEOS/GPTMS bio-composites equalled 1.5 +/- A 0.1, 1.4 +/- A 0.3 mM, 0.40 +/- A 0.02 and 1.8 +/- A 0.2 mu M/s for paraoxon, respectively, thus assuming effective application of such biocatalysts during the detoxifications of organophosphorus compounds. Furthermore, the bio-composite films showed enhanced pH and temperature stability with respect to the free enzymes as they can be easily separated from the reactive media, as well as having multiple reusages.
   Bio-composite materials based on hexahistidine-tagged organophosphorus hydrolase were developed by enzyme encapsulation into silica sol-gel matrixes (tetramethoxysilane/methyltrimethoxysilane, tetraethoxysilane/3-glycidoxypropyltrimethoxysilane). The process of biomaterial production was optimised in several pathways and biomaterials were characterised via IR-spectroscopy, SEM-imaging, so as their catalytic efficiency in organophosphate hydrolysis.
C1 [Francic, Nina; Lobnik, Aleksandra] Univ Maribor, Ctr Sensor Technol, Fac Mech Engn, SLO-2000 Maribor, Slovenia.
   [Lyagin, Ilya V.; Efremenko, Elena N.] Moscow MV Lomonosov State Univ, Fac Chem, Chem Enzymol Dept, Moscow 119991, Russia.
RP Lobnik, A (reprint author), Univ Maribor, Ctr Sensor Technol, Fac Mech Engn, Smetanova 17, SLO-2000 Maribor, Slovenia.
EM aleksandra.lobnik@um.si
RI Efremenko, Elena/E-8386-2014; Lyagin, Ilya/E-6774-2014
OI Efremenko, Elena/0000-0002-6992-854X; Lyagin, Ilya/0000-0002-3970-4334
FU Slovenian Research Agency (ARRS) for Young Researchers [1000-08-310045];
   International Slovenia-Russia Cooperation in Science [BI-RU/10-11-017]
FX This work was supported by Grants from the Slovenian Research Agency
   (ARRS) for Young Researchers (1000-08-310045), and International
   Slovenia-Russia Cooperation in Science, 2010-2011, Project No.
   BI-RU/10-11-017.
CR Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004
   BRINKER CJ, 1994, J MEMBRANE SCI, V94, P85, DOI 10.1016/0376-7388(93)E0129-8
   Carlsson N, 2014, ADV COLLOID INTERFAC, V205, P339, DOI 10.1016/j.cis.2013.08.010
   Chen JP, 2003, ENZYME MICROB TECH, V32, P801, DOI 10.1016/S0141-0229(03)00052-8
   Chu L, 1997, MICROPOROUS MATER, V8, P207, DOI 10.1016/S0927-6513(96)00068-5
   Cipolatti EP, 2014, J MOL CATAL B-ENZYM, V99, P56, DOI 10.1016/j.molcatb.2013.10.019
   Ciriminna R, 2013, CHEM REV, V113, P6592, DOI 10.1021/cr300399c
   Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME
   Cumana S, 2013, J MOL CATAL B-ENZYM, V85-86, P220, DOI 10.1016/j.molcatb.2012.09.014
   Efremenko E, 2006, APPL MICROBIOL BIOT, V70, P558, DOI 10.1007/s00253-005-0103-x
   Efremenko EN, 2001, RUSS CHEM B+, V50, P1826, DOI 10.1023/A:1014377912147
   Francic N, 2011, ANAL BIOANAL CHEM, V401, P2631, DOI 10.1007/s00216-011-5336-1
   Gallardo J, 2002, J NON-CRYST SOLIDS, V298, P219, DOI 10.1016/S0022-3093(02)00921-3
   Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225
   Innocenzi P, 2003, J NON-CRYST SOLIDS, V316, P309, DOI 10.1016/S0022-3093(02)01637-X
   Koszelewski D, 2010, J MOL CATAL B-ENZYM, V63, P39, DOI 10.1016/j.molcatb.2009.12.001
   Lyagin IV, 2014, MOSC UNIV CHEM BULL, V69, P125, DOI 10.3103/S0027131414030055
   Muroya M, 1999, COLLOID SURFACE A, V157, P147, DOI 10.1016/S0927-7757(99)00054-0
   Reetz MT, 2003, ADV SYNTH CATAL, V345, P717, DOI 10.1002/adsc.200303016
   Sirotkina M, 2012, INT BIODETER BIODEGR, V68, P18, DOI 10.1016/j.ibiod.2011.12.004
   Stepankova V, 2013, ACS CATAL, V3, P2823, DOI 10.1021/cs400684x
   Votchitseva YA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P167, DOI 10.1134/S0006297906020088
   Yang G, 2009, BIORESOURCE TECHNOL, V100, P4311, DOI 10.1016/j.biortech.2009.03.069
NR 23
TC 2
Z9 2
U1 0
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD MAY
PY 2015
VL 74
IS 2
BP 387
EP 397
DI 10.1007/s10971-014-3609-9
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA CG7HF
UT WOS:000353472900015
DA 2018-10-20
ER

PT J
AU Behera, PS
   Vasanthavel, S
   Ponnilavan, V
   Kannan, S
AF Behera, Pallavi Suhasinee
   Vasanthavel, S.
   Ponnilavan, V.
   Kannan, S.
TI Influence of gadolinium content on the tetragonal to cubic phase
   transition in zirconia-silica binary oxides
SO JOURNAL OF SOLID STATE CHEMISTRY
LA English
DT Article
DE Zirconia; Silica; Gadolinium; Cubic; Tetragonal; Magnetic
ID NEPHROGENIC SYSTEMIC FIBROSIS; PARTIALLY STABILIZED ZIRCONIA; MRI
   CONTRAST AGENTS; MAGNETIC-PROPERTIES; CRYSTALLINE PHASES; GRADE
   ZIRCONIA; ZRO2; BIOCERAMICS; BIOMATERIAL; GADODIAMIDE
AB The present study reports the effect of gadolinium (Gd3+) in zirconia-silica (ZrO2-SiO2) binary oxides. The pure ZrO2-SiO2 synthesized at 1100 degrees C was tetragonal. The addition of Gd3+ in the concentration range of 5%-10% resulted in the formation of t-ZrO2, whereas higher contents of Gd3+ led to the formation of cubic ZrO2 (c-ZrO2). The presence of Gd3+ also affected the lattice parameters of both t-ZrO2 and c-ZrO2. Magnetic studies confirmed a steady increase in the paramagnetic behaviour with increasing content of Gd3+. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Behera, Pallavi Suhasinee; Vasanthavel, S.; Ponnilavan, V.; Kannan, S.] Pondicherry Univ, Ctr Nanosci & Technol, Pondicherry 605014, India.
RP Kannan, S (reprint author), Pondicherry Univ, Ctr Nanosci & Technol, Pondicherry 605014, India.
EM skannan.nst@pondiuni.edu.in
RI S, Kannan/Q-4342-2017
OI S, Kannan/0000-0003-2285-4907
FU Council of Scientific and Industrial Research, India (CSIR Scheme)
   [22(612)/12/EMR-II]
FX The authors are thankful to the financial support received from the
   Council of Scientific and Industrial Research, India (CSIR Scheme No.
   22(612)/12/EMR-II). The Instrumentation facility availed from the
   Central Instrumentation Facility (CIF) of Pondicherry University is
   greatly acknowledged.
CR ACOSTA DR, 1995, J MATER RES, V10, P1397, DOI 10.1557/JMR.1995.1397
   Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454
   Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p
   CARLONE C, 1992, PHYS REV B, V45, P2079, DOI 10.1103/PhysRevB.45.2079
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353
   del Monte F, 2000, J AM CERAM SOC, V83, P1506
   del Monte F, 2000, J AM CERAM SOC, V83, P628
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   Hayek S.S., 2008, BIOMED SCI ENG, V1, P182
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOWARD CJ, 1988, ACTA CRYSTALLOGR B, V44, P116, DOI 10.1107/S0108768187010279
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   Iqbal MA, 2013, J ALLOY COMPD, V579, P181, DOI 10.1016/j.jallcom.2013.06.033
   Kobayashi Y., 2013, ISRN NANOTECHNOL, P1
   Larson A. C., 2004, LOS ALAMOS NATL LAB, P86
   Leiner T, 2007, EUR RADIOL, V17, P1921, DOI 10.1007/s00330-007-0663-5
   Lopez EF, 2001, J MATER CHEM, V11, P1891
   Murtaza G, 2014, CURR APPL PHYS, V14, P176, DOI 10.1016/j.cap.2013.11.002
   Peng JH, 2011, J MAGN MAGN MATER, V323, P133, DOI 10.1016/j.jmmm.2010.08.048
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SMITH DK, 1965, ACTA CRYSTALLOGR, V18, P983, DOI 10.1107/S0365110X65002402
   Telgmann L, 2013, ANAL CHIM ACTA, V764, P1, DOI 10.1016/j.aca.2012.12.007
   Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242
   Vasanthavel S, 2014, J AM CERAM SOC, V97, P635, DOI 10.1111/jace.12672
   Wang YL, 2007, SOLID STATE IONICS, V178, P53, DOI 10.1016/j.ssi.2006.11.003
   WYCKOFF RWG, 1963, CRYSTAL STRUCTURES, V0001
   Xu HT, 2008, J MATER SCI-MATER EL, V19, P589, DOI 10.1007/s10854-007-9394-2
NR 38
TC 13
Z9 13
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4596
EI 1095-726X
J9 J SOLID STATE CHEM
JI J. Solid State Chem.
PD MAY
PY 2015
VL 225
BP 305
EP 309
DI 10.1016/j.jssc.2014.12.029
PG 5
WC Chemistry, Inorganic & Nuclear; Chemistry, Physical
SC Chemistry
GA CF8QW
UT WOS:000352828000043
DA 2018-10-20
ER

PT J
AU Saied, A
   David, J
   Labarbera, K
   Katz, SC
   Somasundar, P
AF Saied, Abdul
   David, Jenny
   Labarbera, Kim
   Katz, Steven C.
   Somasundar, Ponnandai
TI Chemotherapy Does Not Adversely Impact Outcome Following Post-Incisional
   Hernia Repair With Biomaterial Mesh
SO JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
DE chemotherapy; post-incisional hernia repair; biological mesh
ID LIVER-TRANSPLANTATION; SURGICAL-TREATMENT; MATRIX
AB BackgroundPatients receiving chemotherapy are at increased risk for developing recurrent or post-incisional hernias (PIH). Biological materials are an alternative to synthetic mesh in contaminated fields. The impact of chemotherapy on biomaterial tissue ingrowth and integration has not been well studied.
   MethodsFrom 2008 to 2011 patients who underwent PIH repair with biomaterial mesh (Biodesign (R)) were selected. Patients were divided into two groups: those receiving chemotherapy (CT) and those not receiving chemotherapy (NCT).
   ResultsForty-five patients were identified, 28 (62%) in the NCT group and 17 (38%) in the CT group. Median follow up for NCT and CT groups were 27 and 17 months, respectively. A total of 9/45 (20%) surgical site infections (SSI) were diagnosed, with 6/28 (21%) in the NCT and 3/17 (18%) in the CT group (P=0.53). Seroma formation was seen in 5/28 (18%) of NCT patients and 4/17 (23%) in CT group (P=0.46). Overall hernia recurrence rate was 22%, and the rates of recurrence were similar among the CT 3/17 (18%) and NCT 7/28 (25%) groups (P=0.42).
   ConclusionThe use of perioperative chemotherapy did not increase the rate of wound complications following PIH repair with biologic mesh in this group of patients. J. Surg. Oncol. 2015 111:725-728. (c) 2015 Wiley Periodicals, Inc.
C1 [Saied, Abdul; David, Jenny; Labarbera, Kim; Katz, Steven C.; Somasundar, Ponnandai] Roger Williams Med Ctr, Dept Surg, Providence, RI 02908 USA.
   [Katz, Steven C.; Somasundar, Ponnandai] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA.
RP Somasundar, P (reprint author), Roger Williams Med Ctr, Dept Surg, 825 Chalkstone Ave, Providence, RI 02908 USA.
EM psomasun@chartercare.org
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Boutros C, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-72
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Brewer MB, 2011, HERNIA, V15, P141, DOI 10.1007/s10029-010-0748-y
   Burger JWA, 2005, WORLD J SURG, V29, P1608, DOI 10.1007/s00268-005-7929-3
   Cheng H, 2007, Hernia, V11, P129, DOI 10.1007/s10029-006-0176-1
   Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141
   De Ugarte DA, 2003, J SURG RES, V112, P65, DOI 10.1016/S0022-4804(03)00107-0
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hirsch EF, 2004, J AM COLL SURGEONS, V198, P324, DOI 10.1016/j.jamcollsurg.2003.09.016
   Hodde J, 2007, ACTA CHIR BELG, V107, P641, DOI 10.1080/00015458.2007.11680139
   Holton Luther H 3rd, 2005, J Long Term Eff Med Implants, V15, P547
   Itani KMF, 2012, SURGERY, V152, P498, DOI 10.1016/j.surg.2012.04.008
   Janssen H, 2002, BRIT J SURG, V89, P1049, DOI 10.1046/j.1365-2168.2002.02165.x
   Krpata DM, 2013, SURGERY, V153, P120, DOI 10.1016/j.surg.2012.06.003
   Nho RLH, 2012, J VISC SURG, V149, pE3, DOI 10.1016/j.jviscsurg.2012.05.004
   Ong ES, 2006, J GASTROINTEST SURG, V10, P202, DOI 10.1016/j.gassur.2005.07.004
   Piazzese E, 2004, TRANSPLANT P, V36, P3097, DOI 10.1016/j.transproceed.2004.10.047
   Rettenmaier MA, 2009, J GYNECOL ONCOL, V20, P246, DOI 10.3802/jgo.2009.20.4.246
   SUGARBAKER PH, 1985, ANN SURG, V201, P344, DOI 10.1097/00000658-198503000-00015
NR 20
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-4790
EI 1096-9098
J9 J SURG ONCOL
JI J. Surg. Oncol.
PD MAY 1
PY 2015
VL 111
IS 6
BP 725
EP 728
DI 10.1002/jso.23869
PG 4
WC Oncology; Surgery
SC Oncology; Surgery
GA CG6ND
UT WOS:000353417700011
PM 25580588
OA Other Gold
DA 2018-10-20
ER

PT J
AU McMurray, RJ
   Dalby, MJ
   Tsimbouri, PM
AF McMurray, Rebecca J.
   Dalby, Matthew J.
   Tsimbouri, P. Monica
TI Using biomaterials to study stem cell mechanotransduction, growth and
   differentiation
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE stem cell; self-renewal; differentiation; mechanotransduction; cell
   adhesion; integrins; topography; biomaterials
ID SELF-ASSEMBLED MONOLAYERS; ACTIVATED PROTEIN-KINASE; PRIMARY CILIUM;
   IN-VITRO; SIGNALING PATHWAYS; EXTRACELLULAR-MATRIX; SPINDLE ORIENTATION;
   LINEAGE COMMITMENT; MAMMALIAN-CELLS; CYCLE CONTROL
AB Self-renewal and differentiation are two fundamental characteristics of stem cells. Stem cell self-renewal is critical for replenishing the stem cell population, while differentiation is necessary for maintaining tissue homeostasis. Over the last two decades a great deal of effort has been applied to discovering the processes that control these opposing stem cell fates. One way of examining the role of the physical environment is the use of biomaterial strategies that have the ability to manipulate cells without any requirement for chemical factors. The mechanism whereby cells have been found to respond to a mechanical stimulus is termed mechanotransduction, the process by which a mechanical cue (or alteration in cell spreading changing internal cellular mechanics, i.e. intracellular tension) is transduced into a chemical signal inside the cell, eliciting changes in gene expression. This can occur either directly, as a result of changes in the cell cytoskeleton, or indirectly through a series of biochemical signalling cascades. The main focus of this review is to examine the role of mechanotransduction in the differentiation and self-renewal of stem cells. In particular, we will focus on the use of biomaterials as a tool for examining mechanotrandsuctive effects on self-renewal and differentiation. (c) 2014 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.
C1 [McMurray, Rebecca J.] Northwestern Univ, Dept Biomed Engn, Mrksich Res Grp, Evanston, IL 60208 USA.
   [Dalby, Matthew J.; Tsimbouri, P. Monica] Univ Glasgow, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Dalby, MJ (reprint author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM matthew.dalby@glasgow.ac.uk
OI Dalby, Matthew/0000-0002-0528-3359; Tsimbouri,
   Penelope/0000-0001-5124-7458
FU BBSRC [BB/G008868/1]; Wellcome Trust ISSF fellowship; Biotechnology and
   Biological Sciences Research Council [BB/G008868/1]; Engineering and
   Physical Sciences Research Council [EP/K034898/1]
FX This study was supported by grants from BBSRC (grant number
   BB/G008868/1) and a Wellcome Trust ISSF fellowship awarded to M.P.T.
CR Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Caplan AI, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P243, DOI 10.1016/B978-0-12-374729-7.00029-9
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120
   Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7
   Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676
   Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426
   Connelly JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027259
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Curran JM, 2010, LAB CHIP, V10, P1662, DOI 10.1039/c004149a
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   CURTIS ASG, 1978, NATURE, V274, P52, DOI 10.1038/274052a0
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby Matthew J, 2007, Methods Mol Biol, V370, P121
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Ebara M, 2012, ADV MATER, V24, P273, DOI 10.1002/adma.201102181
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989
   Fus J, 2010, NAT METHODS, V7, P733
   Georges GE, 2007, BIOL BLOOD MARROW TR, V13, P423, DOI 10.1016/j.bbmt.2006.11.011
   Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Hes S, 2009, ANNU REV CELL DEV BI, V25, P377
   Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   Ingber D E, 1997, Gravit Space Biol Bull, V10, P49
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingmar Schoens BLP, 2013, ANN REV MATER RES, V43, P589
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102
   Kawakami K, 2001, J CELL SCI, V114, P3125
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kims S, 2011, NAT CELL BIOL, V13, P351
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Kingham E, 2013, ACS NANO, V7, P1867, DOI 10.1021/nn3037094
   Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223
   Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608
   Les DM, 2011, ADV MATER, V23, P3278
   Lims SH, 2010, BIOMATERIALS, V31, P9031
   Lis A, 2011, NAT CELL BIOL, V13, P402
   Lis L, 2005, ANNU REV CELL DEV BI, V21, P605
   Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312
   Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075
   Ohs S, 2009, P NATL ACAD SCI USA, V106, P2130
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Paszek P, 2005, J THEOR BIOL, V233, P423, DOI 10.1016/j.jtbi.2004.10.023
   Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qis L, 2013, PLOS ONE, V8
   Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498
   SAVATIER P, 1994, ONCOGENE, V9, P809
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571
   Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Sherley JL, 2002, STEM CELLS, V20, P561, DOI 10.1634/stemcells.20-6-561
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365
   Simmonss PJ, 2009, FASEB J, V23, P303
   STEIN GS, 1990, FASEB J, V4, P3111
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001
   Todd SJ, 2007, SOFT MATTER, V3, P547, DOI 10.1039/b618256a
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Toledanos H, 2009, MECH REGULATING STEM
   Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599
   Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x
   Ullah M, 2013, DIFFERENTIATION, V85, P78, DOI 10.1016/j.diff.2013.02.001
   Vincente-Manzanaress M, 2005, J CELL SCI, V118, P4917, DOI [10.1242/jcs.02662, DOI 10.1242/JCS.02662]
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214
   Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84
   Wang YS, 2011, BIOMATERIALS, V32, P6737, DOI 10.1016/j.biomaterials.2011.05.075
   Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.E04-12-1056
   White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Xies T, 2000, SCIENCE, V290, P328
   Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106
   Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009
   Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313
   Yamashita YM, 2009, FRONT BIOSCI-LANDMRK, V14, P3003, DOI 10.2741/3430
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yeos WS, 2001, CHEM BIOCH, V2, P590
   Yeos WS, 2006, LANGMUIR, V22, P10816
   Yims EK, 2010, BIOMATERIALS, V31, P1299
   Yims EK, 2007, EXP CELL RES, V313, P1820
   Yoshikawa HY, 2011, J AM CHEM SOC, V133, P1367, DOI 10.1021/ja1060615
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105
   Zhus X, 1995, MOL BIOL CELL, V6, P273
NR 153
TC 22
Z9 23
U1 3
U2 67
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY
PY 2015
VL 9
IS 5
BP 528
EP 539
DI 10.1002/term.1957
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CG6HI
UT WOS:000353399400005
PM 25370612
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Guerriero, G
   Hausman, JF
   Strauss, J
   Ertan, H
   Siddiqui, KS
AF Guerriero, Gea
   Hausman, Jean-Francois
   Strauss, Joseph
   Ertan, Haluk
   Siddiqui, Khawar Sohail
TI Destructuring plant biomass: Focus on fungal and extremophilic cell wall
   hydrolases
SO PLANT SCIENCE
LA English
DT Review
DE Lignocellulosic biomass; Saccharification; Carbohydrate-active enzymes;
   Fungal secretome; Extremozymes; Synergistic activation
ID ISOTHERMAL TITRATION CALORIMETRY; NEOCALLIMASTIX-PATRICIARUM J11;
   CROSS-PATHWAY CONTROL; LIGNOCELLULOSIC BIOMASS; BETA-GLUCOSIDASE;
   CELLOBIOSE DEHYDROGENASE; ENZYMATIC-HYDROLYSIS; BIOFUEL PRODUCTION;
   NEUROSPORA-CRASSA; CALDICELLULOSIRUPTOR-BESCII
AB The use of plant biomass as feedstock for biomaterial and biofuel production is relevant in the current bio-based economy scenario of valorizing renewable resources. Fungi, which degrade complex and recalcitrant plant polymers, secrete different enzymes that hydrolyze plant cell wall polysaccharides. The present review discusses the current research trends on fungal, as well as extremophilic cell wall hydrolases that can withstand extreme physico-chemical conditions required in efficient industrial processes. Secretomes of fungi from the phyla Ascomycota, Basidiomycota, Zygomycota and Neocallimastigomycota are presented along with metabolic cues (nutrient sensing, coordination of carbon and nitrogen metabolism) affecting their composition. We conclude the review by suggesting further research avenues focused on the one hand on a comprehensive analysis of the physiology and epigenetics underlying cell wall degrading enzyme production in fungi and on the other hand on the analysis of proteins with unknown function and metagenomics of extremophilic consortia. The current advances in consolidated bioprocessing, altered secretory pathways and creation of designer plants are also examined. Furthermore, recent developments in enhancing the activity, stability and reusability of enzymes based on synergistic, proximity and entropic effects, fusion enzymes, structure-guided recombination between homologous enzymes and magnetic enzymes are considered with a view to improving saccharification. (C) 2015 Published by Elsevier Ireland Ltd.
C1 [Guerriero, Gea; Hausman, Jean-Francois] Luxembourg Inst Sci & Technol, Environm Res & Innovat ERIN, Esch Sur Alzette, Luxembourg.
   [Strauss, Joseph] Univ Nat Resources & Life Sci Vienna BOKU, Fungal Genet & Genom Unit, Dept Appl Genet & Cell Biol, Tulln Donau, Austria.
   [Strauss, Joseph] Austrian Inst Technol GmbH AIT, Hlth & Environm Dept, Tulln Donau, Austria.
   [Ertan, Haluk] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [Ertan, Haluk] Istanbul Univ, Dept Mol Biol & Genet, Istanbul, Turkey.
   [Siddiqui, Khawar Sohail] King Fand Univ Petr & Minerals, Dept Biol, Dhahran, Saudi Arabia.
RP Guerriero, G (reprint author), Luxembourg Inst Sci & Technol, Environm Res & Innovat ERIN, Esch Sur Alzette, Luxembourg.
EM gea.guerriero@list.lu; ksiddiqui@kfupm.edu.sa
RI Guerriero, Gea/B-4883-2013
OI Guerriero, Gea/0000-0001-6586-6997; Strauss, Joseph/0000-0003-0474-6267
FU Austrian Science Fund (FWF) [M1315]; Fonds National de la Recherche,
   Luxembourg [CANCAN C13/SR/5774202, CAD-WALL INTER/FWO/12/14]; Lower
   Austria Science Fund NFB [LS12-009]
FX GG gratefully acknowledges the Austrian Science Fund (FWF;
   http://www.fwf.ac.at/en/) Grant No. M1315. GG and JFH wish to thank the
   support by the Fonds National de la Recherche, Luxembourg, (Project
   CANCAN C13/SR/5774202 and project CAD-WALL INTER/FWO/12/14). JS
   acknowledges the support by the Lower Austria Science Fund NFB grant
   LS12-009. Personal assistance of KSS by KFUPM is acknowledged. Dr Lucia
   Silvestrini is thanked for providing the scanning electron microscope
   picture of A. nidulans appearing in the Graphical Abstract. The funde'rs
   had no role in the preparation of the manuscript.
CR Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020
   Adlakha N, 2012, APPL ENVIRON MICROB, V78, P7447, DOI 10.1128/AEM.01386-12
   Alfaro M, 2014, J PROTEOMICS, V102, P28, DOI 10.1016/j.jprot.2014.03.001
   Alftren J, 2014, BIOMASS BIOENERG, V65, P72, DOI 10.1016/j.biombioe.2014.03.009
   Alftren J, 2013, APPL BIOCHEM BIOTECH, V169, P2076, DOI 10.1007/s12010-013-0122-5
   Anand A, 2013, EXTREMOPHILES, V17, P357, DOI 10.1007/s00792-013-0524-x
   Aono E, 2010, MOL BIOSYST, V6, P1216, DOI 10.1039/c000396d
   Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4
   Arfi Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2850
   Bae J, 2015, APPL ENVIRON MICROB, V81, P59, DOI 10.1128/AEM.02864-14
   Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188
   Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38
   Baumann MJ, 2011, ANAL BIOCHEM, V410, P19, DOI 10.1016/j.ab.2010.11.001
   Biver S, 2014, J IND MICROBIOL BIOT, V41, P479, DOI 10.1007/s10295-014-1400-0
   Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007
   Blumer-Schuette SE, 2014, FEMS MICROBIOL REV, V38, P393, DOI 10.1111/1574-6976.12044
   Bommarius AS, 2014, CURR OPIN BIOTECH, V29, P139, DOI 10.1016/j.copbio.2014.04.007
   Boussaid A, 1999, BIOTECHNOL BIOENG, V64, P284, DOI 10.1002/(SICI)1097-0290(19990805)64:3<284::AID-BIT4>3.0.CO;2-C
   Braus GH, 2006, MED MYCOL, V44, pS91, DOI 10.1080/13693780600898029
   Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731
   Brown NA, 2014, MOL MICROBIOL, V94, P1103, DOI 10.1111/mmi.12820
   Brown NA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-91
   Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182
   Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273
   Burguener German F, 2014, Genome Announc, V2, DOI 10.1128/genomeA.01096-13
   Cavicchioli R, 2011, ENVIRON MICROBIOL, V13, P1903, DOI 10.1111/j.1462-2920.2011.02512.x
   Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064
   Chen YC, 2014, BIORESOURCE TECHNOL, V170, P513, DOI 10.1016/j.biortech.2014.08.016
   Cheng YS, 2012, APPL MICROBIOL BIOT, V95, P661, DOI 10.1007/s00253-011-3791-4
   Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111
   Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109
   Cortazar AR, 2014, AMINO ACIDS, V46, P471, DOI 10.1007/s00726-013-1649-z
   Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578
   de Souza WR, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-40
   de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001
   DEKKER RFH, 1990, APPL BIOCHEM BIOTECH, V23, P25, DOI 10.1007/BF02942050
   Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875
   Elleuche S, 2015, APPL MICROBIOL BIOT, V99, P1545, DOI 10.1007/s00253-014-6315-1
   Elliott CE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-169
   Ertan H, 2012, BIOCHIMIE, V94, P1221, DOI 10.1016/j.biochi.2012.02.012
   Foreman P.K., 2003, J BIOL CHEM, V278, P31988
   Gacek A, 2012, APPL MICROBIOL BIOT, V95, P1389, DOI 10.1007/s00253-012-4208-8
   Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044
   Gong ZW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-36
   Gourlay K, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-51
   Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373
   Grum-Grzhimaylo AA, 2013, PERSOONIA, V31, P147, DOI 10.3767/003158513X673080
   GUSAKOV AV, 1992, BIOTECHNOL BIOENG, V40, P663, DOI 10.1002/bit.260400604
   Haitjema CH, 2014, BIOTECHNOL BIOENG, V111, P1471, DOI 10.1002/bit.25264
   Hess M, 2008, TRENDS MICROBIOL, V16, P414, DOI 10.1016/j.tim.2008.06.001
   Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45
   Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624
   Ji L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0130-x
   Jung S, 2013, PLANT MOL BIOL, V83, P317, DOI 10.1007/s11103-013-0088-2
   Kang Y.M., 2015, J MOL CATAL B-ENZYM, V114, P29
   Karnaouri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00281
   KENGEN SWM, 1993, EUR J BIOCHEM, V213, P305, DOI 10.1111/j.1432-1033.1993.tb17763.x
   Klose H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-63
   Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058
   Kong C, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-346
   Kubicek C.P., 2012, TOOLSPART 2 ENZYMOLO
   Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020
   Kumar GN, 2011, BIOMED CHROMATOGR, V25, P707, DOI 10.1002/bmc.1506
   Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g
   Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11
   Lanver D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004272
   Lee HL, 2011, BIORESOURCE TECHNOL, V102, P3973, DOI 10.1016/j.biortech.2010.11.114
   Levasseur A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-486
   Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41
   Lin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108442
   Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549
   Mabee WE, 2006, APPL BIOCHEM BIOTECH, V129, P55, DOI 10.1385/ABAB:129:1:55
   Maehara T, 2013, FUNGAL BIOL-UK, V117, P220, DOI 10.1016/j.funbio.2013.02.002
   Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000
   Makela MR, 2014, FUNGAL GENET BIOL, V72, P2, DOI 10.1016/j.fgb.2014.08.010
   Mardanov AV, 2009, APPL ENVIRON MICROB, V75, P4580, DOI 10.1128/AEM.00718-09
   Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106
   Martins I, 2014, J PROTEOMICS, V98, P175, DOI 10.1016/j.jprot.2013.11.023
   Milstein O., 1983, ARCH MICROBIAL, V135, P147
   Mir BA, 2014, TRENDS BIOTECHNOL, V32, P281, DOI 10.1016/j.tibtech.2014.03.003
   Mitsuzawa S, 2009, J BIOTECHNOL, V143, P139, DOI 10.1016/j.jbiotec.2009.06.019
   Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020
   Nevalainen H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00075
   Oggerin M, 2013, ENVIRON MICROBIOL, V15, P2228, DOI 10.1111/1462-2920.12094
   Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184
   Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y
   Piao HL, 2014, BIOTECHNOL BIOENG, V111, P1550, DOI 10.1002/bit.25250
   Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]
   Ratto M, 1997, APPL MICROBIOL BIOT, V48, P53, DOI 10.1007/s002530051014
   Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009
   Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111
   Rizk M, 2015, BIOTECHNOL LETT, V37, P139, DOI 10.1007/s10529-014-1654-7
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11
   Sagt CMJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-48
   Seckbach J., 2013, HELGA POLYEXTERMOPHI
   Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x
   Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0
   Sharma A, 2012, EXTREMOPHILES, V16, P1, DOI 10.1007/s00792-011-0402-3
   Sharma RK, 2015, CRIT REV MICROBIOL, V41, P52, DOI 10.3109/1040841X.2013.791247
   Shen BZ, 2012, NAT BIOTECHNOL, V30, P1131, DOI 10.1038/nbt.2402
   Siddiqui K.S., 2008, PROTEIN ADAPTATIONS
   Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514
   Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723
   Siddiqui KS, 2014, J BIOTECHNOL, V178, P1, DOI 10.1016/j.jbiotec.2014.03.002
   Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012
   Smith MA, 2012, FEBS J, V279, P4453, DOI 10.1111/febs.12032
   Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514
   Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414
   Trudeau DL, 2014, BIOTECHNOL BIOENG, V111, P2390, DOI 10.1002/bit.25308
   USDA, 2010, USDA BIOF STRAT PROD, P1
   Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001
   Wang HC, 2014, BIOCHEM BIOPH RES CO, V451, P190, DOI 10.1016/j.bbrc.2014.07.088
   Wang HC, 2013, PROTEIN EXPRES PURIF, V90, P153, DOI 10.1016/j.pep.2013.06.004
   Xie SX, 2014, CURR OPIN BIOTECH, V27, P195, DOI 10.1016/j.copbio.2014.02.007
   Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005
   Xiong Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004500
   Youssef NH, 2013, APPL ENVIRON MICROB, V79, P4620, DOI 10.1128/AEM.00821-13
   Zajc J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00708
   Zamocky M, 2006, CURR PROTEIN PEPT SC, V7, P255, DOI 10.2174/138920306777452367
   Zhang SB, 2012, BIORESOURCE TECHNOL, V117, P140, DOI 10.1016/j.biortech.2012.04.042
   Zhao YP, 2014, APPL BIOCHEM BIOTECH, V174, P1246, DOI 10.1007/s12010-014-1102-0
   Zhou P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-294
   Znameroski EA, 2014, J BIOL CHEM, V289, P2610, DOI 10.1074/jbc.M113.533273
   Znameroski EA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-6
NR 125
TC 24
Z9 27
U1 1
U2 99
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-9452
J9 PLANT SCI
JI Plant Sci.
PD MAY
PY 2015
VL 234
BP 180
EP 193
DI 10.1016/j.plantsci.2015.02.010
PG 14
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA CG2HZ
UT WOS:000353096800018
PM 25804821
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Patel, JJ
   Flanagan, CL
   Hollister, SJ
AF Patel, Janki J.
   Flanagan, Colleen L.
   Hollister, Scott J.
TI Bone Morphogenetic Protein-2 Adsorption onto Poly-e-caprolactone Better
   Preserves Bioactivity In Vitro and Produces More Bone In Vivo than
   Conjugation Under Clinically Relevant Loading Scenarios
SO Tissue Engineering Part C-Methods
LA English
DT Article
ID HUMAN OSTEOGENIC PROTEIN-1; CONTROLLED-RELEASE; MANDIBULAR
   RECONSTRUCTION; DELIVERY-SYSTEMS; SCAFFOLDS; REGENERATION; GRAFTS;
   GROWTH; CELLS; BMP-2
AB Background: One strategy to reconstruct large bone defects is to prefabricate a vascularized flap by implanting a biomaterial scaffold with associated biologics into the latissimus dorsi and then transplanting this construct to the defect site after a maturation period. This strategy, similar to all clinically and regulatory feasible biologic approaches to surgical reconstruction, requires the ability to quickly (<1 h within an operating room) and efficiently bind biologics to scaffolds. It also requires the ability to localize biologic delivery. In this study, we investigated the efficacy of binding bone morphogenetic protein-2 (BMP2) to poly-e-caprolactone (PCL) using adsorption and conjugation as a function of time.
   Methods: BMP2 was adsorbed (Ads) or conjugated (Conj) to PCL scaffolds with the same three-dimensional printed architecture while altering exposure time (0.5, 1, 5, and 16 h), temperature (4 degrees C, 23 degrees C), and BMP2 concentration (1.4, 5, 20, and 65 mu g/mL). The in vitro release was quantified, and C2C12 cell alkaline phosphatase (ALP) expression was used to confirm bioactivity. Scaffolds with either 65 or 20 mu g/mL Ads or Conj BMP2 for 1 h at 23 degrees C were implanted subcutaneously in mice to evaluate in vivo bone regeneration. Micro-computed tomography, compression testing, and histology were performed to characterize bone regeneration.
   Results: After 1 h exposure to 65 mu g/mL BMP2 at 23 degrees C, Conj and Ads resulted in 12.83 +/- 1.78 and 10.78 +/- 1.49 mu g BMP2 attached, respectively. Adsorption resulted in a positive ALP response and had a small burst release; whereas conjugation provided a sustained release with negligible ALP production, indicating that the conjugated BMP2 may not be bioavailable. Adsorbed 65 mu g/mL BMP2 solution resulted in the greatest regenerated bone volume (15.0 +/- 3.0 mm(3)), elastic modulus (20.1 +/- 3.0 MPa), and %bone ingrowth in the scaffold interior (17.2%+/- 5.4%) when compared with conjugation.
   Conclusion: Adsorption may be optimal for the clinical application of prefabricating bone flaps due to BMP2 binding in a short exposure time, retained BMP2 bioactivity, and bone growth adhering to scaffold geometry and into pores with healthy marrow development.
C1 [Patel, Janki J.; Flanagan, Colleen L.; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Lurie Biomed Engn 2214, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
FU NIH/NIDCR Tissue Engineering at Michigan trainee grant [DE 007057]; NIH
   [R21 DE 022439, R01 AR 060892]
FX This research was funded by the NIH/NIDCR Tissue Engineering at Michigan
   trainee grant (DE 007057), NIH R21 DE 022439, and NIH R01 AR 060892.
CR Alam M I, 2003, Int J Oral Maxillofac Surg, V32, P508
   [Anonymous], 2005, P SING MIT ALL S SIN
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Bae SE, 2012, J CONTROL RELEASE, V160, P676, DOI 10.1016/j.jconrel.2012.04.021
   Becker ST, 2009, ORAL ONCOL, V45, pE181, DOI 10.1016/j.oraloncology.2009.07.004
   Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010
   Fitzsimmons J, 2014, 510 K PREMARKET NOTI
   Gharibjanian NA, 2009, PLAST RECONSTR SURG, V123, P1169, DOI 10.1097/PRS.0b013e31819f2987
   Han JA, 2011, J BIOMED MATER RES A, V96A, P705, DOI 10.1002/jbm.a.33023
   Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kim TH, 2012, J BIOMED MATER RES A, V100A, P1512, DOI 10.1002/jbm.a.34086
   Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571
   Kontogiorgos E, 2011, CALCIFIED TISSUE INT, V89, P43, DOI 10.1007/s00223-011-9492-2
   Kumagai T., 2007, KEY ENG MATER, V361, P1025
   Liu HW, 2006, BONE, V39, P825, DOI 10.1016/j.bone.2006.04.027
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Partee B, 2006, J MANUF SCI E-T ASME, V128, P531, DOI 10.1115/1.2162589
   Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Schantz J-T, 2006, NEUROSURGERY, V58, pONS
   Smith MH, 2007, INT J MED ROBOT COMP, V3, P207, DOI 10.1002/rcs.143
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1016/j.ijom.2003.08.009
   Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1016/S0901-5027(99)80063-0
   van de Watering FCJ, 2012, J CONTROL RELEASE, V159, P69, DOI 10.1016/j.jconrel.2011.12.041
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yeo A, 2014, 510 K PREMARKET NOTI
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhang Q, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045002
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 46
TC 14
Z9 14
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAY 1
PY 2015
VL 21
IS 5
BP 489
EP 498
DI 10.1089/ten.tec.2014.0377
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CG7SH
UT WOS:000353504800007
PM 25345571
OA Green Published
DA 2018-10-20
ER

PT J
AU Galera, PD
   Ribeiro, CR
   Sapp, HL
   Coleman, J
   Fontes, W
   Brooks, DE
AF Galera, Paula D.
   Ribeiro, Cassio R.
   Sapp, Harold L.
   Coleman, James
   Fontes, Wagner
   Brooks, Dennis E.
TI Proteomic analysis of equine amniotic membrane: characterization of
   proteins
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE amniotic membrane; dermatopontin; horse; lumican; protein; proteome
ID OCULAR SURFACE RECONSTRUCTION; EXTRACELLULAR-MATRIX; DERMATOPONTIN
   EXPRESSION; COLLAGEN FIBRILLOGENESIS; CELL-ADHESION; TRANSPLANTATION;
   LUMICAN; DECORIN; IDENTIFICATION; SKIN
AB IntroductionHuman amniotic membrane (AM) has been used as a biomaterial for surgical wound skin and ocular surface reconstruction for several years. Currently, equine AM has been used for corneal reconstruction in several animal species, and appears to have the same properties as human AM. Despite the observed positive healing abilities of this tissue in horses with ulcerative keratitis the proteins of equine AM have not been described.
   ObjectiveTo identify proteins known to be associated with corneal healing from frozen equine AM.
   ProceduresPlacentas were acquired from healthy live foal births from a local Thoroughbred breeding farm. The amnion was removed from the chorion by blunt dissection, washed with phosphate-buffered saline (PBS), and treated with 0.05% trypsin and 0.02% ethylene diaminetetraacetic acid in PBS. Amnion was attached to nitrocellulose paper (epithelial side up), and cut into 4x4cm pieces. The sheets were frozen at -80 degrees C. The protein samples were solubilized, and analyzed by 2D gel electrophoresis and shotgun proteomics.
   ResultsA reference identification map of the equine AM proteins was produced and 149 different proteins were identified. From gel-based proteomics, 49 spots were excised and 43 proteins identified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Shotgun proteomics identified 116 proteins with an overlap of 10 proteins in both analyses.
   ConclusionsWe have described a reference map for equine AM proteins that may provide a background to explain the positive results found in horses with ulcerative keratopathies using this biomaterial.
C1 [Galera, Paula D.; Ribeiro, Cassio R.] Univ Brasilia, Coll Vet Med, Dept Vet Med, Brasilia, DF, Brazil.
   [Sapp, Harold L.; Coleman, James; Brooks, Dennis E.] Univ Florida, Coll Vet Med, Dept Small & Large Anim Clin Sci, Gainesville, FL USA.
   [Fontes, Wagner] Univ Brasilia, Inst Biol Sci, Dept Cell Biol, Brasilia, DF, Brazil.
RP Galera, PD (reprint author), Univ Brasilia, Coll Vet Med, Dept Vet Med, Brasilia, DF, Brazil.
EM dra.paulagalera@gmail.com
RI Fontes, Wagner/A-1771-2008
OI Fontes, Wagner/0000-0001-5140-8573
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) -
   Brazil [479526/2011-7]; Veterinary College - University of Florida
FX Supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) - Brazil (process no. 479526/2011-7) and Veterinary College -
   University of Florida.
CR Arcelli R, 2009, VET RES COMMUN, V33, pS169, DOI 10.1007/s11259-009-9284-6
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Barachetti L, 2010, VET OPHTHALMOL, V13, P326, DOI 10.1111/j.1463-5224.2010.00821.x
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   Barros PSM, 2005, VET OPHTHALMOL, V8, P189, DOI 10.1111/j.1463-5224.2005.00391.x
   Baum J, 2002, CORNEA, V21, P339, DOI 10.1097/00003226-200205000-00001
   Brooks DE, 2008, VET OPHTHALMOL, V11, P123, DOI 10.1111/j.1463-5224.2008.00611.x
   Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Choi US, 2010, VET OPHTHALMOL, V13, P122, DOI 10.1111/j.1463-5224.2010.00765.x
   Cooper LJ, 2006, INVEST OPHTH VIS SCI, V47, P3303, DOI 10.1167/iovs.05-1426
   CRONSHAW AD, 1993, MATRIX, V13, P255, DOI 10.1016/S0934-8832(11)80009-0
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k
   GELATT K.N, 2011, VET OPHTHALMIC SURG, P191
   Goodrich LR, 2000, AM J VET RES, V61, P326, DOI 10.2460/ajvr.2000.61.326
   Guo Q, 2011, ACTA OPHTHALMOL, V89, P315
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hopkinson A, 2005, PROTEOMICS, V5, P1967, DOI 10.1002/pmic.200401073
   Hopkinson A, 2006, J PROTEOME RES, V5, P2226, DOI 10.1021/pr050425q
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843
   Kalpravidh M, 2009, VET RES COMMUN, V33, P1003, DOI 10.1007/s11259-009-9319-z
   Kato A, 2011, J BIOL CHEM, V286, P14861, DOI 10.1074/jbc.M110.179762
   KIM JC, 1995, CORNEA, V14, P473
   Kim JY, 2009, VET OPHTHALMOL, V12, P36, DOI 10.1111/j.1463-5224.2009.00671.x
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Kuroda K, 1999, J INVEST DERMATOL, V112, P706, DOI 10.1046/j.1523-1747.1999.00563.x
   Lange-Consiglio A, 2011, J TISSUE ENG REGEN M, V6, P622
   Lassaline ME, 2005, VET OPHTHALMOL, V8, P311, DOI 10.1111/j.1463-5224.2005.00405.x
   Leygue E, 2000, J PATHOL, V192, P313
   Liu T, 2012, MOL VIS, V18, P2137
   Long CG, 2006, 52 ANN CONV AM ASS E, V52, P501
   Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006
   Mandal N, 2010, BIOL PROCED ONLINE, V12, P56, DOI 10.1007/s12575-009-9019-7
   Meek Keith M, 2009, Biophys Rev, V1, P83, DOI 10.1007/s12551-009-0011-x
   Mienaltowski MJ, 2009, BMC MED GENOMICS, V2, P1
   Milani JF, 2008, PESQUISA VET BRASIL, V28, P379, DOI 10.1590/S0100-736X2008000800006
   Miragliotta V, 2009, VET DERMATOL, V20, P243, DOI 10.1111/j.1365-3164.2009.00748.x
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537
   Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564
   Ollivier FJ, 2006, VET OPHTHALMOL, V9, P404, DOI 10.1111/j.1463-5224.2006.00480.x
   OXLUND H, 1990, EUR J OBSTET GYN R B, V34, P247, DOI 10.1016/0028-2243(90)90078-F
   Plummer CE, 2009, VET OPHTHALMOL, V12, P17, DOI 10.1111/j.1463-5224.2009.00741.x
   RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059
   Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607
   Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t
   SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348
   Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4
   Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x
   Takemoto S, 2002, BASIC RES CARDIOL, V97, P461, DOI 10.1007/s00395-002-0371-x
   Takeuchi T, 2006, J ENDOCRINOL, V190, P351, DOI 10.1677/joe.1.06619
   Tzen CY, 2004, EXP CELL RES, V294, P30, DOI 10.1016/j.yexer.2003.10.026
   Yamatoji M, 2001, INT J CANCER, V130, P2903
   Yeah LK, 2005, INVEST OPHTHALMOL, V46, P479
NR 60
TC 1
Z9 1
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1463-5216
EI 1463-5224
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD MAY
PY 2015
VL 18
IS 3
BP 198
EP 209
DI 10.1111/vop.12190
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA CG7SE
UT WOS:000353504400004
PM 24981051
DA 2018-10-20
ER

PT J
AU Liu, XD
   Zhang, FB
   Shan, H
   Chen, PY
AF Liu, Xiao-Dong
   Zhang, Fu-Bo
   Shan, Hu
   Chen, Pu-Yan
TI The potential mechanism of bursal-derived BP8 on B cell developments
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Bursa of Fabricus; B cell development; Bursal peptide (BP8); Gene
   microarray; Immunomodulatory peptide; Retinol uptake
ID VITAMIN-A; INTERLEUKIN-6 SYNTHESIS; DEHYDROGENASE; METABOLISM;
   FABRICIUS; CHICKEN; SYSTEM
AB The bursa of Fabricius, the key humoral immune organ unique to birds, is critical for B cell differentiation and antibody production. BP8 (AGHTKKAP) is a novel immunomodulatory peptide that regulates B-cell development. Gene microarray was used to investigate the mechanism of BP8 on B cell development. BP8 regulated expressions of 1,570 genes that were involved in retinol metabolism, the Wnt signaling pathway, MAPK pathway, Jak-Stat pathway, Notch signaling pathway, cytokine-cytokine receptor interaction, and Ca2+ signals. Finally, BP8 triggered ADH7 and RDH10 expression, interacted with retinol binding protein, and regulated retinol uptake in vitro and vivo. These data reveal a bursal-derived multifunctional factor, BP8, as a novel biomaterial which is essential for the development of the immune system and represents an important linker between the B cell development and retinol metabolism. This study elucidates the mechanisms involved in humoral immune system and has implications in treating human diseases.
C1 [Liu, Xiao-Dong; Zhang, Fu-Bo; Shan, Hu] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao 266109, Peoples R China.
   [Chen, Pu-Yan] Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
RP Chen, PY (reprint author), Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
EM shanhu67@163.com; puyanchen@aliyun.com
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); National Special Research Programs for Non-profit
   Trades, Ministry of Agriculture [201203082]; international S&T
   Cooperation Program of China (ISTCP) [2014DFR30980]
FX This work was supported by the Project funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   National Special Research Programs for Non-profit Trades, Ministry of
   Agriculture (No. 201203082) and international S&T Cooperation Program of
   China (ISTCP) (No. 2014DFR30980). The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600
   Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103
   COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75
   Davison F, 2011, AVIAN IMMUNOLOGY, P1
   Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011
   Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152
   FINE JS, 1994, EXP HEMATOL, V22, P1188
   Fritzenwanger M, 2007, CYTOKINE, V38, P137, DOI 10.1016/j.cyto.2007.05.015
   Fritzenwanger M, 2006, CYTOKINE, V36, P101, DOI 10.1016/j.cyto.2006.10.015
   GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224
   Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244
   Liu XD, 2014, AMINO ACIDS, V46, P2705, DOI 10.1007/s00726-014-1824-x
   LYDYARD PM, 1976, J EXP MED, V144, P79, DOI 10.1084/jem.144.1.79
   Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378
   Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07
   Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334
   Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7
   van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832
   ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P4305, DOI 10.1074/jbc.270.9.4305
NR 20
TC 1
Z9 2
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2015
VL 37
IS 5
BP 1013
EP 1020
DI 10.1007/s10529-015-1772-x
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CF6BP
UT WOS:000352641700007
PM 25650343
DA 2018-10-20
ER

PT J
AU Knoll, LD
AF Knoll, L. D.
TI BIOMATERIAL GRAFTING WITH PENILE PROSTHETIC INSERTION IN THE MANAGEMENT
   OF PEYRONIE'S DISEASE: EFFICACY AND SAFETY
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD MAY
PY 2015
VL 12
SU 2
SI SI
MA 071
BP 126
EP 126
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA CF8EQ
UT WOS:000352789100072
DA 2018-10-20
ER

PT J
AU Tszydel, M
   Zablotni, A
   Wojciechowska, D
   Michalak, M
   Krucinska, I
   Szustakiewicz, K
   Maj, M
   Jaruszewska, A
   Strzelecki, J
AF Tszydel, M.
   Zablotni, A.
   Wojciechowska, D.
   Michalak, M.
   Krucinska, I.
   Szustakiewicz, K.
   Maj, M.
   Jaruszewska, A.
   Strzelecki, J.
TI Research on possible medical use of silk produced by caddisfly larvae of
   Hydropsyche angustipennis (Trichoptera, Insecta)
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Silk; Cytotoxicity; Sterilization; Mechanical properties; Caddisfly
AB Silk products are used in medicine as biomaterials, and are particularly promising as scaffolds in tissue engineering. To date only silkworm and spider silk medical potential has been evaluated, whereas the possible application of the material spun by caddisflies in wet environment has not been examined. Biomedical application of every natural material requires biocompatibility testing and evaluation of unique microbiological and mechanical properties. This article focuses on silk fibers formed in caddisflies cocoons of Hydropsyche angustipennis (Insecta, Trichoptera) larvae. Preliminary biological evaluation shows that trichopteran silk is not cytotoxic to human cells. Caddistly silk itself does not possess antiseptic properties and thus sterilization is indispensable for its application in medicine. Among tested methods of sterilization and disinfection only thermal methods (tyndallization and autoclaving) enabled complete eradication of bacteria and gave fully sterile material. Caddisfiy silk appeared to be resistant to high temperature. Fully sterile fibers can be stored without a loss of breaking force and tensile strength. Our work shows that trichopteran silk has a significant potential to be used as a biomaterial. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Tszydel, M.] Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, PL-90237 Lodz, Poland.
   [Zablotni, A.] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Microbiol, PL-90237 Lodz, Poland.
   [Wojciechowska, D.; Michalak, M.; Krucinska, I.] Lodz Univ Technol, Fac Mat Technol & Text Design, Dept Mat & Commod Sci & Text Metrol, PL-90543 Lodz, Poland.
   [Szustakiewicz, K.] Wroclaw Univ Technol, Polymer Engn & Technol Div, PL-50370 Wroclaw, Poland.
   [Maj, M.] Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Tissue Engn Dept, PL-85092 Bydgoszcz, Poland.
   [Jaruszewska, A.; Strzelecki, J.] Nicholas Copernicus Univ, Inst Phys, PL-87100 Torun, Poland.
RP Tszydel, M (reprint author), Univ Lodz, Fac Biol & Environm Protect, Dept Ecol & Vertebrate Zool, 12-16 Banacha Str, PL-90237 Lodz, Poland.
EM mtszydel@biol.uni.lodz.pl; agzab@biol.uni.lodz.pl; dorowoj@gmail.com;
   marina.michalak@p.lodz.pl; konrad.szustakiewicz@pwr.edu.pl;
   m.uzarska@wp.pl; agatabrazkiewicz@gmail.com; jast@fizyka.umk.pl
RI Maj, Malgorzata/D-4366-2014
OI Maj, Malgorzata/0000-0003-2433-8578; Zablotni,
   Agnieszka/0000-0001-7982-9767; Tszydel, Mariusz/0000-0002-0254-7451
FU Polish Ministry of Science and Higher Education [0438/T02/2010/70];
   Institute of Physics, Nicolaus Copernicus University [414-F]
FX M. Tszydel acknowledges the Research Grant 0438/T02/2010/70 from the
   Polish Ministry of Science and Higher Education "Iuventus Plus":
   Structure and properties of trichopteran (Insecta, Trichoptera) fibers
   in view of the possibilities of their applicational using.r J.
   Strzelecki acknowledges the research grant for young scientists 414-F
   from Institute of Physics, Nicolaus Copernicus University.
CR Ashton N.N., 2013, SELF TENSIONING AQUA
   Austin P.R., 1981, SCIENCE, V212, P44
   BASCOMBE AD, 1990, WATER SCI TECHNOL, V22, P173
   Brown SA, 2004, J N AM BENTHOL SOC, V23, P771, DOI 10.1899/0887-3593(2004)023<0771:PPOHST>2.0.CO;2
   Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x
   Cianficconi F., 1992, P 7 INT S TRICH, P33
   Craig L.C., 2003, SPIDERWEBS SILK TRAC, P230
   De Moraes M.A., 2013, J BIOMED MATER RES B, V102, P869
   ELLIOTT JM, 1968, J ANIM ECOL, V37, P615, DOI 10.2307/3078
   ELLIOTT JM, 1969, OIKOS, V20, P110, DOI 10.2307/3543750
   Elliott JM, 1977, FRESHWATER BIOL ASS, V25, P1
   Erman N.A., 1987, P 5 INT S TRICH HAG, P275
   Font R, 2011, J ANAL APPL PYROL, V91, P89, DOI 10.1016/j.jaap.2011.01.007
   Gellynck K., 2006, THESIS U GENT
   Hegazy K.E.S., 2006, P 14 ANN C MISR SOC, P741
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Michalak M, 2005, FIBRES TEXT EAST EUR, V13, P28
   Moretti G P., 1983, TRICOTTERI TRICHOPTE
   Petersen L. B. -M., 1985, VERHANDLUNGEN INT VE, V22, P3270
   PHILIPSON GN, 1974, FRESHWATER BIOL, V4, P525, DOI 10.1111/j.1365-2427.1974.tb00112.x
   Rengasamy RS, 2005, AUTEX RES J, V5, P30
   Saravanan D., 2006, J TEXT APPAREL TECHN, V5, P1
   Sionkowska A., 2001, POLYM DEGRAD STABIL, V96, P523
   SOKAL RR, 1969, BIOMETRY PRINCIPLES
   Statzner B, 2005, LIMNOL OCEANOGR, V50, P713, DOI 10.4319/lo.2005.50.2.0713
   Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d
   Strzelecki J, 2012, ACTA PHYS POL A, V122, P329, DOI 10.12693/APhysPolA.122.329
   Strzelecki JW, 2011, CENT EUR J PHYS, V9, P482, DOI 10.2478/s11534-010-0105-x
   Tsukada M, 2010, INT J BIOL MACROMOL, V46, P54, DOI 10.1016/j.ijbiomac.2009.10.003
   Tszydel M, 2009, FIBRES TEXT EAST EUR, V17, P7
   Urbanczyk G.W., 1985, SCI FIBERS
   Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007
   Van Nimmen E., 2002, P SEM ANN C EXP APPL, P246
   Wichard W., 1992, P 7 INT S TRICH, P25
   Wissman A., 2001, THERMOCHIM ACTA, V525, P129
   Xi Y, 2005, J THERM ANAL CALORIM, V81, P91, DOI 10.1007/s10973-005-0750-2
   Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5
   Yonemura N, 2006, BIOMACROMOLECULES, V7, P3370, DOI 10.1021/bm060663u
   Zhang Y., 2006, J SILK, V7, P22
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
NR 41
TC 3
Z9 3
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAY
PY 2015
VL 45
BP 142
EP 153
DI 10.1016/j.jmbbm.2015.02.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CF6KH
UT WOS:000352665100014
PM 25723346
DA 2018-10-20
ER

PT J
AU Rising, A
   Johansson, J
AF Rising, Anna
   Johansson, Jan
TI Toward spinning artificial spider silk
SO NATURE CHEMICAL BIOLOGY
LA English
DT Article
ID SOLID-STATE NMR; AMYLOID FIBRIL FORMATION; MAJOR AMPULLATE GLAND;
   DRAGLINE SILK; SECONDARY STRUCTURE; NEPHILA-CLAVIPES;
   PHYSICAL-PROPERTIES; TERMINAL DOMAINS; MESSENGER-RNA; PROTEINS
AB Spider silk is strong and extensible but still biodegradable and well tolerated when implanted, making it the ultimate biomaterial. Shortcomings that arise in replicating spider silk are due to the use of recombinant spider silk proteins (spidroins) that lack native domains, the use of denaturing conditions under purification and spinning and the fact that the understanding of how spiders control silk formation is incomplete. Recent progress has unraveled the molecular mechanisms of the spidroin N- and C-terminal nonrepetitive domains (NTs and CTs) and revealed the pH and ion gradients in spiders' silk glands, clarifying how spidroin solubility is maintained and how silk is formed in a fraction of a second. Protons and CO2, generated by carbonic anhydrase, affect the stability and structures of the NT and CT in different ways. These insights should allow the design of conditions and devices for the spinning of recombinant spidroins into native-like silk.
C1 [Rising, Anna; Johansson, Jan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
   [Rising, Anna; Johansson, Jan] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.
RP Rising, A (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
EM anna.rising@ki.se; janne.johansson@ki.se
OI Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council
FX We are grateful to S. Knight for valuable discussions and helpful
   comments on this manuscript. The Swedish Research Council supported work
   in the authors' laboratory.
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921
   Andersson M, 2013, BIOMACROMOLECULES, V14, P2945, DOI 10.1021/bm400898t
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   CANDELAS GC, 1981, J EXP ZOOL, V216, P1, DOI 10.1002/jez.1402160102
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Chen GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052293
   Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126
   Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365
   COHEN AC, 1980, COMP BIOCHEM PHYS A, V66, P715, DOI 10.1016/0300-9629(80)90025-0
   DENNY M, 1976, J EXP BIOL, V65, P483
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121
   Gao ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056142
   Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hagn F, 2011, ANGEW CHEM INT EDIT, V50, P310, DOI 10.1002/anie.201003795
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Hronska M, 2004, BIOMACROMOLECULES, V5, P834, DOI 10.1021/bm0343904
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008
   Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004
   Jenkins JE, 2010, CHEM COMMUN, V46, P6714, DOI 10.1039/c0cc00829j
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Kovoor J., 1987, P160
   Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Landreh M, 2010, J MOL BIOL, V404, P328, DOI 10.1016/j.jmb.2010.09.054
   Lane AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-846
   Lang G, 2013, JOVE-J VIS EXP, DOI 10.3791/50492
   Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517
   Lefevre T, 2012, BIOPOLYMERS, V97, P322, DOI 10.1002/bip.21712
   Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357
   Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765
   Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   STAUFFER SL, 1994, J ARACHNOL, V22, P5
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0
   Wang SJ, 2012, J BIOMOL NMR, V54, P415, DOI 10.1007/s10858-012-9679-5
   Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
NR 69
TC 72
Z9 75
U1 7
U2 140
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
EI 1552-4469
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD MAY
PY 2015
VL 11
IS 5
BP 309
EP 315
DI 10.1038/NCHEMBIO.1789
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CG3FD
UT WOS:000353162600005
PM 25885958
DA 2018-10-20
ER

PT J
AU Kassem, M
AF Kassem, M.
TI Synthesis, physicochemical characterizations, and photocatalytic
   behaviors of Ni (x) K2Mo4O13 systems
SO RESEARCH ON CHEMICAL INTERMEDIATES
LA English
DT Article
DE Potassium tetramolybdate; Nickel; Characterizations; Photocatalytic
   behaviors
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; HYDROTHERMAL
   SYNTHESIS; ANTIMICROBIAL ACTIVITY; TITANIUM-DIOXIDE; MAGNETIC CORE;
   PHOTODEGRADATION; CATALYSTS; CU; DEGRADATION
AB Different samples of Ni (x) K2Mo4O13 have been prepared by mixing appropriate amounts, in solid state, of Ni and K2Mo4O13 (PDF ICDD 27-416) according to the molar ratio Ni/K2Mo4O13 = 0, 0.05, 0.1, 0.2, 0.5, and 1. The prepared samples were characterized using X-ray powder diffraction (XRD), Fourier transform infrared (FT-IR), differential thermal analysis (DTA), nitrogen adsorption apparatus, and UV spectrophotometer. XRD results indicate that the phase composition of the Ni/K2Mo4O13 samples has been significantly changed with the change in molar ratio of Ni/K2Mo4O13. The presence of Ni gave rise to the formation of other new phases identified as K2Mo3O10 (PDF ICDD 37-1467) and alpha-NiMoO4 (PDF ICDD 32-692). The results of FT-IR and DTA also allowed us to track the formation of the above-mentioned substances. The nitrogen adsorption-desorption isotherms and the pore size distribution reveal that the texture of the prepared samples has also been affected by the nickel content. The photocatalytic behaviors of pure K2Mo4O13 and Ni (x) K2Mo4O13 were studied by means of monitoring the ability of these materials to enhance the degradation under UV irradiation of the methyl red in liquid media. It was found that the phase composition is the most influential parameter in the photocatalytic behavior of the studied samples.
C1 Atom Energy Commiss Syria, Dept Chem, Damascus, Syria.
RP Kassem, M (reprint author), Atom Energy Commiss Syria, Dept Chem, POB 6091, Damascus, Syria.
EM cscientific@aec.org.sy
CR [Anonymous], 2008, WINXPOW 32
   Armatas NG, 2008, INORG CHEM, V47, P832, DOI 10.1021/ic701573r
   Bansal P, 2009, DESALIN WATER TREAT, V12, P108, DOI 10.5004/dwt.2009.944
   Cai L.Z., 2003, INORG CHIM ACTA, V344, P6
   Cheng MM, 2008, APPL CATAL B-ENVIRON, V77, P355, DOI 10.1016/j.apcatb.2007.08.006
   Choy JH, 2002, CHEM MATER, V14, P2486, DOI 10.1021/cm010815m
   Deyk C., 2008, E-J CHEM, V5, P1021
   Eda K, 2004, J SOLID STATE CHEM, V177, P916, DOI 10.1016/j.jssc.2003.09.029
   Eda K, 2009, J SOLID STATE CHEM, V182, P55, DOI 10.1016/j.jssc.2008.10.001
   Gnaser H., 2004, ENCY NANOSCIENCE NAN, V6, P505
   Griboval A, 2001, APPL CATAL A-GEN, V217, P173, DOI 10.1016/S0926-860X(01)00588-9
   Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1
   Hegde MS, 2005, PRAMANA-J PHYS, V65, P641, DOI 10.1007/BF03010452
   Kim HG, 1999, CHEM COMMUN, P1077, DOI 10.1039/a902892g
   Korosi L, 2006, COLLOID SURFACE A, V280, P146, DOI 10.1016/j.colsurfa.2006.01.052
   Kubelka P., 1931, Zeitschrift fur Technische Physik, V12, P593
   Lee H.C., 2002, B KOREAN CHEM SOC, V33, P477
   Li D.M., 2007, J MOL STRUCT, V832, P173
   Li HB, 2008, MATER RES BULL, V43, P1971, DOI 10.1016/j.materresbull.2007.10.005
   Li SJ, 2008, SCI CHINA SER B, V51, P179, DOI 10.1007/s11426-007-0100-2
   Madeira LM, 2004, CATAL REV, V46, P53, DOI 10.1081/CR-120030053
   Mitchell S., 2010, J SOLID STATE CHEM, V41, P34
   Mohan Ram R. A., 1986, Proceedings of the Indian Academy of Sciences, Chemical Sciences, V96, P291
   Qu WW, 2010, J PHYS CHEM SOLIDS, V71, P35, DOI 10.1016/j.jpcs.2009.10.005
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Reddy BM, 2002, APPL CATAL A-GEN, V228, P269, DOI 10.1016/S0926-860X(01)00982-6
   Rupa AV, 2007, J HAZARD MATER, V147, P906, DOI 10.1016/j.jhazmat.2007.01.107
   Shaban YA, 2010, INT J NANOTECHNOL, V7, P69, DOI 10.1504/IJNT.2010.029549
   Sing K, 2001, COLLOID SURFACE A, V187, P3, DOI 10.1016/S0927-7757(01)00612-4
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Slamet H.W., 2009, WORLD APPL SCI J, V6, P112
   Storck S, 1998, APPL CATAL A-GEN, V174, P137, DOI 10.1016/S0926-860X(98)00164-1
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   TAKATA T, 2000, STUD SURF SCI CATA B, V130, P1943
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wu CD, 2001, CHIN J STRUCT CHEM, V20, P266
   Wu XY, 2006, B KOR CHEM SOC, V27, P1206
   Xia HL, 2007, J ENVIRON SCI-CHINA, V19, P1141, DOI 10.1016/S1001-0742(07)60186-7
   Xie SB, 2000, J PHYS CHEM B, V104, P10059, DOI 10.1021/jp002419h
   Zaleska A., 2008, RECENT PAT ENG, V2, P157, DOI DOI 10.2174/187221208786306289
   Zhang GK, 2006, J MOL CATAL A-CHEM, V255, P109, DOI 10.1016/j.molcata.2006.03.073
   Zhang XM, 2005, J PHYS CHEM B, V109, P19156, DOI 10.1021/jp052858m
   Zhao G., 2008, J SOLID STATE CHEM, V181, P2133
NR 48
TC 1
Z9 1
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0922-6168
EI 1568-5675
J9 RES CHEM INTERMEDIAT
JI Res. Chem. Intermed.
PD MAY
PY 2015
VL 41
IS 5
BP 2891
EP 2900
DI 10.1007/s11164-013-1397-4
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA CF3XV
UT WOS:000352483300021
DA 2018-10-20
ER

PT J
AU Mardones, R
   Jofre, CM
   Minguell, JJ
AF Mardones, Rodrigo
   Jofre, Claudio M.
   Minguell, Jose J.
TI Cell Therapy and Tissue Engineering Approaches for Cartilage Repair
   and/or Regeneration
SO INTERNATIONAL JOURNAL OF STEM CELLS
LA English
DT Review
AB Articular cartilage injuries caused by traumatic, mechanical and/or by progressive degeneration result in pain, swelling, subsequent loss of joint function and finally osteoarthritis. Due to the peculiar structure of the tissue (no blood supply), chondrocytes, the unique cellular phenotype in cartilage, receive their nutrition through diffusion from the synovial fluid and this limits their intrinsic capacity for healing. The first cellular avenue explored for cartilage repair involved the in situ transplantation of isolated chondrocytes. Latterly, an improved alternative for the above reparative strategy involved the infusion of mesenchymal stem cells (MSC), which in addition to a self-renewal capacity exhibit a differentiation potential to chondrocytes, as well as a capability to produce a vast array of growth factors, cytokines and extracellular matrix compounds involved in cartilage development. In addition to the above and foremost reparative options up till now in use, other therapeutic options have been developed, comprising the design of biomaterial substrates (scaffolds) capable of sustaining MSC attachment, proliferation and differentiation. The implantation of these engineered platforms, closely to the site of cartilage damage, may well facilitate the initiation of an in situ' cartilage reparation process. In this mini-review, we examined the timely and conceptual development of several cell-based methods, designed to repair/regenerate a damaged cartilage. In addition to the above described cartilage reparative options, other therapeutic alternatives still in progress are portrayed.
C1 [Mardones, Rodrigo] Clin Las Condes, Lab Ingn Tejidos, Ctr Traumatol & Ortopedia, Santiago 7550000, Chile.
   [Mardones, Rodrigo; Jofre, Claudio M.; Minguell, Jose J.] Clin Las Condes, Lab Ingn Tejidos, Ctr Terapia Regenerat Celular, Santiago 7550000, Chile.
RP Minguell, JJ (reprint author), Clin Las Condes, Ctr Terapia Regenerat Celular, Av Las Condes 10373,Of 75, Santiago 7550000, Chile.
EM jminguell@clinicalascondes.cl
CR Allers C, 2014, CYTOTHERAPY, V16, P454, DOI 10.1016/j.jcyt.2013.08.006
   [Anonymous], 2005, NICE UPD GUID US AUT
   Athanasiou KA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028825
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Cole Brian J, 2010, Instr Course Lect, V59, P181
   Dvir-Ginzberg M, 2014, BIOMARKERS, P1, DOI DOI 10.3109/1354750X.2014.955884
   Emadedin M, 2012, ARCH IRAN MED, V15, P422, DOI 012157/AIM.0010
   Freymann U, 2013, OA ORTHOPAEDICS, V1, P6
   Frisch J, 2014, HUM GENE THER, V25, P1050, DOI 10.1089/hum.2014.091
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Harvey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079283
   Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196
   Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011
   Lee CSD, 2013, TISSUE ENG PT A, V19, P1451, DOI [10.1089/ten.TEA.2012.0233, 10.1089/ten.tea.2012.0233]
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Minas T, 2010, CLIN ORTHOP RELAT R, V468, P147, DOI 10.1007/s11999-009-0998-0
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Minguell JJ, 2013, STEM CELLS DEV, V22, P193, DOI 10.1089/scd.2012.0417
   Muthuswamy Vasantha, 2013, Perspect Clin Res, V4, P9, DOI 10.4103/2229-3485.106369
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Rodriguez-Merchan E Carlos, 2012, Am J Orthop (Belle Mead NJ), V41, P236
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Schminke B, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0461-4
   Skowronski Jan, 2013, Ortop Traumatol Rehabil, V15, P69, DOI 10.5604/15093492.1012405
   Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]
   Steinert AF, 2008, INJURY, V39, pS97, DOI 10.1016/j.injury.2008.01.034
   Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971
   Zhang Z, 2014, TISSUE ENG B
   Zwolanek D, 2015, BIORESEARCH
NR 38
TC 36
Z9 40
U1 1
U2 16
PU KOREAN SOC STEM CELL RESEARCH
PI BANPO-DONG
PA CATHOLIC UNIV KOREA 505, INST BIOMEDICAL INDUSTRY, BANPO-DONG, SEOCHO-GU
   00000, SOUTH KOREA
SN 2005-3606
EI 2005-5447
J9 INT J STEM CELLS
JI Int J. Stem Cells
PD MAY
PY 2015
VL 8
IS 1
BP 48
EP 53
DI 10.15283/ijsc.2015.8.1.48
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA CJ6XP
UT WOS:000355638800006
PM 26019754
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU De Santis, E
   Lang, NP
   Favero, G
   Beolchini, M
   Morelli, F
   Botticelli, D
AF De Santis, Enzo
   Lang, Niklaus P.
   Favero, Giovanni
   Beolchini, Marco
   Morelli, Fabrizio
   Botticelli, Daniele
TI Healing at mandibular block-grafted sites. An experimental study in dogs
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal study; bone defects; bone graft; bone healing; bone regeneration;
   deproteinized bovine bone mineral; histology
ID LATERAL RIDGE AUGMENTATION; PARTIALLY EDENTULOUS PATIENTS; AUTOGENOUS
   BONE-GRAFTS; BOVINE BONE; IMPLANTS; MEMBRANES; REGENERATION; DEFECTS;
   MAXILLA; MODEL
AB AimThe aim of this study was to evaluate the healing of autologous bone block grafts or deproteinized bovine bone mineral (DBBM) block grafts applied concomitantly with collagen membranes for horizontal alveolar ridge augmentation.
   Material and methodsIn six Labrador dogs, molars were extracted bilaterally, the buccal bony wall was removed, and a buccal box-shaped defect created. After 3months, a bony block graft was harvested from the right ascending ramus of the mandible and reduced to a standardized size. A DBBM block was tailored to similar dimensions. The two blocks were secured with screws onto the buccal wall of the defects in the right and left sides of the mandible, respectively. Resorbable membranes were applied at both sides, and the flaps sutured. After 3months, one implant was installed in each side of the mandible, in the interface between grafts and parent bone. After 3months, biopsies were harvested and ground sections prepared to reveal a 6-month healing period of the grafts.
   Results776.2% and 5.9 +/- 7.5% of vital mineralized bone were found at the autologous bone and DBBM block graft sites, respectively. Moreover, at the DBBM site, 63 +/- 11.7% of connective tissue and 31 +/- 15.5% of DBBM occupied the area analyzed. Only 0.2 +/- 0.4% of DBBM was found in contact with newly formed bone. The horizontal loss was in a mean range of 0.9-1.8mm, and 0.3-0.8mm, at the autologous bone and DBBM block graft sites, respectively.
   ConclusionsAutologous bone grafts were vital and integrated to the parent bone after 6months of healing. In contrast, DBBM grafts were embedded into connective tissue, and only a limited amount of bone was found inside the scaffold of the biomaterial.
C1 [De Santis, Enzo; Botticelli, Daniele] ARDEC, Ariminum Odontol, Rimini, Italy.
   [Lang, Niklaus P.; Botticelli, Daniele] Univ Hong Kong, Prince Philip Dent Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Lang, Niklaus P.] Univ Zurich, Zurich, Switzerland.
   [Favero, Giovanni; Beolchini, Marco; Morelli, Fabrizio; Botticelli, Daniele] Univ Med Sci, Fac Dent, Havana, Cuba.
   [Botticelli, Daniele] UNESP Univ Estadual Paulista, Fac Dent Aracatuba, Sao Paulo, Brazil.
RP Botticelli, D (reprint author), Ave Salvador Allende & G Vedado, Havana, Cuba.
EM daniele.botticelli@gmail.com
OI favero, gian antonio/0000-0002-9126-2393; Botticelli,
   Daniele/0000-0003-2804-1632
FU Sweden & Martina SRL, Due Carrare, Padova, Italy; ARDEC, Ariminum
   Odontologica SRL, Rimini, Italy; Clinical Research Foundation (CRF) for
   the Promotion of Oral Health, Brienz, Switzerland
FX This study has been supported by a grant from Sweden & Martina SRL, Due
   Carrare, Padova, Italy and by ARDEC, Ariminum Odontologica SRL, Rimini,
   Italy and the Clinical Research Foundation (CRF) for the Promotion of
   Oral Health, Brienz, Switzerland. The material for the regenerative
   procedures was kindly provided by Geistlich Biomaterials AG, Wolhusen,
   LU, Switzerland. The competent contributions of Prof. Luiz A. Salata and
   of Mr Sebastiao Bianco (USP - Faculty of Dentistry of Ribeirao Preto -
   University of Sao Paulo, Sao Paulo, Brazil) in the histological
   processing are highly acknowledged.
CR Acocella A, 2010, J CRANIO MAXILL SURG, V38, P222, DOI 10.1016/j.jcms.2009.07.004
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Buser D, 1996, J ORAL MAXIL SURG, V54, P420, DOI 10.1016/S0278-2391(96)90113-5
   Chiapasco M, 1999, CLIN ORAL IMPLAN RES, V10, P278, DOI 10.1034/j.1600-0501.1999.100404.x
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Cordaro L, 2011, CLIN ORAL IMPLAN RES, V22, P1145, DOI 10.1111/j.1600-0501.2010.02093.x
   de Carvalho PSP, 2000, INT J ORAL MAX IMPL, V15, P565
   Neto PJD, 2012, CLIN IMPLANT DENT R, V14, P861, DOI 10.1111/j.1708-8208.2010.00321.x
   De Santis E, 2012, CLIN ORAL IMPLAN RES, V23, P340, DOI 10.1111/j.1600-0501.2011.02326.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P175, DOI 10.1034/j.1600-0501.2002.130208.x
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P167
   Faria PEP, 2008, CLIN ORAL IMPLAN RES, V19, P393, DOI 10.1111/j.1600-0501.2007.01485.x
   Felice P., 2013, CLIN IMPLANT DENT R, DOI [10.1111/cid.12115, DOI 10.1111/CID.12115]
   Hammerle CHF, 2008, CLIN ORAL IMPLAN RES, V19, P19, DOI 10.1111/j.1600-0501.2007.01407.x
   Maiorana C, 2005, INT J PERIODONT REST, V25, P19
   Nystrom E, 1993, Int J Oral Maxillofac Implants, V8, P45
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Raghoebar GM, 1996, J ORAL MAXIL SURG, V54, P1180, DOI 10.1016/S0278-2391(96)90346-8
   Rossi F, 2014, CLIN ORAL IMPLAN RES, V25, P124, DOI 10.1111/clr.12097
   Schmitt C, 2013, CLIN ORAL IMPLAN RES, V24, P450, DOI 10.1111/j.1600-0501.2011.02351.x
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P642, DOI 10.1111/j.1600-0501.2008.01537.x
   Schwarz F, 2010, CLIN ORAL IMPLAN RES, V21, P904, DOI 10.1111/j.1600-0501.2010.01951.x
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   Neto RS, 2014, CLIN ORAL IMPLAN RES, V25, P226, DOI 10.1111/clr.12107
   von Arx T, 2001, INT J ORAL MAX IMPL, V16, P343
   von Arx T, 2006, CLIN ORAL IMPLAN RES, V17, P359, DOI 10.1111/j.1600-0501.2005.01234.x
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
   Yeo A, 2012, CLIN ORAL IMPLAN RES, V23, P1322, DOI 10.1111/j.1600-0501.2011.02366.x
   Zakhary IE, 2012, OR SURG OR MED OR PA, V114, pS179, DOI 10.1016/j.oooo.2011.09.031
   Zerbo IR, 2003, CLIN ORAL IMPLAN RES, V14, P759, DOI 10.1046/j.0905-7161.2003.00967.x
NR 33
TC 14
Z9 14
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2015
VL 26
IS 5
BP 516
EP 522
DI 10.1111/clr.12434
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CF4ZB
UT WOS:000352562200005
PM 24921198
DA 2018-10-20
ER

PT J
AU Moorhoff, C
   Li, Y
   Cook, WD
   Braybrook, C
   Chen, QZ
AF Moorhoff, Cornelis
   Li, Yuan
   Cook, Wayne D.
   Braybrook, Carl
   Chen, Qi-Zhi
TI Characterization of the prepolymer and gel of biocompatible poly(xylitol
   sebacate) in comparison with poly(glycerol sebacate) using a combination
   of mass spectrometry and nuclear magnetic resonance
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(polyol sebacate)s; biomaterial; NMR; MS; structural
   characterization
ID ENZYMATIC DEGRADATION; GLYCEROL ESTERS; DIVINYL SEBACATE; C-13-NMR
   SPECTRA; XYLITOL; POLYMERS; ELASTOMERS; ALDITOLS; NETWORK;
   POLYMERIZATION
AB Atmospheric pressure chemical ionization (negative ion) and electrospray ionization (positive and negative ion) mass spectrometry and nuclear magnetic resonance (H-1 NMR and C-13 NMR) were used to characterize the prepolymer (i.e. uncrosslinked) poly(xylitol sebacate) (PXS), prepared by condensation of xylitol [X] and sebacic acid [S], and this was compared with poly(glycerol sebacate) (PGS), prepared by condensation of glycerol [G] and [S]. The PXS prepolymer, prepared at 118 degrees C/24 h, gave predominantly 1-acyl-[XS] and 1,5-diacyl-[SXS] species and smaller amounts of 2-acyl substitutions. At 130 degrees C/24 h an increase of the amount of the 1-acyl and 1,5-diacyl substitutions in the [(SX)(n)], [S(XS)(n)] and [(XS)(n)X] series was identified, as was found for the analogous PGS prepolymer ([(SG)(n)], [S(GS)(n)] and [(GS)(n)G] series). Novel tetrahydrofuranyl species were found in the PXS prepolymer. Further polymerization of the PXS prepolymer gave a gel which when analysed using C-13 NMR was shown to mainly contain 1-acyl and 1,5-diacyl substitutions. (c) 2014 Society of Chemical Industry
C1 [Moorhoff, Cornelis; Li, Yuan; Cook, Wayne D.; Chen, Qi-Zhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Braybrook, Carl] CSIRO, Mfg Flagship, Mat Sci & Engn, Clayton, Vic 3169, Australia.
RP Moorhoff, C (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM cor-nelis.moorhoff@monash.edu; wayne.cook@monash.edu
RI Braybrook, Carl/L-3093-2017
FU Australian Research Council [DP130101384]
FX The authors thank Dr Peter Nichols of the Monash School of Chemistry for
   conducting the 2D NMR experiment. Q-ZC thanks the Australian Research
   Council for a Discovery Project grant (DP130101384).
CR Adnani A, 2011, CARBOHYD RES, V346, P472, DOI 10.1016/j.carres.2010.12.023
   ANGYAL SJ, 1980, CARBOHYD RES, V84, P201, DOI 10.1016/S0008-6215(00)85551-2
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Chen Q., 2013, PROG POLYM SCI, V38, P581
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Cramer JF, 2007, ENZYME MICROB TECH, V41, P346, DOI 10.1016/j.enzmictec.2007.03.001
   Crombez-Robert C, 1998, CARBOHYD RES, V307, P355, DOI 10.1016/S0008-6215(98)00006-8
   GERWIG GJ, 1984, CARBOHYD RES, V129, P149, DOI 10.1016/0008-6215(84)85307-0
   Goodby JW, 1997, LIQ CRYST, V22, P367, DOI 10.1080/026782997209441
   Gross JH, 2004, MASS SPECTROMETRY TX
   GUNSTONE FD, 1991, CHEM PHYS LIPIDS, V58, P219
   GUNSTONE FD, 1990, CHEM PHYS LIPIDS, V56, P195, DOI 10.1016/0009-3084(90)90102-W
   GUNSTONE FD, 1993, CHEM PHYS LIPIDS, V66, P189, DOI 10.1016/0009-3084(93)90004-M
   HORNING EC, 1973, ANAL CHEM, V45, P936, DOI 10.1021/ac60328a035
   Jung ME, 1999, ORG LETT, V1, P1517, DOI 10.1021/ol990838v
   Kafouris D, 2013, MACROMOLECULES, V46, P622, DOI 10.1021/ma3016882
   Li Y, 2012, POLYM INT, V62, P534
   Li Y, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035006
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liang SL, 2011, BIOMATERIALS, V32, P8486, DOI 10.1016/j.biomaterials.2011.07.080
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liu QY, 2007, J APPL POLYM SCI, V103, P1412, DOI 10.1002/app.24394
   Lloyd JA, 2009, ANAL CHEM, V81, P9158, DOI 10.1021/ac901324j
   MACOSKO CW, 1976, MACROMOLECULES, V9, P199, DOI 10.1021/ma60050a003
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   Nagata M, 1999, J POLYM SCI POL CHEM, V37, P2005, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2005::AID-POLA14>3.3.CO;2-8
   Nagata M, 1996, REACT FUNCT POLYM, V30, P165, DOI 10.1016/1381-5148(95)00107-7
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Pinner S., 1961, PRACTICAL COURSE POL
   Pouillart P, 1999, EUR J PHARM SCI, V7, P93, DOI 10.1016/S0928-0987(98)00011-6
   Pretsch E., 2009, STRUCTURE DETERMINAT
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Rowland SP, 1967, CARBOHYD RES, V3, P361
   Rufino AR, 2009, J CHEM TECHNOL BIOT, V84, P957, DOI 10.1002/jctb.2117
   SCHNARR GW, 1979, J CHEM SOC PERK T 1, P496, DOI 10.1039/p19790000496
   Stochmayer WH, 1945, ADV FRONTS CHEM
   Terrier P, 2011, MASS SPECTROM REV, V30, P854, DOI 10.1002/mas.20302
   Uyama H, 2001, MACROMOL BIOSCI, V1, P40, DOI 10.1002/1616-5195(200101)1:1<40::AID-MABI40>3.3.CO;2-K
   Uyama H, 1999, MACROMOL RAPID COMM, V20, P171, DOI 10.1002/(SICI)1521-3927(19990401)20:4<171::AID-MARC171>3.3.CO;2-U
   WANG N, 1995, CARBOHYD RES, V274, P45, DOI 10.1016/0008-6215(95)00063-Y
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WHITEHOUSE CM, 1985, ANAL CHEM, V57, P675, DOI 10.1021/ac00280a023
   You ZW, 2010, BIOMATERIALS, V31, P3129, DOI 10.1016/j.biomaterials.2010.01.023
NR 45
TC 1
Z9 1
U1 1
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD MAY
PY 2015
VL 64
IS 5
SI SI
BP 668
EP 688
DI 10.1002/pi.4831
PG 21
WC Polymer Science
SC Polymer Science
GA CF0NC
UT WOS:000352239900012
DA 2018-10-20
ER

PT J
AU Stankova, NE
   Atanasov, PA
   Nedyalkov, NN
   Stoyanchov, TR
   Kolev, KN
   Valova, EI
   Georgieva, JS
   Armyanov, SA
   Amoruso, S
   Wang, X
   Bruzzese, R
   Grochowska, K
   Sliwinski, G
   Baert, K
   Hubin, A
   Delplancke, MP
   Dille, J
AF Stankova, N. E.
   Atanasov, P. A.
   Nedyalkov, N. N.
   Stoyanchov, T. R.
   Kolev, K. N.
   Valova, E. I.
   Georgieva, J. S.
   Armyanov, St. A.
   Amoruso, S.
   Wang, X.
   Bruzzese, R.
   Grochowska, K.
   Sliwinski, G.
   Baert, K.
   Hubin, A.
   Delplancke, M. P.
   Dille, J.
TI fs- and ns-laser processing of polydimethylsiloxane (PDMS) elastomer:
   Comparative study
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Laser Interaction with Advaned Materials: Fundamentals and
   Applications
CY 2014
CL Lille, FRANCE
DE PDMS-elastomer; fs and ns laser processing; UV and vis ns- and fs-laser
   treatment; mu-Raman spectrometry; Metallization; Electroless platinga
ID SILICONE-RUBBER; RAMAN-SPECTROSCOPY; ABLATION; POLY(DIMETHYLSILOXANE);
   IRRADIATION; FABRICATION; POLYMERS; MICROSTRUCTURES; DECOMPOSITION;
   INCUBATION
AB Medical grade polydimethylsiloxane (PDMS) elastomer is a widely used biomaterial as encapsulation and/or as substrate insulator carrier for long term neural implants because of its remarkable properties. Femtosecond (lambda = 263 and 527 nm) and nanosecond (266 and 532 nm) laser processing of PDMS-elastomer surface, in air, is investigated. The influence of different processing parameters, including laser wavelength, pulse duration, fluence, scanning speed and overlapping of the subsequent pulses, on the surface activation and the surface morphology are studied. High definition tracks and electrodes are produced. Remarkable alterations of the chemical composition and structural morphology of the ablated traces are observed in comparison with the native material. Raman spectra illustrate well-defined dependence of the chemical composition on the laser fluence, pulse duration, number of pulses and wavelength. An extra peak about similar to 512-518 cm(-1), assigned to crystalline silicon, is observed after ns- or visible fs-laser processing of the surface. In all cases, the intensities of Si-O-Si symmetric stretching at 488 cm(-1), Si-CH3 symmetric rocking at 685 cm(-1), Si-C symmetric stretching at 709 cm(-1), CH3 asymmetric rocking + Si-C asymmetric stretching at 787 cm(-1), and CH3 symmetric rocking at 859 cm(-1), modes strongly decrease. The laser processed areas are also analyzed by SEM and optical microscopy. Selective Pt or Ni metallization of the laser processed traces is produced successfully via electroless plating. The metallization process is not sensitive with respect to the time interval after the laser treatment. DC resistance is measured to be as low as 0.5 Omega mm(-1). Our results show promising prospects with respect to use such a laser-based method for micro-or nano-fabrication of PDMS devices for MEMS and NEMS. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Stankova, N. E.; Atanasov, P. A.; Nedyalkov, N. N.; Stoyanchov, T. R.] Bulgarian Acad Sci, Inst Elect, BU-1784 Sofia, Bulgaria.
   [Kolev, K. N.; Valova, E. I.; Georgieva, J. S.; Armyanov, St. A.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, BU-1113 Sofia, Bulgaria.
   [Amoruso, S.; Wang, X.; Bruzzese, R.] Univ Naples Federico II, Dipartimento Sci Fis, CNR SPIN, I-80126 Naples, Italy.
   [Grochowska, K.; Sliwinski, G.] Polish Acad Sci, Szewalski Inst, Photophys Dept, PL-80231 Gdansk, Poland.
   [Baert, K.; Hubin, A.] Vrije Univ Brussel, Fac Engn, Res Grp, SURF Electrochem & Surface Engn, Brussels, Belgium.
   [Delplancke, M. P.; Dille, J.] Univ Libre Bruxelles, Mat Engn Characterizat Synth & Recycling, Serv 4MAT, Fac Sci Appl, B-1050 Brussels, Belgium.
RP Stankova, NE (reprint author), Bulgarian Acad Sci, Inst Elect, 72 Tsarigradsko Shosse, BU-1784 Sofia, Bulgaria.
EM nestankova@yahoo.com
RI WANG, Xuan/F-1243-2011; amoruso, salvatore/E-3941-2012
OI WANG, Xuan/0000-0002-0830-0898; amoruso, salvatore/0000-0002-1011-3215;
   Grochowska, Katarzyna/0000-0001-7577-3399
FU between Bulgarian Academy of Sciences (BAS); foreign research
   institution: BAS/CNR (Italy) - project "Femtosecond and nanosecond laser
   ablation-assisted fabrication of metal and metal-oxides nanostructures";
   foreign research institution: BAS/Polish Academy of Sciences (Poland) -
   project "Fabrication and characterization of noble metal nanoparticles
   arrays"; foreign research institution: BAS/Fonds Wetenschappelijk
   Onderzoek (Belgium) - project "Electrochemical preparation, modification
   and characterization of nanostructured materials"; foreign research
   institution: BAS/Wallonie-Bruxelles International - project "New methods
   for polymer pretreatment for the deposition of nanostructured coatings";
   BNSF
FX The authors would like to acknowledge the support of the following
   bilateral joint projects between Bulgarian Academy of Sciences (BAS) and
   foreign research institutions: BAS/CNR (Italy) - project "Femtosecond
   and nanosecond laser ablation-assisted fabrication of metal and
   metal-oxides nanostructures"; BAS/Polish Academy of Sciences (Poland) -
   project "Fabrication and characterization of noble metal nanoparticles
   arrays"; BAS/Fonds Wetenschappelijk Onderzoek (Belgium) - project
   "Electrochemical preparation, modification and characterization of
   nanostructured materials"; and BAS/Wallonie-Bruxelles International -
   project "New methods for polymer pretreatment for the deposition of
   nanostructured coatings". Financial support of the BNSF under the
   project entitled "New advanced method for processing nanocomposite
   materials for creation of microsystems for medical and high-tech
   applications" is acknowledged.
CR Asgar A., 2007, LAB CHIP, V7, P1192
   Atanasov PA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887812
   Bae SC, 2005, LANGMUIR, V21, P5685, DOI 10.1021/la050233+
   Blanchet GB, 2000, J APPL PHYS, V88, P2975, DOI 10.1063/1.1288501
   CAIN SR, 1992, J APPL PHYS, V71, P4107, DOI 10.1063/1.350840
   Colas A., 2004, BIOMATERIALS SCI INT, V7.19, p[80, 697]
   Colas A, 2004, BIOMATER SCI, P80
   Darvishi S, 2012, OPT LASER ENG, V50, P210, DOI 10.1016/j.optlaseng.2011.09.003
   Deepak KLN, 2010, PRAMANA-J PHYS, V75, P1221, DOI 10.1007/s12043-010-0210-9
   Dicara C, 2003, P SOC PHOTO-OPT INS, V5147, P255, DOI 10.1117/12.537694
   Dupas-Bruzek C, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236509
   Dupas-Bruzek C, 2009, APPL SURF SCI, V255, P8715, DOI 10.1016/j.apsusc.2009.06.025
   Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Gao KL, 2014, SMALL, V10, P1015, DOI 10.1002/smll.201300116
   Graubner VM, 2006, APPL SURF SCI, V252, P4781, DOI 10.1016/j.apsusc.2005.07.123
   HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704
   Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169
   Huang H., 2012, NAN C EXP 2012 JUN 1
   Huang H, 2010, LASER MED SCI, V25, P517, DOI 10.1007/s10103-009-0741-9
   Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8
   Laude L.D., 1995, [No title captured], Patent No. [EP 1995/0693138 A1, 19950693138]
   Laude L.D., 2008, [No title captured], Patent No. [US 2008/0305320 A1, 20080305320]
   Laude L.D., 1997, [No title captured], Patent No. [US 1997/5599592 A, 19975599592]
   Laude LD, 2003, P SOC PHOTO-OPT INS, V4977, P578, DOI 10.1117/12.483853
   Laude LD, 2003, NUCL INSTRUM METH B, V208, P314, DOI 10.1016/S0168-583X(03)01183-2
   Lippert T, 2004, ADV POLYM SCI, V168, P51, DOI 10.1007/b12682
   Liu KW, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/015012
   Narayana L., 2012, OPT ENG, V51
   Palma C, 1999, APPL SURF SCI, V138, P24, DOI 10.1016/S0169-4332(98)00382-1
   Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8
   Rubahn K, 2004, APPL PHYS A-MATER, V79, P1715, DOI 10.1007/s00339-004-2888-3
   Schuettler M, 2005, J NEURAL ENG, V2, pS121, DOI 10.1088/1741-2560/2/1/013
   Sones CL, 2014, APPL SURF SCI, V298, P125, DOI 10.1016/j.apsusc.2014.01.138
   SRINIVASAN R, 1990, J APPL PHYS, V68, P1842, DOI 10.1063/1.346620
   SRINIVASAN V, 1986, J APPL PHYS, V59, P3861, DOI 10.1063/1.336728
   SUTCLIFFE E, 1986, J APPL PHYS, V60, P3315, DOI 10.1063/1.337698
   Tuthill T.R., 2013, IEEE T BIOMED CIRC S, V7, P1
   van Pelt S, 2014, APPL SURF SCI, V303, P456, DOI 10.1016/j.apsusc.2014.03.025
   Ward Y, 2004, J MATER SCI, V39, P6781, DOI 10.1023/B:JMSC.0000045606.60263.27
   ZWEIG AD, 1993, J APPL PHYS, V74, P4181, DOI 10.1063/1.354422
NR 41
TC 15
Z9 15
U1 2
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 1
PY 2015
VL 336
BP 321
EP 328
DI 10.1016/j.apsusc.2014.12.121
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CE2BL
UT WOS:000351617600055
DA 2018-10-20
ER

PT J
AU Mabry, KM
   Lawrence, RL
   Anseth, KS
AF Mabry, Kelly M.
   Lawrence, Rosa L.
   Anseth, Kristi S.
TI Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct
   valvular interstitial cell phenotype in a three-dimensional environment
SO BIOMATERIALS
LA English
DT Article
DE Heart valve; Valvular interstitial cells; Hydrogel; Elasticity;
   Three-dimensional cell culture; ECM
ID EXTRACELLULAR-MATRIX; IN-VITRO; CULTURE; HEART; MECHANOTRANSDUCTION;
   FIBROBLASTS; ACTIVATION; STIFFNESS; CUES; DEPOSITION
AB Valvular interstitial cells (VICs) are active regulators of valve homeostasis and disease, responsible for secreting and remodeling the valve tissue matrix. As a result of VIC activity, the valve modulus can substantially change during development, injury and repair, and disease progression. While twodimensional biomaterial substrates have been used to study mechanosensing and its influence on VIC phenotype, less is known about how these cells respond to matrix modulus in a three-dimensional environment. Here, we synthesized MMP-degradable poly(ethylene glycol) (PEG) hydrogels with elastic moduli ranging from 0.24 kPa to 12 kPa and observed that cell morphology was constrained in stiffer gels. To vary gel stiffness without substantially changing cell morphology, cell-laden hydrogels were cultured in the 0.24 kPa gels for 3 days to allow VIC spreading, and then stiffened in situ via a second, photoinitiated thiol-ene polymerization such that the gel modulus increased from 0.24 kPa to 1.2 kPa or 13 kPa. VICs encapsulated within soft gels exhibited alpha SMA stress fibers (similar to 40%), a hallmark of the myofibroblast phenotype. Interestingly, in stiffened gels, VICs became deactivated to a quiescent fibroblast phenotype, suggesting that matrix stiffness directs VIC phenotype independent of morphology, but in a manner that depends on the dimensionality of the culture platform. Collectively, these studies present a versatile method for dynamic stiffening of hydrogels and demonstrate the significant effects of matrix modulus on VIC myofibroblast properties in three-dimensional environments. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Mabry, Kelly M.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Lawrence, Rosa L.] Fairview High Sch, Boulder, CO 80305 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM Kristi.Anseth@colorado.edu
FU NIH Pharmaceutical Biotechnology; NIH [R01 HL089260]; HHMI
FX The authors would like to thank Samuel Payne for help with VIC cultures
   and Dr. Huan Wang for PCR primers. The authors would also like to
   acknowledge support to KMM from an NIH Pharmaceutical Biotechnology
   Training Grant, funding from an NIH grant (R01 HL089260) and HHMI.
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795
   Bryant SJ, 2006, SCAFFOLDING TISSUE E, P1
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Duan B, 2013, ACTA BIOMATER, V9, P7640, DOI 10.1016/j.actbio.2013.04.050
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fayet C, 2007, CARDIOVASC PATHOL, V16, P203, DOI 10.1016/j.carpath.2007.02.008
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kural MH, 2014, BIOMATERIALS, V35, P1128, DOI 10.1016/j.biomaterials.2013.10.047
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Liu AC, 2007, HISTOL HISTOPATHOL, V22, P873, DOI 10.14670/HH-22.873
   Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Quinlan AMT, 2012, J BIOMED MATER RES A, V100A, P2474, DOI 10.1002/jbm.a.34162
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767
   Rodriguez KJ, 2011, MATRIX BIOL, V30, P70, DOI 10.1016/j.matbio.2010.09.001
   Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069667
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Witt W, 2014, J MOL CELL CARDIOL, V74, P127, DOI 10.1016/j.yjmcc.2014.05.008
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
NR 43
TC 65
Z9 65
U1 8
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 49
BP 47
EP 56
DI 10.1016/j.biomaterials.2015.01.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2LO
UT WOS:000351647300006
PM 25725554
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, H
   Xu, GW
   Wang, YF
   Zhao, HS
   Xiong, S
   Wu, Y
   Heng, BC
   An, CR
   Zhu, GH
   Xie, DH
AF Liu, Hua
   Xu, Guo Wei
   Wang, Ya Fei
   Zhao, Hong Shi
   Xiong, Si
   Wu, Yan
   Heng, Boon Chin
   An, Cheng Rui
   Zhu, Gang Hua
   Xie, Ding Hua
TI Composite scaffolds of nano-hydroxyapatite and silk fibroin enhance
   mesenchymal stem cell-based bone regeneration via the interleukin 1
   alpha autocrine/paracrine signaling loop
SO BIOMATERIALS
LA English
DT Article
DE Bone regeneration; Hydroxyapatite; Stem cell; Silk; Interleukin;
   Osteogenesis
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; STROMAL CELLS;
   PPAR-GAMMA; ADIPOGENESIS; OSTEOINDUCTIVITY; FABRICATION; ACTIVATION;
   PARTICLES
AB Composite scaffolds of nano-hydroxyapatite (nHAp) and silk fibroin (SF) have been reported to promote bone regeneration mainly through signaling pathways associated with cell biomaterial interaction. However, it is unclear whether soluble factors also play a role in osteoinduction with nHAp-SF. In this study, we confirmed the biocompatibility and superior osteoinductivity of nHAp-SF scaffolds versus SF scaffolds both in vitro and on a calvarial defect model in vivo. This was followed by further analysis with microarray assay. The cDNA microarray results identified 247 differentially expressed genes in bone marrow mesenchymal stem cells (BMSCs) cultured on SF-nHAp scaffolds versus SF scaffolds. The greatest disparity in gene expression levels were observed with Ilia and Ilr2. Real-time PCR assay validated the results. The addition of IL-1 alpha into cultures of BMSCs with SF significantly increased both Bmp2 and Ilr2 expression. However, with BMSCs alone, the Ilr2 expression increased substantially, whereas Bmp2 expression exhibited a decrease rather than increase. These data suggested that nHAp may exert osteoinductive effects on BMSCs via the secretion of IL-1 alpha in an autocrine/paracrine fashion, and IL-1 alpha activity could be regulated through the synthesis of IL1R2 by BMSCs upon interaction with nHAp. These results complemented our understanding of the underlying mechanisms of biomaterial osteoinductivity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhu, Gang Hua; Xie, Ding Hua] Cent S Univ, Xiangya Hosp 2, Dept Otolaryngol Head & Neck Surg, Inst Otol, Changsha 410011, Hunan, Peoples R China.
   [Liu, Hua; Xu, Guo Wei; Wang, Ya Fei; Zhao, Hong Shi; Xiong, Si; Wu, Yan; An, Cheng Rui] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Liu, Hua; Xu, Guo Wei; Wang, Ya Fei; Zhao, Hong Shi; Xiong, Si; Wu, Yan; An, Cheng Rui] Zhejiang Prov Key Lab Tissue Engn & Regenerat Med, Hangzhou 310058, Zhejiang, Peoples R China.
   [Heng, Boon Chin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
RP Zhu, GH (reprint author), Cent S Univ, Xiangya Hosp 2, Dept Otolaryngol Head & Neck Surg, Inst Otol, Changsha 410011, Hunan, Peoples R China.
EM z1g2h3@hotmail.com; dhuaxie@163.com
RI Heng, Boon Chin/E-5462-2016
OI Heng, Boon Chin/0000-0003-2541-3699
FU National Basic Research Program of China (973 Program) [2012CB967904,
   2012CB967900]; National Natural Science Foundation of China [31200739,
   31470948]; Doctoral Fund of Ministry of Education of China
   [20120101120003]; Science and Technology Department Program of Zhejiang
   Province [201303156]; International Science & Technology Cooperation
   Program of China [2011DFA32190]; Regenerative Medicine in Innovative
   Medical Subjects of Zhejiang Province; Zhejiang Provincial Program for
   the Cultivation of High-level Innovative Health talents
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2012CB967904, 2012CB967900), the National Natural Science
   Foundation of China (31200739 and 31470948), the Doctoral Fund of
   Ministry of Education of China (20120101120003), the Science and
   Technology Department Program of Zhejiang Province (201303156), the
   International Science & Technology Cooperation Program of China
   (2011DFA32190), as well as sponsored by Regenerative Medicine in
   Innovative Medical Subjects of Zhejiang Province and Zhejiang Provincial
   Program for the Cultivation of High-level Innovative Health talents.
CR Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724
   Aronsson L, 2010, PLOS ONE, P5
   Bodo M., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P679
   Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023
   Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Graneli C, 2014, CONNECT TISSUE RES, V55, P262, DOI 10.3109/03008207.2014.910198
   Huh JE, 2014, INT J MOL SCI, V15, P13010, DOI 10.3390/ijms150713010
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   JIN CH, 1990, MOL CELL ENDOCRINOL, V74, P221
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kweon H, 2011, J ORAL MAXIL SURG, V69, P1578, DOI 10.1016/j.joms.2010.07.062
   Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431
   Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002
   Lin KL, 2014, ACTA BIOMATER, V10, P4071, DOI 10.1016/j.actbio.2014.06.017
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864
   Liu H, 2009, J CELL MOL MED, V13, P2436, DOI 10.1111/j.1582-4934.2009.00793.x
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu XY, 2014, J BIOMED MATER RES A, V102, P2833, DOI 10.1002/jbm.a.34951
   McNamara SL, 2014, BIOMATERIALS, V35, P6941, DOI 10.1016/j.biomaterials.2014.05.013
   Nyman LR, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.11
   Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Pillai HK, 2014, ENVIRON HEALTH PERSP, V122, P1225, DOI 10.1289/ehp.1408111
   Qian JM, 2014, J BIOMED MATER RES A, V102, P2961, DOI 10.1002/jbm.a.34964
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Song JH, 2008, J BONE MINER METAB, V26, P138, DOI 10.1007/s00774-007-0804-6
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Thorfve A, 2014, ACTA BIOMATER, V10, P1451, DOI 10.1016/j.actbio.2013.12.012
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Zambuzzi WF, 2011, J BIOMED MATER RES A, V97A, P193, DOI 10.1002/jbm.a.32933
   Zhao HS, 2011, TISSUE ENG PT A, V17, P765, DOI [10.1089/ten.tea.2010.0196, 10.1089/ten.TEA.2010.0196]
   Zhao Y, 2009, J BIOMED MATER RES A, V91A, P1140, DOI 10.1002/jbm.a.32272
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zong C, 2010, EUR CELLS MATER, V20, P109
NR 38
TC 56
Z9 59
U1 3
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 49
BP 103
EP 112
DI 10.1016/j.biomaterials.2015.01.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2LO
UT WOS:000351647300011
PM 25725559
DA 2018-10-20
ER

PT J
AU Ensari, N
   Tutar, H
   Ekinci, O
   Ugur, MB
   Bayazit, YA
   Gokdogan, C
   Goksu, N
AF Ensari, Nuray
   Tutar, Hakan
   Ekinci, Ozgur
   Ugur, Mehmet Birol
   Bayazit, Yildirim A.
   Gokdogan, Cagil
   Goksu, Nebil
TI Effects of polylactic acid film on middle ear mucosa and cochlear
   function in Guinea pigs
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE Polylactic acid; Ototoxicity; Middle ear effects; Inner ear effects;
   Adhesive otitis media; Biomaterial
ID EUSTACHIAN-TUBE; OTITIS-MEDIA; TYMPANOPLASTY; REGENERATION; ADHESIONS;
   SURGERY
AB Our aim was to assess the effects of polylactic acid (PLA) on middle ear mucosa and cochlea, to be used as a film barrier for postoperative adhesion prevention in the middle ear. Twenty-one albino Guinea pigs were included in the study. A window was opened on both tympanic bulla and on one side PLA material was placed in the middle ear and on the other side only fenestration was performed and used as a control. All Guinea pigs underwent evaluation of tympanic membranes microscopically; functional hearing was analyzed by auditory brainstem responses preoperatively, in the first and the sixth month. All Guinea pigs were killed on the sixth month for histopathologic evaluation of their temporal bones. There was no statistical difference between both groups regarding hearing thresholds, interpeak wave latencies preoperatively and on first and the sixth months postoperatively. Histopathological evaluation revealed no specific changes. There was a mild local inflammation both in the PLA implanted and control ears. PLA film barrier most likely has no toxic effects on Guinea pig middle ear and does not show any ototoxic side effects.
C1 [Ensari, Nuray] Antalya Ataturk Educ & Res Hosp, Dept Otolaryngol, Antalya, Turkey.
   [Tutar, Hakan; Ugur, Mehmet Birol; Bayazit, Yildirim A.; Goksu, Nebil] Gazi Univ, Dept Otolaryngol, Fac Med, Ankara, Turkey.
   [Ekinci, Ozgur] Gazi Univ, Dept Pathol, Fac Med, Ankara, Turkey.
   [Gokdogan, Cagil] Gazi Univ, Audiol Unit, Fac Med, Ankara, Turkey.
RP Tutar, H (reprint author), Gazi Univ, Dept Otolaryngol, Fac Med, Ankara, Turkey.
EM drhakantutar@yahoo.com
CR Avital S, 2005, DIS COLON RECTUM, V48, P153, DOI 10.1007/s10350-004-0748-z
   BLUESTONE CD, 1988, J ALLERGY CLIN IMMUN, V81, P997, DOI 10.1016/0091-6749(88)90168-6
   Ceylan A, 2007, OTOL NEUROTOL, V28, P341, DOI 10.1097/01.mao.0000253286.48619.1c
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   Hashimoto S, 2000, Auris Nasus Larynx, V27, P39, DOI 10.1016/S0385-8146(99)00033-4
   Lipan MJ, 2011, OTOLARYNG HEAD NECK, V144, P763, DOI 10.1177/0194599810395115
   MAGNUSON B, 1981, INT J PEDIATR OTORHI, V3, P25, DOI 10.1016/0165-5876(81)90016-1
   McGhee MA, 1999, AM J OTOL, V20, P712
   Nankivell PC, 2010, COCHRANE DB SYST REV, V7, P1
   NG M, 1992, LARYNGOSCOPE, V102, P1097, DOI 10.1288/00005537-199210000-00002
   Peltonen LI, 2007, OTOL NEUROTOL, V28, P850, DOI 10.1097/MAO.0b013e318064f199
   Pinilla M, 2003, OTOLARYNG HEAD NECK, V128, P124, DOI 10.1067/mhn.2003.55
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   SADE J, 1986, AM J OTOL, V7, P439
   SHEA MC, 1981, CLIN OTOLARYNGOL, V6, P125, DOI 10.1111/j.1365-2273.1981.tb01797.x
   Shen Y, 2011, LARYNGOSCOPE, V121, P1040, DOI 10.1002/lary.21470
   Vicente J, 2006, ACTA OTO-LARYNGOL, V126, P144, DOI 10.1080/00016480500312570
   WULLSTEIN SR, 1985, AM J OTOL, V6, P31
   Yaguchi Y, 2007, ACTA OTO-LARYNGOL, V127, P1038, DOI 10.1080/00016480701200285
NR 20
TC 2
Z9 2
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0937-4477
EI 1434-4726
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD MAY
PY 2015
VL 272
IS 5
BP 1091
EP 1097
DI 10.1007/s00405-014-2904-y
PG 7
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CE3BE
UT WOS:000351698300006
PM 24504490
DA 2018-10-20
ER

PT J
AU Zeng, DM
   Pan, JJ
   Wang, Q
   Liu, XF
   Wang, H
   Zhang, KQ
AF Zeng, Dong-Mei
   Pan, Jue-Jing
   Wang, Qun
   Liu, Xin-Fang
   Wang, Hui
   Zhang, Ke-Qin
TI Controlling silk fibroin microspheres via molecular weight distribution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Molecular weight; Salting out; Microspheres; Ionic
   strength
ID DRUG-DELIVERY; NANOPARTICLES; BIOMATERIAL; SCAFFOLDS; FEATURES
AB Silk fibroin (SF) microspheres were produced by salting out SF solution via the addition of potassium phosphate buffer solution (K2HPO4-KH2PO4). The morphology, size and polydispersity of SF microspheres were adjusted by changing the molecular weight (MW) distribution and concentration of SF, as well as the ionic strength and pH of the buffer solution. Changing the conditions under which the SF fiber dissolved in the Lithium Boride (LiBr) solution resulted in altering the MW distribution of SF solution. Under optimal salting-out conditions (ionic strength > 0.7 M and pH > 7) and using a smaller and narrower SF MW distribution, SF microspheres with smoother shapes and more uniform sizes were produced. Meanwhile, the size and polydispersity of the microspheres increased when the SF concentration was increased from 0.25 mg/mL to 20 mg/mL. The improved SF microspheres, obtained by altering the distribution of molecular weight, have potential in drug and gene delivery applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zeng, Dong-Mei; Pan, Jue-Jing; Wang, Qun; Liu, Xin-Fang; Wang, Hui; Zhang, Ke-Qin] Soochow Univ, Coll Textile & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhang, Ke-Qin] Soochow Univ, Res Ctr Cooperat Innovat Funct Organ Polymer Mat, Suzhou 215123, Jiangsu, Peoples R China.
RP Zhang, KQ (reprint author), Soochow Univ, Coll Textile & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China.
EM kqzhang@suda.edu.cn
FU National Natural Science Foundation of China [91027039, 51373110,
   51203108]; Natural Science Foundation of Jiangsu Province of China
   [BK2011355]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China [11KJB430011, 10KJA540046]; Nanotechnology
   Foundation of Suzhou [ZXG2013037]; China Postdoctoral Science Foundation
   [2013M531403]; Priority Academic Program Development ofJiangsu Higher
   Education Institutions (PAPD); Qing Lan Project for Excellent Scientific
   and Technological Innovation Team ofJiangsu Province; Jiangsu Scientific
   and Technological Innovation Team
FX We gratefully acknowledge the financial support from the National
   Natural Science Foundation of China under grants 91027039, 51373110 and
   51203108, the Natural Science Foundation of Jiangsu Province of China
   under Grant BK2011355, the Natural Science Foundation of the Jiangsu
   Higher Education Institutions of China under Grants 11KJB430011 and
   10KJA540046, the Nanotechnology Foundation of Suzhou under Grant
   ZXG2013037 and the China Postdoctoral Science Foundation under Grant
   2013M531403. We also acknowledge the fund from the project of the
   Priority Academic Program Development ofJiangsu Higher Education
   Institutions (PAPD), Qing Lan Project for Excellent Scientific and
   Technological Innovation Team ofJiangsu Province (2012) and Project for
   Jiangsu Scientific and Technological Innovation Team (2013).
CR Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Germershaus O, 2014, BIOMATERIALS, V35, P3427, DOI 10.1016/j.biomaterials.2013.12.083
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li GH, 2012, MAT SCI ENG C-MATER, V32, P627, DOI 10.1016/j.msec.2011.12.013
   Liu L, 2011, POLYM ADVAN TECHNOL, V22, P909, DOI 10.1002/pat.1595
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Masuhiro T., 1994, J POLYM SCI B, V32, P1407
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Panday A, 2009, MACROMOLECULES, V42, P4632, DOI 10.1021/ma900451e
   RAO PU, 1994, J AGR FOOD CHEM, V42, P2201, DOI 10.1021/jf00046a023
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Srihanam P, 2011, KOREAN J CHEM ENG, V28, P293, DOI 10.1007/s11814-010-0322-4
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Tang B, 2014, DYES PIGMENTS, V103, P183, DOI 10.1016/j.dyepig.2013.12.008
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wu PY, 2013, ACS APPL MATER INTER, V5, P12638, DOI 10.1021/am403992b
   Yang HC, 2009, MICROCHEM J, V92, P87, DOI 10.1016/j.microc.2009.02.001
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   You XQ, 2011, MAT SCI ENG C-MATER, V31, P1632, DOI 10.1016/j.msec.2011.06.010
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhang YQ, 2011, SOFT MATTER, V7, P9728, DOI 10.1039/c0sm01332c
NR 34
TC 8
Z9 8
U1 6
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2015
VL 50
BP 226
EP 233
DI 10.1016/j.msec.2015.02.005
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CE4MG
UT WOS:000351804100028
PM 25746265
DA 2018-10-20
ER

PT J
AU Gonzalez-Sanchez, MI
   Perni, S
   Tommasi, G
   Morris, NG
   Hawkins, K
   Lopez-Cabarcos, E
   Prokopovich, P
AF Isabel Gonzalez-Sanchez, M.
   Perni, Stefano
   Tommasi, Giacomo
   Glyn Morris, Nathanael
   Hawkins, Karl
   Lopez-Cabarcos, Enrique
   Prokopovich, Polina
TI Silver nanoparticle based antibacterial methacrylate hydrogels potential
   for bone graft applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogels; Silver; Nanoparticles; Infections; Staphylococcus
   epidermidis; Methicillin-resistant Staphylococcus aureus (MRSA)
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; DIFFUSION;
   MINERALIZATION; BIOMATERIALS; GENTAMICIN; STABILITY; IMPLANT; CEMENT;
   PEG
AB Infections are frequent and very undesired occurrences after orthopedic procedures; furthermore, the growing concern caused by the rise in antibiotic resistance is progressively dwindling the efficacy of such drugs. Artificial bone graft materials could solve some of the problems associated with the gold standard use of natural bone graft such as limited bone material, pain at the donor site and rejections if donor tissue is used. We have previously described new acrylate base nanocomposite hydrogels as bone graft materials. In the present paper, we describe the integration of silver nanoparticles in the polymeric mineralized biomaterial to provide non-antibiotic antibacterial activity against Staphylococcus epidermidis and Methicillin-resistant Staphylococcus aureus. Two different crosslinking degrees were tested and the silver nanoparticles were integrated into the composite matrix by means of three different methods; entrapment in the polymeric hydrogel before the mineralization; diffusion during the process of calcium phosphate crystallization and adsorption post-mineralization. The latter being generally the most effective method of encapsulation; however, the adsorption of silver nanoparticles inside the pores of the biomaterial led to a decreasing antibacterial activity for adsorption time longer than 2 days. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
C1 [Isabel Gonzalez-Sanchez, M.] Univ Castilla La Mancha, Sch Ind Engn, Dept Phys Chem, Albacete, Spain.
   [Isabel Gonzalez-Sanchez, M.; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Dept Phys Chem 2, Madrid, Spain.
   [Isabel Gonzalez-Sanchez, M.; Perni, Stefano; Tommasi, Giacomo; Glyn Morris, Nathanael; Prokopovich, Polina] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales.
   [Perni, Stefano; Prokopovich, Polina] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Hawkins, Karl] Univ Coll Swansea, Inst Life Sci, Ctr Nanohlth, Swansea, W Glam, Wales.
RP Prokopovich, P (reprint author), Cardiff Univ, Sch Pharm & Pharmaceut Sci, Redwood Bldg,King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales.
EM prokopovichp@cardiff.ac.uk
RI Perni, Stefano/B-8158-2009; GONZALEZ SANCHEZ, MARIA ISABEL/M-4223-2015
OI Perni, Stefano/0000-0002-3101-0098; GONZALEZ SANCHEZ, MARIA
   ISABEL/0000-0002-7390-5420; Prokopovich, Polina/0000-0002-5700-9570;
   Hawkins, Karl/0000-0003-0174-4151
FU COST [CM1101]; Arthritis Research UK [ARUK:18461]
FX The studies were performed in the frame of COST CM1101 project
   "Colloidal Aspects of Nanoscience for Innovative Processes and
   Materials". PP also would like to thank Arthritis Research UK
   (ARUK:18461) for funding this study.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Bardajee GR, 2012, J INORG BIOCHEM, V117, P367, DOI 10.1016/j.jinorgbio.2012.06.012
   Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568
   Bondarenko O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064060
   Bormann N, 2014, BONE, V59, P162, DOI 10.1016/j.bone.2013.11.005
   Coraca-Huber D, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140728-50
   Dutta S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39873
   Fleiter N, 2014, BONE JOINT RES, V3, P223, DOI 10.1302/2046-3758.37.2000301
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Grosso MJ, 2012, J SHOULDER ELB SURG, V21, P754, DOI 10.1016/j.jse.2011.08.052
   Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008
   Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007
   Haynes William M., 2007, CRC HDB CHEM PHYS
   Hervas-Perez J.P., 2006, BIOMOL ENG, V23, P233
   Huang JJ, 2012, CHEM MATER, V24, P1331, DOI 10.1021/cm203764f
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kaner D., 2010, J CLIN PERIODONTOL, V38, P95
   KARPATISMIDROCZKI E, 1995, COLLOID POLYM SCI, V273, P857, DOI 10.1007/BF00657635
   Killion JA, 2014, INT J POLYM MATER PO, V63, P641, DOI 10.1080/00914037.2013.854238
   Konig DP, 2001, LANGENBECK ARCH SURG, V386, P328, DOI 10.1007/s004230100229
   Krstic J, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40321
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Le T.T., 2010, MAT SCI ENG C, V30, P910
   Li GY, 2013, J APPL POLYM SCI, V127, P2690, DOI 10.1002/app.37609
   Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Lowenstam HA, 1989, BIOMINERALIZATION
   Martin BD, 1998, BIOMATERIALS, V19, P69, DOI 10.1016/S0142-9612(97)00184-1
   McCrory R, 2003, J PHARM PHARMACOL, V55, P411, DOI 10.1211/0022357021035
   Mohamed RR, 2014, INT J BIOL MACROMOL, V69, P95, DOI 10.1016/j.ijbiomac.2014.05.025
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Morris K, 2007, LANCET INFECT DIS, V7, P509, DOI 10.1016/S1473-3099(07)70173-1
   Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09
   Penalba Arias P., 2014, INJURY
   Perni S, 2014, COLLOID SURFACE A, V460, P219, DOI 10.1016/j.colsurfa.2013.09.034
   Perni S, 2014, ADV COLLOID INTERFAC, V206, P265, DOI 10.1016/j.cis.2013.11.008
   Prokopovich P., 2005, J BIOMED MATER RES B, V103, P273
   Prokopovich P, 2013, INT J NANOMED, V8, P2227, DOI 10.2147/IJN.S42822
   Ramadan Y, 2014, MAT SCI ENG C-MATER, V42, P696, DOI 10.1016/j.msec.2014.06.017
   Roberts JJ, 2013, BIOMATERIALS, V34, P9969, DOI 10.1016/j.biomaterials.2013.09.020
   Sallam KI, 2007, FOOD CONTROL, V18, P566, DOI 10.1016/j.foodcont.2006.02.002
   Sander C.G., 2010, BIOMACROMOLECULES, V11, P154
   Selby A, 2014, J MECH BEHAV BIOMED, V35, P144, DOI 10.1016/j.jmbbm.2013.11.023
   Sharma VK, 2014, ADV COLLOID INTERFAC, V204, P15, DOI 10.1016/j.cis.2013.12.002
   Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y
   Sintubin L, 2009, APPL MICROBIOL BIOT, V84, P741, DOI 10.1007/s00253-009-2032-6
   Sophier J., 2010, ACTA BIOMATER, V6, P2932
   Sorli L, 2012, J BONE JOINT SURG BR, V94B, P249, DOI 10.1302/0301-620X.94B2.27779
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Wang JJ, 2012, J APPL POLYM SCI, V125, P548, DOI 10.1002/app.35687
   Wichterle O., 1960, HYDROPHILIC GELS BIO
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yokoi T, 2010, MAT SCI ENG C-MATER, V30, P154, DOI 10.1016/j.msec.2009.09.012
   Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040
NR 59
TC 30
Z9 30
U1 2
U2 80
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2015
VL 50
BP 332
EP 340
DI 10.1016/j.msec.2015.02.002
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CE4MG
UT WOS:000351804100041
PM 25746278
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Ekstrand-Hammarstrom, B
   Hong, J
   Davoodpour, P
   Sandholm, K
   Ekdahl, KN
   Bucht, A
   Nilsson, B
AF Ekstrand-Hammarstrom, Barbro
   Hong, Jaan
   Davoodpour, Padideh
   Sandholm, Kerstin
   Ekdahl, Kristina N.
   Bucht, Anders
   Nilsson, Bo
TI TiO2 nanoparticles tested in a novel screening whole human blood model
   of toxicity trigger adverse activation of the kallikrein system at low
   concentrations
SO BIOMATERIALS
LA English
DT Article
DE Contact system; P25; Platelets; Nanoparticles; Complement
ID AIR-POLLUTION; HEMOCOMPATIBILITY EVALUATION; SURFACE-PROPERTIES;
   COMPLEMENT; TITANIUM; PARTICLES; INFLAMMATION; COAGULATION; BIOMATERIAL;
   THROMBOSIS
AB There is a compelling need to understand and assess the toxicity of industrially produced nanoparticles (NPs). In order to appreciate the long-term effects of NPs, sensitive human-based screening tests that comprehensively map the NP properties are needed to detect possible toxic mechanisms. Animal models can only be used in a limited number of test applications and are subject to ethical concerns, and the interpretation of experiments in animals is also distorted by the species differences.
   Here, we present a novel easy-to-perform highly sensitive whole-blood model using fresh non-anticoagulated human blood, which most justly reflects complex biological cross talks in a human system. As a demonstrator of the tests versatility, we evaluated the toxicity of TiO2 NPs that are widely used in various applications and otherwise considered to have relatively low toxic properties. We show that TiO2 NPs at very low concentrations (50 ng/mL) induce strong activation of the contact system, which in this model elicits thromboinflammation. These data are in line with the finding of components of the contact system in the protein corona of the TiO2 NPs after exposure to blood.
   The contact system activation may lead to both thrombotic reactions and generation of bradykinin, thereby representing fuel for chronic inflammation in vivo and potentially long-term risk of autoimmunity, arteriosclerosis and cancer. These results support the notion that this novel whole-blood model represents an important contribution to testing of NP toxicity. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ekstrand-Hammarstrom, Barbro] Swedish Def Res Agcy, Div CBRN Def & Secur, Linkoping, Sweden.
   [Hong, Jaan; Davoodpour, Padideh; Ekdahl, Kristina N.; Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.
   [Sandholm, Kerstin; Ekdahl, Kristina N.] Linnaeus Univ, Linnaeus Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Bucht, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.
EM bo.nilsson@igp.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; FORMAS; European
   Community [602699]; AFA Insurance
FX We thank Lillemor Stenbeck-Funke and Susanne Lindblom for their
   excellent technical assistance, Linnea Ahlinder for performing PCCS
   measurements, and Dr. Deborah McClellan for excellent editorial
   assistance. This work was supported by grant 2013-65X-05647-34-4 from
   the Swedish Research Council (VR), FORMAS, the European Community's
   Seventh Framework Programme under the grant agreement no 602699 (DIREKT)
   in the project Biodesign, and from the AFA Insurance. AFA is a nonprofit
   insurance company that is jointly owned by the Swedish Labor
   Organization and the Swedish Employers Organization.
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson PO, 2011, SMALL, V7, P514, DOI 10.1002/smll.201001832
   Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Bleeker EAJ, 2013, REGUL TOXICOL PHARM, V65, P119, DOI 10.1016/j.yrtph.2012.11.007
   Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690
   Chen Y, 2011, INT J NANOMED, V6, P2321, DOI 10.2147/IJN.S25460
   COOL DE, 1985, J BIOL CHEM, V260, P3666
   Costa-Neto CM, 2008, INT IMMUNOPHARMACOL, V8, P135, DOI 10.1016/j.intimp.2007.08.003
   da Costa PLN, 2014, CANCER LETT, V345, P27, DOI 10.1016/j.canlet.2013.12.009
   Dales RE, 2010, J THROMB HAEMOST, V8, P669, DOI 10.1111/j.1538-7836.2010.03760.x
   De Falco L, 2013, Reumatismo, V65, P97, DOI 10.4081/reumatismo.2013.97
   Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Ekdahl RN, 2013, EXP BIOL MED, V734, P257
   Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003
   European Commission, 2011, O J L, V54, P38
   Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2
   Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004
   Gustafsson A, 2011, J IMMUNOTOXICOL, V8, P111, DOI 10.3109/1547691X.2010.546382
   Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hulander M, 2009, ACS APPL MATER INTER, V1, P1053, DOI 10.1021/am900028e
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Kaida Takahiro, 2004, J Cosmet Sci, V55, P219
   Kaur IP, 2014, J CONTROL RELEASE
   KILCHHERR E, 1985, J MOL BIOL, V186, P403, DOI 10.1016/0022-2836(85)90114-7
   Krajewski S, 2013, ACTA BIOMATER, V9, P7460, DOI 10.1016/j.actbio.2013.03.016
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028
   Liu YQ, 2014, INT J CLIN EXP MED, V7, P1233
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Newman MD, 2009, J AM ACAD DERMATOL, V61, P685, DOI 10.1016/j.jaad.2009.02.051
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650
   Qui J., 2012, NATURE, V489, P350
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   RATNOFF OD, 1964, J LAB CLIN MED, V63, P359
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Shannahan JH, 2012, INHAL TOXICOL, V24, P320, DOI 10.3109/08958378.2012.668229
   Sul YT, 2010, INT J NANOMED, V5, P87
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Wolf Ronni, 2003, Acta Dermatovenerol Croat, V11, P158
   Yuan YL, 2010, J NANOSCI NANOTECHNO, V10, P4868, DOI 10.1166/jnn.2010.2225
NR 51
TC 12
Z9 12
U1 2
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 51
BP 58
EP 68
DI 10.1016/j.biomaterials.2015.01.031
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE4JK
UT WOS:000351796700007
PM 25770998
DA 2018-10-20
ER

PT J
AU Cohen, HC
   Frost, DC
   Lieberthal, TJ
   Li, LJ
   Kao, WJ
AF Cohen, Hannah Caitlin
   Frost, Dustin C.
   Lieberthal, Tyler Jacob
   Li, Lingjun
   Kao, W. John
TI Biomaterials differentially regulate Src kinases and phosphoinositide
   3-kinase-gamma in polymorphonuclear leukocyte primary and tertiary
   granule release
SO BIOMATERIALS
LA English
DT Article
DE Neutrophil; Acute inflammation; Degranulation; Poly(ethylene glycol);
   Gelatin; Protein adsorption
ID OXYGEN SPECIES GENERATION; HUMAN NEUTROPHIL GRANULES; FAMILY KINASES;
   RESPIRATORY BURST; ADHESION; MONOCYTES; DEGRANULATION; ACTIVATION;
   HYDROGELS; PROTEINS
AB In the foreign body response, infiltrating PMNs exocytose granule subsets to influence subsequent downstream inflammatory and wound healing events. In previous studies, we found that PMNs cultured on poly(ethylene glycol) (PEG)-containing hydrogels (i.e., PEG and gelatin + PEG hydrogels) had enhanced primary granule release, yet similar tertiary granule release compared with PMNs cultured on polydimethylsiloxane or tissue culture polystyrene. PMN primary granules contain microbicidal proteins and proteases, which can potentially injure bystander cells, degrade the extracellular matrix, and promote inflammation. Here, we sought to understand the mechanism of the enhanced primary granule release from PMNs on PEG hydrogels. We found that primary granule release from PMNs on PEG hydrogels was adhesion mediated and involved Src family kinases and PI3K-gamma. The addition of gelatin to PEG hydrogels did not further enhance PMN primary granule release. Using stable-isotope dimethyl labeling-based shotgun proteomics, we identified many serum proteins including Ig gamma constant chain region proteins and alpha-1-acid glycoprotein 1 - that were absorbed/adsorbed in higher quantities on PEG hydrogels than on TCPS, and may be involved in mediating PMN primary granule release. Ultimately, this mechanistic knowledge can be used to direct inflammation and wound healing following biomaterial implantation to promote a more favorable healing response. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Cohen, Hannah Caitlin; Frost, Dustin C.; Li, Lingjun; Kao, W. John] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA.
   [Lieberthal, Tyler Jacob; Kao, W. John] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA.
   [Li, Lingjun] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
FU NIH [HL115482, R01 DK071801]; NIH EUREKA grant [NIH R01NS071513];
   Innovation & Economic Development Research program research grant;
   Wisconsin Alumni Research Foundation technology transfer grant; National
   Defense Science and Engineering Graduate fellowship; NIH shared
   instrument grant [NIH-NCRR S10RR029531]
FX This research was supported in part by NIH HL115482, NIH R01 DK071801,
   NIH EUREKA grant (NIH R01NS071513), an Innovation & Economic Development
   Research program research grant, a Wisconsin Alumni Research Foundation
   technology transfer grant, and a National Defense Science and
   Engineering Graduate fellowship awarded to H.C. Cohen. The Orbitrap
   Elite instrument was purchased through the support of an NIH shared
   instrument grant (NIH-NCRR S10RR029531). We thank David A. Cantu for his
   help with phlebotomy procedures and the University of Wisconsin Carbone
   Comprehensive Cancer Center for use of the Bio-Plex (R) suspension array
   system to complete this research.
CR Abdel-Latif D, 2005, CAN J PHYSIOL PHARM, V83, P69, DOI 10.1139/Y04-123
   Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624
   Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897
   Andrews Simon, 2007, Sci STKE, V2007, pcm3, DOI 10.1126/stke.4072007cm3
   BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
   Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257
   Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739
   Cohen HC, 2013, AM J PATHOL, V182, P2180, DOI 10.1016/j.ajpath.2013.02.022
   Cohen HC, 2014, J BIOMED MATER RES A, V102, P4252, DOI 10.1002/jbm.a.35101
   Faulk DM, 2014, SOC BIOM ANN M EXP
   Fumagalli L, 2010, EUR J CLIN INVEST, V40, P38
   Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874
   Fumagalli L, 2013, J IMMUNOL, V190, P3648, DOI 10.4049/jimmunol.1201951
   Gerasimov I G, 2013, Tsitologiia, V55, P75
   Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com
   Heinzelmann M, 1998, J IMMUNOL, V160, P5530
   HUIZINGA TWJ, 1990, J IMMUNOL, V144, P1432
   Jethwaney D, 2007, PROTEOME SCI, P5
   Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093
   Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223
   Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738
   Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200
   Lundahl J, 1996, SCAND J IMMUNOL, V44, P143, DOI 10.1046/j.1365-3083.1996.d01-296.x
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06
   Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008
   Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321
   Mocsai A, 1999, J IMMUNOL, V162, P1120
   Nijhuis E, 2002, J LEUKOCYTE BIOL, V71, P115
   Rasmussen PB, 1996, FEBS LETT, V390, P109, DOI 10.1016/0014-5793(96)00639-4
   Rauniyar N, 2013, J PROTEOME RES, V12, P1031, DOI 10.1021/pr3008896
   Sicari BM, 2014, SOC BIOM ANN M EXP
   Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740
   Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634
   Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6
   Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630
   Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006
   Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720
   Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495
   Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Takafuji S, 2003, J INVEST ALLERG CLIN, V13, P50
   Takami M, 2001, AM J PHYSIOL-CELL PH, V280, pC1045
   TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394
   Tou J, 2002, BIOCHEM BIOPH RES CO, V292, P951, DOI 10.1006/bbrc.2002.6765
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Wang XT, 2011, J BIOMAT SCI-POLYM E, V22, P1343, DOI 10.1163/092050610X508400
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Xu X, 2002, SCAND J IMMUNOL, V55, P178, DOI 10.1046/j.1365-3083.2002.01041.x
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108
NR 55
TC 5
Z9 5
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2015
VL 50
BP 47
EP 55
DI 10.1016/j.biomaterials.2015.01.050
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE2OX
UT WOS:000351656000006
PM 25736495
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, C
   Di, LZ
   Ding, CH
   Lu, LX
   Zhai, T
   Yang, DA
AF Zhang, C.
   Di, L. Z.
   Ding, C. H.
   Lu, L. X.
   Zhai, T.
   Yang, D. A.
TI Sol-gel synthesis and characterisation of La doped (1-x)
   BaTiO3-x(Bi0.5K0.5) TiO3 PTCR ceramics
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE BT-BKT; Lead free ceramics; Sol-gel; PTCR
ID POSITIVE TEMPERATURE-COEFFICIENT; BARIUM-TITANATE CERAMICS; FERRITE
   COMPOSITE NANOPARTICLES; ELECTRICAL-PROPERTIES; NICKEL FERRITE;
   BIOMATERIAL SYSTEM; ANTIMICROBIAL ACTIVITY; PHOTOCATALYTIC SHELL;
   DRUG-DELIVERY; MAGNETIC CORE
AB As a promising material for lead free positive temperature coefficient of resistivity (PTCR) ceramics, La doped (1-x) BaTiO3-x(Bi0.5K0.5) TiO3 [(12x) BT-xBKT] samples with 0 <= x <= 0.04 were prepared by a citrate-nitrate sol-gel method. The corresponding gels were heated at different temperatures (500, 600 and 800 degrees C) to study the conditions necessary for the formation of the pure BT-BKT. Single phased perovskite powders with average particles size of 70 nm were obtained by heating the precursor gels at 800 degrees C for 1 h in air. The crystal structure, microstructure and the electrical properties of La doped BT-BKT samples were studied. When the content of La was 0.2 mol.-%, the 0.99BT-0.01BKT ceramic showed the lowest rho(RT). With increasing addition of BKT, the Curie temperature (T-c) and the room temperature resistivity (rho(RT)) increased. When the content of BKT was 4 mol.-%, the sample sintered in air atmosphere still showed good PTCR behaviours with T-c = 143 degrees C, RT=1.1 x 10(4) Omega cm and I-g (rho(max)/rho(min))=3.76.
C1 [Zhang, C.; Ding, C. H.; Lu, L. X.; Zhai, T.; Yang, D. A.] Tianjin Univ, Key Lab Adv Ceram & Machining Technol, Minist Educ, Tianjin 300072, Peoples R China.
   [Di, L. Z.] Tianjin Med Coll, Tianjin 300222, Peoples R China.
RP Yang, DA (reprint author), Tianjin Univ, Key Lab Adv Ceram & Machining Technol, Minist Educ, Tianjin 300072, Peoples R China.
EM dayang@tju.edu.cn
CR Brutchey RL, 2008, ADV MATER, V20, P1029, DOI 10.1002/adma.200701804
   Cernea M, 2010, J ALLOY COMPD, V490, P690, DOI 10.1016/j.jallcom.2009.10.140
   Chaouchi A, 2011, J ALLOY COMPD, V509, P9138, DOI 10.1016/j.jallcom.2011.06.085
   Ding SW, 2008, CERAM INT, V34, P2007, DOI 10.1016/j.ceramint.2007.07.023
   Gao P, 2014, CERAM INT, V40, P637, DOI 10.1016/j.ceramint.2013.06.047
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   He ZM, 2009, MATER SCI ENG B-ADV, V164, P116, DOI 10.1016/j.mseb.2009.08.003
   HEYWANG W, 1964, J AM CERAM SOC, V47, P484, DOI 10.1111/j.1151-2916.1964.tb13795.x
   Huo WR, 2006, SENSOR ACTUAT A-PHYS, V128, P265, DOI 10.1016/j.sna.2006.01.022
   JONKER GH, 1964, SOLID STATE ELECTRON, V7, P895, DOI 10.1016/0038-1101(64)90068-1
   Langhammer HT, 2006, J EUR CERAM SOC, V26, P2899, DOI 10.1016/j.jeurceramsoc.2006.02.006
   LEE JH, 1995, J AM CERAM SOC, V78, P2845, DOI 10.1111/j.1151-2916.1995.tb08065.x
   Leng SL, 2009, J AM CERAM SOC, V92, P2772, DOI 10.1111/j.1551-2916.2009.03251.x
   Li HL, 2013, CERAM INT, V39, P7589, DOI 10.1016/j.ceramint.2013.03.013
   Li ZC, 2005, J EUR CERAM SOC, V25, P441, DOI 10.1016/j.jeurceramsoc.2004.03.012
   Liu ML, 2010, J ALLOY COMPD, V508, P559, DOI 10.1016/j.jallcom.2010.08.121
   Mahani RM, 2010, J ALLOY COMPD, V508, P354, DOI 10.1016/j.jallcom.2010.05.060
   Misra RDK, 2010, MATER TECHNOL, V25, P118, DOI 10.1179/175355510X12723642365241
   Morrison FD, 1999, J APPL PHYS, V86, P6355, DOI 10.1063/1.371698
   Morrison FD, 2001, J AM CERAM SOC, V84, P531, DOI 10.1111/j.1151-2916.2001.tb00694.x
   Park K, 2008, CERAM INT, V34, P1573, DOI 10.1016/j.ceramint.2006.04.007
   Petrovic MMV, 2013, MATER RES BULL, V48, P3766, DOI 10.1016/j.materresbull.2013.05.103
   Pu YP, 2011, J MATER SCI-MATER EL, V22, P1479, DOI 10.1007/s10854-011-0333-x
   Pu YP, 2010, J ALLOY COMPD, V498, pL5, DOI 10.1016/j.jallcom.2010.03.149
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Wei JF, 2011, J MATER SCI-MATER EL, V22, P551, DOI 10.1007/s10854-010-0176-x
   Xing XR, 2004, J ALLOY COMPD, V384, P312, DOI 10.1016/j.jallcom.2004.06.062
NR 32
TC 0
Z9 0
U1 3
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2015
VL 30
IS 3
BP 138
EP 143
DI 10.1179/1753555714Y.0000000224
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5LP
UT WOS:000351129500003
DA 2018-10-20
ER

PT J
AU Rahman, A
   Charoo, MS
   Jayaganthan, R
AF Rahman, A.
   Charoo, M. S.
   Jayaganthan, R.
TI Structural, optical and photocatalytic properties of zinc aluminate
   spinel nanoparticles
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE FTI; XRD; Spectrophotometer; Photocatalyst
ID FERRITE COMPOSITE NANOPARTICLES; NICKEL FERRITE; BIOMATERIAL SYSTEM;
   ANTIMICROBIAL ACTIVITY; OXIDE NANOPARTICLES; DRUG-DELIVERY; MAGNETIC
   CORE; TITANIA; KINETICS; TEMPERATURE
AB Zinc aluminate spinel nanoparticles with different concentrations of alumina ( x=0.000, 0.005, 0.010, 0.015 and 0.020) are synthesised by solid state reaction method. The synthesised products are characterised by powder X-ray diffraction, Raman spectroscopy, Fourier transform infrared, UV-visible spectroscopy. The prepared nanoparticles exhibit a cubic structure with average crystallite size 68.3, 48.1, 58.3, 45.2 and 51.4 nm respectively. Optical measurements indicated a slight shift in the absorption band edge by increasing the alumina doping concentration. The band gap values of zinc aluminate spinel nanoparticles are found to increase with increase in alumina concentration ( x=0.000, 0.005, 0.010, 0.015 and 0.020). The photocatalytic activity of zinc aluminate spinel nanoparticles is studied by performing the decomposition of methylene blue dye under UV light irradiation. The dye considerably photocatalytically degraded by 90.0% under UV light irradiation within 5 h with pseudo first order rate constant of 0.3067 min(-1).
C1 [Rahman, A.] Natl Inst Technol Srinagar, Dept Met & Mat Engn, Srinagar 190006, Jammu & Kashmir, India.
   [Charoo, M. S.] Natl Inst Technol Srinagar, Dept Mech Engn, Srinagar 190006, Jammu & Kashmir, India.
   [Jayaganthan, R.] Indian Inst Technol, Dept Met & Mat Engn, Roorkee 247667, Uttar Pradesh, India.
   [Jayaganthan, R.] Indian Inst Technol, Ctr Nanotechnol, Roorkee 247667, Uttar Pradesh, India.
RP Rahman, A (reprint author), Natl Inst Technol Srinagar, Dept Met & Mat Engn, Srinagar 190006, Jammu & Kashmir, India.
EM atikurrhmn@gmail.com
OI RENGASWAMY, JAYAGANTHAN/0000-0002-3634-9306
CR Angelo P. C., 2012, POWDER METALLURGY SC, P1
   Arshad M, 2011, J ALLOY COMPD, V509, P8378, DOI 10.1016/j.jallcom.2011.05.047
   Azam A, 2010, J ALLOY COMPD, V506, P237, DOI 10.1016/j.jallcom.2010.06.184
   Behnajady MA, 2006, J HAZARD MATER, V136, P816, DOI 10.1016/j.jhazmat.2006.01.017
   BRANSON DL, 1965, J AM CERAM SOC, V48, P591, DOI 10.1111/j.1151-2916.1965.tb14679.x
   Chen XY, 2008, MATER SCI ENG B-ADV, V151, P224, DOI 10.1016/j.mseb.2008.09.023
   Dutta M, 2008, APPL SURF SCI, V254, P2743, DOI 10.1016/j.apsusc.2007.10.009
   Elilarassi R, 2010, J MATER SCI-MATER EL, V21, P1168, DOI 10.1007/s10854-009-0041-y
   Escardino A, 2000, J AM CERAM SOC, V83, P2938, DOI 10.1111/j.1151-2916.2000.tb01664.x
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Hu Z.-S., 2013, FUNCT MATER LETT, V6
   Mathur S, 2001, J AM CERAM SOC, V84, P1921
   MAZZA D, 1992, J AM CERAM SOC, V75, P1929, DOI 10.1111/j.1151-2916.1992.tb07219.x
   MCMILLAN P, 1982, J NON-CRYST SOLIDS, V53, P279, DOI 10.1016/0022-3093(82)90086-2
   Mimani T, 2001, J ALLOY COMPD, V315, P123, DOI 10.1016/S0925-8388(00)01262-7
   Misra RDK, 2008, MATER SCI TECH-LOND, V24, P1011, DOI 10.1179/174328408X341690
   Nakamoto K., 2009, INFRARED RAMAN SPECT
   Pandey R, 1999, J AM CERAM SOC, V82, P3337
   Pant HR, 2011, J HAZARD MATER, V189, P465, DOI 10.1016/j.jhazmat.2011.02.062
   Rahman A, 2012, SURF ENG, V28, P620, DOI 10.1179/1743294412Y.0000000041
   Rahman A, 2012, SURF ENG, V28, P249, DOI 10.1179/1743294411Y.0000000030
   Rahman A, 2012, SURF ENG, V28, P285, DOI 10.1179/1743294411Y.0000000039
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, SYNTHESIS CHARACTERI, V119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Samanta K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245213
   Sampath SK, 1999, J PHYS-CONDENS MAT, V11, P3635, DOI 10.1088/0953-8984/11/18/301
   Strek M, 2000, J ALLOY COMPD, V300, P456, DOI 10.1016/S0925-8388(99)00696-9
   Sultan K., 2014, ADV MAT LETT, V5, P9, DOI DOI 10.5185/amlett.2013.6496
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Suwanboon S, 2008, J ALLOY COMPD, V462, P335, DOI 10.1016/j.jallcom.2007.08.048
   Suwanboon S., 2007, J SCI TECHNOL, V4, P111
   TAKAGAHARA T, 1992, PHYS REV B, V46, P15578, DOI 10.1103/PhysRevB.46.15578
   TSUBOI M, 1964, J CHEM PHYS, V40, P1326, DOI 10.1063/1.1725316
   Valenzuela MA, 1997, APPL CATAL A-GEN, V148, P315, DOI 10.1016/S0926-860X(96)00235-9
   van der Laag NJ, 2004, J EUR CERAM SOC, V24, P2417, DOI 10.1016/j.jeurceramsoc.2003.06.001
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wagner C, 1933, Z PHYS CHEM B-CHEM E, V22, P181
   Wang JB, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208564
   Wu X, 2014, MATER TECHNOL, V29, pA20, DOI 10.1179/1753555714Y.0000000145
   Zeng B., 2013, FUNCT MATER LETT, V6
   Zhang LL, 2014, MATER TECHNOL, V29, pA9, DOI 10.1179/1753555713Y.0000000124
   Zhao Z, 2014, MATER TECHNOL, V29, pA3, DOI 10.1179/1753555714Y.0000000148
   Zhu XQ, 2011, APPL CATAL B-ENVIRON, V102, P316, DOI 10.1016/j.apcatb.2010.12.019
   Zou CW, 2009, CHEM PHYS LETT, V476, P84, DOI 10.1016/j.cplett.2009.06.024
   Zou DL, 2008, SURF COAT TECH, V202, P1928, DOI 10.1016/j.surfcoat.2007.08.022
NR 49
TC 1
Z9 1
U1 1
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2015
VL 30
IS 3
BP 168
EP 176
DI 10.1179/1753555714Y.0000000211
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5LP
UT WOS:000351129500009
DA 2018-10-20
ER

PT J
AU Jiang, YY
   Zhu, YJ
   Chen, F
   Wu, J
AF Jiang, Ying-Ying
   Zhu, Ying-Jie
   Chen, Feng
   Wu, Jin
TI Solvothermal synthesis of submillimeter ultralong hydroxyapatite
   nanowires using a calcium oleate precursor in a series of monohydroxy
   alcohols
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Powders: chemical preparation; Fibers; Apatite; Nanowires
ID PHOSPHORUS SOURCE; HYDROTHERMAL SYNTHESIS; DRUG-DELIVERY; PROTEIN
   ADSORPTION; RAPID SYNTHESIS; GROWTH; PHOSPHATE; PROLIFERATION; NANORODS;
   ARRAYS
AB Hydroxyapatite (Ca-10(OH)(2)(PO4)(6), HAP), as the major inorganic component of bones and teeth in vertebrates, is a very important biomaterial with high biocompatibility, nontoxicity and high thermal stability, thus, it has wide applications in various biomedical fields. Among various morphologies of HAP, HAP nanowires are very promising for various applications; however, the synthesis of ultralong HAP nanowires with lengths larger than 100 pm is highly challengeable and has been rarely reported. In this paper, we report, for the first time, the solvothermal synthesis of submillimeter-sized ultralong hydroxyapatite nanowires using calcium oleate as the precursor and NaH2PO4 as the phosphorus source in a series of monohydroxy alcohols. The products are characterized by scanning electron microscopy, X-ray powder diffraction, and Fourier transform infrared (FTIR) spectroscopy. The as-prepared ultralong hydroxyapatite nanowires have diameters of tens of nanometers and lengths from several hundred micrometers up to nearly one millimeter. This method is simple, surfactant-free, environment friendly, and generally applicable in a series of monohydroxy alcohols including methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol and 1-hexanol. Moreover, this method may be scaled up for large-scale production of ultralong hydroxyapatite nanowires. The as-prepared ultralong hydroxyapatite nanowires are promising for applications in various fields such as bone tissue engineering, drug delivery, adsorbent for organic pollutants and heavy metal ions, and nonflammable inorganic paper. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Jiang, Ying-Ying; Zhu, Ying-Jie; Chen, Feng; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI CHEN, Feng/E-4310-2016; Chen, Feng/D-6406-2012
OI CHEN, Feng/0000-0002-1162-1684; Chen, Feng/0000-0002-1162-1684
FU National Natural Science Foundation of China [51172260]
FX Financial support from the National Natural Science Foundation of China
   (51172260) is gratefully acknowledged.
CR Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   Chen F, 2014, CURR NANOSCI, V10, P465, DOI 10.2174/1573413710666140319233658
   Chen F, 2013, BIOMATER SCI-UK, V1, P1074, DOI 10.1039/c3bm60086f
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Costa DO, 2012, ACS APPL MATER INTER, V4, P1490, DOI 10.1021/am201735k
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Guiseppi-Elie A, 2012, J MATER CHEM, V22, P19529, DOI 10.1039/c2jm32516k
   Hui JF, 2011, CHEM-EUR J, V17, P6926, DOI 10.1002/chem.201100680
   Kotanen CN, 2013, BIOMATERIALS, V34, P6318, DOI 10.1016/j.biomaterials.2013.05.022
   Lu BQ, 2014, CHEM-EUR J, V20, P7116, DOI 10.1002/chem.201400252
   Lu BQ, 2014, CHEM-EUR J, V20, P1242, DOI 10.1002/chem.201304439
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2012, MATER LETT, V85, P71, DOI 10.1016/j.matlet.2012.06.106
   Reardon PJT, 2013, J MATER CHEM B, V1, P6170, DOI 10.1039/c3tb21073a
   Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z
   Zhao XY, 2013, CRYSTENGCOMM, V15, P7926, DOI 10.1039/c3ce41255e
   Zhao XY, 2013, CHEM-ASIAN J, V8, P1313, DOI 10.1002/asia.201300142
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 21
TC 24
Z9 24
U1 16
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY
PY 2015
VL 41
IS 4
BP 6098
EP 6102
DI 10.1016/j.ceramint.2014.12.122
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CC6YA
UT WOS:000350513700112
DA 2018-10-20
ER

PT J
AU Wang, YM
   Wang, WJ
   Wo, Y
   Gui, T
   Zhu, H
   Mo, XM
   Chen, CC
   Li, QF
   Ding, WL
AF Wang, Yueming
   Wang, Wenjin
   Wo, Yan
   Gui, Ting
   Zhu, Hao
   Mo, Xiumei
   Chen, Chien-Chung
   Li, Qingfeng
   Ding, Wenlong
TI Orientated Guidance of Peripheral Nerve Regeneration Using Conduits with
   a Microtube Array Sheet (MTAS)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nerve regeneration; nerve guide; surface topography; biomaterial;
   orientated nerve growth
ID SCHWANN-CELLS; FUNCTIONAL RECOVERY; GROWTH-FACTOR; STEM-CELLS; GRAFT;
   RAT; DIFFERENTIATION; DENERVATION; MEMBRANES; SCAFFOLD
AB Material surface topography has been shown to affect the biological behavior of cells in vitro; however, the in vivo effect on peripheral nerve regeneration has not been explored. Here, we studied the potential of a. microtube array sheet (MTAS) with a unique longitudinal surface topography to promote peripheral nerve regeneration efficiency, both in vivo and in vitro. Schwann cells, spinal cord motor neurons, and dorsal root ganglion neurons were Seeded on the MTAS to study the effect of the construct on the biological properties and behaviors of neural cells. The MTAS guided the oriented migration of Schwann cells without affecting other critical biological properties, such as proliferation and neurotrophin expression. In addition, the MTAS guided the directed extension of neurites from both types of neurons. Next, we tested the capability of the MTAS to facilitate peripheral nerve regeneration by bridging a 10 mm sciatic nerve defect in rats with a nerve conduit equipped with an MTAS lining. The MTAS significantly promoted peripheral nerve regeneration, as suggested by the greater fiber caliber in the midconduit and the greater abundance of fibers in nerve segment distal to the conduit. Moreover, scanning electron microscopy (SEM) analysis suggested the orientated guidance of nerve regeneration by the MTAS, as indicated by the smaller eccentricity of the nerve fibers and the concordant arrangement of the collagen fiber in both the fibers and the matrix in the MTAS group. Our results collectively suggest that the conduits with the MTAS developed in this study have significant potential for facilitating peripheral nerve regeneration by modifying critical biological behaviors and guiding orientated nerve growth.
C1 [Wang, Yueming; Wang, Wenjin; Wo, Yan; Gui, Ting; Zhu, Hao; Ding, Wenlong] Shanghai Jiao Tong Univ, Dept Anat Histol & Embryol, Sch Med, Shanghai 200025, Peoples R China.
   [Wang, Wenjin; Li, Qingfeng] Shanghai Ninth Hosp, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China.
   [Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Chen, Chien-Chung] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei 11031, Taiwan.
RP Li, QF (reprint author), Shanghai Ninth Hosp, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China.
EM Dingw1500@sina.com; drliqingfeng@yahoo.cn
RI mo, xiumei/C-9340-2013
FU National Natural Science Funds of China [31100782, 81271380, 81201505];
   Natural Science Fund - Shanghai Committee of Science and Technology
   [11ZR1419400, 1052 nm04200]
FX This work is supported by the National Natural Science Funds of China
   (Project Nos. 31100782, 81271380, 81201505) and by the Natural Science
   Fund, supported by the Shanghai Committee of Science and Technology
   (Project Nos. 11ZR1419400 and 1052 nm04200).
CR Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   BEST TJ, 1993, PLAST RECONSTR SURG, V92, P516, DOI 10.1097/00006534-199309000-00022
   Biazar E, 2013, ASAIO J, V59, P651, DOI 10.1097/MAT.0b013e3182a79151
   BROCKES JP, 1981, J EXP BIOL, V95, P215
   Chan KM, 2014, EXP NEUROL, V261, P826, DOI 10.1016/j.expneurol.2014.09.006
   Day CS, 2002, MICROSURG, V22, P144, DOI 10.1002/micr.21742
   Firat C, 2014, ANN PLAS SURG, V73, P54, DOI 10.1097/SAP.0b013e31829fd2be
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Fukuda Y, 2014, J BIOMED MATER RES B, V102, P674, DOI 10.1002/jbm.b.33046
   Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   Lago N, 2007, J NEUROSCI RES, V85, P2800, DOI 10.1002/jnr.21286
   Li GC, 2014, BIOMATERIALS, V35, P8503, DOI 10.1016/j.biomaterials.2014.05.093
   Lin LC, 2014, CURR NANOSCI, V10, P227, DOI 10.2174/1573413709999131209124001
   Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mohammadi R, 2014, J CRANIO MAXILL SURG, V42, P1389, DOI 10.1016/j.jcms.2014.03.031
   Ou KL, 2011, EUR POLYM J, V47, P882, DOI 10.1016/j.eurpolymj.2011.02.001
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253
   Shih YH, 2012, TEXT RES J, V82, P602, DOI 10.1177/0040517511420756
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tong WY, 2012, BIOMATERIALS, V33, P7686, DOI 10.1016/j.biomaterials.2012.07.002
   Xiao JH, 2009, NEUROSIGNALS, V17, P265, DOI 10.1159/000231893
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yamanaka T., 2014, PLOS ONE, V9
   Yang JC, 2012, MACROMOL MATER ENG, V297, P115, DOI 10.1002/mame.201100045
   Yang XN, 2013, BIOMATERIALS, V34, P5606, DOI 10.1016/j.biomaterials.2013.04.018
   Yu WW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165102
NR 35
TC 15
Z9 15
U1 3
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 29
PY 2015
VL 7
IS 16
BP 8437
EP 8450
DI 10.1021/acsami.5b00215
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CH3LD
UT WOS:000353931300010
PM 25853547
DA 2018-10-20
ER

PT J
AU Pal, RK
   Kurland, NE
   Wang, CZ
   Kundu, SC
   Yadavalli, VK
AF Pal, Ramendra K.
   Kurland, Nicholas E.
   Wang, Congzhou
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
TI Biopatterning of Silk Proteins for Soft Micro-optics
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk protein; photolithography; iridescence; soft optics;
   microfabrication; Fresnel lens
ID FRESNEL ZONE-PLATE; STRUCTURAL COLOR; FIBROIN FIBERS; LITHOGRAPHY;
   SERICIN; FILMS; BIODEGRADATION; BIOMATERIALS; IRIDESCENCE; BIOMIMETICS
AB Silk proteins from spiders and silkworms have been proposed as outstanding candidates for soft micro-optic and photonic applications because of their optical transparency, unique biological properties, and mechanical robustness. Here, we present a Method to font microstructures of the two constituent silk proteins, fibroin and sericin for use as an optical biomaterial. Using photolithography, chemically modified silk protein photoresists are patterned in 2D arrays of periodic patterns and Fresnel zone plates. Angle-dependent iridescent colors are produced in these periodic micropatterns because of the Bragg diffraction. Silk protein photolithography can used to form patterns on different substrates including flexible sheets with features of any shape with high fidelity and resolution over large areas. Finally, we show that these Mechanically stable and transparent iridescent architectures are Also completely biodegradable. This versatile and scalable technique can therefore be used to develop biocompatible, soft micro-optic devices that can be degraded in a controlled manner.
C1 [Pal, Ramendra K.; Kurland, Nicholas E.; Wang, Congzhou; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu
OI Yadavalli, Vamsi/0000-0002-8879-1948; Kundu, Subhas
   C./0000-0002-7170-2291
CR Ainslie KM, 2008, LAB CHIP, V8, P1864, DOI 10.1039/b806446f
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Aramwit P, 2013, NAT PROD COMMUN, V8, P501
   Azofeifa DE, 2012, OPT MATER, V35, P175, DOI 10.1016/j.optmat.2012.07.024
   BAEZ AV, 1961, J OPT SOC AM, V51, P405, DOI 10.1364/JOSA.51.000405
   Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chien CC, 2013, BIOTECHNOL ADV, V31, P375, DOI 10.1016/j.biotechadv.2012.04.005
   Der A, 2010, SENSOR ACTUAT B-CHEM, V151, P26, DOI 10.1016/j.snb.2010.09.064
   Domachuk P., 2009, APPL PHYS LETT, V95
   Fan YH, 2003, OPT EXPRESS, V11, P3080, DOI 10.1364/OE.11.003080
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Glover BJ, 2010, ANN BOT-LONDON, V105, P505, DOI 10.1093/aob/mcq007
   He Y, 2014, J BIOMED NANOTECHNOL, V10, P767, DOI 10.1166/jbn.2014.1769
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Kanellos GT, 2010, OPT EXPRESS, V18, P179, DOI 10.1364/OE.18.000179
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim DH, 2012, SMALL, V8, P3263, DOI 10.1002/smll.201200933
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Masuda Y, 2005, LANGMUIR, V21, P4478, DOI 10.1021/la050075m
   Morgan B, 2004, J MICROELECTROMECH S, V13, P113, DOI 10.1109/JMEMS.2003.823220
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Pang S, 2011, LAB CHIP, V11, P3698, DOI 10.1039/c1lc20654k
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838
   Qin GK, 2013, J POLYM SCI POL PHYS, V51, P254, DOI 10.1002/polb.23204
   Rajasekharan R, 2012, ADV MATER, V24, pOP170, DOI 10.1002/adma.201200296
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267
   Sarrat B, 2011, LANGMUIR, V27, P3174, DOI 10.1021/la104364n
   Seago A.E., 2009, J ROYAL SOC INTERFAC, V6, P165, DOI DOI 10.1098/RSIF.2008.0354.FOCUS
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wang JN, 2012, CHEM-ASIAN J, V7, P301, DOI 10.1002/asia.201100882
   White R.D., 2011, J MICROMECH MICROENG, V21, P11
   Wu D, 2010, SOFT MATTER, V6, P263, DOI 10.1039/b910605g
   Wu SR, 2012, MATERIALS, V5, P1752, DOI 10.3390/ma5101752
   Xia Y., 1999, ANGEW CHEM INT EDIT, V37, P551
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 57
TC 18
Z9 18
U1 2
U2 75
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 29
PY 2015
VL 7
IS 16
BP 8809
EP 8816
DI 10.1021/acsami.5b01380
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CH3LD
UT WOS:000353931300052
PM 25853731
DA 2018-10-20
ER

PT J
AU Jay, L
   Bourget, JM
   Goyer, B
   Singh, K
   Brunette, I
   Ozaki, T
   Proulx, S
AF Jay, Louis
   Bourget, Jean-Michel
   Goyer, Benjamin
   Singh, Kanwarpal
   Brunette, Isabelle
   Ozaki, Tsuneyuki
   Proulx, Stephanie
TI Characterization of Tissue-Engineered Posterior Corneas Using Second-
   and Third-Harmonic Generation Microscopy
SO PLOS ONE
LA English
DT Article
ID 3RD HARMONIC-GENERATION; SELF-ASSEMBLY APPROACH; 2ND-HARMONIC
   GENERATION; IMAGING MICROSCOPY; COLLAGEN LAMELLAE; CELLS; REGENERATION;
   ENDOTHELIUM; ORIENTATION; EQUIVALENT
AB Three-dimensional tissues, such as the cornea, are now being engineered as substitutes for the rehabilitation of vision in patients with blinding corneal diseases. Engineering of tissues for translational purposes requires a non-invasive monitoring to control the quality of the resulting biomaterial. Unfortunately, most current methods still imply invasive steps, such as fixation and staining, to clearly observe the tissue-engineered cornea, a transparent tissue with weak natural contrast. Second-and third-harmonic generation imaging are well known to provide high-contrast, high spatial resolution images of such tissues, by taking advantage of the endogenous contrast agents of the tissue itself. In this article, we imaged tissue-engineered corneal substitutes using both harmonic microscopy and classic histopathology techniques. We demonstrate that second-and third-harmonic imaging can non-invasively provide important information regarding the quality and the integrity of these partial-thickness posterior corneal substitutes (observation of collagen network, fibroblasts and endothelial cells). These two nonlinear imaging modalities offer the new opportunity of monitoring the engineered corneas during the entire process of production.
C1 [Jay, Louis; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Ctr Energie Mat Telecommun, Varennes, PQ, Canada.
   [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada.
   [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.
   [Goyer, Benjamin; Proulx, Stephanie] CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.
   [Goyer, Benjamin; Proulx, Stephanie] Univ Laval, LOEX, Ctr Rech Organogenese Exprt, Quebec City, PQ, Canada.
   [Proulx, Stephanie] Univ Laval, Fac Med, Dept Ophtalmol & Otorhinolaryngol, Quebec City, PQ, Canada.
RP Proulx, S (reprint author), CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.
EM stephanie.proulx@fmed.ulaval.ca
OI Ozaki, Tsuneyuki/0000-0001-8857-3900
FU Canadian Institutes for Health Research (CIHR) [CPG121034]; Natural
   Sciences and Engineering Research Council of Canada (NSERC)
   [414484-2012]; FRQS Vision Health Research Network;  [CHRPJ 313019-05]
FX This work was supported by the Canadian Institutes for Health Research
   (CIHR grant #CPG121034) in partnership with the Natural Sciences and
   Engineering Research Council of Canada (NSERC grant #414484-2012) (SP,
   IB) and grant #CHRPJ 313019-05 (TO). The Eye Bank Banque d'yeux du
   Centre Universitaire d'Ophtalmologie" is partly supported by the FRQS
   Vision Health Research Network (SP, IB). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586
   Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573
   Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442
   Barzda V, 2005, OPT EXPRESS, V13, P8263, DOI 10.1364/OPEX.13.008263
   Buhrmann R., 2007, FDN CANADIAN HLTH ST
   Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813
   EBAA, 2013, 2013 EYE BANK STAT R, P1
   Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]
   Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7
   Germain L, 2004, TISSUE ENG CORNEA EN, P1533
   Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022
   Hsueh CM, 2009, BIOPHYS J, V97, P1198, DOI 10.1016/j.bpj.2009.05.040
   Jay L, 2008, OPT EXPRESS, V16, P16284, DOI 10.1364/OE.16.016284
   L'Heureux N, 1998, FASEB J, V12, P47
   Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15
   Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Mega Y, 2012, OPT LETT, V37, P3312, DOI 10.1364/OL.37.003312
   Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003
   Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657
   Morishige N, 2009, CORNEA, V28, pS46, DOI 10.1097/ICO.0b013e3181ae9f37
   Muller M, 1998, J MICROSC-OXFORD, V191, P266
   Pankert MB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14720
   PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S
   Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013
   Proulx S, 2010, MOL VIS, V16, P2192
   Su PJ, 2010, BIOMATERIALS, V31, P9415, DOI 10.1016/j.biomaterials.2010.08.055
   TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815
   Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520
   Tserevelakis GJ, 2010, MICRON, V41, P444, DOI 10.1016/j.micron.2010.02.006
   VIELREICHER M, 2013, J R SOC INTERFACE, V10
   Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs-030814
NR 41
TC 3
Z9 3
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2015
VL 10
IS 4
AR e0125564
DI 10.1371/journal.pone.0125564
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG9SE
UT WOS:000353659400086
PM 25918849
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Amemiya, T
   Nakamura, T
   Yamamoto, T
   Kinoshita, S
   Kanamura, N
AF Amemiya, Takeshi
   Nakamura, Takahiro
   Yamamoto, Toshiro
   Kinoshita, Shigeru
   Kanamura, Narisato
TI Autologous Transplantation of Oral Mucosal Epithelial Cell Sheets
   Cultured on an Amniotic Membrane Substrate for Intraoral Mucosal Defects
SO PLOS ONE
LA English
DT Article
ID SURFACE RECONSTRUCTION; BASEMENT-MEMBRANE; KERATIN PROTEINS;
   LOCALIZATION; EQUIVALENT; CORNEAL; SERUM; IV
AB The human amniotic membrane (AM) is a thin intrauterine placental membrane that is highly biocompatible and possesses anti-inflammatory and anti-scarring properties. Using AM, we developed a novel method for cultivating oral mucosal epithelial cell sheets. We investigated the autologous transplantation of oral mucosal epithelial cells cultured on AM in patients undergoing oral surgeries. We obtained specimens of AM from women undergoing cesarean sections. This study included five patients without any history of a medical disorder who underwent autologous cultured oral epithelial transplantation following oral surgical procedures. Using oral mucosal biopsy specimens obtained from these patients, we cultured oral epithelial cells on an AM carrier. We transplanted the resultant cell sheets onto the oral mucosal defects. Patients were followed-up for at least 12 months after transplantation. After 2-3 weeks of being cultured on AM, epithelial cells were well differentiated and had stratified into five to seven layers. Immunohistochemistry revealed that the cultured cells expressed highly specific mucosal epithelial cell markers and basement membrane proteins. After the surgical procedures, no infection, bleeding, rejection, or sheet detachment occurred at the reconstructed sites, at which new oral mucous membranes were evident. No recurrence was observed in the long-term follow-up, and the postoperative course was excellent. Our results suggest that AM-cultured oral mucosal epithelial cell sheets represent a useful biomaterial and feasible method for oral mucosal reconstruction. However, our primary clinical study only evaluated their effects on a limited number of small oral mucosal defects.
C1 [Amemiya, Takeshi; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.
   [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Ophthalmol, Kyoto, Japan.
   [Nakamura, Takahiro] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan.
RP Amemiya, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.
EM amemiya@koto.kpu-m.ac.jp
FU Japan Society for the Promotion of Science [21592535]; Kyoto Prefectural
   University of Medicine
FX This work supported by a Grant-in-Aid for Scientific Research (No.
   21592535) from the Japan Society for the Promotion of Science (NK), and
   a Grant for Advanced Medical Treatment in Kyoto Prefectural University
   of Medicine (NK). The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adachi K, 2014, ORAL DIS, V20, P582, DOI 10.1111/odi.12176
   Amemiya T, 2004, J ORAL TISSUE ENG, V1, P89
   Amemiya T, 2010, JPN J CONSERV DENT, V53, P214
   Amemiya T, 2010, INFLAM REGENER, V30, P176
   Amemiya T, 2008, J ORAL TISSUE ENG, V6, P106
   Amemiya T, 2003, J JPN ASS REGENERATI, V1, P25
   Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613
   Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723
   CLAUSEN H, 1986, J ORAL PATHOL MED, V15, P36, DOI 10.1111/j.1600-0714.1986.tb00561.x
   COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P370
   COOPER D, 1986, J BIOL CHEM, V261, P4646
   Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29
   Feghali-Assaly M, 1997, EUR J ORAL SCI, V105, P599, DOI 10.1111/j.1600-0722.1997.tb00224.x
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365
   JUHL M, 1989, SCAND J DENT RES, V97, P159
   Kesting MR, 2014, ORAL MAXILLOFAC SURG, V18, P153, DOI 10.1007/s10006-012-0382-1
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Maragou P, 1999, ORAL DIS, V5, P20
   Modesti A, 1989, Prog Clin Biol Res, V296, P459
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Nakamura T, 2006, INVEST OPHTH VIS SCI, V47, P909, DOI 10.1167/iovs.05-1188
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497
   Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714
   NANAEV AK, 1991, PLACENTA, V12, P573, DOI 10.1016/0143-4004(91)90493-Y
   Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0
   ROSDY M, 1990, J INVEST DERMATOL, V95, P409, DOI 10.1111/1523-1747.ep12555510
   ROSDY M, 1993, BRIT J DERMATOL, V129, P227, DOI 10.1111/j.1365-2133.1993.tb11839.x
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   SHABANA AHM, 1991, ARCH ORAL BIOL, V36, P747, DOI 10.1016/0003-9969(91)90041-R
   STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Yamamoto T, 2007, J ORAL TISSUE ENG, V5, P54
NR 37
TC 5
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2015
VL 10
IS 4
AR e0125391
DI 10.1371/journal.pone.0125391
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG9SB
UT WOS:000353659100126
PM 25915046
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jin, SH
   Kang, SK
   Cho, IT
   Han, SY
   Chung, HU
   Lee, DJ
   Shin, J
   Baek, GW
   Kim, TI
   Lee, JH
   Rogers, JA
AF Jin, Sung Hun
   Kang, Seung-Kyun
   Cho, In-Tak
   Han, Sang Youn
   Chung, Ha Uk
   Lee, Dong Joon
   Shin, Jongmin
   Baek, Geun Woo
   Kim, Tae-il
   Lee, Jong-Ho
   Rogers, John A.
TI Water-Soluble Thin Film Transistors and Circuits Based on Amorphous
   Indium-Gallium-Zinc Oxide
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE a-IGZO; transient electronics; dissolution; PVA; inverter; ring
   oscillators
ID TRANSIENT ELECTRONICS; FABRICATION; BIOCOMPATIBILITY; CYTOTOXICITY;
   BIOMATERIAL; TOXICITY; POLYMERS; ZNO
AB This paper presents device designs, circuit demonstrations, and dissolution kinetics for amorphous indium-gallium-zinc oxide (a-IGZO) thin film transistors (TFTs) comprised completely of water-soluble materials, including SiNx, SiOx, molybdenum, and poly(vinyl alcohol) (PVA). Collections of these types of physically transient a-IGZO TFTs and 5-stage ring oscillators (ROs), constructed 0 with them, show field effect mobilities (similar to 10 cm(2)/Vs), on/off ratios (similar to 2 x 10(6)), subthreshold slopes (similar to 220 mV/dec), Ohmic contact properties, and oscillation frequency of 5:67 kHz at supply voltages of 19 V, all comparable to otherwise similar devices constructed in conventional ways with standard, nontransient materials. Studies of dissolution kinetics for a-IGZO films in deionized water, bovine serum, and phosphate buffer saline solution provide data of relevance for the potential use of these materials and this technology in temporary biomedical implants.
C1 [Jin, Sung Hun; Baek, Geun Woo] Incheon Natl Univ, Dept Elect Engn, Inchon 406772, South Korea.
   [Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn Chem Mech Sci & Engn Elect &, Urbana, IL 61801 USA.
   [Kang, Seung-Kyun; Han, Sang Youn; Chung, Ha Uk; Lee, Dong Joon; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.
   [Kang, Seung-Kyun; Han, Sang Youn; Chung, Ha Uk; Lee, Dong Joon] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Cho, In-Tak; Shin, Jongmin; Lee, Jong-Ho] Seoul Natl Univ, Dept Elect Engn, Seoul 151600, South Korea.
   [Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Inst Basic Sci, CNIR, Suwon 440746, Gyeonggi Do, South Korea.
   [Han, Sang Youn] Samsung Display Co, Display R&D Ctr, Yongin 446711, Gyeongki Do, South Korea.
RP Jin, SH (reprint author), Incheon Natl Univ, Dept Elect Engn, Inchon 406772, South Korea.
EM shjin@inu.ac.kr; jhl@snu.ac.kr; jrogers@illinois.edu
RI Rogers, John/L-2798-2016; Kang, Seung-Kyun/L-3053-2017; Jin, Sung
   Hun/O-2092-2018
OI Kim, Tae-il/0000-0002-6667-5356
FU NSF-INSPIRE Grant [DMR-1242240]; National Research Foundation of Korea
   (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2014R1A1A1038274]
FX This research was supported by NSF-INSPIRE Grant (DMR-1242240) and Basic
   Science Research Program through the National Research Foundation of
   Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
   (NRF-2014R1A1A1038274).
CR Badding MA, 2014, J TOXICOL ENV HEAL A, V77, P1193, DOI 10.1080/15287394.2014.920757
   BARIC A, 1969, LIMNOL OCEANOGR, V14, P796, DOI 10.4319/lo.1969.14.5.0796
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Brumbach M., 2007, ENCY ELECTROCHEMISTR, P18, DOI 10.1002/9783527610426.bard100101
   Chen Y., 2013, SOC INF DISP INT S, V46.3, P640
   Chiu CJ, 2011, IEEE SENS J, V11, P2902, DOI 10.1109/JSEN.2011.2146770
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Horasawa N, 1997, Dent Mater J, V16, P200
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g
   Hwang SW, 2014, ADV MATER, V26, P3905, DOI 10.1002/adma.201306050
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   irimia-Viadu M., 2013, CHEM SOC REV, V43, P588, DOI DOI 10.HTTP://DX.D0I.0RG/10.1039/C3CS60235D
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Jin S. H., 2014, APPL PHYS LETT, V105
   Kang S.-M., 1996, DIGITAL INTEGRATED C
   Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293
   KIM CJ, 2006, IEDM, P307
   Kim MW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713859
   KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205
   Lam C. X. F., 2008, BIOMED MATER, V3
   Lee CH, 2011, NANO LETT, V11, P3435, DOI 10.1021/nl201901z
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park JY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430921
   Ponnusamy Thiruselvam, 2012, Biomatter, V2, P77, DOI 10.4161/biom.20390
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Salvator G. A., 2014, NATURE COMMUN, V5, P1
   Sedra A. S., 2010, MICROELECTRONIC CIRC, P1075
   WATAHA JC, 1994, DENT MATER, V10, P298, DOI 10.1016/0109-5641(94)90037-X
   WEBB DR, 1986, TOXICOL APPL PHARM, V82, P405, DOI 10.1016/0041-008X(86)90276-0
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Yan DH, 2009, INORG CHEM, V48, P6471, DOI 10.1021/ic900420m
   Yang DJ, 2012, SENSOR ACTUAT B-CHEM, V171, P1166, DOI 10.1016/j.snb.2012.06.057
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
NR 42
TC 31
Z9 32
U1 10
U2 77
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 22
PY 2015
VL 7
IS 15
BP 8268
EP 8274
DI 10.1021/acsami.5b00086
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CG9AP
UT WOS:000353607100053
PM 25805699
DA 2018-10-20
ER

PT J
AU Costa, PF
   Hutmacher, DW
   Theodoropoulos, C
   Gomes, ME
   Reis, RL
   Vaquette, C
AF Costa, Pedro F.
   Hutmacher, Dietmar W.
   Theodoropoulos, Christina
   Gomes, Manuela E.
   Reis, Rui L.
   Vaquette, Cedryck
TI Additively Manufactured Device for Dynamic Culture of Large Arrays of 3D
   Tissue Engineered Constructs
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID MINERALIZED MATRIX DEPOSITION; MARROW STROMAL OSTEOBLASTS; PERFUSION
   BIOREACTOR; STEM-CELLS; SCAFFOLD DESIGN; IN-VITRO; BONE-FORMATION; FLOW;
   BIOMATERIALS; 3RD-DIMENSION
AB The ability to test large arrays of cell and biomaterial combinations in 3D environments is still rather limited in the context of tissue engineering and regenerative medicine. This limitation can be generally addressed by employing highly automated and reproducible methodologies. This study reports on the development of a highly versatile and upscalable method based on additive manufacturing for the fabrication of arrays of scaffolds, which are enclosed into individualized perfusion chambers. Devices containing eight scaffolds and their corresponding bioreactor chambers are simultaneously fabricated utilizing a dual extrusion additive manufacturing system. To demonstrate the versatility of the concept, the scaffolds, while enclosed into the device, are subsequently surface-coated with a biomimetic calcium phosphate layer by perfusion with simulated body fluid solution. 96 scaffolds are simultaneously seeded and cultured with human osteoblasts under highly controlled bidirectional perfusion dynamic conditions over 4 weeks. Both coated and noncoated resulting scaffolds show homogeneous cell distribution and high cell viability throughout the 4 weeks culture period and CaP-coated scaffolds result in a significantly increased cell number. The methodology developed in this work exemplifies the applicability of additive manufacturing as a tool for further automation of studies in the field of tissue engineering and regenerative medicine.
C1 [Costa, Pedro F.; Gomes, Manuela E.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-480609 Caldas Das Taipas, Guimaraes, Portugal.
   [Costa, Pedro F.; Gomes, Manuela E.; Reis, Rui L.] ICVS, PT Govt Associate Lab 3Bs, Braga, Guimaraes, Portugal.
   [Hutmacher, Dietmar W.; Theodoropoulos, Christina; Vaquette, Cedryck] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM dietmar.hutmacher@qut.edu.au
RI Group, 3Bs/E-4374-2012; Gomes, Manuela/B-6282-2009; Reis, Rui
   L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Gomes, Manuela/0000-0002-2036-6291;
   Reis, Rui L./0000-0002-4295-6129; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Costa, Pedro/0000-0003-3114-9417; Vaquette,
   Cedryck/0000-0001-7937-4432
FU Australian Research Council; Portuguese Foundation for Science and
   Technology [SFRH/BD/62452/2009]
FX P.F.C. and D.W.H. contributed equally to this work. This work was
   supported by the Australian Research Council. P.F.C. acknowledges the
   Portuguese Foundation for Science and Technology for his PhD grant
   (SFRH/BD/62452/2009).
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Alvarez-Barreto JF, 2007, ANN BIOMED ENG, V35, P429, DOI 10.1007/s10439-006-9244-z
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Costa PF, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035006
   Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Goncalves A., 2011, ACTA BIOMATER, V7, P1644
   Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j
   Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255
   Grylls R., 2003, Machine Design International, V75, P56
   Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101
   Hidalgo-Bastida LA, 2012, BIOTECHNOL BIOENG, V109, P1095, DOI 10.1002/bit.24368
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002
   Mei Y, 2012, MATER TODAY, V15, P444, DOI 10.1016/S1369-7021(12)70196-7
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Oliveira AL, 2009, ACTA BIOMATER, V5, P1626, DOI 10.1016/j.actbio.2008.12.009
   Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373
   Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2006.12.021
   Tian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042804
   Tsuji H, 2003, POLYM INT, V52, P843, DOI 10.1002/pi.1199
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Yang F, 2008, CHEM ENG J, V137, P154, DOI 10.1016/j.cej.2007.07.076
   Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272
   Zapata P, 2007, BIOMACROMOLECULES, V8, P1907, DOI 10.1021/bm061134t
NR 53
TC 6
Z9 6
U1 3
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 22
PY 2015
VL 4
IS 6
BP 864
EP 873
DI 10.1002/adhm.201400591
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CG5SD
UT WOS:000353353500007
PM 25721231
DA 2018-10-20
ER

PT J
AU Monn, MA
   Weaver, JC
   Zhang, TY
   Aizenberg, J
   Kesari, H
AF Monn, Michael A.
   Weaver, James C.
   Zhang, Tianyang
   Aizenberg, Joanna
   Kesari, Haneesh
TI New functional insights into the internal architecture of the laminated
   anchor spicules of Euplectella aspergillum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE structure-property relationship; structural biomaterial; biocomposite;
   variational analysis
ID MECHANICAL-PROPERTIES; FRACTURE-RESISTANCE; COMPOSITES; SPONGE; BONE;
   DEMOSPONGE; NANOSCALE; BIOSILICA; COLLAGEN; SYSTEMS
AB To adapt to a wide range of physically demanding environmental conditions, biological systems have evolved a diverse variety of robust skeletal architectures. One such example, Euplectella aspergillum, is a sediment-dwelling marine sponge that is anchored into the sea floor by a flexible holdfast apparatus consisting of thousands of anchor spicules (long, hair-like glassy fibers). Each spicule is covered with recurved barbs and has an internal architecture consisting of a solid core of silica surrounded by an assembly of coaxial silica cylinders, each of which is separated by a thin organic layer. The thickness of each silica cylinder progressively decreases from the spicule's core to its periphery, which we hypothesize is an adaptation for redistributing internal stresses, thus increasing the overall strength of each spicule. To evaluate this hypothesis, we created a spicule structural mechanics model, in which we fixed the radii of the silica cylinders such that the force transmitted from the surface barbs to the remainder of the skeletal system was maximized. Compared with measurements of these parameters in the native sponge spicules, our modeling results correlate remarkably well, highlighting the beneficial nature of this elastically heterogeneous lamellar design strategy. The structural principles obtained from this study thus provide potential design insights for the fabrication of high-strength beams for load-bearing applications through the modification of their internal architecture, rather than their external geometry.
C1 [Monn, Michael A.; Zhang, Tianyang; Kesari, Haneesh] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Weaver, James C.; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
RP Kesari, H (reprint author), Brown Univ, Sch Engn, Providence, RI 02912 USA.
EM haneesh_kesari@brown.edu
OI Monn, Michael/0000-0002-9966-5891
FU National Science Foundation [DMR-0520651, DMR-1420570]; Korean Institute
   of Machinery and Materials-Brown Nano and Micromechanics for Disaster
   Mitigation and Technological Reliability project
FX We thank Prof. Huajian Gao for helpful discussions. This work was
   supported by the National Science Foundation through Materials Research
   Science and Engineering Centers Program DMR-0520651 at Brown University,
   Materials Research Science and Engineering Centers Program DMR-1420570
   at Harvard University, and the Korean Institute of Machinery and
   Materials-Brown Nano and Micromechanics for Disaster Mitigation and
   Technological Reliability project.
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Bazant ZP, 2005, SCALING STRUCTURAL S, P3
   Browning A, 2013, J MECH BEHAV BIOMED, V19, P75, DOI 10.1016/j.jmbbm.2012.11.003
   CattaneoVietti R, 1996, NATURE, V383, P397, DOI 10.1038/383397b0
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591
   Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Gere JM, 1997, MECH MATER, P220
   Green DJ, 1998, CAMBRIDGE SOLID STAT, P210
   Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221, P163
   Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Launey ME, 2009, ACTA MATER, V57, P2919, DOI 10.1016/j.actamat.2009.03.003
   Lawn B., 1993, FRACTURE BRITTLE SOL, P1
   Leys SP, 2003, MICROSC RES TECHNIQ, V62, P300, DOI 10.1002/jemt.10397
   Marsden JE, 1993, ELEMENTARY CLASSICAL, P19
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135
   Nalla RK, 2003, J BIOMED MATER RES A, V67A, P484, DOI 10.1002/jbm.a.10079
   Porter MM, 2013, JOM-US, V65, P720, DOI 10.1007/s11837-013-0606-3
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]
   Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a
   Thompson DW, 1942, GROWTH FORM NEW EDIT, P665
   Tomisa A.P., 2011, INT J ORAL MAXILLOF, V26, P45
   Vincent JFV, 1990, STRUCTURAL BIOMATERI, P204
   Vincent JFV, 1990, STRUCTURAL BIOMATERI, P126
   Wang XH, 2009, FRONTIERS MAT SCI CH, V3, P226
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Weaver JC, 2010, J ADHESION, V86, P72, DOI 10.1080/00218460903417917
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yang W, 2013, ACTA BIOMATER, V9, P5876, DOI 10.1016/j.actbio.2012.12.026
   Zlotnikov I, 2013, RSC ADV, V3, P5798, DOI 10.1039/c3ra40574e
NR 35
TC 13
Z9 13
U1 6
U2 47
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 21
PY 2015
VL 112
IS 16
BP 4976
EP 4981
DI 10.1073/pnas.1415502112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG4FJ
UT WOS:000353239100049
PM 25848003
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Berdichevski, A
   Yameen, HS
   Dafni, H
   Neeman, M
   Seliktar, D
AF Berdichevski, Alexandra
   Yameen, Haneen Simaan
   Dafni, Hagit
   Neeman, Michal
   Seliktar, Dror
TI Using bimodal MRI/fluorescence imaging to identify host angiogenic
   response to implants
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial scaffold; angiogenesis; hydrogel; contrast agents; tissue
   regeneration
ID ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FOREIGN-BODY
   REACTION; IN-VIVO; FACTOR DELIVERY; FIBRINOGEN HYDROGEL; SYNTHETIC
   MATRIX; SOFT-TISSUE; VEGF; SCAFFOLDS
AB Therapies that promote angiogenesis have been successfully applied using various combinations of proangiogenic factors together with a biodegradable delivery vehicle. In this study we used bimodal noninvasive monitoring to show that the host response to a proangiogenic biomaterial can be drastically affected by the mode of implantation and the surface area-to-volume ratio of the implant material. Fluorescence/MRI probes were covalently conjugated to VEGF-bearing biodegradable PEG-fibrinogen hydrogel implants and used to document the in vivo degradation and liberation of bioactive constituents in an s.c. rat implantation model. The hydrogel biodegradation and angiogenic host response with three types of VEGF-bearing implant configurations were compared: preformed cylindrical plugs, preformed injectable microbeads, and hydrogel precursor, injected and polymerized in situ. Although all three were made with identical amounts of precursor constituents, the MRI data revealed that in situ polymerized hydrogels were fully degraded within 2 wk; microbead degradation was more moderate, and plugs degraded significantly more slowly than the other configurations. The presence of hydrogel degradation products containing the fluorescent label in the surrounding tissues revealed a distinct biphasic release profile for each type of implant configuration. The purported in vivo VEGF release profile from the microbeads resulted in highly vascularized s.c. tissue containing up to 16-fold more capillaries in comparison with controls. These findings demonstrate that the configuration of an implant can play an important role not only in the degradation and resorption properties of the materials, but also in consequent host angiogenic response.
C1 [Berdichevski, Alexandra; Yameen, Haneen Simaan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Dafni, Hagit] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel.
   [Neeman, Michal] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
RI Neeman, Michal/A-8264-2008
OI Neeman, Michal/0000-0002-6296-816X; Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation; Lorry I. Lokey Interdisciplinary
   Center for Life Sciences and Engineering; Russell Berrie Nanotechnology
   Institute; EC-IP FP7 Grants Angioscaff and Biodesign; 7th Framework
   European Research Council Advanced Grant [232640-IMAGO]
FX We wish to thank the Preclinical Research Authority and the Imaging and
   Microscopy Center at the Bruce Rappaport Faculty of Medicine for their
   help and technical support. This work was supported by the Singapore
   National Research Foundation (D.S. and A.B.), the Lorry I. Lokey
   Interdisciplinary Center for Life Sciences and Engineering (D.S.),
   Russell Berrie Nanotechnology Institute (D.S.), EC-IP FP7 Grants
   Angioscaff and Biodesign (to D.S.), and in part by the 7th Framework
   European Research Council Advanced Grant 232640-IMAGO (to M.N.). M.N. is
   incumbent of the Helen and Morris Mauerberger Chair.
CR Aghion E, 2012, J MATER SCI-MATER M, V23, P805, DOI 10.1007/s10856-011-4536-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bland E, 2013, J TISSUE ENG REGEN M, V7, P505, DOI 10.1002/term.540
   Chwalek K, 2011, BIOMATERIALS, V32, P9649, DOI 10.1016/j.biomaterials.2011.08.078
   Cunha-Reis C, 2013, J TISSUE ENG REGEN M, V7, P39, DOI 10.1002/term.494
   Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724
   Dafni H, 2002, CANCER RES, V62, P6731
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Ge YB, 2011, YAKUGAKU ZASSHI, V131, P1807, DOI 10.1248/yakushi.131.1807
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Griffith CK, 2009, TISSUE ENG PT A, V15, P2423, DOI 10.1089/ten.tea.2008.0267
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Jiang HL, 2001, J BIOMAT SCI-POLYM E, V12, P1281, DOI 10.1163/156856202753419222
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726
   Kotkova Z, 2010, CHEM-EUR J, V16, P10094, DOI 10.1002/chem.200903519
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   RAPPOLEE DA, 1988, CURR OPIN IMMUNOL, V1, P47, DOI 10.1016/0952-7915(88)90050-7
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   Sahni A, 2000, BLOOD, V96, P3772
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Wang YT, 2011, NANOMED-NANOTECHNOL, V7, P1009, DOI 10.1016/j.nano.2011.03.006
   Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang Y, 2005, ANALYST, V130, P1502, DOI 10.1039/b506911d
   Yang Z, 2012, J DIGEST DIS, V13, P168, DOI 10.1111/j.1751-2980.2011.00566.x
   Yilgor P, 2013, J TISSUE ENG REGEN M, V7, P687, DOI 10.1002/term.1456
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Zheng J, 2004, PEGYLATED LIPOSOME C
NR 54
TC 20
Z9 20
U1 3
U2 44
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 21
PY 2015
VL 112
IS 16
BP 5147
EP 5152
DI 10.1073/pnas.1502232112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG4FJ
UT WOS:000353239100078
PM 25825771
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Moshaverinia, A
   Chen, C
   Xu, XT
   Ansari, S
   Zadeh, HH
   Schricker, SR
   Paine, ML
   Moradian-Oldak, J
   Khademhosseini, A
   Snead, ML
   Shi, ST
AF Moshaverinia, Alireza
   Chen, Chider
   Xu, Xingtian
   Ansari, Sahar
   Zadeh, Homayoun H.
   Schricker, Scott R.
   Paine, Michael L.
   Moradian-Oldak, Janet
   Khademhosseini, Ali
   Snead, Malcolm L.
   Shi, Songtao
TI Regulation of the Stem Cell-Host Immune System Interplay Using Hydrogel
   Coencapsulation System with an Anti-Inflammatory Drug
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NF-KAPPA-B; TNF-ALPHA; TISSUE REGENERATION; ALGINATE HYDROGELS;
   CO-ENCAPSULATION; UP-REGULATION; IFN-GAMMA; RELEASE; DIFFERENTIATION;
   BONE
AB The host immune system is known to influence mesenchymal stem cell (MSC)-mediated bone tissue regeneration. However, the therapeutic capacity of hydrogel biomaterial to modulate the interplay between MSCs and T-lymphocytes is unknown. Here it is shown that encapsulating hydrogel affects this interplay when used to encapsulate MSCs for implantation by hindering the penetration of pro-inflammatory cells and/or cytokines, leading to improved viability of the encapsulated MSCs. This combats the effects of the host pro-inflammatory T-lymphocyte-induced nuclear factor kappaB pathway, which can reduce MSC viability through the CASPASE-3 and CASPASE-8 associated proapoptotic cascade, resulting in the apoptosis of MSCs. To corroborate rescue of engrafted MSCs from the insult of the host immune system, the incorporation of the anti-inflammatory drug indomethacin into the encapsulating alginate hydrogel further regulates the local microenvironment and prevents pro-inflammatory cytokine-induced apoptosis. These findings suggest that the encapsulating hydrogel can regulate the MSC-host immune cell interplay and direct the fate of the implanted MSCs, leading to enhanced tissue regeneration.
C1 [Moshaverinia, Alireza; Xu, Xingtian; Ansari, Sahar; Zadeh, Homayoun H.; Paine, Michael L.; Moradian-Oldak, Janet; Snead, Malcolm L.] Univ So Calif, Ostrow Sch Dent, CCMB, Los Angeles, CA 90033 USA.
   [Schricker, Scott R.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Biomat Innovat Res Ctr, Cambridge, MA 02139 USA.
   [Chen, Chider; Shi, Songtao] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA.
RP Moshaverinia, A (reprint author), Univ So Calif, Ostrow Sch Dent, CCMB, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM moshaver@usc.edu; songtaos@dental.upenn.edu
RI Schricker, Scott/A-3957-2008; Chen, Chider/L-9880-2016
OI Schricker, Scott/0000-0003-1982-1282; Chen, Chider/0000-0003-2899-1208;
   Khademhosseini, Ali/0000-0001-6322-8852
FU National Institute of Dental and Craniofacial Research, National
   Institutes of Health, Department of Health and Human Services
   [K08DE023825, R01DE017449, R01 DE019932]; California Institute for
   Regenerative Medicine [RN1-00572]
FX A.M. and C.C. contributed equally to this work. This work was supported
   by grants from the National Institute of Dental and Craniofacial
   Research, National Institutes of Health, Department of Health and Human
   Services (K08DE023825 to A.M., R01DE017449 and R01 DE019932 to S.S.);
   and a grant from the California Institute for Regenerative Medicine
   (RN1-00572 for S.S.).
CR Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Ansari S, 2013, BIOMATERIALS, V34, P10191, DOI 10.1016/j.biomaterials.2013.08.069
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c
   Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792
   Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a
   Higashi T, 2004, J BIOSCI BIOENG, V97, P191, DOI 10.1263/jbb.97.191
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje
   Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim H. K., 2014, BIOMATERIALS, V35, P214
   Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106
   Lin CC, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-8
   Liu Y, 2012, INT J BIOCHEM CELL B, V44, P2044, DOI 10.1016/j.biocel.2012.08.003
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020
   Moshaverinia A, 2014, TISSUE ENG PT A, V20, P611, DOI 10.1089/ten.TEA.2013.0229
   Moshaverinia A, 2013, J BIOMED MATER RES A, V101, P3285, DOI 10.1002/jbm.a.34546
   Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048
   Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000
   Nalbant S, 2006, CLIN EXP RHEUMATOL, V24, P361
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z
   Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x
   Shi J, 2008, J BIOMED MATER RES B, V84B, P595, DOI 10.1002/jbm.b.30907
   Simon LS, 1999, AM J MED, V106, p37S
   Sirota L, 2000, ACTA PAEDIATR, V89, P331
   Suleyman H, 2008, J PHYSIOL PHARMACOL, V59, P661
   Taki H., 1998, CLIN EXP IMMUNOL, V11, P133
   Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064
   van Schilfgaarde R, 1999, J MOL MED-JMM, V77, P199, DOI 10.1007/s001090050336
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133
   Xin JY, 2010, INT J PHARMACEUT, V386, P221, DOI 10.1016/j.ijpharm.2009.11.024
NR 54
TC 24
Z9 24
U1 3
U2 69
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD APR 15
PY 2015
VL 25
IS 15
BP 2296
EP 2307
DI 10.1002/adfm.201500055
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CG1TP
UT WOS:000353057600011
PM 26120294
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhong, Y
   Leung, V
   Wan, LY
   Dutz, S
   Ko, FK
   Hafeli, UO
AF Zhong, Yi
   Leung, Victor
   Wan, Lynn Yuqin
   Dutz, Silvio
   Ko, Frank K.
   Haefeli, Urs O.
TI Electrospun magnetic nanofibre mats - A new bondable biomaterial using
   remotely activated magnetic heating
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on the Scientific and Clinical
   Applications of Magnetic Carriers
CY JUN 10-14, 2014
CL Dresden, GERMANY
DE Solvothermal; Hydrophilic Fe3O4; Magnetic nanofibre; Hyperthermia;
   Electrospinning; Polymer bonding; Heat sealing
ID IRON-OXIDE NANOPARTICLES; FLUID HYPERTHERMIA; DRUG-DELIVERY; IN-VIVO;
   DIAGNOSTICS; THERAPY
AB A solvothermal process was adopted to produce hydrophilic magnetite (Fe3O4) nanoparticles which were subsequently emulsified with a chloroform/methanol (70/30 v/v) solution of poly(caprolactone) (PCL) and then electrospun into a 0.2 mm thick PCL maL. The magnetic heating of the mats at a field amplitude of 25 kA/m and frequency of 400 kHz exhibited promising efficiency for magnetic hyperthermia, with a specific absorption rate of about 40 W/g for the magnetic mat. The produced heat was used to melt the magnetic mat onto the surrounding non-magnetic polymer mat from within, without destroying the nanostructure of the non-magnetic polymer more than 0.5 mm away. Magnetic nanolibre mats might thus be useful for internal heat sealing applications, and potentially also for thermotherapy. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhong, Yi; Leung, Victor; Wan, Lynn Yuqin; Ko, Frank K.] Univ British Columbia, Dept Mat Engn, Vancouver, BC V5Z 1M9, Canada.
   [Haefeli, Urs O.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada.
   [Dutz, Silvio] Tech Univ Ilmenau, Inst Biomed Techn & Informat, D-98684 Ilmenau, Germany.
   [Dutz, Silvio] Leibniz Inst Photon Technol, Dept Nano Biophoton, Jena, Germany.
   [Zhong, Yi] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Key Lab Sci & Technol Ecotext, Minist Educ, Shanghai, Peoples R China.
RP Hafeli, UO (reprint author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada.
EM frank.ko@ubc.ca; urs.hafeli@ubc.ca
RI Dutz, Silvio/E-3865-2010
OI Hafeli, Urs/0000-0003-0671-4509
FU Discovery Grant; Natural Sciences and Engineering Research Council of
   Canada (NSERC) in Canada; Central Universities of China Ministry of
   Education [2013D110525]
FX The authors gratefully acknowledge the support of Discovery Grant and
   CFI by the Natural Sciences and Engineering Research Council of Canada
   (NSERC) in Canada and the Central Universities of China Ministry of
   Education (Item no. 2013D110525) for their financial support to complete
   this work.
CR Amarjargal A, 2013, EUR POLYM J, V49, P3796, DOI 10.1016/j.eurpolymj.2013.08.026
   Andra W, 2007, HDB MAGNETISM ADV MA, V4
   Deng H, 2005, ANGEW CHEM INT EDIT, V44, P2782, DOI 10.1002/anie.200462551
   Dennis CL, 2013, INT J HYPERTHER, V29, P715, DOI 10.3109/02656736.2013.836758
   Dutz S, 2013, INT J HYPERTHER, V29, P790, DOI 10.3109/02656736.2013.822993
   Dutz S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265102
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011
   Ko F, 2003, ADV MATER, V15, P1161, DOI 10.1002/adma.200304955
   Ko K.F., 2013, J FIBER BIOENG INFOR, V6, P129
   Kozissnik B, 2013, INT J HYPERTHER, V29, P706, DOI 10.3109/02656736.2013.837200
   Krishnan KM, 2010, IEEE T MAGN, V46, P2523, DOI 10.1109/TMAG.2010.2046907
   Muller R, 2006, J PHYS-CONDENS MAT, V18, pS2527, DOI 10.1088/0953-8984/18/38/S01
   Ortega D, 2013, NANOSCI-SPEC PER REP, V1, P60, DOI 10.1039/9781849734844-00060
   Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y
   Salunkhe AB, 2014, CURR TOP MED CHEM, V14, P572, DOI 10.2174/1568026614666140118203550
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Tomitaka A, 2011, J MAGN MAGN MATER, V323, P1398, DOI 10.1016/j.jmmm.2010.11.054
   Tran N, 2010, J MATER CHEM, V20, P8760, DOI 10.1039/c0jm00994f
NR 23
TC 6
Z9 6
U1 3
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR 15
PY 2015
VL 380
BP 330
EP 334
DI 10.1016/j.jmmm.2014.09.069
PG 5
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA CB1BG
UT WOS:000349360800058
DA 2018-10-20
ER

PT J
AU Lysenko, O
   Dubok, O
   Borysenko, A
   Shinkaruk, O
AF Lysenko, Oleksandr
   Dubok, Oleksii
   Borysenko, Anatolii
   Shinkaruk, Oleksandr
TI The biological properties of the silver- and copper-doped ceramic
   biomaterial
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Bioactive ceramics; Nanocrystallinity; Silver and copper; Antimicrobial;
   Cytotoxicity; Osteogenesis; Bioinspired nanomaterials
ID CALCIUM-PHOSPHATE SCAFFOLDS; SUBSTITUTED HYDROXYAPATITE; IN-VITRO;
   ANTIBACTERIAL; BONE; BIOCERAMICS; CELLS; ANGIOGENESIS; CAPACITY;
   SURFACES
AB The biological properties of nanostructured bioactive ceramic composite (BCC) granules doped with 0.1-10 at.% silver and 0.05-5 at.% copper have been investigated both in vitro and in vivo to develop effective alloplastic material for infected bone defect substitute. It is assumed that the granules consisting of biphasic calcium phosphate and bioactive glass ceramics due to their nanoscale (15-40 nm) and multiphase structure, bioelement placement in different ceramic phases as well as antimicrobial effect should improve osteogenic properties and biocompatibility. Tests in vitro have been conducted with multipotent mesenchymal stromal cells (MSCs) and test strains of microorganisms. The same biocomposite has been used in vivo to study the repair of bone defects in animal model. The findings indicate that doped BCC leads to antimicrobial activity. Inhibition of MSCs growth has been observed for granules doped with ions of more than 1 at.% silver and 0.5 at.% copper. The results of the in vivo study reveal that BCC implantation significantly improves bone reparation. Differences between bone repair with undoped and doped, with 1 at.% silver and 0.5 at.% copper, ceramic samples were not observed. The BCC doped within 0.5-1 at.% silver and 0.25-0.5 at.% copper stimulates bone tissue repair and has satisfactory biocompatibility and antimicrobial properties.
C1 [Lysenko, Oleksandr; Borysenko, Anatolii] Bogomolets Natl Med Univ, Dept Therapeut Stomatol, UA-01601 Kiev, Ukraine.
   [Dubok, Oleksii; Shinkaruk, Oleksandr] NASU, Inst Problems Mat Sci, Dept Analyt Chem & Funct Ceram, UA-03142 Kiev, Ukraine.
   [Dubok, Oleksii] Natl Taras Shevchenko Univ Kyiv, Fac Chem, Dept Inorgan Chem, UA-01601 Kiev, Ukraine.
RP Lysenko, O (reprint author), Bogomolets Natl Med Univ, Dept Therapeut Stomatol, 34 Peremohy Ave, UA-01601 Kiev, Ukraine.
EM dr.alex.lysenko@gmail.com
FU Branch target preparation Kyiv National Taras Shevchenko University,
   NAMS of Ukraine [0114U003876]
FX The authors gratefully acknowledge the support of Dr. Olena Voloshuk
   from Bogomolets National Medical University (Ukraine), the Department of
   Microbiology, Virology, and Immunology. Dmytro Zubov, leading researcher
   and Roman Vasyliev, researcher from State Institute of Genetic and
   Regenerative Medicine of NAMS (Ukraine), in the implementation phases of
   the study. We express profound gratitude to Prof. Anatolii Levitskyi for
   the access to biochemical laboratory and vivarium facilities at State
   Institute of Stomatology of NAMS (Odesa, Ukraine). This project is
   financially supported by Branch target preparation Kyiv National Taras
   Shevchenko University, NAMS of Ukraine (Grant No. 0114U003876).
CR [Anonymous], 2009, 109935 ISO
   Balagna C, 2011, J BIOMATER APPL, V25, P595, DOI 10.1177/0885328209356603
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   BANCROFT JD, 1990, THEORY PRACTICE HIST
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Dodwad V, 2012, INT J PHARM PHARM SC, V4, P30
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Ewald A, 2012, J BIOMED MATER RES A, V100A, P2392, DOI 10.1002/jbm.a.34184
   Fan J, 2007, MATER CHEM PHYS, V103, P489, DOI 10.1016/j.matchemphys.2007.02.069
   Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009
   Gupta A, 2001, MICROBIOL-SGM, V147, P3393, DOI 10.1099/00221287-147-12-3393
   HAMMOND JS, 1975, ANAL CHEM, V47, P2193, DOI 10.1021/ac60363a019
   Heitz-Mayfield L, 2006, J CLIN PERIODONTOL, V33, P62, DOI 10.1111/j.1600-051X.2005.00872.x
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Luthen F, 2010, MATER SCI FORUM, V638-642, P600, DOI 10.4028/www.scientific.net/MSF.638-642.600
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5
   O'Donnell MD, 2008, ACTA BIOMATER, V4, P1455, DOI 10.1016/j.actbio.2008.04.018
   PARMIGIANI F, 1992, J ELECTRON SPECTROSC, V59, P255, DOI 10.1016/0368-2048(92)87005-7
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rodriguez JP, 2002, J CELL BIOCHEM, V85, P92, DOI 10.1002/jcb.10111
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   SCHON G, 1973, ACTA CHEM SCAND, V27, P2623, DOI 10.3891/acta.chem.scand.27-2623
   Shanmugam S, 2014, CERAM INT, V40, P15655, DOI 10.1016/j.ceramint.2014.07.086
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   STOSCHECK CM, 1990, METHODS ENZYMOL, V182, P50
   Thanyaphoo S, 2012, J PHARM SCI-US, V101, P2870, DOI 10.1002/jps.23230
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xing ZC, 2010, BIOMACROMOLECULES, V11, P1248, DOI 10.1021/bm1000372
NR 39
TC 3
Z9 3
U1 3
U2 44
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD APR 10
PY 2015
VL 17
IS 4
AR 178
DI 10.1007/s11051-015-2971-z
PG 15
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CI9ZR
UT WOS:000355130900001
DA 2018-10-20
ER

PT J
AU Pascual-Gil, S
   Garbayo, E
   Diaz-Herraez, P
   Prosper, F
   Blanco-Prieto, MJ
AF Pascual-Gil, S.
   Garbayo, E.
   Diaz-Herraez, P.
   Prosper, F.
   Blanco-Prieto, M. J.
TI Heart regeneration after myocardial infarction using synthetic
   biomaterials
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Myocardial infarction; Cell therapy; Protein therapy; Clinical trials;
   Synthetic biomaterials; Delivery systems; Tissue engineering
ID STEM-CELL TRANSPLANTATION; IMPROVES CARDIAC-FUNCTION; ASSEMBLING PEPTIDE
   NANOFIBERS; FIBROBLAST-GROWTH-FACTOR; DRUG-DELIVERY; THERMOSENSITIVE
   HYDROGEL; INTRAMYOCARDIAL DELIVERY; CARDIOVASCULAR-DISEASES; INJECTABLE
   HYDROGEL; SUSTAINED-RELEASE
AB Myocardial infarction causes almost 7.3 million deaths each year worldwide. However, current treatments are more palliative than curative. Presently, cell and protein therapies are considered the most promising alternative treatments. Clinical trials performed until now have demonstrated that these therapies are limited by protein short half-life and by low transplanted cell survival rate, prompting the development of novel cell and protein delivery systems able to overcome such limitations. In this review we discuss the advances made in the last 10 years in the emerging field of cardiac repair using biomaterial-based delivery systems with focus on the progress made on preclinical in vivo studies. Then, we focus in cardiac tissue engineering approaches, and how the incorporation of both cells and proteins together into biomaterials has opened new horizons in the myocardial infarction treatment. Finally, the ongoing challenges and the perspectives for future work in cardiac tissue engineering will also be discussed. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Pascual-Gil, S.; Garbayo, E.; Diaz-Herraez, P.; Blanco-Prieto, M. J.] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.
   [Prosper, F.] Univ Navarra, Univ Navarra Clin, Hematol Cardiol & Cell Therapy, E-31080 Pamplona, Spain.
   [Prosper, F.] Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, C Irunlarrea 1, E-31080 Pamplona, Spain.
EM mjblanco@unav.es
RI Garbayo, Elisa/V-1740-2017; Prosper, Felipe/H-6859-2017
OI Garbayo, Elisa/0000-0003-2049-4143; Prosper, Felipe/0000-0001-6115-8790;
   Pascual-Gil, Simon/0000-0003-0560-456X; Blanco-prieto, Maria
   J/0000-0003-0710-899X
FU Spanish Ministry of Economy and Competitiveness [SAF2013-42528-R];
   Fundacion Empresa Universidad de Navarra; Ibercaja; Spanish Ministry of
   Sciences and Innovations [JCI-2011-10737]; "Asociacion de Amigos de la
   Universidad de Navarra"
FX We gratefully acknowledge support from the Spanish Ministry of Economy
   and Competitiveness (SAF2013-42528-R), the Fundacion Empresa Universidad
   de Navarra, Ibercaja, the Spanish Ministry of Sciences and Innovations
   (JCI-2011-10737) and the "Asociacion de Amigos de la Universidad de
   Navarra".
CR ABRA RM, 1981, BIOCHIM BIOPHYS ACTA, V666, P493, DOI 10.1016/0005-2760(81)90311-8
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   AMBROSIO G, 1986, CIRCULATION, V74, P1424, DOI 10.1161/01.CIR.74.6.1424
   Anselmo A.C., 2014, J CONTROL RELEASE
   Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068
   Armstead VE, 1997, FASEB J, V11, P1271
   Aso SI, 2007, J CONTROL RELEASE, V122, P189, DOI 10.1016/j.jconrel.2007.07.003
   Bearzi C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.12
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bernal A, 2013, STEM CELL REV REP, V9, P814, DOI 10.1007/s12015-013-9461-4
   Blumenthal B, 2010, ARTIF ORGANS, V34, pE46, DOI 10.1111/j.1525-1594.2009.00937.x
   Braunschweig F, 2011, EUROPACE, V13, pII13, DOI 10.1093/europace/eur081
   Castellano D, 2014, STEM CELLS DEV, V23, P1479, DOI 10.1089/scd.2013.0578
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007
   Cheng AY, 2013, CURR OPIN BIOTECH, V24, P864, DOI 10.1016/j.copbio.2013.04.005
   Cochain C, 2013, ANTIOXID REDOX SIGN, V18, P1100, DOI 10.1089/ars.2012.4849
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Diaz-Herraez P, 2013, EUR J PHARM BIOPHARM, V85, P143, DOI 10.1016/j.ejpb.2013.03.022
   Diaz-Herraez P., 2014, DRUG DELIV INTEGR CL
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Fathi E, 2013, J TISSUE ENG REGEN M, V7, P697, DOI 10.1002/term.1460
   Formiga FR, 2013, EUR J PHARM BIOPHARM, V85, P665, DOI 10.1016/j.ejpb.2013.02.017
   Formiga FR, 2012, HEART FAIL REV, V17, P449, DOI 10.1007/s10741-011-9285-8
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Fornasini M, 2010, AM J MED, V123, P166, DOI 10.1016/j.amjmed.2009.06.031
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukuhara S, 2005, CIRC J, V69, P850, DOI 10.1253/circj.69.850
   Garbayo E., CONTROLLED INT UNPUB
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Garg T, 2011, INT J PHARM SCI RES, V2, P1600, DOI 10.13040/IJPSR.0975-8232.2(6).1600-02
   Gho JMIH, 2013, J CARD FAIL, V19, P494, DOI 10.1016/j.cardfail.2013.05.006
   Giraud MN, 2010, ARTIF ORGANS, V34, pE184, DOI 10.1111/j.1525-1594.2009.00979.x
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gray WD, 2011, J CARDIOVASC TRANSL, V4, P631, DOI 10.1007/s12265-011-9292-0
   Grimaldi V, 2013, J CARDIOL, V62, P267, DOI 10.1016/j.jjcc.2013.05.017
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108
   Hastings C.L., 2014, ADV DRUG DELIV REV
   He YY, 2013, J CARDIOVASC PHARM, V61, P283, DOI 10.1097/FJC.0b013e31827ecd50
   Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Immordino ML, 2006, INT J NANOMED, V1, P297
   Jay SM, 2013, CIRC RES, V113, P933, DOI 10.1161/CIRCRESAHA.113.300215
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kaila N, 2002, MED RES REV, V22, P566, DOI 10.1002/med.10018
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kiani MF, 2002, PHARM RES-DORDR, V19, P1317, DOI 10.1023/A:1020350708672
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Koudstaal S, 2014, J CARDIOVASC TRANSL, V7, P232, DOI 10.1007/s12265-013-9518-4
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kumar D, 2013, EXPERT OPIN DRUG DEL, V10, P397, DOI 10.1517/17425247.2013.749854
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lammers T, 2010, MOL PHARMACEUT, V7, P1899, DOI 10.1021/mp100228v
   LAURENT TC, 1992, FASEB J, V6, P2397
   Levchenko TS, 2012, THER DELIV, V3, P501, DOI 10.4155/TDE.12.18
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Littarru GP, 2011, BIOFACTORS, V37, P366, DOI 10.1002/biof.154
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   Mathaes R, 2014, INT J PHARMACEUT, V465, P159, DOI 10.1016/j.ijpharm.2014.02.037
   Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Mendis S, 2011, GLOBAL ATLAS CARDIOV
   Meng E, 2012, THER DELIV, V3, P1457, DOI [10.4155/TDE.12.132, 10.4155/tde.12.132]
   Meng J, 2012, CURR DRUG METAB, V13, P1123, DOI 10.2174/138920012802850056
   Miyagi Y, 2010, BIOMATERIALS, V31, P7684, DOI 10.1016/j.biomaterials.2010.06.048
   MOGHIMI SM, 1991, BIOCHEM BIOPH RES CO, V177, P861, DOI 10.1016/0006-291X(91)91869-E
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Mufamadi MS, 2011, J DRUG DELIV, V2011, DOI DOI 10.1155/2011/939851
   Oh KS, 2010, J CONTROL RELEASE, V146, P207, DOI 10.1016/j.jconrel.2010.04.014
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Poppe A, 2012, ARTIF ORGANS, V36, P238, DOI 10.1111/j.1525-1594.2011.01328.x
   Projahn D, 2014, J CELL MOL MED, V18, P790, DOI 10.1111/jcmm.12225
   Ravichandran R, 2012, INT J NANOMED, V7, P5969, DOI 10.2147/IJN.S37575
   Ren S, 2012, J INT MED RES, V40, P2167, DOI 10.1177/030006051204000615
   Ruiz-Esparza GU, 2013, INT J NANOMED, V8, P629, DOI 10.2147/IJN.S30599
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Schulman IH, 2012, REGEN MED, V7, P17, DOI 10.2217/RME.12.80
   Scott RC, 2007, BIOTECHNOL BIOENG, V96, P795, DOI 10.1002/bit.21233
   Scott RC, 2009, FASEB J, V23, P3361, DOI 10.1096/fj.08-127373
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seshadri G, 2010, BIOMATERIALS, V31, P1372, DOI 10.1016/j.biomaterials.2009.10.045
   Sheng C.C., 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/547902
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Simon-Yarza T., 2015, TISSUE ENG IN PRESS
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x
   Srivastava D, 2012, ANN NY ACAD SCI, V1270, P66, DOI 10.1111/j.1749-6632.2012.06696.x
   Sun Xiaolun, 2012, J Cardiovasc Dis Res, V3, P251, DOI 10.4103/0975-3583.102688
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x
   Takehara Naofumi, 2013, Ann Vasc Dis, V6, P137, DOI 10.3400/avd.ra.13.00019
   Tang CK, 2009, INT J MOL SCI, V10, P2136, DOI 10.3390/ijms10052136
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Torchilin V.P., 2010, HDB EXP PHARM
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Toyoda Y, 2013, CIRC J, V77, P1097, DOI 10.1253/circj.CJ-13-0296
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   van der Laan AM, 2009, NAT REV CARDIOL, V6, P515, DOI 10.1038/nrcardio.2009.103
   von Wattenwyl R, 2012, ASAIO J, V58, P268, DOI 10.1097/MAT.0b013e3182523237
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang B, 2013, ADV EXP MED BIOL, V765, P307, DOI 10.1007/978-1-4614-4989-8_43
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wang Y, 2009, TEX HEART I J, V36, P89
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226
   Yamada Y, 2013, AM J PHYSIOL-HEART C, V304, pH1124, DOI 10.1152/ajpheart.00707.2012
   Yasuda S, 2000, J AM COLL CARDIOL, V36, P115, DOI 10.1016/S0735-1097(00)00675-6
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 155
TC 42
Z9 43
U1 5
U2 125
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD APR 10
PY 2015
VL 203
BP 23
EP 38
DI 10.1016/j.jconrel.2015.02.009
PG 16
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CE3AP
UT WOS:000351696600003
PM 25665866
DA 2018-10-20
ER

PT J
AU Chapman, CAR
   Chen, H
   Stamou, M
   Biener, J
   Biener, MM
   Lein, PJ
   Seker, E
AF Chapman, Christopher A. R.
   Chen, Hao
   Stamou, Marianna
   Biener, Juergen
   Biener, Monika M.
   Lein, Pamela J.
   Seker, Erkin
TI Nanoporous Gold as a Neural Interface Coating: Effects of Topography,
   Surface Chemistry, and Feature Size
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE neural electrode; nanostructure; cell-material interaction; nanoporous
   gold; neuron-astrocyte co-culture; nanotopography; multifunctional
   biomaterial; gliosis
ID MECHANICAL-PROPERTIES; CATALYTIC-ACTIVITY; MOLECULAR RELEASE;
   GENE-EXPRESSION; ELECTRODES; BIOMATERIALS; ACTIVATION; NEURONS;
   MICROFABRICATION; HIPPOCAMPAL
AB Designing neural interfaces that maintain close physical coupling of neurons to an electrode surface remains a major challenge for both implantable and in vitro neural recording electrode arrays. Typically, low-impedance nanostructured electrode coatings rely on chemical cues from pharmaceuticals or surface-immobilized peptides to suppress glial scar tissue formation over the electrode surface (astrogliosis), which is an obstacle to reliable neuron-electrode coupling. Nanoporous gold (np-Au), produced by an alloy corrosion process, is a promising candidate to reduce astrogliosis solely through topography by taking advantage of its tunable length scale. In the present in vitro study on np-Aus interaction with cortical neuron-glia co-cultures, we demonstrate that the nanostructure of np-Au achieves close physical coupling of neurons by maintaining a high neuron-to-astrocyte surface coverage ratio. Atomic layer deposition-based surface modification was employed to decouple the effect of morphology from surface chemistry. Additionally, length scale effects were systematically studied by controlling the characteristic feature size of np-Au through variations in the dealloying conditions. Our results show that np-Au nanotopography, not surface chemistry, reduces astrocyte surface coverage while maintaining high neuronal coverage and may enhance neuron-electrode coupling through nanostructure-mediated suppression of scar tissue formation.
C1 [Chapman, Christopher A. R.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Chen, Hao; Stamou, Marianna; Lein, Pamela J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   [Seker, Erkin] Univ Calif Davis, Dept Elect & Comp Engn, Davis, CA 95616 USA.
   [Biener, Juergen; Biener, Monika M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Seker, E (reprint author), Univ Calif Davis, Dept Elect & Comp Engn, 3177 Kemper Hall, Davis, CA 95616 USA.
EM eseker@ucdavis.edu
OI Seker, Erkin/0000-0003-2401-3562; Chapman, Christopher Abbott
   Reece/0000-0002-9009-0139; Lein, Pamela/0000-0001-7665-7584
FU UC Lab Fees Research Program Award [12-LR-237197]; Research Investments
   in the Sciences & Engineering (RISE) Award; UC Davis College of
   Engineering; National Science Foundation [DGE-1148897]; National
   Institute of Health [T32-GM008799]; CounterACT Program; National
   Institutes of Health Office of the Director; National Institute of
   Neurological Disorders and Stroke [U54 NS079202]; National Institute of
   Environmental Health Sciences [T32 ES007059]; Superfund Basic Research
   Program [P42 ES04699]; U.S. DOE [DE-AC52-07NA27344]
FX We gratefully acknowledge support from UC Lab Fees Research Program
   Award [12-LR-237197], Research Investments in the Sciences & Engineering
   (RISE) Award, and UC Davis College of Engineering start-up funds.
   C.A.R.C. was supported by a National Science Foundation Graduate
   Research Fellowship [DGE-1148897] and a predoctoral fellowship from the
   National Institute of Health [T32-GM008799]. Support was also provided
   by the CounterACT Program, National Institutes of Health Office of the
   Director, and the National Institute of Neurological Disorders and
   Stroke [U54 NS079202]. H.C. was supported by a predoctoral fellowship
   from the National Institute of Environmental Health Sciences [T32
   ES007059]; H.C. and M.S. received predoctoral fellowships from the
   Superfund Basic Research Program [P42 ES04699]. Any opinion, findings,
   and conclusions or recommendations expressed in this material are those
   of the authors(s) and do not necessarily reflect the views of the
   National Science Foundation or the National Institutes of Health. Work
   at LLNL was performed under the auspices of the U.S. DOE by LLNL
   [Contract DE-AC52-07NA27344].
CR ARENDS MJ, 1990, AM J PATHOL, V136, P593
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Biener MM, 2011, NANO LETT, V11, P3085, DOI 10.1021/nl200993g
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   BILLINGSLEY ML, 1982, J PHARMACOL EXP THER, V222, P765
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   Bruggemann Dorothea, 2012, International Journal of Nano and Biomaterials, V4, P108
   Bruggemann D., 2013, J NANOMATER, V2013
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Daggumati P, 2013, JOVE-J VIS EXP, DOI 10.3791/50678
   Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340
   Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709
   Ereifej ES, 2011, J BIOMED MATER RES A, V99A, P141, DOI 10.1002/jbm.a.33170
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Feng JD, 2011, BIOSENS BIOELECTRON, V30, P21, DOI 10.1016/j.bios.2011.08.021
   Fujita T, 2012, NAT MATER, V11, P775, DOI [10.1038/nmat3391, 10.1038/NMAT3391]
   George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b
   Gittard SD, 2010, BIOTECHNOL J, V5, P192, DOI 10.1002/biot.200900250
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   Hodge AM, 2006, ADV ENG MATER, V8, P853, DOI 10.1002/adem.200600079
   Howard AS, 2003, TOXICOL APPL PHARM, V190, P72, DOI 10.1016/S0041-008X(03)00156-X
   Huang CL, 2015, ENVIRON RES, V136, P253, DOI 10.1016/j.envres.2014.11.006
   Ilic B, 2000, J MATER SCI, V35, P3447, DOI 10.1023/A:1004884723515
   Jin HJ, 2011, SCIENCE, V332, P1179, DOI 10.1126/science.1202190
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kurtulus O, 2014, NANOSCALE, V6, P7062, DOI 10.1039/c4nr01288g
   Lee D, 2007, SCRIPTA MATER, V56, P437, DOI 10.1016/j.scriptamat.2006.08.069
   Li K, 2011, ANAL LETT, V44, P2559, DOI 10.1080/00032719.2011.553004
   Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012
   Patel J, 2013, ANAL CHEM, V85, P11610, DOI 10.1021/ac403013r
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Santos GM, 2014, NANOSCALE, V6, P5718, DOI 10.1039/c4nr01266f
   Schade L, 2014, LANGMUIR, V30, P7190, DOI 10.1021/la5011192
   Seker E., 2010, NANOTECHNOLOGY, V21, P1
   Seker E, 2012, ADV HEALTHC MATER, V1, P172, DOI 10.1002/adhm.201200002
   Seker E, 2009, MATERIALS, V2, P2188, DOI 10.3390/ma2042188
   Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037
   Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]
   Squire L. R., 2008, FUNDAMENTAL NEUROSCI, V4
   Tan YH, 2014, BIOMATER SCI-UK, V2, P110, DOI 10.1039/c3bm60096c
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Wessling B., 2007, J ELECTROCHEM SOC, V154, P83
   Woolley A. J., 2013, J NEURAL ENG, V10, P1
   Zalups R. K., 2000, MOL BIOL TOXICOLOGY, V1, P609
NR 52
TC 36
Z9 36
U1 3
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 8
PY 2015
VL 7
IS 13
BP 7093
EP 7100
DI 10.1021/acsami.5b00410
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF7QQ
UT WOS:000352751800008
PM 25706691
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mullen, CA
   Vaughan, TJ
   Billiar, KL
   McNamara, LM
AF Mullen, Conleth A.
   Vaughan, Ted J.
   Billiar, Kristen L.
   McNamara, Laoise M.
TI The Effect of Substrate Stiffness, Thickness, and Cross-Linking Density
   on Osteogenic Cell Behavior
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; AVERAGING THEORY;
   MC3T3-E1 CELLS; FAR CELLS; COLLAGEN; DIFFERENTIATION; PROLIFERATION;
   SCAFFOLDS; OSTEOCYTE
AB Osteogenic cells respond to mechanical changes in their environment by altering their spread area, morphology, and gene expression profile. In particular, the bulk modulus of the substrate, as well as its microstructure and thickness, can substantially alter the local stiffness experienced by the cell. Although bone tissue regeneration strategies involve culture of bone cells on various biomaterial scaffolds, which are often cross-linked to enhance their physical integrity, it is difficult to ascertain and compare the local stiffness experienced by cells cultured on different biomaterials. In this study, we seek to characterize the local stiffness at the cellular level for MC3T3-E1 cells plated on biomaterial substrates of varying modulus, thickness, and cross-linking concentration. Cells were cultured on flat and wedge-shaped gels made from polyacrylamide or cross-linked collagen. The cross-linking density of the collagen gels was varied to investigate the effect of fiber cross-linking in conjunction with substrate thickness. Cell spread area was used as a measure of osteogenic differentiation. Finite element simulations were used to examine the effects of fiber cross-linking and substrate thickness on the resistance of the gel to cellular forces, corresponding to the equivalent shear stiffness for the gel structure in the region directly surrounding the cell. The results of this study show that MC3T3 cells cultured on a soft fibrous substrate attain the same spread cell area as those cultured on a much higher modulus, but nonfibrous substrate. Finite element simulations predict that a dramatic increase in the equivalent shear stiffness of fibrous collagen gels occurs as cross-linking density is increased, with equivalent stiffness also increasing as gel thickness is decreased. These results provide an insight into the response of osteogenic cells to individual substrate parameters and have the potential to inform future bone tissue regeneration strategies that can optimize the equivalent stiffness experienced by a cell.
C1 [Mullen, Conleth A.; Vaughan, Ted J.; McNamara, Laoise M.] NUI Galway, Dept Biomed Engn, Ctr Biomech Res BMEC, Galway, Ireland.
   [Mullen, Conleth A.; McNamara, Laoise M.] NUI Galway, NCBES, Galway, Ireland.
   [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
RP McNamara, LM (reprint author), NUI Galway, Dept Biomed Engn, Ctr Biomech Res BMEC, Galway, Ireland.
EM laoise.mcnamara@nuigalway.ie
OI McNamara, Laoise/0000-0002-5050-9230
CR Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Driessen NJB, 2003, J BIOMECH, V36, P1151, DOI 10.1016/S0021-9290(03)00082-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Feng CH, 2013, ACTA BIOMATER, V9, P5502, DOI 10.1016/j.actbio.2012.11.024
   Fischer RS, 2012, NAT PROTOC, V7, P2056, DOI 10.1038/nprot.2012.127
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Huang CJ, 2013, NANO LETT, V13, P1611, DOI 10.1021/nl400033h
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Khatiwala C. B., 2006, AM I CHEM ENG ANN M
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   Lahiri D, 2011, J BIOMED MATER RES A, V96A, P1, DOI 10.1002/jbm.a.32952
   Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052
   Ma XY, 2013, BIOPHYS J, V104, P1410, DOI 10.1016/j.bpj.2013.02.017
   Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923
   Mante F, 1999, BIOMATERIALS, V20, P1051, DOI 10.1016/S0142-9612(98)00257-9
   McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003
   Mullen CA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0885
   Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013
   Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001
   Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Rudnicki MS, 2013, BIOPHYS J, V105, P11, DOI 10.1016/j.bpj.2013.05.032
   SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410
   Santos A, 2009, OSTEOPOROSIS INT, V20, P1027, DOI 10.1007/s00198-009-0858-5
   Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z
   Song W., 2011, J NANOMATER
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200
   Tse J.R., 2001, CURRENT PROTOCOLS CE
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0
   You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047
NR 48
TC 19
Z9 19
U1 2
U2 33
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR 7
PY 2015
VL 108
IS 7
BP 1604
EP 1612
DI 10.1016/j.bpj.2015.02.022
PG 9
WC Biophysics
SC Biophysics
GA CF4DF
UT WOS:000352498100008
PM 25863052
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Autefage, H
   Gentleman, E
   Littmann, E
   Hedegaard, MAB
   Von Erlach, T
   O'Donnell, M
   Burden, FR
   Winkler, DA
   Stevens, MM
AF Autefage, Helene
   Gentleman, Eileen
   Littmann, Elena
   Hedegaard, Martin A. B.
   Von Erlach, Thomas
   O'Donnell, Matthew
   Burden, Frank R.
   Winkler, David A.
   Stevens, Molly M.
TI Sparse feature selection methods identify unexpected global cellular
   response to strontium-containing materials
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE strontium-releasing biomaterials; human mesenchymal stem cells;
   microarray analysis; sparse feature selection analysis; mevalonate
   pathway
ID MESENCHYMAL STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST
   DIFFERENTIATION; MOLECULAR-MECHANISMS; DESCRIPTOR SELECTION; SQUALENE
   SYNTHASE; LIPID RAFTS; RANELATE; OSTEOPOROSIS; CHOLESTEROL
AB Despite the increasing sophistication of biomaterials design and functional characterization studies, little is known regarding cells' global response to biomaterials. Here, we combined nontargeted holistic biological and physical science techniques to evaluate how simple strontium ion incorporation within the well-described biomaterial 45S5 bioactive glass (BG) influences the global response of human mesenchymal stem cells. Our objective analyses of whole gene-expression profiles, confirmed by standard molecular biology techniques, revealed that strontium-substituted BG up-regulated the isoprenoid pathway, suggesting an influence on both sterol metabolite synthesis and protein prenylation processes. This up-regulation was accompanied by increases in cellular and membrane cholesterol and lipid raft contents as determined by Raman spectroscopy mapping and total internal reflection fluorescence microscopy analyses and by an increase in cellular content of phosphorylated myosin II light chain. Our unexpected findings of this strong metabolic pathway regulation as a response to biomaterial composition highlight the benefits of discovery-driven nonreductionist approaches to gain a deeper understanding of global cell-material interactions and suggest alternative research routes for evaluating biomaterials to improve their design.
C1 [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; O'Donnell, Matthew; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England.
   [Autefage, Helene; Gentleman, Eileen; Littmann, Elena; Hedegaard, Martin A. B.; Von Erlach, Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [Gentleman, Eileen] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England.
   [Hedegaard, Martin A. B.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, DK-5230 Odense, Denmark.
   [Burden, Frank R.; Winkler, David A.] CSIRO, Mfg Flagship, Biomed Mfg Program, Cell Biol Grp, Clayton, Vic 3168, Australia.
   [Winkler, David A.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.
   [Winkler, David A.] La Trobe Univ, Latrobe Inst Mol Sci, Bundoora, Vic 3086, Australia.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM stevens@imperial.ac.uk
OI Winkler, Dave/0000-0002-7301-6076; Winkler, David
   Alan/0000-0003-2423-674X; Hedegaard, Martin A.B./0000-0003-2972-0899;
   Gentleman, Eileen/0000-0003-0447-5137
FU Medical Engineering Solutions in Osteoarthritis Centre of Excellence -
   Wellcome Trust; Engineering and Physical Sciences Research Council;
   Technology Strategy Board, United Kingdom; Rosetrees Trust; Wellcome
   Trust; European Commission [289958]; Danish Council for Independent
   Research (Technology and Production Sciences) [0602-02350B]; Newton
   Turner Fellowship
FX We thank Ms. S. Skeete for laboratory assistance; Dr. S. Sampson and
   Prof. T. Cass for providing equipment access and training; Dr. L. Game
   and Ms. N. Lambie, from the Genomics Laboratory of the Clinical Science
   Center, Imperial College London, for advice regarding the design of the
   microarray experiment and for the ChIP hybridization and scanning,
   respectively; and Dr. G. R. Barton from the Bioinformatics Support
   Service, Imperial College London, for statistical analysis and
   assistance in the analysis of the microarray dataset and the study
   design. M.M.S. and H.A. were supported by the Medical Engineering
   Solutions in Osteoarthritis Centre of Excellence funded by the Wellcome
   Trust and the Engineering and Physical Sciences Research Council. M.M.S.
   was also supported by the Technology Strategy Board, United Kingdom, and
   the Rosetrees Trust. H.A. was partially supported by the VIP award from
   the Wellcome Trust. E.L. was supported by European Commission funding
   under the 7th Framework Programme Marie Curie Initial Training Networks
   Grant 289958, bioceramics for bone repair. E.G. is supported by a
   Research Career Development Fellowship from the Wellcome Trust. M.A.B.H.
   was partially supported by The Danish Council for Independent Research
   (Technology and Production Sciences contract 0602-02350B). D.A.W. is the
   recipient of a Newton Turner Fellowship for Exceptional Senior
   Scientists.
CR Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Brancolini C, 1999, MOL BIOL CELL, V10, P2441, DOI 10.1091/mbc.10.7.2441
   Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200
   Burden FR, 2009, QSAR COMB SCI, V28, P645, DOI 10.1002/qsar.200810173
   Burden FR, 2009, QSAR COMB SCI, V28, P1092, DOI 10.1002/qsar.200810202
   Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6
   del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571
   Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Figueiredo MAT, 2003, IEEE T PATTERN ANAL, V25, P1150, DOI 10.1109/TPAMI.2003.1227989
   Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gentleman MM, 2014, INT MATER REV, V59, P417, DOI 10.1179/1743280414Y.0000000038
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Hasse B, 2002, J NEUROSCI RES, V69, P227, DOI 10.1002/jnr.10287
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]
   Lo T, 2012, J PROTEOME RES, V11, P586, DOI 10.1021/pr200868p
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200
   Newman SD, 2014, TISSUE ENG PT A, V20, P1850, DOI [10.1089/ten.tea.2013.0304, 10.1089/ten.TEA.2013.0304]
   O'Donnell MD, 2010, J MATER CHEM, V20, P8934, DOI 10.1039/c0jm01139h
   Park JW, 2010, ACTA BIOMATER, V6, P2843, DOI 10.1016/j.actbio.2010.01.017
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Rosemond E, 2011, MOL PHARMACOL, V79, P251, DOI 10.1124/mol.110.067363
   Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Stepan JJ, 2013, J BONE MINER METAB, V31, P606, DOI 10.1007/s00774-013-0494-1
   Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544
   Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zoltewicz SJ, 2012, ASN NEURO, V4, DOI 10.1042/AN20120045
NR 48
TC 27
Z9 27
U1 2
U2 22
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 7
PY 2015
VL 112
IS 14
BP 4280
EP 4285
DI 10.1073/pnas.1419799112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF1EZ
UT WOS:000352287800040
PM 25831522
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Di Buduo, CA
   Wray, LS
   Tozzi, L
   Malara, A
   Chen, Y
   Ghezzi, CE
   Smoot, D
   Sfara, C
   Antonelli, A
   Spedden, E
   Bruni, G
   Staii, C
   De Marco, L
   Magnani, M
   Kaplan, DL
   Balduini, A
AF Di Buduo, Christian A.
   Wray, Lindsay S.
   Tozzi, Lorenzo
   Malara, Alessandro
   Chen, Ying
   Ghezzi, Chiara E.
   Smoot, Daniel
   Sfara, Carla
   Antonelli, Antonella
   Spedden, Elise
   Bruni, Giovanna
   Staii, Cristian
   De Marco, Luigi
   Magnani, Mauro
   Kaplan, David L.
   Balduini, Alessandra
TI Programmable 3D silk bone marrow niche for platelet generation ex vivo
   and modeling of megakaryopoiesis pathologies
SO BLOOD
LA English
DT Article
ID HEMATOPOIETIC STEM-CELLS; IN-VITRO; VASCULAR NICHE; 3-DIMENSIONAL
   SCAFFOLDS; HUMAN MEGAKARYOCYTES; ENDOTHELIAL-CELLS; CORD BLOOD; FLOW;
   DIFFERENTIATION; THROMBOPOIESIS
AB We present a programmable bioengineered 3-dimensional silk-based bone marrow niche tissue system that successfully mimics the physiology of human bone marrow environment allowing us to manufacture functional human platelets ex vivo. Using stem/progenitor cells, megakaryocyte function and platelet generation were recorded in response to variations in extracellular matrix components, surface topography, stiffness, coculture with endothelial cells, and shear forces. Millions of human platelets were produced and showed to be functional based on multiple activation tests. Using adult hematopoietic progenitor cells our system demonstrated the ability to reproduce key steps of thrombopoiesis, including alterations observed in diseased states. A critical feature of the system is the use of natural silk protein biomaterial allowing us to leverage its biocompatibility, nonthrombogenic features, programmable mechanical properties, and surface binding of cytokines, extracellular matrix components, and endothelial-derived proteins. This in turn offers new opportunities for the study of blood component production ex vivo and provides a superior tissue system for the study of pathologic mechanisms of human platelet production.
C1 [Di Buduo, Christian A.; Wray, Lindsay S.; Tozzi, Lorenzo; Malara, Alessandro; Balduini, Alessandra] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Di Buduo, Christian A.; Wray, Lindsay S.; Tozzi, Lorenzo; Malara, Alessandro; Balduini, Alessandra] San Matteo Fdn, Ist Ricovero & Cura Carattere Sci, Biotechnol Res Labs, Pavia, Italy.
   [Wray, Lindsay S.; Tozzi, Lorenzo; Chen, Ying; Ghezzi, Chiara E.; Smoot, Daniel; Kaplan, David L.; Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Sfara, Carla; Antonelli, Antonella; Magnani, Mauro] Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy.
   [Spedden, Elise; Staii, Cristian] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   [Bruni, Giovanna] Univ Pavia, Chem Phys Sect, Dept Chem, I-27100 Pavia, Italy.
   [De Marco, Luigi] Ctr Riferimento Oncol, Ist Ricovero & Cura Carattere Sci, Stem Cells Unit, Dept Translat Res, I-33081 Aviano, Italy.
   [De Marco, Luigi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
RP Balduini, A (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; alessandra.balduini@tufts.edu
RI Di Buduo, Christian/G-4771-2018; malara, alessandro/K-4027-2016;
   Balduini, Alessandra/K-6802-2016
OI Di Buduo, Christian/0000-0002-6472-2008; malara,
   alessandro/0000-0002-3396-3693; Balduini,
   Alessandra/0000-0003-3145-1245; Bruni, Giovanna/0000-0003-1958-2998;
   Tozzi, Lorenzo/0000-0002-0679-5030
FU Cariplo Foundation [2010-0807]; National Institutes of Health, National
   Institute of Biomedical Imaging and Bioengeneering [EB016041-01];
   Italian Ministry of Health [RF-2009-1550218, RF-2010-2316198]; Italian
   Ministry of University and Research; Fondo per gli Investimenti della
   Ricerca di Base [RBFR1299KO]; Associazione Italiana per la Ricerca sul
   Cancro (AIRC, Milano)
FX This work was supported by the Cariplo Foundation (2010-0807), National
   Institutes of Health, National Institute of Biomedical Imaging and
   Bioengeneering (grant EB016041-01), the Italian Ministry of Health
   (grants RF-2009-1550218 and RF-2010-2316198), the Italian Ministry of
   University and Research, Fondo per gli Investimenti della Ricerca di
   Base (RBFR1299KO), and by a grant from the Associazione Italiana per la
   Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical
   Oncology 5x1000" to AIRC-Gruppo Italiano Malattie Mieloproliferative
   (AGIMM).
CR Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973
   AVRAHAM H, 1993, J CLIN INVEST, V91, P2378, DOI 10.1172/JCI116470
   Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x
   Balduini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021015
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Cabrales P, 2008, AM J RESP CELL MOL, V38, P354, DOI 10.1165/rcmb.2007-0292OC
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cramer EM, 1997, BLOOD, V89, P2336
   De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   DeZern AE, 2014, ONCOLOGIST, V19, P735, DOI 10.1634/theoncologist.2014-0056
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Feng Q, 2014, STEM CELL REP, V3, P817, DOI 10.1016/j.stemcr.2014.09.010
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166
   Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2
   Jiang JL, 2014, BLOOD, V124, P2094, DOI 10.1182/blood-2014-01-547927
   Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304
   KAUFMAN RM, 1965, BLOOD-J HEMATOL, V26, P720
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Lambert MP, 2013, BLOOD, V121, P3319, DOI 10.1182/blood-2012-09-455428
   Lasky LC, 2011, TISSUE ENG PART C-ME, V17, P1081, DOI 10.1089/ten.tec.2011.0108
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   MAGNANI M, 1989, BIOTECHNOL APPL BIOC, V11, P439
   Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626
   Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876
   Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795
   Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25
   Mazzucato M, 2004, BLOOD, V104, P3221, DOI 10.1182/blood-2004-03-1145
   Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Nakagawa Y, 2013, EXP HEMATOL, V41, P742, DOI 10.1016/j.exphem.2013.04.007
   Nakamura S, 2014, CELL STEM CELL, V14, P535, DOI 10.1016/j.stem.2014.01.011
   Ohta M, 1998, BLOOD, V91, P4074
   Pallotta I, 2011, TISSUE ENG PART C-ME, V17, P1223, DOI 10.1089/ten.tec.2011.0134
   Pitchford SC, 2012, BLOOD, V120, P2787, DOI 10.1182/blood-2011-09-378174
   RAFII S, 1995, BLOOD, V86, P3353
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Schlinker AC, 2015, BIOTECHNOL BIOENG, V112, P788, DOI 10.1002/bit.25477
   Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108
   Sullenbarger B, 2009, EXP HEMATOL, V37, P101, DOI 10.1016/j.exphem.2008.09.009
   Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622
   Thiele W, 2012, BLOOD, V120, P1899, DOI 10.1182/blood-2011-09-376657
   Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913
   Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]
   TUSZYNSKI GP, 1984, J BIOL CHEM, V259, P5247
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
NR 60
TC 55
Z9 56
U1 3
U2 27
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 2
PY 2015
VL 125
IS 14
BP 2254
EP 2264
DI 10.1182/blood-2014-08-595561
PG 11
WC Hematology
SC Hematology
GA CI3DD
UT WOS:000354626900013
PM 25575540
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Muller, EA
   Pollard, B
   Raschke, MB
AF Muller, Eric A.
   Pollard, Benjamin
   Raschke, Markus B.
TI Infrared Chemical Nano-Imaging: Accessing Structure, Coupling, and
   Dynamics on Molecular Length Scales
SO JOURNAL OF PHYSICAL CHEMISTRY LETTERS
LA English
DT Article
ID NEAR-FIELD MICROSCOPY; OPTICAL MICROSCOPY; SPATIAL-RESOLUTION;
   ANALYTICAL-MODEL; IR SPECTROSCOPY; SCATTERING; TIP; NANOSPECTROSCOPY;
   ABSORPTION; SURFACE
AB This Perspective highlights recent advances in infrared vibrational chemical nano-imaging. In its implementations of scattering scanning near-field optical microscopy (s-SNOM) and phototherrnal-induced resonance (PTIR), IR nanospectroscopy provides few-nanometer spatial resolution for the investigation of polymer, biomaterial, and related soft-matter surfaces and nanostructures. Broad-band IR s-SNOM with coherent laser and synchrotron sources allows for chemical recognition with small ensemble sensitivity and the potential for sensitivity reaching the single molecule limit Probing selected vibrational marker resonances, it gives access to nanoscale chemical imaging of composition, domain morphologies, order/disorder, molecular orientation, or crystallographic phases. Local intra- and intermolecular coupling can be measured through frequency shifts of a vibrational marker in heterogeneous environments and associated inhomogeneities in vibrational dephasing. In combination with ultrafast spectroscopy, the vibrational coherent evolution of homogeneous sub-ensembles coupled to their environment can be observed. Outstanding challenges are discussed in terms of extensions to coherent and multidimensional spectroscopies, implementation in liquid and in situ environments, general sample limitations, and engineering s-SNOM scanning probes to better control the nano localized optical excitation and to increase sensitivity.
C1 [Raschke, Markus B.] Univ Colorado, Dept Chem, Dept Phys, Boulder, CO 80309 USA.
   Univ Colorado, JILA, Boulder, CO 80309 USA.
RP Raschke, MB (reprint author), Univ Colorado, Dept Chem, Dept Phys, Boulder, CO 80309 USA.
EM markus.raschke@colorado.edu
RI Muller, Eric/J-2161-2012; Raschke, Markus/F-8023-2013
OI Muller, Eric/0000-0002-9629-1767; Pollard, Benjamin/0000-0002-5109-6415
FU U.S. DOE [DEAC06-76RL01830]; Advanced Light Source; Office of Science,
   Office of Basic Energy Sciences of the U.S. Department of Energy
   [DE-AC02-05CH11231]; National Science Foundation (NSF) [CHE 1306398]
FX The authors thank Joanna Atkin, Hans Bechtel, Omar Khatib, Mike Martin,
   Scott Lea, and Tom Perkins for stimulating collaborations and
   discussions. M.B.R acknowledges support through a partner proposal with
   the Environmental Molecular Sciences Laboratory (EMSL), a national
   scientific user facility from the DOE Office of Biological and
   Environmental Research at Pacific Northwest National Laboratory (PNNL).
   PNNL is operated by Battelle for the U.S. DOE under Contract
   DEAC06-76RL01830. E.A.M. and M.B.R. thank the Advanced Light Source for
   support, which is supported by the Director, Office of Science, Office
   of Basic Energy Sciences, of the U.S. Department of Energy under
   Contract No. DE-AC02-05CH11231. Funding from the National Science
   Foundation (NSF Grant CHE 1306398) is gratefully acknowledged.
CR Ade H, 2009, NAT MATER, V8, P281, DOI [10.1038/NMAT2399, 10.1038/nmat2399]
   Akhremitchev BB, 2001, LANGMUIR, V17, P2774, DOI 10.1021/la001401v
   Amarie S, 2012, BEILSTEIN J NANOTECH, V3, P312, DOI 10.3762/bjnano.3.35
   Amenabar I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3890
   Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982
   Baiz CR, 2014, OPT EXPRESS, V22, P18724, DOI 10.1364/OE.22.018724
   Bechtel HA, 2014, P NATL ACAD SCI USA, V111, P7191, DOI 10.1073/pnas.1400502111
   Bensmann S, 2014, OPT EXPRESS, V22, P22369, DOI 10.1364/OE.22.022369
   Berweger S, 2013, J AM CHEM SOC, V135, P18292, DOI 10.1021/ja409815g
   Berweger S, 2011, NANO LETT, V11, P4309, DOI 10.1021/nl2023299
   BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Bloem R, 2010, OPT EXPRESS, V18, P27067, DOI 10.1364/OE.18.027067
   Brehm M, 2006, NANO LETT, V6, P1307, DOI 10.1021/nl0610836
   Calhoun TR, 2012, CHEM PHYS LETT, V523, P1, DOI 10.1016/j.cplett.2011.10.051
   Cvitkovic A, 2007, OPT EXPRESS, V15, P8550, DOI 10.1364/OE.15.008550
   Danckwerts M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026104
   Dazzi A, 2005, OPT LETT, V30, P2388, DOI 10.1364/OL.30.002388
   Donaldson PM, 2013, ANGEW CHEM INT EDIT, V52, P634, DOI 10.1002/anie.201204973
   Eisele M, 2014, NAT PHOTONICS, V8, P841, DOI [10.1038/NPHOTON.2014.225, 10.1038/nphoton.2014.225]
   Filimon M, 2011, PHYS CHEM CHEM PHYS, V13, P11620, DOI 10.1039/c0cp02756a
   Gomez L, 2006, J OPT SOC AM B, V23, P823, DOI 10.1364/JOSAB.23.000823
   Govyadinov AA, 2013, J PHYS CHEM LETT, V4, P1526, DOI 10.1021/jz400453r
   Hauer B, 2012, OPT EXPRESS, V20, P13173, DOI 10.1364/OE.20.013173
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   Hermann P, 2014, OPT EXPRESS, V22, P17948, DOI 10.1364/OE.22.017948
   Hitchcock AP, 2008, MICRON, V39, P311, DOI 10.1016/j.micron.2007.09.008
   Hoffmann JM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766178
   Huth F, 2011, NAT MATER, V10, P352, DOI [10.1038/nmat3006, 10.1038/NMAT3006]
   Huth F, 2013, NANO LETT, V13, P1065, DOI 10.1021/nl304289g
   Huth F, 2012, NANO LETT, V12, P3973, DOI 10.1021/nl301159v
   Ichimura T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220801
   INOUYE Y, 1994, OPT LETT, V19, P159, DOI 10.1364/OL.19.000159
   Katzenmeyer AM, 2013, ANAL CHEM, V85, P1972, DOI 10.1021/ac303620y
   Keilmann F, 2009, ART HSE NANO SCI ENG, P235
   Kjoller K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185705
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Kohlgraf-Owens DC, 2014, NANOPHOTONICS-BERLIN, V3, P105, DOI 10.1515/nanoph-2013-0056
   Lai ZZ, 2013, J PHYS CHEM B, V117, P4661, DOI 10.1021/jp309122b
   Lu F, 2014, NAT PHOTONICS, V8, P307, DOI [10.1038/nphoton.2013.373, 10.1038/NPHOTON.2013.373]
   Marcott C, 2011, APPL SPECTROSC, V65, P1145, DOI [10.1366/11&hyphen06341, 10.1366/11-06341]
   Mastel S, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905507
   McLeod AS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085136
   Moody G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.097401
   Neacsu CC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201402
   Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781
   Pakoulev AV, 2008, J PHYS CHEM A, V112, P6320, DOI 10.1021/jp711014h
   POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865
   Pollard B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4587
   Rajapaksa I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3480608
   Raschke MB, 2003, APPL PHYS LETT, V83, P5089, DOI 10.1063/1.1632023
   Schnell M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4499
   Shim SH, 2009, PHYS CHEM CHEM PHYS, V11, P748, DOI 10.1039/b813817f
   Taubner T, 2004, APPL PHYS LETT, V85, P5064, DOI 10.1063/1.1827334
   Taubner T, 2003, J MICROSC-OXFORD, V210, P311, DOI 10.1046/j.1365-2818.2003.01164.x
   Wagner M, 2014, NANO LETT, V14, P4529, DOI 10.1021/nl501558t
   WESSEL J, 1985, J OPT SOC AM B, V2, P1538, DOI 10.1364/JOSAB.2.001538
   Westermeier C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5101
   Xu XJG, 2013, NANO LETT, V13, P1588, DOI 10.1021/nl304804p
   Xu XJG, 2012, J PHYS CHEM LETT, V3, P1836, DOI 10.1021/jz300463d
   Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]
   Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998
   ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083
NR 63
TC 39
Z9 39
U1 5
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-7185
J9 J PHYS CHEM LETT
JI J. Phys. Chem. Lett.
PD APR 2
PY 2015
VL 6
IS 7
BP 1275
EP 1284
DI 10.1021/acs.jpclett.5b00108
PG 10
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Atomic, Molecular & Chemical
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CF1TS
UT WOS:000352331400032
PM 26262987
DA 2018-10-20
ER

PT J
AU Mestres, G
   Espanol, M
   Xia, W
   Persson, C
   Ginebra, MP
   Ott, MK
AF Mestres, Gemma
   Espanol, Montserrat
   Xia, Wei
   Persson, Cecilia
   Ginebra, Maria-Pau
   Ott, Marjam Karlsson
TI Inflammatory Response to Nano- and Microstructured Hydroxyapatite
SO PLOS ONE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; IN-VITRO; CELL RESPONSE; TRICALCIUM PHOSPHATE;
   PARTICLE-SIZE; BONE-MARROW; MACROPHAGES; BIOMATERIALS; TOPOGRAPHY;
   ACTIVATION
AB The proliferation and activation of leukocytes upon contact with a biomaterial play a crucial role in the degree of inflammatory response, which may then determine the clinical failure or success of an implanted biomaterial. The aim of this study was to evaluate whether nano-and microstructured biomimetic hydroxyapatite substrates can influence the growth and activation of macrophage-like cells. Hydroxyapatite substrates with different crystal morphologies consisting of an entangled network of plate-like and needle-like crystals were evaluated. Macrophage proliferation was evaluated on the material surface (direct contact) and also in extracts i.e. media modified by the material (indirect contact). Additionally, the effect of supplementing the extracts with calcium ions and/or proteins was investigated. Macrophage activation on the substrates was evaluated by quantifying the release of reactive oxygen species and by morphological observations. The results showed that differences in the substrate's microstructure play a major role in the activation of macrophages as there was a higher release of reactive oxygen species after culturing the macrophages on plate-like crystals substrates compared to the almost non-existent release on needle-like substrates. However, the difference in macrophage proliferation was ascribed to different ionic exchanges and protein adsorption/retention from the substrates rather than to the texture of materials.
C1 [Mestres, Gemma; Xia, Wei; Persson, Cecilia; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.
   [Espanol, Montserrat; Ginebra, Maria-Pau] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn, Barcelona, Spain.
RP Ott, MK (reprint author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.
EM marjam.ott@angstrom.uu.se
RI Ginebra, Maria-Pau/J-8149-2017; Espanol, Montserrat/J-8293-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Espanol,
   Montserrat/0000-0001-7510-0602; Mestres, Gemma/0000-0001-7462-4236
FU Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility
   for Growth [GROWTH 291795]; Lars Hiertas Minne Foundation [FO2013-0337];
   STINT [IG2011-2047]; Ollie och Elof Ericssons Stifelse for Vetenskaplig
   Forskning; Spanish Government [MAT2012-38438-003-01]; EU through
   European Regional Development Funds; prize "ICREA Academia'' for
   excellence in research - Generalitat de Catalunya
FX This work was funded by Marie Curie Actions FP7-PEOPLE-2011-COFUND
   (GROWTH 291795) via the VINNOVA programme Mobility for Growth, Lars
   Hiertas Minne Foundation (FO2013-0337 project), STINT (IG2011-2047
   project), and Ollie och Elof Ericssons Stifelse for Vetenskaplig
   Forskning. The authors acknowledge the Spanish Government for financial
   support through project MAT2012-38438-003-01, co-funded by the EU
   through European Regional Development Funds. Support for the research of
   MPG was received through the prize "ICREA Academia'' for excellence in
   research, funded by the Generalitat de Catalunya. Part of this work was
   performed at the BioMat facility/Science for Life Laboratory at Uppsala
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Albrecht C, 2009, TOXICOL IN VITRO, V23, P520, DOI 10.1016/j.tiv.2009.01.005
   Ambrozova G, 2010, EUR J NUTR, V49, P133, DOI 10.1007/s00394-009-0057-3
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139
   BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Espanol M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0037-7
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041
   Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005
   Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106
   Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390
NR 47
TC 9
Z9 9
U1 3
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 2
PY 2015
VL 10
IS 4
AR e0120381
DI 10.1371/journal.pone.0120381
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BS
UT WOS:000352139000020
PM 25837264
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Banerjee, A
   Chatterjee, K
   Madras, G
AF Banerjee, Aditi
   Chatterjee, Kaushik
   Madras, Giridhar
TI Enzymatic degradation of polycaprolactone-gelatin blend
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE polymer blend; degradation; enzyme kinetics
ID POLY-EPSILON-CAPROLACTONE; BIODEGRADATION; HYDROLYSIS; POLYESTERS;
   MIGRATION; LIPASES; FIBERS; GROWTH; RATIO
AB Blends of polycaprolactone (PCL), a synthetic polymer and gelatin, natural polymer offer a optimal combination of strength, water wettability and cytocompatibility for use as a resorbable biomaterial. The enzymatic degradation of PCL, gelatin and PCL-gelatin blended films was studied in the presence of lipase (Novozym 435, immobilized) and lysozyme. Novozym 435 degraded the PCL films whereas lysozyme degraded the gelatin. Though Novozym 435 and lysozyme individually could degrade PCL-gelatin blended films, the combination of these enzymes showed the highest degradation of these blended films. Moreover, the enzymatic degradation was much faster when fresh enzymes were added at regular intervals. The changes in physico-chemical properties of polymer films due to degradation were studied by scanning electron microscopy, Fourier transform infrared spectroscopy and differential scanning calorimetry. These results have important implications for designing resorbable biomedical implants.
C1 [Banerjee, Aditi; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
   [Madras, Giridhar] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.
RP Banerjee, A (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
RI Madras, Giridhar/A-1257-2007; Madras, Giridhar/K-8468-2015
OI Madras, Giridhar/0000-0003-2211-5055; Madras,
   Giridhar/0000-0003-2211-5055; Chatterjee, Kaushik/0000-0002-7204-2926
FU Department of Science and Technology, India (DST); DST
FX The authors thank the Department of Science and Technology, India (DST)
   for financial support. KC acknowledges the Ramanujan Fellowship from
   DST.
CR Banerjee A, 2014, MATER SCI TECH-LOND, V30, P567, DOI 10.1179/1743284713Y.0000000503
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P327, DOI 10.1002/app.1983.070280128
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Cheng Y, 2000, BIOMACROMOLECULES, V1, P782, DOI 10.1021/bm005616v
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   COOK WJ, 1981, J POLYM SCI POL LETT, V19, P159, DOI 10.1002/pol.1981.130190402
   Cortazar I C, 2012, POLYM DEGRAD STABIL, V97, P1241
   Falconi M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035011
   FIELDS RD, 1974, J APPL POLYM SCI, V18, P3571, DOI 10.1002/app.1974.070181207
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hoglund A, 2007, BIOMACROMOLECULES, V8, P2025, DOI 10.1021/bm070292x
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Mobarakeh L. G., 2008, BIOMATERIALS, V29, P4532
   MOCHIZUKI M, 1995, J APPL POLYM SCI, V55, P289, DOI 10.1002/app.1995.070550212
   OLIVER CN, 1983, P NATL ACAD SCI-BIOL, V80, P2156, DOI 10.1073/pnas.80.8.2156
   Reis RL, 2004, BIODEGRADABLE SYSTEM
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Sivalingam G, 2003, CHEM ENG SCI, V58, P2911, DOI 10.1016/S0009-2509(03)00155-6
   Sivalingam G, 2003, POLYM DEGRAD STABIL, V79, P413, DOI 10.1016/S0141-3910(02)00357-9
   TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0
   Waldeck H, 2007, J BIOMED MATER RES A, V82A, P861, DOI 10.1002/jbm.a.31054
   Woei K, 2001, TISSUE ENG, V7, P441, DOI 10.1089/10763270152436490
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zheng R, 2014, BIOMATERIALS, V35, P152, DOI 10.1016/j.biomaterials.2013.09.082
NR 31
TC 5
Z9 5
U1 2
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD APR
PY 2015
VL 2
IS 4
AR 045303
DI 10.1088/2053-1591/2/4/045303
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA DD6AY
UT WOS:000370007300020
DA 2018-10-20
ER

PT J
AU Dorsey, SM
   Haris, M
   Singh, A
   Witschey, WRT
   Rodell, CB
   Kogan, F
   Reddy, R
   Burdick, JA
AF Dorsey, Shauna M.
   Haris, Mohammad
   Singh, Anup
   Witschey, Walter R. T.
   Rodell, Christopher B.
   Kogan, Feliks
   Reddy, Ravinder
   Burdick, Jason A.
TI Visualization of Injectable Hydrogels Using Chemical Exchange Saturation
   Transfer MRI
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE hyaluronic acid; hydrogel; magnetic resonance imaging; chemical exchange
   saturation transfer
ID HYALURONIC-ACID HYDROGEL; IN-VIVO; CONTRAST AGENTS; TRANSFER CEST;
   WATER; DEGRADATION; BIOMATERIALS; METABOLITES; INFARCTION; CREATINE
AB Injectable biomaterials are being developed for a wide range of biomedical applications; however, characterization of materials (e.g., distribution, chemical composition) after injection is often difficult and relies on invasive and destructive procedures. To address this problem, this study utilizes a new magnetic resonance imaging (MRI) acquisition technique based on chemical exchange saturation transfer (CEST), where the signal relies on the exchange of protons in specific molecules with bulk water protons. Such a signal can be generated from specific functional groups endogenous to or engineered into a desired material. Here, CEST MRI was used to visualize injectable hyaluronic acid (HA) hydrogels either alone or after injection into tissue. The CEST effect was shown to track with changes in material properties-as hydrogel macromer concentration was increased, the CEST contrast increased linearly. Furthermore, CEST MRI was used to detect hydrogels injected into cardiac explants with an increase in signal at the hydrogel site relative to the surrounding myocardial signal. Unlike conventional MRI, CEST can simultaneously visualize and discriminate between different injectable materials based on their unique chemistry. To illustrate this, we tuned the CEST signal to detect differences in two hydrogel systems based on their dominant functional groups. The covalent addition of an arginine-based peptide to HA hydrogels led to a 2-fold increase in signal when the exchangeable amine (-NH2) protons in the peptide were targeted. Thus, CEST MRI could become a valuable tool for studying injectable hydrogel properties and enable further optimization of biomaterial therapies aimed at clinical translation.
C1 [Dorsey, Shauna M.; Rodell, Christopher B.; Burdick, Jason A.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.
   [Haris, Mohammad; Singh, Anup; Witschey, Walter R. T.; Kogan, Feliks; Reddy, Ravinder] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
OI Reddy, Ravinder/0000-0003-4580-2392
FU National Institutes of Health [R00 HL108157, R01 HL111090, T32 HL007954,
   P41 EB015893, P41 EB015893S1]; Established Investigator Award from
   American Heart Association
FX The authors acknowledge the assistance of S. Wehrli from the Children's
   Hospital of Pennsylvania for assistance with the high-resolution,
   temperature-controlled spectroscopy. This work was financially supported
   by the National Institutes of Health (R00 HL108157, R01 HL111090, T32
   HL007954, P41 EB015893, P41 EB015893S1) and a predoctoral fellowship
   (C.B.R) and Established Investigator Award (J.A.B.) from the American
   Heart Association.
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Blakely B, 2010, J BIOMED MATER RES B, V93B, P9, DOI 10.1002/jbm.b.31539
   Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615
   Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459
   Guivel-Scharen V, 1998, J MAGN RESON, V133, P36, DOI 10.1006/jmre.1998.1440
   Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436
   Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792
   Hoffman RE, 2006, MAGN RESON CHEM, V44, P606, DOI 10.1002/mrc.1801
   Karfeld-Sulzer LS, 2011, MAGN RESON MED, V65, P220, DOI 10.1002/mrm.22587
   Kichula ET, 2014, ANN BIOMED ENG, V42, P1546, DOI 10.1007/s10439-013-0937-9
   Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873
   Kogan Feliks, 2013, Curr Radiol Rep, V1, P102
   Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011
   Leon CM, 2009, POLYM INT, V58, P847, DOI 10.1002/pi.2616
   Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106
   Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105
   Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899
   Liu GS, 2012, MAGN RESON MED, V67, P1106, DOI 10.1002/mrm.23100
   Liu GS, 2010, CONTRAST MEDIA MOL I, V5, P162, DOI 10.1002/cmmi.383
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   McMahon MT, 2008, MAGN RESON MED, V60, P803, DOI 10.1002/mrm.21683
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Purcell BP, 2014, BIOMATER SCI-UK, V2, P693, DOI 10.1039/c3bm60227c
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Singh A, 2013, MAGN RESON MED, V69, P818, DOI 10.1002/mrm.24290
   Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250
   Soesbe TC, 2013, NMR BIOMED, V26, P829, DOI 10.1002/nbm.2874
   Soranno DE, 2014, J BIOMED MATER RES A, V102, P2173, DOI 10.1002/jbm.a.34902
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun PZ, 2005, J MAGN RESON, V175, P193, DOI 10.1016/j.jmr.2005.04.005
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761
   Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woessner DE, 2005, MAGNET RESON MED, V53, P790, DOI 10.1002/mrm.20408
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu SB, 1999, CHEM REV, V99, P2353, DOI 10.1021/cr980441p
   Yuan ZJ, 2010, TISSUE ENG PART C-ME, V16, P237, DOI [10.1089/ten.tec.2009.0152, 10.1089/ten.TEC.2009.0152]
   Zhang Y, 2014, MACROMOL BIOSCI, V14, P1249, DOI 10.1002/mabi.201400117
NR 47
TC 10
Z9 10
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 227
EP 237
DI 10.1021/ab500097d
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300004
DA 2018-10-20
ER

PT J
AU Muller-Herrmann, S
   Scheibel, T
AF Mueller-Herrmann, Susanne
   Scheibel, Thomas
TI Enzymatic Degradation of Films, Particles, and Nonwoven Meshes Made of a
   Recombinant Spider Silk Protein
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE recombinant silk proteins; cross-linking; biodegradation; MMPs; protease
   XIV; collagenase IA; scaffolds for biomedical applications
ID LEUKOCYTE ELASTASE LEVELS; IN-VITRO DEGRADATION; HIGH SERUM-LEVELS;
   MATRIX-METALLOPROTEINASES; PMN-ELASTASE; INFRARED-SPECTROSCOPY;
   STREPTOMYCES-GRISEUS; CHRONIC WOUNDS; FIBROIN; INHIBITORS
AB The performance of biomaterials in vivo is largely influenced by their stability and the rate and extent to which they degrade. Materials for tissue engineering applications, for example, have to be mechanically stable to support cell adhesion and proliferation without collapsing. On the other hand they need to be replaced gradually by native extracellular matrix and have to be (slowly) biodegradable. Therefore, it is of critical importance to be able to tune the 15 degradation behavior of a biomaterial. Recombinantly produced spider silk proteins have been shown to be versatile biopolymers for medical applications. They can be processed into a variety of morphologies, and by chemical or genetic modification the properties can be adjusted to specific demands. Furthermore, in vivo experiments confirmed the lack of immunological reactions toward certain spider silks. In this study the degradation behavior of the recombinant spider silk protein eADF4(C16) in solution as well as processed into particles, films and nonwoven meshes was analyzed, and the impact of cross linking of the scaffolds was assessed thereon. In addition to two bacterial proteolytic model enzymes, protease type XIV from Streptomyces griseus (PXIV) and collagenase type IA from Clostridium histolyticum (CHC) used in all experiments, several recombinant human matrix metalloproteinases (MMPs) and one elastase were used in studying degradation of soluble eADF4(C16). For soluble eADF4(C16) all degradation kinetics were similar. In case of eADF4(C16) scaffolds significant differences were observable between PXIV and CHC. All scaffolds were more stable toward proteolytic degradation in the presence of CHC than in the presence of PXIV. Further, particles were degraded significantly faster than films, and nonwoven meshes showed the highest proteolytic stability. Chemical cross-linking of the scaffolds led to a decrease in both degradation rate and extent.
C1 [Mueller-Herrmann, Susanne; Scheibel, Thomas] Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
FU Deutsche Forschungsgemeinschaft [SFB840 TP A8]
FX The authors thank Hendrik Bargel for assistance with SEM analyses and
   Martin Humenik for assistance with MALDI-TOF MS measurements. This work
   was supported by the Deutsche Forschungsgemeinschaft (SFB840 TP A8).
CR Akyol N, 1997, ACTA OPHTHALMOL SCAN, V75, P287
   Alexander JS, 2010, MULT SCLER J, V16, P801, DOI 10.1177/1352458510370791
   Amalinei Cornelia, 2007, Rom J Morphol Embryol, V48, P323
   ANDUS T, 1993, DIGEST DIS SCI, V38, P1638, DOI 10.1007/BF01303172
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12
   Asano Y, 2006, RHEUMATOLOGY, V45, P303, DOI 10.1093/rheumatology/kei143
   BAUER CA, 1974, EUR J BIOCHEM, V41, P45, DOI 10.1111/j.1432-1033.1974.tb03242.x
   BAUER CA, 1974, EUR J BIOCHEM, V45, P469, DOI 10.1111/j.1432-1033.1974.tb03571.x
   Blum C, 2014, ADV FUNCT MATER, V24, P763, DOI 10.1002/adfm.201302100
   Blum C., 2012, BIONANOSCIENCE, V2
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   BULLEN EC, 1995, J INVEST DERMATOL, V104, P236, DOI 10.1111/1523-1747.ep12612786
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Decock J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-77
   DEGER O, 1995, CLIN CHIM ACTA, V236, P129, DOI 10.1016/0009-8981(95)06033-A
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Edkins TJ, 2012, CLIN VACCINE IMMUNOL, V19, P562, DOI 10.1128/CVI.00018-12
   Eglin D, 2009, SOFT MATTER, V5, P938, DOI 10.1039/b803718n
   Enoch S, 2007, SURGERY, V26, P31
   Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024
   Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080
   Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   HOFER HP, 1995, INJURY, V26, P103, DOI 10.1016/0020-1383(95)92186-E
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu YP, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/185905
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Imamoto Y, 2001, BIOCHEMISTRY-US, V40, P8997, DOI 10.1021/bi010021l
   Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340
   Jung K, 2008, CLIN CHEM, V54, P772, DOI 10.1373/clinchem.2007.099937
   Karapanagiotidis GT, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-59
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019
   Leal-Egana A, 2012, ADV ENG MATER, V14, pB67, DOI 10.1002/adem.201180072
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370
   McLennan SV, 2009, WOUND PRACT RES, V16, P116
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Metzmacher I., 2005, THESIS LMU MUNCHEN M
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512
   Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neubauer MP, 2013, BIOMATER SCI-UK, V1, P1160, DOI 10.1039/c3bm60108k
   Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Orem A, 1997, CLIN CHIM ACTA, V264, P49, DOI 10.1016/S0009-8981(97)00072-7
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI 10.1093/nar/gkr987
   Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637
   Riley KN, 2005, J BURNS WOUNDS, V4, P112
   Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Schultz GS, 1998, WOUNDS, V10, p1F
   Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, SOFT MATTER, V6, P4168, DOI 10.1039/b927267d
   Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596
   Ulrich D, 2003, PLAST RECONSTR SURG, V112, P1279, DOI 10.1097/01.PRS.0000081462.40448.49
   Ulrich D, 2003, PLAST RECONSTR SURG, V111, P1423, DOI 10.1097/01.PRS.0000049450.95669.07
   Ulrich Dietmar, 2004, Plast Reconstr Surg, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C
   Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011
   Wiegand C, 2010, ARCH DERMATOL RES, V302, P419, DOI 10.1007/s00403-009-1011-1
   Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wittmer CR, 2011, ACTA BIOMATER, V7, P3789, DOI 10.1016/j.actbio.2011.06.001
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41
   Zeplin PH, 2014, ADV FUNCT MATER, V24, P2658, DOI 10.1002/adfm.201302813
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
NR 88
TC 14
Z9 15
U1 5
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 247
EP 259
DI 10.1021/ab500147u
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300006
DA 2018-10-20
ER

PT J
AU Rnjak-Kovacina, J
   Wray, LS
   Burke, KA
   Torregrosa, T
   Golinski, JM
   Huang, WW
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   Wray, Lindsay S.
   Burke, Kelly A.
   Torregrosa, Tess
   Golinski, Julianne M.
   Huang, Wenwen
   Kaplan, David L.
TI Lyophilized Silk Sponges: A Versatile Biomaterial Platform for Soft
   Tissue Engineering
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE silk; scaffold; soft tissue engineering; lyophilized sponge; biomaterial
ID SCAFFOLDS; FIBROIN; BONE; STIFFNESS; IMPACT; SUBSTRATE; CELLS
AB We present a silk biomaterial platform with highly tunable mechanical and degradation properties for engineering and regeneration of soft tissues such as, skin, adipose, and neural tissue, with elasticity properties in the kilopascal range. Lyophilized silk sponges were prepared under different process conditions and the effect of silk molecular weight, concentration and crystallinity on 3D scaffold formation, structural integrity, morphology, mechanical and degradation properties, and cell interactions in vitro and in vivo were studied. Tuning the molecular weight distribution (via degumming time) of silk allowed the formation of stable, highly porous, 3D scaffolds that held form with silk concentrations as low as 0.5% wt/v. Mechanical properties were a function of silk concentration and scaffold degradation was driven by beta-sheet content. Lyophilized silk sponges supported the adhesion of mesenchymal stem cells throughout 3D scaffolds, cell proliferation in vitro, and cell infiltration and scaffold remodeling when implanted subcutaneously in vivo.
C1 [Rnjak-Kovacina, Jelena; Wray, Lindsay S.; Burke, Kelly A.; Torregrosa, Tess; Golinski, Julianne M.; Huang, Wenwen; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Burke, Kelly A.] Univ Connecticut, Chem & Biomol Engn Dept, Storrs, CT 06269 USA.
RP Rnjak-Kovacina, J (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM j.rnjak-kovacina@unsw.edu.au
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU NIH [NIH P41 EB002520, EY020856]; National Science Foundation Graduate
   Research Fellowship Program [NSF DGE 0806676]; Air Force Office of
   Scientific Research
FX We thank the NIH (NIH P41 EB002520; EY020856), the National Science
   Foundation Graduate Research Fellowship Program (NSF DGE 0806676), and
   the Air Force Office of Scientific Research for support. We thank Rachel
   Stern for her contribution to sponge integrity and degradation studies.
   As Rachel has completed her studies at Tufts University, we were unable
   to find her contact details to seek permission to include her as a
   coauthor on the manuscript. We thank Dr. Chiara E. Ghezzi for her
   assistance in analyzing the mechanical properties of silk scaffolds.
CR Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sasithorn N, 2014, J NANOMATER, DOI 10.1155/2014/947315
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yuksel E., 2005, SEMIN PLAST SURG, P261
NR 30
TC 32
Z9 33
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2015
VL 1
IS 4
BP 260
EP 270
DI 10.1021/ab500149p
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RM
UT WOS:000369347300007
PM 25984573
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Ochyl, LJ
   Moon, JJ
AF Ochyl, Lukasz J.
   Moon, James J.
TI Whole-animal Imaging and Flow Cytometric Techniques for Analysis of
   Antigen-specific CD8+T Cell Responses after Nanoparticle Vaccination
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology; Issue 98; nanoparticle; vaccine; biomaterial; subunit
   antigen; adjuvant; cytotoxic CD8+T lymphocyte; whole animal imaging;
   tetramer staining; and lymph node
ID CHRONIC VIRAL-INFECTION; T-CELLS; SYNTHETIC VACCINES; IMMUNE-RESPONSES;
   IN-VITRO; MEMORY; TRAFFICKING; SELECTION; PEPTIDE; ASSAY
AB Traditional vaccine adjuvants, such as alum, elicit suboptimal CD8+ T cell responses. To address this major challenge in vaccine development, various nanoparticle systems have been engineered to mimic features of pathogens to improve antigen delivery to draining lymph nodes and increase antigen uptake by antigen-presenting cells, leading to new vaccine formulations optimized for induction of antigen-specific CD8+ T cell responses. In this article, we describe the synthesis of a "pathogen-mimicking" nanoparticle system, termed interbilayer-crosslinked multilamellar vesicles (ICMVs) that can serve as an effective vaccine carrier for co-delivery of subunit antigens and immunostimulatory agents and elicitation of potent cytotoxic CD8+ T lymphocyte (CTL) responses. We describe methods for characterizing hydrodynamic size and surface charge of vaccine nanoparticles with dynamic light scattering and zeta potential analyzer and present a confocal microscopy-based procedure to analyze nanoparticle-mediated antigen delivery to draining lymph nodes. Furthermore, we show a new bioluminescence whole-animal imaging technique utilizing adoptive transfer of luciferase-expressing, antigen-specific CD8+ T cells into recipient mice, followed by nanoparticle vaccination, which permits non-invasive interrogation of expansion and trafficking patterns of CTLs in real time. We also describe tetramer staining and flow cytometric analysis of peripheral blood mononuclear cells for longitudinal quantification of endogenous T cell responses in mice vaccinated with nanoparticles.
C1 [Ochyl, Lukasz J.; Moon, James J.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.
   [Ochyl, Lukasz J.; Moon, James J.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.
   [Moon, James J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Moon, JJ (reprint author), Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.
EM moonjj@med.umich.edu
FU National Institute of Health [1K22AI097291-01]; National Center for
   Advancing Translational Sciences of the National Institutes of Health
   [UL1TR000433]
FX This study was supported by the National Institute of Health grant
   1K22AI097291-01 and by the National Center for Advancing Translational
   Sciences of the National Institutes of Health under Award Number
   UL1TR000433. We also acknowledge Prof. Darrell Irvine at MIT and Prof.
   Matthias Stephan at Fred Hutchinson Cancer Center for their contribution
   on the initial work on the vaccine nanoparticles and OT-I/Luc transgenic
   mice.
CR Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546
   Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94
   Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155
   Azadniv M, 2007, INT IMMUNOL, V19, P1165, DOI 10.1093/intimm/dxm086
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Bedoya SK, 2013, JOVE-J VIS EXP, DOI 10.3791/50765
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Bilati U, 2005, AAPS PHARMSCITECH, V6
   Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596
   BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
   Chen Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2802
   Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288
   Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78
   Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Kaur R, 2012, J CONTROL RELEASE, V164, P331, DOI 10.1016/j.jconrel.2012.07.012
   Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Machholz E, 2012, JOVE-J VIS EXP, DOI 10.3791/2771
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240
   Noto A, 2013, JOVE-J VIS EXP, DOI 10.3791/51105
   Quah BJC, 2014, JOVE-J VIS EXP, DOI 10.3791/51627
   Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Sahdev P., 2014, PHARM RES
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Scheffold A., 2009, CELLULAR DIAGNOSTICS, P476
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Slingluff CL, 2001, CLIN CANCER RES, V7, P3012
   Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Stivaktakis N, 2004, J BIOMED MATER RES A, V70A, P139, DOI 10.1002/jbm.a.30085
   TILNEY NL, 1971, J ANAT, V109, P369
   van Riet E, 2014, ADV DRUG DELIVER REV, V74, P28, DOI 10.1016/j.addr.2014.05.011
   VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6
   Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006
   WILSON K, 2008, JOVE-J VIS EXP, V14, P740
   Wonderlich J., 2006, CURR PROTOC IMMUNOL
   Xu ZH, 2013, J CONTROL RELEASE, V172, P259, DOI 10.1016/j.jconrel.2013.08.021
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zhuang Y, 2012, J CONTROL RELEASE, V159, P135, DOI 10.1016/j.jconrel.2011.12.017
NR 57
TC 4
Z9 4
U1 2
U2 15
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2015
IS 98
AR e52771
DI 10.3791/52771
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MR
UT WOS:000361534800068
PM 25992469
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Liu, B
   Li, L
   Zhao, JH
   Wang, ZF
   Tan, XY
   Xu, HY
   An, R
   Liu, YP
AF Liu, Bin
   Li, Long
   Zhao, Jian-Hui
   Wang, Zhi-Fa
   Tan, Xin-Ying
   Xu, Hai-Yan
   An, Ran
   Liu, Yan-Pu
TI Platelet-Rich Fibrin and Adipose-Derived Stem Cells Improve the Efficacy
   of Fat Transplantation and Soft Tissue Repair
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Soft Tissue Repair; Fat Transplantation; Platelet-Rich Fibrin;
   Adipose-Derived Stem Cells; Tissue Engineering
ID REGENERATION; SURVIVAL; PLASMA; AUGMENTATION; LIPOTRANSFER;
   BIOMATERIALS; COMBINATION; THERAPY; MODEL; GRAFT
AB Soft tissue defect restoration remains a challenge for clinical practice. Adipose tissue appears to be a promising filler due to its abundance and easy access but its use has been limited by atrophy, liquefaction, and necrosis. This study focuses on producing a novel fat composite biomaterial for fat transplantation. Autologous adipose derived stem cells (ASCs), platelet-rich fibrin (PRF), and adipose granules (AG) were prepared and mixed to make the fat composite for implanting. The ASCs were characterized by cell surface markers CD29 and CD31 as well as their ability to differentiate into multiple types of cells. PRF induced the differentiation of ASCs into adipocytes and osteoblasts and increased the proliferation of ASCs in a dose-dependent fashion. The fat transplantation in rabbits' ears showed that ASCs and PRF were able to individually or synergistically reduce fat absorption, increase fat survival, angiogensis, and remodeling, improving the efficacy and success rate of fat transplantation. This novel fat composite containing ASCs, PRF, and adipose granules is a promising biomaterial for soft tissue defect repair and cosmetic tissue augmentation.
C1 [Liu, Bin] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Liu, Bin; Xu, Hai-Yan; An, Ran] Fourth Mil Med Univ, Lab Anim Ctr, Xian 710032, Shaanxi, Peoples R China.
   [Li, Long; Wang, Zhi-Fa; Tan, Xin-Ying; Liu, Yan-Pu] Fourth Mil Med Univ, Sch Stomatol, Oral Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China.
   [Zhao, Jian-Hui] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.
RP Liu, B (reprint author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
FU National Natural Science Foundation of China [31170942, 81070820]
FX The authors would like to thank Dr. Shi Lei (Puhe Biomed) for critical
   reading. This work was supported by the National Natural Science
   Foundation of China (Nos. 31170942, 81070820).
CR Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI [10.1016/j.yexcr.2003.10.020, 10.1016/j.yexer.2003.10.020]
   Alexander RW, 2013, CLIN COSMET INVESTI, V6, P91, DOI 10.2147/CCID.S40575
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135
   COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gimble Jeffrey M, 2011, Front Biosci (Schol Ed), V3, P69, DOI 10.2741/s133
   Hiraoka Y, 2006, TISSUE ENG, V12, P1475, DOI 10.1089/ten.2006.12.1475
   Huang Y, 2015, MATER EXPRESS, V5, P56, DOI 10.1166/mex.2015.1208
   Keyhan SO, 2013, J ORAL MAXIL SURG, V71, P610, DOI 10.1016/j.joms.2012.06.176
   Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87
   Liao HT, 2014, TISSUE ENG PART B-RE, V20, P267, DOI [10.1089/ten.teb.2013.0317, 10.1089/ten.TEB.2013.0317]
   Liu B, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2012.0126, 10.1089/ten.TEC.2012.0126]
   Luo S, 2013, TOHOKU J EXP MED, V231, P101, DOI 10.1620/tjem.231.101
   Ma XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076103
   Marino G, 2013, J SURG RES, V185, P36, DOI 10.1016/j.jss.2013.05.024
   Marra KG, 2012, BIRTH DEFECTS RES C, V96, P95, DOI 10.1002/bdrc.21001
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Masuda T, 2004, TISSUE ENG, V10, P1672, DOI 10.1089/ten.2004.10.1672
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Padma Rajan, 2013, J Indian Soc Periodontol, V17, P631, DOI 10.4103/0972-124X.119281
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Philips BJ, 2013, PLAST RECONSTR SURG, V132, P845, DOI 10.1097/PRS.0b013e31829fe5b1
   Shiffman MA, 2001, DERMATOL SURG, V27, P819, DOI 10.1046/j.1524-4725.2001.01062.x
   Singh Smita, 2013, Natl J Maxillofac Surg, V4, P94, DOI 10.4103/0975-5950.117825
   Tatullo M, 2012, INT J MED SCI, V9, P872, DOI 10.7150/ijms.5119
   Xu JL, 2012, BIOMATERIALS, V33, P6965, DOI 10.1016/j.biomaterials.2012.06.010
   Yi CG, 2007, J PLAST RECONSTR AES, V60, P272, DOI 10.1016/j.bjps.2006.01.052
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104
   Zhang Y, 2012, J CRANIO MAXILL SURG, V40, P321, DOI 10.1016/j.jcms.2011.04.020
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 33
TC 2
Z9 2
U1 0
U2 10
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD APR
PY 2015
VL 5
IS 4
BP 275
EP 282
DI 10.1166/jbt.2015.1311
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA CO8BZ
UT WOS:000359391300003
DA 2018-10-20
ER

PT J
AU Gumus, S
   Polat, S
   Lackner, JM
   Waldhauser, W
AF Gumus, S.
   Polat, S.
   Lackner, J. M.
   Waldhauser, W.
TI The Correlation Between Elastic Properties and AFM Images of
   Nanocoatings on Polymers
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
ID TEMPERATURE VACUUM DEPOSITION; TOPOGRAPHY FORMATION; BIOMATERIALS;
   MECHANISMS; SURFACES
AB In a biomimetic approach for designing implants, both the physical properties (such as topography, elasticity, roughness, hydrophilicity, charges etc.) and the chemical structure of the artificial biomaterial should be considered, since they affect the adhesion of proteins in the nanometer-scale and of the cells in micro-scale at the interface. In this case, surface modification of biomaterials plays a major role because of the expectations from the material surface. These may be realized by changing the surface chemistry, physically or chemically, or by coating it with a material having a certain chemical composition. In this study, surface properties like topography and roughness, and mechanical properties like elastic modulus and hardness are determined for nanocoated materials.
C1 [Gumus, S.; Polat, S.] Kocaeli Univ, Fac Engn, Dept Met & Mat Engn, TR-41380 Kocaeli, Turkey.
   [Lackner, J. M.; Waldhauser, W.] Joanneum Res Forsch Ges mBH, Inst Surface Technol & Photon, Funct Surfaces, A-8712 Niklasdorf, Austria.
RP Gumus, S (reprint author), Kocaeli Univ, Fac Engn, Dept Met & Mat Engn, Umuttepe Campus, TR-41380 Kocaeli, Turkey.
EM sgumus@kocaeli.edu.tr
CR Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Franco Jr. Adonias Ribeiro, 2004, Mat. Res., V7, P483, DOI 10.1590/S1516-14392004000300018
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Karimi A, 2002, THIN SOLID FILMS, V420, P275, DOI 10.1016/S0040-6090(02)00944-6
   Lackner JM, 2012, THIN SOLID FILMS, V520, P2833, DOI 10.1016/j.tsf.2011.10.149
   Lackner JM, 2010, B POL ACAD SCI-TECH, V58, P281
   Li XD, 2002, MATER CHARACT, V48, P11
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
NR 10
TC 0
Z9 0
U1 0
U2 13
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2015
VL 127
IS 4
BP 1142
EP 1144
PG 3
WC Physics, Multidisciplinary
SC Physics
GA CM8GQ
UT WOS:000357937100080
OA Bronze
DA 2018-10-20
ER

PT J
AU Karacali, O
AF Karacali, O.
TI Material Fatigue Research for Zirconia Ceramic Dental Implant: a
   Comparative Laboratory and Simulation Study in Dentistry
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 4th International Congress in Advances in Applied Physics and Materials
   Science (APMAS)
CY APR 24-27, 2014
CL Fethiye, TURKEY
AB This research focuses on the biocompatible zirconia, ceramic (ZrO2) material and load behavior causing fatigue on the surface of the dental implant in dentistry. Fatigue fracture and wear have been identified as some of the major problems associated with implant loosening, stress-shielding and ultimate implant failure. A static and cyclic fatigue testing of ceramic dental implant in laboratory conditions for this investigation were carried out according to the ISO protocol 14801 under worst-case conditions. A finite element analysis (PEA) of dental implant with accurate geometry and material properties were developed to make realistic investigations on biocompatibility of the implant biomaterial properties and mechanical fatigue behavior of new dental implant comparing Von-Mises criteria and maximum stress levels. The comparison of calculated fatigue life simulation data of and experimental data for the biocompatible zinconia, ceramic dental implants is presented. As a conclusion zirconium. implant exceeded the established values for maximum incisal bite forces reported in the literature and and also shows better performance than titanium implant material. The results of fatigue of biocompatible zirconia analysis are helpful for implant biomaterial selection and design for clinical interest: in dentistry.
C1 Istanbul Univ, Fac Engn, Dept Mech Engn, Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
FU Istanbul University, Turkey [46540]; Istanbul University
FX This research was supported by Scientific Research Projects (BAP) of
   Istanbul University, Turkey, Project No: 46540. The support of Istanbul
   University is greatly appreciated.
CR Coelho PG, 2009, DENT MATER, V25, P1122, DOI 10.1016/j.dental.2009.03.009
   Merdji A., 2010, COMP MATER SCI, V49, P126
   Mick E., 2013, J MAT, V6, P4001
   Prithviraj D.R., J CLIN EXP DENT, V3, P240
NR 4
TC 0
Z9 0
U1 1
U2 11
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2015
VL 127
IS 4
BP 1195
EP 1198
DI 10.12693/APhysPolA.127.1195
PG 4
WC Physics, Multidisciplinary
SC Physics
GA CM8GQ
UT WOS:000357937100094
OA Bronze
DA 2018-10-20
ER

PT J
AU Popa, CL
   Bartha, CM
   Albu, M
   Guegan, R
   Motelica-Heino, M
   Chifiriuc, MC
   Bleotu, C
   Badea, ML
   Antohe, S
AF Popa, C. L.
   Bartha, C. M.
   Albu, M.
   Guegan, R.
   Motelica-Heino, M.
   Chifiriuc, M. C.
   Bleotu, C.
   Badea, M. L.
   Antohe, S.
TI SYNTHESIS, CHARACTERIZATION AND CYTOTOXICITY EVALUATION ON ZINC DOPED
   HYDROXYAPATITE IN COLLAGEN MATRIX
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Zinc; Hydroxyapatite; Collagen; Bio-composite
ID CALCIUM-PHOSPHATE; BONE-FORMATION; EUROPIUM; NANOPARTICLES; TISSUE;
   BIOCOMPATIBILITY; COMPOSITES; SCAFFOLDS; DEXTRIN
AB The goal of this study was to obtain at low temperature a functional nano-composite with characteristics similar to the natural bone by using a cost effective method. The structure and morphology of collagen coated zinc doped hydroxyapatite bio-composites (Zn:HAp-CBc) were examined by X-Ray diffraction (XRD) and Scanning Electron Microscopy (SEM). XRD analysis revealed that the unique hexagonal Ca-10(PO4)(6)(OH)(2) in P-63m space group was observed in the obtained nanocomposites Zn: HAp-CBc. The cytotoxicity of the Zn: HAp-CBc was studied on HeLa cell lines. Cell cycle distribution after treatment was examined by flow cytometry analysis. Our preliminary in vitro studies revealed that the obtained composites based on Zn doped HAp embedded in collagen matrix have excellent biocompatibility and support their further characterization by in vivo approaches and development as a biomaterial used in bone regeneration.
C1 [Popa, C. L.; Bartha, C. M.] Natl Inst Mat Phys, Magurele, Romania.
   [Popa, C. L.; Antohe, S.] Univ Bucharest, Fac Phys, Magurele 077125, Romania.
   [Bartha, C. M.] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania.
   [Albu, M.] Leather & Footwear Res Inst, Natl Res & Dev Inst Text & Leather INCDTP Div, Collagen Dept, Bucharest 031215, Romania.
   [Guegan, R.; Motelica-Heino, M.] Univ Orleans, CNRS, Inst Earth Sci, UMR 7327, F-45071 Orleans 02, France.
   [Chifiriuc, M. C.; Bleotu, C.] Univ Bucharest, Fac Biol, Dept Microbiol Immunol, Bucharest 77206, Romania.
   [Bleotu, C.] Stefan S Nicolau Inst Virol, Bucharest 030304, Romania.
   [Badea, M. L.] Univ Agron Sci & Vet Med, Bucharest 011464, Romania.
   [Antohe, S.] Acad Romanian Scientists, Bucharest 050094, Romania.
RP Antohe, S (reprint author), Univ Bucharest, Fac Phys, 405 Atomistilor St,POB MG1, Magurele 077125, Romania.
EM santohe@solid.fizica.unibuc.ro
RI Chifiriuc, Mariana Carmen/F-9136-2016; ANTOHE, Stefan/C-4954-2011;
   Coralia, Bleotu/B-5976-2011
OI Chifiriuc, Mariana Carmen/0000-0001-6098-1857; Coralia,
   Bleotu/0000-0002-9031-338X; Albu, Madalina Georgiana/0000-0001-9960-2244
FU European Social Found within the Sectorial Operational Program Human
   Resources Development;  [IFA-CEA C4-05/2014];  [PN II 221/2014]; 
   [POSDRU/159/1.5/S/137750]
FX This work was supported by projects IFA-CEA C4-05/2014 and PN II
   221/2014. Also this work was supported by the strategic grant
   POSDRU/159/1.5/S/137750, "Project Doctoral and Postdoctoral programs
   support for increased competitiveness in Exact Sciences research"
   cofinanced by the European Social Found within the Sectorial Operational
   Program Human Resources Development 2007 - 2013.
CR Agrawal K., 2011, J MINER MAT CHARACT, V8, P727, DOI DOI 10.4236/JMMCE.2011.108057
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Buchwald T, 2012, SPECTROSC-INT J, V27, P107, DOI 10.1155/2012/261487
   Carcamo JJ, 2012, SPECTROCHIM ACTA A, V86, P360, DOI 10.1016/j.saa.2011.10.049
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P1639
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P1239
   Ciobanu CS, 2010, OPTOELECTRON ADV MAT, V4, P1515
   Ciobanu C. S., 2012, J NANOMATER, V2012, P1
   Ciobanu C. S., 2014, J NANOMATER, V2014, P1
   Ciobanu CS, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-324
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Ciobanu CS, 2013, J SPECTROS
   David G, 2011, DIG J NANOMATER BIOS, V6, P1575
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   Falguni Pati, 2010, Bioresource Technology, V101, P3737
   Geiger M, 2003, ADV DRUG DELIV REV, V55, P613
   Ito A, 2005, CURR APPL PHYS, V5, P402, DOI 10.1016/j.cap.2004.10.006
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   JORIS SJ, 1971, J PHYS CHEM-US, V75, P3172, DOI 10.1021/j100689a025
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lungu A, 2011, DIG J NANOMATER BIOS, V6, P1867
   Martin RB, 1998, SKELETAL TISSUE MECH
   Matsunaga K, 2010, ACTA BIOMATER, V6, P2289, DOI 10.1016/j.actbio.2009.11.029
   Popa CL, 2014, CENT EUR J CHEM, V12, P1032, DOI 10.2478/s11532-014-0554-y
   Predoi D, 2007, DIG J NANOMATER BIOS, V2, P169
   Predoi D, 2008, J OPTOELECTRON ADV M, V10, P152
   Predoi D, 2010, DIG J NANOMATER BIOS, V5, P373
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Roman-Lopez J, 2014, SPECTROCHIM ACTA A, V120, P610, DOI 10.1016/j.saa.2013.10.027
   Rusu LC, 2014, DIG J NANOMATER BIOS, V9, P317
   Samar K, 2010, MAT SCI ENG C, V30, P295
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Tegza M., 2012, CHEM TECHNOL, V59, P40
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Voicu G, 2014, DIG J NANOMATER BIOS, V9, P99
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
NR 43
TC 3
Z9 3
U1 0
U2 12
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD APR-JUN
PY 2015
VL 10
IS 2
BP 681
EP 691
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CL8YV
UT WOS:000357261800014
DA 2018-10-20
ER

PT J
AU Hastings, CL
   Roche, ET
   Ruiz-Hernandez, E
   Schenke-Layland, K
   Walsh, CJ
   Duffy, GP
AF Hastings, Conn L.
   Roche, Ellen T.
   Ruiz-Hernandez, Eduardo
   Schenke-Layland, Katja
   Walsh, Conor J.
   Duffy, Garry P.
TI Drug and cell delivery for cardiac regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Myocardial infarction; Heart failure; Cell therapy; Growth factor;
   Biomaterials; Medical device; Drug delivery; Regenerative medicine
ID ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION;
   BONE-MARROW-CELLS; MESENCHYMAL STEM-CELLS; CHRONIC HEART-FAILURE;
   GROWTH-FACTOR-I; SKELETAL MYOBLAST TRANSPLANTATION; TISSUE-ENGINEERING
   APPROACH; RANDOMIZED CONTROLLED-TRIAL; MODIFIED MESSENGER-RNA
AB The spectrum of ischaemic cardiomyopathy, encompassing acute myocardial infarction to congestive heart failure is a significant clinical issue in the modem era. This group of diseases is an enormous source of morbidity and mortality and underlies significant healthcare costs worldwide. Cardiac regenerative therapy, whereby pro-regenerative cells, drugs or growth factors are administered to damaged and ischaemic myocardium has demonstrated significant potential, especially preclinically. While some of these strategies have demonstrated a measure of success in clinical trials, tangible clinical translation has been slow. To date, the majority of clinical studies and a significant number of preclinical studies have utilised relatively simple delivery methods for regenerative therapeutics, such as simple systemic administration or local injection in saline carrier vehicles. Here, we review cardiac regenerative strategies with a particular focus on advanced delivery concepts as a potential means to enhance treatment efficacy and tolerability and ultimately, clinical translation. These include (i) delivery of therapeutic agents in biomaterial carriers, (ii) nanoparticulate encapsulation, (iii) multimodal therapeutic strategies and (iv) localised, minimally invasive delivery via percutaneous transcatheter systems. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] RCSI, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] Univ Dublin Trinity Coll, Coll Green, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Hastings, Conn L.; Ruiz-Hernandez, Eduardo; Duffy, Garry P.] TCD, Dublin 2, Ireland.
   [Roche, Ellen T.; Walsh, Conor J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Roche, Ellen T.; Walsh, Conor J.] Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.
   [Schenke-Layland, Katja] Univ Tubingen, Univ Womens Hosp, Dept Womens Hlth, D-72076 Tubingen, Germany.
   [Schenke-Layland, Katja] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, D-70569 Stuttgart, Germany.
   [Schenke-Layland, Katja] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Med Cardiol, Los Angeles, CA 90095 USA.
RP Duffy, GP (reprint author), RCSI, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
EM garryduffy@rcsi.ie
RI Schenke-Layland, Katja/E-5940-2013
OI Schenke-Layland, Katja/0000-0001-8066-5157; Duffy,
   Garry/0000-0002-4994-9511; Roche, Ellen/0000-0002-8952-2993
FU European Union [NMP3-SME-2013-604531]; Fulbright International Science
   and Technology Fund
FX We acknowledge the funding derived from the European Union's Seventh
   Framework Programme for research, technological development and
   demonstration under grant agreement no NMP3-SME-2013-604531 from
   November 2013 to October 2017, entitled AMCARE, and the Fulbright
   International Science and Technology Fund.
CR Abdel-Latif A, 2008, AM HEART J, V156, P216, DOI 10.1016/j.ahj.2008.03.024
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Anastasiadis K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-12
   Angion Biomedica Corp, 2012, ATUD EV SAF ACT BB3
   Armeanu S, 2000, MOL THER, V1, P366, DOI 10.1006/mthe.2000.0053
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Assmus B, 2013, JAMA-J AM MED ASSOC, V309, P1622, DOI 10.1001/jama.2013.3527
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Batista RJV, 1997, ANN THORAC SURG, V64, P634, DOI 10.1016/S0003-4975(97)00779-0
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Behfar A, 2013, CIRC-CARDIOVASC INTE, V6, P710, DOI 10.1161/CIRCINTERVENTIONS.112.000422
   Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066
   Behfar Atta, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS78, DOI 10.1038/ncpcardio0429
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036
   Chachques J.C., 2010, CARDIOL RES PRACT, V2011
   Chachques Juan C, 2007, J Interv Cardiol, V20, P188, DOI 10.1111/j.1540-8183.2007.00255.x
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Chistiakov DA, 2012, DRUG DELIV, V19, P392, DOI 10.3109/10717544.2012.738436
   CHIU RCJ, 1995, ANN THORAC SURG, V60, P12
   Choi Y., 2011, THORAC CARDIOVASC SU, V59, pV143
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Doppler SA, 2013, J THORAC DIS, V5, P683, DOI 10.3978/j.issn.2072-1439.2013.08.71
   Dor V, 2001, Semin Thorac Cardiovasc Surg, V13, P435
   Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Ebelt H, 2013, SHOCK, V39, P353, DOI 10.1097/SHK.0b013e318289728a
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Eschenhagen T., 2002, BASIC RES CARDIOL S1, V97, pI146
   Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739
   Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011
   Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1
   Gill S.L., 2014, TECHNOL HLTH CARE
   Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Gojo S, 2007, ANN THORAC SURG, V83, P661, DOI 10.1016/j.athoracsur.2006.06.074
   Gorman RC, 2004, SURG CLIN N AM, V84, P45, DOI 10.1016/S0039-6109(03)00216-0
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Grossi EA, 2010, J AM COLL CARDIOL, V56, P1984, DOI 10.1016/j.jacc.2010.06.051
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Haider HK, 2008, CURR OPIN MOL THER, V10, P611
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hesse M, 2014, STEM CELLS, V32, P1701, DOI 10.1002/stem.1696
   Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065
   Hsueh YC, 2014, EMBO MOL MED, V6, P496, DOI 10.1002/emmm.201303687
   Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ince H, 2004, J ENDOVASC THER, V11, P695, DOI 10.1583/04-1386R.1
   Ishimaru K, 2013, J THORAC CARDIOV SUR, V146, P1516, DOI 10.1016/j.jtcvs.2013.02.045
   Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152
   Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6
   Jain M, 2001, CIRCULATION, V103, P1920
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035
   Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Johnson NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063075
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Jung DW, 2012, ACS CHEM BIOL, V7, P1773, DOI 10.1021/cb3003368
   Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC
   Kai D., 2014, ACTA BIOMATER
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Kawachi K, 2012, HEART VESSELS, V27, P79, DOI 10.1007/s00380-011-0197-2
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2003, EUR J CARDIO-THORAC, V24, P906, DOI 10.1016/S1010-7940(03)00577-3
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456
   Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733
   Kubota Y, 2014, J THORAC CARDIOV SUR, V147, P1081, DOI 10.1016/j.jtcvs.2013.05.035
   Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6
   Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376
   Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Magovern JA, 2005, SEMIN THORAC CARDIOV, V17, P364, DOI 10.1053/j.semtcvs.2005.09.006
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   Mazhari R, 2007, PROG CARDIOVASC DIS, V49, P387, DOI 10.1016/j.pcad.2007.03.004
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Miyagawa S, 2009, SURG TODAY, V39, P133, DOI 10.1007/s00595-008-3803-x
   Monaghan M, 2014, MOL THER, V22, P786, DOI 10.1038/mt.2013.288
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Mukherjee S, 2010, J MATER CHEM, V20, P8819, DOI 10.1039/c0jm00805b
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Murakoshi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079374
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Muthiah M, 2013, EXPERT OPIN DRUG DEL, V10, P1259, DOI 10.1517/17425247.2013.798640
   Nakamura K, 2007, CLIN SCI, V112, P607, DOI 10.1042/CS20060301
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Nasseri BA, 2007, CELL TRANSPLANT, V16, P941, DOI 10.3727/096368907783338235
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]
   O'Cearbhaill ED, 2014, MAYO CLIN PROC, V89, P259, DOI 10.1016/j.mayocp.2013.10.020
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.04.686
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Parelkar SS, 2014, BIOMACROMOLECULES, V15, P1328, DOI 10.1021/bm401878p
   Pavo N, 2014, BIOMATERIALS, V35, P3541, DOI 10.1016/j.biomaterials.2013.12.071
   Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440
   Perin E.C., 2010, CIRCULATION
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   Plowright AT, 2014, ANGEW CHEM INT EDIT, V53, P4056, DOI 10.1002/anie.201307034
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Pouzet B, 2001, CIRCULATION, V104, pI223
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Projahn D, 2014, J CELL MOL MED, V18, P790, DOI 10.1111/jcmm.12225
   Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/RME.12.17, 10.2217/rme.12.17]
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Qian L, 2012, TISSUE ENG PT A, V18, P1652, DOI [10.1089/ten.tea.2011.0591, 10.1089/ten.TEA.2011.0591]
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rajnoch C, 2001, J THORAC CARDIOV SUR, V121, P871, DOI 10.1067/mtc.2001.112937
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455
   Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104
   Roubille F, 2013, CARDIOVASC DRUG THER, V27, P315, DOI 10.1007/s10557-013-6461-1
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Russo V, 2014, BIOMATERIALS, V35, P3956, DOI 10.1016/j.biomaterials.2014.01.075
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500
   Sanchis-Gomar F, 2014, INT J CARDIOL, V171, P116, DOI 10.1016/j.ijcard.2013.12.011
   Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shafy A, 2013, EUR J CARDIO-THORAC, V43, P1211, DOI 10.1093/ejcts/ezs480
   Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Simpson DL, 2012, BIOTECHNOL BIOENG, V109, P274, DOI 10.1002/bit.23301
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smith R.R., 2013, BIOMATTER, V3
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Smits Pieter C, 2006, EuroIntervention, V1, P417
   Soler-Botija C, 2012, ANN NY ACAD SCI, V1254, P57, DOI 10.1111/j.1749-6632.2012.06519.x
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Song M, 2014, BIOMATERIALS, V35, P2436, DOI 10.1016/j.biomaterials.2013.12.011
   Steendijk Paul, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS94, DOI 10.1038/ncpcardio0416
   Sullivan KMA, 2014, SOUTHERN HUMAN REV, V48, P14
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070
   Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003
   Theiss HD, 2010, INT J CARDIOL, V145, P282, DOI 10.1016/j.ijcard.2009.09.555
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tomita S, 1999, CIRCULATION, V100, P247
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726
   Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yacoub Magdi H, 2013, Glob Cardiol Sci Pract, V2013, P5, DOI 10.5339/gcsp.2013.3
   Yi BA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014050
   Yoon J, 2005, ACTA CARDIOL, V60, P277, DOI 10.2143/AC.60.3.2005005
   YOON PD, 1995, TEX HEART I J, V22, P119
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JC1200522326
   Yost MJ, 2004, TISSUE ENG, V10, P273, DOI 10.1089/107632704322791916
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682
   Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013
   Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang SH, 2004, LIFE SCI, V74, P2853, DOI 10.1016/j.lfs.2003.10.035
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
   Ziegler M, 2012, CIRCULATION, V125, P685, DOI 10.1161/CIRCULATIONAHA.111.070508
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
NR 261
TC 66
Z9 66
U1 13
U2 92
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR
PY 2015
VL 84
BP 85
EP 106
DI 10.1016/j.addr.2014.08.006
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ7WC
UT WOS:000355710100006
PM 25172834
OA Green Published, Other Gold
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Cezar, CA
   Mooney, DJ
AF Cezar, Christine A.
   Mooney, David J.
TI Biomaterial-based delivery for skeletal muscle repair
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Muscle regeneration; Satellite cell; Synthetic niche; Microenvironmental
   cue; Tissue engineered muscle; Cell therapy; Drug delivery
ID SATELLITE CELL ACTIVATION; HEPATOCYTE GROWTH-FACTOR; STEM-CELLS;
   SELF-RENEWAL; IN-VITRO; ENGINEERED MUSCLE; MYOBLAST TRANSPLANTATION;
   BIOARTIFICIAL MUSCLE; EXTRACELLULAR-MATRIX; POSTNATAL MYOGENESIS
AB Skeletal muscle possesses a remarkable capacity for regeneration in response to minor damage, but severe injury resulting in a volumetric muscle loss can lead to extensive and irreversible fibrosis, scarring, and loss of muscle function. In early clinical trials, the intramuscular injection of cultured myoblasts was proven to be a safe but ineffective cell therapy, likely due to rapid death, poor migration, and immune rejection of the injected cells. In recent years, appropriate therapeutic cell types and culturing techniques have improved progenitor cell engraftment upon transplantation. Importantly, the identification of several key biophysical and biochemical cues that synergistically regulate satellite cell fate has paved the way for the development of cell-instructive biomaterials that serve as delivery vehicles for cells to promote in vivo regeneration. Material carriers designed to spatially and temporally mimic the satellite cell niche may be of particular importance for the complete regeneration of severely damaged skeletal muscle. (C) 2014 Elsevier B.V. All rights reserved.
C1 Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.
RP Mooney, DJ (reprint author), 29 Oxford St,Room 319, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
FU NIDCR NIH HHS [R01 DE013349]
CR Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189
   Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003
   Boonen KJM, 2008, TISSUE ENG PART B-RE, V14, P419, DOI 10.1089/ten.teb.2008.0045
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P53, DOI 10.1039/b719928g
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bouchentouf M, 2007, AM J TRANSPLANT, V7, P1491, DOI 10.1111/j.1600-6143.2007.01830.x
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Cezar C.A., 2014, ADV HEALTHC IN PRESS
   Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb
   Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cossu G, 2007, CELL, V129, P859, DOI 10.1016/j.cell.2007.05.029
   Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903
   Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Gates C, 2005, OPER TECHN SPORT MED, V13, P247, DOI 10.1053/j.otsm.2006.01.012
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hall J, 2010, NATION, V291, P2
   Hammers DW, 2012, BIOTECHNOL BIOENG, V109, P1051, DOI 10.1002/bit.24382
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Huang NF, 2010, AM J TRANSL RES, V2, P43
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Juhas M, 2013, CURR OPIN BIOTECH, V24, P880, DOI 10.1016/j.copbio.2013.04.013
   Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013
   Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595
   Lesault PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046698
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7
   Lin S, 2013, MUSCLE NERVE, V47, P194, DOI 10.1002/mus.23447
   Lu YX, 2001, CIRCULATION, V104, P594, DOI 10.1161/hc3101.092215
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   McCullagh K.J., 2014, ADV DRUG DE IN PRESS
   Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.20071
   Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Neal D, 2014, LAB CHIP, V14, P1907, DOI 10.1039/c4lc00023d
   Nguyen HX, 2005, J PHYSIOL-LONDON, V565, P403, DOI 10.1113/jphysiol.2005.085506
   Ota S, 2011, AM J SPORT MED, V39, P1912, DOI 10.1177/0363546511415239
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Palmieri B, 2010, PEDIATR TRANSPLANT, V14, P813, DOI 10.1111/j.1399-3046.2010.01377.x
   Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181
   Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690comd
   Powell C, 1999, HUM GENE THER, V10, P565, DOI 10.1089/10430349950018643
   Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288
   Salimath A.S., 2014, J TISSUE EN IN PRESS
   Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035
   Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111
   Shansky J, 1997, IN VITRO CELL DEV-AN, V33, P659, DOI 10.1007/s11626-997-0118-y
   Shansky J, 2006, TISSUE ENG, V12, P1833, DOI 10.1089/ten.2006.12.1833
   Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
   Shvartsman D, 2014, MOL THER, V22, P1243, DOI 10.1038/mt.2014.76
   Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212
   Slater Clarke R., 2008, V3, P303
   Smythe GM, 2001, J CELL MOL MED, V5, P33, DOI 10.1111/j.1582-4934.2001.tb00136.x
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tedesco FS, 2012, CURR OPIN NEUROL, V25, P597, DOI 10.1097/WCO.0b013e328357f288
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7
   Urciuolo A., 2013, NAT COMMUN, V4
   Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931
   von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110
   Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021
   Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78
   Wang L, 2013, MOL NEUROBIOL, V48, P397, DOI 10.1007/s12035-013-8412-z
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Webster M.T., 2013, PLOS ONE, V8
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 116
TC 41
Z9 42
U1 6
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR
PY 2015
VL 84
BP 188
EP 197
DI 10.1016/j.addr.2014.09.008
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CJ7WC
UT WOS:000355710100013
PM 25271446
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Manfrini, M
   Mazzoni, E
   Barbanti-Brodano, G
   Nocini, P
   D'agostino, A
   Trombelli, L
   Tognon, M
AF Manfrini, Marco
   Mazzoni, Elisa
   Barbanti-Brodano, Giovanni
   Nocini, Pierfrancesco
   D'agostino, Antonio
   Trombelli, Leonardo
   Tognon, Mauro
TI Osteoconductivity of Complex Biomaterials Assayed by
   Fluorescent-Engineered Osteoblast-like Cells
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Osteoconductivity; Osteointegration; Biomaterial; Bone; Osteoblast
ID GUIDED BONE REGENERATION; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION;
   IN-VITRO; GRAFT SUBSTITUTES; HYDROXYAPATITE; PROLIFERATION; COLLAGEN;
   SCAFFOLDS; ADHESION
AB Biomaterials employed for the bone regeneration can be assayed for specific features such as osteoconductivity and gene expression. In this study, the composite HA/collagen/chondroitin-sulfate biomaterial was investigated using an engineered human cell line, named Saos-eGFP. This cell line, a green fluorescent engineered human osteoblast-like cell, was employed as a cellular model for the in vitro study of biomaterial characteristics. The cytotoxicity was indirectly evaluated by fluorescence detection, osteoconductivity was assayed both by fluorescence and electron microscope analysis as well as cell morphology, whereas the RT-PCR technique was employed to assay gene expression. Saos-eGFP cells viability detection after 24 and 96 h of incubation showed that biomaterial enables the adhesion and proliferation of seeded cells as well as that of the plastic surface, the control. Fluorescence and scanning electron microscopy (SEM) analyses indicated that Saos-eGFP cells were homogeneously distributed on the HA granule surfaces, exhibiting cytoplasmic bridges, and were localized on the collagen-chondroitin sulfate extra-cellular matrix. An expression analysis of specific genes encoding for differentiation markers, showed that biomaterial assayed did not alter the osteogenic pathway of the Saos-eGFP cell line. Our assays confirm the cytocompatibility of this biomaterial, suggesting an osteoconductive capacity mediated by its chemical contents. We showed that the Saos-eGFP cellular model is suitable for in vitro biomaterial assays, and more specifically for assessing osteoconductivity. This result suggests that the cytocompatibility and osteoconductive features of the biomaterial assayed as bone substitute, could have a positive downstream effect on implant osteo-integration.
C1 [Manfrini, Marco; Mazzoni, Elisa; Tognon, Mauro] Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
   [Barbanti-Brodano, Giovanni] Rizzoli Orthopaed Inst, Spine Surg Unit, Bologna, Italy.
   [Nocini, Pierfrancesco; D'agostino, Antonio] Univ Verona, Sch Med, Dept Surg, I-37100 Verona, Italy.
   [Trombelli, Leonardo] Univ Ferrara, Res Ctr Study Periodontal & Peri Implant Dis, I-44100 Ferrara, Italy.
RP Tognon, M (reprint author), Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
EM tgm@unife.it
RI Trombelli, Leonardo/I-4671-2015
OI Trombelli, Leonardo/0000-0002-1147-2199
FU Regione Emilia Romagna; Research Project Region/University "Regenerative
   Medicine in Osteo-articular Diseases; Regenerative medicine for bone
   repair"; AOSpine International, Dubendorf, Switzerland; Fondazione Cassa
   di Risparmio di Bologna, Bologna; Fondazione Cassa di Risparmio di
   Cento, Cento; University of Verona. Italy; University of Ferrara. Italy
FX Dr. Rita Bovolenta's technical assistance is gratefully acknowledged for
   her SEM analysis performed at the Center of Electron Microscopy,
   University of Ferrara, Ferrara, Italy. This study was supported, in
   part, by grants from Regione Emilia Romagna, the Research Project
   Region/University "Regenerative Medicine in Osteo-articular Diseases;
   Regenerative medicine for bone repair"; AOSpine International,
   Dubendorf, Switzerland, project "Gene therapy for bone regeneration";
   Fondazione Cassa di Risparmio di Bologna, Bologna; Fondazione Cassa di
   Risparmio di Cento, Cento; and The Universities of Verona and Ferrara.
   Italy.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Benque E, 1999, INT J ORAL MAX IMPL, V14, P258
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Campioni K., 2010, J BIOMATER NANOBIOTE, V1, P1
   Chou YF, 2005, BIOMATERIALS, V26, P285, DOI 10.1016/j.biomaterials.2004.02.030
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jenis L. G., 2006, US MUSCULOSKELETAL R, V2, P48
   Jones GL, 2010, J BIOMED MATER RES A, V94A, P1244, DOI 10.1002/jbm.a.32805
   Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Locci P, 1997, CELL BIOCHEM FUNCT, V15, P163
   Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276
   Manfrini M., 2011, EUROPEAN MUSCULOSKEL, V6, P96
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Morelli C, 2007, J BIOMED MATER RES A, V83A, P178, DOI 10.1002/jbm.a.31262
   Ogiso M, 1998, J LONG-TERM EFF MED, V8, P193
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Rebaudi A, 2003, INT J PERIODONT REST, V23, P371
   Reichardt L. F., 1999, GUIDEBOOK EXTRACELLU, P335
   RODAN SB, 1987, CANCER RES, V47, P4961
   SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292
   Scabbia A, 2004, J CLIN PERIODONTOL, V31, P348, DOI 10.1111/j.1600-051X.2004.00483.x
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Teixeira S, 2008, J MATER SCI-MATER M, V19, P855, DOI 10.1007/s10856-007-3005-x
   Tognon M., 2008, TOPICS TISSUE ENG, V4, P1
   Trombelli L, 2010, Minerva Stomatol, V59, P103
   Trombelli L, 2010, J PERIODONTOL, V81, P1256, DOI 10.1902/jop.2010.100113
   Trombelli L, 2010, J PERIODONTOL, V81, P158, DOI 10.1902/jop.2009.090275
   Villarreal D R, 1998, J Oral Implantol, V24, P67, DOI 10.1563/1548-1336(1998)024<0067:PAAORT>2.3.CO;2
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 39
TC 2
Z9 2
U1 1
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD APR
PY 2015
VL 71
IS 3
BP 1509
EP 1515
DI 10.1007/s12013-014-0374-x
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CJ2VN
UT WOS:000355342900030
PM 25388843
OA Green Published
DA 2018-10-20
ER

PT J
AU Grenho, L
   Barros, J
   Ferreira, C
   Santos, VR
   Monteiro, FJ
   Ferraz, MP
   Cortes, ME
AF Grenho, L.
   Barros, J.
   Ferreira, C.
   Santos, V. R.
   Monteiro, F. J.
   Ferraz, M. P.
   Cortes, M. E.
TI In vitro antimicrobial activity and biocompatibility of propolis
   containing nanohydroxyapatite
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE nanohydroxyapatite; propolis; antibacterial activity; cytocompatibility
ID BRAZILIAN RED PROPOLIS; CHEMICAL-COMPOSITION; BOTANICAL ORIGIN;
   ANTIBACTERIAL ACTIVITY; PERIODONTAL-LIGAMENT; BIOLOGICAL-ACTIVITY;
   DIFFERENT REGIONS; SALMONELLA-TYPHI; FIBROBLASTS; CONSTITUENTS
AB The high number of biomaterial associated infections demands new strategies to prevent this problem. In this study the suitability of nanohydroxyapatite (nanoHA)-based surfaces containing two Brazilian extracts of propolis (green and red ones) to prevent bacterial growth and biofilm formation, as well as its non-cytotoxic nature, was investigated. Optical density, colony forming units and MTT reduction assay were used to assess the materials' antibacterial activity against planktonic and sessile growth of Staphylococcus aureus. NanoHA matrix was able to absorb both types of propolis and the obtained results revealed the antibacterial effectiveness of the novel materials expressed as the reduction of bacterial growth and biofilm formation ability. Additionally, cell culture tests showed the growth of fibroblasts with high metabolic activity and without membrane damage. Therefore, these nanoHA-based surfaces containing natural products deriving from bees may be a promising bioactive biomaterial to be further studied with the aim of application to orthopaedic or dental devices.
C1 [Grenho, L.; Barros, J.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, Inst Biomed Engn, INEB, P-4100 Oporto, Portugal.
   [Grenho, L.; Barros, J.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, Inst Invest & Inovacao Saude I3S, P-4100 Oporto, Portugal.
   [Grenho, L.; Barros, J.; Monteiro, F. J.] Univ Porto, DEMM, Fac Engn, P-4100 Oporto, Portugal.
   [Barros, J.; Ferreira, C.] Univ Porto, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Fac Engn, DEQ, P-4100 Oporto, Portugal.
   [Santos, V. R.; Cortes, M. E.] Univ Fed Minas Gerais, Fac Odontol, Belo Horizonte, MG, Brazil.
   [Ferraz, M. P.] Univ Fernando Pessoa, FP ENAS CEBIMED, Oporto, Portugal.
RP Grenho, L (reprint author), Univ Porto, Inst Biomed Engn, INEB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM liliana.grenho@ineb.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Monteiro, Fernando/0000-0002-1361-4605; Barros,
   Joana/0000-0002-8205-5675
FU INCT/Nanobiofarm; CNPq; FEDER funds through the Programa Operacional
   Factores de Competitividade-COMPETE; Portuguese funds through
   FCT-Fundacao para a Ciencia e a Tecnologia in the framework of the
   NaNOBiofilm project [PTDC/SAU-BMA/111233/2009];  [SFRH/BD/72866/2010]
FX This work was financed by INCT/Nanobiofarm; CNPq; FEDER funds through
   the Programa Operacional Factores de Competitividade-COMPETE; Portuguese
   funds through FCT-Fundacao para a Ciencia e a Tecnologia in the
   framework of the NaNOBiofilm project (PTDC/SAU-BMA/111233/2009); and the
   PhD grant (SFRH/BD/72866/2010). This support is gratefully acknowledged.
   The authors are also grateful to Fluidinova S A for the supply of
   NanoXIM.
CR Al-Shaher A, 2004, J ENDODONT, V30, P359, DOI 10.1097/00004770-200405000-00012
   Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Bankova V, 2005, EVID-BASED COMPL ALT, V2, P29, DOI 10.1093/ecam/neh059
   Barros J, 2014, J BIOMATER APPL, V28, P1325, DOI 10.1177/0885328213507300
   Barud HD, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/703024
   Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057
   de Almeida EB, 2013, J ETHNOPHARMACOL, V147, P419, DOI 10.1016/j.jep.2013.03.031
   De Luca MP, 2014, BIOMED RES INT, DOI 10.1155/2014/348647
   Fernandes A, 2005, MEM I OSWALDO CRUZ, V100, P563, DOI 10.1590/S0074-02762005000500018
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Gao JH, 2011, J MATER SCI-MATER M, V22, P1681, DOI 10.1007/s10856-011-4349-9
   Gatto MT, 2002, BIOORGAN MED CHEM, V10, P269, DOI 10.1016/S0968-0896(01)00275-9
   Gjertsen AW, 2011, ORAL SURG ORAL MED O, V112, P843, DOI 10.1016/j.tripleo.2011.08.004
   Gonsales GZ, 2006, J VENOM ANIM TOXINS, V12, P276, DOI 10.1590/S1678-91992006000200009
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hatunoglu E, 2014, ANGLE ORTHOD, V84, P368, DOI 10.2319/020413-101.1
   Isla MI, 2005, J AGR FOOD CHEM, V53, P1166, DOI 10.1021/jf040130h
   Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x
   Mirzoeva OK, 1997, MICROBIOL RES, V152, P239
   Orsi RO, 2012, NAT PROD RES, V26, P430, DOI 10.1080/14786419.2010.498776
   Orsi RD, 2006, BRAZ J MICROBIOL, V37, P108, DOI 10.1590/S1517-83822006000200002
   Ozan Fatih, 2007, Eur J Dent, V1, P195
   Park YK, 2004, J AGR FOOD CHEM, V52, P1100, DOI 10.1021/jf021060m
   Park YK, 1998, CURR MICROBIOL, V36, P24, DOI 10.1007/s002849900274
   Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b
   Popova M, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-158
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Righi AA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/267878
   Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468
   Salomao K, 2008, EVID-BASED COMPL ALT, V5, P317, DOI 10.1093/ecam/nem058
   Santana HF, 2012, WORLD J MICROB BIOT, V28, P485, DOI 10.1007/s11274-011-0839-7
   Santos VR, 2008, PHYTOTHER RES, V22, P1544, DOI 10.1002/ptr.2541
   Santos VR, 2005, PHYTOTHER RES, V19, P652, DOI 10.1002/ptr.1715
   Sawaya ACHF, 2004, BRAZ J MICROBIOL, V35, P104, DOI 10.1590/S1517-83822004000100017
   Scazzocchio F, 2006, MICROBIOL RES, V161, P327, DOI 10.1016/j.micres.2005.12.003
   Bonvehi JS, 2012, WORLD J MICROB BIOT, V28, P1351, DOI 10.1007/s11274-011-0932-y
   Sforcin JM, 2007, J ETHNOPHARMACOL, V113, P1, DOI 10.1016/j.jep.2007.05.012
   Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032
   Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059
   Sonmez S, 2005, J ETHNOPHARMACOL, V102, P371, DOI 10.1016/j.jep.2005.06.035
   Szliszka E, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/976415
   TAKAISIKIKUNI NB, 1994, PLANTA MED, V60, P222, DOI 10.1055/s-2006-959463
   Topcuoglu Nursen, 2012, Eur J Dent, V6, P428
   Torlak E, 2013, INT J BIOL MACROMOL, V60, P52, DOI 10.1016/j.ijbiomac.2013.05.013
   Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/ne1006
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
NR 51
TC 13
Z9 15
U1 1
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2015
VL 10
IS 2
AR 025004
DI 10.1088/1748-6041/10/2/025004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CJ0BK
UT WOS:000355136900004
PM 25784672
DA 2018-10-20
ER

PT J
AU Uklejewski, R
   Winiecki, M
   Musielak, G
   Tokowicz, R
AF Uklejewski, Ryszard
   Winiecki, Mariusz
   Musielak, Grzegorz
   Tokowicz, Renata
TI Effectiveness of various deproteinization processes of bovine cancellous
   bone evaluated via mechano-biostructural properties of produced
   osteoconductive biomaterials
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE deproteinized xenogenic osteoconductive biomaterials; processes of bone
   deproteinization; mechano-biostructural properties; bone tissue
   regeneration
ID HYDROGEN-PEROXIDE; CORTICAL BONE; SUBSTITUTE; XENOGRAFT; PROTEIN; ANTLER
AB The purpose of this work was to characterize the results of five different processes of bovine tissue deproteinization, resulting in the fabrication of deproteinized xenogenic osteoconductive biomaterials for bone tissue regeneration as an alternative to autogenic bone grafts. The studies on deproteinization processes of bovine cancellous bone specimens, excised from fresh femoral bovine heads, included the following five processes: thermal deproteinization and four chemical deproteinization processes using the solutions 2.6 wt% sodium hypochlorite, 7 wt% hydrogen peroxide, 1 N potassium hydroxide and 1 N sodium hydroxide. The optimal parameters of the thermal deproteinization were designed on the basis of thermogravimetric analysis (TGA) of bovine bone specimens during a pilot study of the process. Periodical evaluation of all the processes of chemical deproteinization was performed via the assessment of protein concentration in bone specimens by the Lowry method. The mechanical properties of deproteinized bone specimens were evaluated by compression testing in the air-dry condition. The compressive strength of the completely deproteinized bone specimens after the thermal deproteinization process was remarkably lower compared with those after the chemical deproteinization processes: 6.5 times lower compared with those deproteinized with 7 wt% hydrogen peroxide solution and 3 times lower compared with those deproteinized with 2.6 wt% sodium hypochlorite solution. The SEM examination of deproteinized bone specimens showed microcracks on the trabecular surfaces generated by thermal deproteinization stresses. The presence of microcracks in the biomaterial resulted in a decrease in its ultimate compressive strength.
C1 [Uklejewski, Ryszard; Winiecki, Mariusz; Musielak, Grzegorz; Tokowicz, Renata] Poznan Univ Tech, Lab Biomat & Periimplant Bioproc Engn, Dept Proc Engn, Inst Technol & Chem Engn, PL-60965 Poznan, Poland.
   [Uklejewski, Ryszard; Winiecki, Mariusz] Casimir Great Univ, Dept Med Bioengn Fundamentals, Inst Technol, PL-85064 Bydgoszcz, Poland.
RP Uklejewski, R (reprint author), Poznan Univ Tech, Lab Biomat & Periimplant Bioproc Engn, Dept Proc Engn, Inst Technol & Chem Engn, Pl Marii Sklodowskiej Curie 2, PL-60965 Poznan, Poland.
EM uklejew@ukw.edu.pl
RI Musielak, Grzegorz/N-9872-2013; Winiecki, Mariusz/J-4565-2013
OI Winiecki, Mariusz/0000-0002-3568-2473
FU Polish Ministry of Science [NN518412638]
FX This research was supported by the Polish Ministry of Science research
   project No. NN518412638: The thermochemical surface modification of
   preprototypes of the minimally invasive RHA endoprostheses and porous
   intraosseous implants (Head: R. Uklejewski).
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389
   Bertazzo S, 2008, J INORG BIOCHEM, V102, P137, DOI 10.1016/j.jinorgbio.2007.07.031
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Castro-Cesena A. B., 2011, MRS P, V1301, DOI [10.1557/opl.2011.194, DOI 10.1557/OPL.2011.194]
   Castro-Cesena AB, 2013, MAT SCI ENG C-MATER, V33, P4958, DOI 10.1016/j.msec.2013.08.022
   Chen PY, 2009, ACTA BIOMATER, V5, P693, DOI 10.1016/j.actbio.2008.09.011
   Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006
   Chen PY, 2011, CALCIFIED TISSUE INT, V88, P351, DOI 10.1007/s00223-011-9462-8
   Cho JS, 2013, J BIOMED MATER RES B, V101B, P855, DOI 10.1002/jbm.b.32890
   Figueiredo MM, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P315
   Hui-fen X., 2011, J CLIN REHAB TISS EN, V15, P8749
   Jankovic B, 2011, THERMOCHIM ACTA, V521, P130, DOI 10.1016/j.tca.2011.02.044
   Jian YK, 2008, CHIN J TRAUMATOL, V11, P152, DOI 10.1016/S1008-1275(08)60032-2
   Liu Lei, 2007, Chin J Traumatol, V10, P59
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manilay Z, 2013, ACTA BIOMATER, V9, P5280, DOI 10.1016/j.actbio.2012.08.040
   Murugan R, 2003, B MATER SCI, V26, P523, DOI 10.1007/BF02707351
   Sciadini MF, 1997, J ORTHOPAED RES, V15, P844, DOI 10.1002/jor.1100150609
   Stavropoulos Andreas, 2008, P119, DOI 10.1007/978-1-59745-239-7_7
   Wynnyckyj C, 2011, BBA-GEN SUBJECTS, V1810, P192, DOI 10.1016/j.bbagen.2010.10.003
   Wynnyckyj C, 2009, BONE, V44, P840, DOI 10.1016/j.bone.2008.12.014
   Zhang XH, 2013, BIOMATERIALS, V34, P9103, DOI 10.1016/j.biomaterials.2013.08.024
NR 24
TC 2
Z9 2
U1 0
U2 11
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
EI 1976-3816
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD APR
PY 2015
VL 20
IS 2
BP 259
EP 266
DI 10.1007/s12257-013-0510-2
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CI4IK
UT WOS:000354711700008
DA 2018-10-20
ER

PT J
AU Kim, DG
   Woo, KD
   Kang, DS
   Lee, T
   Lee, MH
AF Kim, D. G.
   Woo, K. D.
   Kang, D. S.
   Lee, T.
   Lee, M. H.
TI Fabrication and biocompatibility evaluation of porous Ti-Nb-based
   biomaterials with space holder by rapid sintering
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Biomaterial; Ti alloy; Space holder; Spark plasma sintering; High-energy
   mechanical milling; Biocompatibility
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; MICROSTRUCTURE
AB Biomaterials of titanium and its alloys are useful as implant materials in orthopaedic surgery. In this study, porous Ti-13wt% Nb-13wt% Zr biomaterials were successfully fabricated using powder metallurgy by adding 10-30 wt-% NH4HCO3 as a space holder and TiH2 as a foaming agent to mixed and milled Ti-Nb-Zr powders. The alloy powders were consolidated by spark plasma sintering process at 1123 K under 30 MPa conditions. The effect of space holder content on the pore size and distribution of the Ti-13wt% Nb-13wt% Zr (TNZ) alloys was observed by optical microscopy and scanning electron microscopy. These microstructure observations revealed that the volume fraction of the pores increased with increasing space holder content. The pore size of the TNZ alloy changed from the 100 mu m scale to the 10 mu m scale with increasing milling time and space holder content in the TNZ powders. The porous TNZ alloys exhibited good biocompatibility.
C1 [Kim, D. G.; Woo, K. D.; Kang, D. S.; Lee, T.] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
   [Kim, D. G.; Woo, K. D.; Kang, D. S.; Lee, T.] Chonbuk Natl Univ, RCAMD, Jeonju 561756, South Korea.
   [Lee, M. H.] Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Jeonju 561756, South Korea.
RP Woo, KD (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561756, South Korea.
EM kdwoo@jbnu.ac.kr
FU National Research Foundation (NRF) of Korea [2013R1A1A4A01005459];
   Chonbuk National University
FX This research was conducted with financial support from the National
   Research Foundation (NRF) (No. 2013R1A1A4A01005459) of Korea and was
   partially supported by research funds of Chonbuk National University in
   2014.
CR Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Lee B, 2014, MATER DESIGN, V57, P712, DOI 10.1016/j.matdes.2013.12.078
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nouri A, 2010, BIOMIMETICS, LEARNING FROM NATURE, P415
   OKAZAKI Y, 1995, J JPN I MET, V59, P108, DOI 10.2320/jinstmet1952.59.1_108
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Woo K. D., 2014, P 16 INT S MAT SCI E
NR 10
TC 2
Z9 2
U1 0
U2 32
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2015
VL 19
SU 1
BP S301
EP S304
DI 10.1179/1432891715Z.0000000001491
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7QA
UT WOS:000354957900066
DA 2018-10-20
ER

PT J
AU Lee, HC
   Wo, KD
   Kang, DS
   Lee, T
   Oh, ST
   Kang, WJ
AF Lee, H. C.
   Wo, K. D.
   Kang, D. S.
   Lee, T.
   Oh, S. T.
   Kang, W. J.
TI Effect of cobalt-aluminate addition on microstructure and mechanical
   property of Co-Cr-Mo alloy
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Co-Cr-Mo alloy; Inoculant; Lamellar structure; gamma Co-phase; Carbide;
   sigma-phase; Grain refinement; Cobalt-aluminate
ID IMPROVEMENT; SUPERALLOY
AB The as-cast Co-Cr-Mo alloy (ASTM F75) has been widely used as biomaterial in orthopaedic implant because of its excellent mechanical properties, good corrosion resistance and biocompatibility. However, some defects such as porosity and pinhole in an as-cast make some problems for application. Therefore in this study, the cobalt-aluminate (CoAl2O4) used as an inoculant during coating plays to refine the grain size and to reduce the porosity and pinhole content in an as-cast. Therefore, the effect of an inoculant addition on defect content, microstructure and mechanical properties of as-cast Co-Cr-Mo alloy has been investigated. The mechanical properties of the Co-Cr-Mo alloy were improved by addition of an inoculant.
C1 [Lee, H. C.; Wo, K. D.; Kang, D. S.; Lee, T.; Oh, S. T.] Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561765, South Korea.
   [Lee, H. C.; Wo, K. D.; Kang, D. S.; Lee, T.; Oh, S. T.] Chonbuk Natl Univ, RCAMD, Jeonju 561765, South Korea.
   [Kang, W. J.] NIB Mat Co Ltd, Jeonbuk 561330, South Korea.
RP Wo, KD (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Jeonju 561765, South Korea.
EM kdwoo@jbnu.ac.kr
FU Small and Medium Business Administration (SMBA) of Korea [1301000619]
FX This research was conducted with financial support from the Small and
   Medium Business Administration (SMBA) (No. 1301000619) of Korea.
CR Binczyk F., 2011, KOMPOZYTY, V11, P49
   Giacchi JV, 2011, MATER CHARACT, V62, P53, DOI 10.1016/j.matchar.2010.10.011
   Jin WZ, 2008, MATER LETT, V62, P1585, DOI 10.1016/j.matlet.2007.09.028
   Jurosu S., 2010, MATER LETT, V64, P49
   Kaiser R, 2013, J MECH BEHAV BIOMED, V24, P53, DOI 10.1016/j.jmbbm.2013.04.013
   Krauss G., 2005, STEELS PROCESSING ST, P97
   Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220
   Ocampo C.M., 1999, METALL MATER TRANS A, V30, P611
   Szala J, 2006, MATER CHARACT, V56, P325, DOI 10.1016/j.matchar.2005.11.015
   Wang DL, 2006, RARE METAL MAT ENG, V35, P1294
NR 10
TC 0
Z9 0
U1 1
U2 8
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2015
VL 19
SU 1
BP S66
EP S69
DI 10.1179/1432891715Z.0000000001370
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CI7QA
UT WOS:000354957900014
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Rzadkiewicz, S
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Rzadkiewicz, Slawomir
   Raaen, Steiner
TI HIGH-CURRENT-DENSITY ELECTROPOLISHING (HDEP) OF AISI 316L (EN 1.4404)
   STAINLESS STEEL
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE biomaterials; corrosion; electropolishing; electrochemical techniques;
   surface properties; X-ray photo-emission spectroscopy (XPS)
ID MAGNETIC-FIELD; XPS; SURFACE; SPECTROSCOPY; BEHAVIOR; SPECTRA; STENTS;
   RANGE; SS
AB The paper presents new XPS results of surface layers formed after electrochemical polishing of AISI 316L stainless steel at high current density (HDEP) of 1000 A/dm(2) (EP1000) versus a standard electropolishing (EP50) process used in the industry, i.e. at 50 A/dm(2). For the investigation, different compositions of electrolytes, based on orthophosphoric and sulfuric acids in proportions 4:6, 6:4, 1:0, respectively, were used. The obtained results have clearly shown that both the solution composition and current density highly influence the structure and compositions of passive layers formed after electrochemical treatments. For the steel used as a biomaterial, the surface films with a minimum amount of carcinogenic nickel was found; here also a maximum (Cr+ 3.3.Mo)/Fe coefficient was noticed. On the basis of the obtained results it can be concluded that for 316L SS used as a biomaterial, the electrochemical treatments EP50 and EP1000 in 40 vol% H3PO4 and 60 vol% H2SO4 solution as well as EP50 in 60 vol% H3PO4 and 40 vol% H2SO4 solution, should be used. In case of 316L SS not to be used for implants in the human body, EP1000 in pure concentrated orthophosphoric acid, is advised. EP1000 treatment of the 316L SS in 60 vol% H3PO4 and 40 vol% H2SO4 electrolyte may be used in case of applying the biomaterial for a non-Ni-allergic patient.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Rzadkiewicz, Slawomir] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Engn, PL-75620 Koszalin, Poland.
   [Raaen, Steiner] Norwegian Univ Sci & Technol NTNU, Dept Phys, NO-7491 Trondheim, Norway.
RP Rokosz, K (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   steinar.raaen@ntnu.no
CR Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   Chen SC, 2005, SURF COAT TECH, V200, P2065, DOI 10.1016/j.surfcoat.2005.06.008
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   Daulton TL, 2006, ULTRAMICROSCOPY, V106, P561, DOI 10.1016/j.ultramic.2006.02.005
   Faust C. L., 1982, MET FINISH, V80, P89
   Faust C. L., 1982, MET FINISH, V80, P21
   FAUST CL, 1983, MET FINISH, V81, P47
   FAUST CL, 1983, MET FINISH, V81, P53
   Flori M., 2007, ANN FACULTY ENG HUNE, V5, P165
   Geller ZE, 2008, MATER SCI FORUM, V589, P367, DOI 10.4028/www.scientific.net/MSF.589.367
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   Hensel K. B., 2000, MET FINISH, V98, P440, DOI [DOI 10.1016/S0026-0576(00)80353-0, 10.1016/S0026-0576(00)80353-0]
   HOCHENG H, 2001, Patent No. 6315885
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T., 1997, P 1 INT C MACH MEAS, P331
   Hryniewicz T., 1997, P INT SCI C CHALL CI, V2, P515
   Hryniewicz T., 1989, PHYSICOCHEMICAL TECH
   Hryniewicz T., 2004, SURFACE COATINGS TEC
   Hryniewicz T, 1978, THESIS
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Kao PS, 2003, J MATER PROCESS TECH, V140, P255, DOI 10.1016/S0924-0136(03)00747-7
   Kish JR, 2003, CORROS SCI, V45, P1571, DOI 10.1016/S0010-938X(02)00232-9
   Mazumder M. K., 2001, ELECT SURFACE STRUCT
   Nesbitt HW, 1998, AM MINERAL, V83, P305
   Raval A, 2004, MAT SCI ENG A-STRUCT, V386, P331, DOI 10.1016/j.msea.2004.07.051
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P545
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz Krzysztof, 2011, Pomiary Automatyka Kontrola, V57, P563
   Rokosz K., 2011, AUTOBUSY TECHNIKA EK, V5, P1
   Rokosz K., 2012, AUTOBUSY TECHNIKA EK, V5, P421
   Rokosz K, 2012, ELECTROMECHANICAL PO
   Rokosz K., 2010, CORROSION J SCI ENG, V66
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Santonen T., 2010, REV TOXICITY STAINLE
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Srinivasan K., 2002, 202 M SALT LAK CIT U, P355
   Tauson V. L., 2010, GEOCHEM INT, V48, P565
   Toma Y., 2009, Electrochemical polishing method and polishing method, Patent No. [US 2009/0095637 A1, 20090095637]
   Tomassi P., 2002, PORADNIK GALWANOTECH, P125
   Wang Y., 2002, SURF SCI SPECTRA, V9, P91
   Wang Y., 2002, SURFACE SCI SPECTRA, V9, P99
   Zhao H., 2003, PROGR BIOMED RES, V8, P70
NR 46
TC 8
Z9 8
U1 1
U2 10
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD APR
PY 2015
VL 22
IS 2
BP 415
EP 424
DI 10.17559/TV-20140722110711
PG 10
WC Engineering, Multidisciplinary
SC Engineering
GA CG9JK
UT WOS:000353630900021
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Jang, HL
   Lee, K
   Kang, CS
   Lee, HK
   Ahn, HY
   Jeong, HY
   Park, S
   Kim, SC
   Jin, K
   Park, J
   Yang, TY
   Kim, JH
   Shin, SA
   Han, HN
   Oh, KH
   Lee, HY
   Lim, J
   Hong, KS
   Snead, ML
   Xu, J
   Nam, KT
AF Jang, Hae Lin
   Lee, Keunho
   Kang, Chan Soon
   Lee, Hye Kyoung
   Ahn, Hyo-Yong
   Jeong, Hui-Yun
   Park, Sunghak
   Kim, Seul Cham
   Jin, Kyoungsuk
   Park, Jimin
   Yang, Tae-Youl
   Kim, Jin Hong
   Shin, Seon Ae
   Han, Heung Nam
   Oh, Kyu Hwan
   Lee, Ho-Young
   Lim, Jun
   Hong, Kug Sun
   Snead, Malcolm L.
   Xu, Jimmy
   Nam, Ki Tae
TI Biofunctionalized Ceramic with Self-Assembled Networks of Nanochannels
SO ACS NANO
LA English
DT Article
DE nanochannels; hierarchical structures; bioinspired; fluid transports;
   ceramics; pressure gradient sintering; polymer agglomeration
ID POROUS CERAMICS; CAPILLARY-FLOW; MICROSTRUCTURE; BONE; THERMODYNAMICS;
   PRINCIPLES; MECHANISM; TRANSPORT; BINDING; SYSTEMS
AB Nature designs circulatory systems with hierarchically organized networks of gradually tapered channels ranging from micrometer to nanometer in diameter. In most hard tissues in biological systems, fluid, gases, nutrients and wastes are constantly exchanged through such networks. Here, we developed a biologically inspired, hierarchically organized structure in ceramic to achieve effective permeation with minimum void region, using fabrication methods that create a long-range, highly interconnected nanochannel system in a ceramic biomaterial. This design of a synthetic model-material was implemented through a novel pressurized sintering process formulated to induce a gradual tapering in channel diameter based on pressure-dependent polymer agglomeration. The resulting system allows long-range, efficient transport of fluid and nutrients into sites and interfaces that conventional fluid conduction cannot reach without external force. We demonstrate the ability of mammalian bone-forming cells placed at the distal transport termination of the nanochannel system to proliferate in a manner dependent solely upon the supply of media by the self-powering nanochannels. This approach mimics the significant contribution that nanochannel transport plays in maintaining living hard tissues by providing nutrient supply that facilitates cell growth and differentiation, and thereby makes the ceramic composite "alive".
C1 [Jang, Hae Lin; Lee, Keunho; Kang, Chan Soon; Lee, Hye Kyoung; Ahn, Hyo-Yong; Jeong, Hui-Yun; Park, Sunghak; Kim, Seul Cham; Jin, Kyoungsuk; Park, Jimin; Yang, Tae-Youl; Kim, Jin Hong; Shin, Seon Ae; Han, Heung Nam; Oh, Kyu Hwan; Hong, Kug Sun; Nam, Ki Tae] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Lee, Ho-Young] Seoul Natl Univ, Bundang Hosp, Dept Nucl Med, Seoul 463707, South Korea.
   [Lim, Jun] POSTECH, Pohang Accelerator Lab, Pohang 790784, South Korea.
   [Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA.
   [Xu, Jimmy] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Xu, Jimmy] Brown Univ, Dept Phys, Providence, RI 02912 USA.
RP Snead, ML (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.
EM mlsnead@usc.edu; jimmy_xu@brown.edu; nkitae@snu.ac.kr
RI Han, Heung Nam/D-6461-2013; Han, Heung Nam/I-7675-2016; oh,
   kyuhwan/H-5265-2018
OI Han, Heung Nam/0000-0001-5271-9023; Jin, Kyoungsuk/0000-0003-3009-6691;
   Nam, Ki Tae/0000-0001-6353-8877
FU Basic Science Research Program, through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT Future [2011-0011225]; Global
   Frontier R&D Program on Center for Multiscale Energy System - National
   Research Foundation under the Ministry of Science, ICT Future, Korea
   [0420-20130104]; International Research & Development Program of the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [2013K1A3A1A32035536]; Brown University by an Air Force
   Office of Scientific Research (AFOSR); Brown's Institute of Brain
   Sciences; National Institute for Dental and Craniofacial Research Grant
   from the National Institutes of Health; U.S. Public Health Service;
   Basic Science Research Program through the National Research Foundation
   in Korea funded by the Ministry of Science, ICT, and Future Planning
   [NRF-2013R1A2A2A01008806]
FX This research was supported by the Basic Science Research Program,
   through the National Research Foundation of Korea (NRF), funded by the
   Ministry of Science, ICT & Future (No. Grant Number: 2011-0011225); the
   Global Frontier R&D Program on Center for Multiscale Energy System
   funded by the National Research Foundation under the Ministry of
   Science, ICT & Future, Korea (0420-20130104); the International Research
   & Development Program of the National Research Foundation of Korea
   (NRF), funded by the Ministry of Science, ICT & Future Planning (No.
   2013K1A3A1A32035536); and at Brown University by an Air Force Office of
   Scientific Research (AFOSR) grant for functional composite materials and
   seed funding from Brown's Institute of Brain Sciences. MLS was supported
   by National Institute for Dental and Craniofacial Research Grant R37
   DE13045 from the National Institutes of Health, U.S. Public Health
   Service. KL and HNH were supported by the Basic Science Research Program
   through the National Research Foundation in Korea funded by the Ministry
   of Science, ICT, and Future Planning (NRF-2013R1A2A2A01008806).
CR Bal K, 2011, INT J HEAT MASS TRAN, V54, P3096, DOI 10.1016/j.ijheatmasstransfer.2011.02.048
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144
   Barber RW, 2008, MICROFLUID NANOFLUID, V4, P179, DOI 10.1007/s10404-007-0163-6
   Bejan A, 2006, J APPL PHYS, V100, DOI 10.1063/1.2221896
   BROOKES M, 1961, LANCET, V1, P1078
   CHAKLADE.AC, 1965, NATURE, V206, P392, DOI 10.1038/206392c0
   Cho JS, 2013, J EUR CERAM SOC, V33, P233, DOI 10.1016/j.jeurceramsoc.2012.08.029
   Chung S, 2009, SMALL, V5, P609, DOI 10.1002/smll.200800748
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Dickson KM, 2001, CALCIFIED TISSUE INT, V68, P304, DOI 10.1007/BF02390838
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Driessens FCM, 1990, BIOMINERALS
   Eijkel JCT, 2007, LAB CHIP, V7, P1630, DOI 10.1039/b716545p
   Fan JT, 2007, MATER LETT, V61, P561, DOI 10.1016/j.matlet.2006.05.009
   Feldman KE, 2010, MACROMOLECULES, V43, P5121, DOI 10.1021/ma1003776
   Gupta S, 2006, NAT MATER, V5, P229, DOI 10.1038/nmat1582
   Gupta S, 2006, NANO LETT, V6, P2066, DOI 10.1021/nl061336v
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jang H. L., 2013, ACS NANO, V8, P634
   McNamee CE, 2007, BIOPHYS J, V93, P324, DOI 10.1529/biophysj.106.102251
   Nogueiras-Nieto L, 2011, J CONTROL RELEASE, V156, P337, DOI 10.1016/j.jconrel.2011.08.021
   Ozdemir C, 2006, J APPL POLYM SCI, V101, P203, DOI 10.1002/app.23191
   Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108
   Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023
   Ramesh S, 2012, MATER DESIGN, V34, P148, DOI 10.1016/j.matdes.2011.08.011
   Renvoise P, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/64003
   Reyssat M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/56002
   RONCA G, 1985, MACROMOLECULES, V18, P665, DOI 10.1021/ma00146a015
   RUBEGA MA, 1993, AUK, V110, P169
   SAKELLARIOU P, 1986, INT J PHARM, V31, P55, DOI 10.1016/0378-5173(86)90212-7
   Seidl B, 2011, J STRUCT BIOL, V174, P512, DOI 10.1016/j.jsb.2011.03.005
   Shou D., 2013, LANGMUIR, V30, P149
   Shou DH, 2014, LANGMUIR, V30, P5448, DOI 10.1021/la500479e
   Singh R., 2011, ADV MAT RES, V264, P1856
   Sparreboom W, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/015004
   Sparreboom W, 2009, NAT NANOTECHNOL, V4, P713, DOI [10.1038/nnano.2009.332, 10.1038/NNANO.2009.332]
   TRIMM DL, 1986, APPL CATAL, V21, P215, DOI 10.1016/S0166-9834(00)81356-1
   Weibel A, 2007, J EUR CERAM SOC, V27, P2641, DOI 10.1016/j.jeurceramsoc.2006.11.073
   Yang JF, 2001, J MATER RES, V16, P1916, DOI 10.1557/JMR.2001.0262
   Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729
   Zhou J, 2011, NANO RES, V4, P171, DOI 10.1007/s12274-010-0067-8
NR 42
TC 5
Z9 5
U1 0
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD APR
PY 2015
VL 9
IS 4
BP 4447
EP 4457
DI 10.1021/acsnano.5b01052
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA CH2PL
UT WOS:000353867000114
PM 25827409
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kratz, F
   Grass, S
   Umanskaya, N
   Scheibe, C
   Muller-Renno, C
   Davoudi, N
   Hannig, M
   Ziegler, C
AF Kratz, Fabian
   Grass, Simone
   Umanskaya, Natalia
   Scheibe, Christian
   Mueller-Renno, Christine
   Davoudi, Neda
   Hannig, Matthias
   Ziegler, Christiane
TI Cleaning of biomaterial surfaces: Protein removal by different solvents
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biomaterials; Cleaning; BCA-assay; TEM; Protein removal
ID BOVINE SERUM-ALBUMIN; DENTAL MATERIALS; ADSORPTION; HYDROXYAPATITE;
   WETTABILITY; MICROSCOPY; FIBRINOGEN; PELLICLE; FILMS; PH
AB The removal of biofilms or protein films from biomaterials is still a challenging task. In particular, for research investigations on real (applied) surfaces the reuse of samples is of high importance, because reuse allows the comparison of the same sample in different experiments.
   The aim of the present study was to evaluate the cleaning efficiency of different solvents (SOS, water, acetone, isopropanol, RIPA-buffer and Tween-20) on five different biomaterials (titanium, gold, PMMA (no acetone used), ceramic, and PTFE) with different wettability which were covered by layers of two different adsorbed proteins (BSA and lysozyme). The presence of a protein film after adsorption was confirmed by transmission electron microscopy (TEM).
   After treatment of the surfaces with the different solvents, the residual proteins on the surface were determined by BCA-assay (bicinchoninic acid assay). Data of the present study indicate that SDS is an effective solvent, but for several protein substrate combinations it does not show the cleaning efficiency often mentioned in literature. RIPA-buffer and Tween-20 were more effective. They showed very low residual protein amounts after cleaning on all examined material surfaces and for both proteins, however, with small differences for the respective substrate protein combinations. RIPA-buffer in combination with ultrasonication completely removed the protein layer as confirmed by TEM. (c) 2015 Elsevier B.V. All rights reserved.
C1 [Kratz, Fabian; Scheibe, Christian; Mueller-Renno, Christine; Davoudi, Neda; Ziegler, Christiane] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.
   [Kratz, Fabian; Scheibe, Christian; Mueller-Renno, Christine; Davoudi, Neda; Ziegler, Christiane] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany.
   [Grass, Simone; Umanskaya, Natalia; Hannig, Matthias] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, D-66421 Homburg, Germany.
RP Ziegler, C (reprint author), Erwin Schrodinger Str 56, D-67663 Kaiserslautern, Germany.
EM cz@physik.uni-kl.de
OI Ziegler, Christiane/0000-0002-7963-3729
FU German Research Foundation (DFG) as part of the collaborative research
   center [(SFB) 926];  [Zi 487/12-3];  [Ha 2718/7-3]
FX We acknowledge the financial support by the German Research Foundation
   (DFG) within the project B06 as part of the collaborative research
   center (SFB) 926 and the projects Zi 487/12-3 and Ha 2718/7-3. The
   helping hands of Jeanne-Carla Sprenger and Marie-Christine Angermann
   were highly appreciated during the lab work.
CR BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Can B.M.C., 1981, J COLLOID INTERF SCI, V82, P217
   Cheng K.C., 2010, APPL MICROBIOL BIOT, V86, P445
   Ercan D., 2013, CRIT REV BI IN PRESS
   FENG MH, 1995, J BIOMAT SCI-POLYM E, V7, P415
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P440, DOI 10.1016/0003-2697(84)90241-0
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Hannig M, 2005, CLIN ORAL INVEST, V9, P30, DOI 10.1007/s00784-004-0284-1
   Hannig M, 1997, EUR J ORAL SCI, V105, P422, DOI 10.1111/j.1600-0722.1997.tb02139.x
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   KONDO A, 1991, J COLLOID INTERF SCI, V143, P214, DOI 10.1016/0021-9797(91)90454-G
   Kratz F, 2013, PHYS STATUS SOLIDI A, V210, P964, DOI 10.1002/pssa.201200642
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   Li J., 2004, J APPL MICROBIOL, V46, P293
   Luan YF, 2014, LANGMUIR, V30, P1029, DOI 10.1021/la403498w
   MATTILASANDHOLM T, 1992, FOOD REV INT, V8, P573, DOI 10.1080/87559129209540953
   Muller C, 2010, LANGMUIR, V26, P4136, DOI 10.1021/la903299y
   Muller-Renno C., 2013, ADV BIOCH ENG BIOTEC
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   SEEBER SJ, 1991, VACCINE, V9, P201, DOI 10.1016/0264-410X(91)90154-X
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   Sotres J, 2011, LANGMUIR, V27, P13692, DOI 10.1021/la202870c
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
NR 26
TC 5
Z9 5
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 28
EP 35
DI 10.1016/j.colsurfb.2015.02.016
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000005
PM 25725311
DA 2018-10-20
ER

PT J
AU Kandiah, K
   Venkatachalam, R
   Wang, CY
   Valiyaveettil, S
   Ganesan, K
AF Kandiah, Kavitha
   Venkatachalam, Rajendran
   Wang, Chunyan
   Valiyaveettil, Suresh
   Ganesan, Kumaresan
TI In vitro and preliminary in vivo toxicity screening of high-surface-area
   TiO2-chondroitin-4-sulfate nanocomposites for bone regeneration
   application
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Titania-chondroitin-4 sulfate; Biocompatibility; In vitro bioactivity;
   Osteoblast cell line; Gene expression; Zebra fish
ID TISSUE ENGINEERING APPLICATIONS; OSTEOBLAST-LIKE CELLS; CHONDROITIN
   SULFATE; ANTIBACTERIAL ACTIVITY; SILVER NANOPARTICLES; ZEBRAFISH
   EMBRYOS; OXIDATIVE STRESS; CHITOSAN; SCAFFOLDS; GROWTH
AB The goal of this study was to prepare nontoxic, biomimetic TiO2/chondroitin-4-sulfate nanocomposites with osteointegration ability for biomedical applications. Nanocomposites with higher surface area were subjected to bioactivity study and obtained bone-like layer with stoichiometric Ca/P ratio of 1.64 and 1.66. The susceptibility of nanocomposites against Staphylococcus aureus (similar to 16 mm) and Escherichia coli (similar to 12 mm) is favorable in preventing the risk of bone diseases and postoperative infections. Adequate swelling and degradations properties were favorably achieved to reduce the risk of nanoparticle accumulation in cell organelles. Moreover, the toxicity in AGS cell line and biocompatibility in osteoblast-like MG-63 cell line showed no significant mitochondrial damage. In addition, the in vitro expression of osteoblast inducing genes (OCN, OPN, ALP and COL 1) and their up-regulation, and 20% of increased hatching rate in preliminary in vivo (zebrafish) analysis were favorable for the nanocomposite at the ratio of 2:0.50 than pure TiO2. Hence, it can be concluded that among the prepared nanocomposites TCs.5 is a promising biomimetic biomaterial that can be used for advanced orthopedic research and other applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kandiah, Kavitha; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
   [Wang, Chunyan; Valiyaveettil, Suresh] Natl Univ Singapore, Dept Chem, Fac Sci, Singapore 117543, Singapore.
   [Ganesan, Kumaresan] Madurai Kamaraj Univ, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India.
RP Venkatachalam, R (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE Consortium [CSR/Acctts/2010-11/1136]; Metal Physics Section,
   Indira Gandhi Centre for Atomic Research, Kalpakkam node
FX The authors acknowledge the UGC-DAE Consortium for research funding
   (CSR/Acctts/2010-11/1136 dt.06.01.2011) and Dr. G. Amarendra, Head,
   Metal Physics Section, Indira Gandhi Centre for Atomic Research,
   Kalpakkam node, for the financial support and valuable suggestions to
   carry out the research.
CR Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bobe K, 2013, ACTA BIOMATER, V9, P8611, DOI [10.1016/j.actbio.2013.03.035, 10.1016/j.actbio2013.03.035]
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chung YC, 2004, ACTA PHARMACOL SIN, V25, P932
   DREW WL, 1972, APPL MICROBIOL, V24, P240
   Falini G, 2008, J BIOMED MATER RES A, V87A, P470, DOI 10.1002/jbm.a.31771
   Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009
   Han J, 2012, CARBOHYD POLYM, V90, P122, DOI 10.1016/j.carbpol.2012.04.068
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Heinemann S, 2011, ACS APPL MATER INTER, V3, P4323, DOI 10.1021/am200993q
   Hou YP, 2012, J BIOMED MATER RES A, V100A, P939, DOI 10.1002/jbm.a.34031
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kavitha K, 2014, RSC ADV, V4, P43951, DOI 10.1039/c4ra03964e
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kavitha K, 2014, MAT SCI ENG C, V48, P252
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Kim H. C., 2012, APPL PHYS A, V107, P715
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948
   Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Mathew TV, 2013, COLLOID SURFACE B, V101, P14, DOI 10.1016/j.colsurfb.2012.05.017
   Muller G, 2000, CHEM-BIOL INTERACT, V124, P77, DOI 10.1016/S0009-2797(99)00142-8
   Nakayama N, 2007, POLYM DEGRAD STABIL, V92, P1255, DOI 10.1016/j.polymdegradstab.2007.03.026
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Sikong L., 2010, ENERGY RES J, V1, P120, DOI DOI 10.3844/ERJSP.2010.120.125
   Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001
   Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200
   Vandrovcova M, 2011, PHYSIOL RES, V60, P797
   VanLandingham MR, 2001, MACROMOL SYMP, V167, P15, DOI 10.1002/1521-3900(200103)167:1<15::AID-MASY15>3.0.CO;2-T
   Wu ZY, 2014, COLLOID SURFACE B, V120, P38, DOI 10.1016/j.colsurfb.2014.04.010
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
   Yuan Y, 2008, J BIOMED MATER RES B, V86B, P245, DOI 10.1002/jbm.b.31012
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
NR 44
TC 8
Z9 8
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 347
EP 356
DI 10.1016/j.colsurfb.2015.02.027
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000044
PM 25752961
DA 2018-10-20
ER

PT J
AU Fagali, NS
   Grillo, CA
   Puntarulo, S
   de Mele, MAFL
AF Fagali, Natalia S.
   Grillo, Claudia A.
   Puntarulo, Susana
   Fernandez Lorenzo de Mele, Monica A.
TI Cytotoxicity of corrosion products of degradable Fe-based stents:
   Relevance of pH and insoluble products
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biomaterials; Iron; Degradable; Cytotoxicity; Biocompatibility
ID IN-VITRO DEGRADATION; SILVER NANOPARTICLES; BIOCOMPATIBILITY; CELLS;
   IRON; ALLOYS; METAL; IMPLANTATION; VIVO; CADMIUM
AB Fe-based biodegradable metallic materials (Fe-BMMs) have been proposed for cardiovascular applications and are expected to disappear via corrosion after an appropriate period. However, in vivo studies showed that Fe ions release leads to accumulation of orange and brownish insoluble products at the biomaterial/cell interface. As an additional consequence, sharp changes in pH may affect the biocompatibility of these materials. In the present work, the experimental protocols were designed with the aim of evaluating the relative importance that these factors have on biocompatibility evaluation of BMMs. Mitochondrial activity (MU assay) and thiobarbituric acid reactive substances (TBARS) assay on mammalian cells, exposed to 1-5 mM of added Fe3+ salt, were assessed and compared with results linked exclusively to pH effects. Soluble Fe concentration in culture medium and intracellular Fe content were also determined. The results showed that: (i) mitochondrial activity was affected by pH changes over the entire range of concentrations of added Fe3+ assayed, (ii) at the highest added Fe3+ concentrations (>= 3 mM), precipitation was detected and the cells were able to incorporate the precipitate, that seems to be linked to cell damage, (iii) the extent of precipitation depends on the Fe/protein concentration ratio; and (iv) lipid peroxidation products were detected over the entire range of concentrations of added Fe3+. Hence, a new approach opens in the biocompatibility evaluation of Fe-based BMMs, since the cytotoxicity would not be solely a function of released (and soluble) ions but of the insoluble degradation product amount and the pH falling at the biomaterial/cell interface. The concentration of Fe-containing products at the interface depends on diffusional conditions in a very complex way that should be carefully analyzed in the future. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Fagali, Natalia S.; Grillo, Claudia A.; Fernandez Lorenzo de Mele, Monica A.] Univ Nacl La Plata, Inst Res Theoret & Appl Phys Chem INIFTA, CONICET, Dept Chem,Fac Pure Sci, RA-1900 La Plata, Buenos Aires, Argentina.
   [Puntarulo, Susana] UBA CONICET, Sch Pharm & Biochem, Phys Chem Inst Biochem & Mol Med IBIMOL, Buenos Aires, DF, Argentina.
   [Fernandez Lorenzo de Mele, Monica A.] Univ Nacl La Plata, Fac Engn, RA-1900 La Plata, Buenos Aires, Argentina.
RP de Mele, MAFL (reprint author), Univ Nacl La Plata, Inst Res Theoret & Appl Phys Chem INIFTA, CONICET, Dept Chem,Fac Pure Sci, CC 16,Suc 4, RA-1900 La Plata, Buenos Aires, Argentina.
EM mmele@inifta.unlp.edu.ar
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551; Fagali, Natalia
   Soledad/0000-0001-5489-137X
FU University of La Plata (UNLP) [11/I163]; University of Buenos Aires
   (UBA) [UBACyT 555]; ANPCyT [PICT 2012-1795 BID, PICT 00845, PPL 2011
   0003]; CONICET [PIP 00697]
FX The authors would want to acknowledge to Dr. Angel Catala for his
   helpful assistance and collaboration. This study was supported by grants
   from the University of La Plata (UNLP, 11/I163), University of Buenos
   Aires (UBA, UBACyT 555), ANPCyT (PICT 2012-1795 BID, PICT 00845, PPL
   2011 0003) and CONICET (PIP 00697)
CR Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7
   Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brumby PE, 1967, METHOD ENZYMOL, V10, P463
   Buege J A, 1978, Methods Enzymol, V52, P302
   Di Virgilio AL, 2010, J HAZARD MATER, V177, P711, DOI 10.1016/j.jhazmat.2009.12.089
   Di Virgilio AL, 2011, J BIOMED MATER RES B, V99B, P111, DOI 10.1002/jbm.b.31877
   Di Virgilio AL, 2010, J BIOMED MATER RES A, V92A, P80, DOI 10.1002/jbm.a.32339
   Garcia-Fernandez AJ, 2002, COMP BIOCHEM PHYS C, V132, P365, DOI 10.1016/S1532-0456(02)00079-0
   Grillo CA, 2014, COLLOID SURFACE B, V117, P312, DOI 10.1016/j.colsurfb.2014.02.030
   Grillo CA, 2013, J BIOMED MATER RES A, V101, P2129, DOI 10.1002/jbm.a.34503
   Grillo CA, 2010, CONTRACEPTION, V81, P343, DOI 10.1016/j.contraception.2009.12.003
   Han DW, 2012, J NANOSCI NANOTECHNO, V12, P5205, DOI 10.1166/jnn.2012.6367
   Huang T, 2014, MAT SCI ENG C-MATER, V35, P43, DOI 10.1016/j.msec.2013.10.023
   Jiang X, 2014, NANOTOXICOLOGY
   Jiang XM, 2013, TOXICOL LETT, V222, P55, DOI 10.1016/j.toxlet.2013.07.011
   Kraus T, 2014, ACTA BIOMATER, V10, P3346, DOI 10.1016/j.actbio.2014.04.007
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pereda MD, 2008, BIOELECTROCHEMISTRY, V72, P94, DOI 10.1016/j.bioelechem.2007.11.008
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pierson D, 2012, J BIOMED MATER RES B, V100B, P58, DOI 10.1002/jbm.b.31922
   Pivokonsky M, 2012, WATER RES, V46, P5583, DOI 10.1016/j.watres.2012.07.040
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P1882, DOI 10.1016/j.msec.2012.10.013
   Schranz D, 2006, CATHETER CARDIO INTE, V67, P671, DOI 10.1002/ccd.20756
   Soodvilai S, 2011, TOXICOL LETT, V204, P38, DOI 10.1016/j.toxlet.2011.04.005
   Thompson CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042720
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Yang JL, 1996, CHEM RES TOXICOL, V9, P1360, DOI 10.1021/tx960122y
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang M., 2014, P 2014 S AG DIR SIM, P1
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 36
TC 10
Z9 10
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 480
EP 488
DI 10.1016/j.colsurfb.2015.02.047
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000060
PM 25797480
DA 2018-10-20
ER

PT J
AU Raja, IS
   Fathima, NN
AF Raja, I. Selestin
   Fathima, Nishter Nishad
TI A gelatin based antioxidant enriched biomaterial by grafting and
   saturation: Towards sustained drug delivery from antioxidant matrix
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Gelatin; Glutathione; Catechin; Differential scanning calorimetry;
   Circular dichroism
ID HYDROGEN-PEROXIDE; CATECHIN; GLUTATHIONE; NANOPARTICLES; DISEASE;
   SYSTEM; AMPLIFICATION; NANOCRYSTALS; INTERFACE; PEPTIDES
AB Proteins grafted with antioxidant molecules have drawn much attention due to their increased life time and biocompatibility. When protein macromolecules are cross linked chemically and physically with antioxidant molecules, they can act as antioxidant biomaterials as well as scaffolds to release the antioxidant molecules by diffusion. In our work, we have attempted to release catechin molecules from the matrix of glutathione grafted gelatin. Conjugation of glutathione and cross linkage was done by carbodiimide method to achieve smaller pores in the gelatin matrix and the characterization was performed by means of FTIR-ATR and calorimetric analyses. The glutathione grafted gelatin (GGSH) has been shown to have more thermal stability and pores with lesser radii than blank gelatin (bGEL). Free radical scavenging activity of GGSH was also found to be more than that of bGEL. Catechin was added to GGSH and bGEL by physical blending in order to achieve short term release of antioxidant molecules. CD spectra revealed that significant conformational changes occurred in secondary structure of gelatin upon interaction with catechin. Slower rate of catechin release from GGSH reflected the influence of cross linkage and physical interactive forces on the drug release properties. We conclude that the mixture of catechin with GGSH can be a potent antioxidant biomaterial releasing catechin at slower rate than the mixture of catechin with bGEL. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Raja, I. Selestin; Fathima, Nishter Nishad] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad.naveed@gmail.com
FU Department of Science and Technology, Govt. of India Fast Track Project
FX The authors thank Department of Science and Technology, Govt. of India
   Fast Track Project for the financial support.
CR Aravindan L, 2013, MACROMOL BIOSCI, V13, P1163, DOI 10.1002/mabi.201300103
   Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066
   Baron M, 2013, INT J ELECTROCHEM SC, V8, P11072
   Basu S, 2006, NEW J CHEM, V30, P1333, DOI 10.1039/b607399a
   Bernkop-Schnurch A, 1999, PHARMACEUT RES, V16, P876, DOI 10.1023/A:1018830204170
   Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m
   CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102
   COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6
   Conforti F, 2006, BIOL PHARM BULL, V29, P2056, DOI 10.1248/bpb.29.2056
   Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1
   Di Colo G, 2008, J PHARM SCI-US, V97, P1652, DOI 10.1002/jps.21043
   Diaz AN, 1996, ANAL CHIM ACTA, V327, P161, DOI 10.1016/0003-2670(96)00077-3
   Fathima NN, 2010, THERMOCHIM ACTA, V501, P98, DOI 10.1016/j.tca.2010.01.016
   Fathima NN, 2009, INT J BIOL MACROMOL, V45, P274, DOI 10.1016/j.ijbiomac.2009.06.003
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Hornof MD, 2002, J PHARM SCI, V91, P2588, DOI 10.1002/jps.10258
   Ihara N, 2004, BIOMACROMOLECULES, V5, P1633, DOI 10.1021/bm049823x
   Kanungo I, 2011, INT J BIOL MACROMOL, V49, P289, DOI 10.1016/j.ijbiomac.2011.05.003
   Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j
   Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t
   Kurisawa M, 2003, BIOMACROMOLECULES, V4, P1394, DOI 10.1021/bm034136b
   La Penna G, 2013, J PHYS CHEM B, V117, P16455, DOI 10.1021/jp410046w
   Lee SS, 2013, ACS NANO, V7, P9693, DOI 10.1021/nn4026806
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026
   Lynch SM, 2000, BBA-MOL CELL BIOL L, V1485, P11, DOI 10.1016/S1388-1981(00)00030-5
   Mohan T, 2012, ACS APPL MATER INTER, V4, P2743, DOI 10.1021/am300375m
   Mondal K, 2014, ACS APPL MATER INTER, V6, P2516, DOI 10.1021/am404931f
   Morgan PE, 2008, FREE RADICAL BIO MED, V45, P1279, DOI 10.1016/j.freeradbiomed.2008.08.004
   Mudunkotuwa IA, 2014, ANALYST, V139, P870, DOI 10.1039/c3an01684f
   Neilson AP, 2007, J AGR FOOD CHEM, V55, P8941, DOI 10.1021/jf071645m
   PaImberger TF, 2007, EUR J PHARM BIOPHARM, V66, P405, DOI 10.1016/j.ejpb.2006.11.017
   Picquart M, 1999, BIOSPECTROSCOPY, V5, P328, DOI 10.1002/(SICI)1520-6343(1999)5:6<328::AID-BSPY2>3.0.CO;2-J
   Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720
   Raab T, 2010, J AGR FOOD CHEM, V58, P2138, DOI 10.1021/jf9034095
   Ramirez A. R., 2014, CLIN SCI, V126, P19
   Scott MD, 2006, FREE RADICAL BIO MED, V40, P1264, DOI 10.1016/j.freeradbiomed.2005.11.017
   Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191
   Sonni F, 2011, J AGR FOOD CHEM, V59, P3940, DOI 10.1021/jf104575w
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Stenekes RJH, 2000, BIOMACROMOLECULES, V1, P696, DOI 10.1021/bm005574a
   Tsai JC, 2011, AFR J PHARM PHARMACO, V5, P468, DOI 10.5897/AJPP11.059
   Varghese JS, 2014, COLLOID SURFACE B, V113, P346, DOI 10.1016/j.colsurfb.2013.08.049
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 44
TC 7
Z9 7
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2015
VL 128
BP 537
EP 543
DI 10.1016/j.colsurfb.2015.03.005
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CH3KQ
UT WOS:000353930000067
PM 25794444
DA 2018-10-20
ER

PT J
AU McNeill, B
   Vulesevic, B
   Ostojic, A
   Ruel, M
   Suuronen, EJ
AF McNeill, Brian
   Vulesevic, Branka
   Ostojic, Aleksandra
   Ruel, Marc
   Suuronen, Erik J.
TI Collagen matrix-induced expression of integrin alpha V beta 3 in
   circulating angiogenic cells can be targeted by matricellular protein
   CCN1 to enhance their function
SO FASEB JOURNAL
LA English
DT Article
DE biomaterial; cardiovascular disease; cell preconditioning; ischemia;
   neovascularization
ID ENDOTHELIAL PROGENITOR CELLS; HUMAN SKIN FIBROBLASTS; CYR61; MIGRATION;
   THERAPY; ALPHA(V)BETA(3); IDENTIFICATION; PROLIFERATION; FIBRONECTIN;
   MYOCARDIUM
AB Circulating angiogenic cells (CACs) play an important role in vascular homeostasis and hold therapeutic promise for treating a variety of cardiovascular diseases. However, further improvements are needed because the effects of CAC therapy remain minimal or transient. The regenerative potential of these cells can be improved by culture on a collagen-based matrix through the up-regulation of key integrin proteins. We found that human CAC function was enhanced by using the matricellular protein CCN1 (CYR61/CTGF/NOV family member 1) to target integrin alpha V and beta 3, which are up-regulated on matrix. Compared tomatrix-cultured CACs, CCN1-matrix CACs exhibited a 2.2-fold increase in cell proliferation, 1.8-fold greater migration toward VEGF, and 1.7-fold more incorporation into capillary-like structures in an angiogenesis assay. In vivo, intramuscular injection of CCN1-matrix-cultured CACs into ischemic hind limbs of CD-1 nude mice resulted in blood flow recovery to 80% of baseline, which was greater than matrix-cultured CACs (66%) and PBS (35%) treatment groups. Furthermore, transplanted CCN1-matrix CACs exhibited greater engraftment (11-fold) and stimulated the up-regulation of survival and angiogenic genes (>3-fold). These findings reveal the importance of cell-matrix interactions in regulating CAC function and also reveal a mechanism by which these may be exploited to enhance cell therapies for ischemic disease.
C1 [McNeill, Brian; Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada.
RP Suuronen, EJ (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
OI RUEL, MARC/0000-0002-0487-1319
FU Canadian Institutes of Health Research (CIHR) [MOP-77536]; Ottawa Heart
   Institute Cardiac Surgery Endowed Chair; Ottawa Heart Institute Lawrence
   Soloway Research Fellowship; Research Fellowship from the Heart & Stroke
   Foundation of Canada; CIHR Canadian Graduate Scholarship
FX This work was supported from the Canadian Institutes of Health Research
   (CIHR; grant MOP-77536 to M.R. and E.J.S.), and the Ottawa Heart
   Institute Cardiac Surgery Endowed Chair (to M.R.). B.M. was the
   recipient of the Ottawa Heart Institute Lawrence Soloway Research
   Fellowship and a Research Fellowship from the Heart & Stroke Foundation
   of Canada, and B.V. of a CIHR Canadian Graduate Scholarship.
CR Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599
   Brenes RA, 2012, VASCULAR, V20, P360, DOI 10.1258/vasc.2011.201205
   CAMPBELL ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT
   Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200
   Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671
   Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066734
   Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054
   Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733
   Emre Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3842
   Espinoza I, 2014, J CELL COMMUN SIGNAL, V8, P23, DOI 10.1007/s12079-013-0214-6
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200
   Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807
   Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC
   Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012
   Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174
   Kireeva ML, 1996, MOL CELL BIOL, V16, P1326
   Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456
   Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mackie AR, 2011, TEX HEART I J, V38, P474
   Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Schmidt MR, 2012, J CARDIOVASC MED, V13, P667, DOI 10.2459/JCM.0b013e328357bff2
   Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013
   Sun GM, 2012, MACROMOL BIOSCI, V12, P21, DOI 10.1002/mabi.201100258
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
   Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
NR 45
TC 3
Z9 3
U1 1
U2 4
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
IS 4
BP 1198
EP 1207
DI 10.1096/fj.14-261586
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CH5ZN
UT WOS:000354115000009
PM 25466895
OA Bronze
DA 2018-10-20
ER

PT J
AU Warning, AD
   Arquiza, JMR
   Datta, AK
AF Warning, Alexander D.
   Arquiza, J. M. R.
   Datta, Ashim K.
TI A multiphase porous medium transport model with distributed sublimation
   front to simulate vacuum freeze drying
SO FOOD AND BIOPRODUCTS PROCESSING
LA English
DT Article
DE Biomaterial; Food; Transport phenomena; Sublimation; Vacuum; Microwave;
   Non-equilibrium phase change; Porous Media
ID MASS-TRANSFER; THERMOPHYSICAL PROPERTIES; OPERATIONAL POLICIES; WATER;
   PERMEABILITY; TEMPERATURE; EVAPORATION; PRESSURES; PRODUCTS; ICE
AB A porous medium transport model with a distributed sublimation front is developed for low pressure freeze drying of beef by radiant surface heating and volumetric microwave heating. The model incorporates the importance of Knudsen flow in porous materials during low pressure freeze drying. This effort is part of fundamental physics-based framework building for simulating food and biomaterial processes involving rapid evaporation/sublimation. Temperature, pressure and ice saturation histories were computed. Drying rates and spatial temperature profiles showed excellent agreement with literature experimental data. Sublimation front width, a novel result, is seen to increase as ice saturation decreases, justifying the importance of this distributed sublimation formulation in contrast with the sharp sublimation front commonly employed in literature. The insulation effect of the gas fraction in the pores is observed by the slow movement of the sublimation front in 'thick' samples. Effects of porosity, initial ice saturation and microwave heating are illustrated. (C) 2014 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Warning, Alexander D.; Arquiza, J. M. R.; Datta, Ashim K.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA.
RP Warning, AD (reprint author), Cornell Univ, Dept Biol & Environm Engn, 175 Riley Robb, Ithaca, NY 14853 USA.
EM adw88@cornell.edu
RI Datta, Ashim/K-2294-2012
OI Datta, Ashim/0000-0002-1397-6892
CR Atkins P W, 1991, PHYS CHEM
   AYAPPA KG, 1991, CHEM ENG SCI, V46, P1005, DOI 10.1016/0009-2509(91)85093-D
   Bear J., 1972, DYNAMICS FLUIDS PORO
   Bixler N. E., 1985, NORIA FINITE ELEMENT
   Bralsford R., 1967, INT J FOOD SCI TECH, V2, P353
   Cho SY, 2012, J NANOSCI NANOTECHNO, V12, P806, DOI 10.1166/jnn.2012.5364
   Choi Y, 1986, PHYS CHEM PROPERTIES
   Chung NO, 2012, INT J PHARMACEUT, V437, P42, DOI 10.1016/j.ijpharm.2012.07.068
   Dhall A, 2011, CHEM ENG SCI, V66, P6482, DOI 10.1016/j.ces.2011.09.001
   Dibben D, 2001, ELECTROMAGNETICS FUN, V31
   Electric G., 1982, FLUID FLOW DAT
   Fellows P., 2000, FOOD PROCESSING TECH
   FUKUSAKO S, 1990, INT J THERMOPHYS, V11, P353, DOI 10.1007/BF01133567
   Hahn DW, 2012, HEAT CONDUCTION
   Haider A., 2007, FOOD BIOPROD PROCESS, V85, P209, DOI DOI 10.1205/FBP0703
   Halder A., 2011, J HEAT TRANSF, V133
   Halder A, 2012, FOOD BIOPROD PROCESS, V90, P475, DOI 10.1016/j.fbp.2011.10.005
   HARPER JC, 1962, AICHE J, V8, P298, DOI 10.1002/aic.690080308
   Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298
   Hui Y. H., 2004, HDB FROZEN FOODS
   Jiao K, 2009, ELECTROCHIM ACTA, V54, P6876, DOI 10.1016/j.electacta.2009.06.072
   Lewis MJ, 1987, PHYS PROPERTIES FOOD
   Liapis A. I., 1987, HDB IND DRYING
   MA YH, 1975, AICHE J, V21, P335, DOI 10.1002/aic.690210215
   McDonald K, 2002, J FOOD ENG, V52, P167, DOI 10.1016/S0260-8774(01)00100-5
   MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200
   MILLMAN MJ, 1985, AICHE J, V31, P1594, DOI 10.1002/aic.690311003
   Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94
   Nam JH, 2005, DRY TECHNOL, V23, P2491, DOI 10.1080/07373930500341757
   Nam JH, 2007, INT J HEAT MASS TRAN, V50, P4891, DOI 10.1016/j.ijheatmasstransfer.2007.08.004
   Ni H, 1999, INT J HEAT MASS TRAN, V42, P1501, DOI 10.1016/S0017-9310(98)00123-9
   Oroszvari BK, 2006, J FOOD ENG, V74, P1, DOI 10.1016/j.jfoodeng.2005.02.024
   Painter SL, 2011, COMPUTAT GEOSCI, V15, P69, DOI 10.1007/s10596-010-9197-z
   Pojanavaraphan T, 2010, APPL CLAY SCI, V50, P271, DOI 10.1016/j.clay.2010.08.020
   Rakesh V, 2013, AICHE J, V59, P33, DOI 10.1002/aic.13793
   Ratti C, 2001, J FOOD ENG, V49, P311, DOI 10.1016/S0260-8774(00)00228-4
   SANDALL OC, 1967, AICHE J, V13, P428, DOI 10.1002/aic.690130309
   Sheehan P, 1998, BIOTECHNOL BIOENG, V60, P712, DOI 10.1002/(SICI)1097-0290(19981220)60:6<712::AID-BIT8>3.0.CO;2-4
   Singh P., 2001, SNOW GLACIER HYDROLO
   Smith PG, 2011, FOOD SCI TEXT SER, P1, DOI 10.1007/978-1-4419-7662-8
   Tanikawa W, 2009, INT J ROCK MECH MIN, V46, P229, DOI 10.1016/j.ijrmms.2008.03.004
   Vargaftik N. B., 1975, TABLES THERMOPHYSICA
   WAGNER W, 1994, J PHYS CHEM REF DATA, V23, P515, DOI 10.1063/1.555947
   Wang W, 2007, AICHE J, V53, P3077, DOI 10.1002/aic.11336
   Wang Y, 2013, COMPOS PART B-ENG, V45, P625, DOI 10.1016/j.compositesb.2012.05.017
   Wang Z.H., 1999, DRY TECHNOL, V17, P434
   Wang ZH, 1997, DRY TECHNOL, V15, P1475, DOI 10.1080/07373939708917304
   Ward CA, 1999, PHYS REV E, V59, P429, DOI 10.1103/PhysRevE.59.429
   Warning A, 2012, J FOOD ENG, V110, P428, DOI 10.1016/j.jfoodeng.2011.12.024
   Webb S.W, 1996, GAS PHASE DIFFUSION
   Webb SW, 2003, TRANSPORT POROUS MED, V51, P327, DOI 10.1023/A:1022379016613
   Weerts AH, 2003, AICHE J, V49, P1334, DOI 10.1002/aic.690490524
   Yamsaengsung R, 2002, J FOOD ENG, V53, P1, DOI 10.1016/S0260-8774(01)00134-0
   Zhang J, 2005, AICHE J, V51, P2569, DOI 10.1002/aic.10518
NR 54
TC 6
Z9 7
U1 3
U2 42
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0960-3085
EI 1744-3571
J9 FOOD BIOPROD PROCESS
JI Food Bioprod. Process.
PD APR
PY 2015
VL 94
BP 637
EP 648
DI 10.1016/j.fbp.2014.08.011
PG 12
WC Biotechnology & Applied Microbiology; Engineering, Chemical; Food
   Science & Technology
SC Biotechnology & Applied Microbiology; Engineering; Food Science &
   Technology
GA CH6IO
UT WOS:000354140500069
DA 2018-10-20
ER

PT J
AU Kamada, T
   Mashima, N
   Nakashima, Y
   Lmai, H
   Takeba, J
   Miura, H
AF Kamada, Tomomi
   Mashima, Naohiko
   Nakashima, Yasuharu
   Lmai, Hiroshi
   Takeba, Jun
   Miura, Hiromasa
TI Mid-Term Clinical and Radiographic Outcomes of Porous Tantalum Modular
   Acetabular Components for Hip Dysplasia
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total hip arthroplasty; trabecular metal cup of modular type;
   developmental dysplasia of the hip; cementless; bone ingrowth
ID RADIOLOGICAL EVALUATION; SUPERIOR PLACEMENT; FOLLOW-UP; ARTHROPLASTY;
   RECONSTRUCTION; 10-YEAR; REPLACEMENT; BIOMATERIAL; INTERFACE; FIXATION
AB It is still challenging to perform successful cementless cup fixation during total hip arthroplasty for hip dysplasia. In this multicenter study we evaluated the clinical results of porous tantalum modular acetabular cups (TM cups) in 45 dysplastic hips with a mean follow-up period of 9.8 years. The mean Japanese Orthopaedic Association hip score improved from 48.2 preoperatively to 92.1 at the most recent follow-up. All of the cups were radiographically stable with no evidence of progressive radiolucencies or osteolysis regardless of bone grafting. Sixteen hips with bone grafts showed the integration of grafted bone without any radiolucencies. There were no revisions of TM cups. The use of TM cups for dysplastic hips provided satisfactory 10-year clinical and radiographic results. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kamada, Tomomi; Mashima, Naohiko; Lmai, Hiroshi; Takeba, Jun; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.
   [Nakashima, Yasuharu] Kyushu Univ, Sch Med, Dept Orthopaed Surg, Higashi Ku, Fukuoka 812, Japan.
RP Kamada, T (reprint author), Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   CALLAGHAN JJ, 1988, J BONE JOINT SURG AM, V70A, P337, DOI 10.2106/00004623-198870030-00004
   Cameron HU, 1996, J ARTHROPLASTY, V11, P582, DOI 10.1016/S0883-5403(96)80113-6
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Delp SL, 1996, CLIN ORTHOP RELAT R, P137
   Doehring TC, 1996, J ARTHROPLASTY, V11, P693, DOI 10.1016/S0883-5403(96)80008-8
   Engesaeter LB, 2008, J ARTHROPLASTY, V23, P235, DOI 10.1016/j.arth.2007.03.023
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hartofilakidis G, 2008, J BONE JOINT SURG BR, V90B, P724, DOI 10.1302/0301-620X.90B6.20490
   Hartofilakidis G, 1996, J BONE JOINT SURG AM, V78A, P683, DOI 10.2106/00004623-199605000-00007
   HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474
   Hendrich C, 2006, J BONE JOINT SURG AM, V88A, P387, DOI 10.2106/JBJS.D.02373
   Kim M, 2010, CLIN ORTHOP RELAT R, V468, P1611, DOI 10.1007/s11999-010-1288-6
   Kiyama T, 2009, J ARTHROPLASTY, V24, P240, DOI 10.1016/j.arth.2008.08.012
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   Mulroy RD, 1986, J BONE JOINT SURG AM, V72, P1241
   Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9
   Ogawa H, 2010, J ARTHROPLASTY, V25, P375, DOI 10.1016/j.arth.2009.01.012
   Pagnano MW, 1996, J BONE JOINT SURG AM, V78A, P1004, DOI 10.2106/00004623-199607000-00004
   Sanchez-Sotelo Joaquin, 2002, J Am Acad Orthop Surg, V10, P334
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   SUGANO N, 1995, J BONE JOINT SURG BR, V77B, P548
   Takao M, 2011, J ARTHROPLASTY, V26, P562, DOI 10.1016/j.arth.2010.05.025
NR 31
TC 12
Z9 13
U1 0
U2 2
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 2015
VL 30
IS 4
BP 607
EP 610
DI 10.1016/j.arth.2014.11.007
PG 4
WC Orthopedics
SC Orthopedics
GA CG7SV
UT WOS:000353506300022
PM 25443360
DA 2018-10-20
ER

PT J
AU Sheikh, Z
   Javaid, MA
   Hamdan, N
   Hashmi, R
AF Sheikh, Zeeshan
   Javaid, Mohammad Ahmad
   Hamdan, Nader
   Hashmi, Raheel
TI Bone Regeneration Using Bone Morphogenetic Proteins and Various
   Biomaterial Carriers
SO MATERIALS
LA English
DT Review
ID HUMAN OSTEOGENIC PROTEIN-1; BETA-TRICALCIUM PHOSPHATE; MARROW STROMAL
   CELLS; ALVEOLAR RIDGE DEFECTS; SYNTHETIC BIODEGRADABLE POLYMERS; COATED
   ALBUMIN NANOPARTICLES; ABSORBABLE COLLAGEN SPONGE; HEPARIN-CONJUGATED
   FIBRIN; MEDIATED GENE DELIVERY; RAT CALVARIAL DEFECTS
AB Trauma and disease frequently result in fractures or critical sized bone defects and their management at times necessitates bone grafting. The process of bone healing or regeneration involves intricate network of molecules including bone morphogenetic proteins (BMPs). BMPs belong to a larger superfamily of proteins and are very promising and intensively studied for in the enhancement of bone healing. More than 20 types of BMPs have been identified but only a subset of BMPs can induce de novo bone formation. Many research groups have shown that BMPs can induce differentiation of mesenchymal stem cells and stem cells into osteogenic cells which are capable of producing bone. This review introduces BMPs and discusses current advances in preclinical and clinical application of utilizing various biomaterial carriers for local delivery of BMPs to enhance bone regeneration.
C1 [Sheikh, Zeeshan] Univ Toronto, Fac Dent, Toronto, ON M5S 3E2, Canada.
   [Javaid, Mohammad Ahmad] Univ British Columbia, Div Periodont, Fac Dent, Nobel Biocare Oral Hlth Ctr, Vancouver, BC V6T IZ3, Canada.
   [Hamdan, Nader] Univ Manitoba, Div Periodont Dent Diagnost & Surg Sci, Fac Dent, Winnipeg, MB R3E 0W2, Canada.
   [Hashmi, Raheel] South City Hosp, Dept Emergency & Trauma, Clifton Karachi 75400, Pakistan.
RP Sheikh, Z (reprint author), Univ Toronto, Fac Dent, 150 Coll St, Toronto, ON M5S 3E2, Canada.
EM zeeshan.sheikh@utoronto.ca; mohammad.javaid2@mail.mcgill.ca;
   naderful@gmail.com; rhashme@hotmail.com
CR Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117
   Aebli N, 2005, J BIOMED MATER RES A, V73A, P295, DOI 10.1002/jbm.a.30299
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Ansari S, 2014, BIOMED RES INT, DOI 10.1155/2014/940860
   Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016
   Arnander C, 2006, J CRANIOFAC SURG, V17, P275, DOI 10.1097/00001665-200603000-00013
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Arosarena OA, 2005, OTOLARYNG HEAD NECK, V132, P592, DOI 10.1016/j.otohns.2004.09.137
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Bae SE, 2012, J CONTROL RELEASE, V160, P676, DOI 10.1016/j.jconrel.2012.04.021
   Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56
   Baran ET, 2004, J MATER SCI-MATER M, V15, P759, DOI 10.1023/B:JMSM.0000032815.86972.5e
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Bax BE, 1999, CALCIFIED TISSUE INT, V65, P83, DOI 10.1007/s002239900662
   Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bibbo C, 2015, CLIN PODIATR MED SUR, V32, P35, DOI 10.1016/j.cpm.2014.09.005
   Bibbo C, 2009, FOOT ANKLE INT, V30, P597, DOI 10.3113/FAI.2009.0597
   Bilic R, 2006, INT ORTHOP, V30, P128, DOI 10.1007/s00264-005-0045-z
   Blunk T, 2003, GROWTH FACTORS, V21, P71, DOI 10.1080/0897719031000148822
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2005, ORTHOP NURS, V24, P49
   Bong MR, 2005, BULL HOSP JT DIS, V63, P20
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   Bostrom MPG, 1999, ORTHOP CLIN N AM, V30, P647, DOI 10.1016/S0030-5898(05)70117-6
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013
   Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   [曹雪华 CAO Xuehua], 2006, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V20, P916
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561
   Carreira AC, 2014, ARCH BIOCHEM BIOPHYS, V561, P64, DOI 10.1016/j.abb.2014.07.011
   Carter S, 2012, THER ADV MUSCULOSKEL, V4, P293, DOI 10.1177/1759720X12444175
   Celeste A.J., 2002, U.S. Patent, Patent No. [6027917 A, 6027917]
   Cha JK, 2014, J CLIN PERIODONTOL, V41, P86, DOI 10.1111/jcpe.12174
   Chang PC, 2007, J BIOMED MATER RES A, V81A, P771, DOI 10.1002/jbm.a.31031
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen Fa-ming, 2005, Shanghai Kou Qiang Yi Xue, V14, P485
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Chen FM, 2006, INT J PHARMACEUT, V307, P23, DOI 10.1016/j.ijpharm.2005.09.024
   Chen FM, 2005, PHARMACOLOGY, V75, P133, DOI 10.1159/000088212
   CHEN TL, 1991, J BONE MINER RES, V6, P1387
   Chen Wei, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P989
   Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139
   Cook S D, 1995, J Oral Implantol, V21, P281
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Cui Geng, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P70
   CUNNINGHAM NS, 1995, GROWTH FACTORS, V12, P99, DOI 10.3109/08977199509028956
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124
   David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001
   Degat MC, 2005, PATHOL BIOL, V53, P131, DOI 10.1016/j.patbio.2004.03.004
   den Boer FC, 2002, BONE, V31, P158, DOI 10.1016/S8756-3282(02)00816-5
   Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650
   Dohin B, 2009, CLIN ORTHOP RELAT R, V467, P3230, DOI 10.1007/s11999-009-0967-7
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795
   Eckardt H, 2005, INJURY, V36, P489, DOI 10.1016/j.injury.2004.10.019
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Fan Zhongkai, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P903
   Feiner N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-277
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furuya K, 1999, J CELL BIOCHEM, V72, P177, DOI 10.1002/(SICI)1097-4644(19990201)72:2<177::AID-JCB2>3.0.CO;2-#
   Gao TJ, 2002, TISSUE ENG, V8, P429, DOI 10.1089/107632702760184691
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gomes Manuela E, 2004, Methods Mol Biol, V238, P65
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Gruber RM, 2014, J CLIN PERIODONTOL, V41, P820, DOI 10.1111/jcpe.12264
   Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200
   Hagi TT, 2010, BONE, V46, P1322, DOI 10.1016/j.bone.2010.02.010
   HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Han FX, 2015, J BIOMED MATER RES B, V103, P1344, DOI 10.1002/jbm.b.33314
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Hao W, 2010, INT ORTHOP, V34, P1341, DOI 10.1007/s00264-009-0946-3
   Hattori T, 1990, Nihon Seikeigeka Gakkai Zasshi, V64, P824
   He Xiao-bing, 2003, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V17, P185
   Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Herford AS, 2008, J ORAL MAXIL SURG, V66, P616, DOI 10.1016/j.joms.2007.11.021
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong JY, 2014, CYTOTHERAPY, V16, P1441, DOI 10.1016/j.jcyt.2014.04.005
   Hong L, 1998, J BIOMAT SCI-POLYM E, V9, P1001
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Horasawa N, 2015, MAT SCI ENG C-MATER, V46, P86, DOI 10.1016/j.msec.2014.10.025
   Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012
   Hu Ji-jie, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1369
   Hu WH, 2013, ARTIF CELL NANOMED B, V41, P249, DOI 10.3109/10731199.2012.731412
   Hu Yun-Yu, 2003, Chin J Traumatol, V6, P67
   Hubbell JA, 2006, SWISS MED WKLY, V136, P387
   Hubble Matthew J W, 2002, Surg Technol Int, V10, P261
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e
   Hulsart-Billstrom G, 2011, ACTA BIOMATER, V7, P3042, DOI 10.1016/j.actbio.2011.04.021
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Huse K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046117
   Hustedt Joshua W., 2014, Yale Journal of Biology and Medicine, V87, P549
   Ishibe T, 2009, ORAL SURG ORAL MED O, V108, P867, DOI 10.1016/j.tripleo.2009.06.039
   Issa JPM, 2008, ANAT HISTOL EMBRYOL, V37, P181, DOI 10.1111/j.1439-0264.2007.00824.x
   Itoh S, 2001, J MATER SCI-MATER M, V12, P575, DOI 10.1023/A:1011277207574
   Javaid M.A., 2013, INT DENT J STUD RES, V1, P24
   Jensen OT, 2014, INT J ORAL MAX IMPL, V29, pE103, DOI 10.11607/jomi.te48
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Ji Y, 2009, J INT MED RES, V37, P1075, DOI 10.1177/147323000903700412
   Ji Y, 2010, ANN BIOMED ENG, V38, P632, DOI 10.1007/s10439-009-9888-6
   Jones AA, 2006, J PERIODONTOL, V77, P1184, DOI 10.1902/jop.2006.050337
   Jovanovic SA, 2007, CLIN ORAL IMPLAN RES, V18, P224, DOI 10.1111/j.1600-0501.2006.01324.x
   Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Katanec Davor, 2014, Coll Antropol, V38, P325
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Kawamoto T, 2003, CLEFT PALATE-CRAN J, V40, P538, DOI 10.1597/1545-1569(2003)040<0538:ETMIBI>2.0.CO;2
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360
   Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kim SE, 2014, CARBOHYD POLYM, V114, P123, DOI 10.1016/j.carbpol.2014.08.005
   Kim SE, 2015, J TISSUE ENG REGEN M, V9, pE219, DOI 10.1002/term.1668
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Kim SH, 2013, INT J ARTIF ORGANS, V36, P506, DOI 10.5301/ijao.5000215
   Kim TH, 2013, J BIOMED MATER RES A, V101, P1651, DOI 10.1002/jbm.a.34466
   Kinard LA, 2013, PHARM RES-DORDR, V30, P2332, DOI 10.1007/s11095-013-1077-5
   KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   KIRKERHEAD CA, 1995, CLIN ORTHOP RELAT R, P222
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   Kraiwattanapong C, 2005, SPINE, V30, P1001, DOI 10.1097/01.brs.0000160997.91502.3b
   Laurencin CT, 2013, CURR PHARM DESIGN, V19, P3353
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   Lee SY, 2013, CARBOHYD POLYM, V98, P546, DOI 10.1016/j.carbpol.2013.05.095
   LeGeros R.Z., 1997, BONE SUBSTITUTE MAT, P12
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li JH, 2010, J BIOMED MATER RES A, V95A, P973, DOI 10.1002/jbm.a.32926
   Liang Dongchun, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P721
   Lippman Caleb R, 2004, Neurosurg Focus, V16, pE4
   Lomelino RD, 2012, J MATER SCI-MATER M, V23, P781, DOI 10.1007/s10856-011-4530-1
   Lopez-Lacomba JL, 2006, BIOMACROMOLECULES, V7, P792, DOI 10.1021/bm050859e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7
   Maire M, 2005, BIOMATERIALS, V26, P5085, DOI 10.1016/j.biomaterials.2005.01.020
   Malafaya PB, 2003, ADV EXP MED BIOL, V534, P201
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Martinez-Sanz E, 2012, J CRANIOFAC SURG, V23, P594, DOI 10.1097/SCS.0b013e31824cd6c7
   Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102
   Matsushita N, 2006, J ORTHOP SCI, V11, P505, DOI 10.1007/s00776-006-1048-3
   Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249
   Mayer M, 1996, PLAST RECONSTR SURG, V98, P247, DOI 10.1097/00006534-199608000-00006
   McKee M., 2002, P 18 ANN M ORTH TRAU, P11
   McKee M., 2004, P AM AC ORTH SURG 71, P10
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Miranda DAO, 2005, J PERIODONTOL, V76, P210, DOI 10.1902/jop.2005.76.2.210
   Mitri F, 2012, ARTIF ORGANS, V36, P535, DOI 10.1111/j.1525-1594.2011.01409.x
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   Mizumoto Y, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300003-00019
   Moghaddam A, 2010, ARCH ORTHOP TRAUM SU, V130, P71, DOI 10.1007/s00402-009-0982-x
   Moghaddam-Alvandi A, 2012, UNFALLCHIRURG, V115, P518, DOI 10.1007/s00113-011-2100-0
   Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008
   Murakami M, 2002, J DENT RES, V81, P845, DOI 10.1177/154405910208101210
   Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Myllyla RM, 2014, CELL TISSUE RES, V355, P463, DOI 10.1007/s00441-013-1745-0
   Nakase T, 2006, J BONE MINER METAB, V24, P425, DOI 10.1007/s00774-006-0718-8
   Nakashima M, 2003, HUM GENE THER, V14, P591, DOI 10.1089/104303403764539369
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Nicodemo Alberto, 2011, Musculoskelet Surg, V95, P157, DOI 10.1007/s12306-011-0131-x
   Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111
   Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x
   Noshi T, 2001, ARTIF ORGANS, V25, P201, DOI 10.1046/j.1525-1594.2001.025003201.x
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Ong JL, 1997, INT J ORAL MAX IMPL, V12, P649
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Osidak EO, 2014, B EXP BIOL MED+, V158, P104, DOI 10.1007/s10517-014-2702-y
   Pan ZX, 2014, ASIAN PAC J TROP MED, V7, P895, DOI 10.1016/S1995-7645(14)60156-5
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Patel VV, 2006, SPINE, V31, P1201, DOI 10.1097/01.brs.0000217650.90861.99
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Piskounova S, 2009, J BIOMED MATER RES B, V91B, P780, DOI 10.1002/jbm.b.31456
   Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x
   Poth N, 2015, BIOMOLECULES, V5, P3, DOI 10.3390/biom5010003
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Qiao CY, 2013, INT J NANOMED, V8, P2985, DOI 10.2147/IJN.S45184
   Qin Yu, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1021
   Rao Subramaniam M, 2013, N Am J Med Sci, V5, P161, DOI 10.4103/1947-2714.109175
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Ren W., 2000, CHIN J STOMATOL, V35, P18
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ristiniemi J, 2007, J BONE JOINT SURG BR, V89B, P265, DOI 10.1302/0301-620X.89B2.18230
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386
   Robertson PA, 2001, SPINE, V26, P1473, DOI 10.1097/00007632-200107010-00018
   Rohanizadeh R, 2011, J ORAL IMPLANTOL, V37, P659, DOI 10.1563/AAID-JOI-D-10-00005
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Saito E, 2003, J PERIODONTOL, V74, P1808, DOI 10.1902/jop.2003.74.12.1808
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
   SAITOH H, 1994, J ORAL REHABIL, V21, P431, DOI 10.1111/j.1365-2842.1994.tb01157.x
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schmoekel HG, 2005, J SMALL ANIM PRACT, V46, P17, DOI 10.1111/j.1748-5827.2005.tb00269.x
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Schopper C, 2008, J BIOMED MATER RES A, V85A, P954, DOI 10.1002/jbm.a.31525
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE18
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sheikh ZA, 2013, DENT BIOMATERIALS PR
   Shimazu C, 2006, J ORAL REHABIL, V33, P609, DOI 10.1111/j.1365-2842.2005.01593.x
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Skogh ACD, 2009, PLAST RECONSTR SURG, V123, p192E, DOI 10.1097/PRS.0b013e3181a66f52
   Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Stenport VF, 2003, J MATER SCI-MATER M, V14, P247, DOI 10.1023/A:1022884724059
   Sumner DR, 2006, J BONE JOINT SURG AM, V88A, P806, DOI 10.2106/JBJS.E.00846
   Sun SX, 2014, BRAZ J MED BIOL RES, V47, P461, DOI 10.1590/1414-431X20132966
   Sun XJ, 2010, ARCH ORAL BIOL, V55, P195, DOI 10.1016/j.archoralbio.2010.01.006
   Suzuki A, 2006, J ORTHOP RES, V24, P327, DOI 10.1002/jor.20049
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Sweeny L, 2012, J ORAL MAXIL SURG, V70, P1991, DOI 10.1016/j.joms.2011.08.037
   Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   TENDIJKE P, 1994, J BIOL CHEM, V269, P16985
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Tevlin R, 2014, J DENT RES, V93, P1187, DOI 10.1177/0022034514547271
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Tian Weidong, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P844
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Tressler MA, 2011, ORTHOPEDICS, V34, P955, DOI 10.3928/01477447-20111021-09
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Turgeman G, 2002, J CELL BIOCHEM, V86, P461, DOI 10.1002/jcb.10231
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1972, CLIN ORTHOP RELAT R, P275
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang YJ, 2003, ARTIF ORGANS, V27, P162, DOI 10.1046/j.1525-1594.2003.06953.x
   Wang YF, 2013, J SURG RES, V183, P8, DOI 10.1016/j.jss.2012.11.061
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x
   Wikesjo UME, 2004, J CLIN PERIODONTOL, V31, P662, DOI 10.1111/j.1600-051X.2004.00541.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514
   WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Wordinger R, 2002, MOL VIS, V8, P241
   Xiao W, 2013, ACTA BIOMATER, V9, P8374, DOI 10.1016/j.actbio.2013.05.029
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536
   Xu XJ, 2015, CELL BIOCHEM BIOPHYS, V71, P215, DOI 10.1007/s12013-014-0187-y
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yang DH, 2015, J TISSUE ENG REGEN M, V9, P1067, DOI 10.1002/term.1973
   Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039
   Yang KN, 2013, NANOSCALE, V5, P1205, DOI 10.1039/c2nr33575a
   Yang X, 2012, J BIOMED MATER RES A, DOI [10.1002/jbm.a.34064, DOI 10.1002/JBM.A.34064]
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Yonemori K, 1997, AM J PATHOL, V150, P1335
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
   Zhang Chao, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P100
   Zhang HB, 1996, DEVELOPMENT, V122, P2977
   Zhang SF, 2008, BIOTECHNOL PROGR, V24, P945, DOI 10.1002/btpr.12
   Zhang SF, 2010, BIOMATERIALS, V31, P952, DOI 10.1016/j.biomaterials.2009.10.011
   Zhang SF, 2009, BIOMATERIALS, V30, P5143, DOI 10.1016/j.biomaterials.2009.05.060
   Zhang X, 2014, TISSUE ENG PART B-RE, V20, P84, DOI 10.1089/ten.TEB.2013.0204
   Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200
   Zhao GQ, 1996, MECH DEVELOP, V57, P159, DOI 10.1016/0925-4773(96)00543-6
   [郑永欣 ZHENG Yongxin], 2006, [中华眼科杂志, Chinese Journal of Ophthalmology], V42, P535
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V102, P175, DOI 10.1016/j.tripleo.2005.08.034
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V101, P166, DOI 10.1016/j.tripleo.2005.04.006
NR 331
TC 14
Z9 14
U1 1
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2015
VL 8
IS 4
BP 1778
EP 1816
DI 10.3390/ma8041778
PG 39
WC Materials Science, Multidisciplinary
SC Materials Science
GA CH5RD
UT WOS:000354092100029
PM 28788032
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wu, ZK
   Li, N
   Yan, JZ
   Zhao, WQ
AF Wu Zhikai
   Li Ning
   Yan Jiazhen
   Zhao Wanqian
TI Effect of Al2O3 Coating on Densification and Aging Sensibility of 3Y-TZP
   Ceramics
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article
DE 3Y-TZP; Al2O3 coating; densification; aging sensibility
ID PHASE-TRANSFORMATION; Y-TZP; STABILIZED ZIRCONIA; SINTERING BEHAVIOR;
   ALUMINA; DEGRADATION; YTTRIA; ZRO2; BIOMATERIAL; POWDERS
AB Al2O3 dopants in amount up to 1.5 wt% were coated on 3-mol-yttria-stabilized zirconia nanopowders adopting heterogeneous precipitation method. The influences of Al2O3 coating on the densification and the aging sensibility of 3Y-TZP were investigated. The process of densification was measured using a dilatometer. The density, the mean grain size and the mechanical properties of the densified 3Y-TZP were tested. X-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to characterize the microstructures of specimens. The results show that the densification of Al203-coated zirconia compacts was greatly enhanced by the coating process compared with the conventional co-precipitation process. Dense 3Y-TZP (>6.0 g/cm(3)) can be obtained using the Al2O3-coated starting powders by pressureless sintering at 1350 similar to 1400 degrees C. In addition, the aging sensibility of 3Y-TZP is substantially decreased by adding Al2O3. This is probably attributed to the segregation of Al3+ at the grain boundaries of Al2O3-coated 3Y-TZP.
C1 [Wu Zhikai; Li Ning; Yan Jiazhen; Zhao Wanqian] Sichuan Univ, Chengdu 610065, Peoples R China.
RP Li, N (reprint author), Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610065, Peoples R China.
EM wuzhikai@163.com; lining@scu.edu.cn
CR Chen CC, 2008, J CERAM PROCESS RES, V9, P131
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Elshazly ES, 2008, J MATER SCI TECHNOL, V24, P873
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Goncalves RF, 2007, J MATER SCI, V42, P2222, DOI 10.1007/s10853-006-1021-8
   Hodgson S N B, 1999, MAT PROCESSING TECHN, V92, P85
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Matsui K, 2008, J MATER SCI, V43, P2745, DOI 10.1007/s10853-008-2493-5
   Matsui K, 2006, J MATER RES, V21, P2278, DOI 10.1557/JMR.2006.0274
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Srdic VV, 2001, J AM CERAM SOC, V84, P2771, DOI 10.1111/j.1151-2916.2001.tb01093.x
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUKAMA K, 1985, J MATER SCI LETT, V4, P857, DOI 10.1007/BF00720523
   Wu ZK, 2013, J MATER SCI, V48, P1256, DOI 10.1007/s10853-012-6867-3
   Xie QF, 2011, RARE METAL MAT ENG, V40, P48
   Yang SY, 2004, SOLID STATE IONICS, V172, P413, DOI 10.1016/j.ssi.2004.03.026
   Yi YF, 2009, RARE METAL MAT ENG, V38, P870
NR 24
TC 1
Z9 1
U1 0
U2 11
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD APR
PY 2015
VL 44
IS 4
BP 808
EP 812
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CH6JN
UT WOS:000354143000007
DA 2018-10-20
ER

PT J
AU Kakinoki, S
   Yamaoka, T
AF Kakinoki, Sachiro
   Yamaoka, Tetsuji
TI Single-Step Immobilization of Cell Adhesive Peptides on a Variety of
   Biomaterial Substrates via Tyrosine Oxidation with Copper Catalyst and
   Hydrogen Peroxide
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID PLASMA FIBRONECTIN; MYTILUS-EDULIS; SURFACE; MUSSEL; PROTEINS; DOPA;
   3,4-DIHYDROXYPHENYLALANINE; POLYMERIZATION; MECHANISMS
AB Immobilization of biologically active peptides which were isolated from extracellular matrix proteins is a powerful strategy for the design and functionalization of biomaterial substrates. However, the method of peptide immobilization was restricted, that is, peptide is often immobilized through the reactive groups inherent in substrates with multistep reactions. Here, we report a single-step immobilization of fibronectin-derived cell adhesive peptide (Arg-Glu-Asp-Val; REDV) onto polymer materials by use of tyrosine oxidation with copper catalyst and hydrogen peroxide. REDV peptide was successfully immobilized on tissue culture polystyrene, poly(ethylene terephthalate), poly(vinyl chloride), expanded-poly(tetrafluoroethylene), and poly(l-lactic acid), resulting in enhanced adhesion of human umbilical vein endothelial cells. This method is a single-step reaction under very mild conditions and is available for the biological functionalization of various medical devices.
C1 [Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan.
RP Kakinoki, S (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM sachiro@ncvc.go.jp; yamtet@ncvc.go.jp
FU Intramural Research Fund of National Cerebral and Cardiovascular Center
   [25-6-18]; S-Innovation Project of JST
FX This work was supported by the Intramural Research Fund of National
   Cerebral and Cardiovascular Center (25-6-18) and the S-Innovation
   Project of JST.
CR Ali FE, 2004, J INORG BIOCHEM, V98, P173, DOI 10.1016/j.jinorgbio.2003.10.002
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   FRYE AH, 1959, J POLYM SCI, V40, P419, DOI 10.1002/pol.1959.1204013712
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hu BH, 2000, TETRAHEDRON LETT, V41, P5795, DOI 10.1016/S0040-4039(00)00957-6
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   Kakinoki S, 2010, ACTA BIOMATER, V6, P1925, DOI 10.1016/j.actbio.2009.12.001
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kobayashi S, 2003, PROG POLYM SCI, V28, P1015, DOI 10.1016/S0079-6700(03)00014-5
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Ooka AA, 2000, BIOPOLYMERS, V57, P92
   Park KM, 2011, J MATER CHEM, V21, P15906, DOI 10.1039/c1jm13869c
   Seth R, 2004, TOXICOL IN VITRO, V18, P501, DOI 10.1016/j.tiv.2004.01.006
   Sever MJ, 2001, TETRAHEDRON, V57, P6139, DOI 10.1016/S0040-4020(01)00601-9
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   WAITE JH, 1990, INT J BIOL MACROMOL, V12, P139, DOI 10.1016/0141-8130(90)90065-I
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 26
TC 9
Z9 10
U1 2
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD APR
PY 2015
VL 26
IS 4
BP 639
EP 644
DI 10.1021/acs.bioconjchem.5b00032
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA CG3JU
UT WOS:000353177300004
PM 25742028
DA 2018-10-20
ER

PT J
AU Singh, B
   Kumar, S
   Saha, N
   Basu, B
   Gupta, R
AF Singh, Brajendra
   Kumar, Samayendra
   Saha, Naresh
   Basu, Bikramjit
   Gupta, Rajeev
TI Phase stability of silver particles embedded calcium phosphate
   bioceramics
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Biomaterial; hydroxyapatite; Raman spectroscopy
ID NANOPHASE CERAMICS; CRYSTAL-STRUCTURE; HYDROXYAPATITE; BIOCOMPATIBILITY;
   DIFFRACTION; FILM
AB In this paper, we report the compositional variation-dependent phase stability of hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) on doping with silver. The transformation of hydroxyapatite to (beta/alpha) tricalcium phosphate phases during sintering has been explored using Raman spectroscopy and X-ray diffraction techniques. The optical absorption spectroscopy analysis reveals the presence of Ag+ ions at low doping levels. As the doping increases, abundance of Ag particles is enhanced.
C1 [Singh, Brajendra] Univ Allahabad, Ctr Mat Sci, Allahabad 211002, Uttar Pradesh, India.
   [Singh, Brajendra; Gupta, Rajeev] Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India.
   [Kumar, Samayendra; Gupta, Rajeev] Indian Inst Technol, Mat Sci Program, Kanpur 208016, Uttar Pradesh, India.
   [Saha, Naresh; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
RP Singh, B (reprint author), Univ Allahabad, Ctr Mat Sci, Allahabad 211002, Uttar Pradesh, India.
EM brajendr@gmail.com
RI Gupta, Rajeev/C-8262-2012
OI Gupta, Rajeev/0000-0002-8328-9780; Singh, Brajendra/0000-0001-9587-8817
FU CSIR; DST, India
FX We acknowledge the financial support from the CSIR and DST, India. BS
   thanks Dr N P Lalla, IUC-DAEF, Indore, for assistance in TEM analysis.
CR Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Geoffrey I N, 2001, PHYS CHEM CHEM PHYS, V17, P3838
   Han IH, 2007, BIOMED MATER, V2, pS91, DOI 10.1088/1748-6041/2/3/S01
   HANSEN WN, 1968, PHYS REV, V174, P500, DOI 10.1103/PhysRev.174.500
   Jimenez JA, 2008, J APPL PHYS, V104, DOI 10.1063/1.2976171
   Kannan S, 2005, SCRIPTA MATER, V53, P1259, DOI 10.1016/j.scriptamat.2005.07.037
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Lee IS, 2006, NUCL INSTRUM METH B, V242, P45, DOI 10.1016/j.nimb.2005.08.010
   Lee IS, 2002, BIOMATERIALS, V23, P609, DOI 10.1016/S0142-9612(01)00147-8
   LeGeros R.Z., 1980, P 2 INT C PHOSPH COM, P89
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nath S, 2008, SCRIPTA MATER, V58, P1054, DOI 10.1016/j.scriptamat.2008.01.045
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   PETTINGER B, 1994, ANGEW CHEM INT EDIT, V33, P85, DOI 10.1002/anie.199400851
   PNde Aza, 1997, CHEM MATER, V9, P916
   Singh B, 2015, INT J APPL CERAM TEC, V12, P319, DOI 10.1111/ijac.12167
   Singh B, 2013, MATER LETT, V95, P100, DOI 10.1016/j.matlet.2012.12.074
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Wang D. S., 1990, APPL OPTICS, V19, P2135
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2
NR 26
TC 2
Z9 2
U1 3
U2 11
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
EI 0973-7669
J9 B MATER SCI
JI Bull. Mat. Sci.
PD APR
PY 2015
VL 38
IS 2
BP 525
EP 529
DI 10.1007/s12034-014-0839-y
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA CH2CD
UT WOS:000353831200031
DA 2018-10-20
ER

PT J
AU Jeong, ED
   Whang, JY
   Lee, JW
AF Jeong, Euh-Duck
   Whang, Jae Young
   Lee, Joo-Woon
TI Conducting Cell Scaffold-Poly(3 '-aminomethyl-2,2 ':5 ',2
   ''-terthiophene)
SO BULLETIN OF THE KOREAN CHEMICAL SOCIETY
LA English
DT Article
DE Conductive polymer; Polyterthiophene; Scaffold; Cell adhesion
ID NEURAL INTERFACES; POLYMERS; POLYPYRROLE; ATTACHMENT; SCAFFOLDS; GROWTH;
   ACID; ELECTRODES; PLATFORM; CULTURE
AB Electroactive biomaterials such as polythiophene (PT) are highly attractive scaffolds for tissue engineering applications. The introduction of reactive functionalities into the PT backbone structure is desired to enhance the biomaterial-tissue interface for desired tissue responses. Here, we present amino-functionalized conductive polyterthiophene, poly(3'-aminomethyl-2,2':5',2"-terthiophene) (PTTh-NH2), which successfully demonstrates the potential to influence cellular activity. The chemical structure of monomeric 3'-aminomethyl-2,2':5',2"-terthiophene was confirmed by MS and the polymer characteristics of PTTh-NH2 were determined by AFM, XPS, profilometer and four-point probe. In vitro cell viability study with human umbilical vascular endothelial cells (HUVECs) indicates that the primary amine functionality grafted into polythiophene (PT) backbone improve the cell adhesion and proliferation compared to negative (-) control conventional PT. Thus, PTTh-NH2 could be useful in developing PT composites for various biomedical applications.
C1 [Jeong, Euh-Duck] Korea Basic Sci Inst, Div High Technol Mat Res, Busan 618230, South Korea.
   [Whang, Jae Young] Gyeongsang Natl Univ, Res Inst Green Energy Convergence Technol RIGET, Jinju 660701, South Korea.
   [Lee, Joo-Woon] Korea Natl Univ Transportat, Sch Liberal Arts & Sci, Chem, Chungju 380702, South Korea.
RP Lee, JW (reprint author), Korea Natl Univ Transportat, Sch Liberal Arts & Sci, Chem, Chungju 380702, South Korea.
EM jwoonlee@ut.ac.kr
FU Academic Research Program of the Korea National University of
   Transportation
FX This work was supported by a grant from the Academic Research Program of
   the Korea National University of Transportation in 2014.
CR Alberts B, 2002, MOL BIOL CELL
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Cho YN, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205102
   Collis GE, 2003, J ORG CHEM, V68, P8974, DOI 10.1021/jo034855g
   Dawson RA, 1996, BURNS, V22, P93, DOI 10.1016/0305-4179(95)00092-5
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Higgins TB, 1998, CHEM MATER, V10, P1589, DOI 10.1021/cm970765e
   Janorkar AV, 2007, J BIOMED MATER RES B, V81B, P142, DOI 10.1002/jbm.b.30647
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim HJ, 2008, LANGMUIR, V24, P1087, DOI 10.1021/la701689f
   Kim J, 2010, IEEE INT CON MULTI, P7, DOI 10.1109/ICME.2010.5583856
   Lee J. Y., 2009, J R SOC INTERFACE, V6, P735
   Lee JY, 2013, SYNTHETIC MET, V185, P66, DOI 10.1016/j.synthmet.2013.09.044
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Lee JW, 2014, B KOREAN CHEM SOC, V35, P293, DOI 10.5012/bkcs.2014.35.1.293
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee TY, 2002, SYNTHETIC MET, V126, P105, DOI 10.1016/S0379-6779(01)00556-2
   Li GT, 1998, MACROMOL CHEM PHYSIC, V199, P2255, DOI 10.1002/macp.1998.021991025
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   McTiernan CD, 2012, NEW J CHEM, V36, P2106, DOI 10.1039/c2nj40366h
   Poole-Warren L, 2010, EXPERT REV MED DEVIC, V7, P35, DOI 10.1586/ERD.09.58
   Seol H, 2006, SYNTHETIC MET, V156, P65, DOI 10.1016/j.synthmet.2005.10.008
   SMITS FM, 1958, AT&T TECH J, V37, P711, DOI 10.1002/j.1538-7305.1958.tb03883.x
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Sun Y, 2007, MACROMOL SYMP, V256, P137, DOI [10.1002/masy.200751016, 10.1002/masy.20751016]
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yoon JH, 2011, J POWER SOURCES, V196, P8874, DOI 10.1016/j.jpowsour.2011.05.077
NR 32
TC 1
Z9 1
U1 1
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0253-2964
EI 1229-5949
J9 B KOREAN CHEM SOC
JI Bull. Korean Chem. Soc.
PD APR
PY 2015
VL 36
IS 4
BP 1114
EP 1119
DI 10.1002/bkcs.10206
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CG8RJ
UT WOS:000353577900009
DA 2018-10-20
ER

PT J
AU Nishimura, T
   Mukai, S
   Sawada, S
   Akiyoshi, K
AF Nishimura, Tomoki
   Mukai, Sada-atsu
   Sawada, Shin-ichi
   Akiyoshi, Kazunari
TI Glyco Star Polymers as Helical Multivalent Host and Biofunctional
   Nano-Platform
SO ACS Macro Letters
LA English
DT Article
ID COIL BLOCK-COPOLYMERS; DNA STRAND EXCHANGE; ENZYMATIC-SYNTHESIS;
   AMYLOSE-PRIMER; CATALYZED POLYMERIZATION; INCLUSION COMPLEXES; IODINE;
   ACID; CHAPERONE; KINETICS
AB A series of amylose-based star polymers (1, 2, 4, and 8 arms) as a new glyco biomaterial was synthesized by a click reaction and enzymatic polymerization of specific primers with phosphorylase. The molecular weights were controlled by the enzymatic reaction. Further polymerization resulted in a viscous solution and, especially, for the 8-arm primer, a hydrogel was obtained due to effective cross-linking between the multiarmed structures. The star polymers with a degree of polymerization of about 60 per arm acted as an allosteric multivalent host for hydrophobic molecules by helical formation. A cationic 8-arm star polymer catalyzed DNA strand exchange as a nucleic acid chaperone. Amylose-based star polymers are promising building blocks for producing advanced hybrid glyco biomaterials.
C1 [Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan.
   [Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] JST, ERATO Akiyoshi Bionanotransporter Project, Kyoto 6158150, Japan.
RP Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan.
EM akiyoshi@bio.polym.kyoto-u.ac.jp
RI Nishimura, Tomoki/E-5189-2010
OI Nishimura, Tomoki/0000-0002-9034-3626
FU JST ERATO program
FX This work was financially supported by the JST ERATO program.
CR Akiyoshi K, 2002, BIOMACROMOLECULES, V3, P280, DOI 10.1021/bm010144l
   Akiyoshi K, 1999, MACROMOL RAPID COMM, V20, P112, DOI 10.1002/(SICI)1521-3927(19990301)20:3<112::AID-MARC112>3.0.CO;2-Q
   BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6
   Bernard J, 2005, MACROMOLECULES, V38, P5475, DOI 10.1021/ma050050u
   Braunmuehl V. v., 1995, MACROMOLECULES, V28, P17
   Cori GT, 1940, J BIOL CHEM, V135, P733
   Frykholm K, 2009, LANGMUIR, V25, P1606, DOI 10.1021/la8032513
   Gelders GG, 2005, BIOMACROMOLECULES, V6, P2622, DOI 10.1021/bm0502011
   GIDLEY MJ, 1989, MACROMOLECULES, V22, P341, DOI 10.1021/ma00191a062
   HANDA T, 1981, BIOPOLYMERS, V20, P2051, DOI 10.1002/bip.1981.360201003
   Hsien-Chih HW, 1978, CARBOHYD RES, V61, P27
   Inoue K, 2000, PROG POLYM SCI, V25, P453, DOI 10.1016/S0079-6700(00)00011-3
   Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001
   Kadokawa J, 2001, CHEM COMMUN, P449, DOI 10.1039/b008180i
   Kadokawa J, 2011, CHEM REV, V111, P4308, DOI 10.1021/cr100285v
   Kamiya S, 1998, MACROMOL CHEM PHYS, V199, P1589, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1589::AID-MACP1589>3.0.CO;2-V
   Kaneko Y, 2007, BIOMACROMOLECULES, V8, P3959, DOI 10.1021/bm701000t
   Kim WJ, 2002, J AM CHEM SOC, V124, P12676, DOI 10.1021/ja0272080
   Kim WJ, 2001, CHEM-EUR J, V7, P176, DOI 10.1002/1521-3765(20010105)7:1<176::AID-CHEM176>3.0.CO;2-M
   Kobayashi K, 1996, MACROMOLECULES, V29, P8670, DOI 10.1021/ma9603443
   Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006
   Loos K, 2002, BIOMACROMOLECULES, V3, P368, DOI 10.1021/bm0156330
   Loos K, 1997, MACROMOLECULES, V30, P7641, DOI 10.1021/ma971022h
   MILES MJ, 1985, CARBOHYD RES, V135, P257, DOI 10.1016/S0008-6215(00)90777-8
   Milojevic S, 1996, J CONTROL RELEASE, V38, P75, DOI 10.1016/0168-3659(95)00112-3
   Morimoto N, 2007, J AM CHEM SOC, V129, P458, DOI 10.1021/ja065966a
   Morimoto N, 2013, LANGMUIR, V29, P7509, DOI 10.1021/la3047774
   Morimoto N, 2009, CHEM LETT, V38, P496, DOI 10.1246/cl.2009.496
   Morimoto N, 2009, J BIOTECHNOL, V140, P246, DOI 10.1016/j.jbiotec.2009.01.013
   Narumi A, 2003, POLYM BULL, V49, P405, DOI 10.1007/s00289-003-0126-3
   OKAMOTO Y, 1994, J CHROMATOGR A, V666, P403, DOI 10.1016/0021-9673(94)80400-1
   Otsuka I., 2009, LANGMUIR, V26, P2325
   Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011
   Roger P, 2000, MACROMOLECULES, V33, P2446, DOI 10.1021/ma991302s
   SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5
   Sanji T, 2005, ANGEW CHEM INT EDIT, V44, P7301, DOI 10.1002/anie.200502073
   Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267
   Shimada N, 2008, J POLYM SCI POL CHEM, V46, P1440, DOI 10.1002/pola.22483
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l
   Tanaka T, 2013, MACROMOL CHEM PHYS, V214, P2829, DOI 10.1002/macp.201300525
   Vlassopoulos D, 2004, J POLYM SCI POL PHYS, V42, P2931, DOI 10.1002/polb.20152
   Vlist J. v. d., 2012, POLYMERS, V4, P674
   ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7
NR 44
TC 9
Z9 9
U1 6
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD APR
PY 2015
VL 4
IS 4
BP 367
EP 371
DI 10.1021/acsmacrolett.5b00049
PG 5
WC Polymer Science
SC Polymer Science
GA CG6UD
UT WOS:000353437000007
DA 2018-10-20
ER

PT J
AU Jebahi, S
   Saoudi, M
   Farhat, L
   Oudadesse, H
   Rebai, T
   Kabir, A
   El Feki, A
   Keskes, H
AF Jebahi, S.
   Saoudi, M.
   Farhat, L.
   Oudadesse, H.
   Rebai, T.
   Kabir, A.
   El Feki, A.
   Keskes, H.
TI Effect of novel curcumin-encapsulated chitosan-bioglass drug on bone and
   skin repair after gamma radiation: experimental study on a Wistar rat
   model
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Article
DE curcumin; bioglass; chitosan; bone; skin; osteoporosis; irradiation
ID ANTIOXIDANT ACTIVITY; GLASS; MICE; IRRADIATION
AB Radiation therapy contributes to a significant increase in bone osteoporosis and skin loss. Various natural health products might be beneficial to reduce bone and skin alterations. Curcumin (CUR) medicines derived from natural plants have played an important role in health care. This study aims at synthesizing and evaluating the performance therapy of CUR-encapsulated bioglass-chitosan (CUR-BG-CH). In vitro, the antioxidant assay was evaluated by using 1,1-diphenyl-2-picrylhydrazyl free-radical (DPPH) scavenging and the nitroblue tetrazolium reduction. The CUR-BG-CH antimicrobial effects were tested in liquid media. In vivo, after rat Co-60 -radiation, the tissue wound-healing process was studied by grafting CUR and CUR-BG-CH in femoral condyle and dorsal skin rat tissue. The antioxidant studies indicated that CUR-BG-CH quenches free radicals more efficiently than unmodified CUR and had effective DPPH (91%) and superoxide anion (51%) radical scavenging activities. The CUR-BG-CH biomaterial exhibited an important antimicrobial activity against Staphylococcus aureus. The histomorphometric parameters showed amelioration in CUR-BG-CH-treated rats. An improved mechanical property was noticed (33.16 +/- 5.0HV) when compared with that of unmodified CUR group (23.15 +/- 4.9 HV). A significant decrease in tumour necrosis factor- cytokine production was noted in the CUR-BG-CH rats (90pg/ml) as compared with that of unmodified CUR group (240pg/ml). The total amount of hydroxyproline was significantly enhanced (33.5%) in CUR-BG-CH group as compared with that of control. Our findings suggested that CUR-BG-CH might have promising potential applications for wound healing. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Jebahi, S.; Oudadesse, H.] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, Rennes, France.
   [Jebahi, S.; Saoudi, M.; El Feki, A.; Keskes, H.] Sfax Fac Sci, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Farhat, L.] CHU Habib Bourguiba, Med Oncol Serv, Sfax, Tunisia.
   [Rebai, T.; Kabir, A.] Sfax Fac Med, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
RP Jebahi, S (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, Rennes, France.
EM jbahisamira@yahoo.fr
CR Antuness LM, 2000, MUTAT RES, V2, P131
   Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t
   Bls N, 2011, PHYTOMEDICINE, V18, P756
   Bonnet N, 2010, IBMS BONEKEY, V7, P235, DOI DOI 10.1138/20100454
   Buis XV, 2012, KOREAN J CHEM ENG, V29, P215
   Camils CB, 1994, MATURITAS, V18, P199
   Caos X, 2011, P NATL ACAD SCI USA, V108, P1609
   Chos JW, 2007, INT J MOL MED, V19, P469
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Cordina-Duverger E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078016
   Jaques JAD, 2011, CELL BIOCHEM FUNCT, V29, P703, DOI 10.1002/cbf.1804
   El-Sweedys M, 2007, J APPL BIOMED, V5, P131
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   GRANT RA, 1973, J ANAT, V115, P29
   Jagetia GC, 2005, PLAST RECONSTR SURG, V115, P515, DOI 10.1097/01.PRS.0000148372.75342.D9
   Jagetia GC, 2004, J SURG RES, V120, P127, DOI 10.1016/j.jss.2003.12.003
   Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140
   Jebahi S, 2012, J APPL BIOMED, V10, P195, DOI 10.2478/v10136-012-0009-8
   Kents LJ, 2006, BIOMATERIALS, V27, P3249
   Koleva II, 2002, PHYTOCHEM ANALYSIS, V13, P8, DOI 10.1002/pca.611
   Kumagai Yoshito, 2002, Environ Health Prev Med, V7, P141, DOI 10.1007/BF02897942
   Lins C, 2012, BIOMED MATER, V7
   Mamalis A, 2014, J DRUGS DERMATOL, V13, P574
   MERYON SD, 1984, CELL BIOCHEM FUNCT, V2, P43, DOI 10.1002/cbf.290020112
   Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011
   Muns SH, 2013, PHYTOMEDICINE, V20, P714
   Nair SP, 1996, INFECT IMMUN, V64, P2371
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Oudadesse H, 2013, KOREAN J CHEM ENG, V30, P1775, DOI 10.1007/s11814-013-0104-x
   Pezeshki-Modaresss M, 2013, J BIOMED MATER RES A, DOI [10.1002/jbm.a.35054, DOI 10.1002/JBM.A.35054]
   Pierangelos B, 2014, PHYTOMEDICINE, V21, P430
   Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3
   Rais D, 2008, J BIOCH, V410, P147
   Ranas T, 2012, FREE RADIC BIOL MED, V15, P2298
   SCHENK RK, 1969, ACTA ANAT, V74, P44
   Steafans IL, 1995, BIOCH BIOPHYS, V318, P408
   Supper S, 2014, EXPERT OPIN DRUG DEL, V11, P249, DOI 10.1517/17425247.2014.867326
   Tais BJ, 2006, J CLIN PERIODONTOL, V33, P86
   Victoria Delpinos M, 2009, INFECT IMMUN, V77, P984
   Wus SJ, 2013, INT J BIOL MACROMOL, V62, P348
NR 40
TC 8
Z9 9
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0263-6484
EI 1099-0844
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD APR
PY 2015
VL 33
IS 3
BP 150
EP 159
DI 10.1002/cbf.3098
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CG4GN
UT WOS:000353243700007
PM 25809966
DA 2018-10-20
ER

PT J
AU Gellynck, K
   Kodeck, V
   Van De Walle, E
   Kersemans, K
   De Vos, F
   Declercq, H
   Dubruel, P
   Vlaminck, L
   Cornelissen, M
AF Gellynck, Karolien
   Kodeck, Valerie
   Van De Walle, Elke
   Kersemans, Ken
   De Vos, Filip
   Declercq, Heidi
   Dubruel, Peter
   Vlaminck, Lieven
   Cornelissen, Maria
TI First step toward near-infrared continuous glucose monitoring: in vivo
   evaluation of antibody coupled biomaterials
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE In vivo; continuous glucose monitoring; antibody-coupled; vascular
   endothelial-cadherin; enhanced vascularization
ID VASCULAR ENDOTHELIAL-CADHERIN; BLOOD-VESSEL FORMATION; NEOINTIMAL
   FORMATION; DIABETES-MELLITUS; GROWTH-FACTOR; TISSUE; SPECTROSCOPY;
   DIFFUSION; IMPLANTS; SILICON
AB Continuous glucose monitoring (CGM) is crucial in diabetic care. Long-term CGM systems however require an accurate sensor as well as a suitable measuring environment. Since large intravenous sensors are not feasible, measuring inside the interstitial fluid is considered the best alternative. This option, unfortunately, has the drawback of a lag time with blood glucose values. A good strategy to circumvent this is to enhance tissue integration and enrich the peri-implant vasculature. Implants of different optically transparent biomaterials (poly(methyl-methacrylate) [PMMA] and poly(dimethylsiloxane) [PDMS]) - enabling glucose monitoring in the near-infrared (NIR) spectrum - were surface-treated and subsequently implanted in goats at various implantation sites for up to 3 months. The overall in vivo biocompatibility, tissue integration, and vascularization at close proximity of the surfaces of these materials were assessed. Histological screening showed similar tissue reactions independent of the implantation site. No significant inflammation reaction was observed. Tissue integration and vascularization correlated, to some extent, with the biomaterial composition. A modification strategy, in which a vascular endothelial-cadherin antibody was coupled to the biomaterials surface through a dopamine layer, showed significantly enhanced vascularization 3 months after subcutaneous implantation. Our results suggest that the developed strategy enables the creation of tissue interactive NIR transparent packaging materials, opening the possibility of continuous glucose monitoring.
C1 [Gellynck, Karolien; Declercq, Heidi; Cornelissen, Maria] Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium.
   [Kodeck, Valerie; Van De Walle, Elke; Dubruel, Peter] Univ Ghent, PBM, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Kersemans, Ken; De Vos, Filip] Univ Ghent, Lab Radiopharm, B-9000 Ghent, Belgium.
   [Vlaminck, Lieven] Univ Ghent, Dept Surg & Anaesthesiol Domest Anim, B-9820 Merelbeke, Belgium.
RP Cornelissen, M (reprint author), Univ Ghent, Tissue Engn Grp, Pintelaan 185 6B3, B-9000 Ghent, Belgium.
EM Ria.Cornelissen@UGent.be
FU Ghent University; Agency for Innovation by Science and Technology (IWT)
   [SBO] [GlucoSens 090053]
FX The authors would like to thank Leen Pieters and Thoke Thiron for their
   technical assistance, while Ghent University is acknowledged for
   supporting the Multidisciplinary Research Partnership Nano- and
   Biophotonics (2010-2014). This work was supported by the Agency for
   Innovation by Science and Technology (IWT) [SBO project GlucoSens
   090053].
CR Abbasi F, 2006, J BIOMAT SCI-POLYM E, V17, P341, DOI 10.1163/156856206775997287
   Ainslie KM, 2005, NANO LETT, V5, P1852, DOI 10.1021/nl051117u
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13
   Berneel E, 2012, J BIOMED MATER RES A, V100A, P1783, DOI 10.1002/jbm.a.34125
   Block SS, 2001, DISINFECTION STERILI, P1481
   Burmeister JJ, 1999, CLIN CHEM, V45, P1621
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Haghdoost I, 2007, COMPAR CLIN PATHOL, V16, P53
   Hazen KH, 1998, APPL SPECTROSC, V52, P1597, DOI 10.1366/0003702981943103
   JONGEBLOED WL, 1994, BIOMATERIALS, V15, P766, DOI 10.1016/0142-9612(94)90030-2
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JM, 2012, BIOMATERIALS, V33, P8917, DOI 10.1016/j.biomaterials.2012.08.066
   Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168
   Lim WH, 2011, ARTERIOSCL THROM VAS, V31, P2798, DOI 10.1161/ATVBAHA.111.226134
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Olesberg JT, 2006, ANAL CHEM, V78, P215, DOI 10.1021/ac051036i
   Oliver NS, 2009, DIABETIC MED, V26, P197, DOI 10.1111/j.1464-5491.2008.02642.x
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Race A, 2007, J BIOMECH, V40, P1002, DOI 10.1016/j.jbiomech.2006.04.003
   Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x
   Roelkens G, 2012, IEEE J QUANTUM ELECT, V48, P292, DOI 10.1109/JQE.2011.2178090
   Ryckeboer E, 2013, OPT EXPRESS, V21, P6101, DOI 10.1364/OE.21.006101
   Ryckeboer E, 2013, LAB CHIP, V13, P4392, DOI 10.1039/c3lc50752a
   Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159
   Trabelsi A, 2010, INT C MICROELECTRON, P176, DOI 10.1109/ICM.2010.5696108
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   Wan Y, 2011, BIOSENS BIOELECTRON, V26, P2595, DOI 10.1016/j.bios.2010.11.013
   WOOD RC, 1995, BIOMATERIALS, V16, P957, DOI 10.1016/0142-9612(95)93122-T
   Zhu HG, 2005, BIOCONJUGATE CHEM, V16, P1451, DOI 10.1021/bc050171z
NR 41
TC 2
Z9 2
U1 0
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD APR
PY 2015
VL 240
IS 4
BP 446
EP 457
DI 10.1177/1535370214554878
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CG1SP
UT WOS:000353054600005
PM 25304314
OA Green Published
DA 2018-10-20
ER

PT J
AU Lee, KM
   Kim, H
   Nemeno, JG
   Yang, W
   Yoon, J
   Lee, S
   Lee, JI
AF Lee, K. M.
   Kim, H.
   Nemeno, J. G.
   Yang, W.
   Yoon, J.
   Lee, S.
   Lee, J. I.
TI Natural Cardiac Extracellular Matrix Sheet as a Biomaterial for
   Cardiomyocyte Transplantation
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID MYOCARDIAL-INFARCTION; TISSUE RECONSTRUCTION; SCAFFOLDS; CELLS
AB Cardiovascular diseases associated with myocardial infarction are among the major causes of death worldwide due to the limited regenerative capacity of cardiac tissues. Although various approaches, such as biosynthetic biomaterials, have been developed to promote postinfarction cardiac regeneration, a number of limitations, including the immune complications caused by biodegradation of these scaffolds and insufficient cell migration, need to be overcome prior to their clinical application. Hence, the development of natural biomaterials to support myocardial regeneration is crucial. Here, we investigated the effects of a natural biomaterial, cardiac extracellular matrix (ECM) on the proliferation and maintenance of cardiomyocytes in order to assess its suitability for cardiomyocyte expansion. The ECM components not only provide mechanical support, but also induce and preserve the required phenotypic and functional characteristics of the cells. We prepared ECM sheets from decellularized cardiac sections. Cardiomyocytes were then cultured with and without these cardiac ECM sheets. We compared the proliferation rates and phenotypes, and cardiac gene and protein expression, of the cultured cardiomyocytes by automatic cell counting and the MTT assay, microscopy, and RT-PCR and western blotting, respectively. The cardiomyocytes cultured with the natural cardiac ECM sheets exhibited higher proliferation rates and cardiac gene and protein expression than those cultured without the ECM sheets. Our results demonstrate that the ECM sheets are suitable for use in cardiomyocyte transplantation and can provide a novel in vitro model for investigating cell and ECM interactions. We hypothesize that these ECM sheets can be used in the future to improve cardiac transplantation strategies.
C1 [Lee, K. M.; Kim, H.; Nemeno, J. G.; Yang, W.; Lee, S.; Lee, J. I.] Konkuk Univ, IBST, Dept Biomed Sci & Technol, Regenerat Med Lab,Ctr Stem Cell Res, Seoul 143729, South Korea.
   [Yoon, J.] Seoul Natl Univ Sci & Technol, Grad Sch NID Fus Technol, IT Design Fus Program, Seoul, South Korea.
   [Lee, J. I.] Konkuk Univ, Coll Vet Med, Dept Vet Med, Seoul 143729, South Korea.
RP Lee, JI (reprint author), Konkuk Univ, 120 Neungdong Ro, Seoul 143729, South Korea.
EM jeongik@konkuk.ac.kr
RI Lee, Jeong Ik/D-8312-2011
OI Lee, Jeong Ik/0000-0003-2740-2432
FU Korean Health Technology R&D Project, Ministry of Health Welfare
   [A120275]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare (A120275).
CR Alshammary S, 2013, SURG TODAY, V43, P970, DOI 10.1007/s00595-013-0528-2
   Braunwald E, 2000, CIRCULATION, V102, P14
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Takezawa T, 2002, FASEB J, V16, P1847, DOI 10.1096/fj.00-0405fje
   Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011
   Vacanti JP, 1999, LANCET, V354, pSI32
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang W, 2014, TRANSPL P, V46, P1247, DOI 10.1016/j.transproceed.2013.11.082
NR 17
TC 4
Z9 4
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD APR
PY 2015
VL 47
IS 3
BP 751
EP 756
DI 10.1016/j.transproceed.2014.12.030
PG 6
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA CG6PT
UT WOS:000353424900040
PM 25891725
DA 2018-10-20
ER

PT J
AU Zhu, TM
   Tang, QS
   Shen, YW
   Tang, HL
   Chen, LP
   Zhu, JH
AF Zhu, Tongming
   Tang, Qisheng
   Shen, Yiwen
   Tang, Hailiang
   Chen, Luping
   Zhu, Jianhong
TI An acellular cerebellar biological scaffold: Preparation,
   characterization, biocompatibility and effects on neural stem cells
SO BRAIN RESEARCH BULLETIN
LA English
DT Article
DE Extracellular matrix; Cerebellum; Central nervous system;
   Decellularization; Regenerative medicine; Tissue engineering
ID SYSTEM EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE; IN-VIVO; AORTIC
   MATRIX; SPINAL-CORD; BRAIN; DIFFERENTIATION; PROLIFERATION; SUBMUCOSA;
   NEUROGENESIS
AB Biomaterial and regenerative medical research has diversified and developed rapidly. A biological scaffold consisting of an extracellular matrix (ECM) functions not only as a supportive material but also as a regulator of cellular functions. Although decellularized scaffolds have been widely applied for the repair of non-central nervous system (CNS) tissues, their efficacy in the CNS has not been extensively investigated. In this report, we describe a dynamic decellularization protocol that combined intracardial perfusion and a series of treatments to effectively remove the cellular components from the cerebellum, which is a unique and relatively simple CNS structure. The resulting cerebellar scaffold retained neurosupportive proteins and growth factors and, when tested with neural stem cells (NSCs) in vitro, was found to be cytocompatible and to stimulate the proliferation and migration of these cells. NSCs that were cultured in vitro on the scaffold differentiated into neurons and astrocytes, as indicated by their expression of beta III-tubulin and glial fibrillary acidic protein (GFAP). Through subcutaneous and intracranial implantation experiments, this preliminary study demonstrated the in vivo biocompatibility of the cerebellar scaffold and indicated its potential for future applications. Thus, our study demonstrated that the cerebellar ECM scaffold provided tissue-specific advantages for regenerative medical applications. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhu, Tongming; Tang, Qisheng; Shen, Yiwen; Tang, Hailiang; Chen, Luping; Zhu, Jianhong] Fudan Univ, Fudan Univ Huashan Hosp, Natl Key Lab Med Neurobiol, Dept Neurosurg,Inst Brain Sci,Shanghai Med Coll, Shanghai 200040, Peoples R China.
RP Zhu, JH (reprint author), 12 Wulumuqizhonglu, Shanghai 200040, Peoples R China.
EM fdzhujh@163.com
FU National Natural Science Foundation of China [2012CB966300, 81271003]
FX The study was supported by National Natural Science Foundation of China
   (2012CB966300, 81271003).
CR Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5
   Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002
   Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Bolland BJRF, 2007, J BONE JOINT SURG BR, V89B, P686, DOI 10.1302/0301-620X.89B5.18695
   Butler CE, 2005, PLAST RECONSTR SURG, V116, P1263, DOI 10.1097/01.prs.0000181692.71901.bd
   Butler CE, 2005, PLAST RECONSTR SURG, V116, P1276
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Conconi MT, 2004, ANAT REC PART A, V281A, P1303, DOI 10.1002/ar.a.20137
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Erceg S, 2011, STEM CELLS, V29, P564, DOI 10.1002/stem.619
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170
   Hoshino M, 2012, DEV GROWTH DIFFER, V54, P317, DOI 10.1111/j.1440-169X.2012.01330.x
   Ito M, 1999, BRAIN RES BULL, V50, P331, DOI 10.1016/S0361-9230(99)00147-1
   Kauer-Sant'Anna M, 2007, PEPTIDES, V28, P1447, DOI 10.1016/j.peptides.2007.06.010
   Kazanis I, 2011, DEV NEUROBIOL, V71, P1006, DOI 10.1002/dneu.20970
   KOOCHEKPOUR S, 1995, EUR J CANCER, V31A, P375, DOI 10.1016/0959-8049(94)00476-L
   Massirer KB, 2011, WIRES SYST BIOL MED, V3, P107, DOI 10.1002/wsbm.100
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   O'Connor RC, 2002, UROLOGY, V60, P906, DOI 10.1016/S0090-4295(02)01965-9
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Prestwich GD, 2015, EXPERT OPIN BIOL TH, V15, P3, DOI 10.1517/14712598.2015.975200
   Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   SIMONASSMANN P, 1995, EXPERIENTIA, V51, P883, DOI 10.1007/BF01921739
   Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498
   ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9
   Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673
   Yang XT, 2011, BRAIN RES BULL, V84, P1, DOI 10.1016/j.brainresbull.2010.09.008
NR 50
TC 10
Z9 11
U1 3
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD APR
PY 2015
VL 113
BP 48
EP 57
DI 10.1016/j.brainresbull.2015.03.003
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA CG2CQ
UT WOS:000353082900007
PM 25791359
DA 2018-10-20
ER

PT J
AU Kobtan, H
AF Kobtan, H.
TI Use of autologous fascia lata as a natural biomaterial for tectonic
   support in surgically induced necrotizing scleritis
SO EYE
LA English
DT Article
ID CATARACT-SURGERY; AMNIOTIC MEMBRANE; REPAIR; ULCERATION; PATIENT; TISSUE
AB Background Surgically induced scleral necrosis (SINS) is a severe form of scleritis threatening both vision and integrity of the eye. SINS is a rare sequel of ocular surgery and has been described after cataract extraction, trabeculectomy, strabismus, retinal detachment surgery including parsplana vitrectomy, penetrating keratoplasty, pterygium excision, and diode cyclophotocoagulation.
   Materials and methods To report on the application of autologous fascia lata as a readily available natural biomaterial for ocular tectonic support in SINS, we performed this retrospective chart review including two eyes of two patients; one case following both repaired rupture globe, parsplana vitrectomy, and diode laser transscleral cyclophotocoagulation and one case following pterygium surgical excision.
   Results Successful coverage of the area of scleral thinning with autologous fascia lata was achieved in both cases with overlying healthy vascularized conjunctiva and resolution of the ocular inflammation.
   Conclusion The fascia lata transplant combined with systemic immunosuppression was successful in providing adequate tectonic support and controlling the progression of scleral melt for two cases with SINS.
C1 [Kobtan, H.] Cairo Univ, Dept Ophthalmol, Cairo, Egypt.
RP Kobtan, H (reprint author), Eye Care Clin, 16 El Saleh Ayoub St, Cairo 11211, Egypt.
EM H_k1970@hotmail.com
CR Alsagoff Z, 2000, BRIT J OPHTHALMOL, V84, P1050, DOI 10.1136/bjo.84.9.1050
   ARENTSEN JJ, 1976, AM J OPHTHALMOL, V81, P194, DOI 10.1016/0002-9394(76)90730-3
   BLOOMFIELD SE, 1980, BRIT J OPHTHALMOL, V64, P170, DOI 10.1136/bjo.64.3.170
   DELAMAZA MS, 1994, OPHTHALMOLOGY, V101, P389
   Grindle C F, 1979, Mod Probl Ophthalmol, V20, P219
   Kachmaryk M, 1996, OPHTHALMIC SURG LAS, V27, P397
   Kaufman L M, 1989, J Pediatr Ophthalmol Strabismus, V26, P236
   Lazzaro DR, 2010, EYE CONTACT LENS, V36, P60, DOI 10.1097/ICL.0b013e3181c6deb0
   Lin CP, 1996, OPHTHALMIC SURG LAS, V27, P995
   LYNE AJ, 1979, T OPHTHAL SOC UK, V99, P146
   Morley AMS, 2008, EYE, V22, P162, DOI 10.1038/sj.eye.6702708
   ODONOGHUE E, 1992, BRIT J OPHTHALMOL, V76, P17, DOI 10.1136/bjo.76.1.17
   Okhravi N, 2005, SURV OPHTHALMOL, V50, P351, DOI 10.1016/j.survophthal.2005.04.001
   Rodriguez-Ares MT, 1999, OPHTHALMIC SURG LAS, V30, P485
   SALAMON SM, 1982, AM J OPHTHALMOL, V93, P334, DOI 10.1016/0002-9394(82)90535-9
   Schein OD, 1998, AM J OPHTHALMOL, V125, P549, DOI 10.1016/S0002-9394(99)80197-4
   SCOTT JA, 1994, EYE, V8, P292, DOI 10.1038/eye.1994.60
   Sevel D., 1966, THESIS U LONDON LOND
   Shen SY, 2004, OPHTHAL SURG LAS IM, V35, P251
   TUFT SJ, 1991, OPHTHALMOLOGY, V98, P467
   Vagefi MR, 2005, BRIT J OPHTHALMOL, V89, P124, DOI 10.1136/bjo.2004.051359
   Watson PG, 1976, SCLERA SYSTEMIC DISO, P171
NR 22
TC 4
Z9 4
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-222X
EI 1476-5454
J9 EYE
JI Eye
PD APR
PY 2015
VL 29
IS 4
BP 580
EP 584
DI 10.1038/eye.2014.327
PG 5
WC Ophthalmology
SC Ophthalmology
GA CF5WG
UT WOS:000352627400021
PM 25633880
OA Green Published
DA 2018-10-20
ER

PT J
AU Vega, SL
   Dhaliwal, A
   Arvind, V
   Patel, PJ
   Beijer, NRM
   de Boer, J
   Murthy, NS
   Kohn, J
   Moghe, PV
AF Vega, Sebastian L.
   Dhaliwal, Anandika
   Arvind, Varun
   Patel, Parth J.
   Beijer, Nick R. M.
   de Boer, Jan
   Murthy, N. Sanjeeva
   Kohn, Joachim
   Moghe, Prabhas V.
TI Organizational metrics of interchromatin speckle factor domains:
   integrative classifier for stem cell adhesion & lineage signaling
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; IN-VITRO; MESENCHYMAL CELLS; SUBSTRATE;
   BIOMATERIALS; TOPOGRAPHY; NUCLEUS; PATHWAY; SHAPE; FATE
AB Stem cell fates on biomaterials are influenced by the complex confluence of microenvironmental cues emanating from soluble growth factors, cell-to-cell contacts, and biomaterial properties. Cell-microenvironment interactions influence the cell fate by initiating a series of outside-in signaling events that traverse from the focal adhesions to the nucleus via the cytoskeleton and modulate the sub-nuclear protein organization and gene expression. Here, we report a novel imaging-based framework that highlights the spatial organization of sub-nuclear proteins, specifically the splicing factor SC-35 in the nucleoplasm, as an integrative marker to distinguish between minute differences of stem cell lineage pathways in response to stimulatory soluble factors, surface topologies, and microscale topographies. This framework involves the high resolution image acquisition of SC-35 domains and imaging-based feature extraction to obtain quantitative nuclear metrics in tandem with machine learning approaches to generate a predictive cell state classification model. The acquired SC-35 metrics led to 490% correct classification of emergent human mesenchymal stem cell (hMSC) phenotypes in populations of hMSCs exposed for merely 3 days to basal, adipogenic, or osteogenic soluble cues, as well as varying levels of dexamethasone-induced alkaline phosphatase (ALP) expression. Early osteogenic cellular responses across a series of surface patterns, fibrous scaffolds, and micropillars were also detected and classified using this imaging-based methodology. Complex cell states resulting from inhibition of RhoGTPase, beta-catenin, and FAK could be classified with 490% sensitivity on the basis of differences in the SC-35 organizational metrics. This indicates that SC-35 organization is sensitively impacted by adhesion-related signaling molecules that regulate osteogenic differentiation. Our results show that diverse microenvironment cues affect different attributes of the SC-35 organizational metrics and lead to distinct emergent organizational patterns. Taken together, these studies demonstrate that the early organization of SC-35 domains could serve as a "fingerprint'' of the intracellular mechanotransductive signaling that governs growth factor-and topography-responsive stem cell states.
C1 [Vega, Sebastian L.; Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Dhaliwal, Anandika; Arvind, Varun; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Patel, Parth J.] Rutgers State Univ, New Jersey Med Sch, Piscataway, NJ 08854 USA.
   [Beijer, Nick R. M.; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [de Boer, Jan] Maastricht Univ, cBITE Lab, Merln Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
   [Murthy, N. Sanjeeva; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM moghe@rutgers.edu
FU NIH [EB001046]; NSF DGE [0801620]
FX This study was supported by funding from NIH EB001046 (RESBIO,
   Integrated Resources for Polymeric Biomaterials) and NSF DGE 0801620
   (IGERT on Integrated Science and Engineering of Stem Cells).
CR Akter R, 2009, J BONE MINER RES, V24, P283, DOI 10.1359/JBMR.081010
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Bai B, 2013, BIOMED RES INT, DOI 10.1155/2013/361906
   Boltau M, 1998, NATURE, V391, P877
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   de Peppo GM, 2014, INT J NANOMED, V9, P2499, DOI 10.2147/IJN.S58805
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0
   Galli C, 2010, J BIOMED MATER RES A, V95A, P682, DOI 10.1002/jbm.a.32887
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.TEA.2013.0064, 10.1089/ten.tea.2013.0064]
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim J., 2015, UNPUB
   Kim J. J., 2013, METHOD MOL BIOL, V1052, P1
   Krause U, 2011, METHODS MOL BIOL, V698, P215, DOI 10.1007/978-1-60761-999-4_17
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072233
   Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136
   Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545
   Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497
   Moe AAK, 2012, SMALL, V8, P3050, DOI 10.1002/smll.201200490
   Moen PT, 2004, MOL BIOL CELL, V15, P197
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189
   Ozdemir T, 2013, INTEGR BIOL-UK, V5, P1407, DOI 10.1039/c3ib40068a
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Romero-Prado M, 2006, J CELL BIOCHEM, V98, P1457, DOI 10.1002/jcb.20778
   Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074
   Scuteri Arianna, 2014, International Journal of Stem Cells, V7, P127, DOI 10.15283/ijsc.2014.7.2.127
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646
   SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   THIRY M, 1995, HISTOL HISTOPATHOL, V10, P1035
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vega SL, 2012, J BIOMOL SCREEN, V17, P1151, DOI 10.1177/1087057112453853
   Wang WC, 2012, J CELL BIOCHEM, V113, P3567, DOI 10.1002/jcb.24235
   Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139
   Xing H., 2014, J PERIODONTOL, P1
   Xu B., 2013, J BIOSCI BIOENG, P624
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yang Z, 2011, METHODS MOL BIOL, V698, P353, DOI 10.1007/978-1-60761-999-4_26
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
NR 64
TC 4
Z9 4
U1 1
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PD APR
PY 2015
VL 7
IS 4
BP 435
EP 446
DI 10.1039/c4ib00281d
PG 12
WC Cell Biology
SC Cell Biology
GA CF8CX
UT WOS:000352784200006
PM 25765854
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Srivatsan, KV
   Duraipandy, N
   Begum, S
   Lakra, R
   Ramamurthy, U
   Korrapati, PS
   Kiran, MS
AF Srivatsan, Kunnavakkam Vinjimur
   Duraipandy, N.
   Begum, Shajitha
   Lakra, Rachita
   Ramamurthy, Usha
   Korrapati, Puma Sai
   Kiran, Manikantan Syamala
TI Effect of curcumin caged silver nanoparticle on collagen stabilization
   for biomedical applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Curcumin; Silver nanoparticles; Collagen; Stabilization; Anti-microbial;
   Biocompatible
ID CROSS-LINKED COLLAGEN; RAT TAIL TENDON; IN-VITRO; ANTIBACTERIAL
   PROPERTIES; MECHANICAL-PROPERTIES; LINKING; CYTOTOXICITY; SCAFFOLD;
   SKIN; BIOMATERIAL
AB The current study aims at understanding the influence of curcumin caged silver nanoparticle (CCSNP) on stability of collagen. The results indicated that curcumin caged silver nanoparticles efficiently stabilize collagen, indicated by enhanced tensile strength, fibril formation and viscosity. The tensile strength of curcumin caged silver nanoparticle cross-linked collagen and elongation at break was also found to be higher than glutaraldehyde cross-linked collagen. The physicochemical characteristics of curcumin caged nanoparticle cross-linked collagen exhibited enhanced strength. The thermal properties were also good with both thermal degradation temperature and hydrothermal stability higher than native collagen. CD analysis showed no structural disparity in spite of superior physicochemical properties suggesting the significance of curcumin caged nanoparticle mediated cross-linking. The additional enhancement in the stabilization of collagen could be attributed to multiple sites for interaction with collagen molecule provided by curcumin caged silver nanoparticles. The results of cell proliferation and anti-microbial activity assays indicated that curcumin caged silver nanoparticles promoted cell proliferation and inhibited microbial growth making it an excellent biomaterial for wound dressing application. The study opens scope for nano-biotechnological strategies for the development of alternate non-toxic cross-linking agents facilitating multiple site interaction thereby improving therapeutic values to the collagen for biomedical application. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Srivatsan, Kunnavakkam Vinjimur; Duraipandy, N.; Lakra, Rachita; Ramamurthy, Usha; Korrapati, Puma Sai; Kiran, Manikantan Syamala] CSIR, Cent Leather Res Inst, Chennai 600020, Tamil Nadu, India.
   [Duraipandy, N.; Korrapati, Puma Sai; Kiran, Manikantan Syamala] Acad Sci & Innovat Res, New Delhi, India.
   [Begum, Shajitha] Univ Madras, Chennai, Tamil Nadu, India.
RP Kiran, MS (reprint author), CSIR, CLRI, Chennai 600020, Tamil Nadu, India.
EM kiranmsk112@gmail.com
RI Natarajan, Duraipandy/O-2473-2013
OI Natarajan, Duraipandy/0000-0001-5705-3101
FU DBT [GAP 1062]; CSIR, Govt. of India [CSC0201, BSC0112]
FX We would like to thank The Director, CSIR-CLRI, Chennai, India for
   providing the facilities to carry out the experiments. Financial
   assistance from DBT for the project RGYI (GAP 1062) and CSIR, Govt. of
   India for the supra-institutional project-STARIT (CSC0201) and NanoSHE
   (BSC0112) under XII five year plan is greatly acknowledged.
CR Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Amsterdam D., 1996, ANTIBIOTICS LAB MED, P52
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BAILEY AJ, 1974, NATURE, V251, P105, DOI 10.1038/251105a0
   Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   BAILEY AJ, 1969, GERONTOLOGY, V15, P65, DOI 10.1159/000211677
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P575, DOI 10.1016/j.foodhyd.2006.07.001
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   DANIELSEN CC, 1987, MECH AGEING DEV, V40, P9, DOI 10.1016/0047-6374(87)90030-3
   Danilov NA, 2008, BBA-GEN SUBJECTS, V1780, P764, DOI 10.1016/j.bbagen.2008.01.014
   Di Y, 2009, POLYM DEGRAD STABIL, V94, P1684, DOI 10.1016/j.polymdegradstab.2009.06.019
   Duraipandy N, 2015, J MATER CHEM B, V3, P1415, DOI 10.1039/c4tb01791a
   Duraipandy N, 2014, METALLOMICS, V6, P2025, DOI 10.1039/c4mt00165f
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaidau C., 2010, J OPTOELECTRON ADV M, V12, P2157
   GRANT ME, 1972, NEW ENGL J MED, V286, P242, DOI 10.1056/NEJM197202032860505
   Griffiths PR, 2007, FOURIER TRANSFORM IN
   Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jayakumar GC, 2012, CARBOHYD POLYM, V87, P1482, DOI 10.1016/j.carbpol.2011.09.042
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Jurenka JS, 2009, ALTERN MED REV, V14, P141
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   Kandamchira A, 2013, MAT SCI ENG C-MATER, V33, P4985, DOI 10.1016/j.msec.2013.08.018
   Kielty C.M., 2002, CONNECTIVE TISSUE IT
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   LABOUT JJM, 1972, INT J RADIAT BIOL RE, V21, P483, DOI 10.1080/09553007214550561
   Li YP, 2009, MAT SCI ENG C-BIO S, V29, P1643, DOI 10.1016/j.msec.2009.01.001
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   McKusick V.A., 1972, MCKUSICKS HERITABLE
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nimni ME, 1988, MOL STRUCTURE FUNCTI
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004
   Rajaram A., 1989, J BIOMAT SCI-POLYM E, V1, P167
   Ramachandran G. N., 1976, BIOCH COLLAGEN
   Royce P.M., 1993, JPN J HUM GENET, V38, P445
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Sajithlal GB, 1998, BIOCHEM PHARMACOL, V56, P1607, DOI 10.1016/S0006-2952(98)00237-8
   Shanmugasundaram N, 2004, J BIOMATER APPL, V18, P247, DOI 10.1177/0885328204040945
   SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silverstein R. M., 1981, SPECTROMETRIC IDENTI
   Singh S, 2013, COLLOID SURFACE B, V102, P83, DOI 10.1016/j.colsurfb.2012.08.012
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   TANZER ML, 1973, SCIENCE, V180, P561, DOI 10.1126/science.180.4086.561
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Usha R, 2013, COLLOID SURFACE B, V109, P121, DOI 10.1016/j.colsurfb.2013.03.034
   WALLACE DG, 1986, BIOPOLYMERS, V25, P1875, DOI 10.1002/bip.360251006
   WOHLLEBE M, 1978, EUR J BIOCHEM, V92, P183, DOI 10.1111/j.1432-1033.1978.tb12736.x
   Wood G., 1960, BIOCHEM J, P598
   Xu B., 2013, BIOMATTER, V3, P1
   Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126
   Zeugolis DI, 2010, MAT SCI ENG C-MATER, V30, P190, DOI 10.1016/j.msec.2009.09.017
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 63
TC 10
Z9 10
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 306
EP 315
DI 10.1016/j.ijbiomac.2015.01.050
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700041
PM 25661876
DA 2018-10-20
ER

PT J
AU Manna, PJ
   Mitra, T
   Pramanik, N
   Kavitha, V
   Gnanamani, A
   Kundu, PP
AF Manna, Piyali Jana
   Mitra, Tapas
   Pramanik, Nilkamal
   Kavitha, V.
   Gnanamani, A.
   Kundu, P. P.
TI Potential use of curcumin loaded carboxymethylated guar gum grafted
   gelatin film for biomedical applications
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Gelatin; Guar gum; Curcumin
ID CROSS-LINKED GELATIN; IN-VITRO; CONTROLLED-RELEASE; ALGINATE SPONGE;
   HYDROGEL FILMS; VIVO; ANTIBACTERIAL; CHITOSAN; IDENTIFICATION;
   IRRADIATION
AB Present study describes the synthesis of carboxylmethyl guar gum (CMGG) from the native guar gum (GG). Further, the prepared CMGG is grafted with gelatin to form CMGG-g-gelatin and then mixed with curcumin to prepare a biomaterial. The resultant biomaterial is subjected to the analysis of H-1 NMR, ATR-FTIR, TGA, SEM and XRD ensure the carboxymethylation and grafting. The results reveal that 45% of the amine groups of gelatin have been reacted with the -COOH group of CMGG and 90-95% of curcumin is released from CMGG-g-gelatin after 96 h of incubation in the phosphate buffer at physiological pH. In vitro cell line studies reveal the biocompatibility of the biomaterial and the antimicrobial studies display the growth inhibition against gram +ve and gram -ve organisms at a considerable level. Overall, the study indicates that the incorporation of curcumin Into CMGG-g-gelatin can improve the functional property of guar gum as well as gelatin. (C) 2015 Published by Elsevier B.V.
C1 [Manna, Piyali Jana; Mitra, Tapas; Pramanik, Nilkamal; Kundu, P. P.] Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, Kolkata 700009, W Bengal, India.
   [Kavitha, V.; Gnanamani, A.] CSIR, Div Microbiol, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Kundu, PP (reprint author), Univ Calcutta, Univ Coll Sci & Technol, Dept Polymer Sci & Technol, 92,APC Rd, Kolkata 700009, W Bengal, India.
EM tapasbiochem1@gmail.com; ppk923@yahoo.com
OI Mitra, Tapas/0000-0003-0813-7389
FU UGC, New Delhi
FX One of the authors Dr. Tapas Mitra acknowledges UGC, New Delhi for
   financial assistance provided in the form of Dr. D.S. Kothari Post
   Doctoral Fellowship.
CR Ahuja M, 2012, INT J BIOL MACROMOL, V51, P1086, DOI 10.1016/j.ijbiomac.2012.08.023
   Aravindhan R., 2014, COMPLEX MET, V1, P69, DOI DOI 10.1080/2164232X.2014.886963
   Aydin M, 2010, BRAZ J PHYS, V40, P306, DOI 10.1590/S0103-97332010000300008
   Basniwal R.K., 2011, J AGR FOOD CHEM, V59, P2056
   Bhagavathula N, 2009, WOUND REPAIR REGEN, V17, P360, DOI 10.1111/j.1524-475X.2009.00483.x
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Cortesi R, 1998, BIOMATERIALS, V19, P1641, DOI 10.1016/S0142-9612(98)00034-9
   Cunha PLR, 2007, INT J BIOL MACROMOL, V41, P324, DOI 10.1016/j.ijbiomac.2007.04.003
   Dai M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/595126
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   de Carvalho RA, 2004, FOOD HYDROCOLLOID, V18, P717, DOI 10.1016/j.foodhyd.2003.10.005
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dodi G, 2011, CELL CHEM TECHNOL, V45, P171
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Gong HH, 2012, CARBOHYD POLYM, V88, P1015, DOI 10.1016/j.carbpol.2012.01.057
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   Haynes C. A., 2001, GOOGLE PATENTS
   Huang YH, 2006, CARBOHYD POLYM, V66, P500, DOI 10.1016/j.carbpol.2006.04.001
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Liu WG, 2000, POLYMER, V41, P7589, DOI 10.1016/S0032-3861(00)00015-X
   Lv HX, 2011, MOLECULES, V16, P6778, DOI 10.3390/molecules16086778
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Mitra T, 2012, J APPL POLYM SCI, V125, pE490, DOI 10.1002/app.36957
   Mu C., 2010, MACROMOL MATER ENG, V295, P100
   Naveen N, 2010, ADV ENG MATER, V12, pB380, DOI 10.1002/adem.200980067
   Nguyen T.-H., 2010, J BIOMED SCI ENG, V3, P1117, DOI DOI 10.4236/JBISE.2010.312145
   Nguyen V. C., 2013, INT J POLYM SET, V2013, P1
   Pal S, 2007, J APPL POLYM SCI, V105, P3240, DOI 10.1002/app.26440
   Panariello G, 2008, MACROMOL SYMP, V266, P68, DOI 10.1002/masy.200850613
   Qiu X, 2010, J MED CHEM, V53, P8260, DOI 10.1021/jm1004545
   Singh RK, 2010, EUR J MED CHEM, V45, P1078, DOI 10.1016/j.ejmech.2009.12.002
   Stojanovic Z, 2005, STARCH-STARKE, V57, P79, DOI 10.1002/star.200400342
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Verma A, 2013, INT J PHARM SCI RES, V4, P2907, DOI 10.13040/IJPSR.0975-8232.4(8).2907-15
   Wangtueai S, 2009, LWT-FOOD SCI TECHNOL, V42, P825, DOI 10.1016/j.lwt.2008.11.014
   Zhai ML, 2004, CARBOHYD POLYM, V57, P83, DOI 10.1016/j.carbpol.2004.04.003
NR 45
TC 15
Z9 15
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 437
EP 446
DI 10.1016/j.ijbiomac.2015.01.047
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700057
PM 25661877
DA 2018-10-20
ER

PT J
AU Rong, JJ
   Liang, M
   Xuan, FQ
   Sun, JY
   Zhao, LJ
   Zhen, HZ
   Tian, XX
   Liu, D
   Zhang, QY
   Peng, CF
   Yao, TM
   Li, F
   Wang, XZ
   Han, YL
   Yu, WT
AF Rong, Jing-jing
   Liang, Ming
   Xuan, Feng-qi
   Sun, Jing-yang
   Zhao, Li-jun
   Zhen, Hui-zhen
   Tian, Xiao-xiang
   Liu, Dan
   Zhang, Quan-yu
   Peng, Cheng-fei
   Yao, Tian-ming
   Li, Fei
   Wang, Xiao-zeng
   Han, Ya-ling
   Yu, Wei-ting
TI Alginate-calcium microsphere loaded with thrombin: A new composite
   biomaterial for hemostatic embolization
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Alginate; Thrombin; Microsphere; Trauma; Arterial embolization;
   Hemostasis
ID SPLENIC ARTERY EMBOLIZATION; CONTROLLED-RELEASE; POSTPARTUM HEMORRHAGE;
   DELIVERY-SYSTEM; IN-VIVO; INJURY; CHITOSAN; TRAUMA; BIOCOMPATIBILITY;
   COMPLICATIONS
AB To date, transcatheter arterial embolization (TAE) has become a standard treatment to control intracavitary bleeding as an alternative to surgery. Due to excellent biocompatibility and no residual in vivo, biodegradable materials are preferred in TAE. However, gelfoam is the only commercially available biodegradable embolic material used to treat blunt trauma of solid abdominal viscera until now, and controversial on its stability and reliability never stopped in the past five decades. In this study, a new biodegradable macromolecule material (thrombin-loaded alginate-calcium microspheres, TACMs) was prepared using electrostatic droplet techniques and a special method was developed for hemostatic embolization. Thrombin was successfully loaded into microspheres with high encapsulation efficiency and drug loading capacity. A burst release of TACMs was observed at early stage and sustained release later on, with the activity of thrombin preserved well. The strength of TACMs mixed thrombus, which was used as embolic agent, increased in a dose-dependent manner after TACMs were added. In addition, the TACMs were verified to be of no cytotoxicity and systemic toxicity, and biodegradable in vivo. Finally, the results of preliminary applications revealed that the TACMs could serve as an effective and promising embolic material for blunt trauma and hemorrhage of solid abdominal viscera. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Rong, Jing-jing; Liu, Dan; Zhang, Quan-yu] Third Mil Med Univ, Chongqing 400038, Peoples R China.
   [Liang, Ming; Xuan, Feng-qi; Sun, Jing-yang; Zhao, Li-jun; Tian, Xiao-xiang; Liu, Dan; Zhang, Quan-yu; Peng, Cheng-fei; Yao, Tian-ming; Li, Fei; Wang, Xiao-zeng; Han, Ya-ling] Shenyang Mil Reg, Dept Cardiol, Gen Hosp, Shenyang 110016, Peoples R China.
   [Zhen, Hui-zhen; Yu, Wei-ting] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
RP Rong, JJ (reprint author), Shenyang Mil Reg, Dept Cardiol, Gen Hosp, Shenyang 110016, Peoples R China.
EM rjaipx@163.com; lming000919@sina.com; xuanfengqi1988@126.com;
   sjy2003413002@sina.com; symc_zlj@126.com; zhenghz@dicp.ac.cn;
   tian_xx@163.com; liudan1014@qq.com; qyzhang1983@gmail.com;
   1059427125@qq.com; yaotianming2003@sina.com; feili_666@163.com;
   wxiaozeng@163.com; hanyl@medmail.com.cn; yuwt@dicp.ac.cn
FU Key Project of "the Twelfth Five-Year Plan" for Medical Science and
   Technology Research of People's Liberation Army [BWS12J006]; Doctor
   Startup Fund of Liaoning Province [20131135]; Youth Foundation of
   Medical Science and Technology Research of People's Liberation Army
   [13QNP003]
FX This work was supported by grant from the Key Project of "the Twelfth
   Five-Year Plan" for Medical Science and Technology Research of People's
   Liberation Army (No. BWS12J006), Doctor Startup Fund of Liaoning
   Province (No. 20131135) and Youth Foundation of Medical Science and
   Technology Research of People's Liberation Army (No. 13QNP003).
CR Abada HT, 2007, TECH VASC INTERV RAD, V10, P257, DOI 10.1053/j.tvir.2008.03.002
   Abdekhodaie M., 2014, CHEM ENG SCI, V124, P4
   Banerjee A, 2013, J TRAUMA ACUTE CARE, V75, P69, DOI 10.1097/TA.0b013e3182988b3b
   Becker TA, 2007, NEUROSURGERY, V60, P1119, DOI 10.1227/01.NEU.0000255447.90106.12
   Cao XL, 2010, J MATER SCI-MATER M, V21, P2861, DOI 10.1007/s10856-010-4133-2
   Cottier JP, 2002, OBSTET GYNECOL, V100, P1074, DOI 10.1016/S0029-7844(02)02050-1
   Cui D., 2012, INT J PHARMACEUT, V463, P527
   De la Riva B, 2009, EUR J PHARM BIOPHARM, V73, P50, DOI 10.1016/j.ejpb.2009.04.014
   Dutta S, 2012, ACS APPL MATER INTER, V4, P1560, DOI 10.1021/am201759w
   Ekeh AP, 2013, AM J SURG, V205, P250, DOI 10.1016/j.amjsurg.2013.01.003
   Forster REJ, 2010, J MATER SCI-MATER M, V21, P2243, DOI 10.1007/s10856-010-4080-y
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Golzarian J., 2006, VASCULAR EMBOLOTHERA
   Gombotz WR, 2012, ADV DRUG DELIVER REV, V64, P194, DOI 10.1016/j.addr.2012.09.007
   Grizzi I, 1998, J BIOMAT SCI-POLYM E, V9, P189, DOI 10.1163/156856298X00514
   Hu CH, 2012, COLLOID SURFACE B, V95, P162, DOI 10.1016/j.colsurfb.2012.02.030
   Katz MD, 2012, RADIOGRAPHICS, V32, P1713, DOI 10.1148/rg.326125524
   Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI [10.1097/TA.0b013e31819634a1, 10.1097/TA.0b0l3e31819634a1]
   Konya A, 2010, J VASC INTERV RADIOL, V21, P1091, DOI 10.1016/j.jvir.2010.02.037
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leyon JJ, 2014, CURR PROBL DIAGN RAD, V43, P35, DOI 10.1067/j.cpradiol.2013.10.003
   Li S., 2014, POLYM COMPOS
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Liu B, 2013, J BIOMAT SCI-POLYM E, V24, P589, DOI 10.1080/09205063.2012.701160
   Loffroy RF, 2011, WORLD J GASTRO SURG, V3, P89, DOI 10.4240/wjgs.v3.i7.89
   Lv FQ, 2012, CLIN IMAG, V36, P191, DOI 10.1016/j.clinimag.2011.09.013
   Meng J, 2013, J NANOSCI NANOTECHNO, V13, P1467, DOI 10.1166/jnn.2013.6083
   Moreira PL, 2003, CARDIOVASC INTER RAD, V26, P100, DOI 10.1007/s00270-003-2632-y
   Oerlemans C, 2013, ACTA BIOMATER, V9, P4681, DOI 10.1016/j.actbio.2012.08.038
   Ohta S, 2006, J VASC INTERV RADIOL, V17, P533, DOI 10.1097/01.RVI.0000196356.17770.19
   Owen RJ, 2012, CARDIOVASC INTER RAD, V35, P636, DOI 10.1007/s00270-011-0218-7
   Pandey R, 2004, J ANTIMICROB CHEMOTH, V53, P635, DOI 10.1093/jac/dkh139
   Porcu G, 2005, BJOG-INT J OBSTET GY, V112, P122, DOI 10.1111/j.1471-0528.2005.00306.x
   Requarth JA, 2011, J TRAUMA, V71, P898, DOI 10.1097/TA.0b013e318227ea50
   Sambu N, 2012, HEART, V98, P706, DOI 10.1136/heartjnl-2011-301164
   Skattum J, 2012, INJURY, V43, P62, DOI 10.1016/j.injury.2010.06.028
   Sohn VY, 2009, J SURG RES, V154, P258, DOI 10.1016/j.jss.2008.07.040
   Tang J, 2008, J ULTRAS MED, V27, P925, DOI 10.7863/jum.2008.27.6.925
   Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017
   Wu H, 2012, REACT FUNCT POLYM, V72, P427, DOI 10.1016/j.reactfunctpolym.2012.04.007
   Wu SC, 2008, WORLD J SURG, V32, P476, DOI 10.1007/s00268-007-9322-x
   Xu RF, 2013, J BIOMAT SCI-POLYM E, V24, P1, DOI 10.1163/156856211X619630
   Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007
NR 43
TC 15
Z9 17
U1 4
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2015
VL 75
BP 479
EP 488
DI 10.1016/j.ijbiomac.2014.12.043
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CF1UF
UT WOS:000352332700063
PM 25583022
DA 2018-10-20
ER

PT J
AU Hegewald, AA
   Medved, F
   Feng, DX
   Tsagogiorgas, C
   Beierfuss, A
   Schindler, GAK
   Trunk, M
   Kaps, C
   Mern, DS
   Thome, C
AF Hegewald, Aldemar Andres
   Medved, Fabian
   Feng, Daxiong
   Tsagogiorgas, Charalambos
   Beierfuss, Anja
   Schindler, Genevieve Ama Kyremaa
   Trunk, Marcus
   Kaps, Christian
   Mern, Demissew Shenegelegn
   Thome, Claudius
TI Enhancing tissue repair in annulus fibrosus defects of the
   intervertebral disc: analysis of a bio-integrative annulus implant in an
   in-vivo ovine model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE annulus fibrosus; biomaterial; disc herniation; intervertebral disc;
   regeneration; spine surgery
ID BONE MORPHOGENETIC PROTEIN-2; NUCLEUS PULPOSUS CELLS; ANULUS FIBROSUS;
   SHEEP MODEL; DEGENERATION; RESPONSIVENESS; REPLACEMENT; COMPETENCE;
   STRENGTH
AB Annulus fibrosus repair techniques for the intervertebral disc (IVD) address the unsolved problem of reherniation after IVD herniation and might facilitate the development of nucleus pulposus replacement techniques for IVD diseases. This study investigates the suitability of a bio-integrative annulus implant.Standardized box defects were applied to the annulus L3/4 and L4/5 of 16 sheep, followed by randomized insertion of the textile polyglycolic acid/polyvinylidene fluoride annulus implant in one of the defects. Explantation was conducted after 2, 6 and 12 weeks, followed by provocative pressure testing and histological analysis. At 2 weeks' follow-up, all specimens of the control defect group demonstrated uncontained herniated nucleus pulposus tissue in the annulus defects. For the treated specimens, the annulus implant consistently provided an effective barrier for herniating nucleus pulposus tissue, with no implant dislocation at all time-points. After 2 weeks, a homogeneous cell infiltration of the annulus implant was observed, leading to a progressive directional matrix build-up. Repair tissue thickness was significantly stronger with the annulus implant at all follow-ups (p < 0.01). No pronounced foreign body reaction and no difference in the amount of supra-annular scar tissue over the defect sites were observed. The implantation procedure inflicted annulus damage adjacent to the defect. At later time-points, however, no difference in comparison with the control defect group was evident. The investigated biointegrative annulus implant showed promising results with regard to biointegration, enhancement of repair tissue and function as a mechanical barrier in an ovine model. (c) 2013 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.
C1 [Hegewald, Aldemar Andres; Medved, Fabian; Feng, Daxiong; Schindler, Genevieve Ama Kyremaa; Mern, Demissew Shenegelegn] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany.
   [Hegewald, Aldemar Andres; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.
   [Feng, Daxiong] Luzhou Med Coll, Affiliated Hosp, Spinal Surg Dept, Luzhou, Sichuan Provinc, Peoples R China.
   [Tsagogiorgas, Charalambos] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Anaesthesiol & Crit Care Med, D-68167 Mannheim, Germany.
   [Beierfuss, Anja] Univ Munich, Dept Small Anim Surg & Ophthalmol, Munich, Germany.
   [Trunk, Marcus] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-68167 Mannheim, Germany.
   [Kaps, Christian] TransTissue Technol GmbH, Berlin, Germany.
RP Hegewald, AA (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
EM aldemar.hegewald@medma.uni-heidelberg.de
OI Hegewald, Aldemar Andres/0000-0002-2022-2060
FU Federal Ministry of Education and Research [BioInside 13N9831, 13N9830,
   13N9827]
FX This study was supported by the Federal Ministry of Education and
   Research (BioInside 13N9831, 13N9830 and 13N9827). The authors are very
   grateful to Prof. Lothar Schilling for his technical advice, to Marijas
   Jurisic and Michaela Endres for their technical assistance, to Thorsten
   Deichmann and Annahit Arshi from the Institut fur Textiltechnik, Faculty
   for Mechanical Engineering, RWTH Aachen University, for providing the
   annulus implant, to Prof. Kirsten Schmieder for her organizational
   support and to Dr James Melrose for sharing some of his excellent
   histological insights.
CR AHLGREN BD, 1994, SPINE, V19, P948, DOI 10.1097/00007632-199404150-00014
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Barth M, 2008, SPINE, V33, P265, DOI 10.1097/BRS.0b013e318162018c
   Brands B, 2003, THESIS U ZURICH
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01
   ETHIER DB, 1994, SPINE, V19, P2071, DOI 10.1097/00007632-199409150-00012
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Guder E, 2009, Z ORTHOP UNFALLCHIR, V147, P52, DOI 10.1055/s-2008-1039139
   HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009
   Hegewald Aldemar A, 2009, J Orthop Surg Res, V4, P25, DOI 10.1186/1749-799X-4-25
   Hegewalds AA, 2011, SPINE, V37, P101
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Imai Y, 2007, SPINE, V32, P1303, DOI 10.1097/BRS.0b013e3180593238
   Johnson WEB, 2001, CONNECT TISSUE RES, V42, P197, DOI 10.3109/03008200109005650
   KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009
   Kim H, 2009, SPINE, V34, P1834, DOI 10.1097/BRS.0b013e3181ae18ba
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184
   Melrose J, 2004, METH MOLEC MED, V101, P39
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Saads LC, 2007, THESIS MIT CAMBRIDGE
   Sherman J, 2010, SPINE J, V10, P108, DOI 10.1016/j.spinee.2009.08.453
   SMITH JW, 1951, J BONE JOINT SURG BR, V33, P612
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
NR 33
TC 16
Z9 18
U1 2
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2015
VL 9
IS 4
BP 405
EP 414
DI 10.1002/term.1831
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA CG1LM
UT WOS:000353034100008
PM 24227682
OA Other Gold
DA 2018-10-20
ER

PT J
AU Taylor, AC
   Edgington, R
   Jackman, RB
AF Taylor, Alice C.
   Edgington, Robert
   Jackman, Richard B.
TI Patterning of Nanodiamond Tracks and Nanocrystalline Diamond Films Using
   a Micropipette for Additive Direct-Write Processing
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE diamond; nanodiamond; patterning; direct-write; microwave
   plasma-enhanced CVD
ID THIN-FILMS; MICROELECTRODE ARRAYS; LITHOGRAPHY; MEMS; SURFACE; GROWTH;
   FABRICATION; CARBON
AB The ability to pattern the seeding of nanodiamonds (NDs), and thus selectively control areas of diamond growth, is a useful capability for many applications, including photonics, microelectromechanical systems (MEMS) prototyping, and biomaterial design. A microprinting technique using a computer-driven micropipette has been developed to deposit patterns of ND monolayers from an unreactive water/glycerol ND ink to 5-mu m resolution. The concentration and composition of the ND solution were optimized to realize high-density monolayers of NDs and consistent ND printing. Subsequent nanocrystalline diamond (NCD) patterns grown using chemical vapor deposition showed a high level of compliance with the printed ND pattern. This "direct-write", bottom-up, and additive process offers a versatile and simple alternative to pattern diamond. The process has the particular advantage that it does not require lithography or destructive processing such as reactive-ion etching (RIE) and, pertinently, does not involve reactive chemicals that could alter the surface chemistry of NDs. Furthermore, given that this process obviates the use of conventional lithography, substrates that are not suitable for lithographic processing (e.g., excessively small or three-dimensional structured substrates) can be inscribed with ND patterns. The technique also allows for the growth of discrete, localized, single-crystal nanodiamonds with applications in quantum technology.
C1 [Jackman, Richard B.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England.
   UCL, Dept Elect & Elect Engn, London WC1H 0AH, England.
RP Jackman, RB (reprint author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.
EM r.jackman@ucl.ac.uk
FU EU F7 Project "NEUROCARE" [280433-2]; U.K. Engineering and Physical
   Sciences Research Council (EPSRC) [EP/F026110/1]; Engineering and
   Physical Sciences Research Council [EP/F026110/1, EP/N004159/1]
FX This work was performed as part of EU F7 Project "NEUROCARE" (no.
   280433-2) and was partially supported by the U.K. Engineering and
   Physical Sciences Research Council (EPSRC, EP/F026110/1).
CR Ando Y, 2004, DIAM RELAT MATER, V13, P1975, DOI 10.1016/j.diamond.2004.06.025
   ASCARELLI P, 1993, APPL SURF SCI, V64, P307, DOI 10.1016/0169-4332(93)90201-L
   Avigal Y, 1999, DIAM RELAT MATER, V8, P127, DOI 10.1016/S0925-9635(98)00383-5
   Bergonzo P, 2011, IRBM, V32, P91, DOI 10.1016/j.irbm.2011.01.032
   Bongrain A, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/074015
   Bonnauron A, 2008, DIAM RELAT MATER, V17, P1399, DOI 10.1016/j.diamond.2007.12.065
   Chen YC, 2009, DIAM RELAT MATER, V18, P146, DOI 10.1016/j.diamond.2008.10.004
   Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z
   Cottance M., 2013, 2013 S DES TEST INT
   Ding GF, 2000, P SOC PHOTO-OPT INS, V4174, P451, DOI 10.1117/12.396465
   Domonkos M, 2014, PHYS STATUS SOLIDI B, V251, P2587, DOI 10.1002/pssb.201451172
   Edgington RJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056022
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Fox NA, 2000, J APPL PHYS, V87, P8187, DOI 10.1063/1.373516
   Fries MD, 2004, DIAM RELAT MATER, V13, P1740, DOI 10.1016/j.diamond.2004.02.014
   Hebert C, 2014, FARADAY DISCUSS, V172, P47, DOI 10.1039/c4fd00040d
   Hees J, 2012, NANOTECHNOLOGY, V24
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Krueger A, 2011, J MATER CHEM, V21, P12571, DOI 10.1039/c1jm11674f
   Kulakova II, 2004, PHYS SOLID STATE+, V46, P636, DOI 10.1134/1.1711440
   Lee SK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505302
   LU J, 2008, 2008 3 IEEE INT C, P873
   Luo JK, 2007, J MICROMECH MICROENG, V17, pS147, DOI 10.1088/0960-1317/17/7/S12
   Malave A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194478
   May PW, 2012, DIAM RELAT MATER, V23, P100, DOI 10.1016/j.diamond.2012.01.023
   May PW, 2000, PHILOS T ROY SOC A, V358, P473, DOI 10.1098/rsta.2000.0542
   Maybeck V, 2014, ADV HEALTHC MATER, V3, P283, DOI 10.1002/adhm.201300062
   Mortet V, 2008, PHYS STATUS SOLIDI A, V205, P1009, DOI 10.1002/pssa.200777502
   NARAYAN J, 1992, J APPL PHYS, V71, P3795, DOI 10.1063/1.350892
   Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196
   Ondic L, 2011, ACS NANO, V5, P346, DOI 10.1021/nn1021555
   Osswald S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075419
   Pedrosa VA, 2006, ELECTROANAL, V18, P1590, DOI 10.1002/elan.200603561
   Philip J, 2003, J APPL PHYS, V93, P2164, DOI 10.1063/1.1537465
   RALCHENKO VG, 1995, DIAM RELAT MATER, V4, P893, DOI 10.1016/0925-9635(94)00247-9
   Ramanathan M, 2010, J VAC SCI TECHNOL A, V28, P979, DOI 10.1116/1.3299260
   Regan EM, 2011, IEEE J EM SEL TOP C, V1, P557, DOI 10.1109/JETCAS.2011.2174469
   Shimoni O, 2014, ACS APPL MATER INTER, V6, P8894, DOI 10.1021/am5016556
   Sun KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912029
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Taniguchi J, 2002, NANOTECHNOLOGY, V13, P592, DOI 10.1088/0957-4484/13/5/309
   Wang XD, 2002, J MATER PROCESS TECH, V127, P230, DOI 10.1016/S0924-0136(02)00147-4
   Williams JA, 2006, J PHYS D APPL PHYS, V39, pR201, DOI 10.1088/0022-3727/39/12/R01
   Williams OA, 2011, DIAM RELAT MATER, V20, P621, DOI 10.1016/j.diamond.2011.02.015
   Williams OA, 2006, PHYS STATUS SOLIDI A, V203, P3375, DOI 10.1002/pssa.200671406
   Zhuang H, 2011, LANGMUIR, V27, P11981, DOI 10.1021/la2024428
NR 46
TC 2
Z9 2
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6490
EP 6495
DI 10.1021/am507900a
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700018
PM 25669757
DA 2018-10-20
ER

PT J
AU Cao, FY
   Yin, WN
   Fan, JX
   Tao, L
   Qin, SY
   Zhuo, RX
   Zhang, XZ
AF Cao, Feng-Yi
   Yin, Wei-Na
   Fan, Jin-Xuan
   Tao, Li
   Qin, Si-Yong
   Zhuo, Ren-Xi
   Zhang, Xian-Zheng
TI Evaluating the Effects of Charged Oligopeptide Motifs Coupled with RGD
   on Osteogenic Differentiation of Mesenchymal Stem Cells
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE charged oligopeptide; RGD; cBMHP1; stem cell; osteogenic differentiation
ID POLY(ACRYLIC ACID); BONE-MARROW; ADHESION; FATE; PROLIFERATION;
   BIOMATERIALS; INTERFACE; PEPTIDES; PROTEINS; CULTURE
AB Mesenchymal stem cells, due to their multilineage differentiation potential, have emerged as a promising cell candidate for cell-based therapy. In recent years, biomaterials were artificially synthesized to control the differentiation of mesenchymal stem cells. In this study, a series of charged or neutral oligopeptide motifs coupled with RGD were synthesized and used for surface modification using quartz substrates as model. Cell behaviors on the modified surfaces with different charged oligopeptide motifs were studied. It was found that these different charged oligopeptide motifs coupled with RGD were biocompatible for cell proliferation and adhesion. Moreover, it was demonstrated that the positively charged oligopeptide motif could inhibit osteogenic differentiation, while the negatively charged and neutral oligopeptide motifs could enhance osteogenic differentiation in the presence of RGD. This work may bring us enlightenment that different charged oligopeptide motifs coupled with RGD may be used for biomaterial surface modification for different stem cell-based therapies.
C1 [Zhang, Xian-Zheng] Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
   Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Zhang, XZ (reprint author), Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
EM xz-zhang@whu.edu.cn
FU National Natural Science Foundation of China [51125014, 51233003];
   Ministry of Science and Technology of China [2011CB606202]; Natural
   Science Foundation of Hubei Province of China [2013CFA003]
FX This work was supported by the financial support from the National
   Natural Science Foundation of China (51125014 and 51233003), the
   Ministry of Science and Technology of China (2011CB606202), and the
   Natural Science Foundation of Hubei Province of China (2013CFA003).
CR Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Cao FY, 2015, BIOMATER SCI-UK, V3, P345, DOI 10.1039/c4bm00300d
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033
   Lai YX, 2010, BIOMATERIALS, V31, P4809, DOI 10.1016/j.biomaterials.2010.02.064
   Lee IC, 2014, ACS APPL MATER INTER, V6, P20654, DOI 10.1021/am503928u
   Lu HX, 2009, J BIOMAT SCI-POLYM E, V20, P577, DOI 10.1163/156856209X426402
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   McNichols C, 2014, J BIOMED MATER RES A, V102, P532, DOI 10.1002/jbm.a.34700
   Momin EN, 2010, CURR STEM CELL RES T, V5, P326
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qin SY, 2014, SOFT MATTER, V10, P947, DOI 10.1039/c3sm52730a
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Shi XT, 2014, ACS APPL MATER INTER, V6, P11915, DOI 10.1021/am5029236
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   Song W, 2012, SOFT MATTER, V8, P8429, DOI 10.1039/c2sm25718a
   Sun HL, 2010, BIOMATERIALS, V31, P1133, DOI 10.1016/j.biomaterials.2009.10.030
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang Y, 2014, REGEN BIOMATER, V1, P37, DOI 10.1093/rb/rbu012
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
NR 39
TC 14
Z9 14
U1 5
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6698
EP 6705
DI 10.1021/acsami.5b00064
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700042
PM 25748883
DA 2018-10-20
ER

PT J
AU Podlipec, R
   Strancar, J
AF Podlipec, Rok
   Strancar, Janez
TI Cell-Scaffold Adhesion Dynamics Measured in First Seconds Predicts Cell
   Growth on Days Scale - Optical Tweezers Study
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE cell growth; cell adhesion; single cell manipulation; optical tweezers;
   scaffold biocompatibility
ID FORCE SPECTROSCOPY; ADHERENT CELLS; LIVING CELLS; SHEAR-FLOW; IN-VITRO;
   SURFACE; PROLIFERATION; FIBROBLASTS; INTEGRIN; BINDING
AB Understanding the cell-biomaterial interface from the very first contact is of crucial importance for their successful implementation and function in damaged tissues. However, the lack of bio- and mechano-analytical methods to investigate and probe the initial processes on the interface, especially in 3D, raises the need for applying new experimental techniques. In our study, optical tweezers combined with confocal fluorescence microscopy were optimized to investigate the initial cell-scaffold contact and to investigate its correlation with the material-dependent cell growth. By the optical tweezers-induced cell manipulation accompanied by force detection up to 100 pN and position detection by fluorescence microscopy, accurate adhesion dynamics and strength analysis was implemented, where several attachment sites were formed on the interface in the first few seconds. More importantly, we have shown that dynamics of cell adhesion on scaffold surfaces correlates with cell growth on the days scale, which indicates that the first seconds of the contact could markedly direct further cell response. Such a contact dynamics analysis on 3D scaffold surfaces, applied for the first time, can thus serve to predict scaffold biocompatibility.
C1 [Strancar, Janez] Ctr Excellence NAMASTE, SI-1000 Ljubljana, Slovenia.
   Jozef Stefan Inst, Dept Condensed Matter Phys, Biophys Lab, SI-1000 Ljubljana, Slovenia.
RP Strancar, J (reprint author), Ctr Excellence NAMASTE, Jamova Cesta 39, SI-1000 Ljubljana, Slovenia.
EM janez.strancar@ijs.si
FU Centre of Excellence NAMASTE (European Regional Development Fund)
FX This research was financially supported by Centre of Excellence NAMASTE
   (European Regional Development Fund). We gratefully thank S. Pajk
   (Faculty of Pharmacy, University of Ljubljana) for synthesizing membrane
   targeted fluorescent probes.
CR ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0
   Andersson M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2752606
   Arsov Z, 2011, BIOMED OPT EXPRESS, V2, P2083, DOI 10.1364/BOE.2.2083
   Ashkin A., 2006, OPTICAL TRAPPING MAN, P1
   Ayano S, 2006, BIOCHEM BIOPH RES CO, V350, P678, DOI 10.1016/j.bbrc.2006.09.115
   Bausch AR, 2013, NAT MATER, V12, P948, DOI 10.1038/nmat3791
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Bowman RW, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/2/026401
   Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007
   Castelain M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4723566
   Collart-Dutilleul PY, 2014, ACS APPL MATER INTER, V6, P1719, DOI 10.1021/am4046316
   Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574
   Difato F, 2013, INT J MOL SCI, V14, P8963, DOI 10.3390/ijms14058963
   Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143
   Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100
   Gornall JL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.028304
   Gou X, 2013, IEEE T BIO-MED ENG, V60, P2308, DOI 10.1109/TBME.2013.2255287
   Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Hu SY, 2013, J BIOMED NANOTECHNOL, V9, P281, DOI 10.1166/jbn.2013.1528
   Huang WC, 2014, ACTA BIOMATER, V10, P3546, DOI 10.1016/j.actbio.2014.04.025
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jin GZ, 2014, TISSUE ENG REGEN MED, V11, P284, DOI 10.1007/s13770-014-0033-8
   Konig K, 1998, CELL MOL BIOL, V44, P721
   Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   LIU Y, 1995, BIOPHYS J, V68, P2137, DOI 10.1016/S0006-3495(95)80396-6
   Nugiel D J, 1996, Tissue Eng, V2, P127, DOI 10.1089/ten.1996.2.127
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   PAGE B, 1993, INT J ONCOL, V3, P473
   Plieva F. M., 2010, ADV BIOMATER, P499
   Podlipec R, 2014, ACS APPL MATER INTER, V6, P15980, DOI 10.1021/am5037719
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richardson A. C., 2006, P SOC PHOTO-OPT INS, V632628
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289
   Schwarz US, 2013, REV MOD PHYS, V85, P1327, DOI 10.1103/RevModPhys.85.1327
   Schwingel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054850
   Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1
   Sniadecki NJ, 2007, METHOD CELL BIOL, V83, P313, DOI 10.1016/S0091-679X(07)83013-5
   Spillmann CM, 2004, BIOPHYS J, V87, P4237, DOI 10.1529/biophysj.103.031773
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Thoumine O, 2008, CELL MOL BIOENG, V1, P301, DOI 10.1007/s12195-008-0034-6
   Urbancic I., 2013, THESIS U MARIBOR MAR
   Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu YH, 2011, J BIOMECH, V44, P741, DOI 10.1016/j.jbiomech.2010.10.034
   Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052
   Zhang Y., 2014, NAT COMMUN, V5, P1, DOI DOI 10.HTTPS://D0I.0RG/10.3389/FMICB.2014.00110
NR 57
TC 4
Z9 4
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 1
PY 2015
VL 7
IS 12
BP 6782
EP 6791
DI 10.1021/acsami.5b00235
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CF0PM
UT WOS:000352246700051
PM 25764169
DA 2018-10-20
ER

PT J
AU Fernandez-Muinos, T
   Recha-Sancho, L
   Lopez-Chicon, P
   Castells-Sala, C
   Mata, A
   Semino, CE
AF Fernandez-Muinos, Teresa
   Recha-Sancho, Lourdes
   Lopez-Chicon, Patricia
   Castells-Sala, Cristina
   Mata, Alvaro
   Semino, Carlos E.
TI Bimolecular based heparin and self-assembling hydrogel for tissue
   engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell differentiation; Tissue engineering; Biomimetics
ID MOUSE EMBRYONIC FIBROBLASTS; CIRCULAR-DICHROISM SPECTRA; PEPTIDE GELS
   AFFECTS; GROWTH-FACTOR; STEM-CELLS; IN-VITRO; RAPID ANASTOMOSIS; BONE
   REGENERATION; HOST VASCULATURE; CARDIAC-FUNCTION
AB One major goal of tissue engineering is to develop new biomaterials that are similar structurally and functionally to the extracellular matrix (ECM) to mimic natural cell environments. Recently, different types of biomaterials have been developed for tissue engineering applications. Among them, self-assembling peptides are attractive candidates to create artificial cellular niches, because their nanoscale network and biomechanical properties are similar to those of the natural ECM. Here, we describe the development of a new biomaterial for tissue engineering composed by a simple combination of the self-assembling peptide RAD16-I and heparin sodium salt. As a consequence of the presence of heparin moieties the material acquired enhances the capacity of specific binding and release of growth factors (GFs) with heparin binding affinity such as VEGF(165). Promising results were obtained in the vascular tissue engineering area, where the new composite material supported the development of tubular-like structures within a three dimensional (3D) culture model. Moreover, the new scaffold enhances the cell survival and chondrogenic commitment of adipose-derived stem cells (ADSC). Interestingly, the expression of specific markers of mature cartilage tissue including collagen type II was confirmed by western blot and real-time PCR. Furthermore, positive staining for proteoglycans (PGs) indicated the synthesis of cartilage tissue ECM components. Finally, the constructs did not mineralize and exhibited mechanical properties of a tissue undergoing chondrogenesis. Altogether, these results suggest that the new composite is a promising "easy to prepare" material for different reparative and regenerative applications. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fernandez-Muinos, Teresa; Recha-Sancho, Lourdes; Lopez-Chicon, Patricia; Castells-Sala, Cristina; Semino, Carlos E.] IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona 08017, Spain.
   [Mata, Alvaro] Univ London, Sch Engn & Mat Sci, London, England.
RP Semino, CE (reprint author), IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
EM mariafernandezm@iqs.url.edu; lourdesrechas@iqs.url.edu;
   patricia.lopez@iqs.url.edu; cristinacastellss@iqs.url.edu;
   a.mata@qmul.ac.uk; carlos.semino@iqs.url.edu
RI Mata, Alvaro/D-6028-2015
OI Mata, Alvaro/0000-0002-6739-9111
FU European Union [229239]; AO Foundation, Exploratory Research
   Collaborative Research Program Acute Cartilage Injury/lesion/Defect (CRP
   ACI); SUR of DEC of Catalan Government; ESF [2013_FI_B2 00094,
   2014_FI_B1 00202]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under Grant
   Agreement No. 229239, and from the AO Foundation, Exploratory Research
   Collaborative Research Program Acute Cartilage Injury/lesion/Defect (CRP
   ACI) under the project Bioactive and biomimetic scaffolds for cartilage
   regeneration (BIOCART). We thank the SUR of DEC of Catalan Government
   and the ESF for the pre-doctoral fellowship 2013_FI_B2 00094 to T.F.M.
   and 2014_FI_B1 00202 to L.R.S. We also thank the Materials Science
   Laboratory of IQS-School of Engineering for kindly help us with the DMA
   analysis. Finally, we thank M.P.A. from the Genomic Unit of the IGTP for
   her help with the quantitative PCR.
CR Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Borges J, 2007, MINIM INVASIV THER, V16, P141, DOI 10.1080/13645700600935398
   Bussmann B.M., 2013, J TISSUE ENG REGEN M
   Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399
   Castells-sala C, 2013, BIOCHIPS TISSUE CH S, VS2, P004
   Chachques JC, 2013, EXPERT REV CARDIOVAS, V11, P1701, DOI 10.1586/14779072.2013.854165
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Daura X, 2003, EUR BIOPHYS J BIOPHY, V32, P661, DOI 10.1007/s00249-003-0303-1
   Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369
   Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hubbell Jeffrey A, 2007, Swiss Med Wkly, V137 Suppl 155, p72S
   Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315
   Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510
   Kopesky P., 2009, TISSUE ENG A, V16
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Laschke MW, 2012, EUR SURG RES, V48, P85, DOI 10.1159/000336876
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Longo UG, 2012, STEM CELLS INT, V2012
   Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.TEA.2012.0077, 10.1089/ten.tea.2012.0077]
   Mats A, 2010, BIOMATERIALS, V31, P6004
   Miller RE, 2011, CLIN ORTHOP RELAT R, V469, P2716, DOI 10.1007/s11999-011-1891-1
   Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Puig-Sanvicens VAC, 2013, DRUG DELIV TRANSL RE, V3, P330, DOI 10.1007/s13346-012-0125-8
   Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Semino CE, 2004, TISSUE ENG PART, V10
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.3.CO;2-E
   Terry DE, 2000, ANAL BIOCHEM, V285, P211, DOI 10.1006/abio.2000.4761
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Zhang SG, 2003, ADV EXP MED BIOL, V534, P147
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 52
TC 28
Z9 30
U1 12
U2 139
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 35
EP 48
DI 10.1016/j.actbio.2015.01.008
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600004
PM 25595471
DA 2018-10-20
ER

PT J
AU Klymov, A
   Bronkhorst, EM
   te Riet, J
   Jansen, JA
   Walboomers, XF
AF Klymov, Alexey
   Bronkhorst, Ewald M.
   te Riet, Joost
   Jansen, John A.
   Walboomers, X. Frank
TI Bone marrow-derived mesenchymal cells feature selective migration
   behavior on submicro- and nano-dimensional multi-patterned substrates
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Surface topography; Nanotopography; Cell-surface interactions;
   Migration; Proliferation
ID STEM-CELLS; EXTRACELLULAR-MATRIX; ADHESION FORMATION; SURFACE;
   MECHANOTRANSDUCTION; DIFFERENTIATION; TOPOGRAPHY; IMPLANT
AB This study investigated whether cells have an intrinsic ability to recognize nanopatterns, which could lead to their accumulation or diminution on a biomaterial. A multi-patterned "biochip" was made, containing 36 differently designed surfaces, including squares and grooves varying in feature sizes between 10 and 1000 nm. The grooved patterns could additionally be subdivided into three groups having ridge to groove ratios of 1:1, 1:3 and 3:1. These substrates were used for culture of rat bone marrow derived mesenchymal cells. In time cells should accumulate on patterns of preference, while migrating away from patterns of disfavor. A regression analysis model was designed for the analysis of the obtained data.
   Results showed that strong differences existed between the tested patterns regarding the cellular affinity. All sizes of squares showed strong cell-repelling capacity, with the biggest sized squares displaying up to 40% less cells compared to the smooth surface. Among the nano-grooved patterns cell repelling was seen for the grooves with the ridge to groove ratio of 1:3, while grooves with the ridge to groove ratio of 3:1 partially showed cell attraction. Such effects were shown to be based on selective migration rather than proliferation.
   In conclusion, the use of a multi-patterned biochip setup allows for enhanced evaluation of cell behavior, as compared to uniformly patterned setups. Cells exhibit the ability to actively avoid or migrate to surfaces featuring certain topographies on nanometric scale. Such phenomena may be utilized for the development of biomaterials in regenerative medicine. (C) 2015 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Klymov, Alexey; Bronkhorst, Ewald M.; Jansen, John A.; Walboomers, X. Frank] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [te Riet, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.
RP Walboomers, XF (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM Frank.Walboomers@radboudumc.nl
RI Jansen, John/H-8055-2014; Walboomers, X.Frank/B-3692-2013; Bronkhorst,
   Ewald/L-4230-2015; te Riet, Joost/L-1584-2015
OI te Riet, Joost/0000-0002-9093-010X; Bronkhorst,
   Ewald/0000-0003-0953-8053
FU Dutch Government to the Netherlands Institute for Regenerative Medicine
   (NIRM) [FES0908]; Netherlands Organization for Scientific Research (NWO)
   [680-47-421]; NWO Medium Sized Investment [NWO-ZonMW 91110007]
FX This work was supported by a Grant from the Dutch Government to the
   Netherlands Institute for Regenerative Medicine (NIRM, Grant No.
   FES0908). Joost te Riet is supported by the Netherlands Organization for
   Scientific Research (NWO) (Veni Grant No. 680-47-421). The atomic force
   microscope work was supported by NWO Medium Sized Investment (Grant No.
   NWO-ZonMW 91110007).
CR Anil S, 2011, IMPLANT DENTISTRY - A RAPIDLY EVOLVING PRACTICE, P83
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Harrell FE., 2001, SPRINGER SERIES STAT
   Klymov A, 2013, BIOMATER SCI-UK, V1, P135, DOI 10.1039/c2bm00032f
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Svanborg LM, 2010, J BIOMED MATER RES B, V92B, P462, DOI 10.1002/jbm.b.31538
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   van de Sande FH, 2014, J DENT, V42, P1171, DOI 10.1016/j.jdent.2014.07.003
   van Delft FCMJ, 2008, MICROELECTRON ENG, V85, P1362, DOI 10.1016/j.mee.2008.01.028
   van Delft FCMJM, 2000, J VAC SCI TECHNOL B, V18, P3419, DOI 10.1116/1.1319682
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
NR 23
TC 12
Z9 12
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 117
EP 125
DI 10.1016/j.actbio.2015.01.016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600011
PM 25644453
DA 2018-10-20
ER

PT J
AU Zhang, F
   Vanmeensel, K
   Batuk, M
   Hadermann, J
   Inokoshi, M
   Van Meerbeek, B
   Naert, I
   Vleugels, J
AF Zhang, Fei
   Vanmeensel, Kim
   Batuk, Maria
   Hadermann, Joke
   Inokoshi, Masanao
   Van Meerbeek, Bart
   Naert, Ignace
   Vleugels, Jef
TI Highly-translucent, strong and aging-resistant 3Y-TZP ceramics for
   dental restoration by grain boundary segregation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Ceramic structure; Dental restorative material; Zirconia; Aging;
   Translucency
ID LOW-TEMPERATURE DEGRADATION; TETRAGONAL ZIRCONIA; Y-TZP; HYDROTHERMAL
   DEGRADATION; FRACTURE; ALUMINA; POLYCRYSTALS; STRENGTH; SYSTEMS;
   BIOMATERIAL
AB Latest trends in dental restorative ceramics involve the development of full-contour 3Y-TZP ceramics which can avoid chipping of veneering porcelains. Among the challenges are the low translucency and the hydrothermal stability of 3Y-TZP ceramics. In this work, different trivalent oxides (Al2O3, Sc2O3, Nd2O3 and La2O3) were selected to dope 3Y-TZP ceramics. Results show that dopant segregation was a key factor to design hydrothermally stable and high-translucent 3Y-TZP ceramics and the cation dopant radius could be used as a controlling parameter. A large trivalent dopant, oversized as compared to Zr4+, exhibiting strong segregation at the ZrO2 grain boundary was preferred. The introduction of 0.2 mol% La2O3 in conventional 0.1-0.25 wt.% Al2O3-doped 3Y-TZP resulted in an excellent combination of high translucency and superior hydrothermal stability, while retaining excellent mechanical properties. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Fei; Vanmeensel, Kim; Vleugels, Jef] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium.
   [Batuk, Maria; Hadermann, Joke] Univ Antwerp, Elect Microscopy Mat Sci, B-2020 Antwerp, Belgium.
   [Inokoshi, Masanao; Van Meerbeek, Bart; Naert, Ignace] Univ Hosp Leuven, KU Leuven BIOMAT, Dept Oral Hlth Sci, KU Leuven & Dent, B-3000 Louvain, Belgium.
RP Zhang, F (reprint author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Heverlee, Belgium.
EM fei.zhang@mtm.kuleuven.be
RI Hadermann, Joke/F-4644-2011; Vanmeensel, Kim/B-7792-2018; Vleugels,
   Jozef/C-8262-2017
OI Hadermann, Joke/0000-0002-1756-2566; Vanmeensel,
   Kim/0000-0001-5189-7055; Vleugels, Jozef/0000-0003-4432-4675
FU KU Leuven [0T/10/052]; Fund for Scientific Research Flanders
   (FWO-Vlaanderen) [G.0431.10N]
FX We acknowledge the Research Fund of KU Leuven under project 0T/10/052
   and the Fund for Scientific Research Flanders (FWO-Vlaanderen) under
   grant G.0431.10N. We thank M. Peumans and P. Pongprueksa for the
   translucency measurement, W. Veulemans for the flexural strength sample
   preparation, and J.W. Seo (MTM), S. Kuypers (JEOL) and Y. Ohnishi (JEOL)
   for the Al element STEM-EDS map (Fig. 1b-3Y-0.25Al).
CR Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   [Anonymous], 2007, COLORIMETRY UNDERSTA
   [Anonymous], 133562008 ISO
   [Anonymous], 68722008 ISO
   Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959
   ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   Apetz R, 2003, J AM CERAM SOC, V86, P480, DOI 10.1111/j.1151-2916.2003.tb03325.x
   Baldissara P, 2010, J PROSTHET DENT, V104, P6, DOI 10.1016/S0022-3913(10)60086-8
   Beuer F, 2012, DENT MATER, V28, P449, DOI 10.1016/j.dental.2011.11.024
   Bona AD, 2014, J DENT, V42, P1202, DOI 10.1016/j.jdent.2014.07.005
   Boulc'h F, 2004, J ELECTROCHEM SOC, V151, pA1210, DOI 10.1149/1.1764711
   Chen YM, 2008, DENT MATER, V24, P1506, DOI 10.1016/j.dental.2008.03.010
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Communications A, 2014, INSIDE DENT TECHNOLO, V5
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Eichler J, 2007, J AM CERAM SOC, V90, P2830, DOI 10.1111/j.1551-2916.2007.01643.x
   Fujisaki K, 2012, J TOSOH RES, V56, P57
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h
   Guo X, 2003, J AM CERAM SOC, V86, P1867, DOI 10.1111/j.1151-2916.2003.tb03574.x
   Heintze SD, 2010, INT J PROSTHODONT, V23, P493
   HWANG SL, 1990, J AM CERAM SOC, V73, P3269, DOI 10.1111/j.1151-2916.1990.tb06449.x
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Khan MS, 1998, J MATER CHEM, V8, P2299, DOI 10.1039/a803917h
   Klimke J, 2011, J AM CERAM SOC, V94, P1850, DOI 10.1111/j.1551-2916.2010.04322.x
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   LI P, 1994, J AM CERAM SOC, V77, P118, DOI 10.1111/j.1151-2916.1994.tb06964.x
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsui K, 2008, ACTA MATER, V56, P1315, DOI 10.1016/j.actamat.2007.11.026
   Matsui K., 2014, SCI REP, V4
   Matsumoto M, 2005, SURF COAT TECH, V194, P31, DOI 10.1016/j.surfcoat.2004.04.078
   Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001
   Nogiwa-Valdez AA, 2013, ACTA BIOMATER, V9, P6226, DOI 10.1016/j.actbio.2012.11.027
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Preis V, 2012, J DENT, V40, P921, DOI 10.1016/j.jdent.2012.07.010
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Samodurova A, 2014, ACTA BIOMATER
   Schechner G, 2014, J DENT RES
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Studart AR, 2007, BIOMATERIALS, V28, P2695, DOI 10.1016/j.biomaterials.2006.12.033
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Vichi A, 2014, J ESTHET RESTOR DENT, V26, P224, DOI 10.1111/jerd.12105
   Zacate MO, 2000, SOLID STATE IONICS, V128, P243, DOI 10.1016/S0167-2738(99)00348-3
   Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024
   Zhang F, 2015, J EUR CERAM SOC, V35, P741, DOI 10.1016/j.jeurceramsoc.2014.09.018
   Zhang H, 2012, J NANOMATER, V2012, P5
   Zhang Y, 2014, DENT MATER, V30, P1195, DOI 10.1016/j.dental.2014.08.375
   Zhang Y, 2013, DENT MATER, V29, P1201, DOI 10.1016/j.dental.2013.09.004
   Zimmermann A, 1998, J AM CERAM SOC, V81, P2527
NR 55
TC 32
Z9 32
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 215
EP 222
DI 10.1016/j.actbio.2015.01.037
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600021
PM 25662163
DA 2018-10-20
ER

PT J
AU Lu, J
   Webster, TJ
AF Lu, Jing
   Webster, Thomas J.
TI Reduced immune cell responses on nano and submicron rough titanium
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Monocytes; Macrophages; Immune response; Titanium; Thrombosis formation
ID SURFACE-FEATURES; ADHESION; MACROPHAGES; PROLIFERATION; BIOMATERIAL
AB Current bare metal stents can be improved by nanotechnology to support the simultaneous acceleration of endothelialization and consequent reduction of immune cell responses after implantation. In our prior study, electron beam deposition was utilized to create different scales of roughness on titanium stents including flat (F-Ti), a mixture of nanometer and submicron (S-Ti), and nanometer (N-Ti). Enhanced endothelial responses (adhesion, migration, and nitric acid/endothelin-1 secretion) on nanometer to submicron rough titanium were observed compared to flat titanium. The present study aimed to further investigate the influence of nano and submicron titanium surface features on immune cells. Initial monocyte adhesion was found to be reduced on nano and submicron surface features compared to a flat surface. In a model including both endothelial cells and monocytes, it was proven that the submicron surface gave rise to an endothelial cell monolayer which generated the highest amount of NOx and subsequently led to decreased adhesiveness of endothelial cells to monocytes. The analysis of monocyte morphology gave hints to less differentiated monocytes on a submicron surface. Furthermore, the adhesion of and pro-inflammatory cytokine release from macrophages were all reduced on nano and submicron titanium surface features compared to a flat surface. This study, thus, suggests that nano and submicron titanium surfaces should be further studied for improved vascular stent performance. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lu, Jing] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Webster, Thomas J.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
   [Webster, Thomas J.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.
RP Webster, TJ (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
EM th.webster@neu.edu
FU Hermann Foundation
FX The authors would like to thank the Hermann Foundation for funding.
CR Auwerx J., 1991, J EXP, V47, P22, DOI DOI 10.1007/BF02041244
   Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Choudhary S, 2007, TISSUE ENG, V13, P1421, DOI 10.1089/ten.2006.0376
   Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41
   Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x
   Khang D, 2009, ACTA BIOMATER, V5, P1425, DOI 10.1016/j.actbio.2009.01.031
   Lambris John D., CURRENT TOPICS INNAT, P64
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lu J, 2012, TISSUE ENG PT A, V18, P1389, DOI [10.1089/ten.tea.2011.0268, 10.1089/ten.TEA.2011.0268]
   Lu J, 2010, J BIOMED MATER RES A, V94A, P1042, DOI 10.1002/jbm.a.32778
   Niebauer J, 1999, J AM COLL CARDIOL, V34, P1201, DOI 10.1016/S0735-1097(99)00304-6
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Samaroo HD, 2008, INT J NANOMED, V3, P75
   Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   White RA., 1989, ATHEROSCLEROSIS ARTE
NR 21
TC 17
Z9 17
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2015
VL 16
BP 223
EP 231
DI 10.1016/j.actbio.2015.01.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE6WJ
UT WOS:000351978600022
PM 25660564
DA 2018-10-20
ER

PT J
AU Budrugeac, P
AF Budrugeac, Petru
TI Phase transitions of a parchment manufactured from deer leather A
   calorimetric and kinetic analysis
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Parchment; DSC; Phase transitions; Non-isothermal kinetics
ID MULTIVARIATE NONLINEAR-REGRESSION; DIFFERENTIAL SCANNING CALORIMETRY;
   THERMAL-DENATURATION; THERMOOXIDATIVE DEGRADATION; I COLLAGEN;
   HISTORICAL PARCHMENTS; COMPUTATIONAL ASPECTS; EPOXY-RESIN;
   DETERIORATION; PARAMETERS
AB To further understand the thermal stability of a parchment manufactured from deer skin, DSC measurements carried out on this biomaterial at several heating rates were used for kinetic analysis of the endothermic processes of denaturation in water excess and of the phase transition in dry state. The last process could be attributed to melting of crystalline (rigid) zone of parchment or the denaturation consisting in the evaporation of residual strongly bond water and continued conformational changes of super-helix of collagen that is the main component of parchment. The kinetic analyses of non-isothermal DSC data were performed by isoconversional and "multivariate non-linear regression" (Multivar-NLR) methods. The application of differential isoconversional method suggested by Friedman put in evidence that for both investigated processes, the apparent activation energy depends on the conversion degree. This suggests that the investigated processes exhibit complex mechanisms. The computation of non-isothermal data by Multivar-NLR method shows that these processes are described from kinetic point of view by Lumry-Eyring mechanism (a reversible process followed by an irreversible one). According to the results obtained by kinetic analysis, the process occurring in dry state seems to be rather a denaturation than a melting of crystalline (rigid) zone of parchment.
C1 Natl Inst Res & Dev Elect Engn ICPE CA, Bucharest 030138, Romania.
RP Budrugeac, P (reprint author), Natl Inst Res & Dev Elect Engn ICPE CA, Splaiul Unirii 313, Bucharest 030138, Romania.
EM bp@icpe-ca.ro
FU Romanian National Authority for Scientific Research, CNCS-UEFI-SCDI
   [PN-II-224/2012]
FX This work was supported by a Grant of Romanian National Authority for
   Scientific Research, CNCS-UEFI-SCDI, project number PN-II-224/2012.
CR Anderson HL, 1996, THERMOCHIM ACTA, V271, P23, DOI 10.1016/0040-6031(95)02599-5
   Badea E, 2008, J THERM ANAL CALORIM, V91, P17, DOI 10.1007/s10973-007-8513-x
   Badea E, 2011, J THERM ANAL CALORIM, V104, P495, DOI 10.1007/s10973-011-1495-8
   Bischof JC, 2005, ANN NY ACAD SCI, V1066, P12, DOI 10.1196/annals.1363.003
   Brown ME, 2000, THERMOCHIM ACTA, V355, P125, DOI 10.1016/S0040-6031(00)00443-3
   Budrugeac P, 2008, POLYM DEGRAD STABIL, V93, P1073, DOI 10.1016/j.polymdegradstab.2008.03.017
   Budrugeac P, 2008, J THERM ANAL CALORIM, V92, P291, DOI 10.1007/s10973-007-8770-8
   Budrugeac P, 2005, POLYM DEGRAD STABIL, V89, P265, DOI 10.1016/j.polymdegradstab.2004.09.014
   Budrugeac P, 2011, J THERM ANAL CALORIM, V104, P439, DOI 10.1007/s10973-010-1183-0
   Budrugeac P, 2010, THERMOCHIM ACTA, V500, P30, DOI 10.1016/j.tca.2009.12.007
   Budrugeac P, 2009, J THERM ANAL CALORIM, V97, P443, DOI 10.1007/s10973-009-0081-9
   Budrugeac P, 2008, J CULT HERIT, V9, P146, DOI 10.1016/j.culher.2007.10.001
   Budrugeac P, 2013, REV ROUM CHIM, V58, P371
   Budrugeac P, 2013, THERMOCHIM ACTA, V565, P241, DOI 10.1016/j.tca.2013.05.020
   Burnham AK, 1999, ENERG FUEL, V13, P1, DOI 10.1021/ef9800765
   Chahine C, 2000, THERMOCHIM ACTA, V365, P101, DOI 10.1016/S0040-6031(00)00617-1
   Cucos A, 2013, THERMOCHIM ACTA, V516, P19
   Friedman H.L., 2007, J POLYM SCI C, V6, P183, DOI [10.1002/polc.5070060121, DOI 10.1002/P0LC.5070060121]
   Haines BM, 2006, CONSERVATION LEATHER
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045
   Kralova D., 2007, 18 IDAP EUR COMM DIR, P23
   Liu WT, 2014, THERMOCHIM ACTA, V581, P32, DOI 10.1016/j.tca.2014.02.012
   Liu WT, 2010, POLYM DEGRAD STABIL, V95, P2233, DOI 10.1016/j.polymdegradstab.2010.09.012
   LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   NGUYEN AL, 1974, BIOPOLYMERS, V13, P1023, DOI 10.1002/bip.1974.360130516
   OKAMOTO Y, 1964, KOLLOID Z Z POLYM, V194, P124, DOI 10.1007/BF02176215
   Opfermann J, 2000, J THERM ANAL CALORIM, V60, P641, DOI 10.1023/A:1010167626551
   Pietrucha K, 2005, INT J BIOL MACROMOL, V36, P299, DOI 10.1016/j.ijbiomac.2005.07.004
   Popescu C, 2008, POLYM DEGRAD STABIL, V93, P976, DOI 10.1016/j.polymdegradstab.2008.01.031
   Roduit B, 2000, THERMOCHIM ACTA, V355, P171, DOI 10.1016/S0040-6031(00)00447-0
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Tanaka H, 2005, J THERM ANAL CALORIM, V80, P795, DOI 10.1007/s10973-005-0732-4
   Vyazovkin S, 2007, MACROMOL BIOSCI, V7, P1181, DOI 10.1002/mabi.200700162
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   VYAZOVKIN SV, 1990, THERMOCHIM ACTA, V165, P273, DOI 10.1016/0040-6031(90)80227-P
   WITNAUER LP, 1964, J AM LEATHER CHEM AS, V59, P598
   Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546
   Xia ZY, 2012, THERMOCHIM ACTA, V527, P172, DOI 10.1016/j.tca.2011.10.028
NR 39
TC 4
Z9 4
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1572-8943
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD APR
PY 2015
VL 120
IS 1
BP 103
EP 112
DI 10.1007/s10973-014-4252-y
PG 10
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA CE9BZ
UT WOS:000352139800013
DA 2018-10-20
ER

PT J
AU Yan, HD
   Zhang, F
   Wang, CY
   Xia, Z
   Mo, XM
   Fan, CY
AF Yan, Hede
   Zhang, Feng
   Wang, Chunyang
   Xia, Zhen
   Mo, Xiumei
   Fan, Cunyi
TI The Role of an Aligned Nanofiber Conduit in the Management of Painful
   Neuromas in Rat Sciatic Nerves
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE capping technique; traumatic neuroma; neuroma prevention; aligned
   nanofiber nerve conduit; neuropathic pain
ID NEUROPATHIC PAIN; ELECTROSPUN NANOFIBERS; STUMP TRANSPLANTATION; VEIN
   IMPLANTATION; SPINAL-CORD; AUTOTOMY; PATHOBIOLOGY; REGENERATION;
   FABRICATION; ALLODYNIA
AB Background: Capping techniques have been used as a treatment modality for the prevention of neuroma formation and the management of neuropathic pain. However, the results are inconsistent and unpredictable. We hypothesize that this situation may be attributable, in part, to the disparities in the type of materials used to manufacturing of the conduits.
   Methods: In this study, a rat model was used and the sciatic nerve was selected for evaluation. In 1 capping group, a sciatic nerve stump was capped with a nonaligned nanofiber conduit (the nonaligned group), whereas in a second capping group, the conduit was made of aligned nanofibers (the aligned group). In another group, the sciatic nerve stump was not capped as a control (the control group). The results of autotomy behavior, extent of neuroma formation, histological changes in the neuroma, and the expression of c-fos as a pain marker in the fourth lumbar spinal cord were evaluated at 8 weeks postoperatively.
   Results: The control group presented more neuroma-like features in all the observed parameters in comparison with the 2 capping groups; of the 2 capping groups, the aligned group achieved even better outcomes than the nonaligned group.
   Conclusions: Our findings indicate that the aligned nanofiber conduit is a promising biomaterial for the nerve capping technique, and new treatment strategies using aligned nanofiber conduits may be developed for the management of painful amputated neuromas.
C1 [Yan, Hede; Wang, Chunyang; Xia, Zhen; Fan, Cunyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
   [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China.
   [Yan, Hede] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.
   [Zhang, Feng] Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA.
   [Mo, Xiumei] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
RP Fan, CY (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM fancunyi888@gmail.com
RI mo, xiumei/C-9340-2013
FU National Natural Science Foundation of China [81171477]; Health Bureau
   of Shanghai [2012412]; Department of Education of Zhejiang Province
   [20051185]; Health Department of Zhejiang Province [201338025]
FX This study was supported by funding from the National Natural Science
   Foundation of China (81171477), Key Project of Health Bureau of Shanghai
   (2012412), the Department of Education of Zhejiang Province (20051185),
   and Health Department of Zhejiang Province (201338025).
CR Beilke MC, 2013, ANAL CHIM ACTA, V761, P201, DOI 10.1016/j.aca.2012.11.028
   Bowsher D, 2002, PAIN, V95, P187, DOI 10.1016/S0304-3959(01)00389-X
   CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9
   CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0
   COLLINS WF, 1960, ARCH NEUROL-CHICAGO, V3, P381, DOI 10.1001/archneur.1960.00450040031003
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   CRAVIOTO H, 1981, NEUROSURGERY, V8, P181, DOI 10.1227/00006123-198102000-00007
   FARLEY H H, 1965, Minn Med, V48, P347
   Galeano M, 2009, MICROSURG, V29, P568, DOI 10.1002/micr.20652
   Gould JS, 2013, FOOT ANKLE INT, V34, P932, DOI 10.1177/1071100713478927
   Harden RN, 2005, NEUROLOGIST, V11, P111, DOI 10.1097/01.nrl.0000155180.60057.8e
   Herbert TJ, 1998, J HAND SURG-BRIT EUR, V23B, P220, DOI 10.1016/S0266-7681(98)80178-2
   Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4
   Kajander KC, 1996, NEUROSCI LETT, V206, P9, DOI 10.1016/0304-3940(96)12447-2
   Kakinoki R, 2003, INT ORTHOP, V27, P60, DOI 10.1007/s00264-002-0390-0
   KIRVELA O, 1990, PAIN, V41, P161, DOI 10.1016/0304-3959(90)90020-E
   Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57
   Koch H, 2003, ANN PLAS SURG, V50, P354, DOI 10.1097/01.SAP.0000041486.24160.8C
   Krishnan Kartik G, 2005, Neurosurgery, V56, P369, DOI 10.1227/01.NEU.0000156881.10388.D8
   MASS DP, 1984, PLAST RECONSTR SURG, V74, P182, DOI 10.1097/00006534-198408000-00002
   MATHEWS GJ, 1972, SURG CLIN N AM, V52, P1313
   MUEHLEMAN C, 1990, Journal of Foot Surgery, V29, P260
   Niederberger E, 2008, EXPERT REV PROTEOMIC, V5, P799, DOI 10.1586/14789450.5.6.799
   Okuda T, 2006, J ORTHOP RES, V24, P1427, DOI 10.1002/jor.20196
   Prabhakaran MP, 2013, BIOTECHNOL BIOENG, V110, P2775, DOI 10.1002/bit.24937
   Sakai Y, 2005, J BIOMED MATER RES B, V73B, P355, DOI 10.1002/jbm.b.30219
   Siddall PJ, 1999, BRAIN RES, V851, P281, DOI 10.1016/S0006-8993(99)02173-3
   Tupper J W, 1976, J Hand Surg Am, V1, P144
   Vernadakis AJ, 2003, CLIN PLAST SURG, V30, P247, DOI 10.1016/S0094-1298(02)00104-9
   WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2
   WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   WILLIAMS HB, 1984, CLIN PLAST SURG, V11, P79
   Wu J, 1999, ANN PLAS SURG, V43, P661, DOI 10.1097/00000637-199912000-00016
   Xu Y, 2013, TISSUE ENG PART C-ME, V19, P925, DOI [10.1089/ten.tec.2012.0328, 10.1089/ten.TEC.2012.0328]
   Zeltser R, 2000, PAIN, V89, P19, DOI 10.1016/S0304-3959(00)00342-0
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6
NR 42
TC 2
Z9 2
U1 1
U2 26
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2015
VL 74
IS 4
BP 454
EP 461
DI 10.1097/SAP.0000000000000266
PG 8
WC Surgery
SC Surgery
GA CE1SK
UT WOS:000351592000014
PM 25003441
DA 2018-10-20
ER

PT J
AU Bryan, N
   Battersby, C
   Smart, N
   Hunt, J
AF Bryan, N.
   Battersby, C.
   Smart, N.
   Hunt, J.
TI A review of biocompatibility in hernia repair; considerations in vitro
   and in vivo for selecting the most appropriate repair material
SO HERNIA
LA English
DT Review
DE Biocompatibility; Inflammation; Leucocyte; Hernia; In vitro; In vivo
ID ACELLULAR DERMAL MATRIX; BIOLOGIC MESH; RECONSTRUCTION; INFLAMMATION;
   NEUTROPHILS; MECHANISMS; EFFICACY; SURGERY; DECADE; CELLS
AB Repair of hernia typically makes use of a prosthetic material; synthetic or biologic in nature. Any material which enters the body is subject to interrogation by the inflammation and immune system in addition to numerous other cell families, the outcome of which ultimately determines the success of the repair. In this review, we discuss the fundamental biology which occurs in situ when a biomaterial associates with a tissue, compare and contrast the techniques available to predict this in vitro, and review how features of hernia repair materials specifically may manipulate tissue interrogation and integration. Finally, we conclude our article by examining how biocompatibility impacts surgical practise and how a better understanding of the manner by which materials and tissues interact could benefit hernia repair.
   A review of the literature was conducted using appropriate scientific search engines in addition to inclusion of findings from the groups' primary research.
   Using pre-clinical assays to anticipate the biocompatibility of a medical device is critical; however, to maximise the scientific power of in vitro findings, we must carefully consider the in vivo niche of the cells with which we are working. Excessive in vitro culture or contact to non-self materials can add compounding complexity to studies involving leucocytes for instance; therefore, we must ensure careful and stringent assay design when developing techniques for assaying pre-clinical biocompatibility. Furthermore, many of the features associated with hernia repair material design specifically, included to enhance their mechanical or biodegradation characteristics, are inadvertently instructive to cells, and therefore, throughout the prototype stages of a materials development, regular biocompatibility assessment must be performed.
   The biocompatibility of a material is rate limiting in its ability to function as a medical device. The future of hernia repair materials will rely on close cohesion between the surgical and scientific communities to ensure the most robust biocompatibility assessment techniques, and models are utilised to predict the efficacy of a given material in a particular surgical application.
C1 [Bryan, N.; Battersby, C.; Hunt, J.] Inst Ageing & Chron Dis, Clin Engn UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Smart, N.] Royal Devon & Exeter Hosp, Exeter Hlth Sci Res Unit, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Inst Ageing & Chron Dis, Clin Engn UKCTE, Duncan Bldg Ground Floor,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
RI Smart, Neil/F-8837-2014
OI Smart, Neil/0000-0002-3043-8324
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Belyansky I, 2012, PLAST RECONSTR SURG, V130, p203S, DOI 10.1097/PRS.0b013e3182638d5b
   Bochicchio GV, 2013, J AM COLL SURGEONS, V217, P606, DOI 10.1016/j.jamcollsurg.2013.04.041
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Bryan N, 2014, J BIOMED MATER RES B, V102, P709, DOI 10.1002/jbm.b.33050
   Bryan N, 2013, J TISSUE ENG REGEN M, V7, P812, DOI 10.1002/term.1474
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Bryan N, 2012, BIOMATERIALS, V33, P6380, DOI 10.1016/j.biomaterials.2012.05.058
   Bryan N, 2011, BIOSCIENCE REP, V31, P199, DOI 10.1042/BSR20100064
   Butterfield TA, 2006, J ATHL TRAINING, V41, P457
   Cevasco M, 2012, SURG INFECT, V13, P209, DOI 10.1089/sur.2012.123
   Daubay DA, 2003, SURG CLIN N AM, V83, P463
   Gray SH, 2008, ARCH SURG-CHICAGO, V143, P582, DOI 10.1001/archsurg.143.6.582
   Halm JA, 2007, WORLD J SURG, V31, P423, DOI 10.1007/s00268-006-0317-9
   Hamer-Hodges D W, 1985, J R Coll Surg Edinb, V30, P65
   Hood K, 2013, AM J SURG, V205, P322, DOI 10.1016/j.amjsurg.2012.10.024
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   Itani KMF, 2012, SURGERY, V152, P498, DOI 10.1016/j.surg.2012.04.008
   Kanters AE, 2012, J AM COLL SURGEONS, V215, P787, DOI 10.1016/j.jamcollsurg.2012.08.012
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   Le D, 2012, AM J SURG, V205, P602
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Muysoms F, 2012, HERNIA, V16, P239, DOI 10.1007/s10029-012-0912-7
   Muysoms FE, 2013, HERNIA, V17, P423, DOI 10.1007/s10029-013-1108-5
   Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x
   Rosen MJ, 2013, ANN SURG, V257, P991, DOI 10.1097/SLA.0b013e3182849871
   Slater NJ, 2013, AM J SURG, V205, P220, DOI 10.1016/j.amjsurg.2012.05.028
   Smart NJ, 2012, COLORECTAL DIS, V14, P1, DOI 10.1111/codi.12042
   ten Raa S, 2006, J SURG RES, V136, P45, DOI 10.1016/j.jss.2006.05.006
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 32
TC 2
Z9 2
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
EI 1248-9204
J9 HERNIA
JI Hernia
PD APR
PY 2015
VL 19
IS 2
BP 169
EP 178
DI 10.1007/s10029-014-1307-8
PG 10
WC Surgery
SC Surgery
GA CE3BS
UT WOS:000351699800001
PM 25216716
DA 2018-10-20
ER

PT J
AU Reslinski, A
   Dabrowiecki, S
   Glowacka, K
AF Reslinski, A.
   Dabrowiecki, S.
   Glowacka, K.
TI The impact of diclofenac and ibuprofen on biofilm formation on the
   surface of polypropylene mesh
SO HERNIA
LA English
DT Article
DE Biofilm; Diclofenac; Ibuprofen; Polypropylene mesh; Hernia
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STAPHYLOCOCCUS-EPIDERMIDIS;
   IN-VITRO; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES;
   BACTERIAL-COLONIZATION; CONTACT-LENSES; HERNIA REPAIR; INFECTION;
   ASPIRIN
AB The difficulties related to treatment of deep surgical site infection involve formation of biofilm on the surface of synthetic material. It is considered that in treatment of infections involving formation of biofilm, concomitant therapy shall be applied covering anti-inflammatory drugs. The purpose of the work was to assess the impact of diclofenac and ibuprofen on bacterial biofilm formation on the surface of monofilament polypropylene mesh.
   The study involved 70 strains of Staphylococcus aureus and 70 strains of Escherichia coli isolated from different patients and those which differ with chromosomal DNA pattern within the species. The assessment of the impact of non-steroidal anti-inflammatory drugs (NSAIDs) on biofilm formation was carried out with the use of qualitative method (TTC reduction), quantitative (tenfold serial dilution) and with the use of scanning electron microscope (SEM).
   In the qualitative assessment, after incubation in the medium containing NSAIDs statistically significant growth of S. aureus strain amount and E. coli which poorly make up biofilm was stated. Quantitative examination indicated characteristic decrease of the number of colony forming units in 1 ml of the suspension isolated from bacterial biofilm formed as a result of incubation of isolates in the medium with the addition of examined NSAIDs in comparison to biofilm from control regimen. In the examination with the use of SEM it was stated that the effect of isolates incubation in the medium with NSAIDs was decrease of the number of bacteria adjacent to the biomaterial surface.
   Diclofenac and ibuprofen in the concentration obtained in the serum limit the formation of biofilm by S. aureus and E. coli.
C1 [Reslinski, A.] Nicolaus Copernicus Univ Torun, Dept Gen Surg & Transplantol, Ludwik Rydygier Coll Med Bydgoszcz, PL-85094 Bydgoszcz, Poland.
   [Dabrowiecki, S.] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Nutr & Dietet, Bydgoszcz, Poland.
   [Glowacka, K.] Warmia Mazury Univ Olsztyn, Dept Plant Physiol Genet & Biotechnol, Olsztyn, Poland.
RP Reslinski, A (reprint author), Nicolaus Copernicus Univ Torun, Dept Gen Surg & Transplantol, Ludwik Rydygier Coll Med Bydgoszcz, M Sklodowskiej Curie 9 Str, PL-85094 Bydgoszcz, Poland.
EM bigar@wp.pl
OI Glowacka, Katarzyna/0000-0002-3649-4669
FU European Social Fund; National Budget in terms of Integrated Operational
   Programms of Regional Development; European Union; Nicolaus Copernicus
   University (UMK) [06/2009]
FX The authors would like to thank Professor Eugenia Gospodarek, Head of
   the Department of Microbiology of the Ludwik Rydygier College of
   Medicine of the Nicolaus Copernicus University in Torun for making it
   possible to carry out research. The work is co-financed from the
   resources of the European Social Fund and National Budget in terms of
   Integrated Operational Programms of Regional Development, Measure 2.6.
   'Regional Innovation Strategies and Knowledge Transfer', by the European
   Union in terms of European Social Fund - 'Nicolaus Copernicus University
   College of Medicine development programme' and from the resources of
   Nicolaus Copernicus University (UMK) 06/2009 grant.
CR Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x
   Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   Bandara BMK, 2004, CURR EYE RES, V29, P245, DOI 10.1080/02713680490516729
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022
   del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016
   Demirag MK, 2007, ANN VASC SURG, V21, P464, DOI 10.1016/j.avsg.2006.06.006
   Derry C, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001548.PUB2
   Derry P, 2009, COCHRANE DB SYST REV, V2
   Dutta NK, 2008, EUR J CLIN MICROBIOL, V27, P315, DOI 10.1007/s10096-007-0439-5
   Dutta NK, 2009, LETT APPL MICROBIOL, V48, P783, DOI 10.1111/j.1472-765X.2009.02588.x
   Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   FARBER BF, 1992, J INFECT DIS, V166, P861, DOI 10.1093/infdis/166.4.861
   GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220
   Grin I, 2011, ADV EXP MED BIOL, V715, P257, DOI 10.1007/978-94-007-0940-9_16
   Hasani A, 2011, HERNIA, V15, P267, DOI 10.1007/s10029-010-0772-y
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Kwiecinska-Pirog Joanna, 2011, Medycyna Doswiadczalna i Mikrobiologia, V63, P131
   Lissy M, 2009, CURR MED RES OPIN, V25, P2423, DOI 10.1185/03007990903158513
   Lotsch J, 2001, BRIT J CLIN PHARMACO, V52, P387, DOI 10.1046/j.1365-2125.2001.01451.x
   Mixter CG, 1998, ARCH SURG-CHICAGO, V133, P432, DOI 10.1001/archsurg.133.4.432
   Muller E, 1998, J INFECT DIS, V177, P501, DOI 10.1086/517386
   Naves P, 2010, J HOSP INFECT, V76, P165, DOI 10.1016/j.jhin.2010.05.011
   Perilli R, 2000, J BIOMED MATER RES, V49, P53, DOI 10.1002/(SICI)1097-4636(200001)49:1<53::AID-JBM7>3.0.CO;2-C
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   Sanchez VM, 2011, SURG INFECT, V12, P205, DOI 10.1089/sur.2011.033
   Saygun O, 2006, J SURG RES, V131, P73, DOI 10.1016/j.jss.2005.06.020
   Stremitzer S, 2010, WORLD J SURG, V34, P1702, DOI 10.1007/s00268-010-0543-z
   Tolino MJ, 2009, HERNIA, V13, P631, DOI 10.1007/s10029-009-0541-y
   Ulusoy S, 2013, Drug Res (Stuttg), V63, P409, DOI 10.1055/s-0033-1343430
   Wang WH, 2003, GUT, V52, P490, DOI 10.1136/gut.52.4.490
NR 32
TC 7
Z9 8
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
EI 1248-9204
J9 HERNIA
JI Hernia
PD APR
PY 2015
VL 19
IS 2
BP 179
EP 185
DI 10.1007/s10029-013-1200-x
PG 7
WC Surgery
SC Surgery
GA CE3BS
UT WOS:000351699800002
PM 24366755
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ribeiro, S
   Ferreira, V
   Stutz, B
   Casado, P
   Rodrigues, D
   Barboza, EP
AF Ribeiro, Sergio
   Ferreira, Vinicius
   Stutz, Bianca
   Casado, Priscila
   Rodrigues, Diogo
   Barboza, Eliane Porto
TI Evaluation of the Zone of Keratinized Tissue Using Exposed Acellular
   Dermal Matrix Over Tooth Extraction Sites: A Randomized Controlled
   Clinical Trial
SO IMPLANT DENTISTRY
LA English
DT Article
DE acellular dermal matrix; guided bone regeneration; keratinized tissue
ID HISTOLOGIC EVALUATION; GINGIVAL RECESSION; BARRIER MEMBRANES;
   CONNECTIVE-TISSUE; BONE-FORMATION; DEFECTS; AUGMENTATION; SOCKETS;
   HUMANS; GRAFT
AB Background: The presence of an adequate zone of keratinized tissue has been associated with implant health. This study evaluated the zone of keratinized tissue using exposed acellular dermal matrix (ADM) over extraction sites.
   Material and Methods: Fifteen sites received ADM, and fifteen control sites received no biomaterial. All sites were sutured with no attempt to achieve primary closure. Initial measurements of buccal and lingual keratinized tissue were taken from the mucogingival line (MGL) to the most coronal gingival margins. Final measurements were taken from the buccal MGL to the lingual MGL 90 days after surgery. Gingival biopsies were taken before implant placement.
   Results: Test and control groups exhibited a mean value of 4.40 +/- 1.45 mm and 1.40 +/- 1.40 mm, respectively. The newly formed tissue revealed similar histological aspect of normal keratinized tissue.
   Conclusion: Exposed ADM used over tooth extraction sockets can predictably be used to increase the zone of keratinized tissue.
C1 [Ferreira, Vinicius] Univ Estado Rio De Janeiro, Dept Periodontol, Rio De Janeiro, Brazil.
   [Casado, Priscila] Univ Fed Fluminense, Post Graduat Program, Rio De Janeiro, Brazil.
   [Rodrigues, Diogo; Barboza, Eliane Porto] Univ Fed Fluminense, Dept Periodontol, Rio De Janeiro, Brazil.
RP Barboza, EP (reprint author), Ave Presidente Wilson 165-811, BR-20030020 Rio De Janeiro, Brazil.
EM elianeporto.uff@gmail.com
CR Barboza E P, 1999, Implant Dent, V8, P167, DOI 10.1097/00008505-199908020-00010
   Barboza EP, 1999, INT J PERIODONT REST, V19, P601
   Bartee B K, 1995, Implant Dent, V4, P21, DOI 10.1097/00008505-199504000-00004
   Batista EL, 2001, J PERIODONTOL, V72, P265, DOI 10.1902/jop.2001.72.2.265
   Borges GJ, 2009, CLIN ORAL IMPLAN RES, V20, P1105, DOI 10.1111/j.1600-0501.2009.01731.x
   Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x
   Casado PL, 2013, IMPLANT DENT, V22, P143, DOI 10.1097/ID.0b013e3182818792
   Cummings LC, 2005, J PERIODONTOL, V76, P178, DOI 10.1902/jop.2005.76.2.178
   Felipe MEMC, 2007, J PERIODONTOL, V78, P1209, DOI 10.1902/jop.2007.060356
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Fotek PD, 2009, J PERIODONTOL, V80, P776, DOI 10.1902/jop.2009.080514
   Harris RJ, 2000, INT J PERIODONT REST, V20, P51
   JOVANOVIC SA, 1995, INT J PERIODONT REST, V15, P57
   Jung RE, 2007, INT J PERIODONT REST, V27, P251
   LEKHOLM U, 1993, CLIN ORAL IMPLAN RES, V4, P121, DOI 10.1034/j.1600-0501.1993.040302.x
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   Luczyszyn Sonia M, 2005, Implant Dent, V14, P176, DOI 10.1097/01.id.0000165082.77499.41
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Novaes A B Jr, 2001, Implant Dent, V10, P192
   NOVAES AB, 1995, J PERIODONTOL, V66, P864, DOI 10.1902/jop.1995.66.10.864
   Novaes Arthur B Jr, 2002, Implant Dent, V11, P343
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Park JB, 2007, IMPLANT DENT, V16, P246, DOI 10.1097/ID.0b013e3181237926
   Park JB, 2010, IMPLANT DENT, V19, P307, DOI 10.1097/ID.0b013e3181e5abbc
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schulman J, 1996, PRACTICAL PERIODONTI, V8, P201
   Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166
   Tal H, 1999, J PERIODONTOL, V70, P1118, DOI 10.1902/jop.1999.70.9.1118
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P857
NR 31
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2015
VL 24
IS 2
BP 180
EP 184
DI 10.1097/ID.0000000000000225
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CE6AB
UT WOS:000351916700009
PM 25706266
DA 2018-10-20
ER

PT J
AU Revi, D
   Vineetha, VP
   Muhamed, J
   Surendran, GC
   Rajan, A
   Kumary, TV
   Anilkumar, TV
AF Revi, Deepa
   Vineetha, Vadavanath P.
   Muhamed, Jaseer
   Surendran, Geetha C.
   Rajan, Akhila
   Kumary, T. V.
   Anilkumar, Thapasimuthu V.
TI Wound healing potential of scaffolds prepared from porcine jejunum and
   urinary bladder by a non-detergent/enzymatic method
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Extracellular matrix; wound healing; histomorphometry; alpha smooth
   muscle actin; proliferating cell nuclear antigen
ID SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX; GROWTH-FACTORS;
   BIOMATERIAL; VIMENTIN; SKIN; DESIGN; REPAIR; MODEL
AB Scaffolds prepared using extracellular matrices of mammalian organs/tissues, when used as grafts, have wound healing potential. This paper evaluated the physical properties and invivo wound healing potential of jejunum-derived scaffold (JDS) and urinary bladder-derived scaffold (UDS) of porcine origin prepared by a non-detergent/enzymatic method. The former had higher flexural rigidity and suture retention strength compared to the latter, but both of them had the essential flexural rigidity and suture retention strength required for skin grafts. Full thickness skin-wounds on rabbit dorsum were treated with these scaffolds and the wound healing ability was compared by studying histomorphology parameters such as re-epithelialisation, collagen deposition, angiogenesis, proliferation of cells, mesenchymal cell infiltration and myofibroblast response. The extent of these reactions was assessed using histomorphometry. The results indicated that both grafts initiated healing faster than those wounds without any graft, as evidenced by the extent of cell proliferation and mesenchymal cell infiltration. The myofibroblast response persisted longer in the non-graft assisted wound healing reaction compared to the healing in the graft assisted wounds. Moreover, the JDS induced higher cell proliferation and greater angiogenesis than UDS probably indicating better healing by the former. The results suggested that JDS and UDS prepared by non-detergent/enzymatic method have potential clinical applications.
C1 [Revi, Deepa; Vineetha, Vadavanath P.; Muhamed, Jaseer; Surendran, Geetha C.; Rajan, Akhila; Anilkumar, Thapasimuthu V.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
   [Kumary, T. V.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Tissue Culture Lab, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Rajan, Akhila/0000-0002-9624-4696; Muhamed, Jaseer/0000-0001-5046-9438
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/16/7/2011]
FX This research received financial support of the Department of
   Biotechnology, Government of India (BT/PR15461/MED/32/16/7/2011).
CR Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   Boekema BKHL, 2014, J MATER SCI-MATER M, V25, P423, DOI 10.1007/s10856-013-5075-2
   Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Bryan J, 2004, J Wound Care, V13, P227
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   El Kahi CG, 2009, INT WOUND J, V6, P214, DOI 10.1111/j.1742-481X.2009.00597.x
   Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kimmel Howard, 2010, J Am Col Certif Wound Spec, V2, P55, DOI 10.1016/j.jcws.2010.11.002
   Lev-Tov H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-8
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   O'Leary R, 2003, BRIT J DERMATOL, V149, P665, DOI 10.1046/j.1365-2133.2003.05501.x
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Olczyk P, 2014, BIOMED RES INT, DOI 10.1155/2014/747584
   Peh P, 2011, NANOMEDICINE-UK, V6, P593, DOI 10.2217/nnm.11.54
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003
   Revi D, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413518060
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schultze-Mosgau S, 2007, TISSUE ENG, V13, P921
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393
   Wong VW, 2012, INT J BIOMATER, V2012
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yonehiro L, 2013, WOUNDS, V25, P340
NR 32
TC 2
Z9 2
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2015
VL 29
IS 9
BP 1218
EP 1229
DI 10.1177/0885328214560218
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3EE
UT WOS:000351707600002
PM 25425562
DA 2018-10-20
ER

PT J
AU Flanagan, KE
   Tien, LW
   Elia, R
   Wu, JL
   Kaplan, D
AF Flanagan, Kelly E.
   Tien, Lee W.
   Elia, Roberto
   Wu, Julian
   Kaplan, David
TI Development of a sutureless dural substitute from Bombyx mori silk
   fibroin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE dural substitute; silk fibroin; electrospinning; biodegradable
   composite; tissue sealant
ID SPECTROSCOPY; FIBROBLASTS; ADHESIVES; SEALANTS; REPAIR
AB Silk solvent casting, electrospinning, and electrogelation techniques were used to create a biodegradable, biocompatible silk fibroin dural substitute. The all-silk system was designed and produced to improve on currently available materials, grafts and tissue sealants used for dural closure in neurosurgery. The silk biomaterial was successfully fabricated as a dual layer adhesive system designed to seal durotomies while also functioning as a dural regeneration scaffold. The mechanical characteristics, biocompatibility, biodegradability, and hydrodynamic sealing capability of the material were evaluated. Results showed that the biomaterial was biocompatible with neural cells and fibroblasts, had mechanical properties mimicking the natural dura, was biodegradable with controllable degradation, and was able to seal against a hydrodynamic pressure of 205 mmHg, which greatly exceeds the maximum cerebrospinal fluid pressure seen in both cranial and spinal dural closures of 50 mmHg. Based on its design and experimental results, the adhesive silk dual layer composite biomaterial shows potential as a sutureless dural repair system that would improve on current dural closure techniques. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 485-494, 2015.
C1 [Flanagan, Kelly E.; Tien, Lee W.; Elia, Roberto; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Wu, Julian] Tufts Med Ctr, Dept Neurosurg, Boston, MA USA.
RP Kaplan, D (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIH [P41 EB002520]
FX Contract grant sponsor: NIH; contract grant number: P41 EB002520 (DLK)
CR [Anonymous], 2010, F239204 ASTM, DOI [10.1520/F2392-04R10, DOI 10.1520/F2392-04R10]
   Campbell PK, 2005, VITRO TESTING, P1
   Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52
   DOLENC VV, 1997, NEUROL MED CHIR TOKY, V37, P889
   Epstein NE, 2010, SPINE J, V10, P1065, DOI 10.1016/j.spinee.2010.09.017
   Fattahi T, 2004, J ORAL MAXIL SURG, V62, P218, DOI 10.1016/j.joms.2003.01.005
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Liu Y, 2009, EXP CELL RES, V36, P333
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MARCHBANKS R J, 1990, British Journal of Audiology, V24, P179, DOI 10.3109/03005369009076554
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Moskowitz SI, 2009, OPERATIVE NEUROSURG, V1, pons28
   NISHIDA T, 1988, INVEST OPHTH VIS SCI, V29, P1887
   Novitsky YW, 2007, J SURG RES, V140, P6, DOI 10.1016/j.jss.2006.09.015
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Patel N, 1998, FASEB J, V12, P1447
   Rockwood DN, 2010, NAT PROTOC, V6, P1612
   Serban MA, 2011, J BIOMED MATER RES A, V98A, P567, DOI 10.1002/jbm.a.33149
   Thavarajah D, 2009, SPINE J, V35, pE25
   TissueMed Inc, 2012, TISSUEPATCHDURAL BRO
   Vanaclocha V, 1997, ACTA NEUROCHIR, V139, P112, DOI 10.1007/BF02747190
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, J CONTROL RELEASE, V134, P81
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012
NR 31
TC 6
Z9 7
U1 6
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 485
EP 494
DI 10.1002/jbm.b.33217
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000001
PM 24919581
DA 2018-10-20
ER

PT J
AU Hillberg, AL
   Oudshoorn, M
   Lam, JBB
   Kathirgamanathan, K
AF Hillberg, Anna Louise
   Oudshoorn, Matthew
   Lam, Janice B. B.
   Kathirgamanathan, Kalyani
TI Encapsulation of porcine pancreatic islets within an immunoprotective
   capsule comprising methacrylated glycol chitosan and alginate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE diabetes; xenotransplantation; foreign body reactions (response); cell
   therapy; encapsulated cells
ID MICROENCAPSULATED ISLETS; CELL ENCAPSULATION; MICROCAPSULES;
   TRANSPLANTATION; BIOMATERIAL; HYDROGEL; XENOTRANSPLANTATION;
   DEPOLYMERIZATION; OSTEOBLASTS; STABILITY
AB Encapsulation of cells in biocompatible polymer matrices represents a powerful tool for cell-based therapies and therapeutic delivery systems. This technology has successfully been used to deliver pancreatic islets to humans for the treatment of Type 1 diabetes. However, the clinical impact of this technology may be improved by reducing the inflammatory response brought on after implantation of capsules in vivo. Within this study a biocompatible polymeric delivery system combining alginate and photo-crosslinked methacrylated glycol chitosan (MGC) was developed. This approach involved encapsulating cells in calcium-alginate beads, coating with MGC and photo-polymerizing using UVA in the presence of photo-initiator (VA-086), resulting in the formation of capsules approximate to 600 mu m in size. Crosslinking of the MGC outer wall allowed control over capsule swelling and improved the capsules overall properties. Capsule characterization demonstrated the stabilizing influence of polymerization and fluorescence imaging showed that the distribution of glycol chitosan is dependent on molecular weight. Good islet viability and insulin release was demonstrated in vitro over the course of a month, and in vivo transplantation of the capsules demonstrated good biocompatibility, particularly when compared with standard alginate/poly-l-ornithine/alginate capsules. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 503-518, 2015.
C1 [Hillberg, Anna Louise; Oudshoorn, Matthew; Lam, Janice B. B.; Kathirgamanathan, Kalyani] LCT, Auckland, New Zealand.
RP Hillberg, AL (reprint author), LCT, Auckland, New Zealand.
EM annalhillberg@msn.com
CR Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b
   Beenken-Rothkopf LN, 2012, J BIOMATER APPL, V28, P395
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   HORCHER A, 1994, TRANSPLANT P, V26, P784
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   Jean O, 2009, BIOMATERIALS, V30, P1
   Kato Y, 2002, CARBOHYD RES, V337, P561, DOI 10.1016/S0008-6215(02)00021-6
   Knight DK, 2007, J BIOMED MATER RES A, V83A, P787, DOI 10.1002/jbm.a.31430
   Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Luan NM, 2010, BIOMATERIALS, V31, P8847, DOI 10.1016/j.biomaterials.2010.08.004
   MacKenzie DA, 2003, TRANSPLANTATION, V76, P887, DOI 10.1097/01.TP.0000087114.18315.17
   Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022
   Luan NM, 2012, BIOMATERIALS, V33, P8075, DOI 10.1016/j.biomaterials.2012.07.048
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Rouillard AD, 2011, TISSUE ENG PART C-ME, V17, P173, DOI [10.1089/ten.tec.2009.0582, 10.1089/ten.TEC.2009.0582]
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Sakai S, 2000, J MICROENCAPSUL, V17, P691
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Skaugrud O, 1999, BIOTECHNOL GENET ENG, V16, P23, DOI 10.1080/02648725.1999.10647970
   Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243
   Sweidan K., 2011, J EXCIP FOOD CHEM, V2, P16
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005
   Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vos P, 2014, ADV DRUG DELIV REV, V67-68, P15
   Vos P., 2006, BIOMATERIALS, V27, P5603
   Vos P, 1997, DIABETOLOGIA, V40, P262
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
NR 52
TC 7
Z9 7
U1 3
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 503
EP 518
DI 10.1002/jbm.b.33185
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000003
PM 24915784
DA 2018-10-20
ER

PT J
AU Ketabchi, A
   Weck, A
   Variola, F
AF Ketabchi, Amirhossein
   Weck, Arnaud
   Variola, Fabio
TI Influence of oxidative nanopatterning and anodization on the fatigue
   resistance of commercially pure titanium and Ti-6Al-4V
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium; fatigue; oxidative nanopatterning; anodization; nanotopography
ID CONTROLLED CHEMICAL OXIDATION; ALLOYS; SURFACES; FABRICATION; NANOTUBES;
   CORROSION; STRENGTH; IMPLANTS; BEHAVIOR; TI6AL4V
AB With an increasingly aging population, a significant challenge in implantology is the creation of biomaterials that actively promote tissue integration and offer excellent mechanical properties. Engineered surfaces with micro- and nanoscale topographies have shown great potential to control and direct biomaterial-host tissue interactions. Two simple yet efficient chemical treatments, oxidative nanopatterning and anodization, have demonstrated the ability to confer exciting new bioactive capacities to commercially pure titanium and Ti-6Al-4V alloy. However, the resulting nanoporous and nanotubular surfaces require careful assessment in regard to potential adverse effects on the fatigue resistance, a factor which may ultimately cause premature failure of biomedical implants. In this work, we have investigated the impact of oxidative nanopatterning and anodization on the fatigue resistance of commercially pure titanium and Ti-6Al-4V. Quantitative (e.g., S-N curves) and qualitative analyses were carried out to precisely characterize the fatigue response of treated metals and compare it to that of polished controls. Scanning electron microscopy (SEM) imaging revealed the effects of cyclic loading on the fracture surface and on the structural integrity of chemically grown nanostructured oxides. Results from this study reinforce the importance of mechanical considerations in the development and optimization of micro- and nanoscale surface treatments for metallic biomedical implants. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B:563-571, 2015.
C1 [Ketabchi, Amirhossein; Weck, Arnaud; Variola, Fabio] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
   [Weck, Arnaud; Variola, Fabio] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.
RP Weck, A (reprint author), Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada.
EM aweck@uottawa.ca
OI Variola, Fabio/0000-0002-5519-6915; Weck, Arnaud/0000-0001-8768-4449
FU University of Ottawa; Faculty of Engineering; Natural Sciences and
   Engineering Research Council of Canada (NSERC)
FX Dr. Variola acknowledges start-up funding from the University of Ottawa
   and Faculty of Engineering. Dr. Weck gratefully acknowledges the support
   of the Natural Sciences and Engineering Research Council of Canada
   (NSERC).
CR ADACHI M, 1990, J DENT RES, V69, P1230, DOI 10.1177/00220345900690060101
   [Anonymous], 2007, E466 ASTM INT, DOI [10.1520/E0466-07, DOI 10.1520/E0466-07]
   [Anonymous], 2013, E112 ASTM INT, DOI [10.1520/E0112-13, DOI 10.1520/E0112-13]
   Apachitei I, 2009, SCRIPTA MATER, V61, P113, DOI 10.1016/j.scriptamat.2009.03.017
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Costa MYP, 2009, MAT SCI ENG A-STRUCT, V507, P29, DOI 10.1016/j.msea.2008.11.068
   Costa Midori Yoshikawa Pitanga, 2006, Mat. Res., V9, P107, DOI 10.1590/S1516-14392006000100020
   Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Demetrescu I, 2010, MOL CRYST LIQ CRYST, V521, P195, DOI 10.1080/15421401003715918
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Fleck C, 2010, INT J FATIGUE, V32, P929, DOI 10.1016/j.ijfatigue.2009.09.009
   He PG, 2013, COMPOS SCI TECHNOL, V82, P15, DOI 10.1016/j.compscitech.2013.04.007
   Hermawan H., 2012, BIODEGRADABLE METALS
   Ketabchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092080
   Laonapakul T, 2012, J MECH BEHAV BIOMED, V8, P123, DOI 10.1016/j.jmbbm.2011.11.011
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012
   Leinenbach C, 2009, ACTA BIOMATER, V5, P2810, DOI 10.1016/j.actbio.2009.03.029
   Lutjering G., 2007, TITANIUM
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Morrissey RJ, 2005, INT J FATIGUE, V27, P1608, DOI 10.1016/j.ijfatigue.2005.07.009
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Pazos L, 2010, J MECH BEHAV BIOMED, V3, P416, DOI 10.1016/j.jmbbm.2010.03.006
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Ritchie RO, 1999, FATIGUE FRACT ENG M, V22, P621
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   VALLITTU PK, 1995, J PROSTHET DENT, V74, P412, DOI 10.1016/S0022-3913(05)80384-1
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Variola F, 2009, ADV ENG MATER, V11, pB227, DOI 10.1002/adem.200900122
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Yi JH, 2006, SURF SCI, V600, P4613, DOI 10.1016/j.susc.2006.07.053
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zavanelli RA, 2000, J PROSTHET DENT, V84, P274, DOI 10.1067/mpr.2000.108758
NR 42
TC 7
Z9 8
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 563
EP 571
DI 10.1002/jbm.b.33227
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000009
PM 24953745
DA 2018-10-20
ER

PT J
AU Felgueiras, HP
   Castanheira, L
   Changotade, S
   Poirier, F
   Oughlis, S
   Henriques, M
   Chakar, C
   Naaman, N
   Younes, R
   Migonney, V
   Celis, JP
   Ponthiaux, P
   Rocha, LA
   Lutomski, D
AF Felgueiras, H. P.
   Castanheira, L.
   Changotade, S.
   Poirier, F.
   Oughlis, S.
   Henriques, M.
   Chakar, C.
   Naaman, N.
   Younes, R.
   Migonney, V.
   Celis, J. P.
   Ponthiaux, P.
   Rocha, L. A.
   Lutomski, D.
TI Biotribocorrosion (tribo-electrochemical) characterization of anodized
   titanium biomaterial containing calcium and phosphorus before and after
   osteoblastic cell culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biotribocorrosion; titanium biomaterial; anodization; osteoblastic
   cells; wearing
ID ARTIFICIAL SALIVA; OXIDE-FILMS; IN-VITRO; SURFACES; DIFFERENTIATION;
   CORROSION; IMPLANTS; CA; TRIBOCORROSION; BEHAVIOR
AB The purpose of this study was to investigate the relationship between the osteoblastic cells behavior and biotribocorrosion phenomena on bioactive titanium (Ti). Ti substrates submitted to bioactive anodic oxidation and etching treatments were cultured up to 28 days with MG63 osteoblast-like cells. Important parameters of in vitro bone-like tissue formation were assessed. Although no major differences were observed between the surfaces topography (both rough) and wettability (both hydrophobic), a significant increase in cell attachment and differentiation was detected on the anodized substrates as product of favorable surface morphology and chemical composition. Alkaline phosphatase production has increased (approximate to 20 nmol/min/mg of protein) on the anodized materials, while phosphate concentration has reached the double of the etched material and calcium production increased (over 20 mu g/mL). The mechanical and biological stability of the anodic surfaces were also put to test through biotribocorrosion sliding solicitations, putting in evidence the resistance of the anodic layer and the cells capacity of regeneration after implant degradation. The Ti osteointegration abilities were also confirmed by the development of strong cell-biomaterial bonds at the interface, on both substrates. By combining the biological and mechanical results, the anodized Ti can be considered a viable option for dentistry. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 661-669, 2015.
C1 [Felgueiras, H. P.; Changotade, S.; Poirier, F.; Oughlis, S.; Migonney, V.; Lutomski, D.] Univ Paris 13, Sorbonne Paris Cite, CSPBAT UMR CNRS 7244, LBPS,UFR SMBH, F-93017 Paris, France.
   [Felgueiras, H. P.; Castanheira, L.; Rocha, L. A.] Univ Minho, Ctr Mech & Mat Technol, P-4800058 Guimaraes, Portugal.
   [Castanheira, L.; Ponthiaux, P.] Ecole Cent Paris, LGPM, F-92295 Chatenay Malabry, Paris, France.
   [Henriques, M.] Univ Minho, IBB, Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Chakar, C.; Naaman, N.; Younes, R.] Univ St Joseph, Fac Dent, Beirut, Lebanon.
   [Celis, J. P.] Catholic Univ Louvain, MTM, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
RP Lutomski, D (reprint author), Univ Paris 13, Sorbonne Paris Cite, CSPBAT UMR CNRS 7244, LBPS,UFR SMBH, 74 Rue Marcel Cachin, F-93017 Paris, France.
EM lutomski@smbh.univ-paris13.fr
RI Henriques, Mariana/A-2117-2013; Rocha, Luis/A-8592-2008; Felgueiras,
   Helena/H-4323-2017
OI Henriques, Mariana/0000-0003-0317-4877; Rocha, Luis/0000-0002-7219-1518;
   Felgueiras, Helena/0000-0002-4354-0256; Naaman, Nada/0000-0002-1860-8300
CR Alves SA, 2014, LUBR SCI, V26, P500, DOI 10.1002/ls.1234
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285, DOI 10.3109/17453678608994393
   Craig RG, 2002, RESTORATIVE DENT MAT
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Deng HW, 2005, CURRENT TOPICS IN BONE BIOLOGY, P1, DOI 10.1142/9789812701176
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Franco RD, 2009, J BIOMED MATER RES A, V88A, P841, DOI 10.1002/jbm.a.31960
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Gabbi C, 2005, ANN FM VET PARMA, V25, P307
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785
   Kasemo B, 1985, TISSUE INTEGRATED PR, P99
   Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20
   Krishna DSR, 2007, TRIBOL INT, V40, P329, DOI 10.1016/j.triboint.2005.08.004
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Kutz M., 2009, BIOMEDICAL ENG DESIG
   Landolt D, 2001, ELECTROCHIM ACTA, V46, P3913, DOI 10.1016/S0013-4686(01)00679-X
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee JM, 2010, APPL SURF SCI, V256, P3086, DOI 10.1016/j.apsusc.2009.11.078
   LesGuehennec L, 2007, DENT MATER, V23, P844
   Lim YJ, 2001, BIO-MED MATER ENG, V11, P325
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Rodriguez R, 2003, J BIOMED MATER RES A, V65A, P352, DOI 10.1002/jbm.a.10490
   Souza JCM, 2012, WEAR, V292, P82, DOI 10.1016/j.wear.2012.05.030
   Souza JCM, 2010, BIOFOULING, V26, P471, DOI 10.1080/08927011003767985
   Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3
   Thirugnanam A, 2009, TRENDS BIOMATER ART, V32, P76
   VansOss CJ, 1989, J COLLOID INTERF SCI, V128, P313
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhou Z., 2008, J PHYS D, V41, P1
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zhu ZR, 2007, J MED COLL PLA, V22, P303
NR 40
TC 8
Z9 8
U1 0
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2015
VL 103
IS 3
BP 661
EP 669
DI 10.1002/jbm.b.33236
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE3WG
UT WOS:000351760000019
PM 24989830
DA 2018-10-20
ER

PT J
AU Daculsi, G
AF Daculsi, Guy
TI Smart scaffolds: the future of bioceramic
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; GRAFT SUBSTITUTE BIOMATERIALS; ECTOPIC
   BONE-FORMATION; MICROSTRUCTURE; OSTEOINDUCTION; OSTEOGENICITY;
   REGENERATION; DESIGN
AB The commercial offer for bioceramic bone substitutes is very large, however, the prerequisites for applications in bone reconstruction and tissue engineering, are most often absent. The main criteria being: on the one hand physico-chemical features providing surgeons with an injectable and/or shapeable biomaterial; on the second hand the multi-scale bioactivity leading to osteoconduction and osteoinduction properties. In order to obtain greater suitability according to the nature of the bone defect to be treated, new bone regeneration technologies, "smart scaffolds" must be developed and optimize to support suitable Ortho Biology.
C1 Univ Nantes, Fac Dent, Lab Osteoarticular & Dent Tissue Engn, INSERM,U791, F-44042 Nantes, France.
RP Daculsi, G (reprint author), Univ Nantes, Fac Dent, Lab Osteoarticular & Dent Tissue Engn, INSERM,U791, Pl A Ricordeau, F-44042 Nantes, France.
EM guy.daculsi@univ-nantes.fr
FU European Union [FP7-HEALTH-2009-241879]
FX The research leading to these results has received funding from the
   European Union's 7th Framework Programme under Grant Agreement No.
   FP7-HEALTH-2009-241879 (REBORNE).
CR Campion CR, 2013, J MATER SCI-MATER M, V24, P597, DOI 10.1007/s10856-012-4833-x
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Chan O, 2012, ACTA BIOMATER, V8, P2788, DOI 10.1016/j.actbio.2012.03.038
   Coathup MJ, 2012, J BIOMED MATER RES A, V100A, P1550, DOI 10.1002/jbm.a.34094
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G, 2013, IRBM, V34, P346, DOI 10.1016/j.irbm.2013.07.001
   Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y
   Daculsi G, 2013, KEY ENG MATER, V529-530, P19, DOI 10.4028/www.scientific.net/KEM.529-530.19
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jensen SS, 2014, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12376, DOI 10.1111/CLR.12376]
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LeGeros RZ, 2014, SPRING SER BIOMAT S, V2, P1, DOI 10.1007/978-3-642-53980-0_1
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Levengood SKL, 2010, BIOMATERIALS, V31, P3552, DOI 10.1016/j.biomaterials.2010.01.052
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Sanchez-Salcedo S, 2009, ACTA BIOMATER, V5, P2738, DOI 10.1016/j.actbio.2009.03.025
   Vasilescu E, 2011, REV CHIM-BUCHAREST, V62, P212
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Zhang Y, 2013, CERAM INT, V39, P6751, DOI 10.1016/j.ceramint.2013.02.004
NR 26
TC 6
Z9 7
U1 2
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2015
VL 26
IS 4
AR 154
DI 10.1007/s10856-015-5482-7
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PO
UT WOS:000351584300001
PM 25779511
DA 2018-10-20
ER

PT J
AU Grigolo, B
   Cavallo, C
   Desando, G
   Manferdini, C
   Lisignoli, G
   Ferrari, A
   Zini, N
   Facchini, A
AF Grigolo, Brunella
   Cavallo, Carola
   Desando, Giovanna
   Manferdini, Cristina
   Lisignoli, Gina
   Ferrari, Andrea
   Zini, Nicoletta
   Facchini, Andrea
TI Novel nano-composite biomimetic biomaterial allows chondrogenic and
   osteogenic differentiation of bone marrow concentrate derived cells
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOCHONDRAL LESIONS; STROMAL CELLS; SCAFFOLD;
   REPAIR; NICHE; REGENERATION; RATIONALE; DESIGN
AB In clinical orthopedics suitable materials that induce and restore biological functions together with the right mechanical properties are particularly needed for the regeneration of osteochondral lesions. For this purpose, the ideal scaffold should possess the right properties with respect to degradation, cell binding, cellular uptake, non-immunogenicity, mechanical strength, and flexibility. In addition, it should be easy to handle and serve as a template for chondrocyte and bone cells guiding both cartilage and bone formation. The aim of the present study was to estimate the chondrogenic and osteogenic capability of bone marrow concentrated derived cells seeded onto a novel nano-composite biomimetic material. These properties have been evaluated by means of histological, immunohistochemical and electron microscopy analyses. The data obtained demonstrated that freshly harvested cells obtained from bone marrow were able, once seeded onto the biomaterial, to differentiate either down the chondrogenic and osteogenic pathways as evaluated by the expression and production of specific matrix molecules. These findings support the use, for the repair of osteochondral lesions, of this new nano-composite biomimetic material together with bone marrow derived cells in a "one step" transplantation procedure.
C1 [Grigolo, Brunella; Cavallo, Carola; Desando, Giovanna; Manferdini, Cristina; Lisignoli, Gina; Facchini, Andrea] Rizzoli Orthopaed Inst, SSD Lab RAMSES, I-40136 Bologna, Italy.
   [Grigolo, Brunella; Manferdini, Cristina; Lisignoli, Gina; Facchini, Andrea] Rizzoli Orthopaed Inst, SC Lab Immunorheumatol & Tissue Regenerat, I-40136 Bologna, Italy.
   [Ferrari, Andrea; Zini, Nicoletta] Rizzoli Orthopaed Inst, SC Lab Musculoskeletal Cell Biol, I-40136 Bologna, Italy.
   [Zini, Nicoletta] Rizzoli Orthopaed Inst, IGM, CNR Natl Res Council Italy, I-40136 Bologna, Italy.
RP Grigolo, B (reprint author), Rizzoli Orthopaed Inst, SSD Lab RAMSES, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM brunella.grigolo@ior.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; Cavallo,
   Carola/0000-0002-2913-856X; ZINI, NICOLETTA/0000-0002-4442-7079;
   manferdini, cristina/0000-0002-6648-6061
FU Progetto Regione Emilia-Romagna Universita
FX This work was partially supported by Grants from Progetto Regione
   Emilia-Romagna Universita 2010-2012 "Regenerative medicine of cartilage
   and bone". We thank the II Orthopedic and Traumatologic Clinic of our
   Institute (Director Professor Sandro Giannini) for providing us with
   Bone Marrow Concentrate samples. Bone Sialon Protein, osteopontin and
   Alkaline Phopshatase Hybridoma surnatants were obtained from the
   Developmental Studies Hybridoma Bank. We thank Patrizia Rappini and
   Graziella Salmi for their assistance in the preparation of the
   manuscript and Despina Kiriakidu, Massimo Gamberini and Luciano Pizzi
   for their technical assistance.
CR Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   Bluguermann C, 2013, CELL BIOCHEM FUNCT, V31, P271, DOI 10.1002/cbf.2950
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Cavallo C, 2013, J BIOL REG HOMEOS AG, V27, P165
   Cavallo C, 2013, J BIOMED MATER RES A, V101, P1559, DOI 10.1002/jbm.a.34460
   Das Madhurima, 2013, J Stem Cells, V8, P1
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919
   Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI 10.1089/ten.TEC.2008.0569
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Matsumoto T, 2010, J CELL PHYSIOL, V225, P291, DOI 10.1002/jcp.22223
   Murphy MB, 2013, EXP MOL MED, V15, pe54
   Nicoletti A, 2012, J MATER SCI-MATER M, V24, P17
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tonti GA, 2008, INT J DEV BIOL, V52, P1023, DOI 10.1387/ijdb.082725gt
   Velazquez OC, 2007, J VASC SURG, V45, P39
NR 28
TC 4
Z9 4
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2015
VL 26
IS 4
AR 173
DI 10.1007/s10856-015-5500-9
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PO
UT WOS:000351584300020
PM 25804305
DA 2018-10-20
ER

PT J
AU Ko, J
   Mohtaram, NK
   Lee, PC
   Willerth, SM
   Jun, MBG
AF Ko, Junghyuk
   Mohtaram, Nima Khadem
   Lee, Patrick C.
   Willerth, Stephanie M.
   Jun, Martin B. G.
TI Mathematical model for predicting topographical properties of poly
   (epsilon-caprolactone) melt electrospun scaffolds including the effects
   of temperature and linear transitional speed
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
DE melt electrospinning; modeling; topography; microfibers and scaffolds
ID FIBER DIAMETER; POLYPROPYLENE; REGENERATION; FABRICATION; PARAMETERS;
   INDEX; FIELD
AB Melt electrospinning can be used to fabricate various fibrous biomaterial scaffolds with a range of mechanical properties and varying topographical properties for different applications such as tissue scaffold and filtration and etc, making it a powerful technique. Engineering the topography of such electrospun microfibers can be easily done by tuning the operational parameters of this process. Recent experimental studies have shown promising results for fabricating various topographies, but there is no body of work that focuses on using mathematical models of this technique to further understand the effect of operational parameters on these properties of microfiber scaffolds. In this study, we developed a novel mathematical model using numerical simulations to demonstrate the effect of temperature, feed rate and flow rate on controlling topographical properties such as fiber diameter of these spun fibrous scaffolds. These promising modelling results are also compared to our previous and current experimental results. Overall, we show that our novel mathematical model can predict the topographical properties affected by key operational parameters such as change in temperature, flow rate and feed rate, and this model could serve as a promising strategy for the controlling of topographical properties of such structures for different applications.
C1 [Ko, Junghyuk; Mohtaram, Nima Khadem; Willerth, Stephanie M.; Jun, Martin B. G.] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
   [Lee, Patrick C.] Univ Vermont, Sch Engn, Burlington, VT 05405 USA.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Victoria, BC V8W 3P6, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Dept Biomed Engn, Victoria, BC V8W 3P6, Canada.
RP Ko, J (reprint author), Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
EM mbgjun@uvic.ca
OI Willerth, Stephanie/0000-0002-1665-7723
FU Natural Sciences and Engineering Research Council (NSERC)
FX Funding support from Natural Sciences and Engineering Research Council
   (NSERC) Discovery Grants is acknowledged. The authors would also like to
   acknowledge the Advanced Microscopy Facility at the University of
   Victoria.
CR Brown TD, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0013-7
   Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482
   Chung SW, 2010, ACTA BIOMATER, V6, P1958, DOI 10.1016/j.actbio.2009.12.007
   Dalton Paul D., 2006, Biotechnology Journal, V1, P998, DOI 10.1002/biot.200600064
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   Dalton PD, 2006, BIOMACROMOLECULES, V7, P686, DOI 10.1021/bm050777q
   Deng RJ, 2009, J APPL POLYM SCI, V114, P166, DOI 10.1002/app.29864
   Farrugia BL, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025001
   Hao MF, 2011, ADV MATER RES-SWITZ, V221, P129, DOI 10.4028/www.scientific.net/AMR.221.129
   Hao MF, 2011, ADV MATER RES-SWITZ, V221, P111, DOI 10.4028/www.scientific.net/AMR.221.111
   Karchin A, 2011, ACTA BIOMATER, V7, P3277, DOI 10.1016/j.actbio.2011.05.017
   Ko J, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/6/065009
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kong CS, 2009, POLYM ENG SCI, V49, P391, DOI 10.1002/pen.21303
   Li XY, 2012, POLYMER, V53, P248, DOI 10.1016/j.polymer.2011.11.008
   Liu Y, 2014, J POLYM SCI POL PHYS, V52, P946, DOI 10.1002/polb.23511
   Lyons J, 2004, POLYMER, V45, P7597, DOI 10.1016/j.polymer.2004.08.071
   Mazalevska O, 2013, J APPL POLYM SCI, V129, P779, DOI 10.1002/app.38818
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Mota C, 2013, POLYM INT, V62, P893, DOI 10.1002/pi.4509
   Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374
   Nayak R, 2013, TEXT RES J, V83, P606, DOI 10.1177/0040517512458347
   Park SH, 2008, ACTA BIOMATER, V4, P1198, DOI 10.1016/j.actbio.2008.03.019
   Raleigh X L, 1884, DUBLIN PHILOS, P184
   Ren JY, 2014, J BIOMED MATER RES A, V102, P3140, DOI 10.1002/jbm.a.34985
   Wang XN, 2011, ADV MATER RES-SWITZ, V332-334, P1550, DOI 10.4028/www.scientific.net/AMR.332-334.1550
   Zhmayev E, 2010, POLYMER, V51, P274, DOI 10.1016/j.polymer.2009.11.025
   Zhou HJ, 2006, POLYMER, V47, P7497, DOI 10.1016/j.polymer.2006.08.042
   Zhrnayev E, 2008, J NON-NEWTON FLUID, V153, P95, DOI 10.1016/j.jnnfm.2007.11.011
NR 29
TC 3
Z9 3
U1 0
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
EI 1361-6439
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD APR
PY 2015
VL 25
IS 4
AR 045018
DI 10.1088/0960-1317/25/4/045018
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA CE5AF
UT WOS:000351841400019
DA 2018-10-20
ER

PT J
AU Qu, T
   Verma, D
   Shahidi, M
   Pichler, B
   Hellmich, C
   Tomar, V
AF Qu, Tao
   Verma, Devendra
   Shahidi, Mehran
   Pichler, Bernhard
   Hellmich, Christian
   Tomar, Vikas
TI Mechanics of organic-inorganic biointerfaces-Implications for strength
   and creep properties
SO MRS BULLETIN
LA English
DT Article
ID MOLECULAR-DYNAMICS; BIOLOGICAL-MATERIALS; ELECTRON-MICROSCOPY; HARD
   BIOMATERIALS; MINERAL CRYSTALS; BONE; COLLAGEN; HYDROXYAPATITE;
   BEHAVIOR; MICROMECHANICS
AB From the biological/chemical perspective, interface concepts related to the cell surface/synthetic biomaterial interface and the extracellular matrix/biomolecule interface have wide applications in medical and biological technologies. Interfaces also play a significant role in determining structural integrity and mechanical creep and strength properties of biomaterials. Structural arrangement of interfaces combined with interfacial interactions between organic and inorganic phases significantly affects the mechanical properties of biological materials, allowing for a unique combination of seemingly inconsistent properties, such as fracture strength and tensile strength being both high-as opposed to traditional engineering materials, which have high fracture strength linked to low tensile strength and vice versa. While there has been a tremendous amount of work focused on the effects of structural arrangements on biomaterial properties, both experimental and computational studies of the strength, deformation, and viscosity of the interface itself are limited to just a few systems. Even in such studies, the actual interface stress is rarely analyzed, and correlated to the overall material strength or creep properties. This article provides a focused overview of such studies in hard biological materials, followed by a new vision of how the results of interfacial molecular studies could be consistently linked to multiscale, micromechanics-based perceptions of hierarchical biological materials.
C1 [Qu, Tao; Verma, Devendra] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
   [Shahidi, Mehran] Boku Vienna Univ Nat Resources & Life Sci, Vienna, Austria.
   [Shahidi, Mehran] TU Wien Vienna Univ Technol, Vienna, Austria.
   [Pichler, Bernhard] TU Wien Vienna Univ Technol, Lab Macroscop Mat Testing, Vienna, Austria.
   [Hellmich, Christian] TU Wien Vienna Univ Technol, Inst Mech Mat & Struct, Vienna, Austria.
   [Tomar, Vikas] Purdue Univ, W Lafayette, IN 47907 USA.
RP Qu, T (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
EM qut@purdue.edu; vermad@purdue.edu; mehran.shahidi@boku.ac.at;
   bernhard.pichler@tuwien.ac.at; christian.hellmich@tuwien.ac.at;
   tomar@purdue.edu
OI Pichler, Bernhard/0000-0002-6468-1840
FU US Department of Energy [DE-SC0008619]; National Science Foundation
   [CMMI-1131112]; European Research Council [257023]
FX T.Q. acknowledges support from the US Department of Energy Grant
   DE-SC0008619, D.V. acknowledges support from National Science Foundation
   Grant CMMI-1131112, and M.S. and C.H. acknowledge financial support from
   the European Research Council under grant #257023.
CR Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520
   Alexander B, 2012, J R SOC INTERFACE, V9, P1774, DOI 10.1098/rsif.2011.0880
   Almer JD, 2007, J STRUCT BIOL, V157, P365, DOI 10.1016/j.jsb.2006.09.001
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Bhowmik R., 2007, MATER RES SOC S P, V978
   Bhowmik R, 2007, J MATER SCI, V42, P8795, DOI 10.1007/s10853-007-1914-1
   Bhowmik R, 2009, J ENG MECH, V135, P413, DOI 10.1061/(ASCE)0733-9399(2009)135:5(413)
   Bylund G, 2003, DAIRY PROCESSING HDB
   COUSSOT P, 1995, PHYS REV LETT, V74, P3971, DOI 10.1103/PhysRevLett.74.3971
   Dealy J M, 2013, MELT RHEOLOGY ITS AP
   Dubey DK, 2013, J ENG MATER-T ASME, V135, DOI 10.1115/1.4023782
   Dubey DK, 2010, ANN BIOMED ENG, V38, P2040, DOI 10.1007/s10439-010-9988-3
   Dubey DK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3279158
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Dubey DK, 2009, MAT SCI ENG C-MATER, V29, P2133, DOI 10.1016/j.msec.2009.04.015
   Dubey DK, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/205103
   Eberhardsteiner L, 2014, COMPUT METHOD BIOMEC, V17, P48, DOI 10.1080/10255842.2012.670227
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Franck A, 2004, UNDERSTANDING RHEOLO
   Frankland SJV, 2003, SURF SCI, V525, pL103, DOI 10.1016/S0039-6028(02)02532-3
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fritsch A, 2009, J THEOR BIOL, V260, P230, DOI 10.1016/j.jtbi.2009.05.021
   Ghosh P, 2007, BIOMACROMOLECULES, V8, P851, DOI 10.1021/bm060942h
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Hellmich C, 2003, BIOMECH MODEL MECHAN, V2, P21, DOI 10.1007/S10237-002-0025-9
   Hodge A. J., 1963, ASPECTS PROTEIN STRU, P289
   Ichikawa Y, 2002, INT J NUMER METH ENG, V54, P1717, DOI 10.1002/nme.488
   Iyo T, 2004, J BIOMECH, V37, P1433, DOI 10.1016/j.jbiomech.2003.12.023
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Katti DR, 2010, J BIOMECH, V43, P1723, DOI 10.1016/j.jbiomech.2010.02.027
   Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817
   Knauss WG, 2003, COMPREHENSIVE STRUCT, V2, P383
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Launey ME, 2009, ADV MATER, V21, P2103, DOI 10.1002/adma.200803322
   LEES S, 1984, INT J BIOL MACROMOL, V6, P321, DOI 10.1016/0141-8130(84)90017-5
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Lelievre F, 1996, J MATER SCI-MATER M, V7, P489, DOI 10.1007/BF00705430
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Morin C, 2014, ULTRASONICS, V54, P1251, DOI 10.1016/j.ultras.2013.12.005
   Newman S, 1997, BIOPOLYMERS, V41, P337, DOI 10.1002/(SICI)1097-0282(199703)41:3<337::AID-BIP9>3.0.CO;2-T
   Nikolov S, 2008, BIOPHYS J, V94, P4220, DOI 10.1529/biophysj.107.125567
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   POSNER A S, 1975, Seminars in Arthritis and Rheumatism, V4, P267, DOI 10.1016/0049-0172(75)90013-X
   Qu T., 2015, SEM 2015 ANN C EXP E
   Qu T., 2014, P SOC ENG SCI 51 ANN
   Qu T, 2014, MAT SCI ENG C-MATER, V38, P28, DOI 10.1016/j.msec.2014.01.039
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   SALENCON J, 2001, HDB CONTINUUM MECH G
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Shahidi M, 2014, EUR J MECH A-SOLID, V45, P41, DOI 10.1016/j.euromechsol.2013.11.001
   Simone A. D., 2008, BIOCHEM BIOPH RES CO, V372, P121
   Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024
   Vaia RA, 2001, MRS BULL, V26, P394, DOI 10.1557/mrs2001.93
   Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   Yoon YJ, 2002, BIOMECH MODEL MECHAN, V1, P83, DOI 10.1007/s10237-002-0008-x
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
NR 66
TC 15
Z9 15
U1 3
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD APR
PY 2015
VL 40
IS 4
BP 349
EP 358
DI 10.1557/mrs.2015.70
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CE9GG
UT WOS:000352151500014
DA 2018-10-20
ER

PT J
AU Spreckelsen, C
   Schmithausen, D
   Roder, P
   Schmidt, R
   Dahl, E
   Geisler, S
   Kabino, K
AF Spreckelsen, C.
   Schmithausen, D.
   Roeder, P.
   Schmidt, R.
   Dahl, E.
   Geisler, S.
   Kabino, K.
TI Model-based approach for optimizing the storage management of
   bio-repositories
SO SIMULATION MODELLING PRACTICE AND THEORY
LA English
DT Article
DE Computer simulation; Optimization; Biological specimen banks; Decision
   support models; Biomedical ontologies; Modelling; Storage management
ID ONTOLOGY
AB Systematically collected samples of human tissue and fluids (e.g. blood, urine) play a key role in biomedical research. Biomaterial banks aim at collecting such biomaterials systematically and providing long-term availability of samples, which have to be kept constantly frozen at low temperatures. Therefore, storage management has to meet critical constraints in order to maintain high quality of the samples. The project aims at supporting the application of optimization and simulation algorithms for storage management. The approach has to provide means for adapting the algorithms flexibly and systematically to different or changing settings of biomaterial management and, therefore, aims at implementing a model-based framework to specify and run the algorithms.
   The process of establishing an optimization/simulation model for a given Biomaterial bank supported by the project starts with acquiring separately a model (1) of biomaterial handling and (2) of the optimization or simulation approach. The models for specific situations are derived from generic ontologies. A subsequent model mapping step assigns components representing aspects of biomaterial handling and storage to roles in a suitable optimization or simulation scheme. The mapping then enables the semi-automatic generation of optimization and simulation code. In the case of offline optimization problems, the framework produces program code that can be processed by an existing generic solver for mixed integer optimization programs (Zuse Institute Mathematical Programming Language code to be processed by the solver Solving Constraint Integer Programs). In the case of online problems, i.e., problems with an ongoing production of new information relevant for the optimization, the approach generates Java code suitable for processing by an existing simulation kernel (SimKit).
   The mapping module has been verified by reproducing a given solution for the Capacitated Facility Problem. Preliminary results of simulation runs show antagonistic effects of sorting bio-specimens by sample type: Sorting decreases the number of freezer opening operations while it increases fragmentation. The project is the first to adopt ontology-based modeling and model mapping for systematically exploring optimization and simulation approaches to biomaterial storage management. The results of simulation runs not only demonstrate the feasibility of the approach, but yield first practical insights (e.g. the effect of sorting samples). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Spreckelsen, C.; Schmithausen, D.; Roeder, P.; Schmidt, R.; Kabino, K.] Rhein Westfal TH Aachen, Dept Med Informat, D-52057 Aachen, Germany.
   [Schmidt, R.; Dahl, E.] Univ Hosp Aachen, Inst Pathol, Aachen, Germany.
   [Geisler, S.] Rhein Westfal TH Aachen, Chair Comp Sci Informat Syst 5, D-52057 Aachen, Germany.
RP Spreckelsen, C (reprint author), Rhein Westfal TH Aachen, Dept Med Informat, Pauwelsstr 30, D-52057 Aachen, Germany.
EM CSpreckelsen@mi.rwth-aachen.de
RI Spreckelsen, Cord/M-7326-2016
OI Spreckelsen, Cord/0000-0002-7301-1566
CR Achterberg T., 2004, 0419 ZIB
   Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7
   de Koster R, 2007, EUR J OPER RES, V182, P481, DOI 10.1016/j.ejor.2006.07.009
   Eminaga O, 2014, METHOD INFORM MED, V53, P29, DOI 10.3414/ME13-01-0035
   Ericsson C, 2006, ACTA ONCOL, V45, P643, DOI 10.1080/02841860600818047
   Fumi A., 2013, INT J ENG BUSINESS M, V5, P1
   GARFINKEL M, 2005, THESIS GEORGIA I TEC
   Grando M.A., 2012, P IEEE 2 INT C HEALT, P51
   GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008
   Gu JX, 2007, EUR J OPER RES, V177, P1, DOI 10.1016/j.ejor.2006.02.025
   Gu JX, 2010, EUR J OPER RES, V203, P539, DOI 10.1016/j.ejor.2009.07.031
   Han J, 2011, WINT SIMUL C PROC, P2909, DOI 10.1109/WSC.2011.6147994
   Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8
   Hoehndorf R, 2013, BRIEF BIOINFORM, V14, P696, DOI 10.1093/bib/bbs053
   Housseman S., 2011, ACM T MODEL COMPUT S, V21, P1
   KOCH T., 2004, THESIS TU BERLIN
   Koch T., 2001, 0120 KONR ZUS ZENTR
   Kofler M., 2011, LOG IND INF LINDI 20, P77
   Kovacs A, 2011, INT J PROD ECON, V133, P312, DOI 10.1016/j.ijpe.2009.10.028
   Macro JG, 2002, PROCEEDINGS OF THE 2002 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1274, DOI 10.1109/WSC.2002.1166388
   McGuinness D.L., 2004, OWL WEB ONTOLOGY LAN
   Noble G.L., 2001, US Patent, Patent No. [US 20010047451 A1, 20010047451]
   Payer H., 2009, 1 WORKSH INT SOL STA, V1, P1
   Rojas Isabel, 2004, In Silico Biol, V4, P89
   Rudolph S, 2011, LECT NOTES COMPUT SC, V6848, P76, DOI 10.1007/978-3-642-23032-5_2
   Segagni D, 2011, STUD HEALTH TECHNOL, V169, P887, DOI 10.3233/978-1-60750-806-9-887
   SHANKAR RD, 2006, P INT WORKSH HEALTHC, P25
   Silver GA, 2011, SIMUL-T SOC MOD SIM, V87, P747, DOI 10.1177/0037549710386843
   Yu AC, 2006, J BIOMED INFORM, V39, P252, DOI 10.1016/j.jbi.2005.11.006
NR 29
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-190X
EI 1878-1462
J9 SIMUL MODEL PRACT TH
JI Simul. Model. Pract. Theory
PD APR
PY 2015
VL 53
BP 74
EP 87
DI 10.1016/j.simpat.2015.01.008
PG 14
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering
SC Computer Science
GA CE5HP
UT WOS:000351862200005
DA 2018-10-20
ER

PT J
AU Anderson, EM
   Kwee, BJ
   Lewin, SA
   Raimondo, T
   Mehta, M
   Mooney, DJ
AF Anderson, Erin M.
   Kwee, Brian J.
   Lewin, Sarah A.
   Raimondo, Theresa
   Mehta, Manav
   Mooney, David J.
TI Local Delivery of VEGF and SDF Enhances Endothelial Progenitor Cell
   Recruitment and Resultant Recovery from Ischemia
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID INTEGRIN-MEDIATED ARREST; GROWTH-FACTOR DELIVERY; HUMAN CD34(+) CELLS;
   BONE-MARROW; IN-VITRO; LIMB ISCHEMIA; CORD BLOOD; ANGIOGENESIS; VIVO;
   TRANSPLANTATION
AB Biomaterials may improve outcomes of endothelial progenitor-based therapies for the treatment of ischemic cardiovascular disease, due to their ability to direct cell behavior. We hypothesized that local, sustained delivery of exogenous vascular endothelial growth factor (VEGF) and stromal cell-derived factor (SDF) from alginate hydrogels could increase recruitment of systemically infused endothelial progenitors to ischemic tissue, and subsequent neovascularization. VEGF and SDF were found to enhance in vitro adhesion and migration of outgrowth endothelial cells (OECs) and circulating angiogenic cells (CACs), two populations of endothelial progenitors, by twofold to sixfold, and nearly doubled recruitment to both ischemic and nonischemic muscle tissue in vivo. Local delivery of VEGF and SDF to ischemic hind-limbs in combination with systemic CAC delivery significantly improved functional perfusion recovery over OEC delivery, or either treatment alone. Compared with OECs, CACs were more responsive to VEGF and SDF treatment, promoted in vitro endothelial sprout formation in a paracrine manner more potently, and demonstrated greater influence on infiltrating inflammatory cells in vivo. These studies demonstrate that accumulation of infused endothelial progenitors can be enriched using biomaterial-based delivery of VEGF and SDF, and emphasize the therapeutic benefit of using CACs for the treatment of ischemia.
C1 [Anderson, Erin M.; Kwee, Brian J.; Raimondo, Theresa; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Anderson, Erin M.; Lewin, Sarah A.; Mehta, Manav; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Mehta, Manav] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,Pierce Hall 319, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
FU NIH [R01 HL069957]; Wyss Institute for Biologically Inspired Engineering
   at Harvard University
FX Funding was provided by the NIH (R01 HL069957) and Wyss Institute for
   Biologically Inspired Engineering at Harvard University.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chambers SEJ, 2013, IMMUNOBIOLOGY, V218, P1370, DOI 10.1016/j.imbio.2013.06.010
   Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chen RR, 2007, MICROCIRCULATION, V14, P77, DOI 10.1080/10739680601131101
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   Hoefer IE, 2005, ATHEROSCLEROSIS, V181, P285, DOI 10.1016/j.atherosclerosis.2005.01.047
   Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482
   Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994
   Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321
   Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn
   Peled A, 2000, BLOOD, V95, P3289
   Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194
   Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tongers J, 2010, MICROVASC RES, V79, P200, DOI 10.1016/j.mvr.2010.01.012
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
   Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C
NR 49
TC 18
Z9 20
U1 0
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2015
VL 21
IS 7-8
BP 1217
EP 1227
DI 10.1089/ten.tea.2014.0508
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF5RC
UT WOS:000352613600004
PM 25434326
OA Green Published
DA 2018-10-20
ER

PT J
AU Simmers, P
   Gishto, A
   Vyavahare, N
   Kothapalli, CR
AF Simmers, Phillip
   Gishto, Arsela
   Vyavahare, Narendra
   Kothapalli, Chandrasekhar R.
TI Nitric Oxide Stimulates Matrix Synthesis and Deposition by Adult Human
   Aortic Smooth Muscle Cells Within Three-Dimensional Cocultures
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID VASCULAR ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; S-NITROSOGLUTATHIONE;
   NEOINTIMA FORMATION; ELASTIN EXPRESSION; RELAXING FACTOR; BLOOD-VESSELS;
   PROTEIN; HYALURONAN; TISSUE
AB Vascular diseases are characterized by the over-proliferation and migration of aortic smooth muscle cells (SMCs), and degradation of extracellular matrix (ECM) within the vessel wall, leading to compromise in cell-cell and cell-matrix signaling pathways. Tissue engineering approaches to regulate SMC over-proliferation and enhance healthy ECM synthesis showed promise, but resulted in low crosslinking efficiency. Here, we report the benefits of exogenous nitric oxide (NO) cues, delivered from S-Nitrosoglutathione (GSNO), to cell proliferation and matrix deposition by adult human aortic SMCs (HA-SMCs) within three-dimensional (3D) biomimetic cocultures. A coculture platform with two adjacent, permeable 3D culture chambers was developed to enable paracrine signaling between vascular cells. HA-SMCs were cultured in these chambers within collagen hydrogels, either alone or in the presence of human aortic endothelial cells (HA-ECs) cocultures, and exogenously supplemented with varying GSNO dosages (0-100 nM) for 21 days. Results showed that EC cocultures stimulated SMC proliferation within GSNO-free cultures. With increasing GSNO concentration, HA-SMC proliferation decreased in the presence or absence of EC cocultures, while HA-EC proliferation increased. GSNO (100 nM) significantly enhanced the protein amounts synthesized by HA-SMCs, in the presence or absence of EC cocultures, while lower dosages (1-10 nM) offered marginal benefits. Multi-fold increases in the synthesis and deposition of elastin, glycosaminoglycans, hyaluronic acid, and lysyl oxidase crosslinking enzyme (LOX) were noted at higher GSNO dosages, and coculturing with ECs significantly furthered these trends. Similar increases in TIMP-1 and MMP-9 levels were noted within cocultures with increasing GSNO dosages. Such increases in matrix synthesis correlated with NO-stimulated increases in endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) expression within EC and SMC cultures, respectively. Results attest to the benefits of delivering NO cues to suppress SMC proliferation and promote robust ECM synthesis and deposition by adult human SMCs, with significant applications in tissue engineering, biomaterial scaffold development, and drug delivery.
C1 [Simmers, Phillip; Gishto, Arsela; Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.
   [Vyavahare, Narendra] Clemson Univ, Dept Bioengn, Clemson, SC USA.
RP Kothapalli, CR (reprint author), Cleveland State Univ, Dept Chem & Biomed Engn, 2121 Euclid Ave,FH 460, Cleveland, OH 44115 USA.
EM c.kothapalli@csuohio.edu
OI Simmers, Phillip/0000-0002-3761-8328
FU Faculty Research Development Award from the Cleveland State University;
   Provost Undergraduate Research and Creative Achievement Award from the
   Cleveland State University; NSF [1337859]
FX The authors thank the Microfluidics Foundry at Stanford University for
   help with device molds and Mike Sawonik for help with the device design.
   The authors would also like to express their gratitude for the startup
   funds, Faculty Research Development Award (2012-2013), and Provost
   Undergraduate Research and Creative Achievement Award (2012) from the
   Cleveland State University. Partial support from NSF grant (1337859) to
   C.K. is also appreciated.
CR Ahern GP, 1999, J PHYSIOL-LONDON, V520, P165, DOI 10.1111/j.1469-7793.1999.00165.x
   Alonso D, 2003, HEART FAIL REV, V8, P107, DOI 10.1023/A:1022155206928
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Behr-Roussel Delphine, 2004, Journal de la Societe de Biologie, V198, P237
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bhattacharyya A, 2014, TISSUE ENG PT A, V20, P1175, DOI [10.1089/ten.TEA.2013.0268, 10.1089/ten.tea.2013.0268]
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179
   Buttery LDK, 1996, LAB INVEST, V75, P77
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009
   CURRAN RD, 1991, FASEB J, V5, P2085
   Dey NB, 2012, MOL CELL BIOCHEM, V368, P27, DOI 10.1007/s11010-012-1339-2
   Egashira K, 1997, CIRCULATION, V96, P1048
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   FAZIO MJ, 1988, LAB INVEST, V58, P270
   FILLINGER MF, 1993, J VASC SURG, V17, P1058, DOI 10.1016/0741-5214(93)90676-D
   FORNIERI C, 1992, ARTERIOSCLER THROMB, V12, P1008, DOI 10.1161/01.ATV.12.9.1008
   Fukumoto Y, 1997, CIRCULATION, V96, P3104, DOI 10.1161/01.CIR.96.9.3104
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   GARG UC, 1993, EUR J PHARMACOL, V237, P243, DOI 10.1016/0014-2999(93)90275-M
   Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013
   Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024
   Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107
   KEATING M, 1994, TRENDS CARDIOVAS MED, V4, P165, DOI 10.1016/1050-1738(94)90053-1
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim H, 2014, INT J NANOMED, V9, P155, DOI 10.2147/IJN.S48856
   KOLPAKOV V, 1995, CIRC RES, V76, P305, DOI 10.1161/01.RES.76.2.305
   Kothapalli CR, 2008, J TISSUE ENG REGEN M, V2, P106, DOI 10.1002/term.70
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kothapalli CR, 2009, J TISSUE ENG REGEN M, V3, P655, DOI 10.1002/term.214
   Kothapalli CR, 2009, ACTA BIOMATER, V5, P541, DOI 10.1016/j.actbio.2008.09.004
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P501, DOI 10.1089/ten.tea.2008.0040
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P103, DOI 10.1089/ten.tea.2007.0390
   Kuo YR, 2004, SURGERY, V135, P437, DOI 10.1016/j.surg.2003.07.006
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Lin SG, 2011, TISSUE ENG PT A, V17, P1561, DOI 10.1089/ten.tea.2010.0593
   Lin SG, 2012, BIOMATERIALS, V33, P7047, DOI 10.1016/j.biomaterials.2012.06.044
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   LUSCHER TF, 1994, J CARDIOVASC PHARM, V24, pS16
   Mancuso C, 2003, BIOCHEM PHARMACOL, V66, P2355, DOI 10.1016/j.bcp.2003.08.022
   Masters KSB, 2005, J BIOMAT SCI-POLYM E, V16, P659, DOI 10.1163/1568562053783722
   MCMAHON MP, 1985, IN VITRO CELL DEV B, V21, P674
   Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mochizuki S, 2003, BIOCHEM BIOPH RES CO, V306, P505, DOI 10.1016/S0006-291X(03)00985-9
   MOURAO PAS, 1986, BIOCHIM BIOPHYS ACTA, V881, P321, DOI 10.1016/0304-4165(86)90022-X
   Naghavi N, 2013, SMALL, V9, P22, DOI 10.1002/smll.201200458
   Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Petersen E, 2000, EUR J VASC ENDOVASC, V20, P457, DOI 10.1053/ejvs.2000.1211
   Pullens RAA, 2009, J TISSUE ENG REGEN M, V3, P11, DOI 10.1002/term.129
   Ricciardolo FLM, 2000, AM J RESP CELL MOL, V22, P97, DOI 10.1165/ajrcmb.22.1.3706
   Robert L, 1995, CIBA F SYMP, V192, P286
   ROSE JR, 1993, FASEB J, V7, pA1208
   ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043
   Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428
   Sivaraman B, 2012, DRUG DELIV TRANSL RE, V2, P323, DOI 10.1007/s13346-012-0070-6
   Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/rccm.2105032
   Suarez ER, 2007, GROWTH FACTORS, V25, P50, DOI 10.1080/08977190701272701
   Sugitani H, 2001, BIOL PHARM BULL, V24, P461, DOI 10.1248/bpb.24.461
   Tsoukias N, 2008, MICROCIRCULATION, V15, P813, DOI 10.1080/10739680802010070
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Venkataraman L, 2014, TISSUE ENG PT A, V20, P1403, DOI [10.1089/ten.tea.2013.0294, 10.1089/ten.TEA.2013.0294]
   Venkataraman L, 2011, TISSUE ENG PT A, V17, P2879, DOI [10.1089/ten.tea.2010.0749, 10.1089/ten.TEA.2010.0749]
   YANG WD, 1994, BIOCHEM BIOPH RES CO, V203, P1160, DOI 10.1006/bbrc.1994.2304
   Yu H, 2011, CHEM BIOL DRUG DES, V78, P527, DOI 10.1111/j.1747-0285.2011.01174.x
   Zhao HC, 2010, J BIOMED MATER RES A, V93A, P356, DOI 10.1002/jbm.a.32536
   Zhao Q, 2013, BIOMATERIALS, V34, P8450, DOI 10.1016/j.biomaterials.2013.07.045
NR 81
TC 8
Z9 8
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2015
VL 21
IS 7-8
BP 1455
EP 1470
DI 10.1089/ten.tea.2014.0363
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF5RC
UT WOS:000352613600025
PM 25597545
OA Green Published
DA 2018-10-20
ER

PT J
AU Pfiffner, FK
   Waschkies, C
   Tian, YH
   Woloszyk, A
   Calcagni, M
   Giovanoli, P
   Rudin, M
   Buschmann, J
AF Pfiffner, Fatma Kivrak
   Waschkies, Conny
   Tian, Yinghua
   Woloszyk, Anna
   Calcagni, Maurizio
   Giovanoli, Pietro
   Rudin, Markus
   Buschmann, Johanna
TI A New In Vivo Magnetic Resonance Imaging Method to Noninvasively Monitor
   and Quantify the Perfusion Capacity of Three-Dimensional Biomaterials
   Grown on the Chorioallantoic Membrane of Chick Embryos
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CONTRAST AGENT; DEGRAPOL-FOAM; TISSUE; MODEL; ANGIOGENESIS; CELLS;
   BIOCOMPATIBILITY; OSTEOBLASTS; MOLECULES; SCAFFOLDS
AB Adequate vascularization in biomaterials is essential for tissue regeneration and repair. Current models do not allow easy analysis of vascularization of implants in vivo, leaving it a highly desirable goal. A tool that allows monitoring of perfusion capacity of such biomaterials noninvasively in a cheap, efficient, and reliable in vivo model would hence add great benefit to research in this field. We established, for the first time, an in vivo magnetic resonance imaging (MRI) method to quantify the perfusion capacity of a model biomaterial, DegraPol((R)) foam scaffold, placed on the embryonic avian chorioallantoic membrane (CAM) in ovo. Perfusion capacity was assessed through changes in the longitudinal relaxation rate before and after injection of a paramagnetic MRI contrast agent, Gd-DOTA (Dotarem((R)); Guerbet S.A.). Relaxation rate changes were compared in three different regions of the scaffold, that is, at the interface to the CAM, in the middle and on the surface of the scaffold (p<0.05). The highest relaxation rate changes, and hence perfusion capacities, were measured in the interface region where the scaffold was attached to the CAM, whereas the surface of the scaffold showed the lowest relaxation rate changes. A strong positive correlation was obtained between relaxation rate changes and histologically determined vessel density (R-2=0.983), which corroborates our MRI findings. As a proof-of-principle, we measured the perfusion capacity in different scaffold materials, silk fibroin either with or without human dental pulp stem cells. For these, three to four times larger perfusion capacities were obtained compared to DegraPol; demonstrating that our method is sensitive to reveal such differences. In summary, we present a novel in vivo method for analyzing the perfusion capacity in three-dimensional-biomaterials grown on the CAM, enabling the determination of the perfusion capacity of a large variety of bioengineered materials.
C1 [Pfiffner, Fatma Kivrak; Calcagni, Maurizio; Giovanoli, Pietro; Buschmann, Johanna] Univ Zurich Hosp, Plast Surg & Hand Surg, CH-8091 Zurich, Switzerland.
   [Waschkies, Conny; Rudin, Markus] ETH, Inst Biomed Engn, Zurich, Switzerland.
   [Waschkies, Conny] Univ Zurich, Zurich, Switzerland.
   [Waschkies, Conny; Tian, Yinghua] Univ Zurich Hosp, Visceral & Transplant Surg, CH-8091 Zurich, Switzerland.
   [Woloszyk, Anna] Univ Zurich, Inst Oral Biol, Zurich, Switzerland.
   [Woloszyk, Anna] Univ Zurich, Mol Life Sci, Zurich, Switzerland.
   [Woloszyk, Anna] Swiss Fed Inst Technol, Zurich, Switzerland.
RP Buschmann, J (reprint author), Univ Zurich Hosp, Plast Surg & Hand Surg, Sternwartstr 14, CH-8091 Zurich, Switzerland.
EM johanna.buschmann@usz.ch
RI Calcagni, Maurizio/C-9769-2012
OI Calcagni, Maurizio/0000-0003-4372-0561
FU Matching Funds of University Hospital Zurich
FX We would like to thank Ms. Pia Fuchs for H&E staining and Dr. Monika
   Hilbe for von Willebrand Factor staining. PD Dr. Andreas Boss is
   acknowledged for providing the contrast agent. Furthermore, Trudel Silk
   Inc., Zurich, Switzerland is highly acknowledged for providing silk
   fibroin and Dr. Sandra Hofmann, Eindhoven University of Technology, for
   manufacturing the scaffolds. We additionally thank PD Dr. Bernd
   Stadlinger of the clinic for dental medicine, for providing the teeth.
   The Matching Funds of University Hospital Zurich are highly acknowledged
   for financial support. We are thankful to ab medica, Italy, for
   providing the DegraPol foams.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI [10.1089/ten.tea.2010.0278, 10.1089/ten.TEA.2010.0278]
   Buschmann J, 2013, J TISSUE ENG REGEN M, V7, P413, DOI 10.1002/term.538
   Chesnick IE, 2011, MAGN RESON IMAGING, V29, P1244, DOI 10.1016/j.mri.2011.07.022
   Cole R. W., 2010, MICROSCOPY SCI TECHN, V1, P885
   Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4
   Falkner E, 2004, ATLA-ALTERN LAB ANIM, V32, P573
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   Klueh U, 2003, J BIOMED MATER RES A, V67A, P838, DOI 10.1002/jbm.a.10059
   Krishnan R, 2014, BIOMATERIALS, V35, P891, DOI 10.1016/j.biomaterials.2013.10.012
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lemon G, 2009, MATH BIOSCI, V221, P101, DOI 10.1016/j.mbs.2009.07.003
   Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959
   Milleret V, 2009, J BIOMED MATER RES B, V91B, P109, DOI 10.1002/jbm.b.31379
   Mohammad FK, 2012, NEUROTOXICOL TERATOL, V34, P214, DOI 10.1016/j.ntt.2011.09.006
   Mousa SA, 2007, CARCINOGENESIS, V28, P962, DOI 10.1093/carcin/bgl229
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Ribatti D, 1999, HISTOCHEM CELL BIOL, V112, P447, DOI 10.1007/s004180050427
   Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rudin M, 2005, NMR BIOMED, V18, P308, DOI 10.1002/nbm.961
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Saad B, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00775
   Sauerbier S, 2009, TISSUE ENG PART C-ME, V15, P455, DOI 10.1089/ten.tec.2008.0626
   Subauste MC, 2009, CLIN EXP METASTAS, V26, P1033, DOI 10.1007/s10585-009-9293-4
   Sukthankar A., 1999, DEGRAPOL BTC BTGC IN
   Tirino V, 2012, SOMATIC STEM CELLS, V879, P443
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Wang DX, 2012, INT J NANOMED, V7, P1711, DOI 10.2147/IJN.S29341
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 33
TC 0
Z9 0
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2015
VL 21
IS 4
BP 339
EP 346
DI 10.1089/ten.tec.2014.0212
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CF1KE
UT WOS:000352303200001
DA 2018-10-20
ER

PT J
AU Piitulainen, JM
   Posti, JP
   Aitasalo, KMJ
   Vuorinen, V
   Vallittu, PK
   Serlo, W
AF Piitulainen, Jaakko M.
   Posti, Jussi P.
   Aitasalo, Kalle M. J.
   Vuorinen, Ville
   Vallittu, Pekka K.
   Serlo, Willy
TI Paediatric cranial defect reconstruction using bioactive
   fibre-reinforced composite implant: early outcomes
SO ACTA NEUROCHIRURGICA
LA English
DT Article; Proceedings Paper
CT 15th European Congress of Neurosurgery
CY OCT 12-17, 2014
CL Prague, CZECH REPUBLIC
DE Cranioplasty; Craniectomy; Craniofacial bone reconstruction;
   Fibre-reinforced composite; FRC; Bioactive glass; Paediatric; Skull bone
   defect
ID TRAUMATIC BRAIN-INJURY; AUTOGENOUS BONE-GRAFT; DECOMPRESSIVE
   CRANIECTOMY; GLASS S53P4; IN-VITRO; CLINICAL ARTICLE; CHRONIC
   OSTEOMYELITIS; FLAP RESORPTION; RISK-FACTORS; CRANIOPLASTY
AB In children, approximately half of cryopreserved allograft bone flaps fail due to infection and resorption. Synthetic materials offer a solution for allograft bone flap resorption. Fibre-reinforced composite with a bioactive glass particulate filling is a new synthetic material for bone reconstruction. Bioactive glass is capable of chemically bonding with bone and is osteoinductive, osteoconductive and bacteriostatic. Fibre-reinforced composite allows for fabricating thin (0.8 mm) margins for implant, which are designed as onlays on the existing bone. Bioactive glass is dissolved over time, whereas the fibre-reinforced composite serves as a biostable part of the implant, and these have been tested in preclinical and adult clinical trials. In this study, we tested the safety and other required properties of this composite material in large skull bone reconstruction with children.
   Eight cranioplasties were performed on seven patients, aged 2.5-16 years and having large (> 16 cm(2)) skull bone defects. The implant used in this study was a patient-specific, glass-fibre-reinforced composite, which contained a bioactive glass particulate compound, S53P4.
   During follow-up (average 35.1 months), one minor complication was observed and three patients needed revision surgery. Two surgical site infections were observed. After treatment of complications, a good functional and cosmetic outcome was observed in all patients. The implants had an onlay design and fitted the defect well. In clinical and imaging examinations, the implants were in the original position with no signs of implant migration, degradation or mechanical breakage.
   Here, we found that early cranioplasty outcomes with the fibre-reinforced composite implant were promising. However, a longer follow-up time and a larger group of patients are needed to draw firmer conclusions regarding the long-term benefits of the proposed novel biomaterial and implant design. The glass-fibre-reinforced composite implant incorporated by particles of bioactive glass may offer an original, non-metallic and bioactive alternative for reconstruction of large skull bone defects in a paediatric population.
C1 [Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku 20521, Finland.
   [Posti, Jussi P.; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku 20521, Finland.
   [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland.
   [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, TCBC, Turku, Finland.
   [Vallittu, Pekka K.] Oral Hlth Care, City Turku Welf Div, Turku, Finland.
   [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.
RP Piitulainen, JM (reprint author), Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, POB 52, Turku 20521, Finland.
EM jaakko.piitulainen@utu.fi
OI Piitulainen, Jaakko/0000-0001-9788-8904; Posti,
   Jussi/0000-0002-5925-5193
CR Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370
   Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x
   Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483
   De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116
   DeLuca L, 1997, PLAST RECONSTR SURG, V99, P1324, DOI 10.1097/00006534-199704001-00019
   Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584
   Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860
   Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360
   Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312
   Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5
   Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Kamdar MR, 2009, PLAST RECONSTR SURG, V124, P2072, DOI 10.1097/PRS.0b013e3181bcefc4
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268
   Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178
   Ritter L, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130088
   Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605
   Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9
   Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014
   Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wang DY, 2013, CLIN ORAL INVEST, V17, P1601, DOI 10.1007/s00784-012-0841-y
   Yli-Urpo H, 2003, ACTA ODONTOL SCAND, V61, P241, DOI 10.1080/00016350310004719
   Zehnder M, 2006, ORAL SURG ORAL MED O, V101, P530, DOI 10.1016/j.tripleo.2005.03.014
   Zehnder M, 2004, J ENDODONT, V30, P220, DOI 10.1097/00004770-200404000-00009
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
NR 41
TC 18
Z9 18
U1 0
U2 20
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
EI 0942-0940
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PD APR
PY 2015
VL 157
IS 4
BP 681
EP 687
DI 10.1007/s00701-015-2363-2
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA CE0RD
UT WOS:000351511300024
PM 25663141
DA 2018-10-20
ER

PT J
AU Dias, FG
   Prudente, A
   Siniscalchi, RT
   de Vidal, BC
   Riccetto, CLZ
AF Fernandes Dias, Fernando Goulart
   Prudente, Alessandro
   Siniscalchi, Rodrigo Teixeira
   de Vidal, Benedicto Campos
   Zanettini Riccetto, Cassio Luis
TI Can highly purified collagen coating modulate polypropylene mesh
   immune-inflammatory and fibroblastic reactions? Immunohistochemical
   analysis in a rat model
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Collagen; Coating; Immunohistochemistry; Pelvic floor surgery;
   Polypropylene mesh
ID MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; REPAIR; PROLAPSE;
   SURGERY
AB Collagen has been proposed to be a useful biomaterial, but previous attempts to combine meshes with a collagen membrane have failed. The objective was to verify the effect of high-purified collagen gel coating in the immune-inflammatory response, host collagen metabolism, and angiogenesis around polypropylene mesh.
   In 20 female Wistar rats were implanted, at one side of the abdominal wall, a monofilament polypropylene mesh (PP), and, on the other side, a mesh coated with a new highly purified collagen gel (PPC). The animals were divided into sub-groups and euthanized at 7, 14, 21, and 90 days after implantation. Immunohistochemical analysis was performed using interleukin 1 (IL-1), matrix metalloproteinases (MMP-2, MMP-3), surface antigen CD-31, and tumor necrosis factor (TNF-alpha). Objective analysis (percent reactive area, average density, and vessels concentration) was performed using AxioVision Software.
   Comparative analysis showed: higher vessel density in the PPC group after 14 days (p = 0.002); a decrease in the average density of MMP-2 in the PPC group after 21 and 90 days (p = 0.046); more stability in the behavior of MMP-3 in the PPC group throughout the periods with the percentage reactive area for MMP-3 showing a significant decrease just in the PP group after 14 and 90 days (p = 0.017), and also for MMP-3 average density, in which reduction was significant after 21 days in the PP group, but not until after 90 days in PPC group (p < 0.001).
   Highly purified collagen coating causes significant changes in angiogenesis and in the immune reaction of metalloproteinase around mesh implants in rats. These findings can be useful for improving mesh biocompatibility for pelvic floor surgery if such effects could be properly controlled.
C1 [Fernandes Dias, Fernando Goulart; Prudente, Alessandro; Siniscalchi, Rodrigo Teixeira; Zanettini Riccetto, Cassio Luis] Univ Estadual Campinas, Div Urol, Biomat Res Unit, BR-13083888 Sao Paulo, Brazil.
   [de Vidal, Benedicto Campos] Univ Estadual Campinas, Inst Biol, Dept Anat Cell Biol Physiol & Biophys, BR-13083888 Sao Paulo, Brazil.
RP Dias, FG (reprint author), Univ Estadual Campinas, Div Urol, Biomat Res Unit, R Vital Brazil 250, BR-13083888 Sao Paulo, Brazil.
EM fergfdias@yahoo.com.br
RI Vidal, Benedicto/I-3227-2012
OI Vidal, Benedicto/0000-0003-1629-5619
FU FAPESP (Research Support Foundation of Sao Paulo State) [2013/05,841-3]
FX We thank FAPESP (Research Support Foundation of Sao Paulo State) for the
   financial support for the execution of this research project (process
   number 2013/05,841-3).
CR [Anonymous], 2004, CECIL TEXTBOOK
   BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401
   Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Cervigni M, 2011, EUR J OBSTET GYN R B, V156, P223, DOI 10.1016/j.ejogrb.2011.01.027
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   de Tayrac R, 2007, INT UROGYNECOL J, V18, P513, DOI 10.1007/s00192-006-0176-9
   Gibson D, 2009, MMPS MADE EASY WOUND, V1, P1
   Guerette NL, 2009, OBSTET GYNECOL, V114, P59, DOI 10.1097/AOG.0b013e3181a81b41
   Huffaker RK, 2008, AM J OBSTET GYNECOL, V198, P582, DOI [10.1016/j.ajog.2007.12.029, DOI 10.1016/J.AJOG.2007.12.029]
   KNAPP TR, 1977, J SURG RES, V23, P96, DOI 10.1016/0022-4804(77)90196-2
   Kuiper N, 2008, INT J EXP PATHOL, V89, pA1, DOI 10.1111/j.1365-2613.2007.00572.x
   Lobmann R, 2006, J DIABETES COMPLICAT, V20, P329, DOI 10.1016/j.jdiacomp.2005.08.007
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   Maturana LG, 2011, BRAZ J MED BIOL RES, V44, P682, DOI [10.1590/S0100-879X2011007500074, 10.1590/S0100-879X2011000700011]
   National Institute for Health and Clinical Excellence, 2008, SURGICAL REPAIR OF V
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patel H, 2012, INT UROGYNECOL J, V23, P669, DOI 10.1007/s00192-012-1718-y
   Schonleben F, 2006, INT J COLORECTAL DIS, V21, P840, DOI 10.1007/s00384-006-0091-z
   Siniscalchi RT, 2013, INT UROGYNECOL J, V24, P1747, DOI 10.1007/s00192-013-2109-8
   Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201
   Thiel M, 2005, BJU INT, V95, P833, DOI 10.1111/j.1464-410X.2005.05411.x
   van't Riet M, 2004, SURG ENDOSC, V18, P681, DOI 10.1007/s00464-003-9054-4
   Vidal BC, 2010, BIOTECH HISTOCHEM, V85, P365, DOI 10.3109/10520290903430496
   VIDAL BD, 1995, CR ACAD SCI III-VIE, V318, P831
   Yung S, 2006, PERITON DIALYSIS INT, V26, P162
NR 27
TC 6
Z9 6
U1 0
U2 10
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD APR
PY 2015
VL 26
IS 4
BP 569
EP 576
DI 10.1007/s00192-014-2529-0
PG 8
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA CE1XV
UT WOS:000351607100016
PM 25335748
DA 2018-10-20
ER

PT J
AU Sun, J
   Xiao, Y
   Wang, S
   Slepian, MJ
   Wong, PK
AF Sun, Jian
   Xiao, Yuan
   Wang, Shue
   Slepian, Marvin J.
   Wong, Pak Kin
TI Advances in Techniques for Probing Mechanoregulation of Tissue
   Morphogenesis
SO JALA
LA English
DT Review
DE automated biology; microtechnology; nanotechnology
ID COLLECTIVE CELL-MIGRATION; VASCULAR MESENCHYMAL CELLS; AIRWAY
   SMOOTH-MUSCLE; RAT SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; SHEAR-STRESS;
   MECHANICAL INTERACTIONS; FOCAL ADHESIONS; TRACTION FORCE; IN-VITRO
AB Cells process various mechanical cues in the microenvironment to self-organize into high-order architectures during tissue morphogenesis. Impairment of morphogenic processes is the underlying cause of many diseases; as such, understanding the regulatory mechanisms associated with these processes will form the foundation for the development of innovative approaches in cell therapy and tissue engineering. Nevertheless, little is known about how cells collectively respond to mechanical cues in the microenvironment, such as global geometric guidance, local cell-cell interactions, and other physicochemical factors, for the emergence of the structural hierarchy across multiple length scales. To elucidate the mechanoregulation of tissue morphogenesis, numerous approaches based on biochemical, biomaterial, and biophysical techniques have been developed in the past decades. In this review, we summarize techniques and approaches for probing the mechanoregulation of tissue morphogenesis and illustrate their applications in vasculature development. The potential and limitations of these methods are also discussed with a view toward the investigation of a wide spectrum of tissue morphogenic processes.
C1 [Sun, Jian; Xiao, Yuan; Wang, Shue; Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.; Wong, Pak Kin] Univ Arizona, Biomed Engn & Inst Bio5, Tucson, AZ 85721 USA.
   [Slepian, Marvin J.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA.
RP Wong, PK (reprint author), Univ Arizona, Biomed Engn & Inst Bio5, 11130 Mt Ave, Tucson, AZ 85721 USA.
EM pak@email.arizona.edu
RI Wong, Pak Kin/A-7974-2012
OI Wong, Pak Kin/0000-0001-7388-2110
FU National Institutes of Health Director's New Innovator Award
   [DP2OD007161]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by National Institutes of Health Director's New Innovator
   Award (DP2OD007161).
CR Alesutan I, 2013, CELL PHYSIOL BIOCHEM, V32, P728, DOI 10.1159/000354475
   An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001
   Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109
   Bagni M. A., 1992, Journal of Muscle Research and Cell Motility, V13, P516
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178
   Chen Peter C. Y., 2012, Proceedings of the World Congress on Engineering (WCE 2012), P622
   Chen TH, 2012, BIOMATERIALS, V33, P9019, DOI 10.1016/j.biomaterials.2012.08.067
   Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927
   Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Dai SP, 2010, J BIOL CHEM, V285, P4995, DOI 10.1074/jbc.M109.067454
   Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009
   Di Carlo D, 2012, JALA-J LAB AUTOM, V17, P32, DOI 10.1177/2211068211431630
   Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059
   Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540
   Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348
   Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045
   Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annutev.med.57.121304.131306
   Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200
   Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101
   Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Harris AR, 2012, P NATL ACAD SCI USA, V109, P16449, DOI 10.1073/pnas.1213301109
   Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097
   Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092
   Honarmandi P, 2011, LAB CHIP, V11, P684, DOI 10.1039/c0lc00487a
   Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120
   Hsiai TK, 2004, ANN BIOMED ENG, V32, P189, DOI 10.1023/B:ABME.0000012739.88554.01
   Huang H, 2002, BIOPHYS J, V82, P2211, DOI 10.1016/S0006-3495(02)75567-7
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Huang SX, 2010, MICROCIRCULATION, V17, P113, DOI 10.1111/j.1549-8719.2009.00011.x
   Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010
   Junkin M, 2013, BIOMATERIALS, V34, P2049, DOI 10.1016/j.biomaterials.2012.11.060
   Junkin M, 2011, J CELL SCI, V124, P4213, DOI 10.1242/jcs.088898
   Junkin M, 2011, BIOMATERIALS, V32, P1848, DOI 10.1016/j.biomaterials.2010.11.009
   Junkin M, 2009, ADV MATER, V21, P1247, DOI 10.1002/adma.200802122
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kniazeva E, 2009, AM J PHYSIOL-CELL PH, V297, pC179, DOI 10.1152/ajpcell.00018.2009
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Lau DH, 1999, CANCER BIOTHER RADIO, V14, P31, DOI 10.1089/cbr.1999.14.31
   Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Long JX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002847
   Mabeta P, 2009, ANGIOGENESIS, V12, P81, DOI 10.1007/s10456-009-9134-8
   Magidson V, 2007, METHOD CELL BIOL, V82, P239, DOI 10.1016/S0091-679(06)82007-8
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Manser E., 2006, RHO FAMILY GTPASES
   Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007
   Matsugaki A, 2013, ACTA BIOMATER, V9, P7227, DOI 10.1016/j.actbio.2013.03.015
   Matsumura T, 1997, J IMMUNOL, V158, P3408
   Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6
   Milkiewicz M, 2008, J CELL PHYSIOL, V217, P502, DOI 10.1002/jcp.21526
   Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Mowbray AL, 2008, J BIOL CHEM, V283, P1622, DOI 10.1074/jbc.M707985200
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181
   Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8
   Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096
   Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988
   Petersen W, 2004, J ORTHOPAED RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009
   Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352
   Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Rape A, 2011, J CELL SCI, V124, P4233, DOI 10.1242/jcs.090563
   Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917
   Riahi R, 2014, INTEGR BIOL-UK, V6, P192, DOI 10.1039/c3ib40095f
   Riahi R, 2013, ANALYST, V138, P4777, DOI 10.1039/c3an00722g
   Riahi R, 2012, JALA-J LAB AUTOM, V17, P59, DOI 10.1177/2211068211426550
   Rimann M, 2014, JALA-J LAB AUTOM, V19, P191, DOI 10.1177/2211068213508651
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109
   Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110
   Rosenthal R, 2005, EXP EYE RES, V80, P837, DOI 10.1016/j.exer.2004.12.013
   Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217
   Sarin V, 2005, J PHYSIOL-LONDON, V564, P603, DOI 10.1113/jphysiol.2005.083238
   Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4
   Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061
   Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407
   Shen H, 2014, PHYS CHEM CHEM PHYS, V16, P1914, DOI [10.1039/c3cp51435h, 10.1039/C3CP51435H]
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108
   Sun J, 2014, BIOMATERIALS, V35, P3273, DOI 10.1016/j.biomaterials.2013.12.101
   Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107
   Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102
   Tagawa H, 1997, CIRC RES, V80, P281, DOI 10.1161/01.RES.80.2.281
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007
   Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tse Justin R, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1016s47
   Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Turturro MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058897
   Udagawa T, 2000, J PHARMACOL EXP THER, V294, P421
   Ueda A, 2004, AM J PHYSIOL-HEART C, V287, pH994, DOI 10.1152/ajpheart.00400.2003
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van der Meer AD, 2010, AM J PHYSIOL-HEART C, V298, pH719, DOI 10.1152/ajpheart.00933.2009
   Van Gieson EJ, 2001, MICROCIRCULATION, V8, P25
   Wakatsuki T, 2001, J CELL SCI, V114, P1025
   Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17
   Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003
   Wang N, 1998, HYPERTENSION, V32, P162, DOI 10.1161/01.HYP.32.1.162
   Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006
   Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006
   Wang TH, 2010, JALA-J ASSOC LAB AUT, V15, pA15, DOI 10.1016/j.jala.2010.03.002
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Wong PK, 2005, J BIOMECH, V38, P529, DOI 10.1016/j.jbiomech.2004.04.008
   Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009
   Yang WC, 2010, JALA-J LAB AUTOM, V15, P198, DOI 10.1016/j.jala.2010.01.008
   Zhao RG, 2013, ADV MATER, V25, P1699, DOI 10.1002/adma.201203585
NR 129
TC 3
Z9 3
U1 1
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2211-0682
EI 1540-2452
J9 JALA-J LAB AUTOM
JI JALA
PD APR
PY 2015
VL 20
IS 2
SI SI
BP 127
EP 137
DI 10.1177/2211068214554802
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA CE2FK
UT WOS:000351629600005
PM 25331491
OA Bronze
DA 2018-10-20
ER

PT J
AU Trivedi, P
   Patel, AK
   Maurya, R
   Jayaganthan, R
   Balani, K
AF Trivedi, Pramanshu
   Patel, Anup Kumar
   Maurya, Rita
   Jayaganthan, R.
   Balani, Kantesh
TI Nanomechanical Characterization and Protein Adsorption of Cold-Rolled
   Zirconium Alloy
SO JOM
LA English
DT Article
ID SEVERE PLASTIC-DEFORMATION; IN-VITRO BIOCOMPATIBILITY;
   SURFACE-ROUGHNESS; TITANIUM-ALLOYS; BONE; INTERFACE; METALS;
   WETTABILITY; BIOMATERIAL; ADHESION
AB The success of the implants used for bone regeneration and repair is highly dependent on the cell material interaction, which is further influenced by interaction of body proteins with the implant materials. In this study, a novel nanostructured Zircaloy-2 has been developed using cold rolling (reduction of 25%, 50%. 75%, and 85%), which resulted in the refinement of grains by several orders of magnitude. Phase analysis was done using x-ray diffraction, and the microstructures of room-temperature rolled Zircaloy-2 were obtained using optical microscopy. The adsorption behavior of bovine serum albumin as a function of protein concentration on Zircaloy-2 was performed, and the wettability before and after protein adsorption on Zircaloy-2 samples was estimated by measuring the contact angle of a water droplet on the processed samples. Nanoindentation studies were performed, which indicated higher hardness (of 2.15 GPa) and reduced elastic modulus (47.4 GPa) when compared with that of as-received Zircaloy-2 (hardness of 0.12 GPa and reduced elastic modulus of 5.6 GPa). Also, it was found that protein adsorption increases to 0.59 mg/cm(2) for maximum deformed samples when compared with that of 0.38 mg/cm(2) for as-received samples. Contact angle decreased with increasing reduction from 62A degrees (of the as-received sample) to 44A degrees (at a reduction of 85%). But after protein adsorption, a further decrease in the contact angle from 43A degrees (as received) to 26A degrees (for 85% reduction) was observed. Thus, the engineered cold rolling can allow tailoring the nanomechanical properties of Zircaloy-2 while rendering the required protein adsorption as potential implant material.
C1 [Trivedi, Pramanshu; Patel, Anup Kumar; Maurya, Rita; Balani, Kantesh] Indian Inst Technol, Dept Mat Sci & Engn, Biomat Proc & Characterizat Lab, Kanpur 208016, Uttar Pradesh, India.
   [Jayaganthan, R.] Indian Inst Technol, Dept Met & Mat Engn, Roorkee 247667, Uttar Pradesh, India.
RP Trivedi, P (reprint author), Indian Inst Technol, Dept Mat Sci & Engn, Biomat Proc & Characterizat Lab, Kanpur 208016, Uttar Pradesh, India.
EM kbalani@iitk.ac.in
OI RENGASWAMY, JAYAGANTHAN/0000-0002-3634-9306; Balani,
   Kantesh/0000-0003-0619-9164
CR Amato SF, 2015, REGULATORY AFFAIRS B, P27
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gehrke P, 2006, QUINTESSENCE INT, V37, P19
   Goel S, 2014, MATER DESIGN, V55, P612, DOI 10.1016/j.matdes.2013.09.039
   Guglielmotti M B, 1997, Acta Odontol Latinoam, V10, P11
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Hench L.L., 1991, J AM CERAM SOC, V74, P1485
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kulakov O B, 2005, Morfologiia, V127, P52
   Lucas BN, 1997, MATER RES SOC SYMP P, V436, P233
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mordyuk BN, 2012, SURF COAT TECH, V210, P54, DOI 10.1016/j.surfcoat.2012.08.063
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M., 1999, JOM, V4, P32
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Scarborough N., 2015, REGULATORY AFFAIRS B, P11
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sherepo K.M., 1992, MED TEKH, V5, P14
   Sherepo K.M., 2004, MED TEKH, V2, P22
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Trivedi P, 2015, MAT SCI ENG C-MATER, V46, P309, DOI 10.1016/j.msec.2014.10.056
   Trivedi P, 2014, APPL SURF SCI, V293, P143, DOI [10.1016/j.apsusc.2013.12.119, 10.1016/j.apsusc.2013.12.11]
   Valiev R, 2004, NAT MATER, V3, P511, DOI 10.1038/nmat1180
   Valiev RZ, 2006, PROG MATER SCI, V51, P881, DOI 10.1016/j.pmatsci.2006.02.003
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
NR 34
TC 6
Z9 6
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2015
VL 67
IS 4
BP 726
EP 732
DI 10.1007/s11837-015-1324-9
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA CE1QN
UT WOS:000351587000006
DA 2018-10-20
ER

PT J
AU Rokicki, R
   Hryniewicz, T
   Pulletikurthi, C
   Rokosz, K
   Munroe, N
AF Rokicki, Ryszard
   Hryniewicz, Tadeusz
   Pulletikurthi, Chandan
   Rokosz, Krzysztof
   Munroe, Norman
TI Towards a Better Corrosion Resistance and Biocompatibility Improvement
   of Nitinol Medical Devices
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biocompatibility; corrosion resistance; magnetoelectropolishing MEP;
   NaClO surface inclusion detection test; Nitinol biomaterial
ID ALLOY; TITANIUM; SURFACES
AB Haemocompatibility of Nitinol implantable devices and their corrosion resistance as well as resistance to fracture are very important features of advanced medical implants. The authors of the paper present some novel methods capable to improve Nitinol implantable devices to some marked degree beyond currently used electropolishing (EP) processes. Instead, a magnetoelectropolishing process should be advised. The polarization study shows that magnetoelectropolished Nitinol surface is more corrosion resistant than that obtained after a standard EP and has a unique ability to repassivate the surface. Currently used sterilization processes of Nitinol implantable devices can dramatically change physicochemical properties of medical device and by this influence its biocompatibility. The Authors' experimental results clearly show the way to improve biocompatibility of NiTi alloy surface. The final sodium hypochlorite treatment should replace currently used Nitinol implantable devices sterilization methods which rationale was also given in our previous study.
C1 [Rokicki, Ryszard] Electrobright, Macungie, PA 18062 USA.
   [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Koszalin Univ Technol, Surface Electrochem Div, Koszalin, Poland.
   [Pulletikurthi, Chandan; Munroe, Norman] Florida Int Univ, Mech & Mat Engn Dept, Miami, FL 33199 USA.
RP Rokicki, R (reprint author), Electrobright, Macungie, PA 18062 USA.
EM info@electrobright.com; Tadeusz.Hryniewicz@tu.koszalin.pl
OI pulletikurthi, chandan/0000-0002-1804-1164
CR Das KK, 2008, INDIAN J MED RES, V128, P412
   EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   Galante J., 1999, J ORTHOP RES, V9, P760
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T., 2009, MAT RES SOC S P E, V1244E, P21, DOI DOI 10.1557/PROC-1244-3
   Jain M., 2013, J INVASIVE CARDIOL, V25, P180
   Madamba D.L.L., 2013, 4287 SAN JOS STAT U
   Marks James G Jr, 2003, Am J Contact Dermat, V14, P59
   Norwich DW, 2009, J MATER ENG PERFORM, V18, P558, DOI 10.1007/s11665-009-9415-9
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R, 2013, U.S. Patent, Patent No. [8,377,237, 8377237]
   Rokicki R., 2010, MAT DEVICE DIAGN IND, V32, P44
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Schuessler A., 2006, P INT C SHAP MEM SUP
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya S, 2009, J MATER ENG PERFORM, V18, P470, DOI 10.1007/s11665-009-9498-3
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Steegmueller R., 2005, P MAT PROC MED DEV C
   Stoeckel D., 1998, NITINOL MAT UNUSUAL
   van Geuns RJ, 2012, JACC-CARDIOVASC INTE, V5, P1209, DOI 10.1016/j.jcin.2012.08.016
   Zhao TT, 2012, J BIOMED MATER RES B, V100B, P646, DOI 10.1002/jbm.b.31989
NR 22
TC 11
Z9 11
U1 0
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD APR
PY 2015
VL 24
IS 4
BP 1634
EP 1640
DI 10.1007/s11665-015-1429-x
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD7SH
UT WOS:000351291200026
DA 2018-10-20
ER

PT J
AU Correia, RC
   Jozala, AF
   Martins, KF
   Penna, TCV
   Duek, EAD
   Rangel-Yagui, CD
   Lopes, AM
AF Correia, Rafaela Coelho
   Jozala, Angela Faustino
   Martins, Kelly Fernanda
   Vessoni Penna, Thereza Christina
   de Rezende Duek, Eliana Aparecida
   Rangel-Yagui, Carlota de Oliveira
   Lopes, Andre Moreni
TI Poly(lactic-co-glycolic acid) matrix incorporated with nisin as a novel
   antimicrobial biomaterial
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article
DE PLGA; Polymeric matrix; Nisin; Drug delivery system; Antimicrobial
   peptides
ID DRUG-DELIVERY; LISTERIA-MONOCYTOGENES; NANOPARTICLES; PLGA; RELEASE;
   DEGRADATION; SYSTEM; VITRO
AB The use of poly(lactic-co-glycolic acid) (PLGA) matrix as a biomolecule carrier has been receiving great attention due to its potential therapeutic application. In this context, we investigated the PLGA matrix capacity to incorporate nisin, an antimicrobial peptide capable of inhibiting the growth of Gram-positive bacteria and bacterial spores germination. Nisin-incorporated PLGA matrices were evaluated based on the inhibitory effect against the nisin-bioindicator Lactobacillus sakei. Additionally, the PLGA-nisin matrix stability over an 8-months period was investigated, as well as the nisin release profile. For the incorporation conditions, we observed that a 5 h incorporation time, at 30 A degrees C, with 250 mu g/mL nisin solution in PBS buffer pH 4.5, resulted in the highest inhibitory activity of 2.70 logAU/mL. The PLGA-nisin matrix was found to be relatively stable and showed sustained drug delivery, with continuous release of nisin for 2 weeks. Therefore, PLGA-nisin matrix is could be used as a novel antimicrobial delivery system and an alternative to antibiotics incorporated into PLGA matrices.
C1 [Correia, Rafaela Coelho; Jozala, Angela Faustino; Vessoni Penna, Thereza Christina; Rangel-Yagui, Carlota de Oliveira; Lopes, Andre Moreni] Univ Sao Paulo FCF USP, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, BR-05508000 Sao Paulo, SP, Brazil.
   [Jozala, Angela Faustino] Univ Sorocaba UNISO, Dept Pharm, Sorocaba, Brazil.
   [Martins, Kelly Fernanda] Pontifical Catholic Univ Sao Paulo PUCSP, Biomat Lab, Sorocaba, Brazil.
   [de Rezende Duek, Eliana Aparecida] State Univ Campinas FEM UNICAMP, Dept Mat Engn, Fac Mech Engn, Campinas, SP, Brazil.
RP Lopes, AM (reprint author), Univ Sao Paulo FCF USP, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Av Prof Lineu Prestes 580,B16, BR-05508000 Sao Paulo, SP, Brazil.
EM andreml@usp.br
RI Jozala, Angela/D-2373-2013; Lopes, Andre/E-9058-2013; RANGEL-YAGUI,
   CARLOTA/B-2560-2013
OI Jozala, Angela/0000-0002-3763-5451; Lopes, Andre/0000-0002-3570-2470;
   RANGEL-YAGUI, CARLOTA/0000-0003-4221-9505
FU Coordination for Higher Level Graduate Improvements (CAPES/Brazil);
   National Council for Scientific and Technological Development
   (CNPq/Brazil); State of Sao Paulo Research Foundation (FAPESP/Brazil)
FX This research was supported by grants from the Coordination for Higher
   Level Graduate Improvements (CAPES/Brazil), National Council for
   Scientific and Technological Development (CNPq/Brazil) and State of Sao
   Paulo Research Foundation (FAPESP/Brazil).
CR Amann LC, 2010, PHARM RES-DORDR, V27, P1730, DOI 10.1007/s11095-010-0152-4
   Amjadi I, 2012, APPL BIOCHEM BIOTECH, V168, P1434, DOI 10.1007/s12010-012-9868-4
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Bernela M, 2014, LWT-FOOD SCI TECHNOL, V59, P1093, DOI 10.1016/j.lwt.2014.05.061
   Chan CF, 2014, CURR ORG CHEM, V18, P204, DOI 10.2174/13852728113176660144
   Chi-Zhang YD, 2004, INT J FOOD MICROBIOL, V90, P15, DOI 10.1016/S0168-1605(03)00168-5
   de Kwaadsteniet M, 2010, PROBIOTICS ANTIMICRO, V2, P61, DOI 10.1007/s12602-009-9017-8
   Delves-Broughton J, 2005, FOOD AUST, V57, P525
   Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Jozala FA, 2012, FOOD BIOPROCESS TECH, V6, P3456
   Kowalczyk T, 2014, WORLD J MICROB BIOT, V30, P2141, DOI 10.1007/s11274-014-1649-5
   Liu H, 2012, J APPL POLYM SCI, V125, P468
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Malheiros PD, 2010, FOOD MICROBIOL, V27, P175, DOI 10.1016/j.fm.2009.09.013
   Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Pirooznia N., 2012, J NANOBIOTECHNOL, V10, P1
   Prombutara P, 2012, FOOD CONTROL, V24, P184, DOI 10.1016/j.foodcont.2011.09.025
   Ranjan AP, 2012, J NANOBIOTECHNOL, V10, P1
   Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3
   Salmaso S, 2004, INT J PHARM, V287, P163, DOI 10.1016/j.ijpharm.2004.09.003
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Swarbrick J, 2007, ENCY PHARM TECHNOLOG, P1339
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Van De Ven H, 2012, J DRUG TARGET, V20, P142, DOI 10.3109/1061186X.2011.595491
   Van Staden ADP, 2011, THESIS STELLENBOSCH
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   World Health Organization (WHO), 1969, SPEC ID PUR SOM ANT, V69, P53
NR 32
TC 4
Z9 4
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0959-3993
EI 1573-0972
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD APR
PY 2015
VL 31
IS 4
BP 649
EP 659
DI 10.1007/s11274-015-1819-0
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CD7TD
UT WOS:000351294200010
PM 25677652
DA 2018-10-20
ER

PT J
AU An, B
   Tang-Schomer, MD
   Huang, WW
   He, JY
   Jones, JA
   Lewis, RV
   Kaplan, DL
AF An, Bo
   Tang-Schomer, Min D.
   Huang, Wenwen
   He, Jiuyang
   Jones, Justin A.
   Lewis, Randolph V.
   Kaplan, David L.
TI Physical and biological regulation of neuron regenerative growth and
   network formation on recombinant dragline silks
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Neural cell; Silk; Recombinant protein; Tissue engineering
ID CELL-ADHESION MOLECULE; PERIPHERAL-NERVE REGENERATION; HOMOPHILIC
   BINDING-SITE; SPIDER SILK; NEURITE OUTGROWTH; TERMINAL DOMAINS;
   FGF-RECEPTOR; PROTEIN; FIBERS; TISSUE
AB Recombinant spider silks produced in transgenic goat milk were studied as cell culture matrices for neuronal growth. Major ampullate spidroin 1 (MaSp1) supported neuronal growth, axon extension and network connectivity, with cell morphology comparable to the gold standard poly-lysine. In addition, neurons growing on MaSp1 films had increased neural cell adhesion molecule (NCAM) expression at both mRNA and protein levels. The results indicate that MaSp1 films present useful surface charge and substrate stiffness to support the growth of primary rat cortical neurons. Moreover, a putative neuron-specific surface binding sequence GRGGL within MaSp1 may contribute to the biological regulation of neuron growth. These findings indicate that MaSp1 could regulate neuron growth through its physical and biological features. This dual regulation mode of MaSp1 could provide an alternative strategy for generating functional silk materials for neural tissue engineering. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [An, Bo; Tang-Schomer, Min D.; Huang, Wenwen; He, Jiuyang; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Jones, Justin A.; Lewis, Randolph V.] Utah State Univ, Dept Biol, Synthet Biomfg Ctr, Logan, UT 84322 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI An, Bo/N-3466-2014; Huang, Wenwen/H-5352-2018
OI An, Bo/0000-0002-1031-3380; Huang, Wenwen/0000-0001-8175-9083
FU NIH [R01 EB014283, P41 EB002520, R01 EY020856]; USTAR, DOE
   [DE-SC0004791]; NSF [IIP-1318194]
FX A. B. and M.D.T contributed equally to this paper; the order was
   determined alphabetically. We thank the NIH (R01 EB014283, P41 EB002520,
   R01 EY020856) to D.L.K and USTAR, DOE (DE-SC0004791), NSF (IIP-1318194)
   to R.V.L for funding support for these studies.
CR Adrianos SL, 2013, BIOMACROMOLECULES, V14, P1751, DOI 10.1021/bm400125w
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   An B, 2014, FRONT CHEM, V2
   An B, 2012, BIOMACROMOLECULES, V13, P3938, DOI 10.1021/bm301110s
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   DAVIS JQ, 1994, J BIOL CHEM, V269, P27163
   Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2014, BIOL INSPIR SYST, V5, P137, DOI 10.1007/978-94-007-7119-2_8
   Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Huang WW, 2010, J APPL POLYM SCI, V115, P3238, DOI 10.1002/app.31393
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015
   Kiselyov VV, 2010, ADV EXP MED BIOL, V663, P67, DOI 10.1007/978-1-4419-1170-4_4
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827
   McKinnon DD, 2014, BIOMACROMOLECULES, V15, P2808, DOI 10.1021/bm500731b
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Paratcha G, CELL, V113, P867
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   RAO Y, 1993, J BIOL CHEM, V268, P20630
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685
   SANDIG M, 1994, J BIOL CHEM, V269, P14841
   Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196
   Teule F, 2012, BIOPOLYMERS, V97, P418, DOI 10.1002/bip.21724
   Tucker CL, 2014, BIOMACROMOLECULES, V15, P3158, DOI 10.1021/bm5007823
   Virgintino D, 2009, J CELL MOL MED, V13, P3151, DOI 10.1111/j.1582-4934.2009.00694.x
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 63
TC 11
Z9 11
U1 4
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 48
BP 137
EP 146
DI 10.1016/j.biomaterials.2015.01.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD2SF
UT WOS:000350928600013
PM 25701039
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Jing, W
   Smith, AA
   Liu, B
   Li, JT
   Hunter, DJ
   Dhamdhere, G
   Salmon, B
   Jiang, J
   Cheng, D
   Johnson, CA
   Chen, S
   Lee, K
   Singh, G
   Helms, JA
AF Jing, Wei
   Smith, Andrew A.
   Liu, Bo
   Li, Jingtao
   Hunter, Daniel J.
   Dhamdhere, Girija
   Salmon, Benjamin
   Jiang, Jie
   Cheng, Du
   Johnson, Chelsey A.
   Chen, Serafine
   Lee, Katherine
   Singh, Gurpreet
   Helms, Jill A.
TI Reengineering autologous bone grafts with the stem cell activator WNT3A
SO BIOMATERIALS
LA English
DT Article
DE Age/ageing; Biomimetic material; Bone regeneration; Liposome;
   Osteogenesis; Spinal surgery
ID SPINAL-FUSION SURGERY; AGE-RELATED-CHANGES; ILIAC CREST; STROMAL CELLS;
   OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; TRABECULAR BONE;
   GROWTH-FACTORS; CORTICAL BONE; MARROW
AB Autologous bone grafting represents the standard of care for treating bone defects but this biomaterial is unreliable in older patients. The efficacy of an autograft can be traced back to multipotent stem cells residing within the bone graft. Aging attenuates the viability and function of these stem cells, leading to inconsistent rates of bony union. We show that age-related changes in autograft efficacy are caused by a loss in endogenous Wnt signaling. Blocking this endogenous Wnt signal using Dkk1 abrogates autograft efficacy whereas providing a Wnt signal in the form of liposome-reconstituted WNT3A protein (L-WNT3A) restores bone forming potential to autografts from aged animals. The bioengineered autograft exhibits significantly better survival in the hosting site. Mesenchymal and skeletal stem cell populations in the autograft are activated by L-WNT3A and mitotic activity and osteogenic differentiation are significantly enhanced. In a spinal fusion model, aged autografts treated with L-WNT3A demonstrate superior bone forming capacity compared to the standard of care. Thus, a brief incubation in L-WNT3A reliably improves autologous bone grafting efficacy, which has the potential to significantly improve patient care in the elderly. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jing, Wei; Smith, Andrew A.; Liu, Bo; Li, Jingtao; Hunter, Daniel J.; Dhamdhere, Girija; Cheng, Du; Johnson, Chelsey A.; Chen, Serafine; Lee, Katherine; Singh, Gurpreet; Helms, Jill A.] Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
   [Salmon, Benjamin] Univ Paris 05, PRES, Sch Dent, Sorbonne Paris Cite,EA 2496, Montrouge, France.
   [Salmon, Benjamin] Hop Univ Paris Nord Val Seine, AP HP, Odontol Dept Bretonneau, Paris, France.
   [Jiang, Jie] Univ Calif Los Angeles, Clin & Translat Sci Inst, Los Angeles, CA USA.
RP Helms, JA (reprint author), Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.
FU California Institute of Regenerative Medicine (CIRM) [TR1-01249]
FX The authors declare that they have no conflict of interest. This
   research project was supported by a grant from the California Institute
   of Regenerative Medicine (CIRM) TR1-01249 (J.A.H., PI).
CR AAMDAL S, 1984, INT J CANCER, V34, P725, DOI 10.1002/ijc.2910340521
   AN HS, 1995, J SPINAL DISORD, V8, P131
   Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005
   [Anonymous], 2011, CLIN POLICY B, V86, P1
   Ardawi MSM, 2011, J BONE MINER RES, V26, P2812, DOI 10.1002/jbmr.479
   Badrinath R, 2014, SPINE J, V14, P990, DOI 10.1016/j.spinee.2013.10.021
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Belthur MV, 2008, CLIN ORTHOP RELAT R, V466, P2973, DOI 10.1007/s11999-008-0538-3
   Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Borazjani BH, 2006, J BONE JOINT SURG AM, V88A, P1934, DOI 10.2106/JBJS.E.00992
   Bouxsein ML, 1997, J BONE MINER RES, V12, P839, DOI 10.1359/jbmr.1997.12.5.839
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154
   CEVC G, 1991, BIOCHEMISTRY-US, V30, P7186, DOI 10.1021/bi00243a021
   Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110
   Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011
   Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388
   Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174
   Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215
   Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004
   Fu QA, 2011, ADV FUNCT MATER, V21, P1058, DOI 10.1002/adfm.201002030
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Glassman SD, 2007, SPINE J, V7, P547, DOI 10.1016/j.spinee.2006.11.003
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Gstraunthaler G, 2013, CYTOTECHNOLOGY, V65, P791, DOI 10.1007/s10616-013-9633-8
   Harvey N, 2014, J BONE MINER RES, V29, P1917, DOI 10.1002/jbmr.2286
   Hernigou P, 1997, J BONE JOINT SURG AM, V79A, P1047, DOI 10.2106/00004623-199707000-00011
   Institute NC, AN MOD
   Jain A, 2013, J BONE JOINT SURG AM, V95A, P1265, DOI [10.2106/JBJS.L01118, 10.2106/JBJS.L.01118]
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Kim HT, 2008, CLIN ORTHOP RELAT R, V466, P1819, DOI 10.1007/s11999-008-0304-6
   Kim IC, 2013, J KOREAN NEUROSURG S, V54, P323, DOI 10.3340/jkns.2013.54.4.323
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Koerner JD, 2013, SPINE J, V13, P22, DOI 10.1016/j.spinee.2012.11.030
   Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793
   Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100
   Kulisic SM, 2008, ACTA DERMATOVENER CR, V16, P55
   Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298
   Leucht P, 2013, J BONE JOINT SURG AM, V95A, P1278, DOI [10.2106/JBJS.L01502, 10.2106/JBJS.L.01502]
   Li G, 2008, SPINE, V33, P1250, DOI 10.1097/BRS.0b013e3181714a44
   Li H, 2000, Clin Implant Dent Relat Res, V2, P110, DOI 10.1111/j.1708-8208.2000.tb00113.x
   Li J, 2011, CHINESE J CANCER RES, V23, P43, DOI 10.1007/s11670-011-0043-1
   LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227
   Liu B, 2014, J DENT RES, V93, P475, DOI 10.1177/0022034514528211
   Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Miclea RL, 2010, J BONE MINER RES, V25, P2348, DOI 10.1002/jbmr.153
   Minear S, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3000231
   Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Moore ST, 2011, J BIOMATER APPL, V26, P151, DOI 10.1177/0885328210366061
   Morrell NT, 2008, PLOS ONE, V3, pe2930
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528
   Office AE, 2007, AM ASS TISS BANKS AC
   Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1
   Piccin D, 2010, DIS MODEL MECH, V3, P421, DOI 10.1242/dmm.003137
   Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715
   Roforth MM, 2014, BONE, V59, P1, DOI 10.1016/j.bone.2013.10.019
   ROLSTON JLL, 1972, ARCH NEUROL-CHICAGO, V26, P258, DOI 10.1001/archneur.1972.00490090084007
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sagi HC, 2012, J BONE JOINT SURG AM, V94A, P2128, DOI 10.2106/JBJS.L.00159
   Schmidmaier G, 2006, BONE, V39, P1156, DOI 10.1016/j.bone.2006.05.023
   Sevens MM., 2008, MATER TODAY, V11, P18
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   STRATES BS, 1988, AM J MED SCI, V296, P266, DOI 10.1016/S0002-9629(15)40860-2
   Swenson CL, 2003, J BONE JOINT SURG AM, V85A, P323, DOI 10.2106/00004623-200302000-00021
   SZOT GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404
   van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023
   Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x
   Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002
   Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5
   Zwingenberger S, 2012, BIODRUGS, V26, P245, DOI 10.2165/11631680-000000000-00000
NR 86
TC 17
Z9 18
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 47
BP 29
EP 40
DI 10.1016/j.biomaterials.2014.12.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7DN
UT WOS:000350528000004
PM 25682158
DA 2018-10-20
ER

PT J
AU Zhao, FH
   Vaughan, TJ
   Mcnamara, LM
AF Zhao, Feihu
   Vaughan, Ted J.
   Mcnamara, Laoise M.
TI Multiscale fluid-structure interaction modelling to determine the
   mechanical stimulation of bone cells in a tissue engineered scaffold
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article
DE Fluid-structure interaction; Multiscale modelling; Osteoblast; Tissue
   engineered scaffold
ID MARROW STROMAL CELLS; FLOW PERFUSION BIOREACTOR; SHEAR-STRESS;
   OSTEOGENIC DIFFERENTIATION; MATRIX DEPOSITION; IN-VITRO; OSTEOBLASTS;
   OSTEOCYTES; DESIGN; MECHANOTRANSDUCTION
AB Recent studies have shown that mechanical stimulation, by means of flow perfusion and mechanical compression (or stretching), enhances osteogenic differentiation of mesenchymal stem cells and bone cells within biomaterial scaffolds in vitro. However, the precise mechanisms by which such stimulation enhances bone regeneration is not yet fully understood. Previous computational studies have sought to characterise the mechanical stimulation on cells within biomaterial scaffolds using either computational fluid dynamics or finite element (FE) approaches. However, the physical environment within a scaffold under perfusion is extremely complex and requires a multiscale and multiphysics approach to study the mechanical stimulation of cells. In this study, we seek to determine the mechanical stimulation of osteoblasts seeded in a biomaterial scaffold under flow perfusion and mechanical compression using multiscale modelling by two-way fluid-structure interaction and FE approaches. The mechanical stimulation, in terms of wall shear stress (WSS) and strain in osteoblasts, is quantified at different locations within the scaffold for cells of different attachment morphologies (attached, bridged). The results show that 75.4 % of scaffold surface has a WSS of 0.1-10 mPa, which indicates the likelihood of bone cell differentiation at these locations. For attached and bridged osteoblasts, the maximum strains are 397 and 177,200 , respectively. Additionally, the results from mechanical compression show that attached cells are more stimulated ( ) than bridged cells ( ). Such information is important for understanding the biological response of osteoblasts under in vitro stimulation. Finally, a combination of perfusion and compression of a tissue engineering scaffold is suggested for osteogenic differentiation.
C1 [Zhao, Feihu; Vaughan, Ted J.; Mcnamara, Laoise M.] Natl Univ Ireland, Coll Engn & Informat, Biomechan Res Ctr BMEC, Biomed Engn, Galway, Ireland.
RP Mcnamara, LM (reprint author), Natl Univ Ireland, Coll Engn & Informat, Biomechan Res Ctr BMEC, Biomed Engn, Galway, Ireland.
EM laoise.mcnamara@nuigalway.ie
RI Zhao, Feihu/R-9699-2017
OI Zhao, Feihu/0000-0003-0515-6808; McNamara, Laoise/0000-0002-5050-9230
FU European Research Council (ERC) [258992]
FX The authors would like to acknowledge the funding provided by the
   European Research Council (ERC) under Grant Number 258992 (BONEMECHBIO).
   In addition, the first author wishes to express his gratitude to Dr. S.
   W. Verbruggen (Biomedical Engineering, National University of Ireland,
   Galway) for his help with model generation.
CR Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034
   Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27
   Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138
   Ban Y, 2011, TISSUE CELL, V43, P311, DOI 10.1016/j.tice.2011.06.003
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Birmingham E, 2013, ANN BIOMED ENG, V41, P814, DOI 10.1007/s10439-012-0714-1
   Blecha LD, 2010, J BIOMECH, V43, P933, DOI 10.1016/j.jbiomech.2009.11.004
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010
   Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001
   Jungreuthmayer C, 2009, MED ENG PHYS, V31, P420, DOI 10.1016/j.medengphy.2008.11.003
   Keogh MB, 2011, BIOTECHNOL BIOENG, V108, P1203, DOI 10.1002/bit.23032
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI 10.1089/ten.TEA.2008.0540
   Li MM, 2013, ACS APPL MATER INTER, V5, P5921, DOI 10.1021/am401937m
   Liu LY, 2012, BIOMECH MODEL MECHAN, V11, P391, DOI 10.1007/s10237-011-0319-x
   Haber Y, 2013, BIOMED MICRODEVICES, V15, P1055, DOI 10.1007/s10544-013-9797-1
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   McCoy RJ, 2012, BIOTECHNOL BIOENG, V109, P1583, DOI 10.1002/bit.24424
   Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810
   Park SH, 2012, J MATER SCI-MATER M, V23, P2671, DOI 10.1007/s10856-012-4738-8
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Ryan G, 2009, J BIOMED MATER RES B, V90B, P894, DOI 10.1002/jbm.b.31361
   Samavedi S, 2012, BIOMATERIALS, V33, P7727, DOI 10.1016/j.biomaterials.2012.07.008
   Seliktar D, 2002, Google Patents, Patent No. [EP1019489 A4, 1019489]
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sittichockechaiwut A, 2009, BONE, V44, P822, DOI 10.1016/j.bone.2008.12.027
   Stops AJF, 2010, J MECH BEHAV BIOMED, V3, P292, DOI 10.1016/j.jmbbm.2009.12.003
   Stops AJF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979873
   Sugawara Y, 2008, BONE, V43, P19, DOI 10.1016/j.bone.2008.02.020
   Thompson MS, 2010, P I MECH ENG H, V224, P1533, DOI 10.1243/09544119JEIM807
   Vaughan TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0900
   Verbruggen SW, 2014, BIOMECH MODEL MECHAN, V13, P85, DOI 10.1007/s10237-013-0487-y
   Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286
   Vozzi G, 2014, J BIOMED MATER RES A, V102, P1415, DOI 10.1002/jbm.a.34823
   Westbroek I, 2000, BIOCHEM BIOPH RES CO, V268, P414, DOI 10.1006/bbrc.2000.2154
   Xie L, 2013, STEM CELL REV REP, V9, P858, DOI 10.1007/s12015-013-9456-1
   You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
NR 45
TC 16
Z9 18
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
EI 1617-7940
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD APR
PY 2015
VL 14
IS 2
BP 231
EP 243
DI 10.1007/s10237-014-0599-z
PG 13
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA CD1YQ
UT WOS:000350871000003
PM 24903125
DA 2018-10-20
ER

PT J
AU Araujo, MG
   da Silva, JCC
   de Mendonca, AF
   Lindhe, J
AF Araujo, Mauricio G.
   Costa da Silva, Joao Carlos
   de Mendonca, Arthur Furtado
   Lindhe, Jan
TI Ridge alterations following grafting of fresh extraction sockets in man.
   A randomized clinical trial
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone formation; extraction socket; grafting; humans;
   xenograft
ID BEAM COMPUTED-TOMOGRAPHY; COMPLETE DENTURE WEARERS; FACIAL BONE WALL;
   IMPLANT PLACEMENT; TOOTH EXTRACTION; BIO-OSS(R) COLLAGEN; DOG;
   PRESERVATION; MAXILLA; REDUCTION
AB ObjectiveTo evaluate dimensional alterations of the alveolar ridge that occurred following tooth extraction at sites grafted with Bio-Oss((R)) Collagen.
   Material and methodsTwenty-eight subjects with maxillary incisors, canines, and premolars scheduled for extraction were included. The tooth was carefully removed. The patients were randomly assigned to a test or a control group. In the test group patients, Bio-Oss((R)) Collagen was placed in the fresh extraction socket while in the controls no grafting was performed. Radiographic examination (cone beam computed tomograms, CBCT) was performed immediately after tooth extraction and socket treatment. Four months later, a new CBCT was obtained. In the radiographs, (i) the distance (mm) between base of the alveolar process (apex) and the buccal and palatal crests was determined, (ii) the outer profile of alveolar process of the experimental sites was outlined, and the cross section of the area (mm(2)) determined.
   ResultsAfter 4months of healing, the buccal and to a less extent also the palatal bone plate had become markedly reduced in height. The placement of a biomaterial in the socket failed to prevent resorption of the buccal and palatal bone walls. The cross-sectional area of the control ridge was reduced about 25% and of the test ridge with 3%.
   ConclusionThe placement of a xenograft in fresh extraction sockets markedly counteracted the reduction in the hard tissue component of the edentulous sites.
C1 [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [de Mendonca, Arthur Furtado] Univ Estado Rio De Janeiro, Dept Prosthodont, Rio De Janeiro, Brazil.
   [Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim 15,Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
OI Furtado de Mendonca, Arthur/0000-0002-4855-3435
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   ATWOOD DA, 1971, J PROSTHET DENT, V26, P266, DOI 10.1016/0022-3913(71)90069-2
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   BERGMAN B, 1985, J PROSTHET DENT, V53, P56, DOI 10.1016/0022-3913(85)90066-6
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Braut V, 2011, INT J PERIODONT REST, V31, P125
   CARLSSON GE, 1967, ACTA ODONTOL SCAND, V25, P1
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   Ghassemian M, 2012, J PERIODONTOL, V83, P187, DOI 10.1902/jop.2011.110172
   Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   JOHNSON K, 1969, Australian Dental Journal, V14, P241
   Johnson K, 1963, AUST DENT J, V8, P428
   Jung R. E., 2013, J CLIN PERIODONTOL, V40, P2013
   Lindhe J, 2014, CLIN ORAL IMPLAN RES, V25, P786, DOI 10.1111/clr.12170
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Sahlin-Platt A., 2011, SERIES UMEA U, V119
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   Schroeder HE, 1986, THE PERIODONTIUM
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6
   TALLGREN A, 1966, Acta Odontologica Scandinavica, V24, P195, DOI 10.3109/00016356609026127
   TALLGREN ANTJE, 1957, ACTA ODONTOL SCAND, V15, P1
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
NR 36
TC 51
Z9 53
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2015
VL 26
IS 4
BP 407
EP 412
DI 10.1111/clr.12366
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CD0IT
UT WOS:000350755400019
PM 24621203
DA 2018-10-20
ER

PT J
AU Barwacz, CA
   Brogden, KA
   Stanford, CM
   Dawson, DV
   Recker, EN
   Blanchette, D
AF Barwacz, Christopher A.
   Brogden, Kim A.
   Stanford, Clark M.
   Dawson, Deborah V.
   Recker, Erica N.
   Blanchette, Derek
TI Comparison of pro-inflammatory cytokines and bone metabolism mediators
   around titanium and zirconia dental implant abutments following a
   minimum of 6 months of clinical function
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial(s); cytokine(s); dental abutments; oral
   implants/implantology; titanium; zirconium oxide
ID GINGIVAL CREVICULAR FLUID; NECROSIS-FACTOR-ALPHA; PERI-IMPLANTITIS;
   PROINFLAMMATORY CYTOKINES; PERIODONTAL HEALTH; TNF-ALPHA; LEPTIN;
   OSTEOPONTIN; PARAMETERS; IL-1-BETA
AB ObjectivesDental implant abutments are fundamental prosthetic components within dentistry that require optimal biocompatibility. The primary aim of this cross-sectional study was to preliminarily assess differences in the pro-inflammatory cytokine and bone metabolism mediator protein expression in the peri-implant crevicular fluid (PICF) adjacent to transmucosal abutments.
   Material and MethodsAbutments were fabricated from either titanium or zirconia in patients previously receiving single-tooth implant therapy. All subjects sampled in this study had an identical implant system and implant-abutment connection. Participants (n=46) had an average time of clinical function for 22months (6.2-72.8months, SD 17months) and received a clinical and radiographic examination of the implant site at the time of PICF sampling using a paper strip-based sampling technique. Cytokine, chemokine, and bone metabolism mediator quantities (picograms/30s) were determined using a commercial 22-multiplexed fluorescent bead-based immunoassay instrument. A total of 19 pro-inflammatory cytokines and seven bone metabolism mediators were evaluated.
   ResultsMultivariable analyses provided no evidence of a group (titanium or zirconia), gender, or age effect with regard to the expression of pro-inflammatory mediators evaluated. Significant (P=0.022) differences were observed for the bone mediator leptin, with titanium abutments demonstrating significantly elevated levels in comparison with zirconia. Osteopontin demonstrated a significant (P=0.0044) correlation with age of the subjects.
   ConclusionsNo significant differences in pro-inflammatory cytokine or bone metabolism mediator profiles were observed biochemically, with the exception of leptin, for the abutment biomaterials of titanium or zirconia The molecular PICF findings support the observed clinical biocompatibility of both titanium and zirconia abutments.
C1 [Barwacz, Christopher A.] Univ Iowa, Coll Dent, Craniofacial Clin Res Ctr, Iowa City, IA 52242 USA.
   [Brogden, Kim A.; Stanford, Clark M.; Dawson, Deborah V.; Recker, Erica N.; Blanchette, Derek] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA.
RP Barwacz, CA (reprint author), Univ Iowa, Coll Dent, Craniofacial Clin Res Ctr, W425 Dent Sci Bldg, Iowa City, IA 52242 USA.
EM chris-barwacz@uiowa.edu
OI Blanchette, Derek/0000-0001-8591-2460
FU National Institutes of Health (NIH) [UL1 RR024979]; Astra Tech AB,
   Molndal, Sweden
FX This study was supported by the National Institutes of Health (NIH)
   Grant UL1 RR024979 and Astra Tech AB, Molndal, Sweden. The authors
   declare no potential conflict of interest with respect to the authorship
   and/or publication of this article.
CR Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413
   Andreiotelli M, 2008, QUINTESSENCE INT, V39, P289
   Ataoglu H, 2002, CLIN ORAL IMPLAN RES, V13, P470, DOI 10.1034/j.1600-0501.2002.130505.x
   Boynuegri AD, 2012, CLIN ORAL INVEST, V16, P353, DOI 10.1007/s00784-010-0497-4
   Bozkurt FY, 2006, J PERIODONTOL, V77, P634, DOI 10.1902/jop.2006.050277
   Canullo L, 2007, INT J PROSTHODONT, V20, P489
   Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7
   Coen G, 2004, J NEPHROL, V17, P187
   CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Fiorellini JP, 2000, INT J ORAL MAX IMPL, V15, P500
   HOLM S, 1979, SCAND J STAT, V6, P65
   Javed F, 2011, CYTOKINE, V53, P8, DOI 10.1016/j.cyto.2010.08.013
   Johnson RB, 2001, J PERIODONTOL, V72, P1254, DOI 10.1902/jop.2000.72.9.1254
   Karthikeyan BV, 2007, J CLIN PERIODONTOL, V34, P467, DOI 10.1111/j.1600-051X.2007.01078.x
   Kido J, 2001, J PERIODONTAL RES, V36, P328, DOI 10.1034/j.1600-0765.2001.360509.x
   Lachmann S, 2007, CLIN ORAL IMPLAN RES, V18, P212, DOI 10.1111/j.1600-0501.2006.01322.x
   LOWNEY JJ, 1995, AM J ORTHOD DENTOFAC, V108, P519, DOI 10.1016/S0889-5406(95)70052-8
   Machtei EE, 2006, CLIN ORAL IMPLAN RES, V17, P658, DOI 10.1111/j.1600-0501.2006.01282.x
   Murata M, 2002, CLIN ORAL IMPLAN RES, V13, P637, DOI 10.1034/j.1600-0501.2002.130610.x
   Norton Michael R, 2002, Compend Contin Educ Dent, V23, P21
   Nothdurft F, 2010, CLIN ORAL IMPLAN RES, V21, P857, DOI 10.1111/j.1600-0501.2009.01899.x
   Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P166, DOI 10.1111/j.1708-8208.2007.00076.x
   Nowzari H, 2012, CLIN IMPLANT DENT R, V14, P546, DOI 10.1111/j.1708-8208.2010.00299.x
   Petkovic AB, 2010, INT J ORAL MAX SURG, V39, P478, DOI 10.1016/j.ijom.2010.01.014
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Salvi GE, 2012, CLIN ORAL IMPLAN RES, V23, P182, DOI 10.1111/j.1600-0501.2011.02220.x
   Schierano G, 2008, J CLIN PERIODONTOL, V35, P532, DOI 10.1111/j.1600-051X.2008.01224.x
   Seuerino VO, 2011, ARCH ORAL BIOL, V56, P823, DOI 10.1016/j.archoralbio.2011.01.006
   Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x
   Sharma CG, 2007, J PERIODONTAL RES, V42, P450, DOI 10.1111/j.1600-0765.2007.00968.x
   Stanford CM, 1999, ADV DENT RES, V13, P88
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Thomas T, 2003, JOINT BONE SPINE, V70, P18, DOI 10.1016/S1297-319X(02)00005-2
   Zeadin MG, 2012, BIOCHEM BIOPH RES CO, V425, P924, DOI 10.1016/j.bbrc.2012.08.011
   Zembic A, 2013, CLIN ORAL IMPLAN RES, V24, P384, DOI 10.1111/clr.12044
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhou XH, 2005, BIOSTATISTICS, V6, P187, DOI 10.1093/biostatistics/kxi002
NR 38
TC 7
Z9 7
U1 3
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2015
VL 26
IS 4
BP e35
EP e41
DI 10.1111/clr.12326
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA CD0IT
UT WOS:000350755400006
PM 24417614
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Charles, LF
   Woodman, JL
   Ueno, D
   Gronowicz, G
   Hurley, MM
   Kuhn, LT
AF Charles, Lyndon F.
   Woodman, Jessica L.
   Ueno, Daisuke
   Gronowicz, Gloria
   Hurley, Marja M.
   Kuhn, Liisa T.
TI Effects of low dose FGF-2 and BMP-2 on healing of calvarial defects in
   old mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL
   STEM-CELLS; COLLOIDAL GELATIN GELS; AGE-RELATED-CHANGES; OSTEOBLASTIC
   DIFFERENTIATION; OSTEOINDUCTIVE ACTIVITY; STROMAL CELLS; UP-REGULATION;
   SPINE FUSION
AB There is an age-associated reduction in the bone healing activity of bone morphogenetic protein-2 (BMP-2) that is currently addressed by administering higher doses of BMP-2 in elderly patients. The unwanted medical complications from high dose BMP-2 motivated this investigation to determine whether the addition of a low dose of fibroblast growth factor 2 (FGF-2) could enhance the ability of a lower dose of BMP-2 to heal calvarial bone defects in old mice (18-20 months old). FGF-2 (5 ng) and BMP-2 (2 mu g) were administered by a controlled release two-phase biomaterial scaffold placed into the bone defect. FGF-2 released more rapidly and completely in vitro than BMP-2 (40% vs 2%). In vivo, both BMP-2 and FGF-2 + BMP-2 groups formed more new bone in calvarial defects than scaffold alone (p < 0.001) or FGF-2 only groups (p < 0.01). The overall total volume of new bone was not statistically increased by the addition of FGF-2 to BMP-2 as measured by microCT, but the pattern of bone deposition was different. In old mice, but not young, there was enhanced bony fill in the central bone defect area when the BMP-2 was supplemented with FGF-2. Histological analysis of the center of the defect revealed an increased bone volume (%BV/TV (p = 0.004)) from the addition of FGF-2. These studies suggest that combining a low dose of FGF-2 with a low dose of BMP-2 has the potential to increase bone healing in old mice relative to BMP-2 alone. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Charles, Lyndon F.; Woodman, Jessica L.; Kuhn, Liisa T.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA.
   [Ueno, Daisuke] Tsurumi Univ, Sch Dent Med, Unit Oral & Maxillofacial Implantol, Yokohama, Kanagawa, Japan.
   [Gronowicz, Gloria] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA.
   [Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.
RP Kuhn, LT (reprint author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, MC1615,263 Farmington Ave, Farmington, CT 06030 USA.
EM lkuhn@uchc.edu
OI Gronowicz, Gloria/0000-0001-7158-3598
FU International Team for Implantology (ITI; Basel, Switzerland)
   [348/2004]; National Institute of Dental & Craniofacial Research of the
   National Institutes of Health [R01DE021103]
FX Research reported in this publication was supported by the International
   Team for Implantology (ITI; Basel, Switzerland) grant # 348/2004 and the
   National Institute of Dental & Craniofacial Research of the National
   Institutes of Health under award number R01DE021103. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. The
   authors would like to thank Dr. Qin Amy Wang, Dr. Jin Pan, and Dr.
   Roberta Kelm for assistance in conducting animal surgeries. We would
   also like to acknowledge Dr. Doug Adams and the MicroCT Imaging Facility
   at the UConn Health Center for the microCT imaging and Dr. James Grady,
   UCONN Health Center for help with the statistical analysis. The
   nonglycosylated human recombinant BMP-2 was kindly provided by Dr. Peter
   Hortschansky from the Hans Knoll Institute, Jena, Germany and the
   PEG-hydrogel was kindly provided by Institut Straumann.
CR Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30
   Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008
   Bergman RJ, 1996, J BONE MINER RES, V11, P568
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003
   Farhadi J, 2005, PLAST RECONSTR SURG, V116, P1379, DOI 10.1097/01.prs.0000182355.67397.5a
   Fujimura K, 2002, ARCH ORAL BIOL, V47, P577, DOI 10.1016/S0003-9969(02)00046-8
   Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0
   GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Hak DJ, 2006, J ORTHOP RES, V24, P11, DOI 10.1002/jor.20022
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Heersche JNM, 1998, J PROSTHET DENT, V79, P14, DOI 10.1016/S0022-3913(98)70187-8
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Jeon E, 2009, PROTEIN PEPTIDE LETT, V16, P664, DOI 10.2174/092986609788490267
   Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x
   Kakudo N, 2006, WOUND REPAIR REGEN, V14, P336, DOI 10.1111/j.1743-6109.2006.00129.x
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Kotev-Emeth S, 2000, BONE, V27, P777, DOI 10.1016/S8756-3282(00)00389-6
   Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018
   Luong LN, 2012, BIOMATERIALS, V33, P283, DOI 10.1016/j.biomaterials.2011.09.052
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Marie PJ, 2012, GROWTH FACTORS, V30, P117, DOI 10.3109/08977194.2012.656761
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x
   Naganawa T, 2008, J CELL BIOCHEM, V103, P1975, DOI 10.1002/jcb.21589
   Nakamura Y, 2005, BONE, V36, P399, DOI 10.1016/j.bone.2004.11.010
   Ono I, 1996, J CRANIOFAC SURG, V7, P418, DOI 10.1097/00001665-199611000-00006
   Ou GM, 2010, J GERONTOL A-BIOL, V65, P1051, DOI 10.1093/gerona/glq114
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Singhatanadgit W, 2006, J CELL PHYSIOL, V209, P912, DOI 10.1002/jcp.20799
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Tanaka E, 2006, ANN BIOMED ENG, V34, P717, DOI 10.1007/s10439-006-9092-x
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   VARKEY M, 2006, CLIN ORTHOP RELA FEB, P113, DOI DOI 10.1097/01.BLO.0000200236.84189.87
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102
   Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8
   Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4
NR 50
TC 17
Z9 18
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2015
VL 64
BP 62
EP 69
DI 10.1016/j.exger.2015.02.006
PG 8
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA CD1CZ
UT WOS:000350812800008
PM 25681640
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Munirathinam, B
   Neelakantan, L
AF Munirathinam, Balakrishnan
   Neelakantan, Lakshman
TI Titania nanotubes from weak organic acid electrolyte: Fabrication,
   characterization and oxide film properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium; Anodic oxidation; TiO2 nanotubes; Wettability; Impedance; Mott
   Schottky analysis
ID TIO2 NANOTUBES; HYDROPHILIC PROPERTIES; THIN-FILMS; ARRAYS; ANODIZATION;
   ANATASE; GROWTH; SEMICONDUCTOR; BIOMATERIAL; DIMENSIONS
AB In this study, TiO2 nanotubes were fabricated using anodic oxidation in fluoride containing weak organic add for different durations (0.5 h, 1 h, 2 h and 3 h). Scanning electron microscope (SEM) micrographs reveal that the morphology of titanium oxide varies with anodization time. Raman spectroscopy and X-ray diffraction (XRD) results indicate that the as-formed oxide nanotubes were amorphous in nature, yet transform into crystalline phases (anatase and rutile) upon annealing at 600 degrees C. Wettability measurements show that both as-formed and annealed nanotubes exhibited hydrophilic behavior. The electrochemical behavior was ascertained by DC polarization and AC electrochemical impedance spectroscopy (EIS) measurements in 0.9% NaCl solution. The results suggest that the annealed nanotubes showed higher impedance (10(5)-10(6) Omega cm(2)) and lower passive current density (10(-7) A cm(-2)) than the as-formed nanotubes. In addition, we investigated the influence of post heat treatment on the semiconducting properties of the oxides by capacitance measurements. In vitro bioactivity test in simulated body fluid (SBF) showed that precipitation of Ca/P is easier in crystallized nanotubes than the amorphous structure. Our study uses a simple strategy to prepare nano-structured titania films and hints the feasibility of tailoring the oxide properties by thermal treatment, producing surfaces with better bioactivity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Munirathinam, Balakrishnan; Neelakantan, Lakshman] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
RP Munirathinam, B (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM blkrish88@gmail.com
OI Neelakantan, Lakshman/0000-0001-6837-1228; Munirathinam,
   Balakrishnan/0000-0002-7499-6424
CR Acevedo-Pena P., 2014, ELECTROCHIM ACTA
   Ainouche L, 2014, ELECTROCHIM ACTA, V133, P597, DOI 10.1016/j.electacta.2014.04.086
   Balakrishnan M, 2013, THIN SOLID FILMS, V540, P23, DOI 10.1016/j.tsf.2013.05.122
   Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Caliskan N, 2014, MAT SCI ENG C-MATER, V35, P100, DOI 10.1016/j.msec.2013.10.033
   CHENG HM, 1995, CHEM MATER, V7, P663, DOI 10.1021/cm00052a010
   Hahn R, 2007, ELECTROCHEM COMMUN, V9, P947, DOI 10.1016/j.elecom.2006.11.037
   Jiang ZL, 2011, MATER CHEM PHYS, V126, P859, DOI 10.1016/j.matchemphys.2010.12.028
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEACH JSL, 1988, CORROS SCI, V28, P43, DOI 10.1016/0010-938X(88)90005-4
   Liu QJ, 2002, MATER RES BULL, V37, P2255, DOI 10.1016/S0025-5408(02)00972-8
   Marcus P, 1998, ELECTROCHIM ACTA, V43, P109, DOI 10.1016/S0013-4686(97)00239-9
   Narayanan R, 2009, MATER CHEM PHYS, V117, P460, DOI 10.1016/j.matchemphys.2009.06.023
   Narayanan R., 2005, THESIS IIT MADRAS IN
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh S, 2011, MAT SCI ENG C-MATER, V31, P873, DOI 10.1016/j.msec.2011.02.004
   Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042
   Qu DY, 2003, ELECTROCHIM ACTA, V48, P1675, DOI 10.1016/S0013-4686(03)00146-4
   Reclaru L, 2003, BIOMATERIALS, V24, P3027, DOI 10.1016/S0142-9612(03)00145-5
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Regonini D., 2008, THESIS U BATH UK
   Roman I, 2014, MAT SCI ENG C-MATER, V37, P374, DOI 10.1016/j.msec.2014.01.036
   Schmidt-Stein F, 2010, ACTA MATER, V58, P6317, DOI 10.1016/j.actamat.2010.07.053
   Sikora E, 1996, ELECTROCHIM ACTA, V41, P783, DOI 10.1016/0013-4686(95)00312-6
   SPURR RA, 1957, ANAL CHEM, V29, P760, DOI 10.1021/ac60125a006
   Sulka GD, 2010, ELECTROCHIM ACTA, V55, P4359, DOI 10.1016/j.electacta.2009.12.053
   Sunil BR, 2013, MAT SCI ENG C-MATER, V33, P1607, DOI 10.1016/j.msec.2012.12.095
   TOMKIEWICZ M, 1990, ELECTROCHIM ACTA, V35, P1631, DOI 10.1016/0013-4686(90)80019-K
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Venkateswarlu K, 2013, ELECTROCHIM ACTA, V105, P468, DOI 10.1016/j.electacta.2013.05.032
   Xie ZB, 2010, ELECTROCHIM ACTA, V56, P905, DOI 10.1016/j.electacta.2010.10.004
   Xiong JY, 2012, THIN SOLID FILMS, V526, P116, DOI 10.1016/j.tsf.2012.11.027
   Yahia SAA, 2012, J ELECTROCHEM SOC, V159, pK83, DOI 10.1149/2.077204jes
   Yang B, 2011, MATER CHEM PHYS, V130, P1227, DOI 10.1016/j.matchemphys.2011.08.063
   Yang WH, 2014, MAT SCI ENG C-MATER, V34, P410, DOI 10.1016/j.msec.2013.09.042
   Ye Q, 2007, VACUUM, V81, P627, DOI 10.1016/j.vacuum.2006.09.001
   Zhang XY, 2001, CHEM MATER, V13, P2511, DOI 10.1021/cm0007297
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 40
TC 14
Z9 15
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 567
EP 578
DI 10.1016/j.msec.2015.01.045
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100066
PM 25686985
DA 2018-10-20
ER

PT J
AU Kanungo, I
   Chellappa, N
   Fathima, NN
AF Kanungo, Ivy
   Chellappa, Nisha
   Fathima, Nishter Nishad
TI Microfabrication of gelatin-polycaprolactone composites for customized
   drug delivery
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Gelatin; Polycaprolactone; Biomaterial; Thermoporometry; Drug delivery
ID DIFFERENTIAL SCANNING CALORIMETRY; PORE-SIZE DISTRIBUTION;
   THERMOPOROMETRY
AB Dynamic properties of water molecules present in the vicinity of protein are sensitive to its local conformational motions. Water mobility at the protein surface/interfaces is affected by its polar and charged groups, which are capable of anchoring water molecules through H-bonds. Differential scanning calorimetry, ATR-FTIR spectroscopy and circular dichroic analysis have been employed to substantiate the changes in hydration of gelatin, interacting with polycaprolactone. Enthalpy of denaturation and decrease in melting temperature indicate alteration in water-bridges around gelatin. In vitro drug release studies substantiate the influence of hydration on its release kinetics. These studies would aid in exploration of potential drug carrier. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kanungo, Ivy; Chellappa, Nisha; Fathima, Nishter Nishad] Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad@clri.res.in
FU DST Fast Track project [SR/FTP/ETA-0063/2011]
FX The authors thank DST Fast Track project (SR/FTP/ETA-0063/2011) for
   funding this work.
CR AppaRao B., 2010, INT J PHARM BIOMED R, V1, P90
   Chen KY, 2011, BIOMEDICINE-TAIWAN, V1, P29, DOI 10.1016/j.biomed.2011.10.005
   Chiari C, 2006, OSTEOARTHR CARTILAGE, V14, P1056, DOI 10.1016/j.joca.2006.04.007
   Chong SH, 2012, J CHEM THEORY COMPUT, V8, P724, DOI 10.1021/ct200757a
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Huggins DJ, 2011, J CHEM THEORY COMPUT, V7, P3514, DOI 10.1021/ct200465z
   Kanungo I, 2013, MAT SCI ENG C-MATER, V33, P4651, DOI 10.1016/j.msec.2013.07.020
   Kanungo I, 2013, MATER CHEM PHYS, V140, P357, DOI 10.1016/j.matchemphys.2013.03.049
   Kanungo I, 2011, INT J BIOL MACROMOL, V49, P289, DOI 10.1016/j.ijbiomac.2011.05.003
   Lamson D W, 2000, Altern Med Rev, V5, P196
   Landry MR, 2005, THERMOCHIM ACTA, V433, P27, DOI 10.1016/j.tca.2005.02.015
   Manikoth R, 2012, CARBOHYD POLYM, V88, P628, DOI 10.1016/j.carbpol.2012.01.031
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Perez-Mateos M, 2005, J SCI FOOD AGR, V85, P1651, DOI 10.1002/jsfa.2164
   Prouzet E, 2010, J PHYS CHEM B, V114, P8081, DOI 10.1021/jp101176v
   Ramamourthy G., 2012, INT J MOL SCI, V13, P3229
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Riikonen J, 2009, J PHYS CHEM C, V113, P20349, DOI 10.1021/jp908580w
   Safinia L, 2006, LANGMUIR, V22, P3235, DOI 10.1021/la051762g
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Taguchi T, 2009, J BIOACT COMPAT POL, V24, P546, DOI 10.1177/0883911509349688
   Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t
   Woody R.W., 1996, CIRCULAR DICHROISM C
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xu W, 2008, J BIOACT COMPAT POL, V23, P409, DOI 10.1177/0883911508095517
   Yamamoto T, 2005, J COLLOID INTERF SCI, V284, P614, DOI 10.1016/j.jcis.2004.10.025
   Zaman HU, 2011, J MECH BEHAV BIOMED, V4, P1369, DOI 10.1016/j.jmbbm.2011.05.007
   ZHADAN GG, 1994, BIOCHEM J, V299, P731, DOI 10.1042/bj2990731
NR 31
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 597
EP 603
DI 10.1016/j.msec.2015.01.058
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100069
PM 25686988
DA 2018-10-20
ER

PT J
AU Mohammadkhah, A
   Marquardt, LM
   Sakiyama-Elbert, SE
   Day, DE
   Harkins, AB
AF Mohammadkhah, Ali
   Marquardt, Laura M.
   Sakiyama-Elbert, Shelly E.
   Day, Delbert E.
   Harkins, Amy B.
TI Fabrication and characterization of poly-(epsilon)-caprolactone and
   bioactive glass composites for tissue engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Borate glass; Neurite extension; Mechanical properties; Degradation
   rate; Polymer sheet
ID PERIPHERAL-NERVE REGENERATION; MECHANICAL-PROPERTIES; PHYSICOCHEMICAL
   CHARACTERIZATION; GUIDANCE CONDUITS; SILICATE 45S5; REPAIR; BORATE;
   SCAFFOLDS; GUIDES; CONVERSION
AB Much work has focused on developing synthetic materials that have tailored degradation profiles and physical properties that may prove useful in developing biomaterials for tissue engineering applications. In the present study, three different composite sheets consisting of biodegradable poly-epsilon-caprolactone (PCL) and varying types of bioactive glass were investigated. The three composites were composed of 50 wt.% PCL and (1) 50 wt.% 13-93 B3 borate glass particles, (2) 50 wt.% 45S5 silicate glass particles, or (3) a blend of 25 wt.% 13-93 B3 and 25 wt.% 45S5 glass particles. Degradation profiles determined for each composite showed the composite that contained only 13-93 B3 borate glass had a higher degradation rate compared to the composite containing only 45S5 silicate glass. Uniaxial tensile tests were performed on the composites to determine the effect of adding glass to the polymer on mechanical properties. The peak stress of all of the composites was lower than that of PCL alone, but 100% PCL had a higher stiffness when pre-reacted in cell media for 6 weeks, whereas composite sheets did not. Finally, to determine whether the composite sheets would maintain neuronal growth, dorsal root ganglia isolated from embryonic chicks were cultured on composite sheets, and neurite outgrowth was measured. The bioactive glass particles added to the composites showed no negative effects on neurite extension, and neurite extension increased on PCL:4555 PCL:13-93 B3 when pre-reacted in media for 24 h. This work shows that composite sheets of PCL and bioactive glass particles provide a flexible biomaterial for neural tissue engineering applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mohammadkhah, Ali; Day, Delbert E.] Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA.
   [Mohammadkhah, Ali; Day, Delbert E.] Missouri Univ Sci & Technol, Ctr Biomed Sci & Engn, Rolla, MO 65409 USA.
   [Marquardt, Laura M.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Harkins, Amy B.] St Louis Univ, Dept Pharmacol & Physiol Sci, Dept Biomed Engn, St Louis, MO 63104 USA.
RP Harkins, AB (reprint author), St Louis Univ, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.
EM harkinsa@slu.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NSF [DGE-1143954]; Saint Louis University Presidential Research Fund;
   Center for Biomedical Science and Engineering at the Missouri University
   of Science and Technology
FX This work was funded in part by NSF DGE-1143954 (LMM) and a Saint Louis
   University Presidential Research Fund (ABH) and a grant from the Center
   for Biomedical Science and Engineering at the Missouri University of
   Science and Technology. The authors acknowledge the assistance of Dr.
   Scott Sell for use of his MTS Machine and critical reading of this
   manuscript. We thank Mr. Jason Papke for his research assistance.
CR Abedalwafa M, 2013, REV ADV MATER SCI, V34, P123
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Bender MD, 2004, BIOMATERIALS, V25, P1269, DOI 10.1016/j.biomaterials.2003.08.046
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Diamanti E, 2012, MACROMOL SYMP, V321, P25, DOI 10.1002/masy.201251104
   Farole A, 2008, J ORAL MAXIL SURG, V66, P2058, DOI 10.1016/j.joms.2008.06.017
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gu YF, 2013, ACTA BIOMATER, V9, P9126, DOI 10.1016/j.actbio.2013.06.039
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Jeans LA, 2007, J PLAST RECONSTR AES, V60, P1302, DOI 10.1016/j.bjps.2006.06.014
   Ji LJ, 2015, MAT SCI ENG C-MATER, V46, P1, DOI 10.1016/j.msec.2014.09.041
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Lee B, 2001, MICROPOR MESOPOR MAT, V50, P77, DOI 10.1016/S1387-1811(01)00437-1
   Lei B, 2013, MAT SCI ENG C-MATER, V33, P1102, DOI 10.1016/j.msec.2012.11.039
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Lin YN, 2014, J BIOMED MATER RES A, V102, P4491, DOI 10.1002/jbm.a.35120
   Liu X, 2013, J MATER SCI-MATER M, V24, P583, DOI 10.1007/s10856-012-4831-z
   Lloyd Andrew W, 2002, Med Device Technol, V13, P18
   Marquardt LM, 2013, J BIOMED MATER RES A, V102, P2767
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Starritt NE, 2011, LARYNGOSCOPE, V121, P1614, DOI 10.1002/lary.21868
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Takadama H., 2004, PHOS RES B, V17, P119
   Tyner Tim R, 2007, Am J Surg, V193, pe1, DOI 10.1016/j.amjsurg.2006.08.026
   van Neerven S.G.A., 2014, BIOMED RES INT, V2014, P13
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   Wang SF, 2010, INT J POLYM SCI, DOI 10.1155/2010/138686
   Zhang XF, 2011, J MECH BEHAV BIOMED, V4, P1266, DOI 10.1016/j.jmbbm.2011.04.013
NR 36
TC 13
Z9 13
U1 2
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 632
EP 639
DI 10.1016/j.msec.2015.01.060
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100073
PM 25686992
DA 2018-10-20
ER

PT J
AU Gandhimathi, C
   Venugopal, JR
   Tham, AY
   Ramakrishna, S
   Kumar, SD
AF Gandhimathi, Chinnasamy
   Venugopal, Jayarama Reddy
   Tham, Allister Yingwei
   Ramakrishna, Seeram
   Kumar, Srinivasan Dinesh
TI Biomimetic hybrid nanofibrous substrates for mesenchymal stem cells
   differentiation into osteogenic cells
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE PLACL; Silk fibroin; Nanofibrous scaffolds; Nanohydroxyapatite;
   Mineralization
ID SILK FIBROIN SCAFFOLDS; GENE-EXPRESSION; IN-VITRO; COMPOSITE SCAFFOLDS;
   ENDOTHELIAL-CELLS; ASCORBIC-ACID; LIVING CELLS; BONE; GROWTH; COLLAGEN
AB Mimicking native extracellular matrix with electrospun porous bio-composite nanofibrous scaffolds has huge potential in bone tissue regeneration. The aim of this study is to fabricate porous poly(L-lactic acid)-co-poly-(epsilon-caprolactone)/silk fibroin/ascorbic acid/tetracycline hydrochloride (PLACL/SF/AA/TC) and nanohydroxyapatite (n-HA) was deposited by calcium-phosphate dipping method for bone tissue engineering (BTE). Fabricated nanofibrous scaffolds were characterized for fiber morphology, hydrophilicity, porosity, mechanical test and chemical properties by FT-IR and EDX analysis. The results showed that the fiber diameter and pore size of scaffolds observed around 228 +/- 62-320 +/- 22 nm and 1.5-6.9 mu m respectively. Resulting nanofibrous scaffolds are highly porous (87-94%) with ultimate tensile strength observed in the range of 1.51-4.86 MPa and also showed better hydrophilic properties after addition of AA, TC and n-HA. Human mesenchymal stem cells (MSCs) cultured on these bio-composite nanofibrous scaffolds and stimulated to osteogenic differentiation in the presence of AA/TC/n-HA for BTE. The cell proliferation and biomaterial interactions were studied using MTS assay, SEM and CMFDA dye exclusion methods. Osteogenic differentiation of MSCs was proven by using alkaline phosphatase activity, mineralization and double immunofluorescence staining of both CD90 and osteocalcin. The observed results suggested that the fabricated PLACL/SF/AA/TC/n-HA biocomposite hybrid nanofibrous scaffolds have good potential for the differentiation of MSCs into osteogenesis for bone tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Gandhimathi, Chinnasamy; Tham, Allister Yingwei; Kumar, Srinivasan Dinesh] Nanyang Technol Univ, Lee Kong Chian Sch Med, Cellular & Mol Epigenet Lab, Singapore, Singapore.
   [Venugopal, Jayarama Reddy; Ramakrishna, Seeram] Natl Univ Singapore, Ctr Nanofibers & Nanotechnol, Nanosc & Nanotechnol Initiat, Singapore 117548, Singapore.
RP Kumar, SD (reprint author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Cellular & Mol Epigenet Lab, Singapore, Singapore.
EM dineshkumar@ntu.edu.sg
RI Srinivasan, Dinesh Kumar/A-9872-2008
OI Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU Ministry of Education [L0412020]; Lee Kong Chian School of Medicine;
   Nanyang Technological University, Singapore
FX This work was supported by Ministry of Education Start-up Grant
   (L0412020; Srinivasan Dinesh Kumar), Lee Kong Chian School of Medicine,
   and Nanyang Technological University, Singapore.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581
   Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043
   Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Martinez EC, 2007, J MATER SCI-MATER M, V18, P1627, DOI 10.1007/s10856-007-3038-1
   Gandhimathi C, 2013, MACROMOL BIOSCI, V13, P696, DOI 10.1002/mabi.201200435
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Han B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081781
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Lemmouchi Y, 1997, J CONTROL RELEASE, V45, P227, DOI 10.1016/S0168-3659(96)01569-6
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Minoura N., 2005, J BIOMED MATER RES, V29, P1215
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Ramesh B.N., 2005, J MATER SCI, V40, P6319
   Ravandi SAH, 2013, CURR NANOSCI, V9, P423
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116
   Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009
   Schwach A.K., 2001, BIOMATERIALS, V22, P1659
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   ZHANG YZ, 1992, FASEB J, V6, pA1835
   ZHANG YZ, 1991, FASEB J, V5, P3108
NR 50
TC 9
Z9 10
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 776
EP 785
DI 10.1016/j.msec.2015.01.075
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100089
PM 25687008
DA 2018-10-20
ER

PT J
AU Sahiner, N
   Sagbas, S
   Aktas, N
AF Sahiner, Nurettin
   Sagbas, Selin
   Aktas, Nahit
TI Single step natural poly(tannic acid) particle preparation as
   multitalented biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tannic acid; Particles; Microgel; Nanogel antioxidant; Antimicrobial;
   Drug delivery
ID TANNIC-ACID; DRUG-DELIVERY; NANOPARTICLE PREPARATION; ANTIOXIDANT
   ACTIVITY; LIPID OXIDATION; CROSS-LINKING; MICROGELS; HYDROGEL; CHITOSAN;
   RELEASE
AB In this study, we report the preparation of poly(tannic acid) (p(TA)) particles by crosslinking with glycerol diglycidyl ether (GDE) and trimethylolpropane triglycidyl ether (TMPGDE). The p(TA) particles are negatively charged as obtained by the zeta potential measurements, -27 my.P(TA) particles are found to be an effective antioxidant material as 170 mg L-1 of p(TA) particle demonstrated the antioxidant equivalency of 82.5 +/- 7.2 mg L-1 of gallic acid (GA), used as standard in Folin-Ciocalteau (FC) method. Additionally, TA and p(TA) particles have a strong antimicrobial effect against Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 6538, and Bacillus subtilis ATCC 6633. Furthermore, p(TA) particles were used as drug delivery materials by using model drugs such as TA itself, and GA in the release studies in PBS at pH 7.4 at 37.5 degrees C, and found that p(TA) particles can release 80.8 and 87.4% of the loaded TA and GA, respectively. Interestingly, p(TA) maintained its fluorescent property upon crosslinking of TA units. It is further demonstrated that p(TA) particles are as effective as cisplatin (a cancer drug) against A549 cancerous cells that both showed about 36 and 34% cell viability, respectively whereas linear TA showed 66% cell viability at 37.5 mu g mL(-1) concentration. Above this concentration p(TA) and cisplatin showed almost the same toxicity against A549 cancerous cells. Additionally, p(TA) particles are found to be much more biocompatible against L929 Fibroblast cells, about 84% cell viability in comparison to linear TA with about 53% at 75 mu g mL(-1) concentration. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Sahiner, Nurettin; Sagbas, Selin] Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, TR-17100 Canakkale, Turkey.
   [Sahiner, Nurettin] Canakkale Onsekiz Mart Univ, Nanosci & Technol Res & Applicat Ctr NANORAC, TR-17100 Canakkale, Turkey.
   [Aktas, Nahit] Yuzuncu Yil Univ, Dept Chem Engn, TR-65080 Van, Turkey.
RP Sahiner, N (reprint author), Canakkale Onsekiz Mart Univ, Dept Chem, Fac Sci & Arts, Terzioglu Campus, TR-17100 Canakkale, Turkey.
EM sahiner71@gmail.com
OI Sahiner, Nurettin/0000-0003-0120-530X; Sagbas Suner,
   Selin/0000-0002-3524-0675
FU Scientific and Technological Research Council of Turkey [113Z238]
FX This work is supported by the Scientific and Technological Research
   Council of Turkey (113Z238). The authors are grateful to Mustafa Turk
   from Kirikkale University, for the cell studies.
CR Abbas SR, 2014, FOOD CHEM, V147, P10, DOI 10.1016/j.foodchem.2013.09.113
   Aelenei N, 2009, J MATER SCI-MATER M, V20, P1095, DOI 10.1007/s10856-008-3675-z
   Balange AK, 2010, FOOD CHEM, V120, P268, DOI 10.1016/j.foodchem.2009.10.019
   Bouki E, 2013, MAR ENVIRON RES, V85, P13, DOI 10.1016/j.marenvres.2012.12.005
   Bozic M, 2012, CARBOHYD POLYM, V89, P854, DOI 10.1016/j.carbpol.2012.04.021
   Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005
   Chaudhuri S, 2011, BIOPHYS CHEM, V154, P26, DOI 10.1016/j.bpc.2010.12.003
   Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001
   Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273
   Corominas BGT, 2002, TALANTA, V58, P1243, DOI 10.1016/S0039-9140(02)00410-1
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Gali H.U., 1991, IN VIVO CANC RES, V52, P2820
   Gautrot JE, 2006, J BIOMAT SCI-POLYM E, V17, P1123, DOI 10.1163/156856206778530713
   Grassino SB, 1999, PROG ORG COAT, V37, P39, DOI 10.1016/S0300-9440(99)00050-8
   Gulcin I, 2010, ARAB J CHEM, V3, P43, DOI 10.1016/j.arabjc.2009.12.008
   Heijmen FH, 1997, BIOMATERIALS, V18, P749, DOI 10.1016/S0142-9612(96)00202-5
   Hu ZB, 1998, NATURE, V393, P149, DOI 10.1038/30205
   Jagadeesan D, 2011, MACROMOL BIOSCI, V11, P889, DOI 10.1002/mabi.201100045
   Ji HF, 2006, BIOORG MED CHEM LETT, V16, P4095, DOI 10.1016/j.bmcl.2006.04.096
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Kawaguchi H, 1998, BIOSEPARATION, V7, P253, DOI 10.1023/A:1008055211667
   Kim TJ, 2010, FOOD CHEM, V118, P740, DOI 10.1016/j.foodchem.2009.05.060
   Klinger D, 2012, POLYMER, V53, P5209, DOI 10.1016/j.polymer.2012.08.053
   Kurisawa M, 2003, MACROMOL BIOSCI, V3, P758, DOI 10.1002/mabi.200300038
   Labieniec M, 2003, MUTAT RES-GEN TOX EN, V539, P127, DOI 10.1016/S1383-5718(03)00161-X
   Lin JW, 2011, J HAZARD MATER, V193, P102, DOI 10.1016/j.jhazmat.2011.07.035
   Luo CH, 2014, MAT SCI ENG C-MATER, V36, P301, DOI 10.1016/j.msec.2013.12.021
   Maqsood S, 2012, FOOD CHEM, V130, P408, DOI 10.1016/j.foodchem.2011.07.065
   Naus PJ, 2007, J HEPATOL, V46, P222, DOI 10.1016/j.jhep.2006.08.012
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Olalde B, 2013, MAT SCI ENG C-MATER, V33, P3760, DOI 10.1016/j.msec.2013.05.002
   Orlowski P, 2013, TOXICOL IN VITRO, V27, P1798, DOI 10.1016/j.tiv.2013.05.010
   Rivero S, 2010, CARBOHYD POLYM, V82, P270, DOI 10.1016/j.carbpol.2010.04.048
   Sagbas S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1809-5
   Sagbas S, 2012, INT J HYDROGEN ENERG, V37, P18944, DOI 10.1016/j.ijhydene.2012.10.006
   Sagbas S, 2012, CARBOHYD POLYM, V87, P2718, DOI 10.1016/j.carbpol.2011.11.064
   Sahiner N, 2008, TURK J CHEM, V32, P397
   Sahiner N, 2014, COLLOID SURFACE A, V452, P173, DOI 10.1016/j.colsurfa.2014.03.097
   Sahiner N, 2014, J POWER SOURCES, V246, P55, DOI 10.1016/j.jpowsour.2013.07.043
   Sahiner N, 2013, PROG POLYM SCI, V38, P1329, DOI 10.1016/j.progpolymsci.2013.06.004
   Sahiner N, 2012, MICROPOR MESOPOR MAT, V155, P124, DOI 10.1016/j.micromeso.2012.01.027
   Sanchez-Moreno C, 1999, FOOD RES INT, V32, P407, DOI 10.1016/S0963-9969(99)00097-6
   Sanchez-Moreno C, 1998, J SCI FOOD AGR, V76, P270, DOI 10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.3.CO;2-0
   Scarbert A., 1991, PHYTOCHEMISTRY, V30, P3875
   Tan BH, 2010, POLYMER, V51, P3238, DOI 10.1016/j.polymer.2010.04.059
   Tanimura S, 2005, BIOCHEM BIOPH RES CO, V330, P1306, DOI 10.1016/j.bbrc.2005.03.116
   Uyama H, 2007, MACROMOL BIOSCI, V7, P410, DOI 10.1002/mabi.200700005
   Wang JN, 2009, J HAZARD MATER, V169, P794, DOI 10.1016/j.jhazmat.2009.04.013
   Winiarska-Mieczan A, 2013, ENVIRON TOXICOL PHAR, V36, P9, DOI 10.1016/j.etap.2013.02.018
   Xiao CM, 2003, POLYM DEGRAD STABIL, V81, P297, DOI 10.1016/S0141-3910(03)00100-9
   Xie CG, 2003, WATER RES, V37, P233, DOI 10.1016/S0043-1354(02)00247-6
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
   Zhang Y, 2013, J MEMBRANE SCI, V429, P235, DOI 10.1016/j.memsci.2012.11.059
NR 54
TC 32
Z9 32
U1 7
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2015
VL 49
BP 824
EP 834
DI 10.1016/j.msec.2015.01.076
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA CC6YE
UT WOS:000350514100095
PM 25687014
DA 2018-10-20
ER

PT J
AU Staehlke, S
   Koertge, A
   Nebe, B
AF Staehlke, Susanne
   Koertge, Andreas
   Nebe, Barbara
TI Intracellular calcium dynamics dependent on defined microtopographical
   features of titanium
SO BIOMATERIALS
LA English
DT Article
DE Actin; Calcium; Cell signaling; Image analysis; Microstructure;
   Osteoblast
ID CELL-MATRIX ADHESION; ACTIN CYTOSKELETON; 1,25-DIHYDROXYVITAMIN D-3;
   OSTEOBLAST ADHESION; SIGNAL-TRANSDUCTION; FOCAL ADHESION; CA2+ CHANNELS;
   BONE; MECHANOTRANSDUCTION; TRAFFICKING
AB Detailed insights into the complex cellular behavior at the biomaterial interface are crucial for the improvement of implant surfaces with respect to their acceptance and integration. The cells perceive microtopographical features and, in consequence, rearrange their adhesion structures like the actin cytoskeleton and adaptor proteins. But little is known about whether these altered cellular phenotypes have consequences for intracellular calcium signaling and its dynamics. To elucidate if an artificial, geometrical microtopography influences calcium ion (Ca2+) mobilization in osteoblasts, human MG-63 cells were stained with the calcium dye Fluo 3-acetoxymethyl ester and set on defined silicon titanium (Ti) arrays with regular pillar structures (P5, 5 x 5 x 5 mu m) and compared with planar Ti. To induce an immediate calcium signal, cells were stimulated with adenosine 5'-triphosphate (ATP). Interestingly, osteoblasts on micropillars expressing a shortened actin cytoskeleton were hampered in their calcium mobilization potential in signal height as well duration. Even the basal level of the intracellular Ca2+ concentration was reduced, which was accompanied by a disturbed fibronectin synthesis. The expression of the voltage-sensitive calcium channels Ca(v)1.2, Ca(v)13 (L-type) and Ca(v)3.1, Ca(v)3.2, Ca(v)3.3 (T-type) as well as the signaling proteins phospho-AKT and phospho-GSK3 alpha/beta remained unaffected on pillars. The topography-dependent calcium dynamics observed here provide new insights into how topographical cues alter cell functions - via the intracellular Ca2+ signaling. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Staehlke, Susanne; Nebe, Barbara] Univ Med Ctr Rostock, Dept Cell Biol, D-18057 Rostock, Germany.
   [Koertge, Andreas] Univ Rostock, Inst Elect Appliances & Circuits, Interface Res Grp, D-18059 Rostock, Germany.
RP Nebe, B (reprint author), Univ Med Ctr Rostock, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
FU DFG Graduate School welisa [1505/1]; University Medical Center Rostock
   (FORUN) [889061]
FX We are grateful for the financial support of the DFG Graduate School
   welisa (No. 1505/1) and of the University Medical Center Rostock (FORUN
   889061) for SS and AK. We thank Dipl.-Ing. Norbert Zichner (Center for
   Microtechnologies ZFM, Chemnitz University of Technology) for the
   production of the titanium coated materials.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bergh JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC822, DOI 10.1152/ajpcell.00403.2005
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bershadsky AD, 2011, P NATL ACAD SCI USA, V108, P20275, DOI 10.1073/pnas.1116814108
   Bilbao PS, 2007, ARCH BIOCHEM BIOPHYS, V466, P15, DOI 10.1016/j.abb.2007.07.012
   Bootman MD, 2002, CURR BIOL, V12, P563
   Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
   Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Furukawa R, 2003, J CELL SCI, V116, P187, DOI 10.1242/jcs.00220
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Jorgensen NR, 2002, J BIOL CHEM, V277, P7574, DOI 10.1074/jbc.M104608200
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   Li FP, 2011, J BONE MINER METAB, V29, P515, DOI 10.1007/s00774-010-0252-6
   Li QS, 2014, BIOMATERIALS, V35, P961, DOI 10.1016/j.biomaterials.2013.10.037
   Li W, 2001, BONE, V29, P231, DOI 10.1016/S8756-3282(01)00572-5
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898
   McGarth JL., 2007, CURR BIOL, V17, pR357
   Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071283
   NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181
   Nebe J. Barbara, 2014, Materials Science Forum, V783-786, P1320, DOI 10.4028/www.scientific.net/MSF.783-786.1320
   Nebe J. G. B., 2008, METALLIC BIOMATERIAL, P215
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603
   Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795
   Ravenscroft-Chang MS, 2010, BIOMATERIALS, V31, P602, DOI 10.1016/j.biomaterials.2009.09.084
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517
   Shao Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1067, DOI 10.1152/ajpcell.00427.2008
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y
   Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x
   Staehlke Susanne, 2013, Advanced Materials Research, V647, P476, DOI 10.4028/www.scientific.net/AMR.647.476
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013
   Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088
   Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076
   Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zink C, 2012, BIOMATERIALS, V33, P8055, DOI 10.1016/j.biomaterials.2012.07.037
NR 53
TC 9
Z9 9
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 46
BP 48
EP 57
DI 10.1016/j.biomaterials.2014.12.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7CF
UT WOS:000350524600005
PM 25678115
DA 2018-10-20
ER

PT J
AU Zuidema, JM
   Desmond, GP
   Rivet, CJ
   Kearns, KR
   Thompson, DM
   Gilbert, RJ
AF Zuidema, Jonathan M.
   Desmond, Gregory P.
   Rivet, Christopher J.
   Kearns, Kathryn R.
   Thompson, Deanna M.
   Gilbert, Ryan J.
TI Nebulized solvent ablation of aligned PLLA fibers for the study of
   neurite response to anisotropic-to-isotropic fiber/film transition
   (AFFT) boundaries in astrocyte-neuron co-cultures
SO BIOMATERIALS
LA English
DT Article
DE Poly-L-lactic acid; Electrospun fibers; Astrocytes; Fibronectin;
   Chondroitin sulfate proteoglycan; Dorsal root ganglion
ID SPINAL-CORD-INJURY; IN-VITRO MODEL; GLIAL SCAR; NERVE REGENERATION;
   MECHANICAL-PROPERTIES; CELL-DIFFERENTIATION; ASTROGLIAL CELLS;
   ELECTROSPUN; GROWTH; SCAFFOLDS
AB Developing robust in vitro models of in vivo environments has the potential to reduce costs and bring new therapies from the bench top to the clinic more efficiently. This study aimed to develop a biomaterial platform capable of modeling isotropic-to-anisotropic cellular transitions observed in vivo, specifically focusing on changes in cellular organization following spinal cord injury. In order to accomplish this goal, nebulized solvent patterning of aligned, electrospun poly-L-lactic acid (PLLA) fiber substrates was developed. This method produced a clear topographic transitional boundary between aligned PLLA fibers and an isotropic PLLA film region. Astrocytes were then seeded on these scaffolds, and a shift between oriented and non-oriented astrocytes was created at the anisotropic-to-isotropic fiber/film transition (AFFT) boundary. Orientation of chondroitin sulfate proteoglycans (CSPGs) and fibronectin produced by these astrocytes was analyzed, and it was found that astrocytes growing on the aligned fibers produced aligned arrays of CSPGs and fibronectin, while astrocytes growing on the isotropic film region produced randomly-oriented CSPG and fibronectin arrays. Neurite extension from rat dissociated dorsal root ganglia (DRG) was studied on astrocytes cultured on anisotropic, aligned fibers, isotropic films, or from fibers to films. It was found that neurite extension was oriented and longer on PLLA fibers compared to PLLA films. When dissociated DRG were cultured on the astrocytes near the AFFT boundary, neurites showed directed orientation that was lost upon growth into the isotropic film region. The AFFT boundary also restricted neurite extension, limiting the extension of neurites once they grew from the fibers and into the isotropic film region. This study reveals the importance of anisotropic-to-isotropic transitions restricting neurite outgrowth by itself. Furthermore, we present this scaffold as an alternative culture system to analyze neurite response to cellular boundaries created following spinal cord injury and suggest its usefulness to study cellular responses to any aligned-to-unorganized cellular boundaries seen in vivo. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zuidema, Jonathan M.; Desmond, Gregory P.; Rivet, Christopher J.; Kearns, Kathryn R.; Thompson, Deanna M.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Zuidema, Jonathan M.; Desmond, Gregory P.; Rivet, Christopher J.; Kearns, Kathryn R.; Thompson, Deanna M.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Rivet, Christopher J.] Univ Los Andes, Ctr Invest Biomed, Santiago 762001, Chile.
RP Gilbert, RJ (reprint author), Rensselaer Polytech Inst, Biomed Engn, 110 8th St, Troy, NY 12180 USA.
EM gilber2@rpi.edu
OI Kearns, Kathryn/0000-0001-9939-4836; Zuidema,
   Jonathan/0000-0003-2258-0045
FU NSF CAREER Award [1105125]; NSF I-Corps Grant [IIP-1358895]; NIH [RO1
   1RO1EB013281]
FX We acknowledge the following grant support: NSF CAREER Award 1105125 and
   NSF I-Corps Grant IIP-1358895 to RJG, and NIH RO1 1RO1EB013281 to DMT.
   We would like to thank Dr. Linxia Zhang and Christopher Bertucci for
   their help isolating neurons, and Dr. Sergey Pryshchep for his help with
   atomic force microscopy.
CR Achyuta AKH, 2010, MACROMOL BIOSCI, V10, P872, DOI 10.1002/mabi.200900451
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Chao Z, 2011, ADV MATER, V23, P4776
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chow WN, 2007, NEURON GLIA BIOL, V3, P119, DOI 10.1017/S1740925X07000580
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   de Windt TS, 2015, OSTEOARTHR CARTILAGE, V23, P143, DOI 10.1016/j.joca.2014.09.016
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hynds DL, 2001, J NEUROSCI RES, V66, P630, DOI 10.1002/jnr.10020
   Kidoaki S, 2006, J BIOMED MATER RES B, V76B, P219, DOI 10.1002/jbm.b.30336
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Koppes AN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046023
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lau CL, 2014, J NEUROCHEM, V130, P215, DOI 10.1111/jnc.12702
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Mattotti M, 2012, BIOMATERIALS, V33, P1759, DOI 10.1016/j.biomaterials.2011.10.086
   Meng FW, 2012, BIOMATERIALS, V33, P1323, DOI 10.1016/j.biomaterials.2011.10.034
   Mongin AA, 2011, AM J PHYSIOL-CELL PH, V301, pC814, DOI 10.1152/ajpcell.00035.2011
   Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114
   Nahmias Y, 2005, TISSUE ENG, V11, P701, DOI 10.1089/ten.2005.11.701
   Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6
   Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   Sandstrom A, 2014, ADV MATER, V26, P4975, DOI 10.1002/adma.201401286
   Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004
   Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Tutak W, 2013, BIOMATERIALS, V34, P2389, DOI 10.1016/j.biomaterials.2012.12.020
   Vahidi B, 2008, J NEUROSCI METH, V170, P188, DOI 10.1016/j.jneumeth.2008.01.019
   Veazey WS, 2005, J BIOMED MATER RES B, V72B, P334, DOI 10.1002/jbm.b.30159
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022
   Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012
   Xie JW, 2014, ACS NANO, V8, P1878, DOI 10.1021/nn406363j
   Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21
   Zuidema J, 2015, EXTRACELLULAR MATRIX, P181
   Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079
NR 56
TC 9
Z9 9
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2015
VL 46
BP 82
EP 94
DI 10.1016/j.biomaterials.2014.12.046
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7CF
UT WOS:000350524600008
PM 25678118
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ding, M
   Andreasen, CM
   Dencker, ML
   Jensen, AE
   Theilgaard, N
   Overgaard, S
AF Ding, Ming
   Andreasen, Christina M.
   Dencker, Mads L.
   Jensen, Anders E.
   Theilgaard, Naseem
   Overgaard, Soren
TI Efficacy of a small cell-binding peptide coated hydroxyapatite
   substitute on bone formation and implant fixation in sheep
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ABM; P-15; implant fixation; bone formation; microarchitecture;
   histomorphometry
ID HUMAN INFRABONY DEFECTS; CANCELLOUS BONE; P-15 PEPTIDE; COLLAGEN;
   MATRIX; GRAFT; ATTACHMENT; SURFACE; DESIGN; FUSION
AB Cylindrical critical size defects were created at the distal femoral condyles bilaterally of eight female adult sheep. Titanium implants with 2-mm concentric gaps were inserted and the gaps were filled with one of the four materials: allograft; a synthetic 15-amino acid cell-binding peptide coated hydroxyapatite (ABM/P-15); hydroxyapatite+tricalciumphosphate+ Poly-Lactic-Acid (HA/TCP-PDLLA); or ABM/P-15+HA/TCP-PDLLA. After nine weeks, bone-implant blocks were harvested and sectioned for micro-CT scanning, push-out test, and histomorphometry. Significant bone formation and implant fixation could be observed in all four groups. Interestingly, the microarchitecture of the ABM/P-15 group was significantly different from the control group. Tissue volume fraction and thickness were significantly greater in the ABM/P-15 group than in the allograft group. Bone formation and bone ingrowth to porous titanium implant were not significantly different among the four groups. The ABM/P-15 group had similar shear mechanical properties on implant fixation as the allograft group. Adding HA/TCP-PDLLA to ABM/P-15 did not significantly change these parameters. This study revealed that ABM/P-15 had significantly bone formation in concentric gap, and its enhancements on bone formation and implant fixation were at least as good as allograft. It is suggested that ABM/P-15 might be a good alternative biomaterial for bone implant fixation in this well-validated critical-size defect gap model in sheep. Nevertheless, future clinical researches should focus on prospective, randomized, controlled trials in order to fully elucidate whether ABM/P-15 could be a feasible candidate for bone substitute material in orthopedic practices. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1357-1365, 2015.
C1 [Ding, Ming; Andreasen, Christina M.; Dencker, Mads L.; Jensen, Anders E.; Overgaard, Soren] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Orthopaed Res Lab,Dept Orthopaed Surg & Traumatol, DK-5000 Odense C, Denmark.
   [Theilgaard, Naseem] Danish Technol Inst, DK-2630 Taastrup, Denmark.
RP Ding, M (reprint author), Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Orthopaed Res Lab,Dept Orthopaed Surg & Traumatol, DK-5000 Odense C, Denmark.
EM ming.ding@rsyd.dk
OI Jensen, Anders Elkaer/0000-0002-9056-9326; Ding,
   Ming/0000-0002-6610-8079; Overgaard, Soren/0000-0001-6829-4787
FU Ortotech, Denmark; Region of Southern Denmark Research Grant; University
   of Southern Denmark
FX Contract grant sponsors: Ortotech, Denmark, Region of Southern Denmark
   Research Grant, and University of Southern Denmark scholarships
CR Babiker H, 2012, J BIOMED MATER RES B, V100B, P759, DOI 10.1002/jbm.b.32509
   BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2012, J BIOMED MATER RES B, V100B, P1826, DOI 10.1002/jbm.b.32750
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gomar F, 2007, INT ORTHOP, V31, P93, DOI 10.1007/s00264-006-0087-x
   GUNDERSEN HJG, 1993, BONE, V14, P217, DOI 10.1016/8756-3282(93)90144-Y
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kasaj A, 2008, CLIN ORAL INVEST, V12, P241, DOI 10.1007/s00784-008-0191-y
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Overgaard S, 2000, J ORTHOP RES, V18, P313, DOI 10.1002/jor.1100180221
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Scarano Antonio, 2003, Implant Dent, V12, P318, DOI 10.1097/01.ID.0000095467.48241.68
   Sherman BP, 2010, EUR SPINE J, V19, P2156, DOI 10.1007/s00586-010-1546-z
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
NR 24
TC 9
Z9 9
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1357
EP 1365
DI 10.1002/jbm.a.35281
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300008
PM 25045068
DA 2018-10-20
ER

PT J
AU Alexandre, N
   Costa, E
   Coimbra, S
   Silva, A
   Lopes, A
   Rodrigues, M
   Santos, M
   Mauricio, AC
   Santos, JD
   Luis, AL
AF Alexandre, Nuno
   Costa, Elisio
   Coimbra, Susana
   Silva, Alice
   Lopes, Ascensao
   Rodrigues, Miguel
   Santos, Marta
   Mauricio, Ana Colette
   Santos, Jose Domingos
   Luis, Ana Lucia
TI In vitro and in vivo evaluation of blood coagulation activation of
   polyvinyl alcohol hydrogel plus dextran-based vascular grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyvinyl alcohol hydrogel; dextran; coagulation; homeostasis; vascular
   graft
ID PLATELET-ADHESION; D-DIMER; FEMOROPOPLITEAL BYPASS; CARDIOPULMONARY
   BYPASS; THROMBIN GENERATION; PLASMA COAGULATION; MOLECULAR-WEIGHT;
   WHOLE-BLOOD; FACTOR-XII; SURFACE
AB Polyvinyl alcohol hydrogel (PVA) is a water-soluble synthetic polymer that is commonly used in biomedical applications including vascular grafting. It was argued that the copolymerization of PVA with dextran (Dx) can result in improvement of blood-biomaterial interactions. The focus of this experimental study was to assess that interaction through an in vivo and in vitro evaluation of the coagulation system activation. The thrombogenicity of the copolymer was determined by quantification of platelet adhesion through the lactate dehydrogenase assay, determination of whole blood clotting time, and by quantification of platelet activation by flow cytometry. The thrombin-antithrombin complex blood levels were also determined. The obtained results for the in vitro assays suggested a non-thrombogenic profile for PVA/Dx. Additionally in vivo coagulation and hematological parameters were determined in an animal model after PVA/Dx vascular graft implantation. For coagulation homeostasis assessment, the intrinsic and extrinsic pathway's activation was determined by measuring prothrombin time (PT) and activated partial thromboplastin time (aPTT). Other markers of coagulation and inflammation activation including d-dimers, interleukin-6, and C-reactive protein were also assessed. The PVA/Dx copolymer tended to inhibit platelet adhesion/activation process and the contact activation process for coagulation. These results were also confirmed with the in vivo experiments where the measurements for APTT, interleukin-6, and C-reactive protein parameters were normal considering the species normal range of values. The response to those events is an indicator of the in vitro and in vivo hemocompatibility of PVA/Dx and it allows us to select this biomaterial for further preclinical trials in vascular reconstruction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1366-1379, 2015.
C1 [Alexandre, Nuno] Univ Evora, Dept Zootecnia, Polo Mitra, P-7002554 Evora, Portugal.
   [Alexandre, Nuno] ICAAM, Polo Mitra, P-7002554 Evora, Portugal.
   [Costa, Elisio; Silva, Alice] Univ Porto, Dept Ciencias Biol, Lab Bioquim, Fac Farm, P-4050313 Oporto, Portugal.
   [Costa, Elisio; Coimbra, Susana; Silva, Alice] Univ Porto, IBMC, P-4150 Oporto, Portugal.
   [Coimbra, Susana] Cooperat Ensino Super Politecn & Univ CESPU Cent, P-4585116 Gandra, Portugal.
   [Lopes, Ascensao; Rodrigues, Miguel; Santos, Jose Domingos] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn, P-4200465 Oporto, Portugal.
   [Santos, Marta] Tecmaia, Biosckin Mol & Cell Therapies SA, P-4470605 Maia, Portugal.
   [Mauricio, Ana Colette; Luis, Ana Lucia] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4051401 Oporto, Portugal.
   [Mauricio, Ana Colette; Luis, Ana Lucia] Univ Porto, ICBAS, Dept Clin Vet, P-4050313 Oporto, Portugal.
RP Alexandre, N (reprint author), Univ Evora, Dept Zootecnia, Polo Mitra, Apartado 94, P-7002554 Evora, Portugal.
EM nmla@uevora.pt
RI Costa, Elisio/K-1990-2013
OI Costa, Elisio/0000-0003-1158-1480; Mauricio, Ana
   Colette/0000-0002-0018-9363; Alexandre, Nuno/0000-0002-3291-9332; Lopes,
   Maria A./0000-0003-4105-8148; Santos-Silva, Alice/0000-0002-2565-3169;
   Coimbra, Susana/0000-0001-8411-8038; Santos, Jose
   Domingos/0000-0002-6871-9850; Rodrigues, Miguel/0000-0001-8391-5860
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies [QREN 2008/1372]; European Community FEDER fund
   through ON2 - O Novo Norte - North Portugal Regional Operational
   Program; Fundacao para a Ciencia e Tecnologia (FCT), Ministerio da
   Educacao e da Ciencia [FCT - ENMED/0002/2010]; program COMPETE -
   Programa Operacional Factores de Competitividade [OE/AGR/UI0211/2011];
   Nuno Alexandre has a Doctoral Grant from Fundacao para a Ciencia e
   Tecnologia (FCT), Ministerio da Educacao e da Ciencia, Portugal
   [SFRH/BD/64838/2009]
FX Contract grant sponsors: QREN I&DT Cluster in Development of Products
   for Regenerative Medicine and Cell Therapies - Projects Biomat & Cell
   QREN 2008/1372, co-financed by the European Community FEDER fund through
   ON2 - O Novo Norte - North Portugal Regional Operational Program
   2007-2013; Contract grant sponsor: FCT - ENMED/0002/2010 from Fundacao
   para a Ciencia e Tecnologia (FCT), Ministerio da Educacao e da Ciencia
   and EuroNanoMed JTC 2010 Program, and by the program COMPETE - Programa
   Operacional Factores de Competitividade, Project Pest; contract grant
   number: OE/AGR/UI0211/2011; Contract grant sponsor: Nuno Alexandre has a
   Doctoral Grant from Fundacao para a Ciencia e Tecnologia (FCT),
   Ministerio da Educacao e da Ciencia, Portugal; contract grant number:
   SFRH/BD/64838/2009
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007
   Abir Farshad, 2004, Vasc Endovascular Surg, V38, P483, DOI 10.1177/153857440403800601
   Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845
   AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Besednova NN, 2012, BIOL B REV, V2, P525
   Bhat T, 2012, EXPERT REV CARDIOVAS, V11, P55
   BOISCLAIR MD, 1990, BRIT J HAEMATOL, V74, P471, DOI 10.1111/j.1365-2141.1990.tb06337.x
   BOISCLAIR MD, 1993, BLOOD, V82, P3350
   BURMAN JF, 1994, LANCET, V344, P1192, DOI 10.1016/S0140-6736(94)90509-6
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chiaradia E, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-66
   Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009
   Chiumiento A, 2006, BIOMACROMOLECULES, V8, P523
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P399, DOI 10.1002/jbm.820230403
   Connell JM, 2007, ASAIO J, V53, P229, DOI 10.1097/MAT.0b013e31802e192b
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161
   Dindo D, 2009, BLOOD COAGUL FIBRIN, V20, P347, DOI 10.1097/MBC.0b013e32832a5fe6
   Du Clos TW, 2013, ISRN INFLAMM, V2013, P379
   Fink H, 2011, J BIOMED MATER RES A, V97A, P52, DOI 10.1002/jbm.a.33031
   Gentry PA, 2004, VET J, V168, P238, DOI [10.1016/j.tvjl.2003.09.013, 10.1016/j.tvjl.203.09.013]
   Gentry P, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P287, DOI 10.1016/B978-0-12-370491-7.00010-6
   GEORGE JN, 1972, BLOOD-J HEMATOL, V40, P862
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Hanson S. R, 2013, BIOMATERIALS SCI, P551
   Harvey JW, 2011, VET HEMATOLOGY DIAGN
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hassan R, 2010, UPSALA J MED SCI, V115, P245
   Heijnen HFG, 1999, BLOOD, V94, P3791
   Hoke M, 2010, J VASC SURG, V52, P383, DOI 10.1016/j.jvs.2010.02.275
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Iba T, 2007, J TRAUMA, V63, P1093, DOI 10.1097/01.ta.0000251420.41427.d3
   Irvine L, 1991, ASAIO Trans, V37, P569
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kawamoto N, 1998, J ARTIF ORGANS, V1, P4
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   LIU LS, 1991, BIOMATERIALS, V12, P390, DOI 10.1016/0142-9612(91)90007-W
   Maruoka S, 2006, CURR EYE RES, V31, P599, DOI 10.1080/02713680600813854
   Meinhart J, 1997, ASAIO J, V43, P515
   Minnema MC, 1999, SEMIN THROMB HEMOST, V25, P419, DOI 10.1055/s-2007-994944
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Pelagalli A, 2003, J COMP PATHOL, V128, P127, DOI 10.1016/S0021-9975(02)00121-4
   Polizopoulou ZS, 2010, SMALL RUMINANT RES, V92, P88, DOI 10.1016/j.smallrumres.2010.04.015
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   Robinson BI, 2003, ANZ J SURG, V73, P95, DOI 10.1046/j.1445-2197.2003.02653.x
   SHOENFELD NA, 1987, J VASC SURG, V5, P76, DOI 10.1067/mva.1987.avs0050076
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Spadaccio C, 2013, INT J CARDIOL, V168, P5028, DOI 10.1016/j.ijcard.2013.07.165
   STOTT RAW, 1995, CLIN CHEM, V41, P306
   STRATTON JR, 1982, CIRCULATION, V66, P1287, DOI 10.1161/01.CIR.66.6.1287
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tennant BC, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P379, DOI 10.1016/B978-0-12-370491-7.00013-1
   Titushkin IA, 2001, ASAIO J, V47, P11, DOI 10.1097/00002480-200101000-00005
   Tze-Man K, 1993, BIOMATERIALS, V14, P657
   vansderKamp K W HJ, 1994, J BIOMED MATER RES, V28, P349
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Weiss DJ, 2011, SCHALMS VET HEMATOLO
   Wilhelmi MH, 2012, ASAIO J, V58, P79, DOI 10.1097/MAT.0b013e31823a5414
   WOLDHUIS B, 1993, PFLUG ARCH EUR J PHY, V425, P191, DOI 10.1007/BF00374166
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xu M, 2010, COLLOID SURFACE B, V80, P200, DOI 10.1016/j.colsurfb.2010.06.003
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
   Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 82
TC 9
Z9 9
U1 5
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1366
EP 1379
DI 10.1002/jbm.a.35275
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300009
PM 25044790
DA 2018-10-20
ER

PT J
AU Campoccia, D
   Visai, L
   Reno, F
   Cangini, I
   Rizzi, M
   Poggi, A
   Montanaro, L
   Rimondini, L
   Arciola, CR
AF Campoccia, Davide
   Visai, Livia
   Reno, Filippo
   Cangini, Ilaria
   Rizzi, Manuela
   Poggi, Alessandro
   Montanaro, Lucio
   Rimondini, Lia
   Arciola, Carla Renata
TI Bacterial adhesion to poly-(D,L)lactic acid blended with vitamin E:
   Toward gentle anti-infective biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly-(d; l)lactic acid; anti-infective biomaterials; implant-related
   infection; vitamin E; Staphylococcus
ID MOLECULAR-WEIGHT POLYETHYLENE; INFECTION-RESISTANT SURFACES;
   STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; FIBRONECTIN; REPLACEMENT;
   INHIBITION; MECHANISMS; SCAFFOLDS; ADHERENCE
AB Anti-infective properties of biomedical materials are often achieved by loading or coating them with powerful bactericides. Undesirably, these bioactive molecules can damage the host cells at the biomaterial-tissues interface and, sometimes, even determine systemic toxic effects. The search for biomaterials able to actively resist infection while displaying a safe cytocompatibility profile toward eukaryotic cells is being progressively developed. Poly-(d,l)lactic acid (PLA) is a broadly used resorbable material with established biocompatibility properties. The dissolving surfaces of a biodegradable material tend to be per se elusive for bacteria. Here, films of pristine PLA, of PLA blended with vitamin E (VitE) and PLA blended with vitamin E acetate (VitE ac) were challenged in vitro with the biofilm-producers Staphylococcus epidermidis RP62A and Staphylococcus aureus ATCC25923. The bacterial adhesion properties of the different materials were investigated on small film disc specimens by a method based on microtiter plates. Adherent bacteria were quantified by both CFU plating and bioluminescence. Significant decrease in bacterial adhesion and biofilm accumulation was found on the surface of both the enriched polymers. These findings, together with the favorable intrinsic properties of PLA and the desirable bioactivities conferred by VitE, point up the VitE-blended PLA polymers as gentle anti-infective biomaterials. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1447-1458, 2015.
C1 [Campoccia, Davide; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
   [Visai, Livia] Univ Pavia, INSTM UdR Pavia, Dept Mol Med, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Nanotechnol Lab, Dept Occupat Med Ergon & Disabil, Pavia, Italy.
   [Reno, Filippo; Rizzi, Manuela] Univ Eastern Piedmont Amedeo Avogadro, Dept Hlth Sci, Innovat Res Lab Wound Healing, Novara, Italy.
   [Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Rizzi, Manuela] Edo & Elvo Tempia Fdn, Biella, Italy.
   [Poggi, Alessandro] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy.
   [Rimondini, Lia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy.
   [Rimondini, Lia] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Florence, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Bologna, Italy.
EM lucio.montanaro@unibo.it; carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU "5 per mille" financial contribution for Health Research; Edo ed Elvo
   Tempia Foundation; DIMES-University of Bologna
FX The authors thank Dr. Giorgio Gatti and Dr. Davide Aragno (Department of
   Sciences and Technological Innovation, University of Eastern Piedmont
   "Amedeo Avogadro", Alessandria, Italy) for SEM analysis. This work was
   supported by the "5 per mille" financial contribution for Health
   Research to the Rizzoli Orthopaedic Institute of Bologna. Dr. Manuela
   Rizzi is supported by an "Edo ed Elvo Tempia Foundation" senior
   fellowship. Dr. Ilaria Cangini is supported by a "DIMES-University of
   Bologna" senior fellowship.
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   An YH, 1997, J BONE JOINT SURG BR, V79B, P816, DOI 10.1302/0301-620X.79B5.7228
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   Arciola CR, 2012, INT J ARTIF ORGANS, V35, P713, DOI 10.5301/ijao.5000158
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2010, INT J ARTIF ORGANS, V33, P565
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   Banche G, 2011, J ORTHOP RES, V29, P1662, DOI 10.1002/jor.21432
   Bladen CL, 2013, J BIOMED MATER RES B, V101B, P458, DOI 10.1002/jbm.b.32904
   Braem A, 2014, J BIOMED MATER RES A, V102, P215, DOI 10.1002/jbm.a.34688
   Campoccia D, 2007, INT J ARTIF ORGANS, V30, P842
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2012, INT J ARTIF ORGANS, V35, P800, DOI 10.5301/ijao.5000140
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044
   El-Ghannam A, 2010, J BIOMED MATER RES A, V94A, P308, DOI 10.1002/jbm.a.32705
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010
   Gomez-Barrena E, 2011, J MATER SCI-MATER M, V22, P1701, DOI 10.1007/s10856-011-4340-5
   Lee ALZ, 2013, BIOMATERIALS, V34, P10278, DOI 10.1016/j.biomaterials.2013.09.029
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Miyazaki H, 2012, WOUND REPAIR REGEN, V20, P573, DOI 10.1111/j.1524-475X.2012.00811.x
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Pittarella P, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39970
   Provinciali M, 2011, J MED MICROBIOL, V60, P1806, DOI 10.1099/jmm.0.032516-0
   Ren F., 2007, BIOMOL ENG, V24, P307
   Ren F, 2004, BIOMATERIALS, V25, P995
   Ren F, 2007, J BIOMAT SCI-POLYM E, V18, P785
   Ren F, 2012, J BIOMATER APPL, V27, P165
   Ren F., 2013, J APPL POLYM SCI, V129, P1527
   Ren F., 2005, BIOMATERIALS, V26, P5594
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047
   Turner A, 2014, J MECH BEHAV BIOMED, V31, P21, DOI 10.1016/j.jmbbm.2012.12.006
   Uberos J, 2001, LETT APPL MICROBIOL, V32, P303, DOI 10.1046/j.1472-765X.2001.00908.x
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   Wang QS, 2014, J BIOMED MATER RES A, V102, P4098, DOI 10.1002/jbm.a.35083
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
NR 46
TC 11
Z9 11
U1 0
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2015
VL 103
IS 4
BP 1447
EP 1458
DI 10.1002/jbm.a.35284
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC5JQ
UT WOS:000350395300016
PM 25046271
DA 2018-10-20
ER

PT J
AU Velayudhan, S
   Kumar, PRA
   Nair, PD
AF Velayudhan, Shiny
   Kumar, P. R. Anil
   Nair, Prabha D.
TI A Novel, Single Step, Highly Sensitive In-Vitro Cell-Based Metabolic
   Assay Using Honeycomb Microporous Polymer Membranes
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Breath Figure; Cell Based Assay; Honeycomb Membranes; High Throughput
ID POLYURETHANE MEMBRANES; DRUG DISCOVERY; FILMS; MICROARRAY;
   CARCINOGENESIS; PLATFORM
AB This study describes a novel, simple and versatile system for cell-based assays at the bench-top. The system consists of Polyurethane (PU) based honeycomb membrane with the active compounds/assay reagents dispensed on its pore linings. Membranes with functionalized pores were thus created and used for conducting cell based assays. As proof-ofconcept Flourocein acetate (FDA) and Propidium iodide (PI) were embedded on the pore linings and live/dead assays were performed on L929 and Hacat cell lines. The results proved the sensitivity of the membrane based cell assay. To ensure the capacity of this system for high throughput applications, membrane based live/dead assay was performed on L929 cells with varying levels of viability. The results from this experiment were quantified by microscopic and spectrofluourimetric techniques both of which were found to correlate well. It was concluded that this simple membrane based cell assay is highly versatile and enables multiple compounds to be tested on the same cell/tissue. Furthermore, this method requires low volumes of assay reagents and eliminates many of the wet techniques that are involved in a conventional assay, without compromising on the sensitivity. It is anticipated that this functionalized membrane system could be easily adapted for both manual and automated high content screening experiments including in vitro biomaterial evaluation as well as cytotoxicity of nanomaterials.
C1 [Velayudhan, Shiny; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Dept Tissue Engn & Regenerat Technol, Trivandrum 695012, Kerala, India.
   [Kumar, P. R. Anil] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Implant Biol, Trivandrum 695012, Kerala, India.
RP Nair, PD (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Dept Tissue Engn & Regenerat Technol, Trivandrum 695012, Kerala, India.
EM prabha@sctimst.ac.in
FU Department of Biotechnology, Government of India (Center of Excellence
   program)
FX The authors thank The Director, SCTIMST and Head BMT Wing for the
   facilities to carry out this work. Financial assistance from Department
   of Biotechnology, Government of India (Center of Excellence program) is
   also gratefully acknowledged.
CR Bhattacharya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020887
   Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015
   Cheng CX, 2005, LANGMUIR, V21, P6576, DOI 10.1021/la050187d
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Connal LA, 2005, J MATER CHEM, V15, P1286, DOI 10.1039/b414421j
   Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056
   Evenou F, 2012, LAB CHIP, V12, P1717, DOI 10.1039/c2lc20696j
   Fernandes TG, 2008, ANAL CHEM, V80, P6633, DOI 10.1021/ac800848j
   Fukuhira Y, 2009, SOFT MATTER, V5, P2037, DOI 10.1039/b821183c
   George S, 1999, J APPL POLYM SCI, V73, P1949
   Gregor Kijanka R. B., 2011, RECENT DEV CELL BASE
   Guliants VV, 2004, J MEMBRANE SCI, V235, P53, DOI 10.1016/j.memsci.2004.01.019
   Karadag M, 2011, MACROMOL BIOSCI, V11, P1235, DOI 10.1002/mabi.201100024
   Ke BB, 2010, LANGMUIR, V26, P8946, DOI 10.1021/la904729b
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Li JH, 2012, APPL SURF SCI, V258, P6398, DOI 10.1016/j.apsusc.2012.03.049
   Mueller D., 2011, J BIOENGN BIOMED SCI, V2, DOI 10.4172/2155-9538.52-002
   O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006
   Oh TI, 2007, CYTOM PART A, V71A, P857, DOI 10.1002/cyto.a.20427
   Park MS, 2004, LANGMUIR, V20, P5347, DOI 10.1021/la035915g
   Patlolla AK, 2009, INT J ENV RES PUB HE, V6, P643, DOI 10.3390/ijerph6020643
   Shi XL, 1999, J TOXICOL ENV HEAL B, V2, P87, DOI 10.1080/109374099281241
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   Taylor DL, 2001, CURR OPIN BIOTECH, V12, P75, DOI 10.1016/S0958-1669(00)00180-4
   Tian Y, 2007, POLYM INT, V56, P834, DOI 10.1002/pi.2173
   Tsui YK, 2009, J MATER SCI-MATER M, V20, P1729, DOI 10.1007/s10856-009-3722-4
   Wan L. S., 2011, J PHYS CHEM B, V116, P40
   Wan LS, 2012, CHEM COMMUN, V48, P4417, DOI 10.1039/c2cc17451k
   Wu JH, 2011, BIOMATERIALS, V32, P841, DOI 10.1016/j.biomaterials.2010.09.026
   Xiao H., 2001, J CONTROL RELEAS, V73, P121
   Yu BZ, 2006, BIOSENS BIOELECTRON, V21, P2275, DOI 10.1016/j.bios.2005.11.002
   ZANG DLR, 2012, INT J BIOTECH WELL I, V1, P31
NR 33
TC 2
Z9 2
U1 1
U2 73
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2015
VL 11
IS 4
BP 590
EP 599
DI 10.1166/jbn.2015.2066
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FM
UT WOS:000344969600004
PM 26310066
DA 2018-10-20
ER

PT J
AU Joo, JY
   Amin, ML
   Rajangam, T
   An, SSA
AF Joo, Jae Yeon
   Amin, Md. Lutful
   Rajangam, Thanavel
   An, Seong Soo A.
TI Fibrinogen as a promising material for various biomedical applications
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Review
DE Fibrinogen; Drug carrier; Arginine-glycine-aspartate peptide; Tissue
   engineering; Biocompatible material; Autologous; 3D bio-printing;
   Microspheres; Microtubes
ID DRUG-DELIVERY SYSTEMS; ALBUMIN MICROSPHERES; DROPLET FORMATION;
   CANCER-THERAPY; GROWTH-FACTOR; IN-VIVO; NANOPARTICLES; RGD; PARTICLES;
   INTEGRIN
AB As demands for innovative drug carriers and transplantable organs increase, many researchers have developed diverse drug carriers and scaffolds using various materials. However, several candidate materials have shown systemic toxicity, making them unsuitable for clinical use. Fibrinogen (Fbg), a natural polymer, could be a promising material for applications in biomedical engineering owing to its biocompatibility and biodegradability, as reported in numerous studies. Moreover, autologous Fbg is abundant in blood and can be easily extracted, presenting Fbg as an excellent biomaterial for biomedical applications due to minimal immunological rejection. In addition, the biocompatibility of other materials could be improved by combining them with Fbg. Over the next few years, Fbg could be widely used in various biomedical and clinical fields. Here, we discuss the characteristics of Fbg and fabricating methods for Fbg scaffolds in various biomedical applications. The future prospects of Fbg as an applicable biomaterial, especially in organ fabrication by the cutting-edge 3D bioprinting technology, are also presented.
C1 [Joo, Jae Yeon; Amin, Md. Lutful; Rajangam, Thanavel; An, Seong Soo A.] Gachon Univ, Dept Bionano Technol, Gyeonggi Do, South Korea.
RP An, SSA (reprint author), Gachon Univ, Dept Bionano Technol, Gyeonggi Do, South Korea.
EM seongaan@gachon.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government (MEST)
   [2012R1A2A2A030 46819]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korean government (MEST) (2012R1A2A2A030 46819:
   Development of biodegradable and biocompatible nano-patterned
   microfibers and microtubes for skin and vascular tissue engineering).
CR Adhirajan N, 2007, J MICROENCAPSUL, V24, P659, DOI 10.1080/02652040701500137
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Arangoa MA, 2001, PHARMACEUT RES, V18, P1521, DOI 10.1023/A:1013018111829
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Beenken-Rothkopf LN, 2013, ANN CLIN LAB SCI, V43, P111
   Bhunchu S, 2014, PHARMAZIE, V69, P563, DOI 10.1691/ph.2014.3165
   Bohmer MR, 2006, COLLOID SURFACE A, V289, P96, DOI 10.1016/j.colsurfa.2006.04.011
   Bohmer MR, 2010, COLLOID SURFACE B, V79, P47, DOI 10.1016/j.colsurfb.2010.03.021
   Borgman MP, 2009, MOL PHARMACEUT, V6, P1836, DOI 10.1021/mp900134c
   Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788
   Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215
   Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709
   Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj/neo/7900224
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   De Jong WH, 2008, INT J NANOMED, V3, P133
   DEJANA E, 1985, J CLIN INVEST, V75, P11, DOI 10.1172/JCI111661
   Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   DROBNIK J, 1979, J POLYM SCI POL SYM, P65
   Erdogan D, 2008, J BIOMED MATER RES B, V85B, P272, DOI 10.1002/jbm.b.30916
   Fang ZD, 2011, APPL SURF SCI, V257, P4133, DOI 10.1016/j.apsusc.2010.12.011
   Fielding G, 2013, ACTA BIOMATER, V9, P9137, DOI 10.1016/j.actbio.2013.07.009
   Fletcher RA, 2008, TALANTA, V76, P949, DOI 10.1016/j.talanta.2008.04.066
   Francavilla C, 2009, SEMIN CANCER BIOL, V19, P298, DOI 10.1016/j.semcancer.2009.05.004
   Gregor A., 2010, INT C MECAHITECH 10
   Grossman JH, 2012, PHYS TODAY, V65, P38, DOI 10.1063/PT.3.1678
   Hallahan D, 2003, CANCER CELL, V3, P63, DOI 10.1016/S1535-6108(02)00238-6
   HAMAGUCHI M, 1993, BLOOD, V81, P2348
   HAWIGER J, 1987, HUM PATHOL, V18, P111, DOI 10.1016/S0046-8177(87)80330-1
   He CL, 2011, J BIOMED MATER RES A, V97A, P339, DOI 10.1002/jbm.a.33067
   Ji SR, 2012, CANCER BIOL THER, V13, DOI 10.4161/cbt.13.4.18692
   Khatiwala C., 2012, GENE THER REGUL, V7, DOI DOI 10.1142/S1568558611000301
   Kim Gyu Man, 2014, [Journal of the Korean Society for Precision Engineering, 한국정밀공학회지], V31, P743, DOI 10.7736/KSPE.2014.31.8.743
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Lazko J, 2004, COLLOID SURFACE B, V37, P1, DOI 10.1016/j.colsurfb.2004.06.004
   Li XB, 2012, CHEM ENG SCI, V69, P340, DOI 10.1016/j.ces.2011.10.048
   Livney YD, 2010, CURR OPIN COLLOID IN, V15, P73, DOI 10.1016/j.cocis.2009.11.002
   Meng SY, 2011, MED ONCOL, V28, P1180, DOI 10.1007/s12032-010-9621-1
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   MIYAZAKI S, 1986, J PHARM PHARMACOL, V38, P618, DOI 10.1111/j.2042-7158.1986.tb03093.x
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1370
   MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P3384
   MORETZ WH, 1986, OTOLARYNG HEAD NECK, V95, P122, DOI 10.1177/019459988609500124
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Nakamura M., 2011, S VLSI TECHN KYOT JA
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Nisisako T, 2002, LAB CHIP, V2, P24, DOI 10.1039/b108740c
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Percin G, 2003, REV SCI INSTRUM, V74, P1120, DOI 10.1063/1.1532839
   Radulescu D., 2003, P 11 INT S EXH REC A, P1
   Rajangam T, 2011, BIOCHIP J, V5, P175, DOI 10.1007/s13206-011-5211-3
   Rathod S, 2008, INDIAN J PHARM SCI, V70, P193, DOI 10.4103/0250-474X.41454
   Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506
   Rejinold NS, 2011, INT J BIOL MACROMOL, V48, P98, DOI 10.1016/j.ijbiomac.2010.10.003
   Rejinold NS, 2010, INT J BIOL MACROMOL, V47, P37, DOI 10.1016/j.ijbiomac.2010.03.023
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   SCHEFFEL U, 1972, J NUCL MED, V13, P498
   Sharma A, 2011, INT J DRUG DEL, V3, P149
   Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088
   SKOGEN WF, 1988, BLOOD, V71, P1475
   SPORN LA, 1995, BLOOD, V86, P1802
   Spotnitz WD, 2014, ISRN SURG, V2014, P1
   Stec JJ, 2000, CIRCULATION, V102, P1634, DOI 10.1161/01.CIR.102.14.1634
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Xu WC, 2012, INT J NANOMED, V7, P915, DOI 10.2147/IJN.S28314
   Zhan CY, 2010, J CONTROL RELEASE, V143, P136, DOI 10.1016/j.jconrel.2009.12.020
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393
   Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 73
TC 3
Z9 3
U1 2
U2 62
PU KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT
PI GYEONGGI-DO
PA HANYANG UNIV, SCI & TECHNOL BLDG 1, RM 423, SA-DONG, SANGROK-GU, ANSAN,
   GYEONGGI-DO, 426 791, SOUTH KOREA
SN 1738-642X
EI 2092-8467
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD MAR 31
PY 2015
VL 11
IS 1
BP 1
EP 9
DI 10.1007/s13273-015-0001-y
PG 9
WC Biochemistry & Molecular Biology; Toxicology
SC Biochemistry & Molecular Biology; Toxicology
GA CE7QF
UT WOS:000352035700001
DA 2018-10-20
ER

PT J
AU Fisher, LE
   Hook, AL
   Ashraf, W
   Yousef, A
   Barrett, DA
   Scurr, DJ
   Chen, XY
   Smith, EF
   Fay, M
   Parmenter, CDJ
   Parkinson, R
   Bayston, R
AF Fisher, Leanne E.
   Hook, Andrew L.
   Ashraf, Waheed
   Yousef, Anfal
   Barrett, David A.
   Scurr, David J.
   Chen, Xinyong
   Smith, Emily F.
   Fay, Michael
   Parmenter, Christopher D. J.
   Parkinson, Richard
   Bayston, Roger
TI Biomaterial modification of urinary catheters with antimicrobials to
   give long-term broadspectrum antibiofilm activity
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Antimicrobial; Bladder; Catheter infection; Drug release; Silicone;
   Urinary tract
ID RANDOMIZED CONTROLLED-TRIAL; URETHRAL CATHETER; TRACT-INFECTION; REDUCED
   SUSCEPTIBILITY; BACTERIAL ATTACHMENT; PROTEUS-MIRABILIS; HYDROCEPHALUS;
   CARE; IMPREGNATION; PREVENTION
AB Catheter-associated urinary tract infection (CAUTI) is the commonest hospital-acquired infection, accounting for over 100,000 hospital admissions within the USA annually. Biomaterials and processes intended to reduce the risk of bacterial colonization of the catheters for long-term users have not been successful, mainly because of the need for long duration of activity in flow conditions. Here we report the results of impregnation of urinary catheters with a combination of rifampicin, sparfloxacin and triclosan. In flow experiments, the antimicrobial catheters were able to prevent colonization by common uropathogens Proteus mirabilis, Staphylococcus aureus and Escherichia coli for 7 to 12 weeks in vitro compared with 1-3 days for other, commercially available antimicrobial catheters currently used clinically. Resistance development was minimized by careful choice of antimicrobial combinations. Drug release profiles and distribution in the polymer, and surface analysis were also carried out and the process had no deleterious effect on the mechanical performance of the catheter or its balloon. The antimicrobial catheter therefore offers for the first time a means of reducing infection and its complications in long-term urinary catheter users. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Fisher, Leanne E.; Ashraf, Waheed; Yousef, Anfal; Bayston, Roger] Univ Nottingham Hosp, Queens Med Ctr, Sch Med, Biomat Related Infect Grp, Nottingham NG7 2UH, England.
   [Hook, Andrew L.; Scurr, David J.; Chen, Xinyong] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   [Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England.
   [Smith, Emily F.; Fay, Michael; Parmenter, Christopher D. J.] Univ Nottingham, Nottingham Nanotechnol & Nanosci Ctr, Nottingham NG7 2RD, England.
   [Parkinson, Richard] Nottingham Univ Hosp NHS Trust, Nottingham Urol Ctr, Nottingham NG5 1PB, England.
RP Bayston, R (reprint author), Univ Nottingham Hosp, Queens Med Ctr, Sch Med, Biomat Related Infect Grp, C Floor West Block, Nottingham NG7 2UH, England.
EM le.fisher@btinternet.com; Andrew.hook@nottingham.ac.uk;
   waheed.ashraf@nottingham.ac.uk; anfalyousef@gmail.com;
   david.barrett@nottingham.ac.uk; david.scurr@nottingham.ac.uk;
   x.chen@nottingham.ac.uk; Emily.smith@nottingham.ac.uk;
   Michael.fay@nottingham.ac.uk; Christopher.parmenter@nottingham.ac.uk;
   Richard.parkinson@nuh.nhs.uk; roger.bayston@nottingham.ac.uk
RI Scurr, David/E-8441-2012; Barrett, David/C-9922-2011; Hook,
   Andrew/K-6924-2012
OI Scurr, David/0000-0003-0859-3886; Barrett, David/0000-0001-6900-9474;
   Hook, Andrew/0000-0001-7756-8444; Fay, Michael/0000-0003-0017-5196
FU University of Nottingham; Engineering and Physical Sciences Research
   Council [EP/K005138/1]
FX Paul Cooling is gratefully acknowledged for HPLC assistance, Keith
   Dinsdale and Tom Buss for mechanical property testing guidance and Dr
   Ignacio Villar for XPS assistance. LEF received a studentship from the
   University of Nottingham.
CR Aryan HE, 2005, CHILD NERV SYST, V21, P56, DOI 10.1007/s00381-004-1052-x
   ASTM, 2006, F62399 ASTM
   BAYSTON R, 1981, J CLIN PATHOL, V34, P1057, DOI 10.1136/jcp.34.9.1057
   BAYSTON R, 1989, J NEUROL NEUROSUR PS, V52, P605, DOI 10.1136/jnnp.52.5.605
   Bayston R, 2009, BIOMATERIALS, V30, P3167, DOI 10.1016/j.biomaterials.2009.02.028
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Cho YH, 2001, BJU INT, V87, P104, DOI 10.1046/j.1464-410x.2001.00978.x
   Cho YW, 2003, J BIOMAT SCI-POLYM E, V14, P963, DOI 10.1163/156856203322381447
   Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Denstedt D. J., 1998, J ENDOUROL, V12, P493
   Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002
   Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   Holmes PF, 2009, J BIOMED MATER RES A, V91A, P824, DOI 10.1002/jbm.a.32285
   Hook AL, 2013, ADV MATER, V25, P2542, DOI 10.1002/adma.201204936
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Moore KN, 2009, J WOUND OSTOMY CONT, V36, P82, DOI 10.1097/01.WON.0000345181.37656.de
   Muder RR, 2006, CLIN INFECT DIS, V42, P46, DOI 10.1086/498518
   Nicolle LE, 2001, INFECT CONT HOSP EP, V22, P316, DOI 10.1086/501908
   Park JH, 2003, J BIOMAT SCI-POLYM E, V14, P951, DOI 10.1163/156856203322381438
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Rafienia M., 2012, IRAN POLYM J, V22, P75
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Sciubba DM, 2005, J NEUROSURG, V103, P131, DOI 10.3171/ped.2005.103.2.0131
   Stickler DJ, 2008, J HOSP INFECT, V69, P350, DOI 10.1016/j.jhin.2008.04.031
   Stickler DJ, 2008, ANTIMICROB AGENTS CH, V52, P991, DOI 10.1128/AAC.01094-07
   Yuk SH, 1997, MACROMOLECULES, V30, P6856, DOI 10.1021/ma970725w
   Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841
NR 32
TC 34
Z9 36
U1 5
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 28
PY 2015
VL 202
BP 57
EP 64
DI 10.1016/j.jconrel.2015.01.037
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CC6BI
UT WOS:000350449100007
PM 25639970
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Luo, Y
   Shen, H
   Fang, YX
   Cao, YH
   Huang, J
   Zhang, MX
   Dai, JW
   Shi, XY
   Zhang, ZJ
AF Luo, Yu
   Shen, He
   Fang, Yongxiang
   Cao, Yuhua
   Huang, Jie
   Zhang, Mengxin
   Dai, Jianwu
   Shi, Xiangyang
   Zhang, Zhijun
TI Enhanced Proliferation and Osteogenic Differentiation of Mesenchymal
   Stem Cells on Graphene Oxide-Incorporated Electrospun
   Poly(lactic-co-glycolic acid) Nanofibrous Mats
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nanofibrous mat; electrospinning; graphene oxide; mesenchymal stem
   cells; osteogenic differentiation; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; EXTRACELLULAR-MATRIX; PROTEIN ADSORPTION;
   IN-VITRO; DELIVERY; COMPOSITE; PLGA; APOPTOSIS; POLYMER; CULTURE
AB Currently, combining biomaterial scaffolds with living stem cells for tissue regeneration is a main approach for tissue engineering. Mesenchymal stem cells (MSCs) are promising candidates for musculoskeletal tissue repair through differentiating into specific tissues, such as bone, muscle, and cartilage. Thus, successfully directing the fate of MSCs through factors and inducers would improve regeneration efficiency. Here, we report the fabrication of graphene oxide (GO)-doped poly(lactic-co-glycolic acid) (PLGA) nanofiber scaffolds via electrospinning technique for the enhancement of osteogenic differentiation of MSCs. GO-PLGA nanofibrous mats with three-dimensional porous structure and smooth surface can be readily produced via an electrospinning technique. GO plays two roles in the nanofibrous mats: first, it enhances the hydrophilic performance, and protein- and inducer-adsorption ability of the nanofibers. Second, the incorporated GO accelerates the human MSCs (hMSCs) adhesion and proliferation versus pure PLGA nanofiber and induces the osteogenic differentiation. The incorporating GO scaffold materials may find applications in tissue engineering and other fields.
C1 [Luo, Yu; Shen, He; Cao, Yuhua; Huang, Jie; Zhang, Mengxin; Dai, Jianwu; Zhang, Zhijun] Chinese Acad Sci, Key Lab Nano Bio Interface, Div Nanobiomed, Suzhou Inst Nano Tech & Nano Bion, Suzhou 215123, Peoples R China.
   [Luo, Yu; Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Fang, Yongxiang; Dai, Jianwu] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100190, Peoples R China.
   [Fang, Yongxiang] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth Agr Minist, Lanzhou Vet Res Inst, Lanzhou 730046, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Key Lab Nano Bio Interface, Div Nanobiomed, Suzhou Inst Nano Tech & Nano Bion, 398 Ruoshui Rd, Suzhou 215123, Peoples R China.
EM jwdai@genetics.ac.cn; xshi@dhu.edu.cn; zjzhang2007@sinano.ac.cn
RI Shi, Xiangyang/A-1289-2007; Zhang, Zhijun/E-5980-2014
OI Shi, Xiangyang/0000-0001-6785-6645; Zhang, Zhijun/0000-0002-9853-1031
FU National Natural Science Foundation of China [51361130033]; Ministry of
   Science and Technology of China [2014CB965003]
FX We acknowledge financial support of this work from National Natural
   Science Foundation of China (No. 51361130033) and the Ministry of
   Science and Technology of China (No. 2014CB965003). X. Shi thanks the
   Program for Professor of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning. We also thank Professor Wei
   Chen at SINANO for assistance with the electrospinning facility.
CR Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029
   Alzhavan O, 2013, CARBON, V59, P200, DOI 10.1016/j.carbon.2013.03.010
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Caballero Montserrat, 2013, Ann Plast Surg, V70, P568, DOI 10.1097/SAP.0b013e31827ed6f4
   Cao YH, 2013, J MATER CHEM B, V1, P5602, DOI 10.1039/c3tb20764a
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Ebrahimi-Barough S, 2015, MOL NEUROBIOL, V52, P1704, DOI 10.1007/s12035-014-8931-2
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fang X, 2011, J MATER CHEM, V21, P4493, DOI 10.1039/c0jm03987j
   Haider A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-314
   Han SF, 2012, J GENET GENOMICS, V39, P633, DOI 10.1016/j.jgg.2012.08.006
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang YP, 2012, ACS APPL MATER INTER, V4, P3054, DOI 10.1021/am300417s
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Kotchey GP, 2011, ACS NANO, V5, P2098, DOI 10.1021/nn103265h
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lee DY, 2011, BIOMACROMOLECULES, V12, P336, DOI 10.1021/bm101031a
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu FJ, 2010, SOFT MATER, V8, P239, DOI 10.1080/1539445X.2010.495620
   Liu GD, 2013, ACS APPL MATER INTER, V5, P6909, DOI 10.1021/am402128s
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Luo Y, 2013, CARBOHYD POLYM, V91, P419, DOI 10.1016/j.carbpol.2012.08.069
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655
   Meng J, 2010, J BIOMED MATER RES A, V95A, P312, DOI 10.1002/jbm.a.32845
   Meng ZX, 2013, MAT SCI ENG C-MATER, V33, P699, DOI 10.1016/j.msec.2012.10.021
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Qi RL, 2012, ADV MATER RES-SWITZ, V424-425, P1220, DOI 10.4028/www.scientific.net/AMR.424-425.1220
   Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340
   Qi RL, 2010, J MATER CHEM, V20, P10622, DOI 10.1039/c0jm01328e
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Shen H, 2012, ACS APPL MATER INTER, V4, P6317, DOI 10.1021/am3019367
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Soscia DA, 2013, BIOMATERIALS, V34, P6773, DOI 10.1016/j.biomaterials.2013.05.061
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Wang JX, 2014, CONNECT TISSUE RES, V55, P292, DOI 10.3109/03008207.2014.918112
   Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Xiao SL, 2009, J PHYS CHEM C, V113, P18062, DOI 10.1021/jp905542g
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang LM, 2013, J MATER CHEM B, V1, P749, DOI 10.1039/c2tb00096b
   Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
NR 57
TC 94
Z9 98
U1 40
U2 281
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 25
PY 2015
VL 7
IS 11
BP 6331
EP 6339
DI 10.1021/acsami.5b00862
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CE6TZ
UT WOS:000351972400041
PM 25741576
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Liu, K
   Shuai, M
   Chen, D
   Tuchband, M
   Gerasimov, JY
   Su, JJ
   Liu, Q
   Zajaczkowski, W
   Pisula, W
   Mullen, K
   Clark, NA
   Herrmann, A
AF Liu, Kai
   Shuai, Min
   Chen, Dong
   Tuchband, Michael
   Gerasimov, Jennifer Y.
   Su, Juanjuan
   Liu, Qing
   Zajaczkowski, Wojciech
   Pisula, Wojciech
   Muellen, Klaus
   Clark, Noel A.
   Herrmann, Andreas
TI Solvent-free Liquid Crystals and Liquids from DNA
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE DNA; liquids; liquid crystals; smectic mesophases; solvent-free
ID CAST FILM; NANOSTRUCTURES; TEMPERATURE; CHEMISTRY; DELIVERY; BEHAVIOR;
   SYSTEMS; PHASE
AB As DNA exhibits persistent structures with dimensions that exceed the range of their intermolecular forces, solid-state DNA undergoes thermal degradation at elevated temperatures. Therefore, the realization of solvent-free DNA fluids, including liquid crystals and liquids, still remains a significant challenge. To address this intriguing issue, we demonstrate that combining DNA with suitable cationic surfactants, followed by dehydration, can be a simple generic scheme for producing these solvent-free DNA fluid systems. In the anhydrous smectic liquid crystalline phase, DNA sublayers are intercalated between aliphatic hydrocarbon sublayers. The lengths of the DNA and surfactant are found to be extremely important in tuning the physical properties of the fluids. Stable liquid-crystalline and liquid phases are obtained in the -20 degrees C to 200 degrees C temperature range without thermal degradation of the DNA. Thus, a new type of DNA-based soft biomaterial has been achieved, which will promote the study and application of DNA in a much broader context.
C1 [Liu, Kai; Gerasimov, Jennifer Y.; Su, Juanjuan; Liu, Qing; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [Shuai, Min; Chen, Dong; Tuchband, Michael; Clark, Noel A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
   [Shuai, Min; Chen, Dong; Tuchband, Michael; Clark, Noel A.] Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA.
   [Zajaczkowski, Wojciech; Pisula, Wojciech; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Clark, NA (reprint author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
EM noel.clark@colorado.edu; a.herrmann@rug.nl
RI Zajaczkowski, Wojciech/C-1464-2016; Herrmann, Andreas/F-3189-2016;
   Clark, Noel/E-9011-2010
OI Zajaczkowski, Wojciech/0000-0003-0113-0985; Herrmann,
   Andreas/0000-0002-8886-0894; Tuchband, Michael/0000-0001-6560-1913
FU European Union (European Research Council); Netherlands Organization for
   Scientific Research (NWO-Vici, NWO-ChemTheme); Zernike Institute for
   Advanced Materials; US NSF under BMM [1270606]; MRSEC [DMR-0820579,
   DMR-1420736]
FX This research was supported by the European Union (European Research
   Council Starting Grant NUCLEOPOLY and STREP project MICREAGENTS), the
   Netherlands Organization for Scientific Research (NWO-Vici,
   NWO-ChemTheme) and the Zernike Institute for Advanced Materials, and the
   US NSF under BMM Grant 1270606, and MRSEC Grants DMR-0820579 and
   DMR-1420736.
CR Babu S. S., 2012, ANGEW CHEM, V124, P3447
   Babu SS, 2012, ANGEW CHEM INT EDIT, V51, P3391, DOI 10.1002/anie.201108853
   Bonnet J., 2009, NUCLEIC ACIDS RES, V37, P1531
   Bourlinos AB, 2005, ADV FUNCT MATER, V15, P1285, DOI 10.1002/adfm.200500076
   Broer D. J., 2012, ANGEW CHEM, V124, P7210
   Broer DJ, 2012, ANGEW CHEM INT EDIT, V51, P7102, DOI 10.1002/anie.201200883
   Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956
   de Vries JW, 2013, J CONTROL RELEASE, V172, P467, DOI 10.1016/j.jconrel.2013.05.022
   Dias R., 2008, DNA INTERACTIONS POL
   Faul CFJ, 2014, ACCOUNTS CHEM RES, V47, P3428, DOI 10.1021/ar500162a
   Gajria S, 2011, WIRES NANOMED NANOBI, V3, P479, DOI 10.1002/wnan.148
   Gray G.W, 1984, SMECTIC LIQUID CRYST
   Guo W., 2014, ANGEW CHEM, V126, P10298
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78
   Krivtsov A, 2012, LANGMUIR, V28, P13698, DOI 10.1021/la302720d
   Kwak M., 2010, ANGEW CHEM, V122, P8754
   Kwak M, 2011, CHEM SOC REV, V40, P5745, DOI 10.1039/c1cs15138j
   Kwak M, 2010, ANGEW CHEM INT EDIT, V49, P8574, DOI 10.1002/anie.200906820
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/NNANO.2012.211, 10.1038/nnano.2012.211]
   Lehn JM, 2007, CHEM SOC REV, V36, P151, DOI 10.1039/b616752g
   Lenz O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058104
   Leone AM, 2003, J AM CHEM SOC, V125, P6784, DOI 10.1021/ja0348795
   Liu K, 2014, P NATL ACAD SCI USA, V111, P18596, DOI 10.1073/pnas.1421257111
   Liu K, 2014, J AM CHEM SOC, V136, P14255, DOI 10.1021/ja5080486
   McLaughlin CK, 2011, CHEM SOC REV, V40, P5647, DOI 10.1039/c1cs15253j
   Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206
   Mocanu AS, 2011, CHEM COMMUN, V47, P2056, DOI 10.1039/c0cc05012a
   Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826
   Neumann T, 2010, J AM CHEM SOC, V132, P7025, DOI 10.1021/ja909514j
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Perriman A. W., 2009, ANGEW CHEM, V121, P6360
   Perriman AW, 2009, ANGEW CHEM INT EDIT, V48, P6242, DOI 10.1002/anie.200903100
   Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]
   Pluth MD, 2007, CHEM SOC REV, V36, P161, DOI 10.1039/b603168b
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Sato K, 2001, CHEM ENG SCI, V56, P2255, DOI 10.1016/S0009-2509(00)00458-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Tschierske C., 2013, ANGEW CHEM, V125, P8992
   Tschierske C, 2013, ANGEW CHEM INT EDIT, V52, P8828, DOI 10.1002/anie.201300872
   Yuan JY, 2013, PROG POLYM SCI, V38, P1009, DOI 10.1016/j.progpolymsci.2013.04.002
   Zhou J, 2006, BIOPHYS J, V90, P544, DOI 10.1529/biophysj.105.071290
   Zhou SQ, 2004, BIOMACROMOLECULES, V5, P1256, DOI 10.1021/bm034524d
NR 45
TC 8
Z9 9
U1 7
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 23
PY 2015
VL 21
IS 13
BP 4898
EP 4903
DI 10.1002/chem.201500159
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA CE9CB
UT WOS:000352140000002
PM 25712569
DA 2018-10-20
ER

PT J
AU Chang, YC
   Wang, YH
AF Chang, Yu-Chi
   Wang, Yeong-Her
TI Solution-processed Al-chelated gelatin for highly transparent
   non-volatile memory applications
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID RANDOM-ACCESS MEMORY; SWITCHING CHARACTERISTICS; DEVICES
AB Using the biomaterial of Al-chelated gelatin (ACG) prepared by sol-gel method in the ITO/ACG/ITO structure, a highly transparent resistive random access memory (RRAM) was obtained. The transmittance of the fabricated device is approximately 83% at 550 nm while that of Al/gelatin/ITO is opaque. As to the ITO/gelatin/ITO RRAM, no resistive switching behavior can be seen. The ITO/ACG/ITO RRAM shows high ON/OFF current ratio (>10(5)), low operation voltage, good uniformity, and retention characteristics at room temperature and 85 degrees C. The mechanism of the ACG-based memory devices is presented. The enhancement of these electrical properties can be attributed to the chelate effect of Al ions with gelatin. Results show that transparent ACG-based memory devices possess the potential for next-generation resistive memories and bio-electronic applications. (C) 2015 AIP Publishing LLC.
C1 [Wang, Yeong-Her] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Microelect, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Dept Elect Engn, Tainan 701, Taiwan.
RP Wang, YH (reprint author), Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Microelect, Tainan 701, Taiwan.
EM yhw@ee.ncku.edu.tw
FU Ministry of Science and Technology of Taiwan [NSC99-2627-E-006-003,
   NSC98-2221-E-006-213-MY3, NSC NSC101-2221-E-006-141-MY3,
   NSC102-222-E-006-182-MY3, 103CE03]
FX This work was supported in part by the Ministry of Science and
   Technology of Taiwan under Contract Nos. NSC99-2627-E-006-003,
   NSC98-2221-E-006-213-MY3, NSC NSC101-2221-E-006-141-MY3,
   NSC102-222-E-006-182-MY3, and103CE03.
CR Ambrico M, 2010, ORG ELECTRON, V11, P1809, DOI 10.1016/j.orgel.2010.08.001
   Cao X, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/25/255104
   Chang YC, 2014, ACS APPL MATER INTER, V6, P5413, DOI 10.1021/am500815n
   Chen MC, 2010, ELECTROCHEM SOLID ST, V13, pII191, DOI 10.1149/1.3360181
   Hazeri N, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/3/035010
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Kim A, 2011, ACS APPL MATER INTER, V3, P4525, DOI 10.1021/am201215e
   Kim HD, 2011, IEEE ELECTR DEVICE L, V32, P1125, DOI 10.1109/LED.2011.2158056
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648
   Lippard S. J., 1994, PRINCIPLES BIOINORGA
   Liu KC, 2011, MICROELECTRON ENG, V88, P1586, DOI 10.1016/j.mee.2010.11.021
   Matrajt G, 2004, ASTRON ASTROPHYS, V416, P983, DOI 10.1051/0004-6361:20034526
   Misra P, 2010, PHYS STATUS SOLIDI C, V7, P1718, DOI 10.1002/pssc.200983244
   Schmitz N., 1963, INT K FUER REPR GERM, P74
   Sudesh N. Kumar, 2013, SUPERCOND SCI TECH, V26
   Wang ZQ, 2011, IEEE ELECTR DEVICE L, V32, P1442, DOI 10.1109/LED.2011.2162311
   Wang ZS, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529455
   Yang M., 2010, CHINESE PHYS B, V19
NR 19
TC 6
Z9 6
U1 5
U2 32
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAR 23
PY 2015
VL 106
IS 12
AR 123302
DI 10.1063/1.4916028
PG 3
WC Physics, Applied
SC Physics
GA CE5LM
UT WOS:000351876700042
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, C
   Faulkner-Jones, A
   Dun, AR
   Jin, J
   Chen, P
   Xing, YZ
   Yang, ZQ
   Li, ZB
   Shu, WM
   Liu, DS
   Duncan, RR
AF Li, Chuang
   Faulkner-Jones, Alan
   Dun, Alison R.
   Jin, Juan
   Chen, Ping
   Xing, Yongzheng
   Yang, Zhongqiang
   Li, Zhibo
   Shu, Wenmiao
   Liu, Dongsheng
   Duncan, Rory R.
TI Rapid Formation of a Supramolecular Polypeptide-DNA Hydrogel for In Situ
   Three-Dimensional Multilayer Bioprinting
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biodegradability; DNA structures; hydrogels; polypeptides;
   supramolecular chemistry
ID FUNCTIONALIZED HYDROGELS; CELLS; RELEASE; PROTEIN; NANOTECHNOLOGY;
   SCAFFOLD; GEL
AB A rapidly formed supramolecular polypeptide-DNA hydrogel was prepared and used for in situ multilayer three-dimensional bioprinting for the first time. By alternative deposition of two complementary bio-inks, designed structures can be printed. Based on their healing properties and high mechanical strengths, the printed structures are geometrically uniform without boundaries and can keep their shapes up to the millimeter scale without collapse. 3D cell printing was demonstrated to fabricate live-cell-containing structures with normal cellular functions. Together with the unique properties of biocompatibility, permeability, and biodegradability, the hydrogel becomes an ideal biomaterial for 3D bioprinting to produce designable 3D constructs for applications in tissue engineering.
C1 [Li, Chuang; Jin, Juan; Xing, Yongzheng; Yang, Zhongqiang; Liu, Dongsheng] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
   [Faulkner-Jones, Alan; Dun, Alison R.; Shu, Wenmiao; Duncan, Rory R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland.
   [Chen, Ping; Li, Zhibo] Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China.
RP Li, C (reprint author), Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China.
EM w.shu@hw.ac.uk; liudongsheng@tsinghua.edu.cn
RI Liu, Dongsheng/E-7384-2011; Li, Zhibo/K-1614-2013; Xing,
   Yongzheng/A-2618-2012
OI Liu, Dongsheng/0000-0002-2583-818X; Li, Zhibo/0000-0001-9512-1507; Xing,
   Yongzheng/0000-0002-6186-8028; Shu, Wenmiao/0000-0002-1220-361X; Duncan,
   Rory/0000-0003-0693-910X
FU National Basic Research Program of China (973 program) [2013CB932803];
   National Natural Science Foundation of China [91427302, 21421064];
   NSFC-DFG joint project [TRR61]; Beijing Municipal Science & Technology
   Commission; Sino-UK Higher Education Research Partnership for PhD
   Studies Scheme - British Council; Ministry of Education in China; EPSRC
   [EP/M506837/1]; MRC [MRC_G0901607]; Wellcome Trust [WT074146];
   Engineering and Physical Sciences Research Council [EP/M506837/1];
   Medical Research Council [G0901607, MR/K01563X/1]
FX We thank the National Basic Research Program of China (973 program,
   2013CB932803), the National Natural Science Foundation of China
   (91427302, 21421064), the NSFC-DFG joint project TRR61, and the Beijing
   Municipal Science & Technology Commission for financial support. This
   project was also partly supported by the Sino-UK Higher Education
   Research Partnership for PhD Studies Scheme funded by the British
   Council and the Ministry of Education in China and EPSRC (EP/M506837/1)
   and MRC awards to R.R.D. (MRC_G0901607) and by the Wellcome Trust
   (WT074146). The MRC (MRC_MR/K01563X/1) Edinburgh Super-Resolution
   Imaging Consortium (ESRIC) provided the microscope platforms, technical
   assistance, tissue culturing facilities, and analysis packages required
   for the acquisition and analysis of fluorescence imaging data summarized
   in this article.
CR Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104
   Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chen N, 2014, ACCOUNTS CHEM RES, V47, P1720, DOI 10.1021/ar400324n
   Chen P, 2012, MACROMOLECULES, V45, P9579, DOI 10.1021/ma302233m
   Cheng E., 2009, ANGEW CHEM, V121, P7796, DOI DOI 10.1002/ANGE.V121:41
   Cheng EJ, 2011, CHEM COMMUN, V47, P5545, DOI 10.1039/c1cc11028d
   Cheng EJ, 2009, ANGEW CHEM INT EDIT, V48, P7660, DOI 10.1002/anie.200902538
   Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j
   Dave N, 2010, J AM CHEM SOC, V132, P12668, DOI [10.1021/ja106098j, 10.1021/ja106098J]
   Dong YC, 2014, ACCOUNTS CHEM RES, V47, P1853, DOI 10.1021/ar500073a
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durmus NG, 2013, NAT MATER, V12, P478, DOI 10.1038/nmat3665
   Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013
   Haruka K., 2013, BIOFABRICATION, V5
   Hemanth G., 2014, BIOFABRICATION, V6
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Jin J, 2013, ADV MATER, V25, P4714, DOI 10.1002/adma.201301175
   Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Li C., 2015, SMALL, DOI [10.1002/smll.201401906, DOI 10.1002/SMLL.201401906;]
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Liu JW, 2011, SOFT MATTER, V7, P6757, DOI 10.1039/c1sm05284e
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Modi S, 2009, NAT NANOTECHNOL, V4, P325, DOI [10.1038/NNANO.2009.83, 10.1038/nnano.2009.83]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110
   Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/NMAT2419, 10.1038/nmat2419]
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Peng SM, 2012, MATER TODAY, V15, P190, DOI 10.1016/S1369-7021(12)70089-5
   Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]
   Qi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3275
   Reichert JC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065001
   Riccardo L, 2014, BIOFABRICATION, V6, DOI DOI 10.1088/1758-5082/6/3/035020
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]
   Tao X., 2013, BIOFABRICATION, V5
   Um SH, 2006, NAT MATER, V5, P797, DOI 10.1038/nmat1741
   Wei B, 2008, ANGEW CHEM, V120, P337, DOI DOI 10.1002/(ISSN)1521-3757
   Wei B, 2008, ANGEW CHEM INT EDIT, V47, P331, DOI 10.1002/anie.200704143
   Wu YZ, 2014, CHEM COMMUN, V50, P14620, DOI 10.1039/c4cc07144a
   Xing YZ, 2011, ADV MATER, V23, P1117, DOI 10.1002/adma.201003343
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049514
   Zhang YL, 2011, BIOMACROMOLECULES, V12, P2894, DOI 10.1021/bm200423f
   Zhu Z., 2010, ANGEW CHEM, V122, P1070, DOI DOI 10.1002/ANIE.200905570
   Zhu Z, 2010, ANGEW CHEM INT EDIT, V49, P1052, DOI 10.1002/anie.200905570
NR 57
TC 98
Z9 105
U1 34
U2 507
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD MAR 23
PY 2015
VL 54
IS 13
BP 3957
EP 3961
DI 10.1002/anie.201411383
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA CD6NA
UT WOS:000351204600017
PM 25656851
DA 2018-10-20
ER

PT J
AU Xiao, X
   Wang, W
   Liu, D
   Zhang, HQ
   Gao, P
   Geng, L
   Yuan, YL
   Lu, JX
   Wang, Z
AF Xiao, Xin
   Wang, Wei
   Liu, Dong
   Zhang, Haoqiang
   Gao, Peng
   Geng, Lei
   Yuan, Yulin
   Lu, Jianxi
   Wang, Zhen
TI The promotion of angiogenesis induced by three-dimensional porous
   beta-tricalcium phosphate scaffold with different interconnection sizes
   via activation of PI3K/Akt pathways
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BMP-INDUCED OSTEOGENESIS; IN-VIVO; BONE REGENERATION; INTERNAL
   STRUCTURE; ENDOTHELIAL-CELLS; TISSUE; GROWTH; VASCULARIZATION;
   BIOCERAMICS; EXPRESSION
AB The porous architectural characteristics of biomaterials play an important role in scaffold revascularization. However, no consensus exists regarding optimal interconnection sizes for vascularization and its scaffold bioperformance with different interconnection sizes. Therefore, a series of disk-type beta-tricalcium phosphates with the same pore sizes and variable interconnections were produced to evaluate how the interconnection size influenced biomaterial vascularization in vitro and in vivo. We incubated human umbilical vein endothelial cells on scaffolds with interconnections of various sizes. Results showed that scaffolds with a 150 mminterconnection size ameliorated endothelial cell function evidenced by promoting cell adhesion and migration, increasing cell proliferation and enhancing expression of platelet-endothelial cell adhesion molecules and vascular endothelial growth factor. In vivo study was performed on rabbit implanted with scaffolds into the bone defect on femoral condyles. Implantation with scaffolds with 150 mm interconnection size significantly improved neovascularization as shown by micro-CT as compared to scaffolds with 100 and 120 mm interconnection sizes. Moreover, the aforementioned positive effects were abolished by blocking PI3K/Akt/eNOS pathway with LY-294002. Our study explicitly demonstrates that the scaffold with 150 mm interconnection size improves neovascularization via the PI3K/Akt pathway and provides a target for biomaterial inner structure modification to attain improved clinical performance in implant vascularization.
C1 [Xiao, Xin; Liu, Dong; Zhang, Haoqiang; Gao, Peng; Geng, Lei; Yuan, Yulin; Wang, Zhen] Forth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
   [Wang, Wei] Forth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.
   [Lu, Jianxi] Shanghai Biolu Biomat Co Ltd, Shanghai, Peoples R China.
RP Wang, Z (reprint author), Forth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.
EM lujianxi888@hotmail.com; wzfmmu@sina.com
FU Natural Science Foundation of China [31170914]
FX This work was supported by grant from the Natural Science Foundation of
   China (NO. 31170914) to Zhen Wang. The authors are grateful to the
   Shanghai Bio-lu Biomaterials Co., Ltd., for providing beta-TCP
   bioceramics. The authors thank all technicians at the Institute of
   Orthopaedic of XiJing Hospital, Fourth Military Medical University in
   China, for their contribution to the experiment.
CR Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Bohner M, 2000, INJURY, V31, pS37
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Dulak J, 2002, CARDIOVASC RES, V56, P487, DOI 10.1016/S0008-6363(02)00670-3
   Elcin AE, 2006, TISSUE ENG, V12, P959, DOI 10.1089/ten.2006.12.959
   Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liu X, 2010, BIOMATERIALS, V31, P8198, DOI 10.1016/j.biomaterials.2010.07.069
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72
   O'Brien CD, 2004, AM J PHYSIOL-CELL PH, V287, pC1103, DOI 10.1152/ajpcell.00573.2003
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rimondini L, 2005, ORAL SURG ORAL MED O, V99, P148, DOI 10.1016/j.tripleo.2004.05.010
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
NR 46
TC 36
Z9 38
U1 5
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 23
PY 2015
VL 5
AR 9409
DI 10.1038/srep09409
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD8WF
UT WOS:000351376400002
PM 25797242
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Carmichael, D
   Siletti, C
   Petrides, D
AF Carmichael, Doug
   Siletti, Charles
   Petrides, Dimitrios
TI Biomaterial production process intensification, analysis, and
   optimization with process simulation tools
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Carmichael, Doug] Intelligen Inc, Boulder, CO USA.
   [Petrides, Dimitrios] Intelligen Inc, Scotch Plains, NJ USA.
   [Siletti, Charles] Intelligen Inc, Concord, NH USA.
EM dcarmichael@intelligen.com
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 22
PY 2015
VL 249
MA 313
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VA9RL
UT WOS:000411183301095
DA 2018-10-20
ER

PT J
AU Larsson, P
   Wagberg, L
AF Larsson, Per
   Wagberg, Lars
TI Biomaterial-based barrier materials and composites: A review on how to
   prevent unwanted
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Larsson, Per; Wagberg, Lars] KTH Royal Inst Technol, Fibre & Polymer Technol, Stockholm, Sweden.
   [Larsson, Per] KTH Royal Inst Technol, BiMaC Innovat, Stockholm, Sweden.
   [Wagberg, Lars] KTH Royal Inst Technol, Wallenberg Wood Sci Ctr, Stockholm, Sweden.
EM per.larsson@polymer.kth.se
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 22
PY 2015
VL 249
MA 110
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VA9RR
UT WOS:000411186504758
DA 2018-10-20
ER

PT J
AU Fitzpatrick, AWP
   Vanacore, GM
   Zewail, AH
AF Fitzpatrick, Anthony W. P.
   Vanacore, Giovanni M.
   Zewail, Ahmed H.
TI Nanomechanics and intermolecular forces of amyloid revealed by
   four-dimensional electron microscopy
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE nanomechanics; proteins; structural dynamics; 4D electron diffraction
ID A-BETA; FIBRILS; PEPTIDE; VISUALIZATION; MECHANICS; DISEASE; BOND; NMR
AB The amyloid state of polypeptides is a stable, highly organized structural form consisting of laterally associated beta-sheet protofilaments that may be adopted as an alternative to the functional, native state. Identifying the balance of forces stabilizing amyloid is fundamental to understanding the wide accessibility of this state to peptides and proteins with unrelated primary sequences, various chain lengths, and widely differing native structures. Here, we use four-dimensional electron microscopy to demonstrate that the forces acting to stabilize amyloid at the atomic level are highly anisotropic, that an optimized interbackbone hydrogen-bonding network within beta-sheets confers 20 times more rigidity on the structure than sequence-specific sidechain interactions between sheets, and that electrostatic attraction of protofilaments is only slightly stronger than these weak amphiphilic interactions. The potential biological relevance of the deposition of such a highly anisotropic biomaterial in vivo is discussed.
C1 [Fitzpatrick, Anthony W. P.; Vanacore, Giovanni M.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
RP Zewail, AH (reprint author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.
EM zewail@caltech.edu
OI gaber, sarah/0000-0002-5995-7291
FU National Science Foundation [DMR-0964886]; Air Force Office of
   Scientific Research in the Gordon and Betty Moore Center for Physical
   Biology at the California Institute of Technology [FA9550-11-1-0055];
   Marie Curie International Outgoing Fellowship
FX This work was supported by the National Science Foundation (DMR-0964886)
   and the Air Force Office of Scientific Research (FA9550-11-1-0055) in
   the Gordon and Betty Moore Center for Physical Biology at the California
   Institute of Technology. A.W.P.F. is supported by a Marie Curie
   International Outgoing Fellowship.
CR Ashby M. F., 2012, ENG MAT, V1
   Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Clary DC, 1997, OPTICAL ELCT MAGNETI
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   DELANO WL, 2002, DELANO SCI
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Eisenberg D, 2005, STRUCTURE PROPERTIES
   Fandrich M, 2009, PRION, V3, P89
   Feldblum ES, 2014, P NATL ACAD SCI USA, V111, P4085, DOI 10.1073/pnas.1319827111
   Fitzpatrick AWP, 2013, J AM CHEM SOC, V135, P19123, DOI 10.1021/ja4115055
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P10976, DOI 10.1073/pnas.1309690110
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110
   Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250
   Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862
   Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080
   Lide D.R., 1988, CRC HDB CHEM PHYS
   Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102
   Lulevich V, 2010, P NATL ACAD SCI USA, V107, P13872, DOI 10.1073/pnas.1008341107
   Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109
   Mohammed OF, 2009, ANGEW CHEM INT EDIT, V48, P5628, DOI 10.1002/anie.200900513
   Newnham R E, 2005, PROPERTIES MAT ANISO
   Pampaloni F, 2006, P NATL ACAD SCI USA, V103, P10248, DOI 10.1073/pnas.0603931103
   Paparcone R, 2011, BIOMATERIALS, V32, P3367, DOI 10.1016/j.biomaterials.2010.11.066
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Park ST, 2012, J AM CHEM SOC, V134, P9146, DOI 10.1021/ja304042r
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607
   Usov I, 2014, ACS NANO, V8, P11035, DOI 10.1021/nn503530a
   Xu ZP, 2010, BIOPHYS J, V98, P2053, DOI 10.1016/j.bpj.2009.12.4317
   Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034
   Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809
   Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135
NR 43
TC 18
Z9 19
U1 2
U2 59
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 17
PY 2015
VL 112
IS 11
BP 3380
EP 3385
DI 10.1073/pnas.1502214112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD4NM
UT WOS:000351060000069
PM 25733888
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hulsman, M
   Hulshof, F
   Unadkat, H
   Papenburg, BJ
   Stamatialis, DF
   Truckenmuller, R
   van Blitterswijk, C
   de Boer, J
   Reinders, MJT
AF Hulsman, Marc
   Hulshof, Frits
   Unadkat, Hemant
   Papenburg, Bernke J.
   Stamatialis, Dimitrios F.
   Truckenmuller, Roman
   van Blitterswijk, Clemens
   de Boer, Jan
   Reinders, Marcel J. T.
TI Analysis of high-throughput screening reveals the effect of surface
   topographies on cellular morphology
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell morphology; Interface; Surface topography; Modelling; Mesenchymal
   stem cell
ID POROUS SILICON GRADIENTS; EXTRACELLULAR-MATRIX; INTERIOR SURFACES;
   NUCLEAR LAMINA; STEM-CELLS; DIFFERENTIATION; SCAFFOLDS; FATE;
   COMBINATORIAL; ORIENTATION
AB Surface topographies of materials considerably impact cellular behavior as they have been shown to affect cell growth, provide cell guidance, and even induce cell differentiation. Consequently, for successful application in tissue engineering, the contact interface of biomaterials needs to be optimized to induce the required cell behavior. However, a rational design of biomaterial surfaces is severely hampered because knowledge is lacking on the underlying biological mechanisms. Therefore, we previously developed a high-throughput screening device (TopoChip) that measures cell responses to large libraries of parameterized topographical material surfaces. Here, we introduce a computational analysis of high-throughput materiome data to capture the relationship between the surface topographies of materials and cellular morphology. We apply robust statistical techniques to find surface topographies that best promote a certain specified cellular response. By augmenting surface screening with data-driven modeling, we determine which properties of the surface topographies influence the morphological properties of the cells. With this information, we build models that predict the cellular response to surface topographies that have not yet been measured. We analyze cellular morphology on 2176 surfaces, and find that the surface topography significantly affects various cellular properties, including the roundness and size of the nucleus, as well as the perimeter and orientation of the cells. Our learned models capture and accurately predict these relationships and reveal a spectrum of topographies that induce various levels of cellular morphologies. Taken together, this novel approach of high-throughput screening of materials and subsequent analysis opens up possibilities for a rational design of biomaterial surfaces. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hulsman, Marc; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands.
   [Hulshof, Frits; Unadkat, Hemant; Truckenmuller, Roman; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Hulshof, Frits; Stamatialis, Dimitrios F.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [de Boer, Jan] Maastricht Univ, Merln Inst, Lab Cell Biol Inspired Tissue Engn, NL-6211 LK Maastricht, Netherlands.
   [Papenburg, Bernke J.] Materiomics BV, NL-3723 MB Bilthoven, Netherlands.
RP Hulsman, M (reprint author), Delft Univ Technol, Delft Bioinformat Lab, Mekelweg 4, NL-2628 CD Delft, Netherlands.
EM m.hulsman@tudelft.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU STW program; NanoNext NL program [06C.12]
FX M.H. acknowledges the financial support of the STW program. F.H.
   acknowledges the financial support of the NanoNext NL program, project
   06C.12: High throughput screening of biologically active surface
   nano-topographies.
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Amis EJ, 2004, NAT MATER, V3, P83, DOI 10.1038/nmat1064
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Clements LR, 2012, LAB CHIP, V12, P1480, DOI 10.1039/c2lc20732j
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   Drucker H, 1997, ADV NEUR IN, V9, P155
   DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hampoelz B, 2011, CURR OPIN CELL BIOL, V23, P668, DOI 10.1016/j.ceb.2011.10.001
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Huber P. J., 1981, ROBUST STAT
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h
   Li X, 2011, ACS COMB SCI, V13, P50, DOI 10.1021/co100019d
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042
   Mishra KP, 2008, BIOMED PHARMACOTHER, V62, P94, DOI 10.1016/j.biopha.2007.06.012
   Pan Z, 2013, CHINESE J POLYM SCI, V31, P737, DOI 10.1007/s10118-013-1264-1
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016
   Qu ZH, 2013, J BIOMAT SCI-POLYM E, V24, P447, DOI 10.1080/09205063.2012.690285
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Settles B., 2009, 1648 U WISC
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Veith M., 2013, OPEN J REGEN MED, V3, P74
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang PY, 2012, ADV FUNCT MATER, V22, P3414, DOI 10.1002/adfm.201200447
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Zhao Y, 2009, BIOTECHNOL BIOENG, V102, P624, DOI 10.1002/bit.22080
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 45
TC 28
Z9 29
U1 4
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 29
EP 38
DI 10.1016/j.actbio.2014.12.019
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800004
PM 25554402
DA 2018-10-20
ER

PT J
AU Wang, K
   Yu, LY
   Jiang, LY
   Wang, HB
   Wang, CY
   Luo, Y
AF Wang, Kai
   Yu, Lin-Yang
   Jiang, Li-Yang
   Wang, Hai-Bin
   Wang, Chang-Yong
   Luo, Ying
TI The paracrine effects of adipose-derived stem cells on
   neovascularization and biocompatibility of a macroencapsulation device
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adipose-derived stem cell; Macroencapsulation; Foreign body reaction;
   Angiogenesis; Immunomodulation
ID FOREIGN-BODY RESPONSE; STROMAL CELLS; IMMUNOISOLATION DEVICE;
   SUBCUTANEOUS IMPLANTS; REGENERATIVE MEDICINE; BIOMATERIALS;
   INFLAMMATION; MACROPHAGES; ISLETS; ENCAPSULATION
AB The foreign-body response to biomaterials compromises the performance of many biomedical devices by severe fibrosis and limited neovascularization. Mesenchymal stem cells are known to secrete cytokines for treating inflammatory conditions. In this study, we aim to investigate whether the paracrine products of adipose-derived mesenchymal stem cells (ADSCs) can affect the microenvironment of biomaterials and improve tissue responses to biomaterial implants. A model system was built by loading ADSC spheroids into a macroencapsulation device composed of polytetrafluoroethylene (PTFE) filtration membranes. Soluble ADSC factors that diffused out of the device in vitro promoted the angiogenetic activity of endothelial cells and affected the secretion pattern of macrophages. In vivo study was carried out by subcutaneously embedding blank or ADSC-laden devices in rats. Following a 4 week implantation, the ADSC-laden devices were better vascularized and induced significantly less fibrotic tissue formation in comparison to the non-cellular controls. This study may facilitate our understanding of foreign-body responses and suggest new ways to improve the tissue reaction of biomedical devices for cell-based therapy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Kai; Yu, Lin-Yang; Jiang, Li-Yang; Luo, Ying] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Wang, Hai-Bin; Wang, Chang-Yong] Acad Mil Med Sci, Dept Adv Interdisciplinary Studies, Inst Basic Med Sci, Beijing 100039, Peoples R China.
   [Wang, Hai-Bin; Wang, Chang-Yong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing 100039, Peoples R China.
   [Luo, Ying] Natl Engn Lab Regenerat & Implantable Med Devices, Guangzhou 510663, Guangdong, Peoples R China.
RP Luo, Y (reprint author), Peking Univ, Coll Engn, Dept Biomed Engn, Room 206,Fangzheng Bldg,298 Chengfu Rd, Beijing 100871, Peoples R China.
EM ying.luo@pku.edu.cn
RI Luo, Ying/A-9920-2012
OI Luo, Ying/0000-0001-9834-9419
FU Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03];
   National Natural Science Foundation of China [31322021]; Projects Grants
   of National Engineering Laboratory for Regenerative and Implantable
   Medical Devices [2012NELRMD003]
FX This research was financially supported by the Key New Drug Creation and
   Manufacturing Program (2011ZX09102-010-03), the National Natural Science
   Foundation of China (Project No. 31322021), and the Projects Grants of
   National Engineering Laboratory for Regenerative and Implantable Medical
   Devices (2012NELRMD003). We thank Dr. Yong-Jian Deng (Department of
   Pathology, Southern Medical University) for his assistance with the
   analysis of histology slides.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816
   Baraniak PR, 2009, REGEN MED, V5, P121
   Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Bruin JE, 2013, DIABETOLOGIA, V56, P1987, DOI 10.1007/s00125-013-2955-4
   Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039
   Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015
   Geller RL, 1997, ANN NY ACAD SCI, V831, P438
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Johnson AS, 2009, CHEM ENG SCI, V64, P4470, DOI 10.1016/j.ces.2009.06.028
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kumagai-Braesch M, 2013, CELL TRANSPLANT, V22, P1137, DOI 10.3727/096368912X657486
   Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013
   Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612
   Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nichols SP, 2012, BIOMATERIALS, V33, P6305, DOI 10.1016/j.biomaterials.2012.05.053
   O'Sullivan ES, 2011, ENDOCR REV, V32, P827, DOI 10.1210/er.2010-0026
   Orive G., 2013, ADV DRUG DELIV REV, V67-68, P3
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200
   Prichard HL, 2008, STEM CELLS, V26, P2691, DOI 10.1634/stemcells.2008-0140
   Rafael E, 2003, CELL TRANSPLANT, V12, P407, DOI 10.3727/000000003108746957
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Sorenby A, 2004, CELL TRANSPLANT, V13, P713, DOI 10.3727/000000004783983512
   Su J, 2013, CELL DEATH DIFFER, V21, P388
   Swartzlander MD, 2013, BIOMATERIALS, V34, P952, DOI 10.1016/j.biomaterials.2012.10.037
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Wang K, 2013, BIOMACROMOLECULES, V14, P2373, DOI 10.1021/bm4004942
   Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Xu KD, 2013, ACTA BIOMATER, V9, P8802, DOI 10.1016/j.actbio.2013.06.021
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 62
TC 14
Z9 14
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 65
EP 76
DI 10.1016/j.actbio.2014.12.025
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800008
PM 25575852
DA 2018-10-20
ER

PT J
AU Zhou, S
   Huang, WW
   Belton, DJ
   Simmons, LO
   Perry, CC
   Wang, XQ
   Kaplan, DL
AF Zhou, Shun
   Huang, Wenwen
   Belton, David J.
   Simmons, Leo O.
   Perry, Carole C.
   Wang, Xiaoqin
   Kaplan, David L.
TI Control of silicification by genetically engineered fusion proteins:
   Silk-silica binding peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Spider silk; Silica; Silicification; Fusion proteins
ID SPIDER DRAGLINE SILK; BLOCK-COPOLYMERS; CYLINDROTHECA-FUSIFORMIS;
   PRECIPITATING PEPTIDES; NANOPARTICLES; BIOSILICA; DOMAINS
AB In the present study, an artificial spider silk gene, 6mer, derived from the consensus sequence of Nephila clavipes dragline silk gene, was fused with different silica-binding peptides (SiBPs), A1, A3 and R5, to study the impact of the fusion protein sequence chemistry on silica formation and the ability to generate a silk silica composite in two different bioinspired silicification systems: solution solution and solution solid. Condensed silica nanoscale particles (600-800 nm) were formed in the presence of the recombinant silk and chimeras, which were smaller than those formed by 15mer-SiBP chimeras [1], revealing that the molecular weight of the silk domain correlated to the sizes of the condensed silica particles in the solution system. In addition, the chimeras (6mer-A1/A3/R5) produced smaller condensed silica particles than the control (6mer), revealing that the silica particle size formed in the solution system is controlled by the size of protein assemblies in solution. In the solution-solid interface system, silicification reactions were performed on the surface of films fabricated from the recombinant silk proteins and chimeras and then treated to induce beta-sheet formation. A higher density of condensed silica formed on the films containing the lowest beta-sheet content while the films with the highest beta-sheet content precipitated the lowest density of silica, revealing an inverse correlation between the beta-sheet secondary structure and the silica content formed on the films. Intriguingly, the 6mer-A3 showed the highest rate of silica condensation but the lowest density of silica deposition on the films, compared with 6mer-A1 and -R5, revealing antagonistic crosstalk between the silk and the SiBP domains in terms of protein assembly. These findings offer a path forward in the tailoring of biopolymer silica composites for biomaterial related needs. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, Shun; Wang, Xiaoqin; Kaplan, David L.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Zhou, Shun; Huang, Wenwen; Wang, Xiaoqin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Belton, David J.; Perry, Carole C.] Nottingham Trent Univ, Sch Sci & Technol, Interdisciplinary Biomed Res Ctr, Biomol & Mat Interface Res Grp, Nottingham NG11 8NS, England.
   [Simmons, Leo O.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083; Perry, Professor
   Carole/0000-0003-1517-468X
FU NIH [R01 DE017207]; Natural Science Foundation of China (NSFC)
   [51273138]
FX We thank the NIH (R01 DE017207) and Natural Science Foundation of China
   (NSFC, project no. 51273138) for support of this research.
CR Belton DJ, 2008, P NATL ACAD SCI USA, V105, P5963, DOI 10.1073/pnas.0710809105
   Belton DJ, 2012, LANGMUIR, V28, P4373, DOI 10.1021/la205084z
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Canabady-Rochelle LLS, 2012, BIOMACROMOLECULES, V13, P683, DOI 10.1021/bm201555c
   Choi O, 2011, ENZYME MICROB TECH, V49, P441, DOI 10.1016/j.enzmictec.2011.07.005
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huang WW, 2011, MACROMOLECULES, V44, P5299, DOI 10.1021/ma200563t
   Knecht MR, 2003, CHEM COMMUN, P3038, DOI 10.1039/b309074d
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200
   Kuno T, 2011, LANGMUIR, V27, P13154, DOI 10.1021/la202576v
   Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004
   Marner WD, 2008, BIOMACROMOLECULES, V9, P1, DOI 10.1021/bm701131x
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h
   Tang-Schomer MD, 2014, P NATL ACAD SCI US
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Xia X, 2014, BIOMACROMOLECULES
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
NR 33
TC 16
Z9 16
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 173
EP 180
DI 10.1016/j.actbio.2014.10.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800017
PM 25462851
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bhuiyan, D
   Jablonsky, MJ
   Kolesov, I
   Middleton, J
   Wick, TM
   Tannenbaum, R
AF Bhuiyan, D.
   Jablonsky, M. J.
   Kolesov, I.
   Middleton, J.
   Wick, T. M.
   Tannenbaum, R.
TI Novel synthesis and characterization of a collagen-based biopolymer
   initiated by hydroxyapatite nanoparticles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradable polymer; Collagen; PLGA; Hydroxyapatite
ID HYDROXYLAPATITE POLY(L-LACTIDE) COMPOSITES; LACTIDE-CO-GLYCOLIDE; CREST
   BONE-GRAFT; BIORESORBABLE DEVICES; MECHANICAL-PROPERTIES; POLYMER
   COMPOSITES; FORGED COMPOSITES; INTERNAL-FIXATION; BLOCK-COPOLYMERS; HA
   PARTICLES
AB In this study, we developed a novel synthesis method to create a complex collagen-based biopolymer that promises to possess the necessary material properties for a bone graft substitute. The synthesis was carried out in several steps. In the first step, a ring-opening polymerization reaction initiated by hydroxyapatite nanoparticles was used to polymerize D,L-lactide and glycolide monomers to form poly(lactide-co-glycolide) co-polymer. In the second step, the polymerization product was coupled with succinic anhydride, and subsequently was reacted with N-hydroxysuccinimide in the presence of dicyclohexylcarbodiimide as the cross-linking agent, in order to activate the co-polymer for collagen attachment. In the third and final step, the activated co-polymer was attached to calf skin collagen type I, in hydrochloric acid/phosphate buffer solution and the precipitated co-polymer with attached collagen was isolated. The synthesis was monitored by proton nuclear magnetic resonance, infrared and Raman spectroscopies, and the products after each step were characterized by thermal and mechanical analysis. Calculations of the relative amounts of the various components, coupled with initial dynamic mechanical analysis testing of the resulting biopolymer, afforded a preliminary assessment of the structure of the complex biomaterial formed by this novel polymerization process. (C) 2015 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Bhuiyan, D.; Middleton, J.; Wick, T. M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Jablonsky, M. J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.
   [Kolesov, I.] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA.
   [Tannenbaum, R.] SUNY Stony Brook, Program Chem & Mol Engn, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
RP Tannenbaum, R (reprint author), SUNY Stony Brook, Program Chem & Mol Engn, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
EM irena.tannenbaum@stonybrook.edu
OI Wick, Timothy/0000-0001-8922-0939
FU School of Engineering at the University of Alabama at Birmingham
FX The authors acknowledge the financial support of the School of
   Engineering at the University of Alabama at Birmingham and the valuable
   discussions with Drs. Hamid Garmestani Georgia Tech, Paul Eleazer and
   Eugenia Kharlampieva of UAB.
CR Albertsson AC, 2002, ADV POLYM SCI, V157, P1
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   Bishop RC, 1996, J NEUROSURG, V85, P206, DOI 10.3171/jns.1996.85.2.0206
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Cherry DK, 2009, NATL HLTH STAT REP, V3, P1
   Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322
   D'Avila Carvalho Erbetta C, 2012, J BIOMATER NANOBIOTE, V3, P208, DOI DOI 10.4236/JBNB.2012.32027
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Edgecombe BD, 1998, MACROMOLECULES, V31, P1292, DOI 10.1021/ma970832q
   EDWARDS DC, 1990, J MATER SCI, V25, P4175, DOI 10.1007/BF00581070
   Eitan A, 2003, CHEM MATER, V15, P3198, DOI 10.1021/cm020975d
   Flierl MA, 2010, ORTHOPEDICS, V33, P102, DOI 10.3928/01477447-20100104-21
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Guo XE, 1997, FORMA, V12, P185
   Gutierrez GE, 2008, J BONE MINER RES, V23, P1722, DOI 10.1359/JBMR.080603
   Hamley IW, 1999, ADV POLYM SCI, V148, P113
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hong ZK, 2004, POLYMER, V45, P6699, DOI 10.1016/j.polymer.2004.07.036
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Izunobi JU, 2011, J CHEM EDUC, V88, P1098, DOI 10.1021/ed100461v
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Lu XY, 1996, J POLYM SCI POL PHYS, V34, P1795, DOI 10.1002/(SICI)1099-0488(19960730)34:10<1795::AID-POLB11>3.0.CO;2-6
   Mayo FR, 1944, J AM CHEM SOC, V66, P1594, DOI 10.1021/ja01237a052
   MELTON LJ, 1993, BONE, V14, pS1
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   Odian G., 2004, PRINCIPLES POLYM, P464
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Porjazoska A, 2006, J BIOMAT SCI-POLYM E, V17, P323, DOI 10.1163/156856206775997296
   Ren TB, 2005, J BIOMED MATER RES A, V74A, P562, DOI 10.1002/jbm.a.30324
   Roeder BA, 2012, J BIOMECH ENG, V124, P214
   Rovira A, 1996, BIOMATERIALS, V17, P1535, DOI 10.1016/0142-9612(96)89779-1
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Tannenbaum R, 2003, J POLYM SCI POL PHYS, V41, P1814, DOI 10.1002/polb.10557
   VANHOORNE P, 1992, MACROMOLECULES, V25, P37, DOI 10.1021/ma00027a008
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang PB, 2011, BIOMACROMOLECULES, V12, P2667, DOI 10.1021/bm2004725
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhu J, 2004, ADV FUNCT MATER, V14, P643, DOI 10.1002/adfm.200305162
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 54
TC 18
Z9 18
U1 1
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2015
VL 15
BP 181
EP 190
DI 10.1016/j.actbio.2014.11.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC7AT
UT WOS:000350520800018
PM 25481742
DA 2018-10-20
ER

PT J
AU Ahmed, MH
   Byrne, JA
   McLaughlin, J
AF Ahmed, Mukhtar H.
   Byrne, John A.
   McLaughlin, James
TI Kinetics and thermodynamics of human serum albumin adsorption on silicon
   doped diamond like carbon
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Chemical vapour deposition; Adsorption; Thermodynamic
ID DLC THIN-FILMS; AMORPHOUS-CARBON; PROTEIN ADSORPTION; SURFACE-TENSION;
   HEMOCOMPATIBILITY; ELLIPSOMETRY; GLYCINE; BIOMATERIALS; DEPOSITION;
   COMPONENTS
AB To gain a better understanding of protein adsorption onto biomaterial surfaces is required for the control of biocompatibility and bioactivity. Various samples of diamond like carbon (DLC) and silicon-doped DLC were synthesised using plasma enhanced chemical vapour deposition (PECVD). The effects of surface morphology on the interaction of human serum albumin (HSA) with doped and undoped DLC films was investigated using spectroscopic ellipsometry (SE) and other surface analysis techniques. The results highlighted an increase in both contact angle and hydrophobicity with increasing silicon dopant levels. A reduction on the contact angle values.
   After adsorption of HSA, the films showed a reduction in the contact angle with a significant change in the cosh, and this gap increased with increasing surface coverage of HSA. The adsorption kinetics of HSA were also investigated and revealed that the maximum adsorption occurred at pH 5.0 and the process involved chemisorption. The experimental isotherm data were analysed using the Langmuir and Freundlich models. The amount of HSA adsorbed increased with contact time and reached saturation after 30 min. The adsorption process was found to be pseudo first order with respect to the bulk concentration and was dependent on both the concentration of protein and surface characteristics of the samples. The amount of adsorbed HSA was higher with higher levels of silicon doping of the DLC. Therefore, doping DLC may provide an approach to controlling the protein adsorption. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ahmed, Mukhtar H.; Byrne, John A.; McLaughlin, James] Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Belfast BT37 0QB, Antrim, North Ireland.
RP Ahmed, MH (reprint author), Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Shore Rd, Belfast BT37 0QB, Antrim, North Ireland.
EM ahmed-m@email.ulster.ac.uk
OI McLaughlin, James/0000-0001-6026-8971; Byrne, John/0000-0001-9527-7659
CR Ahmed M, 2012, J MATER SCI, V47, P1729, DOI 10.1007/s10853-011-5952-3
   Ahmed M. H., 2013, J BIOMATER NANOBIOTE, V4, P194
   Ahmed MH, 2013, J PHOTOCH PHOTOBIO A, V254, P1, DOI 10.1016/j.jphotochem.2012.12.019
   Ahmed MH, 2012, SURF COAT TECH, V209, P8, DOI 10.1016/j.surfcoat.2012.07.011
   Ahmed MH, 2012, APPL SURF SCI, V258, P5166, DOI 10.1016/j.apsusc.2012.01.162
   Alves CM, 2010, J R SOC INTERFACE, V7, P1367, DOI 10.1098/rsif.2010.0022
   ARWIN H, 1984, THIN SOLID FILMS, V113, P101, DOI 10.1016/0040-6090(84)90019-1
   Bayramoglu G, 2005, BIOCHEM ENG J, V26, P12, DOI 10.1016/j.bej.2005.06.002
   Bayramoglu G, 2007, COLLOID SURFACE A, V294, P56, DOI 10.1016/j.colsurfa.2006.07.043
   Benesch J, 2002, J COLLOID INTERF SCI, V249, P84, DOI 10.1006/jcis.2002.8247
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   Chan D, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435703
   Chen LY, 2003, DIAM RELAT MATER, V12, P968, DOI 10.1016/S0925-9635(02)00351-5
   Choi HW, 2008, DIAM RELAT MATER, V17, P252, DOI 10.1016/j.diamond.2007.12.034
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Damasceno JC, 2000, SURF COAT TECH, V133, P247, DOI 10.1016/S0257-8972(00)00932-4
   Fedosenko G, 2002, THIN SOLID FILMS, V406, P275, DOI 10.1016/S0040-6090(01)01768-0
   Feng WC, 2009, J VAC SCI TECHNOL B, V27, P1559, DOI 10.1116/1.3077271
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P191, DOI 10.1016/0304-3894(95)00156-5
   Golden J.H., 2001, SEMICOND INT, V79
   Goswami S, 2005, WATER SA, V31, P597
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Hameed BH, 2008, J HAZARD MATER, V158, P65, DOI 10.1016/j.jhazmat.2008.01.034
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Howland MC, 2007, BIOPHYS J, V92, P1306, DOI 10.1529/biophysj.106.097071
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Ji XL, 2011, J BIOMOL STRUCT DYN, V28, P621, DOI 10.1080/07391102.2011.10508598
   Kassab A, 2000, J CHROMATOGR B, V746, P123, DOI 10.1016/S0378-4347(00)00311-X
   KERKEB ML, 1993, J COLLOID INTERF SCI, V159, P439, DOI 10.1006/jcis.1993.1344
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Liu BL, 2006, APPL SURF SCI, V252, P7830, DOI 10.1016/j.apsusc.2005.09.058
   Liu M., 2012, INT J RES REV APPL S, V11, P67
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Lousinian S, 2007, BIOMOL ENG, V24, P107, DOI 10.1016/j.bioeng.2006.05.014
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Mahajan SS, 1997, THIN SOLID FILMS, V302, P250, DOI 10.1016/S0040-6090(96)09519-3
   Martra G, 2002, RES CHEM INTERMEDIAT, V28, P359, DOI 10.1163/15685670260188665
   Mohsen-Nia M, 2012, PROTEIN J, V31, P150, DOI 10.1007/s10930-011-9384-3
   Ogwu AA, 2008, J BIOMED MATER RES B, V85B, P105, DOI 10.1002/jbm.b.30922
   Okpalugo TIT, 2006, J BIOMED MATER RES B, V78B, P222, DOI 10.1002/jbm.b.30459
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Robert D, 2000, APPL SURF SCI, V167, P51, DOI 10.1016/S0169-4332(00)00496-7
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Schnell S, 2004, BIOPHYS CHEM, V107, P165, DOI 10.1016/j.bpc.2003.09.003
   Tewari BB, 2007, COLLOID SURFACE A, V296, P264, DOI 10.1016/j.colsurfa.2006.10.007
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Yan WJ, 2013, SCI WORLD J, DOI 10.1155/2013/273023
   Zhang DQ, 2008, MATER CHEM PHYS, V112, P353, DOI 10.1016/j.matchemphys.2008.05.060
   Zhang S, 2006, THIN SOLID FILMS, V515, P66, DOI 10.1016/j.tsf.2005.12.037
   Zhang ZG, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/861804
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 55
TC 5
Z9 6
U1 1
U2 35
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 15
PY 2015
VL 154
BP 84
EP 93
DI 10.1016/j.matchemphys.2015.01.048
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC1BF
UT WOS:000350075500012
DA 2018-10-20
ER

PT J
AU Madeleine-Perdrillat, C
   Karbowiak, T
   Raya, J
   Gougeon, R
   Bodart, PR
   Debeaufort, F
AF Madeleine-Perdrillat, Claire
   Karbowiak, Thomas
   Raya, Jesus
   Gougeon, Regis
   Bodart, Philippe R.
   Debeaufort, Frederic
TI Water-induced local ordering of chitosan polymer chains in thin layer
   films
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Water; Structure; Polymer; Chitosan; NMR
ID SOLID-STATE NMR; RESIDUE CARBONYL CARBONS; ANGLE-SPINNING NMR;
   X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; ALPHA-CHITIN; FOOD APPLICATIONS;
   CHEMICAL-SHIFTS; SPECTROSCOPY; SALTS
AB Carbon-13 NMR (CP-MAS and FSLG H-1-C-13 HETCOR) have been applied to chitosan salt films synthesized in acetic acid and exposed to different relative humidity environments (32% or 75%) at 20 degrees C for 1 month. It gives insight in the relationship between structure and functional properties according to the hydration level of this biomaterial as a film. The acetate ions trapped in the chitosan act as structuring agents between chitosan chains for the low hydration state. But, increasing the moisture content induces spontaneous removal of acetic acid and a subsequent modification in the film structure, with an increase in local ordering. HETCOR experiments also showed a multiplicity of signals for most of the observed carbon atoms and in particular those implied in the glycosidic linkage, which reveals different water-induced conformational states. Changing the water content allows to modify the polymer structure and therefore to modulate the properties such as controlled release of active compounds trapped in chitosan-based coatings, e.g., for medicated dressing or active packaging. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Madeleine-Perdrillat, Claire; Karbowiak, Thomas; Gougeon, Regis; Debeaufort, Frederic] Univ Bourgogne, AgroSup Dijon, Equipe PAPC, UMR A PAM 02 102, F-21078 Dijon, France.
   [Raya, Jesus] Univ Strasbourg, Inst Chim, CNRS, UMR 7177, F-67008 Strasbourg, France.
   [Bodart, Philippe R.] IUT A Univ Sci & Technol Lille, F-59653 Villeneuve Dascq, France.
RP Karbowiak, T (reprint author), Univ Bourgogne, AgroSup Dijon, Equipe PAPC, UMR A PAM 02 102, 1 Esplanade Erasme, F-21078 Dijon, France.
EM thomas.karbowiak@u-bourgogne.fr
RI Gougeon, Regis/T-4069-2017; karbowiak, thomas/Q-2151-2018;
   Madeleine-Perdrillat, Claire/R-4347-2017
OI Gougeon, Regis/0000-0002-5371-5523; karbowiak,
   thomas/0000-0002-4229-3003; Madeleine-Perdrillat,
   Claire/0000-0001-7226-0344; DEBEAUFORT, Frederic/0000-0002-4760-0500
FU Regional Council of Burgundy [2012-9201AAO049S780]
FX This work was supported by the Regional Council of Burgundy through the
   project number 2012-9201AAO049S780.
CR Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   Cunha RA, 2012, COMPLEX WORLD OF POLYSACCHARIDES, P229, DOI 10.5772/51803
   DEMARGERANDRE S, 1994, CARBOHYD POLYM, V23, P211, DOI 10.1016/0144-8617(94)90104-X
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Domjan A, 2009, MACROMOLECULES, V42, P4667, DOI 10.1021/ma8021234
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Epure V, 2011, CARBOHYD POLYM, V83, P947, DOI 10.1016/j.carbpol.2010.09.003
   Franca EF, 2011, BIOPOLYMERS, V95, P448, DOI 10.1002/bip.21602
   Franca EF, 2008, J CHEM THEORY COMPUT, V4, P2141, DOI 10.1021/ct8002964
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y
   Kameda T, 1997, J MOL STRUCT, V412, P197, DOI 10.1016/S0022-2860(96)09529-4
   Kameda T, 2004, MACROMOL BIOSCI, V5, P103, DOI 10.1002/mabi.200400142
   Kameda T, 2004, J BIOMOL NMR, V29, P281, DOI 10.1023/B:JNMR.0000032557.71691.a2
   Kameda T, 1996, J MOL STRUCT, V384, P17, DOI 10.1016/S0022-2860(96)09322-2
   Kono H, 2004, BIOPOLYMERS, V75, P255, DOI 10.1002/bip.20124
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Lertworasirikul A, 2003, CARBOHYD RES, V338, P1229, DOI 10.1016/S0008-6215(03)00145-9
   Ferreira ML, 2008, COLLOID SURFACE A, V315, P241, DOI 10.1016/j.colsurfa.2007.08.006
   Murata K, 2003, POLYMER, V44, P4021, DOI 10.1016/S0032-3861(03)00351-3
   Ogawa K, 2004, INT J BIOL MACROMOL, V34, P1, DOI 10.1016/j.ijbiomac.2003.11.002
   Okuyama K, 1997, MACROMOLECULES, V30, P5849, DOI 10.1021/ma970509n
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   PETER MG, 1995, J MACROMOL SCI PURE, VA32, P629, DOI 10.1080/10601329508010276
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   Prathab B, 2007, J POLYM SCI POL PHYS, V45, P1260, DOI 10.1002/polb.21109
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   SAITO H, 1987, MACROMOLECULES, V20, P2424, DOI 10.1021/ma00176a017
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008
   vanRossum BJ, 1997, J MAGN RESON, V124, P516, DOI 10.1006/jmre.1996.1089
   Webster A, 2006, SOLID STATE NUCL MAG, V30, P150, DOI 10.1016/j.ssnmr.2006.07.001
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 38
TC 9
Z9 9
U1 0
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 15
PY 2015
VL 118
BP 107
EP 114
DI 10.1016/j.carbpol.2014.11.001
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AZ5KL
UT WOS:000348259900016
PM 25542114
DA 2018-10-20
ER

PT J
AU Chutipakdeevong, J
   Ruktanonchai, U
   Supaphol, P
AF Chutipakdeevong, Jesada
   Ruktanonchai, Uracha
   Supaphol, Pitt
TI Hybrid biomimetic electrospun fibrous mats derived from
   poly(epsilon-caprolactone) and silk fibroin protein for wound dressing
   application
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; biomedical applications; biomimetic; nanofiber
ID SCAFFOLDS; SURFACE; POLYCAPROLACTONE; PEPTIDE; STRATEGIES; RESPONSES;
   FIBERS; CELLS
AB To achieve excellent biofunctionality of Bombyx mori silk fibroin (SF), we explored a novel hybridization method to combine the unique properties of SF with poly(epsilon-caprolactone) (PCL) electrospun fibers. The hybrid electrospun fibers demonstrate excellent hydrophilicity and biocompatibility that are important to tissue engineering applications. The biomimetic fibrous structure was fabricated by conventional electrospinning of PCL. The individual surfaces of PCL electrospun fibers were coated with silk fibroin protein using a lyophilization technique. The SF coating layers were durable which were further developed by surface modification with fibronectin to improve their biological function. The hybrid electrospun fibers show excellent support for normal human dermal fibroblast (NHDF) cells adhesion and proliferation than neat PCL fibers, while the surface-modified hybrid electrospun fibers show significantly enhanced proliferation of NHDF cells on their surface. This study indicates the new opportunity of fabrication technique that can construct a biomimetic fibrous structure while the original function as a biomaterial remained existing. (c) 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 41653.
C1 [Chutipakdeevong, Jesada; Supaphol, Pitt] Chulalongkorn Univ, Petr & Petrochem Coll, Bangkok 10330, Thailand.
   [Ruktanonchai, Uracha] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr NANOTEC, Pathum Thani 12120, Thailand.
RP Ruktanonchai, U (reprint author), Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr NANOTEC, 111 Thailand Sci Pk,Paholyothin Rd, Pathum Thani 12120, Thailand.
EM uracha@nanotec.or.th
FU National Nanotechnology Center [BR0108]; 90th Anniversary of
   Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund);
   National Center of Excellence for Petroleum, Petrochemicals, and
   Advanced Materials (NCE-PPAM); Petroleum and Petrochemical College,
   Chulalongkorn University, Thailand; Thailand Graduate Institute of
   Science and Technology (TGIST) [TG-55-09-51-035D]
FX The authors acknowledge partial support received from the National
   Nanotechnology Center (grant number: BR0108), the 90th Anniversary of
   Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund),
   the National Center of Excellence for Petroleum, Petrochemicals, and
   Advanced Materials (NCE-PPAM), and the Petroleum and Petrochemical
   College, Chulalongkorn University, Thailand. J. Chutipakdeevong
   acknowledges a doctoral scholarship received from the Thailand Graduate
   Institute of Science and Technology (TGIST) (TG-55-09-51-035D).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Ahimou F, 2007, J COLLOID INTERF SCI, V309, P49, DOI 10.1016/j.jcis.2007.01.055
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Aznar-Cervantes SD, 2013, MAT SCI ENG C-MATER, V33, P1945, DOI 10.1016/j.msec.2013.01.001
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Chutipakdeevong J, 2013, J APPL POLYM SCI, V130, P3634, DOI 10.1002/app.39611
   Croisier F, 2012, ACTA BIOMATER, V8, P218, DOI 10.1016/j.actbio.2011.08.015
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   K-hasuwan PR, 2011, LANGMUIR, V27, P10938, DOI [10.1021/la20255w, 10.1021/la202255w]
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   Kim M, 2012, CARBOHYD POLYM, V90, P592, DOI 10.1016/j.carbpol.2012.05.082
   Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liao S, 2008, MAT SCI ENG C-BIO S, V28, P1189, DOI 10.1016/j.msec.2008.08.015
   Lim JS, 2012, BIOPOLYMERS, V97, P265, DOI 10.1002/bip.22016
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Okhawilai M, 2010, INT J BIOL MACROMOL, V46, P544, DOI 10.1016/j.ijbiomac.2010.02.008
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Satriano C, 2010, J COLLOID INTERF SCI, V341, P232, DOI 10.1016/j.jcis.2009.09.046
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wutticharoenmongkol P, 2006, J NANOSCI NANOTECHNO, V6, P514, DOI 10.1166/jnn.2006.090
   Zahedi P., 2009, POLYM ADVAN TECHNOL, V21, P77, DOI DOI 10.1002/PAT.1625
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 30
TC 8
Z9 8
U1 3
U2 137
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2015
VL 132
IS 11
AR 41653
DI 10.1002/app.41653
PG 11
WC Polymer Science
SC Polymer Science
GA AW6DK
UT WOS:000346359400032
DA 2018-10-20
ER

PT J
AU Shin, YC
   Lee, JH
   Jin, LH
   Kim, MJ
   Kim, YJ
   Hyun, JK
   Jung, TG
   Hong, SW
   Han, DW
AF Shin, Yong Cheol
   Lee, Jong Ho
   Jin, Linhua
   Kim, Min Jeong
   Kim, Yong-Joo
   Hyun, Jung Keun
   Jung, Tae-Gon
   Hong, Suck Won
   Han, Dong-Wook
TI Stimulated myoblast differentiation on graphene oxide-impregnated
   PLGA-collagen hybrid fibre matrices
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Electrospun fibre matrix; Poly(lactic-co-glycolic acid); Graphene oxide;
   Collagen; Myoblast differentiation; Skeletal tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE;
   IN-VITRO; BIOMEDICAL APPLICATIONS; NANOFIBER SCAFFOLDS;
   SURFACE-ROUGHNESS; VASCULAR GRAFTS; ELECTROSPUN; COMPOSITE
AB Background: Electrospinning is a simple and effective method for fabricating micro- and nanofiber matrices. Electrospun fibre matrices have numerous advantages for use as tissue engineering scaffolds, such as high surface area-to-volume ratio, mass production capability and structural similarity to the natural extracellular matrix (ECM). Therefore, electrospun matrices, which are composed of biocompatible polymers and various biomaterials, have been developed as biomimetic scaffolds for the tissue engineering applications. In particular, graphene oxide (GO) has recently been considered as a novel biomaterial for skeletal muscle regeneration because it can promote the growth and differentiation of myoblasts. Therefore, the aim of the present study was to fabricate the hybrid fibre matrices that stimulate myoblasts differentiation for skeletal muscle regeneration.
   Results: Hybrid fibre matrices composed of poly(lactic-co-glycolic acid, PLGA) and collagen (Col) impregnated with GO (GO-PLGA-Col) were successfully fabricated using an electrospinning process. Our results indicated that the GO-PLGA-Col hybrid matrices were comprised of randomly-oriented continuous fibres with a three-dimensional non-woven porous structure. Compositional analysis showed that GO was dispersed uniformly throughout the GO-PLGA-Col matrices. In addition, the hydrophilicity of the fabricated matrices was significantly increased by blending with a small amount of Col and GO. The attachment and proliferation of the C2C12 skeletal myoblasts were significantly enhanced on the GO-PLGA-Col hybrid matrices. Furthermore, the GO-PLGA-Col matrices stimulated the myogenic differentiation of C2C12 skeletal myoblasts, which was enhanced further under the culture conditions of the differentiation media.
   Conclusions: Taking our findings into consideration, it is suggested that the GO-PLGA-Col hybrid fibre matrices can be exploited as potential biomimetic scaffolds for skeletal tissue engineering and regeneration because these GO-impregnated hybrid matrices have potent effects on the induction of spontaneous myogenesis and exhibit superior bioactivity and biocompatibility.
C1 [Shin, Yong Cheol; Lee, Jong Ho; Jin, Linhua; Kim, Min Jeong; Hong, Suck Won; Han, Dong-Wook] Pusan Natl Univ, Dept Cogno Mechatron Engn & NanoIntegrat CognoMec, Pusan 609735, South Korea.
   [Kim, Yong-Joo] Chungnam Natl Univ, Dept Biosyst Machinery Engn, Daejeon 305764, South Korea.
   [Hyun, Jung Keun] Dankook Univ, Coll Med, Dept Rehabil Med, Cheonan 330714, South Korea.
   [Hyun, Jung Keun] Dankook Univ, BK21PLUS NBM Global Res Ctr, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Hyun, Jung Keun] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea.
   [Jung, Tae-Gon] Med Device Dev Ctr, Osong Med Innovat Fdn, Cheongju 363951, South Korea.
RP Hong, SW (reprint author), Pusan Natl Univ, Dept Cogno Mechatron Engn & NanoIntegrat CognoMec, Pusan 609735, South Korea.
EM swhong@pusan.ac.kr
OI Hong, Suck Won/0000-0001-7291-1020; Hyun, Jung Keun/0000-0001-9254-4424
FU Korea Health Technology R&D Project through Korea Health Industry
   Development Institute - Ministry of Health & Welfare, Republic of Korea
   [HI14C0522]
FX This research was supported by a grant of the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute,
   funded by the Ministry of Health & Welfare, Republic of Korea (No.
   HI14C0522).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Buckingham M, 2003, BIOESSAYS, V25, P13, DOI 10.1002/bies.10221
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Ciofani G, 2011, BIOMED MICRODEVICES, V13, P255, DOI 10.1007/s10544-010-9490-6
   COSSU G, 1995, P NATL ACAD SCI USA, V92, P2254, DOI 10.1073/pnas.92.6.2254
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   DONOVAN DL, 1990, J VASC SURG, V12, P531, DOI 10.1067/mva.1990.22707
   Grinou A, 2012, MACROMOL RES, V20, P84, DOI 10.1007/s13233-012-0002-9
   Guex AG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/021001
   GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709
   Hovhannisyan V, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046004
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Jung DJ, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-23
   KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310
   Khalil KA, 2013, INT J ELECTROCHEM SC, V8, P3483
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052
   Kumar A, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-10
   Lee EJ, 2014, J NANOSCI NANOTECHNO, V14, P8458, DOI 10.1166/jnn.2014.9922
   Lee JH, 2015, J BIOMED NANOTECHNOL, V11, P1461, DOI 10.1166/jbn.2015.2080
   Lee TJ, 2014, BIOCHEM BIOPH RES CO, V452, P174, DOI 10.1016/j.bbrc.2014.08.062
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pirooznia N, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-20
   Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Sabba D, 2013, SCRIPTA MATER, V68, P487, DOI 10.1016/j.scriptamat.2012.11.027
   Shin YC, 2014, INT J NANOMED, V9, P4067, DOI 10.2147/IJN.S68197
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451
   Standley HJ, 2001, DEVELOPMENT, V128, P1347
   Varela JN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-14
   Veerapandian M, 2012, INT J NANOMED, V7, P6123, DOI 10.2147/IJN.S38402
   Wang H, 2014, INT J NANOMED, V9, P1433, DOI 10.2147/IJN.S58783
   Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008
   Wu N, 2012, J MATER CHEM, V22, P17254, DOI 10.1039/c2jm33114d
   Wu SL, 2014, INT J NANOMED, V9, P1413, DOI 10.2147/IJN.S57946
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yoon OJ, 2012, MACROMOL RES, V20, P789, DOI 10.1007/s13233-012-0116-0
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang NN, 2011, CARBON, V49, P827, DOI 10.1016/j.carbon.2010.10.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zuo PP, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-39
NR 61
TC 47
Z9 48
U1 3
U2 146
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD MAR 12
PY 2015
VL 13
AR UNSP 21
DI 10.1186/s12951-015-0081-9
PG 11
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA CE5SK
UT WOS:000351895800001
PM 25886153
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, YW
   Mithieux, SM
   Kong, Y
   Wang, XQ
   Chong, C
   Fathi, A
   Dehghani, F
   Panas, E
   Kemnitzer, J
   Daniels, R
   Kimble, RM
   Maitz, PK
   Li, Z
   Weiss, AS
AF Wang, Yiwei
   Mithieux, Suzanne M.
   Kong, Yvonne
   Wang, Xue-Qing
   Chong, Cassandra
   Fathi, Ali
   Dehghani, Fariba
   Panas, Eleni
   Kemnitzer, John
   Daniels, Robert
   Kimble, Roy M.
   Maitz, Peter K.
   Li, Zhe
   Weiss, Anthony S.
TI Tropoelastin Incorporation into a Dermal Regeneration Template Promotes
   Wound Angiogenesis
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE dermal substitute; integra; skin; tropoelastin; wound healing
ID EXTRACELLULAR-MATRIX; COMPOSITE SCAFFOLDS; SKIN SUBSTITUTES; ELASTIN;
   FABRICATION; ENHANCE; CELLS; TRIAL
AB Severe burn injury results in substantial skin loss and cannot be treated by autografts. The Integra Dermal Regeneration Template (IDRT) is the leading synthetic skin substitute because it allows for wound bed regeneration and wound healing. However, all substitutes suffer from slow blood vessel ingrowth and would benefit considerably from enhanced vascularization to nurture tissue repair. It is shown here that by incorporating the human elastic protein tropoelastin into a dermal regeneration template (TDRT) we can promote angiogenesis in wound healing. In small and large animal models comprising mice and pigs, the hybrid TDRT biomaterial and IDRT show similar contraction to autografts and decrease wound contraction compared to open wounds. In mice, TDRT accelerates early stage angiogenesis by 2 weeks, as evidenced by increased angiogenesis fluorescent radiant efficiency in live animal imaging and the expression of endothelial cell adhesion marker CD146. In the pig, a full thickness wound repair model confirms increased numbers of blood vessels in the regenerating areas of the dermis closest to the hypodermis and immediately below the epidermis at 2 weeks post-surgery. It is concluded that including tropoelastin in a dermal regeneration template has the potential to promote wound repair through enhanced vascularization.
C1 [Wang, Yiwei; Chong, Cassandra; Maitz, Peter K.; Li, Zhe] Univ Sydney, ANZAC Res Inst, Burns Res Grp, Concord, NSW 2139, Australia.
   [Mithieux, Suzanne M.; Kong, Yvonne; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Mithieux, Suzanne M.; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Wang, Xue-Qing; Kimble, Roy M.] Univ Queensland, Queensland Childrens Med Res Inst, Ctr Childrens Burns & Trauma Res, Brisbane, Qld 4072, Australia.
   [Wang, Xue-Qing; Kimble, Roy M.] Royal Childrens Hosp, Stuart Pegg Paediat Burns Ctr, Brisbane, Qld, Australia.
   [Fathi, Ali; Dehghani, Fariba] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia.
   [Panas, Eleni; Kemnitzer, John] Integra Life Sci, Plainsboro, NJ USA.
   [Daniels, Robert] Elastagen Pty Ltd, N Ryde, NSW 2015, Australia.
   [Maitz, Peter K.; Li, Zhe] Concord Repatriat Gen Hosp, Burns & Reconstruct Surg Unit, Concord, NSW 2139, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
OI Dehghani, Fariba/0000-0002-7805-8101; WEISS,
   ANTHONY/0000-0002-8106-4836; Mithieux, Suzanne/0000-0001-6160-9352;
   Kimble, Roy/0000-0002-2449-7707
FU Australian Research Council; National Health and Medical Research
   Council
FX Y.W. and S.M.M. contributed equally to this work. The authors
   acknowledge funding from the Australian Research Council (A.S.W.) and
   the National Health and Medical Research Council (A.S.W. and R.K.). The
   authors acknowledge the facilities and the scientific and technical
   assistance of the Australian Microscopy & Microanalysis Research
   Facility at the Australian Centre for Microscopy & Microanalysis at the
   University of Sydney. A.S.W. is the Scientific Founder of Elastagen Pty
   Ltd.
CR Almine JF, 2013, FASEB J, V27, P3455, DOI 10.1096/fj.13-231787
   Almine JF, 2012, BIRTH DEFECTS RES C, V96, P248, DOI 10.1002/bdrc.21016
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Annabi N, 2011, J SUPERCRIT FLUID, V59, P157, DOI 10.1016/j.supflu.2011.06.010
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019
   Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Daamen WF, 2006, J CONTROL RELEASE, V116, pE84, DOI 10.1016/j.jconrel.2006.09.062
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   Fathi A, 2013, POLYMER, V54, P5534, DOI 10.1016/j.polymer.2013.08.052
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Kamath NV, 2002, J CUTAN PATHOL, V29, P27, DOI 10.1034/j.1600-0560.2002.290105.x
   Lagus H, 2013, BURNS, V39, P1577, DOI 10.1016/j.burns.2013.04.023
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Rnjak J, 2011, TISSUE ENG PART B-RE, V17, P81, DOI [10.1089/ten.teb.2010.0452, 10.1089/ten.TEB.2010.0452]
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x
   Soliman S, 2010, ACTA BIOMATER, V6, P1227, DOI 10.1016/j.actbio.2009.10.051
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   van der Veen VC, 2010, BURNS, V36, P305, DOI 10.1016/j.burns.2009.07.012
   van Zuijlen PPM, 2002, BURNS, V28, P151, DOI 10.1016/S0305-4179(01)00085-7
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   ZIMMERMAN TJ, 1982, OPHTHALMOLOGY, V89, P76
NR 28
TC 13
Z9 13
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 11
PY 2015
VL 4
IS 4
BP 577
EP 584
DI 10.1002/adhm.201400571
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CD6UR
UT WOS:000351225700013
PM 25469903
DA 2018-10-20
ER

PT J
AU Kim, SJ
   Jeon, DB
   Park, JH
   Ryu, MK
   Yang, JH
   Hwang, CS
   Kim, GH
   Yoon, SM
AF Kim, So-Jung
   Jeon, Da-Bin
   Park, Jung-Ho
   Ryu, Min-Ki
   Yang, Jong-Heon
   Hwang, Chi-Sun
   Kim, Gi-Heon
   Yoon, Sung-Min
TI Nonvolatile Memory Thin-Film Transistors Using Biodegradable Chicken
   Albumen Gate Insulator and Oxide Semiconductor Channel on Eco-Friendly
   Paper Substrate
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE eco-friendly device; nonvolatile memory; paper substrate; chicken
   albumen dielectric; oxide semiconductor
AB Nonvolatile memory thin-film transistors (TFTs) fabricated on paper substrates were proposed as one of the eco-friendly electronic devices. The gate stack was composed of chicken albumen gate insulator and In-Ga-Zn-O semiconducting channel layers. All the fabrication processes were performed below 120 degrees C. To improve the process compatibility of the synthethic paper substrate, an Al2O3 thin film was introduced as adhesion and barrier layers by atomic layer deposition. The dielectric properties of biomaterial albumen gate insulator were also enhanced by the preparation of Al2O3 capping layer. The nonvolatile bistabilities were realized by the switching phenomena of residual polarization within the albumen thin film. The fabricated device exhibited a counterclockwise hysteresis with a memory window of 11.8 V, high on/off ratio of approximately 1.1 x 10(6), and high saturation mobility (mu sat) of 11.5 cm(2)/(V s). Furthermore, these device characteristics were not markedly degraded even after the delamination and under the bending situration. When the curvature radius was set as 5.3 cm, the I-ON/I-OFF ratio and mu(sat) were obtained to be 5.9 x 10(6) and 7.9 cm(2)/(V s), respectively.
C1 [Kim, So-Jung; Jeon, Da-Bin; Park, Jung-Ho; Yoon, Sung-Min] Kyung Hee Univ, Dept Adv Mat Engn Informat & Elect, Yongin 446701, Gyeonggi Do, South Korea.
   [Ryu, Min-Ki; Yang, Jong-Heon; Hwang, Chi-Sun; Kim, Gi-Heon] Elect & Telecommun Res Inst, Informat & Commun Core Technol Res Lab, Daejeon 305730, South Korea.
RP Yoon, SM (reprint author), Kyung Hee Univ, Dept Adv Mat Engn Informat & Elect, Yongin 446701, Gyeonggi Do, South Korea.
EM sungmin@khu.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government (MEST)
   [2014063718]; MSIP (Ministry of Science, ICT & Future Planning), Korea
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean government (MEST) (2014063718). This
   research was also funded by the MSIP (Ministry of Science, ICT & Future
   Planning), Korea in the ICT R&D Program (the core technology development
   of light and space adaptable energy-saving I/O platform for future
   advertising service).
CR Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Jeon DB, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.128002
   Khanna R, 2010, J VAC SCI TECHNOL B, V28, pL43, DOI 10.1116/1.3467507
   Li Y, 2012, ORG ELECTRON, V13, P815, DOI 10.1016/j.orgel.2012.01.021
   Lien DH, 2014, ACS NANO, V8, P7613, DOI 10.1021/nn501231z
   Lim W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309753
   Lim W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086394
   Lu AX, 2011, IEEE ELECTR DEVICE L, V32, P518, DOI 10.1109/LED.2011.2107550
   Martins R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3030873
   Mazzeo AD, 2012, ADV MATER, V24, P2850, DOI 10.1002/adma.201200137
   Russo A, 2011, ADV MATER, V23, P3426, DOI 10.1002/adma.201101328
   Siegel AC, 2009, LAB CHIP, V9, P2775, DOI 10.1039/b905832j
   Yoon SM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/245101
NR 13
TC 16
Z9 16
U1 3
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 4
PY 2015
VL 7
IS 8
BP 4869
EP 4874
DI 10.1021/am508834y
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CG1AL
UT WOS:000353005300053
PM 25679117
DA 2018-10-20
ER

PT J
AU Pedron, S
   Becka, E
   Harley, BA
AF Pedron, Sara
   Becka, Eftalda
   Harley, Brendan A.
TI Spatially Gradated Hydrogel Platform as a 3D Engineered Tumor
   Microenvironment
SO ADVANCED MATERIALS
LA English
DT Article
ID STEM-CELL CULTURE; INVASION IN-VITRO; HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; GLIOBLASTOMA CELLS; GLIOMA INVASION; GENERATION;
   CANCER; MATRIX-METALLOPROTEINASE-9; HETEROGENEITY
AB There is an acute need for biomaterial tools that recreate the heterogeneous brain-tumor microenvironment. A microfluidic mixing tool is reported to encapsulate glioblastoma multiforme cells within miniaturized gelatin hydrogels containing overlapping patterns of tumor-inspired matrix signals. This approach permits in situ analysis of glioma cells at the molecular and genomic level as well as the potential for clinical insight.
C1 [Pedron, Sara; Becka, Eftalda] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Harley, Brendan A.] Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Roger Adams Lab 110, Urbana, IL 61801 USA.
RP Harley, BA (reprint author), Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Roger Adams Lab 110, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Pedron, Sara/E-6404-2015
OI Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1254738]; Illini 4000; Department of
   Chemical & Biomolecular Engineering; Institute for Genomic Biology at
   the University of Illinois at Urbana-Champaign
FX The authors would like to acknowledge Mr. Bhushan Mahadik for assistance
   with microfluidic mixer fabrication, Harshita Polishetty for assistance
   with hydrogel fabrication, Dr. Mayandi Sivaguru (IGB, UIUC) for
   assistance with fluorescence imaging, and Prof. Paul Kenis (University
   of Illinois) for access to soft lithography facilities. This material is
   based upon work supported by the National Science Foundation under Grant
   No. 1254738. The authors are grateful for funding provided by the Illini
   4000. The authors are also grateful for additional funding provided by
   the Department of Chemical & Biomolecular Engineering and the Institute
   for Genomic Biology at the University of Illinois at Urbana-Champaign.
CR Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047
   Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58
   Binda Elena, 2012, Front Biosci (Schol Ed), V4, P1235
   Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153
   Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Hambardzumyan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024454
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028
   Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Kondraganti S, 2000, CANCER RES, V60, P6851
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Mahadik BP, 2014, ADV HEALTHC MATER, V3, P449, DOI 10.1002/adhm.201300263
   MERZAK A, 1994, CANCER RES, V54, P3988
   Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5
   Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.2755/jcmm010.003.01
   Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011
   Park MJ, 2002, CANCER RES, V62, P6318
   Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Radotra B, 1997, J PATHOL, V181, P434
   Reynolds BA, 2009, CELL STEM CELL, V5, P466, DOI 10.1016/j.stem.2009.10.017
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110
   Tanaka S, 2013, NAT REV CLIN ONCOL, V10, P14, DOI 10.1038/nrclinonc.2012.204
   Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y
   Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Wiranowska M., 2011, GLIOMA EXPLORING ITS
   Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039
NR 37
TC 35
Z9 36
U1 4
U2 104
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1567
EP +
DI 10.1002/adma.201404896
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100011
PM 25521283
DA 2018-10-20
ER

PT J
AU Reategui, E
   Aceto, N
   Lim, EJ
   Sullivan, JP
   Jensen, AE
   Zeinali, M
   Martel, JM
   Aranyosi, AJ
   Li, W
   Castleberry, S
   Bardia, A
   Sequist, LV
   Haber, DA
   Maheswaran, S
   Hammond, PT
   Toner, M
   Stott, SL
AF Reategui, Eduardo
   Aceto, Nicola
   Lim, Eugene J.
   Sullivan, James P.
   Jensen, Anne E.
   Zeinali, Mahnaz
   Martel, Joseph M.
   Aranyosi, Alexander J.
   Li, Wei
   Castleberry, Steven
   Bardia, Aditya
   Sequist, Lecia V.
   Haber, Daniel A.
   Maheswaran, Shyamala
   Hammond, Paula T.
   Toner, Mehmet
   Stott, Shannon L.
TI Tunable Nanostructured Coating for the Capture and Selective Release of
   Viable Circulating Tumor Cells
SO ADVANCED MATERIALS
LA English
DT Article
ID BREAST-CANCER; EFFICIENT CAPTURE; MELANOMA-CELLS; WHOLE-BLOOD;
   NANOMATERIALS; METASTASIS; MUTATIONS; EGFR
AB A layer-by-layer gelatin nanocoating is presented for use as a tunable, dual response biomaterial for the capture and release of circulating tumor cells (CTCs) from cancer patient blood. The entire nanocoating can be dissolved from the surface of microfluidic devices through biologically compatible temperature shifts. Alternatively, individual CTCs can be released through locally applied mechanical stress.
C1 [Reategui, Eduardo; Lim, Eugene J.; Jensen, Anne E.; Zeinali, Mahnaz; Martel, Joseph M.; Aranyosi, Alexander J.; Toner, Mehmet; Stott, Shannon L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Charlestown, MA 02129 USA.
   [Reategui, Eduardo; Martel, Joseph M.; Toner, Mehmet; Stott, Shannon L.] Harvard Univ, Sch Med, Shriners Hosp Children, Boston, MA 02114 USA.
   [Reategui, Eduardo; Martel, Joseph M.; Toner, Mehmet] Harvard Univ, Med Sch 55, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.
   [Aceto, Nicola; Sullivan, James P.; Bardia, Aditya; Sequist, Lecia V.; Haber, Daniel A.; Maheswaran, Shyamala] Harvard Univ, Med Sch Boston, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.
   [Lim, Eugene J.] MIT, Dept Elect Engn, Cambridge, MA 02139 USA.
   [Li, Wei; Castleberry, Steven; Hammond, Paula T.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Stott, Shannon L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
RP Stott, SL (reprint author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Bldg 114,16th St, Charlestown, MA 02129 USA.
EM sstott@mgh.harvard.edu
RI Li, Wei/P-3546-2016
OI Li, Wei/0000-0002-4738-1475; Aceto, Nicola/0000-0001-9579-6918;
   Reategui, Eduardo/0000-0002-8271-8205; Aranyosi,
   Alexander/0000-0002-8133-5026
FU Stand Up to Cancer; Howard Hughes Medical Institute; NIH [CA129933, P41
   EB002503-11]; National Institute for Biomedical Imaging and
   Bioengineering (NIBIB) [EB008047]
FX The authors acknowledge all our patients who participated in this study
   and the healthy volunteers who kindly donated their blood. Blood
   specimens for CTC isolation were obtained after informed patient consent
   according to institutional review board (IRB) protocol (05-300), at the
   Massachusetts General Hospital. This work was supported by grants from
   Stand Up to Cancer (D.A.H., M.T., S.M.), Howard Hughes Medical Institute
   (D.A.H.), NIH CA129933 (D.A.H.), National Institute for Biomedical
   Imaging and Bioengineering (NIBIB) EB008047 (M.T., D.A.H.), NIH P41
   EB002503-11 (M.T.). Thanks to Laura Libby and Octavio Hurtado for expert
   technical support. Thanks to Bavand Keshavarz for helping with microtip
   design, Matthew Phillips for the CTC enumeration scans, Thomas Carey for
   the atomic force microscopy analysis, and Charles P. Lai for the
   nanoparticle size characterization.
CR Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013
   Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022
   Antonyak M. A., 2011, P NATL ACAD SCI US
   Chen L, 2011, ADV MATER, V23, P4376, DOI 10.1002/adma.201102435
   Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Cristofanilli M, 2006, P NATL ACAD SCI USA, V103, P17073, DOI 10.1073/pnas.0608651103
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   GLAVES D, 1988, BRIT J CANCER, V57, P32, DOI 10.1038/bjc.1988.4
   Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a
   Hou S, 2013, ANGEW CHEM INT EDIT, V52, P3379, DOI 10.1002/anie.201208452
   Hou S, 2013, ADV MATER, V25, P1547, DOI 10.1002/adma.201203185
   Luo X, 2014, CELL REP, V7, P645, DOI 10.1016/j.celrep.2014.03.039
   Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616
   Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270
   Powell A. A., 2012, PLOS ONE, V7, P33788
   Ran R, 2013, ANAL BIOANAL CHEM, V405, P7377, DOI 10.1007/s00216-013-7156-y
   Shah AM, 2012, ANAL CHEM, V84, P3682, DOI 10.1021/ac300190j
   Shen QL, 2013, ADV MATER, V25, P2368, DOI 10.1002/adma.201300082
   Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107
   Vizio D. D., 2012, AM J PATHOL, V181, P1573
   Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853
   Westwood M, 2010, MACROMOLECULES, V43, P10582, DOI 10.1021/ma101466w
   Xie M, 2014, ANAL CHEM, V86, P4618, DOI 10.1021/ac500820p
   Yoon HJ, 2014, ACS NANO, V8, P1995, DOI 10.1021/nn5004277
   Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194
   Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522
   Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217
   Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021
   Zhao LB, 2013, ADV MATER, V25, P2897, DOI 10.1002/adma.201205237
   Zhao WA, 2012, P NATL ACAD SCI USA, V109, P19626, DOI 10.1073/pnas.1211234109
NR 33
TC 64
Z9 65
U1 20
U2 247
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1593
EP +
DI 10.1002/adma.201404677
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100015
PM 25640006
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rutz, AL
   Hyland, KE
   Jakus, AE
   Burghardt, WR
   Shah, RN
AF Rutz, Alexandra L.
   Hyland, Kelly E.
   Jakus, Adam E.
   Burghardt, Wesley R.
   Shah, Ramille N.
TI A Multimaterial Bioink Method for 3D Printing Tunable, Cell-Compatible
   Hydrogels
SO ADVANCED MATERIALS
LA English
DT Article
ID CROSS-LINKING; POTENTIAL BIOMATERIALS; HYALURONIC-ACID; SCAFFOLDS;
   DELIVERY; BIOFABRICATION; FABRICATION; MATRICES; GROWTH; CARBODIIMIDE
AB A multimaterial bio-ink method using polyethylene glycol crosslinking is presented for expanding the biomaterial palette required for 3D bio printing of more mimetic and customizable tissue and organ constructs. Lightly crosslinked, soft hydrogels are produced from precursor solutions of various materials and 3D printed. Rheological and biological characterizations are presented, and the promise of this new bio-ink synthesis strategy is discussed.
C1 [Rutz, Alexandra L.; Hyland, Kelly E.; Jakus, Adam E.; Shah, Ramille N.] Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
   [Rutz, Alexandra L.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Hyland, Kelly E.; Jakus, Adam E.; Burghardt, Wesley R.; Shah, Ramille N.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Burghardt, Wesley R.] Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shah, Ramille N.] Northwestern Univ, Feinberg Sch Med, Dept Surg Organ Transplantat, Chicago, IL 60611 USA.
RP Shah, RN (reprint author), Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
EM ramille-shah@northwestern.edu
RI Burghardt, Wesley/B-7642-2009; Shah, Ramille/E-3737-2010
FU NCI CCSG [P30 CA060553]; NSF [DMR-0520513]; Engineering Center
   [EEC-0118025|003]; Peptide and Equipment Core Facilities at the Simpson
   Querrey Institute for BioNanotechnology at Northwestern University from
   U.S. Army Research Office; U.S. Army Medical Research and Materiel
   Command; Northwestern University; National Institutes of Health
   [1K01DK099454-01]; National Science Foundation
FX The authors thank Sumanas W. Jordan and Phillip L. Lewis for assistance
   with printing cell encapsulating bioinks. They would also like to thank
   the Woodruff Lab (PI: Teresa Woodruff, Ph.D.) at Northwestern University
   for gracious use of their Leica stereoscope as well as Peter Rios (PI:
   Lonnie Shea, Ph.D.) for use of their UV lamp. They also acknowledge use
   of the following facilities: Northwestern University Cell Imaging
   Facility generously supported by NCI CCSG P30 CA060553 awarded to the
   Robert H Lurie Comprehensive Cancer Center, EPIC facility (NUANCE
   Center-Northwestern University) which has received support from NSF
   DMR-0520513 and Engineering Center EEC-0118025|003, and the Peptide and
   Equipment Core Facilities at the Simpson Querrey Institute for
   BioNanotechnology at Northwestern University developed by support from
   the U.S. Army Research Office, the U.S. Army Medical Research and
   Materiel Command, and Northwestern University. This work was supported
   by the National Institutes of Health (1K01DK099454-01) and National
   Science Foundation (Graduate Research Fellowship for A.L.R.).
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079
   Chang CC, 2011, J BIOMED MATER RES B, V98B, P160, DOI 10.1002/jbm.b.31831
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gorgieva S, 2012, J BIOMED MATER RES A, V100A, P1655, DOI 10.1002/jbm.a.34106
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Khalil S., 2009, J BIOMECH ENG, V131, P1, DOI 10.1115/1.3129729
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Loozen LD, 2013, J MATER CHEM B, V1, P6619, DOI 10.1039/c3tb21093f
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pati F., 2014, NAT COMMUN, V5, P1
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ringeisen BR, 2013, MRS BULL, V38, P834, DOI 10.1557/mrs.2013.209
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Skardal A, 2012, BIOMATERIALS, V33, P4565, DOI 10.1016/j.biomaterials.2012.03.034
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 47
TC 132
Z9 134
U1 46
U2 466
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 4
PY 2015
VL 27
IS 9
BP 1607
EP +
DI 10.1002/adma.201405076
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC7IO
UT WOS:000350541100017
PM 25641220
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Mehdizadeh, H
   Somo, SI
   Bayrak, ES
   Brey, EM
   Cinar, A
AF Mehdizadeh, Hamidreza
   Somo, Sami I.
   Bayrak, Elif S.
   Brey, Eric M.
   Cinar, Ali
TI Design of Polymer Scaffolds for Tissue Engineering Applications
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID WOUND-HEALING ANGIOGENESIS; CAPILLARY FORMATION; TUMOR ANGIOGENESIS;
   MULTICELLULAR PATTERNS; SPROUTING ANGIOGENESIS; MATHEMATICAL-MODEL;
   VASCULARIZED BONE; CELL PHENOTYPES; SIMULATION; VEGF
AB Agent-based models (ABMs) provide a flexible multilayer platform for incorporating various modeling techniques into a single hybrid model for designing optimal biomaterial scaffolds for angiogenesis in tissue engineering applications. Scaffold geometrical variables are considered as design variables. The growth-factor concentration profile is the only process variable considered in this study. The product variables used to illustrate the combined effects of scaffold design variables and process variables on the outcome of angiogenesis include the density and depth of capillary invasion within the scaffold. The scaffold design process and the ABM developed to simulate angiogenesis are described in this article. The performance of the ABM and the vascularization of the polymer scaffolds are evaluated by simulation studies. The effects of pore size, pore size distribution, and interconnectivity on the total blood vessel length, invasion depth, and total number of sprouts formed during the vascularization process are reported. The integration of the simulation of angiogenesis with ABMs and scaffold design techniques provides an iterative process for designing optimal scaffold structures. Such an approach facilitates faster design of optimized scaffolds with significantly less cost and enables better understanding of the mechanisms of angiogenesis of polymer scaffolds for tissue engineering applications.
C1 [Mehdizadeh, Hamidreza; Somo, Sami I.; Bayrak, Elif S.; Brey, Eric M.; Cinar, Ali] IIT, Chicago, IL 60616 USA.
RP Cinar, A (reprint author), IIT, 3300 S Fed St, Chicago, IL 60616 USA.
EM cinar@iit.edu
OI Cinar, Ali/0000-0002-1607-9943
FU National Science Foundation [CBET-0731201, IIS-1125412]; Veterans
   Administration
FX This material is based on work supported in part by the National Science
   Foundation (CBET-0731201 and IIS-1125412) and the Veterans
   Administration.
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019
   Ausk BJ, 2006, J BIOMECH, V39, P2638, DOI 10.1016/j.jbiomech.2005.08.023
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   BALDING D, 1985, J THEOR BIOL, V114, P53, DOI 10.1016/S0022-5193(85)80255-1
   Behdani B, 2011, IND ENG CHEM RES, V50, P5086, DOI 10.1021/ie101554b
   Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015
   Blinder YJ, 2014, CURR OPIN CHEM ENG, V3, P56, DOI 10.1016/j.coche.2013.11.003
   Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   BYRNE HM, 1995, B MATH BIOL, V57, P461, DOI 10.1016/S0092-8240(05)81778-1
   Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377
   Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Dia H, 2002, TRANSPORT RES C-EMER, V10, P331, DOI 10.1016/S0968-090X(02)00025-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutton DL, 2014, CURR OPIN CHEM ENG, V3, P75, DOI 10.1016/j.coche.2013.12.002
   Jabbarzadeh E, 2007, TISSUE ENG, V13, P2073, DOI 10.1089/ten.2006.0057
   Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2014, CURR OPIN CHEM ENG, V3, pV, DOI 10.1016/j.coche.2014.01.003
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lemon G, 2011, BIOSYSTEMS, V103, P372, DOI 10.1016/j.biosystems.2010.11.009
   Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240
   Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6
   Long BL, 2013, J THEOR BIOL, V326, P43, DOI 10.1016/j.jtbi.2012.11.030
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lu TL, 2013, INT J NANOMED, V8, P337, DOI 10.2147/IJN.S38635
   Mansbridge J, 2006, J ANAT, V209, P527, DOI 10.1111/j.1469-7580.2006.00631.x
   MEHDIZADEH H, 2011, AGENTS PRINCIPLE AGE, V7047, P113
   Mehdizadeh H., 2014, VASCULARIZATION REGE
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Morreale P, 1998, IEEE SPECTRUM, V35, P34, DOI 10.1109/6.666958
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Olsen L, 1997, IMA J MATH APPL MED, V14, P261
   Orme ME, 1997, IMA J MATH APPL MED, V14, P189
   Peirce SM, 2012, CURR OPIN HEMATOL, V19, P184, DOI 10.1097/MOH.0b013e3283523ea6
   Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331
   Peirce SM, 2004, FASEB J, V18, P731, DOI 10.1096/fj.03-0933fje
   Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018
   Saltzman W. M., 2004, TISSUE ENG ENG PRINC
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Smith Q, 2014, CURR OPIN CHEM ENG, V3, P42, DOI 10.1016/j.coche.2013.11.001
   STOKES CL, 1991, J THEOR BIOL, V152, P377, DOI 10.1016/S0022-5193(05)80201-2
   Tesfatsion L, 2002, ARTIF LIFE, V8, P55, DOI 10.1162/106454602753694765
   Thorne Bryan C., 2007, Birth Defects Research, V81, P344, DOI 10.1002/bdrc.20106
   Tien J, 2014, CURR OPIN CHEM ENG, V3, P36, DOI 10.1016/j.coche.2013.10.006
   Vempati P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-59
   Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009
   ZAWICKI DF, 1981, MICROVASC RES, V21, P27, DOI 10.1016/0026-2862(81)90003-0
   Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034
NR 71
TC 3
Z9 3
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAR 4
PY 2015
VL 54
IS 8
BP 2317
EP 2328
DI 10.1021/ie503133e
PG 12
WC Engineering, Chemical
SC Engineering
GA CC8JT
UT WOS:000350615200007
DA 2018-10-20
ER

PT J
AU Dehoux, T
   Ghanem, MA
   Zouani, OF
   Rampnoux, JM
   Guillet, Y
   Dilhaire, S
   Durrieu, MC
   Audoin, B
AF Dehoux, T.
   Ghanem, M. Abi
   Zouani, O. F.
   Rampnoux, J. -M.
   Guillet, Y.
   Dilhaire, S.
   Durrieu, M. -C.
   Audoin, B.
TI All-optical broadband ultrasonography of single cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; ACOUSTIC MICROSCOPY; PICOSECOND ULTRASONICS;
   LIVING CELLS; LIVE CELLS; RESOLUTION; MECHANICS; MEMBRANE
AB Cell mechanics play a key role in several fundamental biological processes, such as migration, proliferation, differentiation and tissue morphogenesis. In addition, many diseased conditions of the cell are correlated with altered cell mechanics, as in the case of cancer progression. For this there is much interest in methods that can map mechanical properties with a sub-cell resolution. Here, we demonstrate an inverted pulsed opto-acoustic microscope (iPOM) that operates in the 10 to 100 GHz range. These frequencies allow mapping quantitatively cell structures as thin as 10 nm and resolving the fibrillar details of cells. Using this non-invasive all-optical system, we produce high-resolution images based on mechanical properties as the contrast mechanisms, and we can observe the stiffness and adhesion of single migrating stem cells. The technique should allow transferring the diagnostic and imaging abilities of ultrasonic imaging to the single-cell scale, thus opening new avenues for cell biology and biomaterial sciences.
C1 [Dehoux, T.; Ghanem, M. Abi; Guillet, Y.; Audoin, B.] Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
   [Dehoux, T.; Ghanem, M. Abi; Guillet, Y.; Audoin, B.] CNRS, I2M, UMR 5295, F-33400 Talence, France.
   [Zouani, O. F.; Durrieu, M. -C.] Univ Bordeaux, CBMN, UMR CNRS 5248, F-33607 Pessac, France.
   [Rampnoux, J. -M.; Dilhaire, S.] Univ Bordeaux, CNRS, LOMA, UMR 5798, F-33400 Talence, France.
RP Audoin, B (reprint author), Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
EM bertrand.audoin@u-bordeaux.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; dehoux,
   thomas/0000-0003-0808-4037
FU Agence Nationale de la Recherche [ANR-13-BS09-0021-01]; Region
   Aquitaine; GIS Advanced Materials in Aquitaine
FX T.D., B.A. and M.C.D. acknowledge financial support from the Agence
   Nationale de la Recherche (grant no. ANR-13-BS09-0021-01), the Region
   Aquitaine and the GIS Advanced Materials in Aquitaine.
CR Abbas A, 2014, OPT EXPRESS, V22, P7831, DOI 10.1364/OE.22.007831
   Abi Ghanem M., 2014, J BIOPHOTONICS, V7, P453
   [Anonymous], 2008, [No title captured], Patent No. 12090893
   Audoin B, 2010, ULTRASONICS, V50, P202, DOI 10.1016/j.ultras.2009.09.019
   Bartels A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2167812
   Bereiter-Hahn J., 1995, ADV ACOUST MICROS, V1, P79
   Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x
   Che S, 2015, ULTRASONICS, V56, P153, DOI 10.1016/j.ultras.2014.02.010
   Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Dehoux T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4769294
   Dehoux T, 2015, ULTRASONICS, V56, P160, DOI 10.1016/j.ultras.2014.07.010
   Gusev V. E., 1993, LASER OPTOACOUSTICS
   HILDEBRAND JA, 1981, P NATL ACAD SCI-BIOL, V78, P1656, DOI 10.1073/pnas.78.3.1656
   JOHNSTON RN, 1979, P NATL ACAD SCI USA, V76, P3325, DOI 10.1073/pnas.76.7.3325
   Lei Y., 2012, SMALL, V9, P1086, DOI DOI 10.1002/SMLL.201202410)
   Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m
   LUERS H, 1992, ACOUST IMAG, V19, P511
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Maris H., 1998, Scientific American (International Edition), V278, P64
   Mechri C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3220063
   MUHA MS, 1990, APPL PHYS LETT, V56, P1019, DOI 10.1063/1.102603
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   Pernot G, 2010, NAT MATER, V9, P491, DOI [10.1038/NMAT2752, 10.1038/nmat2752]
   Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/NNANO.2011.186, 10.1038/nnano.2011.186]
   Rheinlaender J, 2013, SOFT MATTER, V9, P3230, DOI 10.1039/c2sm27412d
   Rossignol C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988470
   Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250
   Schaus SS, 1997, BIOPHYS J, V73, P1205, DOI 10.1016/S0006-3495(97)78153-0
   Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c
   Sen S, 2005, BIOPHYS J, V89, P3203, DOI 10.1529/biophysj.105.063826
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   TATTERSALL HG, 1973, J PHYS D APPL PHYS, V6, P819, DOI 10.1088/0022-3727/6/7/305
   THOMSEN C, 1984, PHYS REV LETT, V53, P989, DOI 10.1103/PhysRevLett.53.989
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Weiss EC, 2007, ULTRASOUND MED BIOL, V33, P1320, DOI 10.1016/j.ultrasmedbio.2007.01-016
   Yang F, 2010, Journal of Applied Physics, V107, DOI 10.1063/1.3388283
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhao Y, 2006, SENSOR ACTUAT B-CHEM, V114, P1108, DOI 10.1016/j.snb.2005.07.071
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 41
TC 19
Z9 19
U1 0
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 3
PY 2015
VL 5
AR 8650
DI 10.1038/srep08650
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC4UQ
UT WOS:000350349800003
PM 25731090
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Boraphech, P
   Thiravetyan, P
AF Boraphech, Phattara
   Thiravetyan, Paitip
TI Trimethylamine (fishy odor) adsorption by biomaterials: Effect of fatty
   acids, alkanes, and aromatic compounds in waxes
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Adsorption; Leaf biomaterial; Sansevieria trifasciata; Trimethylamine;
   Wax component
ID WASTE-WATER; HEAVY-METALS; CHEMICAL-COMPOSITION; SORPTION KINETICS;
   CUTICULAR WAXES; COIR PITH; BIOFILTRATION; EMISSIONS; REMOVAL; PLANT
AB Thirteen plant leaf materials were selected to be applied as dried biomaterial adsorbents for polar gaseous trimethylamine (TMA) adsorption. Biomaterial adsorbents were efficient in adsorbing gaseous TMA up to 100% of total TMA (100 ppm) within 24 h. Sansevieria trifasciata is the most effective plant leaf material while Plerocatpus indicus was the least effective in TMA adsorption. Activated carbon (AC) was found to be lower potential adsorbent to adsorb TMA when compared to biomaterial adsorbents. As adsorption data, the Langmuir isotherm supported that the gaseous TMA adsorbed monolayer on the adsorbent surface and was followed pseudo-second order kinetic model. Wax extracted from plant leaf could also adsorb gaseous TMA up to 69% of total TMA within 24 h. Another 27-63% of TMA was adsorbed by cellulose and lignin that naturally occur in high amounts in plant leaf. Subsequently, the composition appearing in biomaterial wax showed a large quantity of short-chain fatty acids (<= C-18) especially octadecanoic acid (C-18), and short-chain alkanes (C-12-C-18) as well as total aromatic components dominated in the wax, which affected TMA adsorption. Hence, it has been demonstrated that plant biomaterial is a superior biosorbent for TMA removal. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Boraphech, Phattara; Thiravetyan, Paitip] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand.
RP Thiravetyan, P (reprint author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand.
EM paitip.thi@kmutt.ac.th
FU Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program;
   King Mongkut's University of Technology Thonburi [PHD/0108/2553]
FX The authors would like to thank the Thailand Research Fund through the
   Royal Golden Jubilee Ph.D. Program and King Mongkut's University of
   Technology Thonburi for financially supporting Ms. Phattara Boraphech
   (Grant No. PHD/0108/2553).
CR *ACGIH, 1991, DOC THRESH LIM VAL B
   Amoore J E, 1983, J Appl Toxicol, V3, P272, DOI 10.1002/jat.2550030603
   Asikin Y, 2008, FOOD SCI TECHNOL RES, V14, P583, DOI 10.3136/fstr.14.583
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Beck KR, 1997, TEXT CHEM COLOR, V29, P66
   Buschhaus C, 2007, ANN BOT-LONDON, V100, P1557, DOI 10.1093/aob/mcm255
   Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366
   Cameron Carbon Incorporated, 2006, ACT CARB MAN STRUCT
   Cao NJ, 1997, APPL BIOCHEM BIOTECH, V63-5, P387, DOI 10.1007/BF02920440
   Cao W, 2011, CARBOHYD POLYM, V85, P571, DOI 10.1016/j.carbpol.2011.03.016
   Chakravarty S, 2010, J HAZARD MATER, V173, P502, DOI 10.1016/j.jhazmat.2009.08.113
   Chang CT, 2004, CHEMOSPHERE, V55, P751, DOI 10.1016/j.chemosphere.2003.11.037
   Chien YC, 2000, ANAL CHIM ACTA, V419, P73, DOI 10.1016/S0003-2670(00)00973-9
   Ding Y, 2007, J HAZARD MATER, V143, P341, DOI 10.1016/j.jhazmat.2006.09.031
   Dubey A, 2012, INT J ENVIRON SCI TE, V9, P15, DOI 10.1007/s13762-011-0012-8
   Dubis EN, 2001, J MOL STRUCT, V596, P83, DOI 10.1016/S0022-2860(01)00691-3
   Errasquin EL, 2003, CHEMOSPHERE, V50, P137
   Garnham G.W., 1997, USE ALGAE METAL BIOS, P11
   Gupta R, 2000, CURR SCI INDIA, V78, P967
   Han P., 2013, J HEBEI U SCI TECHNO
   Healy R.M., 2014, ANAL BIOANAL CHEM
   Ho KL, 2008, CHEMOSPHERE, V72, P250, DOI 10.1016/j.chemosphere.2008.01.044
   Ho YS, 2004, PROCESS BIOCHEM, V39, P759, DOI 10.1016/S0032-9592(03)00184-5
   Ho YS, 1999, J ENVIRON SCI HEAL A, V34, P1179, DOI 10.1080/10934529909376889
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   HODGE DS, 1994, ENVIRON PROG, V13, P167, DOI 10.1002/ep.670130311
   Hoerr CW, 1944, J ORG CHEM, V9, P329, DOI 10.1021/jo01186a005
   HSDB Hazardous Substances Data Bank, 2006, TRIM
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Juniper B.E., 1983, PLANT SURFACES, P6
   Kapoor A., 1997, FUNGI BIOSORBENTS BI, P67
   Kumar KV, 2006, J HAZARD MATER, V137, P1538, DOI 10.1016/j.jhazmat.2006.04.036
   Kumar PS, 2009, J ENG SCI TECHNOL, V4, P351
   Lee SW, 2010, J IND ENG CHEM, V16, P973, DOI 10.1016/j.jiec.2010.04.002
   LEONARDOS G, 1969, Journal of the Air Pollution Control Association, V19, P91
   LESON G, 1991, J AIR WASTE MANAGE, V41, P1045, DOI 10.1080/10473289.1991.10466898
   Li Y, 2013, J APPL POLYM SCI, V128, P2746, DOI 10.1002/app.38437
   lyobe Tsutomu, 2004, Journal of Health Science, V50, P148
   Mackiewicz E, 2014, REACT KINET MECH CAT, V111, P763, DOI 10.1007/s11144-013-0666-y
   Martin J. T., 1970, CUTICLES PLANTS
   Melse RW, 2005, T ASAE, V48, P2303
   Nair V, 2014, CHEM ENG J, V254, P491, DOI 10.1016/j.cej.2014.05.045
   National Institute for Occupational Safety and Health (NIOSH)/Occupational Safety and Health Administration (OSHA), 1981, DHHS NIOSH PUBL
   NIST The National Institute of Standards and Technology, 2008, OCT CAN AC 57 11 4 N
   OSHA, 1994, OCC SAF HLTH GUID TR
   Overah L.C., 2011, J APPL SCI ENV MANAG, V15, P87, DOI DOI 10.4314/JASEM.V15I1.65681
   Pillai SM, 2012, CHEM ENGINEER TRANS, V30, P247, DOI 10.3303/CET1230042
   Plazinski W, 2013, ADSORPTION, V19, P1055, DOI 10.1007/s10450-013-9529-0
   Rafatullah M, 2010, J HAZARD MATER, V177, P70, DOI 10.1016/j.jhazmat.2009.12.047
   Rappert S, 2005, WASTE MANAGE, V25, P887, DOI 10.1016/j.wasman.2005.07.008
   RUTH JH, 1986, AM IND HYG ASSOC J, V47, pA142
   SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111, DOI 10.1063/1.555833
   Shieh W.K., 1986, BIOCH ENG J, V33, P132
   Sintermann J, 2014, BIOGEOSCIENCES, V11, P5073, DOI 10.5194/bg-11-5073-2014
   STEPHENS ER, 1971, CALIF AGR, V25, P10
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Suksabye P, 2012, J ENVIRON MANAGE, V102, P1, DOI 10.1016/j.jenvman.2011.10.020
   Szafranek B, 2008, ACTA BIOL CRACOV BOT, V50, P49
   Taghizadeh-Toosi A, 2012, PLANT SOIL, V350, P57, DOI 10.1007/s11104-011-0870-3
   Treesubsuntorn C, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1736-5
   Vieira B. Volesky, 2000, INT MICROBIOL, V3, P17
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Walton T.J., 1990, METHODS PLANT BIOCH, V4, P105
   Zhong QQ, 2014, CARBOHYD POLYM, V111, P788, DOI 10.1016/j.carbpol.2014.05.043
NR 65
TC 7
Z9 7
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAR 2
PY 2015
VL 284
BP 269
EP 277
DI 10.1016/j.jhazmat.2014.11.014
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA AY4YX
UT WOS:000347581900032
PM 25664363
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Wang, CY
   Hu, RS
   Liu, ZH
   Xue, W
AF Zhang, Yi
   Wang, Changyong
   Hu, Rushan
   Liu, Zonghua
   Xue, Wei
TI Polyethylenimine-Induced Alterations of Red Blood Cells and Their
   Recognition by the Complement System and Macrophages
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biosafety evaluation; polyethylenimine; red blood cells; macrophages
ID LOW-DENSITY-LIPOPROTEIN; IN-VITRO; BIOTINYLATED ERYTHROCYTES;
   ALTERNATIVE PATHWAYS; AVIDIN ATTACHMENT; AMINO-GROUPS;
   PHOSPHATIDYLSERINE; ACTIVATION; SURFACE; EXTERNALIZATION
AB In practical applications, biomedical materials introduced in vivo may interact with various host cells and/or biomacromolecules and alter their physiological characteristics. Biomaterial-altered cells and/or biomacromolecules may be recognized as "non-self" by the host immune system and may consequently cause further immune responses. In the present work, the gene carrier material branched polyethylenimine (1.8 lcDa) (BPEI-1.8k) induced a series of alterations of human red blood cells (RBCs), such as a morphological transition from biconcave disks to spheroechinocytes, vesiculation, a size decrease, a change in surface charge from negative to positive, a cell density reduction, membrane oxidation, and PS externalization. Furthermore, BPEI-1.8k-treated RBCs caused autologous complement activation and were recognized by autologous macrophages. This implies that the biomedical material BPEI-1.8k changed the identity of the RBCs, leading to their recognition by the autologous immune system. This study provides novel insights for the biocompatibility evaluation and clinical application of biomedical materials.
C1 [Zhang, Yi; Wang, Changyong; Hu, Rushan; Liu, Zonghua; Xue, Wei] Jinan Univ, Dept Biomed Engn, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
RP Liu, ZH; Xue, W (reprint author), Jinan Univ, Dept Biomed Engn, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
EM tliuzonghua@jnu.edu.cn; weixue_jnu@hotmail.com
FU National Natural Science Foundation of China [81101151, 31271019]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grants 81101151 and 31271019).
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200
   Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2
   Chapanian R, 2012, BIOMATERIALS, V33, P3047, DOI 10.1016/j.biomaterials.2011.12.053
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Fadeel B, 2006, CELL DEATH DIFFER, V13, P360, DOI 10.1038/sj.cdd.4401836
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   Huang YX, 2011, J CELL MOL MED, V15, P2634, DOI 10.1111/j.1582-4934.2011.01310.x
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882
   Kang YH, 2009, ADV EXP MED BIOL, V653, P117
   Koshkaryev A, 2003, AM J PHYSIOL-CELL PH, V285, pC720, DOI 10.1152/ajpcell.00542.2002
   Koshkaryev A, 2010, CELL BIOCHEM BIOPHYS, V56, P109, DOI 10.1007/s12013-009-9074-3
   Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x
   Li CH, 2013, J MATER CHEM B, V1, P1885, DOI 10.1039/c3tb00024a
   Liu ZH, 2012, J CONTROL RELEASE, V160, P14, DOI 10.1016/j.jconrel.2012.02.005
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021
   Merkel OM, 2011, BIOMATERIALS, V32, P4936, DOI 10.1016/j.biomaterials.2011.03.035
   MOSCONE D, 1988, ANAL CHIM ACTA, V211, P195, DOI 10.1016/S0003-2670(00)83679-X
   Muzykantov VR, 1996, BBA-BIOMEMBRANES, V1279, P137, DOI 10.1016/0005-2736(95)00260-X
   MUZYKANTOV VR, 1991, BLOOD, V78, P2611
   Muzykantov VR, 1996, ANAL BIOCHEM, V241, P109, DOI 10.1006/abio.1996.0384
   MUZYKANTOV VR, 1993, FEBS LETT, V318, P108, DOI 10.1016/0014-5793(93)80002-C
   MUZYKANTOV VR, 1992, INT J ARTIF ORGANS, V15, P622
   Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Rihova B, 2002, ADV DRUG DELIVER REV, V54, P653
   Rossi NAA, 2010, BIOMATERIALS, V31, P4167, DOI 10.1016/j.biomaterials.2010.01.137
   SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396
   SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265
   SEEMAN P, 1972, PHARMACOL REV, V24, P583
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   VANDERKAMP KWHJ, 1993, INT J ARTIF ORGANS, V16, P836
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yedgar S, 2002, PATHOPHYSIOL HAEMO T, V32, P263, DOI 10.1159/000073578
   ZALTZMAN AB, 1995, BIOCHEM J, V307, P651, DOI 10.1042/bj3070651
   Zavodnik IB, 2002, BIOELECTROCHEMISTRY, V58, P127, DOI 10.1016/S1567-5394(01)00126-8
   Zavodnik IB, 1999, BBA-BIOMEMBRANES, V1421, P306, DOI 10.1016/S0005-2736(99)00136-4
   Zhong D, 2013, BIOMATERIALS, V34, P294, DOI 10.1016/j.biomaterials.2012.09.060
NR 43
TC 9
Z9 9
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2015
VL 1
IS 3
BP 139
EP 147
DI 10.1021/ab500128q
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RL
UT WOS:000369347200002
DA 2018-10-20
ER

PT J
AU Wang, D
   Bratlie, KM
AF Wang, Daniel
   Bratlie, Kaitlin M.
TI Influence of Polymer Chemistry on Cytokine Secretion from Polarized
   Macrophages
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE macrophage phenotypes; cytokines; TNF-alpha; IL-I0; polymer properties
ID TUMOR-ASSOCIATED MACROPHAGES; TNF-ALPHA; IN-VITRO; ALTERNATIVE
   ACTIVATION; IMMUNE-RESPONSES; NECROSIS-FACTOR; SURFACE; BIOMATERIAL;
   CANCER; VIVO
AB Of central importance to tissue engineering and drug delivery is identifying polymer parameters that increase or decrease specific cytokines in response to biomaterials. In this study, we have interrogated the effects of material descriptors and material.characteristics on pro-inflammatory, pro-angiogenic, and naive macrophages using polymeric particles (similar to 600 nm), functionalized with 13 different moieties. We characterized tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) secretion for the three macrophage populations and used the quantitative structure-activity relationship method (QSAR) to accurately predict cytokine secretion for the different macrophage phenotypes. The findings presented here demonstrate that altering cellular responses to polymers can be achieved through exploiting material parameters. For pro-inflammatory macrophages, polarity and the ability to hydrogen bond appear to significantly impact TNF-alpha secretion while charge impacted pro-angiogenic macrophages. Naive cells were impacted by charge in a similar manner as the proangiogenic cells; however, hydrophilicity also increased TNF-alpha secretion in these cells. For IL-10 secretion, hydrogen bonding was very negatively correlated with pro-inflammatory cells, whereas it was positively correlated with pro-angiogenic cells.
C1 [Wang, Daniel; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
   [Bratlie, Kaitlin M.] Ames Natl Lab, Ames, IA 50011 USA.
RP Bratlie, KM (reprint author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
EM kbratlie@iastate.edu
FU National Science Foundation [CBET 1227867]; Roy J. Carver Charitable
   Trust [13-4265]; NSF ARI-R2 [CMMI-0963224]
FX This work was supported by the National Science Foundation under Grant
   CBET 1227867 and the Roy J. Carver Charitable Trust Grant 13-4265. The
   authors also acknowledge support from NSF ARI-R2 (CMMI-0963224) for
   funding the renovation of the research laboratories used for these
   studies.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Akilbekova D, 2015, J BIOMED MATER RES A, V103, P262, DOI 10.1002/jbm.a.35169
   Alas S, 2001, CANCER RES, V61, P5137
   Ali MM, 2009, CHEM COMMUN, P6640, DOI 10.1039/b911559e
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Bicerano J., 2002, PREDICTION POLYM PRO
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Curnis F, 2000, NAT BIOTECHNOL, V18, P1185
   Das M, 2006, ADV MATER, V18, P80, DOI 10.1002/adma.200501043
   Dong L, 2009, J CONTROL RELEASE, V134, P214, DOI 10.1016/j.jconrel.2008.11.013
   Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kubinyi H, 1993, METHODS PRINCIPLES M
   Kufe D. W., 2003, HOLLAND FREI CANC ME
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160
   Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x
   Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Petersen LK, 2011, BIOMATERIALS, V32, P6815, DOI 10.1016/j.biomaterials.2011.05.063
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5
   Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI 10.1038/NNANO.2011.10
   Randow F, 1997, J IMMUNOL, V158, P2911
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109
   Schmid MC, 2010, J ONCOL, V2010, DOI DOI 10.1155/2010/201026
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Shnyra A, 1998, J IMMUNOL, V160, P3729
   Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602
   Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711
   Wang D, 2014, BIOMACROMOLECULES, V15, P4102, DOI 10.1021/bm5011382
   Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003
   Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275
   WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
   Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357
   Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024
NR 55
TC 7
Z9 7
U1 3
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2015
VL 1
IS 3
BP 166
EP 174
DI 10.1021/ab5001063
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC6RL
UT WOS:000369347200005
DA 2018-10-20
ER

PT J
AU Brezestean, I
   Har, N
   Tantau, A
   Gorea, M
   Venter, MM
   Pinzaru, SC
AF Brezestean, Ioana
   Har, Nicolae
   Tantau, Alina
   Gorea, Maria
   Venter, Monica M.
   Pinzaru, Simona Cinta
TI ANALYTICAL STUDY OF GALLSTONES IN PATIENTS FROM TRANSYLVANIA, ROMANIA
SO STUDIA UNIVERSITATIS BABES-BOLYAI CHEMIA
LA English
DT Article
DE Human gallstones; Transylvania; FT-Raman spectroscopy; FT-IR;
   cholesterol
ID PIGMENT GALLSTONES; CHOLESTEROL; BILE; CRYSTALLIZATION; IDENTIFICATION;
   BILIRUBINATE; DISEASE; LIVER
AB Here we report the vibrational spectroscopy characterization on human gallstones from patients in Transylvania, Romania. A number of 93 gallstones resulted after surgical intervention were preliminary classified in 6 groups after provenance, shape and color aspect and investigated using optical microscopy and FT-(micro)-Raman spectroscopy in conjunction with the FT-IR. Optical microscopy of the gallstones cross sections revealed concentric layers growing depositions alternating with axial crystalline agglomerated biomaterial. Two distinct type of crystallinity on one hand and different spatial crystals distribution, on the other hand were optically observed. The studied specimens randomly showed very narrow amorphous zones. The microstructure, chemical composition, the nucleation and growing mechanism of gallstones were correlated with the vibrational spectroscopy data. Vibrational assignment allowed identifying cholesterol in all the samples. Other weak bands attributable to bilirubinate salts were randomly observed with different extent in all the groups. Brown, yellowish-brown and yellow gallstones showed higher content of bilirubinate as revealed by the relative intensity ratio of the bilirubinate band at 1620 cm(-1) versus cholesterol band at 1464 cm(-1) with values between 0.57 and 0.875. FT-vibrational techniques accurately provided the proof of the cholesterol specificity in the choletitiasis prevalence in the area and allowed getting additional insight into their growing mechanism.
C1 [Brezestean, Ioana; Pinzaru, Simona Cinta] Univ Babes Bolyai, Fac Phys, Biomol Phys Dept, Kogalniceanu 1, RO-400084 Cluj Napoca, Romania.
   [Har, Nicolae] Univ Babes Bolyai, Biol & Geol Fac, Dept Mineral, RO-400084 Cluj Napoca, Romania.
   [Tantau, Alina] Iuliu Hatieganu Univ Med & Pharm, RO-400012 Cluj Napoca, Romania.
   [Gorea, Maria; Venter, Monica M.] Univ Babes Bolyai, Fac Chem & Chem Engn, RO-400028 Cluj Napoca, Romania.
RP Pinzaru, SC (reprint author), Univ Babes Bolyai, Fac Phys, Biomol Phys Dept, Kogalniceanu 1, RO-400084 Cluj Napoca, Romania.
EM simona.cinta@phys.ubbcluj.ro
RI Cinta Pinzaru, Simona/A-4543-2011
OI Cinta Pinzaru, Simona/0000-0001-8016-4408
FU Babes-Bolyai Univesity
FX I. Brezestean would like to thank the financial support from the
   Babes-Bolyai Univesity for the 2013-2014 scientific performance
   scholarship.
CR ABEI M, 1994, GASTROENTEROLOGY, V106, P231, DOI 10.1016/S0016-5085(94)95643-X
   Acalovschi M, 2003, AM J GASTROENTEROL, V98, P1856, DOI 10.1016/S0002-9270(03)00509-4
   AHLBERG J, 1981, J LIPID RES, V22, P404
   Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215
   CHIJIIWA K, 1991, BIOCHIM BIOPHYS ACTA, V1086, P44, DOI 10.1016/0005-2760(91)90152-8
   Donovan M., 1999, GASTROENTEROL CLIN N, V28, P75
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   ELEK G, 1982, KLIN WOCHENSCHR, V60, P33, DOI 10.1007/BF01721585
   Ferraro J.R., 1996, APPL SPECTROSC, V50, P7922
   Harding A.J., 1964, GALLSTONES CAUSES TR
   HARVEY PRC, 1991, J BIOL CHEM, V266, P13996
   Hrbasova H., 2000, INT J BIOCH CELLULAR, V32, P609
   Ko CW, 1999, GASTROENTEROL CLIN N, V28, P99, DOI 10.1016/S0889-8553(05)70045-5
   Kothai S., 2009, INT J CHEMTECH RES, V1, P430
   LI WH, 1995, BIOSPECTROSCOPY, V1, P149, DOI 10.1002/bspy.350010209
   Liu G, 2002, J MOL STRUCT, V616, P187, DOI 10.1016/S0022-2860(02)00330-7
   MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010
   OFFNER GD, 1994, GASTROENTEROLOGY, V106, P755, DOI 10.1016/0016-5085(94)90712-9
   Paluszkiewicz C, 1998, CELL MOL BIOL, V44, P65
   Qiao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074887
   Roslyn J.J., 1994, PRINCIPLES SURG, P1376
   Sakorafas GH, 2007, DIGEST DIS SCI, V52, P1313, DOI 10.1007/s10620-006-9107-3
   SMITH BF, 1987, J LIPID RES, V28, P1088
   Tantau M, 2013, J GASTROINTEST LIVER, V22, P141
   TROTMAN BW, 1982, HEPATOLOGY, V2, P879, DOI 10.1002/hep.1840020624
   Wu J.G., 1979, CHINESE SCI BULL, V24, P1054
   YANG BJ, 1993, SPECTROCHIM ACTA A, V49, P1735, DOI 10.1016/0584-8539(93)80241-2
   Zhang Z., 2008, WORLD CHINESE J DIGE, V16, P1200
NR 28
TC 0
Z9 0
U1 1
U2 3
PU UNIV BABES-BOLYAI
PI CLUJ-NAPOCA
PA MIHAIL KOGALNICEANU NR. 1, CLUJ-NAPOCA RO-3400, ROMANIA
SN 1224-7154
J9 STUD U BABES-BOL CHE
JI Stud. Univ. Babes-Bolyai Chem.
PD MAR
PY 2015
VL 60
IS 1
BP 29
EP 43
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA DC4AI
UT WOS:000369161500003
DA 2018-10-20
ER

PT J
AU Chen, Y
   Shi, JL
AF Chen, Yu
   Shi, Jianlin
TI Mesoporous carbon biomaterials
SO SCIENCE CHINA-MATERIALS
LA English
DT Review
ID ULTRASOUND CANCER-SURGERY; REDUCED GRAPHENE OXIDE; BULKY DYE MOLECULES;
   SILICA NANOPARTICLES; IN-VIVO; BIOMEDICAL APPLICATIONS; PHOTOTHERMAL
   THERAPY; QUANTUM DOTS; FACILE SYNTHESIS; TEMPLATE ROUTE
AB Nano-biotechnology provides highly efficient and versatile strategies to improve the diagnostic precision and therapeutic efficiency of serious diseases. The development of new biomaterial systems provides great opportunities for the successful clinical translation of nano-biotechnology for personalized biomedicine to benefit patients. As a new inorganic material system, mesoporous carbon biomaterials (MCBs) combine the merits of a mesoporous nanostructure and carbonaceous composition, showing superior qualities compared with traditional mesoporous silica and other carbon-based nanosystems, such as graphene, carbon nanotubes, and fullerene. Thus, this review focuses on the rational design, chemical synthesis, and biomedical applications of MCBs. The synthetic strategies for MCBs, especially mesoporous carbon nanoparticles (MCNs), are summarized, and several representative biomedical applications of MCBs are discussed in detail. MCBs perform well for on-demand drug-release, photothermal therapy, synergistic therapy, fluorescent labeling of cancer cells, bio-adsorption of in vivo toxic pathogenic substances, peptide separation, and biosensing. The preliminary biosafety issue of MCBs is also briefly discussed. Finally, the critical issues and challenges facing the future development of MCBs for clinical translation are considered. There is great promise for MCBs to reach clinical translations for biomedical applications based on their unique nanostructure, composition, and biocompatibility once some critical issues are fully addressed.
C1 [Chen, Yu; Shi, Jianlin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Chen, Y (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chenyu@mail.sic.ac.cn; jlshi@mail.sic.ac.cn
FU National Natural Science Foundation of China [51302293, 51132009];
   Natural Science Foundation of Shanghai [13ZR1463500]; Shanghai
   Rising-Star Program [14QA1404100]; Youth Scholar of State Key Laboratory
   of High Performance Ceramics and Superfine Microstructures [SKL201203]
FX This research was supported by the National Natural Science Foundation
   of China (51302293 and 51132009), Natural Science Foundation of Shanghai
   (13ZR1463500), Shanghai Rising-Star Program (14QA1404100), and Youth
   Scholar of State Key Laboratory of High Performance Ceramics and
   Superfine Microstructures (SKL201203).
CR Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d
   Ambrogio MW, 2011, ACCOUNTS CHEM RES, V44, P903, DOI 10.1021/ar200018x
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Beg S, 2011, J PHARM PHARMACOL, V63, P141, DOI 10.1111/j.2042-7158.2010.01167.x
   Cha CY, 2013, ACS NANO, V7, P2891, DOI 10.1021/nn401196a
   Chen BS, 2013, NANOSCALE, V5, P1967, DOI 10.1039/c2nr32675b
   Chen HM, 2014, ADV MATER, V26, P6761, DOI 10.1002/adma.201402964
   Chen Y, CHEM SOC REV, DOI 0.1039/C4CS00300D
   Chen Y, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400127
   Chen Y, 2014, J AM CHEM SOC, V136, P16326, DOI 10.1021/ja508721y
   Chen Y, 2014, ADV MATER, V26, P7019, DOI 10.1002/adma.201402572
   Chen Y, 2014, ADV FUNCT MATER, V24, P4386, DOI 10.1002/adfm.201400221
   Chen Y, 2014, ADV MATER, V26, P4294, DOI 10.1002/adma.201400303
   Chen Y, 2014, MOL PHARMACEUT, V11, P2495, DOI 10.1021/mp400596v
   Chen Y, 2014, EXPERT OPIN DRUG DEL, V11, P917, DOI 10.1517/17425247.2014.908181
   Chen Y, 2014, ACCOUNTS CHEM RES, V47, P125, DOI 10.1021/ar400091e
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Chen Y, 2013, ADV MATER, V25, P3100, DOI 10.1002/adma.201204685
   Chen Y, 2012, BIOMATERIALS, V33, P7126, DOI 10.1016/j.biomaterials.2012.06.059
   Chen Y, 2011, ANGEW CHEM INT EDIT, V50, P12505, DOI 10.1002/anie.201106180
   Chen Y, 2011, SMALL, V7, P2935, DOI 10.1002/smll.201101055
   Chen Y, 2010, ACS NANO, V4, P529, DOI 10.1021/nn901398j
   Cheng G, 2014, ACS APPL MATER INTER, V6, P12719, DOI 10.1021/am502712a
   Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f
   Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006
   Crayton SH, 2011, ACS NANO, V5, P9592, DOI 10.1021/nn202863x
   Cui YY, 2014, J MATER CHEM B, V2, P6947, DOI 10.1039/c4tb01085j
   Ding CQ, 2014, ACCOUNTS CHEM RES, V47, P20, DOI 10.1021/ar400023s
   Dong Y, 2013, J MATER CHEM A, V1, P7391, DOI 10.1039/c3ta10787f
   Dong Y, 2012, CHEM ENG J, V193, P169, DOI 10.1016/j.cej.2012.04.024
   Duffy P, 2012, J MATER CHEM, V22, P432, DOI 10.1039/c1jm14303d
   Fang Y, 2014, ANGEW CHEM INT EDIT, V53, P5366, DOI 10.1002/anie.201402002
   Fang Y, 2010, ANGEW CHEM INT EDIT, V49, P7987, DOI 10.1002/anie.201002849
   Feng LY, 2013, ADV MATER, V25, P168, DOI 10.1002/adma.201203229
   Gu JL, 2011, CHEM COMMUN, V47, P2101, DOI 10.1039/c0cc04598e
   Guo LM, 2010, CHEM COMMUN, V46, P7127, DOI 10.1039/c0cc02060e
   Guo LM, 2009, CHEM COMMUN, P6071, DOI 10.1039/b911083f
   Guo LM, 2009, CHEM-ASIAN J, V4, P1480, DOI 10.1002/asia.200900113
   Guo Y, 2008, ADV FUNCT MATER, V18, P2489, DOI 10.1002/adfm.200800406
   He QJ, 2012, BIOMATERIALS, V33, P4392, DOI 10.1016/j.biomaterials.2012.02.056
   He QJ, 2011, SMALL, V7, P271, DOI 10.1002/smll.201001459
   He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009
   Hu SH, 2012, ADV MATER, V24, P1748, DOI 10.1002/adma.201104070
   Huang XL, 2011, ACS NANO, V5, P5390, DOI 10.1021/nn200365a
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Kamisako T, 2000, J GASTROENTEROL, V35, P659, DOI 10.1007/s005350070044
   Kim TW, 2008, NANO LETT, V8, P3724, DOI 10.1021/nl801976m
   Kong QL, 2014, CHEM COMMUN, V50, P15772, DOI 10.1039/c4cc07121b
   Ku SH, 2013, ADV HEALTHC MATER, V2, P244, DOI 10.1002/adhm.201200307
   Li HT, 2012, J MATER CHEM, V22, P24230, DOI 10.1039/c2jm34690g
   Li LL, 2013, NANOSCALE, V5, P4015, DOI 10.1039/c3nr33849e
   Li M, 2012, J COLLOID INTERF SCI, V377, P169, DOI 10.1016/j.jcis.2012.03.085
   Li RB, 2010, ACS NANO, V4, P1399, DOI 10.1021/nn9011225
   Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g
   Liang CD, 2004, ANGEW CHEM INT EDIT, V43, P5785, DOI 10.1002/anie.200461051
   Liang CD, 2008, ANGEW CHEM INT EDIT, V47, P3696, DOI 10.1002/anie.200702046
   Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e
   Liu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3798
   Liu RL, 2014, CARBON, V76, P84, DOI 10.1016/j.carbon.2014.04.052
   Liu YZ, 2012, J MATER CHEM, V22, P11908, DOI 10.1039/c2jm31581e
   Liu Y, 2014, AUST J CHEM, V67, P151, DOI 10.1071/CH13401
   Liu Y, 2014, BIOMATERIALS, V35, P378, DOI 10.1016/j.biomaterials.2013.09.079
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4
   Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612
   Lu J, 2007, SMALL, V3, P1341, DOI 10.1002/smll.200700005
   Lu XB, 2009, J MATER CHEM, V19, P4707, DOI 10.1039/b903179k
   Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Markovic ZM, 2011, BIOMATERIALS, V32, P1121, DOI 10.1016/j.biomaterials.2010.10.030
   Partha R, 2009, INT J NANOMED, V4, P261
   Qiao ZA, 2013, NANO LETT, V13, P207, DOI 10.1021/nl303889h
   Qin HQ, 2011, ANGEW CHEM INT EDIT, V50, P12218, DOI 10.1002/anie.201103666
   Qin HQ, 2011, ANAL CHEM, V83, P7721, DOI 10.1021/ac201198q
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Ryoo R, 2001, ADV MATER, V13, P677, DOI 10.1002/1521-4095(200105)13:9<677::AID-ADMA677>3.3.CO;2-3
   Saha D, 2014, MICROPOR MESOPOR MAT, V196, P327, DOI 10.1016/j.micromeso.2014.05.024
   Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2
   Shi JL, 2013, J INORG MATER, V28, P1, DOI 10.3724/SP.J.1077.2012.12082
   Sun W, 2009, ELECTROCHEM COMMUN, V11, P2105, DOI 10.1016/j.elecom.2009.09.005
   Sun ZK, 2013, ACS NANO, V7, P8706, DOI 10.1021/nn402994m
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tang J, 2015, ANGEW CHEM INT EDIT, V54, P588, DOI 10.1002/anie.201407629
   Tao GJ, 2014, CARBON, V66, P547, DOI 10.1016/j.carbon.2013.09.037
   Tian B, 2011, ACS NANO, V5, P7000, DOI 10.1021/nn201560b
   Wang J, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.79
   Wang LM, 2015, J AM CHEM SOC, V137, P1947, DOI 10.1021/ja511560b
   Wang TY, 2011, EUR J PHARM SCI, V44, P653, DOI 10.1016/j.ejps.2011.10.012
   Wang X, 2012, ADV MATER, V24, P785, DOI 10.1002/adma.201104033
   Wang XF, 2013, MICROPOR MESOPOR MAT, V180, P257, DOI 10.1016/j.micromeso.2013.06.042
   Wang Y, 2014, ACS NANO, V8, P7870, DOI 10.1021/nn5027214
   Wang Y, 2014, ADV HEALTHC MATER, V3, P485, DOI 10.1002/adhm.201300324
   Wu SH, 2011, CHEM COMMUN, V47, P9972, DOI 10.1039/c1cc11760b
   Xiang D, 2015, ANALYST, V140, P644, DOI 10.1039/c4an01549e
   Xu GJ, 2014, RSC ADV, V4, P33986, DOI 10.1039/c4ra03993a
   Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c
   You CP, 2009, MICROCHIM ACTA, V167, P109, DOI 10.1007/s00604-009-0228-1
   Zhang FQ, 2007, J AM CHEM SOC, V129, P7746, DOI 10.1021/ja072316d
   Zheng M, 2014, ADV MATER, V26, P3554, DOI 10.1002/adma.201306192
   Zhou L, 2015, CARBON, V82, P479, DOI 10.1016/j.carbon.2014.10.091
   Zhu J, 2012, SMALL, V8, P2715, DOI 10.1002/smll.201200217
   Zhu SM, 2011, MATER CHEM PHYS, V126, P357, DOI 10.1016/j.matchemphys.2010.11.013
   Zhu SJ, 2013, ANGEW CHEM INT EDIT, V52, P3953, DOI 10.1002/anie.201300519
   Zhu WQ, 2014, ASIAN J PHARM SCI, V9, P82, DOI 10.1016/j.ajps.2014.02.001
   Zhuang X, 2009, CHEM MATER, V21, P706, DOI 10.1021/cm8028577
NR 106
TC 19
Z9 20
U1 9
U2 68
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 2095-8226
EI 2199-4501
J9 SCI CHINA MATER
JI Sci. China-Mater.
PD MAR
PY 2015
VL 58
IS 3
BP 241
EP 257
DI 10.1007/s40843-015-0037-2
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA CV7TF
UT WOS:000364477200008
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhou, GQ
   He, W
   Pang, ZH
   Chen, XM
   Chen, ZQ
   Zhang, QW
   Fang, B
   Chen, D
AF Zhou, Guangquan
   He, Wei
   Pang, Zhihui
   Chen, Xiumin
   Chen, Zhenqiu
   Zhang, Qingwen
   Fang, Bin
   Chen, Da
TI Share Relationship Adjustment of Femoral Head Necrosis Through
   Biomaterial Allograft Bone
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Femoral Head Necrosis; Load Share Ratio; Allograft Bone; Anterolateral
   Column; Computational Biomechanics
ID TRANSTROCHANTERIC ROTATIONAL OSTEOTOMY; AVASCULAR NECROSIS; FOLLOW-UP;
   OSTEONECROSIS; STRESS; HIP; MODEL
AB Allogeneic bone grafting, as an alternative to autograft, is an effective hip preserving method that can be employed to delay or arrest the progression of the femoral head necrosis (FHN), and it can help to obtain the load balancing between subchondral cortical and cancellous bone, strengthen structural mechanics of the femoral head and provide biology repair materials for bone regeneration during bone healing. However, these conclusions have been drawn primarily from observational clinical experience and lack of biomechanical basis. The purpose of this study was to evaluate the efficacy of biomaterial allograft bone for the treatment of FHN using computational biomechanical models. The results showed that allogeneic bone grafting reduced the collapse risk of the necrotic femoral head and recovered the load share ratio between the cortical bone and trabeculae in weight-bearing areas. This study provided a considerable direction using computational biomechanical technology for orthopedic research and specific biomechanical evidence for the use of allogeneic bone grafting in clinics.
C1 [Zhou, Guangquan; He, Wei; Chen, Zhenqiu; Zhang, Qingwen; Fang, Bin; Chen, Da] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510407, Guangdong, Peoples R China.
   [Zhou, Guangquan; Pang, Zhihui] Guangzhou Univ Chinese Med, Lab Natl Key Discipline Orthopaed & Traumatol Chi, Guangzhou 510405, Guangdong, Peoples R China.
   [Zhou, Guangquan] City Univ Hong Kong, Dept Informat Syst, Hong Kong 999077, Hong Kong, Peoples R China.
   [Chen, Xiumin] Guangdong Prov Hosp Chinese Med, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China.
   [Chen, Xiumin] Guangzhou Univ Chinese Med, China & Postdoctoral Mobile Res Stn, Guangzhou 510000, Guangdong, Peoples R China.
RP He, W (reprint author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510407, Guangdong, Peoples R China.
FU National Science Foundation of China [81173284, 81473697]; Science and
   Technology Project of Guangdong Province [2013A032500009]; Natural
   Science Foundation of Guangdong Province [S2013010011992,
   S2012010008123]
FX The authors would like to acknowledge funding support from National
   Science Foundation of China (81173284, 81473697), Science and Technology
   Project of Guangdong Province (2013A032500009) and Natural Science
   Foundation of Guangdong Province (S2013010011992, S2012010008123). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aldridge JM, 2007, ORTHOP CLIN N AM, V38, P13, DOI 10.1016/j.ocl.2006.10.012
   [Anonymous], 2012, CLIN J JOINT SURG EL, V6, P184
   Bose VC, 2010, J BONE JOINT SURG BR, V92B, P922, DOI 10.1302/0301-620X.92B7.23639
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   BROWN TD, 1981, CLIN ORTHOP RELAT R, P240
   BROWN TD, 1983, J BIOMECH ENG-T ASME, V105, P171, DOI 10.1115/1.3138402
   BUCKLEY PD, 1991, J BONE JOINT SURG AM, V73A, P1357, DOI 10.2106/00004623-199173090-00011
   Chen ZhenQiu, 2010, Chinese Journal of Orthopaedics, V30, P42
   Culpepper BK, 2013, BIOMATERIALS, V34, P2455, DOI 10.1016/j.biomaterials.2012.12.026
   Culpepper BK, 2013, BIOMATERIALS, V34, P1506, DOI 10.1016/j.biomaterials.2012.10.046
   Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083
   GARDENIERS JWM, 1993, NATO ADV SCI INST SE, V247, P375
   Gardeniers JWM, 1992, ARCO NEWS, V4, P41
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goffin JM, 2014, J ORTHOP RES, V32, P39, DOI 10.1002/jor.22469
   Grecu D, 2010, ROM J MORPHOL EMBRYO, V51, P151
   Guo Xiaozhong, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P697
   HARRISON MHM, 1953, J BONE JOINT SURG BR, V35, P598
   Hasegawa Y, 1997, ARCH ORTHOP TRAUM SU, V116, P251
   Hasegawa Y, 2003, J BONE JOINT SURG BR, V85B, P191, DOI 10.1302/0301-620X.85B2.13190
   He Wei, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P530
   Ito H., 2002, J BONE JT SURG BR, V94, P308
   Keizer SB, 2006, J BONE JOINT SURG BR, V88B, P460, DOI 10.1302/0301-620x.88b4.16950
   Krackow K A, 1993, Orthop Rev, V22, P457
   Lee MS, 2006, CLIN BIOMECH, V21, P969, DOI 10.1016/j.clinbiomech.2006.05.005
   [李子荣 Li Zirong], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P515
   Lin Zhi-jiong, 2009, Zhongguo Gu Shang, V22, P628
   MCCORMACK T, 1994, SPINE, V19, P1741, DOI 10.1097/00007632-199408000-00014
   [史风雷 Shi Fenglei], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P7758
   Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
   Xu Weihua, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P527
   Yang SH, 2008, BIOTECHNOL BIOENG, V100, P560, DOI 10.1002/bit.21792
   [尧浩 Yao Hao], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P3311
   Yu X, 2012, J BIOMATER TISS ENG, V2, P170, DOI 10.1166/jbt.2012.1041
   Zhou GQ, 2014, COMPUT BIOL MED, V52, P96, DOI 10.1016/j.compbiomed.2014.04.002
NR 36
TC 0
Z9 0
U1 1
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2015
VL 5
IS 3
BP 208
EP 212
DI 10.1166/jbt.2015.1277
PG 5
WC Cell & Tissue Engineering
SC Cell Biology
GA CN7OW
UT WOS:000358624900005
DA 2018-10-20
ER

PT J
AU de Oliveira, IR
   de Andrade, TL
   Parreira, RM
   Jacobovitz, M
   Pandolfelli, VC
AF de Oliveira, Ivone Regina
   de Andrade, Talita Luana
   Parreira, Renata Martins
   Jacobovitz, Marcos
   Pandolfelli, Victor Carlos
TI Characterization of Calcium Aluminate Cement Phases when in Contact with
   Simulated Body Fluid
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE dental cement; hydroxyapatite; simulated body fluid
ID MINERAL TRIOXIDE AGGREGATE; PORTLAND-CEMENT; IN-VITRO;
   MECHANICAL-PROPERTIES; ENDODONTIC CEMENT; BIOACTIVITY; VIVO; INHIBITION;
   PHOSPHATE
AB Recent studies involving the use of calcium aluminate cement (CAC) as a biomaterial are based on commercial products. Improvements can be attained by investigating the properties of their crystalline phases in order to better design the material's composition. Therefore, calcium aluminate phase samples immersed in simulated body fluid (SBF) solutions prepared according to Kokubo's (KSBF) and Rigo's (RSBF) methodology had their pH evaluated. The surfaces of these samples were analyzed by SEM, EDX and XRD techniques. The treatment with KSBF did not favor the precipitation of calcium phosphate phases on the surface of CAC phases. On the other hand, in RSBF solution, the pH value attained was higher than for the KSBF one and magnesium phosphate was identified on the surface of CA, C(3)A and C(12)A(7) samples. Only for CA(2), the optimal precipitation condition was attained in RSBF and a surface layer of the hydroxyapatite was detected. Based on its ability of stimulating hydroxyapatite deposition in SBF and other properties, CA(2) can be eligible as the most suitable composition for biomedical purposes.
C1 [de Oliveira, Ivone Regina; de Andrade, Talita Luana; Parreira, Renata Martins] Univ Vale Paraiba Univap, IP&D, Sao Jose Dos Campos, SP, Brazil.
   [Pandolfelli, Victor Carlos] Univ Fed Sao Carlos, Dept Engn Mat Dema, Sao Carlos, SP, Brazil.
RP de Oliveira, IR (reprint author), Univ Vale Paraiba Univap, IP&D, Av Shishima Hifumi 2911, Sao Jose Dos Campos, SP, Brazil.
EM ivoneregina.oliveira@gmail.com
FU Sao Paulo Research Foundation [2009/17451-0, 2013/22502-8]; National
   Council for Scientific and Technological Development - Brazil
FX The authors are grateful to grant #2009/17451-0 and #2013/22502-8, Sao
   Paulo Research Foundation and National Council for Scientific and
   Technological Development - Brazil for providing financial support for
   this research.
CR Aguilai FG, 2011, J ENDODONT, V37, P67, DOI 10.1016/j.joen.2010.10.001
   Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002
   Andrade T. L., 2014, Cerâmica, V60, P88, DOI 10.1590/S0366-69132014000100013
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Camilleri J, 2008, INT ENDOD J, V41, P151
   Castro-Raucci LM, 2011, BRAZ DENT J, V22, P99
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Garcia JR, 2007, CERAMICA, V53, P42
   Jacobovitz M, 2009, ORAL SURG ORAL MED O, V108, P140, DOI 10.1016/j.tripleo.2009.03.013
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Loof J, 2003, J MATER SCI-MATER M, V14, P1033, DOI 10.1023/B:JMSM.0000003999.52349.0d
   Loof J., 2008, THESIS FS TECHNOLOGY
   MARTENS CS, 1970, GEOCHIM COSMOCHIM AC, V34, P621, DOI 10.1016/0016-7037(70)90020-7
   Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x
   Oliveira IR, 2013, J ENDODONT, V39, P774, DOI 10.1016/j.joen.2013.01.013
   Orefice RL, 2006, BIOMATERIALS FUNDAME
   Pandolfelli V. C., 2009, Patent No, Patent No. [W02009067774, 2009067774]
   Pompeu L. L. M. F., 2013, Cerâmica, V59, P216, DOI 10.1590/S0366-69132013000200004
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Silva EJNL, 2012, INT ENDOD J, V45, P815, DOI 10.1111/j.1365-2591.2012.02038.x
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Wu Chengtie, 2009, BONE TISSUE REGENERA, V2, P25
NR 27
TC 1
Z9 2
U1 0
U2 18
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2015
VL 18
IS 2
BP 382
EP 389
DI 10.1590/1516-1439.336714
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CJ2IY
UT WOS:000355308800023
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Boulila, S
   Elfeki, A
   Oudadesse, H
   Elfeki, H
AF Boulila, Salha
   Elfeki, Abdelfattah
   Oudadesse, Hassane
   Elfeki, Hafed
TI Substitution effects of a carbonated hydroxyapatite biomaterial against
   intoxication chloride nickel-exposed rats
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Biomaterial; implantation; intoxication; metal; rats
ID AQUEOUS-SOLUTIONS; OXIDATIVE STRESS; TOXICITY; REMOVAL; APOPTOSIS;
   SULFATE; KIDNEY; CELLS; LIVER; BIOACCUMULATION
AB Aims: This study aimed to investigate the potential effects of a synthetic apatite (carbonated hydroxyapatite) on the detoxification of a group of male "Wistar'' rats exposed to nickel chloride.
   Methods: Toxicity was evaluated by rats' bioassay of nickel chloride. Wistar rats received this metal daily by gavage for seven days (4 mg/ml nickel chloride/200 g body weight, BW). To detoxify this organism, a subcutaneous implantation of the apatite is made.
   Results: The results revealed that exposure to nickel induced oxidative stress, disorders in the balances of ferric phosphocalcic, renal failures, liver toxicity and significant increase in nickel rates in the bones of intoxicated rats. The application of the carbonated hydroxyapatite presented in this study restored those disorders back to normal. The synthetic apatite protected the rats against the toxic effects of nickel by lowering the levels of lipid peroxidation markers and improving the activities of defense enzymes. It also amended ferric and phosphocalcic equilibriums, protected liver and kidney functions and reduced the nickel rate in the bones of the rats. Overall, the results provided strong support for the protective role of carbonated hydroxyapatite in the detoxification of rats exposed to nickel. Those beneficial effects were further confirmed by physico-chemical characterization (X-ray diffraction and infrared spectroscopy), which revealed its property of anionic and cationic substitution, thus supporting its promising candidacy for future biomedical application.
   Conclusion: The hydroxyapatite is an effective biomaterial to solve health problems, particularly detoxification against metals (nickel).
C1 [Boulila, Salha; Elfeki, Abdelfattah] Univ Sfax, Fac Sci Sfax, Lab Anim Ecophysiol, Sfax 3000, Tunisia.
   [Boulila, Salha; Oudadesse, Hassane] Univ Rennes 1, UMR CNRS 6226, Rennes, France.
   [Boulila, Salha; Elfeki, Hafed] Univ Sfax, Fac Sci Sfax, Lab Mat Sci & Environm, Sfax 3000, Tunisia.
RP Elfeki, H (reprint author), Univ Sfax, Fac Sci Sfax, Lab Mat Sci & Environm, BP 1171, Sfax 3000, Tunisia.
EM Hafedelfeki@yahoo.com
FU Tunisian Ministry of Higher Education and Scientific Research; Tunisian
   Ministry of Public Health
FX The authors declare no conflict of interest. This research was supported
   by the Tunisian Ministry of Higher Education and Scientific Research and
   the Tunisian Ministry of Public Health.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Kattan A, 2012, INT J PHARMACEUT, V423, P26, DOI 10.1016/j.ijpharm.2011.07.005
   AMIARD JC, 1987, WATER RES, V21, P693, DOI 10.1016/0043-1354(87)90081-9
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Bailliez S, 2004, PROCESS SAF ENVIRON, V82, P175, DOI 10.1205/095758204322972816
   BALTER P, 1976, Annals of Clinical and Laboratory Science, V6, P306
   Boubchir MA, 2002, BIOCH NEPHROLOGIE
   Boulila S, 2014, J ADV CHEM, V8, P1612
   Buege JA, 1984, J METH ENZYMOL, V105, P302
   Chai F, 2011, REV STOMATOL CHIR, V112, P212, DOI 10.1016/j.stomax.2011.06.003
   Chakraborty S, 2008, NUCL MED BIOL, V35, P589, DOI 10.1016/j.nucmedbio.2008.03.003
   Chen CY, 2010, J TOXICOL ENV HEAL A, V73, P529, DOI 10.1080/15287390903421250
   Chen CY, 1998, ARCH BIOCHEM BIOPHYS, V356, P127, DOI 10.1006/abbi.1998.0761
   Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Dandevi K, 2003, REPROD TOXICOL, V17, P451, DOI 10.1016/S0890-6238(03)00040-6
   Das KK, 2000, BIOL TRACE ELEM RES, V73, P175, DOI 10.1385/BTER:73:2:175
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Doreswamy C., 2004, Karnataka Journal of Agricultural Sciences, V17, P345
   DORMER RL, 1974, BIOCHEM J, V140, P135, DOI 10.1042/bj1400135
   Durand D, 2013, CAH NUTR DIET, V48, P218, DOI 10.1016/j.cnd.2013.04.005
   Eisler R, 1998, USGSBRDBSR19980001 P, P95
   El Feki H, 1999, J ALLOY COMPD, V287, P114, DOI 10.1016/S0925-8388(99)00070-5
   El Feki H, 2004, PHYS STATUS SOLIDI C, V1, P1985, DOI 10.1002/pssc.200304450
   El Feki H, 2000, J PHYS-CONDENS MAT, V12, P8331, DOI 10.1088/0953-8984/12/38/309
   Fary JR, 1993, J SCI, V222, P330
   Frank-Kamenetskaya O, 2011, J MOL STRUCT, V992, P9, DOI 10.1016/j.molstruc.2011.02.013
   Georgescu B, 2011, ANIM SCI BIOTECHNOL, V44, P89
   GERHARD I, 1992, GEBURTSH FRAUENHEILK, V52, P383, DOI 10.1055/s-2007-1023774
   GHAZALY KS, 1992, WATER AIR SOIL POLL, V64, P525, DOI 10.1007/BF00483362
   Gupta N, 2012, J TAIWAN INST CHEM E, V43, P125, DOI 10.1016/j.jtice.2011.07.009
   Hfaiedh N, 2005, CR BIOL, V328, P648, DOI 10.1016/j.crvi.2005.03.001
   Hfaiedh N, 2008, FOOD CHEM TOXICOL, V46, P3759, DOI 10.1016/j.fct.2008.09.059
   Jia J, 2008, ENVIRON TOXICOL, V23, P401, DOI 10.1002/tox.20346
   Kakela R, 1999, COMP BIOCHEM PHYS C, V123, P27, DOI 10.1016/S0742-8413(99)00006-7
   Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021
   Koedrith P, 2011, INT J MOL SCI, V12, P9576, DOI 10.3390/ijms12129576
   Krisanapiboon A, 2006, J Orthop Surg (Hong Kong), V14, P315
   Kubrak OI, 2012, AQUAT TOXICOL, V118, P88, DOI 10.1016/j.aquatox.2012.03.016
   Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2
   Legeros RZ, 1980, FORMATION STABILITY, P89
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mathur A. K., 1993, Biomedical and Environmental Sciences, V6, P231
   Mobasherpour I, 2011, J SAUDI CHEM SOC, V15, P105, DOI 10.1016/j.jscs.2010.06.003
   Nielsen PH, 2002, WATER SCI TECHNOL, V46, P73
   Obone E, 1999, J TOXICOL ENV HEAL A, V57, P379, DOI 10.1080/009841099157593
   Osmancik P, 2010, CARDIOLOGY, V116, P302, DOI 10.1159/000319619
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193
   Pandey R, 1999, BIOMETALS, V12, P339, DOI 10.1023/A:1009291816033
   Ptashynski MD, 2002, AQUAT TOXICOL, V58, P249, DOI 10.1016/S0166-445X(01)00231-4
   RAY D, 1990, J INORG BIOCHEM, V38, P169, DOI 10.1016/0162-0134(90)84010-M
   Rosskopfova O, 2013, J RADIOANAL NUCL CH, V295, P459, DOI 10.1007/s10967-012-1799-6
   Sengupta P, 2013, DRUG CHEM TOXICOL, V36, P353, DOI 10.3109/01480545.2012.710631
   Simon FG, 2008, APPL GEOCHEM, V23, P2137, DOI 10.1016/j.apgeochem.2008.04.025
   Smiciklas I, 2006, WATER RES, V40, P2267, DOI 10.1016/j.watres.2006.04.031
   Stengel B, 1996, ENCY MED CHIRURG TOX
   STINSON TJ, 1992, TOXICOL APPL PHARM, V117, P98, DOI 10.1016/0041-008X(92)90222-E
   Sunderman FW, 1977, J ANN CLIN LAB SCI, V5, P377
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   TJALVE H, 1988, WATER RES, V22, P1129, DOI 10.1016/0043-1354(88)90007-3
   Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N
   Uthus EO, 1996, BIOL TRACE ELEM RES, V52, P23, DOI 10.1007/BF02784087
   Veiderma M, 2005, J ORGANOMET CHEM, V690, P2638, DOI 10.1016/j.jorganchem.2004.11.022
   VENUGOPAL B, 1978, METAL TOXICITY MAMMA
   Wang YF, 2012, TOXICOL APPL PHARM, V259, P177, DOI 10.1016/j.taap.2011.12.022
   Yokoi K, 2003, BIOL TRACE ELEM RES, V93, P141, DOI 10.1385/BTER:93:1-3:141
   Young RA, 1975, C INT CNRS, V230, P21
   Zhu RH, 2008, CATAL TODAY, V139, P94, DOI 10.1016/j.cattod.2008.08.011
NR 70
TC 1
Z9 1
U1 2
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1537-6516
EI 1537-6524
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD MAR
PY 2015
VL 25
IS 3
BP 155
EP 165
DI 10.3109/15376516.2014.1003358
PG 11
WC Toxicology
SC Toxicology
GA CK1ST
UT WOS:000355988300001
PM 25560666
DA 2018-10-20
ER

PT J
AU Tas, AC
AF Tas, A Cuneyt
TI Aragonite coating solutions (ACS) based on artificial seawater
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Aragonite; Coating; Biomimicry; Artificial; Seawater
ID AMORPHOUS CALCIUM-CARBONATE; SEA-WATER; SPHERULITIC GROWTH;
   SURFACE-STRUCTURE; SATURATION STATE; SULFATE-IONS; IN-VITRO;
   CRYSTALLIZATION; PRECIPITATION; MAGNESIUM
AB Aragonite (CaCO3, calcium carbonate) is an abundant biomaterial of marine life. It is the dominant inorganic phase of coral reefs, mollusc bivalve shells and the stalactites or stalagmites of geological sediments. Inorganic and initially precipitate-free aragonite coating solutions (ACS) of pH 7.4 were developed in this study to deposit monolayers of aragonite spherules or ooids on biomaterial (e.g., UHMWPE, ultrahigh molecular weight polyethylene) surfaces soaked in ACS at 30 degrees C. The ACS solutions of this study have been developed for the surface engineering of synthetic biomaterials. The abiotic ACS solutions, enriched with calcium and bicarbonate ions at different concentrations, essentially mimicked the artificial seawater composition and started to deposit aragonite after a long (4 h) incubation period at the tropical sea surface temperature of 30 degrees C. While numerous techniques for the solution deposition of calcium hydroxyapatite (Ca-10(PO4)(6)(OH)(2)), of low thermodynamic solubility, on synthetic biomaterials have been demonstrated, procedures related to the solution-based surface deposition of high solubility aragonite remained uncommon. Monolayers of aragonite ooids deposited at 30 degrees C on UHMWPE substrates soaked in organic-free ACS solutions were found to possess nano-structures similar to the mortar-and-bricktype botryoids observed in biogenic marine shells. Samples were characterized using SEM, XRD, FTIR, ICP-AES and contact angle goniometry. (C) 2015 Elsevier B.V. All rights reserved.
C1 Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
RP Tas, AC (reprint author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.
EM c_tas@hotmail.com
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Ahn JW, 2004, J AM CERAM SOC, V87, P286, DOI 10.1111/j.1551-2916.2004.00286.x
   Allison VC, 1923, J GEOL, V31, P106, DOI 10.1086/622988
   [Anonymous], 2013, D114198 ASTM
   Backstrom HLJ, 1925, J AM CHEM SOC, V47, P2432, DOI 10.1021/ja01687a002
   Barchiche C, 2009, ELECTROCHIM ACTA, V54, P3580, DOI 10.1016/j.electacta.2009.01.023
   Barchiche Ch, 2003, ELECTROCHIM ACTA, V48, P1645
   Bayraktar A.C. Tas, 1999, J EUR CERAM SOC, V19, P2573
   Beck R, 2010, J CRYST GROWTH, V312, P2226, DOI 10.1016/j.jcrysgro.2010.04.037
   Benedetti A, 2009, ELECTROCHIM ACTA, V54, P6472, DOI 10.1016/j.electacta.2009.06.022
   BERNER RA, 1965, GEOCHIM COSMOCHIM AC, V29, P947, DOI 10.1016/0016-7037(65)90087-6
   BERNER RA, 1972, AM J SCI, V272, P826, DOI 10.2475/ajs.272.9.826
   BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7
   BILLS PM, 1985, CALCIFIED TISSUE INT, V37, P174, DOI 10.1007/BF02554837
   Bots P, 2011, GEOLOGY, V39, P331, DOI 10.1130/G31619.1
   Bragg WL, 1924, P R SOC LOND A-CONTA, V105, P16, DOI 10.1098/rspa.1924.0002
   BRAND U, 1991, GEOCHIM COSMOCHIM AC, V55, P505, DOI 10.1016/0016-7037(91)90008-S
   Brecevic L, 2007, CROAT CHEM ACTA, V80, P467
   Cubillas P, 2005, CHEM GEOL, V216, P59, DOI 10.1016/j.chemgeo.2004.11.009
   De Choudens-Sanchez V, 2009, J SEDIMENT RES, V79, P363, DOI 10.2110/jsr.2009.043
   de Leeuw NH, 1998, J PHYS CHEM B, V102, P2914, DOI 10.1021/jp973210f
   Debye P, 1923, PHYS Z, V24, P185
   Deng YL, 2013, MAT SCI ENG C-MATER, V33, P1339, DOI 10.1016/j.msec.2012.12.034
   Dill RF, 1998, CARBONATE EVAPORITE, V13, P189, DOI 10.1007/BF03176592
   Fabre S, 2013, PALAEOGEOGR PALAEOCL, V392, P524, DOI 10.1016/j.palaeo.2013.10.006
   FernandezDiaz L, 1996, J SEDIMENT RES, V66, P482
   Fransson A, 2013, J GEOPHYS RES-OCEANS, V118, P7001, DOI 10.1002/2013JC009164
   Gangsto R, 2008, BIOGEOSCIENCES, V5, P1057, DOI 10.5194/bg-5-1057-2008
   Gayathri S, 2007, CHEM-EUR J, V13, P3262, DOI 10.1002/chem.200600825
   Jiang JX, 2012, J AM CERAM SOC, V95, P3735, DOI 10.1111/jace.12077
   Jury CP, 2013, WATER-SUI, V5, P1303, DOI 10.3390/w5031303
   Karoui H, 2013, DESALINATION, V311, P234, DOI 10.1016/j.desal.2012.07.011
   KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176
   Koga N, 2014, CRYST GROWTH DES, V14, P879, DOI 10.1021/cg4018689
   KOJIMA Y, 1993, NIPPON SERAM KYO GAK, V101, P1145
   Lee E, 2013, J ATMOS OCEAN TECH, V30, P2926, DOI 10.1175/JTECH-D-12-00238.1
   Lee JH, 2014, J AM CERAM SOC, V97, P3052, DOI 10.1111/jace.13124
   Lenders H.M., 2012, AM CHEM SOC, V134, P1367
   Lyman J, 1940, J MAR RES, V3, P134
   Mann S, 2001, BIOMINERALIZATION PR
   Matijevic E., 1999, COLLOID INTERFACE SC, V218, P545
   McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7
   MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7
   MUCCI A, 1987, GEOCHIM COSMOCHIM AC, V51, P1977, DOI 10.1016/0016-7037(87)90186-4
   MUCCI A, 1984, GEOCHIM COSMOCHIM AC, V48, P815, DOI 10.1016/0016-7037(84)90103-0
   MUCCI A, 1989, CHEM GEOL, V74, P309, DOI 10.1016/0009-2541(89)90040-5
   Njegic-Dzakula N., 2010, J COLLOID INTERF SCI, V343, P553
   OTA Y, 1995, J AM CERAM SOC, V78, P1983, DOI 10.1111/j.1151-2916.1995.tb08924.x
   Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Papadimitriou S, 2004, GEOCHIM COSMOCHIM AC, V68, P1749, DOI 10.1016/j.gca.2003.07.004
   Park WK, 2008, J CRYST GROWTH, V310, P2593, DOI 10.1016/j.jcrysgro.2008.01.023
   Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006
   Pavlov M, 1998, J PHYS CHEM A, V102, P219, DOI 10.1021/jp972072r
   Plummer LN, 1982, GEOCHIM COSMOCHIM AC, P1011
   Raiteri P, 2010, J AM CHEM SOC, V132, P17623, DOI 10.1021/ja108508k
   Rau GH, 2011, ENVIRON SCI TECHNOL, V45, P1088, DOI 10.1021/es102671x
   REDDY MM, 1976, J CRYST GROWTH, V35, P33, DOI 10.1016/0022-0248(76)90240-2
   Riveiro A, 2014, APPL SURF SCI, V302, P236, DOI 10.1016/j.apsusc.2014.02.130
   rvloeller H., 2007, CORROS SCI, V49, P1992
   Sand KK, 2012, CRYST GROWTH DES, V12, P842, DOI 10.1021/cg2012342
   Segschneider J, 2013, GLOBAL BIOGEOCHEM CY, V27, P1214, DOI 10.1002/2013GB004684
   Sherwin CM, 2011, GEOCHIM COSMOCHIM AC, V75, P3915, DOI 10.1016/j.gca.2011.04.020
   SIMKISS K, 1964, NATURE, V201, P492, DOI 10.1038/201492a0
   Tas AC, 2014, J NON-CRYST SOLIDS, V400, P27, DOI 10.1016/j.jnoncrysol.2014.04.031
   Thachepan S, 2006, CHEM MATER, V18, P3557, DOI 10.1021/cm060847f
   Vater H., 1897, Z KRISTALLOGR MIN, V27, P477
   Villegas-Jimenez A, 2009, LANGMUIR, V25, P6813, DOI 10.1021/la803652x
   Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017
   WRAY JL, 1957, J AM CHEM SOC, V79, P2031, DOI 10.1021/ja01566a001
   Xu J, 2013, P NATL ACAD SCI USA, V110, P17750, DOI 10.1073/pnas.1307612110
   Zakaria FZ, 2008, J RAMAN SPECTROSC, V39, P1204, DOI 10.1002/jrs.1964
   ZHONG SJ, 1989, CHEM GEOL, V78, P283, DOI 10.1016/0009-2541(89)90064-8
   ZHONG SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P443, DOI 10.1016/0016-7037(94)00381-U
   Zhou GT, 2010, EUR J MINERAL, V22, P259, DOI 10.1127/0935-1221/2009/0022-2008
   Zuddas P, 1998, GEOCHIM COSMOCHIM AC, V62, P757, DOI 10.1016/S0016-7037(98)00026-X
   ZUDDAS P, 1994, GEOCHIM COSMOCHIM AC, V58, P4353, DOI 10.1016/0016-7037(94)90339-5
NR 79
TC 3
Z9 3
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2015
VL 330
BP 262
EP 269
DI 10.1016/j.apsusc.2014.12.195
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CB4SE
UT WOS:000349617400033
DA 2018-10-20
ER

PT J
AU Van Ba, OL
   Aharony, S
   Loutochin, O
   Corcos, J
AF Van Ba, Ornella Lam
   Aharony, Shachar
   Loutochin, Oleg
   Corcos, Jacques
TI Bladder tissue engineering: A literature review
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Bladder; Tissue engineering; Scaffold; Biomaterial; Bladder
   reconstruction
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; ENDOTHELIAL
   GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; IN-VIVO DEGRADATION;
   URINARY-BLADDER; ACELLULAR MATRIX; RABBIT MODEL; AUGMENTATION
   CYSTOPLASTY; MAGNETIC-RESONANCE
AB Purpose of review: In bladder cancer and neuro-bladder, reconstruction of the bladder requires bowel segment grafting for augmentation cystoplasty or neo-bladder creation. However, even if currently considered as the gold standard, it is associated with potentially severe short- and long-term adverse effects. Thus, bladder tissue engineering is a promising approach to bladder reconstruction.
   Recent findings: In the last few years, progress has been made with the development of new biomaterials for bladder tissue replacement and in deciphering the role of stem cells as well as their contribution to bladder scaffold integration and tissue regeneration.
   Summary: This review of recently published articles allows us to forecast the characteristics of efficient and safe bladder biomaterials. However, several factors, such as native bladder traits, the specific involvement of urine, and bladder tissue replacement indications, have to be assessed with caution before including bladder tissue engineering in clinical trials. Many authors agree that these challenging techniques could deliver significant benefits with clinical application, reducing morbidity and global long-term costs. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Van Ba, Ornella Lam; Aharony, Shachar; Loutochin, Oleg; Corcos, Jacques] McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada.
RP Corcos, J (reprint author), McGill Univ, Jewish Gen Hosp, Dept Urol, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.
EM jcorcos@uro.jgh.mcgill.ca
CR Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128
   Altai C., 2006, J UROLOGY, V176, P1706
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anilkumar TV, 2014, J BIOMED MATER RES B, V102, P1506, DOI 10.1002/jbm.b.33131
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cheng HLM, 2012, NMR BIOMED, V25, P418, DOI 10.1002/nbm.1617
   Cheng HLM, 2010, MAGN RESON MED, V64, P341, DOI 10.1002/mrm.22404
   Corcos J, 2011, NEUROUROL URODYNAM, V30, P447, DOI 10.1002/nau.20998
   Datum S. E., 1998, BR J UROL, V82, P411
   Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Feng JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096671
   GROVER PK, 1994, MINER ELECTROL METAB, V20, P361
   Hafner C, 2002, INT J CANCER, V101, P1, DOI 10.1002/ijc.10544
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Juszczak K, 2012, CELL MOL BIOL LETT, V17, P196, DOI 10.2478/s11658-012-0002-y
   Kajbafzadeh AM, 2014, PEDIATR SURG INT, V30, P371, DOI 10.1007/s00383-014-3474-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kopparapu PK, 2013, ANTICANCER RES, V33, P2381
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1097/01.ju.0000030040.76258.5a
   Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27
   Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Moad M, 2013, EUR UROL, V64, P753, DOI 10.1016/j.eururo.2013.03.054
   Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Petrovic V, 2011, THESCIENTIFICWORLDJO, V11, P1479, DOI 10.1100/tsw.2011.138
   Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Poluywczynska M., 2014, EXP BIOL MED, V239, P264
   Quek ML, 2003, J UROLOGY, V169, P195, DOI 10.1097/01.ju.0000039782.13395.0a
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102
   Schaefer M, 2013, J PEDIATR UROL, V9, P878, DOI 10.1016/j.jpurol.2012.12.001
   Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038
   Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sloff M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098734
   Spencer R, 2012, NMR BIOMED, V25, P401, DOI 10.1002/nbm.1806
   Subramaniam R, 2011, J UROLOGY, V186, P2014, DOI 10.1016/j.juro.2011.07.031
   Sun Y., 2014, TISSUE ENG C, V24
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yao C, 2013, INT J NANOMED, V8, P3285, DOI 10.2147/IJN.S44901
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zhang F, 2014, J UROLOGY, V192, P544, DOI 10.1016/j.juro.2014.01.116
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 79
TC 17
Z9 17
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAR
PY 2015
VL 82-83
BP 31
EP 37
DI 10.1016/j.addr.2014.11.013
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CH0UF
UT WOS:000353737200005
PM 25446136
DA 2018-10-20
ER

PT J
AU Lin, HK
   Madihally, SV
   Palmer, B
   Frimberger, D
   Fung, KM
   Kropp, BP
AF Lin, Hsueh-Kung
   Madihally, Sundar V.
   Palmer, Blake
   Frimberger, Dominic
   Fung, Kar-Ming
   Kropp, Bradley P.
TI Biomatrices for bladder reconstruction
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Bioactive molecule; Biomaterials; Bladder augmentation; Nanotechnology;
   Stem cell; Tissue engineering
ID SMALL-INTESTINAL SUBMUCOSA; SMOOTH-MUSCLE-CELLS; ACELLULAR MATRIX GRAFT;
   ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING
   APPLICATIONS; NANO-STRUCTURED POLYMERS; HUMAN AMNIOTIC MEMBRANE;
   SILK-BASED BIOMATERIALS; IN-VIVO IMPLICATIONS
AB There is a demand for tissue engineering of the bladder needed by patients who experience a neurogenic bladder or idiopathic detrusor overactivity. To avoid complications from augmentation cystoplasty, the field of tissue engineering seeks optimal scaffolds for bladder reconstruction. Naturally derived biomaterials as well as synthetic and natural polymers have been explored as bladder substitutes. To improve regenerative properties, these biomaterials have been conjugated with functional molecules, combined with nanotechology, or seeded with exogenous cells. Although most studies reported complete and functional bladder regeneration in small-animal models, results from large-animal models and human clinical trials varied. For functional bladder regeneration, procedures for biomaterial fabrication, incorporation of biologically active agents, introduction of nanotechnology, and application of stem-cell technology need to be standardized. Advanced molecular and medical technologies such as next generation sequencing and magnetic resonance imaging can be introduced for mechanistic understanding and non-invasive monitoring of regeneration processes, respectively. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lin, Hsueh-Kung; Palmer, Blake; Frimberger, Dominic; Fung, Kar-Ming; Kropp, Bradley P.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Childrens Hosp Oklahoma, Oklahoma City, OK 73104 USA.
   [Madihally, Sundar V.] Oklahoma State Univ, Dept Chem Engn, Engn North 423, Stillwater, OK 74078 USA.
   [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA.
RP Kropp, BP (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, 920 Stanton L Young Blvd,WP3150, Oklahoma City, OK 73104 USA.
EM Brad-Kropp@ouhsc.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
CR Adamowicz J, 2012, TRANSPL P, V44, P1429, DOI 10.1016/j.transproceed.2012.01.144
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ahvaz HH, 2013, J NANOSCI NANOTECHNO, V13, P4736, DOI 10.1166/jnn.2013.7193
   Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230
   Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   BABU M, 1989, MOL CELL BIOL, V9, P1642, DOI 10.1128/MCB.9.4.1642
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Baumert H, 2007, EUR UROL, V52, P884, DOI 10.1016/j.eururo.2006.11.044
   Baumert H, 2007, EUR UROL, V52, P1492, DOI 10.1016/j.eururo.2007.04.098
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Biers SM, 2012, BJU INT, V109, P1280, DOI 10.1111/j.1464-410X.2011.10650.x
   Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2006, BIOMATERIALS, V27, P3825, DOI 10.1016/j.biomaterials.2006.02.040
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654
   Cartwright L, 2006, J BIOMED MATER RES A, V77A, P390, DOI 10.1002/jbm.a.30648
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   CHEN NX, 1995, TRANSPLANTATION, V59, P933, DOI 10.1097/00007890-199504150-00002
   Chen W, 2014, TISSUE ENG PT A, V20, P2234, DOI [10.1089/ten.tea.2013.0730, 10.1089/ten.TEA.2013.0730]
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Dantzer E, 2001, BRIT J PLAST SURG, V54, P659, DOI 10.1054/bjps.2001.3684
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis LM, 2014, J BIOMED MATER RES B, V102, P89, DOI 10.1002/jbm.b.32985
   Del Gaudio C, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045013
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Denuziere A., 2000, Annales Pharmaceutiques Francaises, V58, P47
   Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55
   Drewa T, 2006, TRANSPLANT P, V38, P133, DOI 10.1016/j.transproceed.2005.11.086
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evren S, 2010, CELLS TISSUES ORGANS, V192, P250, DOI 10.1159/000317332
   Farhat W, 2003, J BIOMED MATER RES A, V67A, P970, DOI 10.1002/jbm.a.10171
   Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237
   Frimberger D, 2005, UROLOGY, V65, P827, DOI 10.1016/j.urology.2004.11.024
   Gabouev AI, 2003, INT J ARTIF ORGANS, V26, P935
   Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   GARG HG, 1991, BURNS, V17, P452, DOI 10.1016/0305-4179(91)90070-W
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Geng HQ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-312
   Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Horst M, 2014, J BIOMED MATER RES A, V102, P2116, DOI 10.1002/jbm.a.34889
   Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Huang X, 2013, UROLOGY, V81, P468, DOI 10.1016/j.urology.2012.12.001
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Iijima K, 2007, TISSUE ENG, V13, P513, DOI 10.1089/ten.2006.0170
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kajbafzadeh AM, 2012, TISSUE ENG PT A, V18, P883, DOI [10.1089/ten.tea.2011.0202, 10.1089/ten.TEA.2011.0202]
   Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P317, DOI 10.1016/j.jpurol.2011.02.014
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kranz H, 2000, J PHARM SCI-US, V89, P1558
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Lawrence BJ, 2009, J BIOMED MATER RES A, V88A, P634, DOI 10.1002/jbm.a.31903
   Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   LINDNER V, 1992, J CLIN INVEST, V90, P2044, DOI 10.1172/JCI116085
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Lorentz KM, 2012, BIOMATERIALS, V33, P494, DOI 10.1016/j.biomaterials.2011.09.088
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Madihally SV, 1999, STEM CELLS, V17, P295, DOI 10.1002/stem.170295
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marques AID, 2009, J SMALL ANIM PRACT, V50, P619, DOI 10.1111/j.1748-5827.2009.00819.x
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Master VA, 2003, J UROLOGY, V170, P1628, DOI 10.1097/01.ju.0000084407.24615.f8
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Moon SJ, 2011, KOREAN J UROL, V52, P150, DOI 10.4111/kju.2011.52.2.150
   Moshfeghian A, 2006, J BIOMED MATER RES A, V79A, P418, DOI 10.1002/jbm.a.30849
   Murphy F, 2007, PEDIATR SURG INT, V23, P353, DOI 10.1007/s00383-007-1882-1
   Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722
   Obara T, 2006, UROLOGY, V68, P892, DOI 10.1016/j.urology.2006.04.030
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   PISTNER H, 1993, BIOMATERIALS, V14, P291, DOI 10.1016/0142-9612(93)90121-H
   Pokrywczynska M, 2013, ARCH IMMUNOL THER EX, V61, P483, DOI 10.1007/s00005-013-0249-7
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Saito N, 1999, J BIOMED MATER RES, V47, P104, DOI 10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7
   Salem SA, 2013, MALAYS J MED SCI, V20, P80
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z
   Sarasam AR, 2007, MACROMOL BIOSCI, V7, P1160, DOI 10.1002/mabi.200700001
   Sarasam AR, 2006, BIOMACROMOLECULES, V7, P1131, DOI 10.1021/bm050935d
   Sartoneva R, 2011, J R SOC INTERFACE, V8, P671, DOI 10.1098/rsif.2010.0520
   Sarwar Iram, 2010, J Ayub Med Coll Abbottabad, V22, P7
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038
   Shakhssalim N, 2013, INT J ARTIF ORGANS, V36, P113, DOI 10.5301/ijao.5000175
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   Sharifiaghdas Farzaneh, 2007, Urol J, V4, P71
   Sharma AK, 2013, P NATL ACAD SCI USA, V110, P4003, DOI 10.1073/pnas.1220764110
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Shoae-Hassani A., 2013, J TISSUE EN IN PRESS
   Shoae-Hassani A, 2013, BJU INT, V112, P854, DOI 10.1111/bju.12195
   Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y
   Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Song LJ, 2014, TISSUE ENG PART B-RE, V20, P163, DOI [10.1089/ten.teb.2013.0103, 10.1089/ten.TEB.2013.0103]
   Stehr M, 2003, J UROLOGY, V169, P1165, DOI 10.1097/01.ju.0000041501.01323.b9
   Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138
   Sun WL, 2012, TISSUE ENG PART C-ME, V18, P731, DOI 10.1089/ten.tec.2011.0593
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Towner RA, 2010, TISSUE ENG PT A, V16, P357, DOI [10.1089/ten.tea.2009.0233, 10.1089/ten.TEA.2009.0233]
   Towner RA, 2010, TISSUE ENG PT A, V16, P365, DOI [10.1089/ten.tea.2009.0234, 10.1089/ten.TEA.2009.0234]
   Tu DD, 2013, BIOMATERIALS, V34, P8681, DOI 10.1016/j.biomaterials.2013.08.001
   Urakami S, 2007, WORLD J UROL, V25, P207, DOI 10.1007/s00345-006-0142-7
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Witt C, 2000, BIOMATERIALS, V21, P931, DOI 10.1016/S0142-9612(99)00262-8
   Xiong Q, 2014, TISSUE EN A IN PRESS
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yang B, 2010, J BIOMED MATER RES A, V93A, P1100, DOI 10.1002/jbm.a.32534
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Yannas IV, 1997, ANN NY ACAD SCI, V831, P280
   Yao C, 2013, INT J NANOMED, V8, P3285, DOI 10.2147/IJN.S44901
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Yu DS, 2007, INT J UROL, V14, P939, DOI 10.1111/j.1442-2042.2007.01871.x
   Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959
   Zderic SA, 2012, J CELL MOL MED, V16, P203, DOI 10.1111/j.1582-4934.2011.01368.x
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 209
TC 20
Z9 21
U1 5
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAR
PY 2015
VL 82-83
BP 47
EP 63
DI 10.1016/j.addr.2014.11.020
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CH0UF
UT WOS:000353737200007
PM 25477305
DA 2018-10-20
ER

PT J
AU Wang, ZZ
   Fang, WZ
   Li, LJ
   Li, Y
   Yu, XT
   Gu, Q
   Zhou, FJ
AF Wang, Zhanzhong
   Fang, Wenzhi
   Li, Lijie
   Li, Yan
   Yu, Xiaoting
   Gu, Qing
   Zhou, Fengjuan
TI Effects of an ionic liquid as an additive on the thermal
   denaturation/degradation of lysozyme crystals
SO ASIA-PACIFIC JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE thermal denaturation; degradation; kinetics; lysozyme; ionic liquid
ID EGG-WHITE LYSOZYME; DIFFERENTIAL SCANNING CALORIMETRY; PROTEIN
   CRYSTALLIZATION; NUCLEATION
AB Ionic liquids (ILs) have biomaterial applications and are used for protein crystallization. The present study explores the thermal denaturation and degradation kinetics of the lysozyme crystals induced by IL [C(4)mim]Cl using differential scanning calorimetry (DSC). Lysozyme crystals were scanned from 10 to 250 degrees C at different heating rates varying from 5 to 20 degrees Cmin(-1). Under the same heating rate, the addition of the IL makes lysozyme crystals confer more resistance to thermal denaturation and change values of conversion rate increase. The denaturation and degradation peak shifted towards higher temperature as heating rate increased and showed an activated denaturing kinetics of the lysozyme. It can be clearly noticed that the addition of the IL increases activation energy for denaturation and decreases it for degradation. The effect of the IL on thermal denaturation is attributed to the change of lysozyme-lysozyme molecular interaction. (c) 2014 Curtin University of Technology and John Wiley & Sons, Ltd.
C1 [Wang, Zhanzhong; Fang, Wenzhi; Li, Yan; Yu, Xiaoting; Gu, Qing; Zhou, Fengjuan] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
   [Li, Lijie] Inner Mongolia Agr Univ, Coll Food Sci & Engn, Hohhot 010018, Peoples R China.
RP Zhou, FJ (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM fengjuanzhou@126.com
FU National Natural Science Foundation of China [20806053]; Science and
   Technology Foundation of Tianjin Municipal Health Bureau [13KG138]
FX This work was funded by the National Natural Science Foundation of China
   (no. 20806053) and the Science and Technology Foundation of Tianjin
   Municipal Health Bureau (no. 13KG138).
CR ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8
   Burke MW, 2001, J CRYST GROWTH, V232, P301, DOI 10.1016/S0022-0248(01)01060-0
   Chang HM, 2000, J AGR FOOD CHEM, V48, P161, DOI 10.1021/jf9902797
   Colombo A, 2010, J AGR FOOD CHEM, V58, P4434, DOI 10.1021/jf903426f
   Dang LP, 2013, APPL BIOCHEM BIOTECH, V169, P290, DOI 10.1007/s12010-012-9986-z
   Hekmat D, 2007, BIOTECHNOL LETT, V29, P1703, DOI 10.1007/s10529-007-9456-9
   Judge R. A., 2007, CRYST GROWTH DES, V9, P3463
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045
   Lange C, 2005, PROTEIN SCI, V14, P2693, DOI 10.1110/ps.051596605
   Li-Chan ECY, 2002, FOOD CHEM, V77, P495, DOI 10.1016/S0308-8146(01)00365-X
   Liu YD, 2005, J CRYST GROWTH, V281, P616, DOI 10.1016/j.jcrysgro.2005.04.073
   McPherson A, 2004, METHODS, V34, P254, DOI 10.1016/j.ymeth.2004.03.019
   Myers C., 1990, THERMAL ANAL FOODS
   OZAWA T, 1992, THERMOCHIM ACTA, V203, P159, DOI 10.1016/0040-6031(92)85192-X
   Ozawa T., 1970, J THERM ANAL, V3, P301, DOI DOI 10.1007/BF01911411
   Paredi ME, 2002, J AGR FOOD CHEM, V50, P830, DOI 10.1021/jf010767q
   PUYOL P, 1994, J DAIRY SCI, V77, P1494, DOI 10.3168/jds.S0022-0302(94)77088-0
   UEDAIRA H, 1980, B CHEM SOC JPN, V53, P2451, DOI 10.1246/bcsj.53.2451
   Wang ZZ, 2012, BIOTECHNOL BIOPROC E, V17, P1025, DOI 10.1007/s12257-012-0096-0
   Wang ZZ, 2010, J AGR FOOD CHEM, V58, P5444, DOI 10.1021/jf1000343
   Zhao Y, 2009, CRYST GROWTH DES, V9, P4984, DOI 10.1021/cg900771c
NR 21
TC 1
Z9 1
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-2135
EI 1932-2143
J9 ASIA-PAC J CHEM ENG
JI Asia-Pac. J. Chem. Eng.
PD MAR-APR
PY 2015
VL 10
IS 2
BP 163
EP 169
DI 10.1002/apj.1855
PG 7
WC Engineering, Chemical
SC Engineering
GA CH2XE
UT WOS:000353887600001
DA 2018-10-20
ER

PT J
AU Green, DW
   Kwon, HJ
   Jung, HS
AF Green, David W.
   Kwon, Hyuk-Jae
   Jung, Han-Sung
TI Osteogenic Potency of Nacre on Human Mesenchymal Stem Cells
SO MOLECULES AND CELLS
LA English
DT Article
DE bone morphogenetic protein; human bone marrow stromal cells; mesenchymal
   stem cells; nacre; nacre soluble matrix proteins; osteoinduction
ID OSTEOBLASTS MAINTAINED INVITRO; MOLECULAR-WEIGHT MOLECULES;
   WATER-SOLUBLE MATRIX; IN-VITRO; BONE-FORMATION; PINCTADA-FUCATA;
   MINERALIZATION; PEARL; BIOMINERALIZATION
AB Nacre seashell is a natural osteoinductive biomaterial with strong effects on osteoprogenitors, osteoblasts, and osteoclasts during bone tissue formation and morphogenesis. Although nacre has shown, in one study, to induce bridging of new bone across large non-union bone defects in 8 individual human patients, there have been no succeeding human surgical studies to confirm this outstanding potency. But the molecular mechanisms associated with nacre osteoinduction and the influence on bone marrow-derived mesenchymal stem cells (BMSC's), skeletal stem cells or bone marrow stromal cells remain elusive. In this study we highlight the phenotypic and biochemical effects of Pinctada maxima nacre chips and the global nacre soluble protein matrix (SPM) on primary human bone marrow-derived stromal cells (hBMSCs) in vitro. In static co-culture with nacre chips, the hBMSCs secreted Alkaline phosphatase (ALP) at levels that exceeded bone morphogenetic protein (rhBMP-2) treatment. Concentrated preparation of SPM applied to Stro-1 selected hBMSC's led to rapid ALP secretions, at concentrations exceeding the untreated controls even in osteogenic conditions. Within 21 days the same population of Stro-1 selected hBMSCs proliferated and secreted collagens I-IV, indicating the premature onset of an osteoblast phenotype. The same SPM was found to promote unselected hBMSC differentiation with osteocalcin detected at 7 days, and proliferation increased at 7 days in a dose-dependent manner. In conclusion, nacre particles and nacre SPM induced the early stages of human bone cell differentiation, indicating that they may be promising soluble factors with osteoinductive capacity in primary human bone cell progenitors such as, hBMSC's.
C1 [Green, David W.; Jung, Han-Sung] Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China.
   [Kwon, Hyuk-Jae] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
   [Jung, Han-Sung] Yonsei Univ, Coll Dent, PLUS Project BK21, Oral Sci Res Ctr,Div Anat & Dev Biol,Dept Oral Bi, Seoul 120749, South Korea.
RP Jung, HS (reprint author), Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China.
EM hsjung@hku.hk
FU National Research Foundation of Korea [2013K2A2A4003305]
FX This work was supported under the framework of international cooperation
   program managed by National Research Foundation of Korea (No.
   2013K2A2A4003305).
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036
   Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Liao HH, 2002, BIOMATERIALS, V23, P2693, DOI 10.1016/S0142-9612(01)00421-5
   Lopez E, 2004, KEY ENG MAT, V254-2, P733, DOI 10.4028/www.scientific.net/KEM.254-256.733
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, French Patent, Patent No. [FR9515650,WO97/24133-10/07/97, 9724133100797]
   Lopez E., 2004, ARGOS SPINE NEWS, V8, P32
   Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010
   Oliveira DV, 2012, SCI WORLD J, DOI 10.1100/2012/765909
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
   Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9
   Wang Jian-jun, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1838
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1
NR 25
TC 11
Z9 14
U1 0
U2 17
PU KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY
PI SEOUL
PA 635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1016-8478
EI 0219-1032
J9 MOL CELLS
JI Mol. Cells
PD MAR
PY 2015
VL 38
IS 3
BP 267
EP 272
DI 10.14348/molcells.2015.2315
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CH8GY
UT WOS:000354275600010
PM 25666352
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Castilho, M
   Rodrigues, J
   Pires, I
   Gouveia, B
   Pereira, M
   Moseke, C
   Groll, J
   Ewald, A
   Vorndran, E
AF Castilho, Miguel
   Rodrigues, Jorge
   Pires, Ines
   Gouveia, Barbara
   Pereira, Manuel
   Moseke, Claus
   Groll, Juegen
   Ewald, Andrea
   Vorndran, Elke
TI Fabrication of individual alginate-TCP scaffolds for bone tissue
   engineering by means of powder printing
SO BIOFABRICATION
LA English
DT Article
DE 3D printing; biocomposite; mechanical properties; bioactivity; bone
   tissue engineering ceramics
ID CALCIUM-PHOSPHATE CEMENT; MECHANICAL CHARACTERIZATION; DRUG-DELIVERY;
   IN-VITRO; BIOMEDICAL APPLICATIONS; COMPOSITE SCAFFOLDS; FRACTURE;
   REGENERATION; BRUSHITE; BEHAVIOR
AB The development of polymer-calcium phosphate composite scaffolds with tailored architectures and properties has great potential for bone regeneration. Herein, we aimed to improve the functional performance of brittle ceramic scaffolds by developing a promising biopolymer-ceramic network. For this purpose, two strategies, namely, direct printing of a powder composition consisting of a 60: 40 mixture of alpha/beta-tricalcium phosphate (TCP) powder and alginate powder or vacuum infiltration of printed TCP scaffolds with an alginate solution, were tracked. Results of structural characterization revealed that the scaffolds printed with 2.5 wt% alginate-modified TCP powders presented a uniformly distributed and interfusing alginate TCP network. Mechanical results indicated a significant increase in strength, energy to failure and reliability of powder-modified scaffolds with an alginate content in the educts of 2.5 wt% when compared to pure TCP, as well as to TCP scaffolds containing 5 wt% or 7.5 wt% in the educts, in both dry and wet states. Culture of human osteoblast cells on these scaffolds also demonstrated a great improvement of cell proliferation and cell viability. While in the case of powder-mixed alginate TCP scaffolds, isolated alginate gels were formed between the calcium phosphate crystals, the vacuum-infiltration strategy resulted in the covering of the surface and internal pores of the TCP scaffold with a thin alginate film. Furthermore, the prediction of the scaffolds' critical fracture conditions under more complex stress states by the applied Mohr fracture criterion confirmed the potential of the powder-modified scaffolds with 2.5 wt% alginate in the educts as structural biomaterial for bone tissue engineering.
C1 [Castilho, Miguel; Rodrigues, Jorge; Pires, Ines; Gouveia, Barbara] Univ Lisbon, Inst Super Tecn, IDMEC, LAETA, P-1699 Lisbon, Portugal.
   [Pereira, Manuel] Univ Lisbon, Inst Super Tecn, CERENA, CEPGIST, P-1699 Lisbon, Portugal.
   [Moseke, Claus; Groll, Juegen; Ewald, Andrea; Vorndran, Elke] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Castilho, Miguel] Altakitin SA, Loures, Portugal.
RP Castilho, M (reprint author), Univ Lisbon, Inst Super Tecn, IDMEC, LAETA, P-1699 Lisbon, Portugal.
EM miguel.castilho@tecnico.ulisboa.pt
RI Moseke, Claus/G-5966-2012; Vorndran, Elke/G-6226-2012; Pereira,
   Manuel/H-7288-2012; Moseke, Claus/H-8982-2018; Groll,
   Jurgen/F-4202-2012; Gouveia, Barbara/E-7654-2012; Rodrigues,
   Jorge/I-7810-2015
OI Pereira, Manuel/0000-0002-7932-8062; Groll, Jurgen/0000-0003-3167-8466;
   Gouveia, Barbara/0000-0001-9930-8889; Rodrigues,
   Jorge/0000-0002-3387-2652; Castilho, Miguel/0000-0002-4269-5889
FU FCT within Altakitin SA [SFRH/BDE/51454/2011]
FX The authors would like to thank the PhD scholarship SFRH/BDE/51454/2011
   (Miguel Castilho), financed by FCT within Altakitin SA. They also want
   to acknowledge to the company FMC Biopolymer (Netherlands) for the
   generous gift of the Sodium alginate Protanal (R) LF10/60 used in these
   experiments; to Prof. Antonio Mauricio (Universidade de Lisboa) for his
   support and valuable discussions with mu-CT; and to Prof. Ana Paula Dias
   (Universidade de Lisboa) for her support with TG analysis.
CR [Anonymous], 2002, ASTME95194, DOI [10.1520/C0033-03, DOI 10.1520/C0033-03]
   Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Bartolo P, 2012, CIRP ANN-MANUF TECHN, V61, P635, DOI 10.1016/j.cirp.2012.05.005
   Bharatham B H, 2014, BIOMED RES INT, V2014
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025005
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015006
   Castilho M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035012
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Chen CHD, 2011, MAT SCI ENG C-MATER, V31, P334, DOI 10.1016/j.msec.2010.10.002
   Christensen R. M., 2013, THEORY MAT FAILURE
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   Cornelsen M, 2013, BIOMED TECH, V58, P4090
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Detsch R, 2011, J BIOMATER APPL, V26, P359, DOI 10.1177/0885328210373285
   Dimas LS, 2014, J MECH PHYS SOLIDS, V63, P481, DOI 10.1016/j.jmps.2013.07.006
   Ding SJ, 2005, CERAM INT, V31, P691, DOI 10.1016/j.ceramint.2004.08.007
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gisep A, 2004, J MATER SCI-MATER M, V15, P1065, DOI 10.1023/B:JMSM.0000046387.70323.41
   Grover LM, 2013, BIOMATERIALS, V34, P6631, DOI 10.1016/j.biomaterials.2013.05.001
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Henriksen SS, 2011, J MATER SCI-MATER M, V22, P1111, DOI 10.1007/s10856-011-4290-y
   Hondros G., 1959, Australian Journal of Applied Science, V10, P243
   Horga R, 2007, APPL CATAL A-GEN, V325, P251, DOI 10.1016/j.apcata.2007.02.042
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Karande T S, 2014, TISSUE ENG NANOTECHN, P63
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kolednik O, 2014, ACTA MATER, V68, P279, DOI 10.1016/j.actamat.2014.01.034
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   LAMON J, 1983, J AM CERAM SOC, V66, P177, DOI 10.1111/j.1151-2916.1983.tb10012.x
   Lamon J, 1990, P 11 RISO INT S MET
   Lamon J, 1988, J AM CERAM SOC, V73, P2204
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lorber B, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015001
   Luo Yongxiang, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P279
   Luo YX, 2013, J MATER CHEM B, V1, P4088, DOI 10.1039/c3tb20511h
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Palmer SH, 1999, J BONE JOINT SURG BR, V81B, P333, DOI 10.1302/0301-620X.81B2.9320
   Peroglio M, 2010, ACTA BIOMATER, V6, P4369, DOI 10.1016/j.actbio.2010.05.022
   Pfister A, 2004, J POLYM SCI POL CHEM, V42, P624, DOI 10.1002/pola.10807
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shanjani Y, 2011, ACTA BIOMATER, V7, P1788, DOI 10.1016/j.actbio.2010.12.017
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shie MY, 2008, ACTA BIOMATER, V4, P646, DOI 10.1016/j.actbio.2007.10.011
   Soares J.P., 2004, ECLET QUIM, V29, P53, DOI DOI 10.1590/S0100-46702004000200009
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Suwanprateeb J, 2006, POLYM INT, V55, P57, DOI 10.1002/pi.1918
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   Torres AL, 2013, MAT SCI ENG C-MATER, V33, P4460, DOI 10.1016/j.msec.2013.07.003
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Vorndran E, 2010, ADV FUNCT MATER, V20, P1585, DOI 10.1002/adfm.200901759
   Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179
   Wachtman J. B., 2009, MECH PROPERTIES CERA
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Wohlers T.T., 2011, ADDITIVE MANUFACTURI
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhao J, 2009, COLLOID SURFACE B, V74, P159, DOI 10.1016/j.colsurfb.2009.07.012
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 70
TC 19
Z9 20
U1 2
U2 83
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2015
VL 7
IS 1
AR 015004
DI 10.1088/1758-5090/7/1/015004
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5OH
UT WOS:000353341000005
PM 25562119
DA 2018-10-20
ER

PT J
AU Ouyang, LL
   Yao, R
   Chen, X
   Na, J
   Sun, W
AF Ouyang, Liliang
   Yao, Rui
   Chen, Xi
   Na, Jie
   Sun, Wei
TI 3D printing of HEK 293FT cell-laden hydrogel into macroporous constructs
   with high cell viability and normal biological functions
SO BIOFABRICATION
LA English
DT Article
DE three dimensional printing; cell viability; signal transduction; Wnt;
   HEK293FT
ID HUMAN STEM-CELLS; IN-VITRO; LIVING CELLS; HEK-293 CELLS; TISSUE;
   BIOFABRICATION; TECHNOLOGY; CANCER; REGENERATION; DAMAGE
AB 3D printing has evolved into a versatile technology for fabricating tissue-engineered constructs with spatially controlled cells and biomaterial distribution to allow biomimicking of in vivo tissues. In this paper, we reported a novel study of 3D printing of cell lines derived from human embryonic kidney tissue into a macroporous tissue-like construct. Nozzle temperature, chamber temperature and the composition of the matrix material were studied to achieve high cell viability (>90%) after 3D printing and construct formation. Long-term construct stability with a clear grid structure up to 30 days was observed. Cells continued to grow as cellular spheroids with strong cell-cell interactions. Two transfected cell lines of HEK 293FT were also 3D printed and showed normal biological functions, i.e. protein synthesis and gene activation in responding to small molecule stimulus. With further refinement, this 3D cell printing technology may lead to a practical fabrication of functional embryonic tissues in vitro.
C1 [Ouyang, Liliang; Yao, Rui; Sun, Wei] Tsinghua Univ, Biomfg Ctr, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Ouyang, Liliang; Yao, Rui; Sun, Wei] Biomfg & Rapid Forming Technol Key Lab Beijing, Beijing 100084, Peoples R China.
   [Chen, Xi; Na, Jie] Tsinghua Univ, Ctr Stem Cell Biol & Regenerat Med, Sch Med, Beijing 100084, Peoples R China.
   [Sun, Wei] Tsinghua Univ, Grad Sch Shenzhen, Biomfg Engn Res Lab, Shenzhen 518055, Peoples R China.
   [Sun, Wei] Drexel Univ, Dept Mech Engn, Philadelphia, PA 19104 USA.
RP Ouyang, LL (reprint author), Tsinghua Univ, Biomfg Ctr, Dept Mech Engn, Beijing 100084, Peoples R China.
EM jie.na@tsinghua.edu.cn; weisun@tsinghua.edu.cn
OI Na, Jie/0000-0003-1820-0548
FU National Natural Science Foundation of China [51235006, 31171381];
   National High Technology Research and Development Program of China (863
   Program) [2012AA020506]; Shenzhen Development and Reform Commission;
   National Basic Research Program of China, 973 program [2012CB966701];
   Tsinghua-Peking Center for Life Sciences
FX The authors acknowledge the funding supports from the National Natural
   Science Foundation of China through project No. 51235006, the National
   High Technology Research and Development Program of China (863 Program)
   through project No. 2012AA020506 and the Shenzhen Development and Reform
   Commission. This work was also supported by the National Natural Science
   Foundation of China Grant 31171381 and the National Basic Research
   Program of China, 973 program grant 2012CB966701 to (J.N.), and the
   funding of the Tsinghua-Peking Center for Life Sciences.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barron JA, 2005, ANN BIOMED ENG, V33, P121, DOI 10.1007/s10439-005-8971-x
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Chang R, 2008, TISSUE ENG PT C-METH, V14, P157, DOI 10.1089/ten.tec.2007.0392
   Chang R, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045004
   Colina M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2191569
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Demirci U, 2007, LAB CHIP, V7, P1428, DOI 10.1039/b705809h
   Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j
   Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h
   Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013
   Fedorovich NE, 2011, TRENDS BIOTECHNOL, V29, P601, DOI 10.1016/j.tibtech.2011.07.001
   Ferris CJ, 2013, APPL MICROBIOL BIOT, V97, P4243, DOI 10.1007/s00253-013-4853-6
   Gaebel R, 2011, BIOMATERIALS, V32, P9218, DOI 10.1016/j.biomaterials.2011.08.071
   Gaetani R, 2012, CIRC RES, V111
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P79, DOI 10.1089/ten.TEC.2010.0359
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P973, DOI [10.1089/ten.tec.2011.0185, 10.1089/ten.TEC.2011.0185]
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Khatiwala C., 2012, GENE THER REGUL, V7, DOI DOI 10.1142/S1568558611000301
   Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]
   Lee W, 2009, NEUROREPORT, V20, P798, DOI 10.1097/WNR.0b013e32832b8be4
   Liu HX, 2011, ADV MATER RES-SWITZ, V189-193, P2986, DOI 10.4028/www.scientific.net/AMR.189-193.2986
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Marucco A, 2013, J PHYS C SER, V429
   Matsusaki M, 2013, ADV HEALTHC MATER, V2, P534, DOI 10.1002/adhm.201200299
   McConnell MP, 2004, TISSUE ENG, V10, P1492, DOI 10.1089/1076327042500463
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606
   Rodriguez-Devora JI, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035001
   Shen CF, 2012, J BIOTECHNOL, V157, P228, DOI 10.1016/j.jbiotec.2011.11.016
   Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005
   Tirella A, 2011, J BIOSCI BIOENG, V112, P79, DOI 10.1016/j.jbiosc.2011.03.019
   Xu F, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034101
   Xu MG, 2010, BIOMATERIALS, V31, P3868, DOI 10.1016/j.biomaterials.2010.01.111
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yan KC, 2010, J BIOMECH, V43, P1031, DOI 10.1016/j.jbiomech.2009.12.018
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
   Yao R, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045005
   Yao R, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025007
   Yao R, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911508099367
   Yu Y, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024575
   Yusof A, 2011, LAB CHIP, V11, P2447, DOI 10.1039/c1lc20176j
   Zhao Y, 2014, IN VITRO BIOFABRICAT, V6
NR 52
TC 31
Z9 32
U1 8
U2 93
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2015
VL 7
IS 1
AR 015010
DI 10.1088/1758-5090/7/1/015010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CG5OH
UT WOS:000353341000011
PM 25691496
DA 2018-10-20
ER

PT J
AU Anzai, R
   Murakami, Y
AF Anzai, Ryosuke
   Murakami, Yoshihiko
TI Poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets for the
   incorporation and release of hydrophilic proteins
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Sheet; Polymeric micelle; Protein; Sustained release; Fractal analysis
ID ANHYDROUS ISOOCTANE; FRACTAL DIMENSION; POLYMERIC MICELLE;
   SUSTAINED-RELEASE; GROWTH-FACTOR; PLA RESEARCH; HYDROGEL; COMPLEX;
   SURFACE; PEG
AB Sheets have several advantages over conventional gel- or particle-type drug carriers. Sheets have several notable attributes: sheets' size and shape are easily adjustable, sheets are highly accessible in surgery, and sheets have a large contact area relative to drug-targeting sites. However, it is difficult to incorporate hydrophilic proteins into hydrophobic sheets and to release the proteins over the long term in a sustained manner. In the present study, we show that "poly(epsilon-caprolactone) (PCL)-polymeric micelle hybrid sheets" can be used for the incorporation and release of hydrophilic proteins. Polymeric micelles (i.e., spaces that can incorporate hydrophilic compounds) are, in this study, uniformly dispersed in hydrophobic and biocompatible biomaterial sheet. We have clarified that the composition of block copolymer, methoxy-terminated poly(ethylene glycol)-block-poly(epsilon-caprolactone) (CH3O-PEG-b-PCL), can affect two variables: the stability of w/o emulsion and the release properties of the resulting sheets, by means of visual qualitative observations, newly developed quantitative analyses (advanced fractal analysis, advanced FD) based on deviation of the fractal dimension (FD), and release experiments. We clarified that the release behavior of BSA was affected by the composition of the block copolymers and the resulting emulsion. The results obtained in this paper show that the hydrophobic sheets in which polymeric micelles providing hydrophilic spaces were dispersed could be an effective platform for incorporating and releasing hydrophilic proteins. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Anzai, Ryosuke; Murakami, Yoshihiko] Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, Koganei, Tokyo 1848588, Japan.
RP Murakami, Y (reprint author), Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Fac Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.
EM muray@cc.tuat.ac.jp
RI Murakami, Yoshihiko/C-9485-2013
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (MEXT) [22700490]
FX This study was funded, in part, by Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science, and Technology
   of Japan (MEXT) (grant number: 22700490).
CR Bisoi AK, 2001, PATTERN RECOGN LETT, V22, P631, DOI 10.1016/S0167-8655(00)00132-X
   BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Eck W, 2005, ADV MATER, V17, P2583, DOI 10.1002/adma.200500900
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Griffin W.C., 1954, J SOC COSMET CHEM, V5, P249
   Ito T, 2013, MAT SCI ENG C-MATER, V33, P3697, DOI 10.1016/j.msec.2013.04.056
   Kanakubo Y, 2010, COLLOID SURFACE B, V78, P85, DOI 10.1016/j.colsurfb.2010.02.017
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lin NM, 2014, APPL SURF SCI, V311, P330, DOI 10.1016/j.apsusc.2014.05.062
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214
   Moroishi H, 2013, COLLOID SURFACE B, V102, P597, DOI 10.1016/j.colsurfb.2012.08.050
   Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330
   Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h
   Murakami Y, 2003, J MOL CATAL B-ENZYM, V22, P79, DOI 10.1016/S1381-1177(03)00009-2
   Murakami Y, 1998, SEIBUTSU-KOGAKU KAIS, V76, P238
   Murakami Y, 1999, BIOTECHNOL TECH, V13, P545, DOI 10.1023/A:1008987431361
   Murakami Y, 2001, BIOTECHNOL LETT, V23, P125, DOI 10.1023/A:1010345318275
   Murakami Y, 1999, J BIOSCI BIOENG, V88, P441, DOI 10.1016/S1389-1723(99)80224-2
   Murakami Y., 2009, J BIOMED MAT RES B, V916, P102
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Okamura Y, 2008, COLLOID SURFACE A, V318, P184, DOI 10.1016/j.colsurfa.2007.12.049
   Pang XA, 2010, BIOTECHNOL J, V5, P1125, DOI 10.1002/biot.201000135
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Takami T, 2014, LANGMUIR, V30, P3329, DOI 10.1021/la500324j
   Takami T, 2011, COLLOID SURFACE B, V87, P433, DOI 10.1016/j.colsurfb.2011.06.004
   Tanaka M, 2008, POWDER TECHNOL, V186, P1, DOI 10.1016/j.powtec.2007.10.030
   Tang HP, 2012, POWDER TECHNOL, V217, P383, DOI 10.1016/j.powtec.2011.10.053
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Uchida Y, 2013, J POLYM SCI POL PHYS, V51, P124, DOI 10.1002/polb.23187
   Vinigradov S.V., 2002, ADV DRUG DELIV REV, V54, P135
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Zhang JT, 2010, ACTA BIOMATER, V6, P3890, DOI 10.1016/j.actbio.2010.05.009
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 46
TC 12
Z9 12
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2015
VL 127
BP 292
EP 299
DI 10.1016/j.colsurfb.2015.01.028
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CG0YY
UT WOS:000353001400037
PM 25723105
DA 2018-10-20
ER

PT J
AU Cheerarot, O
   Baimark, Y
AF Cheerarot, Onanong
   Baimark, Yodthong
TI Biodegradable silk fibroin/chitosan blend microparticles prepared by
   emulsification-diffusion method
SO E-POLYMERS
LA English
DT Article
DE blend microparticles; chitosan; conformational transition; morphology;
   silk fibroin
ID IN-VIVO EVALUATION; BOMBYX-MORI SILK; CHITOSAN MICROSPHERES;
   DRUG-DELIVERY; POLY(ETHYLENE OXIDE); FIBROIN; RELEASE; FILMS;
   CONFORMATION; BIOMATERIAL
AB In this study, biodegradable microparticles of silk fibroin (SF)/chitosan (CS) blends with SF/CS blend ratios of 1:0, 2:1, 1:1, 1:2 and 0:1 (w/w) were prepared using the water-in-oil emulsification-diffusion method without any surfactants. An aqueous SF/CS blend solution and ethyl acetate were used as the water and oil phases, respectively. The plain SF had an irregular shape, while the CS microparticles were spherical. The blend microparticles were spherical in shape with a rough surface. Average microparticle sizes were in the range of 73-80 mu m. The microparticle matrices had a sponge-like morphology. Conformational changes in the SF component, from random coil to the beta-sheet form, were observed in the FTIR data. The dissolution of the blend microparticles was lower than those of the plain SF and CS microparticles. Microparticle density steadily increased and porosity slightly decreased as the amount of CS in the blend increased.
C1 [Cheerarot, Onanong; Baimark, Yodthong] Mahasarakham Univ, Biodegradable Polymers Res Unit, Fac Sci, Dept Chem, Maha Sarakham 44150, Thailand.
   [Cheerarot, Onanong; Baimark, Yodthong] Mahasarakham Univ, Ctr Excellence Innovat Chem, Maha Sarakham 44150, Thailand.
RP Cheerarot, O (reprint author), Mahasarakham Univ, Biodegradable Polymers Res Unit, Fac Sci, Dept Chem, Maha Sarakham 44150, Thailand.
EM onanong.c@msu.ac.th
FU National Metal and Materials Technology Center (MTEC); National Science
   and Technology Development Agency (NSTDA); Ministry of Science and
   Technology, Thailand [MT-B-52-BMD-68-180-G]; Center of Excellence for
   Innovation in Chemistry (PERCH-CIC), Commission on Higher Education,
   Ministry of Education, Thailand
FX This work was supported by the National Metal and Materials Technology
   Center (MTEC), National Science and Technology Development Agency
   (NSTDA), Ministry of Science and Technology, Thailand
   (MT-B-52-BMD-68-180-G) and by the Center of Excellence for Innovation in
   Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of
   Education, Thailand. The authors would like to thank Dr. Christopher M.
   Liauw, Manchester Metropolitan University, England, UK, for proofreading
   of the manuscript.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baimark Y, 2013, POWDER TECHNOL, V249, P436, DOI 10.1016/j.powtec.2013.09.011
   Baimark Y, 2010, J APPL POLYM SCI, V118, P1127, DOI 10.1002/app.32506
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Guerrero S, 2010, CARBOHYD POLYM, V79, P1006, DOI 10.1016/j.carbpol.2009.10.034
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Imsombut T, 2013, E-POLYMERS, V11, P936
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Klingler C, 2009, INT J PHARMACEUT, V377, P173, DOI 10.1016/j.ijpharm.2009.05.008
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Kosaraju SL, 2006, CARBOHYD POLYM, V64, P163, DOI 10.1016/j.carbpol.2005.11.027
   Kotsaeng N, 2010, PARTICUL SCI TECHNOL, V28, P369, DOI 10.1080/02726351003702574
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Li GY, 2011, J MACROMOL SCI A, V48, P904, DOI 10.1080/10601325.2011.614862
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mucha M, 2011, E-POLYMERS
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   Niamsa N, 2009, CARBOHYD POLYM, V78, P60, DOI 10.1016/j.carbpol.2009.04.003
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Rawat A, 2008, J CONTROL RELEASE, V128, P224, DOI 10.1016/j.jconrel.2008.03.013
   Shanmuganathan S, 2008, CARBOHYD POLYM, V73, P201, DOI 10.1016/j.carbpol.2007.11.039
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
NR 41
TC 6
Z9 6
U1 2
U2 34
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD MAR
PY 2015
VL 15
IS 2
BP 67
EP 74
DI 10.1515/epoly-2014-0134
PG 8
WC Polymer Science
SC Polymer Science
GA CF8MJ
UT WOS:000352814600002
OA Bronze
DA 2018-10-20
ER

PT J
AU Comaneanu, RM
   Hancu, V
   Barbu, HM
   Coman, C
   Cotrut, CM
   Tarcolea, M
   Holicov, AM
   Ormenisan, A
AF Comaneanu, Raluca Monica
   Hancu, Violeta
   Barbu, Horia Mihail
   Coman, Costin
   Cotrut, Cosmin Mihai
   Tarcolea, Mihail
   Holicov, Ana Maria
   Ormenisan, Alina
TI Comparative Assessment of Biocompatibility of NiCr and CoCr Alloys Used
   in Metal-fused-to-ceramic Technology
SO REVISTA DE CHIMIE
LA English
DT Article
DE NiCr and CoCr alloys; metal-fused-to-ceramic restoration; biomaterial;
   biocompatibility
AB A material is considered as biocompatible when it does not harm nor create toxic reactions or systemic side effects. Most of reactions caused by dental materials are of allergic type, with symptoms pointed out at the oral mucosa level or cutaneous tissue level. For saliva and dental tissues media, which a dental restoration comes into contact it is of extremely importance the proper knowledge of the changes which can occur in time at the materials level. The present study assays the biocompatibility of six samples of dental alloys used in metal-fused-to-ceramic technology, three based on NiCr and three based on CoCr. All biocompatibility assays were performed on an osteoblast-like cell line, phenotypically close to osteoblasts (MNNG-Human Osteosarcoma cell line - HOS).
C1 [Comaneanu, Raluca Monica; Hancu, Violeta; Barbu, Horia Mihail; Coman, Costin] Titu Maiorescu Univ Bucharest, Fac Med Dent, Bucharest 031593, Romania.
   [Cotrut, Cosmin Mihai; Tarcolea, Mihail] Univ Politehn Bucuresti, Fac Mat Sci & Engn, Bucharest 060042, Romania.
   [Holicov, Ana Maria] Gr T Popa Univ Med & Pharm, Fac Med, Dept Cell & Mol Biol, Iasi 700115, Romania.
   [Ormenisan, Alina] UMF Targu Mures, Fac Med Dent, Targu Mures 540142, Romania.
RP Hancu, V (reprint author), Titu Maiorescu Univ Bucharest, Fac Med Dent, 67A Gh Petrascu Str, Bucharest 031593, Romania.
EM dianateam@yahoo.com
RI Cotrut, Mihai Cosmin/G-4505-2011
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485
FU ANCS, CNDI - UEFISCDI [175/02.07.2012]
FX All authors had equal contributions. This work was supported by
   Partnerships in priority areas program - PN developed with support from
   ANCS, CNDI - UEFISCDI, project no. 175/02.07.2012 (Coat4Dent).
CR Ardelean L, 2010, METAL INT, V15, P31
   Bortun CM, 2012, REV CHIM-BUCHAREST, V63, P906
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   Craig RG, 2001, MAT DENTARE RESTAURA
   CUNNINGHAM DM, 1973, DENT CLIN N AM, V17, P719
   GHIBAN B., 2009, ALIAJE DENTARE COBAL
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   Hancu V, 2014, REV CHIM-BUCHAREST, V65, P706
   Kewal K., 2008, HDB NANOMEDICINE
   Minciuna MG, 2014, REV CHIM-BUCHAREST, V65, P335
   STELEA O., 1999, BIOMATERIALE
   STROSCIO M.A, 2004, BIOL NANOSTRUCTURES, V192
   SUCIU M, 2008, STUDIUL MAT
   VOICU G, LIANTI ANORGANICI SI
   Williams D. F., 1982, BIOCOMPATIBILITY CLI
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
NR 16
TC 7
Z9 7
U1 0
U2 8
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD MAR
PY 2015
VL 66
IS 3
BP 312
EP 315
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA CF7SJ
UT WOS:000352756300004
DA 2018-10-20
ER

PT J
AU Gil, M
   Kawai, T
   Ishikawa-Nagai, S
   Da Silva, J
   Nagai, M
AF Gil, Mindy
   Kawai, Toshihisa
   Ishikawa-Nagai, Shigemi
   Da Silva, John
   Nagai, Masazumi
TI Identification of putative bone anabolic peptides targeting adherent
   plasma membrane
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Peptide display library; Adherent plasma membrane; Bone matrix;
   Biomaterial; Osteoblast; Differentiation
ID VIVO PHAGE DISPLAY; EXTRACELLULAR-MATRIX; DIFFERENTIATION; REPAIR
AB Bone matrix provides unknown essential cues for osteoblast lineage cells to develop, grow, repair and remodel bones via adherent plasma membrane. Because of its tight sealing with bone matrix in vivo and culture surface in vitro as well, the adherent plasma membrane has been unveiled target of investigation to date. Herein, we report a new approach to explore the adherence plasma membrane of osteoblasts with biofunctional peptide candidates in a bacterial peptide library. To accomplish this, human osteoblast like hFOB 1.19 cells were cultured on porous filter with 8 gm pore through which bacterial peptides were allowed to meet the membrane for affinity selection. The affinity-selected peptides were coated on culture plate to further evaluate their influence on osteoblastic cell adhesion, as well as expressions of osteoblast differentiation markers, alkaline phosphatase and osteocalcin. Finally, the serial screenings identified two prominent active peptides that enhanced the differentiation markers nearly to the same level as a control peptide of bone morphogenetic protein-2. Osteogenic activity is expected for the peptides when immobilized on bone implant surface. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gil, Mindy; Kawai, Toshihisa] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.
   [Kawai, Toshihisa; Nagai, Masazumi] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA.
   [Ishikawa-Nagai, Shigemi; Da Silva, John] Harvard Univ, Sch Dent Med, Restorat Dent & Biomat Sci, Boston, MA 02115 USA.
RP Nagai, M (reprint author), Forsyth Inst, Dept Immunol & Infect Dis, 245 First St, Cambridge, MA 02142 USA.
EM mnagai@forsyth.org
FU ITT Foundation, Basel, Switzerland [673_2009]; American Academy of
   Implant Dentistry Foundation (Student Research Grant)
FX This study was supported by the ITT Foundation, Basel, Switzerland
   (673_2009) and the American Academy of Implant Dentistry Foundation
   (Student Research Grant).
CR Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Barthes J., 2014, BIOMED RES INT, V2014, P1
   Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Olmez E.O., 2012, BINGDING PROTEIN, P49
   Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0
   Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008
   Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Shadidi Mohsen, 2003, FASEB Journal, V17, P256
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Thayer AM, 2011, CHEM ENG NEWS, V89, P13
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Zhang JB, 2001, CANCER LETT, V171, P153, DOI 10.1016/S0304-3835(01)00575-4
NR 16
TC 1
Z9 1
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR
PY 2015
VL 459
IS 1
BP 71
EP 74
DI 10.1016/j.bbrc.2015.02.071
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE8UU
UT WOS:000352120400012
PM 25721672
DA 2018-10-20
ER

PT J
AU You, RC
   Li, XF
   Luo, ZW
   Qu, J
   Li, MZ
AF You, Renchuan
   Li, Xiufang
   Luo, Zuwei
   Qu, Jing
   Li, Mingzhong
TI Directional cell elongation through filopodia-steered lamellipodial
   extension on patterned silk fibroin films
SO BIOINTERPHASES
LA English
DT Article
ID CONTACT GUIDANCE; MOTILITY; SURFACE; BIOMATERIALS; SCAFFOLDS; SHAPE
AB Micropatterned biomaterials have been used to direct cell alignment for specific tissue engineering applications. However, the understanding of how cells respond to guidance cues remains limited. Plasticity in protrusion formation has been proposed to enable cells to adapt their motility mode to microenvironment. In this study, the authors investigated the key role of protrusion response in cell guidance on patterned silk fibroin films. The results revealed that the ability to transform between filopodia and small lamellipodia played important roles in directional cell guidance. Filopodia did not show directional extension on patterned substrates prior to spreading, but they transduced topographical cues to the cell to trigger the formation of small lamellipodia along the direction of a microgrooved or parallel nanofiber pattern. The polar lamellipodia formation provided not only a path with directionality, but a driving force for directional cell elongation. Moreover, aligned nanofibers coating provided better mechanical support for the traction of filopodia and lamellipodia, promoting cell attachment, spreading, and migration. This study provides new insight into how cells respond to guidance cues and how filopodia and lamellipodia control cell contact guidance on micropatterned biomaterial surfaces. (C) 2015 American Vacuum Society.
C1 [You, Renchuan; Li, Xiufang; Luo, Zuwei; Qu, Jing; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
FU National Nature Science Foundation of China [31370968]; Nature Science
   Foundation of Jiangsu Province [BK20131177]; College Natural Science
   Research Project of Jiangsu Province [12KJA430003]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions; Jiangsu
   Province Ordinary Universities and Colleges Graduate Scientific and
   Innovation Plan [KYLX_1243]
FX This work was supported by the National Nature Science Foundation of
   China (31370968), Nature Science Foundation of Jiangsu Province
   (BK20131177), College Natural Science Research Project of Jiangsu
   Province (12KJA430003), Priority Academic Program Development of Jiangsu
   Higher Education Institutions and Jiangsu Province Ordinary Universities
   and Colleges Graduate Scientific and Innovation Plan (KYLX_1243).
CR Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bornschlogl T, 2013, CYTOSKELETON, V70, P590, DOI 10.1002/cm.21130
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002
   Franco D, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-34
   Gasiorowski JZ, 2010, BIOMATERIALS, V31, P8882, DOI 10.1016/j.biomaterials.2010.08.026
   Guex AG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/021001
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Heckman CA, 2013, CELL SIGNAL, V25, P2298, DOI 10.1016/j.cellsig.2013.07.006
   Heiman MG, 2010, CURR OPIN NEUROBIOL, V20, P86, DOI 10.1016/j.conb.2009.10.016
   Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370
   Kang K, 2012, ANGEW CHEM INT EDIT, V51, P2855, DOI 10.1002/anie.201106271
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kwon KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073960
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Menna E, 2011, EUR J NEUROSCI, V34, P1655, DOI 10.1111/j.1460-9568.2011.07897.x
   Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884
   Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008
   Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1
   Song KH, 2014, INTEGR BIOL-UK, V6, P450, DOI 10.1039/c4ib00021h
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You RC, 2014, POLYM DEGRAD STABIL, V109, P226, DOI 10.1016/j.polymdegradstab.2014.07.029
   You RC, 2014, J BIOMED MATER RES A, V102, P4206, DOI 10.1002/jbm.a.35097
   Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]
NR 39
TC 12
Z9 12
U1 1
U2 24
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD MAR
PY 2015
VL 10
IS 1
AR 011005
DI 10.1116/1.4914028
PG 8
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA CE8AL
UT WOS:000352063000005
PM 25743615
DA 2018-10-20
ER

PT J
AU Foster, NC
   Henstock, JR
   Reinwald, Y
   El Haj, AJ
AF Foster, Nicola C.
   Henstock, James R.
   Reinwald, Yvonne
   El Haj, Alicia J.
TI Dynamic 3D Culture: Models of Chondrogenesis and Endochondral
   Ossification
SO BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
LA English
DT Review
DE chondrogenesis; mechanical load; 3D models; endochondral ossification
ID EMBRYONIC STEM-CELLS; CYCLIC HYDROSTATIC-PRESSURE; TISSUE-ENGINEERED
   CARTILAGE; MESENCHYMAL PROGENITOR CELLS; FACTOR-RELEASING HYDROGELS;
   FINITE-ELEMENT MODEL; MARROW STROMAL CELLS; FEMUR DEFECT MODEL;
   ARTICULAR-CARTILAGE; BONE-MARROW
AB The formation of cartilage from stem cells during development is a complex process which is regulated by both local growth factors and biomechanical cues, and results in the differentiation of chondrocytes into a range of subtypes in specific regions of the tissue. In fetal development cartilage also acts as a precursor scaffold for many bones, and mineralization of this cartilaginous bone precursor occurs through the process of endochondral ossification. In the endochondral formation of bones during fetal development the interplay between cell signalling, growth factors, and biomechanics regulates the formation of load bearing bone, in addition to the joint capsule containing articular cartilage and synovium, generating complex, functional joints from a single precursor anlagen. These joint tissues are subsequently prone to degeneration in adult life and have poor regenerative capabilities, and so understanding how they are created during development may provide useful insights into therapies for diseases, such as osteoarthritis, and restoring bone and cartilage lost in adulthood. Of particular interest is how these tissues regenerate in the mechanically dynamic environment of a living joint, and so experiments performed using 3D models of cartilage development and endochondral ossification are proving insightful. In this review, we discuss some of the interesting models of cartilage development, such as the chick femur which can be observed in ovo, or isolated at a specific developmental stage and cultured organotypically in vitro. Biomaterial and hydrogel-based strategies which have emerged from regenerative medicine are also covered, allowing researchers to make informed choices on the characteristics of the materials used for both original research and clinical translation. In all of these models, we illustrate the essential importance of mechanical forces and mechanotransduction as a regulator of cell behavior and ultimate structural function in cartilage. Birth Defects Research (Part C) 105:19-33, 2015. (c) 2015 Wiley Periodicals, Inc.
C1 [Foster, Nicola C.; Henstock, James R.; Reinwald, Yvonne; El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7QB, Staffs, England.
RP El Haj, AJ (reprint author), Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7QB, Staffs, England.
EM a.j.el.haj@keele.ac.uk
OI Reinwald, Yvonne/0000-0001-6733-605X
FU Medical Research Council [MR/K006312/1]; Engineering and Physical
   Sciences Research Council [EP/H028277/1]
CR Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9
   Bolgen N, 2008, TISSUE ENG PT A, V14, P1743, DOI 10.1089/ten.tea.2007.0277
   Bonassar LJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P57, DOI 10.1006/abbi.2000.1820
   Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351
   Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237
   Carroll SF, 2014, J BIOMECH, V47, P2115, DOI 10.1016/j.jbiomech.2013.12.006
   Carver SE, 1999, BIOTECHNOL BIOENG, V65, P274
   Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1
   Cheng AX, 2014, TISSUE ENG PART B-RE, V20, P257, DOI [10.1089/ten.teb.2012.0757, 10.1089/ten.TEB.2012.0757]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Correia C, 2012, TISSUE ENG PT A, V18, P1979, DOI [10.1089/ten.tea.2012.0083, 10.1089/ten.TEA.2012.0083]
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Diederichs S, 2014, STEM CELLS DEV, V23, P1594, DOI 10.1089/scd.2013.0477
   Duke PJ, 1999, ADV SPACE RES-SERIES, V24, P821, DOI 10.1016/S0273-1177(99)00077-0
   DuRaine GD, 2015, BIOMECH MODEL MECHAN, V14, P73, DOI 10.1007/s10237-014-0589-1
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086
   Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI 10.1089/tea.2007.0293
   Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012
   Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gong GC, 2010, J CELL PHYSIOL, V224, P664, DOI 10.1002/jcp.22166
   Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752
   Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Handa T, 1997, SPINE, V22, P1085, DOI 10.1097/00007632-199705150-00006
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Henstock JR, 2013, BONE, V53, P468, DOI 10.1016/j.bone.2013.01.010
   Henstock JR, 2014, STEM CELLS TRANSLATI, V3, P1
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Hwang Nathaniel S., 2007, V407, P351, DOI 10.1007/978-1-59745-536-7_24
   Irianto J, 2014, J BIOMECH, V47, P579, DOI 10.1016/j.jbiomech.2013.11.040
   Ishihara H, 1996, J APPL PHYSIOL, V80, P839
   Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397
   Jukes JM, 2010, TISSUE ENG PT A, V16, P565, DOI [10.1089/ten.tea.2009.0173, 10.1089/ten.TEA.2009.0173]
   Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Kopesky PW, 2010, MATRIX BIOL, V29, P427, DOI 10.1016/j.matbio.2010.02.003
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Kunitomo T, 2009, J ORTHOP SCI, V14, P776, DOI 10.1007/s00776-009-1393-0
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lomas AJ, 2013, TISSUE ENG PART C-ME, V19, P577, DOI [10.1089/ten.tec.2012.0457, 10.1089/ten.TEC.2012.0457]
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P1992
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McKay TR, 2011, STEM CELL RES, V7, P154, DOI 10.1016/j.scr.2011.04.005
   Meyer EG, 2011, J MECH BEHAV BIOMED, V4, P1257, DOI 10.1016/j.jmbbm.2011.04.012
   Mikic B, 2004, ANN BIOMED ENG, V32, P18, DOI 10.1023/B:ABME.0000007787.39262.a7
   MITROVIC D, 1982, ACTA ANAT, V113, P313
   Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253
   Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Muhammad H, 2012, CELL MOL LIFE SCI, V69, P2101, DOI 10.1007/s00018-011-0911-3
   Murray PDF, 1930, ROUX ARCH DEV BIOL, V122, P629, DOI 10.1007/BF00573594
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Natoli RM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2939368
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031
   Nowlan NC, 2012, BIOMECH MODEL MECHAN, V11, P207, DOI 10.1007/s10237-011-0304-4
   Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184
   Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Osborne A. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P448
   Oseni AO, 2011, TISSUE ENG TISSUE OR
   Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   Portner R, 2005, J BIOSCI BIOENG, V100, P235, DOI 10.1263/jbb.100.235
   Puetzer J, 2013, TISSUE ENG PT A, V19, P299, DOI [10.1089/ten.tea.2012.0015, 10.1089/ten.TEA.2012.0015]
   Responte DJ, 2012, FASEB J, V26, P3614, DOI 10.1096/fj.12-207241
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   RUANOGIL D, 1978, ACTA ANAT, V101, P36
   RUANOGIL D, 1985, ACTA ANAT, V123, P90
   Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011
   Safshekan F, 2012, ARTIF ORGANS, V36, P1065, DOI 10.1111/j.1525-1594.2012.01507.x
   Sakao K, 2008, OSTEOARTHR CARTILAGE, V16, P805, DOI 10.1016/j.joca.2007.10.021
   Shao YY, 2012, BONE, V50, P79, DOI 10.1016/j.bone.2011.08.033
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011
   Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025
   Smith EL, 2013, EUR CELLS MATER, V26, P91, DOI 10.22203/eCM.v026a07
   Snyder TN, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-10
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Takahashi K, 1998, ANN RHEUM DIS, V57, P231, DOI 10.1136/ard.57.4.231
   Thein-Han WW, 2007, J BIOMED MATER RES B, V80B, P92, DOI 10.1002/jbm.b.30573
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111
   Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649
NR 107
TC 10
Z9 10
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-975X
EI 1542-9768
J9 BIRTH DEFECTS RES C
JI Birth Defects Res. Part C-Embryo Today-Rev.
PD MAR
PY 2015
VL 105
IS 1
BP 19
EP 33
DI 10.1002/bdrc.21088
PG 15
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA CE8QT
UT WOS:000352109700003
PM 25777047
DA 2018-10-20
ER

PT J
AU Phansalkar, RS
   Nam, JW
   Chen, SN
   McAlpine, JB
   Napolitano, JG
   Leme, A
   Vidal, CMP
   Aguiar, T
   Bedran-Russo, AK
   Pauli, GF
AF Phansalkar, Rasika S.
   Nam, Joo-Won
   Chen, Shao-Nong
   McAlpine, James B.
   Napolitano, Jose G.
   Leme, Ariene
   Vidal, Cristina M. P.
   Aguiar, Thaiane
   Bedran-Russo, Ana K.
   Pauli, Guido F.
TI A galloylated dimeric proanthocyanidin from grape seed exhibits dentin
   biomodification potential
SO FITOTERAPIA
LA English
DT Article
DE Centrifugal partition and countercurrent chromatography (CPC/CCC);
   Countercurrent separation (CS); Oligomeric proanthocyanidins (OPACs);
   Dentin stiffness and biomodification; Galloylation; HiFSA
ID COLLAGEN CROSS-LINKERS; EQUIMOLAR CONDENSATION; NATURAL-PRODUCTS;
   VINIFERA L.; PROCYANIDINS; POLYMERIZATION; SEPARATION; APPLE;
   CHROMATOGRAPHY; BIOSYNTHESIS
AB Grape seeds are a rich source of polyphenols, especially proanthocyanidins (PACs), and are also known for the presence of galloylated oligomeric PACs (OPACs). The present study focuses on the phytochemical methodology for grape seed (O)PACs and their potential role as dentin biomodifiers to be used in restorative and reparative dentistry. A new method using centrifugal partition chromatography (CPC) was developed for the preparative separation of the grape seed (O)PACs. Orthogonal phytochemical profiling of the resulting CPC fractions was performed using C18 and diol HPLC, normal phase HPTLC, and IT-TOF MS analysis. A galloylated procyanidin dimer (1) was isolated from a CPC fraction in order to evaluate its potential to enhance dentin biomechanical properties. Moreover, it helped to evaluate the impact of the galloyl moiety on the observed bioactivity. Structure elucidation was performed using ESI-MS, 1D and 2D NMR analyses. For the first time, H-1 iterative full spin analysis (HiFSA) was performed on this type of molecule, enabling a detailed proton chemical shift and coupling constant assignment. The CPC fractions as well as 1 showed promising results in the dentin stiffness bioassay and indicate that they may be used as dental intervention biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Phansalkar, Rasika S.; Nam, Joo-Won; Chen, Shao-Nong; McAlpine, James B.; Napolitano, Jose G.; Pauli, Guido F.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA.
   [Leme, Ariene; Vidal, Cristina M. P.; Aguiar, Thaiane; Bedran-Russo, Ana K.] Univ Illinois, Coll Dent, Dept Restorat Dent, Chicago, IL USA.
RP Pauli, GF (reprint author), UIC Coll Pharm, 833 S Wood St, Chicago, IL 60612 USA.
EM gfp@uic.edu
RI Bedran-Russo, Ana/B-6149-2017; Vidal, Cristina/H-4560-2014
OI Vidal, Cristina/0000-0003-4345-8487; Napolitano,
   Jose/0000-0003-1250-2262; Pauli, Guido/0000-0003-1022-4326; Chen,
   Shao-Nong/0000-0003-0748-0863
FU NIDCR/NIH [R01 DE021040]
FX The authors are particularly grateful to Dr. Benjamin Ramirez from the
   Center for Structural Biology at UIC for his general NMR support and his
   invaluable assistance in performing the low temperature NMR experiments.
   We also thank an anonymous reviewer for helpful suggestions regarding
   the nomenclature of oligomeric proanthocyanidins. This research was
   funded by grant R01 DE021040 from NIDCR/NIH.
CR Abe Y, 2008, TETRAHEDRON LETT, V49, P6413, DOI 10.1016/j.tetlet.2008.08.087
   Aguiar TR, 2014, J DENT RES, V93, P417, DOI 10.1177/0022034514523783
   BEART JE, 1985, J CHEM SOC PERK T 2, P1439, DOI 10.1039/p29850001439
   Bedran-Russo AK, 2014, DENT MATER, V30, P62, DOI 10.1016/j.dental.2013.10.012
   Bedran-Russo AKB, 2008, J BIOMED MATER RES B, V86B, P330, DOI 10.1002/jmb.b.31022
   Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593
   Bogacki RE, 2002, OPER DENT, V27, P488
   Castellan CS, 2011, J MECH BEHAV BIOMED, V4, P1343, DOI 10.1016/j.jmbbm.2011.05.003
   Castellan CS, 2010, DENT MATER, V26, P968, DOI 10.1016/j.dental.2010.06.001
   Castellan CS, 2010, J DENT, V38, P431, DOI 10.1016/j.jdent.2010.02.002
   D'Andrea G, 2010, FITOTERAPIA, V81, P724, DOI 10.1016/j.fitote.2010.06.011
   Esatbeyoglu T, 2010, J AGR FOOD CHEM, V59, P62
   Friesen BJ, 2005, J LIQ CHROMATOGR R T, V28, P2777
   Hayasaka Y, 2003, RAPID COMMUN MASS SP, V17, P9, DOI 10.1002/rcm.869
   Hayes CJ, 2006, J ORG CHEM, V71, P9701, DOI 10.1021/jo061740e
   He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674
   Iglesias J, 2010, J AGR FOOD CHEM, V58, P7423, DOI 10.1021/jf100832z
   Karine F, 2013, LC GC N AM, V13, P132
   Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941
   Latif R, 2013, CURR OPIN CLIN NUTR, V16, P669, DOI 10.1097/MCO.0b013e328365a235
   Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x
   Mitjans M, 2011, J AGR FOOD CHEM, V59, P2113, DOI 10.1021/jf1025532
   Mohri Y, 2009, HETEROCYCLES, V79, P549, DOI 10.3987/COM-08-S(D)14
   Napolitano JG, 2014, J PHARMACEUT BIOMED, V93, P59, DOI 10.1016/j.jpba.2013.06.017
   Napolitano JG, 2013, J ORG CHEM, V78, P2827, DOI 10.1021/jo302720h
   Nonaka G-I, 1982, CHEM PHARM BULL, V31, P1906
   Nunez V, 2006, J SCI FOOD AGR, V86, P915, DOI 10.1002/jsfa.2438
   Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009
   Pauli GF, 2005, J NAT PROD, V68, P133, DOI 10.1021/np0497301
   Pauli GF, 2001, PHYTOCHEM ANALYSIS, V12, P28, DOI 10.1002/1099-1565(200101/02)12:1<28::AID-PCA549>3.0.CO;2-D
   Pauli GF, 2008, J NAT PROD, V71, P1489, DOI 10.1021/np800144q
   Pfeiffer J, 2006, PLANT PHYSIOL BIOCH, V44, P323, DOI 10.1016/j.plaphy.2006.06.001
   Robbins RJ, 2009, J CHROMATOGR A, V1216, P4831, DOI 10.1016/j.chroma.2009.04.006
   Saito A, 2005, BIOORGAN MED CHEM, V13, P2759, DOI 10.1016/j.bmc.2005.02.023
   Schroeter H, 2010, MOL ASPECTS MED, V31, P546, DOI 10.1016/j.mam.2010.09.008
   Shenoy Arvind, 2008, J Conserv Dent, V11, P99, DOI 10.4103/0972-0707.45247
   Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184
   Suda M, 2013, BIOORG MED CHEM LETT, V23, P4935, DOI 10.1016/j.bmcl.2013.06.061
   Vidal CMP, 2014, LANGMUIR, V30, P14887, DOI 10.1021/la5034383
   Xi H, 2005, HUAXUE SHIJIE, V46, P759
   Yanagida A, 2003, J BIOCHEM BIOPH METH, V56, P311, DOI 10.1016/S0165-022X(03)00068-X
NR 41
TC 16
Z9 16
U1 4
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD MAR
PY 2015
VL 101
BP 169
EP 178
DI 10.1016/j.fitote.2014.12.006
PG 10
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CF0RU
UT WOS:000352252700021
PM 25542682
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, D
   Zhang, B
   Tang, XN
   Wang, Y
   Si, T
   Cui, S
AF Zhang, D.
   Zhang, B.
   Tang, X. N.
   Wang, Y.
   Si, T.
   Cui, S.
TI Optimised preparation of silver inorganic antibacterial material
   containing ytterbium using response surface methodology
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Antibacterial material; Silver; Ytterbium; Response surface methodology
ID COMPOSITE NANOPARTICLES; PHOTOCATALYTIC ACTIVITY; ANTIMICROBIAL
   ACTIVITY; BIOMATERIAL SYSTEM; NANOCOMPOSITES; LANTHANUM; SHELL; AG
AB In this work, a silver inorganic antibacterial containing ytterbium was synthesised using response surface methodology. Statistical analysis of the results showed that the bulk density of the Ag-Yb antibacterial white carbon black was characterised by the reaction time, reaction temperature and ytterbium ion concentration. The optimised reaction conditions were as follows: reaction time was 75 min, reaction temperature was 85uC and ytterbium ion concentration was 0.01 mol L-1. The structure and property of the inorganic antibacterial material were characterised by scanning electron microscopy, energy dispersive spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy and antibacterial experiments (Escherichia coli as experimental bacteria). Results showed that the bacteriostatic rate of Ag-Yb antibacterial white carbon black was >0%.
C1 [Zhang, D.; Tang, X. N.; Si, T.; Cui, S.] Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Yunnan, Peoples R China.
   [Zhang, B.; Wang, Y.] Kunming Univ Sci & Technol, Fac Sci, Kunming 650500, Yunnan, Peoples R China.
RP Tang, XN (reprint author), Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Yunnan, Peoples R China.
EM tangxn6666@sina.com
FU Yunnan Provincial Department of Education [2012Z102]; National High-tech
   RD Program [2014AA021801]
FX This work was supported by key projects of the Yunnan Provincial
   Department of Education (no. 2012Z102) and the National High-tech R&D
   Program (no. 2014AA021801).
CR Devesh R., 2012, ADV ENG MATER, V14, P93
   Girase B, 2011, MAT SCI ENG C-MATER, V31, P1759, DOI 10.1016/j.msec.2011.08.007
   Hu JQ, 2013, J DENT, V41, P927, DOI 10.1016/j.jdent.2013.07.014
   Jagdish R., 2007, MAT SCI ENG C, V27C, P540
   Kim JD, 2013, APPL SURF SCI, V283, P227, DOI 10.1016/j.apsusc.2013.06.086
   Konwarh R, 2013, CARBOHYD POLYM, V92, P1100, DOI 10.1016/j.carbpol.2012.10.055
   Li F, 2013, J DENT, V41, P881, DOI 10.1016/j.jdent.2013.07.006
   Li N., 2008, J MATER SCI-MATER M, V19, P3057
   Ma ZJ, 2011, COLLOID SURFACE A, V387, P57, DOI 10.1016/j.colsurfa.2011.07.025
   Olga Polydorou P., 2013, J ODONTOLOGY, V101, P170
   Pana a cek A., 2013, COLLOID SURFACE B, V110B, P191
   Park J, 2013, BIOMATERIALS, V34, P8766, DOI 10.1016/j.biomaterials.2013.07.064
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Ray S, 2011, CHEM ENG J, V169, P116, DOI 10.1016/j.cej.2011.02.061
   Sachsenmaier S, 2013, INJURY, V44, P1363, DOI 10.1016/j.injury.2013.07.014
   Tang XN, 2009, ADV MATER RES-SWITZ, V79-82, P1799, DOI 10.4028/www.scientific.net/AMR.79-82.1799
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Xu Y, 2005, J WUHAN UNIV TECHNOL, V20, P105
   Yao ZT, 2013, J MATER SCI, V48, P8580, DOI 10.1007/s10853-013-7683-0
   Zhang B., 2010, J RARE EARTH, P142
   Zhang B, 2012, LIGHT MET, P157
   Zhang B, 2010, J RARE EARTH, V28, P451, DOI 10.1016/S1002-0721(10)60346-8
   Zhu YJ, 2013, MATER LETT, V108, P103, DOI 10.1016/j.matlet.2013.06.073
NR 25
TC 0
Z9 1
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAR
PY 2015
VL 30
IS 4
BP 241
EP 248
DI 10.1179/1753555714Y.0000000254
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE8OL
UT WOS:000352102600008
DA 2018-10-20
ER

PT J
AU Jeevithan, E
   Zhang, JY
   Wang, NP
   He, L
   Bao, B
   Wu, WH
AF Jeevithan, Elango
   Zhang Jingyi
   Wang, Nanping
   He, Lan
   Bao, Bin
   Wu, Wenhui
TI Physico-chemical, antioxidant and intestinal absorption properties of
   whale shark type-II collagen based on its solubility with acid and
   pepsin
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Shark cartilage collagens; Glycoprotein content; Amino acid composition;
   Gut sac model; Antioxidant activity
ID STURGEON ACIPENSER-SCHRENCKII; CHICK STERNAL CARTILAGE; INDUCED
   ARTHRITIS; SOLUBLE COLLAGEN; SKIN; GELATIN; BONE; OPTIMIZATION;
   PURIFICATION; TOLERANCE
AB Type-II collagens (CIIs) were isolated from whale shark (WS) cartilage; and examined for their physico-functional and structural properties. The protein and ash content of WS cartilage were in the range of 8.02% and 23.39%, respectively. Pepsin soluble collagen (PSC) had high hydroxyproline content than acid soluble collagen (ASC). Fourier transform infrared (FTIR) spectra of ASC and PSC were similar and suggesting that pepsin hydrolysis did not affect the secondary structure of collagen, especially triple-helical structure. SEM microstructure depicted a homogenous, more compact, fibrillary and single-layered sheet like structure with coarse structural integrity. Low content of glycoprotein was observed in PSC than ASC due to the removal of some telopepdies by pepsin digestion. Denaturation temperature (T-d) of PSC (34.02 degrees C) was quite higher than ASC. The antioxidant activity against 1,1-dipheny1-2-picrylhydrazyl radicals and the reducing power of PSC was greater than that of ASC. Similar intestinal absorptive behavior was observed for PSC and ASC in an in vitro gut sac model. These results suggested that CI's isolated from WS cartilage could be the suitable biomaterial for commercial applications as alternative to mammalian collagen. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jeevithan, Elango; Zhang Jingyi; Bao, Bin; Wu, Wenhui] Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
   [Wang, Nanping; He, Lan] Shanghai Fisheries Res Inst, Shanghai 200433, Peoples R China.
   [Wu, Wenhui] Shanghai Ocean Univ, Inst Marine Sci, Shanghai 201306, Peoples R China.
RP Wu, WH (reprint author), Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Pharmacol, Shanghai 201306, Peoples R China.
EM srijeevithan@gmail.com; whwu@shou.edu.cn
OI Elango, Jeevithan/0000-0003-4115-9918; Wu, Wen Hui/0000-0002-1710-8582
FU National High Technology Research and Development Program of China
   [2011AA09070109]; National Natural Science Foundation of China
   [81341082]
FX This work received financial support from National High Technology
   Research and Development Program of China (No. 2011AA09070109) and
   National Natural Science Foundation of China (No. 81341082).
CR AOAC, 2000, OFFICIAL METHODS ANA
   Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Cao H, 2013, EUR REV MED PHARMACO, V17, P1427
   Cao H, 2008, FOOD CHEM, V108, P439, DOI 10.1016/j.foodchem.2007.09.022
   Chang CY, 2007, FOOD CHEM, V100, P1537, DOI 10.1016/j.foodchem.2005.12.019
   Chen LJ, 2012, PHARMACEUTICALS, V5, P339, DOI 10.3390/ph5040339
   Cho SM, 2004, FOOD HYDROCOLLOID, V18, P573, DOI 10.1016/j.foodhyd.2003.10.001
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   Garcia G, 1999, J AUTOIMMUN, V13, P315, DOI 10.1006/jaut.1999.0320
   HELEN E, 2005, J ORTHOP RES, V23, P142
   Jeevithan E, 2014, MAR DRUGS, V12, P3852, DOI 10.3390/md12073852
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Joseph G, 2008, J BIOMED MATER RES A, V87, P1103
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li ZR, 2013, FOOD HYDROCOLLOID, V31, P103, DOI 10.1016/j.foodhyd.2012.10.001
   Liang QF, 2014, PROCESS BIOCHEM, V49, P318, DOI 10.1016/j.procbio.2013.12.003
   Lima OC, 1999, BRAZ J MED BIOL RES, V32, P651, DOI 10.1590/S0100-879X1999000500020
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mendis E, 2005, LIFE SCI, V77, P2166, DOI 10.1016/j.lfs.2005.03.016
   Merly L, 2013, INT IMMUNOPHARMACOL, V15, P309, DOI [10.1016/j.intimp2012.12.001, 10.1016/j.intimp.2012.12.001]
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Oesser S., 1999, J NUTR, V1
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ota KG, 2009, J EXP ZOOL PART B, V312, P1
   Poole A.R., 2005, ARTHRITIS ALLIED CON, P223
   Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584
   Rochdi A, 2000, FOOD CHEM, V69, P295, DOI 10.1016/S0308-8146(99)00267-8
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005
   Tang CH, 2009, FOOD CHEM, V115, P672, DOI 10.1016/j.foodchem.2008.12.068
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Wang L, 2007, J FOOD SCI, V72, P450
   Wang L, 2014, FOOD HYDROCOLLOID, V38, P104, DOI 10.1016/j.foodhyd.2013.12.002
   Wong DWS, 1989, MECH THEORY FOOD CHE, P428
   Zhao W, 2011, INT IMMUNOPHARMACOL, V11, P12, DOI 10.1016/j.intimp.2010.09.018
   Zhu BW, 2012, FOOD HYDROCOLLOID, V28, P182, DOI 10.1016/j.foodhyd.2011.12.010
   Zhuang YL, 2009, J ZHEJIANG UNIV-SC B, V10, P572, DOI 10.1631/jzus.B0920081
NR 44
TC 16
Z9 18
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD MAR
PY 2015
VL 50
IS 3
BP 463
EP 472
DI 10.1016/j.procbio.2014.11.015
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA CF7OD
UT WOS:000352745300017
DA 2018-10-20
ER

PT J
AU Johnson, CT
   Garcia, AJ
AF Johnson, Christopher T.
   Garcia, Andres J.
TI Scaffold-based Anti-infection Strategies in Bone Repair
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterial; Scaffold; Bone repair; Regeneration; Infection
ID RESISTANT STAPHYLOCOCCUS-AUREUS; STABILIZED SEGMENTAL DEFECT; HUMAN
   ANTIMICROBIAL PEPTIDES; BACTERIAL BIOFILM FORMATION;
   PSEUDOMONAS-AERUGINOSA; RAT FEMUR; MOUSE MODEL; SILVER NANOPARTICLES;
   CONTROLLED-RELEASE; ANTIBIOTIC-RESISTANCE
AB Bone fractures and non-union defects often require surgical intervention where biomaterials are used to correct the defect, and approximately 10% of these procedures are compromised by bacterial infection. Currently, treatment options are limited to sustained, high doses of antibiotics and surgical debridement of affected tissue, leaving a significant, unmet need for the development of therapies to combat device-associated biofilm and infections. Engineering implants to prevent infection is a desirable material characteristic. Tissue engineered scaffolds for bone repair provide a means to both regenerate bone and serve as a base for adding antimicrobial agents. Incorporating anti-infection properties into regenerative medicine therapies could improve clinical outcomes and reduce the morbidity and mortality associated with biomaterial implant-associated infections. This review focuses on current animal models and technologies available to assess bone repair in the context of infection, antimicrobial agents to fight infection, the current state of antimicrobial scaffolds, and future directions in the field.
C1 [Johnson, Christopher T.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Johnson, Christopher T.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Johnson, Christopher T.] Emory Univ, Atlanta, GA 30322 USA.
   [Johnson, Christopher T.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU National Institutes of Health [R01 AR062920, R01 AR062368]
FX The authors gratefully acknowledge funding from the National Institutes
   of Health (R01 AR062920, R01 AR062368).
CR Adams CS, 2009, J ORTHOP RES, V27, P701, DOI 10.1002/jor.20815
   Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617
   Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Beattie M, 2011, J CLIN NURS, V20, P2098, DOI 10.1111/j.1365-2702.2010.03561.x
   Bhattacharyya S, 2014, BIOMATERIALS, V35, P509, DOI 10.1016/j.biomaterials.2013.09.073
   Bi L, 2007, J BIOMED MATER RES B, V82B, P418, DOI 10.1002/jbm.b.30747
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004
   Brouwer CPJM, 2008, MINI-REV MED CHEM, V8, P1039, DOI 10.2174/138955708785740670
   Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Chatzistavrou X, 2014, ACTA BIOMATER, V10, P3723, DOI 10.1016/j.actbio.2014.04.030
   Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91
   Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cui X, 2014, J MATER SCI-MATER M, V25, P733, DOI 10.1007/s10856-013-5122-z
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dinjaski N, 2014, ACTA BIOMATER, V10, P2935, DOI 10.1016/j.actbio.2014.03.005
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044
   Eggleston H, 2014, INFORMATICS-BASEL, V1, P72, DOI 10.3390/informatics1010072
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Feng K, 2010, J CONTROL RELEASE, V146, P363, DOI 10.1016/j.jconrel.2010.05.035
   Fridkin SK, 2001, CRIT CARE MED, V29, pN64, DOI 10.1097/00003246-200104001-00002
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c
   Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.02.006
   Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Horst SA, 2012, AM J PATHOL, V181, P1206, DOI 10.1016/j.ajpath.2012.07.005
   Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026
   Jia WT, 2010, INT J PHARMACEUT, V387, P184, DOI 10.1016/j.ijpharm.2009.12.002
   Journeaux SF, 1999, J ARTHROPLASTY, V14, P677, DOI 10.1016/S0883-5403(99)90222-X
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055
   Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008
   Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090411
   Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028
   Ma HY, 2013, J CONTROL RELEASE, V172, P1035, DOI 10.1016/j.jconrel.2013.10.005
   Macia MD, 2011, ANTIMICROB AGENTS CH, V55, P5230, DOI 10.1128/AAC.00617-11
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Meurice E, 2012, J MATER SCI-MATER M, V23, P2445, DOI 10.1007/s10856-012-4711-6
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963
   Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   Penn-Barwell JG, 2014, BONE JOINT RES, V3, P187, DOI 10.1302/2046-3758.36.2000293
   Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2
   Rahaman MN, 2014, MAT SCI ENG C-MATER, V41, P224, DOI 10.1016/j.msec.2014.04.055
   Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X
   Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15
   Rhoads D D, 2009, J Wound Care, V18, P237
   Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276
   Ruckh TT, 2012, J MATER SCI-MATER M, V23, P1411, DOI 10.1007/s10856-012-4609-3
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Schuch R, 2014, J INFECT DIS, V209, P1469, DOI 10.1093/infdis/jit637
   Shi XT, 2009, INT J PHARMACEUT, V373, P85, DOI 10.1016/j.ijpharm.2009.02.013
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068
   Southwood LL, 2004, J ORTHOPAED RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Storm-Versloot MN, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD006478.PUB.2
   Suri S., 2014, J BIOMED MAT RES A
   Thornes B, 2002, J BONE JOINT SURG BR, V84B, P758, DOI 10.1302/0301-620X.84B5.11907
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584
   Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h
   Wang QC, 2013, ADV HEALTHC MATER, V2, P687, DOI 10.1002/adhm.201200306
   Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 104
TC 9
Z9 9
U1 5
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 515
EP 528
DI 10.1007/s10439-014-1205-3
PG 14
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500004
PM 25476163
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mauck, RL
   Burdick, JA
AF Mauck, Robert L.
   Burdick, Jason A.
TI From Repair to Regeneration: Biomaterials to Reprogram the Meniscus
   Wound Microenvironment
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Meniscus; Biomaterials; Wound healing; Regeneration; Scaffold;
   Extracellular matrix
ID STEM-CELL DIFFERENTIATION; NECROSIS-FACTOR-ALPHA; HUMAN KNEE-JOINT;
   IN-VITRO; NUCLEAR MECHANICS; HYALURONIC-ACID; SYNOVIAL-FLUID;
   3-DIMENSIONAL HYDROGELS; NANOFIBROUS SCAFFOLDS; PARTIAL MENISCECTOMY
AB When the field of tissue engineering first arose, scaffolds were conceived of as inert three-dimensional structures whose primary function was to support cellularity and tissue growth. Since then, advances in scaffold and biomaterial design have evolved to not only guide tissue formation, but also to interact dynamically with and manipulate the wound environment. At present, these efforts are being directed towards strategies that directly address limitations in endogenous wound repair, with the goal of reprogramming the local wound environment (and the cells within that locality) from a state that culminates in an inferior tissue repair into a state in which functional regeneration is achieved. This review will address this approach with a focus on recent advances in scaffold design towards the resolution of tears of the knee meniscus as a case example. The inherent limitations to endogenous repair will be discussed, as will specific examples of how biomaterials are being designed to overcome these limitations. Examples will include design of fibrous scaffolds that promote colonization by modulating local extracellular matrix density and delivering recruitment factors. Furthermore, we will discuss scaffolds that are themselves modulated by the wound environment to alter porosity and modulate therapeutic release through precise coordination of scaffold degradation. Finally, we will close with emerging concepts in local control of cell mechanics to improve interstitial cell migration and so advance repair. Overall, these examples will illustrate how emergent features within a biomaterial can be tuned to manipulate and harness the local tissue microenvironment in order to promote robust regeneration.
C1 [Mauck, Robert L.] Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Mauck, Robert L.; Burdick, Jason A.] Philadelphia VA Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA.
RP Mauck, RL (reprint author), Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Perelman Sch Med, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM lemauck@mail.med.upenn.edu; burdick2@seas.upenn.edu
OI Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [R01 EB008722, AR056624]; Department of
   Veterans Affairs [I01 RX000700, RX000174]
FX This work was supported with grants from the National Institutes of
   Health (R01 EB008722 and AR056624) and the Department of Veterans
   Affairs (I01 RX000700 and RX000174). The authors gratefully acknowledge
   Dr. Brendon Baker, Dr. Matt Fisher, Dr. Lara Ionescu, Dr. Iris Kim, Dr.
   Brendan Purcell, and Ms. Feini (Sylvia) Qu for their helpful input,
   graphical design, and in depth discussions on this topic.
CR Adams M. E., 1992, KNEE MENISCUS BASIC, P15
   AHMED AM, 1992, KNEE MENISCUS BASIC, P59
   Andrish J. T., 1996, J AM ACAD ORTHOP SUR, V4, P231
   ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Baker BM, 2011, TISSUE ENG PT A, V17, P1445, DOI [10.1089/ten.TEA.2010.0535, 10.1089/ten.tea.2010.0535]
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Baker BM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192140
   Barrett GR, 1998, ARTHROSCOPY, V14, P824, DOI 10.1016/S0749-8063(98)70018-0
   Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075
   Booth-Gauthier EA, 2013, INTEGR BIOL-UK, V5, P569, DOI 10.1039/c3ib20231c
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Dai M, 2010, AM J PATHOL, V177, P3089, DOI 10.2353/ajpath.2010.100340
   Day B, 1985, Arthroscopy, V1, P58, DOI 10.1016/S0749-8063(85)80080-3
   Dourte LM, 2008, J ORTHOP RES, V26, P1297, DOI 10.1002/jor.20646
   Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004
   Eckhouse SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007244
   EGGLI S, 1995, AM J SPORT MED, V23, P715, DOI 10.1177/036354659502300614
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271
   Fisher MB, 2013, ACTA BIOMATER, V9, P4496, DOI 10.1016/j.actbio.2012.10.018
   Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459
   Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015
   Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j
   Greiner AM, 2014, BIOMATERIALS, V35, P611, DOI 10.1016/j.biomaterials.2013.09.095
   Greis Patrick E, 2002, J Am Acad Orthop Surg, V10, P177
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Han WM, 2013, BIOPHYS J, V105, P807, DOI 10.1016/j.bpj.2013.06.023
   Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029
   Hennerbichler A, 2007, OSTEOARTHR CARTILAGE, V15, P1053, DOI 10.1016/j.joca.2007.03.003
   Hennerbichler A., 2006, T ORS, V31, P1038
   Heo S. J., 2014, T ORTHOP RES SOC, V60, P457
   Heo S. J., 2014, T ORTHOP RES SOC, V60, P180
   Heo SJ, 2011, ANN BIOMED ENG, V39, P2780, DOI 10.1007/s10439-011-0365-7
   Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288
   Ifkovits JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015717
   Imler SM, 2004, OSTEOARTHR CARTILAGE, V12, P736, DOI 10.1016/j.joca.2004.05.007
   Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]
   Ionescu LC, 2013, TISSUE ENG PT A, V19, P538, DOI [10.1089/ten.tea.2012.0052, 10.1089/ten.TEA.2012.0052]
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Kambic HE, 2000, WOUND REPAIR REGEN, V8, P554, DOI 10.1046/j.1524-475x.2000.00554.x
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim I. L., 2014, T SOC BIOM ANN M
   Kim IL, 2013, BIOMATERIALS, V34, P5571, DOI 10.1016/j.biomaterials.2013.04.004
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Krause M, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065002
   Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714
   Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670
   Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18
   Lammerding J, 2011, COMPR PHYSIOL, V1, P783, DOI 10.1002/cphy.c100038
   Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200
   Lange JR, 2013, EXP CELL RES, V319, P2418, DOI 10.1016/j.yexcr.2013.04.023
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Lohmander LS, 2005, ARTHRITIS RHEUM, V52, P3160, DOI 10.1002/art.21345
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Martins RP, 2012, ANNU REV BIOMED ENG, V14, P431, DOI [10.1146/annurev-bioeng-071910-124638, 10.1146/annurev.bioeng-071910-124638]
   Masaeli M., 2013, MULTIPARAMETER HIGH, P383
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   McNulty AL, 2010, OSTEOARTHR CARTILAGE, V18, P830, DOI 10.1016/j.joca.2010.02.009
   McNulty AL, 2008, BIORHEOLOGY, V45, P487, DOI 10.3233/BIR-2008-0489
   McNulty AL, 2007, ARTHRITIS RHEUM, V56, P3033, DOI 10.1002/art.22839
   Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017
   Mesiha M, 2007, AM J SPORT MED, V35, P103, DOI 10.1177/0363546506293700
   Metter RB, 2010, ACTA BIOMATER, V6, P1219, DOI 10.1016/j.actbio.2009.10.027
   Moretti M, 2005, J BIOMECH, V38, P1846, DOI 10.1016/j.jbiomech.2004.08.021
   Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4, DOI 10.2106/00004623-199801000-00003
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Natsu-Ume T, 2005, J ORTHOP SCI, V10, P396, DOI 10.1007/s00776-005-0912-x
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141
   Petrosini AV, 1996, CLIN SPORT MED, V15, P445
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PROCTOR CS, 1989, J ORTHOP RES, V7, P771, DOI 10.1002/jor.1100070602
   Provenzano PP, 2002, J ORTHOPAED RES, V20, P975, DOI 10.1016/S0736-0266(02)00036-0
   Purcell B. P., 2014, T 38 ANN M PION FUT, V38, P63
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Qu F., 2014, MENISCAL SURGERY MAN, P89
   Qu FN, 2015, BIOMATERIALS, V39, P85, DOI 10.1016/j.biomaterials.2014.10.067
   Qu FN, 2013, ACTA BIOMATER, V9, P6393, DOI 10.1016/j.actbio.2013.01.016
   Rath E, 2000, BRIT J SPORT MED, V34, P252, DOI 10.1136/bjsm.34.4.252
   Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720
   Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535
   Scanzello CR, 2013, OSTEOARTHR CARTILAGE, V21, P1392, DOI 10.1016/j.joca.2013.05.011
   Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012
   Scanzello CR, 2011, ARTHRITIS RHEUM-US, V63, P391, DOI 10.1002/art.30137
   Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9
   Shen WL, 2014, STEM CELL TRANSL MED, V3, P387, DOI 10.5966/sctm.2012-0170
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189
   Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046
   Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018
   Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Talwar S, 2013, BIOPHYS J, V104, P553, DOI 10.1016/j.bpj.2012.12.033
   Tchetverikov I, 2005, ANN RHEUM DIS, V64, P694, DOI 10.1136/ard.2004.022434
   TENUTA JJ, 1994, AM J SPORT MED, V22, P797, DOI 10.1177/036354659402200611
   Upton ML, 2006, CONNECT TISSUE RES, V47, P207, DOI 10.1080/03008200600846663
   Upton ML, 2003, J ORTHOPAED RES, V21, P963, DOI 10.1016/S0736-0266(03)00063-9
   Vanderhave KL, 2011, J PEDIATR ORTHOPED, V31, P496, DOI 10.1097/BPO.0b013e31821ffb8d
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079
NR 122
TC 17
Z9 17
U1 1
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 529
EP 542
DI 10.1007/s10439-015-1249-z
PG 14
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500005
PM 25650096
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Allen, AB
   Priddy, LB
   Li, MTA
   Guldberg, RE
AF Allen, Ashley B.
   Priddy, Lauren B.
   Li, Mon-Tzu A.
   Guldberg, Robert E.
TI Functional Augmentation of Naturally-Derived Materials for Tissue
   Regeneration
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Naturally-derived; Natural polymer; Protein-based; Native extracellular
   matrix (ECM); Tissue regeneration; Augmentation; Structural;
   Biofunctional
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR DELIVERY; DEMINERALIZED
   BONE-MATRIX; SMALL-INTESTINAL SUBMUCOSA; CONTROLLED SCAFFOLD
   DEGRADATION; MARROW STROMAL CELLS; EXTRACELLULAR-MATRIX; IN-VIVO;
   SUSTAINED DELIVERY; GENE DELIVERY
AB Tissue engineering strategies have utilized a wide spectrum of synthetic and naturally-derived scaffold materials. Synthetic scaffolds are better defined and offer the ability to precisely and reproducibly control their properties, while naturally-derived scaffolds typically have inherent biological and structural properties that may facilitate tissue growth and remodeling. More recently, efforts to design optimized biomaterial scaffolds have blurred the line between these two approaches. Naturally-derived scaffolds can be engineered through the manipulation of intrinsic properties of the pre-existing backbone (e.g., structural properties), as well as the addition of controllable functional components (e.g., biological properties). Chemical and physical processing techniques used to modify structural properties of synthetic scaffolds have been tailored and applied to naturally-derived materials. Such strategies include manipulation of mechanical properties, degradation, and porosity. Furthermore, biofunctional augmentation of natural scaffolds via incorporation of exogenous cells, proteins, peptides, or genes has been shown to enhance functional regeneration over endogenous response to the material itself. Moving forward, the regenerative mode of action of naturally-derived materials requires additional investigation. Elucidating such mechanisms will allow for the determination of critical design parameters to further enhance efficacy and capitalize on the full potential of naturally-derived scaffolds.
C1 [Allen, Ashley B.; Priddy, Lauren B.; Li, Mon-Tzu A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM aallen37@gatech.edu; lbpriddy@gatech.edu; a.li@gatech.edu;
   robert.guldberg@me.gatech.edu
FU NIBIB NIH HHS [T32 EB006343]; NIGMS NIH HHS [T32 GM008433]
CR Adair-Kirk TL, 2003, J IMMUNOL, V171, P398, DOI 10.4049/jimmunol.171.1.398
   Allen AB, 2014, TISSUE ENG PART C-ME, V20, P806, DOI [10.1089/ten.TEC.2013.0587, 10.1089/ten.tec.2013.0587]
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Breitbart EA, 2010, J ORTHOP RES, V28, P942, DOI 10.1002/jor.21065
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Casettari L, 2012, BIOMATERIALS, V33, P7565, DOI 10.1016/j.biomaterials.2012.06.104
   Cavazzana-Calvo M, 2004, NATURE, V427, P779, DOI 10.1038/427779a
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069
   Chen LW, 2012, ORTHOPEDICS, V35, pE1402, DOI 10.3928/01477447-20120822-29
   Choi YJ, 2010, BIOMATERIALS, V31, P7226, DOI 10.1016/j.biomaterials.2010.05.022
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Collins C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4984
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   DePaoliLacerda S.H, 2005, BIOMATERIALS, V26, P7164
   Dewavrin JY, 2014, ACTA BIOMATER, V10, P4351, DOI 10.1016/j.actbio.2014.06.006
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Evans CH, 2013, MAYO CLIN PROC, V88, P1323, DOI 10.1016/j.mayocp.2013.04.027
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577
   Gu HJ, 2014, CELL TISSUE RES, V358, P453, DOI 10.1007/s00441-014-1952-3
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Haghi AK, 2007, PHYS STATUS SOLIDI A, V204, P1830, DOI 10.1002/pssa.200675301
   Hahn SK, 2007, J BIOMED MATER RES A, V80A, P916, DOI 10.1002/jbm.a.30997
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689
   Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617
   Howes EL, 1929, NEW ENGL J MED, V200, P1285, DOI 10.1056/NEJM192906202002504
   Huang NF, 2009, REGEN MED, V4, P527, DOI [10.2217/rme.09.32, 10.2217/RME.09.32]
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Jang YS, 2014, ACTA OTO-LARYNGOL, V134, P785, DOI 10.3109/00016489.2014.900702
   Jayasuriya AC, 2009, J MATER SCI-MATER M, V20, P1637, DOI 10.1007/s10856-009-3738-9
   Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Ji J, 2012, J MECH BEHAV BIOMED, V13, P185, DOI 10.1016/j.jmbbm.2012.04.016
   Jia HF, 2002, BIOTECHNOL PROGR, V18, P1027, DOI 10.1021/bp020042m
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kumar G, 2012, CYTOTHERAPY, V14, P494, DOI 10.3109/14653249.2011.651529
   Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee HJ, 2014, ACS APPL MATER INTER, V6, P9338, DOI 10.1021/am501714k
   Li J, 2014, STEM CELL REV REP, V10, P79, DOI 10.1007/s12015-013-9478-8
   Lin KL, 2011, CERAM INT, V37, P2397, DOI 10.1016/j.ceramint.2011.03.079
   Liu ZN, 2014, INT J NANOMED, V9, P1275, DOI 10.2147/IJN.S58626
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma FK, 2014, TISSUE ENG PT A, V20, P1253, DOI [10.1089/ten.TEA.2013.0158, 10.1089/ten.tea.2013.0158]
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Martinez EC, 2013, STEM CELLS DEV, V22, P3087, DOI 10.1089/scd.2013.0119
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Mueller-Rath R, 2010, BIO-MED MATER ENG, V20, P317, DOI 10.3233/BME-2010-0645
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73
   Priddy LB, 2014, ACTA BIOMATER, V10, P4390, DOI 10.1016/j.actbio.2014.06.015
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Schmidt C, 2014, J BIOMATER APPL, V28, P1408, DOI 10.1177/0885328213510331
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Schubert T, 2013, BIOMATERIALS, V34, P3279, DOI 10.1016/j.biomaterials.2013.01.057
   SENIOR RM, 1989, AM J RESP CELL MOL, V1, P479, DOI 10.1165/ajrcmb/1.6.479
   Sheyn D, 2010, TISSUE ENG PT A, V16, P3679, DOI [10.1089/ten.tea.2009.0786, 10.1089/ten.TEA.2009.0786]
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva R, 2014, BIOMATERIALS, V35, P6727, DOI 10.1016/j.biomaterials.2014.04.078
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Tejeda-Montes E, 2014, ACTA BIOMATER, V10, P134, DOI 10.1016/j.actbio.2013.09.001
   Thomas CB, 2011, J BIOMAT SCI-POLYM E, V22, P589, DOI 10.1163/092050610X488232
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang L, 2014, ACTA CIR BRAS, V29, P252, DOI 10.1590/S0102-86502014000400006
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Wegman F, 2013, BIOTECHNOL GENET ENG, V29, P206, DOI 10.1080/02648725.2013.801227
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Wust S, 2011, J FUNCT BIOMATER, V2, P119, DOI 10.3390/jfb2030119
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x
   Yue TW, 2007, BIOMATERIALS, V28, P2350, DOI 10.1016/j.biomaterials.2007.01.035
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zurita M, 2010, CYTOTHERAPY, V12, P522, DOI 10.3109/14653241003615164
NR 137
TC 9
Z9 9
U1 3
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 555
EP 567
DI 10.1007/s10439-014-1192-4
PG 13
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500007
PM 25422160
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Londono, R
   Badylak, SF
AF Londono, Ricardo
   Badylak, Stephen F.
TI Biologic Scaffolds for Regenerative Medicine: Mechanisms of In vivo
   Remodeling
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Extracellular matrix; Biomaterial; Tissue repair; Constructive
   remodeling; Macrophage response
ID SYSTEM EXTRACELLULAR-MATRIX; SMALL-INTESTINAL SUBMUCOSA; ESOPHAGEAL
   RECONSTRUCTION; HOST RESPONSE; MACROPHAGE ACTIVATION; CELL-MIGRATION;
   DERMAL MATRIX; GROWTH-FACTOR; DEGRADATION; COLLAGEN
AB Successful regenerative medicine strategies for functional tissue reconstruction include the in situ placement of acellular materials composed of the extracellular matrix (ECM) or individual components of the ECM. The composition and ultrastructure of these materials vary depending on multiple factors including the tissue source and species from which the materials are harvested, the methods of manufacture, the efficiency of decellularization, post-processing modifications such as chemical cross-linking or solubilization, and the methods of terminal sterilization. Appropriately configured materials have the ability to modulate different stages of the healing response by inducing a shift from a process of inflammation and scar tissue formation to one of constructive remodeling and functional tissue restoration. The events that facilitate such a dramatic change during the biomaterial-host interaction are complex and necessarily involve both the immune system and mechanisms of stem cell recruitment, growth, and differentiation. The present manuscript reviews the composition of biologic scaffolds, the methods and recommendations for manufacture, the mechanisms of the biomaterial-host interaction, and the clinical application of this regenerative medicine approach.
C1 [Londono, Ricardo; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Londono, Ricardo] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM londonor@upmc.edu; badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR Agrawal V, 2011, TISSUE ENG PT A, V17, P3033, DOI [10.1089/ten.TEA.2011.0257, 10.1089/ten.tea.2011.0257]
   Aller Maria-Angeles, 2014, World J Exp Med, V4, P16, DOI 10.5493/wjem.v4.i2.16
   Ambrosio F, 2010, PHYS THER, V90, P1807, DOI 10.2522/ptj.20100030
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baker SM, 2009, CALCIFIED TISSUE INT, V85, P66, DOI 10.1007/s00223-009-9248-4
   Birch Helen L, 2013, Muscles Ligaments Tendons J, V3, P12, DOI 10.11138/mltj/2013.3.1.012
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Butterfield JL, 2013, PLAST RECONSTR SURG, V131, P940, DOI 10.1097/PRS.0b013e3182865ab3
   Cao HST, 2010, AM SURGEON, V76, P1123
   Carey LE, 2014, BIOMATERIALS, V35, P8297, DOI 10.1016/j.biomaterials.2014.06.015
   Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486
   Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516
   CLARK RAF, 1988, J BIOL CHEM, V263, P12115
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6
   Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625
   Iozzo RV, 1996, FASEB J, V10, P598
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Keane TJ, 2013, BIOMATERIALS, V34, P6729, DOI 10.1016/j.biomaterials.2013.05.052
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3
   Ladowski JM, 2011, ANN VASC SURG, V25, P646, DOI 10.1016/j.avsg.2010.11.008
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mills Stuart J, 2013, Cells, V2, P621, DOI 10.3390/cells2030621
   Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921
   Nieponice A, 2014, ANN THORAC SURG, V97, P283, DOI 10.1016/j.athoracsur.2013.08.011
   Nieponice A, 2013, J SURG RES, V182, pE1, DOI 10.1016/j.jss.2012.09.029
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Ricard-Blum S, 2011, FRONT BIOSCI-LANDMRK, V16, P674, DOI 10.2741/3712
   Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720
   SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877
   Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Turner M. D., 2014, BIOCH BIOPHYS ACTA
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41
NR 79
TC 65
Z9 65
U1 8
U2 50
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2015
VL 43
IS 3
BP 577
EP 592
DI 10.1007/s10439-014-1103-8
PG 16
WC Engineering, Biomedical
SC Engineering
GA CE3QF
UT WOS:000351742500009
PM 25213186
DA 2018-10-20
ER

PT J
AU Walters, AA
   Krastev, C
   Hill, AVS
   Milicic, A
AF Walters, Adam A.
   Krastev, Christos
   Hill, Adrian V. S.
   Milicic, Anita
TI Next generation vaccines: single-dose encapsulated vaccines for improved
   global immunisation coverage and efficacy
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
DE Controlled release; microparticles
ID DOUBLE-WALLED MICROSPHERES; SHOT SUBUNIT VACCINE; CONTROLLED-RELEASE
   MICROPARTICLES; LOADED PLGA MICROSPHERES; DENDRITIC CELLS; BIODEGRADABLE
   MICROSPHERES; IN-VIVO; IMMUNE-RESPONSE; CROSS-PRESENTATION; DELIVERY
   SYSTEMS
AB ObjectivesVaccination is considered the most successful health intervention; yet incomplete immunisation coverage continues to risk outbreaks of vaccine preventable diseases worldwide. Vaccination coverage improvement through a single-dose prime-boost technology would revolutionise modern vaccinology, impacting on disease prevalence, significantly benefiting health care and lowering economic burden of disease.
   Key findingsOver the past 30 years, there have been efforts to develop a single-dose delayed release vaccine technology that could replace the repeated prime-boost immunisations required for many current vaccines. Biocompatible polymers have been employed to encapsulate model vaccines for delayed delivery in vivo, using either continuous or pulsed release. Biomaterial considerations, safety aspects, particle characteristics and immunological aspects of this approach are discussed in detail.
   SummaryDespite many studies showing the feasibility of vaccine encapsulation for single-dose prime-boost administration, none have been translated into convincing utility in animal models or human trials. Further development of the encapsulation technology, through optimising the particle composition, formulation, antigen loading efficacy and stability, could lead to the application of this important approach in vaccine deployment. If successful, this would provide a solution to better global vaccination coverage through a reduction in the number of immunisations needed to achieve protection against infectious diseases. This review provides an overview of single-dose vaccination in the context of today's vaccine needs and is derived from a body of literature that has not been reviewed for over a decade.
C1 [Walters, Adam A.; Krastev, Christos; Hill, Adrian V. S.; Milicic, Anita] Univ Oxford, Jenner Inst, ORCRB, Oxford OX3 7DQ, England.
RP Milicic, A (reprint author), Univ Oxford, Jenner Inst, ORCRB, Roosevelt Dr, Oxford OX3 7DQ, England.
EM anita.milicic@ndm.ox.ac.uk
FU Medical Research Council [MC_PC_13069]
CR AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5
   AGUADO MT, 1993, VACCINE, V11, P596, DOI 10.1016/0264-410X(93)90241-O
   Allison SD, 2008, EXPERT OPIN DRUG DEL, V5, P615, DOI [10.1517/17425240802157184, 10.1517/17425247.5.6.615 ]
   ALONSO MJ, 1994, VACCINE, V12, P299, DOI 10.1016/0264-410X(94)90092-2
   ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148
   Arevshatian L, 2007, B WORLD HEALTH ORGAN, V85, P449, DOI 10.2471/BLT.06.031526
   ASANO M, 1993, BIOMATERIALS, V14, P797, DOI 10.1016/0142-9612(93)90047-6
   Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003
   BLOOM BR, 1989, NATURE, V342, P115, DOI 10.1038/342115a0
   Boehm G, 2002, PHARMACEUT RES, V19, P1330, DOI 10.1023/A:1020354809581
   Cardamone M, 1997, J CONTROL RELEASE, V47, P205, DOI 10.1016/S0168-3659(97)01639-8
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chang CP, 2006, COLLOID SURFACE B, V50, P136, DOI 10.1016/j.colsurfb.2006.04.008
   Chang MW, 2010, LANGMUIR, V26, P5115, DOI 10.1021/la903592s
   Cleland JL, 1996, J PHARM SCI, V85, P1350, DOI 10.1021/js960329b
   Cleland JL, 1999, TRENDS BIOTECHNOL, V17, P25, DOI 10.1016/S0167-7799(98)01272-4
   Cleland JL, 1997, J CONTROL RELEASE, V47, P135, DOI 10.1016/S0168-3659(96)01625-2
   Cleland JL, 1998, J PHARM SCI, V87, P1489, DOI 10.1021/js980263f
   Cohen S, 1994, Int J Technol Assess Health Care, V10, P121
   Dang YB, 2011, CARBOHYD POLYM, V83, P1075, DOI 10.1016/j.carbpol.2010.08.071
   Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041
   Dhiman N, 1998, FEMS IMMUNOL MED MIC, V21, P19
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   ELDRIDGE JH, 1991, INFECT IMMUN, V59, P2978
   Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692
   Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004
   Feng L, 2006, J CONTROL RELEASE, V112, P35, DOI 10.1016/j.jconrel.2006.01.012
   Freeman P, 1994, Int J Technol Assess Health Care, V10, P1
   Gerelchuluun T, 2007, ARCH PHARM RES, V30, P1440, DOI 10.1007/BF02977369
   Guerin N, 1995, EUROSURVEILLANCE, P5
   Gupta RK, 1998, ADV DRUG DELIV REV, V32, P225
   Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538
   Hirota K, 2007, J CONTROL RELEASE, V119, P69, DOI 10.1016/j.jconrel.2007.01.013
   Hu B, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40048
   Huntimer L, 2013, ADV HEALTHC MATER, V2, P369, DOI 10.1002/adhm.201200181
   Jain RA, 2000, J MICROENCAPSUL, V17, P343
   Jain S, 2011, EXPERT REV VACCINES, V10, P1731, DOI [10.1586/ERV.11.126, 10.1586/erv.11.126]
   Jiang WL, 2008, MOL PHARMACEUT, V5, P808, DOI 10.1021/mp800027f
   Johansen P, 2000, VACCINE, V19, P1047, DOI 10.1016/S0264-410X(00)00343-1
   Johansen P, 2000, TRENDS BIOTECHNOL, V18, P203, DOI 10.1016/S0167-7799(00)01437-2
   Kanchan V, 2009, BIOMATERIALS, V30, P4763, DOI 10.1016/j.biomaterials.2009.05.075
   Kang FR, 2003, INT J PHARM, V260, P149, DOI 10.1016/S0378-5173(03)00263-1
   Katare YK, 2003, DRUG DELIV, V10, P231, DOI 10.1080/10717540390235454
   Kersten GFA, 1996, VACCINE, V14, P1627, DOI 10.1016/S0264-410X(96)00145-4
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee HJ, 1997, J PHARMACOL EXP THER, V281, P1431
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Lugade AA, 2013, NANOMED-NANOTECHNOL, V9, P923, DOI 10.1016/j.nano.2013.03.008
   Machluf M, 2000, WORLD J UROL, V18, P80, DOI 10.1007/s003450050014
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036
   MEN Y, 1995, VACCINE, V13, P683
   Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584
   Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6
   O'Hagan Derek T, 2003, Expert Rev Vaccines, V2, P269, DOI 10.1586/14760584.2.2.269
   Obst R, 2007, P NATL ACAD SCI USA, V104, P15460, DOI 10.1073/pnas.0707331104
   OHAGAN DT, 1991, IMMUNOLOGY, V73, P239
   OKADA H, 1994, PHARMACEUT RES, V11, P1143, DOI 10.1023/A:1018936815654
   Okada H, 1997, ADV DRUG DELIVER REV, V28, P43, DOI 10.1016/S0169-409X(97)00050-1
   Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080
   Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]
   Panos Ines, 2008, Curr Drug Discov Technol, V5, P333, DOI 10.2174/157016308786733528
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Raghuvanshi RS, 2002, DRUG DELIV, V9, P113, DOI 10.1080/10426500290095557
   Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x
   Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155
   Sanchez A, 1996, J PHARM SCI, V85, P547, DOI 10.1021/js960069y
   Sanchez A, 1999, INT J PHARMACEUT, V185, P255, DOI 10.1016/S0378-5173(99)00178-7
   Sansdrap P, 1998, J MICROENCAPSUL, V15, P545, DOI 10.3109/02652049809008239
   Schliehe C, 2011, J IMMUNOL, V187, P2112, DOI 10.4049/jimmunol.1002084
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Singh M, 1997, VACCINE, V15, P475, DOI 10.1016/S0264-410X(97)00225-9
   Singh M, 1998, VACCINE, V16, P346, DOI 10.1016/S0264-410X(97)80912-7
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Slutter B, 2010, J CONTROL RELEASE, V148, P117, DOI 10.1016/j.jconrel.2010.06.009
   Smith J, 2004, PHARM RES, V21, P43, DOI 10.1023/B:PHAM.0000012150.60180.e3
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013
   THAKKER Y, 1992, BRIT MED J, V304, P756, DOI 10.1136/bmj.304.6829.756
   Thomasin C, 1996, J CONTROL RELEASE, V41, P131, DOI 10.1016/0168-3659(96)01363-6
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Visscher G E, 1987, J Biomater Appl, V2, P118
   Vogelhuber W, 2001, J CONTROL RELEASE, V73, P75, DOI 10.1016/S0168-3659(01)00282-6
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016
   Xie SY, 2009, COLLOID SURFACE B, V74, P358, DOI 10.1016/j.colsurfb.2009.08.005
   Xu QX, 2012, J CONTROL RELEASE, V163, P130, DOI 10.1016/j.jconrel.2012.08.032
   Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107
   Zheng W, 2009, INT J PHARMACEUT, V374, P90, DOI 10.1016/j.ijpharm.2009.03.015
NR 92
TC 7
Z9 7
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD MAR
PY 2015
VL 67
IS 3
SI SI
BP 400
EP 408
DI 10.1111/jphp.12367
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE4WZ
UT WOS:000351832300011
PM 25644530
OA Bronze
DA 2018-10-20
ER

PT J
AU Saqlain, F
   Popa, I
   Fernandez, JM
   Alegre-Cebollada, J
AF Saqlain, Farees
   Popa, Ionel
   Fernandez, Julio M.
   Alegre-Cebollada, Jorge
TI A Novel Strategy for Utilizing Voice Coil Servoactuators in Tensile
   Tests of Low Volume Protein Hydrogels
SO MACROMOLECULAR MATERIALS AND ENGINEERING
LA English
DT Article
DE hydrogels; muscle elasticity; protein biomaterial; tensile testing;
   tissue engineering; tissue mechanics; titin
ID MECHANICAL STABILITY; SINGLE PROTEIN; TITIN; BIOMATERIALS; DOMAINS;
   GIANT
AB We present a novel tensile testing system optimized for the mechanical, loading of microliter volume protein hydrogels. Our apparatus incorporates a voice coil servoactuator capable of carrying out fixed velocity extension-relaxation cycles as well as extension step protocols. The setup is equipped with a plastic cuvette permitting day-long incubations in solution. To demonstrate the functionality of the device, we photo-chemically crosslinked polyproteins of the 191 immunoglobulin domain from the muscle protein titin to create solid hydrogels that recapitulate elastic properties of muscle. We present data from tensile tests of these low volume biomaterials that support protein unfolding as a main determinant of the elasticity of protein hydrogels. Our results demonstrate the potential use of protein hydrogels as biomaterials whose elastic properties dynamically respond to their environment.
C1 [Saqlain, Farees; Popa, Ionel; Fernandez, Julio M.; Alegre-Cebollada, Jorge] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.
RP Alegre-Cebollada, J (reprint author), Ctr Nacl Invest Cardiovasc CNIC, Vasc Biol & Inflammat Dept, Madrid, Spain.
EM jfernandez@columbia.edu; jalegre@cnic.es
RI Popa, Ionel/P-4739-2016; Alegre-Cebollada, Jorge/I-4301-2014
OI Popa, Ionel/0000-0003-3111-4716; Alegre-Cebollada,
   Jorge/0000-0003-0542-0170
FU NIH [HL66030, HL61228]; NSF [1252857]; NIH K99 career development award
   [AI106072]; Columbia University Summer Undergraduate Research Fellowship
FX This work was supported by NIH grants HL66030, HL61228, and NSF grant
   1252857 to J.M.F. J.A.-C. was the recipient of an NIH K99 career
   development award (AI106072). F.S. acknowledges a Columbia University
   Summer Undergraduate Research Fellowship.
CR Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034
   Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056
   Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Cao Y, 2011, BIOPHYS J, V100, P1794, DOI 10.1016/j.bpj.2011.02.030
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Elvin CM, 2010, BIOMATERIALS, V31, P8323, DOI 10.1016/j.biomaterials.2010.07.032
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Fang J, 2012, LANGMUIR, V28, P8260, DOI 10.1021/la301225w
   Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619
   Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186
   LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171
   Li HB, 2000, NAT STRUCT BIOL, V7, P1117
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   Li HB, 2010, ACCOUNTS CHEM RES, V43, P1331, DOI 10.1021/ar100057a
   Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286
   Lv SS, 2013, ACTA BIOMATER, V9, P6481, DOI 10.1016/j.actbio.2013.01.002
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Xie YS, 1996, PROTEIN SCI, V5, P517
NR 22
TC 2
Z9 2
U1 4
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-7492
EI 1439-2054
J9 MACROMOL MATER ENG
JI Macromol. Mater. Eng.
PD MAR
PY 2015
VL 300
IS 3
BP 369
EP 376
DI 10.1002/mame.201400271
PG 8
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA CE2OD
UT WOS:000351654000012
PM 25960689
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, H
   Hwang, YS
   Lee, HS
   Choi, S
   Kim, SY
   Moon, JH
   Kim, JH
   Kim, KC
   Han, DW
   Park, HJ
   Bae, H
AF Lee, Hanna
   Hwang, Yu-Shik
   Lee, Hyo-Seol
   Choi, Suji
   Kim, So Yeon
   Moon, Ji-Hoi
   Kim, Jae Hyung
   Kim, Kwang Chul
   Han, Dong-Wook
   Park, Hyun-Jin
   Bae, Hojae
TI Human hair keratin-based biofilm for potent application to periodontal
   tissue regeneration
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE human hair keratin; film; drug-eluting; periodontal tissue
ID CIRCULAR-DICHROISM; FEATHER KERATINS; BIOMATERIALS; EXTRACTION; RELEASE;
   SYSTEMS; FILMS
AB For the treatment of periodontitis, local delivery of antibiotics and their sustained release are preferable to enhance microbial susceptibility and to reduce possible side effects occurrence in systemic drug delivery. To address these issues, antibiotic loaded polymeric matrices implantable into periodontal pocket have been commercially used in dentistry and oral medicine. Recently, keratin has been drawing attention as a natural polymer for its ability to mediate cell behavior with minor or no immunogenicity enabling further process towards autologous implantation. In this study, human hair keratin was extracted with a cocktail of reducing agents, and antibiotic eluting keratin-based biofilms were fabricated. Physicochemical analysis and release test showed proper physical stability and sustained release of the loaded antibiotics. In addition, the released antibiotic suppressed the growth of various types of oral bacteria including porphyromonas gingivalis. Cellular interaction studies showed that human oral epithelial cell, human gingival fibroblast and periodontal ligament cells proliferated and guided well on biofilms. This study propose that antibiotic eluting keratin-based biofilms are provisional device for the treatment of chronic periodontitis offering advantages such as local controlled drug delivery and biocompatibility, and human hair keratin is able to be a good biomaterial for the potent applications to tissue engineering and regenerative medicine.
C1 [Lee, Hanna; Park, Hyun-Jin] Korea Univ, Dept Food Biochem & Engn, Seoul 136713, South Korea.
   [Hwang, Yu-Shik; Choi, Suji; Kim, So Yeon; Moon, Ji-Hoi; Kim, Kwang Chul] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Hwang, Yu-Shik; Choi, Suji; Kim, So Yeon; Moon, Ji-Hoi; Kim, Kwang Chul] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Lee, Hyo-Seol; Kim, Jae Hyung] Kyung Hee Univ, Sch Dent, Dept Pediat Dent, Seoul 130701, South Korea.
   [Han, Dong-Wook] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea.
   [Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
RP Bae, H (reprint author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
EM hojaebae@konkuk.ac.kr
RI Park, Hyun Jin/I-4942-2015
OI Han, Dong-Wook/0000-0001-8314-1981
FU Basic Research Program through the National Research Foundation of Korea
   (NRF) - Korea government (MEST) Republic of Korea [NRF-2013R1A1A2009706,
   2012R1A2A2A02010181, 2012R1A5A2051387]
FX This research was supported by grants NRF-2013R1A1A2009706,
   2012R1A2A2A02010181 and 2012R1A5A2051387 from the Basic Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Korea government (MEST) Republic of Korea.
CR Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x
   HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015
   Ikkai F, 2002, BIOMACROMOLECULES, V3, P482, DOI 10.1021/bm010160i
   Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192
   Lee H, 2014, TISSUE ENG REGEN MED, V11, P255, DOI 10.1007/s13770-014-0029-4
   Lusiana, 2011, EUR J PHARM BIOPHARM, V78, P432, DOI 10.1016/j.ejpb.2011.01.022
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   *NAT COMM CLIN LAB, 2003, PERF STAND ANT DISK
   Paswan S., 2012, THESIS
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   SIEGLE RJ, 1984, ARCH DERMATOL, V120, P183, DOI 10.1001/archderm.120.2.183
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095
   Yamauchi C, 2008, BIOL PHARM BULL, V31, P994, DOI 10.1248/bpb.31.994
   Yin XC, 2013, BIOMATER SCI-UK, V1, P528, DOI 10.1039/c3bm00158j
NR 25
TC 4
Z9 4
U1 0
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAR
PY 2015
VL 23
IS 3
BP 300
EP 308
DI 10.1007/s13233-015-3036-y
PG 9
WC Polymer Science
SC Polymer Science
GA CE5KB
UT WOS:000351870800011
DA 2018-10-20
ER

PT J
AU Beltran-Partida, E
   Moreno-Ulloa, A
   Valdez-Salas, B
   Velasquillo, C
   Carrillo, M
   Escamilla, A
   Valdez, E
   Villarreal, F
AF Beltran-Partida, Ernesto
   Moreno-Ulloa, Aldo
   Valdez-Salas, Benjamin
   Velasquillo, Cristina
   Carrillo, Monica
   Escamilla, Alan
   Valdez, Ernesto
   Villarreal, Francisco
TI Improved Osteoblast and Chondrocyte Adhesion and Viability by
   Surface-Modified Ti6Al4V Alloy with Anodized TiO2 Nanotubes Using a
   Super-Oxidative Solution
SO MATERIALS
LA English
DT Article
ID OSTEOGENIC GENE-EXPRESSION; TITANIUM-ALLOY; HYDROXYAPATITE GROWTH; CELL
   RESPONSE; BIOACTIVITY; TI-6AL-4V; IMPLANTS; COATINGS; BIOCOMPATIBILITY;
   FABRICATION
AB Titanium (Ti) and its alloys are amongst the most commonly-used biomaterials in orthopedic and dental applications. The Ti-aluminum-vanadium alloy (Ti6Al4V) is widely used as a biomaterial for these applications by virtue of its favorable properties, such as high tensile strength, good biocompatibility and excellent corrosion resistance. TiO2 nanotube (NTs) layers formed by anodization on Ti6Al4V alloy have been shown to improve osteoblast adhesion and function when compared to non-anodized material. In his study, NTs were grown on a Ti6Al4V alloy by anodic oxidation for 5 min using a super-oxidative aqueous solution, and their in vitro biocompatibility was investigated in pig periosteal osteoblasts and cartilage chondrocytes. Scanning electron microscopy (SEM), energy dispersion X-ray analysis (EDX) and atomic force microscopy (AFM) were used to characterize the materials. Cell morphology was analyzed by SEM and AFM. Cell viability was examined by fluorescence microscopy. Cell adhesion was evaluated by nuclei staining and cell number quantification by fluorescence microscopy. The average diameter of the NTs was 80 nm. The results demonstrate improved cell adhesion and viability at Day 1 and Day 3 of cell growth on the nanostructured material as compared to the non-anodized alloy. In conclusion, this study evidences the suitability of NTs grown on Ti6Al4V alloy using a super-oxidative water and a short anodization process to enhance the adhesion and viability of osteoblasts and chondrocytes. The results warrant further investigation for its use as medical implant materials.
C1 [Beltran-Partida, Ernesto] Univ Autonoma Baja California, Fac Odontol Mexicali, Mexicali 21040, Baja California, Mexico.
   [Beltran-Partida, Ernesto; Valdez-Salas, Benjamin; Carrillo, Monica; Escamilla, Alan] Univ Autonoma Baja California, Inst Ingn, Mexicali 21280, Baja California, Mexico.
   [Beltran-Partida, Ernesto; Moreno-Ulloa, Aldo; Villarreal, Francisco] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
   [Beltran-Partida, Ernesto; Velasquillo, Cristina] Inst Nacl Rehabil, Mexico City 14389, DF, Mexico.
   [Moreno-Ulloa, Aldo] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad Invest, Mexico City 11340, DF, Mexico.
   [Valdez, Ernesto] Ctr Med Ixchel Bravo & Obregon, Mexicali 21000, Baja California, Mexico.
RP Valdez-Salas, B (reprint author), Univ Autonoma Baja California, Inst Ingn, Mexicali 21280, Baja California, Mexico.
EM beltrane@uabc.edu.mx; aldiux_1@yahoo.com.mx; benval@uabc.edu.mx;
   mvelasquillo@ciencias.unam.mx; monica@uabc.edu.mx;
   alan.escamilla@uabc.edu.mx; ixchelcentromedico@hotmail.com;
   fvillarr@ucsd.edu
RI Moreno Ulloa, Aldo/K-6128-2015
OI Moreno Ulloa, Aldo/0000-0001-7973-4215
FU Consejo Nacional de Ciencia y Tecnologia [CONACYT-CVU 348737, 114359]
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT-CVU 348737, 114359) for a PhD scholarship. The authors would
   like to thank Julieta Garcia (Instituto Nacional de Rehabilitacion,
   Unidad de Ingenieria de Tejidos, Terapia Celular y Medicina
   Regenerativa) for her technical support.
CR Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262
   Advincula MC, 2007, J BIOMED MATER RES B, V80B, P107, DOI 10.1002/jbm.b.30575
   Altmann B, 2014, BIOMATERIALS, V35, P3208, DOI 10.1016/j.biomaterials.2013.12.088
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Blau A, 2013, CURR OPIN COLLOID IN, V18, P481, DOI 10.1016/j.cocis.2013.07.005
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2010, MAT SCI ENG C-MATER, V30, P518, DOI 10.1016/j.msec.2010.01.013
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Burns K, 2009, J BIOMED MATER RES A, V88A, P561, DOI 10.1002/jbm.a.31899
   Cao X, 2012, J MATER SCI-MATER M, V23, P527, DOI 10.1007/s10856-011-4479-0
   Chen ZX, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065003
   Chiapasco Matteo, 2003, Clin Implant Dent Relat Res, V5, P29, DOI 10.1111/j.1708-8208.2003.tb00179.x
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Gao Y, 2009, APPL SURF SCI, V255, P5009, DOI 10.1016/j.apsusc.2008.12.054
   Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054
   Gonzalez-Espinosa Diana, 2007, Int Wound J, V4, P241, DOI 10.1111/j.1742-481X.2007.00331.x
   Grenier S., 2014, J BIOMECH, V48, P122, DOI [10.1016/j.jbiomech.2014.10.02325468298, DOI 10.1016/J.JBIOMECH.2014.10.02325468298]
   Hao YQ, 2013, APPL SURF SCI, V268, P44, DOI 10.1016/j.apsusc.2012.11.142
   Hong Y, 2013, BIOMATERIALS, V34, P11, DOI 10.1016/j.biomaterials.2012.09.043
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kim SY, 2014, APPL SURF SCI, V321, P412, DOI 10.1016/j.apsusc.2014.09.177
   Kim YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038242
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee J. W., 2011, ANAL SCI, DOI [10.2116/analsci.27.36921233569, DOI 10.2116/ANALSCI.27.36921233569]
   Li BE, 2014, J MATER SCI-MATER M, V25, P199, DOI 10.1007/s10856-013-5064-5
   Liu HY, 2008, APPL SURF SCI, V254, P6305, DOI 10.1016/j.apsusc.2008.03.075
   Liu HN, 2010, INT J NANOMED, V5, P299
   Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018
   Mendez-Duran A., 2013, DIALISIS TRASPLANTE, V34, P160, DOI [10.1016/j.dialis.2013.05.006, DOI 10.1016/J.DIALIS.2013.05.006]
   Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575
   Mobasheri A, 2014, MATURITAS, V78, P188, DOI 10.1016/j.maturitas.2014.04.017
   Narayanan R, 2007, J MATER SCI-MATER M, V18, P779, DOI 10.1007/s10856-006-0007-z
   Narayanan R, 2011, MATER CHEM PHYS, V125, P510, DOI 10.1016/j.matchemphys.2010.10.024
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Qu D., 2014, ANN BIOMED ENG, DOI [10.1007/s10439-014-1190-6, DOI 10.1007/S10439-014-1190-6]
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Saharudin KA, 2013, J NANOSCI NANOTECHNO, V13, P1696, DOI 10.1166/jnn.2013.7115
   Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036
   Smith BS, 2011, ACTA BIOMATER, V7, P2686, DOI 10.1016/j.actbio.2011.03.014
   Stan M. S., 2014, J BIOMED MATER RES A, V103, P48, DOI [10.1002/jbm.a.3514824639011, DOI 10.1002/JBM.A.3514824639011]
   Sun SJ, 2013, J MATER SCI-MATER M, V24, P1079, DOI 10.1007/s10856-013-4869-6
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Swami N, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002465
   Tan AW, 2014, APPL SURF SCI, V320, P161, DOI 10.1016/j.apsusc.2014.08.160
   Tan AW, 2014, CERAM INT, V40, P8301, DOI 10.1016/j.ceramint.2014.01.032
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Wang L, 2010, J NANOSCI NANOTECHNO, V10, P8312, DOI 10.1166/jnn.2010.3006
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Zheng CY, 2011, APPL SURF SCI, V257, P9086, DOI 10.1016/j.apsusc.2011.05.105
NR 56
TC 11
Z9 11
U1 4
U2 38
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2015
VL 8
IS 3
BP 867
EP 883
DI 10.3390/ma8030867
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE6KN
UT WOS:000351945400003
PM 28787976
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Andorko, JI
   Hess, KL
   Jewell, CM
AF Andorko, James I.
   Hess, Krystina L.
   Jewell, Christopher M.
TI Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for
   Immunity or Tolerance
SO AAPS JOURNAL
LA English
DT Review
DE autoimmunity and tolerance; biomaterials; immunology; nanoparticles and
   microparticles; vaccine
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS;
   ANTIGEN-PRESENTING CELLS; GERMINAL CENTER B; DENDRITIC CELLS;
   INTRALYMPHATIC IMMUNOTHERAPY; MULTIPLE-SCLEROSIS; CONTROLLED-RELEASE;
   IN-VIVO; NANOPARTICLE VACCINES
AB Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of "tuning" immune responses has recently been used to combat infectious diseases and cancer, and to induce tolerance during organ transplants or autoimmune disease. Lymph nodes and other secondary lymphoid organs such as the spleen play crucial roles in determining if and how these responses develop following vaccination or immunotherapy. Thus, by manipulating the local microenvironments within these immunological command centers, the nature of systemic immune response can be controlled. This review provides recent examples that harness the interactions between biomaterials and lymph nodes or other secondary lymphoid organs to generate immunity or promote tolerance. These strategies draw on mechanical properties, surface chemistry, stability, and targeting to alter the interactions of cells, signals, and vaccine components in lymph nodes. While there are still many unanswered questions surrounding how best to design biomaterial-based vaccines to promote specific structures or functions in lymph nodes, features such as controlled release and targeting will help pave the way for the next generation of vaccines and immunotherapies that generate immune responses tuned for specific applications.
C1 [Andorko, James I.; Hess, Krystina L.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
FU NSF [1351688]; Pharmaceutics division of the PhRMA Foundation; Alex's
   Lemonade Stand "A" Award [27120]; Damon Runyon Foundation; Alliance for
   Cancer Gene Therapy; NIH [T32 AI089621]
FX This work was supported in part by NSF CAREER Award no. 1351688, the
   Pharmaceutics division of the PhRMA Foundation, and Alex's Lemonade
   Stand "A" Award no. 27120. CMJ is a Damon Runyon-Rachleff Innovator
   supported by the Damon Runyon Foundation, and is a Young Investigator
   supported by the Alliance for Cancer Gene Therapy. JIA is a trainee on
   NIH Grant no. T32 AI089621.
CR Abbas A. K, 2012, CELLULAR MOL IMMUNOL
   Adamina M, 2010, MOL THER, V18, P651, DOI 10.1038/mt.2009.275
   Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754
   Andorko JI, 2014, JOVE-J VIS EXP, DOI 10.3791/50984
   Azzi J, 2010, FASEB J, V24, P3927, DOI 10.1096/fj.10-154690
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905
   Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Buyuktimkin B, 2012, MOL PHARMACEUT, V9, P979, DOI 10.1021/mp200614q
   Capini C, 2009, J IMMUNOL, V182, P3556, DOI 10.4049/jimmunol.0802972
   Card CM, 2014, J CLIN INVEST, V124, P943, DOI [10.1172/JC173316, 10.1172/JCI73316]
   Clemente-Casares X, 2014, IMMUNOL LETT, V158, P167, DOI 10.1016/j.imlet.2013.12.018
   Comabella M, 2012, CLIN IMMUNOL, V142, P2, DOI 10.1016/j.clim.2011.03.004
   Cubas R, 2009, J IMMUNOTHER, V32, P118, DOI 10.1097/CJI.0b013e31818f13c4
   Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113
   de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Gallorini S, 2007, J IMMUNOL, V179, P8208, DOI 10.4049/jimmunol.179.12.8208
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298
   Huang L, 2012, J IMMUNOL, V188, P4913, DOI 10.4049/jimmunol.1103668
   Hunter Z, 2014, ACS NANO, V8, P2148, DOI 10.1021/nn405033r
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Irvine DJ, 2012, COMPREHENSIVE BIOMAT
   Jeanbart L, 2014, CANCER IMMUNOL RES, V2, P701
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2012, ADV MATER, V24, P4735, DOI 10.1002/adma.201202513
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   Johansen P, 2008, P NATL ACAD SCI USA, V105, P5189, DOI 10.1073/pnas.0706296105
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254
   Kaur R, 2012, J CONTROL RELEASE, V164, P331, DOI 10.1016/j.jconrel.2012.07.012
   Keijzer C, 2013, J CONTROL RELEASE, V168, P35, DOI 10.1016/j.jconrel.2013.02.027
   Keijzer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026684
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Murphy K., 2012, JANEWAYS IMMUNOBIOLO
   Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019
   Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649
   Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a
   Peine KJ, 2014, MOL PHARMACEUT, V11, P828, DOI 10.1021/mp4005172
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272
   Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155
   Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026
   Senti G, 2009, CURR OPIN ALLERGY CL, V9, P537, DOI 10.1097/ACI.0b013e3283310ff7
   Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shirali AC, 2011, AM J TRANSPLANT, V11, P2582, DOI 10.1111/j.1600-6143.2011.03725.x
   Smith KA, 2009, CLIN CANCER RES, V15, P6167, DOI 10.1158/1078-0432.CCR-09-0645
   Smith KA, 2009, VACCINE, V27, P2603, DOI 10.1016/j.vaccine.2009.02.038
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
   Tang L., 2012, J TRANSPLANT, V2012, DOI DOI 10.1155/2012/896141
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x
   Waeckerle-Men Y, 2013, VACCINE, V31, P1057, DOI 10.1016/j.vaccine.2012.12.034
   Warren KJ, 2014, J CLIN INVEST, V124, P2204, DOI 10.1172/JCI73683
   Witten M, 2013, J ALLERGY CLIN IMMUN, V132, P1248, DOI 10.1016/j.jaci.2013.07.033
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   Zhang WF, 2014, PHARM RES-DORDR, V31, P1015, DOI 10.1007/s11095-013-1224-z
   Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586
NR 91
TC 30
Z9 32
U1 3
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1550-7416
J9 AAPS J
JI AAPS J.
PD MAR
PY 2015
VL 17
IS 2
BP 323
EP 338
DI 10.1208/s12248-014-9708-2
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CE0WM
UT WOS:000351530500007
PM 25533221
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Li, Y
   Wang, SW
   Huang, R
   Huang, Z
   Hu, BF
   Zheng, WF
   Yang, G
   Jiang, XY
AF Li, Ying
   Wang, Shiwen
   Huang, Rong
   Huang, Zhuo
   Hu, Binfeng
   Zheng, Wenfu
   Yang, Guang
   Jiang, Xingyu
TI Evaluation of the Effect of the Structure of Bacterial Cellulose on Full
   Thickness Skin Wound Repair on a Microfluidic Chip
SO BIOMACROMOLECULES
LA English
DT Article
ID MICROBIAL CELLULOSE; GOLD NANOPARTICLES; CELLS; BIOMATERIALS; SCAFFOLD;
   OXYGEN
AB Bacterial cellulose (BC) is a kind of nanobiomaterial for tissue engineering. How the nanoscale structure of BC affects skin wound repair is unexplored. Here, the hierarchical structure of BC films and their different effects on skin wound healing were studied both in vitro and in vivo. The bottom side of the BC film had a larger pore size, and a looser and rougher structure than that of the top side. By using a microfluidics-based in vitro wound healing model, we revealed that the bottom side of the BC film can better promote the migration of cells to facilitate wound healing. Furthermore, the full-thickness skin wounds on Wistar rats demonstrated that, compared with gauze and the top side of the BC film, the wound covered by the bottom side of the BC film showed faster recovery rate and less inflammatory response. The results indicate that the platform based on the microfluidic chip provide a rapid, reliable, and repeatable method for wound dressing screening. As an excellent biomaterial for wound healing, the BC film displays different properties on different sides, which not only provides a method to optimize the biocompatibility of wound dressings but also paves a new way to building heterogeneous BC-based biomaterials for complex tissue engineering.
C1 [Li, Ying; Yang, Guang] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China.
   [Li, Ying; Wang, Shiwen; Huang, Rong; Huang, Zhuo; Hu, Binfeng; Zheng, Wenfu; Jiang, Xingyu] Natl Ctr NanoSci & Technol, Beijing Engn Res Ctr BioNanotechnol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
   [Wang, Shiwen] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Key Lab Adv Technol Mat, Minist Educ China, Chengdu 610031, Peoples R China.
RP Zheng, WF (reprint author), Natl Ctr NanoSci & Technol, Beijing Engn Res Ctr BioNanotechnol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
EM zhengwf@nanoctr.cn; yang_sunny@yahoo.com; xingyujiang@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU Ministry of Science and Technology of China [2011CB933201,
   2012AA022703]; National Natural Science Foundation of China [21074041,
   31170905, 81361140345, 51373043]; Chinese Academy of Sciences
   [XDA09030305]; CAS/SAFEA International Partnership Program for Creative
   Research Teams
FX Financial support was provided by the Ministry of Science and Technology
   of China (2011CB933201, 2012AA022703), the National Natural Science
   Foundation of China (21074041, 31170905, 81361140345, 51373043), the
   Chinese Academy of Sciences (XDA09030305), and Research Supported by the
   CAS/SAFEA International Partnership Program for Creative Research Teams.
   The authors would like to acknowledge Professor Glyn. O. Phillips (the
   founder of the journal: Food Hydrocolloids, UK) for useful discussion.
CR Altmann B, 2013, TISSUE ENG PART C-ME, V19, P850, DOI [10.1089/ten.tec.2012.0695, 10.1089/ten.TEC.2012.0695]
   Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bechtle M, 2010, CURR MED CHEM, V17, P42, DOI 10.2174/092986710789957814
   Chen ZL, 2009, ANGEW CHEM INT EDIT, V48, P8303, DOI 10.1002/anie.200902708
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Fu LN, 2012, J MATER CHEM, V22, P12349, DOI 10.1039/c2jm00134a
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Li Y., 2007, ANGEW CHEM, V119, P1112
   Li Y, 2014, CARBOHYD POLYM, V103, P496, DOI 10.1016/j.carbpol.2013.12.059
   Moreira S, 2009, TOXICOL LETT, V189, P235, DOI 10.1016/j.toxlet.2009.06.849
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   White RJ, 2006, OSTOMY WOUND MANAG, V52, P26
   Wu L, 2013, BIOMACROMOLECULES, V14, P1078, DOI 10.1021/bm3019664
   Xie YY, 2011, LAB CHIP, V11, P2819, DOI 10.1039/c0lc00562b
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhao QL, 2012, ADV HEALTHC MATER, V1, P560, DOI 10.1002/adhm.201200008
   Zhao YY, 2014, ANGEW CHEM INT EDIT, V53, P8127, DOI 10.1002/anie.201401035
   Zhao YY, 2013, J AM CHEM SOC, V135, P12940, DOI 10.1021/ja4058635
   Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843
   Zheng WF, 2010, LAB CHIP, V10, P2906, DOI 10.1039/c005274d
NR 33
TC 35
Z9 37
U1 7
U2 108
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 780
EP 789
DI 10.1021/bm501680s
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100011
PM 25629225
DA 2018-10-20
ER

PT J
AU Kim, SE
   Harker, EC
   De Leon, AC
   Advincula, RC
   Pokorski, JK
AF Kim, Si-Eun
   Harker, Emily C.
   De Leon, Al C.
   Advincula, Rigoberto C.
   Pokorski, Jonathan K.
TI Coextruded, Aligned, and Gradient-Modified Poly(epsilon-caprolactone)
   Fibers as Platforms for Neural Growth
SO BIOMACROMOLECULES
LA English
DT Article
ID AZIDE-ALKYNE CYCLOADDITION; ELECTROSPUN NANOFIBERS; BIOMATERIAL
   SCAFFOLD; NERVE REGENERATION; PEPTIDE; LAMININ; PROTEIN; CELL; SURFACE;
   DIFFERENTIATION
AB Polymeric fibers are of increasing interest to regenerative medicine, as materials made from these fibers are porous, allowing for cell infiltration, influx of nutrients, and efflux of waste products. Recently, multilayered coextrusion has emerged as a scalable and rapid fabrication method to yield microscale to submicron fibers. In this report, we describe the multilayered coextrusion of aligned poly(epsilon-caprolactone) (PCL) fibers, followed by a simple photochemical patterning to create surface-immobilized gradients onto the polymer fibers. PCL fibers were photochemically decorated with a linear gradient of propargyl benzophenone using a gradient photomask to control light source intensity. The pendant alkynes were then able to undergo the copper-catalyzed azide-alkyne cycloaddition reaction with an azide-modified IKVAV peptide to further functionalize the surface. Gradient-modified IKVAV fibers were evaluated for neural cell adhesion and neural differentiation, using PC-12 cells cultured onto the fibers. The aligned gradient fibers provided directional cues for neurite outgrowth and alignment of neural cells, as observed by cellular elongation, neurite differentiation, and orientation. The work presented herein describes a scalable fiber system combined with simple chemical patterning to generate aligned fibers with controlled surface gradients as cell-seeding scaffolds.
C1 [Kim, Si-Eun; Harker, Emily C.; De Leon, Al C.; Advincula, Rigoberto C.; Pokorski, Jonathan K.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
RP Pokorski, JK (reprint author), Case Western Reserve Univ, Dept Macromol Sci & Engn, 2100 Adelbert Rd, Cleveland, OH 44106 USA.
EM jon.pokorski@case.edu
OI Pokorski, Jonathan/0000-0001-5869-6942
FU National Science Foundation (NSF) Center for Layered Polymeric Systems
   [DMR 0423914]; NIH Pathway to Independence Award [R00EB011530]
FX J.K.P. and R.C.A. acknowledge the National Science Foundation (NSF)
   Center for Layered Polymeric Systems for start-up funds (DMR 0423914)
   and generous use of the center's confocal microscope. J.K.P. also
   acknowledges a NIH Pathway to Independence Award for funding
   (R00EB011530).
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028
   Canbolat MF, 2011, MACROMOL BIOSCI, V11, P1346, DOI 10.1002/mabi.201100108
   Chelli B, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0041
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   DHANDAYUTHAPANI B, 2011, INT J POLYM SCI
   Grodowska K, 2010, ACTA POL PHARM, V67, P3
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087
   Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h
   Khadka DB, 2012, NANOMED-NANOTECHNOL, V8, P1242, DOI 10.1016/j.nano.2012.02.013
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kim SE, 2014, ACS MACRO LETT, V3, P585, DOI 10.1021/mz500112d
   Lancaster JR, 2014, PHOTOCHEM PHOTOBIOL, V90, P394, DOI 10.1111/php.12214
   Lancuski A, 2012, ACS APPL MATER INTER, V4, P6499, DOI 10.1021/am301458y
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009
   Mammadov B, 2012, ACTA BIOMATER, V8, P2077, DOI 10.1016/j.actbio.2012.02.006
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Persano L, 2013, MACROMOL MATER ENG, V298, P504, DOI 10.1002/mame.201200290
   Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+
   Repka MA, 2012, EXPERT OPIN DRUG DEL, V9, P105, DOI 10.1517/17425247.2012.642365
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Schneider MH, 2011, LANGMUIR, V27, P1232, DOI 10.1021/la103345k
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sivolella S, 2014, INT J MOL SCI, V15, P3088, DOI 10.3390/ijms15023088
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Wang J, 2014, POLYMER, V55, P673, DOI 10.1016/j.polymer.2013.12.025
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wrobel M. R., 2013, TISSUE ENG PART B-RE
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zheng JK, 2013, POLYM CHEM-UK, V4, P2215, DOI 10.1039/c3py00153a
   Zheng JK, 2012, J AM CHEM SOC, V134, P17274, DOI 10.1021/ja307647x
NR 41
TC 18
Z9 18
U1 1
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 860
EP 867
DI 10.1021/bm501767x
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100020
PM 25715836
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lin, MP
   Wang, HY
   Ruan, CS
   Xing, J
   Wang, JF
   Wang, YL
   Luo, YF
AF Lin, Manping
   Wang, Huaiyu
   Ruan, Changshun
   Xing, Juan
   Wang, Jinfeng
   Wang, Yuanliang
   Luo, Yanfeng
TI Adsorption Force of Fibronectin on Various Surface Chemistries and Its
   Vital Role in Osteoblast Adhesion
SO BIOMACROMOLECULES
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CELL-MATRIX ADHESIONS; FLUID SHEAR-STRESS;
   PROTEIN ADSORPTION; PLASMA FIBRONECTIN; FUNCTIONAL-GROUPS; INTEGRIN
   BINDING; COATED SURFACES; MODEL SURFACES; IN-VITRO
AB The amount, type, and conformation of proteins adsorbed on an implanted biomaterial are believed to influence cell adhesion. Nevertheless, only a few research works have been dedicated to the contribution of protein adsorption force. To verify our hypothesis that the adsorption force of protein on biomaterial is another crucial mediator to cell adhesion, fibronectin (FN) adsorbed on self-assembled monolayers (SAMs) with terminal -OH, -CH3, and -NH2 was quantified for FN adsorption force (Fad) by utilizing a sphere/plane adsorption model and parallel plate flow chamber. As revealed, Fad on SAMs followed a chemistry-dependence of -NH2 > -CH3 >> -OH. It is further demonstrated that Fad together with FN conformation could regulate the late osteoblast adhesion and the consequent reorganization of the adsorbed FN and fibrillogenesis of the endogenous FN. Our study suggests that protein adsorption force plays a key role in cell adhesion and should be involved for better biomaterial design.
C1 [Lin, Manping; Xing, Juan; Wang, Jinfeng; Wang, Yuanliang; Luo, Yanfeng] Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
   [Lin, Manping; Xing, Juan; Wang, Jinfeng; Wang, Yuanliang; Luo, Yanfeng] Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 400030, Peoples R China.
   [Wang, Huaiyu; Ruan, Changshun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518055, Peoples R China.
RP Luo, YF (reprint author), Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
EM yfluo@cqu.edu.cn
FU National Natural Science Foundation of China [31370946]; Fundamental
   Research Funds for the Central Universities [CDJZR11235501]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 31370946) and the Fundamental Research Funds
   for the Central Universities (No. CDJZR11235501).
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Beltran J. B., 2012, J MATER SCI, V23, P195
   Brooks SB, 1996, COMPUT FLUIDS, V25, P741, DOI 10.1016/S0045-7930(96)00024-2
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028
   Li Y, 2013, COLLOID SURFACE B, V112, P51, DOI 10.1016/j.colsurfb.2013.07.001
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   Lorthois S, 2001, J COLLOID INTERF SCI, V241, P52, DOI 10.1006/jcis.2001.7679
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Meadows PY, 2005, LANGMUIR, V21, P4096, DOI 10.1021/la047241v
   Mercier-Bonin M, 2009, J COLLOID INTERF SCI, V338, P73, DOI 10.1016/j.jcis.2009.06.019
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057
   Schwierz N, 2012, J AM CHEM SOC, V134, P19628, DOI 10.1021/ja304462u
   SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x
   Smith M.L., 2007, PLOS BIOL, V5, pe268
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087
   Vadillo-Rodriguez V, 2013, LANGMUIR, V29, P8554, DOI 10.1021/la401776e
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xing J, 2014, J BIOMED MATER RES A, V102, P4151, DOI 10.1002/jbm.a.35087
   Xu LC, 2006, COLLOID SURFACE B, V48, P84, DOI 10.1016/j.colsurfb.2006.01.012
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Zamir E, 2000, NAT CELL BIOL, V2, P191
NR 56
TC 23
Z9 25
U1 6
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2015
VL 16
IS 3
BP 973
EP 984
DI 10.1021/bm501873g
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD1NH
UT WOS:000350841100032
PM 25685886
DA 2018-10-20
ER

PT J
AU Verdonk, P
   Dhollander, A
   Almqvist, KF
   Verdonk, R
   Victor, J
AF Verdonk, P.
   Dhollander, A.
   Almqvist, K. F.
   Verdonk, R.
   Victor, J.
TI Treatment of osteochondral lesions in the knee using a cell-free
   scaffold
SO BONE & JOINT JOURNAL
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; ARTICULAR-CARTILAGE DEFECTS;
   COMPOSITE MULTILAYERED BIOMATERIAL; REPAIR TISSUE; REGENERATION;
   MICROFRACTURE; MOSAICPLASTY; MANAGEMENT
AB The treatment of osteochondral lesions is of great interest to orthopaedic surgeons because most lesions do not heal spontaneously. We present the short-term clinical outcome and MRI findings of a cell-free scaffold used for the treatment of these lesions in the knee. A total of 38 patients were prospectively evaluated clinically for two years following treatment with an osteochondral nanostructured biomimetic scaffold. There were 23 men and 15 women; the mean age of the patients was 30.5 years (15 to 64). Clinical outcome was assessed using the Knee Injury and Osteoarthritis Outcome Score (KOOS), the Tegner activity scale and a Visual Analgue scale for pain. MRI data were analysed based on the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scoring system at three, 12 and 24 months post-operatively. There was a continuous significant clinical improvement after surgery. In two patients, the scaffold treatment failed (5.3%) There was a statistically significant improvement in the MOCART precentage scores. The repair tissue filled most of the defect sufficiently. We found subchondral laminar changes in all patients. Intralesional osteophytes were found in two patients (5.3%). We conclude that this one-step scaffold-based technique can be used for osteochondral repair. The surgical technique is straightforward, and the clinical results are promising. The MRI aspects of the repair tissue continue to evolve during the first two years after surgery. However, the subchondral laminar and bone changes are a concern.
C1 [Verdonk, P.; Dhollander, A.; Almqvist, K. F.; Verdonk, R.; Victor, J.] Ghent Univ Hosp, Ghent, Belgium.
RP Dhollander, A (reprint author), Monica Hosp, Antwerp Orthoped Ctr, Harmoniestr 68, B-2018 Antwerp, Belgium.
EM dhollander.aad@gmail.com
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   FULKERSON JP, 1983, CLIN ORTHOP RELAT R, P176
   Gortz S, 2010, CLIN ORTHOP RELAT R, V468, P1269, DOI 10.1007/s11999-010-1250-7
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hindle P, 2014, KNEE SURG SPORT TR A, V22, P1235, DOI 10.1007/s00167-013-2493-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Peterson L, 2003, MASTER TECHNIQUES OR, P353
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Steadman JR, 1997, OPER TECH ORTHOP, V7, P300, DOI DOI 10.1016/S1048-6666(97)80033-X
   Vijayan S, 2014, BONE JOINT J, V96B, P54, DOI 10.1302/0301-620X.96B1.31979
NR 27
TC 15
Z9 16
U1 0
U2 24
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD MAR
PY 2015
VL 97B
IS 3
BP 318
EP 323
DI 10.1302/0301-620X.97B3.34555
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CD6HP
UT WOS:000351190500007
PM 25737514
DA 2018-10-20
ER

PT J
AU Ma, J
   Qin, JL
AF Ma, Jun
   Qin, Jinli
TI Graphene-like Zinc Substituted Hydroxyapatite
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID CALCIUM-PHOSPHATE; BONE; BIOMINERALIZATION; MINERALIZATION; ADSORPTION;
   SURFACES; CRYSTALLIZATION; BIOMATERIAL; COLLAGEN
AB The biological bone minerals form within a complex microenvironment that consists of various ions and template molecules. Silk fibroin provides an attractive template for biomimetic hydroxyapatite synthesis. In this study, graphene-like zinc substituted hydroxyapatite crystals were prepared using silk fibroin and sodium alginate as template molecules, and the resulting products were investigated. The alginate ions interacted with silk fibroin, and the additional zinc ions also influenced the crystal formation of hydroxyapatite. The graphene-like sheets with hydroxyapatite phase were approximately 3 nm in thickness, and the size was more than 100 nm. The structure of the zinc substituted hydroxyapatite was studied by transmission electron microscopy, and the results revealed that small crystallites of several nanometers were assembled into large size sheets. The synergy effect of zinc and alginate ions led to the preferred growth along (002) and (211) orientations. Accordingly, the mechanisms of crystal growth regulation have been demonstrated.
C1 [Ma, Jun; Qin, Jinli] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   [Ma, Jun] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China.
RP Ma, J (reprint author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
EM caltary@gmail.com
RI Ma, Jun/K-2084-2012
OI Ma, Jun/0000-0001-5167-1750
FU National Basic Research Program of China [2012CB933601]; National
   Natural Science Foundation of China [51202075]; Fundamental Research
   Funds for the Central Universities [2014QN121]
FX This work was supported by the National Basic Research Program of China
   (Grant No. 2012CB933601), the National Natural Science Foundation of
   China (Grant No. 51202075), and the Fundamental Research Funds for the
   Central Universities (Grant No. 2014QN121). We are also grateful to the
   Analytical and Testing Center (HUST).
CR Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   George A, 2010, NANO TODAY, V5, P254, DOI 10.1016/j.nantod.2010.05.005
   Gomez-Morales J, 2011, CRYST GROWTH DES, V11, P4802, DOI 10.1021/cg2004547
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Junginger M, 2010, MACROMOL BIOSCI, V10, P1084, DOI 10.1002/mabi.201000093
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kong XD, 2006, MAT SCI ENG C-BIO S, V26, P639, DOI 10.1016/j.msec.2005.09.097
   Koutsopoulos S, 2000, J CRYST GROWTH, V217, P410, DOI 10.1016/S0022-0248(00)00502-9
   Ma J, 2014, BIOTECHNOL ADV, V32, P744, DOI 10.1016/j.biotechadv.2013.10.014
   Marsi TCO, 2012, LANGMUIR, V28, P4413, DOI 10.1021/la300111k
   Ming JF, 2012, MATER CHEM PHYS, V137, P421, DOI 10.1016/j.matchemphys.2012.10.001
   Mostafa NY, 2011, J AM CERAM SOC, V94, P1584, DOI 10.1111/j.1551-2916.2010.04282.x
   Niu L, 2010, J NANOMATER, DOI 10.1155/2010/729457
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Rosseeva EV, 2008, CHEM MATER, V20, P6003, DOI 10.1021/cm8005748
   Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h
   SANG S, 2004, BONE, V35, P108
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shen LM, 2011, J MATER CHEM, V21, P18868, DOI 10.1039/c1jm12238j
   Shepherd D, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025003
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Unuma H, 2011, J CERAM SOC JPN, V119, P623, DOI 10.2109/jcersj2.119.623
   Velard F, 2009, INT J ARTIF ORGANS, V32, P457
   Wang JL, 2011, J BIOMED MATER RES A, V99A, P327, DOI 10.1002/jbm.a.32602
   Wang J, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/041002
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Wei X, 2012, CRYST GROWTH DES, V12, P3474, DOI 10.1021/cg201685x
   Zhao Y, 2009, J BIOMED MATER RES A, V91A, P1140, DOI 10.1002/jbm.a.32272
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
NR 37
TC 10
Z9 10
U1 5
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
EI 1528-7505
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD MAR
PY 2015
VL 15
IS 3
BP 1273
EP 1279
DI 10.1021/cg501659x
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA CC8JL
UT WOS:000350614400034
DA 2018-10-20
ER

PT J
AU Sriram, M
   Sainitya, R
   Kalyanaraman, V
   Dhivya, S
   Selvamurugan, N
AF Sriram, M.
   Sainitya, R.
   Kalyanaraman, V.
   Dhivya, S.
   Selvamurugan, N.
TI Biomaterials mediated microRNA delivery for bone tissue engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Review
DE Biomaterial; MicroRNA; Runx2; Osteoblast; Bone
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; REGULATES OSTEOGENIC
   DIFFERENTIATION; IN-VIVO; MIRNA EXPRESSION; SCAFFOLDS; MOUSE;
   PROLIFERATION; BIOGENESIS; SUPPRESSES
AB Bone tissue engineering is an alternative strategy to overcome the problems associated with traditional treatments for bone defects. A number of bioactive materials along with new techniques like porous scaffold implantation, gene delivery, 3D organ printing are now-a-days emerging for traditional bone grafts and metal implants. Studying the molecular mechanisms through which these biomaterials induce osteogenesis is an equally hot field. Biomaterials could determine the fate of a cell via microRNAs (miRNAs). miRNAs are short non-coding RNAs that act as post-transcriptional regulators of gene expression and play an essential role for regulation of cell specific lineages including osteogenesis. Thus, this review focuses the recent trends on establishing a link of biomaterials with miRNAs and their delivery for bone tissue engineering applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sriram, M.; Sainitya, R.; Kalyanaraman, V.; Dhivya, S.; Selvamurugan, N.] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India.
RP Selvamurugan, N (reprint author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India.
EM selvamurugan.n@ktr.srmuniv.ac.in
FU Council for Scientific and Industrial Research, India
   [37(1574)/12/EMR-II, 60(0110)/13/EMR-II, N.S37(1574)/12/EMR-II]; Indian
   Council of Medical Research, India [80/11/2013-BMS]
FX We thank S. Saravanan and S. Vimalraj for their help in preparation of
   the article. This work was supported by the Council for Scientific and
   Industrial Research, India (No. 37(1574)/12/EMR-II; No.
   60(0110)/13/EMR-II to N.S37(1574)/12/EMR-II; 60(0110)/13/EMR-II to N.S.)
   and the Indian Council of Medical Research, India (No. 80/11/2013-BMS to
   N.S.).
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chakravorty N, 2012, ACTA BIOMATER, V8, P3516, DOI 10.1016/j.actbio.2012.05.008
   Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615
   Chen S, 2014, MOL MED REP, V9, P1820, DOI 10.3892/mmr.2014.2024
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Deng Y, 2014, EUR CELLS MATER, V27, P13, DOI 10.22203/eCM.v027a02
   Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Guda T, 2008, CURR TOP MED CHEM, V8, P290, DOI 10.2174/156802608783790956
   Hupkes M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-1
   Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106
   James EN, 2014, ACTA BIOMATER, V10, P3571, DOI 10.1016/j.actbio.2014.04.026
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325
   Kroeze RJ, 2009, MATERIALS, V2, P833, DOI 10.3390/ma2030833
   Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lisse TS, 2013, J BONE MINER RES, V28, P1478, DOI 10.1002/jbmr.1882
   Liu H, 2014, J CELL PHYSIOL, V229, P1494, DOI 10.1002/jcp.24591
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Mahmood M, 2011, J CELL MOL MED, V15, P2297, DOI 10.1111/j.1582-4934.2010.01234.x
   Mai ZH, 2013, CHINESE MED J-PEKING, V126, P1544, DOI 10.3760/cma.j.issn.0366-6999.20123137
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mizoguchi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4282
   Moorthi A, 2013, INT J BIOL MACROMOL, V56, P181, DOI 10.1016/j.ijbiomac.2013.02.017
   Moorthi A, 2012, J BIOMATER TISS ENG, V2, P197, DOI 10.1166/jbt.2012.1045
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800
   Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028
   Palmieri A, 2008, J MATER SCI-MATER M, V19, P2471, DOI 10.1007/s10856-008-3386-5
   Palmieri A, 2008, BIO-MED MATER ENG, V18, P91, DOI 10.3233/BME-2008-0512
   Palmieri A, 2008, J CRANIOFAC SURG, V19, P328, DOI 10.1097/SCS.0b013e3181534ab3
   Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182
   Palmieri A, 2008, J BIOMED MATER RES B, V84B, P369, DOI 10.1002/jbm.b.30880
   Palmieri Annalisa, 2008, J Oral Implantol, V34, P190, DOI 10.1563/0.869.1
   Palmieri A, 2010, INT J PERIODONT REST, V30, P83
   Palmieri Annalisa, 2008, J Prosthodont, V17, P522, DOI 10.1111/j.1532-849X.2008.00331.x
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Qizhi C., 2012, PROG BIOMATER, V1, P1
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Rani V. V. Divya, 2009, NANOTECHNOLOGY, V19
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983
   Sahithi K, 2010, J BIOMED NANOTECHNOL, V6, P333, DOI 10.1166/jbn.2010.1138
   Sahithi K, 2010, INT J BIOL MACROMOL, V46, P281, DOI 10.1016/j.ijbiomac.2010.01.006
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Schade P., 2014, STEM CELLS INT, V2014
   Shi KK, 2013, BONE, V55, P487, DOI 10.1016/j.bone.2013.04.002
   Sowjanya JA, 2013, COLLOID SURFACE B, V109, P294, DOI 10.1016/j.colsurfb.2013.04.006
   Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200
   Suh JS, 2013, BIOMATERIALS, V34, P4347, DOI 10.1016/j.biomaterials.2013.02.039
   Sun K, 2011, EXPRESS POLYM LETT, V5, P342, DOI 10.3144/expresspolymlett.2011.34
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Tripathi A, 2012, INT J BIOL MACROMOL, V50, P294, DOI 10.1016/j.ijbiomac.2011.11.013
   Trompeter HI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-111
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Vimalraj S, 2014, J CELL PHYSIOL, V229, P1236, DOI 10.1002/jcp.24557
   Vimalraj S, 2014, INT J BIOL MACROMOL, V66, P194, DOI 10.1016/j.ijbiomac.2014.02.030
   Vimalraj S, 2013, DIS MARKERS, DOI 10.1155/2013/451248
   Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072266
   Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057
   Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c
   Yan C, 2011, BIOMATERIALS, V32, P6435, DOI 10.1016/j.biomaterials.2011.05.031
   Yan J, 2014, BIOMATERIALS, V35, P7734, DOI 10.1016/j.biomaterials.2014.05.089
   Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024
   Zhang JF, 2011, RNA BIOL, V8, P829, DOI 10.4161/rna.8.5.16043
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
   Zhou QA, 2011, BIOCHEM BIOPH RES CO, V404, P127, DOI 10.1016/j.bbrc.2010.11.079
NR 74
TC 22
Z9 25
U1 3
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR
PY 2015
VL 74
BP 404
EP 412
DI 10.1016/j.ijbiomac.2014.12.034
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CD7CO
UT WOS:000351248600053
PM 25543062
DA 2018-10-20
ER

PT J
AU Rey, R
   Nimmo, S
   Childs, GS
   Behar-Horenstein, LS
AF Rey, Rosalia
   Nimmo, Susan
   Childs, Gail S.
   Behar-Horenstein, Linda S.
TI Curriculum Time Compared to Clinical Procedures in Amalgam and Composite
   Posterior Restorations in US Dental Schools: A Preliminary Study
SO JOURNAL OF DENTAL EDUCATION
LA English
DT Article
DE dental education; clinical education; dental school clinics; general
   dentistry; operative dentistry; amalgam restorations; composite
   restorations
ID RESIN; PLACEMENT; LONGEVITY; DENTISTRY; FAILURE
AB Dental clinicians have an expanding range of biomaterial choices for restoring tooth structure. Scientific developments in cariology, advances in dental biomaterials, and patients' esthetic concerns have led to a reduction in amalgam restorations and an increase in composite restorations. The aim of this study was to compare teaching time with students' clinical procedures in amalgam and composite posterior restorations in dental schools across the United States. Academic deans in 60 schools were invited to complete a survey that asked for the amount of instructional time for amalgam and composite posterior restorations and the number of clinical restorations performed by their Classes of 2009, 2010, and 2011. Of these 60, 12 returned surveys with complete data, for a 20% response rate. Responses from these schools showed little change in lecture and preclinical laboratory instruction from 2009 to 2011. There was a slight increase in two-surface restorations for both amalgam and composites; however, the total number of reported composite and amalgam restorations remained the same. Of 204,864 restorations reported, 53% were composite, and 47% were amalgam. There were twice as many multisurface large or complex amalgam restorations as composites. One-surface composite restorations exceeded amalgams. Among the participating schools, there was little to no change between curriculum time and clinical procedures. Findings from this preliminary study reflect a modest increase in two-surface resin-based restorations placed by dental students from 2009 to 2011 and little change in curricular time devoted to teaching amalgam restorations. The total number of posterior composite restorations placed by students in these schools was slightly higher than amalgams.
C1 [Rey, Rosalia; Nimmo, Susan] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL 32610 USA.
   [Childs, Gail S.] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Curriculum & Instruct, Gainesville, FL 32610 USA.
   [Behar-Horenstein, Linda S.] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Gainesville, FL 32610 USA.
RP Rey, R (reprint author), Univ Florida, Coll Dent, Dept Restorat Dent Sci, 1395 Ctr Dr,Room D9-31, Gainesville, FL 32610 USA.
EM rrey@dental.ufl.edu
CR American Dental Association Council on Scientific Affairs, 2009, STAT DENT AM
   Ben-Gal G, 2011, J DENT EDUC, V75, P1590
   Commission on Dental Accreditation, 2013, ACCR STAND DENT ED P
   European Commission on Health and Consumer Protection, 2008, SCI OP SAF DENT AM A
   Gordan VV, 2011, J AM DENT ASSOC, V142, P842, DOI 10.14219/jada.archive.2011.0274
   Liew ZL, 2011, INT DENT J, V61, P12, DOI 10.1111/j.1875-595X.2011.00003.x
   Lynch CD, 2006, J AM DENT ASSOC, V137, P619, DOI 10.14219/jada.archive.2006.0257
   Lynch CD, 2006, J AM DENT ASSOC, V129, P1415
   Lynch CD, 2011, J AM DENT ASSOC, V142, P612, DOI 10.14219/jada.archive.2011.0243
   Mjor AM, 1998, J AM DENT ASSOC, V129, P1415
   Mjor IA, 2002, OPER DENT, V27, P528
   Murdoch-Kinch CA, 2003, J AM DENT ASSOC, V134, P87, DOI 10.14219/jada.archive.2003.0021
   Opdam NJM, 2010, J DENT RES, V89, P1063, DOI 10.1177/0022034510376071
   Ottenga ME, 2007, OPER DENT, V32, P524, DOI 10.2341/06-134
   Overton JD, 2012, J DENT EDUC, V76, P338
   Rosenstiel SF, 2004, J PROSTHET DENT, V91, P363, DOI 10.1016/j.prosdent.2004.02.004
   WILSON NHF, 1989, J DENT, V17, pS29, DOI 10.1016/0300-5712(89)90160-7
   Wilson NHF, 2004, J DENT, V32, P367, DOI 10.1016/j.jdent.2004.02.004
NR 18
TC 2
Z9 2
U1 0
U2 1
PU AMER DENTAL EDUCATION ASSOC-ADEA
PI WASHINGTON
PA 655 K STREET NW, SUITE 800, WASHINGTON, DC 20001 USA
SN 0022-0337
EI 1930-7837
J9 J DENT EDUC
JI J. Dent. Educ.
PD MAR
PY 2015
VL 79
IS 3
BP 331
EP 336
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CD7FA
UT WOS:000351255000012
PM 25729027
DA 2018-10-20
ER

PT J
AU Alhalawani, AMF
   Rodriguez, O
   Curran, DJ
   Co, R
   Kieran, S
   Arshad, S
   Keenan, TJ
   Wren, AW
   Crasto, G
   Peel, SAF
   Towler, MR
AF Alhalawani, Adel M. F.
   Rodriguez, Omar
   Curran, Declan J.
   Co, Russell
   Kieran, Sean
   Arshad, Saad
   Keenan, Timothy J.
   Wren, Anthony W.
   Crasto, Gazelle
   Peel, Sean A. F.
   Towler, Mark R.
TI A glass polyalkenoate cement carrier for bone morphogenetic proteins
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SUSTAINED-RELEASE; DELIVERY-SYSTEMS; SPINE FUSION; IN-VITRO; BMP-2;
   REGENERATION; BIOMATERIAL; ADSORPTION; INDUCTION; RHBMP-2
AB This work considers a glass polyalkenoate cement (GPC)-based carrier for the effective delivery of bone morphogenetic proteins (BMPs) at an implantation site. A 0.12 CaO-0.04 SrO-0.36 ZnO-0.48 SiO2 based glass and poly(acrylic acid) (PAA, Mw 213,000) were employed for the fabrication of the GPC. The media used for the water source in the GPC reaction was altered to produce a series of GPCs. The GPC liquid media was either 100 % distilled water with additions of albumin at 0, 2, 5 and 8 wt% of the glass content, 100 % formulation buffer (IFB), and 100 % BMP (150 mu g rhBMP-2/ml IFB). Rheological properties, compressive strength, ion release profiles and BMP release were evaluated. Working times (T-w) of the formulated GPCs significantly increased with the addition of 2 % albumin and remained constant with further increases in albumin content or IFB solutions. Setting time (T-s) experienced an increase with 2 and 5 % albumin content, but a decrease with 8 % albumin. Changing the liquid source to IFB containing 5 % albumin had no significant effect on T-s compared to the 8 % albumin-containing BT101. Replacing the albumin with IFB/BMP-2 did not significantly affect T-w. However, T-s increased for the BT101_BMP-2 containing GPCs, compared to all other samples. The compressive strength evaluated 1 day post cement mixing was not affected significantly by the incorporation of BMPs, but the ion release did increase from the cements, particularly for Zn and Sr. The GPCs released BMP after the first day, which decreased in content during the following 6 days. This study has proven that BMPs can be immobilized into GPCs and may result in novel materials for clinical applications.
C1 [Alhalawani, Adel M. F.; Rodriguez, Omar; Curran, Declan J.; Co, Russell; Kieran, Sean; Arshad, Saad; Towler, Mark R.] Ryerson Univ, Fac Engn & Architectural Sci, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Keenan, Timothy J.; Wren, Anthony W.] Alfred Univ, Inamori Sch Engn, New York, NY USA.
   [Crasto, Gazelle; Peel, Sean A. F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada.
   [Towler, Mark R.] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
RP Curran, DJ (reprint author), Ryerson Univ, Fac Engn & Architectural Sci, Dept Mech & Ind Engn, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM curran@ryerson.ca
OI Alhalawani, Adel/0000-0002-3374-3172; Curran, Declan/0000-0002-8626-1003
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   Engage Program [449,981-13]
FX The authors thank the Natural Sciences and Engineering Research Council
   of Canada (NSERC) Engage Program (Grant # 449,981-13) for facilitating
   this research.
CR Alhalawani AMF, 2013, J FUNCT BIOMATER, V4, P329, DOI 10.3390/jfb4040329
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   BOYAN BD, 1992, CLIN ORTHOP RELAT R, P286
   Boyd D, 2008, J MATER SCI-MATER M, V19, P1745, DOI 10.1007/s10856-007-3363-4
   Boyd D, 2008, J MATER SCI-MATER M, V19, P953, DOI 10.1007/s10856-006-0060-7
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   Chen S, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015005
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   Johnson MR, 2009, ACTA BIOMATER, V5, P23, DOI 10.1016/j.actbio.2008.09.001
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Lee KB, 2012, J ORTHOP RES, V30, P1985, DOI 10.1002/jor.22160
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Pneumaticos SG, 2010, J CELL MOL MED, V14, P2561, DOI 10.1111/j.1582-4934.2010.01062.x
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003
   Redweik S, 2013, ELECTROPHORESIS, V34, P1812, DOI 10.1002/elps.201300050
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seiya J, 2002, J ORTHOP SCI, V7, P490
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   URIST MR, 1983, P SOC EXP BIOL MED, V173, P194
   van de Weert M, 2000, PHARM RES, V17, P1159, DOI DOI 10.1023/A:1026498209874
   WILSON AD, 1970, J DENT RES, V49, P7, DOI 10.1177/00220345700490013301
   Wilson AD, 2005, ACID BASE CEMENTS TH
   Wren AW, 2013, J MATER SCI-MATER M, V24, P1167, DOI 10.1007/s10856-013-4880-y
   Wren AW, 2010, J MATER SCI, V45, P3554, DOI 10.1007/s10853-010-4398-3
   Wren A, 2008, J MATER SCI-MATER M, V19, P1737, DOI 10.1007/s10856-007-3287-z
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 46
TC 0
Z9 0
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 151
DI 10.1007/s10856-015-5494-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PA
UT WOS:000351582800005
PM 25773232
DA 2018-10-20
ER

PT J
AU Cai, MM
   Zhang, J
   Guan, LL
   Zhao, M
AF Cai, Mingming
   Zhang, Jie
   Guan, Lili
   Zhao, Min
TI Novel implantable composite biomaterial by fibrin glue and amniotic
   membrane for ocular surface reconstruction
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORNEAL PERFORATION; TRANSPLANTATION; THERAPY; BURNS; MANAGEMENT;
   EPITHELIUM; INJURIES; FIXATION; ADHESIVE; CLOSURE
AB Amniotic membrane transplantation (AMT) is considered a substantial treatment option in the management of ocular surface disorders. However, several inherent drawbacks still remain. The present study devised a novel implantable composite biomaterial of fibrin glue-double layer Amniotic membrane (AM) and evaluated the biomechanical properties and effects on corneal surface reconstruction in alkali-burned rabbit model. Biomechanic parameters were calculated by an electronic universal testing machine. Corneal alkali burning was done in the right eyes of thirty rabbits, which were randomized into three groups of ten animals each. The eyes in group 1 underwent fibrin glue-double layer AMT, the eyes in group 2 underwent ordinary single layer AMT, and the eyes in group 3 (control group) did not undergo any surgical procedure. Healing of corneal epithelial defect, extent of corneal vascularization and corneal clarity were assessed and compared at two time points. One month after surgery, animals were killed and the eyes were processed for histopathology. The fibrin glue-double layer AM composites had more ideal biomechanical properties. In fibrin glue-double layer AM group, the rate of epithelial healing, vascularization inhibition and corneal clarity was significantly better than the other two groups. Novel fibrin glue-double layer AMT with corneal alkali burns is more effective and useful for ocular surface reconstruction and has great potential applications.
C1 [Cai, Mingming; Zhao, Min] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing 400016, Peoples R China.
   [Cai, Mingming] Ninth Peoples Hosp Chongqing, Dept Ophthalmol, Chongqing 400700, Peoples R China.
   [Zhang, Jie] Ninth Peoples Hosp Chongqing, Dept Urol, Chongqing 400700, Peoples R China.
   [Guan, Lili] Chongqing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Chongqing 400016, Peoples R China.
RP Zhao, M (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing 400016, Peoples R China.
EM cqminzhao@126.com
FU Chongqing Science and Technology Committee (CSTC) [2008AC0086]; First
   Affiliated Hospital of Chongqing Medical University [YXJJ2009-09]
FX This study was supported by Grants from the Chongqing Science and
   Technology Committee (CSTC, 2008AC0086) and the First Affiliated
   Hospital of Chongqing Medical University (YXJJ2009-09). The authors
   thank Wenjun Zhou for providing technical assistance.
CR Baum J, 2002, CORNEA, V21, P339, DOI 10.1097/00003226-200205000-00001
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   Duchesne B, 2001, CORNEA, V20, P230, DOI 10.1097/00003226-200103000-00027
   Gatzioufas Z, 2012, AM J OPHTHALMOL, V153, P379, DOI 10.1016/j.ajo.2011.10.035
   Grau AE, 2012, CORNEA, V31, P98, DOI 10.1097/ICO.0b013e31821f28a2
   Ha HS, 2006, J KOREAN MED SCI, V21, P544, DOI 10.3346/jkms.2006.21.3.544
   Iakimenko SA, 2013, EUR J OPHTHALMOL, V23, P496, DOI 10.5301/ejo.5000243
   Kaufman HE, 2003, OPHTHALMOLOGY, V110, P2168, DOI 10.1016/S0161-6420(03)00832-7
   Kee C, 2002, AM J OPHTHALMOL, V133, P834, DOI 10.1016/S0002-9394(02)01415-0
   Kheirkhah A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1059, DOI 10.1001/archopht.126.8.1059
   Kheirkhah A, 2008, AM J OPHTHALMOL, V145, P787, DOI 10.1016/j.ajo.2008.01.009
   Kheirkhah A, 2013, CORNEA, V32, P155, DOI 10.1097/ICO.0b013e318247983d
   KIM JC, 1995, CORNEA, V14, P473
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   Le Nihouannen D, 2007, J MATER SCI-MATER M, V18, P225, DOI 10.1007/s10856-006-0684-7
   Liu T, 2012, MOL VIS, V18, P2137
   Mahdy RA, 2012, OPHTHALMIC RES, V47, P23, DOI 10.1159/000328629
   Martinez-de-la-Casa JM, 2013, ACTA OPHTHALMOL, V91, P425, DOI 10.1111/j.1755-3768.2012.02436.x
   MATSUDA H, 1973, ARCH OPHTHALMOL-CHIC, V89, P396
   Mohammadi AA, 2013, BURNS, V39, P1137, DOI 10.1016/j.burns.2013.01.017
   Nassiri N, 2011, ARCH OPHTHALMOL-CHIC, V129, P218, DOI 10.1001/archophthalmol.2010.370
   Nubile M, 2008, BRIT J OPHTHALMOL, V92, P54, DOI 10.1136/bjo.2007.123026
   ORMEROD LD, 1989, INVEST OPHTH VIS SCI, V30, P2148
   Pirouzian A, 2011, GRAEF ARCH CLIN EXP, V249, P261, DOI 10.1007/s00417-010-1499-2
   Shi WY, 2007, OPHTHALMOLOGY, V114, P1476, DOI 10.1016/j.ophtha.2006.11.027
   Sinha R, 2013, J CATARACT REFR SURG, V39, P1779, DOI 10.1016/j.jcrs.2013.08.037
   Solomon A, 2003, OPHTHALMOLOGY, V110, P93, DOI 10.1016/S0161-6420(02)01441-0
   Solomon A, 2002, OPHTHALMOLOGY, V109, P694, DOI 10.1016/S0161-6420(01)01032-6
   SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026
   Suri K, 2013, EYE CONTACT LENS, V39, P341, DOI 10.1097/ICL.0b013e3182a2f8fa
   Szurman P, 2006, CORNEA, V25, P460, DOI 10.1097/01.ico.0000183493.00884.8f
   Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022
   VANHERENDAEL BJ, 1978, AM J OBSTET GYNECOL, V131, P872, DOI 10.1016/S0002-9378(16)33135-0
   Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Woo HM, 2001, BRIT J OPHTHALMOL, V85, P345, DOI 10.1136/bjo.85.3.345
   Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2
   Yang MB, 2013, OPHTHALMOLOGY, V120, P1935, DOI 10.1016/j.ophtha.2013.05.008
NR 39
TC 0
Z9 0
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 149
DI 10.1007/s10856-015-5491-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CE1PA
UT WOS:000351582800003
PM 25764084
DA 2018-10-20
ER

PT J
AU Xing, H
   Ma, H
   Fu, Y
   Xue, M
   Zhang, X
   Dong, X
   Zhang, X
AF Xing, H.
   Ma, H.
   Fu, Y.
   Xue, M.
   Zhang, X.
   Dong, X.
   Zhang, X.
TI Preparation of g-C3N4/ZnO composites and their enhanced photocatalytic
   activity
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Photocatalysis; g-C3N4; ZnO; Reactive brilliant blue
ID VISIBLE-LIGHT IRRADIATION; GRAPHITE-LIKE C3N4; SURFACE MODIFICATION;
   NICKEL FERRITE; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; HOLLOW
   MICROSPHERES; BIOMATERIAL SYSTEM; ZNO NANOCRYSTALS; METHYL-ORANGE
AB In this manuscript, g-C3N4/ZnO composite photocatalysts with various loadings of g-C3N4 were synthesised by a facile thermal decomposition method. The obtained g-C3N4/ZnO composites were characterised by X-ray diffraction, SEM, photoluminescence spectroscopy, UV-vis and Xray photoelectron spectroscopy. It is discovered that the introduction of g-C3N4 did not change the morphology and crystal structure of g-C3N4/ZnO composites but enhanced their light absorption in the visible region and promoted the charge separation of photoexcitated electron-hole pairs. As compared to ZnO, the Zn2p peak of the g-C3N4/ZnO composite showed an obvious shift to higher binding energy, implying the existence of a synergistic effect between g-C3N4 and ZnO. Furthermore, the introduction of g-C3N4 also increased the amount of hydroxyl groups where the surface hydroxyl groups can be trapped in the photogenerated holes to form hydroxyl radicals, and improved the photocatalytic efficiency. The photodegradation of reactive brilliant blue (KN-R) showed that the g-C3N4/ZnO composites possess better photocatalytic activity than that of g-C3N4 and ZnO under sunlight irradiation.
C1 [Xing, H.; Ma, H.; Fu, Y.; Xue, M.; Zhang, X.; Dong, X.; Zhang, X.] Dalian Polytech Univ, Sch Light Ind & Chem Engn, Dalian 116034, Liaoning, Peoples R China.
RP Ma, H (reprint author), Dalian Polytech Univ, Sch Light Ind & Chem Engn, 1 Qinggongyuan, Dalian 116034, Liaoning, Peoples R China.
EM m-h-c@sohu.com; dongxl@dlpu.edu.cn
FU National Natural Science Foundation of China [21243005, 21476033];
   Science and Technology Foundation of Liaoning of China [201102111];
   Program for Key Science and Technology Platform in Universities of
   Liaoning Province; Program for Liaoning Excellent Talents in University
   [LR2014013]; Science and Technology Public-Benefit Foundation of
   Liaoning of China [[2011] 49]
FX This study was supported by the National Natural Science Foundation of
   China (grant no. 21243005, 21476033), the Science and Technology
   Foundation of Liaoning of China (grant no. 201102111), the Program for
   Key Science and Technology Platform in Universities of Liaoning
   Province, the Program for Liaoning Excellent Talents in University
   (grant no. LR2014013), and the Science and Technology Public-Benefit
   Foundation of Liaoning of China (grant no. [2011] 49).
CR Ayoub K, 2010, J HAZARD MATER, V178, P10, DOI 10.1016/j.jhazmat.2010.02.042
   Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936
   Bai HW, 2011, PHYS CHEM CHEM PHYS, V13, P6205, DOI 10.1039/c0cp02546a
   Chen CQ, 2011, DALTON T, V40, P9566, DOI 10.1039/c1dt10799b
   Chen JS, 2011, NANOSCALE, V3, P2158, DOI 10.1039/c1nr10162e
   Chen SF, 2006, MATER CHEM PHYS, V98, P116, DOI 10.1016/j.matchemphys.2005.08.073
   Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039
   FRANK SN, 1977, J AM CHEM SOC, V99, P303, DOI 10.1021/ja00443a081
   Futsuhara M, 1998, THIN SOLID FILMS, V322, P274, DOI 10.1016/S0040-6090(97)00910-3
   Ge L, 2011, APPL CATAL B-ENVIRON, V108, P100, DOI 10.1016/j.apcatb.2011.08.014
   Ge L, 2011, MATER LETT, V65, P2652, DOI 10.1016/j.matlet.2011.05.069
   Gopinath CS, 2002, MATER RES BULL, V37, P1323, DOI 10.1016/S0025-5408(02)00763-8
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Hong RY, 2009, POWDER TECHNOL, V189, P426, DOI 10.1016/j.powtec.2008.07.004
   Huang LY, 2013, DALTON T, V42, P8606, DOI 10.1039/c3dt00115f
   Izaki M, 2007, J PHYS D APPL PHYS, V40, P3326, DOI 10.1088/0022-3727/40/11/010
   Jing LQ, 2004, J SOLID STATE CHEM, V177, P4221, DOI 10.1016/j.jssc.2004.08.016
   Kumar S, 2013, J MATER CHEM A, V1, P5333, DOI 10.1039/c3ta00186e
   Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4
   Liu W, 2012, CHEM ENG J, V209, P386, DOI 10.1016/j.cej.2012.08.033
   Lu WW, 2008, J PHYS CHEM C, V112, P16792, DOI 10.1021/jp803654k
   Mills A., 1997, J PHOTOCH PHOTOBIO A, V8A, P11
   Morales-Flores N, 2011, APPL CATAL A-GEN, V394, P269, DOI 10.1016/j.apcata.2011.01.011
   Norberg NS, 2005, J PHYS CHEM B, V109, P20810, DOI 10.1021/jp0535285
   Qin HC, 2011, ACS APPL MATER INTER, V3, P3152, DOI 10.1021/am200655h
   Qiu XQ, 2008, J PHYS CHEM C, V112, P12242, DOI 10.1021/jp803129e
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Ruankham P, 2011, J PHYS CHEM C, V115, P23809, DOI 10.1021/jp204325y
   Sun JX, 2012, DALTON T, V41, P6756, DOI 10.1039/c2dt12474b
   Takanabe K, 2010, PHYS CHEM CHEM PHYS, V12, P13020, DOI 10.1039/c0cp00611d
   Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f
   Udawatte N, 2011, ACS APPL MATER INTER, V3, P4531, DOI 10.1021/am201221x
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]
   Wang YJ, 2012, J MATER CHEM, V22, P11568, DOI 10.1039/c2jm16873a
   Wang YJ, 2011, ENERG ENVIRON SCI, V4, P2922, DOI 10.1039/c0ee00825g
   Wu YL, 2007, APPL SURF SCI, V253, P5473, DOI 10.1016/j.apsusc.2006.12.091
   Xiang QJ, 2011, J PHYS CHEM C, V115, P7355, DOI 10.1021/jp200953k
   Xu HY, 2005, APPL PHYS B-LASERS O, V80, P871, DOI 10.1007/s00340-005-1790-9
   Xu XX, 2011, INT J HYDROGEN ENERG, V36, P13501, DOI 10.1016/j.ijhydene.2011.08.052
   Yan HJ, 2011, J ALLOY COMPD, V509, pL26, DOI 10.1016/j.jallcom.2010.09.201
   Yan SC, 2010, DALTON T, V39, P1488, DOI 10.1039/b914110c
   Yan SC, 2010, LANGMUIR, V26, P3894, DOI 10.1021/la904023j
   Yan SC, 2009, LANGMUIR, V25, P10397, DOI 10.1021/la900923z
   Ye LQ, 2013, APPL CATAL B-ENVIRON, V142, P1, DOI 10.1016/j.apcatb.2013.04.058
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhang Y, 2007, SCRIPTA MATER, V57, P313, DOI 10.1016/j.scriptamat.2007.04.028
   Zhou XS, 2011, CHEM COMMUN, V47, P10323, DOI 10.1039/c1cc13862f
NR 54
TC 7
Z9 7
U1 7
U2 139
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAR
PY 2015
VL 30
IS 2
BP 122
EP 127
DI 10.1179/1753555714Y.0000000216
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5KK
UT WOS:000351126300010
DA 2018-10-20
ER

PT J
AU Dou, Y
   Zhang, BN
   He, M
   Yin, GQ
   Cui, YD
   Savina, IN
AF Dou, Yao
   Zhang, Buning
   He, Ming
   Yin, Guoqiang
   Cui, Yingde
   Savina, Irina N.
TI Keratin/Polyvinyl Alcohol Blend Films Cross-Linked by Dialdehyde Starch
   and Their Potential Application for Drug Release
SO POLYMERS
LA English
DT Article
ID WATER-VAPOR PERMEABILITY; FEATHER KERATIN FILMS; POLY(VINYL ALCOHOL);
   PHYSICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   TENSILE PROPERTIES; COMPOSITE FILMS; PROTEIN; GELATIN
AB Feather keratin (FK) extracted from feathers represents a valuable source of biodegradable and biocompatible polymer. The aim of this study was the development and characterization of blended films based on FK and polyvinyl alcohol (PVA) cross-linked by dialdehyde starch (DAS) for a potential drug release application. The compatibility of FK/PVA was improved when cross-linked by DAS: the relative crystallinity of the PVA/FK film slightly decreased, and the enthalpy value for the melting peak decreased by about 50% for the cross-linked films. The total soluble mass of all blend films in water was below 35% at 37 degrees C, indicating a good stability of the films in water. The results of the Rhodamine B dye (as a model drug) release tests showed that the release rates decreased with increasing DAS content. DAS-induced cross-linking improves several important properties of the FK/PVA films, such as the compactness, the compatibility, and the stability in water. These improvements offer the potential to expand the application of FK films in the biomaterial field.
C1 [Dou, Yao; He, Ming; Cui, Yingde] Northwestern Polytech Univ, Sch Mat Sci & Engn, Xian 710072, Shanxi, Peoples R China.
   [Zhang, Buning; Yin, Guoqiang] Zhongkai Univ Agr & Engn, Green Chem Engn Inst, Guangzhou 510225, Guangdong, Peoples R China.
   [Cui, Yingde] Guangzhou Vocat Coll Sci & Technol, Guangzhou 510550, Guangdong, Peoples R China.
   [Savina, Irina N.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Yin, GQ (reprint author), Zhongkai Univ Agr & Engn, Green Chem Engn Inst, Guangzhou 510225, Guangdong, Peoples R China.
EM douyao1019@aliyun.com; eins001@163.com; heming1026@163.com;
   yingq007@163.com; 13602880087@139.com; I.N.Savina@brighton.ac.uk
FU National Natural Science Foundation of China [21176269]; EU
   FP7-PEOPLE-IRSES project ABREM [247599]; Higher School Science and
   Technology Innovation Project of Guangdong Province [2013KJCX0102];
   Science and Technology Plan Project of Guangdong Province
   [2013B010403029]
FX This work was supported by the National Natural Science Foundation of
   China (21176269) and the EU FP7-PEOPLE-2009-IRSES project ABREM
   (247599). Furthermore, the support from the Higher School Science and
   Technology Innovation Project of Guangdong Province (2013KJCX0102) and
   the Science and Technology Plan Project of Guangdong Province
   (2013B010403029) is also acknowledged.
CR Akhlaghi S, 2012, POLYM INT, V61, P646, DOI 10.1002/pi.3227
   Aluigi A, 2008, COMPOS PART A-APPL S, V39, P126, DOI 10.1016/j.compositesa.2007.08.022
   Alves PMA, 2011, FOOD HYDROCOLLOID, V25, P1751, DOI 10.1016/j.foodhyd.2011.03.018
   Barone JR, 2006, J CHEM EDUC, V83, P1003, DOI 10.1021/ed083p1003
   Bertini F, 2013, POLYM DEGRAD STABIL, V98, P980, DOI 10.1016/j.polymdegradstab.2013.02.011
   Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   Dou Y, 2014, J MACROMOL SCI A, V51, P1009, DOI 10.1080/10601325.2014.967108
   Elizondo NJ, 2009, CARBOHYD POLYM, V75, P592, DOI 10.1016/j.carbpol.2008.08.020
   Figueiredo KCS, 2009, J APPL POLYM SCI, V111, P3074, DOI 10.1002/app.29263
   Flores-Hernandez CG, 2014, POLYMERS-BASEL, V6, P686, DOI 10.3390/polym6030686
   Hernandez-Munoz P, 2004, FOOD HYDROCOLLOID, V18, P403, DOI 10.1016/S0268-005X(03)00128-0
   Jin EQ, 2011, J AGR FOOD CHEM, V59, P1729, DOI 10.1021/jf1039519
   Kavitha A, 2005, J MACROMOL SCI PURE, VA42, P1703, DOI 10.1080/10601320500247154
   Kundu B, 2014, INT J BIOL MACROMOL, V70, P70, DOI 10.1016/j.ijbiomac.2014.06.022
   Langmaler F, 2008, WASTE MANAGE, V28, P549, DOI 10.1016/j.wasman.2007.02.003
   Lasekan A, 2013, WASTE MANAGE, V33, P552, DOI 10.1016/j.wasman.2012.08.001
   Limpan N, 2010, J FOOD ENG, V100, P85, DOI 10.1016/j.jfoodeng.2010.03.031
   Martelli SM, 2006, J POLYM ENVIRON, V14, P215, DOI 10.1007/s10924-006-0017-4
   Martucci JF, 2009, J APPL POLYM SCI, V112, P2166, DOI 10.1002/app.29695
   Mokrejs P, 2009, J THERM ANAL CALORIM, V98, P299, DOI 10.1007/s10973-009-0106-4
   Nakano Y, 2007, MACROMOL SYMP, V258, P63, DOI 10.1002/masy.200751208
   Park M, 2013, MAT SCI ENG C-MATER, V33, P5051, DOI 10.1016/j.msec.2013.08.032
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Pereda M, 2010, J APPL POLYM SCI, V116, P18, DOI 10.1002/app.31425
   Moore GR, 2006, FOOD HYDROCOLLOID, V20, P975, DOI 10.1016/j.foodhyd.2005.11.001
   Prasong Srihanam, 2011, Pak J Biol Sci, V14, P351
   Ramos OL, 2013, FOOD HYDROCOLLOID, V30, P110, DOI 10.1016/j.foodhyd.2012.05.001
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Song NB, 2013, FOOD HYDROCOLLOID, V31, P340, DOI 10.1016/j.foodhyd.2012.11.024
   Su JF, 2010, POLYM DEGRAD STABIL, V95, P1226, DOI 10.1016/j.polymdegradstab.2010.03.035
   Subramanian UM, 2014, INT J POLYM MATER PO, V63, P462, DOI 10.1080/00914037.2013.854216
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tian-Yu Ke, 2013, Advanced Materials Research, V647, P190, DOI 10.4028/www.scientific.net/AMR.647.190
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   Ustunol Z, 2004, J FOOD SCI, V69, pE129
   van den Berg LE, 2009, MAT SCI, V2, P171
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Ye M, 2014, MAT SCI ENG C-MATER, V44, P310, DOI 10.1016/j.msec.2014.08.044
NR 40
TC 11
Z9 12
U1 0
U2 57
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD MAR
PY 2015
VL 7
IS 3
BP 580
EP 591
DI 10.3390/polym7030580
PG 12
WC Polymer Science
SC Polymer Science
GA CE5JM
UT WOS:000351868600010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Patra, C
   Boccaccini, AR
   Engel, FB
AF Patra, Chinmoy
   Boccaccini, Aldo R.
   Engel, Felix B.
TI Vascularisation for cardiac tissue engineering: the extracellular matrix
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE Heart; vascularisation; coronary vasculature; tissue engineering;
   extracellular matrix
ID SMOOTH-MUSCLE-CELLS; ZEBRAFISH HEART REGENERATION; PLURIPOTENT
   STEM-CELLS; BLOOD-VESSEL FORMATION; ACUTE MYOCARDIAL-INFARCTION;
   CORONARY-ARTERY-DISEASE; POROUS SILK SCAFFOLDS; ALPHA-GAL EPITOPE;
   IN-VITRO; ENDOTHELIAL-CELLS
AB Cardiovascular diseases present a major socio-economic burden. One major problem underlying most cardiovascular and congenital heart diseases is the irreversible loss of contractile heart muscle cells, the cardiomyocytes. To reverse damage incurred by myocardial infarction or by surgical correction of cardiac malformations, the loss of cardiac tissue with a thickness of a few millimetres needs to be compensated. A promising approach to this issue is cardiac tissue engineering. In this review we focus on the problem of in vitro vascularisation as implantation of cardiac patches consisting of more than three layers of cardiomyocytes (>100 mu m thick) already results in necrosis. We explain the need for vascularisation and elaborate on the importance to include non-myocytes in order to generate functional vascularised cardiac tissue. We discuss the potential of extracellular matrix molecules in promoting vascularisation and introduce nephronectin as an, example of a new promising candidate. Finally, we discuss current biomaterial-based approaches including micropatterning, electrospinning, 3D micro-manufacturing technology and porogens. Collectively, the current literature supports the notion that cardiac tissue engineering is a realistic option for future treatment of paediatric and adult patients with cardiac disease.
C1 [Patra, Chinmoy] Agharkar Res Inst, Dept Zool, Pune, Maharashtra, India.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany.
   [Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Expt Renal & Cardiovasc Res, D-91054 Erlangen, Germany.
RP Engel, FB (reprint author), Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Univ Str 22, D-91054 Erlangen, Germany.
EM felix.engel@uk-erlangen.de
RI Engel, Felix/A-1767-2008; Boccaccini, Aldo/C-7905-2013
OI Engel, Felix/0000-0003-2605-3429; 
FU ELAN Program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg
FX This work was supported by the ELAN Program of the
   Friedrich-Alexander-Universitat Erlangen-Nurnberg (to F.B.E.).
CR Acarturk TO, 2004, ANN PLAS SURG, V53, P210, DOI 10.1097/01.sap.0000116285.98328.f7
   Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005
   AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223
   Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898
   APPLEBY P, 1994, LANCET, V343, P311
   Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049
   Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.11.010305.104258
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atluri P, 2013, CIRCULATION, V128, pS95, DOI 10.1161/CIRCULATIONAHA.112.000368
   Aubin Hug, 2013, Methods Mol Biol, V1036, P163, DOI 10.1007/978-1-62703-511-8_14
   Aupecle B, 2002, ANN THORAC SURG, V74, P127, DOI 10.1016/S0003-4975(02)03639-1
   Aydin S, 2013, CARDIOVASCULAR SYSTE, V2, P612
   Babiarz JE, 2012, STEM CELLS DEV, V21, P1956, DOI 10.1089/scd.2011.0357
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Beier JP, 2009, MICROSURG, V29, P42, DOI 10.1002/micr.20564
   Bellon G, 2004, CRIT REV ONCOL HEMAT, V49, P203, DOI 10.1016/j.critrevonc.2003.10.004
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bian WN, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024109
   Boffito M, 2014, POLYM INT, V63, P2, DOI 10.1002/pi.4608
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Boukens BJD, 2009, CIRC RES, V104, P19, DOI 10.1161/CIRCRESAHA.108.188698
   Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069
   Braunwald E, 2000, CIRCULATION, V102, P14
   Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2
   Brizzio ME, 2011, REV CARDIOVASC MED, V12, pS40, DOI 10.3909/ricm12S1S0005
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Buja LM, 2013, TEX HEART I J, V40, P221
   Busch R, 2014, ACTA BIOMATER, V10, P688, DOI 10.1016/j.actbio.2013.10.015
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Byrne GW, 2012, CURR OPIN ORGAN TRAN, V17, P148, DOI 10.1097/MOT.0b013e3283509120
   Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Cao JN, 2014, PROTEIN CELL, V5, P1, DOI 10.1007/s13238-013-0003-2
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Ciubotaru A, 2013, BIOMED ENG-BIOMED TE, V58, P389, DOI 10.1515/bmt-2012-0148
   Ciucurel EC, 2014, TISSUE ENG PT A, V20, P1235, DOI [10.1089/ten.tea.2013.0242, 10.1089/ten.TEA.2013.0242]
   Coghlan H C, 2001, Semin Thorac Cardiovasc Surg, V13, P333
   Couzin-Frankel J, 2014, SCIENCE, V345, P252, DOI 10.1126/science.345.6194.252
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   Davies JE, 2007, NAT CLIN PRACT CARD, V4, P330, DOI 10.1038/ncpcardio0885
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693
   Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854
   DiNardo JA, 2013, SEMIN CARDIOTHORAC V, V17, P44, DOI 10.1177/1089253212469841
   Dolati F, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145101
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvorakova MC, 2008, NEUROSCIENCE, V151, P1016, DOI 10.1016/j.neuroscience.2007.07.069
   Echeverri D, 2013, J INVASIVE CARDIOL, V25, P98
   Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010
   Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005
   Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x
   Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Eschenhagen T, 2012, AM J PHYSIOL-HEART C, V303, pH133, DOI 10.1152/ajpheart.00007.2012
   Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018
   Faulk DM, 2014, J CELL PHYSIOL, V229, P984, DOI 10.1002/jcp.24532
   FEIGL EO, 1983, PHYSIOL REV, V63, P1
   Feinstein JA, 2012, J AM COLL CARDIOL, V59, pS1, DOI 10.1016/j.jacc.2011.09.022
   Ferrari R, 2014, EUR HEART J, V35, P2140, DOI 10.1093/eurheartj/ehu244
   Ferreira R, 2010, REV PORT CARDIOL, V29, P1037
   Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003
   Frati C, 2011, CURR PHARM DESIGN, V17, P3252
   Fu XM, 2014, CELL MOL IMMUNOL, V11, P14, DOI 10.1038/cmi.2013.60
   Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086
   Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002
   Garkavenko O, 2008, J MED VIROL, V80, P2046, DOI 10.1002/jmv.21272
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129
   Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5
   GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324
   Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006
   Guo C, 2013, CURR GENE THER, V13, P133, DOI 10.2174/1566523211313020007
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   HARNARAYAN C, 1970, BRIT HEART J, V32, P728
   HASENFUSS G, 1991, CIRC RES, V68, P836, DOI 10.1161/01.RES.68.3.836
   Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Higuchi K, 2000, ARCH HISTOL CYTOL, V63, P115, DOI 10.1679/aohc.63.115
   Hinek A, 1996, BIOL CHEM, V377, P471
   Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hiura H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-32
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hoogaars WMH, 2007, CELL MOL LIFE SCI, V64, P646, DOI 10.1007/s00018-007-6518-z
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kalfa D, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10119
   Kaminsky SM, 2013, HUM GENE THER, V24, P948, DOI 10.1089/hum.2013.2516
   Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042
   Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Keane TJ, 2014, J TISSUE ENG REGEN M, V14
   Kemeny SF, 2013, J CELL PHYSIOL, V228, P1727, DOI 10.1002/jcp.24313
   Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349
   Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010
   Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004
   Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107
   Kim S, 2008, TISSUE ENG PART B-RE, V14, P133, DOI 10.1089/teb.2007.0304
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   KORECKY B, 1982, CAN J PHYSIOL PHARM, V60, P23, DOI 10.1139/y82-003
   Krieger EV, 2014, HEART, V100, P1329, DOI 10.1136/heartjnl-2014-305667
   Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619
   Langone AJ, 2003, NEW ENGL J MED, V349, P704, DOI 10.1056/NEJMe038117
   Lavine KJ, 2007, TRENDS CARDIOVAS MED, V17, P77, DOI 10.1016/j.tcm.2007.01.002
   Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239
   Le Gloan L, 2013, EXPERT REV CARDIOVAS, V11, P233, DOI [10.1586/erc.12.170, 10.1586/ERC.12.170]
   Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358
   Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Longnus SL, 2014, NAT REV CARDIOL, V11, P354, DOI 10.1038/nrcardio.2014.45
   Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307
   Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mammadov R, 2011, BIOMACROMOLECULES, V12, P3508, DOI 10.1021/bm200957s
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Martin-Puig S, 2012, ANN NY ACAD SCI, V1254, P71, DOI 10.1111/j.1749-6632.2012.06488.x
   Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705
   Matsa E, 2014, CIRC RES, V114, P21, DOI 10.1161/CIRCRESAHA.113.302895
   Matsuda K, 2013, TISSUE ENG PT A, V19, P1327, DOI [10.1089/ten.tea.2012.0391, 10.1089/ten.TEA.2012.0391]
   Matsuura K, 2014, INT HEART J, V55, P1
   Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.teb.2012.0577, 10.1089/ten.TEB.2012.0577]
   Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007
   Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   MULVANY MJ, 1990, PHYSIOL REV, V70, P921
   Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679
   Naso F, 2012, XENOTRANSPLANTATION, V19, P215, DOI 10.1111/j.1399-3089.2012.00714.x
   Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005
   Neethling WML, 2013, INTERACT CARDIOV TH, V17, P698, DOI 10.1093/icvts/ivt268
   Neumann A, 2014, TISSUE ENG PT A, V20, P1003, DOI [10.1089/ten.tea.2013.0316, 10.1089/ten.TEA.2013.0316]
   Neve A, 2014, BIOMED RES INT, DOI 10.1155/2014/756078
   Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393
   Nikolic I, 2013, BLOOD, V121, P3041, DOI 10.1182/blood-2011-11-394882
   Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4
   Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047
   Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pagliari S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00210
   Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829
   Panaro F, 2014, J GASTROINTEST SURG, V18, P1518, DOI 10.1007/s11605-014-2484-6
   Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003
   Park H, 2014, STEM CELL TRANSL MED, V3, P599, DOI 10.5966/sctm.2013-0149
   Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Patra C, 2012, BIOMATERIALS, V33, P4327, DOI 10.1016/j.biomaterials.2012.03.021
   Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454
   Pauziene N, 2000, J ANAT, V197, P437, DOI 10.1046/j.1469-7580.2000.19730437.x
   Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016
   Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a
   Picascia A, 2012, EXP CLIN TRANSPLANT, V10, P209, DOI 10.6002/ect.2011.0185
   Pincott ES, 2012, FUTUR CARDIOL, V8, P161, DOI [10.2217/fca.12.13, 10.2217/FCA.12.13]
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708
   Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Pozzi Ambra, 1998, Journal of Cell Biology, V142, P587, DOI 10.1083/jcb.142.2.587
   Pries A. R., 2006, V176, P1
   Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38
   Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533
   Ratajska A, 2008, INT J DEV BIOL, V52, P229, DOI 10.1387/ijdb.072340ar
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Reffelmann T, 2003, HEART FAIL REV, V8, P201, DOI 10.1023/A:1024796912475
   Risau W, 1998, Kidney Int Suppl, V67, pS3
   Rizzoni D, 2009, BLOOD PRESSURE, V18, P242, DOI 10.1080/08037050903254923
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rotenberg MY, 2012, LAB CHIP, V12, P2696, DOI [10.1039/c2lc40144d, 10.1039/c21c40144d]
   Sage H., 1982, PATHOBIOLOGY ENDOTHE, P215
   Samples J, 2013, SURG ONCOL CLIN N AM, V22, P629, DOI 10.1016/j.soc.2013.06.002
   Satchell S, 2013, NAT REV NEPHROL, V9, P717, DOI 10.1038/nrneph.2013.197
   Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004
   Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602
   Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3
   Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005
   Seifert AW, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-2
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   Servick K, 2014, SCIENCE, V345, P254, DOI 10.1126/science.345.6194.254
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps
   Sluijter JPG, 2014, PHARMACOL THERAPEUT, V144, P60, DOI 10.1016/j.pharmthera.2014.05.005
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200
   Suzuki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039562
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takebe T, 2012, TRANSPL P, V44, P1130, DOI 10.1016/j.transproceed.2012.03.039
   Taylor DO, 2008, J HEART LUNG TRANSPL, V27, P943, DOI 10.1016/j.healun.2008.06.017
   Tee R, 2012, TISSUE ENG PT A, V18, P1992, DOI [10.1089/ten.tea.2012.0151, 10.1089/ten.TEA.2012.0151]
   Tian T, 2014, ATHEROSCLEROSIS, V233, P485, DOI 10.1016/j.atherosclerosis.2014.01.027
   Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83
   Tiburcy M, 2011, CIRC RES, V109, P1105, DOI 10.1161/CIRCRESAHA.111.251843
   Tiruvannamalai-Annamalai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084287
   Tonsho M, 2014, COLD SPRING HARB PER
   Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212
   Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Xu J, 2014, BIOCH BIOPHYS ACTA
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang W, 2013, FEBS LETT, V587, P185, DOI 10.1016/j.febslet.2012.11.023
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Yang YK, 2002, J APPL PHYSIOL, V93, P1140, DOI 10.1152/japplphysiol.00307.2002
   Yasui H, 2014, BIOMATERIALS, V35, P7839, DOI 10.1016/j.biomaterials.2014.05.080
   Yoo S. Y, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/127170
   Zebrowski DC, 2013, REV PHYSIOL BIOCH P, V165, P67, DOI 10.1007/112_2013_12
   Zeng QC, 2013, INT HEART J, V54, P40, DOI 10.1536/ihj.54.40
   Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809
   Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75
   Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
   Zieber L, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024102
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6
NR 269
TC 10
Z9 10
U1 1
U2 53
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD MAR
PY 2015
VL 113
IS 3
BP 532
EP 547
DI 10.1160/TH14-05-0480
PG 16
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CD3ZZ
UT WOS:000351023700012
PM 25319066
DA 2018-10-20
ER

PT J
AU Wang, Q
   Zhang, H
   Li, QJ
   Ye, L
   Gan, HQ
   Liu, YJ
   Wang, H
   Wang, ZQ
AF Wang, Qian
   Zhang, Hui
   Li, Qijia
   Ye, Lei
   Gan, Hongquan
   Liu, Yingjie
   Wang, Hui
   Wang, Zhiqiang
TI Biocompatibility and osteogenic properties of porous tantalum
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE porous tantalum; osteogenesis; biocompatibility; cell toxicity; bone
   tissue engineering
ID MECHANICAL-PROPERTIES; METAL IMPLANTS; TITANIUM; PROLIFERATION;
   BIOMATERIAL; SURFACES
AB Porous tantalum has been reported to be a promising material for use in bone tissue engineering. In the present study, the biocompatibility and osteogenic properties of porous tantalum were studied in vitro and in vivo. The morphology of porous tantalum was observed using scanning electron microscopy (SEM). Osteoblasts were cultured with porous tantalum, and cell morphology, adhesion and proliferation were investigated using optical microscopy and SEM. In addition, porous tantalum rods were implanted in rabbits, and osteogenesis was observed using laser scanning confocal microscopy and hard tissue slice examination. The osteoblasts were observed to proliferate over time and adhere to the tantalum surface and pore walls, exhibiting a variety of shapes and intercellular connections. The porous tantalum rod connected tightly with the host bone. At weeks 2 and 4 following implantation, new bone and small blood vessels were observed at the tantalum-host bone interface and pores. At week 10 after the porous tantalum implantation, new bone tissue was observed at the tantalum-host bone interface and pores. By week 12, the tantalum-host bone interface and pores were covered with new bone tissue and the bone trabeculae had matured and connected directly with the materials. Therefore, the results of the present study indicate that porous tantalum is non-toxic, biocompatible and a promising material for use in bone tissue engineering applications.
C1 [Wang, Qian; Zhang, Hui; Wang, Hui] Southern Med Univ, Grad Sch, Guangzhou 510515, Guangdong, Peoples R China.
   [Wang, Qian] Hebei United Univ, Basic Med Coll, Dept Anat, Tangshan 063000, Hebei, Peoples R China.
   [Zhang, Hui] Second Hosp Tangshan, Dept Joint Surg, Tangshan 063000, Hebei, Peoples R China.
   [Li, Qijia] Hebei United Univ, Expt Ctr, Tangshan 063000, Hebei, Peoples R China.
   [Ye, Lei] Chongqing Runze Pharmaceut Co Ltd, Chongqing 401120, Peoples R China.
   [Gan, Hongquan; Liu, Yingjie; Wang, Zhiqiang] Hebei United Univ, Dept Orthoped, Affiliated Hosp, Tangshan 063000, Hebei, Peoples R China.
   [Wang, Hui] Second Hosp Tangshan, Dept Hand Surg, Tangshan 063000, Hebei, Peoples R China.
RP Wang, ZQ (reprint author), Hebei United Univ, Dept Orthoped, Affiliated Hosp, 73 Jianshe Rd, Tangshan 063000, Hebei, Peoples R China.
EM wzhqde@126.com
CR [Anonymous], 2009, 109935 ISO
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Cardaropoli F, 2012, ADV MATER RES-SWITZ, V535-537, P1222, DOI 10.4028/www.scientific.net/AMR.535-537.1222
   Christie Michael J, 2002, Am J Orthop (Belle Mead NJ), V31, P219
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Hacking SA, 1999, CLIN ORTHOP RELAT R, P240
   Jonitz A, 2011, J MATER SCI-MATER M, V22, P2089, DOI 10.1007/s10856-011-4384-6
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li Y, 2008, SURF COAT TECH, V202, P3017, DOI 10.1016/j.surfcoat.2007.11.003
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mrosek EH, 2010, J ORTHOP RES, V28, P141, DOI 10.1002/jor.20983
   Pohler O. E., 2000, INJURY S4, V1, P7
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Wang N, 2012, ACS APPL MATER INTER, V4, P4516, DOI 10.1021/am300727v
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
NR 25
TC 14
Z9 17
U1 2
U2 23
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD MAR
PY 2015
VL 9
IS 3
BP 780
EP 786
DI 10.3892/etm.2015.2208
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CD2OC
UT WOS:000350917900021
OA Green Published
DA 2018-10-20
ER

PT J
AU Notodihardjo, PV
   Morimoto, N
   Kakudo, N
   Matsui, M
   Sakamoto, M
   Liem, PH
   Suzuki, K
   Tabata, Y
   Kusumoto, K
AF Notodihardjo, Priscilla Valentin
   Morimoto, Naoki
   Kakudo, Natsuko
   Matsui, Makoto
   Sakamoto, Michiharu
   Liem, Pham Hieu
   Suzuki, Kenji
   Tabata, Yasuhiko
   Kusumoto, Kenji
TI Gelatin hydrogel impregnated with platelet-rich plasma releasate
   promotes angiogenesis and wound healing in murine model
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Platelet-rich plasma; Biomaterial; Gelatin hydrogel; Growth factors;
   Wound healing
ID FIBROBLAST-GROWTH-FACTOR; BONE REGENERATION; SCAFFOLD; DEFECTS; CELLS
AB Platelet-rich plasma (PRP) contains numerous growth factors to promote wound healing and angiogenesis. The objective of this study was to explore the efficacy of biodegradable gelatin hydrogel impregnated with PRP releasate (PRPr) in the wound healing process compared with the single application of PRPr prepared from mouse PRP centrifuged by a double-spin method. Gelatin hydrogel disks with an isoelectric point of 5.0 were used in this study. A total of 180 mice (n = 45/group) were randomly assigned to the following 4 experimental groups: control group, biodegradable gelatin hydrogel group, PRPr group and gelatin hydrogel impregnated with PRPr (PRPrG) group. Wound area and epithelialization were compared on days 1, 5, 7, 14 and 21 post-wounding. After complete epithelialization, wound contraction was also evaluated. Neovascularization using immunohistochemical staining of von Willebrand factor was analyzed on day 14. The wound area of PRPrG on days 5, 7 and 14 was smaller than that in the other groups (p < 0.01). The epithelialization lengths of PRPrG on days 7 and 14 were significantly longer than the others (p < 0.01). The capillary formation of PRPrG was also superior to those in all other groups on day 14. On day 21, all wounds were completely epithelialized and PRPrG prevented wound contraction the most. It is concluded that the sustained-release system of gelatin impregnated with PRPr can stimulate angiogenesis and accelerate wound healing compared with the single application of PRP.
C1 [Notodihardjo, Priscilla Valentin; Morimoto, Naoki; Kakudo, Natsuko; Suzuki, Kenji; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka 5731010, Japan.
   [Matsui, Makoto; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Field Tissue Engn, Inst Frontier Med Sci, Kyoto, Japan.
   [Sakamoto, Michiharu; Liem, Pham Hieu] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan.
RP Notodihardjo, PV (reprint author), Kansai Med Univ, Dept Plast & Reconstruct Surg, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.
EM priscilla.valentin@gmail.com; mnaoki22@kuhp.kyoto-u.ac.jp
OI Kakudo, Natsuko/0000-0001-9785-1490; Morimoto, Naoki/0000-0002-0712-3172
FU Kansai Medical University
FX This study was supported by a research Grant from Kansai Medical
   University.
CR Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Hong L, 2000, J NEUROSURG, V92, P315, DOI 10.3171/jns.2000.92.2.0315
   Iacopetti I, 2012, J EQUINE VET SCI, V32, P123, DOI 10.1016/j.jevs.2011.08.012
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Ito R, 2013, TISSUE ENG PART A, V19, P140
   Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Martinez-Zapata MJ, 2012, COCHRANE DB SYST REV, V10
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709
   Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.tea.2012.0634, 10.1089/ten.TEA.2012.0634]
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Ozeki M, 2002, TISSUE ENG, V8, P359, DOI 10.1089/107632702760184637
   Liem PH, 2013, J SURG RES, V182, P353, DOI 10.1016/j.jss.2012.10.018
   Sugimori E, 2006, DENT MATER J, V25, P591, DOI 10.4012/dmj.25.591
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
NR 19
TC 11
Z9 11
U1 3
U2 22
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
EI 1619-0904
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD MAR
PY 2015
VL 18
IS 1
BP 64
EP 71
DI 10.1007/s10047-014-0795-8
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA CD2DQ
UT WOS:000350884800009
PM 25326193
DA 2018-10-20
ER

PT J
AU Anderson, JM
AF Anderson, James M.
TI Exploiting the inflammatory response on biomaterials research and
   development
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Exploiting the inflammatory response on biomaterials research and development requires an in-depth understanding of the cellular and molecular mechanisms involved in the events comprising the tissue response continuum. Examples of how the biomaterial surface chemistry may modulate the foreign body reaction to biomaterials. The utilization of different surface chemistries on biomaterials may provide biological design criteria for the appropriate use and function of biomaterials when used in medical devices and prostheses.
C1 [Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM jma6@case.edu
NR 0
TC 13
Z9 14
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 121
DI 10.1007/s10856-015-5423-5
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300001
PM 25690617
DA 2018-10-20
ER

PT J
AU de Mel, A
   Yap, T
   Cittadella, G
   Hale, LR
   Maghsoudlou, P
   de Coppi, P
   Birchall, MA
   Seifalian, AM
AF de Mel, Achala
   Yap, Trixie
   Cittadella, Giorgio
   Hale, Luke Richard
   Maghsoudlou, Panagiotis
   de Coppi, Paolo
   Birchall, Martin A.
   Seifalian, Alexander M.
TI A potential platform for developing 3D tubular scaffolds for paediatric
   organ development
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; BYPASS GRAFTS;
   MECHANICAL-PROPERTIES; TISSUE; DIFFERENTIATION; NANOCOMPOSITE;
   REGENERATION; POROSITY; DESIGN
AB Children suffer from damaged or loss of hollow organs i.e. trachea, oesophagus or arteries from birth defects or diseases. Generally these organs possess an outer matrix consisting of collagen, elastin, and cells such as smooth muscle cells (SMC) and a luminal layer consisting of endothelial or epithelial cells, whilst presenting a barrier to luminal content. Tissue engineering research enables the construction of such organs and this study explores this possibility with a bioabsorbable nanocomposite biomaterial, polyhedral oligomeric silsesquioxane poly(e-caprolactone) urea urethane (POSS-PCL). Our established methods of tubular graft extrusion were modified using a porogen-in-corporated POSS-PCL and a new lamination method was explored. Porogen (40, 60 or 105 mu m) were introduced to POSS-PCL, which were fabricated into a bilayered, dual topography matching the exterior and luminal interior of tubular organs. POSS-PCL with different amounts of porogen were tested for their suitability as a SMC layer by measuring optimal interactions with human adipose derived stem cells. Angiogenesis potential was tested with the chorioallantoic membrane assay. Tensile strength and burst pressures of bilayared tubular grafts were determined. Scaffolds made with 40 mu m porogen demonstrated optimal adipose derived stem cell integration and the scaffolds were able to accommodate angiogenesis. Mechanical properties of the grafts confirmed their potential to match the relevant physiological and biophysical parameters. This study presents a platform for the development of hollow organs for transplantation based on POSS-PCL. These bilayered-tubular structures can be tailor-made for cellular integration and match physico-mechanical properties of physiological systems of interest. More specific luminal cell integration and sources of SMC for the external layer could be further explored.
C1 [de Mel, Achala; Yap, Trixie; Cittadella, Giorgio; Hale, Luke Richard; Seifalian, Alexander M.] UCL Div Surg & Intervent Sci, London NW3 2QG, England.
   [Maghsoudlou, Panagiotis; de Coppi, Paolo] UCL, Great Ormond St Hosp, Inst Child Hlth, London, England.
   [Birchall, Martin A.] UCL, UCL Ear Inst, Royal Natl Throat Nose & Ear Hosp, London, England.
   [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, London, England.
RP de Mel, A (reprint author), UCL Div Surg & Intervent Sci, Royal Free NHS Trust Hosp Campus,9th Floor,Rm 355, London NW3 2QG, England.
EM a.mel@ucl.ac.uk; a.seifalian@ucl.ac.uk
OI De Coppi, Paolo/0000-0002-1659-0207
FU Royal Free Charity; Medical Research Council [G1001539, MR/K026453/1];
   National Institute for Health Research [NF-SI-0513-10089,
   RP_2014-04-046]
FX Authors would like to thank Mr. Arnold Darbyshire for synthesising the
   nanocomposite materials and assistance with mechanical properties of the
   material. Philip Garner and Luke Hale for assistance with imaging during
   their work experience attachment with the authors. Royal Free Charity
   for their funding on development of hollow organs.
CR Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Basu J, 2010, TRENDS BIOTECHNOL, V28, P526, DOI 10.1016/j.tibtech.2010.07.007
   Birchall MA, 2009, BRIT J SURG, V96, P565, DOI 10.1002/bjs.6666
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Cittadella G, 2013, ARTIF ORGANS, V37, P423, DOI 10.1111/aor.12022
   de Mel A, 2014, MACROMOL BIOSCI, V14, P307, DOI 10.1002/mabi.201300382
   de Mel A, 2012, MACROMOL BIOSCI, V12, P1010, DOI 10.1002/mabi.201200039
   Del GC, 2013, J BIOMED MATER RES A, V102, P2427
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Guasti L, 2013, NANOMEDICINE, V10, P279
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Khalil AS, 2013, ACS CHEM BIOL, V9, P45
   Khani MM, 2014, ANN BIOMED ENG, V42, P1373, DOI 10.1007/s10439-013-0889-0
   Lanfranchi A, 2009, EARLY HUM DEV, V85, pS15, DOI 10.1016/j.earlhumdev.2009.08.005
   Lin CH, 2014, STEM CELLS DEV, V23, P2581, DOI 10.1089/scd.2014.0163
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Mun CH, 2013, ARTIF ORGANS, V37, pE168, DOI 10.1111/aor.12108
   Nakamoto T, 2014, COLLOID SURFACE B, V122, P316, DOI 10.1016/j.colsurfb.2014.06.013
   Orbay H, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/461718
   Partington L, 2013, ACTA BIOMATER, V9, P5251, DOI 10.1016/j.actbio.2012.10.004
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Sarkar S, 2006, J VASC SURG, V44, P846, DOI 10.1016/j.jvs.2006.07.023
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Seo CH, 2013, BIOMATERIALS, V34, P1764, DOI 10.1016/j.biomaterials.2012.11.031
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Vacanti JP, 2012, BRIT J SURG, V99, P451, DOI 10.1002/bjs.7819
   Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI [10.1089/ten.tea.2009.0303, 10.1089/ten.TEA.2009.0303]
   Wilson A, 2011, CELL PROLIFERAT, V44, P86, DOI 10.1111/j.1365-2184.2010.00736.x
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   Yildirimer L, 2014, TISSUE ENG C
   Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014
   Zhao J, 2012, ARTIF ORGANS, V36, P93, DOI 10.1111/j.1525-1594.2011.01231.x
NR 39
TC 5
Z9 5
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 141
DI 10.1007/s10856-015-5477-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300021
PM 25737129
DA 2018-10-20
ER

PT J
AU Kucharska, M
   Walenko, K
   Lewandowska-Szumiel, M
   Brynk, T
   Jaroszewicz, J
   Ciach, T
AF Kucharska, Martyna
   Walenko, Katarzyna
   Lewandowska-Szumiel, Malgorzata
   Brynk, Tomasz
   Jaroszewicz, Jakub
   Ciach, Tomasz
TI Chitosan and composite microsphere-based scaffold for bone tissue
   engineering: evaluation of tricalcium phosphate content influence on
   physical and biological properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FABRICATION; ROUGHNESS; MEMBRANE
AB In the hereby presented work the authors describe a technique of high-compression-resistant biodegradable bone scaffold preparation. The methodology is based on the agglomeration of chitosan (CH) and chitosan/beta-tricalcium phosphate (CH/TCP) microspheres and represents a novel approach to 3D matrices design for bone tissue engineering application. The materials were prepared from high deacetylation degree chitosan. The authors describe the method for scaffold fabrication, essential properties of the materials manufactured and the influence of various TCP concentrations on material morphology, mechanical properties (for dry and hydrated materials) and preliminary study on the interaction between CH or CH/TCP scaffolds and within cultured MG-63 osteoblast-like cells. The properties of the obtained materials were significantly affected by the calcium phosphate content, which had a particular influence on the granule microstructure, size distribution and inner biomaterial pore size. The water uptake ability was found to be lower for the materials enriched with the inorganic phase and tended to decrease with the increasing calcium phosphate concentration. The evaluation of mechanical properties has revealed that scaffolds produced with the usage of granule-based technology display a potential to be used as a load-bearing material since the Young's modulus values were limited to the range of 200-500 MPa for dry materials and 15-20 MPa for the hydrated state of the scaffolds. The cell number, identified in three time points (48 h, 7 and 14 days) by Pico Green assay, was lower for the materials enriched with inorganic phase (75 % of control), however cell distribution, when compared to CH only biomaterial, was acknowledged as steadier on the surface of the material containing the highest calcium phosphate concentration.
C1 [Kucharska, Martyna; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00645 Warsaw, Poland.
   [Kucharska, Martyna] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland.
   [Walenko, Katarzyna; Lewandowska-Szumiel, Malgorzata] Med Univ Warsaw, Dept Biophys & Human Physiol, Warsaw, Poland.
   [Brynk, Tomasz; Jaroszewicz, Jakub] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-00645 Warsaw, Poland.
RP Kucharska, M (reprint author), Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, Warynskiego 1, PL-00645 Warsaw, Poland.
EM martyna.kucharska@gmail.com
OI Jaroszewicz, Jakub/0000-0002-5037-8082; Ciach,
   Tomasz/0000-0002-8726-8944; Brynk, Tomasz/0000-0002-5825-4789;
   Lewandowska-Szumiel, Malgorzata/0000-0002-7140-0541
FU European Union through the Warsaw University of Technology Development
   Programme1#; National Centre for Research and Development [NR
   13-0008-10/2010]
FX This work has been supported by the European Union in the framework of
   European Social Fund through the Warsaw University of Technology
   Development Programme<SUP>1#</SUP> and Grant No. NR 13-0008-10/2010 from
   The National Centre for Research and Development.
CR Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Gasser B, 2000, INJURY, V31
   GIANNOUDIS PV, 2005, INJURY, V365, P520
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kucharska M, 2010, MATER LETT, V64, P1059, DOI 10.1016/j.matlet.2010.02.012
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tigli RS, 2007, J MATER SCI-MATER M, V18, P1665, DOI [10.1007/s10856-007-3066, 10.1007/s10856-007-3066-x]
   Yang B, 2010, CARBOHYD POLYM, V80, P860, DOI 10.1016/j.carbpol.2009.12.044
   Yang ZH, 2006, MOL THER, V13, pS76, DOI 10.1016/j.ymthe.2006.08.221
   Zan QF, 2008, APPL SURF SCI, V255, P401, DOI 10.1016/j.apsusc.2008.06.074
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
NR 31
TC 7
Z9 8
U1 1
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 143
DI 10.1007/s10856-015-5464-9
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300023
PM 25737128
DA 2018-10-20
ER

PT J
AU Ospina, NM
   Alvarez, SPO
   Sierra, DME
   Vahos, DFR
   Ocampo, PAZ
   Orozco, CPO
AF Mesa Ospina, Natali
   Ospina Alvarez, Sandra Patricia
   Escobar Sierra, Diana Marcela
   Rojas Vahos, Diego Fernando
   Zapata Ocampo, Paola Andrea
   Ossa Orozco, Claudia Patricia
TI Isolation of chitosan from Ganoderma lucidum mushroom for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CHITIN; DEACETYLATION; COATINGS; QUALITY; LIFE
AB Chitin biopolymer production and its by-product chitosan show great potential. These biomaterials have great applicability in various fields because they are non-toxic, biodegradable, biocompatible, and have antimicrobial effects. The most common source of chitin and chitosan is the crustaceous shell; however, mushrooms are an alternative source for isolating these biopolymers because their cellular wall has a high content of chitin, which may be transformed into chitosan through a deacetylation reaction. The main objective of this research was to obtain chitosan through the deacetylation of chitin isolated from the Ganoderma lucidum basidiomycetes mushroom, which is obtained through biotechnological culture. The material characterization was performed using X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetric analysis, and an evaluation of cytotoxicity comparing the results obtained with results for commercial chitosan. Protocol results showed that chitosan obtained from this mushroom had a significant similitude with commercial chitosan, yet the one obtained using P2 protocol was the one that rendered the best results: including diffractogram peaks, characteristic infrared analysis bands, and an 80.29 % degree of deacetylation. Cytotoxicity in vitro testing showed that the material was non-toxic; furthermore, it rendered very promising information regarding the evaluation of future applications of this biomaterial in the field of biomedicine.
C1 [Mesa Ospina, Natali; Escobar Sierra, Diana Marcela; Ossa Orozco, Claudia Patricia] Univ Antioquia UdeA, Fac Engn, Biomat Res Grp, Bioengn Program, Medellin, Colombia.
   [Ospina Alvarez, Sandra Patricia; Rojas Vahos, Diego Fernando; Zapata Ocampo, Paola Andrea] Univ Antioquia UdeA, Inst Biol, Biotechnol Res Grp, Medellin, Colombia.
RP Orozco, CPO (reprint author), Univ Antioquia UdeA, Fac Engn, Biomat Res Grp, Bioengn Program, Calle 70 52-21, Medellin, Colombia.
EM claudia.ossa@udea.edu.co
FU Universidad de Antioquia CODI
FX The authors of this study express their gratitude to both Universidad de
   Antioquia CODI for its funding of this research project and to the
   Biotechnology and Biomaterial Research Groups.
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   [Anonymous], BIOL REACT TESTS IN
   BOUGH WA, 1978, BIOTECHNOL BIOENG, V20, P1931, DOI 10.1002/bit.260201208
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Caprile MD, C MUND ISWA 2005 HAC
   Cervera MF, 2004, CARBOHYD POLYM, V58, P401, DOI 10.1016/j.carbpol.2004.08.017
   Chandumpai A, 2004, CARBOHYD POLYM, V58, P467, DOI 10.1016/j.carbpol.2004.08.015
   Crestini C, 1996, BIOTECHNOL BIOENG, V50, P207, DOI 10.1002/bit.260500202
   Di Mario F, 2008, INT J BIOL MACROMOL, V43, P8, DOI 10.1016/j.ijbiomac.2007.10.005
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   Elsabee MZ, 2013, MAT SCI ENG C-MATER, V33, P1819, DOI 10.1016/j.msec.2013.01.010
   Galia CR, 2008, CLINICS, V63, P801, DOI 10.1590/S1807-59322008000600016
   Gol NB, 2013, POSTHARVEST BIOL TEC, V85, P185, DOI 10.1016/j.postharvbio.2013.06.008
   Hong KQ, 2012, SCI HORTIC-AMSTERDAM, V144, P172, DOI 10.1016/j.scienta.2012.07.002
   Ivshin VP, 2007, POLYM SCI, V49, P2215
   Kasaal MR, 2008, CARBOHYD POLYM, V71, P497, DOI 10.1016/j.carbpol.2007.07.009
   Kaya M, 2014, MAT SCI ENG C-MATER, V45, P72, DOI 10.1016/j.msec.2014.09.004
   Khor E., 2001, CHITIN FULFILLING BI
   Larez C, 2006, AVANCES QUIMICA, V1, P15
   Liao SK, 2004, MACROMOL RES, V12, P466, DOI 10.1007/BF03218428
   Methacanon P, 2003, CARBOHYD POLYM, V52, P119, DOI 10.1016/S0144-8617(02)00300-4
   Musarrat HM, 2013, FOOD HYDROCOLLOID, V31, P166
   MUZZARELLI RAA, 1976, CHITIN
   Olvera Acosta P., 2003, AISLAMIENTO LEVADURA, P79
   Ospina SP, 2014, BIOMED RES INT, V2014, P1
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Peniche Covas C., 2006, THESIS U LA HABANA C
   Pochanavanich P, 2002, LETT APPL MICROBIOL, V35, P17, DOI 10.1046/j.1472-765X.2002.01118.x
   Prichystalova H, 2014, INT J BIOL MACROMOL, V65, P234, DOI 10.1016/j.ijbiomac.2014.01.050
   Quiriz FA, 2012, EVALUACION PROPIEDAD, P86
   Ramya R., 2012, INT J SCI RES PUBLIC, V2, P1
   Rojas D, 2013, OPEN C P J, V4, P93
   Wan ACA, 2013, BIOTECHNOL ADV, V31, P1776, DOI 10.1016/j.biotechadv.2013.09.007
   Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s
   Zakaria Z, 2012, BIORESOURCES, V7, P5568
   Zapata P, 2012, INT J MED MUSHROOMS, V14, P197, DOI 10.1615/IntJMedMushr.v14.i2.80
NR 36
TC 8
Z9 9
U1 0
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 135
DI 10.1007/s10856-015-5461-z
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300015
PM 25716022
DA 2018-10-20
ER

PT J
AU Salvage, J
   Thorpe, J
   Santin, M
AF Salvage, Jonathan
   Thorpe, Julian
   Santin, Matteo
TI Soybean-based biomaterial granules induce biomineralization in MG-63
   human osteosarcoma osteoblast-like cells through ultrastructural changes
   and phagocytic activity
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTRACELLULAR CALCIUM-PHOSPHATE; ANTIGENIC PHENOTYPE; T-LYMPHOCYTES;
   IFN-GAMMA; DIFFERENTIATION; EXPRESSION; PARTICLES; MOLECULES; CD54
C1 [Salvage, Jonathan; Santin, Matteo] Univ Brighton, Brighton Ctr Regenerat Med, Brighton Studies Tissue Mimicry & Aided Regenerat, Brighton BN2 4GJ, E Sussex, England.
   [Thorpe, Julian] Univ Sussex, Sch Life Sci, Sussex Ctr Adv Microscopy, Brighton BN1 9QG, E Sussex, England.
RP Santin, M (reprint author), Univ Brighton, Brighton Ctr Regenerat Med, Brighton Studies Tissue Mimicry & Aided Regenerat, Huxley Bldg Lewes Rd, Brighton BN2 4GJ, E Sussex, England.
EM M.Santin@brighton.ac.uk
OI Thorpe, Julian/0000-0002-0895-703X
CR Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109
   Diaz-Rodriguez L, 2009, ANN NY ACAD SCI, V1173, pE46, DOI 10.1111/j.1749-6632.2009.04950.x
   Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1
   Garcia-Martinez O, 2006, BIOSCIENCE REP, V26, P39, DOI 10.1007/s10540-006-9006-z
   Giavaresi G, 2010, J MATER SCI-MATER M, V21, P615, DOI 10.1007/s10856-009-3870-6
   Heinemann DEH, 2000, J BONE JOINT SURG BR, V82B, P283, DOI 10.1302/0301-620X.82B2.9730
   Lisignoli G, 2004, J CELL PHYSIOL, V198, P388, DOI 10.1002/jcp.10427
   Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014
   Meikle ST, 2012, TISSUE ENG PT A, V18, P1932, DOI [10.1089/ten.tea.2011.0549, 10.1089/ten.TEA.2011.0549]
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Morris C, 2006, J NUTR, V136, P1166
   Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1
   Reyes-Botella C, 2002, CELL PHYSIOL BIOCHEM, V12, P359, DOI 10.1159/000067906
   Reyes-Botella C, 2000, J PERIODONTOL, V71, P614, DOI 10.1902/jop.2000.71.4.614
   Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436
   Ruiz C, 2007, J BONE MINER METAB, V25, P286, DOI 10.1007/s00774-007-0767-7
   Ruiz C, 2003, CELL PHYSIOL BIOCHEM, V13, P309, DOI 10.1159/000074546
   Santin M, 2008, EXPERT REV MED DEVIC, V5, P349, DOI 10.1586/17434440.5.3.349
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Stanley KT, 2006, J BONE MINER RES, V21, P29, DOI 10.1359/JBMR.051004
   Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
NR 21
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2015
VL 26
IS 3
AR 122
DI 10.1007/s10856-015-5451-1
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC9AI
UT WOS:000350659300002
PM 25690618
DA 2018-10-20
ER

PT J
AU Daoush, WMRM
   Park, HS
   Inam, F
   Lim, BK
   Hong, SH
AF Daoush, Walid Mohamed Rashad Mohamed
   Park, Hee Sup
   Inam, Fawad
   Lim, Byung Kyu
   Hong, Soon Hyung
TI Microstructural and Mechanical Characterization of Ti-12Mo-6Zr
   Biomaterials Fabricated by Spark Plasma Sintering
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article
ID TOTAL HIP-REPLACEMENT; TI-TA ALLOYS; BIOMEDICAL APPLICATIONS; YOUNGS
   MODULUS; TITANIUM-ALLOYS; CORROSION; COATINGS; HYDROXYAPATITE;
   ARTHROPLASTY; COMBINATION
AB Ti-12Mo-6Zr/Al2O3 (titanium biomaterial) was prepared by a powder metallurgy route using Spark Plasma Sintering (SPS). Ti, Mo, and Zr powders were mixed by wet milling with different content of alumina nanoparticles (up to 5 wt pct) as an oxide dispersion strengthening phase. Composite powder mixtures were SPSed at 1273 K (1000 degrees C) followed by heat treatment and quenching. Composite powders, sintered materials, and heat-treated materials were examined using optical and high-resolution electronic microscopy (scanning and transmission) and X-ray diffraction to characterize particle size, surface morphology, and phase identifications for each composition. All sintered materials were evaluated by measuring density, Vickers hardness, and tensile properties. Fully dense sintered materials were produced by SPS and mechanical properties were found to be improved by subsequent heat treatment. The tensile properties as well as the hardness were increased by increasing the content of Al2O3 nanoparticles in the Ti-12Mo-6Zr matrix. (C) The Minerals, Metals & Materials Society and ASM International 2014
C1 [Daoush, Walid Mohamed Rashad Mohamed] Helwan Univ, Fac Ind Educ, Prod Technol Dept, Cairo 1151111668, Egypt.
   [Park, Hee Sup] ILJIN Diamond Co Ltd, Ind Technol Inst, Eumsung Kun 369824, Chungcheongbuk, South Korea.
   [Inam, Fawad] Northumbria Univ, Fac Engn & Environm, Dept Mech & Construct Engn, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
   [Lim, Byung Kyu; Hong, Soon Hyung] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Composite Mat Lab, Taejon 305701, South Korea.
RP Daoush, WMRM (reprint author), Helwan Univ, Fac Ind Educ, Prod Technol Dept, 30 El Sawah St, Cairo 1151111668, Egypt.
EM waliddaoush@techedu.helwan.edu.eg
RI Hong, Soon Hyung/C-1943-2011; Inam, Fawad/Q-9531-2017
OI Inam, Fawad/0000-0002-3149-7991; daoush, walid/0000-0002-6430-5749;
   Hong, Soon Hyung/0000-0001-7358-3989
CR Akahori T., 2001, P PRICM, P209
   Bal SB, 2006, SEMIN ARTHROPLASTY, V17, P94
   Bierbaum BE, 2002, CLIN ORTHOP RELAT R, P158, DOI 10.1097/01.blo.0000038043.63743.9f
   Bigi A, 2007, J BIOMED MATER RES A, V82A, P213, DOI 10.1002/jbm.a.31132
   Black J., 1998, HDB BIOMATERIAL PROP
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   BOUTIN P, 1971, PRESSE MED, V79, P639
   Carbajal G, 2001, ANTI-CORROS METHOD M, V48, P241, DOI 10.1108/00035590110398899
   Chang J-D, 2007, STEINKOPFF, P123
   Cui Z., 2000, METALLOGRAPHY HEAT T
   Davidson J.A., 1987, P IMPL MAN MAT TECHN, P122
   DIETER DE, 1976, MECH METALLURGY
   Gibbesch B, 1989, Int J Oral Maxillofac Implants, V4, P131
   Hannouche D, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000149996.91974.83
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   Jackson HF, 2010, INT J APPL CERAM TEC, V7, P316, DOI 10.1111/j.1744-7402.2009.02434.x
   Kawahara H., 1963, J JPN SOC DENT APPAR, V4, P65
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   Laskin RS, 2004, TECH KNEE SURG, V3, P187
   Lawrence K., 1980, NATURE, V283, P106, DOI DOI 10.1038/283106A07350519
   Lee HN, 2000, ACTA MATER, V48, P3221, DOI 10.1016/S1359-6454(00)00123-3
   LEE YT, 1991, METALL TRANS A, V22, P709, DOI 10.1007/BF02670293
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Majima T, 2008, KNEE SURG SPORT TR A, V16, P152, DOI 10.1007/s00167-007-0435-4
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Oonishi H, 2002, KEY ENG MAT, V218-2, P499, DOI 10.4028/www.scientific.net/KEM.218-220.499
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Oonishi H., 2006, BIOCERAMICS ALTERNAT, P101
   Pandorf T, 2007, CER ORTHO, P137, DOI 10.1007/978-3-7985-1783-7_18
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016
   Skinner HB, 1999, CLIN ORTHOP RELAT R, P83
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Wang Y, 2006, WEAR, V260, P976, DOI 10.1016/j.wear.2005.06.013
   Wang YM, 2009, APPL SURF SCI, V255, P6875, DOI 10.1016/j.apsusc.2009.03.007
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1222
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xu JW, 2015, J ALLOY COMPD, V618, P343, DOI 10.1016/j.jallcom.2014.08.223
   Yoshimitsu O., 2004, BIOMATERIALS, V25, P5913
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 53
TC 0
Z9 0
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5623
EI 1543-1940
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD MAR
PY 2015
VL 46A
IS 3
BP 1385
EP 1393
DI 10.1007/s11661-014-2693-3
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CC4DE
UT WOS:000350300200036
DA 2018-10-20
ER

PT J
AU Watts, MP
   Coker, VS
   Parry, SA
   Pattrick, RAD
   Thomas, RAP
   Kalin, R
   Lloyd, JR
AF Watts, Mathew P.
   Coker, Victoria S.
   Parry, Stephen A.
   Pattrick, Richard A. D.
   Thomas, Russell A. P.
   Kalin, Robert
   Lloyd, Jonathan R.
TI Biogenic nano-magnetite and nano-zero valent iron treatment of alkaline
   Cr(VI) leachate and chromite ore processing residue
SO APPLIED GEOCHEMISTRY
LA English
DT Article
ID PERMEABLE REACTIVE BARRIERS; X-RAY-ABSORPTION; MEDIATED CHROMATE
   REDUCTION; NANOSCALE ZEROVALENT IRON; CATION SITE OCCUPANCY; HEXAVALENT
   CHROMIUM; AQUEOUS CR(VI); PHOTOELECTRON-SPECTROSCOPY; ENVIRONMENTAL
   CHEMISTRY; MICROBIAL REDUCTION
AB Highly reactive nano-scale biogenic magnetite (BnM), synthesized by the Fe(III)-reducing bacterium Geobacter sulfurreducens, was tested for the potential to remediate alkaline Cr(VI) contaminated waters associated with chromite ore processing residue (COPR). The performance of this biomaterial, targeting aqueous Cr(VI) removal, was compared to a synthetic alternative, nano-scale zero valent iron (nZVI). Samples of highly contaminated alkaline groundwater and COPR solid waste were obtained from a contaminated site in Glasgow, UK. During batch reactivity tests, Cr(VI) removal from groundwater was inhibited by similar to 25% (BnM) and similar to 50% (nZVI) when compared to the treatment of less chemically complex model pH 12 Cr(VI) solutions. In both the model Cr(VI) solutions and contaminated groundwater experiments the surface of the nanoparticles became passivated, preventing complete coupling of their available electrons to Cr(VI) reduction. To investigate this process, the surfaces of the reacted samples were analyzed by TEM-EDX, XAS and XPS, confirming Cr(VI) reduction to the less soluble Cr(III) on the nanoparticle surface. In groundwater reacted samples the presence of Ca, Si and S was also noted on the surface of the nanoparticles, and is likely responsible for earlier onset of passivation. Treatment of the solid COPR material in contact with water, by addition of increasing weight % of the nanoparticles, resulted in a decrease in aqueous Cr(VI) concentrations to below detection limits, via the addition of >= 5% w/w BnM or >= 1% w/w nZVI. XANES analysis of the Cr K edge, showed that the % Cr(VI) in the COPR dropped from 26% to a minimum of 4-7% by the addition of 5% w/w BnM or 2% w/w nZVI, with higher additions unable to reduce the remaining Cr(VI). The treated materials exhibited minimal re-mobilization of soluble Cr(VI) by re-equilibration with atmospheric oxygen, with the bulk of the Cr remaining in the solid fraction. Both nanoparticles exhibited a considerable capacity for the remediation of COPR related Cr(VI) contamination, with the synthetic nZVI demonstrating greater reactivity than the BnM. However, the biosynthesized BnM was also capable of significant Cr(VI) reduction and demonstrated a greater efficiency for the coupling of its electrons towards Cr(VI) reduction than the nZVI. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Watts, Mathew P.; Coker, Victoria S.; Pattrick, Richard A. D.; Lloyd, Jonathan R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
   [Watts, Mathew P.; Coker, Victoria S.; Pattrick, Richard A. D.; Lloyd, Jonathan R.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England.
   [Parry, Stephen A.] Diamond Light Source, Didcot OX11 ODE, Oxon, England.
   [Thomas, Russell A. P.] Parsons Brinckerhoff, Bristol BS6 6US, Avon, England.
   [Kalin, Robert] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow G1 1XJ, Lanark, Scotland.
RP Lloyd, JR (reprint author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
EM Jon.Lloyd@manchester.ac.uk
OI Parry, Stephen/0000-0001-5205-4543; Lloyd, Jonathan/0000-0002-0719-0498;
   Coker, Victoria/0000-0002-1332-216X
FU BBSRC; European Union [309517]; Office of Science, Office of Basic
   Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231];
   CASE support from Parsons Brinckerhoff
FX This work was supported by funding from BBSRC and CASE support from
   Parsons Brinckerhoff. In addition to support from the European Union
   Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No.
   309517 (NANOREM). Thanks are due to Dr. A. Walton and Dr. M. Ward for
   their assistance with XPS and TEM analysis via the Leeds EPSRC
   Nanoscience and Nanotechnology Research Equipment Facility (LENNF). Dr.
   J. Waters, Mr. P. Lythgoe and Mr. A. Bewsher are thanked for their
   assistance with XRD, ICP-AES, XRF and IC analyses. Thanks also to Dr. P.
   Wincott for XPS analysis and data analysis. Special thanks to Mr. N.
   Johnson of ERS Land Regeneration and Dr. T. Henman of Parsons
   Brinckerhoff for help with obtaining COPR and groundwater samples
   respectively. We acknowledge Diamond Light Source for time on beam-line
   B18 under proposal SP8163. The Advanced Light Source is supported by the
   Director, Office of Science, Office of Basic Energy Sciences, of the
   U.S. Department of Energy under Contract No. DE-AC02-05CH11231.
CR Arenholz E, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2008027
   Aronniemi M, 2005, SURF SCI, V578, P108, DOI 10.1016/j.susc.2005.01.019
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   Ashwal LD, 1997, CONTRIB MINERAL PETR, V127, P75, DOI 10.1007/s004100050266
   BAJT S, 1993, ANAL CHEM, V65, P1800, DOI 10.1021/ac00061a026
   Biesinger MC, 2004, SURF INTERFACE ANAL, V36, P1550, DOI 10.1002/sia.1983
   Blowes DW, 1997, ENVIRON SCI TECHNOL, V31, P3348, DOI 10.1021/es960844b
   Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Burke T., 1991, CHROMITE ORE PROCESS
   Byrne JM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455709
   Cao HS, 2006, J HAZARD MATER, V132, P213, DOI 10.1016/j.jhazmat.2005.09.008
   Chaplin BP, 2012, ENVIRON SCI TECHNOL, V46, P3655, DOI 10.1021/es204087q
   Chen JM, 1998, CRIT REV ENV SCI TEC, V28, P219, DOI 10.1080/10643389891254214
   Cheng YJ, 2012, ELEMENTS, V8, P107, DOI 10.2113/gselements.8.2.107
   Chrysochoou M, 2009, ENVIRON SCI TECHNOL, V43, P5461, DOI 10.1021/es9005338
   CLAIRE, 2007, CLAIRE TECHN B, VTB14
   Coker V.S., 2013, ENVIRON TECHNOL, V35, P1
   Coker VS, 2007, EUR J MINERAL, V19, P707, DOI 10.1127/0935-1221/2007/0019-1758
   Crane RA, 2012, J HAZARD MATER, V211, P112, DOI 10.1016/j.jhazmat.2011.11.073
   Crean DE, 2012, ENVIRON SCI TECHNOL, V46, P3352, DOI 10.1021/es2037146
   Cutting RS, 2009, GEOCHIM COSMOCHIM AC, V73, P4004, DOI 10.1016/j.gca.2009.04.009
   Cutting RS, 2010, ENVIRON SCI TECHNOL, V44, P2577, DOI 10.1021/es902119u
   Darrie G, 2001, ENVIRON GEOCHEM HLTH, V23, P187, DOI 10.1023/A:1012295927081
   Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062
   Dermatas D, 2006, ENVIRON SCI TECHNOL, V40, P5786, DOI 10.1021/es0604461
   Du J., 2012, J HAZARD MAT
   EARY LE, 1987, ENVIRON SCI TECHNOL, V21, P1187, DOI 10.1021/es00165a005
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   EPA U., 1992, 3060A EPA
   Farmer JG, 2006, SCI TOTAL ENVIRON, V360, P90, DOI 10.1016/j.scitotenv.2005.08.027
   Farmer JG, 2002, J ENVIRON MONITOR, V4, P235, DOI 10.1039/b108681m
   Farmer JG, 1999, ENVIRON GEOCHEM HLTH, V21, P331, DOI 10.1023/A:1006788418483
   Fendorf S, 2000, INT GEOL REV, V42, P691, DOI 10.1080/00206810009465107
   Fendorf SE, 1996, ENVIRON SCI TECHNOL, V30, P1614, DOI 10.1021/es950618m
   FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F
   FENDORF SE, 1992, ENVIRON SCI TECHNOL, V26, P79, DOI 10.1021/es00025a006
   Fordyce F.M., 2012, OR08002 BRIT GEOL SU, P1
   Fuller SJ, 2013, IND ENG CHEM RES, V52, P4704, DOI 10.1021/ie302914b
   Furukawa Y, 2002, ENVIRON SCI TECHNOL, V36, P5469, DOI 10.1021/es025533h
   Geelhoed JS, 2003, ENVIRON SCI TECHNOL, V37, P3206, DOI 10.1021/es0264798
   Geelhoed JS, 2002, GEOCHIM COSMOCHIM AC, V66, P3927, DOI 10.1016/S0016-7037(02)00977-8
   Giampaolo C, 2002, CEMENT CONCRETE RES, V32, P769, DOI 10.1016/S0008-8846(01)00760-8
   GIBB TC, 1992, J MATER CHEM, V2, P105, DOI 10.1039/jm9920200105
   Graham MC, 2006, SCI TOTAL ENVIRON, V364, P32, DOI 10.1016/j.scitotenv.2005.11.007
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   GUPTA RP, 1975, PHYS REV B, V12, P15, DOI 10.1103/PhysRevB.12.15
   Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P401, DOI 10.1016/S0016-7037(02)01081-5
   He F, 2008, APPL CATAL B-ENVIRON, V84, P533, DOI 10.1016/j.apcatb.2008.05.008
   He YT, 2005, ENVIRON SCI TECHNOL, V39, P4499, DOI [10.1021/es0483692, 10.1021/eso0483692]
   He YT, 2004, ENVIRON SCI TECHNOL, V38, P5535, DOI 10.1021/es049809s
   Hillier S, 2007, ENVIRON SCI TECHNOL, V41, P1921, DOI 10.1021/es0621997
   Hillier S, 2003, SCI TOTAL ENVIRON, V308, P195, DOI 10.1016/S0048-9697(02)00680-0
   Hochella MF, 2008, SCIENCE, V319, P1631, DOI 10.1126/science.1141134
   Jimenez-Villacorta F, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.172404
   Jung Y, 2007, CHEMOSPHERE, V68, P1968, DOI 10.1016/j.chemosphere.2007.02.028
   Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4
   Kelly S.D., 2008, SOIL SCI SOC AM J
   Kendelewicz T, 2000, SURF SCI, V469, P144, DOI 10.1016/S0039-6028(00)00808-6
   Kendelewicz T, 1999, SURF SCI, V424, P219, DOI 10.1016/S0039-6028(98)00940-6
   Kim C, 2001, ENVIRON SCI TECHNOL, V35, P2219, DOI 10.1021/es0017007
   Kimbrough DE, 1999, CRIT REV ENV SCI TEC, V29, P1, DOI 10.1080/10643389991259164
   Kosmulski M, 2004, J COLLOID INTERF SCI, V275, P214, DOI 10.1016/j.jcis.2004.02.029
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Lai KCK, 2008, ENVIRON SCI TECHNOL, V42, P1238, DOI 10.1021/es071572n
   Li XQ, 2008, IND ENG CHEM RES, V47, P2131, DOI 10.1021/ie061655x
   Li XQ, 2006, CRIT REV SOLID STATE, V31, P111, DOI 10.1080/10408430601057611
   Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597
   Lo IMC, 2006, WATER RES, V40, P595, DOI 10.1016/j.watres.2005.11.033
   LOVLEY DR, 1995, J IND MICROBIOL, V14, P85, DOI 10.1007/BF01569889
   LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751
   Malherbe J, 2011, ENVIRON SCI TECHNOL, V45, P10492, DOI 10.1021/es201002g
   Manning BA, 2007, ENVIRON SCI TECHNOL, V41, P586, DOI 10.1021/es061721m
   MCCAFFERTY E, 1988, CORROS SCI, V28, P559, DOI 10.1016/0010-938X(88)90024-8
   MCINTYRE NS, 1977, ANAL CHEM, V49, P1521, DOI 10.1021/ac50019a016
   Moon DH, 2007, J HAZARD MATER, V143, P629, DOI [10.1016/j.jhazmat.2007.01.013, 10.1016/j.hazmat.2007.01.013]
   Moon DH, 2011, GEOSCI J, V15, P287, DOI 10.1007/s12303-011-0023-y
   Pattrick RAD, 2002, EUR J MINERAL, V14, P1095, DOI 10.1127/0935-1221/2002/0014-1095
   Peterson ML, 1997, ENVIRON SCI TECHNOL, V31, P1573, DOI 10.1021/es960868i
   Peterson ML, 1996, COLLOID SURFACE A, V107, P77, DOI 10.1016/0927-7757(95)03345-9
   Phillips DH, 2010, ENVIRON SCI TECHNOL, V44, P3861, DOI 10.1021/es902737t
   Pollock J, 2007, APPL MICROBIOL BIOT, V77, P927, DOI 10.1007/s00253-007-1220-5
   Ponder S.M., 2001, CHEM MAT, V13
   Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420
   Puls RW, 1999, APPL GEOCHEM, V14, P989, DOI 10.1016/S0883-2927(99)00010-4
   RAI D, 1989, SCI TOTAL ENVIRON, V86, P15, DOI 10.1016/0048-9697(89)90189-7
   Ravel B., 2009, ATHENA USERS GUIDE 1
   Rizoulis A, 2012, MINERAL MAG, V76, P3261, DOI 10.1180/minmag.2012.076.8.39
   Rowbotham AL, 2000, J TOXICOL ENV HEAL B, V3, P145, DOI 10.1080/10937400050045255
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Skougstad M.W., 1979, 5 USGS, P5
   Stewart DI, 2007, GEOMICROBIOL J, V24, P655, DOI 10.1080/01490450701758221
   Stewart DI, 2010, ECOL ENG, V36, P211, DOI 10.1016/j.ecoleng.2008.12.028
   STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016
   Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001
   Telling ND, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3249578
   Tinjum JM, 2008, SCI TOTAL ENVIRON, V391, P13, DOI 10.1016/j.scitotenv.2007.10.041
   Tratnyek PG, 2006, NANO TODAY, V1, P44, DOI 10.1016/S1748-0132(06)70048-2
   Wang YT, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P225
   Wazne M, 2007, J HAZARD MATER, V143, P620, DOI 10.1016/j.jhazmat.2007.01.012
   Whalley C, 1999, WATER AIR SOIL POLL, V112, P389, DOI 10.1023/A:1005017506227
   Whittleston RA, 2011, GEOMICROBIOL J, V28, P68, DOI 10.1080/01490451.2010.498297
   Whittleston R.A., 2012, APPL GEOCHEM
   Whittleston RA, 2011, J HAZARD MATER, V194, P15, DOI 10.1016/j.jhazmat.2011.07.067
   WHO, 2008, GUID DRINK WAT QUAL
   Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b
   Wilkin RT, 2005, ENVIRON SCI TECHNOL, V39, P4599, DOI 10.1021/es050157x
   Wilkin RT, 2003, GROUND WATER, V41, P493, DOI 10.1111/j.1745-6584.2003.tb02383.x
   Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12
   Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004
   Yuan P, 2009, J HAZARD MATER, V166, P821, DOI 10.1016/j.jhazmat.2008.11.083
   ZACHARA JM, 1987, ENVIRON SCI TECHNOL, V21, P589, DOI 10.1021/es00160a010
   Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015
NR 113
TC 23
Z9 24
U1 7
U2 93
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0883-2927
J9 APPL GEOCHEM
JI Appl. Geochem.
PD MAR
PY 2015
VL 54
BP 27
EP 42
DI 10.1016/j.apgeochem.2014.12.001
PG 16
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA CC2JW
UT WOS:000350172300003
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Sonnenberg, SB
   Rane, AA
   Liu, CJ
   Rao, N
   Agmon, G
   Suarez, S
   Wang, R
   Munoz, A
   Bajaj, V
   Zhang, S
   Braden, R
   Schup-Magoffin, PJ
   Kwan, OL
   De Maria, AN
   Cochran, JR
   Christman, KL
AF Sonnenberg, Sonya B.
   Rane, Aboli A.
   Liu, Cassie J.
   Rao, Nikhil
   Agmon, Gillie
   Suarez, Sophia
   Wang, Raymond
   Munoz, Adam
   Bajaj, Vaibhav
   Zhang, Shirley
   Braden, Rebecca
   Schup-Magoffin, Pamela J.
   Kwan, Oi Ling
   De Maria, Anthony N.
   Cochran, Jennifer R.
   Christman, Karen L.
TI Delivery of an engineered HGF fragment in an extracellular
   matrix-derived hydrogel prevents negative LV remodeling post-myocardial
   infarction
SO BIOMATERIALS
LA English
DT Article
DE Myocardial infarction; Growth factor; Extracellular matrix;
   Decellularization; Hydrogel
ID HEPATOCYTE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; HEART-FAILURE; ALGINATE
   BIOMATERIAL; CARDIAC-FUNCTION; FACTOR-BETA; FIBROSIS; LIVER;
   CARDIOMYOPATHY; DYSFUNCTION
AB Hepatocyte growth factor (HGF) has been shown to have anti-fibrotic, pro-angiogenic, and cardio-protective effects; however, it is highly unstable and expensive to manufacture, hindering its clinical translation. Recently, a HGF fragment (HGF-f), an alternative c-MET agonist, was engineered to possess increased stability and recombinant expression yields. In this study, we assessed the potential of HGF-f, delivered in an extracellular matrix (ECM)-derived hydrogel, as a potential treatment for myocardial infarction (MI). HGF-f protected cardiomyocytes from serum-starvation and induced down-regulation of fibrotic markers in whole cardiac cell isolate compared to the untreated control. The ECM hydrogel prolonged release of HGF-f compared to collagen gels, and in vivo delivery of HGF-f from ECM hydrogels mitigated negative left ventricular (LV) remodeling, improved fractional area change (FAC), and increased arteriole density in a rat myocardial infarction model. These results indicate that HGF-f may be a viable alternative to using recombinant HGF, and that an ECM hydrogel can be employed to increase growth factor retention and efficacy. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Sonnenberg, Sonya B.; Rane, Aboli A.; Rao, Nikhil; Agmon, Gillie; Suarez, Sophia; Wang, Raymond; Munoz, Adam; Bajaj, Vaibhav; Zhang, Shirley; Braden, Rebecca; Schup-Magoffin, Pamela J.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Sonnenberg, Sonya B.; Rane, Aboli A.; Rao, Nikhil; Agmon, Gillie; Suarez, Sophia; Wang, Raymond; Munoz, Adam; Bajaj, Vaibhav; Zhang, Shirley; Braden, Rebecca; Schup-Magoffin, Pamela J.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Liu, Cassie J.; Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Liu, Cassie J.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Kwan, Oi Ling; De Maria, Anthony N.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
OI Zhang, Shirley/0000-0002-5882-5721; Agmon, Gillie/0000-0002-3451-3694
FU National Institutes of Health (NIH) [R01HL113468, R01CA151706,
   5UL1TR000100]
FX This research was supported in part by National Institutes of Health
   (NIH) through R01HL113468, R01CA151706, and 5UL1TR000100.
CR Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039
   Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6
   Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4
   Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105
   Cheng AS, 2008, SEMIN THORAC CARDIOV, V20, P94, DOI 10.1053/j.semtcvs.2008.04.003
   Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Esposito C, 2005, KIDNEY INT, V67, P2143, DOI 10.1111/j.1523-1755.2005.00319.x
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x
   Haruyama T, 2000, BIOCHEM BIOPH RES CO, V272, P681, DOI 10.1006/bbrc.2000.2837
   Jin HK, 2004, CURR PHARM DESIGN, V10, P2525, DOI 10.2174/1381612043383863
   Jin HK, 2003, J PHARMACOL EXP THER, V304, P654, DOI 10.1124/jpet.102.041772
   Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   LEE AA, 1995, J MOL CELL CARDIOL, V27, P2347, DOI 10.1016/S0022-2828(95)91983-X
   Li RK, 1997, CIRCULATION, V96, P874
   Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8
   Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034
   Liu CJ, 2014, FEBS LETT, V588, P4831, DOI 10.1016/j.febslet.2014.11.018
   Messerli FH, 2004, EUR HEART J, V25, P1475, DOI 10.1016/j.ehj.2004.07.015
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176
   Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003
   NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x
   Ono M, 2002, CIRCULATION, V106, pI264, DOI 10.1161/cir.0000032879.55215.f4
   Rajendran R, 2006, Indian J Dent Res, V17, P161
   Ross J, 2012, GASTROENTEROLOGY, V142, P897, DOI 10.1053/j.gastro.2011.12.006
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Stewart N, 2013, AM J PHYSIOL-RENAL, V304, pF625, DOI 10.1152/ajprenal.00504.2012
   TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485
   Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF
   Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273
   Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3
   Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132
   Yang ZJ, 2010, MOL BIOL REP, V37, P2075, DOI 10.1007/s11033-009-9665-5
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 47
TC 31
Z9 33
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2015
VL 45
BP 56
EP 63
DI 10.1016/j.biomaterials.2014.12.021
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CC2RD
UT WOS:000350191400007
PM 25662495
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Laothumthut, T
   Jantarat, J
   Paemanee, A
   Roytrakul, S
   Chunhabundit, P
AF Laothumthut, Titikan
   Jantarat, Jeeraphat
   Paemanee, Atchara
   Roytrakul, Sittiruk
   Chunhabundit, Panjit
TI Shotgun proteomics analysis of proliferating STRO-1-positive human
   dental pulp cell after exposure to nacreous water-soluble matrix
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Human dental pulp cell; Mineralization; Nacre; Pinctada maxima; Shotgun
   proteomics
ID HUMAN BONE-MARROW; PINCTADA-MAXIMA; ORGANIC MATRIX; STEM-CELLS;
   IN-VITRO; PROTEINS; REGENERATION; OSTEOBLASTS; EXPRESSION; INDUCTION
AB For dental treatment, dentin regeneration is required after a tooth injury with dental pulp exposure. The effects of the water-soluble matrix (WSM) extracted from the nacreous layer of the bivalve Pinctada maxima on human dental pulp cells in vitro were challenging and useful for clinical application.
   The biological activity of the STRO-1-positive human dental pulp cells in response to WSM compared to Dulbecco's modified Eagle medium (DMEM) as a normal control was monitored. The cell survival rate was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Proteomic profiles among inducers and noninducers with time dependency were compared by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis combined with liquid chromatography-tandem mass spectrometry (GeLC-MS/MS).
   The human dental pulp cells cultured in nacreous WSM exhibited higher relative cell viability than those in DMEM with similar morphological appearance. Significant changes were found in the relative abundance of 44 proteins in cells after exposure to WSM for 2 weeks. They play a role in cell adhesion, cell proliferation, metabolic process, signal transduction, stress response, transcription, translation, and transport.
   These results indicate that WSM of P. maxima has the ability to induce proliferation of human dental pulp cells.
   This finding initiated the study to evaluate the suitability of nacre as biomaterial for dentistry.
C1 [Laothumthut, Titikan] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.
   [Jantarat, Jeeraphat] Mahidol Univ, Fac Dent, Dept Operat Dent & Endodont, Bangkok 10700, Thailand.
   [Paemanee, Atchara; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Klongluang, Pathumthani, Thailand.
   [Chunhabundit, Panjit] Mahidol Univ, Fac Dent, Dept Anat, Bangkok 10700, Thailand.
RP Laothumthut, T (reprint author), Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.
EM titikan.lao@mahidol.ac.th
OI Jantarat, Jeeraphat/0000-0001-8239-0716
CR Akkouch A, 2014, J BIOMATER APPL, V28, P922, DOI 10.1177/0885328213486705
   Asvanund P, 2012, IMPLANT DENT, V21, P248, DOI 10.1097/ID.0b013e3182563ae0
   Asvanund P, 2011, IMPLANT DENT, V20, P32, DOI 10.1097/ID.0b013e3182061be1
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7
   Bedouet L, 2007, MAR BIOTECHNOL, V9, P638, DOI 10.1007/s10126-007-9017-1
   Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   Helmut B, 1987, ELECTROPHORESIS, V8, P93
   Honda JY, 2008, HISTOL HISTOPATHOL, V23, P423, DOI 10.14670/HH-23.423
   Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921
   Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207
   Lee SK, 2010, J ENDODONT, V36, P1537, DOI 10.1016/j.joen.2010.04.027
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Melin M, 2000, J DENT RES, V79, P1689, DOI 10.1177/00220345000790090901
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2002, GENE THER, V9, P814, DOI 10.1038/sj/gt/3301692
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nie X, 2006, CELL BIOL INT, V30, P295, DOI 10.1016/j.cellbi.2005.12.001
   Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Saad FA, 2011, INT ORTHOP, V35, P447, DOI 10.1007/s00264-010-1076-7
   Benedete APS, 2008, PEDIATR DEVEL PATHOL, V11, P206, DOI 10.2350/07-09-0333.1
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Shichijo S, 2004, CLIN CANCER RES, V10, P5828, DOI 10.1158/1078-0432.CCR-04-0350
   Terry DE, 2004, J AM SOC MASS SPECTR, V15, P784, DOI 10.1016/j.jasms.2004.02.005
   Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898
   Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1
   WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379
   Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16
   Zhu Q, 2000, Chin J Dent Res, V3, P21
NR 37
TC 2
Z9 2
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2015
VL 19
IS 2
BP 261
EP 270
DI 10.1007/s00784-014-1256-8
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC4VT
UT WOS:000350353300012
PM 24923583
DA 2018-10-20
ER

PT J
AU Karygianni, L
   Anderson, AC
   Tennert, C
   Kollmar, K
   Altenburger, MJ
   Hellwig, E
   Al-Ahmad, A
AF Karygianni, L.
   Anderson, A. C.
   Tennert, C.
   Kollmar, K.
   Altenburger, M. J.
   Hellwig, E.
   Al-Ahmad, A.
TI Supplementary sampling of obturation materials enhances microbial
   analysis of endodontic treatment failures: a proof of principle study
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Posttreatment apical periodontitis; Obturation materials; Bacterial
   colonization; Culture method; 16S rDNA; Clone library analysis
ID ROOT-FILLED TEETH; CANAL-TREATED TEETH; GUTTA-PERCHA; PERIRADICULAR
   LESIONS; DENTIN INTERFACES; MICROORGANISMS; BACTERIAL; IDENTIFICATION;
   INFECTIONS; PERIODONTITIS
AB Root canal treatment failures often correlate with persistent biomaterial-associated endodontic infections. The aim of the present study was to assess the impact of endodontic obturation material sampling from root canals with posttreatment apical periodontitis on improving standard study protocols.
   Samples from previously filled root canals and their corresponding endodontic filling materials were obtained from five root-filled teeth with posttreatment periradicular lesions. After cultivation, the isolated microorganisms were quantified and biochemically identified. Moreover, clone libraries were constructed after the amplification of bacterial 16S ribosomal DNA (rDNA) from the same samples. DNA from selected clones was sequenced to identify microbial species. Transmission electron microscopy (TEM) aided visualization of the detected bacteria.
   Overall, 22 taxa of the phyla Firmicutes, Actinobacteria, and Bacteroidetes were detected in both obturation and root canal samples by culture-dependent and culture-independent methods. Root canal fillings sheltered 17 species (3.30-7.50 x 10(3) CFU/ml). Of these, nine were detected solely in the retrieved obturation materials. The reinfected root canals harbored 13 taxa (3.48-7.36 x 10(3) CFU/ml). Obligate and facultative anaerobic bacteria prevailed. The number of different species ranged from 1 to 5 within a single sample. Fungi were not detected.
   Bacteria can colonize both root canals and endodontic fillings in vivo.
   Integrating the sampling of obturation materials with standard root canal sample collection offers a clearer insight into the actual microbial flora of reinfected root canals and improves the study protocols of secondary/persistent endodontic infections.
C1 [Karygianni, L.; Anderson, A. C.; Tennert, C.; Kollmar, K.; Altenburger, M. J.; Hellwig, E.; Al-Ahmad, A.] Univ Freiburg, Dept Operat Dent & Periodontol, Ctr Dent Med, D-79106 Freiburg, Germany.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Dept Operat Dent & Periodontol, Ctr Dent Med, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM ali.al-ahmad@uniklinik-freiburg.de
FU German Research Foundation (DFG) [AL 1179/1-1]
FX The authors express their gratitude to Annette Wittmer, Bettina
   Spitzmuller, and Barbara Joch for their excellent technical help. This
   study was supported by the German Research Foundation (DFG, AL
   1179/1-1).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anderson AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049576
   Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005
   Borgo F, 2013, J BASIC MICROB, V53, P20, DOI 10.1002/jobm.201100464
   Chen TC, 2010, FLORA CHINA, V10, P6
   Cheung GSP, 2001, ORAL MICROBIOL IMMUN, V16, P332, DOI 10.1034/j.1399-302X.2001.160603.x
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Farzaneh M, 2004, J ENDODONT, V30, P627, DOI 10.1097/01.DON.0000129958.12388.82
   Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07
   GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x
   George S, 2010, J ENDODONT, V36, P1241, DOI 10.1016/j.joen.2010.03.024
   Gomes BPFD, 2005, ORAL SURG ORAL MED O, V100, P512, DOI 10.1016/j.tripleo.2004.10.002
   Hirai VHG, 2010, ORAL SURG ORAL MED O, V109, pE131, DOI 10.1016/j.tripleo.2009.09.038
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hashimoto M, 2010, J BIOMED MATER RES B, V92B, P268, DOI 10.1002/jbm.b.31535
   Kermanshahi S, 2010, J DENT RES, V89, P996, DOI 10.1177/0022034510372885
   Linares DM, 2013, INT J FOOD MICROBIOL, V165, P43, DOI 10.1016/j.ijfoodmicro.2013.04.021
   Love RM, 2002, ORAL MICROBIOL IMMUN, V17, P32, DOI 10.1046/j.0902-0055.2001.00090.x
   Nagy E, 2013, ANAEROBE, V20, P20, DOI 10.1016/j.anaerobe.2013.01.007
   Nambu T, 2013, ARCH ORAL BIOL, V58, P681, DOI 10.1016/j.archoralbio.2012.10.017
   Nawal RR, 2011, ORAL SURG ORAL MED O, V111, P387, DOI 10.1016/j.tripleo.2010.09.070
   Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001
   Paiva SSM, 2013, J ENDODONT, V39, P190, DOI 10.1016/j.joen.2012.09.014
   Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x
   Pinheiro ET, 2003, ORAL MICROBIOL IMMUN, V18, P100, DOI 10.1034/j.1399-302X.2003.00058.x
   Richardson N, 2009, INT ENDOD J, V42, P908, DOI 10.1111/j.1365-2591.2009.01594.x
   Rocas IN, 2004, J ENDODONT, V30, P504, DOI 10.1097/00004770-200407000-00011
   Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12
   Rolph HJ, 2001, J CLIN MICROBIOL, V39, P3282, DOI 10.1128/JCM.39.9.3282-3289.2001
   Roth KA, 2012, J ENDODONT, V38, P1253, DOI 10.1016/j.joen.2012.05.014
   Sakamoto SM, 2008, ORAL MICROBIOL IMMUN, V23, P275
   Schirrmeister JF, 2007, J ENDODONT, V33, P536, DOI 10.1016/j.joen.2007.01.012
   Schirrmeister JF, 2009, J ENDODONT, V35, P169, DOI 10.1016/j.joen.2008.10.024
   Senges C, 2011, J ENDODONT, V37, P1247, DOI 10.1016/j.joen.2011.05.034
   Shokati B, 2010, J BIOMED MATER RES B, V94B, P230, DOI 10.1002/jbm.b.31645
   Siqueira JF, 2007, ORAL MICROBIOL IMMUN, V22, P266, DOI 10.1111/j.1399-302X.2007.00355.x
   Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6
   Siqueira JF, 2005, J CLIN MICROBIOL, V43, P3314, DOI 10.1128/JCM.43.7.3314-3319.2005
   Subramanian K, 2009, J ENDODONT, V35, P950, DOI 10.1016/j.joen.2009.04.010
   Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8
   Takemura N, 2004, EUR J ORAL SCI, V112, P523, DOI 10.1111/j.1600-0722.2004.00165.x
   Teixeira CS, 2009, J APPL ORAL SCI, V17, P129, DOI 10.1590/S1678-77572009000200011
   Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006
   Wahab R, 2010, APPL MICROBIOL BIOT, V87, P1917, DOI 10.1007/s00253-010-2692-2
   Young G, 2007, J ENDODONT, V33, P1417, DOI 10.1016/j.joen.2007.09.002
NR 45
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAR
PY 2015
VL 19
IS 2
BP 319
EP 327
DI 10.1007/s00784-014-1231-4
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC4VT
UT WOS:000350353300018
PM 24677170
DA 2018-10-20
ER

PT J
AU Barton, MJ
   Morley, JW
   Stoodley, MA
   Shaikh, S
   Mahns, DA
   Lauto, A
AF Barton, Matthew J.
   Morley, John W.
   Stoodley, Marcus A.
   Shaikh, Sumaiya
   Mahns, David A.
   Lauto, Antonio
TI Long term recovery of median nerve repair using laser-activated chitosan
   adhesive films
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article
DE biomaterial; chitosan; laser; peripheral-nerve-repair;
   photochemical-tissue-bonding and rose-bengal
ID PROTEIN BAND TECHNIQUE; RAT SCIATIC-NERVE; IN-VITRO; PERIPHERAL-NERVES;
   SCHWANN-CELLS; FIBRIN GLUE; ROSE-BENGAL; TISSUE; REGENERATION; SUTURE
AB Sutures remain the standard peripheral nerve repair technique, whether applied directly or indirectly to nerve tissue. Unfortunately, significant postoperative complications can result, such as inflammation, neuroma formation and foreign body reactions. Photochemical-tissue-bonding (PTB) using rose Bengal (RB) integrated into a chitosan bioadhesive is an alternative nerve repair device that removes the need for sutures. Rats were arranged into three groups: RB-chitosan adhesives-repair, end-to-end epineural suture-repair (surgical standard) and sham laser-irradiated control. Groups were compared through histological assessment, electrophysiological recordings and grip motor strength. RB-chitosan adhesive repaired nerves displayed comparable results when compared to the standard suture-repair based on histological and electrophysiological findings. Functionally, RB-chitosan adhesive was associated with a quicker and more pronounced recovery of grip force when compared to the suture-repair.
   [GRAPHICS]
   Longitudinal sections of nerve anastomosis after 4 weeks (top) and 12 weeks (bottom); the nerves were repaired using the laser-adhesive technique (scale bar 50 mu m).
C1 [Barton, Matthew J.; Morley, John W.; Shaikh, Sumaiya; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, Sch Med, Penrith, NSW 2751, Australia.
   [Morley, John W.; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, MARCS Inst, Bioelect & Neurosci BENS Res Grp, Penrith, NSW 2751, Australia.
   [Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.
RP Lauto, A (reprint author), Univ Western Sydney, Sch Med, Locked Bag 1797, Penrith, NSW 2751, Australia.
EM a.lauto@uws.edu.au
OI Stoodley, Marcus/0000-0002-4207-8493; Mahns, David/0000-0003-2131-9638
FU University of Western Sydney
FX This study was supported by internal University of Western Sydney
   funding. We thank Dr Hong Duong for her assistance with the LFB
   histology preparation and Dr Richard Wuhrer for assistance with the SEM
   work.
CR Barton M, 2013, J BIOPHOTONICS, V6, P938, DOI 10.1002/jbio.201300054
   Barton M, 2012, LASER SURG MED, V44, P762, DOI 10.1002/lsm.22076
   Basbaum AI, 2009, SCI PAIN
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   BENKE TA, 1989, LASER SURG MED, V9, P602, DOI 10.1002/lsm.1900090611
   CAMPION ER, 1990, J BONE JOINT SURG AM, V72A, P715, DOI 10.2106/00004623-199072050-00011
   CAREY DJ, 1983, J CELL BIOL, V97, P473, DOI 10.1083/jcb.97.2.473
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Cheng J. W., 2013, BMC ANESTHESIOL, V13
   CHUDLER EH, 1983, PAIN, V17, P341, DOI 10.1016/0304-3959(83)90165-3
   Cronin L, 2014, J BIOPHOTONICS, V7, P410, DOI 10.1002/jbio.201200168
   Dagum A B, 1998, J Hand Ther, V11, P111
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   FITZGERALD M, 1979, J PHYSIOL-LONDON, V297, P207, DOI 10.1113/jphysiol.1979.sp013035
   HUANG TC, 1992, OTOLARYNG HEAD NECK, V107, P14, DOI 10.1177/019459989210700103
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Hwang K, 2005, J CRANIOFAC SURG, V16, P1102, DOI 10.1097/01.scs.0000179740.60671.e5
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Johnson TS, 2007, J SURG RES, V143, P224, DOI 10.1016/j.jss.2007.01.028
   KAJANDER KC, 1992, NEUROSCI LETT, V138, P225, DOI 10.1016/0304-3940(92)90920-3
   Kamegaya Y, 2005, LASER SURG MED, V37, P264, DOI 10.1002/lsm.20221
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 1998, MICROSURG, V18, P55, DOI 10.1002/(SICI)1098-2752(1998)18:1<55::AID-MICR12>3.0.CO;2-R
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A., 2012, J VIS EXP, V68
   Lauto A., 2010, BIOMED ENG, V9, P47
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   LUNDBORG G, 1987, ACTA ORTHOP SCAND, V58, P145, DOI 10.3109/17453678709146461
   Martins RS, 2011, NEUROSURGERY, V68, P765, DOI 10.1227/NEU.0b013e3182077332
   Matras H, 1973, J Maxillofac Surg, V1, P37, DOI 10.1016/S0301-0503(73)80010-4
   Menovsky T, 1995, NEUROSURG REV, V18, P225, DOI 10.1007/BF00383873
   Menovsky T, 2003, MICROSURG, V23, P109, DOI 10.1002/micr.10100
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   O'Neill AC, 2007, LASER SURG MED, V39, P716, DOI 10.1002/lsm.20548
   O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025
   Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   POPPAS DP, 1992, J UROLOGY, V148, P220, DOI 10.1016/S0022-5347(17)36557-6
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011
   Santos AP, 2007, ANAT REC, V290, P477, DOI 10.1002/ar.20519
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Spector D, 2009, LASER SURG MED, V41, P504, DOI 10.1002/lsm.20799
   Talmor M, 2001, Arch Facial Plast Surg, V3, P207, DOI 10.1001/archfaci.3.3.207
   Temple CLF, 2004, J RECONSTR MICROSURG, V20, P645, DOI 10.1055/s-2004-861525
   Wachter E, 2003, LASER SURG MED, V32, P101, DOI 10.1002/lsm.10138
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019
   Yang PG, 2012, LASER SURG MED, V44, P163, DOI 10.1002/lsm.21137
   Yao M, 2010, LASER SURG MED, V42, P123, DOI 10.1002/lsm.20869
NR 54
TC 11
Z9 11
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD MAR
PY 2015
VL 8
IS 3
BP 196
EP 207
DI 10.1002/jbio.201300129
PG 12
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA CC6CQ
UT WOS:000350452700002
PM 24132983
DA 2018-10-20
ER

PT J
AU Jayakumar, GC
   Usharani, N
   Yasothai, A
   Kanth, SV
   Rao, JR
AF Jayakumar, Gladstone Christopher
   Usharani, Nagarajan
   Yasothai, Arjunan
   Kanth, Swarna Vinodh
   Rao, Jonnalagadda Raghava
TI KINETICS OF INHIBITION OF TYPE I COLLAGENASE BY DIALDEHYDE CELLULOSE IN
   STABILIZATION OF TYPE I COLLAGEN
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID CLOSTRIDIUM-HISTOLYTICUM COLLAGENASE; CIRCULAR-DICHROISM SPECTRA;
   ATOMIC-FORCE MICROSCOPY; MOLECULAR-STRUCTURE; TRIPLE-HELIX; PROTEINS;
   STABILITY; OXIDATION; PEPTIDE; SITES
AB Collagen is one of the widely studied biomaterial for various industrial applications. However, search of eco-friendly and biocompatible stabilizing agent is a thrust research domain. In this research work, application of dialdehyde cellulose (DAC) was studied to understand the effect on the enzymatic and conformational stability in collagen. The secondary structure of collagen is not significantly altered on interaction with DAC. But, it was found that DAC lead to changes in the amplitude of the circular dichroic (CD) spectrum but did not alter the triple helical conformation of collagen. DAC treated collagen exhibited 93% resistance to collagenolytic hydrolysis. Conversely, DAC treated collagenase exhibited 89% inhibition against collagen degradation and the inhibition was found to be concentration dependent. The kinetics of inhibition of collagenase by DAC was derived from the extent of hydrolysis of (2-furanacryloyl-L-leucyl-glycyl-L-prolyl-L-alanine), FALGPA. DAC exhibited non-competitive mode of inhibition against collagenase. CD data on DAC-modified collagenase substantiate the hypothesis that the inhibition of collagenase by DAC arises from secondary and quaternary structural changes in the enzyme. Gaining new insights in understanding the mechanism of stabilization of collagen by DAC through kinetics of inhibition of collagenase was presented.
C1 [Kanth, Swarna Vinodh] Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Kanth, SV (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
EM chordclri@lycos.com
CR ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BOND MD, 1984, BIOCHEMISTRY-US, V23, P3085, DOI 10.1021/bi00308a036
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Calvini P, 2006, CELLULOSE, V13, P571, DOI 10.1007/s10570-005-9035-y
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Espenson J.H., 1995, CHEM KINETICS REACTI, P113
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095
   GALARDY RE, 1983, BIOCHEMISTRY-US, V22, P4556, DOI 10.1021/bi00288a032
   Goodman M, 1996, J AM CHEM SOC, V118, P5156, DOI 10.1021/ja954132h
   HEINDL MC, 1980, BIOCHIM BIOPHYS ACTA, V624, P51, DOI 10.1016/0005-2795(80)90224-X
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Kanth SV, 2006, J AM LEATHER CHEM AS, V101, P444
   KELLER S, 1963, ARCH BIOCHEM BIOPHYS, V101, P81, DOI 10.1016/0003-9861(63)90537-X
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Massova M., 1998, FASEB J, V12, P1075
   MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3
   Ohtani K, 1997, FEMS MICROBIOL LETT, V146, P155, DOI 10.1016/S0378-1097(96)00472-7
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A
   PERCZEL A, 1992, PROTEINS, V13, P57, DOI 10.1002/prot.340130106
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   Sang QXA, 1996, J PROTEIN CHEM, V15, P137, DOI 10.1007/BF01887395
   Silvia V., 2004, THERMOCHIM ACTA, V418, P123
   STOCKER W, 1995, PROTEIN SCI, V4, P823
   VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0
   Varma AJ, 2002, POLYM DEGRAD STABIL, V77, P25, DOI 10.1016/S0141-3910(02)00073-3
   VENCILL CF, 1985, BIOCHEMISTRY-US, V24, P3149, DOI 10.1021/bi00334a012
   Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 33
TC 0
Z9 0
U1 2
U2 13
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA 1314 50 ST, STE 103, LUBBOCK, TX 79412 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD MAR
PY 2015
VL 110
IS 3
BP 72
EP 79
PG 8
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA CC7AP
UT WOS:000350520400002
DA 2018-10-20
ER

PT J
AU Jones, CH
   Chen, CK
   Chen, MF
   Ravikrishnan, A
   Zhang, HG
   Gollakota, A
   Chung, TC
   Cheng, C
   Pfeifer, BA
AF Jones, Charles H.
   Chen, Chih-Kuang
   Chen, Mingfu
   Ravikrishnan, Anitha
   Zhang, Hanguang
   Gollakota, Akhila
   Chung, Taichun
   Cheng, Chong
   Pfeifer, Blaine A.
TI PEGylated Cationic Polylactides for Hybrid Biosynthetic Gene Delivery
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE cationic polymer; polylactide; gene therapy; gene delivery; biosynthetic
   hybrid
ID MICROBIAL ADHESION; E. COLI; POLYMERS; RECOMBINANT; HYDROPHOBICITY;
   NANOPARTICLES; HYDROCARBONS; CHEMISTRY; CELLS; MATH
AB Genetic vaccination is predicated on the underlying principle that diseases can be prevented by the controlled introduction of genetic material encoding antigenic proteins from pathogenic organisms to elicit the formation of protective immune responses. Driving this process is the choice of carrier that is responsible for navigating the obstacles associated with gene delivery. In this work, we expand upon a novel class of hybrid biosynthetic gene delivery vectors that are composed of a biomaterial outer coating and a bacterial (Escherichia coli) inner core. Specifically, a series of newly developed biodegradable cationic polylactides (CPLAs) and their PEGylated variants were selected to investigate the role of low polydispersity index (PDI), charge density, and PEGylation upon hybrid vector assembly and gene delivery efficacy. Upon assembly, hybrid vectors mediated increased gene delivery beyond that of the individual bacterial vector in isolation, including assays with increasing medium protein content to highlight shielding properties afforded by the PEG-functionalized CPLA component. Furthermore, after extensive characterization of surface deposition of the polymer, results prompted a new model for describing hybrid vector assembly that includes cellular coating and penetration of the CPLA component. In summary, these results provide new options and insight toward the assembly and application of next-generation hybrid biosynthetic gene delivery vectors.
C1 [Jones, Charles H.; Chen, Chih-Kuang; Chen, Mingfu; Ravikrishnan, Anitha; Zhang, Hanguang; Gollakota, Akhila; Chung, Taichun; Cheng, Chong; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Chen, Chih-Kuang] Feng Chia Univ, Dept Fiber & Composite Mat, Taichung 40724, Taiwan.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
RI Cheng, Chong/K-2050-2014
OI Chen, Mingfu/0000-0002-0169-613X
FU NSF [CBET-1019227, DMR-1133737]; NIH [AI088485]; SUNY-Buffalo Schomburg
   fellowship
FX The authors recognize support from NSF grants CBET-1019227 and
   DMR-1133737 (to C.C.), NIH award AI088485 (to B.A.P.), and a
   SUNY-Buffalo Schomburg fellowship (to C.H.J.).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Chen CK, 2013, BIOMATERIALS, V34, P9688, DOI 10.1016/j.biomaterials.2013.08.063
   Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8
   Chen HA, 2010, BIOMATERIALS, V31, P8172, DOI 10.1016/j.biomaterials.2010.07.056
   Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Jones CH, 2013, MOL PHARMACEUT, V10, P1138, DOI 10.1021/mp300666s
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Parsa S, 2008, PHARM RES, V25, P1202, DOI 10.1007/s11095-008-9563-x
   Parsa S, 2007, MOL PHARMACEUT, V4, P4, DOI 10.1021/mp0600889
   Radford KJ, 2002, GENE THER, V9, P1455, DOI 10.1038/sj.gt.3301812
   Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x
   Salton M. R. J., 1996, MED MICROBIOLOGY
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Zou J, 2011, ADV MATER, V23, P4274, DOI 10.1002/adma.201101646
NR 28
TC 10
Z9 10
U1 0
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAR
PY 2015
VL 12
IS 3
BP 846
EP 856
DI 10.1021/mp500683c
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA CC5HY
UT WOS:000350390900018
PM 25625426
DA 2018-10-20
ER

PT J
AU Yasmin, C
   Otoi, T
   Setiadi, MA
   Karja, NWK
AF Yasmin, Cut
   Otoi, Takeshige
   Setiadi, Mohamad Agus
   Karja, Ni Wayan Kurniani
TI MATURATION AND FERTILISATION OF SHEEP OOCYTES CULTURED IN SERUM-FREE
   MEDIUM CONTAINING SILK PROTEIN SERICIN
SO ACTA VETERINARIA HUNGARICA
LA English
DT Article
DE Albumin; antioxidants; in vitro maturation; meiotic competence; ovine
   oocyte; silk protein; sericin
ID IN-VITRO MATURATION; EMBRYO DEVELOPMENT; BOVINE EMBRYOS; SILKWORMS
AB Sericin is a water-soluble component of silk and has been used as a biomaterial due to its antibacterial and ultraviolet radiation-resistant properties. This study was designed to evaluate the effect of sericin supplementation in a maturation medium on the meiotic competence and fertilisability of sheep oocytes. Cumulus-oocyte complexes (COCs) were cultured in TCM199 supplemented with sericin at various concentrations of 0 (control), 0.1, 0.25 and 0.5%, either with or without bovine serum albumin (BSA). When the COCs were matured without BSA, the supplementation of 0.1% sericin significantly increased the rates of maturation to metaphase II and the total fertilisation of oocytes compared with the other concentrations of sericin. When the COCs were matured with BSA, the beneficial effects of 0.1% sericin supplementation on the maturation and fertilisation of oocytes were not observed. Our findings indicate that supplementation with 0.1% sericin during maturation culture may improve the nuclear maturation and fertilisability of sheep oocytes. Moreover, it may be possible to replace BSA with sericin in chemically defined media without the risk of disease transmission.
C1 [Yasmin, Cut; Setiadi, Mohamad Agus; Karja, Ni Wayan Kurniani] Bogor Agr Univ, Dept Clin Reprod & Pathol, Div Reprod, Bogor, Jawa Barat, Indonesia.
   [Otoi, Takeshige] United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.
RP Otoi, T (reprint author), United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.
EM otoi@yamaguchi-u.ac.jp
OI Otoi, Takeshige/0000-0002-0382-959X
FU JSPS/DGHE
FX This work was partly supported by the JSPS/DGHE Joint Research Project
   2011-2013.
CR Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   de Matos DG, 2002, THERIOGENOLOGY, V57, P1443, DOI 10.1016/S0093-691X(02)00643-X
   Do LTK, 2014, REPROD DOMEST ANIM, V49, pe17, DOI 10.1111/rda.12274
   George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008
   Hosoe M, 2014, J REPROD DEVELOP, V60, P268, DOI 10.1262/jrd.2013-110
   Isobe T, 2012, THERIOGENOLOGY, V78, P747, DOI 10.1016/j.theriogenology.2012.03.021
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057
   Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 13
TC 9
Z9 9
U1 0
U2 2
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0236-6290
EI 1588-2705
J9 ACTA VET HUNG
JI Acta Vet. Hung.
PD MAR
PY 2015
VL 63
IS 1
BP 110
EP 117
DI 10.1556/AVet.2015.009
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA CC0NT
UT WOS:000350033300011
PM 25655418
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Liu, X
   Pi, B
   Wang, H
   Wang, XM
AF Liu, Xi
   Pi, Bin
   Wang, Hui
   Wang, Xiu-Mei
TI Self-assembling peptide nanofiber hydrogels for central nervous system
   regeneration
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE self-assembling peptide; hydrogel; central nervous system (CNS); nerve
   regeneration
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PROMOTES
   FUNCTIONAL RECOVERY; OLFACTORY ENSHEATHING CELLS; AXONAL GROWTH;
   AMPHIPHILE NANOFIBERS; ADULT-RAT; IN-VIVO; NEUROTROPHIC FACTOR
AB Central nervous system (CNS) presents a complex regeneration problem due to the inability of central neurons to regenerate correct axonal and dendritic connections. However, recent advances in developmental neurobiology, cell signaling, cell-matrix interaction, and biomaterials technologies have forced a reconsideration of CNS regeneration potentials from the viewpoint of tissue engineering and regenerative medicine. The applications of a novel tissue regeneration-inducing biomaterial and stem cells are thought to be critical for the mission. The use of peptide nanofiber hydrogels in cell therapy and tissue engineering offers promising perspectives for CNS regeneration. Self-assembling peptide undergo a rapid transformation from liquid to gel upon addition of counterions or pH adjustment, directly integrating with the host tissue. The peptide nanofiber hydrogels have mechanical properties that closely match the native central nervous extracellular matrix, which could enhance axonal growth. Such materials can provide an optimal three dimensional microenvironment for encapsulated cells. These materials can also be tailored with bioactive motifs to modulate the wound environment and enhance regeneration. This review intends to detail the recent status of self-assembling peptide nanofiber hydrogels for CNS regeneration.
C1 [Liu, Xi; Wang, Hui] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Liu, Xi; Wang, Xiu-Mei] Tsinghua Univ, Sch Mat Sci & Engn, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Beijing 100084, Peoples R China.
   [Pi, Bin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou 215006, Peoples R China.
RP Wang, XM (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Inst Regenerat Med & Biomimet Mat, Key Lab Adv Mat, Beijing 100084, Peoples R China.
EM wxm@mail.tsinghua.edu.cn
FU National Natural Science Foundation of China [51303119, 51203108];
   Natural Science Foundation of Jiangsu Province [BK20130309, BK201341421,
   BK2011355]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions [13KJB430019]; National Science Foundation for
   Post-doctoral Scientists of China [2013M541724, 2014T70545]; Tsinghua
   University Initiative Scientific Research Program [20121087982]; 973
   Program [2011CB606205]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 51303119 and 51203108), Natural Science Foundation of
   Jiangsu Province (BK20130309, BK201341421, BK2011355), Natural Science
   Foundation of the Jiangsu Higher Education Institutions (13KJB430019),
   National Science Foundation for Post-doctoral Scientists of China
   (2013M541724 and 2014T70545), Tsinghua University Initiative Scientific
   Research Program (20121087982), and 973 Program (2011CB606205).
CR Abidian MR, 2009, ADV MATER, V21, P3764, DOI 10.1002/adma.200900887
   Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Alivisatos AP, 1998, ADV MATER, V10, P1297
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Angeloni N, 2013, J SEX MED, V10, P1240, DOI 10.1111/j.1743-6109.2012.02930.x
   Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bakota EL, 2013, BIOMACROMOLECULES, V14, P1370, DOI 10.1021/bm4000019
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Bakota EL, 2009, BIOMACROMOLECULES, V10, P2201, DOI 10.1021/bm900382a
   Bartolomei JC, 2000, NEUROSURGERY, V47, P1057, DOI 10.1097/00006123-200011000-00006
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0
   Bond CW, 2013, J SEX MED, V10, P730, DOI 10.1111/jsm.12030
   BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   Braun PV, 1999, J AM CHEM SOC, V121, P7302, DOI 10.1021/ja9833725
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ellis-Behnke RG, 2011, METHODS MOL BIOL, V726, P259, DOI 10.1007/978-1-61779-052-2_17
   French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1
   Grill R, 1997, J NEUROSCI, V17, P5560
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Hou TY, 2012, TISSUE ENG PT A, V18, P974, DOI [10.1089/ten.tea.2011.0151, 10.1089/ten.TEA.2011.0151]
   Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hutchinson RW, 2011, NEUROSURGERY, V69, P921, DOI 10.1227/NEU.0b013e318222ad63
   Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794
   Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011
   Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Kato T, 2002, SCIENCE, V295, P2414, DOI 10.1126/science.1070967
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471
   Kubinova S, 2010, NANOMEDICINE-UK, V5, P99, DOI [10.2217/nnm.09.93, 10.2217/NNM.09.93]
   Kuchner E F, 1976, Surg Neurol, V6, P371
   Kumada Y, 2010, SOFT MATTER, V6, P5073, DOI 10.1039/c0sm00333f
   Ladd MR, 2011, NANOFIBERS PRODUCTIO
   Langer R, 1998, NATURE, V392, P5
   Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Liang YX, 2011, NANOMED-NANOTECHNOL, V7, P351, DOI 10.1016/j.nano.2010.12.001
   Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031
   Liu X, 2013, ACTA BIOMATER, V9, P6798, DOI 10.1016/j.actbio.2013.01.027
   Liu X, 2012, NANOSCALE, V4, P2720, DOI [10.1039/c2nr00001, 10.1039/c2nr00001f]
   Liu Y, 1999, J NEUROSCI, V19, P4370
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mao HQ, 2010, STUD MECHANOBIOL TIS, V2, P89, DOI 10.1007/8415_2010_2
   Mershin A, 2005, NAT BIOTECHNOL, V23, P1379, DOI 10.1038/ndt1105-1379
   Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120
   Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021
   Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765
   Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Russell LE, 2010, J AM CHEM SOC, V132, P3242, DOI 10.1021/ja909720g
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150
   Silva GA, 2005, SURG NEUROL, V63, P301, DOI 10.1016/j.surneu.2004.06.008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stupp SI, 2005, CHEM REV, V105, P1023, DOI 10.1021/cr030060y
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Suzuki S, 2012, BIOMATERIALS SURG OP
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tosi G, 2010, J CONTROL RELEASE, V145, P49, DOI 10.1016/j.jconrel.2010.03.008
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wang XM, 2011, PROG NAT SCI, V21, P111, DOI 10.1016/S1002-0071(12)60043-4
   Wang XM, 2012, INTERFACE FOCUS, V2, P278, DOI 10.1098/rsfs.2012.0016
   Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang HN, 2013, NEUROSCI LETT, V556, P63, DOI 10.1016/j.neulet.2013.09.063
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang WW, 2012, J NANOMATER, DOI 10.1155/2012/724857
   Zhao X, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-60
   Zhou YF, 2009, CHEM COMMUN, P1172, DOI 10.1039/b814560c
   Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x
   Zubarev ER, 2002, J AM CHEM SOC, V124, P5762, DOI 10.1021/ja020071t
NR 138
TC 6
Z9 7
U1 3
U2 113
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2015
VL 9
IS 1
BP 1
EP 13
DI 10.1007/s11706-015-0274-z
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC0VZ
UT WOS:000350057700001
DA 2018-10-20
ER

PT J
AU Wang, P
   Pi, B
   Wang, JN
   Zhu, XS
   Yang, HL
AF Wang, Peng
   Pi, Bin
   Wang, Jin-Ning
   Zhu, Xue-Song
   Yang, Hui-Lin
TI Preparation and properties of calcium sulfate bone cement incorporated
   with silk fibroin and Sema3A-loaded chitosan microspheres
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE Sema3A; chitosan microsphere; sustained release; silk fibroin (SF); bone
   cement
ID PHOSPHATE CEMENT; IN-VIVO; TRANSFORMING GROWTH-FACTOR-BETA-1;
   COMPRESSION FRACTURES; BIOMATERIAL SCAFFOLDS; VERTEBROPLASTY; SYSTEM;
   TISSUE; CELLS; PROLIFERATION
AB To search for new bioactive materials which can be used as the substitute of bone repairing and drug carriers, Sema3A-loaded chitosan microspheres (SLCM) and silk fibroin (SF) were mixed with calcium sulfate cement (CSC). SEM, particle size analysis and swelling rate determination were performed to study properties of the microspheres. The drug loading, encapsulation efficiency and drug release rate were determined by ELISA. Microspheres with different SLCM weight contents (0.5%, 1% and 5%) were prepared to determine which one has the strongest mechanical properties and the appropriate setting time. It was revealed that CSC/SF/0.5SLCM has satisfactory mechanical properties, and its in vitro biocompatibility was assessed by MTS. Chitosan microspheres (5-18 mu m) were globular, the surface was smooth, and the swelling rate is (77.02 +/- 5.57)%. With this formula, the setting time was increased with the addition of SLCM in CSC/SF, and the cumulative drug release rate is 44.62% in 28 d. XRD results demonstrate that the main component is calcium sulfate. Also it was found that CSC/SF/0.5SLCM supports the growth of MC3T3 cells. Thus the preparation of CSC/SF/0.5SLCM was reliable, and the products had good structures, physical properties and biocompatibility, appearing to be a promising bone substitute material.
C1 [Wang, Peng; Pi, Bin; Wang, Jin-Ning; Zhu, Xue-Song; Yang, Hui-Lin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped Surg, Suzhou 215006, Peoples R China.
RP Zhu, XS (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped Surg, Suzhou 215006, Peoples R China.
EM zhuxs@126.com; hlyang@suda.edu.cn
FU National Natural Science Foundation of China [81071454, 81171689,
   81301559]; Department of Orthopedics Clinical Medical Centers in Jiangsu
   Province [BL2012004]; Natural Science Foundation of Jiangsu Province
   [BK20130275]; Key Laboratory of Orthopedic Institute of Soochow
   University
FX This work was generously supported by the National Natural Science
   Foundation of China (Grant Nos. 81071454, 81171689 and 81301559),
   Department of Orthopedics Clinical Medical Centers in Jiangsu Province
   (BL2012004), the Natural Science Foundation of Jiangsu Province
   (BK20130275), and the Key Laboratory of Orthopedic Institute of Soochow
   University.
CR Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Cai L, 2011, ACTA BIOMATER, V7, P2185, DOI 10.1016/j.actbio.2011.01.034
   Chen CC, 2014, J ALLOY COMPD, V585, P25, DOI 10.1016/j.jallcom.2013.09.138
   Cunin G, 2000, SPINE, V25, P1070, DOI 10.1097/00007632-200005010-00006
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Grenha A, 2008, EUR J PHARM BIOPHARM, V69, P83, DOI 10.1016/j.ejpb.2007.10.017
   Gupta KC, 2006, CARBOHYD POLYM, V66, P43, DOI 10.1016/j.carbpol.2006.02.019
   Habraken WJEM, 2009, J BIOMED MATER RES B, V91B, P555, DOI 10.1002/jbm.b.31429
   Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000
   Hazra C, 2014, ULTRASON SONOCHEM, V21, P1117, DOI 10.1016/j.ultsonch.2013.12.020
   Heini PF, 2000, EUR SPINE J, V9, P445, DOI 10.1007/s005860000182
   Hesaraki S, 2009, J BIOMED MATER RES B, V91B, P651, DOI 10.1002/jbm.b.31441
   Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b
   Jensen ME, 2007, AM J NEURORADIOL, V28, P1439
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kim SY, 2012, J IND ENG CHEM, V18, P128, DOI 10.1016/j.jiec.2011.11.001
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Li F, 2013, J CRYST GROWTH, V374, P31, DOI 10.1016/j.jcrysgro.2013.03.042
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   Lin Q, 2010, J MATER SCI-MATER M, V21, P3065, DOI 10.1007/s10856-010-4160-z
   Lu JX, 2002, J MATER SCI-MATER M, V13, P803, DOI 10.1023/A:1016135410934
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Potiron V, 2007, ADV EXP MED BIOL, V600, P132
   Puricelli E, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-10
   Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z
   Ruediger T, 2012, DENT MATER, V28, pE239, DOI 10.1016/j.dental.2012.05.008
   Sadiasa A, 2014, J BIOMATER APPL, V28, P739, DOI 10.1177/0885328213478256
   Sariibrahimoglu K, 2014, J BIOMED MATER RES B, V102, P415, DOI 10.1002/jbm.b.33018
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z
   Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002
   Wang AH, 2009, J MICROENCAPSUL, V26, P593, DOI 10.3109/02652040802586167
   Wang BA, 2011, ADV MATER RES-SWITZ, V332-334, P1655, DOI 10.4028/www.scientific.net/AMR.332-334.1655
   Wang BA, 2011, ADV MATER RES-SWITZ, V175-176, P100, DOI 10.4028/www.scientific.net/AMR.175-176.100
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
   Wang QZ, 2008, J MATER SCI-MATER M, V19, P1371, DOI 10.1007/s10856-007-3243-y
   Zhang C, 2008, CARBOHYD POLYM, V72, P390, DOI 10.1016/j.carbpol.2007.09.004
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhu C, 2011, J MATER SCI-MATER M, V22, P1965, DOI 10.1007/s10856-011-4376-6
NR 47
TC 7
Z9 9
U1 8
U2 51
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2015
VL 9
IS 1
BP 51
EP 65
DI 10.1007/s11706-015-0278-8
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA CC0VZ
UT WOS:000350057700004
DA 2018-10-20
ER

PT J
AU Kanitkar, A
   Chen, C
   Smoak, M
   Hogan, K
   Scherr, T
   Aita, G
   Hayes, D
AF Kanitkar, Akanksha
   Chen, Cong
   Smoak, Mollie
   Hogan, Katie
   Scherr, Thomas
   Aita, Giovanna
   Hayes, Daniel
TI In vitro characterization of polyesters of aconitic acid, glycerol, and
   cinnamic acid for bone tissue engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Polyesters; aconitic acid; stem cells; bone scaffolds; mineralization
ID SUGARCANE BAGASSE; CANE MOLASSES; SCAFFOLDS; FABRICATION;
   HYDROXYAPATITE; OSTEOGENESIS; BIODEGRADATION; PROLIFERATION;
   FERMENTATION; BIOMATERIAL
AB In this study, a novel class of polyesters of glycerol, aconitic acid, and cinnamic acid were synthesized along with their hydroxyapatite (HA) composites, and studied for their potential application in bone defect repair. An osteogenic study was conducted with human adipose derived mesenchymal stem cells (hASCs) to determine the osteoinductive ability of aconitic acid-glycerol (AG) polyesters, AG:HA (80:20), aconitic acid-glycerol-cinnamic acid (AGC) polyesters, and AGC:HA (80:20) to serve as bone scaffolds. The results indicate that AGC scaffolds have the highest mechanical strength in comparison to AG, AG:HA (80:20), and AGC:HA (80:20) scaffolds due to its low porosity. It was determined by cytotoxicity and osteogenesis experiments that hASCs cultured for 21 days on AG:HA (80:20) scaffolds in stromal medium exhibited a greater number of live cells than control PCL:HA composites. Moreover, hASCs cultured on foamed AG:HA (80:20) scaffolds resulted in the highest levels of mineralization, increased alkaline phosphatase (ALP) expression, and the greatest osteocalcin (OCN) expression after 21 days. Overall, AG:HA (100:0 and 80:20) scaffolds had higher mechanical strength and cytocompatibility than the PCL:HA control. Invitro osteogenic study demonstrated that AG:HA (100:0 and 80:20) synthesized using sugarcane industry by-products hold potential as scaffolds for bone tissue engineering applications.
C1 [Kanitkar, Akanksha; Aita, Giovanna] Louisiana State Univ, Ctr Agr, Audubon Sugar Inst, St Gabriel, LA 70776 USA.
   [Kanitkar, Akanksha; Chen, Cong; Smoak, Mollie; Hogan, Katie; Hayes, Daniel] Louisiana State Univ & Agr Ctr, Dept Biol & Agr Engn, Baton Rouge, LA USA.
   [Scherr, Thomas] Louisiana State Univ, Cain Dept Chem Engn, Baton Rouge, LA 70803 USA.
RP Aita, G (reprint author), Louisiana State Univ, Ctr Agr, Audubon Sugar Inst, 3845 Hwy 75, St Gabriel, LA 70776 USA.
EM GAita@agcenter.lsu.edu
RI Chen, Cong/G-3137-2017
OI Scherr, Thomas/0000-0002-7077-535X; Hayes, Daniel/0000-0001-9499-4111
FU National Science Foundation [CMMI-963482, CBET-1254281]; LSU AgCenter
FX Financial support was provided from the National Science Foundation
   grants (Proposal numbers CMMI-963482 and CBET-1254281) and from LSU
   AgCenter.
CR Arsad M.S.M., 2011, 2 INT C BIOT FOOD SC, V7, P184
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Barrett DG, 2009, MOLECULES, V14, P4022, DOI 10.3390/molecules14104022
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Cao HL, 2011, POLYM INT, V60, P630, DOI 10.1002/pi.2993
   Cardona CA, 2010, BIORESOURCE TECHNOL, V101, P4754, DOI 10.1016/j.biortech.2009.10.097
   Cazetta ML, 2007, BIORESOURCE TECHNOL, V98, P2824, DOI 10.1016/j.biortech.2006.08.026
   FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125
   Garber L, 2013, J BIOMED MATER RES A, V101, P3531, DOI 10.1002/jbm.a.34651
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Jayabalan M, 2010, ACTA BIOMATER, V6, P763, DOI 10.1016/j.actbio.2009.09.015
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim M, 2011, J IND MICROBIOL BIOT, V38, P803, DOI 10.1007/s10295-010-0812-8
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Leong David Tai, 2008, Curr Drug Discov Technol, V5, P319, DOI 10.2174/157016308786733537
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McMurray SH, 2002, J CHEM TECHNOL BIOT, V77, P1262, DOI 10.1002/jctb.703
   Moradi A, 2013, MATER DESIGN, V50, P446, DOI 10.1016/j.matdes.2013.03.026
   Navarro AR, 2000, WASTE MANAGE, V20, P581, DOI 10.1016/S0956-053X(00)00026-X
   Nelson C, 2013, J BIOMATER TISS ENG, V3, P426, DOI 10.1166/jbt.2013.1098
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Otsu N., 1975, AUTOMATICA, V11, P23, DOI DOI 10.1109/TSMC.1979.4310076
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Rahimi F, 1997, J Foot Ankle Surg, V36, P192
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Serbetci K, 2004, POLYM TEST, V23, P145, DOI 10.1016/S0142-9418(03)00073-4
   Smoak M, 2014, J APPL POLYM SCI, V131, P1
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Thomas Lynda V, 2011, Biomatter, V1, P81, DOI 10.4161/biom.1.1.17301
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Xu F, 2005, ANAL CHIM ACTA, V552, P207, DOI 10.1016/j.aca.2005.07.037
   Zanetti AS, 2013, J BIOMATER APPL, P998
   Zebarjad S. M., 2011, ENGINEERING, V3, P795, DOI DOI 10.4236/ENG.2011.38096
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang L, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P597, DOI 10.1007/978-3-642-02824-3_27
NR 45
TC 2
Z9 2
U1 2
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2015
VL 29
IS 8
BP 1075
EP 1085
DI 10.1177/0885328214553961
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB9UY
UT WOS:000349980100003
PM 25281649
DA 2018-10-20
ER

PT J
AU Ivashchenko, S
   Ivirico, JLE
   Cruz, DMG
   Campillo-Fernandez, A
   Ferrer, GG
   Pradas, MM
AF Ivashchenko, Sergiy
   Escobar Ivirico, Jorge L.
   Garcia Cruz, Dunia M.
   Campillo-Fernandez, Alberto
   Gallego Ferrer, Gloria
   Monleon Pradas, Manuel
TI Bioactive organic-inorganic poly(CLMA-co-HEA)/silica nanocomposites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Nanocomposites; organic polymer; silica; bioactivity; biocompatibility
ID MODULATED WATER-UPTAKE; SOL-GEL SYNTHESIS;
   POLY(EPSILON-CAPROLACTONE)/SILICA HYBRID; POLYMER/SILICA NANOCOMPOSITES;
   BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; SURFACE-CHEMISTRY; BONE
   REPAIR; HYDROPHILICITY; SCAFFOLDS
AB A series of novel poly(CLMA-co-HEA)/silica nanocomposites is synthesized from caprolactone 2-(methacryloyloxy)ethyl ester (CLMA) and 2-hydroxyethyl acrylate (HEA) as organic comonomers and the simultaneous sol-gel polymerization of tetraethyloxysilane (TEOS) as silica precursor, in different mass ratios up to a 30wt% of silica. The nanocomposites are characterized as to their mechanical and thermal properties, water sorption, bioactivity and biocompatibility, reflecting the effect on the organic matrix provided by the silica network formation. The nanocomposites nucleate the growth of hydroxyapatite (HAp) on their surfaces when immersed in the simulated body fluid of the composition used in this work. Proliferation of the MC3T3 osteoblast-like cells on the materials was assessed with the MTS assay showing their biocompatibility. Immunocytochemistry reveals osteocalcin and type I collagen production, indicating that osteoblast differentiation was promoted by the materials, and calcium deposition was confirmed by von Kossa staining. The results indicate that these poly(CLMA-co-HEA)/silica nanocomposites could be a promising biomaterial for bone tissue engineering.
C1 [Ivashchenko, Sergiy; Escobar Ivirico, Jorge L.; Garcia Cruz, Dunia M.; Gallego Ferrer, Gloria; Monleon Pradas, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
   [Campillo-Fernandez, Alberto] Univ Politecn Valencia, Appl Thermodynam Dept, E-46022 Valencia, Spain.
   [Gallego Ferrer, Gloria; Monleon Pradas, Manuel] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Valencia, Spain.
RP Ivashchenko, S (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
EM seriv@posgrado.upv.es
RI Gallego-Ferrer, Gloria/H-6690-2015; Escobar ivirico, Jorge/J-1203-2016
OI Gallego-Ferrer, Gloria/0000-0002-2428-0903; Escobar ivirico,
   Jorge/0000-0002-1077-2333; MONLEON PRADAS, MANUEL/0000-0001-6457-0414;
   Ivashchenko, Sergiy/0000-0003-1633-4665
FU Spanish Ministry of Science and Innovation [DPI2010-20399-c04-03,
   MAT2011-28791-C03-02]; Torres Quevedo [PTQ08-02-06321]; CIBER-BBN
   initiative - Instituto de Salud Carlos III (Spain)
FX The authors acknowledge the financial support from the Spanish Ministry
   of Science and Innovation through projects DPI2010-20399-c04-03 and
   MAT2011-28791-C03-02. AJCF acknowledges support through Torres Quevedo
   grant PTQ08-02-06321. GGF and MMP acknowledge support of CIBER-BBN
   initiative, financed by Instituto de Salud Carlos III (Spain) with the
   assistance of the European Regional Development Fund.
CR Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Barone DTJ, 2011, POLYM ADVAN TECHNOL, V22, P463, DOI 10.1002/pat.1845
   Bera O, 2011, THERMOCHIM ACTA, V515, P1, DOI 10.1016/j.tca.2010.12.006
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Boxberg Y, 2006, J POLYM SCI POL PHYS, V44, P656, DOI 10.1002/polb.20723
   BRINKER CJ, 1982, J NON-CRYST SOLIDS, V48, P47, DOI 10.1016/0022-3093(82)90245-9
   Catauro M, 2004, J MATER SCI-MATER M, V15, P991, DOI 10.1023/B:JMSM.0000042684.13247.38
   Catauro M, 2003, J MATER SCI, V38, P3097, DOI 10.1023/A:1024773113001
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Ivirico JLE, 2006, MACROMOL CHEM PHYSIC, V207, P2195, DOI 10.1002/macp.200600399
   Hajji P, 1999, J POLYM SCI POL PHYS, V37, P3172, DOI 10.1002/(SICI)1099-0488(19991115)37:22<3172::AID-POLB2>3.3.CO;2-I
   Hanemann T, 2010, MATERIALS, V3, P3468, DOI 10.3390/ma3063468
   Izquierdo-Barba I, 2013, INT J APPL GLASS SCI, V4, P149, DOI 10.1111/ijag.12028
   Jones JR, 2009, J EUR CERAM SOC, V29, P1275, DOI 10.1016/j.jeurceramsoc.2008.08.003
   Kawai T, 2007, J MATER SCI-MATER M, V18, P1037, DOI 10.1007/s10856-006-0081-2
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022
   Lluch AV, 2009, POLYMER, V50, P2874, DOI 10.1016/j.polymer.2009.04.022
   Nie KM, 2005, MATER LETT, V59, P1325, DOI 10.1016/j.matlet.2004.12.034
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Palacio MLB, 2012, PHILOS T R SOC A, V370, P2321, DOI 10.1098/rsta.2011.0483
   Pantaleon R, 2010, POLYM COMPOSITE, V31, P1585, DOI 10.1002/pc.20946
   Olmedilla MPR, 2012, J BIOMATER APPL, V27, P299, DOI 10.1177/0885328211404263
   Poologasundarampillai G, 2010, J MATER CHEM, V20, P8952, DOI 10.1039/c0jm00930j
   Rhee SH, 2003, KEY ENG MAT, V240-2, P187, DOI 10.4028/www.scientific.net/KEM.240-242.187
   Rimer JD, 2007, CHEM MATER, V19, P4189, DOI 10.1021/cm070708d
   Hernandez JCR, 2008, J NON-CRYST SOLIDS, V354, P1900, DOI 10.1016/j.jnoncrysol.2007.10.016
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salinas AJ, 2013, BIOMATER SCI-UK, V1, P40, DOI 10.1039/c2bm00071g
   Sprio S, 2010, J BIOTECHNOL, V156, P347
   Valles-Lluch A, 2010, COMPOS SCI TECHNOL, V70, P1789, DOI 10.1016/j.compscitech.2010.07.008
   Valles-Lluch A, 2010, EUR POLYM J, V46, P1446, DOI 10.1016/j.eurpolymj.2010.04.010
   Valles-Lluch A, 2010, EUR POLYM J, V46, P910, DOI 10.1016/j.eurpolymj.2010.02.004
   Yan SF, 2011, COLLOID SURFACE B, V86, P218, DOI 10.1016/j.colsurfb.2011.04.004
   Zhang ZG, 2011, CYTOTECHNOLOGY, V63, P437, DOI 10.1007/s10616-011-9367-4
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 42
TC 2
Z9 2
U1 6
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2015
VL 29
IS 8
BP 1096
EP 1108
DI 10.1177/0885328214554816
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB9UY
UT WOS:000349980100005
PM 25294191
DA 2018-10-20
ER

PT J
AU Cho, Y
   Hong, J
   Ryoo, H
   Kim, D
   Park, J
   Han, J
AF Cho, Y.
   Hong, J.
   Ryoo, H.
   Kim, D.
   Park, J.
   Han, J.
TI Osteogenic Responses to Zirconia with Hydroxyapatite Coating by Aerosol
   Deposition
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE implant dentistry; biomaterial(s); osteogenesis; surface chemistry;
   osseointegration; prosthetic dentistry
ID TITANIUM DENTAL IMPLANTS; ACID-ETCHED SURFACE; IN-VITRO; THICK-FILMS;
   BONE; OSSEOINTEGRATION; BIOCOMPATIBILITY; BIOMATERIAL; IMPROVEMENT;
   EXPRESSION
AB Previously, we found that osteogenic responses to zirconia co-doped with niobium oxide (Nb2O5) or tantalum oxide (Ta2O5) are comparable with responses to titanium, which is widely used as a dental implant material. The present study aimed to evaluate the in vitro osteogenic potential of hydroxyapatite (HA)-coated zirconia by an aerosol deposition method for improved osseointegration. Surface analysis by scanning electron microscopy and x-ray diffraction proved that a thin as-deposited HA film on zirconia showed a shallow, regular, crater-like surface. Deposition of dense and uniform HA films was measured by SEM, and the contact angle test demonstrated improved wettability of the HA-coated surface. Confocal laser scanning microscopy indicated that MC3T3-E1 pre-osteoblast attachment did not differ notably between the titanium and zirconia surfaces; however, cells on the HA-coated zirconia exhibited a lower proliferation than those on the uncoated zirconia late in the culture. Nevertheless, ALP, alizarin red S staining, and bone marker gene expression analysis indicated good osteogenic responses on HA-coated zirconia. Our results suggest that HA-coating by aerosol deposition improves the quality of surface modification and is favorable to osteogenesis.
C1 [Cho, Y.; Hong, J.; Han, J.] Seoul Natl Univ, Sch Dent, Dept Prosthodont, Seoul 110749, South Korea.
   [Cho, Y.; Hong, J.; Ryoo, H.; Han, J.] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea.
   [Cho, Y.] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea.
   [Ryoo, H.] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea.
   [Kim, D.] Sejong Univ, Dept Adv Mat Engn, Seoul, South Korea.
   [Park, J.] IONES Co Ltd, Nano Business, R&D Ctr, Gyeonggi Do, South Korea.
RP Han, J (reprint author), Seoul Natl Univ, Sch Dent, Dept Prosthodont, 28 Yeongeon Dong, Seoul 110749, South Korea.
EM proshan@snu.ac.kr
FU Technology Innovation Program - Ministry of Trade, Industry & Energy
   (MI, Seoul, Korea) [10043164]; National Research Foundation - Ministry
   of Science, ICT & Future Planning [NRF-2014M3A9E3064466]
FX This research was supported by the Technology Innovation Program
   (10043164) funded by the Ministry of Trade, Industry & Energy (MI,
   Seoul, Korea) and the Bio & Medical Technology Development Program of
   the National Research Foundation (NRF-2014M3A9E3064466) funded by the
   Ministry of Science, ICT & Future Planning. The authors declare no
   potential conflicts of interest with respect to the authorship and/or
   publication of this article.
CR Akedo J, 2000, APPL PHYS LETT, V77, P1710, DOI 10.1063/1.1309029
   Akedo J, 2006, J AM CERAM SOC, V89, P1834, DOI 10.1111/j.1551-2916.2006.01030.x
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x
   Chang YL, 1999, INT J ORAL MAX IMPL, V14, P239
   Cho YD, 2014, INT J MOL SCI, V15, P4442, DOI 10.3390/ijms15034442
   Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391
   De Maeztu MA, 2008, INT J ORAL MAX SURG, V37, P441, DOI 10.1016/j.ijom.2008.01.010
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gremillard L, 2008, KEY ENG MAT, V361-363, P791, DOI 10.4028/www.scientific.net/KEM.361-363.791
   Han JY, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044109
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hsu SH, 2007, BIO-MED MATER ENG, V17, P53
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Kim DJ, 2000, J BIOMED MATER RES, V53, P438, DOI 10.1002/1097-4636(2000)53:4<438::AID-JBM19>3.0.CO;2-3
   Knabe C, 2004, J BIOMED MATER RES A, V71A, P98, DOI 10.1002/jbm.a.30130
   Kuroda K, 2002, J BIOMED MATER RES, V59, P390, DOI 10.1002/jbm.10002
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LEE J, 1995, BIO-MED MATER ENG, V5, P49
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Mistry Surajit, 2011, J Indian Soc Periodontol, V15, P215, DOI 10.4103/0972-124X.85663
   OGISO M, 1992, J LONG-TERM EFF MED, V2, P235
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   Orsini G, 2000, INT J ORAL MAX IMPL, V15, P779
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sailer I, 2007, INT J ESTHET DENT, V2, P296
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tamura M, 2006, DENT MATER J, V25, P32, DOI 10.4012/dmj.25.32
   Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
NR 38
TC 10
Z9 10
U1 1
U2 40
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2015
VL 94
IS 3
BP 491
EP 499
DI 10.1177/0022034514566432
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC2CB
UT WOS:000350151400013
PM 25586588
OA Green Published
DA 2018-10-20
ER

PT J
AU Masood, R
   Miraftab, M
   Hussain, T
   Edward-Jones, V
AF Masood, Rashid
   Miraftab, Mohsen
   Hussain, Tanveer
   Edward-Jones, Valerie
TI Development of slow release silver-containing biomaterial for wound care
   applications
SO JOURNAL OF INDUSTRIAL TEXTILES
LA English
DT Article
DE Medical textiles; materials; polymer formation; fibrous materials;
   strength
ID MANAGEMENT; DRESSINGS; MODELS
AB Silver-containing wound dressings are now commonly available with much publicised claims of antimicrobial activities against all kinds of pathogens including methicillin-resistant Staphylococcus aureus (MRSA). However, there are little or no credible reports on the control release agents for the minimum potent quantities of silver needed in dressings for antimicrobial purposes over time. This paper introduces a new biomaterial fibre made from natural polymers with an inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known microorganisms including methicillin-resistant S. aureus. The paper concludes that the developed fibre has long-lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings.
C1 [Masood, Rashid; Hussain, Tanveer] Natl Text Univ, Fac Engn & Technol, Faisalabad 37610, Pakistan.
   [Miraftab, Mohsen] Univ Bolton, Inst Mat Res & Innovat, Bolton, England.
   [Edward-Jones, Valerie] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England.
RP Masood, R (reprint author), Natl Text Univ, Sheikhpura Rd, Faisalabad 37610, Pakistan.
EM rashidmasood78@gmail.com
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell Robert E, 2003, Ostomy Wound Manage, V49, P19
   Cooper R, 2004, WORLDWIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Howe PD, 2002, SILVER SILVER COMPOU
   Jones-Edward V., 2002, J MED MICROBIOL, V51, P50
   Kalsen HJ, 2000, BURNS, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Kostenko V, 2010, ANTIMICROB AGENTS CH, V54, P5120, DOI 10.1128/AAC.00825-10
   Landis Stephan J, 2008, Adv Skin Wound Care, V21, P531, DOI 10.1097/01.ASW.0000323578.87700.a5
   Masood R, 2009, THESIS U BOLTON UK
   Patil BS, 2011, ORIENTAL PHARM EXP M, V11, P123, DOI 10.1007/s13596-011-0012-8
   Qin Y, 2004, TEXT MAG, V4, P23
   Ryan KJ, 2003, SHERRIS MED MICROBIL
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI, P71
   Stashak T. S., 2004, Clinical Techniques in Equine Practice, V3, P148, DOI 10.1053/j.ctep.2004.08.006
   Thomas S, 2004, ONLINE J WORLDWIDE W
   White WC, 2005, ANTIMICROBIAL TREATE
NR 24
TC 4
Z9 4
U1 2
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1528-0837
EI 1530-8057
J9 J IND TEXT
JI J. Ind. Text.
PD MAR
PY 2015
VL 44
IS 5
BP 699
EP 708
DI 10.1177/1528083713510013
PG 10
WC Materials Science, Textiles
SC Materials Science
GA CB9XY
UT WOS:000349988900003
DA 2018-10-20
ER

PT J
AU Frohbergh, ME
   Katsman, A
   Mondrinos, MJ
   Stabler, CT
   Hankenson, KD
   Oristaglio, JT
   Lelkes, PI
AF Frohbergh, Michael E.
   Katsman, Anya
   Mondrinos, Mark J.
   Stabler, Collin T.
   Hankenson, Kurt D.
   Oristaglio, Jeffrey T.
   Lelkes, Peter I.
TI Osseointegrative Properties of Electrospun Hydroxyapatite-Containing
   Nanofibrous Chitosan Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; GUIDED BONE REGENERATION; IN-VIVO; PERIOSTEAL
   CELLS; STROMAL CELLS; CORTICAL BONE; ILIAC BONE; FIBERS; INFILTRATION;
   CARTILAGE
AB Our long-term goal is to develop smart biomaterials that can facilitate regeneration of critical-size craniofacial lesions. In this study, we tested the hypothesis that biomimetic scaffolds electrospun from chitosan (CTS) will promote tissue repair and regeneration in a critical size calvarial defect. To test this hypothesis, we first compared in vitro ability of electrospun CTS scaffolds crosslinked with genipin (CTS-GP) to those of mineralized CTS-GP scaffolds containing hydroxyapatite (CTS-HA-GP), by assessing proliferation/metabolic activity and alkaline phosphatase (ALP) levels of murine mesenchymal stem cells (mMSCs). The cells' metabolic activity exhibited a biphasic behavior, indicative of initial proliferation followed by subsequent differentiation for all scaffolds. ALP activity of mMSCs, a surrogate measure of osteogenic differentiation, increased over time in culture. After 3 weeks in maintenance medium, ALP activity of mMSCs seeded onto CTS-HA-GP scaffolds was approximately two times higher than that of cells cultured on CTS-GP scaffolds. The mineralized CTS-HA-GP scaffolds were also osseointegrative in vivo, as inferred from the enhanced bone regeneration in a murine model of critical size calvarial defects. Tissue regeneration was evaluated over a 3 month period by microCT and histology (Hematoxylin and Eosin and Masson's Trichrome). Treatment of the lesions with CTS-HA-GP scaffolds induced a 38% increase in the area of de novo generated mineralized tissue area after 3 months, whereas CTS-GP scaffolds only led to a 10% increase. Preseeding with mMSCs significantly enhanced the regenerative capacity of CTS-GP scaffolds (by similar to 3-fold), to 35% increase in mineralized tissue area after 3 months. CTS-HA-GP scaffolds preseeded with mMSCs yielded 45% new mineralized tissue formation in the defects. We conclude that the presence of HA in the CTS-GP scaffolds significantly enhances their osseointegrative capacity and that mineralized chitosan-based scaffolds crosslinked with genipin may represent a unique biomaterial with possible clinical relevance for the repair of critical calvarial bone defects.
C1 [Frohbergh, Michael E.; Lelkes, Peter I.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   [Frohbergh, Michael E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Katsman, Anya] Drexel Univ, Coll Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA.
   [Mondrinos, Mark J.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA.
   [Stabler, Collin T.; Lelkes, Peter I.] Temple Univ, Coll Engn, Dept Bioengn, Philadelphia, PA 19122 USA.
   [Hankenson, Kurt D.] Michigan State Univ, Dept Nat Sci & Human Med, E Lansing, MI 48824 USA.
   [Oristaglio, Jeffrey T.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.
RP Lelkes, PI (reprint author), Temple Univ, Coll Engn, Dept Bioengn, Engn Bldg Room 811,1947 North 12th St, Philadelphia, PA 19122 USA.
EM pilelkes@temple.edu
OI Hankenson, Kurt/0000-0001-6361-143X
FU National Science Foundation [0434108]
FX This study was supported, in part, by a grant from the National Science
   Foundation [grant # 0434108]. The authors are grateful to Dr. Gozde
   Senel for her help with the SEM, Dr. Darwin Prokop from the Institute of
   Regenerative Medicine at Texas A&M University for his generous gift of
   the mMSCs used for this study, and Drs. Anant Chopra and Yasha Kresh for
   the use of the Z1 Observer Zeiss microscope for fluorescent imaging.
   P.I.L. is the Laura H. Carnell Professor of Bioengineering, College of
   Engineering, Temple University.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Bavariya AJ, 2014, J BIOMED MATER RES B, V102, P1084, DOI 10.1002/jbm.b.33090
   Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Ghasemi-Mobarakeh L, 2013, J NANOSCI NANOTECHNO, V13, P4656, DOI 10.1166/jnn.2013.7186
   Grassel Susanne, 2012, Methods Mol Biol, V879, P203, DOI 10.1007/978-1-61779-815-3_14
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Hoffman MD, 2013, CLIN ORTHOP RELAT R, V471, P721, DOI 10.1007/s11999-012-2695-7
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Hu ZM, 2011, J BIOMED MATER RES A, V98A, P473, DOI 10.1002/jbm.a.33119
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Im Jin-Young, 2013, Lab Anim Res, V29, P196, DOI 10.5625/lar.2013.29.4.196
   Kaji Hiroshi, 2007, Clin Calcium, V17, P1574
   Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Kumaran S Thanga, 2010, Indian J Dent Res, V21, P3, DOI 10.4103/0970-9290.62796
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee DW, 2010, J CRANIOFAC SURG, V21, P1084, DOI 10.1097/SCS.0b013e3181e1b64b
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   LELKES PI, 1992, NATO ADV SCI I A-LIF, V227, P339
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Martins A, 2010, TISSUE ENG PT A, V16, P3599, DOI 10.1089/ten.TEA.2009.0779
   Menard C, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt214
   Mohammadi Y, 2007, INT J ARTIF ORGANS, V30, P204
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Norowski PA, 2015, J TISSUE ENG REGEN M, V9, P577, DOI 10.1002/term.1648
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72
   Peng HJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485102
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Senagore A. J., 2004, GALE ENCY SURG GUIDE
   Shafiee A, 2011, BIOTECHNOL LETT, V33, P1257, DOI 10.1007/s10529-011-0541-8
   Skotak M, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055012
   Son SR, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015009
   Stoddart MJ, 2011, METHODS MOL BIOL, V740, P1, DOI 10.1007/978-1-61779-108-6
   Tawonsawatruk Tulyapruek, 2012, J Med Assoc Thai, V95 Suppl 10, pS189
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wolf-Brandstetter C., 2012, J BIOMED MATER RES B, V4, P599
   Xie C, 2007, TISSUE ENG, V13, P435, DOI 10.1089/ten.2006.0182
   Xie XH, 2015, J TISSUE ENG REGEN M, V9, P961, DOI 10.1002/term.1679
   Zhang W, 2013, BIOMATERIALS, V34, P713, DOI 10.1016/j.biomaterials.2012.10.027
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
   Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhu HY, 2013, J BIOMED MATER RES B, V101B, P541, DOI 10.1002/jbm.b.32854
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
NR 66
TC 12
Z9 12
U1 4
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 970
EP 981
DI 10.1089/ten.tea.2013.0789
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500011
PM 25336062
OA Green Published
DA 2018-10-20
ER

PT J
AU Peng, Y
   Xuan, M
   Zou, JP
   Liu, HW
   Zhuo, ZY
   Wan, Y
   Cheng, B
AF Peng, Yan
   Xuan, Min
   Zou, Jiping
   Liu, Hongwei
   Zhuo, Ziyuan
   Wan, Yu
   Cheng, Biao
TI Freeze-Dried Rat Bone Marrow Mesenchymal Stem Cell Paracrine Factors: A
   Simplified Novel Material for Skin Wound Therapy
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PLATELET-RICH PLASMA; IMPROVES CARDIAC-FUNCTION; MYOCARDIAL-INFARCTION;
   STROMAL CELLS; GROWTH-FACTOR; INJURY; MODEL; TRANSPLANTATION;
   REGENERATION; MACROPHAGES
AB The mesenchymal stem cell (MSC) supernatant is well known as a rich source of autologous cytokines and universally used for tissue regeneration in current clinical medicine. However, the limitation of conditioned medium used in open-wound repair compels the need to find a more sophisticated way to take advantage of the trophic factors of MSCs. We have now fabricated a three-dimensional membrane from freeze-dried bone marrow mesenchymal stem cells-conditioned medium (FBMSC-CM) using a simple freeze-dried protocol. Scanning electron microscopy images showed the microstructure of the FBMSC-CM membrane (FBMSC-CMM) resembling a mesh containing growth factors. ELISA was used to test the paracrine factors retained in the FBMSC-CMM, and the results indicated that FBMSC-CMM withheld over 80% of the paracrine factors. Live/dead assays were adopted to test the toxicity of the FBMSC-CMM on cultured rat dermal fibroblasts, and the results confirmed its biological safety with low toxicity. Moreover, the FBMSC-CMM could significantly accelerate wound healing and enhance the neovascularization as well as epithelialization through strengthening the trophic factors in the wound bed as determined by immunohistochemical staining. Thus, the ability to maintain paracrine factors and enhance the effectiveness of these growth factors in the wound as well as the simple procedure and economical materials required for production qualifies the FBMSC-CMM to be a candidate biomaterial for open-wound regeneration.
C1 [Peng, Yan; Zou, Jiping; Zhuo, Ziyuan; Wan, Yu; Cheng, Biao] PLA, Key Lab Trauma Treatment & Tissue Repair Trop Are, Guangzhou Gen Hosp Guangzhou Command, Dept Plast Surg, Guangzhou 510010, Guangdong, Peoples R China.
   [Peng, Yan] Univ Hong Kong, LKS Fac Med, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Xuan, Min] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Liu, Hongwei] Jinan Univ, Dept Plast Surg, Key Lab Regenerat Med, Affiliated Hosp 1,Minist Educ, Guangzhou, Guangdong, Peoples R China.
RP Cheng, B (reprint author), PLA, Key Lab Trauma Treatment & Tissue Repair Trop Are, Guangzhou Gen Hosp Guangzhou Command, Dept Plast Surg, Guangzhou 510010, Guangdong, Peoples R China.
EM chengbiaocheng@163.com
FU Science and Technology Project of Guangzhou, China [2012J4100044];
   National Natural Science Foundation of China [81171812]; National Basic
   Science and Development Program, China (973 Program) [2012CB518105]
FX This study was supported by grants from the Science and Technology
   Project of Guangzhou, China (2012J4100044), the National Natural Science
   Foundation of China (81171812), and the National Basic Science and
   Development Program, China (973 Program 2012CB518105).
CR Afzal MR, 2010, ANTIOXID REDOX SIGN, V12, P693, DOI 10.1089/ars.2009.2755
   Balogun WO, 2013, GERONTOLOGY, V59, P3, DOI 10.1159/000340062
   Buikema JW, 2013, STEM CELLS, V31, P2587, DOI 10.1002/stem.1467
   Burdon TJ, 2011, BONE MARROW RES, V2011, DOI DOI 10.1155/2011/207326
   Chan JKY, 2013, CANCER GENE THER, V20, P539, DOI 10.1038/cgt.2013.59
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Du ZY, 2013, J SURG RES, V183, P907, DOI 10.1016/j.jss.2013.02.009
   Evsikov Alexei V, 2003, Science, V302, P393
   Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015
   Kawase T, 2011, J BIOMED MATER RES A, V98A, P100, DOI 10.1002/jbm.a.33074
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x
   Mastri Michalis, 2014, World J Stem Cells, V6, P82, DOI 10.4252/wjsc.v6.i2.82
   Moghadasali R, 2013, EXP TOXICOL PATHOL, V65, P595, DOI 10.1016/j.etp.2012.06.002
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Nakajima Y, 2012, PLATELETS, V23, P594, DOI 10.3109/09537104.2011.645923
   Nie C., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1622, DOI 10.1002/TERM.1622]
   Noale M, 2012, DIABETES METAB, V38, P135, DOI 10.1016/j.diabet.2011.09.005
   Patterson TE, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.G.01572
   Pietramaggiori G, 2008, WOUND REPAIR REGEN, V16, P218, DOI 10.1111/j.1524-475X.2008.00362.x
   Pietramaggiori G, 2006, WOUND REPAIR REGEN, V14, P573, DOI 10.1111/j.1743-6109.2006.00164.x
   Pijpers E, 2012, AGE AGEING, V41, P358, DOI 10.1093/ageing/afr145
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Shi RZ, 2009, EXP CELL RES, V315, P10, DOI 10.1016/j.yexcr.2008.09.024
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tam K, 2014, J CELL BIOCHEM, V115, P794, DOI 10.1002/jcb.24723
   Tang JM, 2010, MOL CELLS, V29, P9, DOI 10.1007/s10059-010-0001-7
   Titmarsh DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052405
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Wilkins RG, 2013, ADV SKIN WOUND CARE, V26, P160, DOI 10.1097/01.ASW.0000428861.26671.41
   Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z
   Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142
   Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503
NR 41
TC 7
Z9 8
U1 1
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 1036
EP 1046
DI 10.1089/ten.tea.2014.0102
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500017
PM 25343727
OA Green Published
DA 2018-10-20
ER

PT J
AU White, JD
   Wang, SR
   Weiss, AS
   Kaplan, DL
AF White, James D.
   Wang, Siran
   Weiss, Anthony S.
   Kaplan, David L.
TI Silk-tropoelastin protein films for nerve guidance
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nerve regeneration; Nerve guide; Silk; Elastin; Protein blends
ID ROOT GANGLION NEURONS; PERIPHERAL-NERVE; NEURITE EXTENSION;
   SCHWANN-CELLS; ELECTRICAL-STIMULATION; SUBSTRATE STIFFNESS; GEL
   STIFFNESS; COLLAGEN GEL; REGENERATION; BIOMATERIALS
AB Peripheral nerve regeneration may be enhanced through the use of biodegradable thin film biomaterials as highly tuned inner nerve conduit liners. Dorsal root ganglion neuron and Schwann cell responses were studied on protein films comprising silk fibroin blended with recombinant human tropoelastin protein. Tropoelastin significantly improved neurite extension and enhanced Schwann cell process length and cell area, while the silk provided a robust biomaterial template. Silk-tropoelastin blends afforded a 2.4-fold increase in neurite extension, when compared to silk films coated with poly-D-lysine. When patterned by drying on grooved polydimethylsiloxane (3.5 mu m groove width, 0.5 mu m groove depth), these protein blends induced both neurite and Schwann cell process alignment. Neurons were functional as assessed using patch-clamping, and displayed action potentials similar to those cultured on poly(lysine)-coated glass. Taken together, silk-tropoelastin films offer useful biomaterial interfacial platforms for nerve cell control, which can be considered for neurite guidance, disease models for neuropathies and surgical peripheral nerve repairs. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [White, James D.; Wang, Siran; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI WEISS, ANTHONY/0000-0002-8106-4836
FU Australian Research Council; National Health & Medical Research Council;
   NIH [EB014283]; NIH P41 Tissue Engineering Resource Cente [P41 EB002520]
FX The authors thank Dr Chuang Du for his expertise and assistance with
   electrophysiological experiments and Dr Min Tang-Schomer, Dr Lee W.
   Tien, Dr Amy Hopkins and Prof. Cristian Staii for insightful
   discussions. The authors also thank the NIH P41 Tissue Engineering
   Resource Center (P41 EB002520). A.S.W. is Scientific Founder of
   Elastagen Pty Ltd. A.S.W. acknowledges grant support from the Australian
   Research Council and the National Health & Medical Research Council.
   Part of this research was funded by NIH EB014283 (D.L.K. and A.S.W.).
CR Agnew SP, 2010, J HAND SURG-AM, V35A, P838, DOI 10.1016/j.jhsa.2010.02.025
   Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Battiston B, 2009, INT REV NEUROBIOL, V87, P227, DOI 10.1016/S0074-7742(09)87011-6
   Bax DV, 2011, BIONANOSCIENCE, V1, P123, DOI 10.1007/s12668-011-0018-1
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Blewitt MJ, 2007, ANN BIOMED ENG, V35, P2159, DOI 10.1007/s10439-007-9389-4
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006
   Chiono V, 2011, MACROMOL BIOSCI, V11, P245, DOI 10.1002/mabi.201000354
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   de Boer R, 2011, MICROSURG, V31, P293, DOI 10.1002/micr.20869
   DICHTER MA, 1977, J PHYSIOL-LONDON, V267, P281, DOI 10.1113/jphysiol.1977.sp011813
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Isaacs J, 2013, HAND CLIN, V29, P371, DOI 10.1016/j.hcl.2013.04.006
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Koppes AN, 2014, TISSUE ENG PT A, V20, P494, DOI 10.1089/ten.TEA.2013.0012
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Loverde JR, 2011, J NEUROTRAUM, V28, P2389, DOI 10.1089/neu.2010.1598
   Lu MC, 2009, J MATER SCI-MATER M, V20, P1175, DOI 10.1007/s10856-008-3646-4
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   Mithieux SM, 2013, ADV DRUG DELIVER REV, V65, P421, DOI 10.1016/j.addr.2012.06.009
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Reid AJ, 2013, NEUROSCI LETT, V544, P125, DOI 10.1016/j.neulet.2013.04.001
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529
   Shakhbazau A, 2012, MOL CELL NEUROSCI, V50, P103, DOI 10.1016/j.mcn.2012.04.004
   Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Thaxton C, 2011, MOL CELL NEUROSCI, V47, P1, DOI 10.1016/j.mcn.2010.12.006
   Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4
   Thorsen F, 2012, J PLAST SURG HAND SU, V46, P184, DOI 10.3109/2000656X.2012.676554
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   YANG J, 1990, J NEUROBIOL, V21, P661, DOI 10.1002/neu.480210413
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Zhou ZL, 2012, BIOMATERIALS, V33, P2473, DOI 10.1016/j.biomaterials.2011.12.005
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
NR 60
TC 14
Z9 13
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2015
VL 14
BP 1
EP 10
DI 10.1016/j.actbio.2014.11.045
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB6JR
UT WOS:000349733800001
PM 25481743
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kutikov, AB
   Gurijala, A
   Song, J
AF Kutikov, Artem B.
   Gurijala, Anvesh
   Song, Jie
TI Rapid Prototyping Amphiphilic Polymer/Hydroxyapatite Composite Scaffolds
   with Hydration-Induced Self-Fixation Behavior
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID DYNAMIC-MECHANICAL PROPERTIES; TISSUE ENGINEERING SCAFFOLDS; GUIDED BONE
   REGENERATION; MARROW STROMAL CELLS; IN-VITRO; CONFORMATIONAL-CHANGES;
   FREEFORM FABRICATION; BLOCK-COPOLYMERS; POROUS SCAFFOLDS; DESIGN
AB Two major factors hampering the broad use of rapid prototyped biomaterials for tissue engineering applications are the requirement for custom-designed or expensive research-grade three-dimensional (3D) printers and the limited selection of suitable thermoplastic biomaterials exhibiting physical characteristics desired for facile surgical handling and biological properties encouraging tissue integration. Properly designed thermoplastic biodegradable amphiphilic polymers can exhibit hydration-dependent hydrophilicity changes and stiffening behavior, which may be exploited to facilitate the surgical delivery/self-fixation of the scaffold within a physiological tissue environment. Compared to conventional hydrophobic polyesters, they also present significant advantages in blending with hydrophilic osteoconductive minerals with improved interfacial adhesion for bone tissue engineering applications. Here, we demonstrated the excellent blending of biodegradable, amphiphilic poly(D,L-lactic acid)-poly(ethylene glycol)-poly(D,L-lactic acid) (PLA-PEG-PLA) (PELA) triblock co-polymer with hydroxyapatite (HA) and the fabrication of high-quality rapid prototyped 3D macroporous composite scaffolds using an unmodified consumer-grade 3D printer. The rapid prototyped HA-PELA composite scaffolds and the PELA control (without HA) swelled (66% and 44% volume increases, respectively) and stiffened (1.38-fold and 4-fold increases in compressive modulus, respectively) in water. To test the hypothesis that the hydration-induced physical changes can translate into self-fixation properties of the scaffolds within a confined defect, a straightforward in vitro pull-out test was designed to quantify the peak force required to dislodge these scaffolds from a simulated cylindrical defect at dry versus wet states. Consistent with our hypothesis, the peak fixation force measured for the PELA and HA-PELA scaffolds increased 6-fold and 15-fold upon hydration, respectively. Furthermore, we showed that the low-fouling 3D PELA inhibited the attachment of NIH3T3 fibroblasts or bone marrow stromal cells while the HA-PELA readily supported cellular attachment and osteogenic differentiation. Finally, we demonstrated the feasibility of rapid prototyping biphasic PELA/HA-PELA scaffolds for potential guided bone regeneration where an osteoconductive scaffold interior encouraging osteointegration and a nonadhesive surface discouraging fibrous tissue encapsulation is desired. This work demonstrated that by combining facile and readily translatable rapid prototyping approaches with unique biomaterial designs, biodegradable composite scaffolds with well-controlled macroporosities, spatially defined biological microenvironment, and useful handling characteristics can be developed.
C1 [Kutikov, Artem B.; Gurijala, Anvesh; Song, Jie] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA.
   [Kutikov, Artem B.; Song, Jie] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.
RP Song, J (reprint author), Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, 55 Lake Ave North, Worcester, MA 01655 USA.
EM jie.song@umassmed.edu
OI Kutikov, Artem/0000-0001-9444-9156
FU National Institutes of Health [R01GM088678, R01AR055615]; University of
   Massachusetts Commercial Ventures and Intellectual Property Technology
   Award; National Center for Research Resources [S10RR021043]
FX This work was supported in part by the National Institutes of Health
   grants R01GM088678 and R01AR055615, and a University of Massachusetts
   Commercial Ventures and Intellectual Property Technology Award. Core
   resources supported by the National Center for Research Resources Grant
   S10RR021043 were used. We thank Evanthia Fylaktou and Prof. Stephen
   McCarthy at the University of Massachusetts Lowell for the generous help
   in extruding the amphiphilic polymer filaments and the kind permission
   for access of the extruder by Metabolix, Inc.
CR Bedoui F, 2012, SOFT MATTER, V8, P2230, DOI 10.1039/c1sm06619f
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   Cohn D, 2005, POLYMER, V46, P2068, DOI 10.1016/j.polymer.2005.01.012
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81
   Faour O, 2011, INJURY, V42, pS87, DOI 10.1016/j.injury.2011.06.020
   Filion TM, 2011, TISSUE ENG PT A, V17, P503, DOI [10.1089/ten.tea.2010.0274, 10.1089/ten.TEA.2010.0274]
   Filion TM, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P233
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Heo SJ, 2009, TISSUE ENG PT A, V15, P977, DOI 10.1089/ten.tea.2008.0190
   Kapfer SC, 2011, BIOMATERIALS, V32, P6875, DOI 10.1016/j.biomaterials.2011.06.012
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim J, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025003
   Kutikov AB, 2013, ACTA BIOMATER, V9, P8354, DOI 10.1016/j.actbio.2013.06.013
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JH, 2005, BIOMATERIALS, V26, P671, DOI 10.1016/j.biomaterials.2004.03.009
   Leferink A., 2013, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1842
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Melchels FPW, 2010, ACTA BIOMATER, V6, P4208, DOI 10.1016/j.actbio.2010.06.012
   Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Murthy NS, 2010, POLYMER, V51, P3978, DOI 10.1016/j.polymer.2010.06.024
   Neuendorf RE, 2008, ACTA BIOMATER, V4, P1288, DOI 10.1016/j.actbio.2008.04.006
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Song J, 2003, J EUR CERAM SOC, V23, P2905, DOI 10.1016/S0955-2219(03)00302-9
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   Sun Y, 2012, J BIOMED MATER RES A, V100A, P2739, DOI 10.1002/jbm.a.34210
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Xu JQ, 2007, J AM CHEM SOC, V129, P506, DOI 10.1021/ja067986i
   Yang DJ, 2009, ACTA BIOMATER, V5, P2467, DOI 10.1016/j.actbio.2009.03.034
   Yang DJ, 2009, J BIOMAT SCI-POLYM E, V20, P1321, DOI 10.1163/156856209X453024
   Yoo D, 2013, MAT SCI ENG C-MATER, V33, P1759, DOI 10.1016/j.msec.2012.12.092
   Yoo D, 2012, MED ENG PHYS, V34, P762, DOI 10.1016/j.medengphy.2012.05.008
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 52
TC 11
Z9 11
U1 1
U2 57
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAR 1
PY 2015
VL 21
IS 3
BP 229
EP 241
DI 10.1089/ten.tec.2014.0213
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC0RL
UT WOS:000350043400001
PM 25025950
OA Green Published
DA 2018-10-20
ER

PT J
AU Custodio, CA
   Cerqueira, MT
   Marques, AP
   Reis, RL
   Mano, JF
AF Custodio, C. A.
   Cerqueira, M. T.
   Marques, A. P.
   Reis, R. L.
   Mano, J. F.
TI Cell selective chitosan microparticles as injectable cell carriers for
   tissue regeneration
SO BIOMATERIALS
LA English
DT Article
DE Cell separation; Antibody immobilization; Injectable materials;
   Functional materials; Chitosan microparticles
ID MESENCHYMAL STROMAL CELLS; CIRCULATING TUMOR-CELLS; STEM-CELLS;
   ENGINEERING APPLICATIONS; CANCER-PATIENTS; SEPARATION; DERIVATIVES;
   SCAFFOLDS; MEDICINE; ANTIBODY
AB The detection, isolation and sorting of cells holds an important role in cell therapy and regenerative medicine. Also, injectable systems have been explored for tissue regeneration in vivo, because it allows repairing complex shaped tissue defects through minimally invasive surgical procedures. Here we report the development of chitosan microparticles with a size of 115.8 mu m able to capture and expand a specific cell type that can also be regarded as an injectable biomaterial. Monoclonal antibodies against cell surface antigens specific to endothelial cells and stem cells were immobilized on the surface of the microparticles. Experimental results showed that particles bioconjugated with specific antibodies provide suitable surfaces to capture a target cell type and subsequent expansion of the captured cells. Primarily designed for an application in tissue engineering, three main challenges are accomplished with the herein presented microparticles: separation, scale-up expansion of specific cell type and successful use as an injectable system to form small tissue constructs in situ. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Custodio, C. A.; Cerqueira, M. T.; Marques, A. P.; Reis, R. L.; Mano, J. F.] Univ Minho, Res Grp 3Bs, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Custodio, C. A.; Cerqueira, M. T.; Marques, A. P.; Reis, R. L.; Mano, J. F.] ICVS 3Bs, PT Govt Associated Lab, Braga, Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Mano, Joao/A-4418-2009; Group,
   3Bs/E-4374-2012; Custodio, Catarina/N-3290-2016; Marques,
   Alexandra/B-1238-2012
OI Reis, Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765; Group,
   3Bs/0000-0002-5195-3456; Custodio, Catarina/0000-0003-2967-700X;
   Marques, Alexandra/0000-0002-3222-0310; Cerqueira,
   Mariana/0000-0002-2430-7758
FU European Research Council [ERC-2012-ADG 20120216-321266]; European
   Union's Seventh Framework Programme (FP7)
   [REGPOT-CT2012-316331-POLARIS]; FCT [SFRH/BD/61390/2009]
FX This work was supported by European Research Council grant agreement
   ERC-2012-ADG 20120216-321266 for project CornplexiTE and by the European
   Union's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no REGPOT-CT2012-316331-POLARIS. The authors acknowledge the
   FCT for the fellowship SFRH/BD/61390/2009 (C.A.C.) for the financial
   support. We are grateful to Hospital da Prelada for the lipoaspirates
   donations.
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Astori G, 2007, J TRANSL MED, P5
   Balmayor ER, 2011, J R SOC INTERFACE, V8, P896, DOI 10.1098/rsif.2010.0531
   Borg DJ, 2009, J BIOMED MATER RES A, V88A, P184, DOI 10.1002/jbm.a.31864
   Cerqueira MT, 2013, BIOMACROMOLECULES, V14, P3997, DOI 10.1021/bm4011062
   Chen YC, 2014, LAB CHIP, V14, P626, DOI 10.1039/c3lc90136j
   Custodio CA, 2014, ADV FUNCT MATER, V24, P1391, DOI 10.1002/adfm.201301516
   Custodio CA, 2012, BIOINTERPHASES, P7
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Declercq HA, 2013, BIOMATERIALS, V34, P1004, DOI 10.1016/j.biomaterials.2012.10.051
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DIAMANDIS EP, 1991, CLIN CHEM, V37, P625
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Cruz DMG, 2008, J TISSUE ENG REGEN M, V2, P378, DOI 10.1002/term.106
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Hervy M, 2014, PLOS ONE, P9
   Juopperi TA, 2007, EXP HEMATOL, V35, P335, DOI 10.1016/j.exphem.2006.09.014
   Kamihira M, 2007, ADV BIOCHEM ENG BIOT, V106, P173, DOI 10.1007/10_2006_043
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Mihaila SM, 2013, TISSUE ENG PT A, V19, P235, DOI [10.1089/ten.TEA.2012.0092, 10.1089/ten.tea.2012.0092]
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618
   Say EAT, 2013, PLOS ONE, P8
   Schop D, 2010, J TISSUE ENG REGEN M, V4, P131, DOI 10.1002/term.224
   Sheng WA, 2014, LAB CHIP, V14, P89, DOI 10.1039/c3lc51017d
   Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720
   Valimaa L, 2003, BIOCONJUGATE CHEM, V14, P103, DOI 10.1021/bc020058y
   Vallee M, 2009, PATHOL BIOL, V57, P309, DOI 10.1016/j.patbio.2008.04.010
   Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Ye XF, 2009, TISSUE ENG PT A, V15, P1, DOI 10.1089/ten.tea.2008.0001
   Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d
NR 37
TC 24
Z9 24
U1 3
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2015
VL 43
BP 23
EP 31
DI 10.1016/j.biomaterials.2014.11.047
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB4GX
UT WOS:000349587300003
PM 25591958
DA 2018-10-20
ER

PT J
AU Appel, AA
   Larson, JC
   Garson, AB
   Guan, HF
   Zhong, Z
   Nguyen, BNB
   Fisher, JP
   Anastasio, MA
   Brey, EM
AF Appel, Alyssa A.
   Larson, Jeffery C.
   Garson, Alfred B., III
   Guan, Huifeng
   Zhong, Zhong
   Nguyen, Bao-Ngoc B.
   Fisher, John P.
   Anastasio, Mark A.
   Brey, Eric M.
TI X-ray Phase Contrast Imaging of Calcified Tissue and Biomaterial
   Structure in Bioreactor Engineered Tissues
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE X-ray phase contrast; micro-computed tomography; bioreactor; alginate
   microbeads; synchrotron; analyzer-based imaging
ID MARROW STROMAL CELLS; OPTICAL COHERENCE TOMOGRAPHY; TUBULAR PERFUSION
   SYSTEM; MICROCOMPUTED TOMOGRAPHY; DYNAMIC CULTURE; IN-VITRO; SCAFFOLDS;
   RADIOGRAPHY; EXPRESSION; CONSTRUCT
AB Tissues engineered in bioreactor systems have been used clinically to replace damaged tissues and organs. In addition, these systems are under continued development for many tissue engineering applications. The ability to quantitatively assess material structure and tissue formation is critical for evaluating bioreactor efficacy and for preimplantation assessment of tissue quality. Techniques that allow for the nondestructive and longitudinal monitoring of large engineered tissues within the bioreactor systems will be essential for the translation of these strategies to viable clinical therapies. X-ray Phase Contrast (XPC) imaging techniques have shown tremendous promise for a number of biomedical applications owing to their ability to provide image contrast based on multiple X-ray properties, including absorption, refraction, and scatter. In this research, mesenchymal stem cell-seeded alginate hydrogels were prepared and cultured under osteogenic conditions in a perfusion bioreactor. The constructs were imaged at various time points using XPC microcomputed tomography (mu CT). Imaging was performed with systems using both synchrotron- and tube-based X-ray sources. XPC mu CT allowed for simultaneous three-dimensional (3D) quantification of hydrogel size and mineralization, as well as spatial information on hydrogel structure and mineralization. Samples were processed for histological evaluation and XPC showed similar features to histology and quantitative analysis consistent with the histomorphometry. These results provide evidence of the significant potential of techniques based on XPC for noninvasive 3D imaging engineered tissues grown in bioreactors. Biotechnol. Bioeng. 2015;112: 612-620. (c) 2014 Wiley Periodicals, Inc.
C1 [Appel, Alyssa A.; Larson, Jeffery C.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Appel, Alyssa A.; Larson, Jeffery C.; Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.
   [Garson, Alfred B., III; Guan, Huifeng; Anastasio, Mark A.] Washington Univ, Dept Biomed Engn, St Louis, MO USA.
   [Zhong, Zhong] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA.
   [Nguyen, Bao-Ngoc B.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 South Dearborn St, Chicago, IL 60616 USA.
EM brey@iit.edu
FU Veterans Administration; National Science Foundation [CBET-1263994,
   IIS-1125412]; National Institute of Health [R01EB009715, R01AR061460]
FX Contract grant sponsor: Veterans Administration; Contract grant sponsor:
   National Science Foundation; Grant numbers: CBET-1263994; IIS-1125412;
   Contract grant sponsor: National Institute of Health; Grant numbers:
   R01EB009715; R01AR061460
CR Ahearne M, 2008, J TISSUE ENG REGEN M, V2, P521, DOI 10.1002/term.124
   Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788
   Brey EM, 2010, TISSUE ENG PART C-ME, V16, P1597, DOI 10.1089/ten.tec.2010.0150
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chou CY, 2007, PHYS MED BIOL, V52, P1923, DOI 10.1088/0031-9155/52/7/011
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Guan H, 2014, P SPIE, V9033
   Hofmann M, 2012, INT J COMPUT VISION, V96, P103, DOI 10.1007/s11263-011-0451-1
   Hofmann MC, 2012, J BIOMED OPT, V17
   Izadifar Z, 2014, TISSUE ENG PART C-ME, V20, P140, DOI [10.1089/ten.tec.2013.0138, 10.1089/ten.TEC.2013.0138]
   Kak A. C., 1999, PRINCIPLES COMPUTERI
   Kotecha M, 2012, NMR BIOMED, V26, P709
   Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P1
   Langer M, 2010, J MICROSC-OXFORD, V238, P230, DOI [10.1111/j.1365-2818.2009.03545.x, 10.1111/j.1365-2818.2009.03345.x]
   Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005
   Mason C, 2004, PHYS MED BIOL, V49, P1097, DOI 10.1088/0031-9155/49/7/002
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9
   Othman SF, 2012, NMR BIOMED, V25, P452, DOI 10.1002/nbm.1663
   Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007
   Porter BD, 2007, BIOMATERIALS, V28, P2525, DOI 10.1016/j.biomaterials.2007.01.013
   Ramaswamy S, 2008, TISSUE ENG PART C-ME, V14, P243, DOI 10.1089/ten.tec.2007.0423
   Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677
   Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.tea.2011.0136, 10.1089/ten.TEA.2011.0136]
   Reiter DA, 2012, NMR BIOMED, V25, P476, DOI 10.1002/nbm.1804
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Smith S, 2010, ESSAY CAUSES VARIETY, P55
   Thompson AD, 2009, TISSUE ENG PT A, V15, P1181, DOI 10.1089/ten.tea.2007.0275
   Wenk PA, 2010, TECH POINTS, V39, P3
   Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006
   Wystrychowski W, 2013, J VASC SURG
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI 10.1089/ten.TEC.2010.0172
   Yeatts AB, 2012, BIOTECHNOL BIOENG, V109, P2381, DOI 10.1002/bit.24497
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P1171, DOI 10.1089/ten.tec.2011.0263
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Zhong Z, 2000, NUCL INSTRUM METH A, V450, P556, DOI 10.1016/S0168-9002(00)00308-9
   Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006
   Zhu N, 2011, TISSUE ENG PART C-ME, V17, P1071, DOI 10.1089/ten.tec.2011.0102
   Zysk AM, 2012, BIOMED OPT EXPRESS, V3, P1924, DOI 10.1364/BOE.3.001924
NR 47
TC 9
Z9 9
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR
PY 2015
VL 112
IS 3
BP 612
EP 620
DI 10.1002/bit.25467
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CA8IJ
UT WOS:000349161400018
PM 25257802
DA 2018-10-20
ER

PT J
AU Banche, G
   Bracco, P
   Allizond, V
   Bistolfi, A
   Boffano, M
   Cimino, A
   del Prever, EMB
   Cuffini, AM
AF Banche, Giuliana
   Bracco, Pierangiola
   Allizond, Valeria
   Bistolfi, Alessandro
   Boffano, Michele
   Cimino, Andrea
   del Prever, Elena Maria Brach
   Cuffini, Anna Maria
TI Do Crosslinking and Vitamin E Stabilization Influence Microbial
   Adhesions on UHMWPE-based Biomaterials?
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENT; IN-VITRO;
   STAPHYLOCOCCUS-EPIDERMIDIS; MECHANICAL-PROPERTIES; LINKED POLYETHYLENE;
   SURFACE-PROPERTIES; BIOFILM FORMATION; CANDIDA-ALBICANS; OXIDATION
AB Microorganism adhesion on polyethylene for total joint arthroplasty is a concern. Many studies have focused on vitamin E-stabilized ultrahigh-molecular-weight polyethylene (UHMWPE), whereas first-generation, highly crosslinked UHMWPE, which is the most commonly used in clinical practice, has been scarcely evaluated.
   We aimed (1) to compare the adherence of Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Candida albicans with virgin (untreated) UHMWPE (PE) and crosslinked UHMWPE (XLPE); (2) to correlate the results with the biomaterial surface properties; and (3) to determine whether the decreased adhesion on vitamin E-stabilized UHMWPE (VE-PE) previously recorded for bacteria can also be confirmed for C albicans.
   Microbial adhesion of biofilm-producing American Type Culture Collection (ATCC) and clinical strains on XLPE and VE-PE were compared with PE at 3, 7, 24, and 48 hours of incubation and quantified, as colony forming units (CFU)/mL, using a sonication protocol. Sample surfaces were characterized by scanning electron microscopy, roughness and contact angle measurements, attenuated total reflection-Fourier transform infrared spectroscopy, and x-ray photoelectron spectroscopy (XPS) to reveal qualitative differences in surface composition and topography that could influence the microbial adhesion. The results were analyzed by descriptive statistics and tested by unpaired t-tests.
   All microorganisms, both ATCC and clinical strains, showed lower adhesion (p < 0.05) on XLPE with adhesion percentages ranging from 18% to 25%, compared with PE with adhesion percentages ranging from 51% to 55%, after 48 hours. Only the ATCC S epidermidis showed a reduced adhesion profile even at 3 hours (adhesion ratio of 14% on XLPE versus 50% on PE) and 24 hours (19% on XLPE versus 55% on PE) of incubation. ATCC and clinical C albicans were less adherent to XLPE than to PE (p < 0.05) showing even at the earlier incubation time points adhesion values always of 10(3) CFU/mL and 10(4) CFU/mL, respectively. Roughness and contact angle were 0.8 +/- A 0.2 mu m and 92A degrees A A +/- A 3A degrees, respectively, with no differences among samples. Qualitative differences in the surface chemical composition were revealed by XPS only. A confirmation of the decreased adhesion on VE-PE respect to PE was also registered here for C albicans strains (p < 0.05).
   Vitamin E stabilization and crosslinking of UHMWPE are capable of reducing microbial adhesion. Further studies are needed to fully elucidate the mechanisms of modulation of microbial adhesion to medical-grade UHMWPE.
   Our results suggest that VE-PE and XLPE may have an added benefit of being more resistant to bacterial adhesion, even fungal strains.
C1 [Banche, Giuliana; Allizond, Valeria; del Prever, Elena Maria Brach; Cuffini, Anna Maria] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy.
   [Bracco, Pierangiola] Univ Turin, Dept Chem, Turin, Italy.
   [Bracco, Pierangiola] Univ Turin, NIS Nanostruct Interfaces & Surfaces Interdept Ct, Turin, Italy.
   [Bistolfi, Alessandro; Boffano, Michele; Cimino, Andrea] AO Citta Sci & Salute, Dept Orthoped, I-10126 Turin, Italy.
RP Bistolfi, A (reprint author), AO Citta Sci & Salute, Dept Orthoped, Via Zuretti 29, I-10126 Turin, Italy.
EM abistolfi@cittadellasalute.to.it
RI Bracco, Pierangiola/G-8522-2011
OI Bracco, Pierangiola/0000-0003-0477-2086; Banche,
   Giuliana/0000-0003-2219-0223; Allizond, Valeria/0000-0003-0585-9247;
   Cuffini, Anna Maria/0000-0002-2698-164X; bistolfi,
   alessandro/0000-0002-4396-6222
CR Banche G, 2014, BONE JOINT J, V96B, P497, DOI [10.1302/0301-620X.96B4.32895, 10.1302/0301-620X.96B4/32895]
   Banche G, 2011, J ORTHOP RES, V29, P1662, DOI 10.1002/jor.21432
   Banche G, 2010, INT J ANTIMICROB AG, V36, P319, DOI 10.1016/j.ijantimicag.2010.06.041
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bistolfi A, 2011, ACTA BIOMATER, V7, P3398, DOI 10.1016/j.actbio.2011.05.018
   Bistolfi A, 2009, J BIOMED MATER RES B, V90B, P137, DOI 10.1002/jbm.b.31265
   Bladen CL, 2013, J BIOMED MATER RES B, V101B, P407, DOI 10.1002/jbm.b.32798
   Bracco P, 2006, POLYM DEGRAD STABIL, V91, P2030, DOI 10.1016/j.polymdegradstab.2006.02.003
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Costa L, 2006, J BIOMED MATER RES B, V78B, P20, DOI 10.1002/jbm.b.30454
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   Del Prado G, 2012, J BIOMED MATER RES A, V100A, P2813, DOI 10.1002/jbm.a.34220
   delPrever EB, 1996, BIOMATERIALS, V17, P873, DOI 10.1016/0142-9612(96)83282-0
   Esteban J, 2012, ACTA ORTHOP, V83, P299, DOI 10.3109/17453674.2012.693019
   Gomez-Barrena E, 2011, J MATER SCI-MATER M, V22, P1701, DOI 10.1007/s10856-011-4340-5
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4
   Liu HJ, 2011, SURF COAT TECH, V205, P2697, DOI 10.1016/j.surfcoat.2010.08.120
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Manning DW, 2005, J ARTHROPLASTY, V20, P880, DOI 10.1016/j.arth.2005.03.033
   Metso L, 2014, ACTA ORTHOP, V85, P165, DOI 10.3109/17453674.2014.889978
   Molina-Manso D, 2010, J PHYS C SER, V252, P1
   Monsen T, 2009, J CLIN MICROBIOL, V47, P2496, DOI 10.1128/JCM.02316-08
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Scalas D, 2012, INT J ANTIMICROB AG, V39, P73, DOI 10.1016/j.ijantimicag.2011.09.015
   Shinde RB, 2012, MYCOSCIENCE, V53, P220, DOI 10.1007/s10267-011-0155-y
   STREICHER RM, 1988, RADIAT PHYS CHEM, V31, P693
   Terada A, 2006, MICROBIOL-SGM, V152, P3575, DOI 10.1099/mic.0.28881-0
NR 34
TC 8
Z9 8
U1 2
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD MAR
PY 2015
VL 473
IS 3
BP 974
EP 986
DI 10.1007/s11999-014-4024-9
PG 13
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CA9KM
UT WOS:000349242200036
PM 25367109
OA Green Published
DA 2018-10-20
ER

PT J
AU Flores, C
   Diaz-Barrera, A
   Martinez, F
   Galindo, E
   Pena, C
AF Flores, Celia
   Diaz-Barrera, Alvaro
   Martinez, Fabiola
   Galindo, Enrique
   Pena, Carlos
TI Role of oxygen in the polymerization and de-polymerization of alginate
   produced by Azotobacter vinelandii
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Bioprocesses; Biotechnology; Fermentation; Bacteria; Bioreactors
ID PSEUDOMONAS-AERUGINOSA ALGX; MOLECULAR-WEIGHT; SHAKE FLASKS; CONTINUOUS
   CULTURES; LIMITED CONDITIONS; ESCHERICHIA-COLI; BIOSYNTHESIS;
   ACETYLATION; LYASE; GROWTH
AB Microbial polymers have diverse chemical structures, which determine their functional properties. Many microbial sources produce either intracellular or extracellular biopolymers. For example, Azotobacter vinelandii is a non-pathogenic soil bacterium that produces alginate, an extracellular polysaccharide. Alginates are used mainly in the food and pharmaceutical industries as stabilizing, thickening, gel- or film-forming agents. Due to its characteristics of biocompatibility, biodegradability and non-antigenicity, new applications for alginate are being discovered, such as biomaterial in the biomedical field and tissue engineering. It is well established that alginate is first synthesized as a polymannuronate from its cytosolic precursor. However, the mechanisms involved in the polymerization, modification (acetylation, epimerization and depolymerization) and translocation of alginate have been poorly elucidated. Two of the most important parameters in alginate production by A. vinelandii are dissolved oxygen tension (DOT) and the oxygen supply conditions, as these impact both the polymer concentration and its composition, particularly its molecular weight (MW). Several studies have revealed that increased alginate molecular weight occurs in oxygen limited conditions, specifically at oxygen concentrations near zero. This article reviews recent studies examining the influence of oxygen, under limitation (microaerophilic) and non-limitation conditions (measured as DOT and oxygen transfer rate, OTR), on the polymerization and degradation of alginate produced by A. vinelandii. This review also provides evidence for understanding these processes at the cellular level and the effect of oxygen on alginate biosynthesis. (c) 2014 Society of Chemical Industry
C1 [Flores, Celia; Galindo, Enrique; Pena, Carlos] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico.
   [Diaz-Barrera, Alvaro; Martinez, Fabiola] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.
RP Pena, C (reprint author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Apdo Post 510-3, Cuernavaca 62250, Morelos, Mexico.
EM carlosf@ibt.unam.mx
OI Alvaro, Diaz-Barrera/0000-0002-0922-8648
FU CONACyT (Mexico) [131851]; DGAPA-PAPIIT [IT100513]; Fondecyt from
   CONICYT (Chile) [11110311]
FX Financial support from CONACyT (Mexico) (grant 131851) and DGAPA-PAPIIT
   (IT100513) is gratefully acknowledged. Alvaro Diaz-Barrera thanks
   Fondecyt, Grant 11110311 from CONICYT (Chile).
CR AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355
   Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Clementi F, 1997, CRIT REV BIOTECHNOL, V17, P327, DOI 10.3109/07388559709146618
   Clementi F, 1999, J SCI FOOD AGR, V79, P602, DOI 10.1002/(SICI)1097-0010(19990315)79:4<602::AID-JSFA224>3.0.CO;2-N
   Diaz-Barrera A, 2007, APPL MICROBIOL BIOT, V76, P903, DOI 10.1007/s00253-007-1060-3
   Diaz-Barrera A, 2009, BIOTECHNOL LETT, V31, P825, DOI 10.1007/s10529-009-9949-9
   Diaz-Barrera A, 2014, BIOPROC BIOSYST ENG, V37, P1133, DOI 10.1007/s00449-013-1084-2
   Diaz-Barrera A, 2012, J IND MICROBIOL BIOT, V39, P613, DOI 10.1007/s10295-011-1055-z
   Diaz-Barrera A, 2011, PROCESS BIOCHEM, V46, P1879, DOI 10.1016/j.procbio.2011.06.022
   Diaz-Barrera A, 2010, BIORESOURCE TECHNOL, V101, P9405, DOI 10.1016/j.biortech.2010.07.038
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Ertesvag H., 2009, ALGINATES BIOL APPL
   Flores C, 2013, ENZYME MICROB TECH, V53, P85, DOI 10.1016/j.enzmictec.2013.04.010
   FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/jb.176.7.1821-1830.1994
   Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002
   Franklin MJ, 2011, FRONT MICROBIOL, V2, P1
   Galindo E, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-7
   Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09
   Hay ID, 2014, ENVIRON MICROBIOL, V16, P2997, DOI 10.1111/1462-2920.12389
   Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076
   Hay ID, 2009, APPL ENVIRON MICROB, V75, P1110, DOI 10.1128/AEM.02416-08
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hu XK, 2005, J APPL PHYCOL, V17, P57, DOI 10.1007/s10811-005-5524-5
   Hu XK, 2004, J APPL PHYCOL, V16, P73, DOI 10.1023/B:JAPH.0000019139.35046.0c
   Huang Y-C, 2006, SCAFFOLDING TISSUE E
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005
   Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838
   Jimenez-Escrig A, 2000, NUTR RES, V20, P585, DOI 10.1016/S0271-5317(00)00149-4
   Kawada A, 1999, ARCH DERMATOL RES, V291, P542, DOI 10.1007/s004030050451
   Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015
   Kim HS, 2011, BIOTECHNOL BIOPROC E, V16, P843, DOI 10.1007/s12257-011-0352-8
   Kurachi Maki, 2005, Journal of Infection and Chemotherapy, V11, P199, DOI 10.1007/s10156-005-0392-0
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LEITAO JH, 1993, J APPL BACTERIOL, V74, P452, DOI 10.1111/j.1365-2672.1993.tb05153.x
   Lozano E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-13
   Manzo J, 2011, J MOL MICROB BIOTECH, V21, P147, DOI 10.1159/000334244
   MejiaRuiz H, 1997, GENE, V199, P271, DOI 10.1016/S0378-1119(97)00380-6
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/i.1365-2958.2007.05817.x
   Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0
   Parente E, 1998, J IND MICROBIOL BIOT, V20, P171, DOI 10.1038/sj.jim.2900510
   Pena C, 2006, LETT APPL MICROBIOL, V43, P200, DOI 10.1111/j.1472-765X.2006.01925.x
   Pena C, 2002, J BIOTECHNOL, V95, P1, DOI 10.1016/S0168-1656(01)00384-4
   Pena C, 2011, PROCESS BIOCHEM, V46, P290, DOI 10.1016/j.procbio.2010.08.025
   Pena C, 2002, J IND MICROBIOL BIOT, V29, P209, DOI 10.1038/sj.jim.7000310
   Pena C, 1997, APPL MICROBIOL BIOT, V48, P510, DOI 10.1007/s002530051088
   Pena C, 2000, ENZYME MICROB TECH, V27, P390, DOI 10.1016/S0141-0229(00)00221-0
   Pena C, 2007, BIOCHEM ENG J, V36, P73, DOI 10.1016/j.bej.2007.02.019
   POST E, 1983, ARCH MICROBIOL, V134, P68, DOI 10.1007/BF00429410
   Priego-Jimenez R, 2005, BIOCHEM ENG J, V25, P187, DOI 10.1016/j.bcj.2005.05.003
   Ramnani P, 2012, ANAEROBE, V18, P1, DOI 10.1016/j.anaerobe.2011.08.003
   Rediers H, 2004, MICROBIOL-SGM, V150, P1117, DOI 10.1099/mic.0.27096-0
   Rehm B. H. A, 2009, ALGINATES BIOL APPL
   REHM BHA, 1994, J BACTERIOL, V176, P5639
   Rehm BHA, 1997, APPL MICROBIOL BIOT, V48, P281, DOI 10.1007/s002530051051
   Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077
   Remminghorst U, 2009, J BIOTECHNOL, V140, P176, DOI 10.1016/j.jbiotec.2009.02.006
   Reyes C, 2003, J BIOTECHNOL, V105, P189, DOI 10.1016/S0168-1656(03)00186-X
   Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931
   Robles-Price A, 2004, J BACTERIOL, V186, P7369, DOI 10.1128/JB.186.21.7369-7377.2004
   Sabra W, 1999, APPL MICROBIOL BIOT, V52, P773, DOI 10.1007/s002530051590
   Sabra W, 2000, APPL ENVIRON MICROB, V66, P4037, DOI 10.1128/AEM.66.9.4037-4044.2000
   SADOFF HL, 1975, BACTERIOL REV, V39, P516
   Salzig M, 2006, MICROBIAL NANOTECHNO
   SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995
   Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09
   SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Trujillo-Roldan MA, 2004, APPL MICROBIOL BIOT, V63, P742, DOI 10.1007/s00253-003-1419-z
   Trujillo-Roldan MA, 2001, BIOTECHNOL PROGR, V17, P1042, DOI 10.1021/bp010106d
   Vazquez A, 1999, GENE, V232, P217, DOI 10.1016/S0378-1119(99)00119-5
   Weadge JT, 2010, ACTA CRYSTALLOGR F, V66, P588, DOI 10.1107/S1744309110011851
   Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108
   Xu B, 1999, BIOTECHNOL PROGR, V15, P81, DOI 10.1021/bp9801087
NR 79
TC 10
Z9 10
U1 1
U2 44
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2015
VL 90
IS 3
BP 356
EP 365
DI 10.1002/jctb.4548
PG 10
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA CB2NY
UT WOS:000349465800002
DA 2018-10-20
ER

PT J
AU Li, XY
   Chen, RT
   Xu, SH
   Liu, HL
   Hu, Y
AF Li, Xiangye
   Chen, Ruting
   Xu, Shouhong
   Liu, Honglai
   Hu, Ying
TI Thermoresponsive behavior and rheology of SiO2-hyaluronic
   acid/poly(N-isopropylacrylamide) (NaHA/PNIPAm) core-shell structured
   microparticles
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE biomaterial; inorganic; organic hybrid materials; core-shell structure;
   injectable gel; thermoresponsive polymer
ID ORGANIZED NANOSTRUCTURE FORMATION; N-ISOPROPYLACRYLAMIDE COPOLYMER;
   SERUM-ALBUMIN MONOLAYER; PHASE-TRANSITION; DRUG-RELEASE; HYDROGELS;
   POLY(N-ISOPROPYLACRYLAMIDE); GELS; HYALURONATE; KINETICS
AB BACKGROUNDInjectable polymer gels for tissue engineering offer specific advantages over preformed scaffolds. They can transform from a sol to a block gel as a response to an external stimulus. One effective strategy for improving the mechanical strength of a gel is to introduce an inorganic material.
   RESULTSMicroparticles composed of a hard SiO2 core covered with a thermoresponsive hybrid gel (sodium hyaluronate/poly(N-isopropylacrylamide); NaHA/PNIPAm) were synthesized. The microparticles were characterized by dynamic light-scattering and transmission electron microscopy; rheological measurements were also performed. The microparticles were perfectly spherical and had a core-shell structure. They can perform a sol-gel transformation, that is, they shrank and assembled to form a macroscopic hydrogel through physical cross-linking at the gelation temperature (T-gel), which was determined by rheological measurements. The T-gel was adjusted by changing the concentration of microparticles or Ca2+ ions.
   CONCLUSIONThe introduction of NaHA and SiO2 improved the mechanical properties of the macroscopic gels. The rigidity and stability of the macroscopic gel were controlled by the molecular weight of NaHA and the amount of PNIPAm. Such injectable hydrogels might have potential as scaffold biomaterials, and are expected to be the ink' for three-dimensional bioprinters. (c) 2014 Society of Chemical Industry
C1 [Xu, Shouhong] E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
   [Xu, Shouhong] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China.
RP Xu, SH (reprint author), E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
EM xushouhong@ecust.edu.cn
FU National Natural Science Foundation of China [21076071, 21276074,
   91334203]; 111 Project of the Ministry of Education of China [B08021];
   Fundamental Research Funds for the Central Universities of China
FX Financial support for this work is provided by the National Natural
   Science Foundation of China (No. 21076071, No. 21276074, No. 91334203),
   the 111 Project of the Ministry of Education of China (No. B08021), and
   the Fundamental Research Funds for the Central Universities of China.
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Arai K, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034113
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Chen SB, 2012, MAT SCI ENG C-MATER, V32, P2199, DOI 10.1016/j.msec.2012.05.052
   Dai YL, 2012, ACS NANO, V6, P3327, DOI 10.1021/nn300303q
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   Gan TT, 2010, J MATER CHEM, V20, P5937, DOI 10.1039/c0jm00338g
   Gan TT, 2009, BIOMACROMOLECULES, V10, P1410, DOI 10.1021/bm900022m
   Gariepy E. R., 2004, EUR J PHARM BIOPHARM, V58, P409
   Hijon N, 2005, CHEM MATER, V17, P1591, DOI 10.1021/cm048755i
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Katta JK, 2004, I ELECT ELECT ENG, V4, P142
   Kawasaki H, 1998, LANGMUIR, V14, P773, DOI 10.1021/la970886t
   Kawasaki H, 2000, LANGMUIR, V16, P3195, DOI 10.1021/la991272m
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kraan PM, 2002, OSTEOARTHR CARTILAGE, V8, P631
   Lin ZF, 2013, BIOMACROMOLECULES, V14, P2206, DOI 10.1021/bm4003442
   Mortisen D, 2010, BIOMACROMOLECULES, V11, P1261, DOI 10.1021/bm100046n
   Naik VV, 2011, LANGMUIR, V27, P13276, DOI 10.1021/la202876g
   Newbloom GM, 2012, SOFT MATTER, V8, P8854, DOI 10.1039/c2sm26114f
   Nonogaki T, 2000, LANGMUIR, V16, P4272, DOI 10.1021/la990444c
   Pan YZ, 2011, ADV FUNCT MATER, V21, P2754, DOI 10.1002/adfm.201100078
   Parsa S, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025003
   Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325
   Recillas M, 2009, BIOMACROMOLECULES, V10, P1633, DOI 10.1021/bm9002317
   Schonhoff M, 2002, J PHYS CHEM B, V106, P7800, DOI 10.1021/jp0155381
   Sun BJ, 2008, MACROMOLECULES, V41, P1512, DOI 10.1021/ma702062h
   Tsai SW, 2006, BIOPOLYMERS, V83, P381, DOI 10.1002/bip.20568
   Vakifli A, 2010, J APPL POLYM SCI, V117, P817, DOI 10.1002/app.31188
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Wang DD, 2011, BIOMACROMOLECULES, V12, P578, DOI 10.1021/bm101187b
   Wang ZC, 2010, ACS APPL MATER INTER, V2, P1009, DOI 10.1021/am900712e
   Xu SH, 2003, MOL SIMULAT, V29, P711, DOI 10.1080/0892702031000103266
   Xu SH, 2013, J CHEM TECHNOL BIOT, V88, P1561, DOI 10.1002/jctb.4005
   Yang J, 2012, REACT FUNCT POLYM, V72, P438, DOI 10.1016/j.reactfunctpolym.2012.04.006
   You J, 2012, LANGMUIR, V28, P4965, DOI 10.1021/la2046417
NR 41
TC 1
Z9 1
U1 4
U2 76
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2015
VL 90
IS 3
BP 407
EP 414
DI 10.1002/jctb.4308
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA CB2NY
UT WOS:000349465800007
DA 2018-10-20
ER

PT J
AU Sealy, C
AF Sealy, Cordelia
TI Conducting polymer makes promising biomaterial
SO MATERIALS TODAY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD MAR
PY 2015
VL 18
IS 2
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA CB4UZ
UT WOS:000349625100004
DA 2018-10-20
ER

PT J
AU Trombino, S
   Poerio, T
   Ferrarelli, T
   Mauro, MV
   Giraldi, C
   Giorno, L
   Cassano, R
AF Trombino, Sonia
   Poerio, Teresa
   Ferrarelli, Teresa
   Mauro, Maria Vittoria
   Giraldi, Cristina
   Giorno, Lidietta
   Cassano, Roberta
TI Multifunctional membranes based on natural polymers: preparation,
   characterization and in vitro performance evaluation
SO POLYMER INTERNATIONAL
LA English
DT Article
DE hemp fibres; antioxidant; antibacterial; chelation; membranes
ID CELLULOSE; SYSTEM; COMBINATIONS; CADMIUM; LEAVES; ACID
AB The aim of this study was to synthesize new multifunctional biopolymers via esterification of hemp fibres with two reagents: meso-2,3-dimercaptosuccinic acid and ethylenediaminetetraacetic acid. The obtained biopolymers were characterized using infrared spectroscopy. The antibacterial activity of the derivative containing ethylenediaminetetraacetic acid moiety was evaluated by assessing the growth inhibition of Pseudomonas aeruginosa in Petri dishes. The results suggest that this biomaterial exhibits an excellent in vitro antibacterial activity. The antioxidant activity of the biopolymer from meso-2,3-dimercaptosuccinic acid was tested in rat liver microsomal membranes in the presence of tert-butylhydroperoxide as free radical source. Results suggest that this material inhibits lipid peroxidation induced by the free radical species. Both derivatives were used to prepare multifunctional membranes that were characterized and tested indicating the maintenance of biopolymer functionalized properties. Moreover, these functionalized biopolymers interact with metal ions due to their chelating functional groups. The absorption capacity for a selected metal ion, Cd(II), was investigated in aqueous solutions at pH = 0.65, 4.1 and 7.0 using optical emission spectroscopy. This study demonstrates that these new materials are very effective in chelating cadmium ions showing maximum efficiency at pH = 7.0. (c) 2014 Society of Chemical Industry
C1 [Trombino, Sonia; Ferrarelli, Teresa; Cassano, Roberta] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87030 Arcavacata Di Rende, CS, Italy.
   [Poerio, Teresa; Giorno, Lidietta] Univ Calabria, Inst Membrane Technol ITM CNR, I-87030 Arcavacata Di Rende, CS, Italy.
   [Mauro, Maria Vittoria; Giraldi, Cristina] Annunziata Hosp, Virol & Microbiol Serv, I-87100 Cosenza, Italy.
RP Cassano, R (reprint author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87030 Arcavacata Di Rende, CS, Italy.
EM roberta.cassano@unical.it
OI Poerio, Teresa/0000-0001-8449-9344; Giorno, Lidietta/0000-0002-4408-5849
CR Alen R, 2000, PAPERMAKING SCI TECH, V3, P11
   APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279
   BARTOLI GM, 1988, BIOCHIM BIOPHYS ACTA, V966, P214, DOI 10.1016/0304-4165(88)90114-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brooks G. F., 2008, JAWETZ MELNICK ADELB
   Cadogan JIG, 1973, PRINCIPLES FREE RADI
   Cassano R, 2008, J AGR FOOD CHEM, V55, P9489
   Cassano R, 2013, CELLULOSE, V20, P547, DOI 10.1007/s10570-012-9804-3
   Cassano R, 2009, CARBOHYD POLYM, V78, P639, DOI 10.1016/j.carbpol.2009.05.030
   DAWSEY TR, 1990, J MACROMOL SCI R M C, VC30, P405, DOI 10.1080/07366579008050914
   Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b
   HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Hutmacher DW, 2000, BIOMATERIALS, V2, P2529
   Ioan S, 2011, J APPL POLYM SCI, V121, P127, DOI 10.1002/app.33380
   Jansen JC, 2011, CELLULOSE, V18, P359, DOI 10.1007/s10570-011-9492-4
   Montford S., 1999, Journal of the International Hemp Association, V6, P53
   Morgenstern B, 1996, TRENDS POLYM SCI, V4, P87
   MORGENSTERN B, 1993, ACTA POLYM, V44, P100, DOI 10.1002/actp.1993.010440208
   Mulder M., 1996, BASIC PRINCIPLES MEM
   Murray P, 2008, MICROBIOLOGIA MED
   Ohta T, 1997, BIOSCI BIOTECH BIOCH, V61, P1942, DOI 10.1271/bbb.61.1942
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Reddy SA, 2008, J HAZARD MATER, V152, P903, DOI 10.1016/j.jhazmat.2007.07.063
   Saka S, 2000, WOOD CELLULOSIC CHEM, P51
   Salim R, 2008, J ENVIRON MANAGE, V87, P521, DOI 10.1016/j.jenvman.2007.01.028
   Shogren R.L., 1999, ACS SYM SER, V723, P2
   Sjoholm E, 2000, CARBOHYD POLYM, V41, P153, DOI 10.1016/S0144-8617(99)00080-6
   Slater TF, 1984, BIOCHEMISTRY-US, V222, P1
   SPARKS TA, 1994, VET RES COMMUN, V18, P241, DOI 10.1007/BF01839190
   Steinbrecher UP, 1999, BIOCHIM BIOPHYS ACTA, V1496, P279
   Strathmann H., 2006, INTRO MEMBRANE SCI T
   Sun RC, 1999, J WOOD CHEM TECHNOL, V19, P287, DOI 10.1080/02773819909349613
   TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752
   Trombino S, 2007, MACROMOL BIOSCI, V8, P86
   Trzcinka-Ochocka M, 2004, ENVIRON RES, V95, P143, DOI 10.1016/j.envres.2003.10.003
   Webb M., 1986, CADMIUM, V80, P281
   Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X
NR 38
TC 1
Z9 1
U1 1
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD MAR
PY 2015
VL 64
IS 3
BP 344
EP 351
DI 10.1002/pi.4844
PG 8
WC Polymer Science
SC Polymer Science
GA CB1PX
UT WOS:000349401200004
DA 2018-10-20
ER

PT J
AU Deng, BY
   Shen, L
   Wu, YZ
   Shen, YL
   Ding, XF
   Lu, SY
   Jia, JG
   Qian, JY
   Ge, JB
AF Deng, Biyong
   Shen, Li
   Wu, Yizhe
   Shen, Yunli
   Ding, Xuefeng
   Lu, Shuyang
   Jia, Jianguo
   Qian, Juying
   Ge, Junbo
TI Delivery of alginate-chitosan hydrogel promotes endogenous repair and
   preserves cardiac function in rats with myocardial infarction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE infarction; cardiac; tissue engineering; biomaterial
ID STEM-CELLS; HEART; IMPROVEMENT; SCAFFOLDS; BIOMATERIALS; OPTIMIZATION;
   REGENERATION; GEOMETRY; SURVIVAL
AB The regenerative potential of alginate-chitosan composite in bone and cartilage tissue has been well documented, but its potential utility in cardiac tissue engineering has remained unknown. This study sought to determine whether early intramyocardial injection of alginate-chitosan could prevent left ventricular (LV) remodeling after myocardial infarction (MI), leading to a more favorable course of tissue restoration. In a rat model of acute MI, local injection of alginate-chitosan hydrogel into the peri-infarct zone preserved scar thickness, attenuated infarct expansion, and reduced scar fibrosis after 8 weeks, concomitantly with promoting increased angiogenesis and greater recruitment of endogenous repair at the infarct zone. Furthermore, this treatment prevented cell apoptosis, induced cardiomyocyte cell cycle re-entry. The cardiac function of the control-injected animals deteriorated over the 8-week course, while that of the hydrogel-injected animals did not.In addition, the hydrogel did not exacerbate inflammation in the heart. Intramyocardial injection of alginate-chitosan hydrogel represents a useful strategy to treat MI. It demonstrated marked therapeutic efficacies on various tissue levels after extensive MI, as well as potential to induce endogenous cardiomyocyte proliferation and recruit cardiac stem cells. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 907-918, 2015.
C1 [Deng, Biyong; Shen, Li; Wu, Yizhe; Ding, Xuefeng; Lu, Shuyang; Jia, Jianguo; Qian, Juying; Ge, Junbo] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China.
   [Deng, Biyong; Shen, Li; Wu, Yizhe; Ding, Xuefeng; Qian, Juying; Ge, Junbo] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China.
   [Shen, Yunli] Tongji Univ, Shanghai East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China.
   [Lu, Shuyang] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Cardiovasc Surg, Shanghai 200032, Peoples R China.
RP Qian, JY (reprint author), Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China.
EM qian.juying@zs-hospital.sh.cn
FU National Natural Science Foundation of China [81370323]; Science and
   Technology Commission of Shanghai Municipality, China [11nm0504900]
FX The authors extend appreciation to Dr. Ruiming Yao, Dr. Bingyu Li, and
   Prof. Xiangdong Yang for technical support and expertise. This work was
   supported by National Natural Science Foundation of China (No. 81370323)
   and Science and Technology Commission of Shanghai Municipality, China
   (No. 11nm0504900).
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH1708, DOI 10.1152/ajpheart.00911.2004
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Lesman A, 2010, ANN NY ACAD SCI, V1188, P46, DOI 10.1111/j.1749-6632.2009.05082.x
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Migrino RQ, 1997, CIRCULATION, V96, P116
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sankalia MG, 2007, EUR J PHARM BIOPHARM, V65, P215, DOI 10.1016/j.ejpb.2006.07.014
   Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Yu JH, 1999, J WUHAN U NAT SCI ED, V45, P440
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 36
TC 24
Z9 25
U1 2
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 907
EP 918
DI 10.1002/jbm.a.35232
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500006
PM 24827141
DA 2018-10-20
ER

PT J
AU Kroustalli, A
   Kotsikoris, V
   Karamitri, A
   Topouzis, S
   Deligianni, D
AF Kroustalli, A.
   Kotsikoris, V.
   Karamitri, A.
   Topouzis, S.
   Deligianni, D.
TI Mechanoresponses of human primary osteoblasts grown on carbon nanotubes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; primary osteoblasts; bone; mechanotransduction;
   adhesion integrins
ID MESENCHYMAL STEM-CELLS; MECHANICAL STRAIN; MESSENGER-RNA; BONE REPAIR;
   DIFFERENTIATION; PROLIFERATION; EXPRESSION; MECHANOTRANSDUCTION;
   STIMULATION; PATHWAYS
AB Bone mechanotransduction is strongly influenced by the biomaterial properties. A good understanding of these mechanosensory mechanisms in bone has the potential to provide new strategies in the highly evolving field of bone tissue engineering. The aim of the present investigation was to study the interactive effects of local mechanical stimuli on multiwalled carbon nanotubes (MWCNTs)/osteoblast interface, using an in vitro model that allows the study of cell growth, attachment and differentiation. Strain was applied at physiological levels [strain magnitudes 500 microstrain (), at frequency of load application 0.5 Hz]. The effect of mechanical strain and substrate was thus studied by measuring the messenger RNA expression of alkaline phosphatase, vinculin, collagen 1A, and integrins 1, 3, 4, and v, using real-time quantitative polymerase chain reaction. The osteoblasts grown on MWCNTs displayed quick adaptation to the new environment by modulating the expression of key adhesion integrins. Furthermore, the addition of mechanical strain interplayed with the extracellular matrix and was efficiently transduced by cells grown on MWCNTs, providing stronger adhesion and survival. MWCNTs are therefore a material perfectly compatible with osteoblast differentiation, adhesion, and growth, and should be further evaluated, to derive new-generation biomaterial scaffolds for the treatment of skeletal defects which require bone reconstruction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1038-1044, 2015.
C1 [Kroustalli, A.; Deligianni, D.] Univ Patras, Lab Biomechan & Biomed Engn, Dept Mech Engn & Aeronaut, Patras, Greece.
   [Kotsikoris, V.; Karamitri, A.; Topouzis, S.] Univ Patras, Mol Pharmacol Lab, Dept Pharm, Patras, Greece.
RP Deligianni, D (reprint author), Univ Patras, Lab Biomechan & Biomed Engn, Dept Mech Engn & Aeronaut, Patras, Greece.
EM deligian@mech.upatras.gr
OI Karamitri, Angeliki/0000-0002-8397-5529
FU EU [REGPOT-2011-1]; NSRF
FX Contract grant sponsor: EU grant: "Establishment of a Centre of
   Excellence for Structure-Based Drug Target Characterization:
   Strengthening the Research Capacity of South-Eastern Europe" ("SEE-DRUG"
   www.seedrug.upatras.gr; to Dr. Kotsikoris); contract grant number:
   FP7-REGPOT-2011-1; Contract grant sponsor: NSRF 2007-2013 National
   action: Cooperation sub-action II: Large Scale Cooperative Projects.
   DAMP (Development of novel Angiogenesis-Modulating Pharmaceuticals by
   screening of natural compounds and synthetic analogues; to Dr.
   Karamitri)
CR Ambikaipalan A, 2013, CURR STEM CELL RES T, V8, P210, DOI 10.2174/1574888X11308030005
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Boccafoschi F, 2013, CELL ADHES MIGR, V7, P165, DOI 10.4161/cam.23020
   BUCKLEY MJ, 1988, BONE MINER, V4, P225
   Carter DR, 1996, BONE, V18, p5S
   CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F
   Crowley C, 2013, CURR STEM CELL RES T, V8, P243, DOI 10.2174/1574888X11308030009
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007
   Judex S, 2009, ORTHOD CRANIOFAC RES, V12, P94, DOI 10.1111/j.1601-6343.2009.01442.x
   Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y
   Kokkinos PA, 2009, J BIOMED MATER RES A, V90A, P387, DOI 10.1002/jbm.a.32105
   Kroustalli AA, 2013, ANN BIOMED ENG, V41, P2655, DOI 10.1007/s10439-013-0860-0
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   Nagatomi J, 2001, TISSUE ENG, V7, P717, DOI 10.1089/107632701753337672
   Nayak TR, 2010, ACS NANO, V4, P7717, DOI 10.1021/nn102738c
   NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   PENDER N, 1991, J CELL SCI, V100, P187
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   STANFORD CM, 1995, J ORTHOPAED RES, V13, P664, DOI 10.1002/jor.1100130505
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2
   Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061
   Wijdicks FJG, 2013, CAN J SURG, V56, P58, DOI 10.1503/cjs.029511
   Zeng DH, 2010, BIOMECH MODEL MECHAN, V9, P19, DOI 10.1007/s10237-009-0156-3
NR 31
TC 1
Z9 1
U1 0
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1038
EP 1044
DI 10.1002/jbm.a.35250
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500019
PM 24910375
DA 2018-10-20
ER

PT J
AU Garcia-Gareta, E
   Hua, J
   Blunn, GW
AF Garcia-Gareta, Elena
   Hua, Jia
   Blunn, Gordon W.
TI Osseointegration of acellular and cellularized osteoconductive
   scaffolds: Is tissue engineering using mesenchymal stem cells necessary
   for implant fixation?
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; mesenchymal stem cells; in vivo;
   osseointegration; implant; bone fixation strength
ID TOTAL HIP-ARTHROPLASTY; DEBRIS-INDUCED OSTEOLYSIS; SYNTHETIC BONE-GRAFT;
   FUNCTIONAL ASSESSMENT; TITANIUM IMPLANTS; INGROWTH; MARROW;
   DIFFERENTIATION; REPLACEMENT; BIOMATERIAL
AB The main issue associated with revision total hip replacements (rTHRs) is how to generate new bone adjacent to implants and achieve fixation of the revision implant. In its simplest form, bone tissue engineering (BTE) combines cells and scaffolds in vitro to replace damaged or lost bone in vivo. Our aim was to develop BTE porous TiAl6V4 constructs with a calcium-phosphate coating without or with mesenchymal stem cells (MSCs) seeded throughout the entire porous structure to enhance new bone formation and which could be used for rTHRs. Porous titanium scaffolds made by selective laser sintering were seeded throughout with autologous bone marrow MSCs and cultured in a perfusion bioreactor. Constructs were implanted in the medial femoral condyle of 20 skeletally mature mule sheep with and without a gap of 2.5 mm between the construct and the host bone. After 6 weeks, the addition of MSCs to the scaffolds did not significantly increase osseointegration or implant-bone fixation strength. However, in the defects with a gap, the cellularized constructs showed higher implant-bone contact area and implant-bone fixation strength. BTE can be applied to develop acellular or cellularized constructs with clinical application in rTHRs where a lack of bone stock is problematic. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1067-1076, 2015.
C1 [Garcia-Gareta, Elena; Hua, Jia; Blunn, Gordon W.] Univ Coll, Royal Natl Orthopaed Hosp, Inst Orthopaed & Musculoskeletal Sci, John Scales Ctr Biomed Engn, Stanmore HA7 4LP, Middx, England.
RP Garcia-Gareta, E (reprint author), Mt Vernon Hosp, RAFT Inst Plast Surg, Northwood HA6 2RN, Middx, England.
EM garciae@raft.ac.uk
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Babiker H, 2013, J TISSUE ENG REGEN M, DOI 10.1002/term.1685
   Babiker H, 2012, J BIOMED MATER RES B, V100B, P759, DOI 10.1002/jbm.b.32509
   Barckman Jeppe, 2013, Open Orthop J, V7, P18, DOI 10.2174/1874325001307010018
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bohner M., 2000, INJURY, V31, pSD37
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cooper R A, 1992, J Arthroplasty, V7, P285, DOI 10.1016/0883-5403(92)90050-Z
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   Disegi J. A., 2000, INJURY S4, V31, P14, DOI DOI 10.1016/S0020-1383(00)80017-0
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Eslaminejad MB, 2008, YAKHTEH, V10, P205
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Garcia-Gareta E, 2014, J MATER SCI-MATER M, V25, P1553, DOI 10.1007/s10856-014-5170-z
   Garcia-Gareta E, 2013, J MATER SCI-MATER M, V24, P199, DOI 10.1007/s10856-012-4789-x
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   Heisel C, 2003, J BONE JOINT SURG AM, V85A, P1366, DOI 10.2106/00004623-200307000-00026
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Pastoureau PME, 1989, J BONE MINER RES   S, V4, P237
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   WOLFF D, 1994, J ORTHOP RES, V12, P439, DOI 10.1002/jor.1100120317
NR 41
TC 8
Z9 8
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1067
EP 1076
DI 10.1002/jbm.a.35256
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500023
PM 24913035
DA 2018-10-20
ER

PT J
AU Ngwuluka, NC
   Choonara, YE
   Kumar, P
   du Toit, LC
   Khan, RA
   Pillay, V
AF Ngwuluka, Ndidi C.
   Choonara, Yahya E.
   Kumar, Pradeep
   du Toit, Lisa C.
   Khan, Riaz A.
   Pillay, Viness
TI A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral
   delivery of levodopa. Part II: Characterization and formulation of an
   IPEC-based tablet matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE interpolyelectrolyte complex; methacrylic acid copolymer;
   carboxymethylcellulose; hydrogel; controlled release; drug delivery;
   levodopa
ID MOISTURE-CONTENT; DRUG-DELIVERY; RELEASE; DSC
AB This study was undertaken in order to apply a synthesized interpolyelectrolyte complex (IPEC) of polymethacrylate and carboxymethylcellulose as a controlled release oral tablet matrix for the delivery of the model neuroactive drug levodopa. The IPEC (synthesized in Part I of this work) was characterized by techniques such as Fourier Transform Infra-Red (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Advanced DSC (ADSC), and Scanning Electron Microscopy (SEM). The tablet matrices were formulated and characterized for their drug delivery properties and in vitro drug release. FTIR confirmed the interaction between the two polymers. The IPEC composite generated tablet matrices with a hardness ranging from 19.152-27.590 N/mm and a matrix resilience ranging between 42 and 46%. An IPEC of polymethacrylate and carboxymethylcellulose was indeed an improvement on the inherent properties of the native polymers providing a biomaterial with the ability to release poorly soluble drugs such as levodopa at a constant rate over a prolonged period of time. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1085-1094, 2015.
C1 [Ngwuluka, Ndidi C.; Choonara, Yahya E.; Kumar, Pradeep; du Toit, Lisa C.; Pillay, Viness] Univ Witwatersrand, Dept Pharm & Pharmacol, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Fac Hlth Sci, ZA-2193 Parktown, South Africa.
   [Khan, Riaz A.] Manav Rachna Int Univ, Dept Chem, Faridabad, Haryana, India.
RP Pillay, V (reprint author), Univ Witwatersrand, Dept Pharm & Pharmacol, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Fac Hlth Sci, 7 York Rd, ZA-2193 Parktown, South Africa.
EM viness.pillay@wits.ac.za
RI Pillay, Viness/C-1569-2010; Choonara, Yahya/B-2955-2013; Kumar,
   Pradeep/C-9424-2013
OI Pillay, Viness/0000-0002-8119-3347; Choonara, Yahya/0000-0002-3889-1529;
   Kumar, Pradeep/0000-0002-8640-4350; Khan, Riaz/0000-0003-0185-0149
FU National Research Foundation (NRF) of South Africa
FX Contract grant sponsor: National Research Foundation (NRF) of South
   Africa
CR Bravo-Osuna I, 2008, EUR J PHARM BIOPHARM, V69, P285, DOI 10.1016/j.ejpb.2007.09.020
   Bravo-Osuna I, 2007, EUR J PHARM BIOPHARM, V66, P63, DOI 10.1016/j.ejpb.2006.08.003
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Jivraj Mira, 2000, Pharmaceutical Science and Technology Today, V3, P58, DOI 10.1016/S1461-5347(99)00237-0
   KAMAT MS, 1989, PHARM RES-DORDR, V6, P961, DOI 10.1023/A:1015997530367
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Nur AO, 2000, DRUG DEV IND PHARM, V26, P965, DOI 10.1081/DDC-100101323
   O'Brien S, 2009, CARBOHYD POLYM, V76, P557, DOI 10.1016/j.carbpol.2008.11.024
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X
   Steendam R, 2000, INT J PHARM, V204, P23, DOI 10.1016/S0378-5173(00)00456-7
   Verdonck E, 1999, INT J PHARM, V192, P3, DOI 10.1016/S0378-5173(99)00267-7
   Zhao Q, 2009, J MEMBRANE SCI, V333, P68, DOI 10.1016/j.memsci.2009.02.001
NR 14
TC 2
Z9 2
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1085
EP 1094
DI 10.1002/jbm.a.35258
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500025
PM 24909309
DA 2018-10-20
ER

PT J
AU Wang, R
   Levi-Polyanchenko, N
   Morykwas, M
   Argenta, L
   Wagner, WD
AF Wang, Rui
   Levi-Polyanchenko, Nicole
   Morykwas, Michael
   Argenta, Louis
   Wagner, William D.
TI Novel nanofiber-based material for endovascular scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE heart valve; heart valve scaffold; nanocomposite scaffold; polyglycerol
   sebacate; fibroin; silk; collagen
ID IN-VITRO DEGRADATION; MORI SILK FIBROIN; HEART-VALVES; BOMBYX-MORI;
   POLY(GLYCEROL SEBACATE); MECHANICAL-PROPERTIES; TISSUE; COLLAGEN; ACID;
   MEMBRANE
AB Conventional collagen-based heart valves eventually fail because of insufficient replacement of graft material by host tissue. In this study, type I collagen was blended with silk fibroin and the synthetic elastic polymer poly (glycerol-sebacate) (PGS) in varying proportions to create multifunctional electrospun nanofibrous materials tailored for use as endovascular scaffolds such as heart valve replacement. Depending on the blended material the elastic moduli ranged from 2.3 to 5.0 Mpa; tensile stresses ranged from 0.8 to 1.5 Mpa; and strains ranged from 30% to 70%. Electrospun materials with a weight ratio of 4.5:4.5:1 (collagen, fibroin, and PGS) (termed PFC mats) were the most similar to native heart valves. In vitro degradation of PFC mats was 0.01% per week. Endothelial cells adhered to, proliferated, and formed cell-cell junctions on PFC mats. Compared with collagen hydrogels and electrospun collagen mats respectively 220-290% less platelet adhesion was observed for PFC mats. The study demonstrates that PFC material has superior mechanical properties, low degradation, and reduced thrombogenic potential and suggests that further investigation of this biomaterial for cardiovascular applications is warranted. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1150-1158, 2015.
C1 [Wang, Rui; Levi-Polyanchenko, Nicole; Morykwas, Michael; Argenta, Louis; Wagner, William D.] Wake Forest Univ, Sch Med, Dept Plast & Reconstruct Surg, Winston Salem, NC 27157 USA.
   [Wang, Rui; Levi-Polyanchenko, Nicole; Morykwas, Michael; Wagner, William D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27157 USA.
RP Wagner, WD (reprint author), Wake Forest Univ, Sch Med, Dept Plast & Reconstruct Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM wwagner@wakehealth.edu
FU Department of Plastic and Reconstructive Surgery Research Funds
FX Contract grant sponsor: Department of Plastic and Reconstructive Surgery
   Research Funds
CR Apte SS, 2011, FUTUR CARDIOL, V7, P77, DOI [10.2217/fca.10.120, 10.2217/FCA.10.120]
   Beun LH, 2011, ACS NANO, V6, P133
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161
   Cilurzo F, 2011, INT J PHARMACEUT, V414, P218, DOI 10.1016/j.ijpharm.2011.05.023
   De Cupere VM, 2003, LANGMUIR, V19, P6957, DOI 10.1021/la030081n
   Dijkman PE, 2012, BIOMATERIALS, V33, P4545, DOI 10.1016/j.biomaterials.2012.03.015
   Edwards MB, 2005, J CARDIOV MAGN RESON, V7, P835, DOI 10.1080/10976640500288149
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Hayashi T, 2007, J PHYS CHEM B, V111, P11032, DOI 10.1021/jp070369b
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jordan JE, 2012, J THORAC CARDIOV SUR, V143, P201, DOI 10.1016/j.jtcvs.2011.10.005
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108
   Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831
   LUCAS F, 1957, BIOCHEM J, V66, P468, DOI 10.1042/bj0660468
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sant S, 2010, ENG MED BIOL SOC EMB
   Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159
   SCHROEDER WA, 1955, J AM CHEM SOC, V77, P3908, DOI 10.1021/ja01619a066
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   Shekaran A, BBA GEN SUBJECTS, V1810, P350
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   TROWBRIDGE EA, 1989, J BIOMED ENG, V11, P311, DOI 10.1016/0141-5425(89)90065-4
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
   Zong XH, 2003, BIOMACROMOLECULES, V4, P416, DOI 10.1021/bm025717o
   Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972
NR 46
TC 6
Z9 6
U1 5
U2 59
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1150
EP 1158
DI 10.1002/jbm.a.35267
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500031
PM 25044469
DA 2018-10-20
ER

PT J
AU Janson, IA
   Putnam, AJ
AF Janson, Isaac A.
   Putnam, Andrew J.
TI Extracellular matrix elasticity and topography: Material-based cues that
   affect cell function via conserved mechanisms
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE topography; matrix mechanics; cell fate; mechanotransduction;
   differentiation
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; COPOLYMER MICELLE
   NANOLITHOGRAPHY; POLYMER-DEMIXED NANOTOPOGRAPHY; FOCAL ADHESION KINASE;
   NANOSCALE TOPOGRAPHY; OSTEOGENIC DIFFERENTIATION; COLLAGEN-I;
   OSTEOPROGENITOR RESPONSE; SUBSTRATE STIFFNESS
AB Chemical, mechanical, and topographic extracellular matrix (ECM) cues have been extensively studied for their influence on cell behavior. These ECM cues alter cell adhesion, cell shape, and cell migration and activate signal transduction pathways to influence gene expression, proliferation, and differentiation. ECM elasticity and topography, in particular, have emerged as material properties of intense focus based on strong evidence these physical cues can partially dictate stem cell differentiation. Cells generate forces to pull on their adhesive contacts, and these tractional forces appear to be a common element of cells' responses to both elasticity and topography. This review focuses on recently published work that links ECM topography and mechanics and their influence on differentiation and other cell behaviors. We also highlight signaling pathways typically implicated in mechanotransduction that are (or may be) shared by cells subjected to topographic cues. Finally, we conclude with a brief discussion of the potential implications of these commonalities for cell based therapies and biomaterial design. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1246-1258, 2015.
C1 [Janson, Isaac A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
OI Putnam, Andrew/0000-0002-1262-4377
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R01HL085339, R01HL118259]
FX Contract grant sponsor: National Heart, Lung, and Blood Institute of the
   National Institutes of Health; contract grant numbers: R01HL085339 and
   R01HL118259
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ballet T, 2010, B POL ACAD SCI-TECH, V58, P303, DOI 10.2478/v10175-010-0028-0
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Choi SJ, 2011, J MATER CHEM, V21, P14325, DOI 10.1039/c1jm12201k
   Choi SJ, 2004, J AM CHEM SOC, V126, P7744, DOI 10.1021/ja048972k
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076
   Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HORBETT TA, 1982, ADV CHEM SER, P233
   Huang XD, 2002, J VAC SCI TECHNOL B, V20, P2872, DOI 10.1116/1.1523404
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jain R, 2003, J INVEST SURG, V16, P263, DOI 10.1080/08941930390230388
   Janson IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090719
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/JBMR.081240, 10.1359/jbmr.081240]
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029
   Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong YP, 2013, ACTA BIOMATER, V9, P6369, DOI 10.1016/j.actbio.2013.01.036
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   LaPointe VLS, 2013, ADV HEALTHC MATER, V2, P1644, DOI 10.1002/adhm.201200382
   Li B., 2013, SCI REP, P3
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Liu WF, 2007, ADV DRUG DELIVER REV, V59, P1319, DOI 10.1016/j.addr.2007.08.011
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mello AP, 2003, ANN BIOMED ENG, V31, P1106, DOI 10.1114/1.1603261
   Mosqueira D, 2014, ACS NANO, V8, P2033, DOI 10.1021/nn4058984
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Norde W, 2012, ACS SYM SER, V1120, P1
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pompe T, 2009, BIOPHYS J, V97, P2154, DOI 10.1016/j.bpj.2009.07.047
   Prodanov L, 2013, BIOMATERIALS, V34, P2920, DOI 10.1016/j.biomaterials.2013.01.027
   Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P677, DOI 10.1016/j.cbpa.2011.04.021
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wheeldon I, 2011, NANOTECHNOLOGY, P22
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wood JA, 2012, EXP CELL RES, V318, P2438, DOI 10.1016/j.yexcr.2012.06.022
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 134
TC 40
Z9 42
U1 9
U2 126
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2015
VL 103
IS 3
BP 1246
EP 1258
DI 10.1002/jbm.a.35254
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7NG
UT WOS:000349103500041
PM 24910444
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, WF
   Chen, CY
AF Lee, Wen-Fu
   Chen, Chien-Yu
TI Graft copolymerization of 3-(trimethoxysilyl) propyl methacrylate onto
   styrene-butadiene-styrene triblock copolymer
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Article
DE Styrene-butadiene-styrene triblock copolymer; graft copolymerization;
   silicone monomer
ID MALEIC-ANHYDRIDE; GLYCIDYL METHACRYLATE; SBS; RUBBER; POLYMERIZATION;
   BIOMATERIAL; ACID
AB Graft copolymerization of silicone monomer3-(trimethoxysilyl) propyl methacrylate (TMSPMA) grafted onto styrene-butadiene-styrene (SBS; SBS-g-TMSPMA) triblock copolymer was carried out by free radical polymerization, and the improvement of adhesive property of the grafted SBS for glass materials is the major purpose of this study. To gain the optimal reaction conditions and grafting effect, the effect of various factors, such as the monomer ratio and reaction time, on the grafting ratio and grafting efficiency (GE) of SBS-g-TMSPMA graft copolymers were investigated. In addition, various SBS-g-TMSPMA graft copolymers were coated on different substrates based on glass and their tensile strengths that were tested. The optimal graft condition for the SBS-g-TMSPMA was obtained when the molar ratio of TMSPMA to SBS was 1 and reaction time was 4 h. Their grafting ratio and GEreached to a maximum of 56.8% and 60.2%, respectively, and the tensile strength also reached maximum. In this article, we confirm that the higher the grafting ratio, the more the silicone-containing in the graft copolymer. Hence, the -Si-O-Si- bonding between SBS-g-TMSPMA and glass substrate was more intensive and tensile strength was stronger.
C1 [Lee, Wen-Fu; Chen, Chien-Yu] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan.
RP Lee, WF (reprint author), Tatung Univ, Dept Chem Engn, 40 Sec 3,Jhonhshan N Rd, Taipei 104, Taiwan.
EM wflee@ttu.edu.tw
FU Tatung University [B 101-C01-017]
FX The authors wish to thank the Tatung University for the financial
   support under Grant B 101-C01-017.
CR Brinkmann-Rengel S, 1999, KAUT GUMMI KUNSTST, V52, P806
   Coiai S, 2006, MACROMOL SYMP, V234, P193, DOI 10.1002/masy.200650225
   Cordella CD, 2003, J APPL POLYM SCI, V87, P2074, DOI 10.1002/app.11455
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kennedy JE, 2011, MAT SCI ENG C-MATER, V31, P246, DOI 10.1016/j.msec.2010.09.004
   Kennedy JE, 2009, MAT SCI ENG C-BIO S, V29, P1655, DOI 10.1016/j.msec.2009.01.015
   Lasalle VL, 2003, J ADHES SCI TECHNOL, V17, P1713, DOI 10.1163/156856103322396758
   Lee WF, 2001, J APPL POLYM SCI, V82, P2641, DOI 10.1002/app.2117
   LEE WF, 1995, J APPL POLYM SCI, V55, P1197, DOI 10.1002/app.1995.070550807
   Lee WF, 2009, J ELASTOM PLAST, V42, P49
   Peng J, 2007, RADIAT PHYS CHEM, V76, P1741, DOI 10.1016/j.radphyschem.2007.02.086
   Wilhelm HM, 2002, J APPL POLYM SCI, V83, P2953, DOI 10.1002/app.10355
   Wu GL, 2010, MAT SCI ENG C-MATER, V30, P1030, DOI 10.1016/j.msec.2010.05.004
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yin CJ, 2011, J APPL POLYM SCI, V119, P2808, DOI 10.1002/app.33073
   Zhang A, 2003, EUR POLYM J, V39, P1291
   ZHAO Y, 1992, MACROMOLECULES, V25, P4705, DOI 10.1021/ma00044a035
   Zhou T, 2003, CHIN J COLLOID POLYM, V21, P15
NR 20
TC 1
Z9 1
U1 1
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
EI 1530-8006
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD MAR
PY 2015
VL 47
IS 2
BP 103
EP 116
DI 10.1177/0095244313489911
PG 14
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA CB0OV
UT WOS:000349326900001
DA 2018-10-20
ER

PT J
AU Ijaz, MF
   Kim, HY
   Hosoda, H
   Miyazaki, S
AF Ijaz, Muhammad Farzik
   Kim, Hee Young
   Hosoda, Hideki
   Miyazaki, Shuichi
TI Superelastic properties of biomedical (Ti-Zr)-Mo-Sn alloys
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Superelasticity; Reaystallization texture; Biomaterial; Ti alloy;
   Martensitic transformation
ID SHAPE-MEMORY ALLOY; TI-BASED ALLOYS; MECHANICAL-PROPERTIES;
   PHASE-STABILITY; NB ALLOYS; THERMOMECHANICAL TREATMENT; YOUNGS MODULUS;
   TITANIUM-ALLOY; HEAT-TREATMENT; SN CONTENT
AB A new class of Ti-50Zr base biomedical superelastic alloys was developed in this study. The (Ti-Zr)-Mo-Sn alloys exhibited a shape memory effect and superelastic property by adjusting Mo and Sn contents. The (Ti-Zr)-1.5Mo-3Sn alloy revealed the most stable superelasticity among (Ti-Zr)-(1-2)Mo-(2-4)Sn alloys. The superelastic recovery strain showed a strong dependence on heat treatment temperature after cold working in the (Ti-Zr)1.5Mo-3Sn alloy. The superelastic recovery strain increased as the heat treatment temperature increased although the critical stress for slip decreased. The (Ti-Zr)-1.5Mo-3Sn alloy heat treated at 1073 K exhibited excellent superelastic properties with a large recovery strain as large as 7% which is due to the strong {001}(beta)< 110 >(beta) recrystallizadon texture. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ijaz, Muhammad Farzik; Kim, Hee Young; Miyazaki, Shuichi] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   [Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Kim, HY (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM heeykim@ims.tsukuba.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Kim, Hee Young/F-6065-2011; Miyazaki, Shuichi/A-3113-2012
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176
FU JSPS KAKENHI [26249104]; MEXT KAKENHI [25102704]
FX This work was partially supported by JSPS KAKENHI Grant Number 26249104
   and MEXT KAKENHI Grant Number 25102704.
CR Abdel-Hady M, 2008, MAT SCI ENG A-STRUCT, V480, P167, DOI 10.1016/j.msea.2007.06.083
   Abdel-Hady M, 2007, SCRIPTA MATER, V57, P1000, DOI 10.1016/j.scriptamat.2007.08.003
   Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Abriata J.P., 1983, B ALLOY PHASE DIAGRA, V4, P147, DOI DOI 10.1007/BF02884861
   Al-Zain Y, 2011, ACTA MATER, V59, P1464, DOI 10.1016/j.actamat.2010.11.008
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   BURSTONE CJ, 1980, AM J ORTHOD DENTOFAC, V77, P121, DOI 10.1016/0002-9416(80)90001-9
   Cai S, 2013, ACTA MATER, V61, P6830, DOI 10.1016/j.actamat.2013.07.062
   Cai S, 2013, MAT SCI ENG A-STRUCT, V562, P172, DOI 10.1016/j.msea.2012.11.005
   Cui Y, 2010, MAT SCI ENG A-STRUCT, V527, P652, DOI 10.1016/j.msea.2009.08.063
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   DUWEZ P, 1951, J I MET, V80, P525
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Gloriant T, 2006, ADV ENG MATER, V8, P961, DOI 10.1002/adem.200600106
   Hanawa T, 2009, J ARTIF ORGANS, V12, P73, DOI 10.1007/s10047-008-0456-x
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   HATT BA, 1959, ACTA METALL, V70, P682
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2006, MAT SCI ENG A-STRUCT, V438, P870, DOI 10.1016/j.msea.2006.02.151
   Ijaz MF, 2014, SCRIPTA MATER, V72-73, P29, DOI 10.1016/j.scriptamat.2013.10.007
   Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim JI, 2006, MATER TRANS, V47, P505, DOI 10.2320/matertrans.47.505
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   KOBAYASHI S, 2004, MAT T, V42, P2398
   Li Q, 2012, MAT SCI ENG A-STRUCT, V536, P197, DOI 10.1016/j.msea.2011.12.103
   Li Y, 2011, SCRIPTA MATER, V64, P584, DOI 10.1016/j.scriptamat.2010.11.048
   Lin L, 1996, SCRIPTA MATER, V34, P1411, DOI 10.1016/1359-6462(96)00006-1
   Ma LW, 2013, INTERMETALLICS, V32, P44, DOI 10.1016/j.intermet.2012.07.024
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326
   MURRAY JI, 1987, BINARY ALLOY PHASE D, P294
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Obbard EG, 2011, ACTA MATER, V59, P112, DOI 10.1016/j.actamat.2010.09.015
   Otsuka K, 1998, SHAPE MEMORY MATERIA
   Ramarolahy A, 2012, J MECH BEHAV BIOMED, V9, P83, DOI 10.1016/j.jmbbm.2012.01.017
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   Saltykov VA, 2008, J ALLOY COMPD, V459, P348, DOI 10.1016/j.jallcom.2007.04.268
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Tada H, 2012, MATER TRANS, V53, P1981, DOI 10.2320/matertrans.M2012184
   Tahara M, 2010, MAT SCI ENG A-STRUCT, V527, P6844, DOI 10.1016/j.msea.2010.07.052
   Tahara M, 2009, MATER TRANS, V50, P2726, DOI 10.2320/matertrans.MA200907
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Wang BL, 2008, MAT SCI ENG A-STRUCT, V486, P146, DOI 10.1016/j.msea.2007.08.073
   Yang Y, 2014, J ALLOY COMPD, V591, P85, DOI 10.1016/j.jallcom.2013.12.207
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Zhan YZ, 2009, J ALLOY COMPD, V485, P170, DOI 10.1016/j.jallcom.2009.05.110
   Zhang DC, 2013, MAT SCI ENG A-STRUCT, V559, P706, DOI 10.1016/j.msea.2012.09.012
   Zhang JY, 2013, MAT SCI ENG A-STRUCT, V563, P78, DOI 10.1016/j.msea.2012.11.045
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
NR 58
TC 25
Z9 25
U1 5
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 11
EP 20
DI 10.1016/j.msec.2014.11.010
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200003
PM 25579891
DA 2018-10-20
ER

PT J
AU Dalmau, A
   Pina, VG
   Devesa, F
   Amigo, V
   Munoz, AI
AF Dalmau, A.
   Guinon Pina, V.
   Devesa, F.
   Amigo, V.
   Igual Munoz, A.
TI Electrochemical behavior of near-beta titanium biomedical alloys in
   phosphate buffer saline solution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Near-beta titanium alloys; Passivation; Biomaterials; Corrosion;
   Electrochemical impedance spectroscopy (EIS)
ID NB-SN ALLOYS; AGING HEAT-TREATMENT; TI-NB; MECHANICAL-PROPERTIES;
   PHYSIOLOGICAL SOLUTION; POWDER-METALLURGY; PASSIVE FILM; CORROSION
   BEHAVIOR; MICROSTRUCTURE; IMPLANTS
AB The electrochemical behavior of three different near-beta titanium alloys (composed by Ti, Nb and Sn) obtained by powder metallurgy for biomedical applications has been investigated. Different electrochemical and microscopy techniques were used to study the influence of the chemical composition (Sn content) and the applied potential on the microstructure and the corrosion mechanisms of those titanium alloys. The addition of Sn below 4 wt% to the titanium powder improves the microstructural homogeneity and generates an alloy with high corrosion resistance with low elastic modulus, being more suitable as a biomaterial. When the Sn content is above 4%, the corrosion resistance considerably decreases by increasing the passive dissolution rate; this effect is enhanced with the applied potential. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Dalmau, A.; Guinon Pina, V.; Igual Munoz, A.] Univ Politecn Valencia, Inst Ind Radiophys & Environm Safety, E-46071 Valencia, Spain.
   [Devesa, F.; Amigo, V.] Univ Politecn Valencia, Inst Mat Technol, E-46071 Valencia, Spain.
RP Dalmau, A (reprint author), Univ Politecn Valencia, Inst Ind Radiophys & Environm Safety, POB 22012, E-46071 Valencia, Spain.
EM aldalbor@posgrado.upv.es
RI igual munoz, anna/K-7996-2014; Guinon Pina, Virginia/I-1845-2015; Amigo,
   Vicente/K-6893-2014
OI igual munoz, anna/0000-0002-1372-621X; Guinon Pina,
   Virginia/0000-0002-6630-6227; Amigo, Vicente/0000-0002-2107-0273;
   Dalmau, Alba/0000-0002-4224-4463
FU Ministerio de Ciencia e Innovacion of the Spanish Government
   [MAT2011-22481]
FX The authors would like to thank the Ministerio de Ciencia e Innovacion
   of the Spanish Government for the financial support under the project
   MAT2011-22481.
CR Aleixo GT, 2011, SOLID STATE PHENOMEN, V172-174, P190, DOI 10.4028/www.scientific.net/SSP.172-174.190
   Barranco V, 2011, ACTA BIOMATER, V7, P2716, DOI 10.1016/j.actbio.2011.02.040
   BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/S0022-0728(84)80324-1
   Dalmau A, 2013, ELECTROCHIM ACTA, V95, P102, DOI 10.1016/j.electacta.2013.01.155
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Devesa F, 2012, MATER SCI FORUM, V727-728, P61, DOI 10.4028/www.scientific.net/MSF.727-728.61
   Dewidar MM, 2008, J ALLOY COMPD, V454, P442, DOI 10.1016/j.jallcom.2006.12.143
   Fan JK, 2014, MATER CHARACT, V96, P93, DOI 10.1016/j.matchar.2014.07.018
   Fan JK, 2014, RARE METAL MAT ENG, V43, P808, DOI 10.1016/S1875-5372(14)60089-8
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guo S, 2013, PROG NAT SCI-MATER, V23, P1, DOI 10.1016/j.pnsc.2013.01.008
   Ivasishin OM, 2008, J ALLOY COMPD, V457, P296, DOI 10.1016/j.jallcom.2007.03.070
   Jo YJ, 2007, J MATER PROCESS TECH, V194, P121, DOI 10.1016/j.matprotec.2007.04.102
   Kolachev BA, 1997, RUSS METALL+, P118
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes ESN, 2011, MATER CHARACT, V62, P673, DOI 10.1016/j.matchar.2011.04.015
   Lopes ESN, 2011, ADV MATER RES-SWITZ, V324, P61, DOI 10.4028/www.scientific.net/AMR.324.61
   Martin E, 2010, TRIBOL INT, V43, P918, DOI 10.1016/j.triboint.2009.12.055
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Milosev I, 2013, ELECTROCHIM ACTA, V99, P176, DOI 10.1016/j.electacta.2013.03.086
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   More NS, 2011, MAT SCI ENG C-MATER, V31, P400, DOI 10.1016/j.msec.2010.10.021
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Rehder D, 2003, INORG CHEM COMMUN, V6, P604, DOI 10.1016/S1387-7003(03)00050-9
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Vidal CV, 2012, J ELECTROCHEM SOC, V159, pC233, DOI 10.1149/2.090205jes
   Wang BL, 2008, MAT SCI ENG A-STRUCT, V486, P146, DOI 10.1016/j.msea.2007.08.073
   Wang XP, 2013, MATER DESIGN, V49, P511, DOI 10.1016/j.matdes.2013.01.012
   Yang YL, 2009, MATER SCI FORUM, V618-619, P169, DOI 10.4028/www.scientific.net/MSF.618-619.169
   Yu S, 2011, COLLOID SURFACE B, V85, P103, DOI 10.1016/j.colsurfb.2011.02.025
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
NR 37
TC 11
Z9 12
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 55
EP 62
DI 10.1016/j.msec.2014.11.036
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200008
PM 25579896
DA 2018-10-20
ER

PT J
AU Chatzinikolaidou, M
   Rekstyte, S
   Danilevicius, P
   Pontikoglou, C
   Papadaki, H
   Farsari, M
   Vamvakaki, M
AF Chatzinikolaidou, Maria
   Rekstyte, Sima
   Danilevicius, Paulius
   Pontikoglou, Charalampos
   Papadaki, Helen
   Farsari, Maria
   Vamvakaki, Maria
TI Adhesion and growth of human bone marrow mesenchymal stem cells on
   precise-geometry 3D organic-inorganic composite scaffolds for bone
   repair
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Human bone marrow mesenchymal stem cells; 3D scaffold fabrication;
   Hybrid material; Cell adhesion and proliferation; Cell variability
ID STROMAL CELLS; LASER; OSTEOGENESIS; FABRICATION; HYDROGELS; CULTURE;
   BIOLOGY
AB Engineering biomaterial scaffolds that promote attachment and growth of mesenchymal stem cells in three dimensions is a crucial parameter for successful bone tissue engineering. Towards this direction, a lot of research effort has focused recently into the development of three-dimensional porous scaffolds, aiming to elicit positive cellular behavior. However, the fabrication of three-dimensional tissue scaffolds with a precise geometry and complex micro- and nano-features, supporting cell in-growth remains a challenge. In this study we report on a positive cellular response of human bone marrow-derived (BM) mesenchymal stem cells (MSCs) onto hybrid material scaffolds consisting of methacryloxypropyl trimethoxysilane, zirconium propoxide, and 2-(dimethylamino)ethyl methacrylate (DMAEMA). First, we use Direct Is Laser Writing, a 3D scaffolding technology to fabricate the complex structures. Subsequently, we investigate the morphology, viability and proliferation of BM-MSCs onto the hybrid scaffolds and examine the cellular response from different donors. Finally, we explore the effect of the materials' chemical composition on cell proliferation, employing three different material surfaces: (i) a hybrid consisting of methacryloxypropyl trimethoxysilane, zirconium propoxide and 50 mol% DMAEMA, (ii) a hybrid material comprising methacryloxypropyl trimethoxysilane and zirconium propoxide, and (iii) a purely organic polyDMAEMA. Our results show a strong adhesion of BM-MSCs onto the hybrid material containing 50% DMAEMA from the first 2 h after seeding, and up to several days, and a proliferation increase after 14 and 21 days, similar to the polystyrene control, independent of cell donor. These findings support the potential use of our proposed cell material combination in bone tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Chatzinikolaidou, Maria; Vamvakaki, Maria] Univ Crete, Dept Mat Sci & Technol, GR-71003 Iraklion, Greece.
   [Pontikoglou, Charalampos; Papadaki, Helen] Univ Crete, Sch Med, Hematol Lab, GR-71003 Iraklion, Greece.
   [Chatzinikolaidou, Maria; Rekstyte, Sima; Danilevicius, Paulius; Farsari, Maria; Vamvakaki, Maria] Fdn Res & Technol Hellas FORTH, Inst Elect Struct & Laser, Iraklion, Greece.
RP Chatzinikolaidou, M (reprint author), Univ Crete, Dept Mat Sci & Technol, POB 2208, GR-71003 Iraklion, Greece.
EM mchatzin@materials.uoc.gr
RI Farsari, Maria/B-3767-2011
OI Farsari, Maria/0000-0003-2435-4156
FU Special Account for Research Fund of the University of Crete [3090];
   THALIS 3DSET Program of the Hellenic Ministry of Education [MIS380278];
   FP7 Marie Curie ITN program TopBio [PITN-GA-2010-264362]
FX This work was partly funded by the Special Account for Research Fund of
   the University of Crete (3090) and by the THALIS 3DSET Program
   (MIS380278) of the Hellenic Ministry of Education. PD and MF acknowledge
   financial support from the FP7 Marie Curie ITN program TopBio
   (PITN-GA-2010-264362). Konstantina Terzaki is acknowledged for the block
   structures, Maria Kissamitaki for the thin films preparation, and Prof.
   Pavlos Katonis is acknowledged for the donation of the bone marrow
   tissues. We would also like to thank Ms. Alexandra Siakouli for expert
   technical assistance with SEM.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Danilevicius P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081405
   Delorme Bruno, 2007, V140, P67
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HULBERT SF, 1971, FED PROC, V30, pA705
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Isaksson H, 2010, J BIOMECH, V43, P2410, DOI 10.1016/j.jbiomech.2010.04.017
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kastrinaki MC, 2008, ANN RHEUM DIS, V67, P741, DOI 10.1136/ard.2007.076174
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Klein F, 2011, ADV MATER, V23, P1341, DOI 10.1002/adma.201004060
   Koller MR, 1996, EXP HEMATOL, V24, P1484
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Maruo S, 2008, LASER PHOTONICS REV, V2, P100, DOI 10.1002/lpor.200710039
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Oyen ML, 2009, J MECH BEHAV BIOMED, V2, P396, DOI 10.1016/j.jmbbm.2008.10.002
   Pontikoglou C, 2008, REGEN MED, V3, P731, DOI 10.2217/17460751.3.5.731
   Pontikoglou C, 2013, STEM CELLS DEV, V22, P1329, DOI 10.1089/scd.2012.0255
   Pountos I, 2005, INJURY, V36, P8, DOI 10.1016/j.injury.2005.07.028
   Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278
   Ritschdorff ET, 2010, ANAL CHEM, V82, P8733, DOI 10.1021/ac101274u
   Sakellari I, 2010, APPL PHYS A-MATER, V100, P359, DOI 10.1007/s00339-010-5864-0
   Sakellari I, 2012, ACS NANO, V6, P2302, DOI 10.1021/nn204454c
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Skarmoutsou A, 2013, J MECH BEHAV BIOMED, V25, P48, DOI 10.1016/j.jmbbm.2013.05.003
   Skoog SA, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4873688
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Terzaki K, 2013, J BIOMED MATER RES A, V101, P2283, DOI 10.1002/jbm.a.34516
   Terzaki K, 2011, OPT MATER EXPRESS, V1, P586, DOI 10.1364/OME.1.000586
   Torgersen J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.105008
   Turunen S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045002
   Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5
   Vasilantonakis N, 2012, ADV MATER, V24, P1101, DOI 10.1002/adma.201104778
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 41
TC 18
Z9 18
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 301
EP 309
DI 10.1016/j.msec.2014.12.007
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200039
PM 25579927
DA 2018-10-20
ER

PT J
AU Pardun, K
   Treccani, L
   Volkmann, E
   Streckbein, P
   Heiss, C
   Li Destri, G
   Marietta, G
   Rezwan, K
AF Pardun, Karoline
   Treccani, Laura
   Volkmann, Eike
   Streckbein, Philipp
   Heiss, Christian
   Li Destri, Giovanni
   Marietta, Giovanni
   Rezwan, Kurosch
TI Mixed zirconia calcium phosphate coatings for dental implants: Tailoring
   coating stability and bioactivity potential
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate; Zirconia; Coating stability; Bioactivity;
   Dissolution; Cellular biocompatibility
ID OSTEOBLAST-LIKE CELLS; SIMULATED BODY-FLUID; MECHANICAL-PROPERTIES;
   TITANIUM-ALLOYS; HYDROXYAPATITE COATINGS; ADHESION; ROUGHNESS; CERAMICS;
   BIOCERAMICS; BIOMATERIAL
AB Enhanced coating stability and adhesion are essential for long-term success of orthopedic and dental implants. In this study, the effect of coating composition on mechanical, physico-chemical and biological properties of coated zirconia specimens is investigated. Zirconia discs and dental screw implants are coated using the wet powder spraying (WPS) technique. The coatings are obtained by mixing yttria-stabilized zirconia (TZ) and hydroxyapatite (HA) in various ratios while a pure HA coating served as reference material. Scanning electron microscopy (SEM) and optical profilometer analysis confirm a similar coating morphology and roughness for all studied coatings, whereas the coating stability can be tailored with composition and is probed by insertion and dissections experiments in bovine bone with coated zirconia screw implants. An increasing content of calcium phosphate (CP) resulted in a decrease of mechanical and chemical stability, while the bioactivity increased in simulated body fluid (SBF). In vitro experiments with human osteoblast cells (HOB) revealed that the cells grew well on all samples but are affected by dissolution behavior of the studied coatings. This work demonstrates the overall good mechanical strength, the excellent interfacial bonding and the bioactivity potential of coatings with higher TZ contents, which provide a highly interesting coating for dental implants. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Pardun, Karoline; Treccani, Laura; Volkmann, Eike; Rezwan, Kurosch] Univ Bremen, D-28359 Bremen, Germany.
   [Streckbein, Philipp] Univ Giessen, Univ Hosp, Dept Craniomaxillofacial Surg, D-35385 Giessen, Germany.
   [Heiss, Christian] Univ Hosp Giessen Marburg, Dept Trauma Surg, D-35385 Giessen, Germany.
   [Heiss, Christian] Expt Surg Lab, D-35392 Giessen, Germany.
   [Li Destri, Giovanni; Marietta, Giovanni] Univ Catania, Lab Mol Surfaces & Nanotechnol LAMSUN, Dept Chem, I-95125 Catania, Italy.
   [Li Destri, Giovanni; Marietta, Giovanni] CSGI, I-95125 Catania, Italy.
RP Treccani, L (reprint author), Biol Garten 2, D-28359 Bremen, Germany.
EM treccani@uni-bremen.de
RI Li Destri, Giovanni/C-8807-2012; Treccani, Laura/R-1725-2016; Rezwan,
   Kurosch/K-9451-2013; Marletta, Giovanni/F-3154-2012
OI Li Destri, Giovanni/0000-0001-6195-659X; Treccani,
   Laura/0000-0001-5365-9827; Rezwan, Kurosch/0000-0002-7318-1119;
   Marletta, Giovanni/0000-0002-6929-9499
FU Deutsche Forschungsgemeinschaft, DFG [RE 2735/7-1]
FX Authors would like to acknowledge financial support from the Deutsche
   Forschungsgemeinschaft, DFG (Grant No. RE 2735/7-1). We thank Petra
   Witte of Historical Geology-Palaeontology, University of Bremen for the
   performance of SEM and EDX analysis. We are also grateful to Martin
   Ellerhorst from BEGO Implant Systems for providing implant geometries
   and Andreas Reindl from Fraunhofer IFAM Bremen for preparation of
   zirconia implants, as well as Michael Teck for his help with
   experimental investigations.
CR Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Barnes D, 2012, J MECH BEHAV BIOMED, V6, P128, DOI 10.1016/j.jmbbm.2011.10.010
   Borger A, 2002, J EUR CERAM SOC, V22, P1425, DOI 10.1016/S0955-2219(01)00458-7
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Dorozhkin SV, 2013, J MATER SCI-MATER M, V24, P1335, DOI 10.1007/s10856-013-4898-1
   Fu L, 2002, J AM CERAM SOC, V85, P800
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holthaus MG, 2012, ACTA BIOMATER, V8, P394, DOI 10.1016/j.actbio.2011.07.031
   Holthaus MG, 2013, J BIOMATER APPL, V27, P791, DOI 10.1177/0885328211426354
   IOKU K, 1990, BIOMATERIALS, V11, P57, DOI 10.1016/0142-9612(90)90053-S
   Izquierdo-Barba I, 2006, ACTA BIOMATER, V2, P445, DOI 10.1016/j.actbio.2006.02.002
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LHERMITTESEBIRE I, 1986, THIN SOLID FILMS, V138, P221, DOI 10.1016/0040-6090(86)90395-0
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsumoto TJ, 2011, DENT MATER, V27, pE205, DOI 10.1016/j.dental.2011.07.009
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pardun K, 2015, CLIN IMPLANT DENT R, V17, P186, DOI 10.1111/cid.12071
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Reinhardt B, 2014, ADVANCED CERAMICS FOR DENTISTRY, P51, DOI 10.1016/B978-0-12-394619-5.00004-3
   RUDER A, 1992, SURF COAT TECH, V53, P71, DOI 10.1016/0257-8972(92)90105-J
   Stefanic M, 2014, J MATER SCI-MATER M, V25, P2333, DOI 10.1007/s10856-014-5246-9
   Stefanic M, 2013, J EUR CERAM SOC, V33, P3455, DOI 10.1016/j.jeurceramsoc.2013.05.015
   Tang Q, 2010, J MATER SCI-MATER M, V21, P173, DOI 10.1007/s10856-009-3841-y
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WHITE EM, 1983, AM ANTIQUITY, V48, P316, DOI 10.2307/280453
   Wu CT, 2008, ACTA BIOMATER, V4, P569, DOI 10.1016/j.actbio.2007.11.005
   Yang JZ, 2011, J EUR CERAM SOC, V31, P2065, DOI 10.1016/j.jeurceramsoc.2011.05.025
   Yugeswaran S, 2012, J MECH BEHAV BIOMED, V9, P22, DOI 10.1016/j.jmbbm.2011.11.002
   Zhang JX, 2006, J AM CERAM SOC, V89, P3348, DOI 10.1111/j.1551-2916.2006.01237.x
NR 36
TC 17
Z9 17
U1 3
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 337
EP 346
DI 10.1016/j.msec.2014.12.031
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200043
PM 25579931
DA 2018-10-20
ER

PT J
AU Almeida, JC
   Lancastre, J
   Fernandes, MHV
   Margaca, FMA
   Ferreira, L
   Salvado, IMM
AF Carlos Almeida, J.
   Lancastre, Joana
   Helena Vaz Fernandes, M.
   Margaca, Fernanda M. A.
   Ferreira, Luis
   Miranda Salvado, Isabel M.
TI Evaluating structural and microstructural changes of PDMS-SiO2 hybrid
   materials after sterilization by gamma irradiation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Sterilization; Gamma irradiation; Hybrid materials; Structure;
   Microstructure
ID MODIFIED CAO-SIO2-TIO2 HYBRIDS; NUCLEAR-MAGNETIC-RESONANCE; SI-29 NMR;
   IN-VITRO; FT-IR; SILOXANE; POLYDIMETHYLSILOXANE; NANOCOMPOSITES;
   HYDROLYSIS; TEOS
AB PDMS-SiO2 hybrid materials obtained by sol-gel process have been extensively studied over the past years due to its promising biomedical applications namely as bone substitutes, catheters, and drug delivery devices. Regardless of the intended biomedical application, all these materials should go through a sterilization process before interfacing with a living structure. However, it is unclear whether they undergo structural and microstructural changes when subjected to sterilization by gamma irradiation. This paper addresses this issue by showing that a sol-gel processed biomaterial based on the PDMS-CaO-SiO2 hybrid system suffers only small structural changes when submitted to a radiation dose of 25 kGy, the dose usually recommended to achieve a Sterility Assurance Level of 10(-6) when the natural contamination level and microorganism types cannot be calculated. The characterization was assessed by FT-IR, Si-29-{H-1} CP-MAS, thermal analysis (DTG), and SEM. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Carlos Almeida, J.; Helena Vaz Fernandes, M.; Miranda Salvado, Isabel M.] Univ Aveiro, Dept Mat & Ceram Engn, CICECO, P-3810193 Aveiro, Portugal.
   [Lancastre, Joana; Margaca, Fernanda M. A.; Ferreira, Luis] Univ Lisbon, IST, P-268695 Sacavem, Portugal.
RP Salvado, IMM (reprint author), Univ Aveiro, Dept Mat & Ceram Engn, CICECO, P-3810193 Aveiro, Portugal.
EM isabelmsalvado@ua.pt
RI Almeida, Jose/H-1629-2011; Margaca, Fernanda/J-6938-2013
OI Almeida, Jose/0000-0003-1552-9532; Margaca,
   Fernanda/0000-0002-3452-1870; V Fernandes, Maria
   Helena/0000-0002-1240-2512; Salvado, Isabel/0000-0003-0265-4553
FU FEDER funds (Program COMPETE); FCT [PTDC/CTM/101115/2008]; CICECO
   [Pest-C/CTM/LA0011/2013];  [SFRH/BD/72074/2010]; 
   [RECI/AAG-TEC/0400/2012]
FX This work is financed by FEDER funds (Program COMPETE) and by FCT funds,
   on the project PTDC/CTM/101115/2008 and by the grants SFRH/BD/72074/2010
   and RECI/AAG-TEC/0400/2012. We also acknowledge the program financing
   CICECO, Pest-C/CTM/LA0011/2013.
CR Aguiar H, 2009, J NON-CRYST SOLIDS, V355, P475, DOI 10.1016/j.jnoncrysol.2009.01.010
   Almeida JC, 2014, MATER CHEM PHYS, V143, P557, DOI 10.1016/j.matchemphys.2013.09.032
   Babonneau F, 2000, POLYHEDRON, V19, P315, DOI 10.1016/S0277-5387(99)00361-7
   BABONNEAU F, 1994, POLYHEDRON, V13, P1123, DOI 10.1016/S0277-5387(00)80249-1
   BABONNEAU F, 1993, MAT RES S C, V286, P289
   Babonneau F, 1989, CHEM MATER, V1, P554
   Babonneau F, 2010, CR CHIM, V13, P58, DOI 10.1016/j.crci.2009.08.001
   Camino G, 2002, POLYMER, V43, P2011, DOI 10.1016/S0032-3861(01)00785-6
   Almeida JC, 2014, MATER LETT, V128, P105, DOI 10.1016/j.matlet.2014.04.135
   Castro AGB, 2012, MATER LETT, V88, P12, DOI 10.1016/j.matlet.2012.08.022
   Chen Q, 2000, J SOL-GEL SCI TECHN, V19, P101, DOI 10.1023/A:1008774524468
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Czarnobaj K, 2011, POLYM BULL, V66, P223, DOI 10.1007/s00289-010-0332-8
   de Monredon-Senani S, 2009, J SOL-GEL SCI TECHN, V50, P152, DOI 10.1007/s10971-009-1920-7
   Deng ZY, 2014, J MATER CHEM A, V2, P4178, DOI 10.1039/c3ta14942k
   Elvira MR, 2013, J CHEM CHEM ENG, V7, P120
   Fernandez MR, 2010, COLLOID SURFACE B, V81, P289, DOI 10.1016/j.colsurfb.2010.07.018
   GLASER RH, 1989, J NON-CRYST SOLIDS, V113, P73, DOI 10.1016/0022-3093(89)90320-7
   Gomes SR, 2006, NUCL INSTRUM METH B, V248, P291, DOI 10.1016/j.nimb.2006.04.070
   Hasegawa I, 1999, APPL ORGANOMET CHEM, V13, P273, DOI 10.1002/(SICI)1099-0739(199904)13:4<273::AID-AOC840>3.0.CO;2-D
   HASEGAWA I, 1994, MATER RES SOC SYMP P, V346, P163
   IAEA, 2008, TRENDS RAD STER HLTH
   Julian B, 2003, CHEM MATER, V15, P3026, DOI 10.1021/cm031054l
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Lancastre JJH, 2012, RADIAT PHYS CHEM, V81, P1336, DOI 10.1016/j.radphyschem.2012.02.016
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   MILLER AA, 1960, J AM CHEM SOC, V82, P3519, DOI 10.1021/ja01499a011
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Ortega J, 2000, FLUID PHASE EQUILIBR, V170, P87, DOI 10.1016/S0378-3812(00)00317-4
   Prokopowicz M, 2012, COLLOID SURFACE B, V93, P249, DOI 10.1016/j.colsurfb.2012.01.020
   Rubio F, 1998, SPECTROSC LETT, V31, P199, DOI 10.1080/00387019808006772
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Tellez L, 2004, SPECTROSC LETT, V37, P11, DOI 10.1081/SL-120028420
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Williams IR, 1998, CLIN ORTHOP RELAT R, P170
   Yamashita T, 2011, CELL TRANSPLANT, V20, P95, DOI 10.3727/096368910X532800
   Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117
   Zheludkevich ML, 2005, J MATER CHEM, V15, P5099, DOI 10.1039/b419153f
NR 41
TC 4
Z9 4
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 354
EP 358
DI 10.1016/j.msec.2014.12.025
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200045
PM 25579933
OA Bronze
DA 2018-10-20
ER

PT J
AU Matsui, N
   Nozaki, K
   Ishihara, K
   Yamashita, K
   Nagai, A
AF Matsui, Natsuno
   Nozaki, Kosuke
   Ishihara, Kazuhiko
   Yamashita, Kimihiro
   Nagai, Akiko
TI Concentration-dependent effects of fibronectin adsorbed on
   hydroxyapatite surfaces on osteoblast adhesion
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Fibronectin; AFM; QCM-D; Concentration effect
ID HUMAN PLASMA FIBRONECTIN; ELECTRICALLY POLARIZED HYDROXYAPATITE;
   CELL-ADHESION; PROTEIN ADSORPTION; MULTILAYER FILMS; QCM-D; ATTACHMENT;
   DOMAIN; INTEGRINS; BINDING
AB Fibronectin (Fn) is an essential protein that is involved in cell attachment, migration, and differentiation. It is known that the conformation of Fn changes depending on its surrounding environment or on the surface properties of the substrate to which it is adsorbed. Here, we show that Fn adopts different conformations in physiological solutions and can play different roles in osteoblast adhesion on hydroxyapatite (HAp) depending on its concentration. The results of in situ observations showed that the adsorption configuration of Fn was an oblate ellipsoidal structure at low concentrations and a fibrillar structure at high concentrations, suggesting that individual Fn molecules attach to HAp with a side-on or end-on orientation, under low and high concentrations, respectively. Osteoblasts adhered more to the HAp surface under low concentrations of adsorbed Fn than under high concentrations. These observations suggest that the Fn concentration gradient is important for regulating biomaterial-cell interactions in regenerative medicine. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Matsui, Natsuno; Nozaki, Kosuke; Yamashita, Kimihiro; Nagai, Akiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Nagai, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nag-bcr@tmd.ac.jp
FU JSPS [23500540]
FX We thank Dr. Yusuke Tsutsumi and Prof. Takao Hanawa for technical advice
   on the use of the AFM. This work was supported by Grants-in-Aid for
   Scientific Research (C) (23500540) from JSPS.
CR Ballet T, 2010, B POL ACAD SCI-TECH, V58, P303, DOI 10.2478/v10175-010-0028-0
   Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013
   Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047
   Hook H., 2002, COLLOID SURFACE B, V24, P155
   Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473
   Kaselowsky B.G., 2003, J BIOMED MATER RES A, V66, P247
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Liem KF, 2000, DEVELOPMENT, V127, P4855
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MCDONALD JA, 1987, J BIOL CHEM, V262, P2957
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   Ohba S, 2012, ACTA BIOMATER, V8, P2778, DOI 10.1016/j.actbio.2012.04.015
   PEARLSTEIN E, 1978, INT J CANCER, V22, P32, DOI 10.1002/ijc.2910220108
   Pellenc D, 2006, J COLLOID INTERF SCI, V298, P132, DOI 10.1016/j.jcis.2005.11.059
   Pirouz A.D., 2009, LANGMUIR, V25, P2971
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   Tagaya M, 2011, LANGMUIR, V27, P7635, DOI 10.1021/la200008z
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   Vadillo-Rodriguez V, 2013, LANGMUIR, V29, P8554, DOI 10.1021/la401776e
   Watarai E, 2012, SENSOR ACTUAT B-CHEM, V171, P1297, DOI 10.1016/j.snb.2012.05.010
   WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 33
TC 8
Z9 8
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 378
EP 383
DI 10.1016/j.msec.2014.12.042
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200049
PM 25579937
DA 2018-10-20
ER

PT J
AU Shah, DU
   Vollrath, F
   Stires, J
   Deheyn, DD
AF Shah, Darshil U.
   Vollrath, Fritz
   Stires, John
   Deheyn, Dimitri D.
TI The biocomposite tube of a chaetopterid marine worm constructed with
   highly-controlled orientation of nanofilaments
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biological composites; Parchment biomaterial; Ultrastructural
   organisation; Chaetopterus; Marine polychaete; Tube housing; Composite
   pipes and tanks
ID VARIOPEDATUS RENIER; WINDING ANGLE; POLYCHAETA; PIPES; BIOMECHANICS;
   BEHAVIOR
AB The ultrastructure of the self-constructed tube housing of the bioluminescent marine worm, Chaetopterus sp. reveals that the bio-nanocomposite tube comprises of multiple non-woven plies of multi-axially oriented organic nanofilaments (empty set 50-1100 nm) cemented together by an unstructured organic matrix binder. The thin-walled, impermeable tubes are bin-inspirational for conventional pipe technology. Orientation distribution analyses revealed that the dominant orientation angles of nanofilaments in the tube were 0 degrees, +/- 45 degrees and +/- 65 degrees, which correlate well with optimal winding angles for 'man-made' fibre reinforced composite pipes subjected to specific loading conditions. Such a use of high aspect ratio nanofilaments in multi-axial laminates would impart toughness and flexibility to the tube structure, and facilitate rapid tube growth. While the tube production mechanism is not entirely known at this stage, our time-lapse studies show that, contrary to generic assumptions in literature, the worm actively, rapidly and sporadically produces and expands the tube. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Shah, Darshil U.; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford Silk Grp, Oxford OX1 3PS, England.
   [Stires, John; Deheyn, Dimitri D.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.
RP Shah, DU (reprint author), Univ Oxford, Dept Zool, Oxford Silk Grp, South Pk Rd, Oxford OX1 3PS, England.
EM darshil.shah@zoo.ox.ac.uk; ddeheyn@ucsd.edu
OI Shah, Darshil/0000-0002-8078-6802
FU US Air Force Office for Scientific Research (AFOSR) [F49620-03-1-0111,
   FA9550-10-1-0112]; European Research Council [SP2-GA-2008-233409]
FX We are grateful to Phil Zerofski, marine collector at SIO, who kept a
   constant supply of the tube worms. We thank the US Air Force Office for
   Scientific Research (AFOSR Grant Number F49620-03-1-0111 to F.V. and
   FA9550-10-1-0112 to D.D.D.) and the European Research Council advanced
   Grant (SP2-GA-2008-233409) to F.V. for the generous funding.
CR BARNES RD, 1965, BIOL BULL, V129, P217, DOI 10.2307/1539840
   Bhaud MR, 1998, SARSIA, V83, P243, DOI 10.1080/00364827.1998.10413685
   BROWN SC, 1971, TISSUE CELL, V3, P65, DOI 10.1016/S0040-8166(71)80031-9
   BROWN SC, 1975, BIOL BULL-US, V149, P136, DOI 10.2307/1540485
   BROWN SC, 1978, ANIM BEHAV, V26, P160, DOI 10.1016/0003-3472(78)90015-5
   BROWN SC, 1977, BIOL BULL, V153, P121, DOI 10.2307/1540696
   Chen F, 2010, J MAT SCI ENG, V4, P28
   Chen FJ, 2012, MAT SCI ENG C-MATER, V32, P772, DOI 10.1016/j.msec.2012.01.023
   Costa Maria Angélica Martins, 2005, Mat. Res., V8, P177, DOI 10.1590/S1516-14392005000200016
   Dales R. P., 1969, CHEM ZOOLOGY, V4
   Deheyn DD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P702, DOI 10.1086/673869
   Dill LM, 1997, BEHAV ECOL, V8, P186, DOI 10.1093/beheco/8.2.186
   DIXON DR, 1980, J MAR BIOL ASSOC UK, V60, P655, DOI 10.1017/S0025315400040340
   Ehrlich H, 2010, BIOL INSPIR SYST, V1, P465, DOI 10.1007/978-90-481-9130-7_34
   Enders H., 1907, P INDIANA ACAD SCI, P128
   FLOOD PR, 1982, MAR BIOL, V72, P27, DOI 10.1007/BF00393944
   Hickman C.J., 2001, INTEGRATED PRINCIPLE, P362
   Kiel S, 2009, ACTA PALAEONTOL POL, V54, P443, DOI 10.4202/app.2009.0022
   Liu DHF, 1997, ENV ENG HDB
   Macginitie GE, 1939, BIOL BULL-US, V77, P115, DOI 10.2307/1537850
   Majid MSA, 2013, ADV MATER RES-SWITZ, V795, P424, DOI 10.4028/www.scientific.net/AMR.795.424
   MISTRY J, 1992, COMPOS STRUCT, V20, P83, DOI 10.1016/0263-8223(92)90064-J
   Performance Composites Ltd, 2009, FIL WIND CARB FIBR A
   Reddy P., 2012, INT J ENG RES TECHNO, V1, P1
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   ROSENOW MWK, 1984, COMPOSITES, V15, P144, DOI 10.1016/0010-4361(84)90727-4
   Schnelle K. B., 2001, AIR POLLUTION CONTRO
   Shah DU, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0525
   Shillito Bruce, 1995, Geological Society Special Publication, V87, P295, DOI 10.1144/GSL.SP.1995.087.01.22
   SPENCER B, 1978, COMPOSITES, V9, P263, DOI 10.1016/0010-4361(78)90180-5
   Thompson ML, 2001, LIMNOL OCEANOGR, V46, P1899, DOI 10.4319/lo.2001.46.8.1899
   Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x
NR 32
TC 3
Z9 3
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 408
EP 415
DI 10.1016/j.msec.2014.12.015
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200053
PM 25579941
DA 2018-10-20
ER

PT J
AU Basile, MA
   d'Ayala, GG
   Malinconico, M
   Laurienzo, P
   Coudane, J
   Nottelet, B
   Della Ragione, F
   Oliva, A
AF Basile, Maria Assunta
   d'Ayala, Giovanna Gomez
   Malinconico, Mario
   Laurienzo, Paola
   Coudane, Jean
   Nottelet, Benjamin
   Della Ragione, Fulvio
   Oliva, Adriana
TI Functionalized PCL/HA nanocomposites as microporous membranes for bone
   regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(epsilon-caprolactone); Functionalization of polymers;
   Nanocomposites; Membranes; Biocompatibility; Guided tissue regeneration
ID SOL-GEL PROCESS; EPSILON-CAPROLACTONE; ALIPHATIC POLYESTERS; TISSUE
   REGENERATION; NANOPHASE CERAMICS; STEM-CELLS; IN-VITRO; DEGRADATION;
   POLY(EPSILON-CAPROLACTONE); COMPOSITES
AB In the present work, microporous membranes based on poly(epsilon-caprolactone) (PCL) and PCL functionalized with amine (PCL-DMAEA) or anhydride groups (PCL-MAGMA) were realized by solvent-non solvent phase inversion and proposed for use in Guided Tissue Regeneration (GTR). Nanowhiskers of hydroxyapatite (HA) were also incorporated in the polymer matrix to realize nanocomposite membranes. Scanning Electron Microscopy (SEM) showed improved interfacial adhesion with HA for functionalized polymers, and highlighted substantial differences in the porosity. A relationship between the developed porous structure of the membrane and the chemical nature of grafted groups was proposed. Compared to virgin PCL, hydrophilicity increases for functionalized PCL, while the addition of HA influences significantly the hydrophilic characteristics only in the case of virgin polymer. A significant increase of in vitro degradation rate was found for PCL-MAGMA based membranes, and at lower extent of PCL-DMAEA membranes. The novel materials were investigated regarding their potential as support for cell growth in bone repair using multipotent mesenchymal stromal cells (MSC) as a model. MSC plated onto the various membranes were analyzed in terms of adhesion, proliferation and osteogenic capacity that resulted to be related to chemical as well as porous structure. In particular, PCL-DMAEA and the relative nanocomposite membranes are the most promising in terms of cell-biomaterial interactions. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Basile, Maria Assunta; d'Ayala, Giovanna Gomez; Malinconico, Mario; Laurienzo, Paola] CNR, Inst Polymers Composites & Biomat, I-80125 Naples, Italy.
   [Coudane, Jean; Nottelet, Benjamin] Univ Montpellier I, Inst Biomol Max Mousseron, Artificial Biopolymers Grp, CNRS UMR 5247,Fac Pharm, F-34093 Montpellier, France.
   [Della Ragione, Fulvio; Oliva, Adriana] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy.
RP Laurienzo, P (reprint author), CNR, Inst Polymers Composites & Biomat, Via Campi Flegrei 34, I-80125 Naples, Italy.
EM paola.laurienzo@ipcb.cnr.it; adriana.oliva@unina2.it
OI Della Ragione, Fulvio/0000-0002-0592-4283
CR Aslan S, 2000, J MATER SCI, V35, P1615, DOI 10.1023/A:1004787326273
   Barra GMO, 1999, J BRAZIL CHEM SOC, V10, P31, DOI 10.1590/S0103-50531999000100006
   Basile MA, 2012, J APPL BIOMATER FUNC, V10, P210, DOI 10.5301/JABFM.2012.10374
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   CABASSO I, 1979, J APPL POLYM SCI, V23, P2967, DOI 10.1002/app.1979.070231016
   Calandrelli L, 2004, J BIOACT COMPAT POL, V19, P301, DOI 10.1177/0883911504045234
   Chen BQ, 2005, POLYM TEST, V24, P978, DOI 10.1016/j.polymertesting.2005.07.013
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   d'Ayala GG, 2009, EUR POLYM J, V45, P3215, DOI 10.1016/j.eurpolymj.2009.07.021
   Dorj B, 2013, J BIOMED MATER RES A, V101, P1670, DOI 10.1002/jbm.a.34470
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   Fu SZ, 2010, J NANOSCI NANOTECHNO, V10, P711, DOI 10.1166/jnn.2010.1888
   Garcia-Martinez JM, 1999, J APPL POLYM SCI, V73, P2837, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2837::AID-APP6>3.0.CO;2-2
   Gentile P, 2011, BIOTECHNOL J, V6, P1187, DOI 10.1002/biot.201100294
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Ikada Y., 2006, TISSUE ENG FUNDAMENT
   Lanzetta V, 2007, J MATER CHEM, V17, P4508, DOI 10.1039/b708153g
   Laurienzo P, 2006, MACROMOL CHEM PHYSIC, V207, P1861, DOI 10.1002/macp.200600262
   Lei LJ, 2009, POLYM DEGRAD STABIL, V94, P1494, DOI 10.1016/j.polymdegradstab.2009.04.034
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Mayer U., 1993, CELLS MAT, V3, P129
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Natu MV, 2013, POLYM DEGRAD STABIL, V98, P44, DOI 10.1016/j.polymdegradstab.2012.10.030
   Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Rezaei A, 2013, MAT SCI ENG C-MATER, V33, P390, DOI 10.1016/j.msec.2012.09.004
   Rezaei A, 2012, TISSUE ENG REGEN MED, V9, P295, DOI 10.1007/s13770-012-0002-z
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Sclavons M, 1996, J APPL POLYM SCI, V62, P1205, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1205::AID-APP10>3.0.CO;2-6
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Shalaby W.S., 1994, ACS S SERIES
   Suming L., 1996, J CONTROL RELEASE, V40, P41
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
   Xie XM, 2000, POLYM INT, V49, P1677, DOI 10.1002/1097-0126(200012)49:12<1677::AID-PI590>3.0.CO;2-0
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   Yoshioka T, 2010, POLYM ENG SCI, V50, P1895, DOI 10.1002/pen.21714
   Yubao L, 1994, J MATER SCI-MATER M, V5, P326
   Zhang Y., 2013, ANN ORAL MAXILLOFAC, V1, P1, DOI DOI 10.1007/S11365-012-0246-Z
   Zhao ZT, 2012, J APPL POLYM SCI, V125, P2502, DOI 10.1002/app.36355
NR 47
TC 13
Z9 14
U1 3
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 457
EP 468
DI 10.1016/j.msec.2014.12.019
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200059
PM 25579947
DA 2018-10-20
ER

PT J
AU Cheng, J
   Huang, T
   Zheng, YF
AF Cheng, J.
   Huang, T.
   Zheng, Y. F.
TI Relatively uniform and accelerated degradation of pure iron coated with
   micro-patterned Au disc arrays
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Micro-patterned Au coating; Pure iron; Biodegradation
ID IMMERSION ION-IMPLANTATION; CELL VIABILITY; IN-VITRO; STENTS;
   BIOMATERIAL; DEPOSITION; ALLOYS; BIOCOMPATIBILITY; NANOPARTICLES;
   SURFACES
AB Pure iron has been proven to be a potential biodegradable metal, but its degradation rate was too slow. To accelerate its biodegradation, micro-patterned Au disc films were deposited on the surface of pure iron by vacuum sputtering. The influence of Au disc films on the degradation of pure iron matrix in vitro was investigated in the present study. Electrochemical measurement results indicated that the corrosion current density of pure iron coated with micro-patterned Au disc films in Hank's solution was 4 times larger than that of the uncoated one, while the difference between the influences of micro-patterned Au discs with different diameters on the corrosion rate of pure iron was insignificant. Immersion test indicated that the corrosion depth for pure iron coated with Au disc films was about three times as that of bare pure iron. Both electrochemical test and immersion test revealed that the corrosion of pure iron matrix coated with Au disc array became more uniform. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Cheng, J.; Zheng, Y. F.] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Huang, T.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Mat Sci & Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; National Science Fund for Distinguished Young Scholars
   [51225101]; National Natural Science Foundation of China [51431002,
   31170909]; NSFC/RGC Joint Research Scheme in Mainland China
   [51361165101]; NSFC/RGC Joint Research Scheme in Hong Kong
   [N_CUHK449/13]; Beijing Municipal Science and Technology Project
   [Z131100005213002]; Project for Supervisor of Excellent Doctoral
   Dissertation of Beijing [20121000101]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant Nos. 2012CB619102 and 2012CB619100), National
   Science Fund for Distinguished Young Scholars (Grant No. 51225101),
   National Natural Science Foundation of China (Grant Nos. 51431002 and
   31170909), NSFC/RGC Joint Research Scheme under Grant Nos. 51361165101
   in Mainland China and N_CUHK449/13 in Hong Kong, Beijing Municipal
   Science and Technology Project (Z131100005213002) and Project for
   Supervisor of Excellent Doctoral Dissertation of Beijing (20121000101).
CR ALLEN BT, 1986, ANN SURG, V203, P318, DOI 10.1097/00000658-198603000-00019
   [Anonymous], 2004, ASTM BOOK STAND
   Chang E, 2002, BIOMATERIALS, V23, P2917, DOI 10.1016/S0142-9612(01)00420-3
   Cheng J, 2013, J BIOMED MATER RES B, V101B, P485, DOI 10.1002/jbm.b.32783
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P107, DOI 10.4028/www.scientific.net/AMR.15-17.107
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jing FJ, 2007, SURF COAT TECH, V201, P6874, DOI 10.1016/j.surfcoat.2006.09.088
   Kong G, 2000, CANCER RES, V60, P4440
   Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Milazzo G., 1978, J ELECTROCHEM SOC, V125, p261C
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Nie FL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065015
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Vanysek P., 2005, CRC HDB CHEM PHYS, P20
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Wang B., 2012, ACCOUNTS CHEM RES, V46, P761
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Zhang LM, 2013, BIOMATERIALS, V34, P7117, DOI 10.1016/j.biomaterials.2013.05.043
   Zhu SF, 2009, APPL SURF SCI, V256, P99, DOI 10.1016/j.apsusc.2009.07.082
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 35
TC 8
Z9 8
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2015
VL 48
BP 679
EP 687
DI 10.1016/j.msec.2014.12.053
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CA2PE
UT WOS:000348749200083
PM 25579971
DA 2018-10-20
ER

PT J
AU Montes, R
   Bartroli, J
   Baeza, M
   Cespedes, F
AF Montes, R.
   Bartroli, J.
   Baeza, M.
   Cespedes, F.
TI Improvement of the detection limit for biosensors: Advances on the
   optimization of biocomposite composition
SO MICROCHEMICAL JOURNAL
LA English
DT Article
DE Amperometric biosensor; EIS; CV; Graphite-epoxy; GOD; (Bio)composite
ID NANOTUBE-EPOXY COMPOSITES; AMPEROMETRIC BIOSENSOR; L-LACTATE;
   ELECTRODES; GLUCOSE; MICROELECTRODES; PERCOLATION; SENSOR
AB In this work the application of advanced characterization techniques in the development of amperometric biosensors based on biocomposites is described. The optimization of the conductive particle distribution and the amount of the biological material inside the biomaterial have allowed an improvement of the electrochemical properties, regarding the electroanalytical properties such as signal stability and limit of detection. The high signal-to-noise ratio obtained in the electrochemical transduction has allowed enhancing the limit of detection of the biosensor. In the present study, it has been demonstrated the feasibility of electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) for the characterization and optimization of biosensors based On graphite-epoxy-enzyme, using an enzyme model. The optimum biocomposite proportion based on graphite-epoxy which incorporates the enzyme glucose oxidase (GOD) on the matrix ranges between 16% and 17% of graphite using 1% and 2% of enzyme. This range provides the optimal electroanalytical properties. Low limit of detection and good sensitivity have been achieved. Furthermore, confocal laser scanning microscopy was used to visualize the enzyme distribution onto the surface electrode. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Montes, R.; Bartroli, J.; Baeza, M.; Cespedes, F.] Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, Grp Sensors Biosensors, Cerdanyola Del Valles Be 08193, Bellaterra, Spain.
RP Baeza, M (reprint author), Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, Grp Sensors Biosensors, Edifici C Nord, Cerdanyola Del Valles Be 08193, Bellaterra, Spain.
EM mariadelmar.baeza@uab.cat
RI Cespedes, Francisco/L-7435-2014; Baeza Labat, Maria del Mar/C-1577-2010;
   Bartroli Molins, Jordi/L-6019-2017; Montes Martinez, Raquel/J-9405-2017
OI Cespedes, Francisco/0000-0002-0296-6314; Baeza Labat, Maria del
   Mar/0000-0002-2240-6410; Montes Martinez, Raquel/0000-0001-8805-9987
FU Universitat Autonoma de Barcelona (UAB)
FX R. Montes thanks Universitat Autonoma de Barcelona (UAB) for the award
   of PIF studentship.
CR BAEZA M, 2011, RESIN COMPOS PROP PR, P153
   Barsan MM, 2009, BIOELECTROCHEMISTRY, V76, P135, DOI 10.1016/j.bioelechem.2009.03.004
   Bellido-Milla D, 2013, ANAL BIOANAL CHEM, V405, P3525, DOI 10.1007/s00216-013-6816-2
   Bojorge N, 2011, METAL, CERAMIC AND POLYMERIC COMPOSITES FOR VARIOUS USES, P597
   Caro-Jara N, 2013, ELECTROANAL, V25, P308, DOI 10.1002/elan.201200391
   Cespedes F, 2000, TRAC-TREND ANAL CHEM, V19, P276, DOI 10.1016/S0165-9936(99)00179-X
   Cespedes F, 1996, TRAC-TREND ANAL CHEM, V15, P296, DOI 10.1016/0165-9936(96)00042-8
   CESPEDES F, 1993, ANAL CHIM ACTA, V273, P409, DOI 10.1016/0003-2670(93)80184-M
   Esplandiu MJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355502
   ESPLANDIU MJ, 2010, DEV TUNABLE NANOCOMP, pCH5
   Haccoun J, 2004, BIOSENS BIOELECTRON, V19, P1325, DOI 10.1016/j.bios.2003.11.006
   Hare D. O., 2002, ELECTROCHEM COMMUN, V4, P245
   Ibanez AB, 2008, ANAL LETT, V41, P1419, DOI 10.1080/00032710802119483
   Marzouk SAM, 1997, ANAL CHEM, V69, P2646, DOI 10.1021/ac970020s
   McCreery RL, 2008, CHEM REV, V108, P2646, DOI 10.1021/cr068076m
   Morales A, 1996, ANAL CHIM ACTA, V332, P131, DOI 10.1016/0003-2670(96)82793-0
   Numnuam A, 2014, ANAL BIOANAL CHEM, V406, P3763, DOI 10.1007/s00216-014-7770-3
   Olive-Monllau R, 2010, TALANTA, V81, P1593, DOI 10.1016/j.talanta.2010.03.008
   Olive-Monllau R, 2010, SENSOR ACTUAT B-CHEM, V146, P353, DOI 10.1016/j.snb.2010.02.017
   Olive-Monllau R, 2009, ELECTROANAL, V21, P931, DOI 10.1002/elan.200804494
   Pacios M, 2008, J ELECTROANAL CHEM, V619, P117, DOI 10.1016/j.jelechem.2008.03.019
   Palmisano F, 2000, BIOSENS BIOELECTRON, V15, P531, DOI 10.1016/S0956-5663(00)00107-X
   Parra A, 2006, ANAL CHIM ACTA, V555, P308, DOI 10.1016/j.aca.2005.09.025
   Perez B, 2005, J NANOSCI NANOTECHNO, V5, P1694, DOI 10.1166/jnn.2005.400
   Perez S, 2012, ELECTROANAL, V24, P967, DOI 10.1002/elan.201100628
   Pumera M, 2006, SENSOR ACTUAT B-CHEM, V113, P617, DOI 10.1016/j.snb.2005.07.010
   Ramirez-Garcia S, 2004, ANAL CHEM, V76, P503, DOI 10.1021/ac034536p
   Ramirez- Garcia S, 2002, ANALYST, V127, P1512, DOI 10.1039/b206201a
   Ramirez-Garcia S, 2001, ELECTROANAL, V13, P529, DOI 10.1002/1521-4109(200105)13:7<529::AID-ELAN529>3.0.CO;2-I
   Rassaei L, 2007, ELECTROANAL, V19, P1461, DOI 10.1002/elan.200703887
   Rubianes MD, 2005, ELECTROANAL, V17, P73, DOI 10.1002/elan.200403121
   Sadana A, 2011, HANDBOOK OF BIOSENSORS AND BIOSENSOR KINETICS, P1, DOI 10.1016/B978-0-444-53262-6.00001-2
   Sanchez S, 2007, BIOSENS BIOELECTRON, V23, P332, DOI 10.1016/j.bios.2007.04.021
   Stulik K, 2000, PURE APPL CHEM, V72, P1483, DOI 10.1351/pac200072081483
   Trijueque J, 1999, ELECTROCHIM ACTA, V45, P789, DOI 10.1016/S0013-4686(99)00257-1
   WANG J, 1993, ANAL LETT, V26, P1819, DOI 10.1080/00032719308017433
   Wang J, 2003, ANALYST, V128, P1382, DOI 10.1039/b309928h
   Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#
   WANG J, 2000, PRACTICAL CONSIDERAT, P100
   Zacco E, 2004, J IMMUNOL METHODS, V286, P35, DOI 10.1016/j.jim.2003.11.014
   Zhao H, 2008, J PHYS CHEM C, V112, P9351, DOI 10.1021/jp711366u
NR 41
TC 7
Z9 7
U1 2
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0026-265X
EI 1095-9149
J9 MICROCHEM J
JI Microchem J.
PD MAR
PY 2015
VL 119
BP 66
EP 74
DI 10.1016/j.microc.2014.11.004
PG 9
WC Chemistry, Analytical
SC Chemistry
GA CA5ON
UT WOS:000348957800011
DA 2018-10-20
ER

PT J
AU He, SY
   Shen, L
   Wu, YX
   Li, L
   Chen, W
   Hou, CL
   Yang, MC
   Zeng, W
   Zhu, CH
AF He, Siyi
   Shen, Lei
   Wu, Yangxiao
   Li, Li
   Chen, Wen
   Hou, Chunli
   Yang, Mingcan
   Zeng, Wen
   Zhu, Chuhong
TI Effect of Brain-Derived Neurotrophic Factor on Mesenchymal Stem
   Cell-Seeded Electrospinning Biomaterial for Treating Ischemic Diabetic
   Ulcers via Milieu-Dependent Differentiation Mechanism
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID IN-VITRO; ENDOTHELIAL-CELLS; STROMAL CELLS; ANGIOGENESIS; PROMOTE;
   DISEASE; GLUCOSE; GENE; VEGF; MICE
AB Great challenges in transplantation of mesenchymal stem cells (MSCs) for treating ischemic diabetic ulcers (IDUs) are to find a suitable carrier and create a beneficial microenvironment. Brain-derived neurotrophic factor (BDNF), a member of neurotrophin family, is considered angiogenic and neuroprotective. Given that IDUs are caused by vascular disease and peripheral neuropathy, we used BDNF as a stimulant, and intended to explore the role of new biomaterials complex with MSCs in wound healing. BDNF promoted the proliferation and migration of MSCs using MTT, transwell, and cell scratch assays. The activity of human umbilical vein endothelial cells (HUVECs) was also enhanced by the MSC-conditioned medium in the presence of BDNF, via a vascular endothelial growth factor-independent pathway. Since proliferated HUVECs in the BDNF group made the microenvironment more conducive to endothelial differentiation of MSCs, by establishing co-culture systems with the two cell types, endothelial cells derived from MSCs increased significantly. A new biomaterial made of polylactic acid, silk and collagen was used as the carrier dressing. After transplantation of the BDNF-stimulated MSC/biomaterial complex, the ulcers in hindlimb ischemic mice healed prominently. More blood vessel formation was observed in the wound tissue, and more MSCs were co-stained with some endothelial-specific markers such as cluster of differentiation (CD)31 and von Willebrand Factor (vWF) in the treatment group than in the control group. These results demonstrated that BDNF could improve microenvironment in the new biomaterial, and induce MSCs to differentiate into endothelial cells indirectly, thus accelerating ischemic ulcer healing.
C1 [He, Siyi; Shen, Lei; Wu, Yangxiao; Li, Li; Chen, Wen; Hou, Chunli; Yang, Mingcan; Zeng, Wen; Zhu, Chuhong] Third Mil Med Univ, Key Lab Biomech Chongqing, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Chongqing 400038, Peoples R China.
   [He, Siyi] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing 400038, Peoples R China.
   [Shen, Lei] Qiqihar Med Univ, Dept Anat, Qiqihar, Peoples R China.
RP Zhu, CH (reprint author), Third Mil Med Univ, Key Lab Biomech Chongqing, Dept Anat, Natl & Reg Engn Lab Tissue Engn, Gao Tan Yan St, Chongqing 400038, Peoples R China.
EM zw0105@aliyun.com; zhuch99@yahoo.com
FU Training Program of the Major Research Plan of the National Natural
   Science Foundation of China [91439116]; National Science Foundation of
   China [31200731]; Natural Science Foundation Project of CQ CSTC
   [cstc2011jjjq0016]; Military Twelfth Five-year Key Project [BWS11C056];
   National High Technology Research and Development Program 863
   [2012AA020504]
FX This work was supported by the Training Program of the Major Research
   Plan of the National Natural Science Foundation of China (No.:
   91439116), the National Science Foundation of China (No.: 31200731),
   Natural Science Foundation Project of CQ CSTC (cstc2011jjjq0016), the
   Military Twelfth Five-year Key Project (BWS11C056), and National High
   Technology Research and Development Program 863 (2012AA020504).
CR Albayati MA, 2013, MED CLIN N AM, V97, P821, DOI 10.1016/j.mcna.2013.03.009
   Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138
   Bittira B, 2002, ANN THORAC SURG, V74, P1154, DOI 10.1016/S0003-4975(02)03857-2
   Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334
   Chin JA, 2014, CLIN PODIATR MED SUR, V31, P11, DOI 10.1016/j.cpm.2013.09.001
   Dinh T, 2005, CURR PHARM DESIGN, V11, P2301, DOI 10.2174/1381612054367328
   Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5
   Han YF, 2014, CYTOTHERAPY, V16, P160, DOI 10.1016/j.jcyt.2013.10.014
   Han YF, 2011, BIOCHEM BIOPH RES CO, V413, P561, DOI 10.1016/j.bbrc.2011.09.001
   He W, 2011, J ASIAN NAT PROD RES, V13, P1, DOI 10.1080/10286020.2010.535519
   Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009
   Hou CL, 2013, BIOMATERIALS, V34, P112, DOI 10.1016/j.biomaterials.2012.09.022
   Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893
   Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655
   Lim J. Y., 2011, CELL TRANSPLANT, V20, P11
   Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669
   Liu KM, 2008, MICROVASC RES, V75, P59, DOI 10.1016/j.mvr.2007.06.003
   Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]
   Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200
   Nakagawa T, 2002, DIABETES METAB RES, V18, P185, DOI 10.1002/dmrr.290
   Neufeld G, 1999, FASEB J, V13, P9
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Shen L, 2013, CELL TRANSPLANT, V22, P1011, DOI 10.3727/096368912X657495
   Sun CY, 2006, CHINESE MED J-PEKING, V119, P589
   Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1
   Yamanaka M, 2007, DIABETES OBES METAB, V9, P59, DOI 10.1111/j.1463-1326.2006.00572.x
   Yu Q, 2000, GENE DEV, V14, P163
   Zeng W, 2010, BIOMATERIALS, V31, P1636, DOI 10.1016/j.biomaterials.2009.11.037
   Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025
NR 29
TC 9
Z9 11
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2015
VL 21
IS 5-6
BP 928
EP 938
DI 10.1089/ten.tea.2014.0113
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CC7LQ
UT WOS:000350549500007
PM 25316594
DA 2018-10-20
ER

PT J
AU Gopi, D
   Bhuvaneshwari, N
   Kavitha, L
   Ramya, S
AF Gopi, D.
   Bhuvaneshwari, N.
   Kavitha, L.
   Ramya, S.
TI Novel malic acid mediated green route for the synthesis of
   hydroxyapatite particles and their spectral characterization
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Calcination; Spectroscopy; X-ray methods; Apatite; Biomedical
   applications
ID SOL-GEL TECHNIQUE; CALCIUM-PHOSPHATE; SILVER NANOPARTICLES;
   SPECTROSCOPIC CHARACTERIZATION; ELECTRODEPOSITION METHOD; ANTIBACTERIAL
   ACTIVITY; LEAF EXTRACT; IN-VITRO; NANOHYDROXYAPATITE; TEMPERATURE
AB Hydroxyapatite (Ca-10(PO4)(6)(OH)(2), HAP], a principal inorganic constituent of bone and teeth, is widely used in the biomedical field, due to its similarity, chemically and structurally to the bones. In this paper, We have reported the synthesis of HAP particles using the malic acid mediated green template method. The malic acid used in this method has been obtained from various sources, such as natural and commercially available one. The extract of the apple fruit is taken as the natural source of malic acid. The extracted malic acid and the as-synthesized HAP particles are characterized by various spectral techniques like Fourier transform infrared spectroscopy (FT-IR), proton-1 nuclear magnetic resonance spectroscopy (H-1-NMR), carbon-13 nuclear magnetic resonance spectroscopy (C-13-NMR) and X-ray diffraction (XRD) technique for the phase identification of the HAP particles. The morphology of the HAP particles were assessed thoroughly using a scanning electron microscope (SEM) equipped with energy dispersive X-ray analysis (EDAX). Moreover, the antibacterial activity of the as-synthesized HAP particles was evaluated against the two pathogen bacteria strains. The experimental results revealed that the HAP particles synthesized in the presence of an extracted malic acid are pure, low crystalline and spherical particles with reduced size. These HAP particles also showed an enhanced antibacterial activity than that of the HAP synthesized in the presence of commercially available malic acid. Hence, the HAP particles synthesized using the extracted malic acid as a green template can act as a good biomaterial for biomedical applications. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Gopi, D.; Bhuvaneshwari, N.; Ramya, S.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Gopi, D.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Bhuvaneshwari, N.] Chikkaiah Naicker Coll, Dept Chem, Erode 638004, Tamil Nadu, India.
   [Kavitha, L.] Cent Univ Tamilnadu, Sch Basic & Appl Sci, Dept Phys, Thiruvarur 610101, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com
RI Gopi, Dhanaraj/A-9163-2012; Louis, Kavitha/B-9313-2017
OI Gopi, Dhanaraj/0000-0001-6662-1238; Louis, Kavitha/0000-0002-8893-2050
FU Department of Science and Technology, New Delhi, India (DST-TSD)
   [DST/TSG/NTS/2011/73]; DST-EMEQ [SB/EMEQ-185/2013]; CSIR
   [01(2547)/11/EMR-II]; UGC [F. 30-1/2013
   (SA-II)/RA-2012-14-NEW-SC-TAM-3240, F. 30-1/2013
   (SA-II)/RA-2012-14-NEW-GT-TAM-3228]
FX One of the authors D. Gopi acknowledges the major functional support
   from the Department of Science and Technology, New Delhi, India
   (DST-TSD, Ref. no. DST/TSG/NTS/2011/73), DST-EMEQ, Ref. no.
   SB/EMEQ-185/2013 and CSIR, Ref. no. 01(2547)/11/EMR-II, Dated:
   12.12.2011). Also, D. Gopi and L. Kavitha acknowledge the UGC (Ref. no.
   F. 30-1/2013 (SA-II)/RA-2012-14-NEW-SC-TAM-3240 and Ref. no. F.
   30-1/2013 (SA-II)/RA-2012-14-NEW-GT-TAM-3228) for the Research Awards.
CR Arce H, 2004, POLYHEDRON, V23, P1897, DOI 10.1016/j.poly.2004.04.021
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bankar A, 2010, COLLOID SURFACE B, V80, P45, DOI 10.1016/j.colsurfb.2010.05.029
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Bogdanoviciene I, 2006, MATER RES BULL, V41, P1754, DOI 10.1016/j.materresbull.2006.02.016
   Boyer J., 2003, NY FRUIT Q, V11, P11
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chaturvedi D, 2012, POLYMER, V53, P2681, DOI 10.1016/j.polymer.2012.04.009
   Chaturvedi D, 2011, POLYMER, V52, P3118, DOI 10.1016/j.polymer.2011.05.011
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Edison TJI, 2013, SPECTROCHIM ACTA A, V104, P262, DOI 10.1016/j.saa.2012.11.084
   GOMIS DB, 1988, CHROMATOGRAPHIA, V25, P1054, DOI 10.1007/BF02259384
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gopi D, 2014, COLLOID SURFACE A, V451, P172, DOI 10.1016/j.colsurfa.2014.03.035
   Gopi D, 2014, SPECTROCHIM ACTA A, V118, P589, DOI 10.1016/j.saa.2013.09.034
   Gopi D, 2013, CORROS SCI, V73, P321, DOI 10.1016/j.corsci.2013.04.021
   Gopi D, 2012, B MATER SCI, V35, P1195, DOI 10.1007/s12034-012-0398-z
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Gopi D, 2012, SPECTROCHIM ACTA A, V92, P194, DOI 10.1016/j.saa.2012.02.069
   Gopi D, 2010, SPECTROCHIM ACTA A, V77, P545, DOI 10.1016/j.saa.2010.06.013
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P590
   Hattori H., 1990, J AM CERAM SOC, V73, P1803
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, J MATER SCI-MATER M, V24, P1853, DOI 10.1007/s10856-013-4955-9
   Huang Y, 2013, APPL SURF SCI, V271, P299, DOI 10.1016/j.apsusc.2013.01.187
   Jiao FP, 2009, LAT AM APPL RES, V39, P127
   Karayil S, 1998, J Postgrad Med, V44, P93
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Klinkaewnarong J, 2010, CURR APPL PHYS, V10, P521, DOI 10.1016/j.cap.2009.07.014
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lata B., 2005, Folia Horticulturae, V17, P47
   LAVERNIA C, 1991, AM CERAM SOC BULL, V70, P95
   LeGeros R.Z., 1993, ADV SERIES CERAMICS, P139
   Lim GK, 1999, LANGMUIR, V15, P7472, DOI 10.1021/la981659+
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Lopez-Macipe A, 1998, J MATER SYNTH PROCES, V6, P21, DOI 10.1023/A:1022603024806
   Manso-Silvan M, 2003, J EUR CERAM SOC, V23, P243, DOI 10.1016/S0955-2219(02)00187-5
   Matthes A, 2009, J APPL BOT FOOD QUAL, V82, P152
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Otsuka Makoto, 1994, Bio-Medical Materials and Engineering, V4, P357
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Patil RS, 2012, SPECTROCHIM ACTA A, V91, P234, DOI 10.1016/j.saa.2012.02.009
   Prabakaran K, 2009, SPECTROCHIM ACTA A, V74, P1127, DOI 10.1016/j.saa.2009.09.021
   Prelot B, 2005, MAT SCI ENG C-BIO S, V25, P553, DOI 10.1016/j.msec.2005.07.008
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rao YS, 2013, SPECTROCHIM ACTA A, V103, P156, DOI 10.1016/j.saa.2012.11.028
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   RICHMOND ML, 1981, J AGR FOOD CHEM, V29, P4, DOI 10.1021/jf00103a002
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun YX, 2006, J PHYS CHEM SOLIDS, V68, P373, DOI 10.1016/j.jpcs.2006.11.026
   van der Houwen JAM, 2003, J CRYST GROWTH, V249, P572, DOI 10.1016/S0022-0248(02)02227-3
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Viswanath B, 2008, BIOMATERIALS, V29, P4855, DOI 10.1016/j.biomaterials.2008.09.001
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Weng W., 2002, MATER CHEM PHYS, P92
   Willmann G, 1996, BRIT CERAM T, V95, P212
NR 66
TC 2
Z9 3
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2015
VL 41
IS 2
BP 3116
EP 3127
DI 10.1016/j.ceramint.2014.10.156
PN B
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA AZ1MM
UT WOS:000348003100062
DA 2018-10-20
ER

PT J
AU Yang, S
   Umbrello, D
   Dillon, OW
   Puleo, DA
   Jawahir, IS
AF Yang, Shu
   Umbrello, Domenico
   Dillon, Oscar W., Jr.
   Puleo, David A.
   Jawahir, I. S.
TI Cryogenic cooling effect on surface and subsurface microstructural
   modifications in burnishing of Co-Cr-Mo biornaterial
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE Cryogenic burnishing; Co-Cr-Mo biomaterial; Surface and subsurface
   microstructural modifications; Severe plastic deformation (SPD)
ID WEAR-RESISTANCE; MECHANICAL-PROPERTIES; PHASE-TRANSFORMATION; ALLOY;
   PARAMETERS; TOOL; DEFORMATION; COMPONENTS; INTEGRITY; STRENGTH
AB The aim of the present work is to investigate the effect of a severe plastic deformation (SPD) process, cryogenic burnishing, on the surface integrity modifications of a Co-Cr-Mo alloy due to the burnishing-induced surface integrity properties. A set of experiments was conducted to investigate the influence of different burnishing parameters on distribution of grain size, phase structure and hardness of the processed material. The results from this work show that the proper selection of burnishing conditions can significant improve the surface integrity of the Co-Cr-Mo alloy due to refined microstructure, high hardness, and favorable phase structure on the surface layer, which could potentially lead to advanced wear performance of such material. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Yang, Shu; Dillon, Oscar W., Jr.; Jawahir, I. S.] Univ Kentucky, Inst Sustainable Mfg, Lexington, KY 40506 USA.
   [Umbrello, Domenico] Univ Calabria, Dept Mech Energy & Management Engn, I-87036 Arcavacata Di Rende, CS, Italy.
   [Puleo, David A.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40506 USA.
RP Yang, S (reprint author), Univ Kentucky, Inst Sustainable Mfg, Lexington, KY 40506 USA.
EM shuyang1031@gmail.com
RI Umbrello, Domenico/C-5519-2012
OI Umbrello, Domenico/0000-0002-4211-6322
CR Ben Fredj N, 2006, CRYOGENICS, V46, P439, DOI 10.1016/j.cryogenics.2006.01.015
   Buckley H, 1968, COBALT, P20
   Buscher R, 2005, WEAR, V259, P887, DOI 10.1016/j.wear.2005.02.036
   Buscher R, 2003, MATERIALWISS WERKST, V34, P966, DOI 10.1002/mawe.200300680
   Chan CLH, 1996, J BONE JOINT SURG BR, V78B, P78
   CHAPELLIER P, 1990, ACTA METALL MATER, V38, P1475, DOI 10.1016/0956-7151(90)90116-X
   CROOK P, 1983, WEAR MAT, P272
   El-Axir MH, 2003, J MATER PROCESS TECH, V132, P82, DOI 10.1016/S0924-0136(02)00269-8
   GRAHAM AH, 1970, METALL TRANS, V1, P423, DOI 10.1007/BF02811551
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hassan AM, 1999, J MATER PROCESS TECH, V96, P73
   Hassan AM, 1996, J MATER PROCESS TECH, V59, P250, DOI 10.1016/0924-0136(95)02149-3
   HUANG JY, 1995, APPL PHYS LETT, V66, P308, DOI 10.1063/1.113527
   Khan AA, 2008, J MATER PROCESS TECH, V196, P149, DOI 10.1016/j.jmatprotec.2007.05.030
   Kohzu M, 2007, MATER TRANS, V48, P764, DOI 10.2320/matertrans.48.764
   Kumar KVBSK, 2008, J MATER PROCESS TECH, V203, P95, DOI 10.1016/j.jmatprotec.2007.10.036
   Kuroda M, 2005, AIP CONF PROC, V778, P445
   LOH NH, 1989, J MECH WORK TECHNOL, V18, P53, DOI 10.1016/0378-3804(89)90109-5
   Maximov JT, 2009, INT J MACH TOOL MANU, V49, P824, DOI 10.1016/j.ijmachtools.2009.05.011
   O'Sullivan D, 2002, P I MECH ENG B-J ENG, V216, P135, DOI 10.1243/0954405021519645
   OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Prevey P. S., 2000, EFFECT COLD WORK THE
   RAJAN K, 1982, J MATER SCI, V17, P769, DOI 10.1007/BF00540374
   Rao DS, 2008, MATER MANUF PROCESS, V23, P295, DOI 10.1080/10426910801937306
   Saldivar-Garcia AJ, 2005, J BIOMED MATER RES A, V74A, P269, DOI 10.1002/jbm.a.30392
   Salinas-Rodrfguez A., 1999, ASTM STP, V1365
   Seemikeri CY, 2008, TRIBOL INT, V41, P724, DOI 10.1016/j.triboint.2008.01.003
   Stoot F.H., 1977, MET TECHNOL, V4, P66
   Vandamme NS, 2005, J MATER SCI-MATER M, V16, P647, DOI 10.1007/s10856-005-2536-2
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Yang S, 2013, J BIOMED MATER RES B, V101B, P139, DOI 10.1002/jbm.b.32827
   Zhang P, 2005, SCRIPTA MATER, V52, P1011, DOI 10.1016/j.scriptamat.2005.01.026
   Zurecki Z., 2003, P IMECE 03 WASH DC
NR 35
TC 5
Z9 5
U1 3
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAR
PY 2015
VL 217
BP 211
EP 221
DI 10.1016/j.jmatprotec.2014.11.004
PG 11
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA AY5AM
UT WOS:000347585900021
DA 2018-10-20
ER

PT J
AU Jaganathan, SK
   Balaji, A
   Vellayappan, MV
   Subramanian, AP
   John, AA
   Asokan, MK
   Supriyanto, E
AF Jaganathan, Saravana Kumar
   Balaji, Arunpandian
   Vellayappan, Muthu Vignesh
   Subramanian, Aruna Priyadarshni
   John, Agnes Aruna
   Asokan, Manjeesh Kumar
   Supriyanto, Eko
TI Review: Radiation-induced surface modification of polymers for
   biomaterial application
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID ANTIBACTERIAL LDPE SURFACE; PLASMA-TREATED POLYMERS; ADHESION; TISSUE;
   IMPROVEMENT; POLYDIMETHYLSILOXANE; BIOCOMPATIBILITY; ATTACHMENT;
   MORPHOLOGY; SCAFFOLDS
AB The field of biomaterials is one of the fast growing and continuously dominating in medical arena for the last five decades. Biomaterials utilize various kinds of materials ranging from metals, polymers, ceramics and biological substances as an alternative for replacing/assisting the functions of different parts of human system. Major issues associated with biomaterials are their properties and the biocompatibility which have to be addressed and resolved before promoting it to the market or clinical setting. In this scenario, polymers have emerged as a better candidate with versatile properties that make them ideal choice for biomedical applications. However, still the problem of biocompatibility limits the use of polymers in the human body. Several surface modification strategies are continuously evolving to improve the biocompatibility of polymers. This review initially outlines the polymers' biomedical applications and also elicits the immune aspects of biocompatibility. Further, a thorough attempt is made to summarize the radiation-induced surface modification of the polymers. This review will help us to keep abreast of the recent advances in the radiation-induced surface modification and also in promoting radiation as a probable candidate to enhance the biocompatibility of polymers.
C1 [Jaganathan, Saravana Kumar; Balaji, Arunpandian; Vellayappan, Muthu Vignesh; Subramanian, Aruna Priyadarshni; John, Agnes Aruna; Supriyanto, Eko] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
   [Asokan, Manjeesh Kumar] PSNA Coll Engn & Technol, Dept Res & Dev, Dindigul 624622, Tamil Nadu, India.
RP Jaganathan, SK (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Johor Baharu 81310, Malaysia.
EM jaganathaniitkgp@gmail.com
RI Jaganathan, Saravana Kumar/N-2385-2017
OI Balaji, Arunpandian/0000-0002-6745-9188
FU Ministry of Higher Education Malaysia [R.J130000.7809.4F444,
   PY/2014/03167]
FX This work was supported partly by the Ministry of Higher Education
   Malaysia with the Grant Vot No. R.J130000.7809.4F444 and the Ref No:
   PY/2014/03167.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AREFI F, 1992, PURE APPL CHEM, V64, P715, DOI 10.1351/pac199264050715
   BADEY JP, 1994, POLYMER, V35, P2472, DOI 10.1016/0032-3861(94)90365-4
   Bilek F, 2013, COLLOID SURFACE B, V102, P842, DOI 10.1016/j.colsurfb.2012.08.026
   Bilek F, 2011, COLLOID SURFACE B, V88, P440, DOI 10.1016/j.colsurfb.2011.07.027
   Boretos JW, 1984, CONT BIOMATERIALS MA, P232
   Chang HI, 2011, REGENERATIVE MED TIS, P1
   Costa CAS., 2001, METODOLOGIA CIENTIFI, P145
   Dadsetan M, 1999, RADIAT PHYS CHEM, V56, P597, DOI 10.1016/S0969-806X(99)00293-5
   Ginn BT, 2003, LANGMUIR, V19, P8117, DOI 10.1021/La034138h
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hamid Mirzadeh, 1996, IRAN PDYRM J, V5, P225
   Heidari S, 2011, INT J NANOMED, V6, P641, DOI DOI 10.1080/10426500902917644
   Heitz J, 2004, BIOTECHNOL APPL BIOC, V39, P59, DOI 10.1042/BA20030107
   Hoffman Allan S, 1995, CHIN J POLYM SCI, V13, P1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jaganathan SK, 2014, BIOMATERIALS CARDIOV
   Junkar I, 2011, MATER TEHNOL, V45, P221
   Kasalkova NS, 2012, NUCL INSTRUM METH B, V272, P391, DOI 10.1016/j.nimb.2011.01.108
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Khorasani MT, 2004, J BIOMAT SCI-POLYM E, V15, P59, DOI 10.1163/156856204322752237
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   Kolska Z, 2012, VACUUM, V86, P643, DOI 10.1016/j.vacuum.2011.07.015
   Kwan-Hoong N., 2003, P INT C NON RAD UNIT
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   LEMONS J, 1986, DENT CLIN N AM, V30, P3
   Melnig V, 2005, J OPTOELECTRON ADV M, V7, P2521
   Michael Olbricha, 2007, J BIOMATER SCI, V18, P453
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mohandas H, 2013, BIOMED RES INT, DOI 10.1155/2013/253473
   MUTEL B, 1988, REV PHYS APPL, V23, P1253, DOI 10.1051/rphysap:019880023070125300
   Nechifor CD, 2009, ROM J PHYS, V54, P349
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   O'Brien William J, DENT MAT THEIR SELEC
   Pallister CJ, 2010, HAEMATOLOGY, P334
   Rabiei A, 2013, J BIOMED MATER RES A, V101, P2621, DOI 10.1002/jbm.a.34557
   Rajajeyaganthan R, 2011, MACROMOL SYMP, V299-300, P175, DOI 10.1002/masy.200900128
   Reznickova A, 2011, NUCL INSTRUM METH B, V269, P83, DOI 10.1016/j.nimb.2010.11.018
   ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W
   Ryou M, 2006, TECH GASTROINTEST EN, V8, P33, DOI 10.1016/j.tgie.2005.12.007
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Schmalz G, 2002, J DENT RES, V81, P660, DOI 10.1177/154405910208101001
   Sharma DS, 2004, IND APPL C, V4, P932
   Siegel J, 2008, RADIAT EFF DEFECT S, V163, P779, DOI 10.1080/10420150801969654
   Silvio LD, 2008, CELLULAR RESPONSE BI, P648
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Slepicka P, 2010, NUCL INSTRUM METH B, V268, P2111, DOI 10.1016/j.nimb.2010.02.012
   Stevens K. N. J., 2011, BLOOD CONTACTING BIO
   Su WY, 2010, SURF COAT TECH, V205, P465, DOI 10.1016/j.surfcoat.2010.07.013
   Subedi D.P., 2009, KATHMANDU U J SCI EN, V5, P37
   Suggs Allison, 2002, KR F LASER SURFACE T
   Toan Leaz Quoc, 2013, ECS J SOLID STATE SC, V5, pN93
   Valentin J., 2007, RECOMMENDATIONS INT
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   Wang ZK, 2010, SIMTECH TECHNICAL RE, V11
   Weibel DE, 2009, THIN SOLID FILMS, V517, P5489, DOI 10.1016/j.tsf.2009.03.204
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Williams R, 2010, WOODHEAD PUBL MATER, P1
NR 63
TC 18
Z9 19
U1 3
U2 109
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2015
VL 50
IS 5
BP 2007
EP 2018
DI 10.1007/s10853-014-8718-x
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AY6SS
UT WOS:000347696500001
DA 2018-10-20
ER

PT J
AU Gilca, IA
   Pupa, VI
   Crestini, C
AF Gilca, Iulian Andrei
   Pupa, Valentin I.
   Crestini, Claudia
TI Obtaining lignin nanoparticles by sonication
SO ULTRASONICS SONOCHEMISTRY
LA English
DT Article
DE Lignins; Ultrasound; Nanoparticles; Characterization
ID P-31 NMR; WOOD CHEMISTRY; ULTRASOUND; SPECTROSCOPY; ACCURATE; FTIR
AB Lignin, the main natural aromatic polymer was always aroused researchers interest. Currently around 90% of this biomaterial is burned for energy. It has a very complex and complicated structure which depends on the separation method and plant species, what determine difficulties to use as a raw material widely. This research presents a physical method to modify lignin by ultrasonic irradiation in order to obtain nanoparticles. The nanoparticles synthesized were dimensionally and morphologically characterized. At the same time the preoccupations were to determine the structural and compositional changes that occurred after sonication. To achieve this, two types of commercial lignins (wheat straw and Sarkanda grass) were used and the modifications were analyzed by FTIR-spectroscopy, GPC-chromatography, P-31-NMR-spectroscopy and HSQCO. The results confirm that the compositional and structural changes of nanoparticles obtained are not significantly modified at the intensity applied but depend on the nature of lignin. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gilca, Iulian Andrei; Pupa, Valentin I.] Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Iasi 700050, Romania.
   [Crestini, Claudia] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy.
RP Gilca, IA (reprint author), Gheorghe Asachi Tech Univ, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Blvd Mangeron 73, Iasi 700050, Romania.
EM andreigilca@tuiasi.ro
RI Crestini, Claudia/O-6781-2015
OI Crestini, Claudia/0000-0001-9903-2675
FU POSDRU CUANTUMDOC [ID79407]; European Social Found and Romanian
   Government; University of Rome; Institute of Macromolecular Chemistry
FX This paper was realised with the support of POSDRU CUANTUMDOC "DOCTORAL
   STUDIES FOR EUROPEAN PERFORMANCES IN RESEARCH AND INOVATION" ID79407
   project funded by the European Social Found and Romanian Government.;
   Dr. Federica Me lone and Silvia Decina from University of Rome "Tor
   Vergata" for support in GPC acetylated and NMR analysis; Dr. Florica
   Doroftei from Institute of Macromolecular Chemistry "Petru Poni" Iasi
   for support in TEM analysis.
CR Alonso MV, 2001, J APPL POLYM SCI, V82, P2661, DOI 10.1002/app.2119
   ARGYROPOULOS DS, 1994, J WOOD CHEM TECHNOL, V14, P45, DOI 10.1080/02773819408003085
   ARGYROPOULOS DS, 1993, J WOOD CHEM TECHNOL, V13, P187, DOI 10.1080/02773819308020514
   ARGYROPOULOS DS, 1995, RES CHEM INTERMEDIAT, V21, P373, DOI 10.1007/BF03052265
   Asikkala J, 2012, J AGR FOOD CHEM, V60, P8968, DOI 10.1021/jf303003d
   Benar P, 1999, J WOOD CHEM TECHNOL, V19, P151, DOI 10.1080/02773819909349605
   Crestini C, 2011, BIOMACROMOLECULES, V12, P3928, DOI 10.1021/bm200948r
   Crestini C, 2011, BIOORGAN MED CHEM, V19, P5071, DOI 10.1016/j.bmc.2011.05.058
   Derkacheva O, 2008, MACROMOL SYMP, V265, P61, DOI 10.1002/masy.200850507
   Dimmel D., 2010, LIGNIN LIGNANS ADV C, P1
   Garcia A, 2012, CHEM ENG PROCESS, V62, P150, DOI 10.1016/j.cep.2012.07.011
   Garcia A, 2012, BIORESOURCE TECHNOL, V108, P155, DOI 10.1016/j.biortech.2012.01.010
   Gilca I.A., 2011, ITALIC 6 SCI TECHNOL
   Gilca IA, 2013, CELL CHEM TECHNOL, V47, P239
   Gilca IA, 2011, CELL CHEM TECHNOL, V45, P227
   GRANATA A, 1995, J AGR FOOD CHEM, V43, P1538, DOI 10.1021/jf00054a023
   Guerra A, 2007, PHYTOCHEMISTRY, V68, P2570, DOI 10.1016/j.phytochem.2007.05.026
   Hainal AR, 2012, CELL CHEM TECHNOL, V46, P87
   Huang Y, 2012, J WOOD CHEM TECHNOL, V32, P294, DOI 10.1080/02773813.2012.666316
   Iordache I., 2009, SONOCHIMIA EPURAREA
   Kim KH, 2008, ULTRASON SONOCHEM, V15, P1019, DOI 10.1016/j.ultsonch.2007.11.004
   Kuijpers MWA, 2002, ULTRASONICS, V40, P675, DOI 10.1016/S0041-624X(02)00197-X
   Lange H, 2013, EUR POLYM J, V49, P1151, DOI 10.1016/j.eurpolymj.2013.03.002
   Lu FC, 1998, J WOOD CHEM TECHNOL, V18, P219, DOI 10.1080/02773819809349578
   Mishra SP, 2011, BIORESOURCES, V6, P121
   Nada AAMA, 1998, POLYM DEGRAD STABIL, V60, P247, DOI 10.1016/S0141-3910(97)00072-4
   Patil MN, 2007, ULTRASON SONOCHEM, V14, P519, DOI 10.1016/j.ultsonch.2006.10.007
   Perazzini R, 2011, BIOORGAN MED CHEM, V19, P440, DOI 10.1016/j.bmc.2010.11.009
   Petrovici G., 1997, CHIMIA SI PRELUCRARE
   Popa VI, 2011, CELL CHEM TECHNOL, V45, P221
   Schilling P., 1993, US Patent, Patent No. [5,192,361, 5192361]
   Seino T, 2001, WOOD SCI TECHNOL, V35, P97, DOI 10.1007/s002260000080
   Sette M, 2011, CHEM-EUR J, V17, P9529, DOI 10.1002/chem.201003045
   SJOSTROM E, 1981, WOOD CHEM FUNDAMENTA
   Sun RC, 2002, ULTRASON SONOCHEM, V9, P85, DOI 10.1016/S1350-4177(01)00106-7
   Wells T, 2013, ULTRASON SONOCHEM, V20, P1463, DOI 10.1016/j.ultsonch.2013.05.001
   Wu CD, 2001, WATER RES, V35, P3927, DOI 10.1016/S0043-1354(01)00133-6
   Zimniewska M, 2008, MOL CRYST LIQ CRYST, V484, P409, DOI 10.1080/15421400801903395
NR 38
TC 35
Z9 36
U1 1
U2 86
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4177
EI 1873-2828
J9 ULTRASON SONOCHEM
JI Ultrason. Sonochem.
PD MAR
PY 2015
VL 23
BP 369
EP 375
DI 10.1016/j.ultsonch.2014.08.021
PG 7
WC Acoustics; Chemistry, Multidisciplinary
SC Acoustics; Chemistry
GA AX6HH
UT WOS:000347023100048
PM 25218770
OA Green Published
DA 2018-10-20
ER

PT J
AU Yang, MY
   Zhou, GS
   Castano-Izquierdo, H
   Zhu, Y
   Mao, CB
AF Yang, Mingying
   Zhou, Guanshan
   Castano-Izquierdo, Harold
   Zhu, Ye
   Mao, Chuanbin
TI Biomineralization of Natural Collagenous Nanofibrous Membranes and Their
   Potential Use in Bone Tissue Engineering
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Biomineralization; Hydroxyapatite; Stem Cells; Tissue Engineering;
   Collagen
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; IN-VITRO;
   OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; BIOLOGICAL
   NANOFIBERS; ORIENTED GROWTH; WALL REPAIR; MINERALIZATION; REGENERATION
AB Small intestinal submucosa (SIS) membranes as a decellularized tissue are known to be a natural nanofibrous biomaterial mainly made of type I collagen fibers and containing some growth factors (fibroblast growth factor 2 and transforming growth factor beta) desired in tissue engineering. Here we show that the SIS membranes can promote the formation of bone mineral hydroxylapatite (HAP) crystals along the collagen fibers constituting the membranes from a HAP-supersaturated solution. The resultant biomineralized HAP-SIS scaffolds were found to promote the attachment, growth and osteogenic differentiation of mesenchymal stem cells (MSCs) in both basal and osteogenic media by the evaluation of osteogenic marker formation. More importantly, the HAP-SIS scaffolds could induce the osteogenic differentiation in the basal media without osteogenic supplements due to the presence of HAP crystals in the scaffolds. Histological characterization of the MSC-seeded scaffolds showed that HAP-SIS scaffolds are biocompatible and promote the formation of new tissue in vitro. The biomineralized SIS membranes mimic some aspects of natural bone in terms of the composition and nanostructures and can find potential use in bone tissue engineering.
C1 [Yang, Mingying; Zhou, Guanshan] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Hangzhou 310058, Zhejiang, Peoples R China.
   [Castano-Izquierdo, Harold; Zhu, Ye; Mao, Chuanbin] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Norman, OK 73019 USA.
RP Yang, MY (reprint author), Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM yangm@zju.edu.cn; cbmao@ou.edu
OI Mao, Chuanbin/0000-0002-8142-3659
FU National Science Foundation [CBET-0854465, CMMI-1234957, CBET-0854414,
   DMR-0847758]; National Institutes of Health [HL0925264, EB015190,
   AR056848]; Department of Defense Peer Reviewed Medical Research Program
   [W81XWH-12-1-0384]; Oklahoma Center for the Advancement of Science and
   Technology [HR11-006]; Oklahoma Center for Adult Stem Cell Research
   [434003]; National High Technology Research and Development Program 863
   [2013AA102507]; Zhejiang Provincial Natural Science Foundation of China
   [LZ12C17001]; National Natural Science Foundation of China [20804037,
   21172194]; Silkworm Industry Science and Technology Innovation Team
   [2011R50028]
FX We would like to thank the financial support from National Science
   Foundation (CBET-0854465, CMMI-1234957, CBET-0854414, and DMR-0847758),
   National Institutes of Health (HL0925264, EB015190, AR056848),
   Department of Defense Peer Reviewed Medical Research Program
   (W81XWH-12-1-0384), Oklahoma Center for the Advancement of Science and
   Technology (HR11-006) and Oklahoma Center for Adult Stem Cell Research
   (434003). MY also thank the generous support from National High
   Technology Research and Development Program 863 (2013AA102507), Zhejiang
   Provincial Natural Science Foundation of China (LZ12C17001), National
   Natural Science Foundation of China (20804037 and 21172194) and Silkworm
   Industry Science and Technology Innovation Team (2011R50028).
CR Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Bera S., 2005, BIOMATERIALS, V26, P1997
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Cao B, 2007, LANGMUIR, V23, P10701, DOI 10.1021/1a7014435
   Cao BR, 2014, METHODS MOL BIOL, V1108, P123, DOI 10.1007/978-1-62703-751-8_10
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Lai JY, 2003, J PEDIATR SURG, V38, P1752, DOI 10.1016/S0022-3468(03)00617-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Ledet Eric H, 2002, Spine J, V2, P188, DOI 10.1016/S1529-9430(02)00182-1
   Li D, 2012, J MATER CHEM, V22, P15702, DOI 10.1039/c2jm31034a
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lock J, 2012, J MATER SCI-MATER M, V23, P2543, DOI 10.1007/s10856-012-4709-0
   Mann S., 2001, BIOMINERALIZATION PR, P1
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Mao CB, 1999, J MATER CHEM, V9, P2573, DOI 10.1039/a901309a
   Mao CB, 1998, J MATER CHEM, V8, P2795, DOI 10.1039/a801384e
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   SILVERSTONE LM, 1981, CARIES RES, V15, P138, DOI 10.1159/000260512
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Venugopal J, 2013, J BIOMAT SCI-POLYM E, V24, P170, DOI 10.1163/156856212X629845
   Venugopal JR, 2011, CELL BIOL INT, V35, P73, DOI 10.1042/CBI20090066
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang JL, 2014, ADV MATER, V26, P4961, DOI 10.1002/adma.201400154
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P2929, DOI 10.1002/jbm.a.34236
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xu H, 2011, BIOMACROMOLECULES, V12, P2193, DOI 10.1021/bm200274r
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
NR 60
TC 20
Z9 20
U1 0
U2 110
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2015
VL 11
IS 3
BP 447
EP 456
DI 10.1166/jbn.2015.2038
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AT5FL
UT WOS:000344969500008
PM 25883539
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Seo, SH
   Uhm, SH
   Kwon, JS
   Choi, EH
   Kim, KM
   Kim, KN
AF Seo, Sang-Hee
   Uhm, Soo-Hyuk
   Kwon, Jae-Sung
   Choi, Eun Ha
   Kim, Kwang-Mahn
   Kim, Kyoung-Nam
TI An Alternative to Annealing TiO2 Nanotubes for Morphology Preservation:
   Atmospheric Pressure Plasma Jet Treatment
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Non-Thermal Atmospheric Pressure Plasma; Plasma Electrolytic Oxidation;
   TiO2 Nanotube Structure; Surface Characteristic; Osteoblast Behavior
ID HYDROTHERMAL TREATMENT; CHEMICAL-COMPOSITION; TITANIA NANOTUBES; CELL
   FATE; IN-VITRO; SURFACE; OSTEOBLAST; BONE; IMPLANTS; ADHESION
AB Titanium oxide nanotube layer formed by plasma electrolytic oxidation (PEO) is known to be excellent in biomaterial applications. However, the annealing process which is commonly performed on the TiO2 nanotubes cause defects in the nanotubular structure. The purpose of this work was to apply a non-thermal atmospheric pressure plasma jet on diameter-controlled TiO2 nanotubes to mimic the effects of annealing while maintaining the tubular structure for use as biomaterial. Diameter-controlled nanotube samples fabricated by plasma electrolytic oxidation were dried and prepared under three different conditions: untreated, annealed at 450 degrees C for 1 h in air with a heating rate of 10 degrees C/min, and treated with an air-based non-thermal atmospheric pressure plasma jet for 5 minutes. The contact angle measurement was investigated to confirm the enhanced hydrophilicity of the TiO2 nanotubes. The chemical composition of the surface was studied using X-ray photoelectron spectroscopy, and the morphology of TiO2 nanotubes was examined by field emission scanning electron microscopy. For the viability of the cell, the attachment of the osteoblastic cell line MC3T3-E1 was determined using the water-soluble tetrazolium salt assay. We found that there are no morphological changes in the TiO2 nanotubular structure after the plasma treatment. Also, we investigated a change in the chemical composition and enhanced hydrophilicity which result in improved cell behavior. The results of this study indicated that the non-thermal atmospheric pressure plasma jet results in osteoblast functionality that is comparable to annealed samples while maintaining the tubular structure of the TiO2 nanotubes. Therefore, this study concluded that the use of a non-thermal atmospheric pressure plasma jet on nanotube surfaces may replace the annealing process following plasma electrolytic oxidation.
C1 [Seo, Sang-Hee; Uhm, Soo-Hyuk; Kwon, Jae-Sung; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Dept & Res Inst Dent Biomat & Bioengn, Coll Dent, Seoul 120752, South Korea.
   [Seo, Sang-Hee; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Seoul 120752, South Korea.
   [Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Dept & Res Inst Dent Biomat & Bioengn, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [NRF-2010-0027963]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (NRF-2010-0027963).
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Albu SP, 2010, EUR J INORG CHEM, P4351, DOI 10.1002/ejic.201000608
   Bai Y, 2011, SURF INTERFACE ANAL, V43, P998, DOI 10.1002/sia.3683
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   De S, 2005, J BIOMAT SCI-POLYM E, V16, P973, DOI 10.1163/1568562054414612
   GONBEAU D, 1991, SURF SCI, V254, P81, DOI 10.1016/0039-6028(91)90640-E
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Kwon JS, 2013, CURR APPL PHYS, V13, pS42, DOI 10.1016/j.cap.2012.12.022
   Lee EJ, 2013, CURR APPL PHYS, V13, pS36, DOI 10.1016/j.cap.2012.12.023
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Mazare A, 2012, BIOELECTROCHEMISTRY, V87, P124, DOI 10.1016/j.bioelechem.2012.01.002
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ou HH, 2007, SEP PURIF TECHNOL, V58, P179, DOI 10.1016/j.seppur.2007.07.017
   Park G, 2012, J KOREAN PHYS SOC, V60, P916, DOI 10.3938/jkps.60.916
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sreekantan S, 2009, THIN SOLID FILMS, V518, P16, DOI 10.1016/j.tsf.2009.06.002
   Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Uhm HS, 2012, J KOREAN PHYS SOC, V60, P897, DOI 10.3938/jkps.60.897
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Wong CL, 2011, J ENVIRON MANAGE, V92, P1669, DOI 10.1016/j.jenvman.2011.03.006
   Yang B, 2011, MATER CHEM PHYS, V130, P1227, DOI 10.1016/j.matchemphys.2011.08.063
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
NR 31
TC 4
Z9 4
U1 3
U2 50
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2015
VL 15
IS 3
BP 2501
EP 2507
DI 10.1166/jnn.2015.10244
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AT6NC
UT WOS:000345054200093
PM 26413696
DA 2018-10-20
ER

PT J
AU Rong, ZC
   Zeng, W
   Kuang, YS
   Zhang, JW
   Liu, XY
   Lu, Y
   Cheng, XR
AF Rong, Zhicheng
   Zeng, Wen
   Kuang, Yanshen
   Zhang, Jianwei
   Liu, Xingyun
   Lu, Yuan
   Cheng, Xiangrong
TI Enhanced Bioactivity of Osteoblast-like Cells on Poly(lactic
   acid)/Poly(methyl methacrylate)/Nano-hydroxyapatite Scaffolds for Bone
   Tissue Engineering
SO FIBERS AND POLYMERS
LA English
DT Article
DE Hydroxyapatite nanoparticles; Nanofibrous scaffolds; Bioactivity; Bone
   tissue engineering
ID INTERCALATED NANOFIBROUS MATS; BACTERIAL-INHIBITION ACTIVITY;
   MECHANICAL-PROPERTIES; DRUG-DELIVERY; IN-VITRO; CULTURE; FABRICATION;
   COLLAGEN; COMPOSITE; FIBERS
AB Bone tissue engineering has great potential but requires an appropriate substrate with good bioactivity. In this study, poly(lactic acid) (PLA)/poly(methyl methacrylate) (PMMA)/nano-hydroxyapatite (n-HA) hybrid nanofibrous scaffolds were fabricated via electrospinning. The morphologies of the scaffolds were observed by scanning electron microscopy, transmission electron microscopy and the structures of the scaffolds were measured by fourier transform infrared spectrum. After immersion in simulated body fluid, the more deposition of ball-like apatite can be observed on the surface of the hybrid PLA/PMMA/n-HA scaffold. In vitro degradation experiments showed that the less degradation occurred in the hybrid PLA/PMMA/n-HA scaffold. The studies of cell adhesion and growth capability were investigated by incubating the osteoblast-like cells (MG-63) in the scaffolds, which verified the addition of n-HA could promote the adhesion and proliferation of the Human osteoblast-like cells (MG-63). Hence, the electrospun hybrid PLA/PMMA/n-HA nanofibrous 'scaffold is a promising biomaterial, propitious to be a substrate for bone tissue engineering.
C1 [Rong, Zhicheng; Cheng, Xiangrong] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed Engn, Minist Educ, Wuhan 430079, Peoples R China.
   [Zeng, Wen; Zhang, Jianwei] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430079, Peoples R China.
   [Kuang, Yanshen] Wuhan Univ, Zhongnan Hosp, Wuhan 430079, Peoples R China.
   [Liu, Xingyun; Lu, Yuan] Guangxi Univ, Sch Chem & Chem Engn, Nanning 530004, Peoples R China.
RP Cheng, XR (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed Engn, Minist Educ, Wuhan 430079, Peoples R China.
EM xiangrongcheng@hotmail.com
FU National Natural Science Foundation of China [30772445]
FX This project was funded by National Natural Science Foundation of China
   (No.30772445).
CR Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Cao H., 2012, J MATER SCI, V48, P150
   Chang BW, 2005, SENSOR ACTUAT B-CHEM, V105, P159, DOI 10.1016/j.snb.2004.05.048
   Chaplin RPS, 2006, J MATER SCI-MATER M, V17, P1433, DOI 10.1007/s10856-006-0619-3
   Deng HB, 2011, CARBOHYD POLYM, V83, P973, DOI 10.1016/j.carbpol.2010.09.008
   Deng HB, 2011, CARBOHYD POLYM, V83, P239, DOI 10.1016/j.carbpol.2010.07.042
   Deng HB, 2010, CARBOHYD POLYM, V80, P474, DOI 10.1016/j.carbpol.2009.12.004
   Dong H, 2004, J POLYM SCI POL PHYS, V42, P3934, DOI 10.1002/polb.20253
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du J, 2013, CURR NANOSCI, V9, P8
   Fischer RL, 2012, J MATER SCI-MATER M, V23, P1645, DOI 10.1007/s10856-012-4641-3
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Goh YF, 2013, J MATER SCI, V48, P3027, DOI 10.1007/s10853-013-7145-8
   Hou XN, 2011, APPL SURF SCI, V257, P3417, DOI 10.1016/j.apsusc.2010.11.037
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jaiswal AK, 2013, APPL SURF SCI, V268, P477, DOI 10.1016/j.apsusc.2012.12.152
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kane RJ, 2012, J MECH BEHAV BIOMED, V7, P41, DOI 10.1016/j.jmbbm.2011.09.010
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Li W, 2012, EUR POLYM J, V48, P1846, DOI 10.1016/j.eurpolymj.2012.08.001
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Liu HH, 2010, J BIOMED MATER RES B, V95B, P36, DOI 10.1002/jbm.b.31680
   Liu H, 2012, J APPL POLYM SCI, V125, pE468, DOI 10.1002/app.36757
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mao L, 2013, NANOSCALE, V5, P9517, DOI 10.1039/c3nr02912c
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Nagarwal RC, 2011, COLLOID SURFACE B, V86, P28, DOI 10.1016/j.colsurfb.2011.03.023
   Nirmala R, 2010, SURF COAT TECH, V205, P174, DOI 10.1016/j.surfcoat.2010.06.027
   Pelipenko J., 2012, EUR J PHARM BIOPHARM, V84, P401
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Rabadjieva D., 2011, NANOSCI NANOTECHNOL, V11, P182
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tian LL, 2013, J BIOMAT SCI-POLYM E, V24, P1952, DOI 10.1080/09205063.2013.814096
   Wang XF, 2013, PROG MATER SCI, V58, P1173, DOI 10.1016/j.pmatsci.2013.05.001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu CT, 2006, J BIOMED MATER RES B, V78B, P47, DOI 10.1002/jbm.b.30456
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan J, 2008, POLYM INT, V57, P1188, DOI 10.1002/pi.2463
   Zhang HL, 2011, J BIOACT COMPAT POL, V26, P590, DOI 10.1177/0883911511424015
NR 46
TC 7
Z9 7
U1 8
U2 63
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
EI 1875-0052
J9 FIBER POLYM
JI Fiber. Polym.
PD FEB 28
PY 2015
VL 16
IS 2
BP 245
EP 253
DI 10.1007/s12221-015-0245-0
PG 9
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA CC3TB
UT WOS:000350271200003
DA 2018-10-20
ER

PT J
AU Tverdokhlebov, SI
   Bolbasov, EN
   Shesterikov, EV
   Antonova, LV
   Golovkin, AS
   Matveeva, VG
   Petlin, DG
   Anissimov, YG
AF Tverdokhlebov, S. I.
   Bolbasov, E. N.
   Shesterikov, E. V.
   Antonova, L. V.
   Golovkin, A. S.
   Matveeva, V. G.
   Petlin, D. G.
   Anissimov, Y. G.
TI Modification of polylactic acid surface using RF plasma discharge with
   sputter deposition of a hydroxyapatite target for increased
   biocompatibility
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polylactic acid; Biomaterial; Biocompatibility; Magnetron sputter
   deposition; Calcium-phosphate
ID CALCIUM-PHOSPHATE COATINGS; INFRARED CORRELATION SPECTROSCOPY; MULTIPLE
   MELTING BEHAVIOR; L-LACTIC ACID; POLY(L-LACTIC ACID); IMPLANT SURFACES;
   CRYSTALLIZATION; POLYMERS; POLYETHYLENE; CONFORMATION
AB Surface modification of polylactic acid (PLLA) by plasma of radio-frequency magnetron discharge with hydroxyapatite target sputtering was investigated. Increased biocompatibility was demonstrated using studies with bone marrow multipotent mesenchymal stromal cells. Atomic force microscopy demonstrates that the plasma treatment modifies the surface morphology of PLLA to produce rougher surface. Infrared spectroscopy and X-ray diffraction revealed that changes in the surface morphology are caused by the processes of PLLA crystallization. Fluorescent X-ray spectroscopy showed that the plasma treatment also changes the chemical composition of PLLA, enriching it with ions of the sputtered target: calcium, phosphorus and oxygen. It is hypothesized that these surface modifications increase biocompatibility of PLLA without increasing toxicity. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Tverdokhlebov, S. I.; Bolbasov, E. N.; Shesterikov, E. V.] Tomsk Polytech Univ, Tomsk 634050, Russia.
   [Antonova, L. V.; Golovkin, A. S.; Matveeva, V. G.] Fed State Budgetary Inst Res Inst Complex Issues, Kemerovo 650002, Russia.
   [Petlin, D. G.; Anissimov, Y. G.] Griffith Univ, Sch Nat Sci, Southport, Qld 4222, Australia.
RP Tverdokhlebov, SI (reprint author), Tomsk Polytech Univ, 30 Lenin Ave, Tomsk 634050, Russia.
EM tverd@tpu.ru
RI Griffith University, QMNC/I-5498-2013; Golovkin, Alexey/I-2583-2014;
   Anissimov, Yuri/H-4947-2013
OI Golovkin, Alexey/0000-0002-7577-628X; Anissimov,
   Yuri/0000-0002-1124-5826; Bolbasov, Evgeny/0000-0002-9789-2185;
   Tverdokhlebov, Sergei/0000-0002-2242-6358
FU Federal Target Program [14.578.21.0031, RFMEFI57714X0036]; Russian
   Foundation for Basic Research [13-08-98052 r_sibir_a]
FX The authors would like to thank V. Novikov (Tomsk State University) for
   conducting AFM studies. This work was financially supported by the
   Federal Target Program (agreement # 14.578.21.0031, unique identifier
   RFMEFI57714X0036); Russian Foundation for Basic Research (projects
   #13-08-98052 r_sibir_a).
CR Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bolbasov EN, 2014, MATER LETT, V132, P281, DOI 10.1016/j.matlet.2014.06.115
   Boyd AR, 2013, SURF COAT TECH, V233, P131, DOI 10.1016/j.surfcoat.2013.04.017
   Boyd AR, 2013, J MATER SCI-MATER M, V24, P2845, DOI 10.1007/s10856-013-5021-3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   Djafer AZA, 2014, APPL SURF SCI, V312, P57, DOI 10.1016/j.apsusc.2014.05.084
   Feddes B, 2004, J ADHES SCI TECHNOL, V18, P655, DOI 10.1163/156856104839347
   Feddes B, 2004, SURF COAT TECH, V185, P346, DOI 10.1016/S0257-8972(03)01313-6
   Feddes B, 2004, BIOMATERIALS, V25, P633, DOI 10.1016/S0142-9612(03)00574-X
   Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Konischev ME, 2014, RUSS PHYS J+, V56, P1144, DOI 10.1007/s11182-014-0154-5
   Lizundia E, 2013, J MECH BEHAV BIOMED, V17, P242, DOI 10.1016/j.jmbbm.2012.09.006
   Ma TY, 2013, APPL SURF SCI, V286, P131, DOI 10.1016/j.apsusc.2013.09.035
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Pan P, 2007, MACROMOLECULES, V40, P6898, DOI 10.1021/ma071258d
   Pan P, 2009, MACROMOLECULES, V42, P3374, DOI 10.1021/ma8024943
   Pichugin VF, 2008, SURF COAT TECH, V202, P3913, DOI 10.1016/j.surfcoat.2008.01.038
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P2526, DOI 10.1016/j.msec.2013.02.010
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Ribeiro C., 2011, SCI TECHNOL ADV MAT, V12, P1
   Ryu GH, 2005, SURF COAT TECH, V193, P60, DOI 10.1016/j.surfcoat.2004.07.062
   Saeidlou S, 2012, PROG POLYM SCI, V37, P1657, DOI 10.1016/j.progpolymsci.2012.07.005
   Shtansky DV, 2013, APPL SURF SCI, V285, P331, DOI 10.1016/j.apsusc.2013.07.169
   Shtansky DV, 2011, SURF COAT TECH, V206, P1188, DOI 10.1016/j.surfcoat.2011.08.029
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tverdokhlebov SI, 2012, APPL SURF SCI, V263, P187, DOI 10.1016/j.apsusc.2012.09.025
   Vasanthan N, 2009, POLYM DEGRAD STABIL, V94, P1364, DOI 10.1016/j.polymdegradstab.2009.05.015
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Yasuniwa M, 2008, POLYMER, V49, P1943, DOI 10.1016/j.polymer.2008.02.034
   Yoshida S, 2013, SURF COAT TECH, V233, P99, DOI 10.1016/j.surfcoat.2013.02.042
   Zhang J, 2008, MACROMOLECULES, V41, P1352, DOI 10.1021/ma0706071
   Zhang JM, 2004, MACROMOLECULES, V37, P6433, DOI 10.1021/ma049288t
   Zhang JM, 2004, J PHYS CHEM B, V108, P11514, DOI 10.1021/jp048308q
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
NR 40
TC 17
Z9 18
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2015
VL 329
BP 32
EP 39
DI 10.1016/j.apsusc.2014.12.127
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA CB4RV
UT WOS:000349616500005
DA 2018-10-20
ER

PT J
AU Liu, Y
   Li, Y
   Yang, G
   Zheng, XT
   Zhou, SB
AF Liu, Ye
   Li, Ying
   Yang, Guang
   Zheng, Xiaotong
   Zhou, Shaobing
TI Multi-Stimulus-Responsive Shape-Memory Polymer Nanocomposite Network
   Cross-Linked by Cellulose Nanocrystals
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE shape memory; water-responsive; thermoresponsive; nonocomposite;
   cellulose nanocrystals
ID MICROCRYSTALLINE CELLULOSE; CRYSTAL-STRUCTURE; POLYURETHANE; COMPOSITES;
   COPOLYMER; DELIVERY; MOISTURE; BEHAVIOR; RELEASE; LIGHT
AB In this study, we developed a thermoresponsive and water-responsive shape-memory polymer nanocomposite network by chemically cross-linking cellulose nanocrystals (CNCs) with polycaprolactone (PCL) and polyethylene glycol (PEG). The nanocomposite network was fully characterized, including the microstructure, cross-link density, water contact angle, water uptake, crystallinity, thermal properties, and static and dynamic mechanical properties. We found that the PEG[60]-PCL[40]-CNC[10] nanocomposite exhibited excellent thermo-induced and water-induced shape-memory effects in water at 37 degrees C (close to body temperature), and the introduction of CNC clearly improved the mechanical properties of the mixture of both PEG and PCL polymers with low molecular weights. In addition, Alamar blue assays based on osteoblasts indicated that the nanocomposites possessed good cytocompatibility. Therefore, this thermoresponsive and water-responsive shape-memory nanocomposite could be potentially developed into a new smart biomaterial.
C1 [Liu, Ye; Li, Ying; Yang, Guang; Zheng, Xiaotong; Zhou, Shaobing] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Zhou, SB (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
EM shaobingzhou@swjtu.edu.cn
RI zhou, shaobing/B-3148-2010
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51173150, 51203130,
   51373138]; National Key Project of Scientific and Technical Supporting
   Programs - MSTC [2012BAI17B06]; Research Fund for the Doctoral Program
   of Higher Education of China [20120184110029]; Construction Program for
   Innovative Research Team of University in Sichuan Province [14TD0050]
FX This work was partially supported by the National Basic Research Program
   of China (973 Program, 2012CB933600), the National Natural Science
   Foundation of China (51173150, 51203130, and 51373138), the National Key
   Project of Scientific and Technical Supporting Programs Funded by MSTC
   (2012BAI17B06), the Research Fund for the Doctoral Program of Higher
   Education of China (20120184110029), and the Construction Program for
   Innovative Research Team of University in Sichuan Province (14TD0050).
CR Agarwal P, 2011, ANGEW CHEM INT EDIT, V50, P8670, DOI 10.1002/anie.201103908
   Auad ML, 2008, POLYM INT, V57, P651, DOI 10.1002/pi.2394
   Auad ML, 2012, POLYM INT, V61, P321, DOI 10.1002/pi.3193
   Azizi Samir M.A.S., 2005, BIOMACROMOLECULES, V6, P612, DOI DOI 10.1021/BM0493685
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Cao XD, 2009, J MATER CHEM, V19, P7137, DOI 10.1039/b910517d
   Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379
   Chen SJ, 2011, J MATER SCI, V46, P6581, DOI 10.1007/s10853-011-5606-5
   Chen SJ, 2009, POLYMER, V50, P4424, DOI 10.1016/j.polymer.2009.07.031
   De Souza Lima M.M., 2004, MACROMOL RAPID COMM, V25, P771, DOI DOI 10.1002/MARC.200300268
   FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514
   Gong T, 2014, J MATER CHEM B, V2, P6855, DOI 10.1039/c4tb01155d
   Gu XZ, 2013, RSC ADV, V3, P15783, DOI 10.1039/c3ra41337c
   Gu XZ, 2012, POLYMER, V53, P5924, DOI 10.1016/j.polymer.2012.09.056
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   HU HL, 1990, MACROMOLECULES, V23, P4604, DOI 10.1021/ma00223a017
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005
   Jung YC, 2006, J MACROMOL SCI B, V45, P453, DOI 10.1080/00222340600767513
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Liu X, 2014, BIOMACROMOLECULES, V15, P1019, DOI 10.1021/bm401911p
   Liu YJ, 2009, COMPOS SCI TECHNOL, V69, P2064, DOI 10.1016/j.compscitech.2008.08.016
   Liu Y, 2014, CARBOHYD POLYM, V104, P101, DOI 10.1016/j.carbpol.2014.01.031
   Luo XF, 2010, SOFT MATTER, V6, P2146, DOI 10.1039/c001295e
   Marcovich NE, 2006, J MATER RES, V21, P870, DOI 10.1557/JMR.2006.0105
   Mendez J, 2011, MACROMOLECULES, V44, P6827, DOI 10.1021/ma201502k
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Mya KY, 2011, J MATER CHEM, V21, P4827, DOI 10.1039/c0jm04459h
   Pei AH, 2011, MACROMOLECULES, V44, P4422, DOI 10.1021/ma200318k
   Qi XD, 2014, J MATER CHEM A, V2, P2240, DOI 10.1039/c3ta14340f
   Ratna D, 2008, J MATER SCI, V43, P254, DOI 10.1007/s10853-007-2176-7
   Sahoo NG, 2007, COMPOS SCI TECHNOL, V67, P1920, DOI 10.1016/j.compscitech.2006.10.013
   Shao SJ, 2011, INT J PHARMACEUT, V421, P310, DOI 10.1016/j.ijpharm.2011.09.033
   TAKAHASHI Y, 1973, MACROMOLECULES, V6, P672, DOI 10.1021/ma60035a005
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   TSAGAROPOULOS G, 1995, MACROMOLECULES, V28, P6067, DOI 10.1021/ma00122a011
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Xiao Y, 2010, ACS APPL MATER INTER, V2, P3506, DOI 10.1021/am100692n
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
   Yu XJ, 2012, J MATER SCI-MATER M, V23, P581, DOI 10.1007/s10856-011-4475-4
   Yu XJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235702
   Zhang YM, 2011, J MATER CHEM, V21, P9073, DOI 10.1039/c1jm11022e
   Zhao Q, 2013, CARBOHYD POLYM, V91, P169, DOI 10.1016/j.carbpol.2012.08.020
   Zheng XT, 2009, COLLOID SURFACE B, V71, P67, DOI 10.1016/j.colsurfb.2009.01.009
   Zheng XT, 2006, BIOMATERIALS, V27, P4288, DOI 10.1016/j.biomaterials.2006.03.043
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
   Zhu Y, 2012, SOFT MATTER, V8, P2509, DOI 10.1039/c2sm07035a
NR 56
TC 56
Z9 56
U1 20
U2 215
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 25
PY 2015
VL 7
IS 7
BP 4118
EP 4126
DI 10.1021/am5081056
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CC2RT
UT WOS:000350193000030
PM 25647407
DA 2018-10-20
ER

PT J
AU Hauptmann, V
   Menzel, M
   Weichert, N
   Reimers, K
   Spohn, U
   Conrad, U
AF Hauptmann, Valeska
   Menzel, Matthias
   Weichert, Nicola
   Reimers, Kerstin
   Spohn, Uwe
   Conrad, Udo
TI In planta production of ELPylated spidroin-based proteins results in
   non-cytotoxic biopolymers
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Spider silk; Immunogenicity; Synthetic spidroin; Biomaterial;
   Biocompatibility; Atomic force microscopy
ID RECOMBINANT SPIDER SILK; DRAGLINE SILK; TRANSGENIC PLANTS;
   ESCHERICHIA-COLI; MECHANICAL-PROPERTIES; PURIFICATION; BIOMATERIALS;
   ELASTIN; FUSION; GENES
AB Background: Spider silk is a tear-resistant and elastic biopolymer that has outstanding mechanical properties. Additionally, exiguous immunogenicity is anticipated for spider silks. Therefore, spider silk represents a potential ideal biomaterial for medical applications. All known spider silk proteins, so-called spidroins, reveal a composite nature of silk-specific units, allowing the recombinant production of individual and combined segments.
   Results: In this report, a miniaturized spidroin gene, named VSO1 that contains repetitive motifs of MaSp1 has been synthesized and combined to form multimers of distinct lengths, which were heterologously expressed as elastin-like peptide (ELP) fusion proteins in tobacco. The elastic penetration moduli of layered proteins were analyzed for different spidroin-based biopolymers. Moreover, we present the first immunological analysis of synthetic spidroin-based biopolymers. Characterization of the binding behavior of the sera after immunization by competitive ELISA suggested that the humoral immune response is mainly directed against the fusion partner ELP. In addition, cytocompatibility studies with murine embryonic fibroblasts indicated that recombinant spidroin-based biopolymers, in solution or as coated proteins, are well tolerated.
   Conclusion: The results show that spidroin-based biopolymers can induce humoral immune responses that are dependent on the fusion partner and the overall protein structure. Furthermore, cytocompatibility assays gave no indication of spidroin-derived cytotoxicity, suggesting that recombinant produced biopolymers composed of spider silk-like repetitive elements are suitable for biomedical applications.
C1 [Hauptmann, Valeska; Weichert, Nicola; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
   [Menzel, Matthias; Spohn, Uwe] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany.
   [Reimers, Kerstin] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-30659 Hannover, Germany.
RP Conrad, U (reprint author), Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Stadt Seeland, Ot Gatersleben, Germany.
EM conradu@ipk-gatersleben.de
FU Fachagentur Nachwachsende Rohstoffe e.V. [FKZ 22037511]; Federal
   Ministry of Food and Agriculture, Germany
FX We kindly acknowledge the skillful technical support of Isolde Tillack,
   Christine Helmold and Ulrike Gresch. The authors are also grateful to
   Christina Reufsteck (BioMedImplant) for her support in the
   hemocompatibility tests and to Frank Rabenstein (JKI Quedlinburg) for
   his support on the immunization experiments. Further, we acknowledge all
   members of the International Society for Plant Molecular Farming for
   inspiring us and the exciting discussions about the production of spider
   silks. AFM analysis was financed by grant FKZ 22037511 of the
   Fachagentur Nachwachsende Rohstoffe e.V., supported by the Federal
   Ministry of Food and Agriculture, Germany.
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Annabi N, 2013, BIOCHEM ENG J, V77, P110, DOI 10.1016/j.bej.2013.05.006
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   BAUMLEIN H, 1986, NUCLEIC ACIDS RES, V14, P2707, DOI 10.1093/nar/14.6.2707
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Chung H, 2012, CURR OPIN BIOTECH, V23, P957, DOI 10.1016/j.copbio.2012.03.013
   Conrad U, 2011, PLANT BIOTECHNOL J, V9, P22, DOI 10.1111/j.1467-7652.2010.00523.x
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fiedler U, 1997, IMMUNOTECHNOLOGY, V3, P205, DOI 10.1016/S1380-2933(97)00014-6
   Floss DM, 2013, FUSION PROTEIN TECHN, P211
   Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Floss DM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/274346
   FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1
   Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17
   Ge X, 2006, BIOTECHNOL BIOENG, V95, P424, DOI 10.1002/bit.21046
   Gerritsen VB, 2002, PROTEIN SPOTLIGHT
   Hauptmann V, 2013, TRANSGENIC RES, V22, P369, DOI 10.1007/s11248-012-9655-6
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Phan HT, 2011, INT J MOL SCI, V12, P2808, DOI 10.3390/ijms12052808
   Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053
   HORSCH RB, 1985, SCIENCE, V227, P1229
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Korayem AM, 2007, BIOCHEM BIOPH RES CO, V352, P317, DOI 10.1016/j.bbrc.2006.11.022
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Mackay JA, 2008, INT J HYPERTHER, V24, P483, DOI 10.1080/02656730802149570
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9
   NOACK S, 1980, FRESEN Z ANAL CHEM, V304, P250, DOI 10.1007/BF00488792
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Vollrath F, 2002, IN VIVO, V16, P229
   WANDELT CI, 1992, PLANT J, V2, P181
   Weichert N, 2014, PLANT BIOTECHNOL J, V12, P265, DOI 10.1111/pbi.12135
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zeplin PH, 2014, ADV FUNCT MATER, V24, P2658, DOI 10.1002/adfm.201302813
NR 55
TC 5
Z9 5
U1 1
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD FEB 19
PY 2015
VL 15
AR 9
DI 10.1186/s12896-015-0123-2
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CC2JK
UT WOS:000350171100001
PM 25888206
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bellas, E
   Lo, TJ
   Fournier, EP
   Brown, JE
   Abbott, RD
   Gil, ES
   Marra, KG
   Rubin, JP
   Leisk, GG
   Kaplan, DL
AF Bellas, Evangelia
   Lo, Tim J.
   Fournier, Eric P.
   Brown, Joseph E.
   Abbott, Rosalyn D.
   Gil, Eun S.
   Marra, Kacey G.
   Rubin, J. Peter
   Leisk, Gary G.
   Kaplan, David L.
TI Injectable Silk Foams for Soft Tissue Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID ADIPOSE-TISSUE; IN-VITRO; STEM-CELLS; MACROPHAGE PHENOTYPE; SCAFFOLDS;
   VIVO; FIBROIN; MODEL; AUGMENTATION; BIOMATERIALS
AB Soft tissue fillers are needed for restoration of a defect or augmentation of existing tissues. Autografts and lipotransfer have been under study for soft tissue reconstruction but yield inconsistent results, often with considerable resorption of the grafted tissue. A minimally invasive procedure would reduce scarring and recovery time as well as allow the implant and/or grafted tissue to be placed closer to existing vasculature. Here, the feasibility of an injectable silk foam for soft tissue regeneration is demonstrated. Adipose-derived stem cells survive and migrate through the foam over a 10-d period in vitro. The silk foams are also successfully injected into the subcutaneous space in a rat and over a 3-month period integrating with the surrounding native tissue. The injected foams are palpable and soft to the touch through the skin and returning to their original dimensions after pressure is applied and then released. The foams readily absorb lipoaspirate making the foams useful as a scaffold or template for existing soft tissue filler technologies, useful either as a biomaterial alone or in combination with the lipoaspirate.
C1 [Bellas, Evangelia; Lo, Tim J.; Fournier, Eric P.; Brown, Joseph E.; Abbott, Rosalyn D.; Gil, Eun S.; Leisk, Gary G.; Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
   [Marra, Kacey G.; Rubin, J. Peter] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
OI Marra, Kacey/0000-0002-8437-4864; Abbott, Rosalyn/0000-0003-3287-3175
FU Armed Forces Institute for Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0032]; NIH [P41 EB002520]
FX The authors wish to thank Dr. Sonal Pandya for providing the surgical
   specimens and Jodie Moreau and Jonathan Kluge for insightful
   discussions. This work was funded by Armed Forces Institute for
   Regenerative Medicine (AFIRM) W81XWH-08-2-0032 and the NIH - P41
   EB002520.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 2010, AM SOC PLAST SURG RE
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Bellas E, 2013, BIOMATERIALS, V34, P2960, DOI 10.1016/j.biomaterials.2013.01.058
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Park JE, 2011, J MATER SCI-MATER M, V22, P1171, DOI 10.1007/s10856-011-4289-4
   Patrick C., 2001, ANAT REC, V366, P361
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rohrich RJ, 2004, PLAST RECONSTR SURG, V113, P391, DOI 10.1097/01.PRS.0000097293.56504.00
   Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310
   Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7
   Stosich MS, 2009, METHODS, V47, P116, DOI 10.1016/j.ymeth.2008.10.013
   Suga H, 2008, PLAST RECONSTR SURG, V122, P103, DOI 10.1097/PRS.0b013e31817742ed
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
NR 27
TC 24
Z9 24
U1 4
U2 46
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB 18
PY 2015
VL 4
IS 3
DI 10.1002/adhm.201400506
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA CB9OQ
UT WOS:000349961600013
PM 25323438
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Maepa, CE
   Jayaramudu, J
   Okonkwo, JO
   Ray, SS
   Sadiku, ER
   Ramontja, J
AF Maepa, C. E.
   Jayaramudu, J.
   Okonkwo, J. O.
   Ray, S. S.
   Sadiku, E. R.
   Ramontja, J.
TI Extraction and Characterization of Natural Cellulose Fibers from Maize
   Tassel
SO INTERNATIONAL JOURNAL OF POLYMER ANALYSIS AND CHARACTERIZATION
LA English
DT Article
DE Infrared spectroscopy; Chemical composition; Maize tassel fiber; X-ray
   diffraction; Thermal properties
ID IONIC LIQUID PRETREATMENT; PHYSICOCHEMICAL CHARACTERIZATION;
   STERCULIA-URENS; BIOMASS; SWITCHGRASS; COMPOSITES; NANOFIBERS; FEATURES;
   BEHAVIOR; STRAW
AB This article reports on the extraction and characterization of novel natural cellulose fibers obtained from the maize (tassel) plant. Cellulose was extracted from the agricultural residue (waste biomaterial) of maize tassel. The maize tassel fibers were obtained after treatment with NaOH and were carefully characterized while the chemical composition was determined. The chemical composition of the maize tassel fibers showed that the cellulose content increased from 41% to 56%, following alkali treatment. FT-IR spectroscopic analysis of maize tassel fibers confirmed that this chemical treatment also shows the way to partial elimination of hemicelluloses and lignin from the structure of the maize tassel fibers. X-ray diffraction results indicated that this process resulted in enhanced crystallinity of the maize tassel fibers. The thermal properties of the maize tassel fibers were studied by the TGA technique and were found to have improved significantly. The degradation temperature of the alkali-treated maize tassel fiber is higher than that of the untreated maize tassel fibers. This value convincingly showed the potential of maize tassel fibers for use in reinforced biocomposites and waste water treatment.
C1 [Maepa, C. E.; Jayaramudu, J.; Ray, S. S.] CSIR, DST CSIR Natl Ctr Nanostruct Mat Mat Sci & Mfg, ZA-0001 Pretoria, South Africa.
   [Sadiku, E. R.] Tshwane Univ Technol, Dept Chem Met & Mat Engn, Pretoria, South Africa.
   [Maepa, C. E.; Okonkwo, J. O.] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Pretoria, South Africa.
   [Ramontja, J.] Univ Johannesburg, Dept Appl Chem, Johannesburg, South Africa.
RP Ray, SS (reprint author), CSIR, DST CSIR Natl Ctr Nanostruct Mat Mat Sci & Mfg, ZA-0001 Pretoria, South Africa.
EM rsuprakas@csir.co.za
RI RAY, SUPRAKAS/E-7908-2011
OI RAY, SUPRAKAS/0000-0002-0007-2595
FU DST/CSIR National Centre for Nanostructured Materials; Tshwane
   University of Technology
FX The authors would like to thank the DST/CSIR National Centre for
   Nanostructured Materials, and the Tshwane University of Technology for
   their financial support.
CR Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Batra S.K., 1985, HDB FIBER SCI TECHNO, V4, P727
   Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z
   Ganjyal GM, 2004, J APPL POLYM SCI, V93, P2627, DOI 10.1002/app.20843
   Gastaldi G, 1998, IND CROP PROD, V8, P205, DOI 10.1016/S0926-6690(98)00004-1
   Gressel J, 2003, TRENDS BIOTECHNOL, V21, P525, DOI 10.1016/j.tibtech.2003.10.007
   Han J. S., 1998, P KOR SOC WOOD SCI T, P3
   He JX, 2007, IRAN POLYM J, V16, P807
   Jayaramudu J, 2013, ADV POLYM TECH, V32, DOI 10.1002/adv.21349
   Jayaramudu J, 2013, CARBOHYD POLYM, V93, P622, DOI 10.1016/j.carbpol.2013.01.032
   Jayaramudu J, 2011, CARBOHYD POLYM, V86, P1623, DOI 10.1016/j.carbpol.2011.06.071
   Jayaramudu J, 2010, CARBOHYD POLYM, V79, P847, DOI 10.1016/j.carbpol.2009.10.046
   Jayaramudu J, 2009, FIBER POLYM, V10, P338, DOI 10.1007/s12221-009-0338-8
   Jayaramudu J, 2009, INT J POLYM ANAL CH, V14, P115, DOI 10.1080/10236660802601415
   John MJ, 2008, CARBOHYD POLYM, V71, P343, DOI 10.1016/j.carbpol.2007.05.040
   Kadla JF, 2000, CELL CHEM TECHNOL, V34, P197
   Kim J, 2006, MACROMOLECULES, V39, P4202, DOI 10.1021/ma060261e
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075
   Le Troedec M, 2008, COMPOS PART A-APPL S, V39, P514, DOI 10.1016/j.compositesa.2007.12.001
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li RJ, 2009, CARBOHYD POLYM, V76, P94, DOI 10.1016/j.carbpol.2008.09.034
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Liu CF, 2006, CARBOHYD RES, V341, P2677, DOI 10.1016/j.carres.2006.07.008
   Liu XY, 2007, EXPRESS POLYM LETT, V1, P299, DOI 10.3144/expresspolymlett.2007.43
   Maya J. J., 2008, POLYM COMPOSITE, V29, P187
   Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9
   Park BD, 2003, BIOMASS BIOENERG, V25, P319, DOI 10.1016/S0961-9534(03)00014-X
   Park SM, 2010, BIOTECHNOL BIOFUELS, V3, P1, DOI DOI 10.1186/1754-6834-3-10
   Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022
   Ramasamy S, 2013, BIORESOURCES, V8, P4258
   Reddy KO, 2014, INT J POLYM ANAL CH, V19, P48, DOI 10.1080/1023666X.2014.854520
   Reddy N, 2005, POLYMER, V46, P5494, DOI 10.1016/j.polymer.2005.04.073
   Reddy N, 2005, GREEN CHEM, V7, P190, DOI 10.1039/b415102j
   Reddy N., 2004, POLYM PREPRINTS, V45, P411
   Reddy N, 2007, BIOTECHNOL BIOENG, V97, P1021, DOI 10.1002/bit.21330
   Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059
   Rowell R. M., 1997, PAPER COMPOSITES AGR, P7
   Sun JX, 2004, CARBOHYD RES, V339, P291, DOI 10.1016/j.carres.2003.10.027
   Van de Velde K, 2002, J APPL POLYM SCI, V83, P2634, DOI 10.1002/app.10229
   Wang B, 2007, COMPOS SCI TECHNOL, V67, P2521, DOI 10.1016/j.compscitech.2006.12.015
   Zuluaga R, 2009, CARBOHYD POLYM, V76, P51, DOI 10.1016/j.carbpol.2008.09.024
NR 42
TC 15
Z9 15
U1 1
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1023-666X
EI 1563-5341
J9 INT J POLYM ANAL CH
JI Int. J. Polym. Anal. Charact.
PD FEB 17
PY 2015
VL 20
IS 2
BP 99
EP 109
DI 10.1080/1023666X.2014.961118
PG 11
WC Polymer Science
SC Polymer Science
GA CA5EK
UT WOS:000348931000001
DA 2018-10-20
ER

PT J
AU Sirry, MS
   Davies, NH
   Kadner, K
   Dubuis, L
   Saleh, MG
   Meintjes, EM
   Spottiswoode, BS
   Zilla, P
   Franz, T
AF Sirry, Mazin S.
   Davies, Neil H.
   Kadner, Karen
   Dubuis, Laura
   Saleh, Muhammad G.
   Meintjes, Ernesta M.
   Spottiswoode, Bruce S.
   Zilla, Peter
   Franz, Thomas
TI Micro-structurally detailed model of a therapeutic hydrogel injectate in
   a rat biventricular cardiac geometry for computational simulations
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE myocardial infarction; hydrogel; therapeutic injectate; image-based
   reconstruction; computational modelling
ID FINITE-ELEMENT MODEL; MYOCARDIAL-INFARCTION; HEART; CELLS;
   TRANSPLANTATION; BIOMATERIAL; EXPANSION; DELIVERY
AB Biomaterial injection-based therapies have showed cautious success in restoration of cardiac function and prevention of adverse remodelling into heart failure after myocardial infarction (MI). However, the underlying mechanisms are not well understood. Computational studies utilised simplified representations of the therapeutic myocardial injectates. Wistar rats underwent experimental infarction followed by immediate injection of polyethylene glycol hydrogel in the infarct region. Hearts were explanted, cryo-sectioned and the region with the injectate histologically analysed. Histological micrographs were used to reconstruct the dispersed hydrogel injectate. Cardiac magnetic resonance imaging data from a healthy rat were used to obtain an end-diastolic biventricular geometry which was subsequently adjusted and combined with the injectate model. The computational geometry of the injectate exhibited microscopic structural details found the in situ. The combination of injectate and cardiac geometry provides realistic geometries for multiscale computational studies of intra-myocardial injectate therapies for the rat model that has been widely used for MI research.
C1 [Sirry, Mazin S.; Davies, Neil H.; Kadner, Karen; Dubuis, Laura; Zilla, Peter; Franz, Thomas] Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, Fac Hlth Sci, ZA-7935 Observatory, South Africa.
   [Saleh, Muhammad G.; Meintjes, Ernesta M.; Spottiswoode, Bruce S.] Univ Cape Town, Dept Human Biol, MRC UCT Med Imaging Res Unit, ZA-7935 Observatory, South Africa.
   [Spottiswoode, Bruce S.] Univ Stellenbosch, Dept Radiol, ZA-7505 Tygerberg, South Africa.
   [Franz, Thomas] Univ Cape Town, Programme Enhancement Res Capac, Res Off, Mowbray, South Africa.
   [Franz, Thomas] Univ Cape Town, Ctr Res Computat & Appl Mech, ZA-7700 Rondebosch, South Africa.
   [Franz, Thomas] Ctr High Performance Comp, Johannesburg, South Africa.
RP Franz, T (reprint author), Univ Cape Town, Chris Barnard Div Cardiothorac Surg, Cardiovasc Res Unit, Fac Hlth Sci, Private Bag X3, ZA-7935 Observatory, South Africa.
EM thomas.franz@uct.ac.za
OI Franz, Thomas/0000-0002-1504-3842
FU National Research Foundation (NRF) of South Africa; South African
   Research Chairs Initiative of the Department of Science and Technology
   and National Research Foundation of South Africa; Medical Research
   Council of South Africa; NIH [R21AA017410]
FX This study was supported financially, in part, by the National Research
   Foundation (NRF) of South Africa, the South African Research Chairs
   Initiative of the Department of Science and Technology and National
   Research Foundation of South Africa, the Medical Research Council of
   South Africa, and NIH Grant No. R21AA017410. Any opinion, findings and
   conclusions or recommendations expressed in this publication are those
   of the authors and therefore the NRF does not accept any liability in
   regard thereto. MSS acknowledges the International Society of
   Biomechanics Matching Dissertation Grant.
CR AHA, 2008, HEART DIS STROK STAT
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Guccione JM, 2003, ANN THORAC SURG, V76, P1171, DOI 10.1016/S0003-4975(03)00731-8
   Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Katz A.M., 2009, HEART FAILURE PATHOP
   Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kortsmit J, 2013, COMPUT METHOD BIOMEC, V16, P1185, DOI 10.1080/10255842.2012.656611
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   OMENS JH, 1991, AM J PHYSIOL, V261, pH918
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Saleh MG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/504037
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
   World Health Organization, 2008, ATLAS HEART DIS STRO
NR 26
TC 6
Z9 6
U1 1
U2 35
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD FEB 17
PY 2015
VL 18
IS 3
BP 325
EP 331
DI 10.1080/10255842.2013.793765
PG 7
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA AR8GS
UT WOS:000343814400010
PM 23682845
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mohajernia, S
   Hejazi, S
   Eslami, A
   Saremi, M
AF Mohajernia, Sh.
   Hejazi, S.
   Eslami, A.
   Saremi, M.
TI Modified nanostructured hydroxyapatite coating to control the
   degradation of magnesium alloy AZ31 in simulated body fluid
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Corrosion; Hydroxyapatite; Hydrogen evolution; Biomaterial
ID BONE-LIKE HYDROXYAPATITE; IN-VITRO DEGRADATION; PULSE ELECTRODEPOSITION;
   STAINLESS-STEEL; DEFICIENT HYDROXYAPATITE; VIVO CORROSION; BEHAVIOR;
   TITANIUM; BIOACTIVITY; PH
AB This research covers a different microstructural and electrochemical investigation on hydroxyapatite (HAP) coatings deposited on AZ31 magnesium alloy. Microstructure characterization and functional group identification were performed using X-ray diffraction (XRD), Fourier transform infrared and scanning electron microscopy (SEM) techniques. The prepared samples were immersed in simulated body fluid to study the degradation behavior of AZ31 and the amount of hydrogen produced. Electrochemical techniques were employed to evaluate and compare the corrosion behavior of the nano-HAP (n-HAP) coated and uncoated samples. The changes in pH value during the corrosion process were also measured. Results suggest the noticeable capability of n-HAP coatings to stabilize the alkalization behavior and to improve the corrosion resistance of AZ31 alloy. Consequently, the hydrogen evolution process beneath the n-HAP coating decreased significantly. It was concluded that an n-HAP coated AZ31 alloy could be a good candidate as a type of biodegradable implant material for biomedical applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Mohajernia, Sh.; Hejazi, S.; Eslami, A.; Saremi, M.] Univ Tehran, Fac Engn, Mat & Met Engn Dept, Tehran 14395515, Iran.
RP Hejazi, S (reprint author), Univ Tehran, Fac Engn, Mat & Met Engn Dept, North Kargar St, Tehran 14395515, Iran.
EM hejazi.sina@alumni.ut.ac.ir
OI Hejazi, Seyedsina/0000-0003-1526-5629
FU University of Tehran [810790067]
FX The authors would like to recognize financial support from the
   University of Tehran (Grant No. 810790067) and provision of laboratory
   facilities during the period that this research was conducted.
CR Altun H, 2004, MATER DESIGN, V25, P637, DOI 10.1016/j.matdes.2004.02.002
   Atrens A, 2013, J MAGNES ALLOY, V1, P177, DOI 10.1016/j.jma.2013.09.003
   Ayati NS, 2011, MATER CHEM PHYS, V126, P873, DOI 10.1016/j.matchemphys.2010.12.023
   Bakhsheshi-Rad HR, 2014, T NONFERR METAL SOC, V24, P2516, DOI 10.1016/S1003-6326(14)63378-1
   Batory D, 2012, SURF COAT TECH, V206, P2110, DOI 10.1016/j.surfcoat.2011.09.036
   Conz MB, 2011, J APPL ORAL SCI, V19, P337, DOI 10.1590/S1678-77572011005000007
   Demnati I, 2012, SURF COAT TECH, V206, P2346, DOI 10.1016/j.surfcoat.2011.10.025
   Drevet R, 2012, ADV ENG MATER, V14, P377, DOI 10.1002/adem.201100331
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Frankel GS, 2013, CORROS SCI, V70, P104, DOI 10.1016/j.corsci.2013.01.017
   Geng F, 2009, J MATER SCI-MATER M, V20, P1149, DOI 10.1007/s10856-008-3669-x
   Gopi D, 2012, SURF COAT TECH, V206, P2859, DOI 10.1016/j.surfcoat.2011.12.011
   Hu JL, 2014, SENSOR ACTUAT B-CHEM, V196, P194, DOI 10.1016/j.snb.2014.01.119
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jin S, 2007, ADV ENG MATER, V9, P75, DOI 10.1002/adem.200600199
   King AD, 2014, ELECTROCHIM ACTA, V121, P394, DOI 10.1016/j.electacta.2013.12.124
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Leeflang MA, 2011, MATER SCI ENG B-ADV, V176, P1741, DOI 10.1016/j.mseb.2011.08.002
   Mansur MR, 2013, SURF COAT TECH, V232, P482, DOI 10.1016/j.surfcoat.2013.06.006
   Mohajernia S, 2013, J IRAN CHEM SOC, V10, P831, DOI 10.1007/s13738-012-0218-9
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   NAGASE M, 1993, FEBS LETT, V325, P247, DOI 10.1016/0014-5793(93)81082-B
   Orazem ME, 2008, ELECTROCHEMICAL IMPE
   Pardo A., 2010, INT J CORROS, V2010
   Park JH, 2006, MATER LETT, V60, P2573, DOI 10.1016/j.matlet.2005.07.091
   PERRAULT GG, 1974, J ELECTROANAL CHEM, V51, P107, DOI 10.1016/S0022-0728(74)80298-6
   Prawel DA, 2013, MATER LETT, V97, P81, DOI 10.1016/j.matlet.2013.01.091
   Razavi M, 2010, MAT SCI ENG A-STRUCT, V527, P6938, DOI 10.1016/j.msea.2010.07.063
   Rojaee R, 2014, CERAM INT, V40, P15149, DOI 10.1016/j.ceramint.2014.06.129
   Rojaee R, 2013, MAT SCI ENG C-MATER, V33, P3817, DOI 10.1016/j.msec.2013.05.014
   Saremi M, 2014, MATER LETT, V129, P111, DOI 10.1016/j.matlet.2014.05.050
   Seydlova M, 2008, Prague Med Rep, V109, P142
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P90, DOI 10.1007/BF00120414
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Singh G, 2013, SURF COAT TECH, V228, P242, DOI 10.1016/j.surfcoat.2013.04.036
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2011, WOODHEAD PUBL MATER, P1, DOI 10.1533/9780857091413
   Song L, 2012, SURF COAT TECH, V206, P2986, DOI 10.1016/j.surfcoat.2011.12.034
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Surmenev RA, 2012, SURF COAT TECH, V206, P2035, DOI 10.1016/j.surfcoat.2011.11.002
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang J, 2009, ACTA BIOMATER, V5, P1798, DOI 10.1016/j.actbio.2009.01.005
   Wen CL, 2009, APPL SURF SCI, V255, P6433, DOI 10.1016/j.apsusc.2008.09.078
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yang JX, 2010, SURF COAT TECH, V205, pS182, DOI 10.1016/j.surfcoat.2010.07.045
   Yang Y, 2013, SURF COAT TECH, V216, P282, DOI 10.1016/j.surfcoat.2012.11.059
NR 56
TC 12
Z9 12
U1 1
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 15
PY 2015
VL 263
BP 54
EP 60
DI 10.1016/j.surfcoat.2014.12.059
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA CB3FC
UT WOS:000349512600008
DA 2018-10-20
ER

PT J
AU Naveen, SV
   Tan, IKP
   Goh, YS
   Raghavendran, HRB
   Murali, MR
   Kamarul, T
AF Naveen, Sangeetha Vasudevaraj
   Tan, Irene Kit Ping
   Goh, Yuh Shan
   Raghavendran, Hanumantha Rao Balaji
   Murali, Malliga Raman
   Kamarul, Tunku
TI Unmodified medium chain length polyhydroxyalkanoate (uMCL-PHA) as a thin
   film for tissue engineering application - characterization and in vitro
   biocompatibility
SO MATERIALS LETTERS
LA English
DT Article
DE Natural polymer; Polyhydroxyalkanoate; Low crystalline; Elastic
   properties; Thin films; Biomaterial
AB In the present study, we developed an unmodified/raw Medium chain length -PHA (MCL-PHA) polyhydroxyalkanoate (PHA), natural microbial polyester by using cost-effective saponified palm kernel oil (SPKO) technique. The functional groups, elemental composition, phase purity, water contact angle, and in vitro human-derived mesenchymal stromal cell attachment were examined. FTIR confirmed the presence of functional groups corresponding to alkyl halide, alkyne, hydroxyl group, and alkane groups, while XRD and EDX results revealed its phase purity and presence of elements such as carbon and oxygen respectively. SEM and confocal microscope analyses revealed that the bin-material supports cell attachment and this was further confirmed through cell viability assay. In conclusion, the characterization and compatibility studies revealed that this novel scaffold could be a potential candidate for possible tissue engineering applications. (C) 2014 Published by Elsevier B.V.
C1 [Naveen, Sangeetha Vasudevaraj; Raghavendran, Hanumantha Rao Balaji; Murali, Malliga Raman; Kamarul, Tunku] Univ Malaya, Tissue Engn Grp, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Dept Orthopaed Surg,Fac Med, Kuala Lumpur 50603, Malaysia.
   [Tan, Irene Kit Ping; Goh, Yuh Shan] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.
RP Kamarul, T (reprint author), Univ Malaya, Tissue Engn Grp, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Dept Orthopaed Surg,Fac Med, Kuala Lumpur 50603, Malaysia.
EM sangeethanaveen@um.edu.my; tkzrea@um.edu.my
RI Tan, Irene/B-8661-2010; Malliga Raman, Murali/A-6987-2012; balaji
   raghavendran, hanumantha rao/B-8507-2012; Naveen, Sangeetha/F-4035-2011;
   Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Tan, Irene/0000-0001-9601-5810; Malliga Raman,
   Murali/0000-0002-5696-4541; Naveen, Sangeetha/0000-0003-3180-6237; Tunku
   Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313
FU HIR-MoE Grant [UM.C/625/1/HIR/ MOHE/MED/04, E000003-20001]; 
   [FP025/2010B]
FX This research was supported by HIR-MoE Grant (Reference number -
   UM.C/625/1/HIR/ MOHE/MED/04, Account number - E000003-20001) and
   FP025/2010B.
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   DO YK, 2007, J MICROBIOL, V45, P87
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Krishnamurithy G, 2011, J BIOMED MATER RES A, V99A, P500, DOI 10.1002/jbm.a.33184
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Sabine N, 2008, BIOMATERIALS, V29, P302
   Tan IKP, 1997, APPL MICROBIOL BIOT, V47, P207, DOI 10.1007/s002530050914
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Wang ZX, 2003, J BIOSCI BIOENG, V95, P541, DOI 10.1016/S1389-1723(03)80059-2
   Wenbin Guo, 2013, Microbiological Research, V168, P231
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
NR 13
TC 5
Z9 6
U1 1
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2015
VL 141
BP 55
EP 58
DI 10.1016/j.matlet.2014.10.144
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AZ5LU
UT WOS:000348263300013
DA 2018-10-20
ER

PT J
AU Reichel, CA
   Hessenauer, MET
   Pflieger, K
   Rehberg, M
   Kanse, SM
   Zahler, S
   Krombach, F
   Berghaus, A
   Strieth, S
AF Reichel, Christoph A.
   Hessenauer, Maximilian E. T.
   Pflieger, Kerstin
   Rehberg, Markus
   Kanse, Sandip M.
   Zahler, Stefan
   Krombach, Fritz
   Berghaus, Alexander
   Strieth, Sebastian
TI Components of the Plasminogen Activation System Promote Engraftment of
   Porous Polyethylene Biomaterial via Common and Distinct Effects
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELL PROLIFERATION; ISCHEMIA-REPERFUSION INJURY;
   INFLAMMATORY RESPONSES; INHIBITOR-1 PROMOTES; UROKINASE RECEPTOR;
   TURKISH DELIGHT; HOST TISSUE; IMPLANTS; ANGIOGENESIS; RECONSTRUCTION
AB Rapid fibrovascularization is a prerequisite for successful biomaterial engraftment. In addition to their well-known roles in fibrinolysis, urokinase-type plasminogen activator (uPA) and tissue plasminogen activator (tPA) or their inhibitor plasminogen activator inhibitor-1 (PAI-1) have recently been implicated as individual mediators in non-fibrinolytic processes, including cell adhesion, migration, and proliferation. Since these events are critical for fibrovascularization of biomaterial, we hypothesized that the components of the plasminogen activation system contribute to biomaterial engraftment. Employing in vivo and ex vivo microscopy techniques, vessel and collagen network formation within porous polyethylene (PPE) implants engrafted into dorsal skinfold chambers were found to be significantly impaired in uPA-, tPA-, or PAI-1-deficient mice. Consequently, the force required for mechanical disintegration of the implants out of the host tissue was significantly lower in the mutant mice than in wild-type controls. Conversely, surface coating with recombinant uPA, tPA, non-catalytic uPA, or PAI-1, but not with non-catalytic tPA, accelerated implant vascularization in wild-type mice. Thus, uPA, tPA, and PAI-1 contribute to the fibrovascularization of PPE implants through common and distinct effects. As clinical perspective, surface coating with recombinant uPA, tPA, or PAI-1 might provide a novel strategy for accelerating the vascularization of this biomaterial.
C1 [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Berghaus, Alexander] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.
   [Reichel, Christoph A.; Hessenauer, Maximilian E. T.; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.
   [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany.
   [Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway.
   [Strieth, Sebastian] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-55122 Mainz, Germany.
RP Reichel, CA (reprint author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.
EM christoph.reichel@med.uni-muenchen.de
OI Zahler, Stefan/0000-0002-5140-7287; Kanse, Sandip/0000-0003-0782-9957
FU Forderprogramm Forschung und Lehre (FoFoLe) der Medizinischen Fakultat
   der Ludwig-Maximilians-Universitat Manchen
FX This study was supported by Forderprogramm Forschung und Lehre (FoFoLe)
   der Medizinischen Fakultat der Ludwig-Maximilians-Universitat Manchen
   (to CAR and AB). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562
   Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669
   Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243
   Brodsky S, 2001, AM J PHYSIOL-HEART C, V281, pH1784
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0
   CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892
   Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481
   Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002
   Deindl E, 2003, FASEB J, V17, P1174, DOI 10.1096/fj.02-0800fje
   Del Rosso M, 2011, CURR PHARM DESIGN, V17, P1924
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.TEA.2011.0340, 10.1089/ten.tea.2011.0340]
   Erol OO, 2000, PLAST RECONSTR SURG, V105, P2229, DOI 10.1097/00006534-200005000-00051
   Gosau M, 2006, ORAL MAXILLOFAC SURG, V10, P178, DOI 10.1007/s10006-006-0688-y
   Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269
   Isogai C, 2001, CANCER RES, V61, P5587
   Kim Nam Ju, 2006, Korean J Ophthalmol, V20, P143
   Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104
   Laschke MW, 2012, EUR CELLS MATER, V24, P266, DOI 10.22203/eCM.v024a19
   Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lau CL, 2009, J THORAC CARDIOV SUR, V137, P1241, DOI 10.1016/j.jtcvs.2008.12.029
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   Nicaeus TE, 1996, OPHTHALMIC PLAST REC, V12, P235, DOI 10.1097/00002341-199612000-00004
   Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4
   Park Won Chan, 2005, Korean J Ophthalmol, V19, P1
   PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535
   PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I
   Potter JK, 2012, ORAL MAXIL SURG CLIN, V24, P609, DOI 10.1016/j.coms.2012.07.002
   Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210
   Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237
   Reichel CA, 2012, TRENDS CARDIOVAS MED, V22, P192, DOI 10.1016/j.tcm.2012.07.019
   Reichel CA, 2011, CIRCULATION, V124, P1849, DOI 10.1161/CIRCULATIONAHA.110.017012
   Richardson S, 2011, INT J ORAL MAX SURG, V40, P979, DOI 10.1016/j.ijom.2011.03.013
   Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089
   Schumann P, 2013, J BIOMED MAT RES A
   Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150
   Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225
   Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821
   Soparkar CNS, 2000, OPHTHALMIC PLAST REC, V16, P337, DOI 10.1097/00002341-200009000-00006
   Stefansson Steingrimur, 2003, Sci STKE, V2003, ppe24, DOI 10.1126/stke.2003.189.pe24
   Stelter K, 2007, RHINOLOGY, V45, P325
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056
   Thakker MM, 2004, OPHTHAL PLAST RECONS, V20, P368, DOI 10.1097/01.IOP.0000134247.29702.90
   Uhl B, 2014, ARTERIOSCL THROM VAS, V34, P1495, DOI 10.1161/ATVBAHA.114.303721
   van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17
   Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
   Yip HK, 2013, INT J CARDIOL, V168, P226, DOI 10.1016/j.ijcard.2012.09.090
   Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003
NR 57
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2015
VL 10
IS 2
AR e0116883
DI 10.1371/journal.pone.0116883
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB2GK
UT WOS:000349444900075
PM 25658820
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Trentin, DS
   Silva, DB
   Frasson, AP
   Rzhepishevska, O
   da Silva, MV
   Pulcini, ED
   James, G
   Soares, GV
   Tasca, T
   Ramstedt, M
   Giordani, RB
   Lopes, NP
   Macedo, AJ
AF Trentin, Danielle S.
   Silva, Denise B.
   Frasson, Amanda P.
   Rzhepishevska, Olena
   da Silva, Marcia V.
   Pulcini, Elinor de L.
   James, Garth
   Soares, Gabriel V.
   Tasca, Tiana
   Ramstedt, Madeleine
   Giordani, Raquel B.
   Lopes, Norberto P.
   Macedo, Alexandre J.
TI Natural Green Coating Inhibits Adhesion of Clinically Important Bacteria
SO Scientific Reports
LA English
DT Article
ID CRANBERRY PROANTHOCYANIDINS; TISSUE INTEGRATION; SURFACE-PROPERTIES;
   A-TYPE; BIOFILM; BIOMATERIALS; INFECTIONS; CELLS; STRATEGIES; SILICONE
AB Despite many advances, biomaterial-associated infections continue to be a major clinical problem. In order to minimize bacterial adhesion, material surface modifications are currently being investigated and natural products possess large potential for the design of innovative surface coatings. We report the bioguided phytochemical investigation of Pityrocarpa moniliformis and the characterization of tannins by mass spectrometry. It was demonstrated that B-type linked proanthocyanidins-coated surfaces, here termed Green coatings, reduced Gram-positive bacterial adhesion and supported mammalian cell spreading. The proposed mechanism of bacterial attachment inhibition is based on electrostatic repulsion, high hydrophilicity and the steric hindrance provided by the coating that blocks bacterium-substratum interactions. This work shows the applicability of a prototype Green-coated surface that aims to promote necessary mammalian tissue compatibility, while reducing bacterial colonization.
C1 [Trentin, Danielle S.; Frasson, Amanda P.; Tasca, Tiana; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   [Trentin, Danielle S.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Silva, Denise B.; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Nucleo Pesquisas Prod Nat & Sintet NPPNS, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Rzhepishevska, Olena; Ramstedt, Madeleine] Umea Univ, Dept Chem, SE-90187 Umea, Sweden.
   [da Silva, Marcia V.] Univ Fed Pernambuco, Ctr Ciencias Biol, BR-50670901 Recife, PE, Brazil.
   [da Silva, Marcia V.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [James, Garth] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.
   [Soares, Gabriel V.] Univ Fed Rio Grande do Sul, Inst Fis, BR-91509900 Porto Alegre, RS, Brazil.
   [Giordani, Raquel B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farm, BR-59010180 Natal, RN, Brazil.
RP Lopes, NP (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Nucleo Pesquisas Prod Nat & Sintet NPPNS, BR-14040903 Ribeirao Preto, SP, Brazil.
EM npelopes@fcfrp.usp.br; alexandre.macedo@ufrgs.br
RI Vieira Soares, Gabriel/E-5065-2010; Lopes, Norberto/C-7148-2012
OI Vieira Soares, Gabriel/0000-0002-6875-0145; Lopes,
   Norberto/0000-0002-8159-3658; Trentin, Danielle/0000-0002-8622-1052; da
   Silva, Denise/0000-0003-0872-2756; Ramstedt,
   Madeleine/0000-0003-2646-8501
FU FAPERGS [1008844]; FAPESP [2009/54098-6, 2012/18031-7, 2014/50265-3];
   MCTI/CNPq [576774/2008-1]; INCT-if, NANOBIOTEC-Brazil from CAPES
   [703/2009]; STINT [IG2011-2048]
FX We acknowledge to FAPERGS (1008844), FAPESP (2009/54098-6; 2012/18031-7,
   2014/50265-3), MCTI/CNPq (576774/2008-1), INCT-if, NANOBIOTEC-Brazil
   from CAPES (703/2009) and STINT (IG2011-2048) for financial support. We
   thankfully acknowledge the CME/UFRGS for assistance in confocal and
   electron microscopies and Steve Fisher for support on LIVE/DEAD confocal
   microscopy.
CR Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chan M, 2013, COLLOID SURFACE B, V110, P275, DOI 10.1016/j.colsurfb.2013.03.047
   Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   desla Fuente-Nunez C., 2013, CURR OPIN MICROBIOL, V16, P580
   Diaz JF, 2000, J BIOL CHEM, V275, P26265, DOI 10.1074/jbc.M003120200
   Douthwaite S, 2010, P NATL ACAD SCI USA, V107, P17065, DOI 10.1073/pnas.1012547107
   Eydelnant IA, 2008, LANGMUIR, V24, P10273, DOI 10.1021/la801525d
   Feliciano RP, 2012, FOOD CHEM, V135, P1485, DOI 10.1016/j.foodchem.2012.05.102
   Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gu H, 2014, FRONT CHEM SCI ENG, V8, P20, DOI 10.1007/s11705-014-1412-3
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P1532, DOI 10.1128/AEM.02201-10
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008
   Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Shah SR, 2013, MATER TODAY, V16, P177, DOI 10.1016/j.mattod.2013.05.003
   Shlaes DM, 2003, CURR OPIN PHARMACOL, V3, P470, DOI 10.1016/j.coph.2003.04.003
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Trentin D. S., 2013, PLOS ONE, V8, P1
   Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030
   Trentin DS, 2014, SURF COAT TECH, V245, P84, DOI 10.1016/j.surfcoat.2014.02.046
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Wang, 2012, ARCH INTERN MED, V172, P988
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
NR 42
TC 19
Z9 19
U1 0
U2 44
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 6
PY 2015
VL 5
AR 8287
DI 10.1038/srep08287
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA4VK
UT WOS:000348903900002
PM 25655943
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jin, L
   Guo, W
   Xue, PH
   Gao, HN
   Zhao, M
   Zheng, C
   Zhang, YL
   Han, D
AF Jin, Lin
   Guo, Wen
   Xue, Peihong
   Gao, Hainan
   Zhao, Ming
   Zheng, Chen
   Zhang, Yali
   Han, Dong
TI Quantitative assay for the colonization ability of heterogeneous
   bacteria on controlled nanopillar structures
SO NANOTECHNOLOGY
LA English
DT Article
DE nanotopography; bacterial colonization; roughness; morphology
ID BIOFILM FORMATION; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA;
   STAPHYLOCOCCUS-AUREUS; COLLOIDAL LITHOGRAPHY; SURFACE-ROUGHNESS; POLYMER
   SURFACES; GLASS SURFACES; SOLID-SURFACES; CELL-SHAPE
AB The colonization ability of bacteria on biomaterial surfaces is influenced by the morphology of the bacteria and the nanotopography of the biomaterial. However, interactions between the bacterial morphology and nanotopography of biomaterials have not yet been completely elucidated. In this article, we quantitatively characterized the bacterial morphology to illuminate the integrated effects of polyethylene terephthalate (PET) nanopillar arrays on the colonization of bacteria cells with different shapes. Our results demonstrated that the interaction between interpillar spacing and the diameter of the bacterial cells impacted the number of bacterial cells that adhered to different PET substrates. The interpillar spacing of nanopillar arrays promotes bacterial adhesion in a definite range (<50 nm). However, further increasing the interpillar spacing inhibited the adhesion of bacteria to the nanopillar arrays. Moreover, the interpillar spacing also influenced the morphologies of adherent bacterial cells on the PET nanopillar arrays, which consequently facilitated bacterial adhesion to the nanopillar arrays. Our findings enhance the understanding of interactions between controlled nanotopography and bacterial colonization and provide an appropriate parameter for the design of antibacterial materials with nanotopography.
C1 [Jin, Lin; Guo, Wen; Zhang, Yali] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.
   [Jin, Lin; Zheng, Chen; Han, Dong] Natl Ctr Nanosci & Technol, Beijing, Peoples R China.
   [Xue, Peihong; Gao, Hainan] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China.
   [Zhao, Ming] Southern Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.
RP Jin, L (reprint author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.
EM zyl41531@163.com; dhan@nanoctr.cn
FU National Basic Research Program of China [2012CB933800]
FX This work was support by National Basic Research Program of China
   (2012CB933800).
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x
   Braga PC, 1997, J ANTIMICROB CHEMOTH, V39, P79, DOI 10.1093/jac/39.1.79
   Callow M. E., 2002, BIOFOULING, V18, P229, DOI DOI 10.1080/08927010290014908
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chen R, 2012, COLLOID SURFACE B, V96, P62, DOI 10.1016/j.colsurfb.2012.03.019
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Diaz C, 2011, COLLOID SURFACE B, V82, P536, DOI 10.1016/j.colsurfb.2010.10.013
   Diaz C, 2007, MAT RES, V10, P11
   Diaz C, 2009, ACS APPL MATER INTER, V1, P136, DOI 10.1021/am8000677
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Hou SY, 2011, LANGMUIR, V27, P2686, DOI 10.1021/la1046194
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Ivanova EP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00165
   Jiantao F, 2014, NANO RES, V7, P432
   Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Li YF, 2010, LANGMUIR, V26, P9842, DOI 10.1021/la100183y
   Loo CY, 2012, ACTA BIOMATER, V8, P1881, DOI 10.1016/j.actbio.2012.01.015
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Madara J L, 2011, PHYSIOL
   Mitik-Dineva N, 2010, BIOFOULING, V26, P461, DOI 10.1080/08927011003753399
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   MURPHY JG, 1992, CIRCULATION, V86, P1596, DOI 10.1161/01.CIR.86.5.1596
   Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062
   Neufeld KA, 2009, J PSYCHIATR NEUROSCI, V34, P230
   Nie M, 2009, 2009 4TH IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS, VOLS 1 AND 2, P1017, DOI 10.1109/NEMS.2009.5068746
   Paynter RW, 2000, SURF INTERFACE ANAL, V29, P56, DOI 10.1002/(SICI)1096-9918(200001)29:1<56::AID-SIA693>3.0.CO;2-2
   Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]
   Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m
   Saito N, 2002, HELICOBACTER, V7, P112, DOI 10.1046/j.1083-4389.2002.00070.x
   Scardino AJ, 2006, BIOFOULING, V22, P55, DOI 10.1080/08927010500506094
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Verran J, 2001, BIOFOULING, V17, P59, DOI 10.1080/08927010109378465
   Weiser JN, 2013, CURR OPIN MICROBIOL, V16, P59, DOI 10.1016/j.mib.2013.01.001
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Yang SM, 2006, SMALL, V2, P458, DOI 10.1002/smll.200500390
   Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06
NR 53
TC 5
Z9 5
U1 3
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD FEB 6
PY 2015
VL 26
IS 5
AR 055702
DI 10.1088/0957-4484/26/5/055702
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AZ0RJ
UT WOS:000347952000023
PM 25581320
DA 2018-10-20
ER

PT J
AU Toumia, Y
   Orlanducci, S
   Basoli, F
   Licoccia, S
   Paradossi, G
AF Toumia, Yosra
   Orlanducci, Silvia
   Basoli, Francesco
   Licoccia, Silvia
   Paradossi, Gaio
TI "Soft" Confinement of Graphene in Hydrogel Matrixes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID VOLUME PHASE-TRANSITION; EXFOLIATED GRAPHITE OXIDE; DRUG-DELIVERY;
   FUNDAMENTAL PROPERTIES; AQUEOUS DISPERSIONS; CONTROLLED-RELEASE;
   BLOCK-COPOLYMERS; TEMPERATURE; REDUCTION; SHEETS
AB Graphene plays as protagonist among the newly discovered carbon nanomaterials on the laboratory bench. Confinement of graphene, combined with enhanced exchange properties within aqueous environment, is key for the development of biosensors, biomedicine devices, and water remediation applications. Such confinement is possible using hydrogels as soft matrixes. Many entrapment methods focused on the modification of the graphene structure. In this paper, however, we address a confinement method that leaves unchanged the graphene structure, although intimately participating in the buildup of a network of polyvinyl alcohol (PVA) chains. PVA is a polymer known as biomaterial for its hydrophilicity, biocompatibility, and chemical versatility. A robust hybrid PVA - graphene construct was obtained starting from a surfactant-assisted sonication of an aqueous dispersion of graphite. Stable graphene sheets suspension was photopolymerized in a methacryloyl-grafted PVA, using the vinyl moiety present on the surfactant scaffold. This method can allow the incorporation in the polymer network of oligomers of N-(isopropylacrylammide), p(NiPAAm). These chains display in aqueous solution a low critical solution temperature, LCST, around 33 degrees C and trigger a volume phase transition when incorporated in a hydrophilic network around the physiological temperature. Raman analysis was used to characterize the state of hydrogel embedded graphene single sheets. Evidence for an intimate interaction of graphene sheets and polymer matrix was collected. Release of the anticancer drug doxorubicin showed the active role of the graphene/PVA/p(NiPAAm) construct in the drug delivery.
C1 [Toumia, Yosra; Orlanducci, Silvia; Basoli, Francesco; Licoccia, Silvia; Paradossi, Gaio] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; Basoli,
   Francesco/0000-0003-0549-0048
CR Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Cavalieri F, 2004, BIOMACROMOLECULES, V5, P2439, DOI 10.1021/bm049654g
   Constantin M, 2011, EXPRESS POLYM LETT, V5, P839, DOI 10.3144/expresspolymlett.2011.83
   Cui X, 2011, NANOSCALE, V3, P2118, DOI 10.1039/c1nr10127g
   Das TK, 2012, J RES NANOBIOTECHNOL, V1
   Delbecq F, 2013, POLYMER, V54, P1064, DOI 10.1016/j.polymer.2012.11.052
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P9336, DOI 10.1002/anie.201003024
   El-Toony M. M, 2011, NAT SCI, V9, P160
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Frank O, 2011, ACS NANO, V5, P2231, DOI 10.1021/nn103493g
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Ghugare SV, 2011, MACROMOLECULES, V44, P4470, DOI 10.1021/ma200979h
   Ghugare SV, 2010, J PHYS CHEM B, V114, P10285, DOI 10.1021/jp100962p
   Ghugare SV, 2009, BIOMACROMOLECULES, V10, P1589, DOI 10.1021/bm900185u
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Green AA, 2009, NANO LETT, V9, P4031, DOI 10.1021/nl902200b
   Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]
   Guardia L, 2011, CARBON, V49, P1653, DOI 10.1016/j.carbon.2010.12.049
   Guo J, 2011, COMPOS PART B-ENG, V42, P2130, DOI 10.1016/j.compositesb.2011.05.008
   Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215
   Jablan M, 2013, P IEEE, V101, P1689, DOI 10.1109/JPROC.2013.2260115
   Jastrzebska AM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1320-8
   Koshino M, 2013, NEW J PHYS, V15
   Layek RK, 2010, POLYMER, V51, P5846, DOI 10.1016/j.polymer.2010.09.067
   Lee DW, 2011, CHEM COMMUN, V47, P8259, DOI 10.1039/c1cc12868j
   Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Liu JH, 2011, MACROMOLECULES, V44, P7682, DOI 10.1021/ma201620w
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lotya M, 2009, J AM CHEM SOC, V131, P3611, DOI 10.1021/ja807449u
   Matassa R, 2014, J APPL CRYSTALLOGR, V47, P222, DOI 10.1107/S1600576713029488
   Notley SM, 2012, LANGMUIR, V28, P14110, DOI 10.1021/la302750e
   Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201
   Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Papageorgiou G, 2010, POLYM INT, V59, P1630, DOI 10.1002/pi.2896
   Park MH, 2012, SURF INTERFACE ANAL, V44, P1538, DOI 10.1002/sia.4995
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Potts JR, 2011, POLYMER, V52, P5, DOI 10.1016/j.polymer.2010.11.042
   Pu NW, 2012, J TAIWAN INST CHEM E, V43, P140, DOI 10.1016/j.jtice.2011.06.012
   Rao R, 2011, ACS NANO, V5, P1594, DOI 10.1021/nn1031017
   Ritter KA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015704
   Salavagione HJ, 2009, MACROMOLECULES, V42, P6331, DOI 10.1021/ma900845w
   Seo JWT, 2011, J PHYS CHEM LETT, V2, P1004, DOI 10.1021/jz2003556
   Sham AYW, 2013, SOFT MATTER, V9, P6645, DOI 10.1039/c3sm00092c
   Shen JF, 2012, COMPOS PART A-APPL S, V43, P1476, DOI 10.1016/j.compositesa.2012.04.006
   SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1
   Smith RJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125008
   Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Tang ZH, 2012, POLYMER, V53, P673, DOI 10.1016/j.polymer.2011.11.056
   Topel O, 2013, J MOL LIQ, V177, P40, DOI 10.1016/j.molliq.2012.10.013
   Tyagi M.G., 2013, WORLD J PHARM PHARM, V3, P339
   USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Wang CY, 2013, NANOMED-NANOTECHNOL, V9, P903, DOI 10.1016/j.nano.2013.01.003
   Wang PJ, 2013, CHEM PHYS LETT, V556, P146, DOI 10.1016/j.cplett.2012.11.018
   Wenceslau AC, 2012, MAT SCI ENG C-MATER, V32, P1259, DOI 10.1016/j.msec.2012.04.001
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Zhang M, 2010, SMALL, V6, P1100, DOI 10.1002/smll.200901978
   Zheng W., 2013, NEW PROGR GRAPHENE R, P207
NR 65
TC 12
Z9 12
U1 3
U2 79
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD FEB 5
PY 2015
VL 119
IS 5
BP 2051
EP 2061
DI 10.1021/jp510654h
PG 11
WC Chemistry, Physical
SC Chemistry
GA CA7ZT
UT WOS:000349137000028
PM 25574863
DA 2018-10-20
ER

PT J
AU Kamath, AF
   Lewallen, DG
   Hanssen, AD
AF Kamath, Atul F.
   Lewallen, David G.
   Hanssen, Arlen D.
TI Porous Tantalum Metaphyseal Cones for Severe Tibial Bone Loss in
   Revision Knee Arthroplasty A Five to Nine-Year Follow-up
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID TRABECULAR METAL CONES; STRUCTURAL ALLOGRAFT; UNCONTAINED DEFECTS; HUMAN
   OSTEOBLASTS; HINGE PROSTHESIS; REPLACEMENT; RECONSTRUCTION; BIOMATERIAL;
   DEFICIENCY; OSTEOLYSIS
AB Background: Severe metaphyseal and meta-diaphyseal bone loss poses important challenges in revision total knee arthroplasty. The best strategy for addressing massive tibial bone loss has not been determined. The purpose of this study was to assess the intermediate-term clinical and radiographic results of porous tibial cone implantation.
   Methods: Sixty-six porous tantalum tibial cones (sixty-three patients) were reviewed at a mean follow-up time of seventy months (range, sixty to 106 months). According to the Anderson Orthopaedic Research Institute bone defect classification, twenty-four knees had a Type-3 defect, twenty-five knees had a Type-2B defect, and seventeen knees had a Type-2A defect.
   Results: The mean age at the time of the index revision was sixty-seven years (range, forty-one to eighty-three years), and 57% of patients were female. The mean American Society of Anesthesiologists Physical Status was 2.4 (range, 2 to 3), and the mean body mass index was 33 kg/m(2) (range, 25 to 53 kg/m(2)). Fifteen patients (24%) were on immunosuppressant medications, and eight patients (13%) were current smokers. The patients underwent a mean number of 3.4 prior knee surgical procedures (range, one to twenty procedures), and 49% of patients (thirty-one patients) had a history of periprosthetic infection. The mean Knee Society Scores improved significantly from 55 points preoperatively (range, 4 to 97 points) to 80 points (range, 28 to 100 points) at the time of the latest follow-up (p < 0.0001). One patient had progressive radiolucencies about the tibial stem and cone on radiographs. One patient had complete radiolucencies about the tibial cone, concerning for fibrous ingrowth. Three other cones were revised: one for infection, one for aseptic loosening, and one for periprosthetic fracture. Revision-free survival of the tibial cone component was >95% at the time of the latest follow-up.
   Conclusions: Porous tantalum tibial cones offer a promising management option for severe tibial bone loss. At the intermediate-term follow-up (five to nine years), porous tantalum tibial cones had durable clinical results and radiographic fixation. The biologic ingrowth of these implants offers the potential for successful long-term structural support in complex knee reconstruction.
C1 [Kamath, Atul F.; Lewallen, David G.; Hanssen, Arlen D.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Kamath, AF (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW,Gonda 14, Rochester, MN 55905 USA.
EM hanssen.arlen@mayo.edu
CR Alexander GE, 2013, J ARTHROPLASTY, V28, P604, DOI 10.1016/j.arth.2012.08.006
   ASA, 2014, ASA PHYS STAT CLASS
   Backstein D, 2006, CLIN ORTHOP RELAT R, P104, DOI 10.1097/01.blo.0000214426.52206.2c
   Bauman RD, 2009, CLIN ORTHOP RELAT R, V467, P818, DOI 10.1007/s11999-008-0679-4
   Benjamin J, 2001, CLIN ORTHOP RELAT R, P62
   Berend KR, 2010, ORTHOPEDICS, V33, P8, DOI [10.3928/01477447-20100722-37, 10.3928/01477447-20100722-61, 10.3928/01477447-20100722-38]
   Berry Daniel J, 2004, Instr Course Lect, V53, P261
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Breer S, 2012, INT ORTHOP, V36, P2269, DOI 10.1007/s00264-012-1640-4
   Bush JL, 2006, CLIN ORTHOP RELAT R, P186, DOI 10.1097/01.blo.0000229360.04620.93
   Clatworthy MG, 2001, J BONE JOINT SURG AM, V83A, P404, DOI 10.2106/00004623-200103000-00013
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Dennis DA, 2002, J ARTHROPLASTY, V17, P90, DOI 10.1054/arth.2002.32456
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Engh G A, 1997, Instr Course Lect, V46, P227
   Engh GA, 2004, ORTHOPEDICS, V27, P999
   Engh GA, 1997, REVISION TOTAL KNEE, P63
   Engh GA, 1999, INSTR COURSE LECT, V48, P167
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   EWALD FC, 1989, CLIN ORTHOP RELAT R, P9
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   Hanzlik JA, 2013, J ARTHROPLASTY, V28, P922, DOI 10.1016/j.arth.2013.01.035
   HARRIS AI, 1995, J BONE JOINT SURG AM, V77A, P373, DOI 10.2106/00004623-199503000-00007
   Harrysson OLA, 2004, CLIN ORTHOP RELAT R, P162, DOI 10.1097/01.blo.0000127115.05754.ce
   Hockman DE, 2005, J ARTHROPLASTY, V20, P35, DOI 10.1016/j.arth.2004.09.059
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P478, DOI 10.2106/JBJS.l.01322
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Jensen CL, 2012, J ARTHROPLASTY, V27, P1820, DOI 10.1016/j.arth.2012.04.036
   Jensen CL, 2012, INT ORTHOP, V36, P1857, DOI 10.1007/s00264-012-1601-y
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   Jones RE, 2001, J ARTHROPLASTY, V16, P279, DOI 10.1054/arth.2001.21498
   Kuchinad RA, 2011, ADV ORTHOP, V2011
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Lonner JH, 2002, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000036534.46246.4b
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meneghini RM, 2009, J BONE JOINT SURG AM, V91A, P131, DOI 10.2106/JBJS.H.01061
   MNAYMNEH W, 1990, CLIN ORTHOP RELAT R, P144
   Mow CS, 1996, J ARTHROPLASTY, V11, P235, DOI 10.1016/S0883-5403(96)80072-6
   MURRAY PB, 1994, CLIN ORTHOP RELAT R, P116
   Nadaud MC, 2004, J ARTHROPLASTY, V19, P110, DOI 10.1016/j.arth.2003.08.005
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Parks NL, 1997, CLIN ORTHOP RELAT R, P17
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Peters CL, 2005, J ARTHROPLASTY, V20, P302, DOI 10.1016/j.arth.2004.08.010
   Rao BM, 2013, BONE JOINT J, V95B, P1069, DOI 10.1302/0301-620X.95B8.29194
   Richards CJ, 2011, J ARTHROPLASTY, V26, P1299, DOI 10.1016/j.arth.2010.12.003
   Ries M D, 1996, Am J Knee Surg, V9, P51
   Ritter MA, 2004, J ARTHROPLASTY, V19, P587, DOI 10.1016/j.arth.2003.11.009
   Rorabeck CH, 1998, ORTHOP CLIN N AM, V29, P361, DOI 10.1016/S0030-5898(05)70335-7
   Schildhauer TA, 2009, J BIOMED MATER RES A, V88A, P332, DOI 10.1002/jbm.a.31850
   Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028
   Shen C, 2014, J ARTHROPLASTY, V29, P127, DOI [10.1016/j.arth.2013.09.048, 10.1016/j.arth.2013.04.042]
   Springer BD, 2001, CLIN ORTHOP RELAT R, P283
   STOCKLEY I, 1992, J BONE JOINT SURG BR, V74, P393
   Suarez-Suarez M A, 2002, Acta Orthop Belg, V68, P163
   Toms AD, 2004, J BONE JOINT SURG AM, V86A, P2050, DOI 10.2106/00004623-200409000-00028
   TSAHAKIS PJ, 1994, CLIN ORTHOP RELAT R, P86
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Wang JW, 2013, BONE JOINT J, V95B, P643, DOI 10.1302/0301-620X.95B5.29915
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   Whiteside LA, 1998, ORTHOPEDICS, V21, P1041
   WILDE AH, 1990, J BONE JOINT SURG AM, V72A, P815, DOI 10.2106/00004623-199072060-00004
NR 70
TC 29
Z9 30
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD FEB 4
PY 2015
VL 97A
IS 3
BP 216
EP 223
DI 10.2106/JBJS.N.00540
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CB1NQ
UT WOS:000349395000015
PM 25653322
DA 2018-10-20
ER

PT J
AU Rodrguez-Fuentes, N
   Reynoso-Ducoing, O
   Rodriguez-Hernandez, A
   Ambrosio-Hernandez, JR
   Pina-Barba, MC
   Zepeda-Rodriguez, A
   Cerbon-Cervantes, MA
   Tapia-Ramirez, J
   Alcantara-Quintana, LE
AF Rodrguez-Fuentes, Nayeli
   Reynoso-Ducoing, Olivia
   Rodriguez-Hernandez, Ana
   Ambrosio-Hernandez, Javier R.
   Pina-Barba, Maria C.
   Zepeda-Rodriguez, Armando
   Cerbon-Cervantes, Marco A.
   Tapia-Ramirez, Jose
   Alcantara-Quintana, Luz E.
TI Isolation of Human Mesenchymal Stem Cells and their Cultivation on the
   Porous Bone Matrix
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Developmental Biology; Issue 96; Human mesenchymal stem cells; porous
   biomaterials; Nukbone; bone; bone tissue engineering; amnion
ID HUMAN AMNIOTIC MEMBRANE; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS;
   CULTURE
AB Mesenchymal stem cells (MSCs) have a differentiation potential towards osteoblastic lineage when they are stimulated with soluble factors or specific biomaterials. This work presents a novel option for the delivery of MSCs from human amniotic membrane (AM-hMSCs) that employs bovine bone matrix Nukbone (NKB) as a scaffold. Thus, the application of MSCs in repair and tissue regeneration processes depends principally on the efficient implementation of the techniques for placing these cells in a host tissue. For this reason, the design of biomaterials and cellular scaffolds has gained importance in recent years because the topographical characteristics of the selected scaffold must ensure adhesion, proliferation and differentiation into the desired cell lineage in the microenvironment of the injured tissue. This option for the delivery of MSCs from human amniotic membrane (AM-hMSCs) employs bovine bone matrix as a cellular scaffold and is an efficient culture technique because the cells respond to the topographic characteristics of the bovine bone matrix Nukbone (NKB), i.e., spreading on the surface, macroporous covering and colonizing the depth of the biomaterial, after the cell isolation process. We present the procedure for isolating and culturing MSCs on a bovine matrix.
C1 [Rodrguez-Fuentes, Nayeli; Pina-Barba, Maria C.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Dept Mat Met & Ceram, Mexico City 04510, DF, Mexico.
   [Reynoso-Ducoing, Olivia; Rodriguez-Hernandez, Ana; Ambrosio-Hernandez, Javier R.] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico.
   [Zepeda-Rodriguez, Armando] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City 04510, DF, Mexico.
   [Cerbon-Cervantes, Marco A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol Celular, Mexico City 04510, DF, Mexico.
   [Tapia-Ramirez, Jose] CINVESTAV, IPN, Dept Genet & Mol Biol, Ciudad De Mexico, DF, Mexico.
   [Alcantara-Quintana, Luz E.] Secretaria Salud, Ctr Nacl Transfus Sanguinea, Subd Invest, Madrid, Spain.
RP Alcantara-Quintana, LE (reprint author), Secretaria Salud, Ctr Nacl Transfus Sanguinea, Subd Invest, Madrid, Spain.
EM luzalcantara@gmail.com
RI Rodriguez-Hernandez, Ana/E-8729-2011
OI Rodriguez-Hernandez, Ana/0000-0001-7094-1912; Ambrosio,
   Javier/0000-0001-7441-0609
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT) [49887]; Facultad de
   Medicina-UNAM [DGAPA IN201510, DGAPA IN216213]
FX We acknowledge the scholarship and financial support provided by the
   Consejo Nacional de Ciencia y Tecnologia (CONACyT No. 49887), Facultad
   de Medicina-UNAM DGAPA IN201510 and DGAPA IN216213; Salvador Correa of
   Instituto Nacional de Perinatologia for help with the biological
   material; and Biocriss, S. A. de C. V for donating Nukbone. Also thank
   to Ing. Hector Martinez of IIM, UNAM and M en C Fabiola Gonzalez of
   CINVESTAV for technical assistance.
CR Alviano F, 2007, BMC DEV BIOL, V7, P1
   Anker P. S., STEM CELLS, V22, P1338
   Fassina L, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/456240
   Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359
   Pochsmpally R., 2008, MESENCHYMAL STEM CEL
   Rivera N, 2013, PARASITOL RES, V112, P1021, DOI 10.1007/s00436-012-3224-z
   Rodriguez-Fuentes N, 2013, BIOCHEM BIOPH RES CO, V434, P676, DOI 10.1016/j.bbrc.2013.04.007
   Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017
   Villajosa C.L.M.-O.d., 2006, REV ORTOP TRAUMATOL, V50, P224
NR 11
TC 3
Z9 3
U1 1
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2015
IS 96
AR e51999
DI 10.3791/51999
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR7MH
UT WOS:000361533700009
PM 25742362
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Deng, J
   Sun, MC
   Wang, SS
   Han, LL
   Mao, ZW
   Li, D
   Chen, H
   Gao, CY
AF Deng, Jun
   Sun, Mingcong
   Wang, Shasha
   Han, Lulu
   Mao, Zhengwei
   Li, Dan
   Chen, Hong
   Gao, Changyou
TI Adsorption of Fibronectin on Salt-Etched Polyelectrolyte Multilayers and
   its Roles in Mediating the Adhesion and Migration of Vascular Smooth
   Muscle Cells
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterial surfaces; cell adhesion and migration; fibronectin;
   multilayers; protein adsorption
ID PROTEIN ADSORPTION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELL; MODEL
   SURFACES; NMR ANALYSIS; FILMS; SUBSTRATE; DENSITY; GRADIENTS;
   POLYURETHANE
AB Protein adsorption on biomaterials strongly mediates the subsequent cell responses. Here adsorption of fibronectin (Fn) on salt-treated PEI(PSS/PDDA)(7) multilayers was characterized. The amounts of adsorbed Fn increased linearly along with the increase of thickness of multilayers pretreated with 1 M and 5 M NaCl solutions (Multilayer-1M and 5M), but was independent on the thickness of Multilayer-3M. The normalized relative RGD activity of Fn were significantly higher on the Multilayer-3M than on others. By comparison of cellular behaviors of VSMCs being cultured in the normal and Fn-depleted serum-containing medium, the significant role of Fn on modulating the behaviors of VSMCs was verified. The Fn adsorption model and its role on linking the biomaterials surface to the VSMCs behaviors are proposed.
C1 [Deng, Jun; Sun, Mingcong; Han, Lulu; Mao, Zhengwei; Gao, Changyou] Zhejiang Univ, MOE Key Lab Macromol Synth & Functionalizat, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Wang, Shasha; Li, Dan; Chen, Hong] Soochow Univ, Jiangsu Key Lab Adv Funct Polymer Design & Applic, Dept Polymer Sci & Engn, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, MOE Key Lab Macromol Synth & Functionalizat, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
EM cygao@mail.hz.zj.cn
RI mao, zhengwei/I-5785-2012; Li, Dan/R-8422-2016
OI Li, Dan/0000-0002-1141-8838; Deng, Jun/0000-0002-9951-2393
FU National Basic Research Programme of China [2011CB606203]; Natural
   Science Foundation of China [21434006, 21374097]
FX This study was financially supported by the National Basic Research
   Programme of China (2011CB606203), and the Natural Science Foundation of
   China (21434006 and 21374097).
CR Asakura T, 2011, BIOMACROMOLECULES, V12, P3910, DOI 10.1021/bm2011196
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Chen H, 2009, J BIOMED MATER RES A, V90A, P940, DOI 10.1002/jbm.a.32152
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Dubas ST, 2001, LANGMUIR, V17, P7725, DOI 10.1021/la0112099
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Han LL, 2013, BIOMATERIALS, V34, P975, DOI 10.1016/j.biomaterials.2012.10.041
   Han LL, 2012, J R SOC INTERFACE, V9, P3455, DOI 10.1098/rsif.2012.0546
   Han LL, 2012, LANGMUIR, V28, P193, DOI 10.1021/la2040533
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   Heuvingh J, 2005, LANGMUIR, V21, P3165, DOI 10.1021/la047388m
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Idiris A, 2005, BIOMACROMOLECULES, V6, P2776, DOI 10.1021/bm0502617
   Inoue Y, 2011, REACT FUNCT POLYM, V71, P350, DOI 10.1016/j.reactfunctpolym.2010.11.017
   Ramos JJI, 2010, MACROMOLECULES, V43, P9063, DOI 10.1021/ma1015984
   Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lucassen-Reynders EH, 2004, J PHYS CHEM B, V108, P9173, DOI 10.1021/jp049682t
   MAZZUCOTELLI JP, 1991, INT J ARTIF ORGANS, V14, P482
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Miyamoto S., 1981, ANN NY ACAD SCI, V91, P673
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Sivaraman B, 2011, BIOMATERIALS, V32, P5365, DOI 10.1016/j.biomaterials.2011.04.011
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu JD, 2012, BIOMATERIALS, V33, P810, DOI 10.1016/j.biomaterials.2011.10.022
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhang C, 2014, J BIOMED MATER RES A, V102, P170, DOI 10.1002/jbm.a.34687
NR 55
TC 8
Z9 8
U1 3
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB
PY 2015
VL 15
IS 2
BP 241
EP 252
DI 10.1002/mabi.201400344
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA CE2VJ
UT WOS:000351677900006
PM 25283882
DA 2018-10-20
ER

PT J
AU Wu, CC
   Wei, CK
   Ho, CC
   Ding, SJ
AF Wu, Ching-Chou
   Wei, Chung-Kai
   Ho, Chia-Che
   Ding, Shinn-Jyh
TI Enhanced Hydrophilicity and Biocompatibility of Dental Zirconia Ceramics
   by Oxygen Plasma Treatment
SO MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; VITRO PHYSICOCHEMICAL PROPERTIES; OSTEOGENIC
   ACTIVITY; SURFACE MODIFICATION; COMPOSITE COATINGS; DICALCIUM SILICATE;
   ADHESION; WETTABILITY; TOPOGRAPHY; BONE
AB Surface properties play a critical role in influencing cell responses to a biomaterial. The objectives of this study were (1) to characterize changes in surface properties of zirconia (ZrO2) ceramic after oxygen plasma treatment; and (2) to determine the effect of such changes on biological responses of human osteoblast-like cells (MG63). The results indicated that the surface morphology was not changed by oxygen plasma treatment. In contrast, oxygen plasma treatment to ZrO2 not only resulted in an increase in hydrophilicity, but also it retained surface hydrophilicity after 5-min treatment time. More importantly, surface properties of ZrO2 modified by oxygen plasma treatment were beneficial for cell growth, whereas the surface roughness of the materials did not have a significant efficacy. It is concluded that oxygen plasma treatment was certified to be effective in modifying the surface state of ZrO2 and has the potential in the creation and maintenance of hydrophilic surfaces and the enhancement of cell proliferation and differentiation.
C1 [Wu, Ching-Chou] Natl Chung Hsing Univ, Dept Bioind Mechatron Engn, Taichung 402, Taiwan.
   [Wei, Chung-Kai; Ho, Chia-Che; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
EM ccwu@dragon.nchu.edu.tw; tiyeg2@gmail.com; sfox1223@gmail.com;
   sjding@csmu.edu.tw
OI Wu, Ching-Chou/0000-0002-8683-3796
CR Chen CC, 2014, J ALLOY COMPD, V585, P25, DOI 10.1016/j.jallcom.2013.09.138
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chiang TY, 2014, J MED BIOL ENG, V34, P30, DOI 10.5405/jmbe.1386
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Eriksson C, 2004, BIOMATERIALS, V25, P4759, DOI 10.1016/j.biomaterials.2003.12.006
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Giljean S, 2011, APPL SURF SCI, V257, P9631, DOI 10.1016/j.apsusc.2011.06.088
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Hao L, 2004, J BIOMED MATER RES A, V69A, P748, DOI 10.1002/jbm.a.30055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Huang SC, 2015, J MATER CHEM B, V3, P570, DOI 10.1039/c4tb01617c
   Ito H, 2013, DENT MATER J, V32, P122, DOI 10.4012/dmj.2012-208
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Lee PJ, 2014, SURF COAT TECH, V258, P374, DOI 10.1016/j.surfcoat.2014.08.066
   Nakamura M, 2014, J MED BIOL ENG, V34, P44, DOI 10.5405/jmbe.1450
   Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846
   Novotna K, 2013, MATERIALS, V6, P1632, DOI 10.3390/ma6051632
   Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014
   Sandhyarani M, 2013, J ALLOY COMPD, V553, P324, DOI 10.1016/j.jallcom.2012.11.147
   Shie MY, 2014, J BIOMED MATER RES A, V102, P769, DOI 10.1002/jbm.a.34737
   Shon WJ, 2014, CLIN ORAL IMPLAN RES, V25, P573, DOI 10.1111/clr.12115
   Smeacetto F, 2010, MATER LETT, V64, P2450, DOI 10.1016/j.matlet.2010.08.016
   Vesel A, 2006, PLASMA CHEM PLASMA P, V26, P577, DOI 10.1007/s11090-006-9025-3
   Wang CW, 2014, J MATER SCI-MATER M, V25, P2193, DOI 10.1007/s10856-014-5258-5
   Watanabe H, 2012, DENT MATER J, V31, P806, DOI 10.4012/dmj.2012-069
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wu BC, 2013, MATERIALS, V6, P5675, DOI 10.3390/ma6125675
   Wu CC, 2011, SURF COAT TECH, V205, P3182, DOI 10.1016/j.surfcoat.2010.11.036
   Xu XX, 2009, NANO RES, V2, P891, DOI 10.1007/s12274-009-9092-x
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 36
TC 23
Z9 23
U1 3
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2015
VL 8
IS 2
BP 684
EP 699
DI 10.3390/ma8020684
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA CE7WM
UT WOS:000352052600022
PM 28787965
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Augustine, R
   Kalarikkal, N
   Thomas, S
AF Augustine, Robin
   Kalarikkal, Nandakumar
   Thomas, Sabu
TI An In vitro Method for the Determination of Microbial Barrier Property
   (MBP) of Porous Polymeric Membranes for Skin Substitute and Wound
   Dressing Applications
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE skin substitutes; wound dressings; microbial barrier; in vitro method
ID GAMMA-IRRADIATION; SCAFFOLDS; NANOFIBERS
AB Barrier property of materials to microbes is an important aspect in many applications like wound dressings and skin substitutes. Lack of a standard method for the evaluation of microbial barrier property limits the consideration of this important aspect by many bioengineers and biomaterial scientists. Thus, in this study we are intended to develop a standard method for the quantitative assessment of Microbial Barrier Property (MBP) and express this in terms of percentage in comparison with a control which resembles a bare wound or a standard existing wound coverage material. In this study, we have evaluated the microbial barrier property of electrospun materials with different pore spaces and our study showed that this method can be successfully used for the assessment of bacterial barrier property of materials intended for wound dressing and skin substitute applications. Further, the results showed that the MBP will vary with the test conditions. This methodology can be used to measure the microbial barrier property of wide range of materials like skin substitute materials, wound dressings, medical textiles and many other materials where microbial prevention is important. This methodology can also be extended to the specific determination of bacterial, fungal or viral barrier property with minor modifications.
C1 [Augustine, Robin; Kalarikkal, Nandakumar; Thomas, Sabu] Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotech, Kottayam 686560, Kerala, India.
   [Kalarikkal, Nandakumar] Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, Kerala, India.
   [Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Thomas, S (reprint author), Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotech, Priyadarshini Hills, Kottayam 686560, Kerala, India.
EM nkkalarikkal@mgu.ac.in; sabuchathukulam@yahoo.co.uk
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746; KALARIKKAL,
   NANDAKUMAR/0000-0002-4595-6466; Augustine, Robin/0000-0001-9724-8392
FU Department of Science and Technology (DST); Department of Biotechnology
   (DBT), Government of India, New Delhi; UGC SAP; DST-FIST; SAARD-KSCSTE
FX The authors acknowledge Department of Science and Technology (DST) and
   Department of Biotechnology (DBT), Government of India, New Delhi for
   the financial support through Nanomission and MSUB IPLSARE programs
   respectively. Funding from UGC SAP, DST-FIST, SAARD-KSCSTE are also
   gratefully acknowledged.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Ali AA, 2012, APPL NANOSCI, V2, P55, DOI 10.1007/s13204-011-0042-z
   Augustine R, 2012, INT J NANO DIMENS, V2, P205, DOI 10.7508/ijnd.2011.03.009
   Augustine R., 2014, RSC ADV, V4, P93
   Augustine R, 2014, DIABETES MELLITUS HU, P273
   Augustine R., 2013, HDB BIOPOLYMER BASED, P801
   Augustine R., 2014, RSC ADV, V4, P48
   Augustine R, 2014, PROG BIOMATER, V3, P103, DOI 10.1007/s40204-014-0030-y
   Augustine R, 2015, INT J POLYM MATER PO, V64, P526, DOI 10.1080/00914037.2014.977900
   Augustine R, 2014, J POLYM RES, V21, DOI 10.1007/s10965-013-0347-6
   Bhende Shubhangi, 2002, Surg Infect (Larchmt), V3, P251, DOI 10.1089/109629602761624216
   Biazar E, 2010, INT J NANO DIMENS, V1, P1, DOI 10.7508/ijnd.2010.0x.001
   Blocher J, 2009, EFFECT RELATIVE HUMI
   Garcia-Vargas M, 2014, INT J PHARMACEUT, V461, P286, DOI 10.1016/j.ijpharm.2013.11.060
   Jeong SI, 2014, TISSUE ENG REGEN MED, V11, P64, DOI 10.1007/s13770-014-0423-y
   Jeong SI, 2014, TISSUE ENG REGEN MED, V11, P56, DOI 10.1007/s13770-014-0424-x
   Jiang LY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-65
   Jin GR, 2013, EUR J PHARM BIOPHARM, V85, P689, DOI 10.1016/j.ejpb.2013.06.002
   Jin GR, 2013, BIOMATERIALS, V34, P724, DOI 10.1016/j.biomaterials.2012.10.026
   Jo AR, 2014, TISSUE ENG REGEN MED, V11, P16, DOI 10.1007/s13770-013-1105-x
   Joo YH, 2013, TISSUE ENG REGEN MED, V10, P65, DOI 10.1007/s13770-013-0358-8
   Kim HS, 2013, ACTA BIOMATER, V9, P7371, DOI 10.1016/j.actbio.2013.03.018
   Kobsa S, 2013, BIOMATERIALS, V34, P3891, DOI 10.1016/j.biomaterials.2013.02.016
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Lakshman LR, 2010, J MACROMOL SCI A, V47, P1012, DOI 10.1080/10601325.2010.508001
   Osathanon T, 2014, TISSUE ENG REGEN MED, V11, P239, DOI 10.1007/s13770-014-0015-x
   Ovington L, 2010, WOUND HEALING EVIDEN, V180
   Rezaei A, 2012, TISSUE ENG REGEN MED, V9, P295, DOI 10.1007/s13770-012-0002-z
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Yanez F, 2010, J MEMBRANE SCI, V365, P248, DOI 10.1016/j.memsci.2010.09.012
NR 30
TC 15
Z9 15
U1 0
U2 10
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2015
VL 12
IS 1
BP 12
EP 19
DI 10.1007/s13770-014-0032-9
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA CE5JG
UT WOS:000351867900002
DA 2018-10-20
ER

PT J
AU Wach, RA
   Adamus, A
   Kowalska-Ludwicka, K
   Grobelski, B
   Cala, J
   Rosiak, JM
   Pasieka, Z
AF Wach, Radoslaw A.
   Adamus, Agnieszka
   Kowalska-Ludwicka, Karolina
   Grobelski, Bartlomiej
   Cala, Jaroslaw
   Rosiak, Janusz M.
   Pasieka, Zbigniew
TI In vivo evaluation of nerve guidance channels of PTMC/PLLA porous
   biomaterial
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE peripheral nerve regeneration; poly(L-lactic acid); poly(trimethylene
   carbonate); tubulisation
ID PERIPHERAL-NERVE; POLY(TRIMETHYLENE CARBONATE); 1,3-TRIMETHYLENE
   CARBONATE; POLY(L-LACTIC ACID); VITRO DEGRADATION; REPAIR; REGENERATION;
   COPOLYMERS; SCAFFOLDS; CONDUITS
AB Introduction: Peripheral nerve disruptions, frequently occurring during limb injuries, give rise to serious complications of patients recovery resulting from limitations in neural tissue regeneration capabilities. To overcome this problem bridging techniques utilizing guidance channels gain their importance. Biodegradable polymeric tubes seem to be more prospective then non-degradable materials - no necessity of implant removal and possibilities of release of incorporated drugs or biologically active agents that may support nerve regeneration process are the main advantages.
   Material and methods: Polymer blend of commercial poly(L-lactic acid) (PLLA) and in-house synthesized poly(trimethylene carbonate) (PTMC) were processed in an organic solvent - phase inversion process on a supporting rod - to form a guidance porous tube of 1.1 mm inner diameter. In vivo experiments on rat's cut femoral nerve by using either the tubes or end-to-end suturing (control group) involved 22 and 19 rats, respectively. Motor recovery of operated limbs, neuroma occurrence and histopathology of explanted nerves were evaluated after 30, 60 and 90 days of implantation.
   Results: Motor recovery of the limbs was of similar rate for the two animal groups. The neuroma formation was evident in over 90% control specimens, while for the bridging group it was less than 40% of all evaluable samples (p = 0.0022). Biocompatibility of applied materials was affirmed by moderate tissue response.
   Conclusions: Application of the biodegradable PLLA/PTMC polymeric tubes effectively supports regeneration of discontinued nerves. The applied material prevents neuroma formation, by reducing the scar tissue formation time and, thus, accelerating the process of neural tissue restoration.
C1 [Wach, Radoslaw A.; Adamus, Agnieszka; Rosiak, Janusz M.] Tech Univ Lodz, Fac Chem, Inst Appl Radiat Chem, PL-90924 Lodz, Poland.
   [Kowalska-Ludwicka, Karolina] Lodz Univ Technol, Inst Tech Biochem, Lodz, Poland.
   [Grobelski, Bartlomiej] Med Univ Lodz, Fac Pharm, Lodz, Poland.
   [Cala, Jaroslaw; Pasieka, Zbigniew] Med Univ Lodz, Dept Expt Surg, Lodz, Poland.
RP Wach, RA (reprint author), Tech Univ Lodz, Fac Chem, Inst Appl Radiat Chem, 15 Wroblewskiego St, PL-90924 Lodz, Poland.
EM wach@mitr.p.lodz.pl
FU European Commission project 'NerveRegeneration' [MIGR-CT-2007-206269];
   Ministry of Science and Higher Education, Poland [1953/B/P01/2008/35];
   Ministry of Science and Higher Education, Poland SPB grant [843/7 PR
   UE/2008/7]
FX This work has been partially financed by the European Commission project
   'NerveRegeneration' MIGR-CT-2007-206269 within 7FP and by the Ministry
   of Science and Higher Education, Poland: 1953/B/P01/2008/35 and SPB
   grant 843/7 PR UE/2008/7.
CR Adamus A, 2012, POLYM DEGRAD STABIL, V97, P532, DOI 10.1016/j.polymdegradstab.2012.01.021
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Diao E, 2000, HAND CLIN, V16, P53
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   DUDA A, 1994, MACROMOL RAPID COMM, V15, P559, DOI 10.1002/marc.1994.030150617
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jozwiakowska J, 2011, POLYM DEGRAD STABIL, V96, P1430, DOI 10.1016/j.polymdegradstab.2011.05.010
   Kowalska-Ludwicka K, ARCH MED SC IN PRESS
   Kryger GS, 2001, J HAND SURG-AM, V26A, P635, DOI 10.1053/jhsu.2001.26035
   Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127
   Medical Research Council Nerve Injuries Committee, 1943, 7 MRC NERV INJ COMM, V7
   Nugroho P, 2001, POLYM DEGRAD STABIL, V72, P337, DOI 10.1016/S0141-3910(01)00030-1
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   Ro LS, 1999, PAIN, V79, P265, DOI 10.1016/S0304-3959(98)00164-X
   ROWSHAN K, 2004, OPER TECH ORTHOP, V14, P163
   Sun HZ, 2012, ARCH MED SCI, V8, P924, DOI 10.5114/aoms.2012.31623
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Wach RA, 2013, J APPL POLYM SCI, V127, P2259, DOI 10.1002/app.37932
   Wolford Larry M, 2003, Proc (Bayl Univ Med Cent), V16, P152
   Yuksel F, 1999, PLAST RECONSTR SURG, V104, P2092
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
NR 35
TC 1
Z9 1
U1 6
U2 39
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 1734-1922
EI 1896-9151
J9 ARCH MED SCI
JI Arch. Med. Sci.
PD FEB
PY 2015
VL 11
IS 1
BP 210
EP 219
DI 10.5114/aoms.2013.34732
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA CE1BX
UT WOS:000351547900024
PM 25861309
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bean, AC
   Tuan, RS
AF Bean, Allison C.
   Tuan, Rocky S.
TI Fiber diameter and seeding density influence chondrogenic
   differentiation of mesenchymal stem cells seeded on electrospun
   poly(epsilon-caprolactone) scaffolds
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE mesenchymal stem cells; chondrogenesis; electrospinning; fibrous
   scaffolds; biomaterials
ID ARTICULAR-CARTILAGE; PROGENITOR CELLS; PROLIFERATION; GROWTH;
   CHONDROCYTES; PREVALENCE; MIGRATION; ARTHRITIS; MATRICES; MESHES
AB Chondrogenic differentiation of mesenchymal stem cells is strongly influenced by the surrounding chemical and structural milieu. Since the majority of the native cartilage extracellular matrix is composed of nanofibrous collagen fibrils, much of recent cartilage tissue engineering research has focused on developing and utilizing scaffolds with similar nanoscale architecture. However, current literature lacks consensus regarding the ideal fiber diameter, with differences in culture conditions making it difficult to compare between studies. Here, we aimed to develop a more thorough understanding of how cell-cell and cell-biomaterial interactions drive in vitro chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells (MSCs). Electrospun poly(epsilon-caprolactone) microfibers (4.3 +/- 0.8 mu m diameter, 90 mu m(2) pore size) and nanofibers (440 +/- 20 nm diameter, 1.2 mu m(2) pore size) were seeded with MSCs at initial densities ranging from 1 x 10(5) to 4 x 10(6) cells cm(-3)-scaffold and cultured under transforming growth factor-beta (TGF-beta) induced chondrogenic conditions for 3 or 6 weeks. Chondrogenic gene expression, cellular proliferation, as well as sulfated glycosaminoglycan and collagen production were enhanced on microfiber in comparison to nanofiber scaffolds, with high initial seeding densities being required for significant chondrogenic differentiation and extracellular matrix deposition. Both cell-cell and cell-material interactions appear to play important roles in chondrogenic differentiation of MSCs in vitro and consideration of several variables simultaneously is essential for understanding cell behavior in order to develop an optimal tissue engineering strategy.
C1 [Bean, Allison C.; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15219 USA.
RP Bean, AC (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
FU Commonwealth of Pennsylvania; Cardiovascular Bioengineering Training
   Program at the University of Pittsburgh [NIH T32HL076124]
FX Funding for this work was provided by the Commonwealth of Pennsylvania
   and the Cardiovascular Bioengineering Training Program at the University
   of Pittsburgh (NIH T32HL076124). We would also like to acknowledge the
   Center for Biologic Imaging at the University of Pittsburgh for the use
   of their confocal microscopes and the staff for their technical
   assistance.
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Buxton A, 2010, TISSUE ENG PART A, V17, P371
   Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   CLARKE I C, 1971, Journal of Bone and Joint Surgery British Volume, V53, P732
   Darling EM, 2004, J ORTHOP RES, V22, P1182, DOI 10.1016/j.orthres.2004.03.001
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   DESSAU W, 1980, J EMBRYOL EXP MORPH, V57, P51
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Health N I, 2003, NIH CONSENS STATE SC, V20, P1
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Huang AH, 2009, TISSUE ENG PT A, V15, P3461, DOI [10.1089/ten.tea.2009.0198, 10.1089/ten.TEA.2009.0198]
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Lee WC, 2011, LAB CHIP, V11, P1359, DOI 10.1039/c0lc00579g
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971
   Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, P29, DOI DOI 10.1186/1471-2474-12-222
   Noriega SE, 2012, CELLS TISSUES ORGANS, V195, P207, DOI 10.1159/000325144
   Shanmugasundaram S, 2011, TISSUE ENG PT A, V17, P831, DOI [10.1089/ten.tea.2010.0409, 10.1089/ten.TEA.2010.0409]
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   STOCKWELL RA, 1967, J ANAT, V101, P753
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tan F, 2011, BIOTECHNOL ADV, V30, P352
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 43
TC 23
Z9 24
U1 3
U2 46
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015018
DI 10.1088/1748-6041/10/1/015018
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400019
PM 25634427
OA Green Accepted
DA 2018-10-20
ER

PT J
AU He, T
   Zhang, Y
   Lai, ACK
   Chan, V
AF He, Tao
   Zhang, Ying
   Lai, Alvin C. K.
   Chan, Vincent
TI Engineering bio-adhesive functions in an antimicrobial polymer
   multilayer
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE adhesive ligands; bacteria/cell adhesion; detachment force;
   antibacterial; S. aureus; E. coli
ID STAPHYLOCOCCUS-AUREUS; STAINLESS-STEEL; POLYELECTROLYTE MULTILAYER;
   BACTERIAL ADHESION; ESCHERICHIA-COLI; CELL-ADHESION; SURFACE;
   ANTIBACTERIAL; TITANIUM; COLLAGEN
AB Functionalization of a biomaterial surface with adhesive ligands is an effective way to promote specific cell adhesion. Ideally, biomaterial for applications in biomedical implants should simultaneously promote host cell adhesion and inhibit bacterial adhesion. Currently, little attention has been paid to the design of antimicrobial biomaterial with selective adhesiveness towards only targeted cells or tissues. In this study, the role of two typical adhesive ligands on the bioadhesion functions of a model antimicrobial film was elucidated. First, an adhesive ligand including an RGD peptide or collagen (CL) was chemically coupled to an antimicrobial polymeric multilayer composed of dextran sulfate (DS) and chitosan (CS). It was demonstrated that the density of RGD and CL immobilized on the DS/CS multilayer ranges between 4 to 137 ng cm(-2) and 100 to 1000 ng cm(-2), respectively. Then the effect of immobilized RGD or CL on both bacterial and fibroblast adhesion was investigated. By determining the density and morphology of adherent fibroblast on a DS/CS multilayer with or without an adhesive ligand, it was shown that RGD or CL effectively promoted fibroblast adhesion and proliferation in a concentration-dependent manner. Interestingly, the type of adhesive ligands imposed distinct effects in bacterial adhesion. Immobilized RGD did not enhance Staphylococcus aureus and Escherichia coli adhesion on DS/CS multilayers under all concentrations. In contrast, CL triggered significant S. aureus adhesion on DS/CS multilayers even at low surface concentration and when fibroblast adhesion was absent. Moreover, the detachment forces of individual S. aureus on CL coated DS/CS multilayers probed by atomic force microscopy (AFM) was 3 times and 20 times higher than that on the control substrate and on unmodified DS/CS multilayers, respectively. Interestingly, the lowest detachment force of E. coli was found on the CL coated DS/CS multilayers. This study demonstrated the possibility of engineering an antimicrobial multilayer coating with tailored adhesive properties towards specific cell types for potential applications in biomedical implants.
C1 [He, Tao] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore.
   [Zhang, Ying; Chan, Vincent] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Lai, Alvin C. K.] City Univ Hong Kong, Dept Civil & Architectural Engn, Kowloon, Hong Kong, Peoples R China.
RP He, T (reprint author), ASTAR, Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
EM het@imre.a-star.edu.sg; mvchan@ntu.edu.sg
RI Chan, Vincent/G-6197-2010
OI Chan, Vincent/0000-0003-2149-4479; LAI, Chi Keung
   Alvin/0000-0002-6202-1988
CR Adams Katherine T, 2014, Manag Care, V23, P54
   Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Baier R E, 1984, J BIOMED MATER RES, V18, P327
   Beloin C, 2014, CURR OPIN PHARMACOL, V18, P61, DOI 10.1016/j.coph.2014.09.005
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cue DR, 1997, INFECT IMMUN, V65, P2759
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   He T, 2009, BIOMATERIALS, V30, P317, DOI 10.1016/j.biomaterials.2008.09.049
   Ho Cht S C, 2004, ADV MATER, P16957
   Hogan S, 2014, CURR PHARM DESIGN, V21, P100
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Ignatova M, 2006, LANGMUIR, V22, P255, DOI 10.1021/la051954b
   Jo YK, 2014, ACS APPL MATER INTER, V6, P20242, DOI 10.1021/am505784k
   Khalil F, 2014, COLLOID SURFACE B, V117, P185, DOI 10.1016/j.colsurfb.2014.02.022
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   LJUNGH A, 1990, ZBL BAKT-INT J MED M, V274, P126, DOI 10.1016/S0934-8840(11)80982-5
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Medina MB, 2001, INT J FOOD MICROBIOL, V69, P199, DOI 10.1016/S0168-1605(01)00497-4
   Mohamed N, 1999, INFECT IMMUN, V67, P589
   Orgovan N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04034
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021
   PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002
   Ramstedt M, 2009, BIOMATERIALS, V30, P1524, DOI 10.1016/j.biomaterials.2008.12.008
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Senechal A, 2004, LANGMUIR, V20, P4172, DOI 10.1021/la035847y
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shinji H, 2003, INFECT IMMUN, V71, P140, DOI 10.1128/IAI.71.1.140-146.2003
   Sin MC, 2014, ACS APPL MATER INTER, V6, P861, DOI 10.1021/am4041256
   Taschner S, 2002, BIOCHEM J, V367, P393, DOI 10.1042/BJ20020164
   Tedjo C, 2007, J BIOMED MATER RES A, V82A, P479, DOI 10.1002/jbm.a.31172
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   WALDVOGEL FA, 1980, NEW ENGL J MED, V303, P360, DOI 10.1056/NEJM198008143030703
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035005
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yu DG, 2007, J BIOMED MATER RES B, V83B, P105, DOI 10.1002/jbm.b.30772
NR 52
TC 5
Z9 5
U1 1
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015015
DI 10.1088/1748-6041/10/1/015015
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400016
PM 25634058
DA 2018-10-20
ER

PT J
AU Yu, J
   Zhang, WY
   Li, Y
   Wang, G
   Yang, LD
   Jin, JF
   Chen, QH
   Huang, MH
AF Yu, Jian
   Zhang, Wenyun
   Li, Yang
   Wang, Gang
   Yang, Lidou
   Jin, Jianfeng
   Chen, Qinghua
   Huang, Minghua
TI Synthesis, characterization, antimicrobial activity and mechanism of a
   novel hydroxyapatite whisker/nano zinc oxide biomaterial
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hydroxyapatite whisker; zinc oxide; antibacterial mechanism; biomaterial
ID ANTIBACTERIAL ACTIVITY; ZNO NANOPARTICLES; BROAD-SPECTRUM; BONE-CEMENT;
   BIOCOMPATIBILITY; PHOTOCATALYSIS; SUSCEPTIBILITY; INFECTIONS; BACTERIA;
   RELEASE
AB Postoperative infections remain a risk factor that leads to failures in oral and maxillofacial artificial bone transplantation. This study aimed to synthesize and evaluate a novel hydroxyapatite whisker (HAPw) / nano zinc oxide (n-ZnO) antimicrobial bone restorative biomaterial. A scanning electron microscope (SEM), energy dispersive spectroscopy (EDS) and x-ray diffraction (XRD) were employed to characterize and analyze the material. Antibacterial capabilities against Staphylococcus aureus, Escherichia coli, Candida albicans and Streptococcus mutans were determined by minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and kinetic growth inhibition assays were performed under darkness and simulated solar irradiation. The mode of antibiotic action was observed by transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM). The MIC and MBC were 0.078-1.250 mg ml(-1) and 0.156-2.500 mg ml(-1), respectively. The inhibitory function on the growth of the microorganisms was achieved even under darkness, with gram-positive bacteria found to be more sensitive than gram-negative, and enhanced antimicrobial activity was exhibited under simulated solar excitation compared to darkness. TEM and CLSM images revealed a certain level of bacterial cell membrane destruction after treatment with 1 mg ml(-1) of the material for 12 h, causing the leakage of intracellular contents and bacteria death. These results suggest favorable antibiotic properties and a probable mechanism of the biomaterial for the first time, and further studies are needed to determine its potential application as a postoperative anti-inflammation method in bone transplantation.
C1 [Yu, Jian; Zhang, Wenyun; Li, Yang; Wang, Gang; Yang, Lidou] Kunming Gen Hosp Chengdu Mil Reg, Dept Stomatol, Kunming, Yunnan Province, Peoples R China.
   [Yu, Jian; Li, Yang] Kunming Med Univ, Clin Coll, Kunming, Peoples R China.
   [Jin, Jianfeng] Kunming Municipal Stomatol Hosp, Kunming, Peoples R China.
   [Chen, Qinghua; Huang, Minghua] Kunming Univ Sci & Technol, Fac Mat Sci & Engn, Kunming, Peoples R China.
RP Zhang, WY (reprint author), Kunming Gen Hosp Chengdu Mil Reg, Dept Stomatol, 212 Daguan Rd, Kunming, Yunnan Province, Peoples R China.
EM wenyunzh88@126.com
FU Natural Science Foundation of China (NSFC) [81260272]
FX The research was funded by the Natural Science Foundation of China
   (NSFC) No. 81260272. We are grateful to Professor Fukai Bao (Kunming
   Medical University, China) for providing the bacterial strains and
   Professor Qinghua Chen (Kunming University of Science and Technology,
   China) for providing the hydroxyapatite whisker in this experiment.
CR Applerot G, 2012, RSC ADV, V2, P2314, DOI 10.1039/c2ra00602b
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k
   Bamba H, 1997, AM J GASTROENTEROL, V92, P659
   Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Esberg A, 2012, INFECT IMMUN, V80, P3869, DOI 10.1128/IAI.00435-12
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008
   Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   Fukui H, 2012, CHEM-BIOL INTERACT, V198, P29, DOI 10.1016/j.cbi.2012.04.007
   Ghosh S, 2012, RSC ADV, V2, P930, DOI 10.1039/c1ra00815c
   Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x
   Gong HY, 2013, ASIAN PAC J CANCER P, V14, P3351, DOI 10.7314/APJCP.2013.14.5.3351
   Gopikrishnan R, 2010, NANO-MICRO LETT, V2, P31, DOI 10.5101/nml.v2i1.p31-36
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hirota K, 2010, CERAM INT, V36, P497, DOI 10.1016/j.ceramint.2009.09.026
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Jalal R, 2010, MATER CHEM PHYS, V121, P198, DOI 10.1016/j.matchemphys.2010.01.020
   Jan J. I. Tariq, 2013, INT J NANOMED, V8, P3679, DOI DOI 10.2147/IJN.S45439
   Jin J F, 2013, APPL MECH MAT, V364, P655
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Kim SG, 2010, IMPLANT DENT, V19, P115, DOI 10.1097/ID.0b013e3181d43a76
   Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004
   Li F, 2011, J AM DENT ASSOC, V142, P184, DOI 10.14219/jada.archive.2011.0062
   Li M., 2010, ENVIRON SCI TECHNOL, V45, P755, DOI DOI 10.1021/ES102266G
   Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x
   Lu WW, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445711
   Lusvardi G, 2002, J MATER SCI-MATER M, V13, P91, DOI 10.1023/A:1013655123340
   Mori R, 2011, CLIN ORTHOP RELAT R, V469, P600, DOI 10.1007/s11999-010-1626-8
   Ohira T, 2008, J MATER SCI-MATER M, V19, P1407, DOI 10.1007/s10856-007-3246-8
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raqhupathi K R, 2011, LANGMUIR, V27, P4020
   Rodriguez-Tudela JL, 2001, J CLIN MICROBIOL, V39, P2513, DOI 10.1128/JCM.39.7.2513-2517.2001
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Seil JT, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495101
   Sevinc BA, 2010, J BIOMED MATER RES B, V94B, P22, DOI 10.1002/jbm.b.31620
   Shrestha A, 2010, J ENDODONT, V36, P1030, DOI 10.1016/j.joen.2010.02.008
   Siamani S, 2013, J BIOMED MATER RES A, V101, P222
   Siddique S, 2013, ACTA CHIM SLOV, V60, P660
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Smith AJ, 2001, J MED MICROBIOL, V50, P940, DOI 10.1099/0022-1317-50-11-940
   Tan JW, 2013, CHINESE MED J-PEKING, V126, P2495, DOI 10.3760/cma.j.issn.0366-6999.20120323
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Torroni A, 2009, J ORAL MAXIL SURG, V67, P1121, DOI 10.1016/j.joms.2008.11.020
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Vidic J., 2013, J NANOPART RES, V15, P1
   Wilson APR, 2012, J ANTIMICROB CHEMOTH, V67, pI23, DOI 10.1093/jac/dks198
   Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10
   Xu XL, 2013, LANGMUIR, V29, P5573, DOI 10.1021/la400378t
   Yamamoto O, 2004, J MATER SCI-MATER M, V15, P847, DOI 10.1023/B:JMSM.0000036271.35440.36
   Yamamoto O, 2001, CARBON, V39, P1643, DOI 10.1016/S0008-6223(00)00289-X
   Yang L, 2006, BIOTECHNOL PROGR, V22, P387, DOI 10.1021/bp050282c
   Yang ZH, 2006, COLLOID SURFACE B, V47, P140, DOI 10.1016/j.colsurfb.2005.12.007
   Zaragoza O, 2011, ANTIMICROB AGENTS CH, V55, P1563, DOI 10.1128/AAC.01631-10
   Zhang HQ, 2011, ACTA BIOMATER, V7, P2960, DOI 10.1016/j.actbio.2011.03.020
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
   Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109
NR 67
TC 15
Z9 15
U1 3
U2 91
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2015
VL 10
IS 1
AR 015001
DI 10.1088/1748-6041/10/1/015001
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CD3JU
UT WOS:000350975400002
PM 25534679
DA 2018-10-20
ER

PT J
AU Sadaf, S
   Bhatti, HN
   Nausheen, S
   Amin, M
AF Sadaf, Sana
   Bhatti, Haq Nawaz
   Nausheen, Sana
   Amin, Misbah
TI Application of a novel lignocellulosic biomaterial for the removal of
   Direct Yellow 50 dye from aqueous solution: Batch and column study
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Biosorption; Polyethyleneimine; Kinetic studies; Thermodynamic study;
   Bed depth service time (BDST) model
ID DE-OILED SOYA; SUGARCANE BAGASSE; ADSORPTIVE REMOVAL; CRYSTAL VIOLET;
   HAZARDOUS DYE; BED COLUMN; BASIC DYE; WASTE; BIOSORPTION; EQUILIBRIUM
AB This study focused on the utilization of sugarcane bagasse for the removal of Direct Yellow 50 dye from aqueous solution. Sugarcane bagasse was used in native, modified and immobilized forms. Polyethyleneimine (PEI) was used as the modifying agent and modified biomass depicted the enhanced biosorption capacity as compare to native and immobilized forms. Batch mode experiments were conducted to explore the biosorption potential of sugarcane bagasse at different operating conditions. The best conditions for the maximum dye removal were found to be lower pH (2.0), low biosorbent dose (0.05 g) and low temperature (30 degrees C). Maximum dye removal with native, PEI treated and immobilized biomass was 43.17, 65.8 and 15.7 mg/g, respectively. Kinetic studies were carried out and results showed the best fitness of pseudo-second-order kinetic model on the experimental results. Experimental results were also interpreted by different equilibrium isotherms. Thermodynamic study was carried out to evaluate Gibbs free energy (Delta G degrees), enthalpy (Delta H degrees) and entropy (Delta S degrees). Continuous mode experiments were conducted to check the optimized conditions of bed height, flow rate and initial dye concentration for maximum dye removal. Maximum dye removal in continuous study was 10.4 mg/g at 4 cm bed height and 50 mg/L initial dye concentration. Thomas and bed depth service time (BDST) models were applied on the experimental results of column study. The results prove that sugarcane bagasse can be used as a potential biosorbent for the removal of Direct Yellow 50 dye from aqueous solutions. (C) 2014 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Sadaf, Sana] Govt Coll Women Univ, Dept Chem, Faisalabad, Pakistan.
   [Bhatti, Haq Nawaz; Nausheen, Sana; Amin, Misbah] Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
RP Sadaf, S (reprint author), Govt Coll Women Univ, Dept Chem, Faisalabad, Pakistan.
EM sanasadaf@gmail.com; hnbhatti2005@yahoo.com
OI Bhatti, Haq Nawaz/0000-0002-5445-8338
CR Ahmad AA, 2010, J HAZARD MATER, V175, P298, DOI 10.1016/j.jhazmat.2009.10.003
   Akar T, 2009, J HAZARD MATER, V168, P1302, DOI 10.1016/j.jhazmat.2009.03.011
   Aksu Z, 2010, J ENVIRON MANAGE, V91, P1546, DOI 10.1016/j.jenvman.2010.02.026
   Asgher M, 2011, CAN J CHEM ENG, V9999, P1
   Asgher M, 2012, ECOL ENG, V38, P79, DOI 10.1016/j.ecoleng.2011.10.004
   Bayramoglu G, 2002, MICROCHEM J, V72, P63, DOI 10.1016/S0026-265X(01)00151-5
   Bhatti HN, 2009, CHEM ENG J, V148, P434, DOI 10.1016/j.cej.2008.09.028
   Chakraborty S, 2012, SEP SCI TECHNOL, V47, P1898, DOI 10.1080/01496395.2012.663047
   Chakraborty S, 2012, J WATER REUSE DESAL, V2, P55, DOI 10.2166/wrd.2012.008
   Charumathi D, 2012, DESALINATION, V285, P22, DOI 10.1016/j.desal.2011.09.023
   Chowdhury S, 2012, ENVIRON PROG SUSTAIN, V31, P415, DOI 10.1002/ep.10564
   Chowdhury S, 2011, CLEAN-SOIL AIR WATER, V39, P274, DOI 10.1002/clen.201000170
   Das Saha P, 2012, SEP SCI TECHNOL, V47, P112, DOI 10.1080/01496395.2011.610397
   Doubinin M., 1947, PHYS CHEM, V55, P327
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gupta VK, 2006, J COLLOID INTERF SCI, V293, P16, DOI 10.1016/j.cis.2005.06.021
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Haq IU, 2011, CAN J CHEM ENG, V89, P593, DOI 10.1002/cjce.20436
   Harkins WD, 1944, J AM CHEM SOC, V66, P1366, DOI 10.1021/ja01236a048
   Helfferich F.G., 1962, ION EXCHANGE
   Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Kara I, 2012, CHEM ENG J, V211, P442, DOI 10.1016/j.cej.2012.09.086
   Khaled A, 2009, J HAZARD MATER, V165, P100, DOI 10.1016/j.jhazmat.2008.09.122
   Kundu S, 2006, SEP PURIF TECHNOL, V51, P165, DOI 10.1016/j.seppur.2006.01.007
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mall ID, 2006, COLLOID SURFACE A, V278, P175, DOI 10.1016/j.colsurfa.2005.12.017
   Mao J, 2009, BIORESOURCE TECHNOL, V100, P1463, DOI 10.1016/j.biortech.2008.07.053
   Mittal A, 2013, J MOL LIQ, V179, P133, DOI 10.1016/j.molliq.2012.11.032
   Mittal A, 2010, J COLLOID INTERF SCI, V342, P518, DOI 10.1016/j.jcis.2009.10.046
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Pehlivan E, 2013, FOOD CHEM, V138, P133, DOI 10.1016/j.foodchem.2012.09.110
   Sadaf S, 2014, ARCH ENVIRON CON TOX, V66, P557, DOI 10.1007/s00244-013-9992-3
   Sadaf S, 2014, DESALIN WATER TREAT, V52, P184, DOI 10.1080/19443994.2013.780985
   Sadaf S, 2011, AFR J BIOTECHNOL, V10, P13548
   Safa Y, 2011, AFR J BIOTECHNOL, V10, P3128
   Safa Y, 2011, DESALINATION, V272, P313, DOI 10.1016/j.desal.2011.01.040
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Savova D, 2003, CARBON, V41, P1897, DOI 10.1016/S0008-6223(03)00179-9
   Sene L, 2002, BIORESOURCE TECHNOL, V83, P153, DOI 10.1016/S0960-8524(01)00192-4
   Tahir SS, 2006, CHEMOSPHERE, V63, P1842, DOI 10.1016/j.chemosphere.2005.10.033
   Temkin MI, 1940, ACTA PHYSIOCHIM USSR, V12, P217
   Teng MY, 2006, DESALINATION, V194, P156, DOI 10.1016/j.desal.2005.11.008
   Thomas HC, 1944, J AM CHEM SOC, V66, P1664, DOI 10.1021/ja01238a017
   Uddin MT, 2009, J ENVIRON MANAGE, V90, P3443, DOI 10.1016/j.jenvman.2009.05.030
   Vijayaraghavan K, 2005, SEP PURIF TECHNOL, V44, P53, DOI 10.1016/j.seppur.2004.12.003
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 48
TC 47
Z9 48
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD FEB
PY 2015
VL 47
BP 160
EP 170
DI 10.1016/j.jtice.2014.10.001
PG 11
WC Engineering, Chemical
SC Engineering
GA CD8BU
UT WOS:000351321000017
DA 2018-10-20
ER

PT J
AU Gangadoo, S
   Taylor-Robinson, A
   Chapman, J
AF Gangadoo, S.
   Taylor-Robinson, A.
   Chapman, J.
TI Nanoparticle and biomaterial characterisation techniques
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nanoparticle; Biomaterials; Microscopy; Characterisation
ID SULFATE-REDUCING BACTERIA; ATOMIC-FORCE MICROSCOPY;
   DEPOSITION-PRECIPITATION; SILVER NANOPARTICLES; INHIBITION; GROWTH;
   STAPHYLOCOCCUS; QUANTITATION; ABSORPTION; PHTHALATE
AB The physicochemical properties of nanoparticles and biomaterials exert influences over their interactions with cells and consequently play an important role when introduced into any given system. Characterisation of these said materials is a detailed and, above all, a cross-disciplinary relationship of physical, chemical, mechanical, surface, in vitro and in vivo multi-integrated research topics. The biocompatibility of a functional structure with desired properties is affected by the biomaterials' structural characteristics and building block pathways. Moreover, the sensitivity, depth of field, resolution and dimension of a given material also make structural analysis of a nano-biomaterial particularly challenging to characterise. In this paper, we discuss the use of biomaterial characterisation techniques (fluorescent and optical) to characterise structural aspects of biomaterials, with the aim of improving both the understanding and relationship between a biomaterials' structure and its functionality.
C1 [Gangadoo, S.; Taylor-Robinson, A.; Chapman, J.] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.
RP Chapman, J (reprint author), Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.
EM j.chapman@cqu.edu.au
RI Chapman, James/J-7883-2018
OI Chapman, James/0000-0002-9850-0403; Taylor-Robinson,
   Andrew/0000-0001-7342-8348
FU CQUniversity HEALTH CRN; Australian Government's Collaborative Research
   Networks Program
FX This manuscript and project has been supported by the CQUniversity
   HEALTH CRN www.cqu.edu.au/crn and the Australian Government's
   Collaborative Research Networks Program.
CR ABDOLLAHI H, 1990, J GEN MICROBIOL, V136, P1025, DOI 10.1099/00221287-136-6-1025
   Amos WB, 2003, BIOL CELL, V95, P335, DOI 10.1016/S0248-4900(03)00078-9
   Beech IB, 2005, INT MICROBIOL, V8, P157
   Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9
   Briggs D., 1983, PRACTICAL SURFACE AN, p[500, 605]
   Callow ME, 2002, BIOLOGIST, V49, P1
   Chapman J, 2012, RSC NANOSCI NANOTECH, P1, DOI 10.1039/9781849735261
   Chapman J., 2011, DEV NOVEL ANTIFOULIN
   CHAPMAN J, 2014, INT J MATER ENG TECH, V12, P1
   Chapman J, 2014, HIST J FILM RADIO TV, V34, P1, DOI 10.1080/01439685.2014.879010
   Chapman J, 2013, J MATER CHEM B, V1, P6194, DOI 10.1039/c3tb21285h
   Chapman J, 2012, ADV ENG MATER, V14, pB175, DOI 10.1002/adem.201180037
   Chapman J, 2011, J APPL BIOMATER BIOM, V9, P176, DOI 10.5301/JABB.2011.8787
   Chapman J, 2010, J MEMBRANE SCI, V365, P180, DOI 10.1016/j.memsci.2010.09.003
   Chapman J, 2010, COLLOID SURFACE B, V78, P208, DOI 10.1016/j.colsurfb.2010.03.002
   CLAUSE O, 1991, J CATAL, V130, P21, DOI 10.1016/0021-9517(91)90088-L
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   DEALMEIDA JLG, 1994, J AM OIL CHEM SOC, V71, P675, DOI 10.1007/BF02541423
   DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123
   Dulon S, 2007, J APPL ELECTROCHEM, V37, P173, DOI 10.1007/s10800-006-9250-8
   Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e
   Eby GA, 2008, MED HYPOTHESES, V71, P584, DOI 10.1016/j.mehy.2008.04.025
   FELIU S, 1990, ACI MATER J, V87, P457
   FREUNDLICH M, 1963, SCIENCE, V142, P185, DOI 10.1126/science.142.3589.185
   Goda T., 2006, SOFT CONTACT LENS BI
   Grunenwald A, 2014, J ARCHAEOL SCI, V49, P134, DOI 10.1016/j.jas.2014.05.004
   Gu J. D., 2002, MICROBES ENVIRON, V17, P105
   HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873
   Holm ER, 2004, BIOFOULING, V20, P219, DOI 10.1080/08927010400011245
   Horn O, 2004, WATER RES, V38, P3693, DOI 10.1016/j.watres.2004.06.012
   Iverson F., 1959, ADV APPL MICROBIOL, V1
   Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o
   Janagama D. G., NANOBIOELECTRONIC PH, P613
   Jeong L, 2014, INT J MOL SCI, V15, P6857, DOI 10.3390/ijms15046857
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   Knipe E., 1985, CONF850606
   Kodama Y, 2003, APPL ENVIRON MICROB, V69, P107, DOI 10.1128/AEM.69.1.107-112.2003
   Koh IO, 2001, J PHOTOCH PHOTOBIO A, V139, P205, DOI 10.1016/S1010-6030(00)00427-5
   Kumar VG, 2006, ULTRASON SONOCHEM, V13, P549, DOI 10.1016/j.ultsonch.2005.09.010
   Landau MV, 2001, J CATAL, V201, P22, DOI 10.1006/jcat.2001.3227
   Lemire M, 1996, MAR ECOL PROG SER, V135, P77, DOI 10.3354/meps135077
   Li H, 2007, SCI TOTAL ENVIRON, V380, P181, DOI 10.1016/j.scitotenv.2006.12.033
   Li X, 2007, MICROPOR MESOPOR MAT, V102, P151, DOI 10.1016/j.micromeso.2006.12.048
   LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403
   Lytle FW, 1999, J SYNCHROTRON RADIAT, V6, P123, DOI 10.1107/S0909049599001260
   Magot M, 1997, INT J SYST BACTERIOL, V47, P818, DOI 10.1099/00207713-47-3-818
   Margui E, 2014, TRAC-TREND ANAL CHEM, V53, P73, DOI 10.1016/j.trac.2013.09.009
   Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Menzel M, 2014, ANAL CHEM, V86, P3053, DOI 10.1021/ac404017u
   Minz D, 1999, APPL ENVIRON MICROB, V65, P4666
   Nagao E, 1998, J MICROSC-OXFORD, V191, P8
   Nakamiya K, 2005, J BIOSCI BIOENG, V99, P115, DOI 10.1263/jbb.99.115
   Papoulis D, 2014, APPL CATAL B-ENVIRON, V147, P526, DOI 10.1016/j.apcatb.2013.09.025
   Porter A. L., 1990, SCI PUBL POLICY, V17, P229
   Pumera M, 2011, ENERG ENVIRON SCI, V4, P668, DOI 10.1039/c0ee00295j
   Qiao YQ, 2014, BIOMATERIALS, V35, P6882, DOI 10.1016/j.biomaterials.2014.04.101
   Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x
   Regan F., 2011, INSTRUMENT VIEWPOINT, P11
   Seto J, 1996, THIN SOLID FILMS, V273, P97, DOI 10.1016/0040-6090(95)06800-7
   Shapiro L, 2007, THIN SOLID FILMS, V515, P4624, DOI 10.1016/j.tsf.2006.11.117
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Tatsumisago M, 2005, SOLID STATE IONICS, V176, P2909, DOI 10.1016/j.ssi.2005.09.022
   Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V287, P223, DOI 10.1016/S0022-0981(02)00570-1
   TSAI CL, 1988, J ORTHOPAED RES, V6, P666, DOI 10.1002/jor.1100060507
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   Whelan A, 2006, J ENVIRON MONITOR, V8, P880, DOI 10.1039/b603289c
   Whitehead K, 2001, MAR BIOL, V139, P1013
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Yonehara Y, 2001, PROG ORG COAT, V42, P150, DOI 10.1016/S0300-9440(01)00157-6
   Zhang ML, 2013, MATER LETT, V93, P282, DOI 10.1016/j.matlet.2012.11.103
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 73
TC 2
Z9 2
U1 1
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD FEB
PY 2015
VL 30
IS B1
SI SI
BP B44
EP B56
DI 10.1179/1753555714Y.0000000201
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA CD5KE
UT WOS:000351125700009
DA 2018-10-20
ER

PT J
AU Oguchi, Y
   Akahori, T
   Hattori, T
   Fukui, H
   Niinomi, M
AF Oguchi, Yurie
   Akahori, Toshikazu
   Hattori, Tomokazu
   Fukui, Hisao
   Niinomi, Mitsuo
TI Change in Mechanical Strength and Bone Contactability of Biomedical
   Titanium Alloy with Low Young's Modulus Subjected to Fine Particle
   Bombarding Process
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE metallic biomaterial; microstructure; tensile and fatigue properties;
   Young's modulus; biocompatibility
ID BIOCOMPATIBILITY; IMPROVEMENT; STABILITY
AB Beta-type Ti-29Nb-13Ta-4.6Zr (TNTZ), which is a recently developed biomedical titanium alloys, shows a relatively low Young's modulus of around 60 GPa when subjected to a solution treatment.
   However, our focus in this study was on the practical applications of TNTZ in vivo because its mechanical strength decreases with solution treatment progress. Therefore, we investigated the effect of fine particle bombarding (FPB) on the mechanical properties of TNTZ subjected to a cold-swaging treatment in order to maintain its relatively low Young's modulus and to improve its mechanical properties. The relative bone contact ratios between the cancellous bones of Japanese white rabbits and column-shaped TNTZ samples subjected to FPB were also evaluated.
   The microstructure of cold-swaged TNTZ showed a single beta-phase with a marble-like structure. Moreover, its Vickers hardness did not increase remarkably with changes in its diameter, although the average diameter of the beta-grains of solutionized TNTZ ranged from 5.0 to 20 mu m, depending on the increase in the holding time of the solution treatment. The Vickers hardness and Young's modulus of TNTZ subjected to FPB increased at the edge of the specimen surface to be around 70% and 15%, respectively, more than those of cold-swaged TNTZ. Further, the fatigue strength of TNTZ subjected to FPB became significantly higher than that of cold-swaged TNTZ in the high-cycle fatigue life region. Lastly, TNTZ with a rough surface texture (Ra: 0.65 mu m) showed a relative bone contact ratio of more than 80% after undergoing FPB; this value was significantly higher than that of cold-swaged TNTZ with a very smooth surface texture (Ra: 0.07 mu m).
C1 [Oguchi, Yurie] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan.
   [Akahori, Toshikazu; Hattori, Tomokazu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.
   [Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Oguchi, Y (reprint author), Meijo Univ, Nagoya, Aichi 4688502, Japan.
RI Niinomi, Mitsuo/B-5965-2011
FU Light Metal Educational Foundation; Amada Foundation; Tatematsu
   Foundation; Japan Titanium Society
FX This work was supported in part by The Light Metal Educational
   Foundation, The Amada Foundation, The Tatematsu Foundation and The Japan
   Titanium Society.
CR Abe T., 1994, T JSS, V39, P17
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B., 1990, J BIOMED MATER RES, V24, P1067
   Egami N., 2006, Journal of the Japan Society of Precision Engineering, V72, P1071
   Fujimori S., 1995, J JPN DENT MAT, V17, P155
   Furuta T, 2006, J JPN I MET, V70, P579, DOI 10.2320/jinstmet.70.579
   Hattori H., 2002, JPN CLIN BIOMECHANIC, V23, P299
   Ishikura K, 2013, J JPN I MET, V77, P253, DOI 10.2320/jinstmet.J2013003
   Itakura R., 1987, ANN JPN PROSTHODONTI, V31, P21
   John R, 2010, PROCEDIA ENGINEER, V2, P1887, DOI 10.1016/j.proeng.2010.03.203
   Kagaya C., 2006, Journal of the Japan Society of Precision Engineering, V72, P1067
   Ko H., 2002, T JPN SOC MECH ENG A, V68, P484
   Maeda H., 2001, T JPN SOC MECH ENG, V67, P306
   Mitsubayashi M., 1995, T JPN SOC MECH ENG A, V61, P1172
   Miyahara T, 2006, SOLID STATE PHENOMEN, V118, P215, DOI 10.4028/www.scientific.net/SSP.118.215
   MURAKAMI Y, 1993, EFFECT SMALL DEFECTS
   Nakazawa H., 1982, FATIGUE STRENGTH MET, V51
   Nambu K., 2010, T JPN SOC MECH ENG, V76, P88
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   Oshida Y., 2007, BIOSCIENCE BIOENGINE, P179
   Takagi M., 2006, J IRON STEEL I JPN, V92, P24
   Todaka Y, 2003, J JPN I MET, V67, P690, DOI 10.2320/jinstmet1952.67.12_690
   Ushida K, 2012, J JPN I MET, V76, P397, DOI 10.2320/jinstmet.76.397
NR 28
TC 0
Z9 0
U1 0
U2 14
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2015
VL 56
IS 2
BP 218
EP 223
DI 10.2320/matertrans.M2014349
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CE2MQ
UT WOS:000351650100008
OA Bronze
DA 2018-10-20
ER

PT J
AU Hac-Wydro, K
   Wydro, P
   Cetnar, A
   Wlodarczyk, G
AF Hac-Wydro, Katarzyna
   Wydro, Pawel
   Cetnar, Andrzej
   Wlodarczyk, Grzegorz
TI Phospatidylserine or ganglioside - Which of anionic lipids determines
   the effect of cationic dextran on lipid membrane?
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Cationic dextran; Lipid-polymer interactions; Model membrane; BAM images
ID CARRIER; CELLS; PHOSPHATIDYLSERINE; ACCUMULATION; PERMEABILITY;
   DERIVATIVES; POLYMERS; AGENTS; LIVER; RAT
AB In this work the influence of cationic polymer, namely diethylaminoethyl DEAE-dextran on model lipid membranes was investigated. This polymer is of a wide application as a biomaterial and a drug carrier and its cytotoxicity toward various cancer cells was also confirmed. It was suggested that anticancer effect of cationic dextran is connected with the binding of the polymer to the negatively charged sialic acid residues overexpressed in cancer membrane. This fact encouraged us to perform the studies aimed at verifying whether the effect of cationic DEAE-dextran on membrane is determined only by the presence of the negatively charged lipid in the system or the kind of anionic lipid is also important. To reach this goal systematic investigations on the effect of dextran on various one-component lipid monolayers and multicomponent hepatoma cell model membranes differing in the level and the kind of anionic lipids (phosphatidylserine, sialic acid-containing ganglioside GM3 or their mixture) were done. As evidenced the results the effect of DEAE-dextran on the model system is determined by anionic lipid-polymer electrostatic interactions. However, the magnitude of the effect of cationic polymer is strongly dependent on the kind of anionic lipid in the model system. Namely, the packing and ordering of the mixtures containing ganglioside GM3 were more affected by DEAE-dextran than phosphatidylserine-containing monolayers. Although the experiments were done on model systems and therefore further studies are highly needed, the collected data may indicate that ganglioside may be important in the differentiation of the effect of cationic dextran on membranes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Hac-Wydro, Katarzyna; Cetnar, Andrzej; Wlodarczyk, Grzegorz] Jagiellonian Univ, Fac Chem, Dept Environm Chem, PL-30387 Krakow, Poland.
   [Wydro, Pawel] Jagiellonian Univ, Fac Chem, Dept Phys Chem & Electrochem, PL-30060 Krakow, Poland.
RP Hac-Wydro, K (reprint author), Jagiellonian Univ, Fac Chem, Dept Environm Chem, Gronostajowa 3, PL-30387 Krakow, Poland.
EM hac@chemia.uj.edu.pl
CR Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Davies J.T., 1963, INTERFACIAL PHENOMEN
   Dhaneshwar Suneela S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P705
   Dreher MR, 2006, J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070
   Dyatlovitskaya E.V., 1997, EUR J BIOCHEM, V63, P357
   Eshita Y., 2012, J NANOMED NANOTECHNO, VS5, P2, DOI [10.4172/2157-7439.S5-002, DOI 10.4172/2157-7439.S5-002]
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y
   Karp G., 2004, CELL MOL BIOL CONCEP
   Kay JG, 2011, SENSORS-BASEL, V11, P1744, DOI 10.3390/s110201744
   Kolter T., 2012, GANGLIOZIDE BIOCH
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   Marquez M, 2004, ANTICANCER RES, V24, P1347
   Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322
   Nevozhay D, 2006, ANTICANCER RES, V26, P1135
   Onishi Y, 2007, NANOMED-NANOTECHNOL, V3, P184, DOI 10.1016/j.nano.2007.07.002
   Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026
   Tabata Y, 1997, DRUG DELIV, V4, P213, DOI 10.3109/10717549709051895
   Tanaka T, 2004, INT J PHARM, V286, P9, DOI 10.1016/j.ijpharm.2004.07.031
   VANHOEVEN RP, 1972, J MEMBRANE BIOL, V9, P105, DOI 10.1007/BF01868047
   YAMAOKA T, 1995, INT J PHARM, V113, P149, DOI 10.1016/0378-5173(94)00189-C
NR 23
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2015
VL 126
BP 204
EP 209
DI 10.1016/j.colsurfb.2014.12.031
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA CD2OM
UT WOS:000350918900025
PM 25576813
DA 2018-10-20
ER

PT J
AU Morra, M
   Cassinelli, C
   Bollati, D
   Cascardo, G
   Bellanda, M
AF Morra, Marco
   Cassinelli, Clara
   Bollati, Daniele
   Cascardo, Giovanna
   Bellanda, Marco
TI Adherent Endotoxin on Dental Implant Surfaces: A Reappraisal
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE Dental implants; implant surface; endotoxin; osteoimmunology;
   inflammatory response
ID BONE MORPHOGENETIC PROTEIN-2; MACROPHAGE CELL-LINE; BIOMATERIAL;
   OSTEOIMMUNOLOGY; CYTOKINES; TOPOGRAPHY; EXPRESSION; J774A.1
AB Osteoimmunology is the crosstalk between cells from the immune and skeletal systems, suggesting a role of pro-inflammatory cytokines in the stimulation of osteoclast activity. Endotoxin or bacterial challenges to inflammatory cells are directly relevant to dental implant pathologies involving bone resorption, such as osseointegration failure and peri-implantitis. While the endotoxin amount on implant devices is regulated by standards, it is unknown whether commercially available dental implants elicit different levels of adherent-endotoxin stimulated cytokines. The objective of this work is to develop a model system and evaluate endotoxin-induced expression of pro-inflammatory cytokine genes relevant to osteoclast activation on commercially available dental implants. Murine J774-A1 macrophages were cultured on Ti disks with different level of lipopolysaccharide (LPS) contamination to define the time-course of the inflammatory response to endotoxin, as evaluated by reverse transcription polymerase chain reaction analysis. The developed protocol was then used to measure adherent endotoxin on commercially available packaged and sterile dental implants in the "as-implanted" condition. Results show that tested dental implants induce variable expression of endotoxin-stimulated genes, sometimes above the level expected to promote bone resorption in vivo. Results are unaffected by the specific surface treatment; rather, they likely reflect care in cleaning and packaging protocols. In conclusion, expression of genes that enhance osteoclast activity through endotoxin stimulation of inflammatory cells is widely different on commercially available dental implants. A reappraisal of the clinical impact of adherent endotoxins on dental (and bone) implant devices is required in light of increasing knowledge on crosstalk between cells from the immune and skeletal systems.
C1 [Morra, Marco; Cassinelli, Clara; Bollati, Daniele; Cascardo, Giovanna; Bellanda, Marco] Nobil Bio Ric, Portacomaro, Italy.
RP Morra, M (reprint author), Nobil Bio Ric, Portacomaro, Italy.
EM mmorra@nobilbio.it
CR Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bryans Trabue D., 2004, Biomedical Instrumentation & Technology, V38, P73, DOI 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233
   Dean David D, 2008, J Oral Implantol, V34, P303, DOI 10.1563/1548-1336-34.6.303
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P525, DOI 10.1563/AAID-JOI-D-11-00080
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P506, DOI 10.1563/AAID-JOI-D-11-00081
   Gorbet B, 2005, BIOMATERIALS, V26, P6811
   Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   Henderson B, 1996, MICROBIOL REV, V60, P316
   Irinakis T, 2009, J ORAL IMPLANTOL, V35, P277, DOI 10.1563/AAID-JOI-D-09-00020.1
   Juodzbalys Gintaras, 2007, J Oral Implantol, V33, P177, DOI 10.1563/1548-1336(2007)33[177:TDISMO]2.0.CO;2
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495
   Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z
   Omar MO, 2001, BIOMATERIALS, V32, P8190
   Ota-Tsuzuki C, 2011, J ORAL IMPLANTOL, V37, P641, DOI 10.1563/AAID-JOI-D-09-00125.1
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Sugiyama T, 2011, J ORAL IMPLANTOL, V37, P273, DOI 10.1563/AAID-JOI-D-09-00113.1
   Takebe J, 2007, J BIOMED MATER RES A, V80A, P711, DOI 10.1002/jbm.a.30988
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Wataha JC, 2001, J ORAL IMPLANTOL, V27, P174
   Wieland M, 2000, BONE ENG, P163
NR 33
TC 5
Z9 5
U1 0
U2 5
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD FEB
PY 2015
VL 41
IS 1
BP 10
EP 16
DI 10.1563/AAID-JOI-D-12-00137
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC7BM
UT WOS:000350522700003
PM 25699642
DA 2018-10-20
ER

PT J
AU Babbush, CA
   Kanawati, A
AF Babbush, Charles A.
   Kanawati, Ali
TI Clinical Evaluation of 262 Osseointegrated Implants Placed in Sites
   Grafted With Calcium Phosphosilicate Putty: A Retrospective Study
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE bone grafting; implant dentistry; maxillofacial surgery; oral surgery;
   prosthodontics
ID RIDGE PRESERVATION; SUCCESS; RECONSTRUCTION; ALLOGRAFT
AB Along with the widespread use of dental implants, regenerative procedures have become an indispensable tool for implant surgeons in managing residual ridges and the surrounding bone. Putty bone grafts have significantly superior handling characteristics in comparison to particulates. These include ease of placement, enhanced particle containment, and a viscous consistency that has allowed for unique delivery systems to be developed. The aim of this study was to report the clinical efficacy of calcium phosphosilicate (CPS) putty in a wide variety of indications related to implant reconstruction and to report the survival rate of implants placed in these grafted sites. The CPS putty was used as the graft material of choice. Treatments were categorized into following groups: extraction graft, extraction with immediate implant placement, all-on-four concept, peri-implantitis treatment, bone augmentation before implant placement, implant replacement graft, and grafting around implant placed in resorbed ridges. Included in the analysis were 65 patients (36 men, 29 women) with a mean age of 63 +/- 12 years. In total, 262 implants were placed. Four implants were diagnosed with peri-implantitis and were treated as described in category 4, for a total of 266 grafted sites. Two implants from the extraction graft category and 3 implants from the all-on-four group were lost and replaced with successfully osseointegrated implants during a mean study follow-up period of 12.24 +/- 2.32 months. The implant success rate at 1 year was 98.1% (257/262). Based on results of this large-scale, retrospective study we conclude that (1) the use of putty bone grafts can simplify bone-grafting procedures and reduce intraoperative time in various grafting indications, (2) this study verified the efficacy of a CPS putty bone graft biomaterial in a large array of implant-related surgical indications, and (3) implants placed in sites grafted with CPS putty yield very high survival rates.
C1 [Babbush, Charles A.; Kanawati, Ali] ClearChoice Dent Implant Ctr, Cleveland, OH 44124 USA.
   [Babbush, Charles A.; Kanawati, Ali] Case Western Reserve Univ, Case Sch Dent Med, Cleveland, OH 44106 USA.
   [Kanawati, Ali] W Virginia Univ, Sch Dent, Dept Prosthodont, Morgantown, WV 26506 USA.
RP Babbush, CA (reprint author), ClearChoice Dent Implant Ctr, Cleveland, OH 44124 USA.
EM cbabbush@bellsouth.net
FU Novabone Products, LLC, Alachua, Fla
FX This project/study was supported by a grant from Novabone Products, LLC,
   Alachua, Fla.
CR Aichelmann-Reidy ME, 2004, J PERIODONTOL, V75, P340, DOI 10.1902/jop.2004.75.3.340
   Babbush C A, 1998, Implant Dent, V7, P205, DOI 10.1097/00008505-199807030-00008
   BABBUSH CA, 1986, J ORAL MAXIL SURG, V44, P274, DOI 10.1016/0278-2391(86)90078-9
   Babbush CA., 2011, DENTAL IMPLANTS THE
   Babbush Charles A, 2003, Implant Dent, V12, P325, DOI 10.1097/01.ID.0000095466.18042.31
   Babbush CA, 2011, J ORAL IMPLANTOL, V37, P431, DOI 10.1563/AAID-JOI-D-10-00133
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Clementini M, 2012, INT J ORAL MAX SURG, V41, P847, DOI 10.1016/j.ijom.2012.03.016
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hu YC, 2009, CHINESE MED J-PEKING, V122, P2386, DOI 10.3760/cma.j.issn.0366-6999.2009.19.035
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   Kotsakis G, 2014, J ORAL IMPLANTOL, V40, P690, DOI 10.1563/AAID-JOI-D-12-00028
   Kotsakis GA, 2014, INT J PERIODONT REST, V34, P233, DOI 10.11607/prd.1855
   Kotsakis GA, 2014, INT J ORAL MAX IMPL, V29, P141, DOI 10.11607/jomi.3230
   Mahesh L, J ORAL IMPLANTOL IN
   Mahesh Lanka, 2012, Compend Contin Educ Dent, V33, pe109
   Mazor Z, 2013, INT J ORAL IMPLANTOL, V4, P78
   Misch CE, 2008, CONT IMPLANT DENT, P645
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Soltan M, 2012, IMPLANT DENT, V21, P295, DOI 10.1097/ID.0b013e31825e5425
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
NR 21
TC 1
Z9 1
U1 0
U2 7
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD FEB
PY 2015
VL 41
IS 1
BP 63
EP 69
DI 10.1563/AAID-JOI-D-13-00336
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CC7BM
UT WOS:000350522700011
PM 25072734
DA 2018-10-20
ER

PT J
AU Byun, J
AF Byun, Jonghoe
TI Emerging Frontiers of Graphene in Biomedicine
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Graphene; graphene oxide; nanosheet; functionalization; biomedicine;
   nanobiotechnology
ID STEM-CELLS; DRUG-DELIVERY; LABEL-FREE; OXIDE; DNA; CHALLENGES; TOXICITY;
   ACID; FUNCTIONALIZATION; DIFFERENTIATION
AB Graphene is a next-generation biomaterial with increasing biomedical applicability. As a new class of one-atom-thick nanosheets, it is a true two-dimensional honeycomb network nanomaterial that attracts interest in various scientific fields and is rapidly becoming the most widely studied carbon-based material. Since its discovery in 2004, its unique optical, mechanical, electronic, thermal, and magnetic properties are the basis of exploration of the potential applicability of graphene. Graphene materials, such as graphene oxide and its reduced form, are studied extensively in the biotechnology arena owing to their multivalent functionalization and efficient surface loading with various biomolecules. This review provides a brief summary of the recent progress in graphene and graphene oxide biological research together with current findings to spark novel applications in biomedicine. Graphene-based applications are progressively developing; hence, the opportunities and challenges of this rapidly growing field are discussed together with the versatility of these multifaceted materials.
C1 [Byun, Jonghoe] Dankook Univ, Dept Mol Biol, Yongin 448701, South Korea.
   [Byun, Jonghoe] Dankook Univ, Inst Nanosensor & Biotechnol, Yongin 448701, South Korea.
RP Byun, J (reprint author), Dankook Univ, Dept Mol Biol, Yongin 448701, South Korea.
EM jonghoe@dankook.ac.kr
FU Dankook University
FX The present research was conducted by the research fund of Dankook
   University in 2013.
CR Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Bressan E, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0296-9
   Carpio IEM, 2012, NANOSCALE, V4, P4746, DOI 10.1039/c2nr30774j
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chung C, 2012, ACCOUNTS CHEM RES, V46, P2211
   Dong HF, 2010, ANAL CHEM, V82, P5511, DOI 10.1021/ac100852z
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379
   Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gurunathan S, 2012, INT J NANOMED, V7, P5901, DOI 10.2147/IJN.S37397
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   Kanakia S, 2014, BIOMATERIALS, V35, P7022, DOI 10.1016/j.biomaterials.2014.04.066
   Kim H, 2014, SMALL, V10, P117, DOI 10.1002/smll.201202636
   Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085
   Kong HY, 2012, B KOREAN CHEM SOC, V33, P657, DOI 10.5012/bkcs.2012.33.2.657
   Kong HY, 2011, B KOREAN CHEM SOC, V32, P53, DOI 10.5012/bkcs.2011.32.1.53
   Kong HY, 2015, MOL CELLS
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Krishna KV, 2013, NANOMEDICINE-UK, V8, P1669, DOI [10.2217/NNM.13.140, 10.2217/nnm.13.140]
   Kuzum D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6259
   Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li F, 2013, ADV FUNCT MATER, V23, P4140, DOI 10.1002/adfm.201203816
   Li JL, 2014, J BIOMED MATER RES A, V102, P2181, DOI 10.1002/jbm.a.34871
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lu BG, 2012, NANOSCALE, V4, P2978, DOI 10.1039/c2nr11958g
   Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a
   Mir M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04434
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Park DW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6258
   Pinto AM, 2013, COLLOID SURFACE B, V111, P188, DOI 10.1016/j.colsurfb.2013.05.022
   Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22
   Santos CM, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395101
   Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c
   Shen H, 2012, ACS APPL MATER INTER, V4, P6317, DOI 10.1021/am3019367
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Tang ZW, 2010, SMALL, V6, P1205, DOI 10.1002/smll.201000024
   Tao Y, 2012, ANALYST, V137, P2588, DOI 10.1039/c2an35373c
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Wells DB, 2012, NANO LETT, V12, P4117, DOI 10.1021/nl301655d
   Xu ZY, 2014, ACS APPL MATER INTER, V6, P17268, DOI 10.1021/am505308f
   Yang M, 2013, ANALYST, V138, P72, DOI 10.1039/c2an35744e
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang M, 2011, BIOSENS BIOELECTRON, V26, P3260, DOI 10.1016/j.bios.2010.12.037
   Zhou XF, 2014, CURR MED CHEM, V21, P855, DOI 10.2174/0929867320666131119124325
NR 54
TC 22
Z9 22
U1 6
U2 105
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
EI 1738-8872
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD FEB
PY 2015
VL 25
IS 2
BP 145
EP 151
DI 10.4014/jmb.1412.12045
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA CC3RN
UT WOS:000350267100001
PM 25563423
DA 2018-10-20
ER

PT J
AU Vano-Herrera, K
   Misiun, A
   Vogt, C
AF Vano-Herrera, Kelim
   Misiun, Anna
   Vogt, Carla
TI Preparation and characterization of poly( lactic acid)/poly(methyl
   methacrylate) blend tablets for application in quantitative analysis by
   micro Raman spectroscopy
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE poly(lactic acid); poly(methyl methacrylate) blend; polymer blend;
   quantification; implant; micro Raman spectroscopy
ID GLASS-TRANSITION TEMPERATURES; POLY(METHYL METHACRYLATE); DETECTION
   LIMITS; BINARY BLENDS; POLYLACTIDE; COPOLYMERS; MISCIBILITY; DEFINITION;
   MORPHOLOGY; MIXTURES
AB Poly(lactic acid) (PLA) is a biodegradable polymer that has a variety of applications, one of which is as biomaterial in surgery or as functional layers on implants, due to its compatibility with living tissue. This paper reports the possibilities of quantification of poly(lactic acid) (PLA) in a polymer matrix such as poly(methyl methacrylate) (PMMA) by micro Raman spectroscopy (MRS). Blends of amorphous poly(DL-lactic acid) with poly(methyl methacrylate) were prepared by the procedure of dissolution/precipitation. Thermal properties of the blends such as the glass transition temperature (Tg) were characterized by differential scanning calorimetry (DSC). The PLA/PMMA blends exhibited only a single glass transition region, indicating that this system is miscible. The PLA/PMMA system obeys the Gordon-Taylor equation (Tg versus PLA content). Various concentration ratios of PLA blends were prepared to use as a basis for quantitative analysis by MRS. Intensities of the characteristic bands at 813cm(-1) (COC of PMMA) and 873cm(-1) (C?COO of PLA) were used for the calculation. The calibration graph showed a good linear correlation with an R-2 value of 0.9985. On the basis of the calibration curve obtained, the determined content of several PLA/PMMA blends was in good agreement when compared with nominal contents. The limit of detection (LOD) and quantification (LOQ) were calculated by the calibration data set as signal-to-noise method. The relative standard deviation of this method was lower than 10% and the accuracy better than 4%. This study demonstrated that Raman spectroscopy provides an alternative non destructive method for quantitative analysis of PLA in a PMMA matrix. Copyright (c) 2015 John Wiley & Sons, Ltd.
C1 [Vano-Herrera, Kelim; Vogt, Carla] Leibniz Univ Hannover, Dept Analyt Chem, Inst Inorgan Chem, D-30167 Hannover, Germany.
   [Misiun, Anna] German Inst Rubber Technol, Dept Mat Dev & Testing, D-30511 Hannover, Germany.
RP Vogt, C (reprint author), Leibniz Univ Hannover, Dept Analyt Chem, Callinstr 9, D-30167 Hannover, Germany.
EM vogt@acc.uni-hannover.de
OI Vano Herrera, Kelim/0000-0001-8553-5060
CR [Anonymous], 2013, 113572 DIN EN ISO
   [Anonymous], 2008, 32645 DIN
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Auras R., 2010, POLYLACTIC ACID SYNT
   Babu RJ, 2009, MATER LETT, V63, P2666, DOI 10.1016/j.matlet.2009.09.033
   Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008
   Craver C., 2000, APPL POLYM SCI 21 CE
   Eguiburu JL, 1998, POLYMER, V39, P6891, DOI 10.1016/S0032-3861(98)00182-7
   EURACHEM / CITAT, 2012, QUANT UNC AN MEAS
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Kalogeras IM, 2010, THERMOCHIM ACTA, V509, P135, DOI 10.1016/j.tca.2010.06.016
   KISTER G, 1995, J RAMAN SPECTROSC, V26, P307, DOI 10.1002/jrs.1250260409
   Kister G, 1998, POLYMER, V39, P3335, DOI 10.1016/S0032-3861(97)10057-X
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Kister G, 2000, POLYMER, V41, P925, DOI 10.1016/S0032-3861(99)00223-2
   Koenig J. L., 1999, SPECTROSCOPY POLYM
   Kromidas S., 2011, HDB VALIDIERUNG ANAL
   Kucharczyk P., 2011, 5 INT C EN DEV ENV B, V11, P341
   Kucharczyk P., 2011, 5 INT C EN DEV ENG B
   Larkin PJ, 2011, INFRARED AND RAMAN SPECTROSCOPY: PRINCIPLES AND SPECTRAL INTERPRETATION, P1
   Li SH, 2008, POLYM INT, V57, P1242, DOI 10.1002/pi.2469
   Miller J. N., 2005, STAT CHEMOMETRICS AN
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   NEPPEL A, 1984, J RAMAN SPECTROSC, V15, P257, DOI 10.1002/jrs.1250150410
   Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8
   Pinal R, 2008, ENTROPY, V10, P207, DOI 10.3390/entropy-e10030207
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Reichenbacher M, 2011, CHALLENGES IN ANALYTICAL QUALITY ASSURANCE, P1
   Ren J, 2010, BIODEGRADABLE POLY(LACTIC ACID): SYNTHESIS, MODIFICATION, PROCESSING AND APPLICATIONS, P1
   Shemouratov YV, 2009, LASER PHYS, V19, P2179, DOI 10.1134/S1054660X09220010
   Sin L. T, 2012, POLYLACTIC ACID PLA
   Taddei P, 2001, J RAMAN SPECTROSC, V32, P619, DOI 10.1002/jrs.723
   Vandenabeele P, 2012, PLANET SPACE SCI, V62, P48, DOI 10.1016/j.pss.2011.12.006
   Vandenabeele P, 2012, J RAMAN SPECTROSC, V43, P1545, DOI 10.1002/jrs.4055
   Zavgorodnev Y. V., P INT C ADV LAS TECH
   Zhang GB, 2003, J POLYM SCI POL PHYS, V41, P23, DOI 10.1002/polb.10353
   Zou YA, 2010, J BIOMED MATER RES A, V94A, P288, DOI 10.1002/jbm.a.32692
NR 38
TC 12
Z9 12
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD FEB
PY 2015
VL 46
IS 2
BP 273
EP 279
DI 10.1002/jrs.4603
PG 7
WC Spectroscopy
SC Spectroscopy
GA CB8PC
UT WOS:000349891900011
DA 2018-10-20
ER

PT J
AU Teoh, GZ
   Klanrit, P
   Kasimatis, M
   Seifalian, AM
AF Teoh, G. Z.
   Klanrit, P.
   Kasimatis, M.
   Seifalian, A. M.
TI Role of nanotechnology in development of artificial organs
SO MINERVA MEDICA
LA English
DT Article
DE Artificial organs; Tissue engineering; Nanomedicine; Regenerative
   medicine; Chemistry
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; MESENCHYMAL STEM-CELLS; QUANTUM
   DOTS; NANOCOMPOSITE POLYMER; IN-VITRO; SILVER NANOPARTICLES; SURFACE
   MODIFICATION; POSS-NANOCOMPOSITE; NANOPHASE CERAMICS; CARBON NANOTUBE
AB Improvements in our understanding of the interactions between implants and cells have directed attention towards nanoscale technologies. To date, nanotechnology has played a helping hand in the development of synthetic artificial organs and regenerative medicine. This includes the production of smart nanocomposite materials; fluorescent nanoparticles like Quantum Dots (QD) and magnetic nano particles (MNP) for stem cell tracking; and carbon nano tubes (CNT) and graphene for enhancement of material properties. The scope of this paper includes the role of nanoparticles in the development of nanomaterials; the chemical surface modifications possible to improve implant function and an overview of the performance of nano-engineered organs thus far. This includes implants developed for aesthetic purposes like nasal and auricular scaffolds, plastic and reconstructive surgical constructs (i.e. dermal grafts), hollow organs for cardiothoracic applications; and last but not least, orthopedic implants. The five-year outlook for nanoenhanced artificial organs is also discussed, highlighting the key research and development areas, available funds and the hurdles we face in accomplishing progression from prototypes on the laboratory bench to offthe-shelf products for the consumer market. Ultimately, this review aims to delineate the advantages of incorporating nanotechnology, as an individual entity or as a part of a construct for the development of tissue engineering scaffolds and/or artificial organs, and unravel the mechanisms of tissue cell-biomaterial interactions at the nanoscale, allowing for better progress in the development and optimization of unique nanoscale surface features for a wide range of applications.
C1 [Teoh, G. Z.; Klanrit, P.; Kasimatis, M.; Seifalian, A. M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Seifalian, A. M.] Royal Free London NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, London, England.
EM a.seifalian@ucl.ac.uk
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Alves P, 2014, J MATER SCI-MATER M, V25, P2017, DOI 10.1007/s10856-014-5233-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   Cardoso VS, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0036-6
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chang JC, 2008, BIOMATERIALS, V29, P925, DOI 10.1016/j.biomaterials.2007.10.046
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chen Y, 2013, J NANOSCI NANOTECHNO, V13, P2136, DOI 10.1166/jnn.2013.6903
   Chen Y, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4878461
   Cheng K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5880
   Choi HS, 2009, NIH PUBLIC ACCESS, V25, P1165
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   Dinklage A., 2005, PLASMA PHYS
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Gong FR, 2010, INT J POLYM SCI, DOI 10.1155/2010/807935
   Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938
   Guo YL, 2010, J TISSUE ENG REGEN M, V4, P553, DOI 10.1002/term.272
   Gupta A, 2009, BIOTECHNOL APPL BIOC, V54, P221, DOI 10.1042/BA20090214
   HERGENROTHER RW, 1992, J MATER SCI-MATER M, V3, P313, DOI 10.1007/BF00705361
   Hervault A, 2014, NANOSCALE, V21, P11553
   Holbrook RD, 2014, J MATER SCI-MATER M, V25, P2481, DOI 10.1007/s10856-014-5265-6
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.30517
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kong LR, 2014, ADV MATER, V26, P1025, DOI 10.1002/adma.201303432
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502
   Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282
   Liu QS, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40789, 10.1002/app.40789]
   Lu LH, 2012, ADV MATER, V24, P4317, DOI 10.1002/adma.201201320
   Mattheakis LC, 2004, ANAL BIOCHEM, V327, P200, DOI 10.1016/j.ab.2004.01.031
   McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005
   Meyer U., 2009, FUNDAMENTALS TISSUE
   Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Nezakati T, 2014, ARCH TOXICOL, V88, P1987, DOI 10.1007/s00204-014-1361-0
   Nezakati T, 2014, J COLLOID INTERF SCI, V435, P145, DOI 10.1016/j.jcis.2014.08.020
   Oseni AO, 2011, BRIT J SURG, V98, P6
   Pacak CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108695
   Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]
   Petryk AA, 2013, INT J HYPERTHER, V29, P819, DOI 10.3109/02656736.2013.845801
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rahimi M, 2010, NANOMED-NANOTECHNOL, V6, P672, DOI 10.1016/j.nano.2010.01.012
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586
   Recek N, 2013, MOLECULES, V18, P12441, DOI 10.3390/molecules181012441
   Schroeder JE, 2007, J CONTROL RELEASE, V124, P28, DOI 10.1016/j.jconrel.2007.08.028
   Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711
   Shah BS, 2011, METHODS MOL BIOL, V680, P61, DOI 10.1007/978-1-60761-901-7_4
   Shameli K, 2011, INT J NANOMED, V6, P331, DOI 10.2147/IJN.S16964
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Tan A, 2013, BIOINTERPHASES, V8, P1
   Tao ZW, 2014, J TISSUE ENG REGEN M
   Thomas S, 2003, J Wound Care, V12, P101
   Verma S, 2011, NANOMEDICINE-UK, V6, P157, DOI [10.2217/nnm.10.157, 10.2217/NNM.10.146]
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu XR, 2010, DENT MATER, V26, P456, DOI 10.1016/j.dental.2009.11.161
   Xin L, 2014, HUM EXP TOXICOL
   Yoshioka T, 2011, J TISSUE ENG REGEN M, V5, P437, DOI 10.1002/term.329
   Yue WW, 2013, J MEMBRANE SCI, V446, P79, DOI 10.1016/j.memsci.2013.06.029
NR 80
TC 3
Z9 3
U1 4
U2 45
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4806
EI 1827-1669
J9 MINERVA MED
JI Minerva Med.
PD FEB
PY 2015
VL 106
IS 1
BP 17
EP 33
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA CC0DP
UT WOS:000350006300003
PM 25300897
DA 2018-10-20
ER

PT J
AU Molino, PJ
   Innis, PC
   Higgins, MJ
   Kapsa, RMI
   Wallace, GG
AF Molino, Paul J.
   Innis, Peter C.
   Higgins, Michael J.
   Kapsa, Robert M. I.
   Wallace, Gordon G.
TI Influence of biopolymer loading on the physiochemical and
   electrochemical properties of inherently conducting polymer biomaterials
SO SYNTHETIC METALS
LA English
DT Article
DE Conducting polymer; Polypyrrole; Biopolymer; QCM; Biomaterial
ID POLYPYRROLE FILMS; SURFACE-MORPHOLOGY; NEURITE OUTGROWTH; STIMULATION;
   GROWTH
AB The physicochemical and electrochemical properties of polypyrrole (PPy) doped with the biological dopant dextran sulphate (DS) were shown to be significantly altered as a function of varying the salt concentration (0.2, 2 or 20 mg/ml) in the polymerisation electrolyte. Films grown in the presence of 0.2 mg/ml DS generated the highest potential during galvanostatic growth, with the potential decreasing with each subsequent increase in DS concentration. The electroactivity of the polymers was similar for all three DS concentrations, with the 20 mg/ml film drawing slightly more current upon reduction in PBS. Increasing the DS concentration reduced film interfacial roughness and increased polymer hydrophilicity. Polymer mass and thickness was larger for DS films grown from 0.2 mg/ml and 2 mg/ml DS electrolyte solutions, compared to the 20 mg/ml films. The latter also demonstrated a much higher shear modulus than the 2 mg/ml and 0.2 mg/ml films, respectively. The changes in the polymer physicochemical properties were associated with an increase in polymer densification with increasing DS loading, correlating with a likely higher conjugation generated during polymerisation at a potential closer to the ideal oxidation potential of pyrrole. Herein we describe a facile approach through which polymer properties may be varied significantly by varying the dopant concentration in the electrolyte, providing the ability to tune polymer properties for enhanced functionality while preserving fundamental polymer chemistry. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Molino, Paul J.; Innis, Peter C.; Higgins, Michael J.; Kapsa, Robert M. I.; Wallace, Gordon G.] Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
RP Molino, PJ (reprint author), Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
EM pmolino@uow.edu.au; gordon_wallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011; Innis, Peter/D-6715-2012
OI Wallace, Gordon/0000-0002-0381-7273; Innis, Peter/0000-0003-4445-3899;
   Molino, Paul/0000-0002-8868-2733
FU National Health and Medical Research Council [573430]; Australian
   Research Council
FX The authors gratefully acknowledge the Australian Research Council and
   the National Health and Medical Research Council (Grant No. 573430). We
   also acknowledge the Australian National Nanofabrication Facility (ANFF)
   for access to equipment. The authors acknowledge the use of the
   facilities and the assistance of Mr Tony Romeo at the UOW Electron
   Microscopy Centre.
CR Almario AAA, 2009, J CHIL CHEM SOC, V54, P14, DOI 10.4067/S0717-97072009000100004
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fonner J.M., 2008, BIOMED MAT, V3
   Fonner JM, 2010, POLYMER, V51, P4985, DOI 10.1016/j.polymer.2010.08.024
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   HALL M, 1952, J CLIN PATHOL, V5, P366, DOI 10.1136/jcp.5.4.366
   Irie H., 2005, ELECTROCHEM SOLID ST, V8
   Kaynak A, 2000, MATER RES BULL, V35, P813, DOI 10.1016/S0025-5408(00)00280-4
   Kaynak A, 1997, MATER RES BULL, V32, P271, DOI 10.1016/S0025-5408(96)00200-0
   Liu YC, 2004, J ELECTROANAL CHEM, V571, P255, DOI 10.1016/j.jelechem.2004.05.015
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053
   Wallace G. G, 2009, CONDUCTIVE ELECTROAC
   Wang SF, 2011, INT J POLYM SCI, DOI 10.1155/2011/184623
NR 23
TC 4
Z9 4
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD FEB
PY 2015
VL 200
BP 40
EP 47
DI 10.1016/j.synthmet.2014.12.018
PG 8
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA CC2PI
UT WOS:000350186700005
DA 2018-10-20
ER

PT J
AU Verissimo, DM
   Leitao, RF
   Figueiro, SD
   Goes, JC
   Lima, V
   Silveira, CO
   Brito, GAC
AF Verissimo, Denusa M.
   Leitao, Renata F. C.
   Figueiro, Sonia D.
   Goes, Julio C.
   Lima, Vilma
   Silveira, Charles O.
   Brito, Gerly A. C.
TI Guided bone regeneration produced by new mineralized and reticulated
   collagen membranes in critical-sized rat calvarial defects
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Biomaterial(s); bone regeneration; collagen(s); guided bone
   regeneration; tissue engineering
ID TISSUE REGENERATION; EXPERIMENTAL-MODEL; DENTAL IMPLANTS; CROSS-LINKING;
   IN-VITRO; GLUTARALDEHYDE; MATRIX; DEGRADATION; MECHANISM
AB The aim of this study was to evaluate the bone regenerative effect of glutaraldehyde (GA) cross-linking on mineralized polyanionic collagen membranes in critical-sized defects on rat calvarias. Bone calvarial defects were induced in Wistar rats, which were then divided into five groups: a sham group; a control group, which received a commercial membrane; and GA, 25GA, and 75GA groups, which received one of three different polyanionic collagen membranes mineralized by 0, 25, or 75 hydroxyapatite cycles and then cross-linked by GA. Bone formation was evaluated based on digital radiography and computerized tomography. Histological analyses were performed 4 and 12 weeks after the surgical procedure to observe bone formation, membrane resorption, and fibrous tissue surrounding the membranes. Measurement of myeloperoxidase activity, tumor necrosis factor alpha, and interleukin 1beta production was performed 24h after surgery. The percentage of new bone formation in the GA, 25GA, and 75GA groups was higher compared with the control and sham groups. In the GA and 25 GA groups, the membranes were still in place and were contained in a thick fibrous capsule after 12 weeks. No significant difference was found among the groups regarding myeloperoxidase activity and interleukin 1beta levels, although the GA, 25GA, and 75GA groups presented decreased levels of tumor necrosis factor alpha compared with the control group. These new GA cross-linked membranes accelerated bone healing of the calvarium defects and did not induce inflammation. In addition, unlike the control membrane, the experimental membranes were not absorbed during the analyzed period, so they may offer advantages in large bone defects where prolonged membrane barrier functions are desirable.
C1 [Verissimo, Denusa M.; Lima, Vilma] Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Leitao, Renata F. C.; Brito, Gerly A. C.] Univ Fed Ceara, Sch Med, Dept Morphol, BR-60430270 Fortaleza, Ceara, Brazil.
   [Figueiro, Sonia D.; Goes, Julio C.] Univ Fed Ceara, Dept Phys, BR-60430270 Fortaleza, Ceara, Brazil.
   [Silveira, Charles O.] Univ Fed Ceara, Sch Med, BR-60430270 Fortaleza, Ceara, Brazil.
RP Verissimo, DM (reprint author), Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil.
EM denusa.verissimo@terra.com.br
RI Universidade Federal do Ceara, Physics Department/J-4630-2016; UFC,
   DF/E-1564-2017; Brito, Gerly/C-8597-2013
OI Universidade Federal do Ceara, Physics Department/0000-0002-9247-6780;
   Brito, Gerly/0000-0002-8214-4379; Lima, Vilma/0000-0002-8652-4133; Goes,
   Julio Cesar/0000-0002-6324-7647
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico
   (FUNCAP);  [INCT 573928/2008-8]
FX The authors thank Conceicao da Silva Martins and Maria do Socorro Franca
   Monte, Department of Morphology, Faculty of Medicine, Federal University
   of Ceara, Brazil, for providing technical assistance and Perboyre
   Castelo in Dentistry Radiology for radiological assistance. This work
   was supported by Grant INCT 573928/2008-8 and Fundacao Cearense de Apoio
   ao Desenvolvimento Cientifico e Tecnologico (FUNCAP).
CR Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   BRADLEY PP, 1982, BLOOD, V60, P618
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   CUNHA FQ, 1993, EUR J PHARMACOL, V238, P47, DOI 10.1016/0014-2999(93)90503-A
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Furlaneto FAC, 2007, CLIN ORAL IMPLAN RES, V18, P311, DOI 10.1111/j.1600-0501.2006.01331.x
   Goes JC, 2007, ACTA BIOMATER, V3, P773, DOI 10.1016/j.actbio.2007.02.008
   Goissis G, 2009, MATER RES-IBERO-AM J, V12, P113, DOI 10.1590/S1516-14392009000100015
   Greenstein G, 2000, PERIODONTOL, V1, P36
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Hollinger JO, 1999, APPL MAXILLOFACIAL S, P17
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275
   Kozlovsky A, 2009, CLIN ORAL IMPLAN RES, V20, P1116, DOI 10.1111/j.1600-0501.2009.01740.x
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Nowzari H, 1995, Int J Oral Maxillofac Implants, V10, P67
   Nowzari J, 1998, J PERIODONTOL, V69, P528
   NYMAN S, 1987, J PERIODONTAL RES, V22, P252, DOI 10.1111/j.1600-0765.1987.tb01581.x
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Potijanyakul P, 2010, J ORAL IMPLANTOL, V36, P195, DOI 10.1563/AAID-JOI-D-09-00042
   Pryor ME, 2006, J CLIN PERIODONTOL, V33, P455, DOI 10.1111/j.1600-051X.2006.00921.x
   SaWeh-Garabedian B, 1995, BRIT J PHARMACOL, V115, P1265
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Simion M, 1997, INT J ORAL MAX IMPL, V12, P159
   SIMION M, 1994, J PERIODONTOL, V65, P755, DOI 10.1902/jop.1994.65.8.755
   Verissimo DM, 2010, ACTA BIOMATER, V6, P4011, DOI 10.1016/j.actbio.2010.04.012
   Verna C, 2002, J CLIN PERIODONTOL, V29, P865, DOI 10.1034/j.1600-051X.2002.290912.x
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yeom H, 2008, J CRANIOFAC SURG, V19, P446, DOI 10.1097/SCS.0b013e318052fe05
   Yoshioka SA, 2008, J MATER SCI-MATER M, V19, P1215, DOI 10.1007/s10856-007-0151-0
   Zhu XL, 2006, J BIOMED MATER RES A, V79A, P114, DOI 10.1002/jbm.a.30706
NR 41
TC 4
Z9 4
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD FEB
PY 2015
VL 240
IS 2
BP 175
EP 184
DI 10.1177/1535370214549518
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CB4VT
UT WOS:000349627100006
PM 25245073
OA Green Published
DA 2018-10-20
ER

PT J
AU Bawazer, L
AF Bawazer, Lukmaan
TI Bio Focus Biomaterial NanoART combats HIV
SO MRS BULLETIN
LA English
DT News Item
CR BIOMATERIALS, P141, DOI DOI 10.1016/J.BIOMATERIALS.2014.11.012
NR 1
TC 0
Z9 0
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD FEB
PY 2015
VL 40
IS 2
BP 105
EP 105
DI 10.1557/mrs.2015.16
PG 1
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CB5SB
UT WOS:000349686700006
DA 2018-10-20
ER

PT J
AU Zhou, Y
   Snead, ML
   Tamerler, C
AF Zhou, Yan
   Snead, Malcolm L.
   Tamerler, Candan
TI Bio-inspired hard-to-soft interface for implant integration to bone
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Biomaterial interface; Chimeric peptide; Wnt signaling; Osteogenesis;
   Bone regeneration
ID RICH AMELOGENIN PEPTIDE; OSTEOBLASTOGENESIS; NANOTECHNOLOGY;
   BIOMATERIALS; WNT10B
AB Accomplishing full, functional integration at the host-to-biomaterial interface has been a critical roadblock in engineering implants with performance similar to biological materials. Molecular recognition-based self-assembly, coupled with biochemical signaling, may lead to controllable and predictable cellular differentiation at the implant interface. Here, we engineer a bio-inspired interface built upon a chimeric peptide. Binding to the biomaterial interface is achieved using a molecular recognition domain specific for the titanium/titanium alloy implant surface and a biochemical signal guiding stem cells to differentiate by activating the Wnt signaling pathway for bone formation. During a critical period of host cell growth and determination, the bioactive implant interface signals mouse, as well as human, stem cells to differentiate along osteogenic lineages. The Wnt-induced cells show enhanced mineral deposition in an extracellular matrix of their creation and an enhanced gene expression profile consistent with osteogenesis, thereby providing a bone-to-implant interface that promotes bone regeneration. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhou, Yan; Snead, Malcolm L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent USC, Los Angeles, CA USA.
   [Tamerler, Candan] Univ Kansas, Sch Engn, Dept Mech Engn, Res Ctr, Lawrence, KS 66045 USA.
RP Snead, ML (reprint author), Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.
EM yzhou@usc.edu; mlsnead@usc.edu; ctamerler@ku.edu
OI Tamerler, Candan/0000-0002-1960-2218
FU USPHS; National Institutes of Health, the National Institute of Dental
   and Craniofacial Research [DE13045]; National Institute of Arthritis and
   Musculoskeletal and Skin Disease [AR062249]; University of Kansas,
   School of Engineering
FX Supported by USPHS, National Institutes of Health, the National
   Institute of Dental and Craniofacial Research, DE13045 (YZ, MLS), the
   National Institute of Arthritis and Musculoskeletal and Skin Disease,
   AR062249 (CT), and the University of Kansas, School of Engineering. We
   thank Bridget Samuel for excellent assistance with manuscript
   preparation.
CR Anand Rajan, 2011, J Bone Joint Surg Am, V93 Suppl 3, P51, DOI 10.2106/JBJS.K.00867
   [Anonymous], 2012, BIOM IMP AR FUT INV
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Bhatia Dinesh, 2013, J Pharm Bioallied Sci, V5, P30, DOI 10.4103/0975-7406.106561
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Evans JS, 2008, MRS BULL, V33, P514, DOI 10.1557/mrs2008.103
   Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d
   Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200
   Levy Y, 2006, ACCOUNTS CHEM RES, V39, P135, DOI 10.1021/ar040204a
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Saiz E, 2013, DENT MATER, V29, P103, DOI 10.1016/j.dental.2012.08.001
   Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058
   Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
NR 20
TC 12
Z9 12
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD FEB
PY 2015
VL 11
IS 2
BP 431
EP 434
DI 10.1016/j.nano.2014.10.003
PG 4
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA CB6NW
UT WOS:000349744700020
PM 25461292
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hozumi, K
   Kumai, J
   Yamada, Y
   Nomizu, M
AF Hozumi, Kentaro
   Kumai, Jun
   Yamada, Yuji
   Nomizu, Motoyoshi
TI Active Peptide-Conjugated Chitosan Matrices as an Artificial Basement
   Membrane
SO POLYMERS
LA English
DT Review
ID LAMININ ALPHA-1 CHAIN; CELL-BINDING SEQUENCES; BIOLOGICAL-ACTIVITIES;
   EXTRACELLULAR-MATRIX; TARGETED DISRUPTION; SYNTHETIC PEPTIDES; SCAFFOLD
   MATERIAL; GLOBULAR DOMAIN; LG4 MODULE; STEM-CELLS
AB The basement membrane, a thin extracellular matrix, plays a critical role in tissue development and repair. Laminins are the major component of basement membrane and have diverse biological activities. We have identified various cell-adhesive peptides from laminins and their specific cell surface receptors. Polysaccharides, including chitosan, have been used as scaffolds, which regulate cellular functions for tissue engineering. We have developed laminin-derived active peptide-chitosan matrices as functional scaffolds. The biological activity of the peptides was enhanced when the peptides were conjugated to a chitosan matrix, suggesting that the peptide-chitosan matrix approach has an advantage for an active biomaterial. Further, the laminin peptide-chitosan matrices have the potential to mimic the basement membrane and are useful for tissue engineering as an artificial basement membrane.
C1 [Hozumi, Kentaro; Kumai, Jun; Yamada, Yuji; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
RP Hozumi, K (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM hozumi@toyaku.ac.jp; y071096@toyaku.ac.jp; y041219@toyaku.ac.jp;
   nomizu@toyaku.ac.jp
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [24500530, 25560228]
FX We are grateful to Yamato Kikkawa, Fumihiko Katagiri and Yuichi Kadoya
   for invaluable comments and suggestions. This work was supported by
   Grants-in-Aid for Scientific Research from the Ministry of Education,
   Cultures, Sports, Science and Technology of Japan (24500530 and
   25560228).
CR Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Charonis A, 2005, CURR MED CHEM, V12, P1495, DOI 10.2174/0929867054039071
   Chen HP, 2014, EXP CELL RES, V323, P346, DOI 10.1016/j.yexcr.2014.02.028
   Chen YH, 2012, BIOMATERIALS, V33, P1336, DOI 10.1016/j.biomaterials.2011.10.048
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x
   Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3
   Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Hibino S, 2005, CANCER RES, V65, P10494, DOI 10.1158/0008-5472.CAN-05-0314
   Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074
   Kikkawa Y, 2013, CELL ADHES MIGR, V7, P150, DOI 10.4161/cam.22827
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kuang W, 1998, EXP CELL RES, V241, P117, DOI 10.1006/excr.1998.4025
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martin-Lopez E, 2012, J BIOMAT SCI-POLYM E, V23, P207, DOI 10.1163/092050610X546426
   Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713
   Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Otagiri D, 2013, BIOPOLYMERS, V100, P751, DOI 10.1002/bip.22303
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   Renner L, 2004, J MATER SCI-MATER M, V15, P387, DOI 10.1023/B:JMSM.0000021107.12809.8d
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   Wang JM, 2006, J BIOL CHEM, V281, P213, DOI 10.1074/jbc.M505061200
   Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044
   Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Zhu N, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045002
NR 71
TC 2
Z9 2
U1 4
U2 32
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD FEB
PY 2015
VL 7
IS 2
BP 281
EP 297
DI 10.3390/polym7020281
PG 17
WC Polymer Science
SC Polymer Science
GA CC3AP
UT WOS:000350216800006
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, HS
   Dastgheyb, SS
   Hickok, NJ
   Eckmann, DM
   Composto, RJ
AF Lee, Hyun-Su
   Dastgheyb, Sana S.
   Hickok, Noreen J.
   Eckmann, David M.
   Composto, Russell J.
TI Targeted Release of Tobramycin from a pH-Responsive Grafted Bilayer
   Challenged with S. aureus
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; POLYMER BRUSHES; BACTERIAL BIOFILMS;
   IN-SITU; STAPHYLOCOCCUS-AUREUS; TITANIUM-ALLOY; DRUG-RELEASE;
   THIN-FILMS; SURFACES; INFECTION
AB A stimuli-responsive, controlled release bilayer for the prevention of bacterial infection on biomaterials is presented. Drug release is locally controlled by the pH-responsiveness of the bilayer, comprised of an inner poly(acrylic acid) (PAA) monolayer grafted to a biomaterial and cross-linked with an outer chitosan (CH) brush. Tobramycin (TOB) is loaded in the inner PAA in part to minimize bacteria resistance. Because biofilm formation causes a decrease in local pH, TOB is released from PAA and permeates through the CH, which is in contact with the biofilm. Antibiotic capacity is controlled by the PAA thickness, which depends on PAA brush length and the extent of cross-linking between CH and PAA at the bilayer interface. This TOB-loaded, pH-responsive bilayer exhibits significantly enhanced antibacterial activity relative to controls.
C1 [Lee, Hyun-Su; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Dastgheyb, Sana S.; Hickok, Noreen J.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
RP Composto, RJ (reprint author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.
EM composto@seas.upenn.edu
OI Dastgheyb, Sana/0000-0001-8275-1614; Lee, Hyun-Su/0000-0002-5245-8430
FU Pennsylvania Nanomaterials Commercialization Center [NANO-2013-0065];
   Benjamin Franklin Technology Partners of Southeastern PA [NTI
   1011-05-10]; National Institutes of Health [NIH R01 HL60230]; NIH
   [HD-061053, DE-019901]; NIH (National Institute of Arthritis and
   Musculoskeletal and Skin Diseases) training grant [T32-AR-05227];
   NSF/NBIC [DMR08-32802]; Colgate-Palmolive
FX R.J.C., D.M.E., and H.L. acknowledge funding from the Pennsylvania
   Nanomaterials Commercialization Center (NANO-2013-0065) and Benjamin
   Franklin Technology Partners of Southeastern PA (NTI 1011-05-10). This
   work was supported by the National Institutes of Health (NIH R01
   HL60230). N.J.H. and S.S.D thank the NIH (HD-061053 and DE-019901) and
   the NIH (National Institute of Arthritis and Musculoskeletal and Skin
   Diseases) training grant (T32-AR-05227) for support. R.J.C. and H.L.
   also thank NSF/NBIC (DMR08-32802) and Colgate-Palmolive for support. We
   also thank Dr. Daeyeon Lee for permission to use SE and thank Dr.
   Alexander Horswill for permission to use his AH1710 strain.
CR Abu-Lail NI, 2006, SENSOR ACTUAT B-CHEM, V114, P371, DOI 10.1016/j.snb.2005.06.003
   Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Ayres N, 2007, LANGMUIR, V23, P182, DOI 10.1021/la0615261
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Bromberg L, 2007, POLYMER, V48, P7490, DOI 10.1016/j.polymer.2007.10.040
   Brunner H, 1999, J COLLOID INTERF SCI, V212, P545, DOI 10.1006/jcis.1998.6062
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Caruso F, 2000, LANGMUIR, V16, P8932, DOI 10.1021/la000401s
   COLTON MB, 1953, J AM DENT ASSOC, V47, P524, DOI 10.14219/jada.archive.1953.0206
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Deiss F, 2014, LAB CHIP, V14, P167, DOI 10.1039/c3lc50887k
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Draper J, 2004, LANGMUIR, V20, P4064, DOI 10.1021/la0361316
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   Guegan C, 2014, COLLOID SURFACE B, V114, P193, DOI 10.1016/j.colsurfb.2013.10.010
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]
   Hidalgo G, 2009, APPL ENVIRON MICROB, V75, P7426, DOI 10.1128/AEM.01220-09
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Hiller J, 2003, MACROMOLECULES, V36, P4078, DOI 10.1021/ma025837o
   HUANG CT, 1995, APPL ENVIRON MICROB, V61, P2252
   Itano K, 2005, MACROMOLECULES, V38, P3450, DOI 10.1021/ma047667g
   Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002
   Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134
   Jhon YK, 2006, MACROMOL RAPID COMM, V27, P697, DOI 10.1002/marc.200600031
   Kandel J, 2014, BIOSENS BIOELECTRON, V58, P249, DOI 10.1016/j.bios.2014.02.053
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kharlampieva E, 2004, LANGMUIR, V20, P9677, DOI 10.1021/la048763d
   Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1446, DOI 10.1128/AAC.00054-07
   Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538
   Lee H., 2013, POLYM MAT SCI ENG, V109, P76
   Lee HS, 2008, MACROMOLECULES, V41, P8124, DOI 10.1021/ma8009307
   Lee HS, 2013, J MATER CHEM B, V1, P6382, DOI [10.1039/C3TB21218A, 10.1039/c3tb21218a]
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lego B, 2008, LANGMUIR, V24, P379, DOI 10.1021/la703051b
   Lego B, 2009, LANGMUIR, V25, P5313, DOI 10.1021/la804060s
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323
   Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011
   McLeod BR, 1999, METHOD ENZYMOL, V310, P656
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Moya S, 2005, ANGEW CHEM INT EDIT, V44, P4578, DOI 10.1002/anie.200500228
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Sanjuan S, 2007, LANGMUIR, V23, P5769, DOI 10.1021/la063450z
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   SAUERBREY G, 1959, Z PHYS, V155, P155
   Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231
   Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Vats N, 2000, ARCH ORAL BIOL, V45, P305, DOI 10.1016/S0003-9969(99)00139-9
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Vogt BD, 2004, J PHYS CHEM B, V108, P12685, DOI 10.1021/jp0481005
   Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502
   Walter F, 1999, CURR OPIN CHEM BIOL, V3, P694, DOI 10.1016/S1367-5931(99)00028-9
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Wu T, 2007, MACROMOLECULES, V40, P8756, DOI 10.1021/ma0710176
   YU FP, 1994, J MICROBIOL METH, V20, P1, DOI 10.1016/0167-7012(94)90058-2
   Yuan Y, 2013, ADV MATER, V25, P6619, DOI 10.1002/adma.201301955
   Zhuk I, 2014, ACS NANO, V8, P7733, DOI 10.1021/nn500674g
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 86
TC 23
Z9 23
U1 3
U2 81
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2015
VL 16
IS 2
BP 650
EP 659
DI 10.1021/bm501751v
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CA9VN
UT WOS:000349273000024
PM 25585173
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jiang, X
   Jeffries, RE
   Acosta, MA
   Tikunov, AP
   Macdonald, JM
   Walker, GM
   Gamcsik, MP
AF Jiang, Xiao
   Jeffries, Rex E.
   Acosta, Miguel A.
   Tikunov, Andrey P.
   Macdonald, Jeffrey M.
   Walker, Glenn M.
   Gamcsik, Michael P.
TI Biocompatibility of Tygon (R) tubing in microfluidic cell culture
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Biomaterial; Cancer cell; Biocompatibility; Toxicity; Polyvinylchloride;
   Spectroscopy
ID SMALL MOLECULES
AB Growth of the MDA-MB-231 breast cancer cell line in microfluidic channels was inhibited when culture media was delivered to the channels via microbore Tygon (R) tubing. Culture media incubated within this tubing also inhibited growth of these cells in conventional 96-well plates. These detrimental effects were not due to depletion of critical nutrients due to adsorption of media components onto the tubing surface. A pH change was also ruled out as a cause. Nuclear magnetic resonance spectroscopy of the cell growth media before and after incubation in the tubing confirmed no detectable loss of media components but did detect the presence of additional unidentified signals in the aliphatic region of the spectrum. These results indicate leaching of a chemical species from microbore Tygon (R) tubing that can affect cell growth in microfluidic devices.
C1 [Jiang, Xiao; Jeffries, Rex E.; Acosta, Miguel A.; Tikunov, Andrey P.; Macdonald, Jeffrey M.; Walker, Glenn M.; Gamcsik, Michael P.] UNC NCSU Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
RP Gamcsik, MP (reprint author), UNC NCSU Joint Dept Biomed Engn, 4206D Engn Bldg 3,911 Oval Dr, Raleigh, NC 27695 USA.
EM mgamcsi@ncsu.edu
OI Jiang, Xiao/0000-0001-8307-2170
FU National Institutes of Health [CA167471]
FX This work was supported by National Institutes of Health grant CA167471.
   NMR data was collected at the Hamner-UNC Metabolomics Facility of the
   Hamner Institutes for Health Sciences, Research Triangle Park, NC.
CR Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g
   Cooksey GA, 2011, ANAL CHEM, V83, P3890, DOI 10.1021/ac200273f
   Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Kim T, 2009, BIOMED MICRODEVICES, V11, P65, DOI 10.1007/s10544-008-9210-7
   Kolnik M, 2012, LAB CHIP, V12, P4732, DOI 10.1039/c2lc40569e
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   PRICE NM, 1986, MAR ECOL PROG SER, V34, P41, DOI 10.3354/meps034041
   Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c
   Walker GM, 2007, LAB CHIP, V7, P226, DOI 10.1039/b608990a
   Zhou JH, 2011, LAB CHIP, V11, P2288, DOI 10.1039/c0lc00466a
NR 14
TC 1
Z9 1
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 2015
VL 17
IS 1
AR 20
DI 10.1007/s10544-015-9938-9
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA CB3SH
UT WOS:000349548200020
PM 25653072
DA 2018-10-20
ER

PT J
AU Pieretti, EF
   Pessine, EJ
   Correa, OV
   de Rossi, W
   das Neves, MDM
AF Pieretti, Eurico Felix
   Pessine, Elisabete Jorge
   Correa, Olandir Vercino
   de Rossi, Wagner
   Martins das Neves, Maurcio David
TI Effect of Laser Parameters on the Corrosion Resistance of the ASTM F139
   Stainless Steel
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomaterials; stainless steel; corrosion; laser marks
ID SEMICONDUCTING PROPERTIES; SURFACE-ROUGHNESS; IMPLANT MATERIALS;
   OXIDE-FILMS; MARKING; SPECTROSCOPY; IMPEDANCE; HARDNESS; ALBUMIN
AB The investigation on the corrosion resistance of biomaterials and the effects of manufacturing processes, including marking for traceability, is extremely important to evaluate whether the surface modification caused by marking affects the properties of the biomaterial. The engraving process by laser beam has been used to ensure the identification and traceability of orthopedic implants. This study evaluates the influence of the laser marking parameters, specifically the pulse energy and engraving rate, on the corrosion resistance of the ASTM F139 austenitic stainless steel, after engraving with Nd: YAG laser beam by means of electrochemical methods. The electrolyte used was a phosphate buffered solution, with pH 7.4, and 37 degrees C. The results showed that the laser marking parameters affect the protective properties of the passive film and influence the susceptibility to corrosion of this biomaterial.
C1 [Pieretti, Eurico Felix; Pessine, Elisabete Jorge; Correa, Olandir Vercino; de Rossi, Wagner; Martins das Neves, Maurcio David] Inst Pesquisas Energet & Nucl IPEN CNEN, BR-05508000 Sao Paulo, Brazil.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
EM efpieretti@usp.br
RI de Rossi, Wagner/J-8344-2013; Neves, Mauricio/D-7588-2012
OI Neves, Mauricio/0000-0002-1304-2117; de Rossi,
   Wagner/0000-0003-1371-7521
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   [Anonymous], 129322010 ABNT NBR
   AZUMI K, 1986, T JPN I MET, V27, P382, DOI 10.2320/matertrans1960.27.382
   Belo MD, 1998, CORROS SCI, V40, P447, DOI 10.1016/S0010-938X(97)00158-3
   Bizi-Bandoki P, 2011, APPL SURF SCI, V257, P5213, DOI 10.1016/j.apsusc.2010.12.089
   Bonora PL, 1996, ELECTROCHIM ACTA, V41, P1073, DOI 10.1016/0013-4686(95)00440-8
   BORRUTO A, 1995, WEAR, V184, P119, DOI 10.1016/0043-1648(94)06554-3
   Diaci J, 2011, OPT LASER ENG, V49, P195, DOI 10.1016/j.optlaseng.2010.09.003
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hakiki NE, 1998, J ELECTROCHEM SOC, V145, P3821, DOI 10.1149/1.1838880
   HENCH LL, 1975, ANNU REV MATER SCI, V5, P279, DOI 10.1146/annurev.ms.05.080175.001431
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Leone C., 2010, J MAT PROC TEC, V210, P1293
   Okasaki Y., 2002, BIOMATERIALS, V23, P2071
   Patrikar RA, 2004, APPL SURF SCI, V228, P213, DOI 10.1016/j.apsusc.2004.01.010
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P3828
   Pieretti EF, 2014, ELECTROCHIM ACTA, V124, P150, DOI 10.1016/j.electacta.2013.10.137
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P2435
   Pieretti EF, 2013, ELECTROCHIM ACTA, V114, P838, DOI 10.1016/j.electacta.2013.05.101
   Pourbaix M., 1963, CORROS SCI, V3, P239
   Qi J, 2003, J MATER PROCESS TECH, V139, P273, DOI 10.1016/S0924-0136(03)00234-6
   Qian M, 2010, CORROS SCI, V52, P3548, DOI 10.1016/j.corsci.2010.07.007
   Soriano C, 2011, APPL SURF SCI, V257, P7101, DOI 10.1016/j.apsusc.2011.03.059
   Valette S, 2006, APPL SURF SCI, V252, P4696, DOI 10.1016/j.apsusc.2005.07.161
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
   Zhang GA, 2009, ELECTROCHIM ACTA, V55, P316, DOI 10.1016/j.electacta.2009.09.001
NR 29
TC 3
Z9 3
U1 1
U2 14
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2015
VL 10
IS 2
BP 1221
EP 1232
PG 12
WC Electrochemistry
SC Electrochemistry
GA AZ6YS
UT WOS:000348365800015
DA 2018-10-20
ER

PT J
AU Manchon, A
   Alkhraisat, M
   Rueda-Rodriguez, C
   Torres, J
   Prados-Frutos, JC
   Ewald, A
   Gbureck, U
   Azama, JC
   Rodriguez-Gonzalez, A
   Lopez-Cabarcos, E
AF Manchon, A.
   Alkhraisat, M.
   Rueda-Rodriguez, C.
   Torres, J.
   Prados-Frutos, J. C.
   Ewald, A.
   Gbureck, U.
   Cabrejos Azama, J.
   Rodriguez-Gonzalez, A.
   Lopez-Cabarcos, E.
TI Silicon calcium phosphate ceramic as novel biomaterial to simulate the
   bone regenerative properties of autologous bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biphasic calcium phosphate; silicon doped ceramic; bone substitution;
   tricalcium phosphate; bone graft
ID SUBSTITUTED HYDROXYAPATITE GRANULES; STABILIZED TRICALCIUM PHOSPHATE;
   IN-VIVO BEHAVIOR; MECHANICAL-PROPERTIES; GENE-EXPRESSION; IONIC
   PRODUCTS; DIFFERENTIATION; PROLIFERATION; DISSOLUTION; RELEASE
AB This study was conducted to develop novel ceramic bone substitute that resembles the autologous bone behavior when used as graft material. Solid-state reaction at 1100 degrees C was performed to synthesize beta-tricalcium phosphate (beta-TCP) and biphasic calcium phosphate (BCP). The ceramics were further analyzed to characterize phase composition, microstructural properties, cytocompatability and then challenged to regenerate critical bone defects in the parietal bone of rabbits. X-ray diffraction analysis confirmed the production of beta-TCP and indicated the synthesis of novel BCP composed of beta-TCP and silicocarnotite (calcium phosphate silicate mineral). The cytocompatibility test with human osteoblast cell line revealed enhanced cell proliferation on the BCP ceramic. The novel BCP induced the filling of about 73% of the bone defect with a newly formed bone tissue and an almost complete degradation after 12 weeks of healing. This novel ceramic resembles the autologous bone properties of complete degradation and efficient enhancement of bone formation, making it promising as bone graft material. (C) 2014 Wiley Periodicals, Inc.
C1 [Manchon, A.; Torres, J.; Prados-Frutos, J. C.; Rodriguez-Gonzalez, A.] Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
   [Alkhraisat, M.; Rueda-Rodriguez, C.; Cabrejos Azama, J.; Lopez-Cabarcos, E.] URJC, Fac Hlth Sci, Dept Stomatol, Alcorcon Madrid 28922, Spain.
   [Ewald, A.; Gbureck, U.] Univ Wurzburg, D-97070 Wurzburg, Germany.
RP Manchon, A (reprint author), Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
EM angel.manchon@urjc.es
RI Gbureck, Uwe/G-1430-2012
OI Alkhraisat, Mohammad/0000-0003-4422-4527; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209; Prados Frutos, Juan
   Carlos/0000-0003-1464-0968
FU Spanish Science and Innovation Ministry [MAT2010-15349]
FX Contract grant sponsor: Spanish Science and Innovation Ministry;
   contract grant number: MAT2010-15349
CR Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Camire CL, 2006, J BIOMED MATER RES B, V76B, P424, DOI 10.1002/jbm.b.30385
   CARLISLE EM, 1982, NUTR REV, V40, P193
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   CARLISLE EM, 1970, SCIENCE, V167, P179
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Ghanaati SM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025004
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Alkhraisat MH, 2013, MAT SCI ENG C-MATER, V33, P475, DOI 10.1016/j.msec.2012.09.017
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kruse A, 2011, CLIN ORAL IMPLAN RES, V22, P506, DOI 10.1111/j.1600-0501.2010.02039.x
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Patel N, 2005, J MATER SCI-MATER M, V16, P429, DOI 10.1007/s10856-005-6983-6
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Porter AE, 2006, MICRON, V37, P681, DOI 10.1016/j.micron.2006.03.006
   Rawal A, 2008, CHEM MATER, V20, P2583, DOI 10.1021/cm702928h
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Vandiver J, 2006, J BIOMED MATER RES A, V78A, P352, DOI 10.1002/jbm.a.30737
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamada M, 2003, BIOL TRACE ELEM RES, V95, P113, DOI 10.1385/BTER:95:2:113
   Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x
NR 40
TC 14
Z9 14
U1 3
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 479
EP 488
DI 10.1002/jbm.a.35196
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700006
PM 24737706
DA 2018-10-20
ER

PT J
AU Kumar, A
   Biswas, K
   Basu, B
AF Kumar, Alok
   Biswas, Krishanu
   Basu, Bikramjit
TI Hydroxyapatite-titanium bulk composites for bone tissue engineering
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE hydroxyapatite; titanium; composite; fracture toughness;
   biocompatibility
ID FUNCTIONALLY GRADED BIOMATERIAL; CRACK DEFLECTION PROCESSES; TOTAL JOINT
   REPLACEMENT; IN-VITRO BIOACTIVITY; MECHANICAL-PROPERTIES; CELLULAR
   PROLIFERATION; THERMAL-EXPANSION; MICROSTRUCTURE; BIOCOMPATIBILITY;
   SCAFFOLDS
AB The research work on bulk hydroxyapatite (HA)-based composites are driven by the need to develop biomaterials with better mechanical properties without compromising its bioactivity and biocompatibility properties. Despite several years of research, the mechanical properties of the HA-based composites still need to be enhanced to match the properties of natural cortical bone. In this regard, the scope of this review on the HA-based bulk biomaterials is limited to the processing and the mechanical as well as biocompatibility properties for bone tissue engineering applications of a model system that is hydroxyapatite-titanium (HA-Ti) bulk composites. It will be discussed in this review how HA-Ti based bulk composites can be processed to have better fracture toughness and strength without compromising biocompatibility. The advantages of the functionally gradient materials to integrate the mechanical and biocompatibility properties is a promising approach in hard tissue engineering and has been emphasized here in reference to the limited literature reports. On the biomaterials fabrication aspect, the recent results are discussed to demonstrate that advanced manufacturing techniques, like spark plasma sintering can be adopted as a processing route to restrict the sintering reactions, while enhancing the mechanical properties. Various toughening mechanisms related to careful tailoring of microstructure are discussed. The in vitro cytocompatibilty, cell fate processes as well as in vivo biocompatibility results are also reviewed and the use of flow cytometry to quantify in vitro cell fate processes is being emphasized. (C) 2014 Wiley Periodicals, Inc.
C1 [Kumar, Alok; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Biswas, Krishanu] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
RI Kumar, Alok/O-1876-2016
OI Kumar, Alok/0000-0002-8363-2286
FU Department of Science and Technology, Government of India; Department of
   Biotechnology, Government of India; CARE Grant, IIT Kanpur
FX Contract grant sponsors: CARE Grant, IIT Kanpur, Department of Science
   and Technology, Government of India and Department of Biotechnology,
   Government of India
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   ASHBY MF, 1989, ACTA METALL MATER, V37, P1847, DOI 10.1016/0001-6160(89)90069-2
   Audekercke RV, 1984, MECH PROPERTIES CANC
   AZIMOV SY, 1981, INORG MATER+, V17, P1384
   BABUSHKIN O, 1994, J MATER CHEM, V4, P413, DOI 10.1039/jm9940400413
   Bajpai I, 2013, J AM CERAM SOC, V96, P2100, DOI 10.1111/jace.12386
   BAO G, 1990, INT J SOLIDS STRUCT, V26, P631, DOI 10.1016/0020-7683(90)90034-S
   Basu B., 2011, ADV STRUCTURAL CERAM
   Basu B, 2013, RSC ADV, V3, P14622, DOI 10.1039/c3ra42369g
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Billi F, 2010, J APPL BIOMATER BIOM, V8, P1
   Biring G, 2007, FRICTION LUBRICATION
   Black J, 1988, ORTHOPEDIC BIOMATERI
   Blitterswijk CAv, 1991, BIOMATERIALS, V12, P187
   BONEL G, 1964, CR HEBD ACAD SCI, V258, P923
   Bonfield W, 1984, ELASTICITY VISCOELAS
   BONFIGLIO M, 1972, CLIN ORTHOP RELAT R, P19
   CARPINTERI A, 1994, MECH MATER, V18, P89, DOI 10.1016/0167-6636(94)00008-5
   Charkaluk E, 1998, ENG FRACT MECH, V61, P119, DOI 10.1016/S0013-7944(98)00035-6
   Chenglin C., 1999, MAT SCI ENG A-STRUCT, V271, P95
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Chu C, 2002, J MATER SCI-MATER M, V13, P985, DOI 10.1023/A:1019873015772
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chun Y., 2010, T NONFERR METAL SOC, V20, P254
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Dowson D., 1992, BIOTRIBOLOGY NATURAL
   Dubey AK, 2013, J AM CERAM SOC, V96, P3753, DOI 10.1111/jace.12566
   Dujovne A R, 1993, J Arthroplasty, V8, P7, DOI 10.1016/S0883-5403(06)80102-6
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   EVANS AG, 1986, ACTA METALL MATER, V34, P2435, DOI 10.1016/0001-6160(86)90146-X
   Evans FG, 1961, BIOMEDICAL STUDIES M
   FABER KT, 1983, ACTA METALL MATER, V31, P565, DOI 10.1016/0001-6160(83)90046-9
   FABER KT, 1983, ACTA METALL MATER, V31, P577, DOI 10.1016/0001-6160(83)90047-0
   Fahami A, 2011, SOLID STATE SCI, V13, P135, DOI 10.1016/j.solidstatesciences.2010.10.026
   Faiz MA, 2012, MAT SCI ENG C, V32, P1164
   GDB GD, 1983, J BONE JOINT SURG AM, V65-A, P239
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Ghaith ES, 2006, J MATER SCI, V41, P2521, DOI 10.1007/s10853-006-5241-8
   Groot K., 1983, BIOCERAMICS CALCIUM
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Huang SP, 2008, J MATER SCI-MATER M, V19, P437, DOI 10.1007/s10856-006-0104-z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jee WSS, 1983, HISTOLOGY CELL TISSU
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kaw AK, 2006, MACHANICS COMPOSITE
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   Kreidler ER, 1970, AM MINERAL, V55, P170
   Kumar A, 2013, MICROSTRUCTURE DEV B
   Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   Kumar A, 2013, J BIOMED MATER RES B, V101B, P223, DOI 10.1002/jbm.b.32829
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Lawn B., 1998, FRACTURE BRITTLE SOL
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LeGeros RZ, 1982, EFFECT FLUORIDE STAB
   LeGeros RZ, 2008, BIOACTIVE BIOCERAMIC
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lutjering G., 2007, TITANIUM
   MacDonald DE, 2001, J BIOMED MATER RES, V54, P480
   Mallik PK, 2014, J BIOMED MATER RES A, V102, P842, DOI 10.1002/jbm.a.34752
   Mandal S, 2013, MAT TECHNOL ADV PERF, V29, pB21
   MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0
   MIYAKE M, 1986, J SOLID STATE CHEM, V61, P230, DOI 10.1016/0022-4596(86)90026-5
   Mondal D, 2013, J BIOMED MATER RES A, V101, P1489, DOI 10.1002/jbm.a.34455
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Muller RT, 1997, ARCH ORTHOP TRAUM SU, V116, P334
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Murugan R, 2004, NANOSTRUCTURED BIOMA
   Nakahira A, 2001, J CERAM PROCESS RES, V2, P108
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Palsson BO, 2009, TISSUE ENG
   Park Joon, 2008, BIOCERAMICS PROPERTI
   PRENDERGAST PJ, 1995, IRISH J MED SCI, V164, P152, DOI 10.1007/BF02973285
   Putlyaev VI, 2006, GLASS CERAM+, V63, P99, DOI 10.1007/s10717-006-0049-1
   Rapacz-Kmita A, 2006, J EUR CERAM SOC, V26, P1481, DOI 10.1016/j.jeurceramsoc.2005.01.059
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Reddy KM, 2010, SCRIPTA MATER, V62, P435, DOI 10.1016/j.scriptamat.2009.11.030
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ribeiro CC, 2006, BIOMATERIALS, V27, P1749, DOI 10.1016/j.biomaterials.2005.09.043
   Rishabh A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3445869
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rivera-Munoz E, 2001, J MATER SCI-MATER M, V12, P305, DOI 10.1023/A:1011290919642
   Rudnik E, 1997, J THERM ANAL, V49, P471, DOI 10.1007/BF01987473
   Saenz A, 1999, J MATER EDUC, V21, P297
   Saha N, 2012, J BIOMED MATER RES B, V100B, P256, DOI 10.1002/jbm.b.31948
   Sanosh KP, 2009, CURR APPL PHYS, V9, P1459, DOI 10.1016/j.cap.2009.03.024
   Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034
   Silva RV, 2004, INT J ORAL MAXILLOF, V10, P1
   Steinemann S. G., 1980, CORROSION SURG IMPLA
   Steinemann SG., 1985, CORROSION TITANIUM T, P1373
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   SUZUKI T, 1981, J CHEM SOC FARAD T 1, V77, P1059, DOI 10.1039/f19817701059
   Swanson PL, 1988, CRACK INTERFACE TRAC
   Tagai H, 1980, PREPARATION SYNTHETI
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   TUMMALA RR, 1970, J APPL PHYS, V41, P5104, DOI 10.1063/1.1658618
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Valiathan MS, 1999, NATL MED J INDIA, V12, P270
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   Wang YY, 2002, J IMMUNOL METHODS, V268, P179, DOI 10.1016/S0022-1759(02)00190-4
   Weertman J., 1996, DISLOCATION BASED FR
   WENG J, 1994, J MATER SCI LETT, V13, P159, DOI 10.1007/BF00278148
   Whang Peter G, 2003, Spine J, V3, P155, DOI 10.1016/S1529-9430(02)00539-9
   WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wolff J., 1986, LAW BONE REMODELLING
   Xu LH, 2005, CERAM INT, V31, P953, DOI 10.1016/j.ceramint.2004.10.008
   Yang YZ, 2004, BIOMATERIALS, V25, P2927, DOI 10.1016/j.biomaterials.2003.09.072
   ZHANG SZ, 1989, J PHYS D APPL PHYS, V22, P790, DOI 10.1088/0022-3727/22/6/012
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
NR 129
TC 20
Z9 22
U1 0
U2 73
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 791
EP 806
DI 10.1002/jbm.a.35198
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700036
PM 24737723
OA Bronze
DA 2018-10-20
ER

PT J
AU Frick, CP
   DiRienzo, AL
   Hoyt, AJ
   Safranski, DL
   Saed, M
   Losty, EJ
   Yakacki, CM
AF Frick, Carl P.
   DiRienzo, Amy L.
   Hoyt, Anthony J.
   Safranski, David L.
   Saed, Mohand
   Losty, Eric J.
   Yakacki, Christopher M.
TI High-strength poly(para-phenylene) as an orthopedic biomaterial (vol
   102, pg 3122, 2014)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Correction
C1 [Frick, Carl P.; DiRienzo, Amy L.; Hoyt, Anthony J.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Safranski, David L.] MedShape Inc, Res & Dev, Atlanta, GA 30318 USA.
   [Saed, Mohand; Losty, Eric J.; Yakacki, Christopher M.] Univ Colorado, Dept Mech Engn, Denver, CO 80217 USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
CR Frick CP, 2014, J BIOMED MATER RES A, V102, P3122, DOI 10.1002/jbm.a.34982
NR 1
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2015
VL 103
IS 2
BP 860
EP 860
DI 10.1002/jbm.a.35350
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA7MP
UT WOS:000349101700041
OA Bronze
DA 2018-10-20
ER

PT J
AU Hench, LL
AF Hench, Larry L.
TI The future of bioactive ceramics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; IN-VITRO; IMPLANT INTERFACE; HUMAN OSTEOBLASTS;
   IONIC PRODUCTS; BONE-FORMATION; GLASS; BIOGLASS; DIFFERENTIATION;
   ANGIOGENESIS
AB Two important worldwide needs must be satisfied in the future; (1) treatment of the deteriorating health of an aging population and, (2) decreasing healthcare costs to meet the needs of an increased population. The ethical and economic dilemma is how to achieve equality in quality of care while at the same time decreasing cost of care for an ever-expanding number of people. The limited lifetime of prosthetic devices made from first-generation nearly inert biomaterials requires new approaches to meet these two large needs. This paper advises an expanded emphasis on: (1) regeneration of tissues and (2) prevention of tissue deterioration to meet this growing need. Innovative use of bioactive ceramics with genetic control of in situ tissue responses offers the potential to achieve both tissue regeneration and prevention. Clinical success of use of bioactive glass for bone regeneration is evidence that this concept works. Likewise the use of micron sized bioactive glass powders in a dentifrice for re-mineralization of teeth provides evidence that prevention of tissue deterioration is also possible. This opinion paper outlines clinical needs that could be met by innovative use of bioactive glasses and ceramics in the near future; including: regeneration of skeletal tissues that is patient specific and genetic based, load-bearing bioactive glass-ceramics for skeletal and ligament and tendon repair, repair and regeneration of soft tissues, and rapid low-cost analysis of human cell-biomaterial interactions leading to patient specific diagnoses and treatments using molecularly tailored bioceramics.
C1 Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA.
RP Hench, LL (reprint author), Florida Inst Technol, Dept Biomed Engn, 150 W Univ Blvd, Melbourne, FL 32901 USA.
EM larryhench@embarqmail.com
CR BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gillette RL, 2001, AM J VET RES, V62, P1149, DOI 10.2460/ajvr.2001.62.1149
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench L. L., 2013, INTRO BIOCERAMICS
   Hench LL, 2013, J AUST CERAM SOC, V49, P1
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 2002, J INORG MATER, V17, P897
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu GF, 2012, INT J NANOMED, V7, P2613, DOI 10.2147/IJN.S31081
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Jung S. B., 2012, BIOGLASSES INTRO, P75
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Notingher L, 2004, VIB SPECTROSC, V35, P199, DOI 10.1016/j.vibspec.2004.01.014
   Peitl O, 2012, ACTA BIOMATER, V8, P321, DOI 10.1016/j.actbio.2011.10.014
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 35
TC 13
Z9 15
U1 8
U2 92
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 86
DI 10.1007/s10856-015-5425-3
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400025
PM 25644100
DA 2018-10-20
ER

PT J
AU Kido, HW
   Tim, CR
   Bossini, PS
   Parizotto, NA
   de Castro, CA
   Crovace, MC
   Rodrigues, ACM
   Zanotto, ED
   Peitl, O
   Anibal, FD
   Renno, ACM
AF Kido, Hueliton Wilian
   Tim, Carla Roberta
   Bossini, Paulo Sergio
   Parizotto, Nivaldo Antonio
   de Castro, Cynthia Aparecida
   Crovace, Murilo Camuri
   Martins Rodrigues, Ana Candida
   Zanotto, Edgar Dutra
   Peitl Filho, Oscar
   Anibal, Fernanda de Freitas
   Muniz Renno, Ana Claudia
TI Porous bioactive scaffolds: characterization and biological performance
   in a model of tibial bone defect in rats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OF-THE-ART; GRAFT SUBSTITUTES; ORTHOPEDIC TRAUMA; BIOSILICATE(R);
   MICROSPHERES; BIOMATERIALS; REGENERATION; OSTEOGENESIS; ENHANCEMENT;
   PERSPECTIVE
AB The aim of this study was to evaluate the effects of highly porous Biosilicate (R) scaffolds on bone healing in a tibial bone defect model in rats by means of histological evaluation (histopathological and immunohistochemistry analysis) of the bone callus and the systemic inflammatory response (immunoenzymatic assay). Eighty Wistar rats (12 weeks-old, weighing +/-300 g) were randomly divided into 2 groups (n = 10 per experimental group, per time point): control group and Biosilicate (R) group (BG). Each group was euthanized 3, 7, 14 and 21 days post-surgery. Histological findings revealed a similar inflammatory response in both experimental groups, 3 and 7 days post-surgery. During the experimental periods (3-21 days post-surgery), it was observed that the biomaterial degradation, mainly in the periphery region, provided the development of the newly formed bone into the scaffolds. Immunohistochemistry analysis demonstrated that the Biosilicate (R) scaffolds stimulated cyclooxygenase-2, vascular endothelial growth factor and runtrelated transcription factor 2 expression. Furthermore, in the immunoenzymatic assay, BG presented no difference in the level of tumor necrosis factor alpha in all experimental periods. Still, BG showed a higher level of interleukin 4 after 14 days post-implantation and a lower level of interleukin 10 in 21 days post-surgery. Our results demonstrated that Biosilicate (R) scaffolds can contribute for bone formation through a suitable architecture and by stimulating the synthesis of markers related to the bone repair.
C1 [Kido, Hueliton Wilian; Tim, Carla Roberta; Parizotto, Nivaldo Antonio] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Postgrad Program Biotechnol, Sao Carlos, SP, Brazil.
   [Bossini, Paulo Sergio; Muniz Renno, Ana Claudia] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [de Castro, Cynthia Aparecida] Fed Univ Sao Carlos UFSCar, Dept Physiol Sci, Sao Carlos, SP, Brazil.
   [Crovace, Murilo Camuri; Martins Rodrigues, Ana Candida; Zanotto, Edgar Dutra; Peitl Filho, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, Vitreous Mat Lab LaMaV, Sao Carlos, SP, Brazil.
   [Anibal, Fernanda de Freitas] Fed Univ Sao Carlos UFSCar, Dept Morphol & Pathol, Sao Carlos, SP, Brazil.
RP Renno, ACM (reprint author), Fed Univ Sao Paulo UNIFESP, Dept Biosci, Ana Costa 95, Santos, SP, Brazil.
EM hueliton_kido@yahoo.com.br; a.renno@unifesp.br
RI Bossini, Paulo/G-2333-2014; Parizotto, Nivaldo/D-5347-2014; Kido,
   Hueliton/O-9970-2015; CerTEV, CeRTEV/J-6817-2015; Castro,
   Cynthia/I-7368-2016
OI Parizotto, Nivaldo/0000-0003-1774-9053; Kido,
   Hueliton/0000-0001-8554-432X; Castro, Cynthia/0000-0002-2675-8069; Tim,
   Carla/0000-0002-4745-9375
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
FX The authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo) for their financial support.
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Axelrad TW, 2007, INJURY, V38, pS49, DOI 10.1016/j.injury.2007.02.010
   Bhatt RA, 2012, HAND CLIN, V28, P457, DOI 10.1016/j.hcl.2012.08.001
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Crovace MC, 2009, THESIS FEDERAL U SAO
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Drosse I, 2008, TISSUE ENG PART C-ME, V14, P79, DOI 10.1089/tec.2007.0234
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hu YC, 2009, CHINESE MED J-PEKING, V122, P2386, DOI 10.3760/cma.j.issn.0366-6999.2009.19.035
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   Kido HW, 2013, J BIOMED MATER RES A, V101, P667, DOI 10.1002/jbm.a.34360
   Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Matsumoto MA, 2012, J MATER SCI-MATER M, V23, P1447, DOI 10.1007/s10856-012-4612-8
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Phieffer LS, 2006, J BONE JOINT SURG AM, V88A, P206, DOI 10.2106/00004623-200601000-00026
   Renno ACM, 2013, BIOMED RES INT, DOI 10.1155/2013/141427
   Sachot N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0684
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Xin RL, 2010, J NON-CRYST SOLIDS, V356, P1180, DOI 10.1016/j.jnoncrysol.2010.03.010
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Pinto KNZ, 2013, PHOTOMED LASER SURG, V31, P252, DOI 10.1089/pho.2012.3435
   ZANOTTO ED, 2004, Patent No. 2004074199
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 43
TC 4
Z9 4
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 74
DI 10.1007/s10856-015-5411-9
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400014
PM 25631271
DA 2018-10-20
ER

PT J
AU Mas-Moruno, C
   Garrido, B
   Rodriguez, D
   Ruperez, E
   Gil, FJ
AF Mas-Moruno, Carlos
   Garrido, Beatriz
   Rodriguez, Daniel
   Ruperez, Elisa
   Javier Gil, F.
TI Biofunctionalization strategies on tantalum-based materials for
   osseointegrative applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS-TANTALUM; IN-VITRO; TITANIUM SURFACES; HUMAN OSTEOBLASTS;
   TRABECULAR METAL; CELL-ADHESION; COLLAGEN IMMOBILIZATION; IMPLANT
   MATERIALS; RGD PEPTIDES; BONE
AB The use of tantalum as biomaterial for orthopedic applications is gaining considerable attention in the clinical practice because it presents an excellent chemical stability, body fluid resistance, biocompatibility, and it is more osteoconductive than titanium or cobalt-chromium alloys. Nonetheless, metallic biomaterials are commonly bioinert and may not provide fast and long-lasting interactions with surrounding tissues. The use of short cell adhesive peptides derived from the extracellular matrix has shown to improve cell adhesion and accelerate the implant's biointegration in vivo. However, this strategy has been rarely applied to tantalum materials. In this work, we have studied two immobilization strategies (physical adsorption and covalent binding via silanization) to functionalize tantalum surfaces with a cell adhesive RGD peptide. Surfaces were used untreated or activated with either HNO3 or UV/ozone treatments. The process of biofunctionalization was characterized by means of physicochemical and biological methods. Physisorption of the RGD peptide on control and HNO3-treated tantalum surfaces significantly enhanced the attachment and spreading of osteoblast-like cells; however, no effect on cell adhesion was observed in ozone-treated samples. This effect was attributed to the inefficient binding of the peptide on these highly hydrophilic surfaces, as evidenced by contact angle measurements and X-ray photoelectron spectroscopy. In contrast, activation of tantalum with UV/ozone proved to be the most efficient method to support silanization and subsequent peptide attachment, displaying the highest values of cell adhesion. This study demonstrates that both physical adsorption and silanization are feasible methods to immobilize peptides onto tantalum-based materials, providing them with superior bioactivity.
C1 [Mas-Moruno, Carlos; Garrido, Beatriz; Rodriguez, Daniel; Ruperez, Elisa; Javier Gil, F.] Tech Univ Catalonia UPC, ETSEIB, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Mas-Moruno, Carlos; Rodriguez, Daniel; Javier Gil, F.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08028, Spain.
   [Mas-Moruno, Carlos; Rodriguez, Daniel; Ruperez, Elisa] Ctr Res NanoEngn CRNE UPC, Barcelona 08028, Spain.
RP Mas-Moruno, C (reprint author), Tech Univ Catalonia UPC, ETSEIB, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Ave Diagonal 647, Barcelona 08028, Spain.
EM carles.mas.moruno@upc.edu
RI Mas-Moruno, Carlos/H-7511-2015; Ruperez, Elisa/J-8792-2017
OI Mas-Moruno, Carlos/0000-0001-8337-0872; Ruperez,
   Elisa/0000-0001-8845-512X
FU Spanish Government [MAT2012-30706]; European Union through European
   Regional Development Funds; Government of Catalonia [SGR2009 1039];
   Ministry of Economy and Knowledge of the Government of Catalonia
   [2011-BP-B-00042]; European Union [321985]
FX The authors acknowledge the Spanish Government for financial support
   through Project MAT2012-30706, co-funded by the European Union through
   European Regional Development Funds, and the Government of Catalonia
   (SGR2009 1039). Carlos Mas-Moruno thanks the support of the Secretary
   for Universities and Research of the Ministry of Economy and Knowledge
   of the Government of Catalonia (2011-BP-B-00042) and the People
   Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme (FP7-PEOPLE-2012-CIG, REA Grant Agreement 321985).
   The authors thank Mrs. Montse Dominguez and Mr. Trifon Trifonov (CRNE)
   for their excellent technical support with the XPS and SEM measurements,
   respectively.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Aubry D, 2009, APPL SURF SCI, V255, P4765, DOI 10.1016/j.apsusc.2008.11.022
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Balla VK, 2010, ACTA BIOMATER, V6, P2234
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Budge MD, 2013, J SHOULDER ELB SURG, V22, P709, DOI 10.1016/j.jse.2012.07.001
   Chen X., 2013, THIN FILMS COATINGS, P105
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Dahmen C, 2004, ANGEW CHEM INT EDIT, V43, P6649, DOI 10.1002/anie.200460770
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Hanawa T, 2011, J PERIODONTAL IMPLAN, V41, P263, DOI 10.5051/jpis.2011.41.6.263
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Kaivosoja E, 2013, J BIOMATER APPL, V27, P862, DOI 10.1177/0885328211428094
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Liu PS, 2011, ACTA BIOMATER, V7, P3488, DOI 10.1016/j.actbio.2011.05.025
   Maccauro Giulio, 2009, Recent Pat Biotechnol, V3, P157, DOI 10.2174/187220809789389153
   Mantripragada VP, 2013, J BIOMED MATER RES A, V101, P3349, DOI 10.1002/jbm.a.34605
   Mas-Moruno C, 2013, BIOMATERIALS SURFACE SCIENCE, P337
   Mas-Moruno C, 2014, ACS APPL MATER INTER, V6, P6525, DOI 10.1021/am5001213
   Mas-Moruno C, 2013, J BIOMED MATER RES A, V101, P87, DOI 10.1002/jbm.a.34303
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McNichols C, 2014, J BIOMED MATER RES A, V102, P532, DOI 10.1002/jbm.a.34700
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   PetrieTA Raynor JE, 2008, BIOMATERIALS, V29, P2849
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rechenmacher F, 2013, CHEM-EUR J, V19, P9218, DOI 10.1002/chem.201301478
   Rechenmacher F, 2013, ANGEW CHEM INT EDIT, V52, P1572, DOI 10.1002/anie.201206370
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Song YY, 2010, SURF SCI, V604, P346, DOI 10.1016/j.susc.2009.11.027
   Stiehl JB, 2005, ORTHOPEDICS, V28, P662
   Stiehler C, 2013, CELL MOL BIOENG, V6, P199, DOI 10.1007/s12195-012-0255-6
   Stilling M, 2011, ACTA ORTHOP, V82, P177, DOI 10.3109/17453674.2011.566139
   Sun YS, 2013, THIN SOLID FILMS, V528, P130, DOI 10.1016/j.tsf.2012.06.088
   Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066263
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Pham VH, 2013, THIN SOLID FILMS, V536, P269, DOI 10.1016/j.tsf.2013.03.042
   Welander M, 2007, J CLIN PERIODONTOL, V34, P452, DOI 10.1111/j.1600-051X.2007.01073.x
   WILLIAMS DF, 2001, ENG MAT SER, P13
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Zhu MJ, 2012, LANGMUIR, V28, P416, DOI 10.1021/la203638g
NR 61
TC 11
Z9 13
U1 2
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 109
DI 10.1007/s10856-015-5445-z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400048
PM 25665847
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Vamze, J
   Pilmane, M
   Skagers, A
AF Vamze, Jolanta
   Pilmane, Mara
   Skagers, Andrejs
TI Biocompatibility of pure and mixed hydroxyapatite and alpha-tricalcium
   phosphate implanted in rabbit bone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; BETA-DEFENSINS; OSTEOPROTEGERIN; BIOMATERIALS; OSTEOCALCIN;
   EXPRESSION; CYTOKINES; DISEASE
AB Calcium phosphates and hydroxyapatite, in particular, are used as substitute materials in experimental implantology. These materials are primarily used in hard tissue replacement because their chemical and crystallographic characteristics are considered to be similar to the mineral content, osteoconductivity and bioactivity of normal bone. Cytokines, such as interleukin (IL)-1, IL-6, IL-8, IL-10 and antimicrobial protein beta-defensin-2 (beta Def-2), are used as biomarkers of non-specific reactogenicity. Other biomarkers, including bone morphogenetic protein-2/4 (BMP-2/4), bone regeneration protein osteoprotegerin (OPG), bone matrix protein osteopontin (OP) and osteocalcin (OC), are regarded as specific factors of reactogenicity in bone substitution. The aim of our study was to assess the changes in the distribution and expression of the aforementioned proteins in the lower jaws of rabbits following implantation with pure hydroxyapatite (HAP), alpha-tricalcium phosphate (alpha-TCP) or a mix of the two (HAP/alpha-TCP) manufactured under different temperatures. Our results reveal osteoblast proliferation and regions of granulation tissue formation between biomaterial granules close to the original implantation site, but in the control tissue these changes were less noticeable. Our study showed low variability in the distribution of bDef-2, OPG and all of the tested interleukins and these proteins were less expressed than BMP2/4, OP and OC. But across all experiments, no statistically significant difference in mean bDef-2, IL-1, IL-6, IL-8, IL-10, OP, OC, BMP-2/4 and OPG expression in osteocytes was detected between experimental and control groups. We concluded that pure and mixed HAP and alpha-TCP sintered at different temperatures do not affect the production of cytokines and bone-specific proteins; regions with osteoblast proliferation and low levels of anti-inflammatory cytokines IL-6 and IL-10 indicates better biocompatibility for HAP/alpha-TCP and alpha TCP-2 biomaterials and the moderate number of BMP-2/4 and a prevalence of OC- and OP-positive osteocytes in experimental tissues implanted with HAP at 3 months after implantation indicates potential bone regeneration stimulated by pure HAP.
C1 [Vamze, Jolanta] Riga Stradins Univ, LV-1007 Riga, Latvia.
   [Pilmane, Mara] Riga Stradins Univ, Inst Anat & Anthropol, LV-1007 Riga, Latvia.
   [Skagers, Andrejs] Riga Stradins Univ, Dept Oral & Maxillofacial Surg, LV-1007 Riga, Latvia.
RP Vamze, J (reprint author), Riga Stradins Univ, Dzirciema Str 16, LV-1007 Riga, Latvia.
EM jolantavmz@gmail.com
CR Bissell J, 2004, J ORAL PATHOL MED, V33, P278, DOI 10.1111/j.0904-2512.2004.00143.x
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Crovella S, 2005, CURR PROTEIN PEPT SC, V6, P7, DOI 10.2174/1389203053027593
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250
   Haake SK, 2002, MOL BIOL HOST MICROB
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kiernan JA, 2008, HISTOLOGICAL HISTOCH, P141
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Lee AJ, 2000, ANN CLIN BIOCHEM, V37, P432, DOI 10.1258/0004563001899573
   Madhwani T, 2012, FEMS IMMUNOL MED MIC, V64, P374, DOI 10.1111/j.1574-695X.2011.00922.x
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Pearce G, 2008, PEPTIDES, V29, P2083, DOI 10.1016/j.peptides.2008.08.019
   PILMANE M, 1995, THORAX, V50, P551, DOI 10.1136/thx.50.5.551
   Reinis A, 2011, MED LITH, V47, P560
   Salma Ilze, 2009, Stomatologija, V11, P113
   Sarfati J, 2004, J CREAT, V18, P11
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Yun TJ, 2001, J IMMUNOL, V166, P1482, DOI 10.4049/jimmunol.166.3.1482
NR 26
TC 2
Z9 2
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2015
VL 26
IS 2
AR 73
DI 10.1007/s10856-015-5406-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CB1QI
UT WOS:000349402400013
PM 25631269
DA 2018-10-20
ER

PT J
AU Deng, YH
   Li, LH
   He, J
   Li, M
   Zhang, Y
   Wang, XM
   Cui, FZ
   Xia, H
AF Deng, Ying-Hu
   Li, Li-Hua
   He, Jin
   Li, Mei
   Zhang, Yu
   Wang, Xiu-Mei
   Cui, Fu-Zhai
   Xia, Hong
TI Self-assembled monolayers of alkanethiolates on surface chemistry groups
   in osteosarcoma cells
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE osteosarcoma; functional groups; self-assembled monolayers
ID FIBRONECTIN CONFORMATION; INTEGRIN BINDING; IN-VITRO; ADHESION;
   PROLIFERATION; APOPTOSIS; DIFFERENTIATION; BIOMATERIALS; SPECIFICITY;
   SARCOMA
AB Cell biomedical behavior is influenced by a number of factors, and the extracellular matrix (ECM) of the cellular microenvironment affects certain cancer cells. In the current study, U-2OS cells were cultured on gold surfaces 'modified with different terminal chemical groups [methyl (-CH3), amino (-NH2), hydroxyl (-OH) and carboxyl (-COOH)]. The results revealed that different chemical surfaces convey different behaviors. The density of the different functional surfaces was confirmed by atomic force microscopy. Cell morphology, proliferation rate and cell cycle were investigated using scanning electron microscopy, cell counting and flow cytometry. In conclusion, the type of chemical group on a biomaterial is an important property for the growth of osteosarcoma cells; -NH2 and -COOH surfaces sustained visible cell adhesion and promoted cell growth.
C1 [Deng, Ying-Hu] Southern Med Univ, Clin Med Coll 1, Dept Orthopaed Surg, Guangzhou 510515, Guangdong, Peoples R China.
   [Deng, Ying-Hu] Tongling Peoples Hosp, Dept Orthopaed, Tongling 244000, Anhui, Peoples R China.
   [Li, Li-Hua; Li, Mei; Zhang, Yu; Cui, Fu-Zhai; Xia, Hong] Guangzhou Mil Command, Guangzhou Gen Hosp, Orthoped Hosp, Dept Spinal Surg, Guangzhou 510010, Guangdong, Peoples R China.
   [He, Jin; Wang, Xiu-Mei] Tsinghua Univ, Inst Regenerat & Biomimet Mat, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Xia, H (reprint author), Guangzhou Mil Command, Guangzhou Gen Hosp, Orthoped Hosp, Dept Spinal Surg, 111 Liuhua Rd, Guangzhou 510010, Guangdong, Peoples R China.
EM gzxiahong2@126.com
FU National Natural Science Foundation of China [81272057]; Military
   Medical Science and Technology Research of China during the '12th
   five-year plan' [81271957]
FX The authors thank Professor Zhang of the Herbarium at Guangdong
   Institute of Microbiology (HMIGD) for the use of the scanning electron
   microscope. This study was supported by grants from the National Natural
   Science Foundation of China General program (no. 81272057) and The
   Military Medical Science and Technology Research of China during the
   '12th five-year plan' (no. 81271957).
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LAPPALAINEN K, 1994, PHARMACEUT RES, V11, P1127, DOI 10.1023/A:1018932714745
   Li LH, 2013, J BIOMATER TISS ENG, V3, P554, DOI 10.1166/jbt.2013.1114
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6
   Ryan D, 2004, LANGMUIR, V20, P9080, DOI 10.1021/la048443u
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   WIDRIG CA, 1991, J AM CHEM SOC, V113, P2805, DOI 10.1021/ja00008a001
   Wu JX, 1996, ANTICANCER RES, V16, P2233
   Yan HJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035008
   Yu XL, 2013, SURF COAT TECH, V228, pS48, DOI 10.1016/j.surfcoat.2012.08.054
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 24
TC 1
Z9 1
U1 0
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD FEB
PY 2015
VL 11
IS 2
BP 975
EP 981
DI 10.3892/mmr.2014.2876
PG 7
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CB3CS
UT WOS:000349506400030
PM 25373556
OA Green Published
DA 2018-10-20
ER

PT J
AU Gawlitta, D
   Benders, KEM
   Visser, J
   van der Sar, AS
   Kempen, DHR
   Theyse, LFH
   Malda, J
   Dhert, WJA
AF Gawlitta, Debby
   Benders, Kim E. M.
   Visser, Jetze
   van der Sar, Anja S.
   Kempen, Diederik H. R.
   Theyse, Lars F. H.
   Malda, Jos
   Dhert, Wouter J. A.
TI Decellularized Cartilage-Derived Matrix as Substrate for Endochondral
   Bone Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MULTIPOTENT STROMAL CELLS; EQUINE
   ARTICULAR-CARTILAGE; TISSUE; OSSIFICATION; CHONDROGENESIS; CONSTRUCTS;
   SCAFFOLDS; REPAIR
AB Following an endochondral approach to bone regeneration, multipotent stromal cells (MSCs) can be cultured on a scaffold to create a cartilaginous callus that is subsequently remodeled into bone. An attractive scaffold material for cartilage regeneration that has recently regained attention is decellularized cartilage-derived matrix (CDM). Since this material has shown potential for cartilage regeneration, we hypothesized that CDM could be a potent material for endochondral bone regeneration. In addition, since decellularized matrices are known to harbor bioactive cues for tissue formation, we evaluated the need for seeded MSCs in CDM scaffolds. In this study, ectopic bone formation in rats was evaluated for CDM scaffolds seeded with human MSCs and compared with unseeded controls. The MSC-seeded samples were preconditioned in chondrogenic medium for 37 days. After 8 weeks of subcutaneous implantation, the extent of mineralization was significantly higher in the MSC-seeded constructs versus unseeded controls. The mineralized areas corresponded to bone formation with bone marrow cavities. In addition, rat-specific bone formation was confirmed by collagen type I immunohistochemistry. Finally, fluorochrome incorporation at 3 and 6 weeks revealed that the bone formation had an inwardly directed progression. Taken together, our results show that decellularized CDM is a promising biomaterial for endochondral bone regeneration when combined with MSCs at ectopic locations. Modification of current decellularization protocols may lead to enhanced functionality of CDM scaffolds, potentially offering the prospect of generation of cell-free off-the-shelf bone regenerative substitutes.
C1 [Gawlitta, Debby; Benders, Kim E. M.; Visser, Jetze; Kempen, Diederik H. R.; Malda, Jos; Dhert, Wouter J. A.] Univ Med Ctr Utrecht, Dept Orthoped, NL-3508 GA Utrecht, Netherlands.
   [van der Sar, Anja S.] Cent Lab Anim Inst, Utrecht, Netherlands.
   [Theyse, Lars F. H.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.
   [Malda, Jos] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands.
   [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.
RP Gawlitta, D (reprint author), Univ Med Ctr Utrecht, Dept Orthopaed, G05-228,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM d.gawlitta@umcutrecht.nl
OI Kempen, Diederik/0000-0002-4504-7756; Malda, Jos/0000-0002-9241-7676
FU Dutch Technology Foundation, STW [Veni 11208]; Alexandre Suerman
   Fellowship of the UMC Utrecht; Dutch Arthritis Foundation; Netherlands
   Institute for Regenerative Medicine (NIRM); NICHD
FX The authors would like to acknowledge Rick van der Spek, Jason
   Doppenberg, and Selynda Toma for their input and technical assistance.
   D.G. was supported by the Dutch Technology Foundation, STW (Veni 11208).
   K.B. was funded by an Alexandre Suerman Fellowship of the UMC Utrecht.
   J.M. was supported by the Dutch Arthritis Foundation, and J.V. was
   supported by the Netherlands Institute for Regenerative Medicine
   (NIRM).; The antibody against collagen type II (II-II6B3), developed by
   T.F. Linsenmayer, was obtained from the DSHB developed under the
   auspices of the NICHD and maintained by The University of Iowa,
   Department of Biology, Iowa City, IA 52242. The authors are grateful to
   Dr. E. Muinos Pury Ripalda for providing the protocol for the anti-human
   mitochondria staining.
CR ASCH L, 1989, Archives d'Anatomie d'Histologie et d'Embryologie Normales et Experimentales, V72, P81
   Barradas A. M. C., 2010, TERMIS
   Benders KEM, 2014, CARTILAGE, V5, P221, DOI 10.1177/1947603514535245
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Brama PAJ, 1999, AM J VET RES, V60, P341
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297
   GABRIELLI M F, 1986, Journal of Nihon University School of Dentistry, V28, P87
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gawlitta D, 2010, TISSUE ENG PART B-RE, V16, P385, DOI 10.1089/ten.TEB.2009.0712
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Platt D, 1998, EQUINE VET J, V30, P43, DOI 10.1111/j.2042-3306.1998.tb04087.x
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   URIST M R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P198
   URIST MR, 1952, J BONE JOINT SURG AM, V34-A, P443, DOI 10.2106/00004623-195234020-00015
   van Gaalen S. M., 2009, TISSUE ENG PART B-RE, V16, P209
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]
NR 32
TC 29
Z9 29
U1 3
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 694
EP 703
DI 10.1089/ten.tea.2014.0117
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600027
PM 25316202
DA 2018-10-20
ER

PT J
AU Sosio, C
   Di Giancamillo, A
   Deponti, D
   Gervaso, F
   Scalera, F
   Melato, M
   Campagnol, M
   Boschetti, F
   Nonis, A
   Domeneghini, C
   Sannino, A
   Peretti, GM
AF Sosio, Corrado
   Di Giancamillo, Alessia
   Deponti, Daniela
   Gervaso, Francesca
   Scalera, Francesca
   Melato, Marco
   Campagnol, Marino
   Boschetti, Federica
   Nonis, Alessandro
   Domeneghini, Cinzia
   Sannino, Alessandro
   Peretti, Giuseppe Michele
TI Osteochondral Repair by a Novel Interconnecting Collagen-Hydroxyapatite
   Substitute: A Large-Animal Study
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE-ENGINEERING APPLICATIONS; MESENCHYMAL STEM-CELLS; FIBRIN GLUE;
   ARTICULAR-CARTILAGE; BILAYERED SCAFFOLD; KNEE LESIONS; FOLLOW-UP;
   IN-VIVO; DEFECTS; REGENERATION
AB A novel three-dimensional bicomponent substitute made of collagen type I and hydroxyapatite was tested for the repair of osteochondral lesions in a swine model. This scaffold was assembled by a newly developed method that guarantees the strict integration between the organic and the inorganic parts, mimicking the biological tissue between the chondral and the osseous phase. Thirty-six osteochondral lesions were created in the trochlea of six pigs; in each pig, two lesions were treated with scaffolds seeded with autologous chondrocytes (cell+group), two lesions were treated with unseeded scaffolds (cell- group), and the two remaining lesions were left untreated (untreated group). After 3 months, the animals were sacrificed and the newly formed tissue was analyzed to evaluate the degree of maturation. The International Cartilage Repair Society (ICRS) macroscopic assessment showed significantly higher scores in the cell- and untreated groups when compared with the cell+ group. Histological evaluation showed the presence of repaired tissue, with fibroblast-like and hyaline-like areas in all groups; however, with respect to the other groups, the cell- group showed significantly higher values in the ICRS II histological scores for "cell morphology" and for the "surface/superficial assessment." While the scaffold seeded with autologous chondrocytes promoted the formation of a reparative tissue with high cellularity but low glycosaminoglycans (GAG) production, on the contrary, the reparative tissue observed with the unseeded scaffold presented lower cellularity but higher and uniform GAG distribution. Finally, in the lesions treated with scaffolds, the immunohistochemical analysis showed the presence of collagen type II in the peripheral part of the defect, indicating tissue maturation due to the migration of local cells from the surroundings. This study showed that the novel osteochondral scaffold was easy to handle for surgical implantation and was stable within the site of lesion; at the end of the experimental time, all implants were well integrated with the surrounding tissue and no signs of synovitis were observed. The quality of the reparative tissue seemed to be superior for the lesions treated with the unseeded scaffolds, indicating the promising potential of this novel biomaterial for use in a one-stage procedure for osteochondral repair.
C1 [Sosio, Corrado; Di Giancamillo, Alessia; Deponti, Daniela; Boschetti, Federica; Peretti, Giuseppe Michele] IRCCS Ist Ortoped Galeazzi, Milan, Italy.
   [Gervaso, Francesca; Scalera, Francesca; Sannino, Alessandro] Univ Salento, Dept Engn Innovat, Lecce, Italy.
   [Melato, Marco] Univ Milan, Residency Program Orthopaed & Traumatol, Milan, Italy.
   [Campagnol, Marino] Univ Milan, CRABCC, Rivolta Adda CR, Milan, Italy.
   [Boschetti, Federica] Politecn Milan, Lab Biol Struct Mech, Dept Struct Engn, I-20133 Milan, Italy.
   [Nonis, Alessandro] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci CUSSB, Milan, Italy.
   [Domeneghini, Cinzia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy.
   [Peretti, Giuseppe Michele] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.
RP Peretti, GM (reprint author), Univ Milan, Dept Biomed Sci Hlth, IRCCS Ist Ortoped Galeazzi, Via R Galeazzi 4, I-20161 Milan, Italy.
EM gperetti@iol.it
RI Boschetti, Federica/I-8623-2018; Gervaso, Francesca/G-8874-2013;
   Peretti, Giuseppe/K-6358-2016; scalera, francesca/D-8595-2014
OI Boschetti, Federica/0000-0002-1932-7535; Gervaso,
   Francesca/0000-0002-8644-1653; Peretti, Giuseppe/0000-0001-9341-7187;
   scalera, francesca/0000-0002-1686-6736; Sannino,
   Alessandro/0000-0001-8959-4412; DI GIANCAMILLO,
   ALESSIA/0000-0003-1674-3020; Domeneghini, Cinzia/0000-0002-2040-6783
FU Fondazione CARIPLO [5682]
FX This work was funded by the Fondazione CARIPLO (project No. 5682). The
   authors acknowledge Dr. Alessandro Addis, Dr. Alessandro Pozzi, and Dr.
   Rosa Ballis for the animal care and management and for their precious
   help in the sample preparation and shipping. The authors thank Dr.
   Fraschini for his support in the present study. The authors also
   acknowledge Rahmat Cholas for revising the English language of this
   manuscript. Special thanks is given to Prof. Clelia Di Serio for the
   supervision of the statistical analysis and to Dr. Sanosh Kunjalukkal
   Padmanabhan and Dr. Antonio Licciulli for the synthesis of the HA
   component.
CR Betsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071602
   Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   Deponti D., 2013, J TISSUE ENG REGEN M, DOI 10.1002/term.1760
   Deponti D, 2014, TISSUE ENG PT A, V20, P1113, DOI [10.1089/ten.tea.2013.0171, 10.1089/ten.TEA.2013.0171]
   Deponti D, 2012, TISSUE ENG PT A, V18, P1109, DOI [10.1089/ten.tea.2011.0272, 10.1089/ten.TEA.2011.0272]
   Ding M, 2010, ACTA ORTHOP, V81, P5, DOI 10.3109/17453671003619037
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2014, OSTEOARTHR CARTILAGE, V22, P557, DOI 10.1016/j.joca.2014.01.004
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2014, INT ORTHOP, V38, P1905, DOI 10.1007/s00264-014-2322-1
   Filova E, 2013, INT J PHARMACEUT, V447, P139, DOI 10.1016/j.ijpharm.2013.02.056
   Gervaso Francesca, 2012, Key Engineering Materials, V493-494, P890, DOI 10.4028/www.scientific.net/KEM.493-494.890
   Gervaso F, 2012, INT J APPL CERAM TEC, V9, P507, DOI 10.1111/j.1744-7402.2011.02662.x
   Gross AE, 2008, CLIN ORTHOP RELAT R, V466, P1863, DOI 10.1007/s11999-008-0282-8
   Gun I., 2010, TISSUE ENG, V16, P1189
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004
   Jakob RP, 2002, CLIN ORTHOP RELAT R, P170
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E., 2010, BMC MUSCULOSKEL DIS, V27, P11
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Malicev E, 2007, BIOTECHNOL BIOENG, V96, P364, DOI 10.1002/bit.21038
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694
   Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Perdisa F, 2014, HISTOL HISTOPATHOL, V29, P805, DOI 10.14670/HH-29.805
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Peretti GM, 2001, ANN PLAS SURG, V46, P533, DOI 10.1097/00000637-200105000-00013
   Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   ROFFI A, 2013, BMC MUSCULOSKEL DIS, V21, P330
   Scalera F, 2013, CERAM INT, V39, P4839, DOI 10.1016/j.ceramint.2012.11.076
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]
   Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159
   Siebelt M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4461
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sosio C, 2007, KNEE SURG SPORT TR A, V15, P1251, DOI 10.1007/s00167-007-0339-3
   Sosio C, 2011, KNEE SURG SPORT TR A, V19, P1035, DOI 10.1007/s00167-010-1296-9
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.000011594.52661.29
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
NR 56
TC 7
Z9 7
U1 3
U2 29
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 704
EP 715
DI 10.1089/ten.tea.2014.0129
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600028
PM 25316498
DA 2018-10-20
ER

PT J
AU Magalhaes, J
   Lebourg, M
   Deplaine, H
   Ribelles, JLG
   Blanco, FJ
AF Magalhaes, Joana
   Lebourg, Myriam
   Deplaine, Harmony
   Gomez Ribelles, Jose Luis
   Blanco, Francisco J.
TI Effect of the Physicochemical Properties of Pure or Chitosan-Coated
   Poly(L-Lactic Acid)Scaffolds on the Chondrogenic Differentiation of
   Mesenchymal Stem Cells from Osteoarthritic Patients
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; IN-VITRO; COMPOSITE SCAFFOLDS; POROUS
   SCAFFOLDS; ACID) SCAFFOLDS; HYALURONIC-ACID; FABRICATION; HYDROGELS;
   BIOMATERIAL; RELEASE
AB Due to the attractive properties of poly(L-lactic acid) (PLLA) and chitosan (CHT) for tissue engineering applications, this study is aimed at analyzing the chondrogenic potential of human bone marrow-derived mesenchymal stem cells (BM-MSCs) derived from osteoarthritic (OA) patients, in pure or CHT-coated PLLA, using different coating methodologies. Although PLLA scaffolds coated in one-step (PLLA-CHT1) yielded CHT smooth pellicles filling the PLLA macropores, a two-step strategy resulted in a CHT fiber-like thin coating covering PLLA pore walls (PLLA-CHT2). Both strategies led to the incorporation of similar content of CHT and a two-fold increase in the scaffold's water uptake capacity, providing elastic moduli values comparable to the ones found for human articular cartilage. After confirming OA-derived BM-MSCs, metabolic activity in the scaffolds, the chondrogenic potential was tested at 30 and 60 days, in a chondrogenic differentiation medium. PLLA scaffolds improved the chondrogenic differentiation of BM-MSCs, regarding cell pellet conventional culture and presented a typical cartilage zonal distribution, although was not able to revert a terminal differentiation. In PLLA-CHT1, on a short term, a rather heterogeneous tissue was formed, with confined areas of either slower cell infiltration or a faster maturation, with enhanced chondrogenic phenotype. In PLLA-CHT2, a similar tissue to PLLA was obtained, albeit on the long term, these scaffolds helped to maintain a hyaline-like phenotype and prevented the advance of the hypertrophic process. These results demonstrate the importance of the scaffolds microenvironment on the cellular events of chondrogenesis.
C1 [Magalhaes, Joana; Lebourg, Myriam; Gomez Ribelles, Jose Luis] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.
   [Magalhaes, Joana; Blanco, Francisco J.] Univ Coruna UDC, Grp Bioingn Tisular & Terapia Celular GBTTC CHUAC, Serv Reumatol, Inst Invest Biomed A Coruna INIBIC,Complexo Hosp, La Coruna, Spain.
   [Lebourg, Myriam; Deplaine, Harmony; Gomez Ribelles, Jose Luis] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, E-46022 Valencia, Spain.
RP Magalhaes, J (reprint author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.
EM joana.cristina.silva.magalhaes@sergas.es; fblagar@sergas.es
RI Blanco, Francisco J/C-3192-2014; Gomez Ribelles, Jose Luis/L-5629-2014
OI Blanco, Francisco J/0000-0001-9821-7635; Gomez Ribelles, Jose
   Luis/0000-0001-9099-0885
FU Program ACI-PRO-MOCIONA [ACI2010-1095, MAT2010-21611-CO3-01]; Iniciativa
   Ingenio; Consolider Program
FX The authors are thankful to the microscopy service of UPV for useful
   help and service; the Department of Orthopedic Surgery-CHUAC for
   providing human samples; T.H. Gomez and M.J. Sanchez for cell isolation
   and SCH of INIBIC for histological processing. The Biomedical Research
   Networking Center in Bioengineering, Biomaterials, and Nanomedicine
   (CIBER-BBN) is a national initiative of ISCIII. This study was supported
   by Program ACI-PRO-MOCIONA (ACI2010-1095), MAT2010-21611-CO3-01,
   Iniciativa Ingenio 2010, and Consolider Program.
CR Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]
   da Silva MLA, 2011, J TISSUE ENG REGEN M, V5, P722, DOI 10.1002/term.372
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Blanco FJ, 2013, ANN RHEUM DIS, V72, P631, DOI [10.1136/annrheumdis-2012-202652, 10.1136/annrheumdis-2012-201745]
   Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8
   BRANDRUP J, 1975, POLYM HDB
   Casper ME, 2010, OSTEOARTHR CARTILAGE, V18, P981, DOI 10.1016/j.joca.2010.04.009
   Cicione C, 2010, DIFFERENTIATION, V80, P155, DOI 10.1016/j.diff.2010.06.001
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Deplaine H, 2013, J BIOMED MATER RES B, V101B, P173, DOI 10.1002/jbm.b.32831
   Deplaine H, 2010, COMPOS SCI TECHNOL, V70, P1805, DOI 10.1016/j.compscitech.2010.06.009
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diekman BO, 2013, CURR OPIN RHEUMATOL, V25, P119, DOI 10.1097/BOR.0b013e32835aa28d
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Fujihara Y, 2009, TISSUE ENG PT A, V15, P1565, DOI 10.1089/ten.tea.2008.0154
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007
   Griffon DJ, 2011, J TISSUE ENG REGEN M, V5, P169, DOI 10.1002/term.302
   He LM, 2009, POLYMER, V50, P4128, DOI 10.1016/j.polymer.2009.06.025
   Hellingman CA, 2012, J TISSUE ENG REGEN M, V6, pe1, DOI 10.1002/term.502
   Hermida-Gomez T, 2011, TISSUE ENG PT A, V17, P1169, DOI [10.1089/ten.tea.2010.0346, 10.1089/ten.TEA.2010.0346]
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Izal I, 2013, KNEE SURG SPORT TR A, V21, P1737, DOI 10.1007/s00167-012-2148-6
   Jiao YP, 2007, J BIOMED MATER RES A, V80A, P820, DOI 10.1002/jbm.a.31061
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Lebourg M, 2010, J MATER SCI-MATER M, V21, P33, DOI 10.1007/s10856-009-3838-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028
   Magalhaes J, 2013, J BIOMED MATER RES A, V101, P157, DOI 10.1002/jbm.a.34312
   Ni PY, 2011, INT J NANOMED, V6, P3065, DOI 10.2147/IJN.S25297
   Niu XF, 2012, J BIOMAT SCI-POLYM E, V23, P391, DOI 10.1163/092050610X551961
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Painter P. C, 1997, FUNDAMENTALS POLYM S
   Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ragetly GR, 2010, J BIOMED MATER RES A, V93A, P46, DOI 10.1002/jbm.a.32514
   Ringe J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2572
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Shen Y, 2014, CURR STEM CELL RES T, V9, P254, DOI 10.2174/1574888X09666140213202700
   Silva JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055451
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Tanaka T, 2009, J BIOMED MATER RES A, V91A, P428, DOI 10.1002/jbm.a.32253
   Vaghani SS, 2011, DRUG DEV IND PHARM, V37, P1160, DOI 10.3109/03639045.2011.563422
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yang WD, 2006, TISSUE ENG, V12, P2009, DOI 10.1089/ten.2006.12.2009
   Yang Z, 2012, TISSUE ENG PT A, V18, P242, DOI [10.1089/ten.tea.2011.0315, 10.1089/ten.TEA.2011.0315]
   Zhang JJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035011
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 59
TC 5
Z9 5
U1 4
U2 26
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 716
EP 728
DI 10.1089/ten.tea.2014.0133
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600029
PM 25297938
DA 2018-10-20
ER

PT J
AU Bassi, G
   Guilloton, F
   Menard, C
   Di Trapani, M
   Deschaseaux, F
   Sensebe, L
   Schrezenmeier, H
   Giordano, R
   Bourin, P
   Dominici, M
   Tarte, K
   Krampera, M
AF Bassi, Giulio
   Guilloton, Fabien
   Menard, Cedric
   Di Trapani, Mariano
   Deschaseaux, Frederic
   Sensebe, Luc
   Schrezenmeier, Hubert
   Giordano, Rosaria
   Bourin, Philippe
   Dominici, Massimo
   Tarte, Karin
   Krampera, Mauro
TI Effects of a Ceramic Biomaterial on Immune Modulatory Properties and
   Differentiation Potential of Human Mesenchymal Stromal Cells of
   Different Origin
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BIPHASIC CALCIUM-PHOSPHATE; TISSUE-ENGINEERED BONE; STEM-CELLS;
   OSTEOGENIC DIFFERENTIATION; IMMUNOLOGICAL-PROPERTIES; MOUSE MODEL;
   TNF-ALPHA; T-CELLS; MARROW; GRAFT
AB The aim of this study was to assess the immune modulatory properties of human mesenchymal stromal cells obtained from bone marrow (BM-MSCs), fat (ASCs), and cord blood (CB-MSCs) in the presence of a hydroxyapatite and tricalcium-phosphate (HA/TCP) biomaterial as a scaffold for MSC delivery. In resting conditions, a short-term culture with HA/TCP did not modulate the anti-apoptotic and suppressive features of the various MSC types toward T, B, and NK cells; in addition, when primed with inflammatory cytokines, MSCs similarly increased their suppressive capacities in the presence or absence of HA/TCP. The long-term culture of BM-MSCs with HA/TCP induced an osteoblast-like phenotype with upregulation of OSTERIX and OSTEOCALCIN, similar to what was obtained with dexamethasone and, to a higher extent, with bone morphogenetic protein 4 (BMP-4) treatment. MSC-derived osteoblasts did not trigger immune cell activation, but were less efficient than undifferentiated MSCs in inhibiting stimulated T and NK cells. Interestingly, their suppressive machinery included not only the activation of indoleamine-2,3 dioxygenase (IDO), which plays a central role in T-cell inhibition, but also cyclooxygenase-2 (COX-2) that was not significantly involved in the immune modulatory effect of human undifferentiated MSCs. Since COX-2 is significantly involved in bone healing, its induction by HA/TCP could also contribute to the therapeutic activity of MSCs for bone tissue engineering.
C1 [Bassi, Giulio; Di Trapani, Mariano; Krampera, Mauro] Univ Verona, Sect Hematol, Dept Med, Stem Cell Res Lab, I-37134 Verona, Italy.
   [Guilloton, Fabien; Deschaseaux, Frederic; Sensebe, Luc; Bourin, Philippe] Univ Toulouse 3, EFS Pyrenees Mediterrane, UMR5273, INSERM U1031, F-31062 Toulouse, France.
   [Menard, Cedric; Tarte, Karin] Univ Rennes 1, Fac Med, INSERM U917, EFS Bretagne, F-35043 Rennes, France.
   [Schrezenmeier, Hubert] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany.
   [Schrezenmeier, Hubert] German Red Cross Blood Donor Serv Baden Wurttembe, Ulm, Germany.
   [Giordano, Rosaria] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cell Factory, Milan, Italy.
   [Bourin, Philippe] CSA21, Toulouse, France.
   [Dominici, Massimo] Univ Hosp Modena & Reggio Emilia, Lab Cell Biol & Adv Canc Therapies, Dept Med & Surg Sci Children & Adults, Modena, Italy.
RP Tarte, K (reprint author), Univ Rennes 1, Fac Med, INSERM U917, EFS Bretagne, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.
EM karin.tarte@univ-rennes1.fr; mauro.krampera@univr.it
RI Di Trapani, Mariano/J-9877-2016; Giordano, Rosaria/N-6565-2015
OI Di Trapani, Mariano/0000-0002-3077-8038; Giordano,
   Rosaria/0000-0002-7263-0752; Dominici, Massimo/0000-0002-4007-1503;
   Bourin, Philippe/0000-0002-9652-4380
FU seventh Framework Program of the European Commission: CASCADE
   [FP7-HEALTH-233236]; seventh Framework Program of the European
   Commission: REBORNE "Regenerating bone defects using new biomedical
   approaches" [FP7-HEALTH-241879]; Italian Ministry of University and
   Scientific Research-PRIN; Ricerca Sanitaria Finalizzata; Cariverona
   Foundation, Verona, Italy (Bando); European Center for Transplantation
   Sciences and Immunotherapy (IHU CESTI) [ANR-10-IBHU-0005];
   Infrastructure Program ECELL-FRANCE [ANR-11-INSB-005]; CPER
FX This work was supported by grants from the seventh Framework Program of
   the European Commission: CASCADE (FP7-HEALTH-233236) and REBORNE
   "Regenerating bone defects using new biomedical approaches"
   (FP7-HEALTH-241879) and by grants from the Italian Ministry of
   University and Scientific Research-PRIN 2009; Ricerca Sanitaria
   Finalizzata 2008; Cariverona Foundation, Verona, Italy (Bando 2008 e
   2012); the European Center for Transplantation Sciences and
   Immunotherapy (IHU CESTI, ANR-10-IBHU-0005), the Infrastructure Program
   ECELL-FRANCE (ANR-11-INSB-005), and the CPER 2007-2013 (axe
   Biotherapie). The authors thank Biomatlante for providing customized
   HA/TCP discs. The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of this
   article.
CR Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
   Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Atkins GJ, 2009, BIOMATERIALS, V30, P3672, DOI 10.1016/j.biomaterials.2009.03.035
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1
   Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2
   Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9
   Cordonnier T., 2010, TISSUE ENG PART C-ME, V17, P249
   Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Dupont KM, 2012, CELL TISSUE RES, V347, P575, DOI 10.1007/s00441-011-1197-3
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Huang H, 2011, CELL PROLIFERAT, V44, P420, DOI 10.1111/j.1365-2184.2011.00769.x
   Jegoux F, 2010, ARCH OTOLARYNGOL, V136, P971, DOI 10.1001/archoto.2010.173
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810
   Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042
   Lin CL, 2009, J TRAUMA, V67, P1393, DOI 10.1097/TA.0b013e31818c1595
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Marini JC, 2012, NEW ENGL J MED, V366, P2522, DOI 10.1056/NEJMcibr1204283
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   SKJODT H, 1989, IMMUNOLOGY, V68, P416
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Wang L, 2006, TRANSPLANT P, V38, P2267, DOI 10.1016/j.transproceed.2006.06.048
   Ward WG, 2008, CLIN ORTHOP RELAT R, V466, P1837, DOI 10.1007/s11999-008-0294-4
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025
NR 57
TC 9
Z9 9
U1 2
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB 1
PY 2015
VL 21
IS 3-4
BP 767
EP 781
DI 10.1089/ten.tea.2014.0269
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CB4PZ
UT WOS:000349611600033
PM 25322665
OA Green Published
DA 2018-10-20
ER

PT J
AU Evans, NT
   Torstrick, FB
   Lee, CSD
   Dupont, KM
   Safranski, DL
   Chang, WA
   Macedo, AE
   Lin, ASP
   Boothby, JM
   Whittingslow, DC
   Carson, RA
   Guldberg, RE
   Gall, K
AF Evans, Nathan T.
   Torstrick, F. Brennan
   Lee, Christopher S. D.
   Dupont, Kenneth M.
   Safranski, David L.
   Chang, W. Allen
   Macedo, Annie E.
   Lin, Angela S. P.
   Boothby, Jennifer M.
   Whittingslow, Daniel C.
   Carson, Robert A.
   Guldberg, Robert E.
   Gall, Ken
TI High-strength, surface-porous polyether-ether-ketone for load-bearing
   orthopedic implants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyether-ether-ketone (PEEK); Fatigue; Surface porous; Orthopedic
   implant
ID TREATED POLYETHERETHERKETONE PEEK; FIBER-REINFORCED PEEK; BONE DEFECT
   REPAIR; MECHANICAL-PROPERTIES; BIOMATERIAL SCAFFOLDS; BIOLOGICAL
   RESPONSE; PLASMA; TITANIUM; OSSEOINTEGRATION; ARTHROPLASTY
AB Despite its widespread clinical use in load-bearing orthopedic implants, polyether-ether-ketone (PEEK) is often associated with poor osseointegration. In this study, a surface-porous PEEK material (PEEK-SP) was created using a melt extrusion technique. The porous layer was 399.6 +/- 63.3 lam thick and possessed a mean pore size of 279.9 +/- 31.6 mu m. strut spacing of 186.8 +/- 55.5 mu m, porosity of 67.3 +/- 3.1% and interconnectivity of 99.9 +/- 0.1%. Monotonic tensile tests showed that PEEK-SP preserved 73.9% of the strength (71.06 +/- 2.17 MPa) and 73.4% of the elastic modulus (2.45 +/- 0.31 GPa) of as-received, injection-molded PEEK. PEEK-SP further demonstrated a fatigue strength of 60.0 MPa at one million cycles, preserving 73.4% of the fatigue resistance of injection-molded PEEK. Interfacial shear testing showed the pore layer shear strength to be 23.96 +/- 2.26 MPa. An osseointegration model in the rat revealed substantial bone formation within the pore layer at 6 and 12 weeks via microcomputed tomography and histological evaluation. Ingrown bone was more closely apposed to the pore wall and fibrous tissue growth was reduced in PEEK-SP when compared to non-porous PEEK controls. These results indicate that PEEK-SP could provide improved osseointegration while maintaining the structural integrity necessary for load-bearing orthopedic applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Evans, Nathan T.; Gall, Ken] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Torstrick, F. Brennan; Lin, Angela S. P.; Carson, Robert A.; Guldberg, Robert E.; Gall, Ken] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Torstrick, F. Brennan; Lin, Angela S. P.; Guldberg, Robert E.; Gall, Ken] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Lee, Christopher S. D.; Chang, W. Allen] Vertera Inc, Atlanta, GA 30332 USA.
   [Dupont, Kenneth M.; Safranski, David L.] MedShape Inc, Atlanta, GA 30318 USA.
   [Macedo, Annie E.; Boothby, Jennifer M.; Whittingslow, Daniel C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Macedo, Annie E.; Boothby, Jennifer M.; Whittingslow, Daniel C.] Emory Univ, Atlanta, GA 30332 USA.
RP Evans, NT (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, 771 Ferst Dr,J Erskine Love Bldg, Atlanta, GA 30332 USA.
EM nevans3@gatech.edu
OI Boothby, Jennifer/0000-0003-3095-0640
FU Solvay Specialty Polymers; National Science Foundation [2013162284];
   National Center for Advancing Translational Sciences of the National
   Institutes of Health [UL1TR000454]
FX This work was supported by Solvay Specialty Polymers. The authors would
   like to thank Katie Poynter and Haley Harris for their assistance in the
   mechanical characterization and Laura Gartner for her assistance
   regarding SEM imaging. N.T.E., D.C.W., D.L.S. and K.G. are inventors of
   the technology disclosed in this manuscript. The technology disclosed in
   this manuscript has been licensed from Georgia Tech Research
   Corporation. N.T.E is supported by the National Science Foundation
   Graduate Research Fellowship under Grant No. 2013162284. F.B.T. is
   supported by the National Center for Advancing Translational Sciences of
   the National Institutes of Health under Award No. UL1TR000454. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P141, DOI 10.3109/17453679209154809
   Bakar A, 2003, BIOMATERIALS, V24, P2245
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DiRienzo AL, 2014, J MECH BEHAV BIOMED, V30, P347, DOI 10.1016/j.jmbbm.2013.10.012
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   Gittens RA, 2014, ACTA BIOMATER
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Guldberg RE, 1997, J BIOMECH, V30, P147, DOI 10.1016/S0021-9290(96)00106-6
   Ha SW, 1997, J MATER SCI-MATER M, V8, P683, DOI 10.1023/A:1018535923173
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   He Q, 2012, PLOS ONE, P7
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Jarman-Smith M, 2012, PDL HANDB SER, P181, DOI 10.1016/B978-1-4377-4463-7.10012-0
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kurtz SM, 2012, PDL HANDB SER, P1, DOI 10.1016/B978-1-4377-4463-7.10001-6
   Kurtz SM, 2016, PDL HANDB SER, P1, DOI 10.1016/B978-0-12-374721-1.00001-8
   Landy BC, 2013, J APPL BIOMATER FUNC, V11, P35, DOI 10.5301/JABFM.2012.9771
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Muller U, 2006, EUR CELLS MATER, V11, P8, DOI 10.22203/eCM.v011a02
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Pereira HD, 2013, KNEE SURG SPORT TR A, P1
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Poulsson AHC, 2014, BIOMATERIALS, V35, P3717, DOI 10.1016/j.biomaterials.2013.12.056
   Poulsson AHC, 2012, PDL HANDB SER, P145, DOI 10.1016/B978-1-4377-4463-7.10010-7
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Robotti P, 2012, PDL HANDB SER, P119, DOI 10.1016/B978-1-4377-4463-7.10009-0
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shenton MJ, 2001, J PHYS D APPL PHYS, V34, P2761, DOI 10.1088/0022-3727/34/18/308
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Sinclair SK, 2012, SPINE, V37, pE571, DOI 10.1097/BRS.0b013e318240f981
   Suwanprateeb J, 2006, J BIOMED MATER RES B, V78B, P138, DOI 10.1002/jbm.b.30469
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Wang LM, 2013, J BIOMED MATER RES B, V101B, P813, DOI 10.1002/jbm.b.32885
   WILLIAMS DF, 1987, J MATER SCI LETT, V6, P188, DOI 10.1007/BF01728981
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Yao C, 2007, INT J NANOMED, V2, P487
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
NR 52
TC 30
Z9 31
U1 10
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2015
VL 13
BP 159
EP 167
DI 10.1016/j.actbio.2014.11.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA2QZ
UT WOS:000348753700016
PM 25463499
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Berdichevski, A
   Shachaf, Y
   Wechsler, R
   Seliktar, D
AF Berdichevski, Alexandra
   Shachaf, Yonatan
   Wechsler, Roni
   Seliktar, Dror
TI Protein composition alters in vivo resorption of PEG-based hydrogels as
   monitored by contrast-enhanced MRI
SO BIOMATERIALS
LA English
DT Article
DE MRI; Contrast agents; Biomaterial scaffold; PEG hydrogel;
   Biodegradation; Implant biocompatibility
ID POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; MACROPHAGE RESPONSE;
   TISSUE-REPAIR; HOST RESPONSE; CELL-CULTURE; GELATIN; DEGRADATION;
   FIBRINOGEN; MATRIX; NANOPARTICLES
AB We report on the use of magnetic resonance imaging (MRI)-based non-invasive monitoring to document the role of protein adjuvants in hydrogel implant integration in vivo. Polyethylene glycol (PEG) hydrogels were formed with different protein constituents, including albumin, fibrinogen and gelatin. The hydrogels were designed to exhibit similar material properties, including modulus, swelling and hydrolytic degradation kinetics. The in vivo resorption properties of these PEG-based hydrogels, which contained a tethered gadolinium contrast agent, were characterized by MRI and histology, and compared to their in vitro characteristics. MRI data revealed that PEG-Albumin implants remained completely intact throughout the experiments, PEG-Fibrinogen implants lost about 10% of their volume and PEG-Gelatin implants underwent prominent swelling and returned to their initial volume by day 25. Fully synthetic PEG-diacrylate (PEG DA) control hydrogels lost about half of their volume after 25 days in vivo. Transverse MRI cross-sections of the implants revealed distinct mechanisms of the hydrogel's biodegradation: PEG-Fibrinogen and PEG-Albumin underwent surface erosion, whereas PEG-Gelatin and PEG-DA hydrogels mainly underwent bulk degradation. Histological findings substantiated the MRI data and demonstrated significant cellular response towards PEG-DA and PEG-Gelatin scaffolds with relatively low reaction towards PEG-Fibrinogen and PEG-Albumin hydrogels. These findings demonstrate that PEG-protein hydrogels can degrade via a different mechanism than PEG-hydrogels, and that this difference can be linked to a reduced foreign body response. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Berdichevski, Alexandra; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Shachaf, Yonatan; Wechsler, Roni] Regentis Biomat Ltd, IL-30600 Or Akiva, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
FU Singapore National Research Foundation (NRF)-Technion-NUS Grant for
   Regenerative Medicine Initiative in Cardiac Restoration Therapy; Lorry
   I. Lokey Interdisciplinary Center for Life Sciences and Engineering;
   Russell Berrie Nanotechnology Institute; EC-IP FP7 [262948-2]
FX This work was supported by the Singapore National Research Foundation
   (NRF)-Technion-NUS Grant for Regenerative Medicine Initiative in Cardiac
   Restoration Therapy, the Lorry I. Lokey Interdisciplinary Center for
   Life Sciences and Engineering, Russell Berrie Nanotechnology Institute,
   as well as by EC-IP FP7 grant Biodesign (262948-2). We thank the
   Preclinical Research Authority and the Imaging & Microscopy Center at
   the Bruce Rappaport Faculty of Medicine, Technion, Israel for their help
   and technical support. The authors thank Shlomit Cohen and Dr. Offra
   Sang-Nadir for their help with establishing the IHC staining of
   PEG-based implants.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chen JS, 2002, J MATER SCI-MATER M, V13, P1029, DOI 10.1023/A:1020380203499
   Cheng TL, 2005, BIOCONJUGATE CHEM, V16, P1225, DOI 10.1021/bc050133f
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dumin JA, 2001, PROCOLLAGENASE 1 MAT
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Ge YB, 2011, YAKUGAKU ZASSHI, V131, P1807, DOI 10.1248/yakushi.131.1807
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Gornall JL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031908
   Graves KL, 1996, AM J PHYSIOL-LUNG C, V271, pL61
   Hillel AT, 2011, SCI TRANSL MED, V3, P93
   JANUSZ MJ, 1993, J IMMUNOL, V150, P1922
   Johnstone SA, 2001, BBA-BIOMEMBRANES, V1513, P25, DOI 10.1016/S0005-2736(01)00292-9
   Killer M, 2011, NEURORADIOLOGY, V53, P449, DOI 10.1007/s00234-010-0744-z
   KimberleePotter BJB, 1994, CARBOHYD RES, V257, P117
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kopecek J, 1974, Polim Med, V4, P109
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Labow RS, 2005, BIOMATERIALS, V26, P7357, DOI 10.1016/j.biomaterials.2005.05.048
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu L, MACROMOLECULAR RAPID, V25, P1197
   Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Miyawaki O, 2003, BIOPOLYMERS, V70, P482, DOI 10.1002/bip.10473
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nicodemus GD, 2009, BIOTECHNOL BIOENG, V102, P948, DOI 10.1002/bit.22105
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Reid B, 2013, J TISSUE ENG REGEN M
   Richardson JC, 2005, ADV DRUG DELIVER REV, V57, P1191, DOI 10.1016/j.addr.2005.01.024
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shachaf Y, 2014, J TISSUE ENG REGEN M, V8, P113
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Shen F, 2003, BIOTECHNOL BIOENG, V83, P282, DOI 10.1002/bit.10674
   Shuhendler AJ, 2012, J CONTROL RELEASE, V157, P478, DOI 10.1016/j.jconrel.2011.09.061
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   Simms HH, 1997, ANN SURG, V225, P63
   Skarja GA, 1998, BIOMATERIALS, V19, P2129, DOI 10.1016/S0142-9612(98)00045-3
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Swartzlander MD, 2013, BIOMATERIALS, V34, P952, DOI 10.1016/j.biomaterials.2012.10.037
   Sweryda-Krawiec B, 2004, LANGMUIR, V20, P2054, DOI 10.1021/la034870g
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   van Putten SM, 2011, J BIOMED MATER RES A, V98A, P527, DOI 10.1002/jbm.a.33144
   Xu KD, 2013, ACTA BIOMATER, V9, P8802, DOI 10.1016/j.actbio.2013.06.021
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Yallapu MM, 2010, PHARM RES-DORDR, V27, P2283, DOI 10.1007/s11095-010-0260-1
NR 56
TC 13
Z9 13
U1 3
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 42
BP 1
EP 10
DI 10.1016/j.biomaterials.2014.11.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA4OH
UT WOS:000348883700001
PM 25542788
DA 2018-10-20
ER

PT J
AU Pirvu, T
   Blanquer, SBG
   Benneker, LM
   Grijpma, DW
   Richards, RG
   Alini, M
   Eglin, D
   Grad, S
   Li, Z
AF Pirvu, Tatiana
   Blanquer, Sebastien B. G.
   Benneker, Lorin M.
   Grijpma, Dirk W.
   Richards, Robert G.
   Alini, Mauro
   Eglin, David
   Grad, Sibylle
   Li, Zhen
TI A combined biomaterial and cellular approach for annulus fibrosus
   rupture repair
SO BIOMATERIALS
LA English
DT Article
DE Annulus fibrosus rupture repair; Poly(trimethylene carbonate) scaffold;
   Poly(esterurethane) membrane; Mesenchymal stromal cells; Implantation
ID INTERVERTEBRAL DISC CELLS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   LUMBAR DISKECTOMY; ANULAR REPAIR; SCAFFOLDS; REGENERATION;
   DIFFERENTIATION; DEGENERATION; HERNIATION
AB Recurrent intervertebral disc (IVD) herniation and degenerative disc disease have been identified as the most important factors contributing to persistent pain and disability after surgical discectomy. An annulus fibrosus (AF) closure device that provides immediate closure of the AF rupture, restores disc height, reduces further disc degeneration and enhances self-repair capacities is an unmet clinical need. In this study, a poly(trimethylene carbonate) (PTMC) scaffold seeded with human bone marrow derived mesenchymal stromal cells (MSCs) and covered with a poly(ester-urethane) (PU) membrane was assessed for AF rupture repair in a bovine organ culture annulotomy model under dynamic load for 14 days. PTMC scaffolds combined with the sutured PU membrane restored disc height of annulotomized discs and prevented herniation of nucleus pulposus (NP) tissue. Implanted MSCs showed an up-regulated gene expression of type V collagen, a potential AF marker, indicating in situ differentiation capability. Furthermore, MSCs delivered within PTMC scaffolds induced an up-regulation of anabolic gene expression and down-regulation of catabolic gene expression in adjacent native disc tissue. In conclusion, the combined biomaterial and cellular approach has the potential to hinder herniation of NP tissue, stabilize disc height, and positively modulate cell phenotype of native disc tissue. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Pirvu, Tatiana; Richards, Robert G.; Alini, Mauro; Eglin, David; Grad, Sibylle; Li, Zhen] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Blanquer, Sebastien B. G.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Benneker, Lorin M.] Univ Bern, Dept Orthopaed Surg, CH-3010 Bern, Switzerland.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Pirvu, Tatiana; Blanquer, Sebastien B. G.; Benneker, Lorin M.; Grijpma, Dirk W.; Richards, Robert G.; Alini, Mauro; Eglin, David; Grad, Sibylle; Li, Zhen] AO Fdn, Collaborat Res Partner Annulus Fibrosus Repair Pr, CH-7270 Davos, Switzerland.
RP Li, Z (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM zhen.li@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480; Li, Zhen/0000-0002-9754-6389
FU Annulus Fibrosus Repair Collaborative Research Programme from AO
   Foundation
FX This study is funded by the Annulus Fibrosus Repair Collaborative
   Research Programme from AO Foundation. We thank Markus Glarner for his
   help with the poly(ester-urethane) synthesis, and Xu Chen for his help
   with the OHP assay. Fibrin components were kindly provided by Baxter
   Biosurgery, Vienna.
CR Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034
   Bailey A, 2013, SPINE, V38, P1161, DOI 10.1097/BRS.0b013e31828b2e2f
   Blanquer SBG, 2013, MACROMOL SYMP, V334, P75, DOI 10.1002/masy.201300102
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   Driscoll TP, 2013, J ORTHOP RES, V31, P864, DOI 10.1002/jor.22312
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gilbert HTJ, 2010, ARTHRITIS RHEUM-US, V62, P3385, DOI 10.1002/art.27643
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Gruber HE, 2009, SPINE, V34, P4, DOI 10.1097/BRS.0b013e31818f8c02
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guterl CC, 2014, TISSUE ENG A
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019
   Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Le Visage C, 2006, SPINE, V31, P2036, DOI 10.1097/01.brs.0000231442.05245.87
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   Li Z, 2014, REGEN MED, V9, P309, DOI [10.2217/RME.14.5, 10.2217/rme.14.5]
   Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   See EYS, 2011, SPINE, V36, P1744, DOI 10.1097/BRS.0b013e31821986b3
   Sharifi S, 2014, J TISSUE ENG REGEN M
   Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59
   Weber H, 1994, SPINE, V19, P2233
   Wilke HJ, 2013, SPINE, V38, pE587, DOI 10.1097/BRS.0b013e31828ca4bc
   Wismer N, 2014, TISSUE ENG PT A, V20, P672, DOI 10.1089/ten.TEA.2012.0679
NR 41
TC 26
Z9 27
U1 5
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 42
BP 11
EP 19
DI 10.1016/j.biomaterials.2014.11.049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA4OH
UT WOS:000348883700002
PM 25542789
DA 2018-10-20
ER

PT J
AU Svensson, S
   Trobos, M
   Hoffman, M
   Norlindh, B
   Petronis, S
   Lausmaa, J
   Suska, F
   Thomsen, P
AF Svensson, Sara
   Trobos, Margarita
   Hoffman, Maria
   Norlindh, Birgitta
   Petronis, Sarunas
   Lausmaa, Jukka
   Suska, Felicia
   Thomsen, Peter
TI A novel soft tissue model for biomaterial-associated infection and
   inflammation - Bacteriological, morphological and molecular observations
SO BIOMATERIALS
LA English
DT Article
DE Animal model; Bacteria; Infection; Inflammation; Nanotopography
ID VIVO CELLULAR INTERACTIONS; PERI-IMPLANT TISSUE; KAPPA-B ACTIVATION;
   STAPHYLOCOCCUS-EPIDERMIDIS; NEUTROPHIL ELASTASE; ANODIZED TITANIUM;
   BIOFILM FORMATION; OPERATING-ROOM; COPPER; SURFACES
AB Infection constitutes a major risk for implant failure, but the reasons why biomaterial sites are more vulnerable than normal tissue are not fully elucidated. In this study, a soft tissue infection model was developed, allowing the analysis of cellular and molecular responses in each of the sub-compartments of the implant-tissue interface (on the implant surface, in the surrounding exudate and in the tissue). Smooth and nanostructured titanium disks with or without noble metal chemistry (silver, gold, palladium), and sham sites, were inoculated with Staphylococcus epidermidis and analysed with respect to number of viable bacteria, number, viability and gene expression of host cells, and using different morphological techniques after 4 h, 24 h and 72 h. Non-infected rats were controls. Results showed a transient inflammatory response at control sites, whereas bacterial administration resulted in higher recruitment of inflammatory cells (mainly polymorphonuclear), higher, continuous cell death and higher gene expression of tumour necrosis factor-alpha, interleukin-6, interleukin-8, Toll-like receptor 2 and elastase. At all time points, S. epidermidis was predominantly located in the interface zone, extra- and intracellularly, and lower levels were detected on the implants compared with surrounding exudate. This model allows detailed analysis of early events in inflammation and infection associated to biomaterials in vivo leading to insights into host defence mechanisms in biomaterial-associated infections. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Svensson, Sara; Trobos, Margarita; Hoffman, Maria; Norlindh, Birgitta; Petronis, Sarunas; Lausmaa, Jukka; Suska, Felicia; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, S-40530 Gothenburg, Sweden.
   [Svensson, Sara; Trobos, Margarita; Hoffman, Maria; Norlindh, Birgitta; Suska, Felicia; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, S-40530 Gothenburg, Sweden.
   [Petronis, Sarunas; Lausmaa, Jukka] SP Tech Res Inst Sweden, S-50115 Boras, Sweden.
RP Thomsen, P (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Box 412, S-40530 Gothenburg, Sweden.
EM peter.thomsen@biomaterials.gu.se
OI Thomsen, Peter/0000-0003-3910-6665
FU BIOMATCELL Vinn Excellence Center of Biomaterials and Cell Therapy;
   VINNOVA; Vastra Gotaland Region; Swedish Research Council
   [K2012-52X-09495-25-3]; Hjalmar Svensson Foundation; IngaBritt and Arne
   Lundberg Foundation; Felix Neubergh Foundation
FX The authors would like to acknowledge Dr Hossein Agheli for help with
   AFM measurements and Billy Sodervall and Bactiguard AB for performing
   the noble metal coating of the surfaces and scientific discussion.
   Financial support was obtained from the BIOMATCELL Vinn Excellence
   Center of Biomaterials and Cell Therapy, supported by VINNOVA and the
   Vastra Gotaland Region, the Swedish Research Council (grant
   K2012-52X-09495-25-3), the Hjalmar Svensson Foundation, the IngaBritt
   and Arne Lundberg Foundation and the Felix Neubergh Foundation.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Busscher HJ, 2012, SCI TRANSL MED, V4, P1
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Hughes SPF, 1999, J BONE JOINT SURG BR, V81B, P754, DOI 10.1302/0301-620X.81B5.10370
   Lausmaa J, 2001, TITANIUM MED MAT SCI
   Lederer JW, 2014, J WOUND OSTOMY CONT, V41, P473, DOI 10.1097/WON.0000000000000056
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08
   Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Ozturan KE, 2010, J ORTHOP RES, V28, P1368, DOI 10.1002/jor.21159
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08
   SCHAAD HJ, 1994, J ANTIMICROB CHEMOTH, V33, P1191, DOI 10.1093/jac/33.6.1191
   Schumm K, 2009, COCHRANE SYST REV, V1
   Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Subbiandoss G, 2011, PLOS ONE, V6
   Suska F, 2003, BIOMATERIALS, V24, P461, DOI 10.1016/S0142-9612(02)00359-9
   Suska F, 2001, J MATER SCI-MATER M, V12, P939, DOI 10.1023/A:1012844612753
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   Suska F, 2008, J BIOMED MATER RES A, V85A, P888, DOI 10.1002/jbm.a.31575
   Suska F, 2010, J BIOMED MATER RES B, V92B, P86, DOI 10.1002/jbm.b.31492
   Svensson S, 2014, INT J NANOMED, V9, P775, DOI 10.2147/IJN.S51465
   Svensson S, 2013, NANOMED-NANOTECHNOL, V9, P1048, DOI 10.1016/j.nano.2013.04.009
   TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739
   Tillander J, 2010, CLIN ORTHOP RELAT R, V468, P2781, DOI 10.1007/s11999-010-1370-0
   Verdrengh M, 1997, INFECT IMMUN, V65, P2517
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
NR 49
TC 10
Z9 10
U1 2
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 41
BP 106
EP 121
DI 10.1016/j.biomaterials.2014.11.032
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6XY
UT WOS:000349062100011
PM 25522970
DA 2018-10-20
ER

PT J
AU Choi, JS
   Lee, S
   Kim, DY
   Kim, YM
   Kim, MS
   Lim, JY
AF Choi, Jeong-Seok
   Lee, Songyi
   Kim, Da Yeon
   Kim, Young-Mo
   Kim, Moon Suk
   Lim, Jae-Yol
TI Functional remodeling after vocal fold injury by small intestinal
   submucosa gel containing hepatocyte growth factor
SO BIOMATERIALS
LA English
DT Article
DE Hepatocyte growth factor; Vocal folds; Wound healing; Extracellular
   matrix; Biomimetic materials
ID BOVINE ACELLULAR SCAFFOLD; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   DELIVERY-SYSTEM; LARYNGEAL INJECTION; BIOLOGIC SCAFFOLD; CANINE MODEL;
   RELEASE; FIBROBLASTS; RECONSTRUCTION
AB A biomaterial derived from porcine small intestinal submucosa (SIS) was used in smart drug delivery and tissue remodeling. SIS suspensions were easily formulated by simple mixing with the drug of choice and formed an in situ gel upon injection into tissues, enabling them to act as protein drug depots. This study was conducted to determine whether functional remodeling of an injured vocal fold (VF) could be achieved by hepatocyte growth factor (HGF)-containing SIS in situ-forming gel after VF injury in a rabbit model. To accomplish this, we loaded HGF in SIS suspensions and observed a gradual, sustained release of HGF for at least 21 days in vitro. Evaluation of the in vivo efficacy demonstrated that the HGF and HGF-loaded SIS treated VFs showed improved mucosal healing when compared with the PBS-injected VFs. Histopathological evaluations revealed that treatment with the HGF/SIS group alone successfully ameliorated the deposition of type I collagen and increased synthesis of hyaluronic acids relative to the PBS group at three months post-injury. Functional analyses showed that the HGF/SIS group prevented deterioration of mucosal vibration and induced significant improvement in the mean viscoelastic modulus, but that other groups failed to achieve functional rescue of VF biomechanics. Additionally, the VF oscillation in the HGF/SIS group was superior to that in the HGF group. The results of this study suggest that SIS in situ gel has the potential for use as an HGF delivery carrier for enhancement of wound (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Choi, Jeong-Seok; Lee, Songyi; Kim, Young-Mo; Lim, Jae-Yol] Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.
   [Choi, Jeong-Seok; Lee, Songyi; Kim, Young-Mo; Lim, Jae-Yol] Inha Univ, Sch Med, Translat Res Ctr, Inchon 400711, South Korea.
   [Kim, Da Yeon; Kim, Moon Suk] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
RP Lim, JY (reprint author), Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 27 Inhang Ro, Inchon 400711, South Korea.
EM jylim@inha.ac.kr
FU Basic Science Research Program of the National Research Foundation -
   Korean Ministry of Education, Science and Technology
   [NRF-2013R1A2A2A04014200]; Inha University Research Grant
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation (NRF-2013R1A2A2A04014200) funded by the
   Korean Ministry of Education, Science and Technology and an Inha
   University Research Grant.
CR Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Choi JW, 2014, BIOMATERIALS, V35, P4911, DOI 10.1016/j.biomaterials.2014.03.008
   Choi JS, 2012, OTOLARYNG HEAD NECK, V147, P515, DOI 10.1177/0194599812446913
   Gilbert TW, 2009, LARYNGOSCOPE, V119, P1856, DOI 10.1002/lary.20575
   Hirano S, 2004, LARYNGOSCOPE, V114, P548, DOI 10.1097/00005537-200403000-00030
   Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027
   Hirano S, 2002, ANN OTO RHINOL LARYN, V111, P661, DOI 10.1177/000348940211100801
   Kang KN, 2011, INT J PHARMACEUT, V420, P266, DOI 10.1016/j.ijpharm.2011.08.047
   Kim YM, 2014, LARYNGOSCOPE, V124, pE64, DOI 10.1002/lary.24405
   Kim YM, 2013, ANN OTO RHINOL LARYN, V122, P121, DOI 10.1177/000348941312200208
   Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642
   Kishimoto Y, 2009, ANN OTO RHINOL LARYN, V118, P606, DOI 10.1177/000348940911800813
   Kolachala VL, 2011, LARYNGOSCOPE, V121, P1237, DOI 10.1002/lary.21796
   Kolachala VL, 2010, LARYNGOSCOPE, V120, P988, DOI 10.1002/lary.20856
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256
   Long JL, 2010, CURR OPIN OTOLARYNGO, V18, P521, DOI 10.1097/MOO.0b013e32833febf2
   Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365
   Maytag AL, 2013, J VOICE, V27, P24, DOI 10.1016/j.jvoice.2012.08.004
   Mizuno S, 1998, J CLIN INVEST, V101, P1827, DOI 10.1172/JCI1709
   Mizuta M, 2014, LARYNGOSCOPE, V124, P2131, DOI 10.1002/lary.24690
   Moreno E, 2005, TRANSPLANT P, V37, P3943, DOI 10.1016/j.transproceed.2005.10.089
   Ohno T, 2007, ANN OTO RHINOL LARYN, V116, P762, DOI 10.1177/000348940711601008
   Ueki T, 1999, NAT MED, V5, P226
   Xu CC, 2010, J BIOMED MATER RES A, V93A, P1335, DOI 10.1002/jbm.a.32632
   Xu CC, 2010, J BIOMED MATER RES A, V92A, P18, DOI 10.1002/jbm.a.32279
NR 28
TC 15
Z9 16
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 40
BP 98
EP 106
DI 10.1016/j.biomaterials.2014.11.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA5QW
UT WOS:000348963900011
PM 25433606
DA 2018-10-20
ER

PT J
AU Zhang, LH
   Wu, XJ
   Hu, Y
   Wang, XH
   He, ZH
   Xie, YT
   Pan, KF
   Wang, N
   Dong, ZH
   Zhang, L
   Ji, JF
AF Zhang, Lianhai
   Wu, Xiaojiang
   Hu, Ying
   Wang, Xiaohong
   He, Zhonghu
   Xie, Yuntao
   Pan, Kaifeng
   Wang, Ning
   Dong, Zhihua
   Zhang, Lei
   Ji, Jiafu
TI Establishment of a Network-Based Intra-Hospital Virtual Cancer Biobank
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
ID SAMPLE PREANALYTICAL CODE; STANDARD; CHINA
AB There is a growing interest in integrating biomaterial repositories into larger infrastructures in order to meet research demands. However, even for a single hospital or institute, where both population-based and multiple disease-based biobanks have existed for a long time, the integration of existing separate biobanks into a virtual cancer biobank is still challenging. The guidelines and procedures for biobanking are varied and not universally enforced or followed in separate biobanks. Within the last 2 years, we initiated a project to establish a centralized biobank facility in a common storage environment. Analyzing the challenges and interests of stakeholders for the biobanks, a working group comprised of representatives from the central and separate banks, ethic committees, and research administration offices reached an agreement to implement a central facility by following the ISBER best practices for biobanking, and including regular project reviews by the ethical and scientific boards. Furthermore, by implementing a modified minimum information system with biobank data sharing, a network based intra-hospital virtual cancer bank was established to facilitate sharing information of samples held by separate banks. Meanwhile, this virtual biobank network, which has integrated patient information from hospital health care systems, will gradually integrate follow-up information from the cancer registry office and data from epidemiology studies, providing controlled access for sample providers and resource users. In the future, this infrastructure designed for a single hospital may be helpful for building a broader virtual network for data and specimen exchanges.
C1 [Zhang, Lianhai; Hu, Ying; Wang, Xiaohong; Ji, Jiafu] Peking Univ, Canc Biobank, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China.
   [Zhang, Lianhai; Wu, Xiaojiang; Ji, Jiafu] Peking Univ, Dept Surg, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [He, Zhonghu] Peking Univ, Dept Genet, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Xie, Yuntao] Peking Univ, Dept Breast Canc, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Pan, Kaifeng] Peking Univ, Dept Epidemiol, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Zhang, Lianhai] Peking Univ, Res Adm Off, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Wu, Xiaojiang] Peking Univ, Eth Comm, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Wang, Ning] Peking Univ, Beijing Off Canc Prevent & Control, Canc Hosp & Inst, Beijing 100142, Peoples R China.
   [Dong, Zhihua; Zhang, Lei] Goodwill Informat Technol Co Ltd, Beijing, Peoples R China.
RP Ji, JF (reprint author), Peking Univ, Dept Surg, Canc Hosp & Inst, 52 Fucheng Rd, Beijing 100142, Peoples R China.
EM jiafuj@gmail.com
OI JI, JIAFU/0000-0001-6878-5543
FU National Key Technology RD Program [2012AA02A203-B01, 2012AA02A504-B01,
   2012AA020101, 2015ZX09307-001]; Beijing Municipal Science & Technology
   Commission [Z121100007512010, D131100005313010]
FX The authors declare the following competing financial interests: LZ and
   ZD are employees of Goodwill Information Technology Co. Ltd. This study
   is partially supported by National Key Technology R&D Program
   (2012AA02A203-B01, 2012AA02A504-B01, 2012AA020101, 2015ZX09307-001) and
   Beijing Municipal Science & Technology Commission (Z121100007512010,
   D131100005313010).
CR [Anonymous], 2012, BIOPRESERV BIOBANK, V10, P79
   Betsou F, 2010, CANCER EPIDEM BIOMAR, V19, P1004, DOI 10.1158/1055-9965.EPI-09-1268
   Bjugn R, 2012, BIOPRESERV BIOBANK, V10, P239, DOI 10.1089/bio.2011.0047
   Chen HD, 2013, BIOPRESERV BIOBANK, V11, P267, DOI 10.1089/bio.2013.0016
   De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244
   Gottweis H, 2012, J COMMUN GENET, V3, P61, DOI 10.1007/s12687-011-0070-0
   Harris JR, 2012, EUR J HUM GENET, V20, P1105, DOI 10.1038/ejhg.2012.96
   Ji X, 2014, BIOMED ENVIRON SCI, V27, P481, DOI 10.3967/bes2014.079
   Lehmann S, 2012, BIOPRESERV BIOBANK, V10, P366, DOI 10.1089/bio.2012.0012
   Liu M, 2014, BIOETHICS, V28, P181, DOI 10.1111/j.1467-8519.2012.01985.x
   Mitchell R, 2010, SCI TECHNOL HUM VAL, V35, P330, DOI 10.1177/0162243909340267
   Myles Renate, 2011, Journal of the National Cancer Institute Monographs, P16, DOI 10.1093/jncimonographs/lgr008
   Norlin L, 2012, BIOPRESERV BIOBANK, V10, P343, DOI 10.1089/bio.2012.0003
   Nussbeck SY, 2014, BIOPRESERV BIOBANK, V12, P199, DOI 10.1089/bio.2013.0085
   Quinlan PR, 2014, BIOPRESERV BIOBANK, V12, P184, DOI 10.1089/bio.2013.0089
NR 15
TC 0
Z9 1
U1 1
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
EI 1947-5543
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD FEB 1
PY 2015
VL 13
IS 1
SI SI
BP 43
EP 48
DI 10.1089/bio.2014.0086
PG 6
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA CB1PF
UT WOS:000349399300010
PM 25686047
DA 2018-10-20
ER

PT J
AU Felden, A
   Vaz, G
   Kreps, S
   Anract, P
   Hamadouche, M
   Biau, DJ
AF Felden, A.
   Vaz, G.
   Kreps, S.
   Anract, P.
   Hamadouche, M.
   Biau, D. J.
TI A cemented acetabular component with a reinforcement cross provides
   excellent medium-term fixation in total hip arthroplasty after pelvic
   irradiation
SO BONE & JOINT JOURNAL
LA English
DT Article
ID POROUS TANTALUM BIOMATERIAL; URINARY-TRACT INFECTION; RADIATION-THERAPY;
   COMPETING RISKS; BONE; FAILURE; RADIOTHERAPY; COMPLICATIONS;
   MALIGNANCIES; REPLACEMENT
AB Conventional cemented acetabular components are reported to have a high rate of failure when implanted into previously irradiated bone. We recommend the use of a cemented reconstruction with the addition of an acetabular reinforcement cross to improve fixation.
   We reviewed a cohort of 45 patients (49 hips) who had undergone irradiation of the pelvis and a cemented total hip arthroplasty (THA) with an acetabular reinforcement cross. All hips had received a minimum dose of 30 Gray (Gy) to treat a primary nearby tumour or metastasis. The median dose of radiation was 50 Gy (Q1 to Q3: 45 to 60; mean: 49.57, 32 to 72).
   The mean follow-up after THA was 51 months (17 to 137). The cumulative probability of revision of the acetabular component for a mechanical reason was 0% (0 to 0%) at 24 months, 2.9% (0.2 to 13.3%) at 60 months and 2.9% (0.2% to 13.3%) at 120 months, respectively. One hip was revised for mechanical failure and three for infection.
   Cemented acetabular components with a reinforcement cross provide good medium-term fixation after pelvic irradiation. These patients are at a higher risk of developing infection of their THA.
C1 [Felden, A.; Vaz, G.; Kreps, S.; Anract, P.; Hamadouche, M.; Biau, D. J.] Hop Cochin, F-75014 Paris, France.
RP Felden, A (reprint author), Hop Cochin, 27 Rue Faubourg St Jacques, F-75014 Paris, France.
EM tere_arno@hotmail.fr
CR Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608
   Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013
   Bessell E M, 1994, Clin Oncol (R Coll Radiol), V6, P116, DOI 10.1016/S0936-6555(05)80114-1
   BIALAS I, 1989, RADIOTHER ONCOL, V16, P305, DOI 10.1016/0167-8140(89)90043-1
   Biau DJ, 2011, CLIN ORTHOP RELAT R, V469, P2661, DOI 10.1007/s11999-011-1908-9
   Biau DJ, 2011, INT ORTHOP, V35, P151, DOI 10.1007/s00264-010-1097-2
   Biau DJ, 2008, CLIN ORTHOP RELAT R, V466, P2282, DOI 10.1007/s11999-008-0346-9
   Biau DJ, 2007, CLIN ORTHOP RELAT R, P229, DOI 10.1097/BLO.0b013e3180986753
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BRAGG DG, 1970, RADIOLOGY, V97, P103, DOI 10.1148/97.1.103
   Cho MR, 2005, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000167671.10820.29
   DALINKA MK, 1974, SEMIN ROENTGENOL, V9, P29, DOI 10.1016/0037-198X(74)90007-8
   DAUBIGNE RM, 1990, REV CHIR ORTHOP, V76, P371
   Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400
   Jacobs JJ, 1995, J BONE JOINT SURG AM, V77A, P1829, DOI 10.2106/00004623-199512000-00006
   Joglekar SB, 2012, CLIN ORTHOP RELAT R, V470, P3041, DOI 10.1007/s11999-012-2382-8
   JOHNSON JT, 1989, HEAD NECK-J SCI SPEC, V11, P132, DOI 10.1002/hed.2880110206
   Kawanabe K, 2011, J ARTHROPLASTY, V26, P1061, DOI 10.1016/j.arth.2011.04.019
   Kerboull M, 2000, CLIN ORTHOP RELAT R, P155
   Kim KI, 2007, J BONE JOINT SURG AM, V89A, P798, DOI 10.2106/JBJS.F.00183
   Kwon JW, 2008, AM J ROENTGENOL, V191, P987, DOI 10.2214/AJR.07.3634
   MARKOLF KL, 1976, CLIN ORTHOP RELAT R, P99
   MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847
   Mitchell MJ, 1998, RADIOGRAPHICS, V18, P1125, DOI 10.1148/radiographics.18.5.9747611
   NOBLE PC, 1983, ACTA ORTHOP SCAND, V54, P566, DOI 10.3109/17453678308992890
   Passick J, 1989, J Arthroplasty, V4, P87, DOI 10.1016/S0883-5403(89)80057-9
   Pelker RR, 1997, CLIN ORTHOP RELAT R, P267
   PHILLIPS TW, 1989, CAN J SURG, V32, P353
   PRASAD KN, 1995, GYNECOL ONCOL, V57, P380, DOI 10.1006/gyno.1995.1158
   PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374
   SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005
   SMITHERS D W, 1946, Postgrad Med J, V22, P127
   Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339
   Yang Shu-Hua, 2001, J Orthop Surg (Hong Kong), V9, P41
NR 38
TC 5
Z9 5
U1 0
U2 1
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD FEB
PY 2015
VL 97B
IS 2
BP 177
EP 184
DI 10.1302/0301-620X.97B2.34545
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CA0NG
UT WOS:000348613700008
PM 25628279
DA 2018-10-20
ER

PT J
AU Ilin, Y
   Kraft, ML
AF Ilin, Yelena
   Kraft, Mary L.
TI Secondary ion mass spectrometry and Raman spectroscopy for tissue
   engineering applications
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID EMBRYONIC STEM-CELLS; ADSORBED PROTEIN FILMS; PLASMA-DEPOSITED FILMS;
   IN-VITRO; MULTIVARIATE-ANALYSIS; TOF-SIMS; EXTRACELLULAR-MATRIX;
   MESODERMAL PROGENITORS; SCATTERING MICROSCOPY; NONINVASIVE ANALYSIS
AB Identifying the matrix properties that permit directing stem cell fate is crucial for expanding desired cell lineages ex vivo for disease treatment. Such efforts require knowledge of matrix surface chemistry and the cell responses they elicit. Recent progress in analyzing biomaterial composition and identifying cell phenotype with two label-free chemical imaging techniques, TOF-SIMS and Raman spectroscopy are presented. TOF-SIMS is becoming indispensable for the surface characterization of biomaterial scaffolds. Developments in TOF-SIMS data analysis enable correlating surface chemistry with biological response. Advances in the interpretation of Raman spectra permit identifying the fate decisions of individual, living cells with location specificity. Here we highlight this progress and discuss further improvements that would facilitate efforts to develop artificial scaffolds for tissue regeneration.
EM mlkraft@illinois.edu
FU NIH Training Program in the Chemistry-Biology Interface [T32 GM070421];
   U.S. National Science Foundation [CHE-1058809]
FX This work was partially supported by the NIH Training Program in the
   Chemistry-Biology Interface T32 GM070421, and a grant from the U.S.
   National Science Foundation (CHE-1058809).
CR Anderton CR, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-2
   Anderton CR, 2012, SURF INTERFACE ANAL, V44, P322, DOI 10.1002/sia.3806
   Antonio KA, 2014, ANAL CHEM, V86, P30, DOI 10.1021/ac403640f
   Baker MJ, 2008, ANALYST, V133, P175, DOI 10.1039/b712853c
   Barnes CA, 2012, ANAL CHEM, V84, P893, DOI 10.1021/ac201179t
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bigdeli N, 2010, TISSUE ENG PT A, V16, P3427, DOI 10.1089/ten.tea.2010.0112
   Bonnier F, 2012, VIB SPECTROSC, V61, P124, DOI 10.1016/j.vibspec.2012.03.009
   Boyd AR, 2010, J MATER SCI-MATER M, V21, P2317, DOI 10.1007/s10856-009-3965-0
   Brackmann C, 2012, TISSUE ENG PART C-ME, V18, P227, DOI [10.1089/ten.tec.2011.0211, 10.1089/ten.TEC.2011.0211]
   Brackmann C, 2012, J BIOPHOTONICS, V5, P404, DOI 10.1002/jbio.201100141
   Brackmann C, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3534782
   Brauchle E, 2013, BIOTECHNOL J, V8, P288, DOI 10.1002/biot.201200163
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m
   Chiang HK, 2009, J RAMAN SPECTROSC, V40, P546, DOI 10.1002/jrs.2161
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Conovaloff A, 2009, ORGANOGENESIS, V5, P231, DOI 10.4161/org.5.4.10404
   de Peppo GM, 2010, TISSUE ENG PT A, V16, P3413, DOI [10.1089/ten.tea.2010.0052, 10.1089/ten.TEA.2010.0052]
   de Peppo GM, 2013, TISSUE ENG PT A, V19, P175, DOI [10.1089/ten.tea.2011.0412, 10.1089/ten.TEA.2011.0412]
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Downes A, 2011, J RAMAN SPECTROSC, V42, P1864, DOI 10.1002/jrs.2975
   Fletcher JS, 2011, CURR OPIN CHEM BIOL, V15, P733, DOI 10.1016/j.cbpa.2011.05.016
   Frisz JF, 2012, ANAL CHEM, V84, P4307, DOI 10.1021/ac203329j
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Ghita A, 2012, ANAL CHEM, V84, P3155, DOI 10.1021/ac202994e
   Gonzalez M, 2013, J BIOMED MATER RES A, V101, P819, DOI 10.1002/jbm.a.34388
   Harkness L, 2012, STEM CELLS DEV, V21, P2152, DOI 10.1089/scd.2011.0600
   Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065438
   Ilin Y, 2014, ANALYST, V139, P2177, DOI 10.1039/c3an02156d
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Kim BS, 2008, STEM CELLS DEV, V17, P185, DOI 10.1089/scd.2007.0076
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Klerk LA, 2010, ANAL CHEM, V82, P4337, DOI 10.1021/ac100837n
   Konorov SO, 2007, ANAL CHEM, V79, P7221, DOI 10.1021/ac070544k
   Konorov SO, 2013, ANAL CHEM, V85, P8996, DOI 10.1021/ac400310b
   Krafft C, 2009, ANALYST, V134, P1046, DOI 10.1039/b822354h
   Kraft ML, 2014, BBA-MOL CELL BIOL L, V1841, P1108, DOI 10.1016/j.bbalip.2014.03.003
   Kulp KS, 2006, ANAL CHEM, V78, P3651, DOI 10.1021/ac060054c
   Kunstar A, 2011, TISSUE ENG PART C-ME, V17, P737, DOI [10.1089/ten.tec.2010.0574, 10.1089/ten.TEC.2010.0574]
   Kunstar A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0464
   Lee YJ, 2014, TISSUE ENG PART C-ME, V20, P562, DOI [10.1089/ten.tec.2013.0472, 10.1089/ten.TEC.2013.0472]
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Lo WL, 2011, J RAMAN SPECTROSC, V42, P174, DOI 10.1002/jrs.2688
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   McManus LL, 2011, ANALYST, V136, P2471, DOI 10.1039/c1an15167c
   Meade AD, 2007, ANAL BIOANAL CHEM, V387, P1717, DOI 10.1007/s00216-006-0876-5
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382
   Monroe EB, 2005, J AM CHEM SOC, V127, P12152, DOI 10.1021/ja051223y
   Mortati L, 2012, J RAMAN SPECTROSC, V43, P675, DOI 10.1002/jrs.3171
   Mouras R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116011
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Notingher L, 2004, VIB SPECTROSC, V35, P199, DOI 10.1016/j.vibspec.2004.01.014
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Pascut FC, 2013, BBA-GEN SUBJECTS, V1830, P3517, DOI 10.1016/j.bbagen.2013.01.030
   Pascut FC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3570302
   Pasqui D, 2014, J BIOMED MATER RES A, V102, P1568, DOI 10.1002/jbm.a.34810
   Pliss A, 2013, ANAL CHEM, V85, P3545, DOI 10.1021/ac303806j
   Rangarajan S, 2006, J VAC SCI TECHNOL A, V24, P1730, DOI 10.1116/1.2217980
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Schulze HG, 2010, ANAL CHEM, V82, P5020, DOI 10.1021/ac902697q
   Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720
   Swain RJ, 2008, BIOPHYS J, V95, P5978, DOI 10.1529/biophysj.108.136168
   Tejero R, 2013, LANGMUIR, V29, P902, DOI 10.1021/la303360f
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Tsai TH, 2014, ANALYST, V139, P2799, DOI 10.1039/c4an00155a
   Tyler B, 2003, APPL SURF SCI, V203, P825, DOI 10.1016/S0169-4332(02)00835-8
   Ulrich TA, 2011, BIOMATERIALS, V32, P5633, DOI 10.1016/j.biomaterials.2011.04.045
   Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100
   Wagner MS, 2003, APPL SURF SCI, V203, P704, DOI 10.1016/S0169-4332(02)00795-X
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Xia N, 2003, J BIOMED MATER RES A, V67A, P179, DOI 10.1002/jbm.a.10063
   Yang L, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3654147
   Yang L, 2011, LAB CHIP, V11, P2481, DOI 10.1039/c0lc00676a
   YU ML, 1982, PHYS REV B, V26, P4731, DOI 10.1103/PhysRevB.26.4731
NR 79
TC 13
Z9 12
U1 2
U2 55
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD FEB
PY 2015
VL 31
BP 108
EP 116
DI 10.1016/j.copbio.2014.10.011
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA CA5PL
UT WOS:000348960200016
PM 25462628
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Batista, L
   Rodrigues, SSFR
   Dullius, J
   David, AC
AF Batista, L.
   Rodrigues, S. S. F. R.
   Dullius, J.
   David, A. C.
TI BIOMATERIAL USED AS A WAY TO PREVENTION THE DIABETIC FOOT CONSEQUENCES
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Meeting Abstract
C1 [Batista, L.; Rodrigues, S. S. F. R.; Dullius, J.; David, A. C.] Univ Brasilia, Brasilia, DF, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB 1
PY 2015
VL 17
SU 1
MA 239
BP A106
EP A106
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CB0LL
UT WOS:000349317500240
DA 2018-10-20
ER

PT J
AU Lan, GB
   Li, M
   Tan, Y
   Li, LH
   Yang, XM
   Ma, LM
   Yin, QS
   Xia, H
   Zhang, Y
   Tan, GX
   Ning, CY
AF Lan, Guobo
   Li, Mei
   Tan, Ying
   Li, Lihua
   Yang, Xiaoming
   Ma, Limin
   Yin, Qingshui
   Xia, Hong
   Zhang, Yu
   Tan, Guoxin
   Ning, Chengyun
TI Promoting Bone Mesenchymal Stem Cells and Inhibiting Bacterial Adhesion
   of Acid-Etched Nanostructured Titanium by Ultraviolet Functionalization
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE UV treatment; Nanostructures; Bone mesenchymal stem cells; Antibacterial
   activity; Titanium
ID DIOXIDE PHOTOCATALYTIC OXIDATION; ESCHERICHIA-COLI; OSTEOGENIC
   DIFFERENTIATION; UV PHOTOFUNCTIONALIZATION; HIP-ARTHROPLASTY;
   NANOTOPOGRAPHY; ANTIBACTERIAL; INACTIVATION; SURFACES; DISINFECTION
AB Titanium (Ti) and its alloys are used extensively in orthopedic implants because of their excellent biocompatibility, mechanical properties and corrosion resistance. However, titanium-based implant materials face many severe complications, such as implant loosening due to poor osseointegration and bacterial infections, which may lead to implant failure. Hence, preparing a biomaterial surface, which enhances the interactions with host cells and inhibits bacterial adhesion, may be an optimal strategy to reduce the incidence of implant failure. This study aims to improve osseointegration and confer antibacterial properties on Ti through a combination of two surface modifications including nanostructuring generated by acid etching and ultraviolet (UV) light treatment. Our results showed that without UV treatment, the acid etching treatment of Ti surface was effective at both improving the adhesion of bone mesenchymal stem cells (BMSCs) and increasing bacterial adhesion. A further UV treatment of the acid-etched surface however, not only significantly improved the cell adhesion but also inhibited bacterial adhesion. The acid-etched nanostructured titanium with UV treatment also showed a significant enhancement on cell proliferation, alkaline phosphatase (ALP) activity and mineralization. These results suggest that such nanostructured materials with UV treatment can be expected to have a good potential in orthopedic applications.
C1 [Lan, Guobo; Yang, Xiaoming] Southern Med Univ, Guangzhou 510515, Guangdong, Peoples R China.
   [Lan, Guobo; Li, Mei; Li, Lihua; Ma, Limin; Yin, Qingshui; Xia, Hong; Zhang, Yu] Gen Hosp Guangzhou Mil Command, Orthoped Hosp, Guangzhou 510010, Guangdong, Peoples R China.
   [Tan, Ying; Tan, Guoxin] Guangdong Univ Technol, Fac Light & Chem, Guangzhou 510006, Guangdong, Peoples R China.
   [Ning, Chengyun] S China Univ Technol, Coll Mat Sci & Technol, Guangzhou 510641, Guangdong, Peoples R China.
RP Zhang, Y (reprint author), Gen Hosp Guangzhou Mil Command, Orthoped Hosp, Guangzhou 510010, Guangdong, Peoples R China.
EM luck_2001@126.com; tanguoxin@126.com; imcyning@scut.edu.cn
FU National Key Basic Research Program of China [2012CB619106]; National
   Natural Science Foundation of China [81271957]; Military Medical
   Research "12th Five-Year Plan" General Program of China [cws11c268];
   Guangdong Provincial Science and Technology Project, China
   [2012A030400064]
FX This work was supported by the National Key Basic Research Program of
   China (Grant No. 2012CB619106), the National Natural Science Foundation
   of China (Grant No. 81271957), the Military Medical Research "12th
   Five-Year Plan" General Program of China (Grant No. cws11c268) and
   Guangdong Provincial Science and Technology Project, China (Grant No.
   2012A030400064).
CR Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Aninwene GE, 2008, INT J NANOMED, V3, P257
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005
   Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Havelin LI, 2009, ACTA ORTHOP, V80, P393, DOI 10.3109/17453670903039544
   Hori N, 2011, ACTA BIOMATER, V7, P3679, DOI 10.1016/j.actbio.2011.06.022
   IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668
   Kaur G, 2010, BIOMATERIALS, V31, P5813, DOI 10.1016/j.biomaterials.2010.04.017
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701
   Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133
   National Center for Health Statistics, 2012, NAT HOSP DISCH SURV
   Ogawa T, 2008, J DENT RES, V87, P751, DOI 10.1177/154405910808700809
   Park MR, 2008, INT J NANOMED, V3, P497
   Pedersen AB, 2005, ACTA ORTHOP, V76, P182, DOI 10.1080/00016470510030553
   Pohler OEM, 2000, INJURY, V31, pS7
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Salih FM, 2002, J APPL MICROBIOL, V92, P920, DOI 10.1046/j.1365-2672.2002.01601.x
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Webster TJ, 2005, NANOTECHNOLOGY, V16, pS449, DOI 10.1088/0957-4484/16/7/021
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 39
TC 8
Z9 8
U1 1
U2 47
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD FEB
PY 2015
VL 31
IS 2
BP 182
EP 190
DI 10.1016/j.jmst.2014.08.007
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA CA8ZG
UT WOS:000349209100010
DA 2018-10-20
ER

PT J
AU Sun, Y
   Jallerat, Q
   Szymanski, JM
   Feinberg, AW
AF Sun, Yan
   Jallerat, Quentin
   Szymanski, John M.
   Feinberg, Adam W.
TI Conformal nanopatterning of extracellular matrix proteins onto
   topographically complex surfaces
SO NATURE METHODS
LA English
DT Article
AB Our Patterning on Topography (PoT) printing technique enables fibronectin, laminin and other proteins to be applied to biomaterial surfaces in complex geometries that are inaccessible using traditional soft lithography techniques. Engineering combinatorial surfaces that integrate topographical and biochemical micropatterns enhances control of the biotic-abiotic interface. Here, we used this method to understand cardiomyocyte response to competing physical and chemical cues in the microenvironment.
C1 [Sun, Yan; Jallerat, Quentin; Szymanski, John M.; Feinberg, Adam W.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Sun, Yan] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
   [Feinberg, Adam W.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
RP Feinberg, AW (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
EM feinberg@andrew.cmu.edu
RI Feinberg, Adam/A-7103-2009
OI Feinberg, Adam/0000-0003-3338-5456; Jallerat,
   Quentin/0000-0001-9717-0505
FU China Scholarship Council (CSC) [[2008]3027]; Carnegie Mellon University
   Dowd-ICES Fellowship; NIH Biomechanics in Regenerative Medicine T32
   training grant [T32EB003392]; Bertucci Graduate Fellowship; NIH
   Director's New Innovator Award [DP2HL117750]
FX We acknowledge financial support from China Scholarship Council (CSC)
   for State Scholarship Fund No. [2008]3027 (Y.S.), the Carnegie Mellon
   University Dowd-ICES Fellowship (Q.J.), the NIH Biomechanics in
   Regenerative Medicine T32 training grant (T32EB003392) and the Bertucci
   Graduate Fellowship (J.M.S.) and the NIH Director's New Innovator Award
   (DP2HL117750) (A.W.F.).
CR Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bray MAP, 2010, BIOMATERIALS, V31, P5143, DOI 10.1016/j.biomaterials.2010.03.028
   Chung CY, 2011, FASEB J, V25, P851, DOI 10.1096/fj.10-168625
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Feinberg A.W., 2007, J BIOMED MATER RES A, V86A, P522
   Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885
   Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043
   Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p
   Greene AC, 2011, BIOMATERIALS, V32, P8860, DOI 10.1016/j.biomaterials.2011.08.003
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Palchesko R N, 2012, PLOS ONE, V7, P1
   Szymanski J. M., 2014, JOVE-J VIS EXP, V86
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 13
TC 24
Z9 24
U1 1
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD FEB
PY 2015
VL 12
IS 2
BP 134
EP U168
DI 10.1038/nmeth.3210
PG 5
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA CA4GL
UT WOS:000348862500015
PM 25506720
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, YY
   Deng, H
   Huangfu, CX
   Lu, ZW
   Wang, XX
   Zeng, XY
   He, HB
   Rao, H
AF Wang, Yanying
   Deng, Hao
   Huangfu, Changxin
   Lu, Zhiwei
   Wang, Xianxiang
   Zeng, Xianyin
   He, Hua
   Rao, Hanbing
TI Research of protein adsorption on the different surface topography of
   the zinc oxide
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE zinc oxide (ZnO); surface topography; mono-protein adsorption;
   multi-protein adsorption; adsorption kinetics
ID BOVINE SERUM-ALBUMIN; CONFORMATIONAL-CHANGES; KINETIC-MODEL;
   NANOPARTICLES; FIBRONECTIN; FIBRINOGEN; PARTICLES; TITANIUM; TIO2;
   BIOCOMPATIBILITY
AB The effect of the surface topography on the protein adsorption process is of great significance for designing biomaterial surfaces and the biocompatibility for specific biomedical applications. In this work, we have systematically investigated the mono-protein adsorption kinetics of bovine serum albumin (BSA) and fibrinogen (Fg) adsorbed on the four different surface topographies (nanoparticles (NPs), nanorods (NRs), nanosheets (NSs) and nanobeams (NBs) of Zinc oxide (ZnO), respectively. The competition of multi-protein adsorbed on them has been studied as well. Results showed that each protein had a singular process of adsorption that fitted well by Spreading Particle Model (SPM). It confirmed that ZnO NRs compared with other samples had more adsorption sites, which could provide more opportunities for the interaction between material and protein molecules. In addition, the Fg compared to the BSA could be more tightly adsorbed to the surface, both of which existed slight conformational changes by Fourier transform infrared (FTIR) and circular dichroism spectra (CD). Taken together, all these consequences well demonstrated that NRs may have wider applications in designing biomaterial surfaces and the biocompatibility for implanted biomaterials. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Wang, Yanying; Huangfu, Changxin; Lu, Zhiwei; Wang, Xianxiang; Rao, Hanbing] Sichuan Agr Univ, Coll Sci, Yaan 625014, Peoples R China.
   [Deng, Hao] Southwest Univ Sci & Technol, State Key Lab Cultivat Base Nonmet Composites & F, Mianyang 621010, Peoples R China.
   [Zeng, Xianyin] Sichuan Agr Univ, Coll Life Sci, Yaan 625014, Peoples R China.
   [He, Hua] Sichuan Agr Univ, Anim Genet & Breeding Inst, Yaan 625014, Sichuan, Peoples R China.
RP Rao, H (reprint author), Sichuan Agr Univ, Coll Sci, Yaan 625014, Peoples R China.
EM rhbsau@gmail.com
FU Sichuan Agricultural University [03570113, 121062639]; Education
   Department of Sichuan Provincial, PR China [12ZA268, 13ZA0255]
FX This work was supported by a grant from the Two-Way Support Programs of
   Sichuan Agricultural University (Project No. 03570113), Students
   Innovative projects of Sichuan Agricultural University (No. 121062639)
   and the Education Department of Sichuan Provincial, PR China (Grant Nos.
   12ZA268, 13ZA0255). We thank Professor Feng Zhu from Chongqing
   University and Xinyuan Zhang from Sichuan University for the use of
   equipment. We thank the anonymous reviewers for their valuable
   suggestions.
CR Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Blanco EM, 2008, LANGMUIR, V24, P2284, DOI 10.1021/la702957f
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brusatori MA, 2003, LANGMUIR, V19, P5089, DOI 10.1021/la0269558
   Brusatori MA, 1999, J COLLOID INTERF SCI, V219, P333, DOI 10.1006/jcis.1999.6496
   Chakraborti S, 2010, LANGMUIR, V26, P3506, DOI 10.1021/la903118c
   Damodaran S, 2003, ANAL BIOANAL CHEM, V376, P182, DOI 10.1007/s00216-003-1873-6
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Farmer V. C., 1974, INFRARED SPECTRA MIN
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Goyal K. D., 2010, THIN SOLID FILMS, V518, P2186
   HINRICHSEN EL, 1986, J STAT PHYS, V44, P793, DOI 10.1007/BF01011908
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4
   Lefaix H, 2013, COLLOID SURFACE A, V439, P207, DOI 10.1016/j.colsurfa.2013.04.009
   Li Z, 2008, J PHYS CHEM C, V112, P20114, DOI 10.1021/jp808878p
   Lousinian S, 2013, J COLLOID INTERF SCI, V395, P294, DOI 10.1016/j.jcis.2013.01.007
   Lu T. S., 2010, AM J MED SCI, V2, P325, DOI DOI 10.4297/NAJMS.2010.2325
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Niu LN, 2010, J DENT RES, V89, P746, DOI 10.1177/0022034510366682
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Ozacar M, 2006, J HAZARD MATER, V137, P218, DOI 10.1016/j.jhazmat.2006.01.058
   Pegueroles M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0048-4
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sasidharan NP, 2013, COLLOID SURFACE B, V102, P195, DOI 10.1016/j.colsurfb.2012.07.034
   Satriano C, 2012, J COLLOID INTERF SCI, V365, P90, DOI 10.1016/j.jcis.2011.09.014
   Schmidt DR, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1_1
   Sevinc BA, 2010, J BIOMED MATER RES B, V94B, P22, DOI 10.1002/jbm.b.31620
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Simsikova M, 2013, COLLOID SURFACE B, V103, P630, DOI 10.1016/j.colsurfb.2012.10.058
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   Talebian N, 2011, APPL SURF SCI, V258, P547, DOI 10.1016/j.apsusc.2011.08.070
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Walker J. M., 2002, PROTEOMICS PROTOCOLS
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4
NR 45
TC 5
Z9 5
U1 3
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD FEB
PY 2015
VL 47
IS 2
BP 245
EP 252
DI 10.1002/sia.5698
PG 8
WC Chemistry, Physical
SC Chemistry
GA AZ9GY
UT WOS:000348523000011
DA 2018-10-20
ER

PT J
AU Andreaus, U
   Giorgio, I
   Madeo, A
AF Andreaus, Ugo
   Giorgio, Ivan
   Madeo, Angela
TI Modeling of the interaction between bone tissue and resorbable
   biomaterial as linear elastic materials with voids
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK
LA English
DT Article
DE Mechanical-biological coupling; Mechanical loading; Growth/resorption
   processes; Continuum mixture model; Poro-elasticity
ID PHASE-TRANSITIONS; VARIATIONAL APPROACH; PERTURBATION-METHODS;
   GRANULAR-MATERIALS; HOPF BIFURCATIONS; HUMAN OSTEOCLASTS; CONTINUUM
   MODEL; MIXTURE MODEL; POROUS-MEDIA; TRUSS BEAMS
AB In this paper, a continuum mixture model with evolving mass densities and porosity is proposed to describe the process of bone remodeling in the presence of bio-resorbable materials as driven by externally applied loads. From a mechanical point of view, both bone tissue and biomaterial are modeled as linear elastic media with voids in the sense of Cowin and Nunziato (J Elast 13:125-147, 1983). In the proposed continuum model, the change of volume fraction related to the void volume is directly accounted for by considering porosity as an independent kinematical field. The bio-mechanical coupling is ensured by the introduction of a suitable stimulus which allows for discriminating between resorption (of both bone and biomaterial) and synthesis (of the sole natural bone) depending on the level of externally applied loads. The presence of a 'lazy zone' associated with intermediate deformation levels is also considered in which neither resorption nor synthesis occur. Some numerical solutions of the integro-differential equations associated with the proposed model are provided for the two-dimensional case. Ranges of values of the parameters for which different percentages of biomaterial substitution occur are proposed, namely parameters characterizing initial and maximum values of mass densities of bone tissue and of the bio-resorbable material.
C1 [Andreaus, Ugo; Giorgio, Ivan] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Fac Ingn Civile & Ind, I-00184 Rome, Italy.
   [Giorgio, Ivan; Madeo, Angela] Univ Aquila, Int Res Ctr Math & Mech Complex Syst M& MoCS, I-67100 Laquila, Italy.
   [Madeo, Angela] Univ Lyon, INSA, F-69621 Villeurbanne, France.
RP Andreaus, U (reprint author), Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Fac Ingn Civile & Ind, Via Eudossiana 18, I-00184 Rome, Italy.
EM ugo.andreaus@uniroma1.it; ivan.giorgio@uniroma1.it;
   angela.madeo@insa-lyon.fr
RI madeo, angela/L-5066-2015; Giorgio, Ivan/E-9341-2010
OI madeo, angela/0000-0003-1940-9853; Giorgio, Ivan/0000-0002-0044-9188
CR Andreaus U, 2004, J VIB CONTROL, V10, P625, DOI 10.1177/1077546304038224
   Andreaus U, 2009, P I MECH ENG H, V223, P589, DOI 10.1243/09544119JEIM559
   Andreaus U., 2012, BIOMEDICAL IMAGING C, P19
   Andreaus U., 2013, J APPL MATH MECH ZAM, P1, DOI http://dx.doi.org/10.1063/1A808446
   Andreaus U., 2008, BIOPHYSICS BIOENGINE, V10, P1
   Andreaus U, 2014, COMPUT METH PROG BIO, V113, P80, DOI 10.1016/j.cmpb.2013.09.002
   Andreaus U, 2012, CONTROL ENG PRACT, V20, P575, DOI 10.1016/j.conengprac.2012.02.002
   Andreaus U, 2011, STRUCT MULTIDISCIP O, V43, P43, DOI 10.1007/s00158-010-0531-9
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507
   BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506
   Carcaterra A, 2004, J ACOUST SOC AM, V115, P683, DOI 10.1121/1.1642619
   Carcaterra A, 2002, MECH SYST SIGNAL PR, V16, P905, DOI 10.1006/mssp.2002.1486
   Carcaterra A., 2011, P 7 EUR NONL OSC C J
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Casanova R, 2010, MED BIOL ENG COMPUT, V48, P811, DOI 10.1007/s11517-010-0637-7
   Cazzani A, 1997, COMPUT MECH, V20, P560, DOI 10.1007/s004660050276
   Cazzani A, 2012, SOIL DYN EARTHQ ENG, V37, P56, DOI 10.1016/j.soildyn.2012.01.011
   Contrafatto L, 2005, INT J NUMER METH ENG, V63, P1089, DOI 10.1002/nme.1235
   Contro R., 1988, ENG COMPUTATION, V5, P53
   COWIN SC, 1976, Z ANGEW MATH MECH, V56, P281, DOI 10.1002/zamm.19760560702
   COWIN SC, 1983, J ELASTICITY, V13, P125, DOI 10.1007/BF00041230
   Culla A, 2003, MECH SYST SIGNAL PR, V17, P635, DOI 10.1006/mssp.2002.1487
   Cuomo M, 2006, Computational Modelling of Concrete Structures, P533
   Cuomo M, 2000, INT J SOLIDS STRUCT, V37, P3935, DOI 10.1016/S0020-7683(99)00163-8
   Cuomo M, 1998, MATH COMPUT MODEL, V28, P185, DOI 10.1016/S0895-7177(98)00117-4
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   DELL'ISOLA F, 1987, INT J ENG SCI, V25, P1469, DOI 10.1016/0020-7225(87)90024-3
   dell'Isola F, 1998, ARCH APPL MECH, V68, P1, DOI 10.1007/s004190050142
   dell'Isola F, 2009, INT J SOLIDS STRUCT, V46, P3150, DOI 10.1016/j.ijsolstr.2009.04.008
   DELL'ISOLA F, 1987, INT J ENG SCI, V25, P1459, DOI 10.1016/0020-7225(87)90023-1
   Dell'Isola F, 1998, ARCH APPL MECH, V68, P626, DOI 10.1007/s004190050192
   dell'Isola F, 1998, ACTA MECH, V127, P165, DOI 10.1007/BF01170371
   Dell'Isola F, 1997, Z ANGEW MATH MECH, V77, P519, DOI 10.1002/zamm.19970770711
   Dell'Isola F, 1997, INT J FRACTURE, V83, P175, DOI 10.1023/A:1007331628395
   dell'Isola F, 1997, ARCH APPL MECH, V67, P215
   Dell'Isola F, 1997, J ELASTICITY, V47, P73, DOI 10.1023/A:1007478322647
   Dell'Isola F, 1998, P ROY SOC A-MATH PHY, V454, P1169, DOI 10.1098/rspa.1998.0201
   dell'Isola F, 2000, ARCH APPL MECH, V70, P323, DOI 10.1007/s004199900020
   dell'Isola F, 2012, ZAMM-Z ANGEW MATH ME, V92, P52, DOI 10.1002/zamm.201100022
   DiCarlo A, 2002, MECH RES COMMUN, V29, P449, DOI 10.1016/S0093-6413(02)00297-5
   Epstein M, 2000, INT J PLASTICITY, V16, P951, DOI 10.1016/S0749-6419(99)00081-9
   Eremeev VA, 2003, DOKL PHYS, V48, P359, DOI 10.1134/1.1598247
   Eremeyev VA, 2011, J MECH PHYS SOLIDS, V59, P1395, DOI 10.1016/j.jmps.2011.04.005
   Eremeyev VA, 2009, ARCH MECH, V61, P41
   Eremeyev VA, 2004, J ELASTICITY, V74, P67, DOI 10.1023/B:ELAS.0000026106.09385.8c
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   Federico S, 2010, INT J MECH SCI, V52, P175, DOI 10.1016/j.ijmecsci.2009.09.006
   Garusi E., 2004, INT J COMPUTATIONAL, V5, P589
   Ghiba I.D., MATH MECH SOLI UNPUB
   Giorgio I, 2009, ARCH APPL MECH, V79, P859, DOI 10.1007/s00419-008-0258-x
   GOODMAN MA, 1972, ARCH RATION MECH AN, V44, P249
   Grillo A, 2012, INT J NONLIN MECH, V47, P388, DOI 10.1016/j.ijnonlinmec.2011.09.026
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3
   Klein-Nulend J., 2003, CURR OSTEOPOROS REP, V1, P5
   Koc IM, 2005, J ACOUST SOC AM, V118, P3031, DOI 10.1121/1.2074807
   Lekszycki T, 2002, MECCANICA, V37, P343, DOI 10.1023/A:1020831519496
   Lekszycki T, 2012, ZAMM-Z ANGEW MATH ME, V92, P426, DOI 10.1002/zamm.201100082
   Luongo A, 2004, COMPUT STRUCT, V82, P2705, DOI 10.1016/j.compstruc.2004.04.022
   Luongo A, 2003, NONLINEAR DYNAM, V34, P269, DOI 10.1023/B:NODY.0000013508.50435.39
   Luongo A, 1996, NONLINEAR DYNAM, V10, P317, DOI 10.1007/BF00045480
   Luongo A, 1999, NONLINEAR DYNAM, V19, P133
   Luongo A, 1997, NONLINEAR DYNAM, V14, P193, DOI 10.1023/A:1008201828000
   Madeo A, 2013, J MECH PHYS SOLIDS, V61, P2196, DOI 10.1016/j.jmps.2013.06.009
   Madeo A, 2013, CONTINUUM MECH THERM, V25, P173, DOI 10.1007/s00161-012-0236-y
   Madeo A., 2013, CONTINUUM MECH THERM, DOI [10.1007/s00161-013-0329-2:1-20, DOI 10.1007/S00161-013-0329-2:1-20]
   Madeo A, 2008, J MECH MATER STRUCT, V3, P607, DOI 10.2140/jomms.2008.3.607
   Madeo A, 2012, CR MECANIQUE, V340, P575, DOI 10.1016/j.crme.2012.05.003
   Madeo A, 2011, CR MECANIQUE, V339, P625, DOI 10.1016/j.crme.2011.07.004
   Martin R.B., 1984, POROSITY SPECIFIC SU, P179
   Maurini C, 2004, INT J SOLIDS STRUCT, V41, P4473, DOI 10.1016/j.ijsolstr.2004.03.002
   Maurini C, 2004, MECH SYST SIGNAL PR, V18, P1243, DOI 10.1016/S0888-3270(03)00082-7
   Maurini C, 2006, COMPUT STRUCT, V84, P1438, DOI 10.1016/j.compstruc.2006.01.016
   Neff P., 2013, CONTIN MECH THERMODY, P1, DOI [10.1007/s00161-013-0322-9, DOI 10.1007/S00161-013-0322-9]
   Neff P, 2007, J ELASTICITY, V87, P239, DOI 10.1007/s10659-007-9106-4
   Neff P, 2006, ZAMM-Z ANGEW MATH ME, V86, P892, DOI 10.1002/zamm.200510281
   OLIVETO G, 1988, ENG STRUCT, V10, P2, DOI 10.1016/0141-0296(88)90011-9
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pietraszkiewicz W, 2007, ZAMM-Z ANGEW MATH ME, V87, P150, DOI 10.1002/zamm.200610309
   Placidi L, 2008, EUR J MECH A-SOLID, V27, P582, DOI 10.1016/j.euromechsol.2007.10.003
   Quiligotti S, 2003, ACTA MECH, V160, P45, DOI 10.1007/s00707-002-0968-z
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   Reccia E., 2012, OPEN CIVIL ENG J, V6, P231
   Rinaldi A, 2007, INT J PLASTICITY, V23, P1796, DOI 10.1016/j.ijplas.2007.03.005
   Rinaldi A., 2013, MICROSCALE 2 GRADIEN, DOI [10.1002/zamm.201300028, DOI 10.1002/ZAMM.201300028]
   Rinaldi A, 2009, INT J DAMAGE MECH, V18, P233, DOI 10.1177/1056789508097544
   Rosi G, 2013, J VIB CONTROL, V19, P658, DOI 10.1177/1077546312437236
   Rosi G, 2010, EUR J MECH A-SOLID, V29, P859, DOI 10.1016/j.euromechsol.2010.02.014
   RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217
   Sanz-Herrera JA, 2008, COMPUT METHOD APPL M, V197, P3092, DOI 10.1016/j.cma.2008.02.010
   Sanz-Herrera JA, 2011, INT J SOLIDS STRUCT, V48, P257, DOI 10.1016/j.ijsolstr.2010.09.025
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Sciarra G, 2001, CONTINUUM MECH THERM, V13, P287, DOI 10.1007/s001610100053
   Sethuraman S, 2010, ACTA BIOMATER, V6, P1931, DOI 10.1016/j.actbio.2009.12.012
   Tricoteaux A, 2011, J EUR CERAM SOC, V31, P1361, DOI 10.1016/j.jeurceramsoc.2011.02.005
   Yeremeyev VA, 2007, PMM-J APPL MATH MEC+, V71, P61, DOI 10.1016/j.jappmathmech.2007.03.007
   Yusop AH, 2012, INT J BIOMATER, DOI [10.1155/2012/641430, DOI 10.1155/2012/641430]
   Zanetta M, 2009, ACTA BIOMATER, V5, P1126, DOI 10.1016/j.actbio.2008.12.003
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 100
TC 43
Z9 43
U1 2
U2 18
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0044-2275
EI 1420-9039
J9 Z ANGEW MATH PHYS
JI Z. Angew. Math. Phys.
PD FEB
PY 2015
VL 66
IS 1
BP 209
EP 237
DI 10.1007/s00033-014-0403-z
PG 29
WC Mathematics, Applied
SC Mathematics
GA CA6NE
UT WOS:000349030200013
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Gugerell, A
   Neumann, A
   Kober, J
   Tammaro, L
   Hoch, E
   Schnabelrauch, M
   Kamolz, L
   Kasper, C
   Keck, M
AF Gugerell, Alfred
   Neumann, Anne
   Kober, Johanna
   Tammaro, Loredana
   Hoch, Eva
   Schnabelrauch, Matthias
   Kamolz, Lars
   Kasper, Cornelia
   Keck, Maike
TI Adipose-derived stem cells cultivated on electrospun L-lactide/glycolide
   copolymer fleece and gelatin hydrogels under flow conditions - aiming
   physiological reality in hypodermis tissue engineering
SO BURNS
LA English
DT Article
DE Adipose-derived stem cells; Skin tissue engineering; Scaffold;
   Bioreactor; Hydrogel; Electrospinning
ID SHEAR-STRESS; PERFUSION; MATRIX; VASCULARIZATION; RECONSTRUCTION;
   KERATINOCYTES; BIOREACTORS; SUBSTITUTE; THICKNESS; SURVIVAL
AB Introduction: Generation of adipose tissue for bum patients that suffer from an irreversible loss of the hypodermis is still one of the most complex challenges in tissue engineering. Electrospun materials with their micro- and nanostructures are already well established for their use as extracellular matrix substitutes. Gelatin is widely used in tissue engineering to gain thickness and volume. Under conventional static cultivation methods the supply of nutrients and transport of toxic metabolites is controlled by diffusion and therefore highly dependent on size and porosity of the biomaterial. A widely used method in order to overcome these limitations is the medium perfusion of 3D biomaterial-cell-constructs.
   In this study we combined perfusion bioreactor cultivation techniques with electrospun poly((L)-lactide-co-glycolide) (P(LLG)) and gelatin hydrogels together with adipose-derived stem cells (ASCs) for a new approach in soft tissue engineering.
C1 [Gugerell, Alfred; Kober, Johanna; Keck, Maike] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, A-1090 Vienna, Austria.
   [Neumann, Anne; Kasper, Cornelia] Univ Nat Resources & Life Sci, Dept Biotechnol, A-1190 Vienna, Austria.
   [Tammaro, Loredana] Univ Salerno, Dept Ind Engn, I-84084 Fisciano, SA, Italy.
   [Hoch, Eva] Univ Stuttgart, Inst Interfacial Proc Engn & Plasma Technol, D-70669 Stuttgart, Germany.
   [Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Kamolz, Lars] Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, A-8036 Graz, Austria.
RP Gugerell, A (reprint author), Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM Alfred.Gugerell@meduniwien.ac.at; Anne.Neumann@boku.ac.at;
   Johanna.Kober@meduniwien.ac.at; Itammaro@unisa.it;
   Eva.Hoch@igvp.uni-stuttgart.de; MS@innovent-jena.de;
   Lars.Kamolz@medunigraz.at; Cornelia.Kasper@boku.ac.at;
   Maike.Keck@meduniwien.ac.at
OI Kamolz, Lars-Peter/0000-0002-5975-876X; Gugerell,
   Alfred/0000-0002-5178-9967
FU European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D
   project [263416]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D
   project under grant agreement no. 263416. The funding source had no
   involvement in study design, in the collection, analysis and
   interpretation of data, in the writing of the report and in the decision
   to submit the article for publication.
CR Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428
   Carriel V, 2012, CELLS TISSUES ORGANS, V196, P1, DOI 10.1159/000330682
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265
   Haj AJ, 2009, ADV BIOCHEM ENG BIOT, V112, P81
   Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb
   Hendrickx B, 2011, TISSUE ENG PART B-RE, V17, P13, DOI [10.1089/ten.teb.2010.0315, 10.1089/ten.TEB.2010.0315]
   Hoch E, 2013, J MATER CHEM B, V1, P5675, DOI 10.1039/c3tb20745e
   Hoch E, 2012, J MATER SCI-MATER M, V23, P2607, DOI 10.1007/s10856-012-4731-2
   Horch R, 2009, TISSUE ENG, P123
   Kalyanaraman B, 2008, TISSUE ENG PT A, V14, P583, DOI 10.1089/tea.2007.0237
   Keck M, 2013, EUR SURG, V45, P263, DOI 10.1007/s10353-013-0211-2
   Keck M, 2012, BURNS, V38, P388, DOI 10.1016/j.burns.2011.09.026
   Keck M, 2011, BURNS, V37, P626, DOI 10.1016/j.burns.2010.07.016
   Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122
   Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z
   Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Navarro FA, 2001, WOUND REPAIR REGEN, V9, P507, DOI 10.1046/j.1524-475x.2001.00507.x
   Palumbo FS, 2013, MAT SCI ENG C-MATER, V33, P2541, DOI 10.1016/j.msec.2013.02.015
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009
   Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0
   Shenaq SM, 2002, CLIN PLAST SURG, V29, pvi
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   van den Broek LJ, 2014, TISSUE ENG PT A, V20, P197, DOI [10.1089/ten.TEA.2013.0123, 10.1089/ten.tea.2013.0123]
   van der Veen VC, 2011, WOUND REPAIR REGEN, V19, pS59, DOI 10.1111/j.1524-475X.2011.00713.x
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   Williams C, 2005, ANN BIOMED ENG, V33, P920, DOI 10.1007/s10439-005-3238-0
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
NR 34
TC 10
Z9 11
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
EI 1879-1409
J9 BURNS
JI Burns
PD FEB
PY 2015
VL 41
IS 1
BP 163
EP 171
DI 10.1016/j.burns.2014.06.010
PG 9
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA AZ5JL
UT WOS:000348257400022
PM 25440846
DA 2018-10-20
ER

PT J
AU Wang, YC
   Li, PW
   Chen, LJ
   Gao, WM
   Zeng, FB
   Kong, LX
AF Wang, Yichao
   Li, Puwang
   Chen, Lijue
   Gao, Weimin
   Zeng, Fanbo
   Kong, Ling Xue
TI Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient
   folic acid-conjugated nanoparticles
SO DRUG DELIVERY
LA English
DT Article
DE HT-29; nanoparticles; PLGA-1, 3-diaminopropane-folic acid; targeting
ID DRUG-DELIVERY; IN-VITRO; PLGA NANOPARTICLES; CELLULAR UPTAKE; COATED
   SPHERE; SLOW-RELEASE; TUMOR-CELLS; CHITOSAN; CANCER; DOCETAXEL
AB The incorporation of a high percentage of targeting molecules into drug delivery system is one of the important methods for improving efficacy of targeting therapeutic drugs to cancer cells. PLGA-based drug delivery carriers with folic acid (FA) as targeting molecule have a low targeting efficiency due to a low FA conjugation ratio. In this work, we fabricated a FA-conjugated PLGA system using a crosslinker 1, 3-diaminopropane and have achieved a high conjugation ratio of 46.7% (mol/mol). The as-prepared PLGA-based biomaterial was used to encapsulate therapeutic drug 5-fluorouracil (5-FU) into nanoparticles. In the in vitro experiments, an IC50 of 5.69 mg/mL has been achieved for 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles on HT-29 cancer cells and is significantly lower than that of 5-FU and 5-FU loaded PLGA nanoparticles which only have an IC50 of 22.9 and 14.17 mg/mL, respectively. The fluorescent microscopy images showed that nanoparticles with FA are largely taken up by HT-29 cancer cells and the targeting nanoparticles have more affinity to cancer cells than the pure drugs and untreated nanoparticles. Therefore, the 1, 3-diaminopropane can facilitate the conjugation of FA to PLGA to form a novel polymer and 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles can be a highly efficient system for specific delivery of drugs to cancer cells.
C1 [Wang, Yichao; Li, Puwang; Chen, Lijue; Gao, Weimin; Kong, Ling Xue] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3216, Australia.
   [Li, Puwang] Chinese Acad Trop Agr Sci, Agr Prod Proc Res Inst, Zhanjiang, Peoples R China.
   [Zeng, Fanbo] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China.
RP Kong, LX (reprint author), Deakin Univ, Inst Frontier Mat, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.
EM lingxue.kong@deakin.edu.au
RI Kong, Lingxue/D-8216-2011
OI Kong, Lingxue/0000-0001-6219-3897; Gao, Weimin/0000-0002-7390-169X;
   Wang, Yichao/0000-0002-6295-6492
CR Banfi L, 1999, TETRAHEDRON-ASYMMETR, V10, P3571, DOI 10.1016/S0957-4166(99)00371-7
   Chen YS, 2011, DRUG DELIV, V18, P493, DOI 10.3109/10717544.2011.589088
   Choi SW, 2007, J CONTROL RELEASE, V122, P24, DOI 10.1016/j.jconrel.2007.06.003
   Ebrahimnejad P, 2010, NANOMED-NANOTECHNOL, V6, P478, DOI 10.1016/j.nano.2009.10.003
   Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001
   Esmaeili F, 2008, J DRUG TARGET, V16, P415, DOI [10.1080/10611860802088630, 10.1080/10611860802088630 ]
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kasuya Y, 2001, BIOORG MED CHEM LETT, V11, P2089, DOI 10.1016/S0960-894X(01)00374-2
   LEE DJ, 1995, J PHARM SCI, V84, P1366, DOI 10.1002/jps.2600841119
   Li PW, 2011, CARBOHYD RES, V346, P801, DOI 10.1016/j.carres.2011.01.027
   Liao YC, 1997, J PHARM SCI, V86, P92, DOI 10.1021/js960143c
   Lu YJ, 2002, CANCER IMMUNOL IMMUN, V51, P153, DOI 10.1007/s00262-002-0266-6
   Musumeci T, 2006, INT J PHARM, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023
   Nie Y, 2009, J MATER SCI-MATER M, V20, P1849, DOI 10.1007/s10856-009-3750-0
   Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008
   Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158
   Townsend SA, 2007, BIOMATERIALS, V28, P5176, DOI 10.1016/j.biomaterials.2007.08.011
   Wang YC, 2013, AAPS PHARMSCITECH, V14, P585, DOI 10.1208/s12249-013-9943-3
   Wang YC, 2013, J APPL POLYM SCI, V129, P714, DOI 10.1002/app.38582
   Yoo HS, 2004, J CONTROL RELEASE, V96, P273, DOI 10.1016/j.jconrel.2004.02.003
   Zaki NM, 2014, DRUG DELIV, V21, P265, DOI 10.3109/10717544.2013.838808
   Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018
   Zhang ZP, 2006, BIOMATERIALS, V27, P4025, DOI 10.1016/j.biomaterials.2006.03.006
   Zhao HZ, 2008, INT J PHARMACEUT, V349, P256, DOI 10.1016/j.ijpharm.2007.07.040
   Zheng YL, 2007, EUR J PHARM BIOPHARM, V67, P621, DOI 10.1016/j.ejpb.2007.04.007
NR 27
TC 24
Z9 24
U1 0
U2 40
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD FEB
PY 2015
VL 22
IS 2
BP 191
EP 198
DI 10.3109/10717544.2013.875603
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AZ6UG
UT WOS:000348355200005
PM 24437926
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhang, XW
   Zhang, C
   Zhang, W
   Meng, S
   Liu, DH
   Wang, P
   Guo, J
   Li, JX
   Guan, YM
   Yang, D
AF Zhang, Xiaowei
   Zhang, Chong
   Zhang, Wei
   Meng, Shu
   Liu, Danhua
   Wang, Ping
   Guo, Jing
   Li, Jianxin
   Guan, Yanmin
   Yang, Dan
TI Feasibility of poly (epsilon-caprolactone-co-DL-lactide) as a
   biodegradable material for in situ forming implants: evaluation of drug
   release and in vivo degradation
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Biocompatibility; biodegradable polymers; controlled delivery; in situ
   forming implants; poly (epsilon-caprolactone-co-DL-lactide);
   testosterone undecanoate
ID PHASE INVERSION DYNAMICS; DELIVERY SYSTEMS; MOLECULAR-WEIGHT;
   TESTOSTERONE UNDECANOATE; MALE CONTRACEPTION; SUSTAINED-RELEASE; VITRO
   RELEASE; COPOLYMERS; BLENDS; POLY(EPSILON-CAPROLACTONE)
AB The purpose of this study was to evaluate the technical feasibility of poly (epsilon-caprolactone-coDL-lactide), P (CL/DL-LA), for injectable in situ forming implants (ISFI). The ISFI was prepared by dissolving P (CL/DL-LA) in N-methyl-2-pyrrolidone (NMP), and Testosterone undecanoate (TU) was used as model drug. The effect of various polymer concentrations, molecular weights (Mws) and drug loads on the drug release from the TU-loaded ISFI systems was investigated in vitro. The release of TU-loaded ISFI was also evaluated in rats. In addition, a subcutaneous rabbit model was used to evaluate the degradation and foreign-body reaction of P (CL/DL-LA) ISFI. The use of higher concentration of P (CL/DL-LA) with higher molecule weight and larger CL:DL-LA monomer ratio for the TU-loaded ISFI gave a slower drug release. The ISFI of 80/20 P (CL/DL-LA) (Mw 61 753):NMP 20: 80 with 16% TU formulation increased serum testosterone levels in rats over a period of three months. The in vivo degradation and biocompatibility study of ISFI shows that P (CL/DL-LA) degrades by a process of bulk degradation and that the foreignbody reaction of this biomaterial is relatively mild. In summary, our investigations demonstrate that in situ parenteral drug delivery systems can be obtained from P (CL/DL-LA) solutions.
C1 [Zhang, Xiaowei; Zhang, Chong; Zhang, Wei; Meng, Shu; Liu, Danhua; Wang, Ping; Guo, Jing; Li, Jianxin; Guan, Yanmin; Yang, Dan] Liaoning Res Inst Family Planning, Shenyang 110031, Peoples R China.
RP Yang, D (reprint author), Liaoning Res Inst Family Planning, PuHe Rd 10, Shenyang 110031, Peoples R China.
EM yangdan999@hotmail.com
CR Ahola M., 1999, International Journal of Pharmaceutics (Amsterdam), V181, P181, DOI 10.1016/S0378-5173(99)00022-8
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Barakat NS, 2013, DRUG DEV IND PHARM, V39, P352, DOI 10.3109/03639045.2012.681383
   Bertram U, 2012, DRUG DEV IND PHARM, V38, P659, DOI 10.3109/03639045.2011.598536
   Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5
   Brodbeck KJ, 1999, PHARMACEUT RES, V16, P1825, DOI 10.1023/A:1018943107688
   Camargo JA, 2013, DRUG DEV IND PHARM, V39, P146, DOI 10.3109/03639045.2012.660952
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Cohn D, 2005, BIOMACROMOLECULES, V6, P1168, DOI 10.1021/bm0495250
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   DesNoyer JR, 2001, J CONTROL RELEASE, V70, P285, DOI 10.1016/S0168-3659(00)00354-0
   Einmahl S, 2001, ADV DRUG DELIVER REV, V53, P45, DOI 10.1016/S0169-409X(01)00220-4
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   Gu YQ, 2009, J CLIN ENDOCR METAB, V94, P1910, DOI 10.1210/jc.2008-1846
   Hakkarainen M, 2000, POLYMER, V41, P2331, DOI 10.1016/S0032-3861(99)00393-6
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   JALIL RU, 1990, DRUG DEV IND PHARM, V16, P2353, DOI 10.3109/03639049009058535
   Kang FR, 2005, INT J PHARM, V304, P83, DOI 10.1016/j.ijpharm.2005.07.024
   Lemmouchi Y, 1998, J CONTROL RELEASE, V55, P79, DOI 10.1016/S0168-3659(98)00021-2
   Liu PY, 2010, CONTRACEPTION, V82, P471, DOI 10.1016/j.contraception.2010.03.010
   Liu QF, 2010, INT J PHARMACEUT, V397, P122, DOI 10.1016/j.ijpharm.2010.07.015
   LIU Y, 2010, EUR J PHARM BIOPHARM, V76, P222
   Malin M, 1996, J APPL POLYM SCI, V59, P1289, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1289::AID-APP12>3.0.CO;2-1
   Meriggiola MC, 2005, J CLIN ENDOCR METAB, V90, P2005, DOI 10.1210/jc.2004-1852
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Patel RB, 2010, J CONTROL RELEASE, V147, P350, DOI 10.1016/j.jconrel.2010.08.020
   PEREGO G, 1993, MAKROMOL CHEM, V194, P2463
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   Qian Y, 2010, DRUG DEV IND PHARM, V36, P1340, DOI 10.3109/03639041003801893
   Ravivarapu HB, 2000, INT J PHARM, V194, P181, DOI 10.1016/S0378-5173(99)00371-3
   Rich J, 2001, INT J PHARM, V212, P121, DOI 10.1016/S0378-5173(00)00601-3
   Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   Vieira AC, 2011, J MECH BEHAV BIOMED, V4, P451, DOI 10.1016/j.jmbbm.2010.12.006
   VION JM, 1986, MACROMOLECULES, V19, P1828, DOI 10.1021/ma00161a009
   Wang C, 2010, CURR OPIN UROL, V20, P520, DOI 10.1097/MOU.0b013e32833f1b4a
   Wang LW, 2004, J CONTROL RELEASE, V99, P207, DOI 10.1016/j.jconrel.2004.06.021
   Wang SH, 2007, INT J PHARM, V337, P102, DOI 10.1016/j.ijpharm.2006.12.031
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   Yang Y, 2012, DRUG DEV IND PHARM, V38, P550, DOI 10.3109/03639045.2012.665928
   Ye W P, 1996, Pharm Dev Technol, V1, P1
   Zhang C, 2013, J APPL POLYM SCI, V130, P3800, DOI 10.1002/app.39646
NR 47
TC 1
Z9 1
U1 2
U2 14
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PD FEB
PY 2015
VL 41
IS 2
BP 342
EP 352
DI 10.3109/03639045.2013.866140
PG 11
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CA5BT
UT WOS:000348923200022
PM 24320881
DA 2018-10-20
ER

PT J
AU Villa, MM
   Wang, LP
   Huang, JP
   Rowe, DW
   Wei, M
AF Villa, Max M.
   Wang, Liping
   Huang, Jianping
   Rowe, David W.
   Wei, Mei
TI Bone tissue engineering with a collagen-hydroxyapatite scaffold and
   culture expanded bone marrow stromal cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue engineering; stem cells; bone; collagen; bone marrow
ID MESENCHYMAL STEM-CELLS; I COLLAGEN; EXTRACELLULAR-MATRIX; PROGENITOR
   CELLS; IMAGE-ANALYSIS; DEFECTS; REPAIR; SITES; MICROSCOPY; PROTEIN
AB Osteoprogenitor cells combined with supportive biomaterials represent a promising approach to advance the standard of care for bone grafting procedures. However, this approach faces challenges, including inconsistent bone formation, cell survival in the implant, and appropriate biomaterial degradation. We have developed a collagen-hydroxyapatite (HA) scaffold that supports consistent osteogenesis by donor-derived osteoprogenitors, and is more easily degraded than a pure ceramic scaffold. Herein, the material properties are characterized as well as cell attachment, viability, and progenitor distribution in vitro. Furthermore, we examined the biological performance in vivo in a critical-size mouse calvarial defect. To aid in the evaluation of the in-house collagen-HA scaffold, the in vivo performance was compared with a commercial collagen-HA scaffold (Healos((R)), Depuy). The in-house collagen-HA scaffold supported consistent bone formation by predominantly donor-derived osteoblasts, nearly completely filling a 3.5 mm calvarial defect with bone in all samples (n=5) after 3 weeks of implantation. In terms of bone formation and donor cell retention at 3 weeks postimplantation, no statistical difference was found between the in-house and commercial scaffold following quantitative histomorphometry. The collagen-HA scaffold presented here is an open and well-defined platform that supports robust bone formation and should facilitate the further development of collagen-hydroxyapatite biomaterials for bone tissue engineering. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 243-253, 2015.
C1 [Villa, Max M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Wang, Liping; Huang, Jianping; Rowe, David W.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Reconstruct Sci,Ctr Regenerat Med & Skeletal, Farmington, CT 06030 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
FU GAANN pre-doctoral fellowship from the Department of Education
   [P200A09315]; NIH [1R21AR059962-01A1, 3 R01 AR064381-01S1]; NSF
   [CBET-1133883]
FX Contract grant sponsor: GAANN pre-doctoral fellowship from the
   Department of Education; contract grant number: P200A09315; Contract
   grant sponsor: NIH; contract grant number: 1R21AR059962-01A1, 3 R01
   AR064381-01S1; Contract grant sponsor: NSF; contract grant number:
   CBET-1133883
CR Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Boskey A. L., 2013, PRIMER METABOLIC BON
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560
   Fields GB, 1995, CONNECT TISSUE RES, V31, P235, DOI 10.3109/03008209509010815
   Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Kemppainen JM, 2010, BIOMATERIALS, V31, P279, DOI 10.1016/j.biomaterials.2009.09.041
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x
   PATE FD, 1994, J ARCHAEOL METHOD TH, V1, P161, DOI DOI 10.1007/BF02231415
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qu HB, 2008, J AM CERAM SOC, V91, P3211, DOI 10.1111/j.1551-2916.2008.02634.x
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   VansAmerongen MJ, 2006, BIOMATERIALS, V27, P2247
   Villa MM, 2013, TISSUE ENG PART C-ME, V19, P839, DOI [10.1089/ten.tec.2012.0490, 10.1089/ten.TEC.2012.0490]
   WERB Z, 1975, J EXP MED, V142, P346, DOI 10.1084/jem.142.2.346
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Yu XH, 2013, J TISSUE ENG REGEN M, V7, P974, DOI 10.1002/term.1490
   Yu XH, 2012, J MATER CHEM, V22, P9721, DOI 10.1039/c2jm30332a
   Zeitouni S, 2012, SCI TRANSL MED, V4
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 41
TC 29
Z9 30
U1 1
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 243
EP 253
DI 10.1002/jbm.b.33225
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700001
PM 24909953
OA Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Atayde, LM
   Cortez, PP
   Afonso, A
   Santos, M
   Mauricio, AC
   Santos, JD
AF Atayde, L. M.
   Cortez, P. P.
   Afonso, A.
   Santos, M.
   Mauricio, A. C.
   Santos, J. D.
TI Morphology effect of bioglass-reinforced hydroxyapatite (Bonelike (R))
   on osteoregeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone ingrowth; porous; calcium phosphate(s); in vivo; bone graft
ID BONE-GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE CERAMICS; SPHERICAL
   TETRACALCIUM PHOSPHATE; ANIMAL-MODEL; ORTHOPEDIC TRAUMA; BASIC
   PROPERTIES; FRACTURE REPAIR; SHEEP MODEL; COMPOSITES; SCAFFOLDS
AB In the last decades, the well-known disadvantages of autografts and allografts have driven to the development of synthetic bone grafts for bone regeneration. Bonelike((R)), a glass-reinforced hydroxyapatite (HA) composite was developed and registered for bone grafting. This biomaterial is composed by a modified HA matrix, with - and -tricalcium phosphate secondary phases. Aiming to improve the biological characteristics of Bonelike((R)), new spherical pelleted granules, of different shape and size, were developed with controlled micro and macrostructure. In the present study, it was compared the physicochemical properties and in vivo performance of different Bonelike((R)) granule presentationsBonelike((R)) polygonal (500-1000 mu m size) and Bonelike spherical (250-500 mu m; 500-1000 mu m size). For the in vivo study, Bonelike((R)) was implanted on sheep femurs, with various implantation times (30 days, 60 days, 120 days, and 180 days). X-ray diffraction analysis revealed that the phase composition of different granules presentations was similar. Bonelike((R)) spherical 500-1000 mu m was the most porous material (global porosity and intraporosity) and Bonelike((R)) polygonal 500-1000 mu m the less porous. Considering the in vivo study, both polygonal and spherical granules presented osteoconductive proprieties. The spherical granules showed several advantages, including easier medical application through syringe and improved osteointegration, osteoconduction, and degradation, by the presence of larger pores, controlled micro- and macrosctructure and suitable particle format that adapts to bone growth. Bonelike((R)) spherical 500-1000 mu m showed improved new bone invasion throughout the material's structure and Bonelike((R)) spherical 250-500 mu m appeared to induce faster bone regeneration, presenting less unfilled areas and less lacunae in the histological analysis. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 292-304, 2015.
C1 [Atayde, L. M.; Cortez, P. P.; Mauricio, A. C.] Univ Porto, ICBAS, Dept Clin Vet, P-4050313 Oporto, Portugal.
   [Atayde, L. M.; Cortez, P. P.; Mauricio, A. C.] CECA, ICETA, P-4051401 Oporto, Portugal.
   [Afonso, A.] Univ Porto FMDUP, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Santos, M.] Biosckin Mol & Cell Therapies SA, P-4470605 Maia, Portugal.
   [Santos, J. D.] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn, P-4200465 Oporto, Portugal.
RP Atayde, LM (reprint author), Univ Porto, ICBAS, Dept Clin Vet, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
EM ataydelm@gmail.com
OI Santos, Jose Domingos/0000-0002-6871-9850; Mauricio, Ana
   Colette/0000-0002-0018-9363; Cortez, Paulo/0000-0001-7132-6786
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies - Projects Biomat Cell QREN [2008/1372]; Project
   TRIBONE [11458]; European Community FEDER fund through ON2 - O Novo
   Norte - North Portugal Regional Operational Program; project FCT from
   Fundacao para a Ciencia e Tecnologia (FCT) [ENMED/0002/2010]; Ministerio
   da Educacao e da Ciencia; EuroNanoMed JTC Program; program COMPETE -
   Programa Operacional Factores de Competitividade
   [Pest-OE/AGR/UI0211/2011]
FX This research was supported by QREN I&DT Cluster in Development of
   Products for Regenerative Medicine and Cell Therapies - Projects Biomat
   & Cell QREN 2008/1372 and Project TRIBONE, No 11458, co-financed by the
   European Community FEDER fund through ON2 - O Novo Norte - North
   Portugal Regional Operational Program 2007-2013, by project FCT -
   ENMED/0002/2010 from Fundacao para a Ciencia e Tecnologia (FCT),
   Ministerio da Educacao e da Ciencia and EuroNanoMed JTC 2010 Program,
   and by the program COMPETE - Programa Operacional Factores de
   Competitividade, Project Pest-OE/AGR/UI0211/2011. The authors are
   grateful to Mrs. Ana Mota (FMD-UP) for her technical assistance with the
   histological studies. The authors are grateful to Mrs. Ana Mota (FMD-UP)
   for her technical assistance with the histological studies.
CR ASSELMEIER MA, 1993, AM J SPORT MED, V21, P170, DOI 10.1177/036354659302100202
   Atayde LM, 2014, J MATER SCI-MATER M, V25, P1885, DOI 10.1007/s10856-014-5216-2
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bohner M, 2013, BIOMATTER, V3, P1
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Boyan BD, 2003, BONE GRAFT SUBSTITUT, P231
   Bucholz R, 2000, BONE GRAFTS DERIVATI, V1994, P260
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Reis ECC, 2010, BRAZ ARCH BIOL TECHN, V53, P817, DOI 10.1590/S1516-89132010000400010
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Chen LW, 2012, FOOT ANKLE INT, V33, P424, DOI 10.3113/FAI.2012.0424
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, P131
   Cortez PP, 2011, J BIOMED MATER RES B, V99B, P170, DOI 10.1002/jbm.b.31884
   Cortez PP, 2011, J BIOMATER APPL, P201
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Dorozhkin SV, 2013, MATERIALS, V6, P3840, DOI 10.3390/ma6093840
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   Fujishiro Y, 2001, J BIOMED MATER RES, V54, P525, DOI 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-#
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Gentile JV, 2013, J PEDIATR ORTHOPED, V33, P254, DOI 10.1097/BPO.0b013e318285c56c
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Griffon DJ, 2005, AO PRINCIPLES FRACTU, P72
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Ishikawa K, 2004, J MATER SCI-MATER M, V15, P13, DOI 10.1023/B:JMSM.0000010092.01661.a8
   Ishikawa K, 2003, KEY ENG MAT, V240-2, P369, DOI 10.4028/www.scientific.net/KEM.240-242.369
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Lobato JV, 2006, THIN SOLID FILMS, V515, P362, DOI 10.1016/j.tsf.2005.12.153
   Lobato JV, 2005, KEY ENG MAT, V284-286, P877, DOI 10.4028/www.scientific.net/KEM.284-286.877
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   Martini L, 2001, COMPARATIVE MED, V51, P292
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Ravarian R, 2010, CERAM INT, V36, P291, DOI 10.1016/j.ceramint.2009.09.016
   REJDA BV, 1977, J BIOENG, V1, P93
   Ribeiro CC, 2006, J MATER SCI-MATER M, V17, P455, DOI 10.1007/s10856-006-8473-x
   Sa MJC, 2007, J BIOMATER APPL, V22, P5, DOI 10.1177/0885328206065860
   Salgado P. C., 2011, J BIOMATER NANOBIOTE, V2, P318, DOI 10.4236/jbnb.2011.23039
   Santos JD, 1996, J MATER SCI-MATER M, V7, P181, DOI 10.1007/BF00121258
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SANTOS JD, 2010, Patent No. 2010021559
   SANTOS JD, 2000, Patent No. 2000068164
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   Trombelli L, 2012, CLIN ORAL IMPLAN RES, V23, P424, DOI 10.1111/j.1600-0501.2011.02318.x
   Uchino T, 2010, J MATER SCI-MATER M, V21, P1921, DOI 10.1007/s10856-010-4042-4
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
NR 79
TC 5
Z9 5
U1 0
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 292
EP 304
DI 10.1002/jbm.b.33195
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700006
PM 24819340
DA 2018-10-20
ER

PT J
AU Brochu, ABW
   Matthys, OB
   Craig, SL
   Reichert, WM
AF Brochu, Alice B. W.
   Matthys, Oriane B.
   Craig, Stephen L.
   Reichert, William M.
TI Extended fatigue life of a catalyst free self-healing acrylic bone
   cement using microencapsulated 2-octyl cyanoacrylate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone cement; PMMA; acrylic; mechanical properties; fatigue;
   cyanoacrylate; self-healing
ID TOUGHENED EPOXY COMPOSITE; MECHANICAL-PROPERTIES; POLYMER COMPOSITES;
   REPAIR; RETARDATION; PERFORMANCE; CRACKS
AB The tissue adhesive 2-octyl cyanoacrylate (OCA) was encapsulated in polyurethane microshells and incorporated into bone cement to form a catalyst free, self-healing bone cement comprised of all clinically approved components. The bending strength, modulus, and fatigue lifetime were investigated in accordance with ASTM and ISO standards for the testing of PMMA bone cement. The bending strength of bone cement specimens decreased with increasing wt % capsules content for capsules without or with OCA, with specimens of <5 wt % capsule content showing minimal effect. In contrast, bone cement bending modulus was insensitive to capsule content. Load controlled fatigue testing was performed in air at room temperature on capsule free bone cement (0 wt %), bone cement with 5 wt % OCA-free capsules (5 wt % No OCA), and 5 wt % OCA-containing capsules (5 wt % OCA). Specimens were tested at a frequency of 5 Hz at maximum stresses of 90%, 80%, 70%, and 50% of each specimen's bending strength until failure. The 5 wt % OCA exhibited significant self-healing at 70% and 50% of its reference strength (p<0.05). Fatigue testing of all three specimen types in air at 22 MPa (50% of reference strength of the 5 wt % OCA specimens) showed that the cycles to failure of OCA-containing specimens was increased by two-fold compared with the OCA-free and capsule-free specimens. This study represents the first demonstration of dynamic, catalyst free self-healing in a biomaterial formulation. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 305-312, 2015.
C1 [Brochu, Alice B. W.; Matthys, Oriane B.; Reichert, William M.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Craig, Stephen L.] Duke Univ, Dept Chem, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
EM reichert@duke.edu
RI Craig, Stephen/D-3484-2011
OI Craig, Stephen/0000-0002-8810-0369
FU NIH [EB 013874]
FX Contract grant sponsor: NIH; contract grant number: EB 013874 (to
   W.M.R.)
CR Andersson HM, 2007, SPRINGER SER MATER S, V100, P19, DOI 10.1007/978-1-4020-6250-6_2
   Bergman SD, 2007, SPRINGER SER MATER S, V100, P45, DOI 10.1007/978-1-4020-6250-6_3
   Brochu ABW, 2014, J BIOMED MATER RES B, V102, P181, DOI 10.1002/jbm.b.32994
   Brochu ABW, 2012, J BIOMED MATER RES B, V100B, P1764, DOI 10.1002/jbm.b.32743
   Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987
   Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2474, DOI 10.1016/j.compscitech.2005.04.053
   Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2466, DOI 10.1016/j.compscitech.2005.04.020
   Dailey MMC, 2013, J BIOMED MAT RES A
   Dry C, 1996, COMPOS STRUCT, V35, P263, DOI 10.1016/0263-8223(96)00033-5
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   Garcia SJ, 2011, PROG ORG COAT, V70, P142, DOI 10.1016/j.porgcoat.2010.11.021
   Jeffers JRT, 2007, J BIOMECH, V40, P1525, DOI 10.1016/j.jbiomech.2006.07.029
   Kessler MR, 2007, P I MECH ENG G-J AER, V221, P479, DOI 10.1243/09544100JAERO172
   Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6
   Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4
   Kuehn K-D, 2000, BONE CEMENTS UP TO D
   Kuehn KD, 2005, ORTHOP CLIN N AM, V36, P29, DOI 10.1016/j.ocl.2004.06.011
   LEWIS G, 1994, J APPL BIOMATER, V5, P307, DOI 10.1002/jab.770050405
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P457, DOI 10.1002/jbm.b.10018
   Lewis G, 2005, BIOMATERIALS, V26, P4317, DOI 10.1016/j.biomaterials.2004.11.003
   Lewis G, 2004, BIOMATERIALS, V25, P1415, DOI 10.1016/S0142-9612(03)00631-8
   Lewis G, 2009, J APPL BIOMATER BIOM, V7, P90
   Palacos R, 2012, INSTRUCTIONS FOR USE
   PEREK J, 1992, J MATER SCI-MATER M, V3, P333, DOI 10.1007/BF00705365
   SOLTESZ U, 1994, J MATER SCI-MATER M, V5, P654, DOI 10.1007/BF00120350
   Soltesz UR, 2005, J ASTM INT, V2, P2
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   White SR, 2013, 4 INT C SELF HEAL MA
   Yang JL, 2008, MACROMOLECULES, V41, P9650, DOI 10.1021/ma801718v
   Yang YZ, 2009, CEMENT CONCRETE RES, V39, P382, DOI 10.1016/j.cemconres.2009.01.013
NR 31
TC 6
Z9 6
U1 3
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 305
EP 312
DI 10.1002/jbm.b.33199
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700007
PM 24825796
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Matuska, AM
   McFetridge, PS
AF Matuska, Andrea M.
   McFetridge, Peter S.
TI The effect of terminal sterilization on structural and biophysical
   properties of a decellularized collagen-based scaffold; implications for
   stem cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell adhesion; sterilization; surface modification; tissue engineering;
   collagen
ID TEMPOROMANDIBULAR-JOINT DISC; SELF-ASSEMBLED MONOLAYERS; TENDON-BONE
   ALLOGRAFTS; GAMMA-IRRADIATION; PERACETIC-ACID; BIOMECHANICAL PROPERTIES;
   MECHANICAL-PROPERTIES; VASCULAR TISSUES; RAMAN MICROSCOPY; FOCAL
   ADHESION
AB Terminal sterilization induces physical and chemical changes in the extracellular matrix (ECM) of ex vivo-derived biomaterials due to their aggressive mechanism of action. Prior studies have focused on how sterilization affects the mechanical integrity of tissue-based biomaterials but have rarely characterized effects on early cellular interaction, which is indicative of the biological response. Using a model fibrocartilage disc scaffold, these investigations compare the effect of three common sterilization methods [peracetic acid (PAA), gamma irradiation (GI), and ethylene oxide (EtO)] on a range of material properties and characterized early cellular interactions. GI and EtO produced unfavorable structural damage that contributed to inferior cell adhesion. Conversely, exposure to PAA resulted in limited structural alterations while inducing chemical modifications that favored cell attachment. Results suggest that the sterilization approach can be selected to modulate biomaterial properties to favor cellular adhesion and has relevance in tissue engineering and regenerative medicine applications. Furthermore, the study of cellular interactions with modified biomaterials in vitro provides information of how materials may react in subsequent clinical applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 397-406, 2015.
C1 [Matuska, Andrea M.; McFetridge, Peter S.] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
FU NIH [1R21DE022449]; National Science Foundation Graduate Research
   Fellowship [DGE-1315138]
FX Contract grant sponsor: NIH; contract grant number: 1R21DE022449;
   Contract grant sponsor: National Science Foundation Graduate Research
   Fellowship; contract grant number: DGE-1315138
CR Ali SM, 2013, ANAL METHODS-UK, V5, P2281, DOI 10.1039/c3ay40185e
   Amensag S, 2012, TISSUE ENG PART C-ME, V18, P903, DOI [10.1089/ten.tec.2012.0119, 10.1089/ten.TEC.2012.0119]
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   BAILEY AJ, 1964, RADIAT RES, V23, P145, DOI 10.2307/3571687
   Bailey MM, 2007, TISSUE ENG, V13, P2003, DOI 10.1089/ten.2006.0150
   Balsly CR, 2008, CELL TISSUE BANK, V9, P289, DOI 10.1007/s10561-008-9069-0
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Borges AMG, 2013, MAT SCI ENG C-MATER, V33, P1315, DOI 10.1016/j.msec.2012.12.031
   Chassot Ana Lúcia Campani, 2006, Braz. Dent. J., V17, P117, DOI 10.1590/S0103-64402006000200006
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Conway K, 1999, BIOTECH HISTOCHEM, V74, P20, DOI 10.3109/10520299909066473
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   Cwikel D, 2010, LANGMUIR, V26, P15289, DOI 10.1021/la1020252
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x
   FIDELER BM, 1995, AM J SPORT MED, V23, P643, DOI 10.1177/036354659502300521
   Finnegan M, 2010, J ANTIMICROB CHEMOTH, V65, P2108, DOI 10.1093/jac/dkq308
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goktas S, 2014, J BIOMED MATER RES A, V102, P8, DOI 10.1002/jbm.a.34692
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Haimi S, 2008, BIOLOGICALS, V36, P99, DOI 10.1016/j.biologicals.2007.06.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Huang QH, 2004, WOUND REPAIR REGEN, V12, P276, DOI 10.1111/j.1067-1927.2004.012312.x
   Johns DE, 2007, P I MECH ENG H, V221, P509, DOI 10.1243/09544119JEIM158
   Juran CM, 2013, J DENT RES, V92, P193, DOI 10.1177/0022034512468749
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim KW, 2003, ANN BIOMED ENG, V31, P924, DOI 10.1114/1.1591190
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lindford AJ, 2012, BURNS, V38, P274, DOI 10.1016/j.burns.2011.08.009
   Lomas R. J., 2004, Cell and Tissue Banking, V5, P149, DOI 10.1023/B:CATB.0000046071.11459.bd
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Moore M, 2013, TISSUE ENG PT A, V19, P2005, DOI [10.1089/ten.tea.2012.0592, 10.1089/ten.TEA.2012.0592]
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   Scheffler S. U., 2005, Cell and Tissue Banking, V6, P109, DOI 10.1007/s10561-004-6403-z
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Uzarski JS, 2013, J BIOMED MATER RES A, V101, P123, DOI 10.1002/jbm.a.34308
   Vangsness CT, 2003, AM J SPORT MED, V31, P474, DOI 10.1177/03635465030310032701
   Wang YN, 2000, J BIOMECH, V33, P483, DOI 10.1016/S0021-9290(99)00194-3
   Widgerow AD, 2012, ANN PLAS SURG, V68, P574, DOI 10.1097/SAP.0b013e31824b3d1c
   Woon CYL, 2011, PLAST RECONSTR SURG, V127, P1107, DOI 10.1097/PRS.0b013e318205f298
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 56
TC 30
Z9 31
U1 2
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2015
VL 103
IS 2
BP 397
EP 406
DI 10.1002/jbm.b.33213
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ7TD
UT WOS:000348419700017
PM 24895116
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Kirsten, A
   Hausmann, A
   Weber, M
   Fischer, J
   Fischer, H
AF Kirsten, A.
   Hausmann, A.
   Weber, M.
   Fischer, J.
   Fischer, H.
TI Bioactive and Thermally Compatible Glass Coating on Zirconia Dental
   Implants
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterial(s); materials science(s); ceramics; surface coated
   materials; endosseous dental implantation; cell culture techniques
ID SURFACE-MORPHOLOGY; APATITE-FORMATION; TITANIUM IMPLANT; BONE;
   OSSEOINTEGRATION; CERAMICS; DOG
AB The healing time of zirconia implants may be reduced by the use of bioactive glass coatings. Unfortunately, existing glasses are either bioactive like Bioglass 45S5 but thermally incompatible with the zirconia substrate, or they are thermally compatible but exhibit only a very low level of bioactivity. In this study, we hypothesized that a tailored substitution of alkaline earth metals and alkaline metals in 45S5 can lead to a glass composition that is both bioactive and thermally compatible with zirconia implants. A novel glass composition was analyzed using x-ray fluorescence spectroscopy, dilatometry, differential scanning calorimetry, and heating microscopy to investigate its chemical, physical, and thermal properties. Bioactivity was tested in vitro using simulated body fluid (SBF). Smooth and microstructured glass coatings were applied using a tailored spray technique with subsequent thermal treatment. Coating adhesion was tested on implants that were inserted in bovine ribs. The cytocompatibility of the coating was analyzed using L929 mouse fibroblasts. The coefficient of thermal expansion of the novel glass was shown to be slightly lower (11.5810(-6) K-1) than that of the zirconia (11.6710(-6) K-1). After storage in SBF, the glass showed reaction layers almost identical to the bioactive glass gold standard, 45S5. A process window between 800 degrees C and 910 degrees C was found to result in densely sintered and amorphous coatings. Microstructured glass coatings on zirconia implants survived a minimum insertion torque of 60 Ncm in the in vitro experiment on bovine ribs. Proliferation and cytotoxicity of the glass coatings was comparable with the controls. The novel glass composition showed a strong adhesion to the zirconia substrate and a significant bioactive behavior in the SBF in vitro experiments. Therefore, it holds great potential to significantly reduce the healing time of zirconia dental implants.
C1 [Kirsten, A.; Hausmann, A.; Weber, M.; Fischer, H.] RWTH Aachen Univ Hosp, D-52074 Aachen, Germany.
   [Fischer, J.] Univ Basel, Inst Dent Mat & Engn, Univ Hosp Dent Med, Basel, Switzerland.
RP Fischer, H (reprint author), RWTH Aachen Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.
EM hfischer@ukaachen.de
FU VITA Zahnfabrik, Bad Sackingen, Germany
FX The authors thank Wolfgang Wilsmann and Tanja Mund from the Department
   of Glass and Ceramic Composites, Institute of Mineral Engineering, RWTH
   Aachen for their help concerning the thermal analysis of the novel
   glass. They also thank Peter Konig, Margit Kehren, and Petra Schott from
   the Department of Ceramics and Refractory Materials, Institute of
   Mineral Engineering, RWTH Aachen for their help concerning laser
   granulometry, x-ray fluorescence spectroscopy, and x-ray diffraction
   analysis. Stefan Rutten from the Electron Microscopy Facility, RWTH
   Aachen University Hospital is thanked for his help concerning SEM and
   EDS analysis. Dr. Hendrik Meyer Luckel and Dr. Marcella Esteves Oliveira
   from the Department of Operative Dentistry, Periodontology and
   Preventive Dentistry are thanked for their help concerning laser
   scanning microscopy. The authors are grateful to VITA Zahnfabrik, Bad
   Sackingen, Germany, for financial support and for providing zirconia
   dental implants for the experiments. The authors declare no potential
   conflicts of interest with respect to the authorship and/or publication
   of this article.
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Al-Noaman A, 2012, J NON-CRYST SOLIDS, V358, P3019, DOI 10.1016/j.jnoncrysol.2012.07.039
   Arstila H, 2005, KEY ENG MAT, V284-286, P925, DOI 10.4028/www.scientific.net/KEM.284-286.925
   Bloyer DR, 2007, BIOMATERIALS, V28, P4901, DOI 10.1016/j.biomaterials.2007.08.005
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bredbenner TL, 2000, ORAL SURG ORAL MED O, V90, P574, DOI 10.1067/moe.2000.111025
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   EVANS AG, 1983, OXID MET, V20, P193, DOI 10.1007/BF00656841
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Fischer J, 2007, DENT MATER J, V26, P766, DOI 10.4012/dmj.26.766
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   International Organization for Standardization (ISO), 2014, 233172014 ISO
   International Organization for Standardization (ISO), 2009, 1099320095 ISO
   International Organization for Standardization (ISO), 1997, 42871997 ISO
   Katranji A, 2007, J PERIODONTOL, V78, P874, DOI 10.1902/jop.2007.060342
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   O'Donnell MD, 2012, BIOGLASSES, P13
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Plewinski M, 2013, DENT MATER, V29, P1256, DOI 10.1016/j.dental.2013.09.016
   Priven AI, 2004, GLASS TECHNOL, V45, P244
   Salmang H., 2007, KERAMIK
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Zechner W, 2003, CLIN ORAL IMPLAN RES, V14, P150, DOI 10.1034/j.1600-0501.2003.140203.x
NR 34
TC 7
Z9 7
U1 9
U2 48
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD FEB
PY 2015
VL 94
IS 2
BP 297
EP 303
DI 10.1177/0022034514559250
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CA1BO
UT WOS:000348647900008
PM 25421839
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhao, XB
   Liu, GP
   Zheng, H
   Cao, HL
   Liu, XY
AF Zhao, Xiaobing
   Liu, Gaopeng
   Zheng, Hai
   Cao, Huiliang
   Liu, Xuanyong
TI Dose-Dependent Effects of CeO2 on Microstructure and Antibacterial
   Property of Plasma-Sprayed TiO2 Coatings for Orthopedic Application
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article
DE antibacterial property; ceria; osteoblast; plasma spray; titania
ID TITANIUM SURFACES; BIOACTIVITY; SUBSTRATE; ALLOYS; TOPOGRAPHY;
   RESPONSES; ADHESION; APATITE; ENERGY; LAYER
AB Titanium and its alloys have been used extensively for orthopedic and dental implants. Although these devices have achieved high rates of success, two major complications may be encountered: the lack of osseointegration and the biomaterial-related infection. Accordingly, cerium oxide (CeO2)-doped titanium oxide (TiO2) materials were coated on titanium by an atmospheric plasma spraying (APS) technique. The phase structures, morphologies, and surface chemical states of the obtained coatings were characterized by x-ray diffraction, scanning electron microscopy, and x-ray photoelectron spectroscopy techniques. The in vitro antibacterial and cytocompatibility of the materials were studied with Staphylococcus aureus (S. aureus, ATCC25923) and osteoblast precursor cell line MC3T3-E1. The results indicated that the addition of CeO2 shifts slightly the diffraction peaks of TiO2 matrix to low angles but does not change its rutile phase structure. In addition, the CeO2/TiO2 composite coatings possess dose-dependent corrosion resistance and antimicrobial properties. And doping of 10 wt.% CeO2 exhibits the highest activity against S. aureus, improved corrosion resistance, and competitive cytocompatibility, which argues a promising option for balancing the osteogenetic and antibacterial properties of titanium implants.
C1 [Zhao, Xiaobing; Liu, Gaopeng; Zheng, Hai] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
   [Zheng, Hai; Cao, Huiliang; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhao, XB (reprint author), Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
EM zhaoxiaobing00@163.com
RI Cao, Huiliang/V-1999-2017; Liu, Xuanyong/J-2609-2018
OI Cao, Huiliang/0000-0002-5209-4497; 
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [81271704, 31370962];
   Shanghai Science and Technology RD Fund [11JC1413700, 13441902400]
FX The authors acknowledge the joint financial support form the National
   Basic Research Program of China (973 Program, 2012CB933600), the
   National Natural Science Foundation of China (81271704 and 31370962),
   and Shanghai Science and Technology R&D Fund (11JC1413700 and
   13441902400).
CR BOND GC, 1989, FARADAY DISCUSS, V87, P65, DOI 10.1039/dc9898700065
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Dabala M, 2001, APPL SURF SCI, V172, P312, DOI 10.1016/S0169-4332(00)00873-4
   Goh YF, 2014, CERAM INT, V40, P729, DOI 10.1016/j.ceramint.2013.06.062
   Han Y, 2008, ACTA BIOMATER, V4, P1518, DOI 10.1016/j.actbio.2008.03.005
   Hassan MS, 2012, COLLOID SURFACE A, V415, P268, DOI 10.1016/j.colsurfa.2012.08.058
   Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Kang CW, 2006, SURF COAT TECH, V200, P5462, DOI 10.1016/j.surfcoat.2005.07.067
   Koutcheiko S, 2005, CERAM INT, V31, P965, DOI 10.1016/j.ceramint.2004.10.010
   Li BE, 2009, MATER CHEM PHYS, V118, P99, DOI 10.1016/j.matchemphys.2009.07.011
   Li CL, 2001, MAT SCI ENG A-STRUCT, V308, P268, DOI 10.1016/S0921-5093(00)01976-6
   Liu XY, 2008, ACTA BIOMATER, V4, P544, DOI 10.1016/j.actbio.2008.01.011
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Puchett S. D., 2010, BIOMATERIALS, V31, P706
   Singh SP, 2010, B MATER SCI, V33, P33, DOI 10.1007/s12034-010-0005-0
   Taheri S, 2014, BIOMATERIALS, V35, P4601, DOI 10.1016/j.biomaterials.2014.02.033
   Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011
   Teterin YA, 1998, J ELECTRON SPECTROSC, V88, P275, DOI 10.1016/S0368-2048(97)00139-4
   Wang GC, 2012, J MATER CHEM, V22, P19081, DOI 10.1039/c2jm34367c
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wang HY, 2014, COLLOID SURFACE B, V117, P89, DOI 10.1016/j.colsurfb.2014.02.019
   Wang HF, 2010, MATER CHEM PHYS, V124, P791, DOI 10.1016/j.matchemphys.2010.07.063
   Wang XY, 2004, THIN SOLID FILMS, V451, P37, DOI 10.1016/j.tsf.2003.10.151
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yang YC, 2007, MATER CHEM PHYS, V104, P312, DOI 10.1016/j.matchemphys.2007.03.021
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yun JH, 2012, RSC ADV, V2, P8164, DOI 10.1039/c2ra20827j
   Zhao BX, 2011, DESALINATION, V268, P55, DOI 10.1016/j.desal.2010.09.050
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao XB, 2005, J BIOMED MATER RES A, V75A, P888, DOI 10.1002/jbm.a.30485
   Zhao XB, 2013, J SOL-GEL SCI TECHN, V66, P22, DOI 10.1007/s10971-013-2961-5
   Zhou XW, 2013, SURF COAT TECH, V235, P433, DOI 10.1016/j.surfcoat.2013.07.070
   Zinelis S, 2003, J PROSTHET DENT, V90, P332, DOI 10.1016/S0022-3913(03)00493-1
NR 36
TC 5
Z9 5
U1 4
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
EI 1544-1016
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD FEB
PY 2015
VL 24
IS 3
BP 401
EP 409
DI 10.1007/s11666-014-0179-x
PG 9
WC Materials Science, Coatings & Films
SC Materials Science
GA AZ7CR
UT WOS:000348376500013
DA 2018-10-20
ER

PT J
AU O'Brien, CM
   Holmes, B
   Faucett, S
   Zhang, LG
AF O'Brien, Christopher M.
   Holmes, Benjamin
   Faucett, Scott
   Zhang, Lijie Grace
TI Three-Dimensional Printing of Nanomaterial Scaffolds for Complex Tissue
   Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; CARTILAGE REPAIR;
   OSTEOGENIC DIFFERENTIATION; BACTERIAL NANOCELLULOSE; PHOSPHATE
   SCAFFOLDS; RECENT PROGRESS; AIRWAY SPLINT; IN-VIVO; BONE
AB Three-dimensional (3D) printing has recently expanded in popularity, and become the cutting edge of tissue engineering research. A growing emphasis from clinicians on patient-specific care, coupled with an increasing knowledge of cellular and biomaterial interaction, has led researchers to explore new methods that enable the greatest possible control over the arrangement of cells and bioactive nanomaterials in defined scaffold geometries. In this light, the cutting edge technology of 3D printing also enables researchers to more effectively compose multi-material and cell-laden scaffolds with less effort. In this review, we explore the current state of 3D printing with a focus on printing of nanomaterials and their effect on various complex tissue regeneration applications.
C1 [O'Brien, Christopher M.; Holmes, Benjamin; Zhang, Lijie Grace] George Washington Univ, Sch Engn & Appl Sci, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.
   [Faucett, Scott] George Washington Univ, Dept Orthoped Surg, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Zhang, Lijie Grace] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Washington, DC 20052 USA.
RP Zhang, LG (reprint author), George Washington Univ, Sch Engn & Appl Sci, Dept Mech & Aerosp Engn, 801 22n St NW, Washington, DC 20052 USA.
EM lgzhang@gwu.edu
FU NIH from the NIH National Center for Advancing Translational Sciences
   [UL1TR000075]; George Washington Institute for Biomedical Engineering
   (GWIBE); GW Institute for Nanotechnology (GWIN)
FX This work was supported by NIH Award Number UL1TR000075 from the NIH
   National Center for Advancing Translational Sciences, by the George
   Washington Institute for Biomedical Engineering (GWIBE), and by GW
   Institute for Nanotechnology (GWIN).
CR Ahn SH, 2011, BIOMACROMOLECULES, V12, P4256, DOI 10.1021/bm201126j
   Akhavan O, 2013, J MATER CHEM B, V1, P6291, DOI 10.1039/c3tb21085e
   Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Atala A, 2011, J UROLOGY, V185, P354, DOI 10.1016/S0022-5347(11)60070-0
   Bellucci D, 2013, MAT SCI ENG C-MATER, V33, P1091, DOI 10.1016/j.msec.2012.11.038
   Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257
   Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015006
   Castro NJ, 2014, AICHE J, V60, P432, DOI 10.1002/aic.14296
   Castro NJ, 2012, ANN BIOMED ENG, V40, P1628, DOI 10.1007/s10439-012-0605-5
   Chen Jiang, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P523
   Childs A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065003
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149
   Curley J. L., 2011, JOVE-J VIS EXP, V48, pe2636
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   Duan B, 2014, ACTA BIOMATER, V10, P1836, DOI 10.1016/j.actbio.2013.12.005
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2012, J BIOMED MATER RES A, V100A, P2412, DOI 10.1002/jbm.a.34171
   Ferris CJ, 2013, BIOMATER SCI-UK, V1, P224, DOI 10.1039/c2bm00114d
   Fu LN, 2013, MAT SCI ENG C-MATER, V33, P2995, DOI 10.1016/j.msec.2013.03.026
   Fullhase C, 2009, J UROLOGY, V181, P282, DOI 10.1016/S0022-5347(09)60805-3
   Ganey T, 2011, CELL PROLIFERATION V
   Godino N, 2012, LAB CHIP, V12, P3281, DOI 10.1039/c2lc40223h
   Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116
   Halberstadt Craig, 2013, Methods Mol Biol, V1001, P279, DOI 10.1007/978-1-62703-363-3_23
   Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.tea.2014.0138, 10.1089/ten.TEA.2014.0138]
   Holmes B, 2012, TISSUE ENG PART B-RE, V18, P478, DOI [10.1089/ten.TEB.2012.0096, 10.1089/ten.teb.2012.0096]
   Holmes B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365102
   Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Im O, 2012, INT J NANOMED, V7, P2087, DOI 10.2147/IJN.S29743
   Jolly SW, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731782
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Kane R, 2013, MATER TODAY, V16, P418, DOI 10.1016/j.mattod.2013.11.001
   Kang H, 2012, J BIOMECH, V45, P2241, DOI 10.1016/j.jbiomech.2012.06.011
   Kaplan FS, 1994, AM ACAD ORTHOPAEDIC, V1, P127
   Kettner M, 2011, J FORENSIC SCI, V56, P1015, DOI 10.1111/j.1556-4029.2011.01764.x
   Kolan KCR, 2012, J MECH BEHAV BIOMED, V13, P14, DOI 10.1016/j.jmbbm.2012.04.001
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   Lu Y, 2012, METHODS MOL BIOL, V868, P289, DOI 10.1007/978-1-61779-764-4_17
   Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   Owens CM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045007
   Park SY, 2013, NANOMEDICINE-UK, V8, P715, DOI [10.2217/NNM.12.143, 10.2217/nnm.12.143]
   Pepper ME, 2009, IEEE ENG MED BIO, P6001, DOI 10.1109/IEMBS.2009.5332513
   Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5
   Pilliar RM, 2013, J BIOMED MATER RES B, V101B, P1, DOI 10.1002/jbm.b.32832
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Srouji S, 2011, TISSUE ENG PT A, V17, P269, DOI [10.1089/ten.tea.2010.0250, 10.1089/ten.TEA.2010.0250]
   Sun LL, 2012, TISSUE ENG PT A, V18, P1741, DOI [10.1089/ten.tea.2011.0456, 10.1089/ten.TEA.2011.0456]
   Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Tel-Vered R, 2012, ADV EXP MED BIOL, V733, P1, DOI 10.1007/978-94-007-2555-3_1
   Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107
   Todo M, 2013, IEEE ENG MED BIO, P409, DOI 10.1109/EMBC.2013.6609523
   Tran PA, 2009, ADV DRUG DELIVER REV, V61, P1097, DOI 10.1016/j.addr.2009.07.010
   Tran RT, 2011, BIOTECHNOL APPL BIOC, V58, P335, DOI 10.1002/bab.44
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vatankhah E, 2014, ACS APPL MATER INTER, V6, P4089, DOI 10.1021/am405673h
   Wagner DE, 2013, MAT SCI ENG C-MATER, V33, P1710, DOI 10.1016/j.msec.2012.12.084
   Wang MA, 2014, TISSUE ENG PT A, V20, P1060, DOI [10.1089/ten.tea.2013.0235, 10.1089/ten.TEA.2013.0235]
   Wang M, 2012, J NANOSCI NANOTECHNO, V12, P7692, DOI 10.1166/jnn.2012.6624
   Wang Q, 2010, J BIOMED MATER RES A, V93A, P442, DOI 10.1002/jbm.a.32562
   Williams SK, 2013, BIORESEARCH OPEN ACC, V2, P448, DOI 10.1089/biores.2013.0046
   Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625
   Xu F, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014105
   Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhang L, 2009, ADV BIOMATERIALS FUN, P205
   Zhang L, 2012, VASC PHARMACOL, V56, P280, DOI 10.1016/j.vph.2012.02.014
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang QW, 2011, BIOMATERIALS, V32, P87, DOI 10.1016/j.biomaterials.2010.08.090
   Zhang T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045010
   Zhao CY, 2013, BIOTECHNOL ADV, V31, P654, DOI 10.1016/j.biotechadv.2012.08.001
   Zhao JH, 2012, J MATER SCI-MATER M, V23, P517, DOI 10.1007/s10856-011-4468-3
   Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/NNM.14.36, 10.2217/nnm.14.36]
   Zopf DA, 2014, JAMA OTOLARYNGOL, V140, P66, DOI 10.1001/jamaoto.2013.5644
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 98
TC 37
Z9 43
U1 4
U2 117
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB 1
PY 2015
VL 21
IS 1
BP 103
EP 114
DI 10.1089/ten.teb.2014.0168
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HG
UT WOS:000349011200009
PM 25084122
OA Green Published
DA 2018-10-20
ER

PT J
AU Bernhardt, A
   Schumacher, M
   Gelinsky, M
AF Bernhardt, Anne
   Schumacher, Matthias
   Gelinsky, Michael
TI Formation of Osteoclasts on Calcium Phosphate Bone Cements and
   Polystyrene Depends on Monocyte Isolation Conditions
SO Tissue Engineering Part C-Methods
LA English
DT Article
ID BLOOD MONONUCLEAR-CELLS; DIFFERENTIATION IN-VITRO; T-LYMPHOCYTES;
   RESORPTION; COCULTURE; BIOMATERIALS; PRECURSORS; OSTEOBLAST; BEHAVIOR;
   CULTURE
AB Objectives: Peripheral blood mononuclear cells (PBMC) are an attractive source for the generation of osteoclasts in vitro, which is an important prerequisite for the examination of resorption and remodeling of biomaterials. In this study, different preparation methods are used to obtain cell populations with a rising content of CD14(+) monocytes. We wanted to address the question whether there is a correlation between content of CD14(+) cells in the preparation and functionality of formed osteoclasts.
   Materials and Methods: PBMC obtained by density gradient centrifugation with and without further purification by plastic adherence or immunomagnetic separation of CD14(+) cells were seeded on both cell culture polystyrene and a calcium phosphate bone cement (CPC) and cultivated under stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL). Cell cultures were characterized by histological and fluorescent staining of multinucleated cells that were positive for tartrate-resistant acid phosphatase (TRAP) activity and the presence of actin rings, respectively. Furthermore, activities of osteoclast marker enzymes TRAP and carbonic anhydrase II (CA II) were quantified. For osteoclasts cultured on CPC, resorption pits were visualized using scanning electron microscopy (SEM).
   Results: Monocytes of all preparations were successfully differentiated into multinucleated osteoclasts showing TRAP and CA II activity on both cell culture plastic and CPC. Preparations involving an additional plastic adherence step exhibited only a minor increase of TRAP and CA II activity in the second week of cultivation. Furthermore, the number of resorption pits on CPC was reduced in these cultures compared with immunomagnetically enriched monocytes and preparations without additional plastic adherence steps. Optimal results with regard to yield, number of multinucleated osteoclasts, activity of TRAP and CA II, and resorption of CPC were obtained by simple density gradient centrifugation.
   Conclusion: All examined monocyte preparation protocols were suitable for the generation of osteoclasts on both polystyrene and CPC. Highly purified monocytes are not mandatory to obtain functional osteoclasts for investigation of biomaterial resorption.
C1 [Bernhardt, Anne; Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp, Ctr Translat Bone Joint & Soft Tissue Res, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany.
RP Bernhardt, A (reprint author), Tech Univ Dresden, Univ Hosp, Ctr Translat Bone Joint & Soft Tissue Res, Med Fac Carl Gustav Carus, Fetscher Str 74, D-01307 Dresden, Germany.
EM anne.bernhardt@tu-dresden.de
RI Bernhardt, Anne/O-1242-2015; Schumacher, Matthias/I-1530-2013
OI Bernhardt, Anne/0000-0002-1903-1929; Schumacher,
   Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121
FU DFG [SFB/TR79]
FX The authors wish to thank Hella Luksch (Pediatric Clinic of the
   University Hospital Dresden) and Angela Jacobi for FACS measurements.
   They are grateful to InnoTERE GmbH (Radebeul, Germany) for providing CPC
   precursor powder and acknowledge the technical assistance of Sophie
   Brueggemeier, Anna Rumiantseva, and Kristin Faulwasser and the financial
   support rendered by DFG (SFB/TR79).
CR Alatalo SL, 2000, CLIN CHEM, V46, P1751
   BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236
   Bernhardt A, 2010, J BIOMED MATER RES A, V95A, P848, DOI 10.1002/jbm.a.32856
   Botelho C. M., 2006, J BIOMED MATER RES, V78, P708
   Costa-Rodrigues J, 2011, CELL PROLIFERAT, V44, P410, DOI 10.1111/j.1365-2184.2011.00768.x
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014
   Detsch R, 2010, ACTA BIOMATER, V6, P3223, DOI 10.1016/j.actbio.2010.03.003
   Detsch R, 2014, J TISSUE ENG REGEN M, V2014, DOI [10.1002/term.1851, DOI 10.1002/TERM.1851]
   Driessens F. C. M, 1996, BIOCERAMICS, V9, P231
   Gillespie MT, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2141
   Hayden RS, 2014, BIOMATERIALS, V35, P3794, DOI 10.1016/j.biomaterials.2014.01.034
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788
   Jones G. L., 2011, CELL MAT, V21, P80
   Keller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046757
   Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046
   Lehenkari P, 1998, EXP CELL RES, V242, P128, DOI 10.1006/excr.1998.4071
   Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586
   Nakagawa K, 2004, TISSUE ENG, V10, P93, DOI 10.1089/107632704322791736
   Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355
   Panzavolta S, 2010, J INORG BIOCHEM, V104, P1099, DOI 10.1016/j.jinorgbio.2010.06.008
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535
   Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X
   Rochet N, 2009, BIOMATERIALS, V30, P4260, DOI 10.1016/j.biomaterials.2009.04.044
   Rousselle AV, 2002, BONE, V30, P533, DOI 10.1016/S8756-3282(02)00672-5
   Rumpler M, 2013, CALCIFIED TISSUE INT, V93, P526, DOI 10.1007/s00223-013-9786-7
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027
   Seager DJ, 2004, J IMMUNOL METHODS, V288, P123
   Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x
   Sinclair SSK, 2011, J BIOMAT SCI-POLYM E, V22, P789, DOI 10.1163/092050610X496260
   Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P1020, DOI 10.1002/art.24413
   Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020
   Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11
NR 37
TC 9
Z9 9
U1 0
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 160
EP 170
DI 10.1089/ten.tec.2014.0187
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400006
PM 24919531
DA 2018-10-20
ER

PT J
AU Neo, PY
   Tan, DJA
   Shi, PJ
   Toh, SL
   Goh, JCH
AF Neo, Puay Yong
   Tan, Daryl Jian-An
   Shi, Pujiang
   Toh, Siew Lok
   Goh, James Cho-Hong
TI Enhancing Analysis of Cells and Proteins by Fluorescence Imaging on
   Silk-Based Biomaterials: Modulating the Autofluorescence of Silk
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID SUDAN BLACK-B; DRUG-DELIVERY; FIBROIN; TISSUE; HISTOCHEMISTRY;
   REDUCTION; ADHESION; SERICIN; IMMUNOFLUORESCENCE; FIBRONECTIN
AB Silk is a versatile and established biomaterial for various tissue engineering purposes. However, it also exhibits strong autofluorescence signals-thereby hindering fluorescence imaging analysis of cells and proteins on silk-derived biomaterials. Sudan Black B (SB) is a lysochrome dye commonly used to stain lipids in histology. It has also been reported to be able to quench autofluorescence of tissues in histology and has been tested on artificial biomedical polymers in recent years. It was hypothesized that SB would exert similar quenching effects on silk, modulating the autofluorescence signals, and thereby enabling improved imaging analysis of cells and molecules of interests. The quenching effect of SB on the intrinsic fluorescence properties of silk and on commercial fluorescent dyes were first investigated in this study. SB was then incorporated into typical fluorescence-based staining protocols to study its effectiveness in improving fluorescence-based imaging of the cells and proteins residing with the silk-based biomaterials. Silk processed into various forms of biomaterials (e.g., films, sponges, fibers, and electrospun mats) was seeded with cells and cultured in vitro. At sacrificial time points, specimens were harvested, fixed, and prepared for fluorescence staining. SB, available commercially as a powder, was dissolved in 70% ethanol (0.3% [w/v]) to form staining solutions. SB treatment was introduced at the last step of typical immunofluorescence staining protocols for 15-120 min. For actin staining protocols by phalloidin toxin, SB staining solutions were added before and after permeabilization with Triton-X for 15-30 min. Results showed that ideal SB treatment duration is about 15 min. Apart from being able to suppress the autofluorescence of silk, this treatment duration was also not too long to adversely affect the fluorescent labeling probes used. The relative improvement brought about by SB treatment was most evident in the blue and green emission wavelengths compared with the red emission wavelength. This study has showed that the use of SB is a cost and time effective approach to enhance fluorescence-based imaging analyses of cell-seeded silk biomaterials, which otherwise would have been hindered by the unmodulated autofluorescence signals.
C1 [Neo, Puay Yong; Tan, Daryl Jian-An; Shi, Pujiang; Toh, Siew Lok; Goh, James Cho-Hong] Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Singapore 117575, Singapore.
   [Shi, Pujiang] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Toh, Siew Lok] Natl Univ Singapore, Dept Mech Engn, Fac Engn, Singapore 117575, Singapore.
   [Goh, James Cho-Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117575, Singapore.
RP Goh, JCH (reprint author), Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Block EA,03-12 9 Engn Dr 1, Singapore 117575, Singapore.
EM biehead@nus.edu.sg
RI Shi, Pujiang/P-7482-2017
OI Shi, Pujiang/0000-0002-8051-6773
FU Biomedical Research Council; Singapore National Research Foundation
FX This research was supported, in part, by the Biomedical Research Council
   and the Singapore National Research Foundation under its Cooperative
   Basic Research Grant and administered by the Singapore Ministry of
   Health's National Medical Research Council.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   Chiu YC, 2012, J FLUORESC, V22, P907, DOI 10.1007/s10895-011-1029-6
   Clarke RJ, 2004, J CHEM EDUC, V81, P705, DOI 10.1021/ed081p705
   Coleman R, 2000, ACTA HISTOCHEM, V102, P5, DOI 10.1078/0065-1281-00542
   COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396
   FREDERIKS W M, 1977, Histochemistry, V54, P27
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   HIGH OBB, 1981, ACTA HISTOCHEM, P247
   Jaafar IH, 2011, ACTA BIOMATER, V7, P1588, DOI 10.1016/j.actbio.2010.12.007
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Lakowicz J. R., 2007, PRINCIPLES FLUORESCE
   Lu B, 2010, LAB CHIP, V10, P1826, DOI 10.1039/b924855b
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   Mosiman VL, 1997, CYTOMETRY, V30, P151
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Neo PY, 2016, J TISSUE ENG REGEN M, V10, P564, DOI 10.1002/term.1776
   Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315
   Oliveira VC, 2010, HISTOL HISTOPATHOL, V25, P1017, DOI 10.14670/HH-25.1017
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692
   Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601
   Shadpour H, 2006, J CHROMATOGR A, V1111, P238, DOI 10.1016/j.chroma.2005.08.083
   Teh TKH, 2011, TISSUE ENG PART C-ME, V17, P687, DOI 10.1089/ten.tec.2010.0513
   Teuschl AH, 2014, TISSUE ENG PART C-ME, V20, P431, DOI [10.1089/ten.tec.2013.0278, 10.1089/ten.TEC.2013.0278]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Viegas MS, 2007, EUR J HISTOCHEM, V51, P59
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zaoming W., 1995, J INVEST ALLERG CLIN, V6, P237
NR 40
TC 2
Z9 2
U1 3
U2 31
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 218
EP 228
DI 10.1089/ten.tec.2014.0209
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400011
PM 25050876
DA 2018-10-20
ER

PT J
AU Zahn, G
   Schulze, HA
   Lippke, J
   Konig, S
   Sazama, U
   Froba, M
   Behrens, P
AF Zahn, Gesa
   Schulze, Hendrik Albert
   Lippke, Jann
   Koenig, Sandra
   Sazama, Uta
   Froeba, Michael
   Behrens, Peter
TI A water-born Zr-based porous coordination polymer: Modulated synthesis
   of Zr-fumarate MOF
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE Metal-organic frameworks; Water-based synthesis; Microporous materials;
   Modulation approach; Zr-fumarate MOF
ID METAL-ORGANIC FRAMEWORKS; DETERMINING SURFACE-AREAS; NEUTRON-SCATTERING;
   BET METHOD; DIFFRACTION; ADSORPTION; STABILITY; HYDROGEN; SORPTION;
   SITES
AB In this work, we present the water-based synthesis of the Zr-fumarate MOF (Zr-film MOF) by applying a monocarboxylic acid as modulator. The original synthesis of Zr-fum MOF was performed in a DMF-based batch at 120 degrees C. The product showed exceptional stability against aqueous solutions. Thus, a water-based synthesis seemed to be promising. Indeed, by adding various amounts of formic acid, acetic acid or propionic acid as modulator, respectively, highly crystalline Zr-film MOF can be obtained from water at 120 degrees C. The investigation of the influence of modulating molecules with different alkyl chain lengths showed that the particle size decreases when monocarboxylic acids with longer alkyl chains are used, e.g. acetic acid and propionic acid in comparison to formic acid. For the formation of the Zr-fum MOF synthesised with formic acid as modulator, the thermogravimetric and sorption behaviour as well as the stability against various solvents and pH values is discussed in detail. Furthermore, the Zr-turn MOF can also be obtained under very benign reaction conditions at room temperature from water, making this material interesting for various applications, for example as a biomaterial. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zahn, Gesa; Schulze, Hendrik Albert; Lippke, Jann; Behrens, Peter] Leibniz Univ Hannover, Inst Anorgan Chem, D-30167 Hannover, Germany.
   [Zahn, Gesa; Schulze, Hendrik Albert; Lippke, Jann; Behrens, Peter] ZFM Ctr Solid State Chem & New Mat, Hannover, Germany.
   [Koenig, Sandra; Sazama, Uta; Froeba, Michael] Univ Hamburg, Inst Anorgan & Angew Chem, D-20146 Hamburg, Germany.
RP Behrens, P (reprint author), Leibniz Univ Hannover, Inst Anorgan Chem, Callinstr 9, D-30167 Hannover, Germany.
EM Peter.Behrens@acb.uni-hannover.de
FU DFG priority program [1362]
FX This work was performed within the DFG priority program 1362 (Porous
   Metal organic Frameworks). The authors like to thank Georg Platz and
   Natalja Wendt for performing the argon sorption measurements.
CR Bae YS, 2010, LANGMUIR, V26, P5475, DOI 10.1021/la100449z
   Bauer S, 2008, INORG CHEM, V47, P7568, DOI 10.1021/ic800538r
   Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953
   Cravillon J, 2012, CRYSTENGCOMM, V14, P492, DOI 10.1039/c1ce06002c
   DeCoste JB, 2013, J MATER CHEM A, V1, P5642, DOI 10.1039/c3ta10662d
   Diring S, 2010, CHEM MATER, V22, P4531, DOI 10.1021/cm101778g
   Furukawa H, 2014, J AM CHEM SOC, V136, P4369, DOI 10.1021/ja500330a
   Gaab M, 2012, MICROPOR MESOPOR MAT, V157, P131, DOI 10.1016/j.micromeso.2011.08.016
   Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT260B, 10.1038/NMAT2608, 10.1038/nmat2608]
   Jhung SH, 2007, ADV MATER, V19, P121, DOI 10.1002/adma.200601604
   Kandiah M, 2010, CHEM MATER, V22, P6632, DOI 10.1021/cm102601v
   Loiseau T, 2005, CR CHIM, V8, P765, DOI 10.1016/j.crci.2004.10.011
   Peterson VK, 2006, J AM CHEM SOC, V128, P15578, DOI 10.1021/ja0660857
   Rowsell JLC, 2005, J AM CHEM SOC, V127, P14904, DOI 10.1021/ja0542690
   Schaate A, 2012, EUR J INORG CHEM, P790, DOI 10.1002/ejic.201101151
   Schaate A, 2011, CHEM-EUR J, V17, P9320, DOI 10.1002/chem.201101015
   Schaate A, 2011, CHEM-EUR J, V17, P6643, DOI 10.1002/chem.201003211
   Schmitz B, 2008, CHEMPHYSCHEM, V9, P2181, DOI 10.1002/cphc.200800463
   Senkovska I, 2009, MICROPOR MESOPOR MAT, V122, P93, DOI 10.1016/j.micromeso.2009.02.020
   Southon PD, 2002, CHEM MATER, V14, P4313, DOI 10.1021/cm0211913
   Sumida K, 2011, J PHYS CHEM C, V115, P8414, DOI 10.1021/jp200638n
   Tsuruoka T, 2009, ANGEW CHEM INT EDIT, V48, P4739, DOI 10.1002/anie.200901177
   Valenzano L, 2011, CHEM MATER, V23, P1700, DOI 10.1021/cm1022882
   Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k
   Wilssmann G., 2012, MICROPOR MESOPOR MAT, V152, P64
   Zahn G, 2014, CRYSTENGCOMM, V16, P9198, DOI 10.1039/c4ce01095g
NR 26
TC 31
Z9 32
U1 12
U2 103
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
EI 1873-3093
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD FEB
PY 2015
VL 203
BP 186
EP 194
DI 10.1016/j.micromeso.2014.10.034
PG 9
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AY5DI
UT WOS:000347593000022
DA 2018-10-20
ER

PT J
AU Ho, YH
   Vora, HD
   Dahotre, NB
AF Ho, Yee-Hsien
   Vora, Hitesh D.
   Dahotre, Narendra B.
TI Laser surface modification of AZ31B Mg alloy for bio-wettability
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Laser surface modification; bio-implant; bio-wettability; grain
   refinement; contact-angle measurement; surface energy
ID IN-VITRO DEGRADATION; MAGNESIUM ALLOYS; CORROSION-RESISTANCE; TITANIUM
   SURFACES; BODY-FLUID; AZ91D; MICROSTRUCTURE; BIOMATERIAL; BEHAVIOR;
   ALUMINA
AB Magnesium alloys are the potential degradable materials for load-bearing implant application due to their comparable mechanical properties to human bone, excellent bioactivity, and invivo non-toxicity. However, for a successful load-bearing implant, the surface of bio-implant must allow protein absorption and layer formation under physiological environment that can assist the cell/osteoblast growth. In this regard, surface wettability of bio-implant plays a key role to dictate the quantity of protein absorption. In light of this, the main objective of the present study was to produce favorable bio-wettability condition of AZ31B Mg alloy bio-implant surface via laser surface modification technique under various laser processing conditions. In the present efforts, the influence of laser surface modification on AZ31B Mg alloy surface on resultant bio-wettability was investigated via contact-angle measurements and the co-relationships among microstructure (grain size), surface roughness, surface energy, and surface chemical composition were established. In addition, the laser surface modification technique was simulated by computational (thermal) model to facilitate the prediction of temperature and its resultant cooling/solidification rates under various laser processing conditions for correlating with their corresponding composition and phase evolution. These predicted thermal properties were later used to correlate with the corresponding microstructure, chemical composition, and phase evolution via experimental analyses (X-ray diffractometer, scanning electron microscope, energy-dispersive spectroscopy).
C1 [Ho, Yee-Hsien; Vora, Hitesh D.; Dahotre, Narendra B.] Univ N Texas, Dept Mat Sci & Engn, Lab Laser Aided Addit & Subtract Mfg, Denton, TX 76203 USA.
RP Dahotre, NB (reprint author), Univ N Texas, Dept Mat Sci & Engn, Lab Laser Aided Addit & Subtract Mfg, 1155 Union Circle 305310, Denton, TX 76203 USA.
EM Narendra.Dahotre@unt.edu
CR Abbas G, 2006, WEAR, V260, P175, DOI 10.1016/j.wear.2005.01.036
   [Anonymous], 1999, ASM INT HDB COMMITTE, P27
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bargir S, 2009, APPL SURF SCI, V255, P4873, DOI 10.1016/j.apsusc.2008.12.017
   Calin M, 2013, MAT SCI ENG C-MATER, V33, P875, DOI 10.1016/j.msec.2012.11.015
   Cheng YL, 2009, T NONFERR METAL SOC, V19, P517, DOI 10.1016/S1003-6326(08)60305-2
   Dahotre SN, 2014, ANN BIOMED ENG, V42, P50, DOI 10.1007/s10439-013-0898-z
   Dahotre SN, 2013, APPL SURF SCI, V271, P141, DOI 10.1016/j.apsusc.2013.01.151
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Gross S, 2001, J BIOMECH, V34, P995, DOI 10.1016/S0021-9290(01)00072-0
   Guan YC, 2009, SURF REV LETT, V16, P801, DOI 10.1142/S0218625X09013347
   Guan YC, 2009, APPL SURF SCI, V255, P8235, DOI 10.1016/j.apsusc.2009.05.055
   Guan YC, 2009, J APPL ELECTROCHEM, V39, P1457, DOI 10.1007/s10800-009-9825-2
   Guangling Song SS, 2007, ADV ENG MATER, V9, P298
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Haase K, 2013, COMPUT BIOL MED, V43, P1748, DOI 10.1016/j.compbiomed.2013.07.032
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kannatey-Asibu E., 2009, PRINCIPLES LASER MAT
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Kurella AK, 2008, MAT SCI ENG C-BIO S, V28, P1560, DOI 10.1016/j.msec.2008.04.015
   Lin Z, 2013, SURF COAT TECH, V228, pS131, DOI 10.1016/j.surfcoat.2012.07.007
   Luckey TD, 1977, METAL TOXICITY MAMMA
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Moncayo MA, 2013, CERAM INT, V39, P6207, DOI 10.1016/j.ceramint.2013.01.040
   Moncayo MA, 2013, OPT LASER TECHNOL, V48, P570, DOI 10.1016/j.optlastec.2012.11.019
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Ng CC, 2011, APPL SURF SCI, V257, P7447, DOI 10.1016/j.apsusc.2011.03.004
   Paital SR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025001
   Paital SR, 2009, ACTA BIOMATER, V5, P2763, DOI 10.1016/j.actbio.2009.03.004
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park JW, 2009, ACTA BIOMATER, V5, P2311, DOI 10.1016/j.actbio.2009.02.026
   Park JH, 2012, BIOMATERIALS, V33, P7386, DOI 10.1016/j.biomaterials.2012.06.066
   Ren L, 2013, J MATER SCI TECHNOL, V29, P1005, DOI 10.1016/j.jmst.2013.09.008
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069
   Santhanakrishnan S, 2012, MATER TECHNOL, V27, P273, DOI 10.1179/1753555712Y.0000000022
   Sealy MP, 2010, J MECH BEHAV BIOMED, V3, P488, DOI 10.1016/j.jmbbm.2010.05.003
   Sealy MP, 2011, J MED DEVICES T ASME, V5
   Shtansky DV, 2012, SURF COAT TECH, V208, P14, DOI 10.1016/j.surfcoat.2012.07.008
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sunil BR, 2014, MAT SCI ENG C-MATER, V39, P315, DOI 10.1016/j.msec.2014.03.004
   Sunil BR, 2013, MAT SCI ENG C-MATER, V33, P1607, DOI 10.1016/j.msec.2012.12.095
   Taltavull C, 2014, MATER DESIGN, V57, P40, DOI 10.1016/j.matdes.2013.12.069
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vora HD, 2013, MAT SCI TECHNOL, P1
   Vora HD, 2014, J MECH BEHAV BIOMED, V37, P153, DOI 10.1016/j.jmbbm.2014.05.017
   Vora HD, 2013, ADV MATER PROCESS, V171, P45
   Vora HD, 2013, INT J PRECIS ENG MAN, V14, P1421, DOI 10.1007/s12541-013-0192-x
   Vora HD, 2013, J ALLOY COMPD, V570, P133, DOI 10.1016/j.jallcom.2013.03.115
   Vora HD, 2012, J EUR CERAM SOC, V32, P4205, DOI 10.1016/j.jeurceramsoc.2012.06.015
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xiao DM, 2012, T NONFERR METAL SOC, V22, P2554, DOI 10.1016/S1003-6326(11)61500-8
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Zhou DW, 2007, MATER SCI-POLAND, V25, P145
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
NR 57
TC 12
Z9 13
U1 5
U2 56
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 915
EP 928
DI 10.1177/0885328214551156
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300001
PM 25201909
OA Green Published
DA 2018-10-20
ER

PT J
AU Ferreira, LB
   Bradaschia-Correa, V
   Moreira, MM
   Marques, NDM
   Arana-Chavez, VE
AF Ferreira, Lorraine B.
   Bradaschia-Correa, Vivian
   Moreira, Mariana M.
   Marques, Natasha D. M.
   Arana-Chavez, Victor E.
TI Evaluation of bone repair of critical size defects treated with
   simvastatin-loaded poly(lactic-co-glycolic acid) microspheres in rat
   calvaria
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Bone regeneration; osteoconduction; osteoinduction; PLGA; simvastatin
ID IN-VITRO DEGRADATION; FRACTURE; STATINS; DELIVERY; BIOCOMPATIBILITY;
   OSTEOADHERIN; REGENERATION; OSTEOBLASTS; SCAFFOLD; GROWTH
AB Purpose Statins are hypolipemiant drugs with osteoinductive effect. We evaluated the potential of simvastatin loaded into poly(lactic-co-glycolic acid) (PLGA) microspheres to heal critical size defects in rat calvaria.
   Methods PLGA scaffolds (50:50 ratio) were synthesized as pure membranes or as microspheres loaded with 2.5% simvastatin. Critical size defects (5-mm diameter) were created in the parietal bone of 3-month-old male Wistar rats; they were either left filled with blood clot (C group), covered with a PLGA membrane (M group) or with PLGA microspheres loaded with simvastatin (MSI group) or not (MM group), and then covered with the PLGA membrane. The defects were evaluated after 30 or 60 days by light and electron microscopy, immunohistochemistry for osteopontin (OPN), bone sialoprotein (BSP) and osteoadherin (OSAD), and immunocytochemistry for OPN.
   Results Scanning electron microscopy showed that the calvarial defects treated with MSI were almost completely healed after 60 days, while groups M and C presented less bone formation, whereas the bone matrix formed into the defects of MSI group was more organized and mature. The immunolabeling for OPN and BSP on the matrix in groups C and M showed typical areas of primary bone unlike the MSI that presented weak labeling at the formed area. In the MSI group, there was an intense immunostaining for OSAD in osteoid, as well as in osteocyte cytoplasm. The immunocytochemistry showed intense labeling for OPN with homogeneous distribution in the interfibrillar spaces in all groups after 30 days and after 60 days; however, while C and M groups exhibited similar aspect, the MSI specimens showed weak labeling. The ultrastructural evaluation showed the interaction between the biomaterial and the surrounding tissue where some cells established intimate contact with microspheres.
   Conclusions The repair of critical size bone defects was accelerated and enhanced by the implantation of simvastatin-loaded PLGA microspheres.
C1 [Ferreira, Lorraine B.; Bradaschia-Correa, Vivian; Moreira, Mariana M.; Marques, Natasha D. M.; Arana-Chavez, Victor E.] Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, BR-05508900 Sao Paulo, Brazil.
RP Arana-Chavez, VE (reprint author), Univ Sao Paulo, Sch Dent, Dept Biomat & Oral Biol, Ave Prof Lineu Prestes 2227, BR-05508900 Sao Paulo, Brazil.
EM vearana@usp.br
FU CAPES/Brazil; CNPq; FAPESP, Brazil
FX This study was supported by CAPES/Brazil and partially supported by CNPq
   and FAPESP, Brazil.
CR Adeeb N, 2012, CHILD NERV SYST, V28, P827, DOI 10.1007/s00381-012-1744-6
   Arana-Chavez VE, 2001, J HISTOCHEM CYTOCHEM, V49, P1099, DOI 10.1177/002215540104900904
   ARANACHAVEZ VE, 1995, ARCH HISTOL CYTOL, V58, P285, DOI 10.1679/aohc.58.285
   Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78
   Brown J. L., 2013, BIOMATERIALS SCI INT, P1194
   Cameron JA, 2013, CURR TOP MICROBIOL, V367, P113, DOI 10.1007/82_2012_291
   Chang PC, 2012, J BIOMED MATER RES A, V100A, P2970, DOI 10.1002/jbm.a.34244
   Couble ML, 2004, HISTOCHEM CELL BIOL, V121, P47, DOI 10.1007/s00418-003-0608-2
   Davignon J, 1999, CURR OPIN LIPIDOL, V10, P543, DOI 10.1097/00041433-199912000-00010
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Imbronito AV, 2005, J BIOMED MATER RES A, V74A, P215, DOI 10.1002/jbm.a.30350
   Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Maciel-Oliveira N, 2011, ORAL SURG ORAL MED O, V112, P170, DOI 10.1016/j.tripleo.2010.08.027
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Massa LF, 2000, EUR J ORAL SCI, V108, P74, DOI 10.1034/j.1600-0722.2000.00753.x
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nath SD, 2014, J BIOMATER APPL, V28, P1151, DOI 10.1177/0885328213499272
   Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F
   Oxlund H, 2004, BONE, V34, P609, DOI 10.1016/j.bone.2003.12.014
   Pietro L, 2008, J MATER SCI-MATER M, V19, P1069, DOI 10.1007/s10856-007-3017-6
   Ramstad VE, 2003, CALCIFIED TISSUE INT, V72, P57, DOI 10.1007/s00223-002-2047-6
   Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y
   Scaglione S, 2010, J TISSUE ENG REGEN M, V4, P505, DOI 10.1002/term.265
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Skoglund B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-98
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861
   Tai IC, 2013, INT J NANOMED, V8, P3895, DOI 10.2147/IJN.S48694
NR 33
TC 7
Z9 7
U1 0
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 965
EP 976
DI 10.1177/0885328214550897
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300005
PM 25209881
DA 2018-10-20
ER

PT J
AU Son, SR
   Sarkar, SK
   Linh, NTB
   Padalhin, AR
   Kim, BR
   Jung, HI
   Lee, BT
AF Son, So-Ra
   Sarkar, Swapan Kumar
   Linh, Nguyen-Thuy Ba
   Padalhin, Andrew R.
   Kim, Bo Ram
   Jung, Hae Il
   Lee, Byong-Taek
TI Platelet-rich plasma encapsulation in hyaluronic acid/gelatin-BCP
   hydrogel for growth factor delivery in BCP sponge scaffold for bone
   regeneration
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Hyaluronic acid; gelatin; biphasic calcium phosphate; platelet-rich
   plasma; bone substitutes
ID CALCIUM-PHOSPHATE CERAMICS; RAT ECTOPIC MODEL; IN-VITRO; BIOMATERIAL
   CARRIERS; SUSTAINED DELIVERY; FACTOR-BB; COMBINATION; SURGERY; RELEASE;
   REPAIR
AB Microporous calcium phosphate based synthetic bone substitutes are used for bone defect healing. Different growth factor loading has been investigated for enhanced bone regeneration. The platelet is a cellular component of blood which naturally contains a pool of necessary growth factors that mediate initiation, continuation, and completion of cellular mechanism of healing. In this work, we have investigated the encapsulation and immobilization of platelet-rich plasma (PRP) with natural polymers like hyaluronic acid (HA) and gelatin (Gel) and loading them in a biphasic calcium phosphate (BCP) scaffold, for a synthetic-allologous hybrid scaffold. Effect of PRP addition in small doses was evaluated for osteogenic potential invitro and invivo. BCP (10%) mixed HA-Gel hydrogel with or without PRP, was loaded into a BCP sponge scaffold. We investigated the hydrogel-induced improvement in mechanical property and PRP-mediated enhancement in biocompatibility. Invitro studies for cytotoxicity, cell attachment, and proliferation were carried out using MC3T3-E1 pre-osteoblast cells. In invitro studies, the cell count, cell proliferation, and cell survival were higher in the scaffold with PRP loading than without PRP. However, in the invivo studies using a rat model, the PRP scaffold was not superior to the scaffold without PRP. This discrepancy was investigated in terms of the interaction of PRP in the invivo environment.
C1 [Son, So-Ra; Padalhin, Andrew R.; Kim, Bo Ram; Lee, Byong-Taek] Dept Regenerat Med, Ssangyong Dong, Chungnam, South Korea.
   [Sarkar, Swapan Kumar; Linh, Nguyen-Thuy Ba; Lee, Byong-Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Ssangyong Dong, Chungnam, South Korea.
   [Jung, Hae Il] Soonchunhyang Univ, Cheonan Hosp, Dept Surg, Cheonan, South Korea.
RP Lee, BT (reprint author), Dept Regenerat Med, Cheonan 330090, Chungnam, South Korea.
EM lbt@sch.ac.kr
FU Korea Health Technology R & D project, Ministry of Health & Welfare,
   Republic of Korea [A111084]; Soonchunhyang University research fund
FX This work was supported by a grant of the Korea Health Technology R & D
   project, Ministry of Health & Welfare, Republic of Korea (A111084). The
   work was partially supported by the Soonchunhyang University research
   fund.
CR [Anonymous], 2010, Hydrogel and biomedical applications thereof US 20100021544, A1 Xavier Bourges, Serge Baroth, Patent No. 20100021544
   Aspenberg P, 2011, ACTA ORTHOP, V82, P511, DOI 10.3109/17453674.2011.623576
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Blumenfeld I, 2002, EXP GERONTOL, V37, P553, DOI 10.1016/S0531-5565(01)00215-7
   Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x
   Castellani C, 2009, CLIN ORAL IMPLAN RES, V20, P1367, DOI 10.1111/j.1600-0501.2009.01760.x
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 2004, KEY ENG MAT, V254-2, P1005, DOI 10.4028/www.scientific.net/KEM.254-256.1005
   Daculsi G, 2013, IRBM, V34, P346, DOI 10.1016/j.irbm.2013.07.001
   De Biase P, 2005, INJURY, V36, P43, DOI 10.1016/j.injury.2005.07.034
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dorhozin S, 2012, ACTA BIOMATER, V8, P963
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Frechette JP, 2005, J DENT RES, V84, P434, DOI 10.1177/154405910508400507
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Guehennec LL, 2004, EUR CELLS MATER, V8, P1
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   KIURU J, 1991, LIFE SCI, V49, P1997, DOI 10.1016/0024-3205(91)90642-O
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Gimeno FL, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-18
   Malizos KN, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.07.030
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nguyen LTB, TISSUE ENG PART A, DOI [10.1089/ten.tea.2013.0352, DOI 10.1089/TEN.TEA.2013.0352.]
   NIHOUANNEN DL, 2006, BIOMATERIALS, V27, P2716
   Park MS, 2006, J BIOMED MATER RES B, V79B, P353, DOI 10.1002/jbm.b.30549
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027
   Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Ranly DM, 2005, J BONE JOINT SURG AM, V87A, P2052, DOI 10.2106/JBJS.D.02752
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6
   Saffarzadeh A, 2009, CLIN ORAL IMPLAN RES, V20, P1133, DOI 10.1111/j.1600-0501.2009.01738.x
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 57
TC 13
Z9 14
U1 4
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2015
VL 29
IS 7
BP 988
EP 1002
DI 10.1177/0885328214551373
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AZ0YH
UT WOS:000347967300007
PM 25234121
DA 2018-10-20
ER

PT J
AU Zhang, QB
   Shan, GH
   Cao, P
   He, J
   Lin, ZS
   Huang, YX
   Ao, NJ
AF Zhang, Quanbin
   Shan, Guanghua
   Cao, Ping
   He, Jia
   Lin, Zhongshi
   Huang, Yaoxiong
   Ao, Ningjian
TI Mechanical and biological properties of oxidized horn keratin
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Horn keratin; Protein oxidation; Mechanical properties;
   Biocompatibility; Biomaterial
ID TRANSFORM INFRARED-SPECTROSCOPY; HYDROGEN-PEROXIDE TREATMENT;
   FOREIGN-BODY REACTION; BLOOD COMPATIBILITY; SECONDARY STRUCTURE; SILK
   FIBROIN; FORMIC-ACID; WOOL FIBERS; HEMOCOMPATIBILITY; HEPARIN
AB The goal of this study was to investigate the mechanical and biological properties of oxidized keratin materials, which were obtained by using buffalo horns to oxidize. It could provide a way to evaluate their potential for clinical translatability. The characterization on their composition, mechanical properties, and biological responses was performed. It is found that the oxidation process could lead the disulfide bond to break down and then to form sulfonic acid, or even make partial peptide chain to be fragment for the new modification of amino acid. Hence the oxidized horn keratins have lower thermal stability and hydrolytic stability in comparison with horn keratin, but the degradation products of oxidized horn keratins have no significant difference. In addition, the mechanical properties of oxidized horn keratins are poorer than that of horn keratin, but the oxidized horn keratins still have disulfide bonds to form a three-dimensional structure, which benefits for their mechanical properties. The fracture toughness of oxidized horn keratins increases with the increase in the degree of oxidation. After oxidation, the oxidized horn keratins have lower cytotoxicity and lower hemolysis ratio. Moreover, when the oxidized horn keratins, as well as different concentration of degradation products of oxidized horn keratins, are directly in contact with platelet-rich plasma, platelets are not activated. It suggests that the oxidized horn keratins have good hemocompatibility, without triggering blood thrombosis. The implantation experiment in vivo also demonstrates that the oxidized horn keratins are compatible with the tissue, because there are minimal fibrous capsule and less of infiltration of host cells, without causing serious inflammation. In summary, the oxidized horn keratins can act as implanted biomaterigdevices that are directly in contact with blood and tissue. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Quanbin; Huang, Yaoxiong; Ao, Ningjian] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Shan, Guanghua] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.
   [Cao, Ping; He, Jia; Lin, Zhongshi] Shenzhen Testing Ctr Med Devices, Shenzhen 518057, Peoples R China.
RP Ao, NJ (reprint author), Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM taonj@jnu.edu.cn
FU National Natural Science Foundation of China [20976068/B060805]; Science
   and Technology Program of Guangdong Province [268017]
FX This work has been financially supported by the National Natural Science
   Foundation of China (Grant No. 20976068/B060805) and the Science and
   Technology Program of Guangdong Province (No. 268017). In addition, the
   authors would like to thank Shenzhen Testing Center of Medical Devices,
   China. They would also like to thank Yuan Tian, coming from Biomedical
   Engineering of Jinan University.
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barone JR, 2005, J APPL POLYM SCI, V97, P1644, DOI 10.1002/app.21901
   Brady P.R, 1997, FINISHING WOOL FABRI
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   Callister WD, 2007, MAT SCI ENG INTRO
   Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001
   COHEN J, 1959, J BONE JOINT SURG AM, V41, P152, DOI 10.2106/00004623-195941010-00018
   Douglas JE, 1996, J EXP BIOL, V199, P1829
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   Edwards HGM, 1998, SPECTROCHIM ACTA A, V54, P745, DOI 10.1016/S1386-1425(98)00013-4
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   FEUGHELMAN M, 1971, TEXT RES J, V41, P469, DOI 10.1177/004051757104100601
   Franck A, 2006, BIOSYST ENG, V93, P459, DOI 10.1016/j.biosystemseng.2006.01.007
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Gama RM, 2011, J THERM ANAL CALORIM, V106, P399
   GIROUD A, 1951, ANN NY ACAD SCI, V53, P613, DOI 10.1111/j.1749-6632.1951.tb31963.x
   Guzman R. C. D., 2011, BIOMATERIALS, V32, P8205
   Hashemi S, 2000, J MATER SCI, V35, P5851, DOI 10.1023/A:1026704323702
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Li JS, 2013, FOOD CHEM TOXICOL, V57, P338, DOI 10.1016/j.fct.2013.03.047
   Li LH, 2001, BIOMATERIALS, V22, P2595, DOI 10.1016/S0142-9612(00)00222-2
   Li Q, 2011, TEXT RES J, V82, P195
   Li Q, 2012, J TEXT I, V103, P662, DOI 10.1080/00405000.2011.597569
   Lin SY, 1996, METHOD FIND EXP CLIN, V18, P175
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Liu X., 2012, J THERM ANAL CALORIM, V111, P259
   MACLAREN JA, 1962, AUST J CHEM, V15, P824, DOI 10.1071/CH9620824
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   Marti M, 2007, J APPL POLYM SCI, V104, P545, DOI 10.1002/app.25586
   Merouani S, 2010, J HAZARD MATER, V178, P1007, DOI 10.1016/j.jhazmat.2010.02.039
   Miale J.B., 1962, ACAD MED, V37, P1147
   MOEN O, 1995, ANN THORAC SURG, V60, P1317, DOI 10.1016/0003-4975(95)00777-I
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Nagarajan M, 2013, FOOD CHEM, V138, P1101, DOI 10.1016/j.foodchem.2012.11.069
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Rahmany MB, 2013, BIOMATERIALS, V34, P2492, DOI 10.1016/j.biomaterials.2012.12.008
   Rizvi TZ, 2008, INT J BIOL MACROMOL, V42, P292, DOI 10.1016/j.ijbiomac.2008.01.001
   Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Tombolato L, 2010, ACTA BIOMATER, V6, P319, DOI 10.1016/j.actbio.2009.06.033
   Tonin C, 2004, J THERM ANAL CALORIM, V77, P987, DOI 10.1023/B:JTAN.0000041674.04961.b4
   Trim MW, 2011, ACTA BIOMATER, V7, P1228, DOI 10.1016/j.actbio.2010.11.024
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2013, CURR DRUG TARGETS, V14, P612, DOI 10.2174/1389450111314050010
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Vincent J. F. V., 1980, MECH PROPERTIES BIOL
   Wang X, 2012, APPL SURF SCI, V258, P10012, DOI 10.1016/j.apsusc.2012.06.065
   Wang X, 2009, J APPL POLYM SCI, V112, P1959, DOI 10.1002/app.29573
   Yang SL, 2008, POLYM TEST, V27, P957, DOI 10.1016/j.polymertesting.2008.08.009
   ZAHN H, 1980, IND ENG CHEM PROD RD, V19, P496, DOI 10.1021/i360076a005
   Zhang J, 2013, POWDER TECHNOL, V246, P356, DOI 10.1016/j.powtec.2013.05.037
   Zhang QB, 2013, MAT SCI ENG C-MATER, V33, P5036, DOI 10.1016/j.msec.2013.08.034
   Zoccola M, 2009, J MOL STRUCT, V938, P35, DOI 10.1016/j.molstruc.2009.08.036
NR 63
TC 9
Z9 9
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2015
VL 47
BP 123
EP 134
DI 10.1016/j.msec.2014.11.051
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AY4YT
UT WOS:000347581600015
PM 25492180
DA 2018-10-20
ER

PT J
AU Sakthivel, N
   Socrates, R
   Shanthini, GM
   Rajaram, A
   Kalkura, SN
AF Sakthivel, N.
   Socrates, R.
   Shanthini, G. M.
   Rajaram, A.
   Kalkura, S. Narayana
TI Silver ion impregnated composite biomaterial optimally prepared using
   zeta potential measurements
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Zeta potential; Isoelectric point; Silver ion release; Composites
ID HYDROXYAPATITE-GELATIN NANOCOMPOSITE; SUBSTITUTED HYDROXYAPATITE;
   ANTIMICROBIAL ACTIVITY; DOPED HYDROXYAPATITE; PROTEIN ADSORPTION;
   ANTIBACTERIAL; NANOPARTICLES; SPECTROSCOPY; STRENGTH; MATRICES
AB Biodegradable, antimicrobial composite of various silver ion concentrations was synthesized using zeta potential and isoelectric point measurements, for a controlled release of silver ions, and in addition to assess the effect of protein adsorption with the increase of the silver ion concentration. The interaction between hydroxyapatite (HAp) and silver incorporated hydroxyapatite (AgHAp) with gelatin was increased by optimally adjusting the zeta potential and isoelectric point of the ceramic (HAp and AgHAp), and bio-polymer individually. The electrostatic interactions between the ceramic and biopolymer were confirmed, through shifts in N-H stretching, decrease in the swelling ratio, and increase in the degradation temperature observed by the derivative thermo-gravimetric analysis (DTG). These results substantiate that, the zeta potential is a novel tool to increase the ceramic-biopolymer interaction. Increasing electrostatic interaction between the biopolymer and ceramic, decreases the release of silver ions in the simulated body fluid, due to the controlled degradation of the biopolymer. The isoelectric point decreases with the increase of the silver ion concentration, which evidenced the change in the net surface charge. With the increase of the silver ion concentration, the protein adsorption decreases due to an increase in hydrophilic character of the composite. This study examines the minimum concentration of silver ion essential for maximum protein adsorption, antimicrobial and hemocompatibility. This study provides a novel route to control the release of silver ions by enhancing the ceramic-polymer interaction and estimate the silver ion concentration suitable for protein adsorption. The prepared composite is nontoxic, degradable, and antimicrobial, with the controlled release of silver ions in the simulated body fluid. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sakthivel, N.; Shanthini, G. M.; Kalkura, S. Narayana] Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
   [Socrates, R.; Rajaram, A.] Cent Leather Res Inst, Biophys Lab, Madras 600025, Tamil Nadu, India.
RP Kalkura, SN (reprint author), Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
EM kalkura@yahoo.com
OI , G.M. Shanthini/0000-0002-2381-5996
FU Department of Biotechnology, New Delhi (DBT)
   [BT/PR11799/MED/32/103/2009]
FX This work was supported by Department of Biotechnology, New Delhi (DBT)
   through the project BT/PR11799/MED/32/103/2009. The authors thank Dr.
   Rama Rajaram, Central Leather Research Institute, Chennai for valuable
   discussion.
CR Bajpai AK, 2006, J MATER SCI-MATER M, V17, P49, DOI 10.1007/s10856-006-6329-z
   Barbani N, 2012, J MATER SCI-MATER M, V23, P51, DOI 10.1007/s10856-011-4505-2
   Bera T, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025001
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2008, J MATER SCI-MATER M, V19, P3411, DOI 10.1007/s10856-008-3488-0
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Dibrov P., 2002, ANTIMICROB AGENTS CH, V46, P8
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Haider S, 2008, SOFT MATTER, V4, P485, DOI 10.1039/b713944f
   ISIKLI B, 1998, TURK J MED SCI, V28, P655
   Ivashchenko OA, 2011, MATERIALWISS WERKST, V42, P98, DOI 10.1002/mawe.201100739
   Joshy MIA, 2013, MAT SCI ENG C-MATER, V33, P466, DOI 10.1016/j.msec.2012.09.016
   Kim J.H., 2002, ENCY SURFACE COLLOID, V1, P4373
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kusmanto F, 2008, CHEM ENG J, V139, P398, DOI 10.1016/j.cej.2007.11.041
   Lim PN, 2013, J BIOMED MATER RES A, V101, P2456, DOI 10.1002/jbm.a.34544
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mucksch C, 2011, LANGMUIR, V27, P12938, DOI 10.1021/la201972f
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   RAMSDEN JJ, 1994, J PHYS CHEM-US, V98, P5376, DOI 10.1021/j100071a031
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Rodenas LG, 2005, J COLLOID INTERF SCI, V290, P145, DOI 10.1016/j.jcis.2005.04.041
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Smeets Ralf, 2009, Head Face Med, V5, P13, DOI 10.1186/1746-160X-5-13
   Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   SVENSSON H, 1961, ACTA CHEM SCAND, V15, P325, DOI 10.3891/acta.chem.scand.15-0325
   TRIPPEL SB, 1986, J BONE JOINT SURG AM, V68A, P1297, DOI 10.2106/00004623-198668080-00026
   Wu X, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044105
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yang JM, 1996, J BIOMED MATER RES, V33, P83, DOI 10.1002/(SICI)1097-4636(199622)33:2<83::AID-JBM4>3.0.CO;2-H
   Yang ZW, 2005, J MATER CHEM, V15, P1807, DOI 10.1039/b418015c
   Yu LL, 2013, J CHROMATOGR A, V1305, P85, DOI 10.1016/j.chroma.2013.07.016
NR 41
TC 1
Z9 1
U1 3
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2015
VL 47
BP 222
EP 229
DI 10.1016/j.msec.2014.11.018
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AY4YT
UT WOS:000347581600027
PM 25492192
DA 2018-10-20
ER

PT J
AU Zhang, SC
   Liu, P
   Chen, L
   Wang, YJ
   Wang, ZG
   Zhang, B
AF Zhang, Shichang
   Liu, Ping
   Chen, Li
   Wang, Yingjie
   Wang, Zhengguo
   Zhang, Bo
TI The effects of spheroid formation of adipose-derived stem cells in a
   microgravity bioreactor on sternness properties and therapeutic
   potential
SO BIOMATERIALS
LA English
DT Article
DE Adipose-derived stem cells; Microgravity bioreactor; Sternness property;
   Therapeutic potential
ID ACUTE LIVER-FAILURE; PROGENITOR CELLS; DROSOPHILA-OVARY; TISSUE;
   DIFFERENTIATION; MAINTENANCE; SCAFFOLD; CHITOSAN; NICHES; REGENERATION
AB Adipose-derived stem cells (ADSCs) represent a valuable source of stem cells for regenerative medicine, but the loss of their sternness during in vitro expansion remains a major roadblock. We employed a microgravity bioreactor (MB) to develop a method for biomaterial-free-mediated spheroid formation to maintain the sternness properties of ADSCs. ADSCs spontaneously formed three-dimensional spheroids in the MB. Compared with monolayer culture, the expression levels of E-cadherin and pluripotent markers were significantly upregulated in ADSC spheroids. Spheroid-derived ADSCs exhibited increased proliferative ability and colony-forming efficiency. By culturing the spheroid-derived ADSCs in an appropriate induction medium, we found that the multipotency differentiation capacities of ADSCs were significantly improved by spheroid culture in the MB. Furthermore, when ADSCs were administered to mice with carbon tetrachloride-induced acute liver failure, spheroid-derived ADSCs showed more effective potentials to rescue liver failure than ADSCs derived from constant monolayer culture. Our results suggest that spheroid formation of ADSCs in an MB enhances their sternness properties and increases their therapeutic potential. Therefore, spheroid culture in an MB can be an efficient method to maintain stemness properties, without the involvement of any biomaterials for clinical applications of in vitro cultured ADSCs. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, Shichang; Liu, Ping; Wang, Zhengguo; Zhang, Bo] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept 4,Inst Surg Res, Chongqing 400042, Peoples R China.
   [Chen, Li] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing 210017, Jiangsu, Peoples R China.
   [Wang, Yingjie] Third Mil Med Univ, Southwest Hosp, Inst Infect Dis, Chongqing 400038, Peoples R China.
RP Zhang, B (reprint author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept 4,Inst Surg Res, Chongqing 400042, Peoples R China.
EM zhangbo67184@l63.com
FU National Program on Key Basic Research Project of China [2011CB964701];
   National Natural Science Foundation of China [30800237]; Foundation for
   Science and Technology Research Project of Chongqing [CSTC2012GGB1003]
FX This research was supported by funds from the National Program on Key
   Basic Research Project of China (2011CB964701), the National Natural
   Science Foundation of China (30800237) and the Foundation for Science
   and Technology Research Project of Chongqing (CSTC2012GGB1003). We
   gratefully acknowledge all of the members of the laboratory for sharing
   reagents and advice.
CR Baer PC, 2010, CYTOTHERAPY, V12, P96, DOI 10.3109/14653240903377045
   Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Bongso A, 2013, STEM CELL REV REP, V9, P226, DOI 10.1007/s12015-012-9418-z
   Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003
   Cheng NC, 2013, STEM CELL TRANSL MED, V2, P584, DOI 10.5966/sctm.2013-0007
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Cho HJ, 2012, MOL THER, V20, P1750, DOI 10.1038/mt.2012.109
   Emmert MY, 2013, BIOMATERIALS, V34, P6339, DOI 10.1016/j.biomaterials.2013.04.034
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202
   Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]
   Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010
   Hsu SH, 2014, BIOMATERIALS, V35, P7295, DOI 10.1016/j.biomaterials.2014.05.033
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Huang JY, 2009, CELL RES, V19, P1127, DOI 10.1038/cr.2009.106
   Kapur SK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025004
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013
   Lee EJ, 2012, MOL THER, V20, P1424, DOI 10.1038/mt.2012.58
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371
   Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335
   Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Marx V, 2013, NATURE, V496, P253, DOI 10.1038/496253a
   Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Park E, 2010, CELL BIOL INT, V34, P979, DOI 10.1042/CBI20100124
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9
   Russo FP, 2011, CYTOTHERAPY, V13, P135, DOI 10.3109/14653249.2010.545386
   Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041
   Saleh Fatima A, 2012, Methods Mol Biol, V916, P31, DOI 10.1007/978-1-61779-980-8_4
   Saraswati S, 2012, WOUND REPAIR REGEN, V20, P185, DOI 10.1111/j.1524-475X.2012.00767.x
   Shah FS, 2013, CYTOTHERAPY, V15, P979, DOI 10.1016/j.jcyt.2013.04.001
   Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399
   Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871
   Spelke DP, 2011, METHODS MOL BIOL, V690, P151, DOI 10.1007/978-1-60761-962-8_10
   Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875
   Su GN, 2013, BIOMATERIALS, V34, P3215, DOI 10.1016/j.biomaterials.2013.01.044
   Trohatou O, 2014, STEM CELL TRANSL MED, V3, P54, DOI 10.5966/sctm.2013-0081
   Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wei JS, 2014, BIOMATERIALS, V35, P7724, DOI 10.1016/j.biomaterials.2014.05.060
   Yan XZ, 2014, TISSUE ENG PART B-RE, V20, P340, DOI [10.1089/ten.TEB.2013.0349, 10.1089/ten.teb.2013.0349]
   Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069
   Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015
   Zamperone A, 2013, STEM CELLS DEV, V22, P2873, DOI 10.1089/scd.2012.0718
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhang SC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt356
   Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.TEA.2011.0516, 10.1089/ten.tea.2011.0516]
NR 55
TC 32
Z9 33
U1 4
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2015
VL 41
BP 15
EP 25
DI 10.1016/j.biomaterials.2014.11.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA6XY
UT WOS:000349062100002
PM 25522961
DA 2018-10-20
ER

PT J
AU Tallawi, M
   Rai, R
   Boccaccini, AR
   Aifantis, KE
AF Tallawi, Marwa
   Rai, Ranjana
   Boccaccini, Aldo. R.
   Aifantis, Katerina E.
TI Effect of Substrate Mechanics on Cardiomyocyte Maturation and Growth
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID EMBRYONIC STEM-CELLS; ATOMIC-FORCE MICROSCOPY; CARDIAC MYOCYTES;
   NEONATAL CARDIOMYOCYTES; HEART-DISEASE; SARCOPLASMIC-RETICULUM;
   INTRACELLULAR CALCIUM; VENTRICULAR MYOCYTES; CYCLIC STRAIN; STIFFNESS
AB Cardiac tissue engineering constructs are a promising therapeutic treatment for myocardial infarction, which is one of the leading causes of death. In order to further advance the development and regeneration of engineered cardiac tissues using biomaterial platforms, it is important to have a complete overview of the effects that substrates have on cardiomyocyte (CM) morphology and function. This article summarizes recent studies that investigate the effect of mechanical cues on the CM differentiation, maturation, and growth. In these studies, CMs derived from embryos, neonates, and mesenchymal stem cells were seeded on different substrates of various elastic modulus. Measuring the contractile function by force production, work output, and calcium handling, it was seen that cell behavior on substrates was optimized when the substrate stiffness mimicked that of the native tissue. The contractile function reflected changes in the sarcomeric protein confirmation and organization that promoted the contractile ability. The analysis of the literature also revealed that, in addition to matrix stiffness, mechanical stimulation, such as stretching the substrate during cell seeding, also played an important role during cell maturation and tissue development.
C1 [Tallawi, Marwa; Rai, Ranjana; Boccaccini, Aldo. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91054 Erlangen, Germany.
   [Aifantis, Katerina E.] Aristotle Univ Thessaloniki, Lab Mech & Mat, Sch Engn, GR-54006 Thessaloniki, Greece.
   [Aifantis, Katerina E.] Univ Arizona, Tucson, AZ USA.
RP Aifantis, KE (reprint author), Dept Civil Engn Engn Mech, 1209 E Second St, Tucson, AZ 85721 USA.
EM aifantis@email.arizona.edu
RI Boccaccini, Aldo/C-7905-2013
FU European Research Council [MINATRAN 211166]
FX The authors would like to acknowledge the financial support received
   from the European Research Council Starting Grant MINATRAN 211166 to
   initiate this study.
CR Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101
   Azeloglu EU, 2010, AM J PHYSIOL-HEART C, V298, pH853, DOI 10.1152/ajpheart.00427.2009
   Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   BORG TK, 1981, FED PROC, V40, P2037
   BRADY AJ, 1991, PHYSIOL REV, V71, P413
   De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060
   Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2
   Du AP, 2003, DEV BIOL, V257, P382, DOI 10.1016/S0012-1606(03)00104-0
   Ehler E, 1999, J CELL SCI, V112, P1529
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FISHER DJ, 1992, PEDIATR RES, V32, P664, DOI 10.1203/00006450-199212000-00007
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e
   GOMEZ JP, 1994, CELL CALCIUM, V15, P265, DOI 10.1016/0143-4160(94)90066-3
   Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506
   Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050
   Hazeltine LB, 2014, ACTA BIOMATER, V10, P604, DOI 10.1016/j.actbio.2013.10.033
   Husse B, 1996, MOL CELL BIOCHEM, V164, P13
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003
   Liu JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037559
   LODISH HB, 2000, MOL CELL BIOL
   McCain ML, 2011, PFLUG ARCH EUR J PHY, V462, P89, DOI 10.1007/s00424-011-0951-4
   Menasche P, 2005, CURR OPIN MOL THER, V7, P293
   Miller CE, 2000, IN VITRO CELL DEV-AN, V36, P633
   MOORMAN AFM, 1995, CIRC RES, V76, P616, DOI 10.1161/01.RES.76.4.616
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005
   Patel AA, 2010, BIOMED MICRODEVICES, V12, P287, DOI 10.1007/s10544-009-9384-7
   Patel JK, 2011, CIRCULATION, V124, pE132, DOI 10.1161/CIRCULATIONAHA.110.017319
   Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441
   Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15
   Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961
   Tobita K, 2006, AM J PHYSIOL-HEART C, V291, pH1829, DOI 10.1152/ajpheart.00205.2006
   Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001
   Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021
   WIBO M, 1991, CIRC RES, V68, P662, DOI 10.1161/01.RES.68.3.662
NR 47
TC 17
Z9 18
U1 1
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB 1
PY 2015
VL 21
IS 1
BP 157
EP 165
DI 10.1089/ten.teb.2014.0383
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HG
UT WOS:000349011200012
PM 25148904
OA Green Published
DA 2018-10-20
ER

PT J
AU Wolf, MT
   Vodovotz, Y
   Tottey, S
   Brown, BN
   Badylak, SF
AF Wolf, Matthew T.
   Vodovotz, Yoram
   Tottey, Stephen
   Brown, Bryan N.
   Badylak, Stephen F.
TI Predicting In Vivo Responses to Biomaterials via Combined In Vitro and
   In Silico Analysis
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID FOREIGN-BODY REACTION; INCISIONAL HERNIA REPAIR; DECELLULARIZED
   PERICARDIAL BIOMATERIAL; CLASSICALLY ACTIVATED MACROPHAGES;
   EXTRACELLULAR-MATRIX; INFLAMMATORY RESPONSE; POLYPROPYLENE MESHES;
   SKELETAL-MUSCLE; GENE-EXPRESSION; BIOLOGIC MESHES
AB The host response to both synthetic and biologically derived biomaterials is a temporally regulated, complex process that involves multiple interacting cell types. This complexity has classically limited the efficacy of in vitro assays for predicting the in vivo outcome, necessitating the use of costly animal models for biomaterial development. The present study addressed these challenges by developing an in vitro assay that characterized the dynamic inflammatory response of human monocyte-derived-macrophages to biomaterials, coupled with quasi-mechanistic analysis in silico analysis: principal component analysis (PCA) and dynamic network analysis (DyNA). Synthetic and extracellular matrix (ECM)-derived materials were evaluated using this method, and were then associated with the in vivo remodeling and macrophage polarization response in a rodent skeletal muscle injury model. PCA and DyNA revealed a distinct in vitro macrophage response to ECM materials that corresponded to constructive remodeling and an increased M2 macrophage presence in vivo. In contrast, PCA and DyNA suggested a response to crosslinked ECM and synthetic materials characteristic of a foreign body reaction and dominant M1 macrophage response. These results suggest that in silico analysis of an in vitro macrophage assay may be useful as a predictor for determining the in vivo host response to implanted biomaterials.
C1 [Wolf, Matthew T.; Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Wolf, Matthew T.; Vodovotz, Yoram; Tottey, Stephen; Brown, Bryan N.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Vodovotz, Yoram; Tottey, Stephen; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr Suite 300, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIH-NHLBI [T32-HL76124-6]; NIH K12 Award [HD043441]
FX M.T.W. was partially supported by the NIH-NHLBI training grant
   (T32-HL76124-6) entitled "Cardiovascular Bioengineering Training
   Program," and B.N.B. was partially supported by the NIH K12 Award
   "Interdisciplinary Research Careers in Women's Health" (HD043441). The
   authors would like to thank Deanna Rhoads and the McGowan Histology
   Center for histologic section preparation, and Hongbin Jiang for
   assistance with animal care.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008
   Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P880, DOI 10.1016/j.jamcollsurg.2011.01.006
   Di Vita G, 2006, AM J SURG, V191, P785, DOI 10.1016/j.amjsurg.2005.11.008
   Di Vita G, 2005, LANGENBECK ARCH SURG, V390, P306, DOI 10.1007/s00423-004-0534-3
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde J, 2007, J MATER SCI-MATER M, V18, P537, DOI 10.1007/s10856-007-2300-x
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Jansen PL, 2007, FASEB J, V21, P1047, DOI 10.1096/fj.06-6755com
   Klinge U, 1999, EUR J SURG, V165, P665
   Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106
   Nelson DM, 2011, PHARM RES-DORDR, V28, P1282, DOI 10.1007/s11095-011-0391-z
   Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   USHER FC, 1963, SURG GYNECOL OBSTET, V117, P239
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb0306152
   Weyhe D, 2008, ANZ J SURG, V78, P55, DOI 10.1111/j.1445-2197.2007.04362.x
   Weyhe D, 2007, REGUL PEPTIDES, V138, P10, DOI 10.1016/j.regpep.2006.07.010
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248
   Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804
NR 52
TC 25
Z9 25
U1 2
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2015
VL 21
IS 2
BP 148
EP 159
DI 10.1089/ten.tec.2014.0167
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA CA6HR
UT WOS:000349012400005
PM 24980950
OA Green Published
DA 2018-10-20
ER

PT J
AU Djordjevic, A
   Ignjatovic, N
   Seke, M
   Jovic, D
   Uskokovic, D
   Rakocevic, Z
AF Djordjevic, Aleksandar
   Ignjatovic, Nenad
   Seke, Mariana
   Jovic, Danica
   Uskokovic, Dragan
   Rakocevic, Zlatko
TI Synthesis and Characterization of Hydroxyapatite/Fullerenol
   Nanocomposites
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Hydroxyapatite; Fullerenol; Nanocomposite; Surface Analysis
ID DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; COMPOSITE BIOMATERIALS; CALCIUM
   PHOSPHATES; NANO-RODS; FULLERENE; BONE; NANOPARTICLES; CHEMISTRY; TISSUE
AB Fullerenols are polyhydroxylated, water soluble derivatives of fullerene C-60, with potential application in medicine as diagnostic agents, antioxidants or nano drug carriers. This paper describes synthesis and physical characterization of a new nanocomposite hydroxyapatite/fullerenol. Surface of the nanocomposite hydroxyapatite/fullerenol is inhomogeneous with the diameter of the particles in the range from 100 nm to 350 nm. The zeta potential of this nanocomposite is ten times lower when compared to hydroxyapatite. Surface phosphate groups of hydroxyapatite are prone to forming hydrogen bonds, when in close contact with hydroxyl groups, which could lead to formation of hydrogen bonds between hydroxyapatite and hydroxyl groups of fullerenol. The surface of hydroxyapatite particles (-2.5 mV) was modified by fullerenol particles, as confirmed by the obtained zeta potential value of the nanocomposite biomaterial hydroxyapatite/fullerenol (-25.0 mV).
C1 [Djordjevic, Aleksandar; Jovic, Danica] Univ Novi Sad, Fac Sci, Dept Chem Biochem & Environm Protect, Novi Sad 21000, Serbia.
   [Ignjatovic, Nenad; Uskokovic, Dragan] Serbian Acad Arts & Sci, Inst Tech Sci, Ctr Fine Particles Proc & Nanotechnol, Belgrade 11000, Serbia.
   [Seke, Mariana; Rakocevic, Zlatko] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade 11001, Serbia.
RP Djordjevic, A (reprint author), Univ Novi Sad, Fac Sci, Dept Chem Biochem & Environm Protect, Trg Dositeja Obradovica 3, Novi Sad 21000, Serbia.
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; , Aleksandar/0000-0003-4120-7318
FU Ministry of Science, Republic of Serbia [III45005, III45004]
FX This work is supported by the Ministry of Science, Republic of Serbia
   (No. III45005, No. III45004). The authors acknowledge Milos Bokorov and
   Ph.D. Danijela Petrovic for the special contribution in carrying out
   this paper.
CR Borum-Nicholas L, 2003, BIOMATERIALS, V24, P3671, DOI 10.1016/S0142-9612(03)00239-4
   Chao TC, 2011, ANAL CHEM, V83, P1777, DOI 10.1021/ac1031379
   Chen Y, 2001, J PHYS CHEM SOLIDS, V62, P999, DOI 10.1016/S0022-3697(00)00242-0
   CHIANG LY, 1993, J AM CHEM SOC, V115, P5453, DOI 10.1021/ja00066a014
   Dhanalakshmi CP, 2012, J BIOMATER TISS ENG, V2, P314, DOI 10.1166/jbt.2012.1052
   Djordjevic A, 2006, J BUON, V11, P391
   Djordjevic A, 1998, FULLERENE SCI TECHN, V6, P689, DOI 10.1080/10641229809350229
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Fileti E., 2008, NANOTECHNOLOGY, V19, P365
   Gonzalez KA, 2002, BIOORGAN MED CHEM, V10, P1991, DOI 10.1016/S0968-0896(02)00049-4
   Hinokuma K, 2001, CHEM PHYS LETT, V341, P442, DOI 10.1016/S0009-2614(01)00549-8
   Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2004, SPECTROSC-INT J, V18, P553, DOI 10.1155/2004/917656
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic NL, 2010, J MATER SCI-MATER M, V21, P231, DOI 10.1007/s10856-009-3854-6
   Injac R., 2008, AFR J BIOTECHNOL, V7, P4940
   Ishikawa T., 1989, LANGMUIR, V5, P144
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Joshy MIA, 2011, CURR APPL PHYS, V11, P1100, DOI 10.1016/j.cap.2011.02.003
   Kalambettu A. B., 2012, J BIOMATER TISS ENG, V2, P244
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Mrdanovic JZ, 2012, DIG J NANOMATER BIOS, V7, P673
   Nikcevic I, 2006, MATER TRANS, V47, P2980, DOI 10.2320/matertrans.47.2980
   Oviedo MJ, 2012, SCI ADV MATER, V4, P558, DOI 10.1166/sam.2012.1318
   Partha R, 2009, INT J NANOMED, V4, P261
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Victoria E. Caroline, 2002, TRENDS BIOMATER ARTI, V16, P12
   Vileno B, 2006, ADV FUNCT MATER, V16, P120, DOI 10.1002/adfm.200500425
   Vukomanovic M, 2011, COLLOID SURFACE B, V87, P226, DOI 10.1016/j.colsurfb.2011.05.023
   Wiglusz RJ, 2012, J BIOMED NANOTECHNOL, V8, P605, DOI 10.1166/jbn.2012.1424
NR 33
TC 2
Z9 2
U1 4
U2 76
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2015
VL 15
IS 2
BP 1538
EP 1542
DI 10.1166/jnn.2015.8671
PG 5
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AT6NB
UT WOS:000345054100091
PM 26353688
DA 2018-10-20
ER

PT J
AU Zhang, F
   Vanmeensel, K
   Inokoshi, M
   Batuk, M
   Hadermann, J
   Van Meerbeek, B
   Naert, I
   Vleugels, J
AF Zhang, F.
   Vanmeensel, K.
   Inokoshi, M.
   Batuk, M.
   Hadermann, J.
   Van Meerbeek, B.
   Naert, I.
   Vleugels, J.
TI Critical influence of alumina content on the low temperature degradation
   of 2-3 mol% yttria-stabilized TZP for dental restorations
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Y-TZP; Degradation; Amount of alumina
ID MONOCLINIC PHASE-TRANSFORMATION; ZIRCONIA CERAMICS; TETRAGONAL ZRO2;
   Y-TZP; HYDROTHERMAL DEGRADATION; FRACTURE-TOUGHNESS; BIOMATERIAL;
   SYSTEM; FUTURE; 3Y-TZP
AB The influence of 0.25, 2 and 5 wt.% alumina addition on the mechanical properties and low temperature degradation (LTD) of 3, 2.5 and 2 mol% yttria-stabilized TZP ceramics was investigated. The amount of alumina addition was observed to have a crucial impact on the degradation of Y-TZP ceramics.
   Independent on the yttria stabilizer content, 0.25 wt.% alumina had a higher degradation retarding effect to Y-TZP ceramics than 2 and 5 wt.% of alumina addition, which had a comparable effect. The apparent activation energy for the degradation process was increased by adding alumina, but it was the same for 0.25-5 wt.% alumina doped 3Y-TZP ceramics. For Y-TZPs containing a small amount of alumina addition, only the segregated Al3+ at the grain boundaries of the zirconia grains was effective to retard the degradation of Y-TZPs. The secondary phase Al2O3 grains increased the degradation kinetics, which might be attributed to the residual stresses. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, F.; Vanmeensel, K.; Vleugels, J.] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium.
   [Inokoshi, M.; Van Meerbeek, B.; Naert, I.] KU Leuven & Dent, Univ Hosp Leuven, Dept Oral Hlth Sci, KU Leuven BIOMAT, B-3000 Leuven, Belgium.
   [Batuk, M.; Hadermann, J.] Univ Antwerp, B-2020 Antwerp, Belgium.
RP Zhang, F (reprint author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Heverlee, Belgium.
EM fei.zhang@mtm.kuleuven.be
RI Vleugels, Jozef/C-8262-2017; Vanmeensel, Kim/B-7792-2018; Hadermann,
   Joke/F-4644-2011
OI Vleugels, Jozef/0000-0003-4432-4675; Vanmeensel,
   Kim/0000-0001-5189-7055; Hadermann, Joke/0000-0002-1756-2566
FU Research Fund of KU Leuven [0T/10/052]; Fund for Scientific Research
   Flanders [G.0431.10N]; Fund for Scientific Research Flanders (FWO)
FX This work was performed within the framework of the Research Fund of KU
   Leuven under project 0T/10/052 and the Fund for Scientific Research
   Flanders under grant G.0431.10N. K. Vanmeensel thanks the Fund for
   Scientific Research Flanders (FWO) for his post-doctoral fellowship.
CR ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   Ban S, 2008, JPN DENT SCI REV, V44, P3, DOI 10.1016/j.jdsr.2008.04.001
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gutknecht D, 2007, J EUR CERAM SOC, V27, P1547, DOI 10.1016/j.jeurceramsoc.2006.04.123
   Jiang L, 2011, J WUHAN UNIV TECHNOL, V26, P690, DOI 10.1007/s11595-011-0294-1
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   Kosmac T, 2012, J EUR CERAM SOC, V32, P2613, DOI 10.1016/j.jeurceramsoc.2012.02.024
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEE RR, 1988, J AM CERAM SOC, V71, P694, DOI 10.1111/j.1151-2916.1988.tb06390.x
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lorente MC, 2011, ACTA BIOMATER, V7, P858
   MECARTNEY ML, 1989, ACTA METALL MATER, V37, P1859, DOI 10.1016/0001-6160(89)90070-9
   Nogiwa-Valdez AA, 2013, ACTA BIOMATER, V9, P6226, DOI 10.1016/j.actbio.2012.11.027
   Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679
   Olga F, 2004, Z METALLK MAT RES AD, V95, P27
   Ozkurt Z, 2010, J PROSTHODONT, V19, P64, DOI 10.1111/j.1532-849X.2009.00513.x
   Pecharroman C, 2003, ADV MATER, V15, P507, DOI 10.1002/adma.200390117
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ross IM, 2004, J EUR CERAM SOC, V24, P2023, DOI 10.1016/S0955-2219(03)00375-3
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   SATO T, 1985, J MATER SCI, V20, P3988, DOI 10.1007/BF00552389
   Schechner G, 2013, Patent, Patent No. [US20130341812 A1, 20130341812]
   Stough MA, 2002, J AM CERAM SOC, V85, P2895
   Suzuki T, 2013, J JPN SOC DENT MAT D, V32, P92
   Takaki M, 1986, INT J HIGH TECH CERA, V2, P85
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   TSUBAKINO H, 1993, J MATER SCI LETT, V12, P196, DOI 10.1007/BF00819957
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   Vleugels J, 2002, J EUR CERAM SOC, V22, P873, DOI 10.1016/S0955-2219(01)00389-2
   Wang F, 2013, J PROSTHET DENT, V110, P14, DOI 10.1016/S0022-3913(13)60333-9
   Zhang F, 2014, J EUR CERAM SOC, V34, P2453, DOI 10.1016/j.jeurceramsoc.2014.02.026
NR 37
TC 22
Z9 23
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD FEB
PY 2015
VL 35
IS 2
BP 741
EP 750
DI 10.1016/j.jeurceramsoc.2014.09.018
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA AT8SG
UT WOS:000345201700032
DA 2018-10-20
ER

PT J
AU Sukumar, N
   Ramachandran, T
   Kalaiarasi, H
   Sengottuvelu, S
AF Sukumar, Nachiappan
   Ramachandran, T.
   Kalaiarasi, H.
   Sengottuvelu, S.
TI Characterization and in vivo evaluation of silk hydrogel with
   enhancement of dextrin, rhEGF, and alginate beads for diabetic Wistar
   Albino wounded rats
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE chitosan; medical textile; dextrin; rhEGF; diabetic wound; silk fibroin
ID DRUG-DELIVERY SYSTEMS; GROWTH-FACTOR; CHITOSAN; FIBROIN; VITRO;
   BIOMATERIAL; RELEASE; ACCELERATION; FORMULATION; SCAFFOLDS
AB Silk is a natural bio material that is used as a wound-healing material for a long period. Favorable properties like natural slow biodegradation, superior mechanical properties, and biocompatibility make it an ideal material for the wound-healing process. It was observed that diabetic wounds require increased protection and treatment than the normal wounds. Therefore, current research is focused on preparation of silk-based hydrogels for diabetic wound healing with the combination of chitosan-alginate beads, dextrin, and recombinant human epidermal growth factor. The prepared hydrogel was tested and established for its morphology, water uptake ability, and porosity that are the special properties required for an ideal wound-dressing material. In extrapolating these findings, the prepared silk-based hydrogel was applied and tested for its wound-healing effect on diabetic-induced rats that is a widely used in vivo method of wound healing. Full-thickness wounds were created in the dorsal of rat's skin. Wounded rats were treated topically with silk fibroin hydrogel immediately after the injury. The wound-healing rate was observed through tissue deposition and wound closure for over a 21-days period. The results established that integrated silk-based hydrogel promotes the healing process through controlled release of drug and recovery of the deep wounds of diabetic-induced male Wistar Albino rats was commendable. Therefore, the use of silk fibroin-based hydrogel may be extended to the clinical setting and act as an effective promoter for wound healing in human beings with diabetics.
C1 [Sukumar, Nachiappan] KSR Coll Technol, Dept Text Technol, Tiruchengode, India.
   [Ramachandran, T.] Karpagam Inst Technol, Dept Text Technol, Coimbatore, India.
   [Kalaiarasi, H.] PSG Coll Technol, PSG Inst Management, Coimbatore, Tamil Nadu, India.
   [Sengottuvelu, S.] Nandha Coll Pharm, Dept Pharmacol, Erode, India.
RP Sukumar, N (reprint author), KSR Coll Technol, Dept Text Technol, Tiruchengode, India.
EM sugumaraan@yahoo.com
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   [Anonymous], 2012, IDF DIABETES ATLAS
   Babaei S, 2013, EUR J PHARMACOL, V700, P165, DOI 10.1016/j.ejphar.2012.11.024
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   DANCKWERTS M, 1991, DRUG DEV IND PHARM, V17, P1465, DOI 10.3109/03639049109026629
   Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Hardwicke J, 2008, J CONTROL RELEASE, V130, P275, DOI 10.1016/j.jconrel.2008.07.023
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   Holliday EG, 2013, DIABETES, V62, P1369, DOI 10.2337/db12-1836
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kwon AH, 2009, AM J SURG, V197, P503, DOI 10.1016/j.amjsurg.2007.11.021
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lee YH, 2012, CARBOHYD POLYM, V88, P809, DOI 10.1016/j.carbpol.2011.12.045
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Ma YF, 2013, MAT SCI ENG C-MATER, V33, P2413, DOI 10.1016/j.msec.2013.02.006
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Musson DS, 2013, PROCEDIA ENGINEER, V59, P138, DOI 10.1016/j.proeng.2013.05.103
   Ngah WSW, 2008, CHEM ENG J, V143, P62, DOI 10.1016/j.cej.2007.12.006
   Pattanayak SR, 2008, J ETHNOPHARMACOL, V120, P241, DOI 10.1016/j.jep.2008.08.019
   PRITCHARD EM, 2011, SILK BIOMATERIALS FO
   Ribeiro MP, 2013, MAT SCI ENG C-MATER, V33, P2958, DOI 10.1016/j.msec.2013.03.025
   Ribeiro MP, 2009, WOUND REPAIR REGEN, V17, P817, DOI 10.1111/j.1524-475X.2009.00538.x
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Simsek-Ege FA, 2003, J APPL POLYM SCI, V88, P346, DOI 10.1002/app.11989
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   Sukumar N, 2014, J IND TEXT, V43, P565, DOI 10.1177/1528083712470159
   Thu HE, 2012, INT J PHARMACEUT, V434, P375, DOI 10.1016/j.ijpharm.2012.05.044
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
NR 35
TC 1
Z9 1
U1 3
U2 58
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PD FEB 1
PY 2015
VL 106
IS 2
BP 133
EP 140
DI 10.1080/00405000.2014.906100
PG 8
WC Materials Science, Textiles
SC Materials Science
GA AU4HH
UT WOS:000345570900003
DA 2018-10-20
ER

PT J
AU Oliva, N
   Carcole, M
   Beckerman, M
   Seliktar, S
   Hayward, A
   Stanley, J
   Parry, NMA
   Edelman, ER
   Artzi, N
AF Oliva, Nuria
   Carcole, Maria
   Beckerman, Margarita
   Seliktar, Sivan
   Hayward, Alison
   Stanley, James
   Parry, Nicola Maria Anne
   Edelman, Elazer R.
   Artzi, Natalie
TI Regulation of dendrimer/dextran material performance by altered tissue
   microenvironment in inflammation and neoplasia
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID COLITIS
AB A "one material fits all" mindset ignores profound differences in target tissues that affect their responses and reactivity. Yet little attention has been paid to the role of diseased tissue on material performance, biocompatibility, and healing capacity. We assessed material-tissue interactions with a prototypical adhesive material based on dendrimer/dextran and colon as a model tissue platform. Adhesive materials have high sensitivity to changes in their environment and can be exploited to probe and quantify the influence of even subtle modifications in tissue architecture and biology. We studied inflammatory colitis and colon cancer and found not only a difference in adhesion related to surface chemical interactions but also the existence of a complex interplay that determined the overall dendrimer/dextran biomaterial compatibility. Compatibility was contextual, not simply a constitutive property of the material, and was related to the extent and nature of immune cells in the diseased environment present before material implantation. We then showed how to use information about local alterations of the tissue microenvironment to assess disease severity. This in turn guided us to an optimal dendrimer/dextran formulation choice using a predictive model based on clinically relevant conditions.
C1 [Oliva, Nuria; Carcole, Maria; Beckerman, Margarita; Seliktar, Sivan; Edelman, Elazer R.; Artzi, Natalie] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Carcole, Maria] Univ Ramon Llull, Inst Quim Sarria, Dept Ind Engn, Barcelona 08017, Spain.
   [Beckerman, Margarita; Seliktar, Sivan] Ort Braude Coll, IL-21982 Karmiel, Israel.
   [Hayward, Alison; Stanley, James] Concord Biomed Sci & Emerging Technol, Lexington, MA 02421 USA.
   [Parry, Nicola Maria Anne] MIT, Div Comparat Med, Cambridge, MA 02139 USA.
   [Edelman, Elazer R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, Boston, MA 02115 USA.
   [Artzi, Natalie] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.
RP Artzi, N (reprint author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM nartzi@mit.edu
RI Oliva, Nuria/P-7825-2016
OI Oliva, Nuria/0000-0002-6305-0801
FU RO1 grant [GM49039]; MIT Deshpande Center for Technological Innovation;
   Fundacio d'Investigacio de l'Hospital Sant Pau (FISP)
FX Supported by RO1 grant (GM49039), MIT Deshpande Center for Technological
   Innovation, and the Fundacio d'Investigacio de l'Hospital Sant Pau
   (FISP).
CR Armentano Ilaria, 2013, Recent Pat Drug Deliv Formul, V7, P9
   Artzi N., ADV MAT, V21, P3399
   Artzi N, 2009, MACROMOL BIOSCI, V9, P754, DOI 10.1002/mabi.200800355
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Cam C, 2013, CURR OPIN BIOTECH, V24, P855, DOI 10.1016/j.copbio.2013.04.007
   Cury DB, 2013, CELL IMMUNOL, V282, P66, DOI 10.1016/j.cellimm.2013.04.004
   Lenglet S, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/659282
   Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5
   Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099
   Oliva N, 2012, LANGMUIR, V28, P15402, DOI 10.1021/la303155p
   Orive G., 2013, ADV DRUG DELIV REV, V67-68, P3
   Orlando G, 2013, GUT, V62, P774, DOI 10.1136/gutjnl-2011-301111
   Saiz E, 2013, DENT MATER, V29, P103, DOI 10.1016/j.dental.2012.08.001
NR 13
TC 24
Z9 25
U1 2
U2 18
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 28
PY 2015
VL 7
IS 272
AR 272ra11
DI 10.1126/scitranslmed.aaa1616
PG 8
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CB1YA
UT WOS:000349422700004
PM 25632035
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kanungo, I
   Fathima, NN
   Rao, JR
   Nair, BU
AF Kanungo, Ivy
   Fathima, Nishter Nishad
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Go natural and smarter: fenugreek as a hydration designer of collagen
   based biomaterials
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID DIELECTRIC-PROPERTIES; CIRCULAR-DICHROISM; RELEASE; TISSUE;
   POLYSACCHARIDES; COMPOSITES; PROTEINS; DYNAMICS; WATER; GUM
AB Collagen-based biomaterials have received considerable attention for smarter biomedical applications due to their inherent superior mechano-biological properties. However, accumulating evidence suggests that water, as a probe liquid bound in collagen, might be investigated to explore the influence of additives on the static and dynamic solvation behavior of collagen. The structure and dynamics of water near the surface/interface of collagen-fenugreek composites were demonstrated via circular dichroic spectroscopy, thermoporometry and impedimetric measurements to enlighten about the configuration-function relationship of collagen. Thermodynamic parameters of the composites signify the fenugreek concentration dependent structural robustness of collagen. Thermodynamic parameters such as free energies for unfolding, enthalpies, entropies and activation energies indicate that the residual structure modulates the stability of the denatured state up to 22 kcal mol(-1) and the parameters correlate with structural data for collagen complexed with fenugreek. The association constant of fenugreek is found to be 0.5807 M-1. The binding of fenugreek influences rearrangement of the collagen-water network, resulting in the transition from a disordered (high entropy) unbound state to a structured (lower entropy) bound state. Fenugreek concentration plays a crucial role in shaping up the free energy that governs the folding, structure and stability of collagen. Dielectric data emphasize the effect of hydrophobic and hydrophilic clusters on the side chain motion constraints. The thermoporometry technique probes the pore size distributions of the composites. These methods provide insights into the role of excluded volume, chain stiffness and stability of a new collagen-galactomannan based composite, expanding its utility in "smart biomaterial applications''.
C1 [Kanungo, Ivy; Fathima, Nishter Nishad; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Rao, JR (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM jrrao@clri.res.in
FU CSIR; CSIR under the Suprainstitutional Project-S&T Revolution in
   Leather with a Green Touch [CSC0201]
FX One of the authors (I. Kanungo) would like to acknowledge CSIR for
   providing senior research fellowship. The authors thank CSIR for funding
   under the Suprainstitutional Project-S&T Revolution in Leather with a
   Green Touch (CSC0201). CSIR communication code: 1077.
CR Antipova AS, 1999, COLLOID SURFACE B, V12, P261, DOI 10.1016/S0927-7765(98)00081-2
   Barnes FS, 2006, HDB BIOL EFFECTS ELE
   Cametti C, 2011, J PHYS CHEM B, V115, P7144, DOI 10.1021/jp2019389
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Garti N, 1997, FOOD SCI TECHNOL-LEB, V30, P305
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gratton SEA, 2008, ACCOUNTS CHEM RES, V41, P1685, DOI 10.1021/ar8000348
   Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   Jafarpour G, 2009, J NON-CRYST SOLIDS, V355, P1669, DOI 10.1016/j.jnoncrysol.2009.06.026
   Jezek J, 2011, ADV DRUG DELIVER REV, V63, P1107, DOI 10.1016/j.addr.2011.09.008
   Kaminski K, 2009, J PHYS CHEM B, V113, P10088, DOI 10.1021/jp809760t
   Kanungo I, 2014, CARBOHYD POLYM, V103, P250, DOI 10.1016/j.carbpol.2013.12.051
   Kanungo I, 2013, MAT SCI ENG C-MATER, V33, P4651, DOI 10.1016/j.msec.2013.07.020
   Kanungo I, 2013, MATER CHEM PHYS, V140, P357, DOI 10.1016/j.matchemphys.2013.03.049
   Khodadadi S, 2011, J PHYS CHEM B, V115, P6222, DOI 10.1021/jp1122213
   Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, V278, P113
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Lima CGA, 2006, MATER CHEM PHYS, V99, P284, DOI 10.1016/j.matchemphys.2005.10.027
   Manikoth R, 2012, CARBOHYD POLYM, V88, P628, DOI 10.1016/j.carbpol.2012.01.031
   Marion M., 2008, ADV ENG MATER, V10, P33
   Marzec E, 2005, BIOELECTROCHEMISTRY, V65, P89, DOI 10.1016/j.bioelechem.2004.10.001
   Mathur V, 2005, J SCI IND RES INDIA, V64, P475
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Myshakina NS, 2008, J PHYS CHEM B, V112, P11873, DOI 10.1021/jp8057355
   Orzechowski K, 2008, PHYSIOL MEAS, V29, pS321, DOI 10.1088/0967-3334/29/6/S27
   Pietrucha K, 2005, BIOPHYS CHEM, V118, P51, DOI 10.1016/j.bpc.2005.07.006
   Prado BA, 2005, J AGR FOOD CHEM, V53, P2823, DOI 10.1021/jf0485537
   Ray N, 2013, ZAMM-Z ANGEW MATH ME, V93, P811, DOI 10.1002/zamm.201200196
   REID JSG, 1973, PLANTA, V112, P301
   Shah N, 2011, EXPERT OPIN DRUG DEL, V8, P779, DOI 10.1517/17425247.2011.574121
   Shayegan M., 2013, PLOS ONE, V8, P1
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Smiechowski MF, 2006, BIOSENS BIOELECTRON, V22, P670, DOI 10.1016/j.bios.2006.02.008
   Srinivasan R, 2008, CHINESE J POLYM SCI, V26, P679, DOI 10.1142/S0256767908003424
   Sulea D, 2010, REV ROUM CHIM, V55, P543
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Turquois T, 1996, CARBOHYD POLYM, V31, P269, DOI 10.1016/S0144-8617(96)00031-8
   Wang ZD, 2013, CARBOHYD POLYM, V94, P505, DOI 10.1016/j.carbpol.2013.01.090
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xiao FJ, 2014, SPECTROCHIM ACTA A, V118, P1106, DOI 10.1016/j.saa.2013.09.074
   Xu X, 2007, CARBOHYD POLYM, V70, P192, DOI 10.1016/j.carbpol.2007.03.017
   Yalcin O, 2013, J PHYS CHEM B, V117, P8931, DOI 10.1021/jp402219t
NR 46
TC 6
Z9 6
U1 1
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JAN 28
PY 2015
VL 17
IS 4
BP 2778
EP 2793
DI 10.1039/c4cp04363d
PG 16
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA AX4MN
UT WOS:000346906700055
PM 25502597
DA 2018-10-20
ER

PT J
AU Griffin, MF
   Butler, PE
   Seifalian, AM
   Kalaskar, DM
AF Griffin, Michelle F.
   Butler, Peter E.
   Seifalian, Alexander M.
   Kalaskar, Deepak M.
TI Control of stem cell fate by engineering their micro and nanoenvironment
SO WORLD JOURNAL OF STEM CELLS
LA English
DT Review
DE Biomaterials; Scaffold; Stem cells; Surface topography; Tissue
   engineering
AB Stem cells are capable of long-term self-renewal and differentiation into specialised cell types, making them an ideal candidate for a cell source for regenerative medicine. The control of stem cell fate has become a major area of interest in the field of regenerative medicine and therapeutic intervention. Conventional methods of chemically inducing stem cells into specific lineages is being challenged by the advances in biomaterial technology, with evidence highlighting that material properties are capable of driving stem cell fate. Materials are being designed to mimic the clues stem cells receive in their in vivo stem cell niche including topographical and chemical instructions. Nanotopographical clues that mimic the extracellular matrix (ECM) in vivo have shown to regulate stem cell differentiation. The delivery of ECM components on biomaterials in the form of short peptides sequences has also proved successful in directing stem cell lineage. Growth factors responsible for controlling stem cell fate in vivo have also been delivered via biomaterials to provide clues to determine stem cell differentiation. An alternative approach to guide stem cells fate is to provide genetic clues including delivering DNA plasmids and small interfering RNAs via scaffolds. This review, aims to provide an overview of the topographical, chemical and molecular clues that biomaterials can provide to guide stem cell fate. The promising features and challenges of such approaches will be highlighted, to provide directions for future advancements in this exciting area of stem cell translation for regenerative medicine.
C1 [Griffin, Michelle F.; Butler, Peter E.; Seifalian, Alexander M.; Kalaskar, Deepak M.] UCL, Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, 9th Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
   [Butler, Peter E.] Royal Free Hampstead NHS Trust Hosp, Dept Plast & Reconstruct Surg, London NW3 2PF, England.
RP Kalaskar, DM (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, 9th Floor,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
EM d.kalaskar@ucl.ac.uk
OI Butler, Peter/0000-0001-7419-1493
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Andersen MO, 2010, MOL THER, V18, P2018, DOI 10.1038/mt.2010.166
   Bagasra O, 2004, J MOL HISTOL, V35, P545
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Basnar B, 2009, SMALL, V5, P28, DOI 10.1002/smll.200800583
   Beazley KE, 2014, BIOTECHNOL LETT, V36, P1901, DOI 10.1007/s10529-014-1551-0
   Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458
   Biehl JK, 2009, DEV DYNAM, V238, P1964, DOI 10.1002/dvdy.22030
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chuang CK, 2007, GENE THER, V14, P1417, DOI 10.1038/sj.gt.3302996
   Connelly JT, 2011, EUR CELLS MATER, V22, P168, DOI 10.22203/eCM.v022a13
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   D'Angelo F, 2010, EUR CELLS MATER, V20, P231
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987
   EMERMAN JT, 1979, TISSUE CELL, V11, P109, DOI 10.1016/0040-8166(79)90011-9
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Ferrand A, 2014, MACROMOL BIOSCI, V14, P45, DOI 10.1002/mabi.201300283
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Gandavarapu NR, 2013, ACTA BIOMATER, V9, P4525, DOI 10.1016/j.actbio.2012.09.007
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Hudalla GA, 2009, LANGMUIR, V25, P5737, DOI 10.1021/la804077t
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kantawong Fahsai, 2011, J Tissue Eng, V2011, P534603, DOI 10.4061/2011/534603
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Krebs MD, 2011, CHEM-EUR J, V17, P3054, DOI 10.1002/chem.201003144
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lafrenie RM, 1996, J CELL BIOCHEM, V61, P543, DOI 10.1002/(SICI)1097-4644(19960616)61:4<543::AID-JCB7>3.0.CO;2-O
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee SJ, 2010, BIOMATERIALS, V31, P5652, DOI 10.1016/j.biomaterials.2010.03.019
   Li JH, 2010, J BIOMED MATER RES A, V95A, P973, DOI 10.1002/jbm.a.32926
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Liu XJ, 2014, ACS APPL MATER INTER, V6, P9733, DOI 10.1021/am502170s
   Low WC, 2013, BIOMATERIALS, V34, P3581, DOI 10.1016/j.biomaterials.2013.01.093
   Lu David, 2016, Methods Mol Biol, V1307, P281, DOI 10.1007/7651_2014_81
   Lu HX, 2012, BIOMATERIALS, V33, P6140, DOI 10.1016/j.biomaterials.2012.05.038
   Luo W, 2008, LANGMUIR, V24, P12129, DOI 10.1021/la802836g
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   MERRY K, 1993, J CELL SCI, V104, P1013
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Morito A, 2009, ARCH HISTOL CYTOL, V72, P51, DOI 10.1679/aohc.72.51
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nimesh S, 2011, NANOMEDICINE-UK, V6, P729, DOI [10.2217/NNM.11.15, 10.2217/nnm.11.15]
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Pan HT, 2013, MAT SCI ENG C-MATER, V33, P3336, DOI 10.1016/j.msec.2013.04.019
   Park JS, 2011, BIOMATERIALS, V32, P3679, DOI 10.1016/j.biomaterials.2011.01.063
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peng LH, 2011, DRUG DISCOV TODAY, V16, P957, DOI 10.1016/j.drudis.2011.07.009
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001
   Rao Meenakshi, 2005, Birth Defects Res C Embryo Today, V75, P28, DOI 10.1002/bdrc.20030
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin YM, 2014, MACROMOL BIOSCI, V14, P1190, DOI 10.1002/mabi.201400023
   Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200
   STAATZ WD, 1990, J BIOL CHEM, V265, P4778
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Strauss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051264
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   van Dorp WF, 2012, ACS NANO, V6, P10076, DOI 10.1021/nn303793w
   Wang GC, 2011, TISSUE ENG PT A, V17, P1341, DOI [10.1089/ten.tea.2010.0497, 10.1089/ten.TEA.2010.0497]
   Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6
   Wilkinson AE, 2014, J BIOMED MATER RES A, V102, P3419, DOI 10.1002/jbm.a.35001
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
   Yang X, 2012, J BIOMED MATER RES A, DOI [10.1002/jbm.a.34064, DOI 10.1002/JBM.A.34064]
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 115
TC 33
Z9 33
U1 2
U2 15
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1948-0210
J9 WORLD J STEM CELLS
JI World J. Stem Cells
PD JAN 26
PY 2015
VL 7
IS 1
BP 37
EP 50
DI 10.4252/wjsc.v7.i1.37
PG 14
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA V64OT
UT WOS:000211111000004
PM 25621104
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lo, TY
   Wang, YJ
   Liu, DM
   Whang, WT
AF Lo, Teng-Yuan
   Wang, Yen-Jen
   Liu, Dean-Mo
   Whang, Wha-Tzong
TI Surface characteristics and biofunctionality of a novel
   high-performance, hydrophilic Jeffamine-added fluoro-containing
   polyimide for biomedical applications
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Fluoro-containing PI; Jeffamine; 6FPI-J(x) series; Biocompatibility;
   Surface biofunctionality
ID NANOSCALE ROUGHNESS; BLOCK-COPOLYMERS; FLUORINATED POLYIMIDE;
   POLY(ETHYLENE GLYCOL); BIOCOMPATIBILITY; ATTACHMENT; MEMBRANES;
   DELIVERY; FILMS
AB A brand-new class of Jeffamine-modified fluorocontaining polyimide (6FPI-J(x) series, where x ranges from 10, 20, and 30 % by weight) was developed in this study. The existing pristine fluoro-containing polyimide (6FPI) is a flexible and high-performance polymer with low surface energy for advanced engineering applications. Although it has been considered a promising biomaterial for its good blood compatibility, it has known to be toxic to normal cells. Here, we modified 6FPI [with -C (CF3)(2)-group on backbone] with a hydrophilic diamine monomer, Jeffamine, denoted as 6FPI-J(x), where x is the molar percentage of the total diamines. The newly synthesized 6FPI-J(x) series was systematically characterized in terms of surface properties included surface texture, chemistry, potential, and charging. Besides, the 6FPI-J(x) copolymer exhibited good mechanical and stability as pristine 6FPI. With the addition of Jeffamine (x=10 %), 6FPI-J(10) displayed considerably improved blood and cell compatibility compared to 6FPI, which was explainable as a combined effect of morphological texture and chemical environment of resulting surface. The new class of 6FPI-J(x) exhibited excellent solubility toward a number of organic solvents, which rendered the 6FPI-J(10) a great potential candidate as a biocompatible coating for implantable medical devices and also for potential therapeutic applications.
C1 [Lo, Teng-Yuan; Wang, Yen-Jen; Liu, Dean-Mo; Whang, Wha-Tzong] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30049, Taiwan.
RP Whang, WT (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30049, Taiwan.
EM wtwhang@mail.nctu.edu.tw
FU Ministry of Science and Technology, Taiwan [NSC 100-2221-E-009-023-MY3,
   MOST 103-2221-E-009-216]
FX This project is supported by the Ministry of Science and Technology,
   Taiwan, under Contract No. NSC 100-2221-E-009-023-MY3 and MOST
   103-2221-E-009-216.
CR ANANTHAPADMANABHAN KP, 1987, LANGMUIR, V3, P25, DOI 10.1021/la00073a005
   Bruck R, 2011, BIOSENS BIOELECTRON, V26, P3832, DOI 10.1016/j.bios.2011.02.042
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Chen J, 2005, GREEN CHEM, V7, P64, DOI 10.1039/b413546f
   Childress AE, 1996, J MEMBRANE SCI, V119, P253, DOI 10.1016/0376-7388(96)00127-5
   Choi JK, 2010, SYNTHETIC MET, V160, P1938, DOI 10.1016/j.synthmet.2010.07.013
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   FENTON DE, 1973, POLYMER, V14, P589, DOI 10.1016/0032-3861(73)90146-8
   Froimowicz P, 2012, MACROMOL RES, V20, P800, DOI 10.1007/s13233-012-0120-4
   HOUGHAM G, 1994, MACROMOLECULES, V27, P3642, DOI 10.1021/ma00091a028
   Hsiao YS, 2008, THIN SOLID FILMS, V516, P4258, DOI 10.1016/j.tsf.2007.12.166
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Julien S, 2011, BIOMATERIALS, V32, P3890, DOI 10.1016/j.biomaterials.2011.02.016
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Kawakami H, 2003, J BIOMED MATER RES A, V67A, P1393, DOI 10.1002/jbm.a.20052
   Kawakami H, 2008, J ARTIF ORGANS, V11, P177, DOI 10.1007/s10047-008-0427-2
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Kim SH, 2011, BIOMATERIALS, V32, P5505, DOI 10.1016/j.biomaterials.2011.04.017
   Melnik E, 2011, ANAL CHIM ACTA, V699, P206, DOI 10.1016/j.aca.2011.05.017
   Metz S, 2004, BIOSENS BIOELECTRON, V19, P1309, DOI 10.1016/j.bios.2003.11.021
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Myllymaa S, 2010, COLLOID SURFACE B, V76, P505, DOI 10.1016/j.colsurfb.2009.12.011
   Nagaoka S, 2001, INT J ARTIF ORGANS, V4, P107
   Nagarajan S, 1998, PURE APPL CHEM, V70, P1245, DOI 10.1351/pac199870061245
   Nakayama Y, 1999, BIOMATERIALS, V20, P963, DOI 10.1016/S0142-9612(98)00252-X
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Postiglione L, 2003, J DENT RES, V82, P692, DOI 10.1177/154405910308200907
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Qiu ZM, 2006, POLYMER, V47, P8444, DOI 10.1016/j.polymer.2006.10.031
   Quesnel R, 2005, MOLECULES, V10, P98, DOI 10.3390/10010098
   Rubehn B, 2010, BIOMATERIALS, V31, P3449, DOI 10.1016/j.biomaterials.2010.01.053
   Saeed MB, 2007, INT J ADHES ADHES, V27, P9, DOI 10.1016/j.ijadhadh.2005.12.001
   Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010
   Sen SK, 2009, J APPL POLYM SCI, V113, P1550, DOI 10.1002/app.30032
   Severcan F, 2000, TALANTA, V53, P55, DOI 10.1016/S0039-9140(00)00379-9
   Tian WW, 2003, EUR POLYM J, V39, P1935, DOI 10.1016/S0014-3057(03)00091-0
   Tsai MH, 2013, THIN SOLID FILMS, V544, P324, DOI 10.1016/j.tsf.2013.02.105
   Tsai MH, 2011, THIN SOLID FILMS, V519, P5238, DOI 10.1016/j.tsf.2011.01.167
   Wang CY, 2009, POLYM DEGRAD STABIL, V94, P1526, DOI 10.1016/j.polymdegradstab.2009.04.032
   Xiao S, 2007, MACROMOL CHEM PHYSIC, V208, P2665, DOI 10.1002/macp.200700328
   Yang CY, 2005, J VAC SCI TECHNOL A, V23, P862, DOI 10.1116/1.1868632
   Yang CY, 2006, J ELECTROCHEM SOC, V153, P120
   Yuan J, 2004, POLYM INT, V53, P1722, DOI 10.1002/pi.1545
   Zimmermann J, 2002, BIOMATERIALS, V23, P2121
   Zivanovic S, 2007, BIOMACROMOLECULES, V8, P1505, DOI 10.1021/bm061140p
NR 45
TC 6
Z9 6
U1 3
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD JAN 24
PY 2015
VL 22
IS 2
AR 4
DI 10.1007/s10965-014-0628-8
PG 12
WC Polymer Science
SC Polymer Science
GA CD7WF
UT WOS:000351305100002
DA 2018-10-20
ER

PT J
AU Khajuria, DK
   Razdan, R
   Mahapatra, DR
AF Khajuria, Deepak Kumar
   Razdan, Rema
   Mahapatra, Debiprosad Roy
TI Development, in vitro and in vivo characterization of zoledronic acid
   functionalized hydroxyapatite nanoparticle based formulation for
   treatment of osteoporosis in animal model
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Rat model; Postmenopausal osteoporosis; Zoledronic acid; Hydroxyapatite
   nanoparticles
ID MESENCHYMAL STEM-CELLS; OVARIECTOMIZED RATS; DRUG-DELIVERY; BONE
   TURNOVER; BISPHOSPHONATE; OSTEOINDUCTIVITY; ALFACALCIDOL; PROPRANOLOL;
   BIOMATERIAL; ALENDRONATE
AB We investigated the potential of using novel zoledronic acid (ZOL)-hydroxyapatite (HA) nanoparticle based drug formulation in a rat model of postmenopausal osteoporosis. By a classical adsorption method, nanoparticles of HA loaded with ZOL (HNLZ) drug formulation with a size range of 100-130 nm were prepared. 56 female Wistar rats were ovariectomized (OVX) or sham-operated at 3 months of age. Twelve weeks post surgery, rats were randomized into seven groups and treated with various doses of HNLZ (100, 50 and 25 mu g/kg, intravenous single dose), ZOL (100 mu g/kg, intravenous single dose) and HA nanoparticle (100 mu g/kg, intravenous single dose). Untreated OVX and sham OVX served as controls. After three months treatment period, we evaluated the mechanical properties of the lumbar vertebra and femoral mid-shaft. Femurs were also tested for trabecular microarchitecture. Sensitive biochemical markers of bone formation and bone resorption in serum were also determined. With respect to improvement in the mechanical strength of the lumbar spine and the femoral mid-shaft, the therapy with HNLZ drug formulation was more effective than ZOL therapy in OVX rats. Moreover, HNLZ drug therapy preserved the trabecular microarchitecture better than ZOL therapy in OVX rats. Furthermore, the HNLZ drug formulation corrected increase in serum levels of bone-specific alkaline phosphatase, procollagen type I N-terminal propeptide, osteocalcin, tartrate-resistant acid phosphatase 5b and C-telopeptide of type 1 collagen better than ZOL therapy in OVX rats. The results strongly suggest that HNLZ novel drug formulation appears to be more effective approach for treating severe osteoporosis in humans. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Khajuria, Deepak Kumar; Razdan, Rema] Al Ameen Coll Pharm, Dept Pharmacol, Bangalore 560027, Karnataka, India.
   [Khajuria, Deepak Kumar; Mahapatra, Debiprosad Roy] Indian Inst Sci, Dept Aerosp Engn, Lab Integrat Multiscale Engn Mat & Syst, Bangalore 560012, Karnataka, India.
RP Khajuria, DK (reprint author), Al Ameen Coll Pharm, Dept Pharmacol, Bangalore 560027, Karnataka, India.
EM deepak_kumarkhajuria@yahoo.co.in
OI /0000-0002-3737-8504
FU Indian Council of Medical Research (ICMR), Govt. of India, New Delhi
   [45/35/2010-PHA/BMS]
FX Authors would wholeheartedly thank Prof. B.G. Shivananda, Principal,
   Al-Ameen College of Pharmacy for his kind support and encouragement to
   carry out this project. Authors gratefully acknowledge financial support
   and granting research fellowship (File No: 45/35/2010-PHA/BMS) from
   Indian Council of Medical Research (ICMR), Govt. of India, New Delhi.
   Authors are thankful to Mr. B.K. Jain, Naprod Life Sciences,
   Maharashtra, India for providing gift sample of Zoledronic acid. Authors
   also gratefully acknowledge the contribution of Mr. Shashishekarayya
   Hiremath, Mr. Vijay Kumar, Mr. Anil Krishna Konduri, Mr. Aman Chandra,
   and Mr. Manish Kumar Priydarshi from Department of Aerospace
   Engineering, Indian Institute of Science, in carrying out the X-ray
   imaging, three point-bending and compression tests.
CR Aoki H, 2000, J Mater Sci Mater Med, V11, P67, DOI 10.1023/A:1008993814033
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Fernandez-Pareja A, 2007, CLIN DRUG INVEST, V27, P227, DOI 10.2165/00044011-200727040-00001
   Fox K, 2012, CHEMPHYSCHEM, V13, P2495, DOI 10.1002/cphc.201200080
   Gomes AJ, 2007, INT J PHARM, V332, P153, DOI 10.1016/j.ijpharm.2006.09.035
   Hengst V, 2007, INT J PHARM, V331, P224, DOI 10.1016/j.ijpharm.2006.11.024
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kalu DK, 1991, BONE MINER, V1991, P175
   Khajuria D.K., 2014, J ORTHOP SC IN PRESS, V10
   Khajuria D.K., 2013, SCI PHARM IN PRESS, V10
   Khajuria D.K., 2014, J OSTEOPOROS, V2014
   Khajuria DK, 2013, LAT AM J PHARM, V32, P968
   Khajuria DK, 2013, J ORTHOP SCI, V18, P832, DOI 10.1007/s00776-013-0433-y
   Khajuria DK, 2012, REV BRAS REUMATOL, V52, P462
   Khajuria DK, 2011, REV BRAS REUMATOL, V51, P365
   Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu Li-Ping, 2005, Wei Sheng Yan Jiu, V34, P474
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   McLeod K, 2006, J BIOMED MATER RES A, V79A, P271, DOI 10.1002/jbm.a.30792
   Ong HT, 2008, J NANOPART RES, V10, P141, DOI 10.1007/s11051-007-9239-1
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Papapoulos SE, 2008, BEST PRACT RES CL EN, V22, P831, DOI 10.1016/j.beem.2008.07.001
   Pignatello R, 2009, NANOMEDICINE-UK, V4, P161, DOI 10.2217/17435889.4.2.161
   Power RA, 2004, OSTEOPOROSIS INT, V15, P716, DOI 10.1007/s00198-004-1595-4
   Rao BM, 2005, J PHARMACEUT BIOMED, V39, P781, DOI 10.1016/j.jpba.2005.04.012
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Saleh A, 2013, ORTHOP CLIN N AM, V44, P137, DOI 10.1016/j.ocl.2013.01.001
   Shirke SS, 2008, EXP BIOL MED, V233, P1403, DOI 10.3181/0803-RM-93
   Singer FR, 2008, CLEV CLIN J MED, V75, P739, DOI 10.3949/ccjm.75.10.739
   Sorensen TC, 2013, J BIOMATER APPL, V27, P727, DOI 10.1177/0885328211424623
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Becerril NV, 2013, J AUST CERAM SOC, V49, P112
   Ye F, 2010, ACTA BIOMATER, V6, P2212, DOI 10.1016/j.actbio.2009.12.014
   Zhang Y, 2007, BIOL PHARM BULL, V30, P898, DOI 10.1248/bpb.30.898
NR 39
TC 19
Z9 19
U1 1
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JAN 23
PY 2015
VL 66
BP 173
EP 183
DI 10.1016/j.ejps.2014.10.015
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AX7ZP
UT WOS:000347130500022
PM 25444840
DA 2018-10-20
ER

PT J
AU Han, KS
   Song, JE
   Kang, SJ
   Lee, D
   Khang, G
AF Han, Kap-Soo
   Song, Jeong Eun
   Kang, Su Ji
   Lee, Dongwon
   Khang, Gilson
TI Effect of demineralized bone particle/poly(lactic-co-glycolic acid)
   scaffolds on the attachment and proliferation of mesenchymal stem cells
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE mesenchymal stem cells; proliferation; demineralized bone particle;
   intervertebral disc; poly(lactide-co-glycolide)
ID INTERVERTEBRAL DISC DEGENERATION; PLGA/DBP HYBRID SCAFFOLD; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; MATRIX; MODEL; RAT; THERAPY; REGENERATION;
   VIVO
AB The aim of this study was to investigate the effect of demineralized bone particle/ poly(lactic-co-glycolic acid) (DBP/PLGA) scaffolds on the proliferation of mesenchymal stem cells (MSCs). DBP/PLGA hybrid scaffolds were fabricated by solvent casting/salt-leaching with DBP contents of 0, 20, 40, and 80 wt%. MSCs were seeded on the DBP/PLGA scaffolds and then evaluated by a series of analytical process: SEM, MTT, RT-PCR, and in vivo histological assay. As the DBP contents increased, the cell attachment behavior and cell viability also increased. A DBP content of 80 wt% marked the best water absorption performance and the highest cell viability. Gene expression of aggrecan on DBP/PLGA scaffolds tended to increase, whereas that on PLGA scaffolds was decreased at 1week. However, strong expression of aggrecan was observed at 2weeks regardless of the contents of DBP. Scaffolds showed a trend of increasing type II and I collagen at 2weeks. The results showed that MSCs on DBP/PLGA scaffolds showed more efficient cell proliferation and tissue formation in the presence of tissue-inductive stimuli. Suitable biomaterials could be more conducive to proliferation of MSCs. These results suggest that the DBP/PLGA scaffolds are a feasible biomaterial for intervertebral disc regeneration.
C1 [Han, Kap-Soo] Chonbuk Natl Univ, Sch Med, Jeonju 561180, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept Polymer Nano Sci & Technol, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Kang, Su Ji; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, Jeonju 561756, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea.
EM gskhang@jbnu.ac.kr
RI song, jeong eun/P-9106-2015; Khang, Gilson/B-2109-2013
OI song, jeong eun/0000-0001-6879-7616; 
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean government (MEST) [2012M3A9C6050204];
   Industry, University and Research Institute Core Technology development
   & Industrialized Supporting Business
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by Korean
   government (MEST) (2012M3A9C6050204), and Industry, University and
   Research Institute Core Technology development & Industrialized
   Supporting Business conducted by Jeonbuk province in 2013.
CR BOKORI J, 1980, MAGY ALLATORVOSOK, V35, P44
   Boxberger JI, 2006, J ORTHOP RES, V24, P1906, DOI 10.1002/jor.20221
   Boyd L, 2006, EUR SPINE J, V15, P414
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Cartmell SH, 2014, J BIOMED MATER RES A, V102, P1047, DOI 10.1002/jbm.a.34790
   CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   Chen D, 2004, FRONT BIOSCI, V9, P349, DOI 10.2741/1090
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825
   Freemont AJ, 2002, J PATHOL, V196, P374, DOI 10.1002/path.1050
   Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21
   Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040
   HANAMURA H, 1980, CLIN ORTHOP RELAT R, P281
   Huang SS, 2011, CURR STEM CELL RES T, V6, P317, DOI 10.2174/157488811797904335
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Kim HE, 2012, MACROMOL RES, V20, P1044, DOI 10.1007/s13233-012-0148-5
   Kim SH, 2011, J BIOMATER SCI POLYM, V29, P31
   Kim SH, 2006, ADV EXP MED BIOL, V585, P167
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Ko YK, 2007, POLYM-KOREA, V31, P14
   Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Munirah S, 2008, J BIOMAT SCI-POLYM E, V19, P1219
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   Omlor GW, 2012, EUR SPINE J, V21, P1700, DOI 10.1007/s00586-012-2291-2
   Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]
   Preradovic A, 2005, CELL TISSUE RES, V321, P459, DOI 10.1007/s00441-005-1116-6
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Rui YF, 2012, INT ORTHOP, V36, P1099, DOI 10.1007/s00264-011-1417-1
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Shoukry M, 2013, STEM CELLS DEV, V22, P1162, DOI 10.1089/scd.2012.0597
   Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011
   Vadala G, 2013, J TISSUE ENG REGEN M
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3
   Woo Y., 2012, INT J TISSUE REGEN, V3, P63
   Yang D. H., 2011, INT J TISSUE REGEN, V2, P119
   Yerramalli CS, 2007, BIOMECH MODEL MECHAN, V6, P13, DOI 10.1007/s10237-006-0043-0
   Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34
NR 48
TC 7
Z9 7
U1 0
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 22
PY 2015
VL 26
IS 2
BP 92
EP 110
DI 10.1080/09205063.2014.982930
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU8ID
UT WOS:000345838900002
PM 25431827
DA 2018-10-20
ER

PT J
AU Saini, M
   Singh, Y
   Arora, P
   Arora, V
   Jain, K
AF Saini, Monika
   Singh, Yashpal
   Arora, Pooja
   Arora, Vipin
   Jain, Krati
TI Implant biomaterials: A comprehensive review
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE Biomaterials; Zirconium; Surface roughness; Ceramic; Corrosion
AB Appropriate selection of the implant biomaterial is a key factor for long term success of implants. The biologic environment does not accept completely any material so to optimize biologic performance, implants should be selected to reduce the negative biologic response while maintaining adequate function. Every clinician should always gain a thorough knowledge about the different biomaterials used for the dental implants. This article makes an effort to summarize various dental biomaterials which were used in the past and as well as the latest material used now.
C1 [Saini, Monika; Singh, Yashpal] Al Qaseem Pvt Coll, Dept Oral & Maxillofacial Rehabil, POB 156, Buraydah 51431, Qassim, Saudi Arabia.
   [Arora, Pooja; Jain, Krati] Subharati Dent Coll, Dept Prosthodont, Meerut 250003, Uttar Pradesh, India.
   [Arora, Vipin] Subharati Dent Coll, Dept Operat Dent & Endodont, Meerut 250003, Uttar Pradesh, India.
RP Singh, Y (reprint author), Al Qaseem Pvt Coll, Dept Oral & Maxillofacial Rehabil, POB 156, Buraydah 51431, Qassim, Saudi Arabia.
EM dryashpal.singh@gmail.com
CR Adatia ND, 2009, J PROSTHODONT, V18, P17, DOI 10.1111/j.1532-849X.2008.00378.x
   Adya N., 2005, J INDIAN PROSTHODONT, V5, P126, DOI DOI 10.4103/0972-4052.17104
   ARVIDSON K, 1987, SCAND J DENT RES, V95, P356
   ASHMAN A, 1971, J PROSTHET DENT, V25, P342, DOI 10.1016/0022-3913(71)90197-1
   Block MS, 1997, IMPLANTS DENT, P4
   Carvalho TLL, 1997, INT J ORAL MAX SURG, V26, P149, DOI 10.1016/S0901-5027(05)80838-0
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Chiapasco M, 2012, CLIN ORAL IMPLAN RES, V23, P1136, DOI 10.1111/j.1600-0501.2011.02296.x
   Cranin AN, 1982, BIOCOMPATIBILITY DEN, V4, P92
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   GETTLEMAN L, 1977, J PROSTHET DENT, V37, P74, DOI 10.1016/0022-3913(77)90195-0
   HODOSH M, 1969, J PROSTHET DENT, V22, P371, DOI 10.1016/0022-3913(69)90200-5
   Hoffmann O, 2008, INT J ORAL MAX IMPL, V23, P691
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   HULBERT SF, 1975, J DENT RES, V54, pB153, DOI 10.1177/00220345750540021001
   KAWAHARA H, 1983, INT DENT J, V33, P350
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   LEMONS JE, 1990, J AM DENT ASSOC, V121, P716, DOI 10.14219/jada.archive.1990.0268
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Misch CE, 1999, IMPLANT DENT, V8, P90, DOI DOI 10.1097/00008505-199901000-00013
   Muddugangadhar B., 2011, INT J ORAL IMPLANTOL, V2, P13, DOI DOI 10.5005/JP-JOURNALS-10012-1030
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Phillips R. W., 1982, SKINNERS SCI DENT MA
   Prithviraj D R, 2012, Indian J Dent Res, V23, P643, DOI 10.4103/0970-9290.107383
   RAVNHOLT G, 1988, SCAND J DENT RES, V96, P466
   SHKLAR G, 1970, J PROSTHET DENT, V24, P636, DOI 10.1016/0022-3913(70)90100-9
   Smith D C, 1993, Int J Prosthodont, V6, P106
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
   WAERHAUG J., 1956, ORAL SURG ORAL MED AND ORAL PATHOL, V9, P46, DOI 10.1016/0030-4220(56)90173-6
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   WILLIAMS DF, 1981, BIOMATERIALS, V2, P133, DOI 10.1016/0142-9612(81)90039-9
NR 34
TC 61
Z9 63
U1 6
U2 33
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD JAN 16
PY 2015
VL 3
IS 1
BP 52
EP 57
DI 10.12998/wjcc.v3.i1.52
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA VB7SD
UT WOS:000417235100006
PM 25610850
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yan, LP
   Silva-Correia, J
   Oliveira, MB
   Vilela, C
   Pereira, H
   Sousa, RA
   Mano, JF
   Oliveira, AL
   Oliveira, JM
   Reis, RL
AF Yan, Le-Ping
   Silva-Correia, Joana
   Oliveira, Mariana B.
   Vilela, Carlos
   Pereira, Helder
   Sousa, Rui A.
   Mano, Joao F.
   Oliveira, Ana L.
   Oliveira, Joaquim M.
   Reis, Rui L.
TI Bilayered silk/silk-nanoCaP scaffolds for osteochondral tissue
   engineering: In vitro and in vivo assessment of biological performance
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bilayered scaffold; Silk fibroin; Calcium phosphate; Osteochondral
   regeneration; Nanocomposite
ID CALCIUM-PHOSPHATE SCAFFOLDS; MESENCHYMAL STEM-CELLS; MARROW STROMAL
   CELLS; SILK-BASED SCAFFOLDS; ARTICULAR-CARTILAGE; MACRO/MICROPOROUS
   SILK; BIOMATERIAL SCAFFOLDS; COMPOSITE SCAFFOLD; SUBCHONDRAL BONE;
   REPAIR
AB Novel porous bilayered scaffolds, fully integrating a silk fibroin (SF) layer and a silk-nano calcium phosphate (silk-nanoCaP) layer for osteochondral defect (OCD) regeneration, were developed. Homogeneous porosity distribution was achieved in the scaffolds, with calcium phosphate phase only retained in the silk-nanoCaP layer. The scaffold presented compressive moduli of 0.4 MPa in the wet state. Rabbit bone marrow mesenchymal stromal cells (RBMSCs) were cultured on the scaffolds, and good adhesion and proliferation were observed. The silk-nanoCaP layer showed a higher alkaline phosphatase level than the silk layer in osteogenic conditions. Subcutaneous implantation in rabbits demonstrated weak inflammation. In a rabbit knee critical size OCD model, the scaffolds firmly integrated into the host tissue. Histological and immunohistochemical analysis showed that collagen II positive cartilage and glycosaminoglycan regeneration presented in the silk layer, and de novo bone ingrowths and vessel formation were observed in the silk-nanoCaP layer. These bilayered scaffolds can therefore be promising candidates for OCD regeneration. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yan, Le-Ping; Silva-Correia, Joana; Oliveira, Mariana B.; Vilela, Carlos; Pereira, Helder; Sousa, Rui A.; Mano, Joao F.; Oliveira, Ana L.; Oliveira, Joaquim M.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Yan, Le-Ping; Silva-Correia, Joana; Oliveira, Mariana B.; Vilela, Carlos; Pereira, Helder; Sousa, Rui A.; Mano, Joao F.; Oliveira, Ana L.; Oliveira, Joaquim M.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Vilela, Carlos] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4719 Braga, Portugal.
   [Vilela, Carlos] Ctr Hosp Alto Ave, Dept Orthoped, Guimaraes, Portugal.
   [Pereira, Helder] Univ Minho, Saude Atlantica Sports Ctr, FC Porto Stadium, Oporto, Portugal.
   [Pereira, Helder] Univ Porto, Res Ctr, P-4100 Oporto, Portugal.
   [Pereira, Helder] Ctr Hosp Povoa Varzim, Dept Orthoped, Vila Do Conde, Portugal.
   [Oliveira, Ana L.] Portuguese Catholic Univ, Sch Biotechnol, CBQF Ctr Biotechnol & Fine Chem, P-4200072 Oporto, Portugal.
RP Oliveira, JM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Silva-Correia, Joana/D-4980-2012; Oliveira, Joaquim Miguel/H-8636-2012;
   Oliveira, Mariana/H-6933-2017; Oliveira, Mariana/A-1440-2014; Mano,
   Joao/A-4418-2009; Oliveira, Ana/J-3404-2013; Group, 3Bs/E-4374-2012;
   Reis, Rui L./A-8938-2008
OI Silva-Correia, Joana/0000-0003-1312-3109; Oliveira, Joaquim
   Miguel/0000-0001-7052-8837; Oliveira, Mariana/0000-0002-6104-6075;
   Oliveira, Mariana/0000-0002-6104-6075; Mano, Joao/0000-0002-2342-3765;
   Oliveira, Ana/0000-0001-8012-4203; Group, 3Bs/0000-0002-5195-3456; Reis,
   Rui L./0000-0002-4295-6129; Yan, Leping/0000-0002-4806-5052; Sousa,
   Rui/0000-0003-0362-7418
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/105703/2008, PTDC/CTM-BPC/115977/2009]; European Union
   [REGPOT-CT2012-316331-POLARIS]; FCT PhD scholarship
   [SFRH/BD/64717/2009]; FCT program [IF/00423/2012]
FX This study was funded by the Portuguese Foundation for Science and
   Technology (FCT) projects Tissue2Tissue (PTDC/CTM/105703/2008) and
   OsteoCart (PTDC/CTM-BPC/115977/2009), as well as the European Union's
   FP7 Programme under grant agreement no REGPOT-CT2012-316331-POLARIS. The
   authors are grateful to Viviana P. Ribeiro and Teresa Oliveira for the
   assistance with the immunohistochemical staining. L-P.Y. was awarded a
   FCT PhD scholarship (SFRH/BD/64717/2009). The FCT distinction attributed
   to J.M.O. under the Investigator FCT program (IF/00423/2012) is also
   greatly acknowledged.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bedi A, 2010, CARTILAGE, V1, P20, DOI 10.1177/1947603509355970
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bitton Ryan, 2009, Am J Manag Care, V15, pS230
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kon E, 2012, J BONE JOINT SURG AM
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   McMahon LA, 2008, REGEN MED, V3, P743, DOI 10.2217/17460751.3.5.743
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Oliveira AL, 2006, 20 EUR C BIOM NANT 2
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira JM, 2009, J BIOMED MATER RES A, V91A, P175, DOI 10.1002/jbm.a.32213
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Reyes R, 2014, J TISSUE ENG REGEN M, V8, P521, DOI 10.1002/term.1549
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Weil Lowell Jr, 2011, Foot Ankle Spec, V4, P249, DOI 10.1177/1938640011415373
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yan LP, 2014, KEY ENG MATER, V587, P245, DOI 10.4028/www.scientific.net/KEM.587.245
   Yan LP, 2013, J BIOACT COMPAT POL, V28, P439, DOI 10.1177/0883911513503538
   Yan LP, 2013, NANOMEDICINE-UK, V8, P359, DOI [10.2217/NNM.12.118, 10.2217/nnm.12.118]
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
NR 57
TC 42
Z9 43
U1 6
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2015
VL 12
BP 227
EP 241
DI 10.1016/j.actbio.2014.10.021
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA1QF
UT WOS:000348686100024
PM 25449920
DA 2018-10-20
ER

PT J
AU Minagar, S
   Li, YC
   Berndt, CC
   Wen, C
AF Minagar, Sepideh
   Li, Yuncang
   Berndt, Christopher C.
   Wen, Cuie
TI The influence of titania-zirconia-zirconium titanate nanotube
   characteristics on osteoblast cell adhesion
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanotube; Titania (TiO2); Zirconia (ZrO2); Zirconium titanate (ZrTiO4);
   Osteoblast cell response
ID SURFACE-TOPOGRAPHY; TIO2 NANOTUBES; TERM ADHESION; ANODIZATION;
   CHEMISTRY; ROUGHNESS; ALLOY; TIZR; FABRICATION; BEHAVIOR
AB Studies of biomaterial surfaces and their influence on cell behavior provide insights concerning the design of surface physicochemical and topography properties of implant materials. Fabrication of biocompatible metal oxide nanotubes on metallic biomaterials, especially titanium alloys such as Ti50Zr via anodization, alters the surface chemistry as well as surface topography of the alloy. In this study, four groups of TiO2-ZrO2-ZrTiO4 nanotubes that exhibit diverse nanoscale dimensional characteristics (i.e. inner diameter D-i, outer diameter Do and wall thicknesses W-t) were fabricated via anodization. The nanotubes were annealed and characterized using scanning electron microscopy and 3-D profilometry. The potential applied during anodization influenced the oxidation rate of titanium and zirconium, thereby resulting in different nanoscale characteristics for the nanotubes. The different oxidation and dissolution rates both led to changes in the surface roughness parameters. The in vitro cell response to the nanotubes with different nanoscale dimensional characteristics was assessed using osteoblast cells (SaOS2). The results of the MTS assay indicated that the nanotubes with inner diameter (D-i) approximate to 40 nm exhibited the highest percentage of cell adhesion of 41.0%. This result can be compared to (i) 25.9% cell adhesion at D-i approximate to 59 nm, (ii) 33.1% at D-i approximate to 64 nm, and (iii) 33.5% at D-i approximate to 82 nm. The nanotubes with D-i approximate to 59 nm exhibited the greatest roughness parameter of Sa (mean roughness), leading to the lowest ability to interlock with SaOS2 cells. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Minagar, Sepideh; Berndt, Christopher C.; Wen, Cuie] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
   [Li, Yuncang] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia.
   [Berndt, Christopher C.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.
RP Wen, C (reprint author), Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
EM cwen@swin.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772; Minagar, Sepideh/0000-0002-0822-3239
FU Australian Research Council (ARC) through the ARC Discovery Project
   [DP110101974]; State Government of Victoria, Australia through a
   Victorian International Research Scholarship
FX This research is supported by the Australian Research Council (ARC)
   through the ARC Discovery Project DP110101974. S.M. would like to
   acknowledge the State Government of Victoria, Australia, for supporting
   and funding this research project through a Victorian International
   Research Scholarship.
CR Alexander J. F. S. a. W., 2000, CRC MAT SCI ENG HDB
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2011, OSTEOPOROSIS INT, V22, P2037, DOI 10.1007/s00198-011-1618-x
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Capellato P, 2012, MAT SCI ENG C-MATER, V32, P2060, DOI 10.1016/j.msec.2012.05.013
   Chen XB, 2008, BIOTECHNOL BIOENG, V101, P378, DOI 10.1002/bit.21900
   Choe HC, 2011, THIN SOLID FILMS, V519, P4652, DOI 10.1016/j.tsf.2011.01.011
   DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Grigorescu S, 2014, BIOELECTROCHEMISTRY, V98, P39, DOI 10.1016/j.bioelechem.2014.03.002
   Jha H, 2010, ELECTROCHIM ACTA, V55, P8883, DOI 10.1016/j.electacta.2010.07.098
   Kim SE, 2008, ELECTROCHIM ACTA, V53, P4846, DOI 10.1016/j.electacta.2008.02.005
   Kim WG, 2009, T NONFERR METAL SOC, V19, P1005, DOI 10.1016/S1003-6326(08)60396-9
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Minagar S, 2014, J MATER CHEM B, V2, P71, DOI 10.1039/c3tb21204a
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shin D.H., 2011, NANOTECHNOLOGY, V22
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Veeco Instruments Inc, 2009, VIS FOR PROF
   Yasuda K, 2007, J ELECTROCHEM SOC, V154, pC472, DOI 10.1149/1.2749091
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
   Zhang WY, 2009, SMALL, V5, P1742, DOI 10.1002/smll.200900148
NR 32
TC 21
Z9 21
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2015
VL 12
BP 281
EP 289
DI 10.1016/j.actbio.2014.10.037
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA CA1QF
UT WOS:000348686100029
PM 25448349
DA 2018-10-20
ER

PT J
AU Kumar, D
   Akhtar, SN
   Patel, AK
   Ramkumar, J
   Balani, K
AF Kumar, Dharmesh
   Akhtar, Syed Nadeem
   Patel, Anup Kumar
   Ramkumar, J.
   Balani, Kantesh
TI Tribological performance of laser peened Ti-6Al-4V
SO WEAR
LA English
DT Article
DE Fretting; Other materials (Ti-6Al-4V); Laser processing; Profilometry;
   Residual stress; Stick-slip
ID ALLOYS; ABLATION
AB Ti-6Al-4V is a well-known metallic biomaterial used for implants, but its use is limited by its inferior hardness and tribological resistance in vivo. Laser peening (LP) is one potential means to enhance its tribological properties. LP induces surface residual compressive stresses due to plastic deformation caused by the propagation of a shock wave. Further, performing laser peening under water can enhance a material's hardness and wear resistance because it confines shock waves to the surface of the material. In the current research, the influence of an excimer laser (Kr-F, 248 nm) with varying fluence on the fretting behavior of Ti-6Al-4V was carried out. An optimized laser fluence of 100 J/cm(2) resulted in an increase in hardness by 28% in air and 35% in water confining media, respectively, when compared to that of an untreated Ti-6Al-4V substrate. It was observed that the residual compressive stresses from LP increased from 540 MPa in air to 604 MPa in water. Fretting wear against bearing steel type AISI E52100 shows a major wear reduction on LP Ti-6Al-4V samples as wear volume decreased from 1.211 x 10(-3) mm(3) to either 0.139 x 10(-3) mm(3) or to 0.106 x 10(-3) mm(3) in samples peened in air and water, respectively. Frictional hysteresis data show that the dissipation energy loss for Ti-6Al-4V substrate from 11.412 x 10(-4) J is decreased to 3.284 x 10(-4) J for LP sample at 20 N load. Moreover, a considerable fall in contact diameter is observed from the non-processed surface (0.29 x 10(-3) mu m) to the LP sample (0.176 x 10(-3) mu m). Friction log plots indicate that wear mechanisms are mostly adhesion, abrasion and delamination. Enhanced tribological performance of LP Ti-6Al-4V was observed using LP in a water medium, and indicates potential improvements when the alloy is used in joint replacements. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kumar, Dharmesh] Indian Inst Technol, Mat Sci Programme, Kanpur 208016, Uttar Pradesh, India.
   [Akhtar, Syed Nadeem; Ramkumar, J.] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
   [Patel, Anup Kumar; Balani, Kantesh] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
RP Balani, K (reprint author), Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.
EM kbalani@iitk.ac.in
OI Balani, Kantesh/0000-0003-0619-9164
CR Ageev V.A., 1997, J APPL SPECTROSC, P64
   BALLARD P, 1991, J PHYS IV, V1, P487, DOI 10.1051/jp4:1991369
   Ballard P, 1991, THESIS ECOLE POLYTEC
   Bhushan B., 1991, HDB TRIBOLOGY MAT CO, P155
   Boyer R, 1994, MAT PROPERTIES HDB T, V42, P1339
   Buckley D.H., 1981, SURFACE EFFECTS ADHE, P220
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   Holt John M., 1996, STRUCTURAL ALLOYS HD
   IHLEMANN J, 1992, APPL PHYS A-MATER, V54, P363, DOI 10.1007/BF00324203
   Kolsky H., 1963, STRESS WAVES SOLIDS, P177
   Mallozi P. I., 1974, US Patent, Patent No. [3 850 698, 3850698]
   Menezes PL, 2008, SADHANA-ACAD P ENG S, V33, P181, DOI 10.1007/s12046-008-0011-8
   Meyers M. A., 1994, DYNAMIC BEHAV MAT
   Montross CS, 2002, INT J FATIGUE, V24, P1021, DOI 10.1016/S0142-1123(02)00022-1
   Moore A.J.W., P ROYAL SOC LONDON M, V212, P452
   Moroz E.M., 1963, SOVIET PHYS JETP USS, V17, P1463
   Payre P., 1995, OPT QUANT ELECTRON, V27, P1213
   Qu J., 2004, WEAR, V126, P1348
   See D., 2003, P 8 NAT TURB ENG HIG
   Sikdar K, 2014, WEAR, V318, P177, DOI 10.1016/j.wear.2014.06.012
   Stachowiak G., 2013, ENG TRIBOLOGY, P525
   Swaminathan V, 2012, BIOMATERIALS, V33, P5487, DOI 10.1016/j.biomaterials.2012.04.015
   Trdan U, 2012, SURF COAT TECH, V208, P109, DOI 10.1016/j.surfcoat.2012.08.048
   VINCENT L, 1994, MAT FRETTING, P323
   Waterhouse R.B, RESIDUAL STRESSES FR, VIV
   Welsch Gerhard, MAT PROPERTIES HDB T, P101
   Ye C., 2010, ADV ENG MAT, V12
   Zhu S, 2001, J APPL PHYS, V89, P2400, DOI 10.1063/1.1342200
NR 28
TC 19
Z9 19
U1 1
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JAN 15
PY 2015
VL 322
BP 203
EP 217
DI 10.1016/j.wear.2014.11.016
PG 15
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA CA4PD
UT WOS:000348886000020
DA 2018-10-20
ER

PT J
AU Ye, XX
   Tse, ZTH
   Tang, GY
   Song, GL
AF Ye, Xiaoxin
   Tse, Zion T. H.
   Tang, Guoyi
   Song, Guolin
TI The effect of electropulsing induced gradient topographic oxide coating
   of Ti-Al-V alloy strips on the fibroblast adhesion and growth
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Electropulsing effect; Gradient topographic coating; Titanium alloy;
   Biocompatibility; Biomedical application
ID TI-6AL-4V ALLOY; TITANIUM-ALLOY; IN-VITRO; MECHANICAL-PROPERTIES; CARBON
   NANOTUBES; PART II; MICROSTRUCTURE; BIOCOMPATIBILITY; PHASE; CELLS
AB The effects of electropulsing induced gradient topographic oxide coating of Ti-Al-V alloy matrix strips on the fibroblast adhesion and growth were investigated. The goal in biomaterial surface modification was to possess desired recognition and specificity through modifying its surface condition like topological structure. Here we developed a unique strategy of high-energy electropulsing treatment (EPT) for manipulating surface gradient bio-functionalization of basal textured Ti-6Al-4V alloy strips with the surface gradient topographic oxide coating, which brings in the gradient distribution of surface conditions including matrix alloy, ordinary TiO2 film and TiO2 microwaves on a single strip. High-energy electropulse is frequently used as an electrically-treated method in improving the material microstructure and mechanical property. This paper reports firstly the surface modification under EPT aiming to improve the biocompatibility, which will meet the demand of biomaterials in different parts of human beings.
   Novel TiO2 microwave topological structure on the material surface resulted in better biocompatibility with more active fibroblast bio-reaction including higher cell viability, better physiological morphology and stronger adhesion binding, which is ascribed to surface chemical components, surface energy and specific surface area under EPT manipulation. The key role of forming TiO2 microwave structure solely under EPT is the selective effect of the electropulses going through the textured specimen, which thus builds a selective growth of the oxide and forms the microwave topological structure on the material surface. The positive contributions of EPT in the thermodynamics and kinetics of oxide coating growth are attributed to the reduction of nucleation energy barrier and acceleration of atomic diffusion. Thus, the gradient functionalization of biomaterials can be tuned over several second EPT in the titanium alloys, opening an energy-saving and high-efficiency door to diverse biomedical applications including the tissue engineering and biological interfaces. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ye, Xiaoxin; Tang, Guoyi; Song, Guolin] Tsinghua Univ, Adv Mat Inst, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
   [Ye, Xiaoxin; Tang, Guoyi] Tsinghua Univ, Key Lab Adv Mat, Minist Educ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Tse, Zion T. H.] Univ Georgia, Coll Engn, Athens, GA 30602 USA.
RP Tang, GY (reprint author), Tsinghua Univ, Adv Mat Inst, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
EM xiaoxinye905@gmail.com; tanggy@mails.tsinghua.edu.cn
FU National Natural Science Foundation of China [50571048]; Shenzhen
   Science and Technology Research funding project of China
   [SGLH20121008144756946]
FX The work is supported by National Natural Science Foundation of China
   (No. 50571048) and Shenzhen Science and Technology Research funding
   project of China (No. SGLH20121008144756946).
CR Auden EC, 2013, IEEE T NUCL SCI, V60, P4094, DOI 10.1109/TNS.2013.2289737
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Chen HY, 2006, ADV MATER, V18, P3089, DOI 10.1002/adma.200600615
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Docampo P, 2014, ADV MATER, V26, P4013, DOI 10.1002/adma.201400486
   Garay JE, 2003, ACTA MATER, V51, P4487, DOI 10.1016/S1359-6454(03)00284-2
   Hofmann D. C., 2008, NATURE, V451, P1083
   Jeon TY, 2014, ADV MATER, V26, P1422, DOI 10.1002/adma.201304317
   Jiang YB, 2009, ACTA MATER, V57, P4797, DOI 10.1016/j.actamat.2009.06.044
   Kotanen CN, 2013, BIOMATERIALS, V34, P6318, DOI 10.1016/j.biomaterials.2013.05.022
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Levitas VI, 2013, ACTA MATER, V61, P4305, DOI 10.1016/j.actamat.2013.03.034
   Li JT, 2014, BIOMATERIALS, V35, P642, DOI 10.1016/j.biomaterials.2013.09.099
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liu H, 2011, ADV MATER, V23, P3832, DOI 10.1002/adma.201101783
   Miola M, 2009, J MATER SCI-MATER M, V20, P741, DOI 10.1007/s10856-008-3618-8
   Mush J., 2011, SURF COAT TECH, V2052, pS84
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Seh ZW, 2012, ADV MATER, V24, P2310, DOI 10.1002/adma.201104241
   Sun YS, 2013, THIN SOLID FILMS, V528, P130, DOI 10.1016/j.tsf.2012.06.088
   Duong TT, 2011, ADV MATER, V23, P5557, DOI 10.1002/adma.201103030
   Twite AA, 2012, ADV MATER, V24, P2380, DOI 10.1002/adma.201104336
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464
   Wang H, 2013, INT J PLASTICITY, V47, P49, DOI 10.1016/j.ijplas.2013.01.007
   Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046
   Xiaoxin Y., 2014, MAT SCI ENG A
   Xiaoxin Y., J MAT SCI MAT MED
   Yang XM, 2013, SURF COAT TECH, V233, P65, DOI 10.1016/j.surfcoat.2013.01.052
   Ye X., APPL PHYS A
   Ye X., ADV ENG MAT
   Ye XX, 2014, MATER CHARACT, V98, P147, DOI 10.1016/j.matchar.2014.10.026
   Ye XX, 2014, SURF COAT TECH, V258, P467, DOI 10.1016/j.surfcoat.2014.08.052
   Ye XX, 2015, J ALLOY COMPD, V621, P66, DOI 10.1016/j.jallcom.2014.09.192
   Ye XX, 2014, J MECH BEHAV BIOMED, V40, P287, DOI 10.1016/j.jmbbm.2014.08.022
   Ye XX, 2014, J ALLOY COMPD, V616, P173, DOI 10.1016/j.jallcom.2014.07.143
   Ye XX, 2014, J MATER RES, V29, P1500, DOI 10.1557/jmr.2014.171
   Ye XX, 2014, J ALLOY COMPD, V599, P1, DOI 10.1016/j.jallcom.2014.02.055
   Zhang PC, 2013, ADV MATER, V25, P3566, DOI 10.1002/adma.201300888
   Zhao Y, 2013, SURF COAT TECH, V229, P130, DOI 10.1016/j.surfcoat.2012.08.053
   Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622
   Zhu RF, 2013, APPL PHYS A-MATER, V111, P1195, DOI 10.1007/s00339-012-7342-3
NR 42
TC 9
Z9 10
U1 3
U2 50
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 15
PY 2015
VL 261
BP 213
EP 218
DI 10.1016/j.surfcoat.2014.11.028
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA AZ5IR
UT WOS:000348255500029
DA 2018-10-20
ER

PT J
AU Zivkovic, LTI
   Zivkovic, LS
   Babic, BM
   Kokunesoski, MJ
   Jokic, BM
   Karadzic, IM
AF Zivkovic, Lidija T. Izrael
   Zivkovic, Ljiljana S.
   Babic, Biljana M.
   Kokunesoski, Maja J.
   Jokic, Bojan M.
   Karadzic, Ivanka M.
TI Immobilization of Candida rugosa lipase by adsorption onto biosafe
   meso/macroporous silica and zirconia
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Immobilization; Adsorption; Lipase; SBA-15; Zirconia; Kinetic parameters
ID OLIVE OIL HYDROLYSIS; BOVINE SERUM-ALBUMIN; ENZYME IMMOBILIZATION;
   MESOPOROUS SILICA; MICROBIAL LIPASES; SOLID-SURFACES; NANOPARTICLES;
   STABILIZATION; BIOMATERIAL; PARTICLES
AB Lipase from Candida rugosa was immobilized by adsorption onto laboratory prepared supports, silica SBA-15 and zirconia. The adsorption process was studied as a function of pH in terms of percent of adsorbed lipase, enzyme activity and zeta potential of support and enzyme. Several analytical approaches such as laser Doppler electrophoresis, Fourier transform infrared spectroscopy (FTIR) and field emission scanning electron microscopy (FESEM) showed that the lipase was successfully immobilized onto both supports. The zeta-potential data suggest that the adsorption efficiency does not depends on the sign but on the magnitude of the surface charge of adsorption partners, and therefore underline the importance of their dispersion stability. Adsorption to material surface altered enzyme characteristics. nu(max), for the lipase immobilized onto silica and zirconia were 4.8-fold and 3.6-fold lower than that of the free lipase, respectively. The Km showed no alteration of enzyme-substrate affinity on zirconia support, whereas the enzyme immobilized on silica had 3.6 times lower affinity. Thermostability at 60 degrees C of the lipase was improved 12-fold on zirconia and 4-fold on silica. Finally, in examining reusability, the immobilized lipase retained more than 90% of initial activity after eight reuses on both supports. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zivkovic, Lidija T. Izrael; Karadzic, Ivanka M.] Univ Belgrade, Sch Med, Inst Med Chem, Belgrade 11000, Serbia.
   [Zivkovic, Ljiljana S.; Babic, Biljana M.; Kokunesoski, Maja J.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade 11000, Serbia.
   [Jokic, Bojan M.] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
RP Zivkovic, LTI (reprint author), Univ Belgrade, Sch Med, Inst Med Chem, Visegradska 26, Belgrade 11000, Serbia.
EM lidija.izrael-zivkovic@mfub.bg.ac.rs
RI Kokunesoski, Maja/N-8046-2017
OI Kokunesoski, Maja/0000-0003-1732-002X; Izrael Zivkovic,
   Lidija/0000-0002-0385-4373
FU Ministry of Education, Science and Technological Development, Republic
   of Serbia [III 43004, III 45012]
FX The zirconia powder was supplied by courtesy of Prof. E.A. Levashov,
   Moscow State Institute of Steel and Alloys, Technological Institute, in
   the framework of Russian-Serbian project 2003-2005. This research was
   financed by the Ministry of Education, Science and Technological
   Development, Republic of Serbia (Projects Nos. III 43004 and III 45012).
CR Adlercreutz P, 2013, CHEM SOC REV, V42, P6406, DOI 10.1039/c3cs35446f
   Andrew H.L., 2005, PROTEINS, V61, P704
   Andualema B., 2012, Biotechnology, V11, P100
   Aubin-Tam ME, 2005, LANGMUIR, V21, P12080, DOI 10.1021/la052102e
   Blagoveschenskii Y.Y., 1999, ELECTROMETALLURGIYA, V3, P28
   Boncel S, 2013, ENZYME MICROB TECH, V53, P263, DOI 10.1016/j.enzmictec.2013.05.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chen GC, 2011, BIOTECHNOL LETT, V33, P525, DOI 10.1007/s10529-010-0451-1
   Chen YZ, 2008, LANGMUIR, V24, P8877, DOI 10.1021/la801384c
   Dandavate V, 2009, PROCESS BIOCHEM, V44, P349, DOI 10.1016/j.procbio.2008.11.001
   Datta S., 2013, BIO-TECHNOL, V3, P1, DOI DOI 10.1007/S13205-012-0071-7
   Ehlert N, 2013, CHEM SOC REV, V42, P3847, DOI 10.1039/c3cs35359a
   Fadiloglu S, 1998, J AGR FOOD CHEM, V46, P3411, DOI 10.1021/jf9709865
   Fariha H., 2006, ENZYME MICROB TECHNO, V39, P235
   Gardimalla HMR, 2005, CHEM COMMUN, P4432, DOI 10.1039/b504128g
   GOPALAN R, 1995, J MATER SCI, V30, P3075, DOI 10.1007/BF01209219
   Hanefeld U, 2013, CHEM SOC REV, V42, P6211, DOI 10.1039/c3cs90042h
   Hartmann M, 2013, CHEM SOC REV, V42, P6277, DOI 10.1039/c3cs60021a
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Huang L, 2008, CHEM ENG J, V144, P103, DOI 10.1016/j.cej.2008.05.015
   Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v
   Hudson S, 2005, J PHYS CHEM B, V109, P19496, DOI 10.1021/jp052102n
   Karadzic I., 2006, J BIOSCI BIOENG, V102, P309
   Kim MI, 2006, J MOL CATAL B-ENZYM, V39, P62, DOI 10.1016/j.molcatb.2006.01.028
   Kim MI, 2007, BIOTECHNOL BIOENG, V96, P210, DOI 10.1002/bit.21107
   Klein MP, 2011, PROCESS BIOCHEM, V46, P1375, DOI 10.1016/j.procbio.2011.02.021
   Knezevic Z, 2006, BIOCHEM ENG J, V30, P269, DOI 10.1016/j.bej.2006.05.009
   Kokunesoski M, 2010, MATER CHEM PHYS, V124, P1248, DOI 10.1016/j.matchemphys.2010.08.066
   Krajewska B, 2005, BIOCATAL BIOTRANSFOR, V23, P225, DOI 10.1080/10242420500208852
   Lee DH, 2006, J IND ENG CHEM, V12, P777
   Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803
   Magner E, 2013, CHEM SOC REV, V42, P6213, DOI 10.1039/c2cs35450k
   Mak K. H., 2009, SCI TECHNOL VISION, V5, P19
   Mendes A.A., 2009, BIOCATAL BIOTRANSFOR, V25, P393
   Metin AU, 2013, MACROMOL RES, V21, P176, DOI 10.1007/s13233-013-1026-5
   Michele M., 2011, ENZYME RES, V2011, P10
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Oh JM, 2007, J IND ENG CHEM, V13, P429
   Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119
   Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7
   Pereira EB, 2001, APPL BIOCHEM BIOTECH, V91-3, P739, DOI 10.1385/ABAB:91-93:1-9:739
   Pimentel MCB, 2007, ARTIF CELL BLOOD SUB, V35, P221, DOI 10.1080/10731190601188380
   Pugh R.J., 1994, DISPERSION COLLOIDAL
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rajendran A, 2009, BRAZ ARCH BIOL TECHN, V52, P207, DOI 10.1590/S1516-89132009000100026
   Ratledge C., 2006, BASIC BIOTECHNOLOGY, P605
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Rezwan K, 2005, J PHYS CHEM B, V109, P14469, DOI 10.1021/jp050528w
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   Santos JC, 2007, CHEM ENG TECHNOL, V30, P1255, DOI 10.1002/ceat.200700153
   Schultz N, 2008, COLLOID SURFACE B, V66, P39, DOI 10.1016/j.colsurfb.2008.05.004
   Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k
   Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Walker J.M., 2005, PROTEOMICS PROTOCOLS, P571
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   Xia HS, 2010, J POROUS MAT, V17, P225, DOI 10.1007/s10934-009-9284-5
NR 57
TC 28
Z9 29
U1 1
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1369-703X
EI 1873-295X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD JAN 15
PY 2015
VL 93
BP 73
EP 83
DI 10.1016/j.bej.2014.09.012
PG 11
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA AY1OL
UT WOS:000347362100010
DA 2018-10-20
ER

PT J
AU Periyathambi, P
   Vedakumari, WS
   Baskar, SK
   Bojja, S
   Sastry, TP
AF Periyathambi, Prabu
   Vedakumari, Weslen S.
   Baskar, Santhosh Kumar
   Bojja, Sreedhar
   Sastry, Thotapalli P.
TI Osteogenic potency of magnetic fibrin nanoparticles-A novel perspective
   in bone tissue engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Nanoparticles; Magnetic materials; Electron microscopy; Saos-2; Cell
   viability
AB In the present study, goat blood has been used as the starting material for the preparation of novel magnetic fibrin nanoparticles (MAG-FNPs) in tissue engineering. The synthesised nanoparticles were characterized by X-ray diffractometer (XRD), transmittance electron microscope (TEM), scanning electron microscope (SEM), Fourier Transform Infrared spectroscopy (FTIR), energy dispersive X-ray spectroscopy (EDX) and vibrating sample magnetometer (VSM) analysis. The osteogenic potential of MAG-FNPs was evaluated by performing cell viability assay and quantifying alkaline phosphatase (ALP) levels using Saos-2 cells. The results obtained suggested that MAG-FNPs could serve as promising biomaterial for bone tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Periyathambi, Prabu; Vedakumari, Weslen S.; Baskar, Santhosh Kumar; Sastry, Thotapalli P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Bojja, Sreedhar] Indian Inst Chem Technol, Inorgan & Phys Chem Div, Hyderabad 500607, Andhra Pradesh, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
FU Council of Scientific and Industrial Research (CSIR) Network project-ADD
   [CSCO302]
FX The authors greatly acknowledge the financial support from Council of
   Scientific and Industrial Research (CSIR) Network project-ADD (CSCO302)
   under XII Plan.
CR Chamundeeswari M, 2011, MATER RES BULL, V46, P901, DOI 10.1016/j.materresbull.2011.02.021
   Niketica AS, 2014, MATER LETT, V120, P86
   Vedakumari WS, 2014, COLLOID SURFACE B, V120, P208, DOI 10.1016/j.colsurfb.2014.04.021
   Vittlakumari WS, 2013, BIECHRO BIOOHYS ACTA, V1830, P4244
NR 4
TC 6
Z9 6
U1 2
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JAN 15
PY 2015
VL 139
BP 108
EP 111
DI 10.1016/j.matlet.2014.045
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AU5IN
UT WOS:000345640300029
DA 2018-10-20
ER

PT J
AU Deepthi, S
   Jeevitha, K
   Sundaram, MN
   Chennazhi, KP
   Jayakumar, R
AF Deepthi, S.
   Jeevitha, K.
   Sundaram, M. Nivedhitha
   Chennazhi, K. P.
   Jayakumar, R.
TI Chitosan-hyaluronic acid hydrogel coated poly(caprolactone) multiscale
   bilayer scaffold for ligament regeneration
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Electrospinning; Hydrogel coating; Poly(caprolactone); Multiscale
   fibers; Layered scaffold; Ligament tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; IN-VITRO; FIBROUS SCAFFOLDS; DESIGN;
   ADHESION; CHITIN; CELLS; NANO
AB Ligament tears, seen in young athletes to elderly people, pose a very challenging problem to achieve complete healing, due to its hypocellularity that decelerate regeneration of ligament after injury. Tissue engineering is an approach for the ligament regeneration that optimizes the response of cell biomaterial interaction to fasten regeneration using engineered scaffolds that mimic the native environment. Electrospinning techniques and hydrogels are useful to engineer the structure of ligament. In this study, electrospun multiscale fibrous scaffold of PCL aligned microfibers/random nanofibers (PCL aligned multiscale fibers) and PCL random microfibers/nanofibers (PCL random multiscale fibers) were developed. Chitosan hyaluronic acid hydrogel coating was done on these fibrous scaffolds and this was layered to form a bilayered construct. The developed scaffold was characterized by SEM, FTIR, and tensile testing. Protein adsorption studies show better protein adsorption on coated scaffolds compared to uncoated scaffolds which further improved the cell viability as determined by Alamar blue assay and DNA quantification by Pico green assay. Rabbit ligament fibroblast cell attachment and infiltration study conducted on the scaffolds showed cell elongation along the aligned fibers, which would be advantageous in the need to align cells along the direction of force in native ligament environment. Hydrogel coating on PCL random multiscale fibers show better cell infiltration. This study implies the use of hydrogel coated systems to provide a reservoir for cells and nutrients and further modifications of these systems would make it promising for ligament regeneration. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Deepthi, S.; Jeevitha, K.; Sundaram, M. Nivedhitha; Chennazhi, K. P.; Jayakumar, R.] Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Kochi 682041, Kerala, India.
RP Jayakumar, R (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Kochi 682041, Kerala, India.
EM rjayakumar@aims.amrita.edu
FU Department of Biotechnology (DBT), India [BT/PR 13585/NNT/28/474/2010];
   Council of Scientific and Industrial Research, India
   [9/963(0034)2K13-EMR-I]
FX One of the authors R. jayakumar is grateful to the Department of
   Biotechnology (DBT), India, for providing fund under the scheme of
   Nanoscience and Nanotechnology Program (Ref. No. BT/PR
   13585/NNT/28/474/2010). The author Deepthi Sankar is grateful to the
   Council of Scientific and Industrial Research, India for supporting
   financially under the CSIR-SRF Award No: 9/963(0034)2K13-EMR-I. The
   authors are thankful to Mr. Sajin. P. Ravi for his help in SEM studies
   and Mr. Sarath for confocal microscopic imaging.
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Harrison SL, 2011, J ORTHOP RES, V29, P1361, DOI 10.1002/jor.21321
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Sabir Muhammad Iqbal, 2009, J MATER SCI, V44, P5713
   Sankar D, 2014, TISSUE ENG PT A, V20, P1689, DOI [10.1089/ten.tea.2013.0569, 10.1089/ten.TEA.2013.0569]
   Shalumon KT, 2011, J MACROMOL SCI A, V48, P21, DOI 10.1080/10601325.2011.528288
   Snook G.A., 1983, CLIN ORTHOP RELAT R, V172, P3
   Srinivasan S, 2012, ADV POLYM SCI, V246, P1, DOI 10.1007/12_2011_163
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Thayer PS, 2014, BIOMACROMOLECULES, V15, P75, DOI 10.1021/bm4013056
   Voytik Harbin S.L., 1997, J CELL BIOCHEM, V67, P478
   Wang PY, 2013, BIOTECHNOL BIOENG, V110, P327, DOI 10.1002/bit.24615
   WIIG ME, 1990, J ORTHOP RES, V8, P425, DOI 10.1002/jor.1100080314
   Xia X., 1994, J INNER MONGOLIA I A, V15, P15
NR 33
TC 23
Z9 23
U1 14
U2 180
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD JAN 15
PY 2015
VL 260
BP 478
EP 485
DI 10.1016/j.cej.2014.08.106
PG 8
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA AU2XE
UT WOS:000345477100051
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Ying, GM
   Ren, CH
   Jizhang, YN
   Brogan, D
   Liu, ZJ
   Li, SJ
   Ding, YC
   Borlongan, CV
   Zhang, J
   Ji, XM
AF Zhang, Ying
   Ying, Guomin
   Ren, Changhong
   Jizhang, Yunneng
   Brogan, David
   Liu, Zongjian
   Li, Sijie
   Ding, Yuchuan
   Borlongan, Cesar V.
   Zhang, Jian
   Ji, Xunming
TI Administration of human platelet-rich plasma reduces infarction volume
   and improves motor function in adult rats with focal ischemic stroke
SO BRAIN RESEARCH
LA English
DT Article
DE Biomaterials; Neuroprotection; Stroke; Therapeutics; Platelets; Albumin
ID FIBROBLAST-GROWTH-FACTOR; CEREBRAL-ISCHEMIA; INFUSION; INJURY; BRAIN;
   NEUROPROTECTION; ANGIOGENESIS; DAMAGE; MODEL; BETA
AB Platelet-rich plasma (PRP) is a milieu of bioactive factors, including platelet derived growth factor, transforming growth factor beta, among many others. Despite accumulating evidence on PRP's safety and efficacy for treating musculoskeletal injuries, limited studies have been performed using PRP in brain disorders. This study aimed to explore the potential benefits of administration of human PRP lysate after ischemic stroke in rats. An ischemic stroke model was generated by occlusion of the right middle cerebral artery, then 90 min later, stroke rats were randomly assigned to receive local infusion to the ischemic area of human PRP lysate, human albumin solution (HSA), saline or no treatment at all. An additional group of stroke rats received systemic infusion of human PRP lysate to further assess the therapeutic effects of this treatment. Results showed that while local infusion of HSA or saline, and systemic administration of human PRP lysate, compared to no treatment significantly reduced infarct volume (37.4%, 40.1%, and 39.9% vs 49.7%) and neurological deficit score (2.2, 2.6, and 2.8 vs 3.7), the greatest neuroprotection (31.0% infarct volume and 1.6 neurological deficit score) was found in stroke animals that received local intra-arterial infusion of human PRP lysate (p's <0.05). In conclusion, administration of human PRP attenuates brain injury after focal ischemia. Our results suggest PRP should be investigated further as a potential point-of-care biomaterial following stroke. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Ying; Ying, Guomin; Ren, Changhong; Liu, Zongjian; Li, Sijie; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing 100053, Peoples R China.
   [Zhang, Ying; Ying, Guomin; Ren, Changhong; Liu, Zongjian; Li, Sijie; Ji, Xunming] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
   [Jizhang, Yunneng] Brownell Talbot Sch, Omaha, NE USA.
   [Brogan, David; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA.
   [Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL USA.
   [Zhang, Jian] Capital Med Univ, Xuanwu Hosp, Dept Vasc Surg, Beijing 100053, Peoples R China.
   [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China.
RP Zhang, J (reprint author), Capital Med Univ, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.
EM zhangyzh@public3.bta.net.cn; jixm@ccmu.edu.cn
FU National Basic Research Program of China [2011CB707804]; National
   Science Fund for Distinguished Young Scholars of China [81325007]
FX This work was supported by the National Basic Research Program of China
   (2011CB707804), and National Science Fund for Distinguished Young
   Scholars of China (81325007). We thank Jinhuan Gao and Ning Li
   (Institute of Hypoxia Medicine, Xuanwu Hospital) for technical
   assistance.
CR Arboix A, 2004, CEREBROVASC DIS, V18, P304, DOI 10.1159/000080356
   Ay H, 1999, CEREBROVASC DIS, V9, P131, DOI 10.1159/000015941
   Boswell SG, 2012, ARTHROSCOPY, V28, P429, DOI 10.1016/j.arthro.2011.10.018
   Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796
   Chen J, 2013, STROKE, V44, P260, DOI 10.1161/STROKEAHA.112.675462
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Clark WM, 2000, NEUROLOGY, V54, pA88
   Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7
   Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC
   FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121
   Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Gonshor A, 2002, INT J PERIODONT REST, V22, P547
   GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558
   Guo HL, 2006, NEUROSCI LETT, V393, P56, DOI 10.1016/j.neulet.2005.09.043
   Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1
   Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8
   Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564
   Lee SC, 2010, EUR J NEUROL, V17, P45, DOI 10.1111/j.1468-1331.2009.02731.x
   Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994
   Moraes VY, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD010071.PUB2
   Osterhout DJ, 1997, J NEUROSCI, V17, P9122
   PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67
   Ren CH, 2011, NEUROL RES, V33, P514, DOI 10.1179/016164111X13007856084241
   Ren Jing Mei, 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P121, DOI 10.2174/1568007053544101
   Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8
   Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008
   Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Willemsen JCN, 2013, EUR J PLAST SURG, V36, P777, DOI 10.1007/s00238-013-0887-3
   Woitzik J, 2007, J NEUROSURG, V106, P872, DOI 10.3171/jns.2007.106.5.872
   Won SJ, 2006, BRAIN RES, V1123, P237, DOI 10.1016/j.brainres.2006.09.055
   Yu WJ, 2011, INT J NEUROSCI, V121, P176, DOI 10.3109/00207454.2010.544432
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002
NR 37
TC 3
Z9 6
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD JAN 12
PY 2015
VL 1594
BP 267
EP 273
DI 10.1016/j.brainres.2014.10.035
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA AY5CE
UT WOS:000347590100026
PM 25452023
DA 2018-10-20
ER

PT J
AU Sharma, BB
   Verma, AK
   Thomas, S
   Murli, C
   Sharma, SM
AF Sharma, Bharat Bhooshan
   Verma, Ashok K.
   Thomas, Susy
   Murli, Chitra
   Sharma, Surinder M.
TI Hydrogen Bonds and Ionic Forms versus Polymerization of Imidazole at
   High Pressures
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SOLID-STATE; CRYSTAL; NH
AB Imidazole (C3H4N2) is an important biomaterial for material research and applications. Our high-pressure Raman spectroscopic investigations combined with ab initio calculations on crystalline imidazole suggest that C-H---X (X = N, pi) and N-H---N intermolecular hydrogen bonding interactions largely influence the nature of its structural and polymeric transformations under pressure. At pressures around similar to 10 GPa, the reduction in the N---N distances close to the symmetrization limit and the emergence of the spectral features of the cationic form indicate the onset of proton disorder. The pressure-induced strengthening of the "blue-shifting hydrogen bonds" C-H---X (X = N, pi) in this compound is revealed by the Raman spectra and the ab initio calculations. No polymer phase was retrieved on release from the highest pressure of 20 GPa in this study.
C1 [Sharma, Bharat Bhooshan; Verma, Ashok K.; Thomas, Susy; Murli, Chitra; Sharma, Surinder M.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.
RP Murli, C (reprint author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.
EM cmurli@barc.gov.in
CR AFTERGUT S, 1961, NATURE, V191, P379, DOI 10.1038/191379a0
   Benoit M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.145501
   Bernasconi M, 1997, PHYS REV LETT, V78, P2008, DOI 10.1103/PhysRevLett.78.2008
   Carven B. M., 1977, ACTA CRYSTALLOGR B, VB33, P2585
   Ceppatelli M., 2010, PHASE TRANSITION, V80, P1085
   DAYCOCK JT, 1968, NATURE, V218, P672, DOI 10.1038/218672a0
   De L. L., 2006, CURR MED CHEM, V13, P1
   Dziubek K, 2007, J AM CHEM SOC, V129, P12620, DOI 10.1021/ja074885r
   Fischbach I, 2004, J PHYS CHEM B, V108, P18500, DOI 10.1021/jp046848h
   Goncharov AF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.065505
   Hermansson K, 2002, J PHYS CHEM A, V106, P4695, DOI 10.1021/jp0143948
   Hobza P, 2000, CHEM REV, V100, P4253, DOI 10.1021/cr990050q
   Horiuchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2322
   Inagaki S, 2012, PHYS CHEM CHEM PHYS, V14, P2008, DOI 10.1039/c2cp23047j
   Ji CM, 2013, CRYSTENGCOMM, V15, P2157, DOI 10.1039/c3ce26942f
   Jiong R., 2006, THEORETICAL STUDY CH
   KAWADA A, 1970, J CHEM PHYS, V52, P3121, DOI 10.1063/1.1673447
   Lankau T, 2011, PHYS CHEM CHEM PHYS, V13, P12758, DOI 10.1039/c0cp02172e
   MAJOUBE M, 1982, J CHEM PHYS, V76, P2838, DOI 10.1063/1.443385
   Murli C, 2012, J PHYS CHEM B, V116, P4671, DOI 10.1021/jp300248b
   Murli C, 2010, J PHYS CHEM B, V114, P9744, DOI 10.1021/jp1034757
   NAKAMOTO K, 1955, J AM CHEM SOC, V77, P6480, DOI 10.1021/ja01629a013
   NISHIO M, 1998, CH PI INTERACTION EV
   Palasyuk T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4460
   Paliwoda D, 2012, CRYST GROWTH DES, V12, P4302, DOI 10.1021/cg300852t
   Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511
   SADLEJ J, 1992, J MOL STRUCT, V274, P247, DOI 10.1016/0022-2860(92)80161-A
   Serpell CJ, 2013, CRYST GROWTH DES, V13, P2866, DOI 10.1021/cg400273p
   Sharma BB, 2013, J RAMAN SPECTROSC, V44, P785, DOI 10.1002/jrs.4264
   Sharma SM, 1996, PROG MATER SCI, V40, P1, DOI 10.1016/0079-6425(95)00006-2
   Sikora M, 2013, J PHYS CHEM C, V117, P10661, DOI 10.1021/jp401389v
   Su CC, 2003, J CHEM PHYS, V119, P10753, DOI 10.1063/1.1620500
   Wang G, 2002, J RAMAN SPECTROSC, V33, P125, DOI 10.1002/jrs.825
   Xu WM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.175501
   Zhou M, 2012, SPECTROCHIM ACTA A, V97, P526, DOI 10.1016/j.saa.2012.07.001
   Zielinski W, 2013, CRYST GROWTH DES, V13, P696, DOI 10.1021/cg301374z
NR 36
TC 4
Z9 4
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JAN 8
PY 2015
VL 119
IS 1
BP 372
EP 378
DI 10.1021/jp510688c
PG 7
WC Chemistry, Physical
SC Chemistry
GA AY7QJ
UT WOS:000347753900038
PM 25494241
DA 2018-10-20
ER

PT J
AU de Vera, P
   Garcia-Molina, R
   Abril, I
AF de Vera, Pablo
   Garcia-Molina, Rafael
   Abril, Isabel
TI Angular and Energy Distributions of Electrons Produced in Arbitrary
   Biomaterials by Proton Impact
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID TRACK STRUCTURE; WATER-VAPOR; CHARGED-PARTICLES; CROSS-SECTIONS; LIQUID
   WATER; ION IMPACT; IONIZATION; EMISSION; COLLISIONS; MOLECULES
AB We present a simple method for obtaining reliable angular and energy distributions of electrons ejected from arbitrary condensed biomaterials by proton impact. Relying on a suitable description of the electronic excitation spectrum and a physically motivated relation between the ion and electron scattering angles, it yields cross sections in rather good agreement with experimental data in a broad range of ejection angles and energies, by only using as input the target composition and density. The versatility and simplicity of the method, which can be also extended to other charged particles, make it especially suited for obtaining ionization data for any complex biomaterial present in realistic cellular environments.
C1 [de Vera, Pablo; Abril, Isabel] Univ Alacant, Dept Fis Aplicada, E-03080 Alacant, Spain.
   [Garcia-Molina, Rafael] Univ Murcia, Dept Fis, Ctr Invest Opt & Nanofis, E-30100 Murcia, Spain.
RP de Vera, P (reprint author), Univ Alacant, Dept Fis Aplicada, E-03080 Alacant, Spain.
EM pablo.vera@ua.es
RI Abril, Isabel/L-6938-2014; de Vera, Pablo/L-6674-2014; Garcia-Molina,
   Rafael/L-5679-2014
OI Abril, Isabel/0000-0001-9366-3484; de Vera, Pablo/0000-0002-5645-412X;
   Garcia-Molina, Rafael/0000-0001-8755-8709
FU Spanish Ministerio de Economia y Competitividad; European Regional
   Development Fund [FIS2010-17225]; European Union's FP7-People Program
   (Marie Curie Actions) within the Initial Training Network [608163];
   European COST Action [MP1002 NanoIBCT]
FX The authors recognize the financial support from the Spanish Ministerio
   de Economia y Competitividad and the European Regional Development Fund
   (Project No. FIS2010-17225). PdV acknowledges financial support from the
   European Union's FP7-People Program (Marie Curie Actions) within the
   Initial Training Network No. 608163 "ARGENT". Support from the European
   COST Action MP1002 NanoIBCT is gratefully acknowledged.
CR Abdoul-Carime H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168103
   Abril I, 2010, NUCL INSTRUM METH B, V268, P1763, DOI 10.1016/j.nimb.2010.02.069
   Agnihotri AN, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032716
   Belkic D, 2013, ADV QUANTUM CHEM, V65, P1
   BELKIC D, 1978, J PHYS B-AT MOL OPT, V11, P3529, DOI 10.1088/0022-3700/11/20/015
   Belkic D., 2012, FAST ION ATOM ION MO
   Belkic D, 2010, J MATH CHEM, V47, P1366, DOI 10.1007/s10910-010-9662-x
   Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658
   Champion C, 2009, NUCL INSTRUM METH B, V267, P881, DOI 10.1016/j.nimb.2009.02.040
   CROTHERS DSF, 1983, J PHYS B-AT MOL OPT, V16, P3229, DOI 10.1088/0022-3700/16/17/015
   Cucinotta FA, 1996, ADV SPACE RES-SERIES, V18, P183, DOI 10.1016/0273-1177(96)00039-7
   Dal Cappello C, 2009, NUCL INSTRUM METH B, V267, P781, DOI 10.1016/j.nimb.2008.12.010
   de Vera P, 2013, J PHYS CONF SER, V438, DOI 10.1088/1742-6596/438/1/012015
   de Vera P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148104
   Dingfelder M, 2002, RADIAT PROT DOSIM, V99, P23, DOI 10.1093/oxfordjournals.rpd.a006770
   Egerton R. F., 1989, ELECT ENERGY LOSS SP
   EMERSON LC, 1975, RADIAT RES, V63, P235, DOI 10.2307/3574149
   Galassi ME, 2012, PHYS MED BIOL, V57, P2081, DOI 10.1088/0031-9155/57/7/2081
   Garcia-Molina R, 2012, RAD DAMAGE BIOMOLECU
   Gobet F, 2001, PHYS REV LETT, V86, P3751, DOI 10.1103/PhysRevLett.86.3751
   Hayashi H, 2000, P NATL ACAD SCI USA, V97, P6264, DOI 10.1073/pnas.110572097
   Heredia-Avalos S, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052902
   Iriki Y, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032704
   Konig C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.018105
   Lindhard J., 1954, VIDENSK SELSK MAT FY, V28, P8
   Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79
   LONG KA, 1991, J CHEM PHYS, V95, P1049, DOI 10.1063/1.461132
   MERMIN ND, 1970, PHYS REV B-SOLID ST, V1, P2362, DOI 10.1103/PhysRevB.1.2362
   Nandi S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052710
   Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176
   Nikjoo H., 2012, INTERACTION RAD MATT
   Olivera GH, 1996, PHYS MED BIOL, V41, P1633, DOI 10.1088/0031-9155/41/9/005
   RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874
   RITCHIE RH, 1977, PHILOS MAG, V36, P463, DOI 10.1080/14786437708244948
   Rudd M.E., 1996, SECONDARY ELECT SPEC
   RUDD ME, 1992, REV MOD PHYS, V64, P441, DOI 10.1103/RevModPhys.64.441
   SALIN A, 1969, J PHYS PT B ATOM M P, V2, P631, DOI 10.1088/0022-3700/2/6/301
   Salvat F., 2011, PENELOPE 2011 CODE S
   Schardt D, 2010, REV MOD PHYS, V82, P383, DOI 10.1103/RevModPhys.82.383
   SCHOLZ M, 1996, ADV SPACE RES-SERIES, V18, P5, DOI 10.1016/0273-1177(95)00784-C
   SENGER B, 1984, NUCL INSTRUM METH B, V2, P204, DOI 10.1016/0168-583X(84)90190-3
   Solov'yov AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011909
   Surdutovich E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051918
   Tan ZY, 2004, NUCL INSTRUM METH B, V222, P27, DOI 10.1016/j.nimb.2004.02.017
   VRIENS L, 1967, P PHYS SOC LOND, V90, P935, DOI 10.1088/0370-1328/90/4/307
NR 45
TC 17
Z9 17
U1 2
U2 13
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD JAN 5
PY 2015
VL 114
IS 1
AR 018101
DI 10.1103/PhysRevLett.114.018101
PG 5
WC Physics, Multidisciplinary
SC Physics
GA AZ0HI
UT WOS:000347926300003
PM 25615504
OA Green Published
DA 2018-10-20
ER

PT J
AU Sugiura, Y
   Onuma, K
   Yamazaki, A
AF Sugiura, Yuki
   Onuma, Kazuo
   Yamazaki, Atsushi
TI Solution Chemical Synthesis of Hollow Vaterite Particles for Advanced
   Biomaterial Applications
SO CHEMISTRY LETTERS
LA English
DT Article
ID AMORPHOUS CALCIUM-CARBONATE; PHOSPHATE IONS; BIOMINERALIZATION;
   TRANSFORMATION; ARAGONITE; GROWTH
AB In this work, we develop a new simple synthesis method of hollow polycrystalline monophase vaterite particles without impurities such as calcite and toxic buffer (tris(hydroxylmethyl)-aminomethane: Tris). Starting materials consist of CaCl2, NaHCO3, NaCl, and a flavin mononucleotide, a vitamin B-2 derivative. The resulting vaterite particles showed a spherical shell of 2-5 mu m surrounding a 50-500 nm diameter cavity. The shells comprised 10-100 nm wide elongated fibrous crystals, which were tightly packed and radially elongated from the center of a vaterite sphere.
C1 [Sugiura, Yuki; Yamazaki, Atsushi] Waseda Univ, Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1860049, Japan.
   [Sugiura, Yuki; Onuma, Kazuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
RP Sugiura, Y (reprint author), Waseda Univ, Sch Creat Sci & Engn, Shinjuku Ku, 3-1-4 Okubo, Tokyo 1860049, Japan.
EM ya81349@waseda.jp
RI Sugiura, Yuki/L-6895-2018
OI Sugiura, Yuki/0000-0003-1472-5435
FU material characterization central laboratory (MCCL), Waseda University;
   Japan Society for the Promotion of Science; Ministry of Education,
   Culture, Sports, Science and Technology of Japan [25-2283]
FX We thank Dr. A. Oyane and Dr. K. Yoshinaka for their helpful advice. Dr.
   A. Ito helped us for XRD measurement; Mr. N. Sugimura helped us for
   FT-LR measurement. This study was supported by material characterization
   central laboratory (MCCL), Waseda University and a Grant-in-Aid of
   Research for Doctoral Course Students (DC2) from the Japan Society for
   the Promotion of Science, Ministry of Education, Culture, Sports,
   Science and Technology of Japan (Grant number 25-2283).
CR ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018
   Beck R, 2012, CRYST RES TECHNOL, V47, P404, DOI 10.1002/crat.201100599
   Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007
   BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1
   Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI [10.1002/9780470994603., DOI 10.1002/9780470994603]
   Deer W.A., 1992, INTRO ROCK FORMING M
   Gago-Duport L, 2008, J STRUCT BIOL, V162, P422, DOI 10.1016/j.jsb.2008.02.007
   Karampas IA, 2013, VIB SPECTROSC, V64, P126, DOI 10.1016/j.vibspec.2012.11.003
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Katsifaras A, 1999, J CRYST GROWTH, V204, P183, DOI 10.1016/S0022-0248(99)00174-8
   Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d
   Mann S, 2001, BIOMINERALIZATION PR
   Nakamura J, 2014, J MATER CHEM B, V2, P1250, DOI 10.1039/c3tb21571g
   PLUMMER LN, 1982, GEOCHIM COSMOCHIM AC, V46, P1011, DOI 10.1016/0016-7037(82)90056-4
   Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d
   Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532
   Sugiura Y, 2014, J CERAM SOC JPN, V122, P679, DOI 10.2109/jcersj2.122.679
   Sugiura Y, 2013, AM MINERAL, V98, P262, DOI 10.2138/am.2013.4212
   Sunagawa I., 2005, CRYSTALS GROWTH MORP
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   Xu AW, 2006, ADV FUNCT MATER, V16, P903, DOI 10.1002/adfm.200500716
NR 21
TC 3
Z9 3
U1 3
U2 40
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0366-7022
EI 1348-0715
J9 CHEM LETT
JI Chem. Lett.
PD JAN 5
PY 2015
VL 44
IS 1
BP 20
EP 22
DI 10.1246/cl.140823
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AY2SC
UT WOS:000347438400004
DA 2018-10-20
ER

PT J
AU Schwitalla, AD
   Abou-Emara, M
   Spintig, T
   Lackmann, J
   Muller, WD
AF Schwitalla, A. D.
   Abou-Emara, M.
   Spintig, T.
   Lackmann, J.
   Mueller, W. D.
TI Finite element analysis of the biomechanical effects of PEEK dental
   implants on the peri-implant bone
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Finite element analysis; Platform-switched dental implant; PEEK;
   Titanium; Endolign
ID STRESS-DISTRIBUTION; LOADING CONDITIONS; REPLACEMENT; PARAMETERS;
   DENTISTRY; DESIGN; FORCE; MODEL
AB Dental implants are mostly fabricated of titanium. Potential problems associated with these implants are discussed in the literature, for example, overloading of the jawbone during mastication due to the significant difference in the elastic moduli of titanium (110 GPa) and bone (approximate to 1-30 GPa). Therefore polyether-ether-ketone (PEEK) could represent an alternative biomaterial (elastic modulus 3-4 GPa). Endolign (R) represents an implantable carbon fiber reinforced (CFR)-PEEK including parallel oriented endless carbon fibers. According to the manufacturer it has an elastic modulus of 150 GPa. PEEK compounds filled with powders show an elastic modulus around 4 GPa.
   The aim of the present finite element analysis was to point out the differences in the biomechanical behavior of a dental implant of Endoligne (R) and a commercial powder-filled PEEK. Titanium served as control.
   These three materials were used for a platform-switched dental implant-abutment assembly, whereas Type 1 completely consisted of titanium, Type 2 of a powder-filled PEEK and Type 3 of Endolign (R). A force of 100 N was applied vertically and of 30 degrees to the implant axis.
   All types showed a minimum safety factor regarding the yield strength of cortical bone. However, within the limits of this study the Type 2 implant showed higher stresses within the adjacent cortical bone than Type 1 and Type 3. These implant assemblies showed similar stress distributions. Endless carbon fibers give PEEK a high stability.
   Further investigations are necessary to evaluate whether there is a distinct amount of endless carbon fibers causing an optimal stress distribution behavior of CFR-PEEK. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Schwitalla, A. D.; Spintig, T.; Mueller, W. D.] Charite, Sch Dent, Dept Dent Mat & Biomat Res, D-14197 Berlin, Germany.
   [Abou-Emara, M.; Lackmann, J.] Beuth Univ Appl Sci, Berlin, Germany.
RP Muller, WD (reprint author), Charite, Sch Dent, Dept Dent Mat & Biomat Res, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM wolf-dieter.mueller@charite.de
FU Central Innovation Programme for SMEs (ZIM) of the German Federal
   Ministry for Economic Affairs and Energy; AiF Projekt GmbH, Berlin
   [ZIM-2863301KJ1]
FX This work was supported by the Central Innovation Programme for SMEs
   (ZIM) of the German Federal Ministry for Economic Affairs and Energy
   (Project management agency: AiF Projekt GmbH, Berlin; grant number
   ZIM-2863301KJ1).
CR Barbero E.J, 2008, FINITE ELEMENT ANAL
   BORCHERS L, 1983, J DENT RES, V62, P155, DOI 10.1177/00220345830620021401
   Colling EW, 1984, PHYS METALLURGY TITA
   Cook S D, 1995, J Oral Implantol, V21, P176
   COOK SD, 1982, J DENT RES, V61, P1006, DOI 10.1177/00220345820610080201
   Corvelli AA, 1997, J ADV MATER, V28, P2
   Cowin SC, 1989, BONE MECH, P97
   Demenko V, 2011, J DENT RES, V90, P1211, DOI 10.1177/0022034511417442
   Gomes SGF, 2011, BRAZ ORAL RES, V25, P446, DOI 10.1590/S1806-83242011000500012
   Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251
   Guan H, 2010, INT J ORAL MAX IMPL, V25, P461
   Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024
   Kelsey DJ, 1997, J COMPOS MATER, V31, P1593, DOI 10.1177/002199839703101603
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lewinstein I, 1995, Int J Oral Maxillofac Implants, V10, P355
   LIAO K, 1994, EXP TECHNIQUES, V18, P33
   MAHARAJ GR, 1993, AM SOC TEST MATER, V1178, P98, DOI 10.1520/STP15546S
   Mehrali M, 2013, J BIOMED MATER RES A, V101, P3046, DOI 10.1002/jbm.a.34588
   Meijer HJA, 1996, J ORAL REHABIL, V23, P757, DOI 10.1046/j.1365-2842.1996.d01-185.x
   Payne E.V., 1961, NEW TECHNOL B, V1, P36
   Rieg F., 2006, HDB MACHINE DESIGN
   Sarot JR, 2010, J MATER SCI-MATER M, V21, P2079, DOI 10.1007/s10856-010-4084-7
   Schwartz-Dabney CL, 2003, AM J PHYS ANTHROPOL, V120, P252, DOI 10.1002/ajpa.10121
   Van Staden R. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P257, DOI 10.1080/10255840600837074
   WEINSTEIN AM, 1979, BIOMATER ARTIF CELL, V7, P169, DOI 10.3109/10731197909119384
   WIDERA GEO, 1976, J BIOMED MATER RES, V10, P613, DOI 10.1002/jbm.820100418
   Winter W, 2013, J ORAL IMPLANTOL, V39, P23, DOI 10.1563/AAID-JOI-D-11-00221
NR 27
TC 11
Z9 11
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JAN 2
PY 2015
VL 48
IS 1
BP 1
EP 7
DI 10.1016/j.jbiomech.2014.11.017
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AZ6NL
UT WOS:000348336200001
PM 25435385
DA 2018-10-20
ER

PT J
AU Leigh, DR
   Kim, MS
   Kovacevic, D
   Baker, AR
   Tan, CD
   Calabro, A
   Derwin, KA
AF Leigh, Diane R.
   Kim, Myung-Sun
   Kovacevic, David
   Baker, Andrew R.
   Tan, Carmela D.
   Calabro, Anthony
   Derwin, Kathleen A.
TI Human fascia lata ECM scaffold augmented with immobilized hyaluronan:
   inflammatory response and remodeling in the canine body wall and
   shoulder implantation sites
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polarized light microscopy; animal model; graft remodeling; biologic
   graft; tyramine-substituted hyaluronan
ID ROTATOR CUFF REPAIR; EXTRACELLULAR-MATRIX; COMPOSITIONAL PROPERTIES;
   MACROPHAGE PHENOTYPE; ARTICULAR-CARTILAGE; TENDON
AB We postulate that immobilization of tyramine-substituted hyaluronan (THA) into an extracellular matrix (ECM) scaffold may be a strategy to promote an anti-inflammatory response to the ECM. Further, we posit that the implantation site could influence the inflammatory response and remodeling of an ECM scaffold. Eight beagles underwent implantation of fascia ECM grafts, treated with either immobilized low molecular weight (57kDa) THA or water only, in both the shoulder injury and body wall sites. Dogs were euthanized at 12weeks and fascia grafts harvested en bloc for histology. Grafts implanted at the body wall had significantly higher inflammatory cell infiltrate and vascularity, and significantly lower retardance (collagen density), than grafts at the shoulder, suggestive of a more intense, persistent, and perhaps degradative inflammatory and remodeling response at the body wall than shoulder injury site in the canine model. However, the presence of immobilized low MW THA had no effect on the inflammation response or remodeling of fascia ECM compared to water-treated controls. Importantly, these results suggest that the inflammatory response and remodeling of biomaterial implants depends on the location of implantation and therefore our animal models need to be carefully chosen. Further, the potential anti-inflammatory advantages of hyaluronan (HA) in wound healing do not appear to be realized when presenting it to the host as non-degradable hydrogel even if its capacity for binding HA binding protein is maintained. Further study treating ECM with uncross-linked (free) HA or immobilized low MW THA as a means to deliver free HA or other biomolecules to a surgical repair site is warranted.
C1 [Leigh, Diane R.; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.
   [Leigh, Diane R.; Baker, Andrew R.; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Orthopaed Res Ctr, Cleveland, OH 44195 USA.
   [Kim, Myung-Sun] Chonnam Natl Univ, Coll Med, Dept Orthopaed Surg, Kwangju, South Korea.
   [Kovacevic, David] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44195 USA.
   [Tan, Carmela D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44195 USA.
RP Derwin, KA (reprint author), Cleveland Clin, Dept Biomed Engn, ND 20,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM derwink@ccf.org
OI Kovacevic, David/0000-0002-1900-5181
FU National Institutes of Health [AR056633]
FX This work was supported by The National Institutes of Health [AR056633].
CR Alhadlaq HA, 2007, CONNECT TISSUE RES, V48, P76, DOI 10.1080/03008200601130950
   Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bedi Asheesh, 2009, HSS J, V5, P51, DOI 10.1007/s11420-008-9096-1
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chin LK, 2011, J MATER SCI-MATER M, V22, P1465, DOI 10.1007/s10856-011-4325-4
   Cook JL, 2008, AM J VET RES, V69, P148, DOI 10.2460/ajvr.69.1.148
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Derwin KA, 2008, J BIOMED MATER RES A, V84A, P500, DOI 10.1002/jbm.a.31455
   Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Hu M, 2003, J BIOMED MATER RES B, V67B, P586, DOI 10.1002/jbm.b.20001
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Raub CB, 2013, OSTEOARTHR CARTILAGE, V21, P860, DOI 10.1016/j.joca.2013.03.014
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Snyder SJ, 2009, ARTHROSCOPY, V25, P329, DOI 10.1016/j.arthro.2008.05.023
   Thomopoulos S, 2003, J BIOMECH ENG-T ASME, V125, P106, DOI 10.1115/1.1536660
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Van Kampen Craig, 2013, Muscles Ligaments Tendons J, V3, P229
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Yagi M, 2010, J HAND SURG-AM, V35A, P791, DOI 10.1016/j.jhsa.2010.02.010
   Yasuda T, 2010, TOHOKU J EXP MED, V220, P229, DOI 10.1620/tjem.220.229
NR 27
TC 0
Z9 0
U1 1
U2 27
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2015
VL 26
IS 1
BP 1
EP 15
DI 10.1080/09205063.2014.975394
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU1KM
UT WOS:000345379600001
PM 25400204
DA 2018-10-20
ER

PT J
AU Lim, JI
   Im, H
   Lee, WK
AF Lim, Jin Ik
   Im, Heejung
   Lee, Woo-Kul
TI Fabrication of porous chitosan-polyvinyl pyrrolidone scaffolds from a
   quaternary system via phase separation
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE minute pore; chitosan-PVP; quaternary system; tissue engineering; porous
   scaffold
ID POLY(VINYLPYRROLIDONE)/POLY(ACRYLIC ACID) FILM; TISSUE ENGINEERING
   APPLICATIONS; BIOMATERIAL SCAFFOLDS; DESIGN; POLYMERS; GROWTH;
   REGENERATION; FIBROBLAST; CELLS
AB Three-dimensional porous chitosan-polyvinyl pyrrolidone (PVP) scaffolds were fabricated for tissue engineering applications via liquid-liquid or liquid-solid phase separation. A mixture of an acidic aqueous solution with butanol as a non-solvent and a chitosan-PVP quaternary system were freeze-dried. We then studied the homogenous open pore structure and the minute pore distribution in order to improve the mass transfer and cell seeding efficiency while also obtaining the optimal ratio of PVP to provide high interconnectivity and to improve the open-pore structure. The properties of the porous chitosan-PVP scaffolds - including the microstructure, chemical release, water absorption properties, and cell proliferation tests were studied - and the results were compared against those obtained from conventional scaffolds. chitosan-PVP scaffolds with a porosity of over 70% were obtained, and the pore morphology on the surface and within the porous scaffolds showed the presence of homogenous open pores with excellent interconnectivity. As the PVP content increased, main pores (50-100 mu m) and minute pores (4-10 mu m) could be clearly observed. Also, the porous scaffold showed an improved efficiency for cell adhesion after the cells were cultured for 4h. After 72h, the cultured cells presented an increase in the cell proliferation and on the porous scaffolds. These results strongly suggest that the porous chitosan-PVP scaffolds can be widely used in tissue engineering, including for biopatches and artificial skin applications.
C1 [Lim, Jin Ik; Im, Heejung; Lee, Woo-Kul] Dankook Univ, Inst Tissue Regenerat Engn, Dept Chem Engn, Lab Biointerfaces Tissue Engn,Coll Engn, Yongin, Gyeonggi Do, South Korea.
RP Lee, WK (reprint author), Dankook Univ, Inst Tissue Regenerat Engn, Dept Chem Engn, Lab Biointerfaces Tissue Engn,Coll Engn, Yongin, Gyeonggi Do, South Korea.
EM leewo@dankook.ac.kr
CR Baldino L, 2014, J SUPERCRIT FLUID, V90, P27, DOI 10.1016/j.supflu.2014.03.002
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Cao YG, 2011, COLLOID SURFACE A, V392, P83, DOI 10.1016/j.colsurfa.2011.09.037
   Choong C, 2009, REACT FUNCT POLYM, V69, P77, DOI 10.1016/j.reactfunctpolym.2008.11.003
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Dorati R, 2014, MAT SCI ENG C-MATER, V34, P130, DOI 10.1016/j.msec.2013.08.037
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Ji CD, 2013, MAT SCI ENG C-MATER, V33, P3780, DOI 10.1016/j.msec.2013.05.010
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim MS, 2012, CARBOHYD POLYM, V87, P2683, DOI 10.1016/j.carbpol.2011.11.060
   Lee LY, 2009, EUR POLYM J, V45, P3247, DOI 10.1016/j.eurpolymj.2009.07.016
   Li J, 2010, CARBOHYD POLYM, V79, P786, DOI 10.1016/j.carbpol.2009.09.028
   Lim JI, 2013, COLLOID SURFACE B, V103, P463, DOI 10.1016/j.colsurfb.2012.11.016
   Lim JI, 2007, KEY ENG MATER, V342-343, P65, DOI 10.4028/www.scientific.net/KEM.342-343.65
   Lu Q, 2009, MAT SCI ENG C-MATER, V29, P2239, DOI 10.1016/j.msec.2009.05.014
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mou ZL, 2011, J SUPERCRIT FLUID, V58, P398, DOI 10.1016/j.supflu.2011.07.003
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Serrano MC, 2014, PROG POLYM SCI, V39, P1448, DOI 10.1016/j.progpolymsci.2014.02.004
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Yao CK, 2012, APPL SURF SCI, V262, P218, DOI 10.1016/j.apsusc.2012.05.128
   Yuan Q, 2014, COLLOID SURFACE A, V456, P153, DOI 10.1016/j.colsurfa.2014.05.030
NR 31
TC 6
Z9 6
U1 1
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2015
VL 26
IS 1
BP 32
EP 41
DI 10.1080/09205063.2014.979386
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AU1KM
UT WOS:000345379600003
PM 25410721
DA 2018-10-20
ER

PT B
AU Djordjevic, N
AF Djordjevic, Nina
BE Ristic, G
TI ANTIBIOTIC-LOADED HYDROXIAPATITE AND CALCIUM SULPHATE COMPOSITE IS A
   POTENT BIOMATERIAL FOR ONE STAGE TREATMENT OF THE EXTENSIVE INFECTED
   BONE DEFECT
SO RAD 2015: THE THIRD INTERNATIONAL CONFERENCE ON RADIATION AND
   APPLICATIONS IN VARIOUS FIELDS OF RESEARCH
LA English
DT Proceedings Paper
CT 3rd International Conference on Radiation and Applications in Various
   Fields of Research (RAD)
CY JUN 08-12, 2015
CL Budva, MONTENEGRO
DE Chronic osteomyelitis; Septic bone defect; PerOssal; One stage surgery
ID GENTAMICIN-PMMA-BEADS; CHRONIC OSTEOMYELITIS; SUBSTITUTES
AB Antibiotic-loaded hydroxyapatite and calcium sulphate (PerOssal, aap Bioniaterials GmbH, Dieburg, Germany) compound is completely absorbable biomaterial able to deliver high concentration of an active antimicrobial agent directly to the site of infection.
   Paper is presenting one stage surgery of the extensive infected bone defect. During the operation segestrectomy left a large bone defect which was filled with the PerOssal pellets soaked in the high concetrated antibiotic of choice. This patient is a good example of the efficient way to treat extensive septic bone defect with local administration of very high concentration of specific antibiotic. High concentration is achieved due to the technological characteristics of PerOssal pellets. This and the fact that the PerOssal is completely absorbable made this biomaterial a very potent weapon against the most resistant infections and even in one stage surgery. The osteoinductive and osteoconductive effects of PerOssal are additional contribution when the extensive bone defect is in case.
C1 [Djordjevic, Nina] Univ Nis, Sch Med, Nish, Serbia.
   [Djordjevic, Nina] Clin Ctr Nis, Univ Clin Orthopaed Surg & Traumatol, Nish, Serbia.
RP Djordjevic, N (reprint author), Univ Nis, Sch Med, Nish, Serbia.
CR Anagnostakos K, 2008, ACTA ORTHOP, V79, P302, DOI 10.1080/17453670710015120
   DACQUET V, 1992, CLIN ORTHOP RELAT R, P241
   Drakou A, 2011, J BONE JOINT SURG BR, V93, P323
   Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189
   KLEMM K, 1979, ZBL CHIR, V104, P934
   Kraus R, 2010, SEPTIC BONE JOINT SU, P126
   Lee Gregory H, 2002, Iowa Orthop J, V22, P35
   MAJID SA, 1985, ACTA ORTHOP SCAND, V56, P265, DOI 10.3109/17453678508993010
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Robinson D, 1999, Ann Transplant, V4, P91
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   VECSEI V, 1981, CLIN ORTHOP RELAT R, P201
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
NR 15
TC 0
Z9 0
U1 0
U2 1
PU RAD ASSOC
PI `
PA BULEVAR NIKOLE TESLE 17-12, `, 18000, SERBIA
BN 978-86-80300-01-6
PY 2015
BP 483
EP 486
PG 4
WC Nuclear Science & Technology; Physics, Applied; Radiology, Nuclear
   Medicine & Medical Imaging
SC Nuclear Science & Technology; Physics; Radiology, Nuclear Medicine &
   Medical Imaging
GA BG3KU
UT WOS:000387979700101
DA 2018-10-20
ER

PT S
AU Park, S
   Kim, S
   Choi, J
AF Park, Sanghoon
   Kim, Seongjun
   Choi, Jaesoon
GP IEEE
TI Development of a Multi-nozzle Bioprinting System for 3D Tissue Structure
   Fabrication
SO 2015 15TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS
   (ICCAS)
SE International Conference on Control Automation and Systems
LA English
DT Proceedings Paper
CT 15th International Conference on Control, Automation and Systems (ICCAS)
CY OCT 13-16, 2015
CL Busan, SOUTH KOREA
SP Busan Tourism Org, Korea Tourism Org, Koh Young Technol Inc, Chonnam Natl Univ, Robot Res Initiat, SNU, Bio Mimet Robot Res Ctr, Samsung Heavy Ind Co Ltd, LS Ind Syst Co Ltd, RS Automat, Dongil SHIMADZI Corp
DE Bioprinting; Multi-nozzle; 3D structure
ID CELL-LADEN; HYDROGEL
AB The aim of this study was to develop a multi-nozzle based bioprinting system for fabrication of three-dimensional (3D) biological structure. In this study, a thermoplastic biomaterial that has relatively high mechanical stability, polycaprolactone (PCL), was used to make the 3D structure. A multi-nozzle bioprinting system was designed to dispense thermoplastic biomaterial and hydrogel simultaneously. The system consists of three axes of x-y-z motion control stage and I-axis actuator for change of nozzle. The controllability of the printed line width was tested as a representative performance index.
C1 [Park, Sanghoon; Kim, Seongjun; Choi, Jaesoon] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul 138736, South Korea.
   Univ Ulsan, Coll Med, Ulsan 680749, South Korea.
RP Choi, J (reprint author), Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul 138736, South Korea.
EM dieuaimer@gmail.com; jaesoon@gmail.com
CR Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Shim J. H., 2012, J MICROMECH MICROENG, V22, P1
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
NR 6
TC 2
Z9 2
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2093-7121
BN 978-8-9932-1509-0
J9 INT C CONTR AUTOMAT
PY 2015
BP 1874
EP 1877
PG 4
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA BF5MU
UT WOS:000382295200391
DA 2018-10-20
ER

PT B
AU Muller, R
   Zhou, M
   Liebert, T
   Dellith, A
   Dutz, S
   Borin, D
   Heinze, T
AF Mueller, R.
   Zhou, M.
   Liebert, T.
   Dellith, A.
   Dutz, S.
   Borin, D.
   Heinze, T.
GP IEEE
TI Bio-nano composite for remote melting
SO 2015 IEEE 15TH INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY (IEEE-NANO)
LA English
DT Proceedings Paper
CT IEEE NANO 2015 15th INTERNATIONAL CONFERENCE ON NANOTECHNOLOGY
CY JUL 27-30, 2015
CL ROME, ITALY
SP Univ di Roma, SAPIENZA UNIV DI ROMA, IEEE, IEEE NANO, USN DEPT OF THE NAVY SCI & TECHNOL, ISTITUTO ITALIANO DI TECNOLOGIA, CAMBRIDGE UNIV PRESS, Centro Studi e Documentazione sulla Sensoristica, FEI, Nanoscale Horizons, UNIV NOTRE DAME
DE bio-nano composite; remote melting; magnetic field
ID PARTICLES
AB The fabrication of biocompatible composites, consisting of magnetite nanoparticles embedded into a matrix of meltable dextran ester is presented which can be softened under an induced alternating magnetic field and may allow in that way a magnetically controlled release application. This could be a suitable alternative for swellable hydrogel composites embedded with magnetic particles as remote controlled biomaterial. Furthermore a texturing of particles in the polymer matrix by a static magnetic field was investigated.
C1 [Mueller, R.; Dellith, A.] Leibniz Inst Photon Technol IPHT, D-07743 Jena, Germany.
   [Zhou, M.; Liebert, T.; Heinze, T.] Univ Jena, Inst Organ Chem & Macromol Chem, D-07743 Jena, Germany.
   [Dutz, S.] Tech Univ Ilmenau, Inst Biomed Engn & Informat, D-98693 Ilmenau, Germany.
   [Borin, D.] Tech Univ Dresden, Inst Fluid Mech, D-01062 Dresden, Germany.
RP Muller, R (reprint author), Leibniz Inst Photon Technol IPHT, D-07743 Jena, Germany.
RI Dutz, Silvio/E-3865-2010
CR Campbell SB, 2013, BIOMACROMOLECULES, V14, P644, DOI 10.1021/bm301703x
   Dutz S, 2012, J NANO ELECTRON PHYS, V4
   HENKEL O, 1964, PHYS STATUS SOLIDI, V7, P919, DOI 10.1002/pssb.19640070320
   Liebert T, 2011, BIOMACROMOLECULES, V12, P3107, DOI 10.1021/bm200841b
   Muller R, 2011, J MAGN MAGN MATER, V323, P1223, DOI 10.1016/j.jmmm.2010.11.010
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   WOHLFARTH EP, 1958, J APPL PHYS, V29, P595, DOI 10.1063/1.1723232
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-8155-0
PY 2015
BP 1
EP 4
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BF3AF
UT WOS:000380515200111
DA 2018-10-20
ER

PT J
AU Agbay, A
   Edgar, JM
   Robinson, M
   Styan, T
   Wilson, K
   Schroll, J
   Ko, J
   Mohtaram, NK
   Jun, MBG
   Willerth, SM
AF Agbay, Andrew
   Edgar, John M.
   Robinson, Meghan
   Styan, Tara
   Wilson, Krista
   Schroll, Julian
   Ko, Junghyuk
   Mohtaram, Nima Khadem
   Jun, Martin Byung-Guk
   Willerth, Stephanie M.
TI Biomaterial Strategies for Delivering Stem Cells as a Treatment for
   Spinal Cord Injury
SO CELLS TISSUES ORGANS
LA English
DT Review
DE Hydrogels; Electrospinning; Neuroscience; Stem cells; Controlled release
ID PROMOTES FUNCTIONAL RECOVERY; ANTI-INHIBITORY MOLECULES; NEURAL
   PROGENITOR CELLS; FIBRIN SCAFFOLDS; NEURONAL DIFFERENTIATION;
   DRUG-DELIVERY; GROWTH-FACTOR; TISSUE; SURVIVAL; RELEASE
AB Ongoing clinical trials are evaluating the use of stem cells as a way to treat traumatic spinal cord injury (SCI). However, the inhibitory environment present in the injured spinal cord makes it challenging to achieve the survival of these cells along with desired differentiation into the appropriate phenotypes necessary to regain function. Transplanting stem cells along with an instructive biomaterial scaffold can increase cell survival and improve differentiation efficiency. This study reviews the literature discussing different types of instructive biomaterial scaffolds developed for transplanting stem cells into the injured spinal cord. We have chosen to focus specifically on biomaterial scaffolds that direct the differentiation of neural stem cells and pluripotent stem cells since they offer the most promise for producing the cell phenotypes that could restore function after SCI. In terms of biomaterial scaffolds, this article reviews the literature associated with using hydrogels made from natural biomaterials and electrospun scaffolds for differentiating stem cells into neural phenotypes. It then presents new data showing how these different types of scaffolds can be combined for neural tissue engineering applications and provides directions for future studies. (C) 2016 S. Karger AG, Basel
C1 [Agbay, Andrew; Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Dept Neurosci, Victoria, BC, Canada.
   [Edgar, John M.; Robinson, Meghan; Styan, Tara; Wilson, Krista; Schroll, Julian; Willerth, Stephanie M.] Univ Victoria, Dept Biomed Engn, Victoria, BC, Canada.
   [Ko, Junghyuk; Jun, Martin Byung-Guk; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, Victoria, BC, Canada.
   [Mohtaram, Nima Khadem] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Willerth, Stephanie M.] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Div Med Sci, Dept Mech Engn, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
CR Abbasi N, 2016, J BIOMED MATER RES A, V104, P155, DOI 10.1002/jbm.a.35551
   Assuncao-Silva R.C., 2015, STEM CELLS INT, V2015
   Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008
   Brown AC, 2014, ACTA BIOMATER, V10, P1502, DOI 10.1016/j.actbio.2013.09.008
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Cheung Vincent, 2015, Surg Neurol Int, V6, P142, DOI 10.4103/2152-7806.163452
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71
   Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5
   Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Hutmacher DW, 2011, CHEM-ASIAN J, V6, P44, DOI 10.1002/asia.201000436
   Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Kandel ER, 2013, PRINCIPLES NEURAL SC
   Kaneko A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015008
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Ko J, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/6/065009
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Kolehmainen K, 2012, JOVE-J VIS EXP, V2012, pe3641
   Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271
   Liu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117709
   Low WC, 2015, DRUG DELIV TRANSL RE, V5, P89, DOI 10.1007/s13346-013-0131-5
   Lu P, 2014, JOVE-J VIS EXP, V89
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a
   Mohtaram NK, 2015, J BIOMED MATER RES A, V103, P2591, DOI 10.1002/jbm.a.35392
   Mohtaram NK, 2014, J BIOMATER TISS ENG, V4, P906, DOI 10.1166/jbt.2014.1223
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Montgomery A, 2015, BIOMATER SCI-UK, V3, P401, DOI 10.1039/c4bm00299g
   Rajangam T, 2013, INT J NANOMED, V8, P3641, DOI 10.2147/IJN.S43945
   Raspa A, 2016, BIOTECHNOL BIOENG, V113, P253, DOI 10.1002/bit.25689
   Robinson M, 2015, BIOMARK INSIGHTS, V10, P61, DOI 10.4137/BMIMI.S20064
   Schaub NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136780
   Scott CT, 2014, STEM CELL TRANSL MED, V3, P1398, DOI 10.5966/sctm.2014-0147
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silver J., 2014, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A020602
   Sugai K, 2015, J NEUROSCI RES, V93, P1826, DOI 10.1002/jnr.23636
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsukamoto A, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-102, 10.1186/scrt313]
   Wang J, 2015, NEUROCHEM RES, V40, P98, DOI 10.1007/s11064-014-1470-4
   Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018
   Wilems TS, 2015, J CONTROL RELEASE, V213, P103, DOI 10.1016/j.jconrel.2015.06.031
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yuan N, 2014, NEURAL REGEN RES, V9, P1014, DOI 10.4103/1673-5374.133160
   Zhang N, 2012, INDIAN J MED RES, V135, P287
   Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017
NR 64
TC 6
Z9 7
U1 2
U2 15
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 42
EP 51
DI 10.1159/000446474
PG 10
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800004
PM 27701166
DA 2018-10-20
ER

PT J
AU Russell, LN
   Lampe, KJ
AF Russell, Lauren N.
   Lampe, Kyle J.
TI Engineering Biomaterials to Influence Oligodendroglial Growth,
   Maturation, and Myelin Production
SO CELLS TISSUES ORGANS
LA English
DT Review
DE Oligodendrocytes; Neural stem cells; Differentiation; Biomaterials;
   Nerve regeneration
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY;
   CENTRAL-NERVOUS-SYSTEM; PROMOTES FUNCTIONAL RECOVERY; PROGENITOR CELLS;
   MULTIPLE-SCLEROSIS; POLY(ETHYLENE GLYCOL); HYDROGEL SCAFFOLDS; NEURITE
   EXTENSION
AB Millions of people suffer from damage or disease to the nervous system that results in a loss of myelin, such as through a spinal cord injury or multiple sclerosis. Diminished myelin levels lead to further cell death in which unmyelinated neurons die. In the central nervous system, a loss of myelin is especially detrimental because of its poor ability to regenerate. Cell therapies such as stem or precursor cell injection have been investigated as stem cells are able to grow and differentiate into the damaged cells; however, stem cell injection alone has been unsuccessful in many areas of neural regeneration. Therefore, researchers have begun exploring combined therapies with biomaterials that promote cell growth and differentiation while localizing cells in the injured area. The regrowth of myelinating oligodendrocytes from neural stem cells through a biomaterials approach may prove to be a beneficial strategy following the onset of demyelination. This article reviews recent advancements in biomaterial strategies for the differentiation of neural stem cells into oligodendrocytes, and presents new data indicating appropriate properties for oligodendrocyte precursor cell growth. In some cases, an increase in oligodendrocyte differentiation alongside neurons is further highlighted for functional improvements where the biomaterial was then tested for increased myelination both in vitro and in vivo. (C) 2016 S. Karger AG, Basel
C1 [Russell, Lauren N.; Lampe, Kyle J.] Univ Virginia, Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.
RP Lampe, KJ (reprint author), Univ Virginia, Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.
EM lampe@virginia.edu
FU UVA Biotechnology Training Program; University of Virginia
FX This work was supported by the UVA Biotechnology Training Program
   (L.N.R.) and the University of Virginia. The authors thank the Gaultier
   lab at UVA for the generous gift of OPC lines.
CR Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007
   Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8
   Asmani MN, 2013, CELL BIOL INT, V37, P1340, DOI 10.1002/cbin.10171
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226
   Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240
   Carenini S, 1998, GLIA, V22, P213, DOI 10.1002/(SICI)1098-1136(199803)22:3<213::AID-GLIA1>3.0.CO;2-6
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Diao HJ, 2015, J CONTROL RELEASE, V208, P85, DOI 10.1016/j.jconrel.2015.03.005
   Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Gingras M, 2008, GLIA, V56, P354, DOI 10.1002/glia.20617
   Goddard DR, 1999, J NEUROSCI RES, V57, P74, DOI 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kandel E. R., 2000, PRINCIPLES NEURAL SC
   Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380
   Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249
   Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803
   Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096
   Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI 10.1089/ten.TEA.2009.0509
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042
   Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039
   Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li H, 2014, BIOMATERIALS, V35, P9049, DOI 10.1016/j.biomaterials.2014.07.038
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014
   LODISH HB, 2000, MOL CELL BIOL
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Martin BC, 2008, J NEURAL ENG, V5, P221, DOI 10.1088/1741-2560/5/2/013
   McDonald JW, 2002, PROG BRAIN RES, V137, P299
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Morell P., 1999, BASIC NEUROCHEMISTRY
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Noble M, 2013, CELL STEM CELL, V12, P503, DOI 10.1016/j.stem.2013.04.021
   Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230
   Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71
   Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011
   Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735
   Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1227/01.NEU.0000027826.68845.CF
   Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501
   Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Sindou MP, 2001, NEUROSURG QUART, V11, P45, DOI 10.1097/00013414-200103000-00006
   Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026
   Stabenfeldt SE, 2011, CURR STEM CELL RES T, V6, P208
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Syed YA, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E4
   Tam RY, 2012, J MATER CHEM, V22, P19402, DOI 10.1039/c2jm33680d
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a
   Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313
   van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wilkinson AE, 2014, J BIOMED MATER RES A, V102, P3419, DOI 10.1002/jbm.a.35001
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706
   Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564
   Yla-Outinen L, 2014, J TISSUE ENG REGEN M, V8, P186, DOI 10.1002/term.1512
   Yu D, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E10
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
   Zustiak SP, 2013, BIOTECHNOL PROGR, V29, P1255, DOI 10.1002/btpr.1761
NR 102
TC 4
Z9 4
U1 3
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 85
EP 101
DI 10.1159/000446645
PG 17
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800007
PM 27701172
DA 2018-10-20
ER

PT J
AU Johnson, CDL
   D'Amato, AR
   Gilbert, RJ
AF Johnson, Christopher D. L.
   D'Amato, Anthony R.
   Gilbert, Ryan J.
TI Electrospun Fibers for Drug Delivery after Spinal Cord Injury and the
   Effects of Drug Incorporation on Fiber Properties
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Electrospun fibers; Drug incorporation; Riluzole; Neurotrophin-3; Spinal
   cord injury; Fiber characteristics; Alignment; Diameter
ID TEMPLATED AGAROSE SCAFFOLDS; ADULT SENSORY NEURONS; AXONAL REGENERATION;
   NERVOUS-SYSTEM; NANOFIBER SCAFFOLDS; NEUROTROPHIC FACTOR;
   CONTROLLED-RELEASE; NEURITE OUTGROWTH; POLYMER-SOLUTIONS; SHELL
   NANOFIBERS
AB There is currently no cure for individuals with spinal cord injury (SCI). While many promising approaches are being tested in clinical trials, the complexity of SCI limits several of these approaches from aiding complete functional recovery. Several different categories of biomaterials are investigated for their ability to guide axonal regeneration, to deliver proteins or small molecules locally, or to improve the viability of transplanted stem cells. The purpose of this study is to provide a brief overview of SCI, present the different categories of biomaterial scaffolds that direct and guide axonal regeneration, and then focus specifically on electrospun fiber guidance scaffolds. Much like other polymer guidance approaches, electrospun fibers can retain and deliver therapeutic drugs. The experimental section presents new data showing the incorporation of two therapeutic drugs into electrospun poly- L- lactic acid fibers. Two different concentrations of either riluzole or neurotrophin- 3 were loaded into the electrospun fibers to examine the effect of drug concentration on the physical characteristics of the fibers (fiber alignment and fiber diameter). Overall, the drugs were successfully incorporated into the fibers and the release was related to the loading concentration. The fiber diameter decreased with the inclusion of the drug, and the decreased diameter was correlated with a decrease in fiber alignment. Subsequently, the study includes considerations for successful incorporation of a therapeutic drug without changing the physical properties of the fibers. (C) 2016 S. Karger AG, Basel
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
RP Gilbert, RJ (reprint author), Dept Biomed Engn, 110 8th St, Troy, NY 12180 USA.
EM gilber2@rpi.edu
FU National Science Foundation [11050125]; National Institutes of Health
   [R01 NS092754]; New York Spinal Cord Injury Research Trust [C030239];
   New York Spinal Cord Injury Research Trust (RFA) [1412220226]
FX The authors gratefully acknowledge grant support provided by the
   National Science Foundation (CAREER grant 11050125), National Institutes
   of Health (R01 NS092754), and the New York Spinal Cord Injury Research
   Trust (contract No. C030239) awarded to Ryan J. Gilbert, and the
   Predoctoral Fellowship awarded to Christopher Johnson by the New York
   Spinal Cord Injury Research Trust (RFA No. 1412220226).
CR ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0
   Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623
   Bao J, 2013, J MATER SCI, V48, P4223, DOI 10.1007/s10853-013-7235-7
   Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x
   BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Cox A, 2015, J NEUROTRAUM, V32, P1413, DOI 10.1089/neu.2014.3730
   Dlubek G, 2003, POLYMER, V44, P1921, DOI 10.1016/S0032-3861(03)00056-9
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Elliott Donaghue I, 2015, BIOMATER SCI-UK, V3, P65, DOI 10.1039/c4bm00311j
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Frizzo MED, 2004, CELL MOL NEUROBIOL, V24, P123, DOI 10.1023/B:CEMN.0000012717.37839.07
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Ghitescu RE, 2015, INT J PHARMACEUT, V494, P278, DOI 10.1016/j.ijpharm.2015.08.020
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hou SP, 2012, J NEUROSCI, V32, P13206, DOI 10.1523/JNEUROSCI.5041-11.2012
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jeffries EM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035015
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Krishna V, 2013, J SPINAL CORD MED, V36, P174, DOI 10.1179/2045772313Y.0000000095
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105
   Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445
   Lin K, 2007, POLYMER, V48, P6384, DOI 10.1016/j.polymer.2007.08.056
   LINDSAY RM, 1988, J NEUROSCI, V8, P2394
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Liu XZ, 1997, J NEUROSCI, V17, P5395
   LOO JA, 1991, RAPID COMMUN MASS SP, V5, P101, DOI 10.1002/rcm.1290050303
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Mit-uppatham C, 2004, MACROMOL SYMP, V216, P293, DOI 10.1002/masy.200451227
   Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5
   MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853
   Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a
   Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   NSCISC, 2014, SPIN CORD INJ SCI FA
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101
   Palm MD, 2009, J DRUGS DERMATOL, V8, pS15
   Peluffo H, 1997, NEUROSCI LETT, V228, P207, DOI 10.1016/S0304-3940(97)00384-4
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Qian W, 2014, INT J MOL SCI, V15, P774, DOI 10.3390/ijms15010774
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Schaub N.J., 2015, J NEUROTRAUM, DOI [10.1089/neu.2015.4165, DOI 10.1089/NEU.2015.4165]
   Schaub NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136780
   Schaub NJ, 2013, ACS APPL MATER INTER, V5, P10173, DOI 10.1021/am402827g
   Schaub NJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046026
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Shah BL, 2003, J APPL POLYM SCI, V90, P3278, DOI 10.1002/app.13049
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Su Y, 2012, J BIOMAT SCI-POLYM E, V23, P861, DOI 10.1163/092050611X564137
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Tsintou M, 2015, NEURAL REGEN RES, V10, P726, DOI 10.4103/1673-5374.156966
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zamani M, 2010, EUR J PHARM BIOPHARM, V75, P179, DOI 10.1016/j.ejpb.2010.02.002
   Zeng J., 2013, E-POLYMERS, V3, P102
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhu YQ, 2010, ADV FUNCT MATER, V20, P1433, DOI 10.1002/adfm.200901889
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079
   Zuo WW, 2005, POLYM ENG SCI, V45, P704, DOI 10.1002/pen.20304
NR 100
TC 9
Z9 9
U1 1
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 202
IS 1-2
BP 116
EP 135
DI 10.1159/000446621
PG 20
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DX9OU
UT WOS:000384725800009
PM 27701153
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT B
AU Kutbay, I
   Akfirat, FS
AF Kutbay, Isil
   Akfirat, Funda Senturk
BE Sener, S
   Saridogan, E
   Staub, S
TI Mapping of Biochemical Constituents in Platanus acerifolia Leaves By
   Analytical Techniques
SO WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP
LA English
DT Proceedings Paper
CT World Conference on Technology, Innovation and Entrepreneurship
CY MAY 28-30, 2015
CL Istanbul, TURKEY
DE ATR-FTIR; leaf; Platanus acerifolia; SEM EDX; XRD
ID ORIENTALIS LEAF POWDER; MEDICINAL-PLANTS; BIOSORPTION; GLYCOSIDE
AB Platanus acerifolia (Plataceae) is woody perennial tree, a native of Asia, Europe, and Eastern Mediterranean regions of the world. It is commonly cultivated and highly valued as an ornamental and medicinal tree. Its leaves as a natural waste is available in abudance, easy to obtain and cheap. In the present study, P. acerifolia leaves were obtained from Kocaeli region of Turkey at the autumn period. All of the specimens were dried in air before using analytical techniques. The leaves were analyzed by using X-ray diffraction (XRD), Attenuated Total internal Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR), Scanning Electro Microscopy-Enegy-Dispersive X-ray Spectroscopy (SEM-EDX). All analysis were performed for providing an accurate detection of the leaf molecular structure, crystalline phase, chemical compositions (organic or inorganic constituent), elemental index, morphology and microstructure. From X-ray diffraction pattern, crystaline phase and chemical compositions of the leaf specimens were identified as whewellite (C2CaO4 center dot H2O), schertelite (Mg(NH4)(2)H-2(PO4)(2)4H(2)O), silicon oxide (SiO2), amide (C13H17N7O3), ester (C37H68O8), benzene (C28H40O10). According to ATR-FTIR analysis results, characteristic peak values of the leaf specimens were detected functional groups as (P-O), (C=O), (Cl=O), (C-O), (P-O-H), (C-H), (N-H), (O-C=O), (K-N=O), (Ca-C equivalent to O), (N equivalent to H), (C=H), (N=O), (O-H), (C equivalent to H), (N equivalent to N), (Si-O-Si). SEM-EDX analysis showed the present of carbon, nitrogen, oxygen, magnesium, silicon, phosphor, chloride, potassium, and calcium in the leaf specimens. Morphology and microstructure of opened or closed stomas, fiber of leaf specimens were monitored. The chemical compositions, the functional groups and the elements are responsible for various medicinal properties of P. acerifolia leaves. Nanoparticles obtained from the leaves by using developed plant extract process can be used as biomaterial, biosorbent and nanomedicine against various plant, human, and animal diseases or pathogens. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Kutbay, Isil] Gebze Tech Univ, Dept Mat Sci & Engn, Fac Engn, Kocaeli, Turkey.
   [Akfirat, Funda Senturk] Gebze Tech Univ, Dept Mol Biol & Genet, Fac Basic Sci, Kocaeli, Turkey.
RP Kutbay, I (reprint author), Gebze Tech Univ, Dept Mat Sci & Engn, Fac Engn, Kocaeli, Turkey.
EM kutbay@gtu.edu.tr
CR Bachheti R. K, 2012, INT J PHARM PHARM SC, V4, P359
   Baily LH, 1953, STANDARD CYCLOPEDIA, P2706
   Baseri M. K., 2011, Romanian Journal of Biophysics, V21, P277
   Bibi Samra, 2006, PAK J PL SCI, V12, P141
   Chopra RN, 1956, GLOSSARY INDIAN MED, P196
   Dimas K, 2000, PHARMACOL RES, V41, P85
   Ekinci N, 2004, J RADIOANAL NUCL CH, V260, P127, DOI 10.1023/B:JRNC.0000027071.72742.ee
   El-Alfy TS, 2008, NAT PROD COMMUN, V3, P1899
   Erdik E., 2007, ORGANIK KIMYADA SPEK, P82
   Gunther TR, 1959, GREEK HERBAL DIOSCOR, P58
   Hameed I, 2008, PAK J BOT, V40, P2493
   Ibrahim MA, 2009, J NAT PROD, V72, P2141, DOI 10.1021/np900499q
   Kirmani M. Z., 2011, Journal of Basic & Applied Sciences, V7, P89
   Mahvi A. H., 2007, World Applied Sciences Journal, V2, P40
   Mamikoglu N. G., 2007, TREES SHRUBS TURKEY, P266
   Mitali Konwar, 2011, Archives of Applied Science Research, V3, P214
   Mitrocotsa D, 1999, ANTICANCER RES, V19, P2085
   MITROKOTSA D, 1993, PLANTA MED, V59, P517, DOI 10.1055/s-2006-959751
   Monji AB, 2008, GREEN CHEM LETT REV, V1, P107, DOI 10.1080/17518250802101907
   Nie XQ, 2013, SPECTROSC SPECT ANAL, V33, P1290, DOI 10.3964/j.issn.1000-0593(2013)05-1290-05
   Parekh Jigna, 2007, Turkish Journal of Biology, V31, P53
   Peydayesh M, 2015, J IND ENG CHEM, V21, P1014, DOI 10.1016/j.jiec.2014.05.010
   Rao K.S., 2010, INT J ENG SCI TECHNO, V2, P81
   Sahaya S.S., 2012, INT J PHARM SCI DRUG, V4, P56
   Saxena Mamta, 2012, IJPBR, V3, P498
   Sert S, 2008, HYDROMETALLURGY, V90, P13, DOI 10.1016/j.hydromet.2007.09.006
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Starlin T., 2012, INT RES J PHARM, V3, P180
   Stuart H. B., 2004, INFRARED SPECTROSCOP, P71
   Tantry MA, 2012, FITOTERAPIA, V83, P281, DOI 10.1016/j.fitote.2011.11.004
   Thangarajan S., 2012, INT J PHARM PHARM S5, V4, P343
   Wang X, 2015, RSC ADV, V5, P15969, DOI 10.1039/c4ra14357d
   Zhang DQ, 2011, KEY ENG MATER, V480-481, P502, DOI 10.4028/www.scientific.net/KEM.480-481.502
NR 33
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
PY 2015
BP 1719
EP 1727
DI 10.1016/j.sbspro.2015.06.287
PG 9
WC Business
SC Business & Economics
GA BF2YI
UT WOS:000380509900204
OA Other Gold
DA 2018-10-20
ER

PT B
AU Shreepad, S
   Ravi, W
AF Shreepad, Sarange
   Ravi, Warkhedkar
BE Sener, S
   Saridogan, E
   Staub, S
TI New Revolutionary Ideas of Material Processing - A Path to Biomaterial
   Fabrication by Rapid Prototyping
SO WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP
LA English
DT Proceedings Paper
CT World Conference on Technology, Innovation and Entrepreneurship
CY MAY 28-30, 2015
CL Istanbul, TURKEY
DE Rapid prototyping (RP); Biomaterial; Hydroxyapatite
ID CALCIUM-PHOSPHATE CERAMICS; SCAFFOLDS; POWDERS
AB The fundamentally different features of Rapid prototyping (RP) from that of conventional sintering offerus some new approaches to develop materials with excellent properties. Applying this method, porous Hydroxyapatite (Hap) ceramics, as well as the HAp-zirconia composites have been fabricated successfully. Porous hydroxyapatite (Hap) is expected to have desired mechanical and biological properties for biomedical applications. However, due to material processing problems, to date, this material can only be prepared by conventional techniques. Fuse deposition Machine is modified to fabricate Hap conventional support structure is not required three nozzle system is utilized for fabrication. Main nozzle is provided with heating arrangement. Two nozzles provided for transient Hap and solvent. Three stages heating with two lasers arrangement for gradual temperature change so transformation is faster. Primary result shows mechanical properties and porosity is as per bone structure. The micro structural characterizations such as phase purity and composition of porous BCP granules were performed and verified by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR) analysis. The chemical and the microstructure information of the Fabricated Hap were investigated by FT-IR (Fourier Transform Infra-Red), SEM (Scanning Electron Microscopy), X-ray Diffraction (XRD). Result shows interconnected regular pores and uniformly distribution of Hap. There is covalent boding makes stronger adhesion to prosthetic. Using this technique, it is possible to produce scaffolds with mechanical and structural properties close to those of the natural bone and teeth. The prepared scaffold has an open, regular pattern and uniformly interconnected porous structure. Some extent problem of small Nano particle aggregate together is called Balling and product of different temperature solidify on the layer is called recasting is dominates the process. By optimizing the operating parameter these problem can be minimized. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Shreepad, Sarange; Ravi, Warkhedkar] Govt Coll Engn, Aurangabad 431001, Maharashtra, India.
RP Shreepad, S (reprint author), Govt Coll Engn, Aurangabad 431001, Maharashtra, India.
EM sarangeshreepad@gmail.com
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Archer R, 2005, NAT BIOTECHNOL, V23, P1353, DOI 10.1038/ndt1105-1353
   BLENDELL JE, 1986, J CRYST GROWTH, V75, P138, DOI 10.1016/0022-0248(86)90235-6
   Byrne Damien P., BIOMATERIALS
   Casavola C, 2008, P 11 INT C EXP JUN 2
   Chen TB, 2006, J MANUF SCI E-T ASME, V128, P299, DOI 10.1115/1.2122947
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Frijns A. J. H., NUMERICAL MODELLING
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   HOLLISTER SJ, 2002, ELSEVIER BIOMATERIAL, V23, P4095
   Jafari A., 2008, IUST INT J ENG SCI, V19, P187
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Schroeder Craig, REPRESENTATION POROU
   Simchi A, 2006, MAT SCI ENG A-STRUCT, V428, P148, DOI 10.1016/j.msea.2006.04.117
   SVOBODA J, 1994, ACTA METALL MATER, V42, P435, DOI 10.1016/0956-7151(94)90498-7
   YEH TS, 1990, CERAM TRANS, V7, P309
   ZHENG JM, 1989, J AM CERAM SOC, V72, P810, DOI 10.1111/j.1151-2916.1989.tb06222.x
NR 23
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
PY 2015
BP 2761
EP 2768
DI 10.1016/j.sbspro.2015.06.390
PG 8
WC Business
SC Business & Economics
GA BF2YI
UT WOS:000380509900334
OA Other Gold
DA 2018-10-20
ER

PT B
AU Ribeiro, AC
   Fonseca, LP
   Soares, RMD
   da Silveira, NP
   Peres, GL
AF Ribeiro, C. Andresa
   Fonseca, P. Luis
   Soares, M. D. Rosane
   da Silveira, P. Nadya
   Peres, L. Gisele
BE Jorge, RN
   Belinha, J
   Martins, P
   Parente, M
   LeiteMoreira, A
   Tavares, JMRS
TI PREPARATION AND CHARACTERIZATION OF AMYLOSE-PYRAZINAMIDE INCLUSION
   COMPLEXES
SO 2015 IEEE 4TH PORTUGUESE MEETING ON BIOENGINEERING (ENBENG)
LA English
DT Proceedings Paper
CT IEEE 4th Portuguese meeting on bioengineering (enbeg)
CY FEB 26-28, 2015
CL porto, PORTUGAL
SP emb, ieee, fac engenharia univ porto, univ combra, univ minho, tecnico, ift
DE Amylose; Inclusion complexes; Drug delivery system; Pyrazinamide
AB Amylose is a linear polymer composed almost entirely of alpha-1,4-linked units. This biopolymer tends to form single helical inclusion complexes with suitable agents. The study of these complexes presents a great interest since the guest molecules that have been trapped at some stage can be release later, thus leading to many applications, especially in the pharmaceutical and food industry. Amylose is considered as a promising carrier biomaterial of prodrugs [1]. Pyrazinamide (PZA) has long been recognized as an active drug against Mycobacterium tuberculosis, however the administration of PZA in high dosage can cause bacterial resistance. Therefore there is a need for new methodologies which would reduce the administration time and improve therapeutic effect of PZA [2]. The aim of our study was to characterize the amylose-PZA complex. The inclusion complex was prepared by acidification of an alkali solution. Formation and characterization (particle size) of the inclusion complexes in solution were characterized by dynamic light scattering and UV spectroscopy. As the complexation causes changes in the absorption spectrum of a guest molecule, change in the colour of the solution from yellow to colourless was noticed. Furthermore, differences in intensity of the bands, and a slight shift of the absorption spectrum of inclusion complexes, in comparison with the pure amylose solution were observed. The UV analyses confirmed the formation of the amylose-PZA inclusion complexes. DLS analysis has been made for: complexes with pure amylose (without PZA), with PZA (without amylose) and amylose-PZA complexes. The amylose particle size, without the guest molecule, was (101,16 +/- 2,60) nm and its relative average polydispersity index was 0,41 +/- 0,04. For the PZA particle the size was (223,70 +/- 13,76) nm and its relative average polydispersity index was 0,27 +/- 0,10. On the other hand for the amylose-PZA inclusion complexes the size (81,11 +/- 1,43) nm was observed and its relative average polydispersity index was 0,26 +/- 0,02. As can be seen the size of the complex is smaller than of the pure amylose or PZA particle in solution. This can be attributed to the presence of PZA that induces hydrophobic interactions resulting in the contraction of the complexes and providing a relatively hydrophilic surface. Furthermore, PDI results also indicated that sizes generated from inclusion complexes have a narrow size distribution. Thus, new analysis tests will be conducted to provide more information about structure and morphology of inclusion complexes.
C1 [Ribeiro, C. Andresa; Fonseca, P. Luis] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Biotechnol & Biosci, P-1699 Lisbon, Portugal.
   [Ribeiro, C. Andresa; Soares, M. D. Rosane; da Silveira, P. Nadya; Peres, L. Gisele] Univ Fed Rio Grande do Sul, Inst Quim, Porto Alegre, RS, Brazil.
RP Ribeiro, AC (reprint author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, Inst Biotechnol & Biosci, P-1699 Lisbon, Portugal.
EM desa.ribeiro@hotmail.com
RI P. Fonseca, Luis/A-4228-2013; Soares, Rosane/H-2156-2018; silveira,
   nadya/G-9970-2016
OI P. Fonseca, Luis/0000-0001-8429-6977; Soares,
   Rosane/0000-0002-5225-7559; silveira, nadya/0000-0002-1556-7304
CR Rachmawati R, 2013, BIOMACROMOLECULES, V14, P575, DOI 10.1021/bm301994u
   Saikia N, 2013, J COMPUT AID MOL DES, V27, P257, DOI 10.1007/s10822-013-9638-6
NR 2
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8269-1
PY 2015
PG 1
WC Engineering, Biomedical
SC Engineering
GA BF1QB
UT WOS:000380427000008
DA 2018-10-20
ER

PT S
AU Lideskog, H
   Karlberg, M
   Bergsten, U
AF Lideskog, Hakan
   Karlberg, Magnus
   Bergsten, Urban
BE Roy, R
   Tiwari, A
   Tracht, K
   Shehab, E
   Mehnen, J
   Erkoyuncu, JA
   Tapoglou, N
   Tomiyama, T
TI Development of a research vehicle platform to improve productivity and
   value-extraction in forestry
SO PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON THROUGH-LIFE
   ENGINEERING SERVICES
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 4th International Conference on Through-Life Engineering Services
   (TESConf)
CY NOV 03-04, 2015
CL Cranfield Univ, Cranfield, ENGLAND
HO Cranfield Univ
DE autonomy; automation; forestry; performance-based contract; Functional
   Products
ID INDUCED SUBSOIL COMPACTION; PREVENTION STRATEGIES; DESIGN
AB In spite of the high level of mechanization in most forestry operations there is a continued need for improvements in productivity and cost effectiveness. Automation of mechanised operations is one possible solution to achieve such improvements but new techniques that can acquire information from the surroundings and make proper analyses rendering in streamlined or new work procedures are prerequisites. Furthermore, product producers buying forest biomaterials often have certain quality wishes. As an addition to automatic work procedures, new technology can further be used to retrieve information for identification and selection of certain tree assortments with different biomaterial properties. In this way, performance-based delivery of tree biomaterial extracted with highly automated work procedures has the possibility to be an enabler to continue the productivity development progress in the forest sector. The objective for this paper is therefore to summarize possible technical needs for and to design an experimental terrain vehicle platform for researchers and machine developers to test and validate new solutions that could improve cost effectiveness in forestry. The platform is designed specifically to test and validate various control systems for autonomy and robotics and also to enable tests and validation of attachments, e.g. to enable better planting procedures or identification of trees with certain properties. Sensors are embedded in the platform to register angles, rotation speed, etc., thus actualising machine automation as an enabler for performance-based delivery of planting or of tree biomaterial assortments. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Lideskog, Hakan; Karlberg, Magnus] Lulea Univ Technol, Faste Lab, Div Prod & Prod Dev, SE-97187 Lulea, Sweden.
   [Bergsten, Urban] Swedish Univ Agr Sci, Dept Forest Biomat & Technol, SE-90183 Umea, Sweden.
RP Lideskog, H (reprint author), Lulea Univ Technol, Faste Lab, Div Prod & Prod Dev, SE-97187 Lulea, Sweden.
EM hakan.lideskog@ltu.se
CR Alakukku L, 2003, SOIL TILL RES, V73, P145, DOI 10.1016/S0167-1987(03)00107-7
   Backlund I., 2013, THESIS
   Berg S., 2014, THESIS
   Bucur V, 2003, NONDESTRUCTIVE CHARA
   Chamen T, 2003, SOIL TILL RES, V73, P161, DOI 10.1016/S0167-1987(03)00108-9
   Edlund J, 2013, J TERRAMECHANICS, V50, P73, DOI 10.1016/j.jterra.2013.02.001
   Hallongren H, 2014, SCAND J FOREST RES, V29, P144, DOI 10.1080/02827581.2014.881542
   Hellstrom T, 2006, SPRINGER TRAC ADV RO, V25, P603
   Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018
   Karlsson L., 2013, THESIS
   Kemppainen T, 2013, IEEE INT CONF ROBOT, P739, DOI 10.1109/ICRA.2013.6630655
   Lideskog H., 2012, P 1 INT C THROUGH LI, P139
   Lideskog H, 2014, P 5 FOR ENG C 47 INT
   Lindstrom J, 2013, FUNCTIONAL PRODUCTS, P251
   Lundgren C., 2003, THESIS
   Prahalad CK, 2004, J INTERACT MARK, V18, P5, DOI 10.1002/dir.20015
   Rantala J, 2010, SCAND J FOREST RES, V25, P507, DOI 10.1080/02827581.2010.522591
   Rantala J, 2009, SILVA FENN, V43, P659, DOI 10.14214/sf.186
   Reed Sean, 2013, International Journal of Product Development, V18, P48
   Sutton R. F., 1993, New Forests, V7, P151, DOI 10.1007/BF00034198
   Ulrich K. T., 2012, PRODUCT DESIGN DEV
   Vestlund K, 2006, J TERRAMECHANICS, V43, P505, DOI 10.1016/j.jterra.2005.07.001
NR 22
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2015
VL 38
BP 68
EP 73
DI 10.1016/j.procir.2015.07.014
PG 6
WC Engineering, Industrial
SC Engineering
GA BF4JZ
UT WOS:000381110000012
OA Other Gold
DA 2018-10-20
ER

PT S
AU Carnio, M
   Massimiani, C
   Piperni, SG
   Zambuzzii, W
   Cappelletti, C
   Graziani, F
AF Carnio, Martina
   Massimiani, Chiara
   Piperni, Sara Gemini
   Zambuzzii, Willian
   Cappelletti, Chantal
   Graziani, Filippo
BE Sandau, R
TI Space systems design for research on the interaction of osteoblast-like
   cells and biomaterials (hydroxyapatite particles and titanium) in
   microgravity environment
SO SCIENTIFIC AND TECHNOLOGICAL EXPERIMENTS ON AUTOMATIC SPACE VEHICLES AND
   SMALL SATELLITES
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd IAA-RACTs Conference on Scientific and Technological Experiments on
   Automatic Space Vehicles and Small Satellites (SPEXP)
CY SEP 09-11, 2014
CL Samara State Aerosp Univ, Samara, RUSSIA
SP Int Acad Astronaut, Russian Acad Cosmonaut Tsiolkovsky, Joint Stock Co Rocket & Space Ctr Progress
HO Samara State Aerosp Univ
DE microgravity; hydroxyapatite; titanium discs; bone; biomaterials;
   ionizing radiation
AB Microgravity and ionizing radiations are some of the special condition that characterize the space environment. These conditions cause major changes in human bodies, or in biomedical samples; in particular, the bone tissue in microgravity conditions, lack of mechanical loading which is one of the main stimulus to bone remodelling needed, loose elasticity and toughness.
   In 2014 a cooperation between GAUSS srl. (Group of Astrodynamic for the Use of Space System, Rome, Italy), the University of Brasilia (UnB, Brasilia, Brazil) and the State University of Sao Paulo (UNESP, Botucatu, Sao Paulo, Brazil) has been started to study in orbit the effects of the exposure of osteoblast-like cells, responsible to forming-up a new bone, to gold standard biomaterials (hydroxyapatite particles and titanium).
   Biomaterials are artificial materials, with potential biocompatibility. They are more used in regenerative medicine to support cells behaviour to repair the damage. Nowadays, this field of medicine requires collaboration among engineers, biologists, chemists to create and test new biomaterials and to investigate what might be the best to use to enhance the performance during the repair of the damage. By now, in a field so critical to human health and biomaterial development, it is very important to explore and exploit new research pathways and hence, it is clear that the exposition of osteoblast-like cells to biomaterials under reduced gravity conditions certainly will induce changes in cell adhesion, growth and differentiation of those cells. Each experiment will use the microgravity environment to conduct experimentation that could produce tremendous health benefits for humankind such as advancements in biomaterial screening, tissue engineering/regeneration, cell replacement therapy. Therefor the main goal of this project is to investigate potential effects of the space environment exposure on osteoblast-like cells and biomaterials through an autonomous space system, designed and manufactured specifically for this goal. Specifically, this paper describes the engineering solutions to design and manufacturing autonomous space system that can allow to keep alive and to study these kinds of cells. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Carnio, Martina; Massimiani, Chiara; Piperni, Sara Gemini; Graziani, Filippo] GAUSS Srl, St Via S Scaroni 27, I-25131 Brescia, Italy.
   [Zambuzzii, Willian] Univ Estadual Paulista UNESP, Sao Jose Do Rio Preto, SP, Brazil.
   [Cappelletti, Chantal] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil.
RP Graziani, F (reprint author), GAUSS Srl, St Via S Scaroni 27, I-25131 Brescia, Italy.
EM marti.carnio@gmail.com
OI Cappelletti, Chantal/0000-0003-1995-3728
CR Mettam G. R., 1999, INTRO ELECT AGE, P281
   van der Geer J., 2000, J SCI COMMUN, V163, P51
NR 3
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 104
BP 23
EP 28
DI 10.1016/j.proeng.2015.04.092
PG 6
WC Engineering, Aerospace; Engineering, Multidisciplinary
SC Engineering
GA BF4JS
UT WOS:000381101900004
OA Other Gold
DA 2018-10-20
ER

PT B
AU Basim, GB
   Ozdemir, Z
AF Basim, G. Bahar
   Ozdemir, Zeynep
GP IEEE
TI Chemical Mechanical Polishing Implementation on Dental Implants
SO 2015 INTERNATIONAL CONFERENCE ON PLANARIZATION/CMP TECHNOLOGY (ICPT)
LA English
DT Proceedings Paper
CT International Conference on Planarization/CMP Technology (ICPT)
CY SEP 30-OCT 02, 2015
CL Chandler, AZ
AB In this study, chemical mechanical polishing (CMP) technique is introduced as a new alternative to generate controlled nano/micro scale roughness on the titanium implant surfaces. It is known that micro scale patterns induced on biomaterial surfaces promote bio-compatibility by increasing the capability of cell attachment. However, current developments on biomaterials highlight the impact of nano-scale roughness in promoting the biocompatibility on the metallic implant surfaces. CMP process brings the advantage of inducing smoothness or controlled nano-structures on the bio-implant material surfaces. Here, we focus particularly on the dental implant applications to change the surface roughness and the resulting bioactivity in a controlled manner.
C1 [Basim, G. Bahar; Ozdemir, Zeynep] Ozyegin Univ, Dept Mech Engn, Istanbul, Turkey.
RP Basim, GB (reprint author), Ozyegin Univ, Dept Mech Engn, Istanbul, Turkey.
EM Bahar.Basim@ozyegin.edu.tr; Zeynep.Ozdemir@ozyegin.edu.tr
CR Basim G. B., 2012, P ICPT, P385
   Chathapuram VS, 2003, MICROELECTRON ENG, V65, P478, DOI 10.1016/S0167-9317(03)00177-1
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Jouanny I, 2010, THIN SOLID FILMS, V518, P3212, DOI 10.1016/j.tsf.2009.09.046
   KAUFMAN FB, 1991, J ELECTROCHEM SOC, V138, P3460, DOI 10.1149/1.2085434
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Ozdemir Z, 2014, ECS TRANSACTIONS, V61, P21, DOI 10.1149/06117.0021ecst
   Ozdemir Z., 2015, MRS P
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
PY 2015
PG 4
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA BF1MR
UT WOS:000380410600037
DA 2018-10-20
ER

PT S
AU Rachid, D
   Mohand, OO
AF Rachid, Djeridi
   Mohand, Ould Ouali
BE Papuga, J
   Ruzicka, M
TI On the numerical simulation of damage for the visco-hyperelastic
   anisotropic behavior of the biomaterials in cyclic loading: relationship
   of the Mullins effect and fibers reinforcement
SO 3RD INTERNATIONAL CONFERENCE ON MATERIAL AND COMPONENT PERFORMANCE UNDER
   VARIABLE AMPLITUDE LOADING, VAL 2015
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 3rd International Conference on Material and Component Performance under
   Variable Amplitude Loading, VAL
CY MAR 23-26, 2015
CL Prague, CZECH REPUBLIC
DE visco-hyperelasticty; Mullins effect; biomaterial; fiber reinforcement;
   anisotropic; elastomer
ID FILLER-LOADED RUBBERS; CONSTITUTIVE MODEL; ELASTIC-MATERIALS;
   LARGE-STRAIN; IMPLEMENTATION; POLYMERS; LAWS
AB This work is focused on the homogeneous macroscopic material level in order to provide a suitable formulation for structural finite element simulation. A reduction of the stiffness depending on loading, summarized as ` damage phenomena', is considered. We present the modeling of visco-hyperelastic damage with the Mullins effect of fiberreinforced biomaterials. We show that the Ogden-Roxburgh model is more realistic for a reproduction of the damage of hyperelastic materials. Analyzing the parameters set, compressibility and reinforcement (reinforcement contribution, fibers directions and their dispersion in the material) on the hysteresis phenomenon in the tensile cyclic deformation of these biomaterials is achieved (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Rachid, Djeridi; Mohand, Ould Ouali] Univ Tizi Ouzou, Lab Elaborat & Characterizat Mat & Modeling LEC2M, Tizi Ouzou 15100, Algeria.
RP Rachid, D (reprint author), Univ Tizi Ouzou, Lab Elaborat & Characterizat Mat & Modeling LEC2M, Tizi Ouzou 15100, Algeria.
EM djeridi_rachid@yahoo.fr
OI OULD OUALI, Mohand/0000-0001-7958-4974
CR ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6
   Beatty MF, 2000, J MECH PHYS SOLIDS, V48, P1931, DOI 10.1016/S0022-5096(99)00085-X
   Boyce MC, 2000, RUBBER CHEM TECHNOL, V73, P504, DOI 10.5254/1.3547602
   Dannenberg E. M., 1975, RUBBER CHEM TECHNOL, V48, P410, DOI DOI 10.5254/1.3547460
   Diani J, 2004, MECH MATER, V36, P313, DOI 10.1016/S0167-6636(03)00025-5
   Djeridi R, 2013, KEY ENG MATER, V554-557, P2414, DOI 10.4028/www.scientific.net/KEM.554-557.2414
   Donnet J.B., 1986, J POLYM SCI, V24, P103
   Dorfmann A, 2004, INT J SOLIDS STRUCT, V41, P1855, DOI 10.1016/j.ijsolstr.2003.11.014
   Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073
   GOVINDJEE S, 1992, INT J SOLIDS STRUCT, V29, P1737, DOI 10.1016/0020-7683(92)90167-R
   GOVINDJEE S, 1991, J MECH PHYS SOLIDS, V39, P87, DOI 10.1016/0022-5096(91)90032-J
   Hardwood J.A.C., 1966, J APPL POLYM SCI, V10, P1203
   HARTSMITH LJ, 1966, Z ANGEW MATH PHYS, V17, P608, DOI 10.1007/BF01597242
   HARWOOD JAC, 1966, J APPL POLYM SCI, V10, P315, DOI 10.1002/app.1966.070100212
   HARWOOD JAC, 1965, J APPL POLYM SCI, V9, P3011, DOI 10.1002/app.1965.070090907
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Huber N, 2000, MECH MATER, V32, P1, DOI 10.1016/S0167-6636(99)00045-9
   Kaliske M, 2001, COMPUT STRUCT, V79, P2133, DOI 10.1016/S0045-7949(01)00061-X
   KILIAN HG, 1994, RUBBER CHEM TECHNOL, V67, P1, DOI 10.5254/1.3538664
   Lambert-Diani J, 1999, EUR J MECH A-SOLID, V18, P1027, DOI 10.1016/S0997-7538(99)00147-3
   Marckmann G, 2002, J MECH PHYS SOLIDS, V50, P2011, DOI 10.1016/S0022-5096(01)00136-3
   MIEHE C, 1995, EUR J MECH A-SOLID, V14, P697
   Miehe C, 2000, J MECH PHYS SOLIDS, V48, P323, DOI 10.1016/S0022-5096(99)00017-4
   Mullins L., 1969, RUBBER CHEM TECHNOL, V42, P339, DOI DOI 10.5254/1.3539210
   Mullins L., 1957, RUBBER CHEM TECHNOL, V30, P551
   MULLINS L, 1947, J RUBBER RES, V16, P275, DOI DOI 10.5254/1.3546914
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   Ogden RW, 1999, P ROY SOC A-MATH PHY, V455, P2861, DOI 10.1098/rspa.1999.0431
   Pawelski H, 2001, CONSTITUTIVE MODELS FOR RUBBER II, P27
   Reese S, 2003, INT J PLASTICITY, V19, P909, DOI 10.1016/S0749-6419(02)00086-4
   Rigbi Z., 1981, ADV POLYM SCI, V35
   Rivelin R.S, 1983, ENG FRACT MECAN, P389
   Schmidt J., 2004, 22 CAD FEM US M INT
   Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3
NR 34
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 101
BP 126
EP 134
DI 10.1016/j.proeng.2015.02.017
PG 9
WC Engineering, Multidisciplinary; Engineering, Mechanical
SC Engineering
GA BF2RF
UT WOS:000380492500016
OA Other Gold
DA 2018-10-20
ER

PT S
AU Sun, DW
   Sealy, MP
   Liu, ZY
   Fu, CH
   Guo, YB
   Fang, FZ
   Zhang, B
AF Sun, D. W.
   Sealy, M. P.
   Liu, Z. Y.
   Fu, C. H.
   Guo, Y. B.
   Fang, F. Z.
   Zhang, B.
BE Shih, AJ
   Wang, LH
TI Finite Element Analysis of Machining Damage in Single-Grit Grinding of
   Ceramic Knee Implants
SO 43RD NORTH AMERICAN MANUFACTURING RESEARCH CONFERENCE, NAMRC 43
SE Procedia Manufacturing
LA English
DT Proceedings Paper
CT 43rd North American Manufacturing Research Conference, NAMRC 43
CY JUN 08-12, 2015
CL Charlotte, NC
DE Bioceramics; machining damage; surface integrity; grinding; finite
   element analysis
ID BRITTLE MATERIALS; SURFACE; MECHANISMS; SIMULATION; DUCTILE; CRACKS
AB Alumina is a common biomaterial used for knee implants due to its excellent biomechanical properties. However, the complex geometry and required surface integrity make precision machining of knee implants very difficult. Machining mechanics and damage mechanism is not well understood. In order to better understand the mechanism of alumina grinding, this work presents a numerical simulation of single point grinding of alumina at a shallow depth-of-cut. A 3D finite element model of single-grit ceramic grinding has been developed using the pressure dependent Johnson-Holmquist constitutive model. Failure strain (FS) was adopted as a user-defined element removal criterion to reveal damage mechanism during the grinding process. The predicted machining groove topography correlated well with the experimental observations. Surface and subsurface microcracks were characterized at different FS. The thrust, frictional, and grinding force histories were also investigated. Furthermore, material behaviors at different locations below the machined groove were analyzed to shed light on subsurface microcrack initiation and propagation.
C1 [Sun, D. W.; Sealy, M. P.; Liu, Z. Y.; Fu, C. H.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
   [Fang, F. Z.] Tianjin Univ, Ctr MicroNano Mfg Technol, Tianjin 300072, Peoples R China.
   [Zhang, B.] Univ Connecticut, Dept Mech Engn, Storrs, CT 06269 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
RI Sealy, Michael/K-5248-2017
OI Sealy, Michael/0000-0002-9236-5458; Fang, Fengzhou/0000-0002-8716-5988
CR Agarwal S, 2008, INT J MACH TOOL MANU, V48, P698, DOI 10.1016/j.ijmachtools.2007.10.013
   Axinte D, 2013, INT J MACH TOOL MANU, V74, P12, DOI 10.1016/j.ijmachtools.2013.06.002
   Bergschmidt P, 2011, COMPOSITE CERAMICS T, V22, P264
   BIFANO TG, 1991, J ENG IND-T ASME, V113, P184, DOI 10.1115/1.2899676
   Bombac D, 2007, RMZ MAT GEOENVIRON, V54, P471
   Carter C. B., 2013, CERAMIC MAT SCI ENG
   Chuang TJ, 2003, J EUR CERAM SOC, V23, P1723, DOI 10.1016/S0955-2219(02)00409-0
   Cronin DS, 2003, IMPLEMENTATION VALID, P47
   Holmquist T, 1995, BALLISTIC EXPT COMPU, P265
   Howes T.D., 1994, CIRP ANN-MANUF TECHN, V43, P305
   Isaacson E, 1983, FRACTURE MECH CERAMI, P557
   JOHNSON GR, 1994, AIP C P, V309, P981, DOI DOI 10.1063/1.46199
   Krause R.F., 1995, J AM CERAM SOC, V78, P260
   Li B, 2014, COMP MATER SCI, P9213
   Liu XB, 2002, J MANUF SCI E-T ASME, V124, P553, DOI 10.1115/1.1463034
   Ma LJ, 2014, INT J MACH TOOL MANU, V77, P82, DOI 10.1016/j.ijmachtools.2013.11.001
   Maccauro G, 2011, ALUMINA ZIRCONIA CER, P299
   Maksoud TMA, 1999, J MATER PROCESS TECH, V88, P222, DOI 10.1016/S0924-0136(98)00403-8
   MALKIN S, 1989, J ENG IND-T ASME, V111, P167, DOI 10.1115/1.3188746
   Marsh E.R, 2007, SEMICONDUCTOR MACHIN
   Marti A, 2000, INJURY, V31, pD33
   Patten JA, 2008, J MANUF PROCESS, V10, P28, DOI DOI 10.1016/J.JMAPR0.2008.08.001
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Tan YQ, 2008, INT J MACH TOOL MANU, V48, P975, DOI 10.1016/j.ijmachtools.2008.01.010
   Van Manen MD, 2012, J AM OSTEOPATH ASSOC, V112, P709
   Walter W.L., 2010, SEMINARS ARTHROPLAST, V21, P27
   Zarudi I, 1996, J MATER SCI, V31, P905, DOI 10.1007/BF00352889
   ZHANG BI, 1988, J MATER SCI, V23, P3214
NR 28
TC 5
Z9 5
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2351-9789
J9 PROCEDIA MANUF
PY 2015
VL 1
BP 644
EP 654
DI 10.1016/j.promfg.2015.09.058
PG 11
WC Engineering, Manufacturing
SC Engineering
GA BF2ZE
UT WOS:000380512300057
OA Other Gold
DA 2018-10-20
ER

PT S
AU Caseiro, AR
   Pereira, T
   Bartolo, PJ
   Santos, JD
   Luis, AL
   Mauricio, AC
AF Caseiro, A. R.
   Pereira, T.
   Bartolo, P. J.
   Santos, J. D.
   Luis, A. L.
   Mauricio, A. C.
BE Fernandes, PR
   Bartolo, P
TI Mesenchymal Stem Cells and Biomaterials Systems - Perspectives for
   Skeletal Muscle Tissue Repair and Regeneration
SO 4TH INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING, ICTE2015, AN ECCOMAS
   THEMATIC CONFERENCE
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Tissue Engineering, ICTE2015
CY JUN 25-27, 2015
CL Lisbon, PORTUGAL
SP ECCOMAS, the European Community Association on Computational Methods in Applied Sciences
DE skeletal muscle; mesenchymal stem cells; Wharton's jelly; umbilical
   cord; dental pulp; biomaterials; secretome
ID IN-VIVO; EXTRACELLULAR-MATRIX; STROMAL CELLS; MYOGENIC DIFFERENTIATION;
   SATELLITE CELL; MURINE MODEL; INJURY; VITRO; TRANSPLANTATION;
   PROGENITORS
AB Skeletal muscle is essential in voluntary movement and other major vital functions. Muscle injuries are important in clinical practice and, despite skeletal muscle's good regenerative ability, severe tissue loss impairs complete myofibre regeneration, limiting structural and functional recovery of the affected muscle, eventually leading to the development of non-contractile fibrous scar. The intrinsic healing mechanisms rely in great extent on the residing progenitor population but significant drawbacks to their practical application in regenerative strategies boosted the search for alternative cell sources, such as extra-fetal mesenchymal stem cells (MSCs). MSCs have demonstrated to positively influence the regeneration of different disease models. When severe volumetric muscle tissue loss occurs, the body is seldom capable of replacing the lost portions with fully functional tissue. A rational strategy to aid the healing of such situations is the application of biomaterial implants that provide a structural matrix for the ingrowth of regenerating muscle fibres. Both synthetic and natural biomaterials have been hypothesized for this purpose and some have reached as far clinical cases applications. Obvious improvements are observed in most cases, but reaction to some biomaterials and functional recovery are still a challenge. The addition of MSCs to the biomaterials seems to improve the systems' performance in the overall regenerative milieu. This strategies promote scaffold's vascularization and integration, as well as accelerated tissue ingrowth and reduces scar formation, resulting in improved recovery rates at both structural and functional levels. (C) 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Peer-review under responsibility of IDMEC-IST.
C1 [Caseiro, A. R.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Univ Porto UP, Dept Clin Vet, Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal.
   [Caseiro, A. R.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, Ctr Estudos Ciencia Anim CECA, Oporto, Portugal.
   [Caseiro, A. R.] Inst Politecn Leiria, CDRsp Ctr Desenvolvimento Rapido & Sustentado Pro, Marinha Grande, Portugal.
   [Bartolo, P. J.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England.
   [Bartolo, P. J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
   [Caseiro, A. R.; Santos, J. D.] Univ Porto, Fac Engn, Dept Engn Met & Mat, CEMUC, Oporto, Portugal.
RP Caseiro, AR (reprint author), Univ Porto UP, Dept Clin Vet, Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal.
EM rita.caseiro.santos@gmail.com
OI Mauricio, Ana Colette/0000-0002-0018-9363; Santos, Jose
   Domingos/0000-0002-6871-9850; Caseiro Santos, Ana
   Rita/0000-0002-1143-2461
CR Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Caseiro AR, 2015, PROGR STEM CELL TRAN
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Conconi MT, 2006, INT J MOL MED, V18, P1089
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Do MKQ, 2012, ANIM SCI J, V83, P712, DOI 10.1111/j.1740-0929.2012.01057.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Fossett E, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/46525922448172
   Gates C, 2005, OPER TECHN SPORT MED, V13, P247, DOI 10.1053/j.otsm.2006.01.012
   Gentile NE, 2014, AM J PHYS MED REHAB, V93, pS79, DOI 10.1097/PHM.0000000000000145
   Giordani L, 2013, FEBS J, V280, P4014, DOI 10.1111/febs.12383
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9
   Hwang JH, 2013, BIOMATERIALS, V34, P6037, DOI 10.1016/j.biomaterials.2013.04.049
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004
   Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017
   Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005
   Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n
   Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Mccoy MK, 2008, EXP NEUROL, V210, P14, DOI 10.1016/j.expneurol.2007.10.011
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Mirabella T, 2011, BIOMATERIALS, V32, P4218, DOI [10.1016/j.biomaterials.2011.01.071, 10.1016/j.biomaterials.2010.12.028]
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Muguruma Y, 2003, EXP HEMATOL, V31, P1323, DOI 10.1016/j.exphem.2003.09.003
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326
   Pannerec A, 2012, TRENDS MOL MED, V18, P599, DOI 10.1016/j.molmed.2012.07.004
   Pannerec A, 2010, M S-MED SCI, V26, P797, DOI 10.1051/medsci/20102610797
   Pecanha R, 2012, J BONE JOINT SURG AM, V94A, P609, DOI 10.2106/JBJS.K.00351
   Pereira T, 2012, J TISSUE ENG REGEN M, V6, P396
   Pereira T., 2014, STEM CELLS INT, V2014
   Pereira T., 2012, 17 ANN C EUR COLL SP
   Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103
   Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017
   Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436
   Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Sicari BM, 2014, ANAT REC, V297, P51, DOI 10.1002/ar.22794
   Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Tidball JG, 2014, DEVELOPMENT, V141, P1184, DOI 10.1242/dev.098285
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Vigodarzere GC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00362
   Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026
   Wolf M.T., 2014, ADV DRUG DELIVERY RE
NR 69
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 110
BP 90
EP 97
DI 10.1016/j.proeng.2015.07.014
PG 8
WC Cell & Tissue Engineering; Engineering, Multidisciplinary
SC Cell Biology; Engineering
GA BF2SQ
UT WOS:000380496300013
OA Other Gold
DA 2018-10-20
ER

PT S
AU Heris, HK
   Latifi, N
   Vali, H
   Li, N
   Mongeau, L
AF Heris, Hossein K.
   Latifi, Neda
   Vali, Hojattolah
   Li, Nicole
   Mongeau, Luc
BE Fernandes, PR
   Bartolo, P
TI Investigation of chitosan-glycol/glyoxal as an injectable biomaterial
   for vocal fold tissue engineering
SO 4TH INTERNATIONAL CONFERENCE ON TISSUE ENGINEERING, ICTE2015, AN ECCOMAS
   THEMATIC CONFERENCE
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Tissue Engineering, ICTE2015
CY JUN 25-27, 2015
CL Lisbon, PORTUGAL
SP ECCOMAS, the European Community Association on Computational Methods in Applied Sciences
DE Chitosan; Human fibroblasts; Viability; Migration; Degradation; Vocal
   fold; In vitro
ID BIOMEDICAL APPLICATIONS; IN-VIVO; HYDROGELS; GELATIN; GLYOXAL
AB Injectable hydrogels offer promising tissue engineering approaches for vocal fold (VF) tissue repair. Research on VF tissue engineering scaffolds has largely been focused on derivatives of hyaluronan and collagen. Although chitosan hydrogels have been extensively investigated for various soft tissues, their potential use for VF tissue engineering has been overlooked. The aim of the present study was to investigate cross-linked Chitosan-glycol (GCs)/ glyoxal (Gy) hydrogels for VFLP tissue engineering. The effects of Gy concentration on cell viability, viscoelastic properties, enzymatic degradation, and cell migration were studied. Six different groups of cell-seeded hydrogels, consisting of immortalized human vocal fold fibroblasts encapsulated in GCs/Gy hydrogels, were prepared to obtain target concentrations of 2X106 cells/ml, GCs 2% and Gy 0.02% (Group# 1), 0.015% (Group# 2), 0.01% (Group# 3), 0.0075% (Group# 4), 0.005% (Group# 5), or 0.0025% (Group# 6). The storage and loss moduli were 629 +/- 35Pa and 9 +/- 1 Pa, 560 +/- 28 Pa and 9 +/- 1Pa, 489 +/- 41 Pa and 8 +/- 1 Pa, 307 +/- 25 Pa and 4 +/- 1 Pa, 149 +/- 31 Pa and 3 +/- 1 Pa, 55 +/- 17 Pa and 3 +/- 1 Pa for groups 1, 2, 3, 4, 5, and 6, respectively. The viability rates were above 90% for all groups, 3 hours after encapsulation. The viability rates were 60.0 +/- 2.2%, 80.3 +/- 2.2%, 83.5 +/- 0.5%, 83.1 +/- 1.3%, 88.2 +/- 0.1%, and 88.0 +/- 1.1% for groups 1,2,3,4,5, and 6, respectively, one week after encapsulation inside GCs/Gy hydrogels. The average cell motility speed was 0.09 +/- 0.03 mu m/minute, 0.07 +/- 0.043 +/- m/minute, and 0.09 +/- 0.02 +/- m/minute for groups 4, 5, and 6, respectively. Following four weeks enzymatic degradation study, the mass loss was 10%, 21%, and 100% for groups 4, 5, and 6, respectively. Our results indicated that GCs/Gy hydrogels could be potential candidates for use in human VF tissue repair and regeneration. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) Peer-review under responsibility of IDMEC-IST.
C1 [Heris, Hossein K.; Latifi, Neda; Mongeau, Luc] McGill Univ, Dept Mech Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.
   [Vali, Hojattolah] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ H3A 1G1, Canada.
   [Li, Nicole] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.
RP Heris, HK (reprint author), McGill Univ, Dept Mech Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.
EM hossein.khadiviheris@mail.mcgill.ca
OI Latifi, Neda/0000-0002-8099-8354; Mongeau, Luc/0000-0003-0344-227X
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Coppoolse JMS, 2014, J SPEECH LANG HEAR R, V57, pS658, DOI 10.1044/2014_JSLHR-S-12-0292
   Costa-Pinto AR, 2014, J BIOACT COMPAT POL, V29, P137, DOI 10.1177/0883911514521919
   Heris HK, 2015, J BIOMECHANICS
   Heris HK, 2013, J MECH BEHAV BIOMED, V28, P383, DOI 10.1016/j.jmbbm.2013.05.026
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Kazemirad S, 2015, J BIOMEDICAL MAT R B
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180
   Latifi N, 2014, ASME 2014 INT MECH E
   Latifi N, 2014, J MECH BEHAV BIOMED, V39, P366, DOI 10.1016/j.jmbbm.2014.07.031
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li Nicole Y K, 2013, J Cytol Mol Biol, V1, P001
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Mason B., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   Prestwich GD, 2007, TISSUE ENG, P125
   Shanyari N, 2006, BIOCHEM PHARMACOL, V71, P1610, DOI 10.1016/j.bcp.2006.02.016
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
NR 30
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2015
VL 110
BP 143
EP 150
DI 10.1016/j.proeng.2015.07.022
PG 8
WC Cell & Tissue Engineering; Engineering, Multidisciplinary
SC Cell Biology; Engineering
GA BF2SQ
UT WOS:000380496300021
OA Other Gold
DA 2018-10-20
ER

PT B
AU Violano, A
   Ciravoglu, A
   Erkenez, S
   Montaniero, V
   Verde, F
AF Violano, Antonella
   Ciravoglu, Aysen
   Erkenez, Semin
   Montaniero, Veronica
   Verde, Francesca
BA Piscitelli, M
BF Piscitelli, M
TI BIOMATERIALS: the synthetic biology applied to architecture
SO Heritage and Technology: Mind Knowledge Experience
SE Fabbrica della Conoscenza
LA English
DT Proceedings Paper
CT Heritage and Technology Mind Knowledge Experienc e
CY JUN 11-13, 2015
CL Aversa, ITALY
SP Progetto CAMPUS Pompei, REPVBBLICA ITALIANA, REGIONE CAMPANIA
DE Biomaterial; LCA; technological design; sustainable architecture
AB Currently, our planet is suffering for problems related to overpopulation, accumulation of waste, depletion of raw materials, extreme exploitation of the productive soil and reckless issuance of pollutants in air, soil and water to such an extent as to make the habitat less and less suitable for the survival of living organisms. Thus, project interventions are necessary in order to safeguard first the natural environment so that an adequate social and economic development is possible. In this context, the role of architecture can be significant.
   It is believed that 'making architecture' today means to search for harmony between man, environment and built through cradle-to-cradle sustainable projects that cleverly use natural resources in order to restore the ecological cycles compromised by the destructive impact of the human species. Scientific knowledge acquired in biotechnology and engineering allow us to achieve this goal by working with natural systems and benefiting from them, without destroying the integrity and the capacity for renewal. A new branch of biological sciences, named synthetic biology, will be able to imagine and build new living systems for useful purposes, according the approach: "House like a tree".
   The paper illustrates the contribution of this new discipline to the construction sector and analyses the performances of some kind of biomaterials that offer a paradigm shift in the perception of buildings from mechanical entities to living or like-living organisms. This study discussed how transformation could be achieved with the help of the sustainable design approach and environmental philosophy. The environmentalist discourse has an ideological influence on architectural approaches, as well as shaping these. Thus, we urgently have to change our conceptions about nature, such as human-centrism and the control-over-nature approach. We have to talk about new ways of collaborating with nature.
C1 [Violano, Antonella; Montaniero, Veronica; Verde, Francesca] Univ Naples 2, Dept Architecture & Ind Design L Vanvitelli, Aversa, Italy.
   [Ciravoglu, Aysen; Erkenez, Semin] Yildiz Tech Univ, Istanbul, Turkey.
RP Violano, A (reprint author), Univ Naples 2, Dept Architecture & Ind Design L Vanvitelli, Aversa, Italy.
EM antonella.violano@unina2.it; aysenc@gmail.com; seminerkenez@gmail.com;
   veronica.montaniero1@studenti.unina2.it; francesca.verde7@gmail.com
RI Violano, Antonella/G-5544-2013
OI Violano, Antonella/0000-0002-5313-3988
CR Armstrong R., 2012, LIVING ARCHITECTURE
   BENJAMIN D., 2011, BIOFEVER RECENT DEV
   Birkeland J., 2002, DESIGN SUSTAINABILIT
   Bookchin M., 1986, THE MODERN CRISIS
   CIRAVOGLU A., 2009, MIMARIST, V2, P38
   CIRAVOGLU A., 2008, MIMARLIK, V340, P13
   ERKENEZ S., 2014, WORLD SUST BUILD C B
   European Commission,, 2005, SYNTH BIOL APPL ENG, P5
   FERRARI M., 2012, NEMETON HIGH GREEN T, P7
   FIELSON R., 2004, ARCHITECTURE ENV, V6, P20
   FONTANA J., 2014, COME BIOL PUO DARE N
   Girard L. Fusco, 1997, VALUTAZIONI SVILUPPO
   GOLEMAN D, 2009, INTELLIGENZA ECOLOGI, P55
   GOULD K., 2007, WOMEN GREEN VOICE SU
   Guy S, 2001, J ARCHIT EDUC, V54, P140, DOI 10.1162/10464880152632451
   Hopwood B, 2005, SUSTAIN DEV, V13, P38, DOI 10.1002/sd.244
   Lovelock J. E., 1988, AGES GAIA BIOGRAPHY
   Madge Pauline, 1993, J DESIGN HIST, V6, P149, DOI DOI 10.1093/JDH/6.3.149
   MYERS W., 2012, BIODESIGN NATURE SCI, P8
   NAESS A., 1988, ECOLOGIST, V18
   ORiordan T., 1989, NEW MODELS GEOGRAPHY, P77
   PALLASMAA J., 1996, ACAD SERIES POLEMICS
   PLUMWOOD V., 2004, FEMINIZM DOGAYA HUKM
   Reed B., 2009, INTEGRATIVE DESIGN G
   Rees W. E., 1995, J PLAN LIT, V9, P343, DOI [DOI 10.1177/088541229500900402), DOI 10.1177/088541229500900402]
   VIOLANO A., 2013, ARCHITECTURAL ED REA, P365
   Zimmerman M. J, 2001, NATURE INTRINSIC VAL
NR 27
TC 0
Z9 0
U1 1
U2 6
PU SCUOLA PITAGORA EDITRICE
PI NAPOLI
PA PIAZZA SANTA MARIA DEGLI ANGELI, 1, NAPOLI, 80132, ITALY
BN 978-88-6542-416-2
J9 FABBR CONOSCENZA
PY 2015
VL 56
BP 1930
EP 1939
PG 10
WC Architecture; Art
SC Architecture; Art
GA BF3JE
UT WOS:000380548200219
DA 2018-10-20
ER

PT B
AU Balogova, A
   Harvanova, D
   Hudak, R
   Rosocha, J
   Zivcak, J
AF Balogova, Alena
   Harvanova, Denisa
   Hudak, Radovan
   Rosocha, Jan
   Zivcak, Jozef
GP IEEE
TI 3D cultivation of mesenchymal stromal cells from adipose tissue in
   alginate beads
SO 2015 IEEE 13TH INTERNATIONAL SYMPOSIUM ON APPLIED MACHINE INTELLIGENCE
   AND INFORMATICS (SAMI)
LA English
DT Proceedings Paper
CT IEEE 13th International Symposium on Applied Machine Intelligence and
   Informatics (SAMI)
CY JAN 22-24, 2015
CL Herl'any, SLOVAKIA
AB New trends of 3D printing of biological structures are still expanding and witnessing rapid rise of new knowledge. The basis for proper and successful 3D printed structures of biological materials is to create adequate biomaterial which would serve as ink for a 3D printer. Alginate is one of the materials that can be used. Alginate is a hydrogel, which is used mainly in the field of tissue engineering for its useful properties as a biomaterial. The main aim of this study was to create a biomaterial for the purposes of 3D printing and encapsulate selected type of cells to alginate beads, along with studying cell survival and stability of the biomaterial for three weeks. In this study mesenchymal stem cells (MSCs), isolated from rabbit adipose tissue, were used.
C1 [Harvanova, Denisa; Rosocha, Jan; Zivcak, Jozef] Safarik Univ, Fac Med, Associated Tissue Bank, Kosice 04166, Slovakia.
   [Harvanova, Denisa; Rosocha, Jan; Zivcak, Jozef] L Pasteur Univ Hosp, Kosice 04166, Slovakia.
   [Balogova, Alena; Hudak, Radovan] Tech Univ Kosice, Fac Mech Engn, Dept Biomed Engn & Measurements, Kosice 04200, Slovakia.
RP Balogova, A (reprint author), Tech Univ Kosice, Fac Mech Engn, Dept Biomed Engn & Measurements, Kosice 04200, Slovakia.
EM alena.balogova@tuke.sk; denisa.harvanova@upjs.sk; radovan.hudak@tuke.sk;
   jan.rosocha@upjs.sk; jozef.zivcak@tuke.sk
OI Harvanova, Denisa/0000-0002-3038-7520
CR Cigankova V., 2007, VET HISTOLOGY EMBRAO
   Coatney S., 2013, 3D BIOPRINTING
   Excell J., 2013, ENGINEER
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Hajduk Maros, 2013, THESIS
   Huaping Tan, INJECTABLE BIODEGRAD
   Lin Hong-Ru, 2003, POROUS ALGINATE HYDR
   Organovo, 2014, BIOPR PROC
   Sargus-Patino Catherine, 2013, ALGINATE HYDROGEL 3
NR 9
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8221-9
PY 2015
BP 67
EP 70
PG 4
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications
SC Computer Science
GA BF3CD
UT WOS:000380524900004
DA 2018-10-20
ER

PT B
AU Mozayan, C
   Chabra, R
   Wu, P
   Narayan, R
   Li, C
AF Mozayan, C.
   Chabra, R.
   Wu, P.
   Narayan, R.
   Li, C.
GP IEEE
TI A NOVEL BIOCOMPATIBLE BIOMATERIAL FOR ON-DEMAND GENERATION OF
   THREE-DIMENSIONAL OXYGEN GRADIENTS IN VITRO
SO 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE
   SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS)
LA English
DT Proceedings Paper
CT 18th International Conference on Solid-State Sensors, Actuators and
   Microsystems (TRANSDUCERS)
CY JUN 21-25, 2015
CL Anchorage, AK
SP TRF, IEEE, Elect Devices Soc
DE Oxygen gradient; oxygen tension; hypoxia; macrophage; cell culture
   device
ID CELL-CULTURE; MICROFLUIDIC DEVICE; ISCHEMIC-STROKE
AB Oxygen gradients play essential roles in many in vitro cell, tissue and organ experimental models. This paper reports a novel biocompatible biomaterial for on-demand generation of three-dimensional oxygen gradients in vitro. By exposing the oxygen-consuming biomaterial consisting of glucose oxidase and catalase enzymes to the cell culture media or gel, precisely-controlled oxygen gradients (2.5 mmHg per 100 mu m distance) that closely mimic in vivo hypoxia can be generated. This biomaterial will serve as the basis for a new generation of experimental models previously impossible or very difficult to implement by simplifying and refining the control of in vitro microenvironments.
C1 [Mozayan, C.; Narayan, R.; Li, C.] Hofstra North Shore LIJ Sch Med, Hempstead, NY 11549 USA.
   [Chabra, R.] Rensselaer Polytech Inst, Troy, NY USA.
   [Wu, P.; Narayan, R.; Li, C.] Feinstein Inst Med Res, Manhasset, NY USA.
RP Li, C (reprint author), Hofstra North Shore LIJ Sch Med, Hempstead, NY 11549 USA.
EM cli11@nshs.edu
CR Chang CW, 2014, LAB CHIP, V14, P3762, DOI 10.1039/c4lc00732h
   Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h
   Funamoto K, 2012, LAB CHIP, V12, P4855, DOI 10.1039/c2lc40306d
   Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d
   Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]
   Mehta G, 2007, BIOMED MICRODEVICES, V9, P123, DOI 10.1007/s10544-006-9005-7
   Moore M., 2013, TISSUE ENG PART A, P17
   Rajan N., 2013, TRANSD 2013 C BARC S, P412
   Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11
   TONI D, 1995, ARCH NEUROL-CHICAGO, V52, P670, DOI 10.1001/archneur.1995.00540310040014
   Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325
   Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8955-3
PY 2015
BP 1593
EP 1596
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BF2EU
UT WOS:000380461400397
DA 2018-10-20
ER

PT B
AU Lausecker, R
   Badilita, V
   Wallrabe, U
AF Lausecker, R.
   Badilita, V.
   Wallrabe, U.
GP IEEE
TI NATURAL SHELLAC FOR GREEN MICROFLUIDIC APPLICATIONS
SO 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE
   SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS)
LA English
DT Proceedings Paper
CT 18th International Conference on Solid-State Sensors, Actuators and
   Microsystems (TRANSDUCERS)
CY JUN 21-25, 2015
CL Anchorage, AK
SP TRF, IEEE, Elect Devices Soc
DE Microfluidics; shellac; biomaterial; sustainable
AB We hereby introduce the biomaterial shellac as a new player in the field of sustainable microfluidics.
   We demonstrate a fully "green" technological process for wafer-level fabrication of microstructures by means of shellac hot embossing. The process is labeled as "green" because it can be carried out completely outside the cleanroom, it is fast, cheap, energy saving, and uses natural and exclusively non-toxic materials. Moreover, the end products are biodegradable, opening new perspectives for disposable point-of-care (POC) devices.
   The implementation capability is demonstrated through successful fabrication of basic building blocks such as pillars, channels, mixers and reservoirs. Process parameters, limitations and challenges are clearly defined.
C1 [Lausecker, R.; Badilita, V.; Wallrabe, U.] Univ Freiburg, Dept Microsyst Engn, Lab Microactuators, Freiburg, Germany.
RP Lausecker, R (reprint author), Univ Freiburg, Dept Microsyst Engn, Lab Microactuators, Freiburg, Germany.
EM roland.lausecker@imtek.uni-freiburg.de
RI Wallrabe, Ulrike/F-5217-2013
CR Branham MS, 2010, ENVIRON SCI TECHNOL, V44, P4295, DOI 10.1021/es902388b
   Irimia-Vladu M, 2013, GREEN CHEM, V15, P1473, DOI 10.1039/c3gc40388b
   Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398
   Williams ED, 2002, ENVIRON SCI TECHNOL, V36, P5504, DOI 10.1021/es025643o
NR 4
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8955-3
PY 2015
BP 1680
EP 1683
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BF2EU
UT WOS:000380461400419
DA 2018-10-20
ER

PT S
AU Hughes, G
   Ochsner, A
AF Hughes, Gideon
   Ochsner, Andreas
BE Ochsner, A
   Altenbach, H
TI Design, Manufacture and Testing of Three-Dimensional Scaffolds
SO APPLICATIONS OF COMPUTATIONAL TOOLS IN BIOSCIENCES AND MEDICAL
   ENGINEERING
SE Advanced Structured Materials
LA English
DT Proceedings Paper
CT 8th International Conference on Advanced Computational Engineering and
   Experimenting (ACEX)
CY JUN 30-JUL 03, 2014
CL Paris, FRANCE
DE Additive manufacturing; 3D printing; Unit cells; Periodic structure;
   Biomaterial
AB The presented work involved the design, manufacture and testing of three-dimensional scaffolds with the aim of advancing the field of bio-scaffolds from a mechanical prospective. Three different scaffold structure configurations were tested in regards to stiffness, ultimate stress and their fracture behavior. The configurations were named after the unit-cell geometry which they are based on, 0 degrees-90 degrees cylinder structure, 0 degrees-90 degrees holes in cube structure and negative body centered cubic structure (negative BCC). It could be shown that the negative BCC configuration shows the best performance with respect to the mechanical behavior under compression force.
C1 [Hughes, Gideon; Ochsner, Andreas] Griffith Univ, Sch Engn, Gold Coast, Australia.
RP Hughes, G (reprint author), Griffith Univ, Sch Engn, Gold Coast, Australia.
EM gideon.hughes@griffithuni.edu.au; a.oechsner@griffith.edu.au
CR Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Dao D., 2014, LECT NOTES
   Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/nmat3134, 10.1038/NMAT3134]
   GRENDA E, 2007, MED APPL RAPID PROTO
   Hajar S., 2011, ACTA BIOMATER, V7
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Olson Jennifer L, 2011, Chonnam Med J, V47, P1, DOI 10.4068/cmj.2011.47.1.1
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yen HJ, 2009, BIOMED MICRODEVICES, V11, P615, DOI 10.1007/s10544-008-9271-7
NR 9
TC 3
Z9 3
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1869-8433
BN 978-3-319-19470-7; 978-3-319-19469-1
J9 ADV STRUCT MAT
PY 2015
VL 71
BP 133
EP 179
DI 10.1007/978-3-319-19470-7_9
PG 47
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods
SC Computer Science
GA BF3JJ
UT WOS:000380548700009
DA 2018-10-20
ER

PT S
AU Gutierrez, TJ
   Morales, NJ
   Tapia, MS
   Perez, E
   Fama, L
AF Gutierrez, Tomy J.
   Morales, Noe J.
   Soledad Tapia, Maria
   Perez, Elevina
   Fama, Lucia
BA Schvezov, CE
BF Schvezov, CE
TI Corn Starch 80:20 "Waxy":Regular, "Native" and Phosphated, as
   Bio-Matrixes for Edible Films
SO INTERNATIONAL CONGRESS OF SCIENCE AND TECHNOLOGY OF METALLURGY AND
   MATERIALS, SAM - CONAMET 2013
SE Procedia Materials Science
LA English
DT Proceedings Paper
CT International Congress of Science and Technology of Metallurgy and
   Materials (SAM CONAMET)
CY AUG 20-23, 2013
CL Puerto Iguazu, ARGENTINA
DE Starch; Chemical modification; Corn; Edible films; Biomaterial
ID WATER-VAPOR PERMEABILITY; MECHANICAL-PROPERTIES; BARRIER PROPERTIES;
   COATINGS; GLYCEROL; GELATIN; GELLAN; WHEAT
AB Films made from starches are colorless, tasteless, non-toxic, biodegradable, and economical, besides having a low permeability to oxygen. Moreover, the cross-linking modification (phosphatation) could improve its physicochemical properties by reinforcing the hydrogen links inside the granules. The goals of this study were to elaborate and characterize starch corn films 80:20 "waxy":regular, from native and modified (cross-linked), to define their potential application. Results showed, that films with modified starch had highest hydrophilic properties which increased its thickness, permeability and solubility, and with mayor stability in acidic and alkaline medium. Finally, physicochemical properties and water vapor barrier data of the films denote the strong interaction phosphated starch-plasticizer. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Gutierrez, Tomy J.; Soledad Tapia, Maria; Perez, Elevina] Cent Univ Venezuela, Fac Ciencias, Inst Ciencia & Tecnol Alimentos, Apartado 47097, Caracas 1041A, Venezuela.
   [Morales, Noe J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET UBA, INQUIMAE, RA-1428 Buenos Aires, DF, Argentina.
   [Fama, Lucia] Univ Buenos Aires, LP&MC, Dept Fis, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.
   [Fama, Lucia] Univ Buenos Aires, IFIBA CONICET, Buenos Aires, DF, Argentina.
RP Gutierrez, TJ (reprint author), Cent Univ Venezuela, Fac Ciencias, Inst Ciencia & Tecnol Alimentos, Apartado 47097, Caracas 1041A, Venezuela.
EM tomy.gutierrez@ciens.ucv.ve
OI Gutierrez, Tomy/0000-0001-9968-7778
CR Alejandra Rojas-Graue Maria, 2007, Alimentaria, P105
   Bello-Perez L. A., 2002, Agrociencia (Montecillo), V36, P169
   Chillo S, 2008, J FOOD ENG, V88, P159, DOI 10.1016/j.jfoodeng.2008.02.002
   Fama L, 2013, TECHNOLOGICAL ADVANC
   Fama L, 2005, J LEBENSM WISS TECHN, V38, P631
   Garcia MA, 1998, J SCI FOOD AGR, V76, P411, DOI 10.1002/(SICI)1097-0010(199803)76:3<411::AID-JSFA965>3.0.CO;2-I
   GENNADIOS A, 1994, J FOOD ENG, V21, P395, DOI 10.1016/0260-8774(94)90062-0
   Ghanbarzadeh B, 2010, INNOV FOOD SCI EMERG, V11, P697, DOI 10.1016/j.ifset.2010.06.001
   GONTARD N, 1993, J FOOD SCI, V58, P206, DOI 10.1111/j.1365-2621.1993.tb03246.x
   Gutierrez T. J., 2013, PROPIEDADES FISICAS
   Hu GF, 2009, CARBOHYD POLYM, V76, P291, DOI 10.1016/j.carbpol.2008.10.032
   Jongjareonrak A, 2006, FOOD HYDROCOLLOID, V20, P492, DOI 10.1016/j.foodhyd.2005.04.007
   Kaur L, 2004, CARBOHYD POLYM, V55, P211, DOI 10.1016/j.carbpol.2003.09.011
   Krotchta JM, 1997, J FOOD TECHNOL CHICA, V51, P2
   Lawton JW, 1996, CARBOHYD POLYM, V29, P203, DOI 10.1016/0144-8617(96)00028-8
   Lee KY, 2004, CARBOHYD POLYM, V56, P251, DOI 10.1016/j.carbpol.2003.04.001
   LIGHT JM, 1990, CEREAL FOOD WORLD, V35, P1081
   LIM S, 1993, CEREAL CHEM, V70, P137
   Lu YS, 2005, CARBOHYD POLYM, V61, P174, DOI 10.1016/j.carbpol.2005.04.013
   Mali S, 2004, CARBOHYD POLYM, V56, P129, DOI 10.1016/j.carbpol.2004.01.004
   Matos M. E., 2003, J CEREAL FOOD WORLD, V48, P78
   McHugh T.H., 1994, EDIBLE COATINGS FILM, P139
   MCHUGH TH, 1993, J FOOD SCI, V58, P899, DOI 10.1111/j.1365-2621.1993.tb09387.x
   Melian D., 2006, DESARROLLO PELICULA
   Moorthy S. N., 1994, TECH B SERIES CENTRA, V18, P40
   Perez E, 2012, J CELL PLAST, V48, P545, DOI 10.1177/0021955X12445603
   ROMEROBASTIDAS CA, 2005, J CARBOHYDR POLYM, V60, P235, DOI DOI 10.1016/J.CARBPOL.2005.01.004
   Sivoli L., 2009, THESIS
   Sothornvit R, 2001, J FOOD ENG, V50, P149, DOI 10.1016/S0260-8774(00)00237-5
   Swinkels JJ, 1985, HANBOOK FOOD ADDITIV, VI
   Tapia M., 2007, THESIS
   Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P71, DOI 10.1016/S0924-2244(02)00280-7
   Wurzburg O.B, 1986, MODIFIED STARCHES PR
   WURZBURG OB, 1970, J AGR FOOD CHEM, V18, P997, DOI 10.1021/jf60172a030
   Yang L, 2000, FOOD RES INT, V33, P563, DOI 10.1016/S0963-9969(00)00092-2
NR 35
TC 15
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-8128
J9 PROC MAT SCI
PY 2015
VL 8
BP 304
EP 310
DI 10.1016/j.mspro.2015.04.077
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BF2WT
UT WOS:000380505600036
OA Other Gold
DA 2018-10-20
ER

PT B
AU Lara, H
   Rodriguez, C
   Mendoza-Buenrostro, C
AF Lara, Hernan
   Rodriguez, Ciro
   Mendoza-Buenrostro, Christian
BE Monsalve, C
   Sanchez, A
   Chaczko, Z
TI Fuzzy inference system applied to mechanical design of bone tissue
   engineering scaffolds
SO 2015 ASIA-PACIFIC CONFERENCE ON COMPUTER-AIDED SYSTEM ENGINEERING -
   APCASE 2015
LA English
DT Proceedings Paper
CT 2015 Asia-Pacific Conference on Computer Aided System Engineering
CY JUL 14-16, 2015
CL Quito, ECUADOR
SP Univ San Francisco, IEEE, IEEE Comp Soc, Escuela Super Politecn Litoral, Univ Politecn SALESIANA Ecuador, UTS Engn & Informat Technol, Univ Technol Sydney, Oberosterreich, BINUS Univ People Innovat Excellence, ULPGC, Wroclaw Univ Technol, BCDS Solutions
DE scaffold; bone tissue; fuzzy system; biomaterial properties
AB Solid free form fabrication are now being developed to fabricate scaffolds with controlled architecture for bone tissue engineering. These techniques use computer-aided design (CAD) to aid the design of optimized three-dimensional structures in a large number of materials. The development of mechanical models to simulate the scaffolds behavior for bone tissue engineering represents a relevant area in regenerative medicine. This paper presents a computer tool to design tailored scaffolds as a function of mechanical properties considering a specific kind of bone tissue. The kernel of this tool is formed from a fuzzy inference system (FIS) and a parametric design algorithm. The models obtained from this methodology were evaluated using finite element analysis (FEA) and they exhibit suitable features and characteristics to be used in experimental case studies.
C1 [Lara, Hernan; Rodriguez, Ciro; Mendoza-Buenrostro, Christian] Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, E Garza Sada 2501, Monterrey, Mexico.
   [Lara, Hernan] Univ Fuerzas Armadas ESPE, DECEM, Sangolqui, Ecuador.
RP Lara, H (reprint author), Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, E Garza Sada 2501, Monterrey, Mexico.
OI Mendoza-Buenrostro, Christian/0000-0003-2509-0025
CR Almeida HA, 2014, MED ENG PHYS, V36, P1033, DOI 10.1016/j.medengphy.2014.05.006
   Bayraktar H., 2004, J BIOMECH, V37, P27
   Doppalapudi S, 2015, ADV POLYM MED, P33
   Guldberg R., 2010, FDN REGENERATIVE MED, P260
   Heise R. L., 2015, ADV POLYM MED, P177
   Hollister S., 2005, BONE TISSUE ENG, P168
   Hudson D. L., 2000, NEURAL NETWORKS ARTI
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kovalovs M., 2013, 17 INT C BIOM ENG KA
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Malo MKH, 2013, BONE, V53, P451, DOI 10.1016/j.bone.2013.01.015
   Reichert JC, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P431, DOI 10.1007/978-3-642-02824-3_21
   Ross T.J., 2010, FUZZY LOGIC ENG APPL
   Thavornyutikarn B., 2014, PROG BIOMATER, V3, P61
   TURNER CH, 2001, BONE MECH HDB
   Wolfe PS, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P41, DOI 10.1007/978-3-642-02824-3_3
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-7588-4
PY 2015
BP 409
EP 413
DI 10.1109/APCASE.2015.79
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BF1JY
UT WOS:000380403600064
DA 2018-10-20
ER

PT S
AU Farcasiu, AT
   Farcasiu, C
   Tanasescu, LA
   Andrei, OC
   Stefanescu, DM
   Munteanu, A
AF Farcasiu, Alexandru-Titus
   Farcasiu, Catalina
   Tanasescu, Livia-Alice.
   Andrei, Oana Cella
   Stefanescu, Dan Mihai
   Munteanu, Aneta
GP IEEE
TI In-vitro and in-vivo evaluation of two surface treatments on a
   commercial denture base biomaterial
SO 2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT E-Health And Bioengineering Conference (EHB)
CY NOV 19-21, 2015
CL Iasi, ROMANIA
SP IEEE, IEEE-EMB Romania Chapter, Inst Comp Sci Roamanian Acad Iasi Branch, Romanian Soc Med Bioengineering, IEEE Romania Sect, EHB
DE denture base; plasma deposition; sandblasting; wettability; digital
   measurement
ID ACRYLIC RESIN SURFACES; PLASMA TREATMENT; GLOW-DISCHARGE; WETTABILITY;
   SALIVA; RETENTION
AB Denture base materials are involved in the edentulous patient's therapy as part of a three component system: underlying tissue, saliva and denture. Saliva's properties are influenced by a wide range of factors therefore xerostomic signs and symptoms can be seen increasingly often, especially in geriatric patients. Extensive use of available saliva is possible only respecting clinical design principles and is enhanced by surface treatments. Plasma deposition and sandblasting effect on a commercial denture base material were analyzed in a comparative approach. Wettability with natural saliva represented the in-vitro evaluation of the biological process, while measurement of retention force of palatal plates defined the in-vivo section. Both techniques increased wettability and retention force, plasma deposition proving to be more effective than sandblasting. The difference between in vitro and in vivo experiments may due to variation of quantity and quality of saliva, emphasizing its role in complete denture retention.
C1 [Farcasiu, Alexandru-Titus; Farcasiu, Catalina; Tanasescu, Livia-Alice.; Andrei, Oana Cella; Munteanu, Aneta] Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Stefanescu, Dan Mihai] Romanian Measurement Soc, Bucharest, Romania.
RP Farcasiu, AT (reprint author), Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania.
RI ANDREI, OANA CELLA/P-6128-2014
OI ANDREI, OANA CELLA/0000-0001-7960-4488
CR Anil S., 2014, HONG KONG DENT J, DOI 10.1111/jicd.12120
   Cha S, 2014, CHINESE J PROSTHODON, P4
   Cha S, 2014, CLIN PLASMA MED, V2, P4, DOI 10.1016/j.cpme.2014.04.002
   Chai JN, 2004, LANGMUIR, V20, P10919, DOI 10.1021/la048947s
   Chitre V., 2008, J INDIAN PROSTHODONT, V8, P30
   Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107
   Farcasiu AT, 2011, ROM J ORAL REHABIL, V3, P95
   Hahnel S, 2014, J DENT, V42, P664, DOI 10.1016/j.jdent.2014.03.003
   Han P, 2015, J PROSTHODONT RES, V59, P6, DOI 10.1016/j.jpor.2014.11.001
   Hidetoshi O., 2004, OHU U DENT J, V31, P201
   Husham AM, 2006, AM J DENT, V19, P115
   Kaluzny Jaroslaw, 2014, Otolaryngol Pol, V68, P1, DOI 10.1016/j.otpol.2013.09.002
   Kikuchi M, 1999, J PROSTHET DENT, V81, P399, DOI 10.1016/S0022-3913(99)80005-5
   Kuhar M, 2005, J PROSTHET DENT, V93, P76, DOI 10.1016/j.prosdent.2004.10.002
   Lee J. H., 2001, J KOREAN ACAD PROSTH, V39, P58
   Leun K. C. M, 2005, HONGKONG DENT J, V2, P132
   Murray M D, 1989, Int J Prosthodont, V2, P234
   Murray M.D., 1989, BIOMED RES INT, V2, P234
   Murray MD, 1989, THESIS
   NAVAZESH M, 1992, J DENT RES, V71, P1275, DOI 10.1177/00220345920710060201
   Nobuko K., 2001, J KANAGAWA ODONTOLOG, V36, P63
   Ozden N, 1999, J PROSTHET DENT, V82, P680, DOI 10.1016/S0022-3913(99)70009-0
   Park MS, 2007, ORAL DIS, V13, P181, DOI 10.1111/j.1601-0825.2006.01263.x
   Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009
   Shetty SR, 2012, CONTEMP CLIN DENT, V3, P173, DOI 10.4103/0976-237X.96821
   Stefanescu DM, 2011, HANDBOOK OF FORCE TRANSDUCERS: PRINCIPLES AND COMPONENTS, P1
   Tokita Takuya, 2007, Journal of Medical and Dental Sciences, V54, P177
   Xu H, 2003, MATER CHEM PHYS, V80, P278, DOI 10.1016/S0254-0584(02)00490-X
   Yildirim MS, 2006, J ORAL REHABIL, V33, P775, DOI 10.1111/j.1365-2842.2006.01646.x
   Yodmongkol S, 2014, J PROSTHET DENT, V112, P1530, DOI 10.1016/j.prosdent.2014.06.019
   Zamperini CA, 2010, ARCH ORAL BIOL, V55, P763, DOI 10.1016/j.archoralbio.2010.06.015
   Zhang HQ, 2010, DENT MATER J, V29, P398, DOI 10.4012/dmj.2009-124
   Zissis A, 2001, QUINTESSENCE INT, V32, P457
NR 33
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4673-7545-0
J9 E-HEALTH BIOENG CONF
PY 2015
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BF1HQ
UT WOS:000380397900149
DA 2018-10-20
ER

PT S
AU RossemaryApetroaei, M
   Manea, AM
   Tihan, GT
   Zgarian, RG
   Schroder, V
   Lilios, G
   Apetroaei, MG
   Rau, I
AF RossemaryApetroaei, Manuela
   Manea, Ana-Maria
   Tihan, Gratiela Teodora
   Zgarian, Roxana Gabriela
   Schroder, Verginica
   Lilios, Gabriela
   Apetroaei, Marius Gabriel
   Rau, Ileana
GP IEEE
TI Chitosan an eco-friendly biomaterial from marine invertebrates
SO 2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT E-Health And Bioengineering Conference (EHB)
CY NOV 19-21, 2015
CL Iasi, ROMANIA
SP IEEE, IEEE-EMB Romania Chapter, Inst Comp Sci Roamanian Acad Iasi Branch, Romanian Soc Med Bioengineering, IEEE Romania Sect, EHB
DE marine organisms; chitosan; spawning; crustaceans
ID PHYSICOCHEMICAL CHARACTERISTICS; CHITIN; EXTRACTION; PRODUCTS
AB Marine organisms are formed by bio compounds with a lot of properties and characteristics that may justify their potential applications within the biomedical field. Assuring the exploitation of natural marine resources and the valorization of residues from marine origin, like those obtained from food processing, represent a highly interesting platform for development of novel eco-friendly biomaterials, with higher benefits due to the fact that the source is practically inexhaustible.
   This study involves the extraction and identification of chitosan from samples of invertebrates organisms by chemical extraction method. The samples of aquatic organisms consist of exoskeleton of crab and spawning of gastropoda.
   This paper presents the possible raw materials for production of chitosan extracted from marine organisms and the characterization of the chitosan extract.
C1 [RossemaryApetroaei, Manuela; Manea, Ana-Maria; Tihan, Gratiela Teodora; Rau, Ileana] Univ Politehn Bucuresti, Dept Gen Chem, Bucharest, Romania.
   [Schroder, Verginica; Lilios, Gabriela] Ovidius Univ, Dept Farmaceut Sci, Constanta, Romania.
   [Apetroaei, Marius Gabriel] Mircea Cel Batran Naval Acad, Navigat Dept, Constanta, Romania.
RP Rau, I (reprint author), Univ Politehn Bucuresti, Dept Gen Chem, Bucharest, Romania.
EM ileana_brandusa@yahoo.com
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032
   Bacescu M., 1967, DECAPODA FAUNA R S R, P20
   Bigatti G, 2010, J MOLLUS STUD, V76, P279, DOI 10.1093/mollus/eyq006
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f
   Galed G, 2008, NAT PROD COMMUN, V3, P543
   KNORR D, 1984, FOOD TECHNOL-CHICAGO, V38, P85
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lertsutthiwong P., 2002, J METALS MAT MINERAL, V12, P11
   Mitra T, 2013, MATER RES-IBERO-AM J, V16, P755, DOI [10.1590/S1516-14392013000400009, 10.1590/S1516-14392013005000059]
   No H. K., 1995, Journal of Aquatic Food Product Technology, V4, P27, DOI 10.1300/J030v04n02_03
   No HK, 2000, J FOOD SCI, V65, P1134, DOI 10.1111/j.1365-2621.2000.tb10252.x
   Peniche C, 2008, MONOMERS, POLYMERS AND COMPOSITES FROM RENEWABLE RESOURCES, P517, DOI 10.1016/B978-0-08-045316-3.00025-9
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rawlings TA, 1999, AM ZOOL, V39, P230
NR 16
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4673-7545-0
J9 E-HEALTH BIOENG CONF
PY 2015
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BF1HQ
UT WOS:000380397900260
DA 2018-10-20
ER

PT B
AU Fanous, M
   Ozhikandathil, J
   Badilescu, S
   Packirisamy, M
AF Fanous, Michael
   Ozhikandathil, Jayan
   Badilescu, Simona
   Packirisamy, Muthukumaran
GP IEEE
TI Evaluation Of Optical Properties And Biocompatibility Of Polymer
   Materials For Microfluidic Applications
SO 2015 PHOTONICS NORTH
LA English
DT Proceedings Paper
CT Photonics North 2015
CY JUN 09-11, 2015
CL Ottawa, CANADA
ID PROTEIN
AB Microfluidic technologies have become increasingly effective for diagnostic, physiological, and biochemical applications. The biocompatibility of MEMS devices, which are evolving rapidly in their practicality, has become the paramount property to investigate and optimize through biological and optical testing. Potential applications comprise cell culture, biosensing, immunoisolation, bioparticle sorting, and biomaterial synthesis. In this work we undertake the study of various polymer and nanocomposite materials, such as cyclic olefin copolymer (COC), polymethylmethacrylate (PMMA), polydimethylsiloxane (PDMS), SU-8, polycarbonate (PC) and polystyrene (PS). After the polymer is adequately functionalized, tagged antibodies are attached to the polymer films and, then, the corresponding antigens are brought in contact with the antibodies. The work is novel and complements the contemporary research involving other methods to evaluate the biocompatibility, such as for example, cell culture. The affinity of antibodies toward the polymer is evaluated by the amount of attached antibodies measured by fluorescence spectroscopy.
C1 [Fanous, Michael; Ozhikandathil, Jayan; Badilescu, Simona; Packirisamy, Muthukumaran] Concordia Univ, Mech & Ind Engn Dept, Opt Bio Microsyst Lab, Montreal, PQ, Canada.
RP Fanous, M (reprint author), Concordia Univ, Mech & Ind Engn Dept, Opt Bio Microsyst Lab, Montreal, PQ, Canada.
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Christie R. J, BIOCOMPATIBLE UNPUB
   Cristina I., 2012, INTECH, P47
   Mann K. G., 1978, BIOCHEMSTRY, V78, P0417
   Masson JF, 2005, TALANTA, V67, P918, DOI 10.1016/j.talanta.2005.04.023
   Masson JF, 2004, TALANTA, V64, P716, DOI 10.1016/j.talanta.2004.03.051
   Midwoud P. M., 2010, BIOCOMPATIBILITY ADS, P137
   Ozhikandathil J., 2010, GOLD NANOISLAND STRU
   Ozhikandathil J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017006
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Swatowski B. W, 2013, FLEXIBLE STABLE EASI
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Young EWK, 2011, ANAL CHEM, V83, P1408, DOI 10.1021/ac102897h
NR 14
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-6806-3
PY 2015
PG 4
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BF2ID
UT WOS:000380469700008
DA 2018-10-20
ER

PT B
AU Vaz, P
   Fernandes, MS
   Gois, F
   Braga, A
   Fernandes, JCS
   Felino, A
AF Vaz, Paula
   Fernandes, Margarida Sampaio
   Gois, Francisco
   Braga, Ana
   Sampaio Fernandes, J. C.
   Felino, Antonio
BE Gomes, JFS
   Meguid, SA
TI GTR WITH DENTAL IMPLANTS REHABILITATION OUTCOME AND IL1 GENE
   POLYMORPHISMS
SO M2D2015: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON MECHANICS
   AND MATERIALS IN DESIGN
LA English
DT Proceedings Paper
CT 6th International Conference on Mechanics and Materials in Design (M2D)
CY JUL 26-30, 2015
CL P Delgada, PORTUGAL
SP Univ Porto, Unit Toronto, Univ Azores, Univ Porto, Faculdade Engn, Univ Toronto, Mech & Aerosp Design Lab, Univ Azores, DCDT, Governo Reg Acores, Portuguese Assoc Experimental Mech, European Soc Experimental Mech, Amer Soc Experimental Mech, British Soc Strain Measurement, Japanese Soc Mech Engn, Int Measurement Confederat, Assoc Francaise Mecanique, European Assoc Dynam Mat, Inst Engn Mecanica Gestao Ind, Laboratorio Biomecanica Porto, Fundacao Ciencia Tecnologia, Profess Congress Org
DE biomaterials; IL-1 gene polymorphisms; dental implants rehabilitation;
   GTR
ID GUIDED TISSUE REGENERATION; INTRABONY DEFECTS; PERIODONTAL REGENERATION
AB This study aims to present the relation between dental implants rehabilitations outcome (result success and no success) performed with guided tissue regeneration (GTR) and the IL1 gene polymorphisms (positions IL1A-889, IL1B+3953) in a Portuguese Caucasian population.
   In a sample composed by seventy unrelated patients rehabilitated together with GTR [resorbable membrane Bio-Gide (R) (Geistlich Pharma, Switzerland) and bone reconstruction biomaterial Bio-Oss (R) (Geistlich, Switzerland)-and dental implants, a oral evaluation and a genetic test (TGP (R), CGC genetics) for combined detection of IL1 polymorphisms were performed. The statistical analysis revealed that successful results of dental implant rehabilitations with GTR procedures were more related to the presence of allele1 of IL1A and IL1B genes.
C1 [Vaz, Paula] Univ Porto, Fac Med Dent, Med & Orofacial Genet, Oporto, Portugal.
   [Fernandes, Margarida Sampaio; Gois, Francisco] Univ Porto, Fac Med Dent, Oporto, Portugal.
   [Braga, Ana] U Minho, Div Stat, Dept Prod & Syst Engn, Braga, Portugal.
   [Sampaio Fernandes, J. C.] Univ Porto, Fac Med Dent, Dept Fixed Prosthesis, Oporto, Portugal.
   [Felino, Antonio] Univ Porto, Fac Med Dent, Dept Oral Surg, Oporto, Portugal.
RP Vaz, P (reprint author), Univ Porto, Fac Med Dent, Med & Orofacial Genet, Oporto, Portugal.
EM pvaz@fmd.up.pt
RI Braga, Ana Cristina/O-6628-2014
OI Braga, Ana Cristina/0000-0002-1991-9418
CR Christgau M, 2003, J PERIODONTAL RES, V38, P20, DOI 10.1034/j.1600-0765.2003.01373.x
   Cortellini P, 2000, PERIODONTOL 2000, V22, P104, DOI 10.1034/j.1600-0757.2000.2220108.x
   Galindo-Moreno P, 2005, CLIN ORAL IMPLAN RES, V16, P579, DOI 10.1111/j.1600-0501.2005.01148.x
   Kornman KS, 2000, PERIODONTOL 2000, V22, P22, DOI 10.1034/j.1600-0757.2000.2220103.x
   Slots J, 1999, PERIODONTOL 2000, V19, P164, DOI 10.1111/j.1600-0757.1999.tb00154.x
   Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x
   TONETTI MS, 1995, J CLIN PERIODONTOL, V22, P229
   Vaz P, 2012, CLIN ORAL IMPLAN RES, V23, P1404, DOI 10.1111/j.1600-0501.2011.02322.x
NR 8
TC 0
Z9 0
U1 0
U2 1
PU INEGI-FEUP
PI PORTO
PA RUA DR ROBERTO FRIAS, PORTO, 4200-465, PORTUGAL
BN 978-989-98832-3-9
PY 2015
BP 1505
EP 1508
PG 4
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BF0DR
UT WOS:000378595500265
DA 2018-10-20
ER

PT B
AU Frattolin, J
   Gottellini, L
   Roy, R
   Bertrand, OF
   Mongrain, R
AF Frattolin, Jennifer
   Gottellini, Luca
   Roy, Ranjan
   Bertrand, Olivier F.
   Mongrain, Rosaire
BE Gomes, JFS
   Meguid, SA
TI EFFECT OF ANNEALING ON THE CORROSION RATE OF A NOVEL METALLIC AMALGAMATE
   FOR BIODEGRADABLE STENTS
SO M2D2015: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON MECHANICS
   AND MATERIALS IN DESIGN
LA English
DT Proceedings Paper
CT 6th International Conference on Mechanics and Materials in Design (M2D)
CY JUL 26-30, 2015
CL P Delgada, PORTUGAL
SP Univ Porto, Unit Toronto, Univ Azores, Univ Porto, Faculdade Engn, Univ Toronto, Mech & Aerosp Design Lab, Univ Azores, DCDT, Governo Reg Acores, Portuguese Assoc Experimental Mech, European Soc Experimental Mech, Amer Soc Experimental Mech, British Soc Strain Measurement, Japanese Soc Mech Engn, Int Measurement Confederat, Assoc Francaise Mecanique, European Assoc Dynam Mat, Inst Engn Mecanica Gestao Ind, Laboratorio Biomecanica Porto, Fundacao Ciencia Tecnologia, Profess Congress Org
DE biomaterials; corrosion; biodegradable stent; cold spray
AB Achieving a controlled corrosion rate is a challenging prospect in the design process of a biodegradable stent. Investigations were conducted to determine the effect of annealing temperature and duration on the corrosion rate. A novel nanostructured biomaterial for stent application was utilized, fabricated using cold gas-dynamic spray technology with iron and stainless steel 316L powders. The results from the static immersion tests indicated that increasing the annealing parameters decreased the overall corrosion rate of the material.
C1 [Frattolin, Jennifer; Gottellini, Luca; Roy, Ranjan; Bertrand, Olivier F.; Mongrain, Rosaire] McGill Univ, Dept Mech Chem Engn, Montreal, PQ, Canada.
   [Frattolin, Jennifer; Mongrain, Rosaire] Montreal Heart Inst, Montreal, PQ, Canada.
   [Gottellini, Luca] Politecn Milan, Dept Chem Mat & Chem Engn, Milan, Italy.
   [Bertrand, Olivier F.] Univ Laval, Dept Intervent Cardiol, Quebec City, PQ, Canada.
RP Frattolin, J (reprint author), McGill Univ, Dept Mech Chem Engn, Montreal, PQ, Canada.
EM jennifer.frattolin@mail.mcgill.ca
CR Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091
NR 1
TC 0
Z9 0
U1 0
U2 1
PU INEGI-FEUP
PI PORTO
PA RUA DR ROBERTO FRIAS, PORTO, 4200-465, PORTUGAL
BN 978-989-98832-3-9
PY 2015
BP 1583
EP 1584
PG 2
WC Engineering, Biomedical; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BF0DR
UT WOS:000378595500281
DA 2018-10-20
ER

PT B
AU Sun, G
   Fang, Y
AF Sun, Gang
   Fang, Yan
BE Liu, HC
   Sung, WP
   WenliYao
TI Anisotropic property of the multiple-dimensional rough surface on moth
   wing
SO COMPUTING, CONTROL, INFORMATION AND EDUCATION ENGINEERING
LA English
DT Proceedings Paper
CT 2nd International Conference on Computer, Intelligent Computing and
   Education Technology (CICET)
CY APR 11-12, 2015
CL Guilin, PEOPLES R CHINA
DE Superhydrophobicity; Adhesion; Self-cleaning; Biomaterial; Moth wing
ID MECHANISM
AB The micro-morphology, superhydrophobicity, self-cleaning property and chemical composition of the moth wing surface were investigated by a Scanning Electron Microscope (SEM), a contact angle meter and a Fourier transform infrared spectrometer (FT-IR). The wetting mechanism of the moth wing was discussed from the perspective of biological coupling. The moth wing displays multiple-dimensional structural anisotropism. The micrometric scales constitute the primary structure, the submicrometric vertical ribs and horizontal bridges on the scales constitute the secondary structure, and the nano stripes on the vertical ribs and horizontal bridges constitute the tertiary structure. The moth wing surface is of superhydrophobicity (contact angle 150.5 similar to 158.4 degrees) and low adhesion (sliding angle 1 similar to 3 degrees). In addition, the water droplet exhibits anisotropic sliding behavior on the wing surface. The scale plays a crucial role in determining the self-cleaning property of the moth wing. The coupling effect of material element and structural element contributes to the special wettability of the wing surface. The moth wing can be potentially used as a template for biomimetic design of functional surface with complex wettability. This work may offer insights into the preparation of smart interfacial material and directional self-cleaning coatings.
C1 [Sun, Gang; Fang, Yan] Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.
RP Sun, G (reprint author), Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.
CR Fang Y, 2007, CHINESE SCI BULL, V52, P711, DOI 10.1007/s11434-007-0120-5
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Higgins AM, 2000, NATURE, V404, P476, DOI 10.1038/35006597
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   Wang XJ, 2009, CHINESE SCI BULL, V54, P569, DOI 10.1007/s11434-009-0071-0
NR 6
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-68589-2; 978-1-138-02800-5
PY 2015
BP 241
EP 243
PG 3
WC Automation & Control Systems; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BE9JH
UT WOS:000377652000055
DA 2018-10-20
ER

PT B
AU Krupskaya, LT
   Rastanina, NK
   Gul, LP
   Zvereva, VP
   Volobueva, NG
AF Krupskaya, L. T.
   Rastanina, N. K.
   Gul, L. P.
   Zvereva, V. P.
   Volobueva, N. G.
BE Sung, WP
   Chen, R
TI Heavy Metal Content in Biomaterial as an Integrating Indicator of
   Technogenic Pollution Assessment of the Environment and Human Health
   Impact
SO MANUFACTURING, DESIGN SCIENCE AND INFORMATION ENGINEERING, VOLS I AND II
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Manufacturing and Design
   Science (ICFMD)
CY DEC 18-19, 2015
CL Hong Kong, PEOPLES R CHINA
SP Control Engn & Informat Sci Res Assoc, Int Frontiers Sci & Technol Res Assoc, Natl Chin Yi Univ Technol, Integrated Res Ctr Green Living Tech, Trans Tech Publicat
DE technogenic pollution; environment; processing waste; tin raw materials;
   health
AB The article describes the results of long-term researches of heavy metals environment technogenic pollution with mineral processing waste, contributing to environmentally caused diseases of mining settlement population (Solnechny settlement in Khabarovskiy Krai). It was found that the heavy metals content in biomaterial is an integral indicator of the assessment of their impact on human health. The measures are proposed to decrease the negative waste impact on human morbidity.
C1 [Krupskaya, L. T.; Rastanina, N. K.] Pacific Natl Univ, Khabarovsk, Russia.
   [Krupskaya, L. T.; Gul, L. P.] Far East Sci Res Inst Forestry, Khabarovsk, Russia.
   [Zvereva, V. P.] Far East Fed Univ, Vladivostok, Russia.
   [Zvereva, V. P.] Far East Geol Inst FEB RAS, Vladivostok, Russia.
   [Volobueva, N. G.] Northeastern State Univ, Magadan, Russia.
RP Krupskaya, LT (reprint author), Pacific Natl Univ, Khabarovsk, Russia.
CR Gorgoshidze B.E., 2006, EXPT CLIN MED, V6, P60
   Gorovaya A. I., 2007, MINING NEWS B, V12, P123
   Gudkov A.V., 2004, INFECT PATHOLOGY PRI, P90
   Kharischarishvili I. Z., 2006, EXP CLIN MED, V7, P65
   Kolesnikov B.P., 1978, METHODS STUDY BIOGEO
   Krupskaya L.T., 2010, MINING NEWS B MAGAZI, V4, P349
   Krupskaya LT, 2012, ENVIRON MONIT ASSESS, V184, P2775, DOI 10.1007/s10661-011-2150-3
   Rastanina N.K., 2013, 3 INT REC C DNEPR, P312
   Rastanina N.K., 2007, FAR E, V15, P318
   Rastanina N.K., 2012, MINING INFORM ANAL B, V1, P207
   Sukachev C.O., 1961, METHODICAL RECOMMEND, P9
   Vernadsky V. I., 1967, BIOSPHERE
   Zonn S. V., 1974, PROGRAM MET BIOGEOCE, P215
NR 13
TC 0
Z9 0
U1 0
U2 0
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-300-7
PY 2015
BP 1138
EP 1144
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Operations Research
   & Management Science
SC Engineering; Operations Research & Management Science
GA BE9IK
UT WOS:000377606200180
DA 2018-10-20
ER

PT S
AU Bragazzi, NL
   Gasparini, R
   Amicizia, D
   Panatto, D
   Larosa, C
AF Bragazzi, Nicola Luigi
   Gasparini, Roberto
   Amicizia, Daniela
   Panatto, Donatella
   Larosa, Claudio
BE Donev, R
TI Porous Alumina as a Promising Biomaterial for Public Health
SO ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101
SE Advances in Protein Chemistry and Structural Biology
LA English
DT Review; Book Chapter
ID ATOMIC LAYER DEPOSITION; BACILLUS-CEREUS SPORES; CROSS-FLOW FILTRATION;
   POPULATION HETEROGENEITY; NANOPOROUS MEMBRANE; OUTGROWTH HETEROGENEITY;
   BACTERIAL DETECTION; CERAMIC MEMBRANES; WASTE-WATER; CULTURE
AB Porous aluminum is a nanostructured material characterized by unique properties, such as chemical stability, regular uniformity, dense hexagonal porous lattice with high aspect ratio nanopores, excellent mechanical strength, and biocompatibility. This overview examines how the structure and properties of porous alumina can be exploited in the field of public health. Porous alumina can be employed for fabricating membranes and filters for bioremediation, water ultrafiltration, and microfiltration/nanofiltration, being a promising technique for having clean and fresh water, which is essential for human health. Porous alumina-based nanobiosensor coated with specific antibodies or peptides seem to be a useful tool to detect and remove pathogens both in food and in water, as well as for environmental monitoring. Further, these applications, being low-energy demanding and cost-effective, are particularly valuable in resource-limited settings and contexts, and can be employed as point of use devices in developing countries, where there is an urgent need of hygiene and safety assurance.
C1 [Bragazzi, Nicola Luigi; Gasparini, Roberto; Amicizia, Daniela; Panatto, Donatella] Univ Genoa, Dept Hlth Sci DISSAL, Via Antonio Pastore 1, Genoa, Italy.
   [Larosa, Claudio] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.
RP Gasparini, R (reprint author), Univ Genoa, Dept Hlth Sci DISSAL, Via Antonio Pastore 1, Genoa, Italy.
EM robertobragazzi@gmail.com
OI Bragazzi, Nicola/0000-0001-8409-868X
CR Ashraf A., 2012, AICHE 2012 2012 AICH
   Basu M, 2004, GLYCOCONJUGATE J, V21, P487, DOI 10.1007/s10719-004-5539-1
   Binh TTN, 2012, BIOELECTROCHEMISTRY, V88, P15, DOI 10.1016/j.bioelechem.2012.04.006
   Chai C, 2010, SENSORS-BASEL, V10, P11414, DOI 10.3390/s101211414
   Chai C, 2010, SENSORS-BASEL, V10, P655, DOI 10.3390/s100100655
   Chan KY, 2013, BIOSENS BIOELECTRON, V41, P532, DOI 10.1016/j.bios.2012.09.016
   Chen DD, 2002, ANAL BIOANAL CHEM, V372, P737, DOI 10.1007/s00216-001-1214-6
   Chua YT, 2013, CHEM COMMUN, V49, P4534, DOI 10.1039/c3cc40434j
   den Besten HMW, 2007, APPL ENVIRON MICROB, V73, P4797, DOI 10.1128/AEM.00404-07
   den Besten HMW, 2010, APPL ENVIRON MICROB, V76, P927, DOI 10.1128/AEM.01372-09
   den Hertog AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011008
   Durtschi JD, 2005, J MED MICROBIOL, V54, P843, DOI 10.1099/j.mm.0.46092-0
   Fang H, 2012, J MEMBRANE SCI, V403, P41, DOI 10.1016/j.memsci.2012.02.011
   Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005
   Gefen O, 2008, TRENDS BIOTECHNOL, V26, P345, DOI 10.1016/j.tibtech.2008.03.007
   Hong SU, 2007, LANGMUIR, V23, P1716, DOI 10.1021/la061701y
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   Hua M, 2012, J HAZARD MATER, V211, P317, DOI 10.1016/j.jhazmat.2011.10.016
   Ingham CJ, 2008, INT J TUBERC LUNG D, V12, P645
   Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005
   Ingham C, 2010, LAB CHIP, V10, P1410, DOI 10.1039/b925796a
   Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104
   Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0
   Ingham CJ, 2012, BIOTECHNOL ADV, V30, P1089, DOI 10.1016/j.biotechadv.2011.08.005
   Ingham CJ, 2008, APPL ENVIRON MICROB, V74, P7750, DOI 10.1128/AEM.00982-08
   IWASAKI K, 1993, PROCESS BIOCHEM, V28, P39, DOI 10.1016/0032-9592(94)80034-0
   IWASAKI KI, 1992, J FERMENT BIOENG, V73, P375, DOI 10.1016/0922-338X(92)90282-Y
   Izuhara S, 2001, CERAM T, V112, P553
   Jagminas A, 2015, DALTON T, V44, P4512, DOI 10.1039/c4dt03644a
   Javaid A, 2006, J MEMBRANE SCI, V275, P255, DOI 10.1016/j.memsci.2005.09.038
   Kang WS, 2010, SURF COAT TECH, V205, pS418, DOI 10.1016/j.surfcoat.2010.08.138
   Lee KP, 2013, J MEMBRANE SCI, V435, P52, DOI 10.1016/j.memsci.2013.01.051
   Lee W, 2014, CHEM REV, V114, P7487, DOI 10.1021/cr500002z
   Lei L, 1997, WATER SCI TECHNOL, V35, P311, DOI 10.1016/S0273-1223(97)00040-1
   Li LX, 2004, J COLLOID INTERF SCI, V273, P540, DOI 10.1016/j.jcis.2003.09.008
   Liew MKH, 1997, BIOTECHNOL BIOENG, V56, P89, DOI 10.1002/(SICI)1097-0290(19971005)56:1<89::AID-BIT10>3.0.CO;2-5
   Ling ZY, 2015, SPRINGER SER MATER S, V219, P1, DOI 10.1007/978-3-319-20334-8_1
   Liu TY, 2012, J NANOSCI NANOTECHNO, V12, P5004, DOI 10.1166/jnn.2012.4941
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mishra NN, 2008, NSTI NANOTECH 2008, VOL 3, TECHNICAL PROCEEDINGS, P343
   Mizuno T., 1999, 12 FALL M CER SOC JA
   Moon JM, 2009, BIOMED MICRODEVICES, V11, P135, DOI 10.1007/s10544-008-9217-0
   Moueddeb H, 1996, J MEMBRANE SCI, V114, P59, DOI 10.1016/0376-7388(95)00307-X
   Narayan RJ, 2010, MATER TODAY, V13, P60, DOI 10.1016/S1369-7021(10)70035-3
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P2033, DOI 10.1098/rsta.2010.0011
   Neubacher H, 2014, LANGMUIR, V30, P4767, DOI 10.1021/la500358h
   Nguyen BTT, 2009, ANAL CHEM, V81, P7226, DOI 10.1021/ac900761a
   Nishinaga O, 2013, SCI REP-UK, V3, DOI 10.1038/srep02748
   Nishiyama N, 2003, J MEMBRANE SCI, V218, P165, DOI 10.1016/S0376-7388(03)00169-8
   Oliveira F. R., 2015, DESALINATIO IN PRESS
   OSULLIVAN JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129
   Pinheiro AFM, 2014, J MEMBRANE SCI, V463, P24, DOI 10.1016/j.memsci.2014.03.050
   Qi Hong, 2011, Journal of the Chinese Ceramic Society, V39, P239
   Ray M, 2015, J POROUS MAT, V22, P1043, DOI 10.1007/s10934-015-9978-9
   Rosa D. S., 2006, Cerâmica, V52, P167, DOI 10.1590/S0366-69132006000200008
   Sabbani S, 2010, MICROPOR MESOPOR MAT, V135, P131, DOI 10.1016/j.micromeso.2010.06.020
   Sabbatini P, 2010, WATER RES, V44, P5702, DOI 10.1016/j.watres.2010.05.059
   Schiza MV, 2005, APPL SPECTROSC, V59, P1068, DOI 10.1366/0003702054615188
   Silva K. K. O. S., 2015, DESALINATIO IN PRESS
   Skoog SA, 2012, MATER SCI ENG B-ADV, V177, P992, DOI 10.1016/j.mseb.2012.04.024
   Sondhi R, 2000, ENVIRON TECHNOL, V21, P699, DOI 10.1080/09593332108618086
   Sondhi R, 2000, J MEMBRANE SCI, V174, P111, DOI 10.1016/S0376-7388(00)00384-7
   Tan F, 2011, SENSOR ACTUAT B-CHEM, V159, P328, DOI 10.1016/j.snb.2011.06.074
   Tsou PH, 2010, BIOSENS BIOELECTRON, V26, P289, DOI 10.1016/j.bios.2010.06.034
   Tuaprakone T., 2011, IOP C SERIES MAT SCI, V18
   Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1
   van Melis CCJ, 2014, INT J FOOD MICROBIOL, V177, P57, DOI 10.1016/j.ijfoodmicro.2014.02.015
   Wang ML, 2011, ANALYST, V136, P278, DOI 10.1039/c0an00510j
   Warda AK, 2015, INT J FOOD MICROBIOL, V201, P27, DOI 10.1016/j.ijfoodmicro.2015.02.010
   Wei HR, 2013, WATER RES, V47, P4139, DOI 10.1016/j.watres.2012.11.062
   Yagur-Kroll S, 2015, BIOSENS BIOELECTRON, V64, P625, DOI 10.1016/j.bios.2014.09.076
NR 71
TC 1
Z9 1
U1 0
U2 21
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
BN 978-0-12-803368-5; 978-0-12-803367-8
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PY 2015
VL 101
BP 213
EP 229
DI 10.1016/bs.apcsb.2015.08.003
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BE7PE
UT WOS:000375652700007
PM 26572980
DA 2018-10-20
ER

PT S
AU Racheva, M
   Romero, O
   Julich-Gruner, KK
   Ulrich, AS
   Wischke, C
   Lendlein, A
AF Racheva, M.
   Romero, O.
   Julich-Gruner, K-K
   Ulrich, A. S.
   Wischke, C.
   Lendlein, A.
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Purity of mushroom tyrosinase as a biocatalyst for biomaterial synthesis
   affects the stability of therapeutic peptides
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID GRAMICIDIN-S; HYDROGELS; CHITOSAN; PROTEIN; SURFACE
AB The formation of injectable implants in the presence of cells or solutes has previously been conceptualized to be based on the selectivity of bioorthogonal chemical reactions. As an alternative approach, hydrogel network synthesis by enzymatic reactions with a typically high inherent substrate specificity and low toxicity have been repeatedly proposed, e.g. using commercial mushroom tyrosinase (MTyr), which specifically catalyzes phenol oxidation. In this study, it should be explored whether MTyr is compatible with therapeutic peptides that may be delivered from such hydrogels in the future. Based on the specificity of MTyr to phenol residues, no modification of peptides lacking the amino acid tyrosine would be expected. One example of such peptides is gramicidin S (GS), a potent antimicrobial peptide. However, when GS was incubated with commercial MTyr, peptide degradation occurred as observed by HPLC analysis. Several fragments of the peptide were detected by MALDI-TOF. Contamination of MTyr with peptidases was proven as the source of undesired peptide cleavage, which needs to be considered when preparing enzymatically crosslinked hydrogels for biomedical applications.
C1 [Racheva, M.; Romero, O.; Julich-Gruner, K-K; Wischke, C.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Racheva, M.; Romero, O.; Julich-Gruner, K-K; Wischke, C.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Ulrich, A. S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76131 Karlsruhe, Germany.
   [Ulrich, A. S.] Inst Organ Chem, D-76131 Karlsruhe, Germany.
RP Racheva, M (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
RI Wischke, Christian/K-9651-2013; Romero, Oscar/K-4864-2016; Lendlein,
   Andreas/K-9553-2013
OI Wischke, Christian/0000-0001-5531-9033; Romero,
   Oscar/0000-0002-0223-5167; Lendlein, Andreas/0000-0003-4126-4670;
   Ulrich, Anne S./0000-0001-5571-9483
CR Berditsch M, 2007, APPL ENVIRON MICROB, V73, P6620, DOI 10.1128/AEM.00881-07
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2003, LANGMUIR, V19, P9382, DOI 10.1021/la0347098
   Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10
   Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t
   Jin R, 2014, POLYM CHEM-UK, V5, P391, DOI 10.1039/c3py00864a
   Jin R, 2013, POLYM INT, V62, P353, DOI 10.1002/pi.4306
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee SH, 2011, ACTA BIOMATER, V7, P1468, DOI 10.1016/j.actbio.2010.11.029
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Selinheimo E, 2008, J AGR FOOD CHEM, V56, P3118, DOI 10.1021/jf0730791
   Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Xu DY, 2012, BIOCHEM ENG J, V63, P88, DOI 10.1016/j.bej.2011.11.009
NR 15
TC 0
Z9 0
U1 1
U2 3
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 85
EP 90
DI 10.1557/opl.2015.260
PG 6
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800013
DA 2018-10-20
ER

PT S
AU Roch, T
   Julich-Gruner, KK
   Neffe, AT
   Ma, N
   Lendlein, A
AF Roch, Toralf
   Julich-Gruner, Konstanze K.
   Neffe, Axel T.
   Ma, Nan
   Lendlein, Andreas
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Immuno-compatibility of desaminotyrosine and desaminotyrosyl tyrosine
   functionalized star-shaped oligo(ethylene glycol)s with different
   molecular weights
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID MECHANISMS
AB Polymer-based therapeutic strategies require biomaterials with properties and functions tailored to the demands of specific applications leading to an increasing number of newly designed polymers. For the evaluation of those new materials, comprehensive biocompatibility studies including cyto-, tissue-, and immunocompatibility are essential. Recently, it could be demonstrated that star-shaped amino oligo(ethylene glycol)s (sOEG) with a number average molecular weight of 5 kDa and functionalized with the phenol-derived moieties desaminotyrosine (DAT) or desaminotyrosyl tyrosine (DATT) behave in aqueous solution like surfactants without inducing a substantial cytotoxicity, which may qualify them as solubilizer for hydrophobic drugs in aqueous solution. However, for biomedical applications the polymer solutions need to be free of immunogenic contaminations, which could result from inadequate laboratory environment or contaminated starting material. Furthermore, the materials should not induce uncontrolled or undesired immunological effects arising from material intrinsic properties. Therefore, a comprehensive immunological evaluation as perquisite for application of each biomaterial batch is required. This study investigated the immunological properties of sOEG-DAT(T) solutions, which were prepared using sOEG with number average molecular weights of 5 kDa, 10 kDa, and 20 kDa allowing analyzing the influence of the sOEG chain lengths on innate immune mechanisms. A macrophage-based assay was used to first demonstrate that all DAT(T)-sOEG solutions are free of endotoxins and other microbial contaminations such as fungal products. In the next step, the capacity of the different DAT(T)-functionalized sOEG solutions to induce cytokine secretion and generation of reactive oxygen species (ROS) was investigated using whole human blood. It was observed that low levels of the pro-inflammatory cytokines interleukin(IL)-1 beta and IL-6 were detected for all sOEG solutions but only when used at concentrations above 250 mu g-mL(-1). Furthermore, only the 20 kDa sOEG-DAT induced low amounts of ROS-producing monocytes. Conclusively, the data indicate that the materials were not contaminated with microbial products and do not induce substantial immunological adverse effects in vitro, which is a prerequisite for future biological applications.
C1 [Roch, Toralf; Julich-Gruner, Konstanze K.; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Roch, Toralf; Julich-Gruner, Konstanze K.; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
   [Roch, Toralf; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Hehnholtz Virtual Inst, Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Neffe, Axel T.; Ma, Nan; Lendlein, Andreas] Hehnholtz Virtual Inst, Multifunct Biomat Med, Berlin, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Dept Biol Chem & Pharm, Inst Chem & Biochem, Takustr 3, D-14195 Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
RI Neffe, Axel/H-6997-2013; Lendlein, Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Lendlein, Andreas/0000-0003-4126-4670
CR Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Julich-Gruner K.K., 2013, MATER RES SOC S P, V1569, P9
   Julich-Gruner KK, 2012, J APPL BIOMATER FUNC, V10, P170, DOI 10.5301/JABFM.2012.10342
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042
   Roch T, 2014, CLIN HEMORHEOL MICRO, V57, P203, DOI 10.3233/CH-141831
   Tan Chalet, 2013, Pharmaceutics, V5, P201, DOI 10.3390/pharmaceutics5010201
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
NR 9
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 97
EP 102
DI 10.1557/opl.2015.327
PG 6
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800015
DA 2018-10-20
ER

PT S
AU Pal, RK
   Kurland, NE
   Kundu, SC
   Yadavalli, VK
AF Pal, Ramendra K.
   Kurland, Nicholas E.
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
BE Lendlein, A
   Tirelli, N
   Weiss, RA
   Xie, T
TI Fabrication of Silk Microstructures Using Photolithography
SO MULTIFUNCTIONAL POLYMERIC AND HYBRID MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Multifunctional Polymeric and Hybrid Materials / MRS Fall
   Meeting
CY NOV 30-DEC 05, 2014
CL Boston, MA
SP FEI Deutschland GmbH, Royal Soc Chem, RSC Mat Horizons
ID FIBROIN FILMS; BIOMATERIALS; LITHOGRAPHY; PROTEINS
AB Precise spatial patterns and micro and nanostructures of peptides and proteins have widespread applications in tissue engineering, bioelectronics, photonics, and therapeutics. Optical lithography using proteins provides a route to directly fabricate intricate, bio-friendly architectures rapidly and across a range of length scales. The unique mechanical strength, optical properties, biocompatibility and controllable degradation of biomaterials from silkworms offer several advantages in this paradigm. Here, we present the biochemical synthesis and applications of a "protein photoresist" synthesized from the silk proteins, fibroin and sericin. Using light activated direct-write processes such as photolithography, we show how silk proteins can form high resolution, high fidelity structures in two and three dimensions. Protein features can be precisely patterned at sub-microscale resolution (gm) at the bench-top over macroscale areas (cm), easily and repeatedly with high-throughput. For instance, periodic, microstructured arrays can be patterned over large areas to form structurally induced iridescent patterns and functional opto-electronic structures. We further demonstrate how photocrosslinked protein micro architectures can function for the spatial guidance of cells without use of cell-adhesive ligands as biocompatible and biodegradable scaffolds. The ease of biochemical functionalization, biocompatibility, as well as favorable mechanical properties and biodegradation of this silk biomaterial provide opportunities for otherwise inaccessible applications as sustainable, bioresorbable protein microdevices.
C1 [Pal, Ramendra K.; Kurland, Nicholas E.; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Richmond, VA USA.
   [Kundu, Subhas C.] Indian Inst Technol, Kharagpur 721302, W Bengal, India.
RP Pal, RK (reprint author), Virginia Commonwealth Univ, Richmond, VA USA.
OI Kundu, Subhas C./0000-0002-7170-2291; Yadavalli,
   Vamsi/0000-0002-8879-1948
CR Boretius T, 2011, ARTIF ORGANS, V35, P245, DOI 10.1111/j.1525-1594.2011.01210.x
   Borkner CB, 2014, ACS APPL MATER INTER, V6, P15611, DOI 10.1021/am5008479
   Brenckle MA, 2013, ADV MATER, V25, P2409, DOI 10.1002/adma.201204678
   Coma V, 2013, POLIMEROS, V23, P287, DOI 10.4322/polimeros020ov002
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Galeotti F, 2012, SOFT MATTER, V8, P4815, DOI 10.1039/c2sm25089f
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jagur-Grodzinski J, 2010, POLYM ADVAN TECHNOL, V21, P27, DOI 10.1002/pat.1504
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Li ZX, 2011, J ARTIF ORGANS, V14, P163, DOI 10.1007/s10047-011-0585-5
   Malliaras GG, 2013, BBA-GEN SUBJECTS, V1830, P4286, DOI 10.1016/j.bbagen.2012.10.007
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 25
TC 1
Z9 1
U1 0
U2 7
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-695-2
J9 MATER RES SOC SYMP P
PY 2015
VL 1718
BP 163
EP 170
DI 10.1557/opl.2015.437
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BE8FP
UT WOS:000376420800024
DA 2018-10-20
ER

PT B
AU Slovakova, M
   Srbova, J
   Munzarova, M
   Dvorakova, P
   Bilkova, Z
AF Slovakova, Marcela
   Srbova, Jana
   Munzarova, Marcela
   Dvorakova, Petra
   Bilkova, Zuzana
GP TANGER Ltd
TI TESTING OF COLLAGENASE COVALENTLY LINKED TO CHITOSAN NANOFIBERS FOR
   BIOMEDICAL APPLICATIONS
SO NANOCON 2015: 7TH INTERNATIONAL CONFERENCE ON NANOMATERIALS - RESEARCH &
   APPLICATION
LA English
DT Proceedings Paper
CT 7th International Conference on Nanomaterials - Research and Application
CY OCT 14-16, 2015
CL Brno, CZECH REPUBLIC
SP Tanger Ltd, Czech Soc New Mat & Technologies, Reg Ctr Adv Technologies & Mat, Mat Res Soc Serbia, Norsk Materialteknisk Selskap
DE Chitosan nanofibers; collagenase; enzyme immobilization;
   Michaelis-Menten constant
ID DEBRIDEMENT
AB Nanofibers biofunctionalized with enzymes are materials of interest in the biomedical field due to their potential application in wound healing. This work describes the production and characterisation of electrospun chitosan nanofibers biofunctionalized with a microbial collagenase. The morphology and microstructure of the chitosan nanofibers prepared with Nanospider technology were examined using a scanning electron microscope (SEM). Amino groups of a chitosan nanofiber were connected with the carboxylic acid groups of the collagenase using EDAC and sulfo-NHS methodology. Collagenase enzymatic activity was evaluated with a peptidic substrate (Pz-peptide, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg) in order to estimate the ability of this biomaterial to be used as an enzymatic debriding wound dressing. The characterisation of collagenase chitosan nanofibers in terms of measuring apparent Michaelis-Menten constants (K-M(app) and v(max)) revealed a higher enzyme to substrate affinity than with the soluble form of the collagenase. The resulting novel collagenase chitosan nanofibers exhibited excellent operational stability and long shelf life for at least 6 weeks. Therefore, the novel collagenase chitosan nanofibers are expected to be a potential scaffold for wound healing applications, such as e. g. enzymatic debridement.
C1 [Slovakova, Marcela; Srbova, Jana; Dvorakova, Petra; Bilkova, Zuzana] Univ Pardubice, Fac Chem Technol, Dept Biol & Biochem Sci, Pardubice, Czech Republic.
   [Munzarova, Marcela] Nanovia Ltd, Litvinov Chuderin, Czech Republic.
RP Slovakova, M (reprint author), Univ Pardubice, Fac Chem Technol, Dept Biol & Biochem Sci, Pardubice, Czech Republic.
RI Slovakova, Marcela/M-6650-2015
OI Slovakova, Marcela/0000-0002-4975-0983
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7
   Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004
   Korecka L, 2005, J MAGN MAGN MATER, V293, P349, DOI 10.1016/j.jmmm.2005.02.030
   MOZHAEV VV, 1990, BIOCATALYSIS, V3, P179, DOI DOI 10.3109/10242429008992060
   PAYNE W. G., 2008, EPLASTY, V8, P151
   Qu FN, 2013, ACTA BIOMATER, V9, P6393, DOI 10.1016/j.actbio.2013.01.016
   Ramundo J, 2008, J WOUND OSTOMY CONT, V35, P273, DOI 10.1097/01.WON.0000319125.21854.78
   Ramundo J, 2009, J WOUND OSTOMY CONT, V36, pS4, DOI 10.1097/WON.0b013e3181bfdf83
   SLOVAKOVA M, 2015, PROCESS BIO IN PRESS
   SORU E, 1972, ENZYMOLOGIA, V43, P45
   SRBOVA J., 2015, J BIOMEDICAL B UNPUB
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Tallis A, 2013, CLIN THER, V35, P1805, DOI 10.1016/j.clinthera.2013.09.013
   Treethammathurot B, 2008, INT J PHARMACEUT, V357, P252, DOI 10.1016/j.ijpharm.2008.01.016
   WUNSCH E, 1963, H-S Z PHYSIOL CHEM, V333, P149, DOI 10.1515/bchm2.1963.333.1.149
NR 16
TC 0
Z9 0
U1 2
U2 4
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-63-5
PY 2015
BP 435
EP 441
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BE6SM
UT WOS:000374708800077
DA 2018-10-20
ER

PT B
AU Han, C
   Park, S
   Kim, H
AF Han, Changwan
   Park, Seonghun
   Kim, Hanjong
GP ASME
TI DYNAMIC RESPONSE OF POLYVINYL ALCOHOL(PVA)-HYDROGEL WITH DIFFERENT PVA
   CONCENTRATIONS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION, 2014, VOL 14
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE2014)
CY NOV 14-20, 2014
CL Montreal, CANADA
SP ASME
ID H ARTIFICIAL MENISCUS; BOVINE ARTICULAR-CARTILAGE; UNCONFINED
   COMPRESSION; IN-VIVO; HYDROGEL; COMPOSITES
AB Polyvinyl Alcohol-Hydrogel (PVA-H) is a biomaterial used for manufacturing contact lenses as well as for the medium of drug delivery. Previous studies have also showed that PVA-H exhibits superior biocompatibility with hydrophilic elastic nature. The aim of this study is to examine the possible usage of the PVA-H as cartilage replacement material by determining the static and dynamic mechanical properties of PVA-H with different ratios of polyvinyl alcohol (PVA) and phosphate buffered saline (PBS) compositions.
   Three different types of PVA-H specimens were made by changing the ratio of PVA (Sigma-Aldrich) and PBS (Sigma-Aldrich) compositions (PVA-H1: 10 wt% PVA and 90 wt% PBS; PVA-H2: 20 wt% PVA and 80 wt% PBS; PVA-H3: 25 wt% PVA, 45 wt% PBS and DMSO 30 wt%). Static and dynamic tensile tests under the loading frequencies of 0.001, 0.01, 0:1, and 1 Hz were carried out to measure the biomechanical properties of PVA-H1,-H2 within PBS solution and-H3 within PBS/ DMSO solution.
   The equilibrium Young's moduli (EY) of PVA-H1, -H2 and-H3 evaluated from the static displacement control were 84.2 +/- 35.1 kPa (n=10), 254 +/- 32.2 kPa (n=10) and 588 +/- 38.9 kPa (n=5), respectively. The amplitudes of dynamic tensile moduli were varied from 86.3 +/- 33.4 kPa (n=10) at 0.001 Hz to 96.9 +/- 42.0 kPa (n=10) at 1 Hz for PVA-H1, from 282.7 +/- 26.4 kPa (n=10) at 0.001 Hz to 309.1 +/- 32.2 kPa (n=10) at 1 Hz for PVA-H2 and from 643.8 +/- 49.8 kPa (n=10) at 0.001 Hz to 747.7 +/- 67.7 kPa (n=5) at 1 Hz for PVA-H3. According to the current results, the frequency dependence of the magnitude of the dynamic modulus confirms the viscoelastic nature of PVA-H material. However, it can be noted that the dynamic modulus increases by up to a factor of 1.15 for PVA-H1, 1.22 for PVA-H2 and 1.27 for PVA-H3, showing insignificant viscoelasticity compared with that for cartilage. The result that static and dynamic moduli of PVA-H3 are larger than those of PVA-H1 and PVA-H2 also suggests that the amount of PVA composition in PVA-H plays an important role in improving both static and dynamic mechanical strengths of PVA-H material. The phase angle decreased from 5.2 +/- 2.1 degrees at 0.001 Hz to 0.3 +/- 1.7 degrees at 1 Hz for PVA-H1, from 5.6 +/- 0.6 degrees at 0.001 Hz to 0.3 +/- 0.7 degrees at 1 Hz for PVA-H2 and from 8.2 +/- 1.1 degrees at 0.001 Hz to 0.7 +/- 0.7 degrees at 1 Hz for PVA-H3.
C1 [Han, Changwan; Park, Seonghun; Kim, Hanjong] Pusan Natl Univ, Busan, South Korea.
RP Han, C (reprint author), Pusan Natl Univ, Busan, South Korea.
CR Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   CIFKOVA I, 1990, BIOMATERIALS, V11, P393, DOI 10.1016/0142-9612(90)90093-6
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jo SY, 2009, POLYM-KOREA, V33, P551
   Kobayashi M, 2004, BIO-MED MATER ENG, V14, P505
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kobayashi M, 2010, MATERIALS, V3, P2753, DOI 10.3390/ma3042753
   Kroschwitz J I, 1989, POLYM BIOMATERIALS M
   Li F, 2010, ADV MAT RES, V87-88, P188, DOI 10.4028/www.scientific.net/AMR.87-88.188
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Nakashima K, 2005, JSME INT J C-MECH SY, V48, P555, DOI 10.1299/jsmec.48.555
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Park S, 2006, J BIOMECH ENG-T ASME, V128, P623, DOI 10.1115/1.2206201
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silver F., 1989, BIOCOMPATIBILITY INT
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Vrana N. E., P MACCR S WIL ONL LI, P106
   Wu G, 2007, J WUHAN UNIV TECHNOL, V22, P490, DOI 10.1007/s11595-006-3490-7
NR 23
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4963-7
PY 2015
AR V014T11A044
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BE6KR
UT WOS:000374279300080
DA 2018-10-20
ER

PT B
AU Kotoka, R
   Fialkova, S
   Yarmolenko, S
   Pai, D
   Sankar, J
AF Kotoka, Ruben
   Fialkova, Svitlana
   Yarmolenko, Sergey
   Pai, Devdas
   Sankar, Jag
GP ASME
TI Physical and structural properties of pulsed-DC sputtered Al2O3, MgO and
   ZrO2 coating for Mg corrosion control
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION, 2014, VOL 14
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE2014)
CY NOV 14-20, 2014
CL Montreal, CANADA
SP ASME
DE magnetron sputtering; aluminum oxide; magnesium oxide; simulated body
   fluid (SBF); electrochemical impedance spectroscopy (EIS)
ID THIN-FILMS; OXIDE COATINGS; STEEL; MICROSTRUCTURE; PROTECTION; ALLOYS
AB Magnesium has attracted a lot of attention over the last few decades, due to its light weight and potential use as biomaterial. However, the poor corrosion resistance of magnesium restricts its practical use for application where exposure to aggressive aqueous media is unavoidable. This paper describes the growth, characterization and corrosion analyses of Al2O3, MgO and ZrO2 coatings for slowing down the degradation of Mg. Different thicknesses of Al2O3, MgO and ZrO2 were deposited on pure magnesium (99.95%) substrates using pulsed-DC magnetron sputtering process. The phase composition and microstructure analyses were performed using X-ray diffraction (XRD) and scanning electron microscopy (SEM) respectively. The corrosion protection behavior of the Al2O3, MgO and ZrO2 coated samples were evaluated using electrochemical measurements as such open-circuit potential, potentiodynamics and EIS. The corrosion test were performed in 0.9 wt% saline solution. The results showed that the Al2O3-coated Mg alloy exhibit a much superior stability and lower corrosion rate. The surface analyses of the corroded samples showed that the coating improved the corrosion resistance, whereas the bare Mg suffered severe localized corrosion. Adhesion assay was performed on the Al2O3, MgO and ZrO2 coatings to determine their biocompatibility. The results showed significant cell attachment to the coating compare to the control (bare glass).
C1 [Kotoka, Ruben; Fialkova, Svitlana; Yarmolenko, Sergey; Pai, Devdas; Sankar, Jag] North Carolina A&T State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
RP Kotoka, R (reprint author), North Carolina A&T State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27411 USA.
CR Arrabal R, 2008, CORROS SCI, V50, P1744, DOI 10.1016/j.corsci.2008.03.002
   Ben Amor S, 1998, MAT SCI ENG B-SOLID, V57, P28, DOI 10.1016/S0921-5107(98)00205-0
   Cano E, 2010, J SOLID STATE ELECTR, V14, P381, DOI 10.1007/s10008-009-0902-6
   CHINDAUDOM P, 1994, APPL OPTICS, V33, P2664, DOI 10.1364/AO.33.002664
   Creus J, 2000, SURF COAT TECH, V130, P224, DOI 10.1016/S0257-8972(99)00659-3
   Diaz B, 2011, ELECTROCHIM ACTA, V56, P9609, DOI 10.1016/j.electacta.2011.07.104
   Jia JX, 2006, CORROS SCI, V48, P2133, DOI 10.1016/j.corsci.2005.08.013
   Kelly PJ, 1999, J VAC SCI TECHNOL A, V17, P945, DOI 10.1116/1.581669
   Kotoka R., 2012, ASME 2012 INT MECH C
   Kotoka R., P ASME2013 INT MECH
   Lei T, 2010, CORROS SCI, V52, P3504, DOI 10.1016/j.corsci.2010.06.028
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Musil J, 2005, THIN SOLID FILMS, V475, P208, DOI 10.1016/j.tsf.2004.07.041
   Poinern G. E. J., 2012, AM J BIOMEDICAL ENG, P218
   Sarikaya O, 2005, SURF COAT TECH, V190, P388, DOI 10.1016/j.surfcoat.2004.02.007
   Segda BG, 2001, VACUUM, V62, P27, DOI 10.1016/S0042-207X(01)00114-2
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Stippich F, 1998, SURF COAT TECH, V104, P29, DOI 10.1016/S0257-8972(98)00365-X
   Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang E., ACTA BIOMAT IN PRESS
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang WJ, 2004, SURF COAT TECH, V182, P192, DOI 10.1016/j.surfcoat.2003.08.050
NR 24
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4963-7
PY 2015
AR V014T11A017
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BE6KR
UT WOS:000374279300053
DA 2018-10-20
ER

PT J
AU Kim, J
   Wilson, DR
   Zamboni, CG
   Green, JJ
AF Kim, Jayoung
   Wilson, David R.
   Zamboni, Camila G.
   Green, Jordan J.
TI Targeted polymeric nanoparticles for cancer gene therapy
SO JOURNAL OF DRUG TARGETING
LA English
DT Review
DE Cancer therapy; cell-specificity; gene delivery; nanoparticles;
   polymeric biomaterial; promoter; targeting ligands; tissue-specificity
ID NUCLEIC-ACID DELIVERY; HEPATOCELLULAR-CARCINOMA CELLS; MESENCHYMAL
   STEM-CELLS; SMALL INTERFERING RNAS; PLASMID DNA DELIVERY; IN-VIVO;
   BREAST-CANCER; SUICIDE GENE; TRANSGENE EXPRESSION; PROSTATE-CANCER
AB In this article, advances in designing polymeric nanoparticles for targeted cancer gene therapy are reviewed. Characterization and evaluation of biomaterials, targeting ligands, and transcriptional elements are each discussed. Advances in biomaterials have driven improvements to nanoparticle stability and tissue targeting, conjugation of ligands to the surface of polymeric nanoparticles enable binding to specific cancer cells, and the design of transcriptional elements has enabled selective DNA expression specific to the cancer cells. Together, these features have improved the performance of polymeric nanoparticles as targeted non-viral gene delivery vectors to treat cancer. As polymeric nanoparticles can be designed to be biodegradable, non-toxic, and to have reduced immunogenicity and tumorigenicity compared to viral platforms, they have significant potential for clinical use. Results of polymeric gene therapy in clinical trials and future directions for the engineering of nanoparticle systems for targeted cancer gene therapy are also presented.
C1 [Kim, Jayoung; Wilson, David R.; Zamboni, Camila G.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   [Kim, Jayoung; Wilson, David R.; Zamboni, Camila G.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA.
   [Zamboni, Camila G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA.
   [Zamboni, Camila G.] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil.
   [Green, Jordan J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NIH [1R01EB016721]; Samsung; National Science Foundation; CAPES-Brazil
FX This work was supported in part by the NIH (1R01EB016721). For graduate
   fellowship/scholarship support, JK thanks Samsung, DRW thanks the
   National Science Foundation, and CGZ thanks CAPES-Brazil.
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846
   Adryan B, 2007, FLY, V1, P142, DOI 10.4161/fly.4571
   Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083
   Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85
   Alberts B, 2002, MOL BIOL CELL
   Alvarez RD, 2014, GYNECOL ONCOL, V133, P433, DOI 10.1016/j.ygyno.2014.03.571
   Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Anton M, 2005, CANCER GENE THER, V12, P640, DOI 10.1038/sj.cgt.7700829
   Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637
   Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010
   Barh D, 2010, CURR ONCOL, V17, P70
   Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001
   Bayele HK, 2005, J PHARM SCI-US, V94, P446, DOI 10.1002/jps.20230
   Bazzoni F, 2001, CANCER RES, V61, P1050
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   Benoit MA, 2001, J DRUG TARGET, V9, P253, DOI 10.3109/10611860108997934
   Bhang HEC, 2011, NAT MED, V17, P123, DOI 10.1038/nm.2269
   Bhatia S, 2013, DISCOV MED, V15, P309
   Bhatnagar A, 2014, CANCER RES, V74, P5772, DOI 10.1158/0008-5472.CAN-14-0018
   Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Bivas-Benita M, 2004, EUR J PHARM BIOPHARM, V58, P1, DOI 10.1016/j.ejpb.2004.03.008
   Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Boylan NJ, 2012, J CONTROL RELEASE, V157, P72, DOI 10.1016/j.jconrel.2011.08.031
   Buchholz Daniel R, 2012, Methods Mol Biol, V917, P265, DOI 10.1007/978-1-61779-992-1_16
   BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7
   Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1
   Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894
   Carlberg C, 2014, TRANSCRIPTION FACTOR, P55
   Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
   Chen JQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-15
   Chen J, 2009, BIOMACROMOLECULES, V10, P2921, DOI 10.1021/bm900724c
   Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136
   Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Chiu SH, 2004, J CONTROL RELEASE, V97, P357, DOI 10.1016/j.jconrel.2004.03.019
   Choi KY, 2012, BIOMATERIALS, V33, P6186, DOI 10.1016/j.biomaterials.2012.05.029
   Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318
   Cohen JL, 2011, BIOCONJUGATE CHEM, V22, P1056, DOI 10.1021/bc100542r
   Cohen JA, 2010, ADV MATER, V22, P3593, DOI 10.1002/adma.201000307
   Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856
   Crew JP, 2000, BRIT J CANCER, V82, P161
   Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027
   DARVEAU A, 1985, P NATL ACAD SCI USA, V82, P2315, DOI 10.1073/pnas.82.8.2315
   Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101
   DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   DeFatta RJ, 2002, CANCER GENE THER, V9, P573, DOI 10.1038/sj.cgt.7700468
   Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107
   Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931
   Dutta D, 2007, TOXICOL SCI, V100, P303, DOI 10.1093/toxsci/kfm217
   Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636
   Fields RJ, 2012, J CONTROL RELEASE, V164, P41, DOI 10.1016/j.jconrel.2012.09.020
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Francis SM, 2014, MOL THER, V22, P1643, DOI 10.1038/mt.2014.24
   Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229
   Gao P, 2008, CANCER SCI, V99, P2209, DOI 10.1111/j.1349-7006.2008.00941.x
   Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022
   Green JJ, 2007, NANO LETT, V7, P874, DOI 10.1021/nl062395b
   Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6
   Gu JJ, 2012, BIOMATERIALS, V33, P644, DOI 10.1016/j.biomaterials.2011.09.076
   Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
   GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L
   Han SE, 2009, J DRUG TARGET, V17, P123, DOI [10.1080/10611860802472461, 10.1080/10611860802472461 ]
   Hanna N, 2012, CANCER GENE THER, V19, P374, DOI 10.1038/cgt.2012.10
   Harrington KJ, 2000, ADV DRUG DELIVER REV, V44, P167, DOI 10.1016/S0169-409X(00)00093-4
   HARRIS JD, 1994, GENE THER, V1, P170
   Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005
   Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012
   Hayes GM, 2002, CANCER GENE THER, V9, P133, DOI 10.1038/sj.cgt.7700427
   Hedley ML, 1998, NAT MED, V4, P365, DOI 10.1038/nm0398-365
   Hildebrandt IJ, 2003, GENE THER, V10, P758, DOI 10.1038/sj.gt.3301939
   Hsu YY, 1999, J DRUG TARGET, V7, P313, DOI 10.3109/10611869909085514
   Hu BG, 2014, EXP CELL RES, V324, P183, DOI 10.1016/j.yexcr.2014.04.005
   Huang RQ, 2007, FASEB J, V21, P1117, DOI 10.1096/fj.06-7380com
   Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
   Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032
   Jafari M, 2012, CURR MED CHEM, V19, P197, DOI 10.2174/092986712803414141
   Jaggar RT, 1997, HUM GENE THER, V8, P2239, DOI 10.1089/hum.1997.8.18-2239
   Jeong GJ, 2007, J CONTROL RELEASE, V118, P118, DOI 10.1016/j.jconrel.2006.12.009
   Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275
   Kawashita Y, 1999, HUM GENE THER, V10, P1509, DOI 10.1089/10430349950017842
   KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107
   Kevil C, 1995, ONCOGENE, V11, P2339
   Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165
   Kim J, 2014, BIOCONJUGATE CHEM, V25, P43, DOI 10.1021/bc4002322
   Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
   Klutz K, 2011, MOL THER, V19, P676, DOI 10.1038/mt.2010.296
   Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334
   KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x
   Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2
   Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055
   Labhasetwar V, 1998, J PHARM SCI, V87, P1347, DOI 10.1021/js980077+
   Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
   Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103
   Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77
   Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81
   Li JJ, 2013, CHEM COMMUN, V49, P6974, DOI 10.1039/c3cc43576h
   Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035
   Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415
   Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005
   Lunsford L, 2000, J DRUG TARGET, V8, P39, DOI 10.3109/10611860009009208
   MAKAROV SS, 2000, PROG INFLAM RES, P13
   Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623
   Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k
   Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425
   Meric F, 2002, MOL CANCER THER, V1, P971
   Meyer M, 2009, MOL PHARMACEUT, V6, P752, DOI 10.1021/mp9000124
   Minn I, 2014, ADV CANCER RES, V124, P131, DOI 10.1016/B978-0-12-411638-2.00004-5
   MOCHIZUKI H, 1992, MOL CARCINOGEN, V6, P83, DOI 10.1002/mc.2940060203
   Moffatt S, 2006, GENE THER, V13, P761, DOI 10.1038/sj.gt.3302721
   Needham CJ, 2012, BIOMACROMOLECULES, V13, P1429, DOI 10.1021/bm300145q
   Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2
   O'Keefe DS, 2000, PROSTATE, V45, P149
   Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pan CX, 1999, MED HYPOTHESES, V53, P130, DOI 10.1054/mehy.1998.0731
   PANG S, 1995, HUM GENE THER, V6, P1417, DOI 10.1089/hum.1995.6.11-1417
   Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077
   Parr MJ, 1997, NAT MED, V3, P1145, DOI 10.1038/nm1097-1145
   Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423
   Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074
   Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349
   Poon Z, 2011, NANO LETT, V11, P2096, DOI 10.1021/nl200636r
   Prabha S, 2004, MOL PHARMACEUT, V1, P211, DOI 10.1021/mp049970+
   Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326
   Robson T, 2003, J BIOMED BIOTECHNOL, P110, DOI 10.1155/S1110724303209074
   Rojanarata T, 2008, PHARM RES-DORDR, V25, P2807, DOI 10.1007/s11095-008-9648-6
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55
   Sakae M, 2008, BIOMED PHARMACOTHER, V62, P448, DOI 10.1016/j.biopha.2007.12.009
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Sestakova B, 2006, FOLIA BIOL-PRAGUE, V52, P161
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152
   Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215
   Song J, 2004, CANCER RES, V64, P7661, DOI 10.1158/0008-5472.CAN-04-1751
   Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251
   Studeny M, 2002, CANCER RES, V62, P3603
   Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125
   Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102
   Tinsley-Bown AM, 2000, J CONTROL RELEASE, V66, P229, DOI 10.1016/S0168-3659(99)00275-8
   Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011
   Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R
   Tzeng SY, 2013, J BIOMED MATER RES A, V101, P1837, DOI 10.1002/jbm.a.34616
   Urban-Klein B, 2005, GENE THER, V12, P461, DOI 10.1038/sj.gt.3302425
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vilaboa N, 2011, J GENET SYNDR GENE T, V2, P107
   VILE RG, 1993, CANCER RES, V53, P962
   Viola JR, 2010, EXPERT OPIN DRUG DEL, V7, P721, DOI 10.1517/17425241003716810
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   Walczak H, 1999, NAT MED, V5, P157
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang R, 2009, LUNG CANCER, V66, P237, DOI 10.1016/j.lungcan.2009.02.001
   Wang Z, 2011, PHARM RES-DORDR, V28, P2983, DOI 10.1007/s11095-011-0604-5
   Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250
   Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293
   Xiong J, 2012, CANCER-AM CANCER SOC, V118, P536, DOI 10.1002/cncr.26289
   Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y
   Yao YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003601
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   YOKOTA J, 1988, ONCOGENE, V2, P283
   Zarogoulidis P, 2013, J GENET SYNDR GENE T, V4, P1
   Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100
   Zhang C, 2010, BIOMATERIALS, V31, P6075, DOI 10.1016/j.biomaterials.2010.04.042
   Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698
   Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013
   Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395
   Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
NR 188
TC 16
Z9 18
U1 3
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1061-186X
EI 1029-2330
J9 J DRUG TARGET
JI J. Drug Target.
PY 2015
VL 23
IS 7-8
BP 627
EP 641
DI 10.3109/1061186X.2015.1048519
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DK2UF
UT WOS:000374769200007
PM 26061296
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Marycz, K
   Smieszek, A
   Grzesiak, J
   Siudzinska, A
   Maredziak, M
   Donesz-Sikorska, A
   Krzak, J
AF Marycz, Krzysztof
   Smieszek, Agnieszka
   Grzesiak, Jakub
   Siudzinska, Anna
   Maredziak, Monika
   Donesz-Sikorska, Anna
   Krzak, Justyna
TI The Osteogenic Properties of Multipotent Mesenchymal Stromal Cells in
   Cultures on TiO2 Sol-Gel-Derived Biomaterial
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID 316L STAINLESS-STEEL; IN-VITRO; BONE-MARROW; ADIPOSE-TISSUE;
   CORROSION-RESISTANCE; BIOCOMPATIBILITY; PROLIFERATION; EXPRESSION;
   COATINGS; METALS
AB The biocompatibility of the bone implants is a crucial factor determining the successful tissue regeneration. The aim of this work was to compare cellular behavior and osteogenic properties of rat adipose-derived multipotent stromal cells (ASCs) and bone marrow multipotent stromal cells (BMSCs) cultured on metallic substrate covered with TiO2 sol-gel-derived nanolayer. The morphology, proliferation rate, and osteogenic differentiation potential of both ASCs and BMSCs propagated on the biomaterials were examined. The potential for osteogenic differentiation of ASCs and BMSCs was determined based on the presence of specific markers of osteogenesis, that is, alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCL). Additionally, the concentration of calcium and phosphorus in extracellular matrix was determined using energy-dispersive X-ray spectroscopy (SEM-EDX). Obtained results showed that TiO2 layer influenced proliferation activity of ASCs, which manifested by shortening of population doubling time and increase of OPN secretion. However, characteristic features of cells morphology and growth pattern of cultures prompted us to conclude that ultrathin TiO2 layer might also enhance osteodifferentiation of BMSCs. Therefore in our opinion, both populations of MSCs should be used for biological evaluation of biomaterials compatibility, such results may enhance the area of investigations related to regenerative medicine.
C1 [Marycz, Krzysztof; Smieszek, Agnieszka; Grzesiak, Jakub; Siudzinska, Anna; Maredziak, Monika] Univ Environm & Life Sci, Electron Microscopy Lab, PL-50631 Wroclaw, Poland.
   [Marycz, Krzysztof; Smieszek, Agnieszka; Grzesiak, Jakub; Donesz-Sikorska, Anna] Wroclaw Res Ctr EIT, PL-54066 Wroclaw, Poland.
   [Donesz-Sikorska, Anna; Krzak, Justyna] Wroclaw Univ Technol, Inst Mat Sci & Appl Mech, PL-50370 Wroclaw, Poland.
RP Smieszek, A (reprint author), Univ Environm & Life Sci, Electron Microscopy Lab, Kozuchowska 5b, PL-50631 Wroclaw, Poland.
EM smieszek.agnieszka@gmail.com
RI KRZAK, JUSTYNA/G-4511-2015; Smieszek, Agnieszka/A-4887-2017; Marycz,
   Krzysztof/A-2249-2017
OI KRZAK, JUSTYNA/0000-0002-1525-5589; Smieszek,
   Agnieszka/0000-0002-7314-9821; 
FU Wroclaw Research Centre EIT+ under the project "Biotechnologies and
   advanced medical technologies"-BioMed - European Regional Development
   Fund (Operational Programme Innovative Economy)
   [POIG.01.01.02-02-003/08, 1.1.2]; Leading National Research Centre
   "KNOW" (Krajowy Naukowy Osrodek Wiodacy)
FX The research was supported by Wroclaw Research Centre EIT+ under the
   project "Biotechnologies and advanced medical technologies"-BioMed
   (POIG.01.01.02-02-003/08) financed from the European Regional
   Development Fund (Operational Programme Innovative Economy, 1.1.2).
   Additionally, the authors acknowledge the Leading National Research
   Centre "KNOW" (Krajowy Naukowy Osrodek Wiodacy) for covering the
   publication fees.
CR [Anonymous], 2009, TITANIUM MED, V8, P171
   Antunes RA, 2010, SURF COAT TECH, V205, P2074, DOI 10.1016/j.surfcoat.2010.08.101
   Arenas MA, 2011, J MATER SCI-MATER M, V22, P1005, DOI 10.1007/s10856-011-4284-9
   Bamoulid L, 2008, SURF COAT TECH, V202, P5020, DOI 10.1016/j.surfcoat.2008.05.011
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Buhagiar J, 2011, J MATER SCI-MATER M, V22, P1269, DOI 10.1007/s10856-011-4298-3
   Fink T, 2011, STEM CELL RES, V7, P89, DOI 10.1016/j.scr.2011.03.003
   Gallardo J, 2001, J SOL-GEL SCI TECHN, V21, P65, DOI 10.1023/A:1011257516468
   Habazaki H, 2014, J ELECTROCHEM SOC, V161, pC57, DOI 10.1149/2.060401jes
   Hildebrandt C, 2011, TISSUE CELL, V43, P91, DOI 10.1016/j.tice.2010.12.004
   Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2
   Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Lim YW, 2011, CLIN ORTHOP RELAT R, V469, P330, DOI 10.1007/s11999-010-1613-0
   Maredziak M, 2014, IN VITRO CELL DEV-AN, V50, P562, DOI 10.1007/s11626-013-9730-1
   Marycz K., 2014, J NANOMATER, V2014
   Marycz K, 2014, KAFKAS UNIV VET FAK, V20, P201, DOI 10.9775/kvfd.2013.9799
   Marycz K, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065004
   Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Saino E, 2010, TISSUE ENG PT A, V16, P995, DOI [10.1089/ten.tea.2009.0051, 10.1089/ten.TEA.2009.0051]
   Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Smieszek A, 2014, J BIOMATER APPL, V29, P699, DOI 10.1177/0885328214545095
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Wongkhantee S, 2007, J PERIODONTOL, V78, P1113, DOI 10.1902/jop.2007.060433
   Zhou Yi-li, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P13
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 31
TC 7
Z9 9
U1 2
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 651097
DI 10.1155/2015/651097
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CB6CP
UT WOS:000349714800001
PM 25710015
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT B
AU Yuruker, SU
   Arik, M
   Tamdogan, E
   Melikov, R
   Nizamoglu, S
   Press, DA
   Durak, I
AF Yuruker, Sevket Umut
   Arik, Mehmet
   Tamdogan, Enes
   Melikov, Rustamjon
   Nizamoglu, Sedat
   Press, Daniel Aaron
   Durak, Ilkem
GP ASME
TI THERMAL AND OPTICAL PERFORMANCE OF ECO-FRIENDLY SILK FIBROIN PROTEINS AS
   A CAVITY ENCAPSULATION OVER LED SYSTEMS
SO INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND
   INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2015, VOL 3
LA English
DT Proceedings Paper
CT ASME International Technical Conference and Exhibition on Packaging and
   Integration of Electronic and Photonic Microsystems (InterPACK)
CY JUL 06-09, 2015
CL San Francisco, CA
SP ASME
DE LED efficiency; thermal conductivity; LED encapsulation; silk fibroin;
   optical performance; CFD
AB The demand for high power LEDs for illumination applications is increasing. LED package encapsulation is one of most critical materials that affect the optical path of the generated light by LEDs, and may result in lumen degradation. A typical encapsulation material is a mixture of phosphor and a polymer based binder such as silicone. After LED chips are placed at the base of a cavity, phosphor particles are mixed with silicone and carefully placed into the cavity. One of the important technical challenges is to ensure a better thermal conductivity than 0.2 W/m-K of current materials for most of the traditional polymers in SSL applications.
   In this study, we investigated an unconventional material of the silk fibroin proteins for LED applications, and showed that this biomaterial provides thermal advantages leading to an order of magnitude higher thermal performance than conventional silicones. Silk fibroin is a natural protein and directly extracted from silk cocoons produced by Bombyx mori silkworm. Therefore, it presents a "green" material for photonic applications with its superior properties of biocompatibility and high optical transparency with a minimal absorption. Combining these properties with high thermal performance makes this biomaterial promising for future LED applications.
   An experimental and computational study to understand the optical and thermal performance is performed. A computational fluid dynamics study with a commercial CFD software was performed and an experimental set-up was developed to validate the computational findings to determine the thermal conductivity of the proposed material.
C1 [Yuruker, Sevket Umut; Arik, Mehmet; Tamdogan, Enes; Durak, Ilkem] Ozyegin Univ, Sch Engn, Istanbul, Turkey.
   [Melikov, Rustamjon; Nizamoglu, Sedat; Press, Daniel Aaron] Koc Univ, Sch Engn, Istanbul, Turkey.
RP Yuruker, SU (reprint author), Ozyegin Univ, Sch Engn, Istanbul, Turkey.
RI Nizamoglu, Sedat/H-5845-2018
OI Nizamoglu, Sedat/0000-0003-0394-5790
CR [Anonymous], 2009, THEOR GUID
   Arik M., 2010, ITHERM 2010
   ARIK M, 2006, J ELECTRON PACKAGING, P328
   Arik M., 2014, THERM THERM PHEN EL
   Arik M., 2004, ADV PACKAGING IEEE T
   Garg J., 2004, 9 INT C THERM THERM
   Philips News Center, TECHN LEDS
   Royce C., 2008, ASME JSME THERM ENG
   Tamdogan E., 2013, ASME INTERPACK 2013
NR 9
TC 0
Z9 0
U1 1
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5690-1
PY 2015
AR V003T04A015
PG 7
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BE5WD
UT WOS:000373517400021
DA 2018-10-20
ER

PT J
AU Kostic, MM
   Slipper, IJ
   Antonijevic, MD
   Mitrovic, JZ
   Radovic, MD
   Bojic, DV
   Bojic, AL
AF Kostic, M. M.
   Slipper, I. J.
   Antonijevic, M. D.
   Mitrovic, J. Z.
   Radovic, M. D.
   Bojic, D. V.
   Bojic, A. L.
TI PREPARATION AND CHARACTERISATION OF XANTHATED Lagenaria vulgaris SHELL
   BIOSORBENT
SO OXIDATION COMMUNICATIONS
LA English
DT Article
DE copper(II); kinetics; sorption; thermodynamics; xanthated biomaterial
ID HEAVY-METAL IONS; AQUEOUS-SOLUTIONS; EQUILIBRIUM SORPTION; BIOSORPTION;
   ADSORPTION; REMOVAL; WATER; ULTRAFILTRATION; PARAMETERS; INDUSTRIAL
AB Preparation and characterisation of chemically modified, improved biosorbent, xanthated Lagenaria vulgaris shell (xLVB), and its application for Cu(II) ions removal from aqueous solutions, were investigated in the present study. The chemically modified material was characterised by using FTIR, SEM and EDX analysis. Equilibrium isotherms and kinetics were obtained and the effect of various parameters including contact time, initial pH, biosorbent dosage, particle size, temperature, initial Cu(II) concentration was studied under batch conditions. xLVB was applied to test the sorption of Cu(II) ions in batch column system with recirculation of aqueous phase. The experimental data were best fitted by using pseudo-second order kinetics and the Langmuir isotherm model; equilibrium within less than 40 min and sorption capacity of 25.2 mg g(-1) for Cu(II) ions, at 20 degrees C were achieved. With increasing temperature from 10 to 40 degrees C the free energy change was negative, suggesting that the biosorption was exothermic and spontaneous.
C1 [Kostic, M. M.; Antonijevic, M. D.; Mitrovic, J. Z.; Radovic, M. D.; Bojic, D. V.; Bojic, A. L.] Univ Nis, Fac Sci & Math, Dept Chem, 33 Visegradska St, Nish 18000, Serbia.
   [Slipper, I. J.] Univ Greenwich, Fac Sci & Engn, Sch Sci, Chatham ME4 4TB, Kent, England.
RP Kostic, MM (reprint author), Univ Nis, Fac Sci & Math, Dept Chem, 33 Visegradska St, Nish 18000, Serbia.
EM mk484475@gmail.com
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [TR34008]
FX The authors would like to acknowledge the Ministry of Education, Science
   and Technological Development of the Republic of Serbia (Grant No
   TR34008) for financial support.
CR Al-Rub FAA, 2006, PROCESS BIOCHEM, V41, P457, DOI 10.1016/j.procbio.2005.07.018
   Alok A, 2010, OXID COMMUN, V33, P583
   BASHYAL D., 2010, J NEPAL CHEM SOC, V26, P53
   Bjelajac Z, 2012, OXID COMMUN, V35, P1056
   Brady JM, 1999, J CHEM TECHNOL BIOT, V74, P71, DOI 10.1002/(SICI)1097-4660(199901)74:1<71::AID-JCTB985>3.0.CO;2-8
   Canizares P, 2005, J MEMBRANE SCI, V253, P149, DOI 10.1016/j.memsci.2004.12.042
   Dash Surya Narayan, 2010, International Journal of Environmental Sciences, V1, P296
   Decker-Walters DS, 2004, ECON BOT, V58, P501, DOI 10.1663/0013-0001(2004)058[0501:DAGAOW]2.0.CO;2
   Feng D, 2000, MINER ENG, V13, P623, DOI 10.1016/S0892-6875(00)00045-5
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Horsfall M, 2005, ACTA CHIM SLOV, V52, P174
   HOSSAIN M.A., 2012, J WATER SUSTAINABILI, V2, P87
   Huang YH, 2007, J HAZARD MATER, V144, P406, DOI 10.1016/j.jhazmat.2006.10.061
   Khan MN, 2007, J HAZARD MATER, V141, P237, DOI 10.1016/j.jhazmat.2006.06.119
   Kumar KV, 2007, J HAZARD MATER, V146, P214, DOI 10.1016/j.jhazmat.2006.12.010
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li FT, 2007, CHINESE CHEM LETT, V18, P325, DOI 10.1016/j.cclet.2007.01.034
   Marder L, 2003, J BRAZIL CHEM SOC, V14, P610, DOI 10.1590/S0103-50532003000400018
   Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110
   NORHAFIZAH BINTI A., 2011, ASIAN T ENG, V1, P49
   Ofomaja AE, 2010, BIORESOURCE TECHNOL, V101, P5868, DOI 10.1016/j.biortech.2010.03.033
   Ozaki H, 2002, DESALINATION, V144, P287, DOI 10.1016/S0011-9164(02)00329-6
   Ozer A, 2004, PROCESS BIOCHEM, V39, P2183, DOI 10.1016/j.procbio.2003.11.008
   Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032
   Rehman R, 2011, J CHEM SOC PAKISTAN, V33, P515
   Stancheva KA, 2011, OXID COMMUN, V34, P792
   STANKOVIC M., 2012, AUST J CHEM, V66, P227
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Trivunac K, 2006, CHEMOSPHERE, V64, P486, DOI 10.1016/j.chemosphere.2005.11.073
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yao ZY, 2010, J HAZARD MATER, V174, P137, DOI 10.1016/j.jhazmat.2009.09.027
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SCIBULCOM LTD
PI SOFIA
PA PO BOX 249, 1113 SOFIA, BULGARIA
SN 0209-4541
J9 OXID COMMUN
JI Oxid. Commun.
PY 2015
VL 38
IS 4A
SI SI
BP 2173
EP 2188
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA DI1IR
UT WOS:000373250300021
DA 2018-10-20
ER

PT S
AU Barrias, CC
AF Barrias, Cristina C.
GP IEEE
TI Bioengineered cell-instructive 3D matrices as vehicles for cellular
   therapies
SO 2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 37th Annual International Conference of the IEEE Engineering in Medicine
   and Biology Society (EMBC)
CY AUG 25-29, 2015
CL Milan, ITALY
ID SYNTHETIC EXTRACELLULAR-MATRIX; SENSITIVE ALGINATE HYDROGELS;
   MESENCHYMAL STEM-CELLS; BIOMEDICAL APPLICATIONS; DELIVERY;
   IMMOBILIZATION; FATE
AB The delivery of cells, namely of stem cells, from biomaterial-based vehicles has been used to promote and accelerate functional tissue regeneration. Carrier materials can transport and localize cells into target sites, increase their survival and engraftment, and provide a supportive matrix to assist cellular assembly into a newly formed tissue. Hydrogels are amongst the most widely used carrier materials, as they can entrap and protect cells within a real three-dimensional (3D) microenvironment, and intrinsically present many structural properties of the natural extracellular matrix (ECM). To recreate important features of the native ECM, hydrogels may be bio-functionalized with specific cell-instructive moieties for improved biomimetic properties. The biophysical properties of hydrogels can also be tuned, increasing their versatility, as it is currently recognized that stem cells respond to their biomechanical environment. Here, an overview of some strategies commonly employed in the preparation of biomimetic matrices is presented, using alginate as a model hydrogel.
C1 [Barrias, Cristina C.] Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
RP Barrias, CC (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM ccbarrias@ineb.up.pt
OI Barrias, Cristina/0000-0002-8178-6134
CR Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fonseca KB, 2014, PROG POLYM SCI, V39, P2010, DOI 10.1016/j.progpolymsci.2014.07.003
   Fonseca KB, 2014, BIOMACROMOLECULES, V15, P380, DOI 10.1021/bm4016495
   Fonseca KB, 2013, SOFT MATTER, V9, P3283, DOI 10.1039/c3sm27560d
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Maia FR, 2014, J CONTROL RELEASE, V189, P158, DOI 10.1016/j.jconrel.2014.06.030
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Martin I, 2015, TISSUE ENG PT A, V21, P1, DOI [10.1089/ten.tea.2014.0515, 10.1089/ten.TEA.2014.0515]
   Neves SC, 2015, J MATER CHEM B, V3, P2096, DOI 10.1039/c4tb00885e
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
NR 21
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-9270-1
J9 IEEE ENG MED BIO
PY 2015
BP 1737
EP 1740
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE4HD
UT WOS:000371717202007
PM 26736613
DA 2018-10-20
ER

PT S
AU Neuta, PA
   Rojas, DM
   Agredo, W
   Gutierrez, JO
AF Neuta, P. A.
   Rojas, D. M.
   Agredo, W.
   Gutierrez, J. O.
GP IEEE
TI Evaluation of the Repairing Effect of Collagen Type I and MaxGel on the
   Infarcted Myocardium in an Animal Model
SO 2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 37th Annual International Conference of the IEEE Engineering in Medicine
   and Biology Society (EMBC)
CY AUG 25-29, 2015
CL Milan, ITALY
AB Nowadays and in spite of all the preventive effort made, cardiovascular diseases remain as one of the leading causes of death worldwide. Current treatments decrease the progression of the disease but fail to offer a solution where the contractile function lost due to the injury can be recovered. In response to this, regenerative medicine proposes new approaches and one of this is the use of biomaterials that can mimic the role of the extracellular matrix and provide support for new cells in the affected heart. This study evaluated the repairing effect of collagen type I and MaxGel when injected, alone or combined, into the infarcted heart of Wistar rats. Cardiac function was quantified using the ejection fraction as the main parameter and it was measured in three time points during the study: pre-infarction, post-infarction, and post-treatment. Additionally, histological samples of the hearts were taken for evaluation. The data obtained showed a marked recovery of the cardiac function in the animals were collagen type I was injected with an increase of 8.2% on the mean ejection fraction, suggesting that this biomaterial has the capacity to stop the progressive decline of the cardiac function in an infarcted heart.
C1 [Neuta, P. A.; Rojas, D. M.; Agredo, W.] Univ Autonoma Occidente, G Bio Res Grp, Cali, Colombia.
   [Gutierrez, J. O.] Univ Valle, Pharmacol Res Grp, Cali, Colombia.
RP Neuta, PA (reprint author), Univ Autonoma Occidente, G Bio Res Grp, Cali, Colombia.
EM paneuta@uao.edu.co; dianamarcela.rojasgonzalez@ugent.be
CR Booloki M., 2010, ACUTE MYOCARDIAL INF
   Collins SD, 2007, CARDIOVASC REVASCULA, V8, P43, DOI 10.1016/j.carrev.2006.11.005
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dimarakis I., 2006, J CARDIOTHORACIC REN, V1, P108
   George J., 2010, J LAB CLIN MED, V155, P10
   Ivernici G., EXPT CELL RES, V314, P366
   Jackson K., 2004, STEM CELLS HDB, P259
   Martin-Rendon E., 2009, STEM CELL TREATMENT, P1
   Pan-American Health Organization, 2010, HLTH AM, P10
   Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003
   World Health Organization, 2014, 10 LEAD CAUS DEATH W
   World Health Organization, 2015, CARD DIS CVDS
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-9270-1
J9 IEEE ENG MED BIO
PY 2015
BP 3529
EP 3532
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE4HD
UT WOS:000371717203201
PM 26737054
DA 2018-10-20
ER

PT S
AU Anindyajati, A
   Boughton, P
   Ruys, A
AF Anindyajati, Adhi
   Boughton, Philip
   Ruys, Andrew
BE Guojian, C
   Muhammad, Y
TI The Effect of Rotating Collector Design on Tensile Properties and
   Morphology of Electrospun Polycaprolactone Fibres
SO 2015 4TH INTERNATIONAL CONFERENCE ON ENGINEERING AND INNOVATIVE
   MATERIALS (ICEIM 2015)
SE MATEC Web of Conferences
LA English
DT Proceedings Paper
CT 4th International Conference on Engineering and Innovative Materials
   (ICEIM)
CY SEP 03-04, 2015
CL Penang, MALAYSIA
SP Int Acad Comp Technol, UKM Malaysia
ID HUMAN ACETABULAR LABRUM; INDUCED ORIENTATION; POLYMER NANOFIBERS;
   SCAFFOLDS; FIBROCARTILAGE; ALIGNMENT
AB Electrospinning is a technique that can produce fibres in the nanoscale range. This process is useful for many applications, including fabrication of fibrous scaffolds for fibrocartilage tissue engineering. For this application, cell attachment and tissue development is influenced by fibre morphology and mechanical properties. This electrospinning study investigated the influence of rotating collector design on morphology and mechanical properties of electrospun polycaprolactone fibre. The experiment employed 4 mandrel designs: 1) full surface of aluminium; 2) with gap feature; 3) with gap feature and teflon support; 4) with gap feature and tape support. The highest elastic modulus was obtained from mandrel with gap and tape support, which was 24.6 MPa and significantly higher compared to fibres acquired from other collector designs. Fibre diameter attained was identical across the different collectors, ranging from 0.5 - 2 mu m. Gap introduction showed enhanced alignment in the resultant fibre. It can be concluded that fibre alignment and tensile properties can be improved by simply modifying the collector design. This improved fibre mat can be developed as a biomaterial for fibrocartilage tissue engineering scaffolds.
C1 [Anindyajati, Adhi; Boughton, Philip; Ruys, Andrew] Univ Sydney, Sydney, NSW 2006, Australia.
RP Anindyajati, A (reprint author), Univ Sydney, Sydney, NSW 2006, Australia.
EM aani2456@uni.sydney.edu.au; philip.boughton@sydney.edu.au;
   andrew.ruys@sydney.edu.au
RI Boughton, Philip/N-8359-2016
OI Boughton, Philip/0000-0003-4318-8966
CR Badrossamay MR, 2010, NANO LETT, V10, P2257, DOI 10.1021/nl101355x
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x
   BENJAMIN M, 1990, J ANAT, V171, P1
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Dalton PD, 2005, POLYMER, V46, P611, DOI 10.1016/j.polymer.2004.11.075
   Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Ishiko T, 2005, J ORTHOP RES, V23, P1448, DOI 10.1016/j.orthres.2004.08.025
   Kakade MV, 2007, J AM CHEM SOC, V129, P2777, DOI 10.1021/ja065043f
   Katta P, 2004, NANO LETT, V4, P2215, DOI 10.1021/nl0486158
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Kongkhlang T, 2008, J AM CHEM SOC, V130, P15460, DOI 10.1021/ja804185s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Liao C.-C., 2011, POLYMER, V52, P4303
   Liao CC, 2011, POLYMER, V52, P2263, DOI 10.1016/j.polymer.2011.03.018
   Liao CC, 2011, EUR POLYM J, V47, P911, DOI 10.1016/j.eurpolymj.2011.01.006
   Nerurkar N. L., 2011, BIOMATERIALS, V32, P461
   Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414
   Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P283, DOI 10.1007/s00402-003-0527-7
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Seldes RM, 2001, CLIN ORTHOP RELAT R, P232
   Smith CD, 2009, BRIT J SPORT MED, V43, P574, DOI 10.1136/bjsm.2008.053645
   Sundaray B, 2004, APPL PHYS LETT, V84, P1222, DOI 10.1063/1.1647685
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 32
TC 1
Z9 1
U1 1
U2 7
PU E D P SCIENCES
PI CEDEX A
PA 17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A,
   FRANCE
SN 2261-236X
J9 MATEC WEB CONF
PY 2015
VL 27
AR 02002
DI 10.1051/matecconf/20152702002
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BE5BH
UT WOS:000372507600013
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Kaur, K
   Singh, KJ
   Anand, V
   Kaur, H
   Arora, DS
AF Kaur, Kulwinder
   Singh, K. J.
   Anand, Vikas
   Kaur, Harpreet
   Arora, Daljit Singh
BE Sinha, MM
   Verma, SS
TI In-Vitro Study of Copper Doped SiO2-CaO-P2O5 System for Bioactivity and
   Antimicrobial Properties
SO ADVANCED MATERIALS AND RADIATION PHYSICS (AMRP-2015)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 4th National Conference on Advanced Materials and Radiation Physics
   (AMRP)
CY MAR 13-14, 2015
CL S L I E T, Dept Phys, Longowal, INDIA
SP S L I E T, TEQIP II Project, Dept Sci & Technol
HO S L I E T, Dept Phys
DE Biomaterials; Hydroxylapatite; Antimicrobial Properties
ID GLASS-CERAMIC NANOPARTICLES; SOL-GEL; SCAFFOLDS
AB Samples of the xCuO-(45-x) CaO-10P(2)O(5)-45SiO(2) system (x varies from 0 to 4 mole%) have been synthesized for application as biomaterials to slow or inhibit the growth of living organisms (fungi and other pathogenic microorganisms) by the combination of sol-gel and co-precipitation processes. Prepared samples have been characterized by X-Ray Diffraction, Fourier Transform Infra-Red and Field Emission Scanning Electron Microscopy techniques before and after immersion in simulated body fluid. Antimicrobial activity of samples has been investigated against Staphylococcus aureus. Releasing of Cu2+ and other ions in the simulated body fluid has been determined by Atomic Absorption Spectroscopy to ensure the use of prepared material as biomaterial with good antibacterial properties.
C1 [Kaur, Kulwinder; Singh, K. J.; Anand, Vikas] Guru Nanak Dev Univ, Dept Phys, Amritsar 143005, Punjab, India.
   [Kaur, Harpreet; Arora, Daljit Singh] Guru Nanak Dev Univ, Dept Microbiol, Amritsar 143005, Punjab, India.
RP Singh, KJ (reprint author), Guru Nanak Dev Univ, Dept Phys, Amritsar 143005, Punjab, India.
EM kanwarjitsingh@yahoo.com
CR Anand V, 2014, J NON-CRYST SOLIDS, V406, P88, DOI 10.1016/j.jnoncrysol.2014.09.050
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Hoppe A, 2013, J MATER CHEM B, V1, P5659, DOI 10.1039/c3tb21007c
   Hoppe A, 2013, BIOMATER SCI-UK, V1, P254, DOI 10.1039/c2bm00116k
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Stahli C, 2014, ACTA BIOMATER, V10, P3317, DOI 10.1016/j.actbio.2014.03.015
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Xia W, 2007, MATER LETT, V61, P3251, DOI 10.1016/j.matlet.2006.11.048
   Zhao S., 2015, ACTA BIOMATERIALIA
NR 12
TC 1
Z9 1
U1 1
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1322-1
J9 AIP CONF PROC
PY 2015
VL 1675
AR 020020
DI 10.1063/1.4929178
PG 4
WC Physics, Applied; Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA BE4GI
UT WOS:000371686800020
DA 2018-10-20
ER

PT S
AU Guarino, V
   Altobelli, R
   Cirillo, V
   Ambrosio, L
AF Guarino, Vincenzo
   Altobelli, Rosaria
   Cirillo, Valentina
   Ambrosio, Luigi
BE Pantani, R
   DeSantis, F
   Speranza, V
TI Electro Fluido Dynamic Techniques To Design Instructive Biomaterials For
   Tissue Engineering and Drug Delivery
SO POLYMER PROCESSING WITH RESULTING MORPHOLOGY AND PROPERTIES: FEET IN THE
   PRESENT AND EYES AT THE FUTURE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT GT70 International Conference
CY OCT 15-17, 2015
CL Salerno, ITALY
ID ALGINATE MICROSPHERES; REGENERATION; FIBERS; MINERALIZATION;
   NANOTECHNOLOGY; NANOPARTICLES; ENCAPSULATION; NANOFIBERS; STRATEGIES;
   PLATFORMS
AB A large variety of processes and tools is continuously investigated to discover new solutions to design instructive materials with controlled chemical, physical and biological properties for tissue engineering and drug delivery. Among them, electro fluido dynamic techniques (EFDTs) are emerging as an interesting strategy, based on highly flexible and low-cost processes, to revisit old biomaterial's manufacturing approach by utilizing electrostatic forces as the driving force for the fabrication of 3D architectures with controlled physical and chemical functionalities to guide in vitro and in vivo cell activities. By a rational selection of polymer solution properties and process conditions, EFDTs allow to produce fibres and/or particles at micro and/or nanometric size scale which may be variously assembled by tailored experimental setups, thus giving the chance to generate a plethora of different 3D devices able to incorporate biopolymers (i.e., proteins, polysaccharides) or active molecules (e.g., drugs) for different applications. Here, we focus on the optimization of basic EFDTs-namely electrospinning, electrospraying and electrodynamic atomization - to develop active platforms (i.e., monocomponent, protein and drug loaded scaffolds and mu-scaffolds) made of synthetic (PCL, PLGA) or natural (chitosan, alginate) polymers. In particular, we investigate how to set materials and process parameters to impart specific morphological, biochemical or physical cues to trigger all the fundamental cell-biomaterial and cell-cell cross-talking elicited during regenerative processes, in order to reproduce the complex microenvironment of native or pathological tissues.
C1 [Guarino, Vincenzo; Altobelli, Rosaria; Cirillo, Valentina; Ambrosio, Luigi] Natl Res Council Italy, Dept Chem Sci & Mat Technol, Inst Polymers Composites & Biomat, Vle Kennedy 54, Naples, Italy.
RP Guarino, V (reprint author), Natl Res Council Italy, Dept Chem Sci & Mat Technol, Inst Polymers Composites & Biomat, Vle Kennedy 54, Naples, Italy.
EM vguarino@unina.it
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Guarino,
   Vincenzo/0000-0003-1546-3721
CR Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Bock N, 2012, PROG POLYM SCI, V37, P1510, DOI 10.1016/j.progpolymsci.2012.03.002
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Cirillo V, 2014, J MATER SCI-MATER M, V25, P2323, DOI 10.1007/s10856-014-5214-4
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Gu Z, 2013, ACS NANO, V7, P6758, DOI 10.1021/nn401617u
   Guaccio A, 2011, BIOTECHNOL BIOENG, V108, P1965, DOI 10.1002/bit.23113
   Guarino V, 2012, INT MATER REV, V57, P256, DOI 10.1179/0950660812Z.00000000021
   Guarino V., 2009, Patent No. [WO 2009143947, 2009143947]
   Guarino V., MAT BIOCOMPATIBILI M
   Guarino V, 2015, EXPERT REV MED DEVIC, V12, P113, DOI 10.1586/17434440.2014.953058
   Guarino V, 2013, MACROMOL SYMP, V331, P65, DOI 10.1002/masy.201300074
   Guarino V, 2012, J APPL BIOMATER FUNC, V10, P191, DOI 10.5301/JABFM.2012.10369
   Guarino V, 2011, MACROMOL BIOSCI, V11, P1694, DOI 10.1002/mabi.201100204
   Huang I.Y., 2012, J MATER SCI, V47, P1372
   Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Khodir WKWA, 2013, J BIOACT COMPAT POL, V28, P258, DOI 10.1177/0883911513481133
   Mayol L, 2014, J MATER SCI-MATER M, V25, P383, DOI 10.1007/s10856-013-5080-5
   Midhun BT, 2011, J BIOMAT SCI-POLYM E, V22, P2431, DOI 10.1163/092050610X540486
   Nie HM, 2010, J BIOMED MATER RES A, V95A, P709, DOI 10.1002/jbm.a.32867
   Perez MAA, 2012, J BIOMED MATER RES A, V100A, P3008, DOI 10.1002/jbm.a.34233
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Salata OV, 2005, CURR NANOSCI, V1, P25, DOI 10.2174/1573413052953192
   Xie JW, 2007, J COLLOID INTERF SCI, V312, P247, DOI 10.1016/j.jcis.2007.04.023
   Zamani M., 2013, INT J NANOMED, V13, P4656
NR 29
TC 2
Z9 2
U1 1
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1342-9
J9 AIP CONF PROC
PY 2015
VL 1695
AR 020004
DI 10.1063/1.4937282
PG 5
WC Physics, Applied; Polymer Science
SC Physics; Polymer Science
GA BE4DP
UT WOS:000371592000004
DA 2018-10-20
ER

PT J
AU Peter, I
   Rosso, M
AF Peter, Ildiko
   Rosso, Mario
TI Study of Ti-Enriched CoCrMo Alloy for Dental Application
SO IEEE ACCESS
LA English
DT Article
DE Metallic materials; CoCrMo alloy; microstructure; residual stress;
   biomedical application
ID METAL-ION RELEASE; POROUS TANTALUM BIOMATERIAL; AUSTENITIC
   STAINLESS-STEELS; ZR-NB ALLOYS; MECHANICAL-PROPERTIES; CORROSION
   BEHAVIOR; IN-VITRO; MAGNESIUM ALLOYS; BONE INGROWTH; IMPLANTS
AB Metallic materials can be considered to be in a peculiar position for production of medical devices, because of their attractive properties. In this paper, a new enriched Co-based composition is proposed for dental application, starting from a conventional CoCrMo alloy. Macrostructural and microstructural investigations, mechanical and corrosion resistance evaluation, and metal ions release are carried out. The best composition, among the studied alloys, is identified for dental purpose.
C1 [Peter, Ildiko; Rosso, Mario] Politecn Torino, Dept Appl Sci & Technol, Inst Sci & Engn Mat Innovat Technol, I-10129 Turin, Italy.
RP Peter, I (reprint author), Politecn Torino, Dept Appl Sci & Technol, Inst Sci & Engn Mat Innovat Technol, I-10129 Turin, Italy.
EM ildiko.peter@polito.it
CR [Anonymous], 2001, F7507 ASTM
   [Anonymous], 1999, IARC MON EV CARC RIS, V74, P65
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Ashby M F, 1980, ENG MAT
   Bal W, 2000, J INORG BIOCHEM, V79, P213, DOI 10.1016/S0162-0134(99)00169-5
   Bannon B. P., 1981, TITANIUM ALLOYS SURG, P7
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Blackburn M. J., 1967, PHASE TRANSFORMATION, V239, P1200
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cobb AG, 2006, P I MECH ENG H, V220, P385, DOI 10.1243/09544119JEIM78
   Collings E. W., 1984, PHYS METALLURGY TITA, P321
   Czerwinski F, 2011, MAGNESIUM ALLOYS - CORROSION AND SURFACE TREATMENTS, pIX
   Davis J. R., 2003, HDB MAT MED DEVICES
   DEPALMA VA, 1972, J BIOMED MATER RES, V6, P37, DOI 10.1002/jbm.820060406
   Eftekhari A, 2003, APPL SURF SCI, V220, P343, DOI 10.1016/S0169-4332(03)00842-0
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fischer A, 2012, J MECH BEHAV BIOMED, V9, P50, DOI 10.1016/j.jmbbm.2012.01.007
   Gil FJ, 2001, J ALLOY COMPD, V329, P142, DOI 10.1016/S0925-8388(01)01571-7
   Gomez M, 1997, J BIOMED MATER RES, V34, P157, DOI 10.1002/(SICI)1097-4636(199702)34:2<157::AID-JBM3>3.0.CO;2-P
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kajzer W., 2008, J ACHIEVEMENTS MAT M, V26, P131
   Karaali A, 2005, MAT SCI ENG A-STRUCT, V390, P255, DOI 10.1016/j.msea.2004.08.001
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kondo R, 2011, ACTA BIOMATER, V7, P4278, DOI 10.1016/j.actbio.2011.07.020
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Lin HY, 2008, DENT MATER, V24, P378, DOI 10.1016/j.dental.2007.06.010
   Lin JH, 2007, J MATER PROCESS TECH, V192, P97, DOI 10.1016/j.jmatprotec.2007.04.068
   Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]
   Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Matkovic T, 2006, J ALLOY COMPD, V407, P294, DOI 10.1016/j.jallcom.2005.06.025
   Morais LS, 2007, ACTA BIOMATER, V3, P331, DOI 10.1016/j.actbio.2006.10.010
   Nomura N, 2009, MATER TRANS, V50, P2466, DOI 10.2320/matertrans.M2009187
   Park J. B., 2000, BIOMEDICAL ENG HDB, V1
   Peter Ildiko, 2014, Materials Science Forum, V790-791, P235, DOI 10.4028/www.scientific.net/MSF.790-791.235
   PETER I., 2013, ARCH MAT SCI ENG, V61, P62
   Pilliar R., 1999, COBALT BASE ALLOYS B, V432
   Pilliar RM, 2009, BIOMEDICAL MATERIALS, P41, DOI 10.1007/978-0-387-84872-3_2
   Podrez-Radziszewska M., 2010, ARCH FOUNDRY ENG, V10, P51
   Polmear I. J., 1981, LIGHT METALS METALLU, P239
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Sedriks AJ., 1996, CORROSION STAINLESS
   Semlitsch M. F., 1981, TITANIUM ALLOYS SURG, P120
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Takazawa Kenji, 2003, J Artif Organs, V6, P71, DOI 10.1007/s100470300011
   Talha M, 2014, B MATER SCI, V37, P1321, DOI 10.1007/s12034-014-0078-2
   Tandon R, 1999, AM SOC TEST MATER, V1365, P3, DOI 10.1520/STP14259S
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Tulinski M, 2012, APPL SURF SCI, V260, P80, DOI 10.1016/j.apsusc.2012.07.071
   Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Withers PJ, 2001, MATER SCI TECH-LOND, V17, P355, DOI 10.1179/026708301101509980
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yamanaka K, 2011, MAT SCI ENG A-STRUCT, V528, P5961, DOI 10.1016/j.msea.2011.04.027
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Zangeneh S, 2010, MAT SCI ENG A-STRUCT, V527, P6494, DOI 10.1016/j.msea.2010.06.081
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 75
TC 5
Z9 5
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2015
VL 3
BP 73
EP 80
DI 10.1109/ACCESS.2015.2398312
PG 8
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA DF5JP
UT WOS:000371388200005
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Bertucci, CP
   Ramamoorthy, S
   Karande, PJ
   Thompson, DM
AF Bertucci, C. P.
   Ramamoorthy, S.
   Karande, P. J.
   Thompson, D. M.
GP IEEE
TI 3D High Throughput Assays for Combinatorial Screening of Biomaterials
   for Tissue Regeneration
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
DE high throughput; 3D cell culture; combinatorial screening; neural tissue
   engineering; extracellular matrix; biomaterials
AB Tissue engineered strategies suffer from a lack of complexity, which manifests itself as unsatisfactory functional recovery in clinical applications. Better understanding of cell response to complex combinations of matrix proteins and growth factors mediating regeneration is necessary for increased biomaterial performance. A high throughput 3D multiplex assay has been designed for evaluating cell behavior in response to differential composite biomaterials. Specifically, Schwann cell (SC) and neuronal viability, death, and morphology were measured in response to varying collagen (COL) hydrogel concentration (1-3 mg/mL) and Matrigel T (MAT) concentration (0-100% v/v). SCs were sensitive to differences in MAT and relatively insensitive to COL differences within this range, whereas neurons were sensitive to changes in both MAT and COL concentration. This strategy is capable of rapidly identifying large differences in cell behavior within combinatorial biomaterials, demonstrating its utility for narrowing large experimental libraries to optimal multifunctional composite materials.
C1 [Bertucci, C. P.; Thompson, D. M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Ramamoorthy, S.; Karande, P. J.] Rensselaer Polytech Inst, Dept Chem Engn, Troy, NY 12180 USA.
RP Bertucci, CP (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM Thompd4@rpi.edu
CR Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dumont CM, 2014, TISSUE ENG PART C-ME, V20, P620, DOI [10.1089/ten.tec.2013.0362, 10.1089/ten.TEC.2013.0362]
   Ide C, 1996, NEUROSCI RES, V25, P101
NR 3
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700022
DA 2018-10-20
ER

PT S
AU Ersumo, NT
   Spitler, KL
AF Ersumo, Nathan Tessema
   Spitler, Kara L.
GP IEEE
TI Effects of hydrogel properties and extrusion parameters on 3D
   bioprinting
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
AB In recent years, advances in tissue engineering have brought about the development of 3D bioprinting. By encapsulating cells within a biomaterial for three-dimensional extrusion, this efficient and integrated biofabrication method overcomes the limitations of two-dimensional cell culture, allows for the study of complex cell interactions in a physiologically relevant microenvironment and is a promising stepping stone to the functional replacement of lost or damaged tissue. Despite efforts to improve the cytocompatibility of the extruded biomaterial and to induce specific tissue formation upon extrusion, the effects of hydrogel properties on the extruded construct have been poorly characterized. Here, we assess the impact of various parameters, including biomaterial composition, computer-designed structure and printing speed, on the structural integrity, stress distribution and resolution of the extruded construct.
C1 [Ersumo, Nathan Tessema; Spitler, Kara L.] Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.
RP Ersumo, NT (reprint author), Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.
CR Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105
   Butscher A, 2012, ACTA BIOMATER, V8, P373, DOI 10.1016/j.actbio.2011.08.027
   Cohen D L, 2010, TISSUE ENG PART C-ME, V17, P239
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Tirella A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045002
   Wang M. O., 2014, ADV MAT
NR 10
TC 0
Z9 0
U1 0
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700051
DA 2018-10-20
ER

PT S
AU Ramamoorthy, S
   Bertucci, CP
   Thompson, DM
   Karande, P
AF Ramamoorthy, S.
   Bertucci, C. P.
   Thompson, D. M.
   Karande, P.
GP IEEE
TI High Throughput Screening of Endothelial Cell Response to Combinatorial
   Collagen - Matrigel Biomaterials
SO 2015 41ST ANNUAL NORTHEAST BIOMEDICAL ENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 41st Annual Northeast Biomedical Engineering Conference (NEBEC)
CY APR 17-19, 2015
CL Troy, NY
DE tissue engineering; extracellular matrix; biomaterials; high throughput
   screening; endothelial cells
ID NERVE REGENERATION
AB Peripheral nerve regeneration is limited by lack of growth permissive microenvironment and glial scarring. An ideal biomaterial for regeneration should support neurons and non-neural cells of Schwann cells and endothelial cells. Numerous tissue engineered strategies have been proposed for PNS regeneration but only a few approaches look at the role of support cells and microenvironment. It is therefore necessary to study the effect of scaffold, ECM proteins and growth factors and optimize the microenvironment for supporting all cell types. In this work, we evaluated the endothelial cell response to combinatorial collagen - matrigel library. Composite biomaterial library was fabricated in a microwell array and collagen and matrigel were varied at 1 - 3 mg/mL and 0 - 100% respectively. A flatbed fluorescent scanner was used for high throughput acquisition of images. Cell response analysis of cell number, morphology and metabolic activity was quantified. Endothelial cell responses is modulated by both collagen and matrigel concentration. An optimum matrigel content of 20% supported cell proliferation, spreading and increased metabolic activity.
C1 [Ramamoorthy, S.; Karande, P.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.
   [Bertucci, C. P.; Thompson, D. M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Ramamoorthy, S.; Bertucci, C. P.; Thompson, D. M.; Karande, P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
RP Ramamoorthy, S (reprint author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.
CR Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4
   Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-8360-5
J9 NORTHEAST BIOENGIN C
PY 2015
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BE3MX
UT WOS:000370977700081
DA 2018-10-20
ER

PT S
AU Liviu, S
   Ion, S
AF Liviu, Serbanescu
   Ion, Sima
GP IEEE
TI A Software Architecture for the Control of Biomaterials Maintenance
SO PROCEEDINGS OF THE 2015 7TH INTERNATIONAL CONFERENCE ON ELECTRONICS,
   COMPUTERS AND ARTIFICIAL INTELLIGENCE (ECAI)
SE International Conference on Electronics Computers and Artificial
   Intelligence
LA English
DT Proceedings Paper
CT 7th International Conference on Electronics, Computers and Artificial
   Intelligence (ECAI)
CY JUN 25-27, 2015
CL Bucharest, ROMANIA
SP IEEE Romania section, IEEE Industry Applications Society, Univ Pitesti, Univ Europei Sud Est Lumina, Ministerul Educatiei Cercetarii Stiintifice
DE biomaterial; maintenance; software arhitecture
AB Most biomaterials are undergoing a process degradation faster than other materials. The biomaterials are often combined with other materials by various methods of treatment in order to ensure certain performance and functionality. Maintenance biomaterials must take into account both their particular as well as the evolution of experience accumulated. Treatment of the biomaterial, in many cases does not have an immediate effect and the treatment effect can be retrieve through out the entire life cycle of the biomaterial. This paper aims to outline a software architecture that implements an expert system in order to elaborate decision on choosing optimal maintenance solution.
C1 [Liviu, Serbanescu] Hyper Univ Bucharest, Bucharest, Romania.
   [Ion, Sima] Lumina Univ South East Europe, Bucharest, Romania.
RP Liviu, S (reprint author), Hyper Univ Bucharest, Bucharest, Romania.
EM livius969@gmail.com; ion.sima@lumina.org
CR Baura G.D., 2004, IEMBS 04 26 ANN INT
   Cristian M., 2014, SYST THEOR CONTR COM
   Gasparyan O.N., 2006, COMP AID CONTR SYST, P1958
   Hendler J. A., 1988, EXPERT SYSTEMS USER
   Li-qing Xing, 2007, MAN SCI ENG 2007 ICM
   Noth G., 1999, CONTR C ECC 1999 EUR, P4813
   Rusnak I., 2006, EL EL ENG ISR 2006 I, P320
   Shinskey FG, 1996, PROCESS CONTROL SYST
   Sturrock C. P., 2005, 7255 NISTIR
   WANG H, 1991, IEE PROC-D, V138, P500, DOI 10.1049/ip-d.1991.0069
   Xu Xiangzhong, 2008, SYST SIM SCI COMP 20
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2378-7147
BN 978-1-4673-6647-2
J9 INT C ELECT COMPUT
PY 2015
BP BB5
EP BB8
PG 4
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BE3MO
UT WOS:000370971100103
DA 2018-10-20
ER

PT S
AU Mihaela-Adina, M
   Gheorghisa, P
AF Mihaela-Adina, Mateescu
   Gheorghisa, Pescaru
GP IEEE
TI An Expert System Architecture for Managing the Biomaterials Used in
   Medical Devices
SO PROCEEDINGS OF THE 2015 7TH INTERNATIONAL CONFERENCE ON ELECTRONICS,
   COMPUTERS AND ARTIFICIAL INTELLIGENCE (ECAI)
SE International Conference on Electronics Computers and Artificial
   Intelligence
LA English
DT Proceedings Paper
CT 7th International Conference on Electronics, Computers and Artificial
   Intelligence (ECAI)
CY JUN 25-27, 2015
CL Bucharest, ROMANIA
SP IEEE Romania section, IEEE Industry Applications Society, Univ Pitesti, Univ Europei Sud Est Lumina, Ministerul Educatiei Cercetarii Stiintifice
DE component; biomaterials; expert system; xml database field type
AB Data describing biomaterials have a complex structure because they describe the so static characteristics and dynamic characteristics. These data also include time interaction with other organic or inorganic materials. Due to their large variety looking for a particular biomaterial it is difficult due to the complexity of their representation. A representation of biomaterials by using the techniques of expert systems can help identify a particular biomaterial. By developing methods and analysis techniques for biomaterials increases measurement accuracy. Following their reconsideration they can not meet their purpose intitial medical device. This paper aims to outline the architecture of an expert system that manages a database of biomaterials.
C1 [Mihaela-Adina, Mateescu] Romanian Acad, Econ Ctr Ind & Serv, Bucharest, Romania.
   [Gheorghisa, Pescaru] Lumina Univ South East Europe, Bucharest, Romania.
RP Mihaela-Adina, M (reprint author), Romanian Acad, Econ Ctr Ind & Serv, Bucharest, Romania.
EM mateescuadina@yahoo.com; ghcorghita.pescaru@lumina.org
CR Avouris N. M., 1993, USER INTERFACE DESIG
   Bray Tim, 2006, CONVERSATION T BRAY
   Bria M., 2004, INTRO MAT ENG SCI CH
   Carroll J. M., 1987, INTERFACE DESIGN ISS
   Darlington K., 2000, ESSENCE EXPERT SYSTE
   Jennings N.R., 1993, TRANSFORMING STANDAL
   Khetan S., 2013, 331 BNG BUTT HALL UN
   Liebowitz J, 1997, HDB APPL EXPERT SYST
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Sturrock C. P., 2005, DATA INFORM NEEDS BI
NR 10
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2378-7147
BN 978-1-4673-6647-2
J9 INT C ELECT COMPUT
PY 2015
BP P67
EP P70
PG 4
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BE3MO
UT WOS:000370971100119
DA 2018-10-20
ER

PT S
AU Pearson, C
   Martin, K
AF Pearson, Craig
   Martin, Keith
BE Bagetta, G
   Nucci, C
TI Stem cell approaches to glaucoma: from aqueous outflow modulation to
   retinal neuroprotection
SO NEW TRENDS IN BASIC AND CLINICAL RESEARCH OF GLAUCOMA: A
   NEURODEGENERATIVE DISEASE OF THE VISUAL SYSTEM, PT A
SE Progress in Brain Research
LA English
DT Review; Book Chapter
DE Glaucoma; Stem cells; Retina; Optic nerve; Neuroprotection; Replacement
ID NEURAL PROGENITOR CELLS; NECROSIS-FACTOR-ALPHA; CHONDROITIN SULFATE
   PROTEOGLYCANS; LOADED BIODEGRADABLE MICROSPHERES; HUMAN TRABECULAR
   MESHWORK; CENTRAL-NERVOUS-SYSTEM; GANGLION-LIKE CELLS;
   SPINAL-CORD-INJURY; HUMAN MULLER GLIA; OPTIC-NERVE
AB Long-term pharmacological management of glaucoma currently relies on self-administered drugs to regulate intraocular pressure (IOP). A number of approaches using stem cells have recently shown promise as potential future treatment strategies complementary to IOP lowering. Several sources of endogenous stem cells have been identified in the eye, some of which may be able to repair the damaged trabecular meshwork and restore functional regulation of aqueous outflow. Neural and mesenchymal stem cells secrete growth factors which provide neuroprotective effects, reducing loss of retinal ganglion cells (RGCs) in animal models. In the future, stem cells may even replace RGCs to reform functional connections between the eye and the brain, although the complexity of such a repair task is formidable. With advances in biomaterial cell scaffolds and concurrent efforts in other neural systems, stem cell therapies are becoming a realistic option for treating multiple eye diseases, and despite ongoing challenges, there are reasons for optimism that stem cells may play a role in the treatment of human glaucoma in the future.
C1 [Pearson, Craig; Martin, Keith] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.
   [Pearson, Craig; Martin, Keith] Cambridge NIHR Biomed Res Ctr, Cambridge, England.
   [Pearson, Craig] NHLBI, NIH, Bethesda, MD 20892 USA.
   [Martin, Keith] Wellcome Trust Res Labs, MRC, Cambridge Stem Cell Inst, Cambridge, England.
RP Martin, K (reprint author), Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.
EM krgm2@cam.ac.uk
CR Abu-Hassan DW, 2015, STEM CELLS, V33, P751, DOI 10.1002/stem.1885
   Acott T. S., 2014, J OCUL PHARMACOL TH, V30, P1
   Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013
   ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011
   Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112
   Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009
   Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110
   Becker S, 2013, MOL VIS, V19, P1925
   Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793
   Bonner JF, 2015, BRAIN RES, V1619, P115, DOI 10.1016/j.brainres.2015.01.006
   Braunger BM, 2014, INVEST OPHTH VIS SCI, V55, P7499, DOI 10.1167/iovs.14-14872
   Bull ND, 2008, PROG BRAIN RES, V173, P511, DOI 10.1016/S0079-6123(08)01135-7
   Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770
   Bull ND, 2011, STEM CELLS, V29, P1170, DOI 10.1002/stem.676
   Bull ND, 2009, INVEST OPHTH VIS SCI, V50, P4244, DOI 10.1167/iovs.08-3239
   BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156
   Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152
   Carr AJ, 2009, MOL VIS, V15, P283
   Cartarozzi LP, 2015, BRAIN RES BULL, V112, P14, DOI 10.1016/j.brainresbull.2015.01.005
   Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029
   de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109
   Ding QJ, 2014, INVEST OPHTH VIS SCI, V55, P7065, DOI 10.1167/iovs.14-14800
   Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056
   Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134
   Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Emre E, 2015, CYTOTHERAPY, V17, P543, DOI 10.1016/j.jcyt.2014.12.005
   Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005
   Flachsbarth K, 2014, INVEST OPHTH VIS SCI, V55, P7029, DOI 10.1167/iovs.14-15266
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338
   Gill KP, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.4.2
   Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052
   Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723
   GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38
   Guo Y, 2003, INVEST OPHTH VIS SCI, V44, P3194, DOI 10.1167/iovs.02-0875
   Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172
   Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329
   Harper MM, 2011, INVEST OPHTH VIS SCI, V52, P4506, DOI 10.1167/iovs.11-7346
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035
   Hu Y, 2013, CLIN INTERV AGING, V8, P1467, DOI 10.2147/CIA.S47350
   Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013
   Iwabe S, 2007, VET OPHTHALMOL, V10, P12, DOI 10.1111/j.1463-5224.2007.00504.x
   Jiang C, 2007, MOL VIS, V13, P1783
   Jiao Y, 2014, BIOMED RES INT, DOI 10.1155/2014/356415
   Johnson TV, 2011, EXPERT REV OPHTHALMO, V6, P165, DOI 10.1586/EOP.11.3
   Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509
   Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884
   Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023
   Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010
   Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131
   Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103
   Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763
   Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015
   Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310
   Li TQ, 2013, CELL RES, V23, P788, DOI 10.1038/cr.2013.48
   Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0
   Manuguerra-Gagne R, 2013, STEM CELLS, V31, P1136, DOI 10.1002/stem.1364
   Martin KRG, 2006, EXP EYE RES, V83, P255, DOI 10.1016/j.exer.2005.11.025
   Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Mellough CB, 2007, RESTOR NEUROL NEUROS, V25, P177
   Mellough CB, 2004, EXP NEUROL, V186, P6, DOI 10.1016/j.expneurol.2003.10.021
   Nadri S, 2013, NEUROSCI LETT, V541, P43, DOI 10.1016/j.neulet.2012.12.055
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006
   Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268
   Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235
   Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944
   Park HYL, 2012, BRAIN RES, V1469, P10, DOI 10.1016/j.brainres.2012.06.006
   Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997
   Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200
   Pease ME, 2009, INVEST OPHTH VIS SCI, V50, P2194, DOI 10.1167/iovs.08-3013
   Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Quittet MS, 2015, ACTA BIOMATER, V15, P77, DOI 10.1016/j.actbio.2014.12.017
   Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9
   Riazifar H, 2014, STEM CELL TRANSL MED, V3, P424, DOI 10.5966/sctm.2013-0147
   Roozafzoon R, 2015, BIOCHEM BIOPH RES CO, V457, P154, DOI 10.1016/j.bbrc.2014.12.069
   Sadan O, 2008, STEM CELLS, V26, P2542, DOI 10.1634/stemcells.2008-0240
   Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411
   Sadan O, 2009, ISR MED ASSOC J, V11, P201
   Schroeder J, 2015, WORLD J STEM CELLS, V7, P186, DOI 10.4252/wjsc.v7.i1.186
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Singhal S, 2008, STEM CELLS, V26, P1074, DOI 10.1634/stemcells.2007-0898
   Singhal S, 2012, STEM CELL TRANSL MED, V1, P188, DOI 10.5966/sctm.2011-0005
   Song W. T., 2014, CYTOTECHNOLOGY
   Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e
   STREILEIN JW, 1990, SURV OPHTHALMOL, V35, P67, DOI 10.1016/0039-6257(90)90048-Z
   Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594
   Sun GW, 2006, DEV BIOL, V289, P243, DOI 10.1016/j.ydbio.2005.10.035
   Sun Y., 2014, SURV OPHTHALMOL, V60, P93
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721
   Tanaka T., 2015, SCI REP, V5, P1
   Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787
   Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013
   Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831
   Wang X, 2002, HISTOL HISTOPATHOL, V17, P1043, DOI 10.14670/HH-17.1043
   Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629
   Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887
   Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192
   Wohl SG, 2012, PROG RETIN EYE RES, V31, P213, DOI 10.1016/j.preteyeres.2012.02.001
   Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
   Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106
   Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231
   Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3
   Zhang XY, 2007, EXP EYE RES, V84, P275, DOI 10.1016/j.exer.2006.09.022
   Zhong X., 2014, NAT COMMUN, V5, P1
NR 121
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0079-6123
BN 978-0-444-63566-2
J9 PROG BRAIN RES
JI Prog. Brain Res.
PY 2015
VL 220
BP 241
EP 256
DI 10.1016/bs.pbr.2015.04.005
PG 16
WC Medicine, Research & Experimental; Neurosciences; Ophthalmology
SC Research & Experimental Medicine; Neurosciences & Neurology;
   Ophthalmology
GA BE3CT
UT WOS:000370523000013
PM 26497794
DA 2018-10-20
ER

PT J
AU Szklarska, M
   Dercz, G
   Rak, J
   Simka, W
   Losiewicz, B
AF Szklarska, M.
   Dercz, G.
   Rak, J.
   Simka, W.
   Losiewicz, B.
TI THE INFLUENCE OF PASSIVATION TYPE ON CORROSION RESISTANCE OF Ti15Mo
   ALLOY IN SIMULATED BODY FLUIDS
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial; electrochemical impedance spectroscopy; corrosion
   resistance; passivation; titanium alloys
ID TI-MO ALLOYS; TI-13NB-13ZR ALLOY; BEHAVIOR; TITANIUM
AB This work reports on determination of the influence of passivation type of Ti15wt.% Mo implant alloy surface on its corrosion resistance in simulated body fluids. The alloy under investigation was subjected to natural self-passivation in air, and forced passivation by autoclaving in steam, boiling in 30 % solution of H2O2, and electrochemical passivation in 0.9 % NaCl solution. Resistance of the passivated Ti15Mo alloy to pitting corrosion was studied at 37 degrees C in 0.9 % NaCl solution using open circuit potential method, anodic polarization curves, and electrochemical impedance spectroscopy (EIS). Comparative estimation of the determined parameters of corrosion resistance revealed that the obtained passive layers improve anticorrosive properties of the tested alloy. Surface of the alloy subjected to passivation in steam autoclave reveals the highest protection against pitting corrosion. Anodic potentiodynamic curves showed that the Ti15Mo alloy after different passivation types of the surface is characterized by a lack of susceptibility to pitting corrosion up to potential of 9 V. Based on the EIS investigations, the thickness of the formed oxide layers (TiO2, anatase) was determined to be in the range from 2.0 to 7.8 nm in dependence on the applied type of passivation. It was ascertained that electrochemical properties of the Ti15Mo alloy and possibility of its surface passivation using simple methods, make it an attractive material for use in biomedicine for long-term implants.
C1 [Szklarska, M.; Dercz, G.; Rak, J.; Losiewicz, B.] Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland.
   [Simka, W.] Silesian Tech Univ, Fac Chem, PL-44100 Gliwice, Poland.
RP Szklarska, M (reprint author), Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland.
EM mszklarska@us.edu.pl
OI Simka, Wojciech/0000-0002-2648-5523; Dercz,
   Grzegorz/0000-0003-3682-7184; Szklarska, Magdalena/0000-0001-8716-630X
FU European Social Fund
FX Research under the FORSZT project financed by the European Social Fund.
CR [Anonymous], G10289 ASTM
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   Blaszczyk T., 2010, ENG BIOMAT, V96-98, P10
   Disegi J, 2009, IMPLANT MAT WROUGHT
   Freitag M, 2012, SOLID STATE PHENOMEN, V183, P57, DOI 10.4028/www.scientific.net/SSP.183.57
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   Lasia A., 2002, MODERN ASPECTS ELECT, V35
   Lekston Z., 2010, ENG BIOMAT, V96-98, P29
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Morawiec H., 2004, ENG BIOMATERIALS, V37, P32
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   Pardo A, 2008, CORROS SCI, V50, P1796, DOI 10.1016/j.corsci.2008.04.005
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Simka W, 2011, ELECTROCHIM ACTA, V56, P9831, DOI 10.1016/j.electacta.2011.08.049
   Szewczenko J., 2011, ENG BIOMAT, V106-108, P21
   Takeno N., 2005, 419 NAT I ADV IND SC
   Wang K, 1998, ELECTROCHIM ACTA, V43, P2459, DOI 10.1016/S0013-4686(97)00317-4
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
NR 20
TC 3
Z9 3
U1 2
U2 11
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 4
BP 2687
EP 2693
DI 10.1515/amm-2015-0433
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DC8XB
UT WOS:000369502200035
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Gadjanski, I
   Vunjak-Novakovic, G
AF Gadjanski, Ivana
   Vunjak-Novakovic, Gordana
TI Challenges in engineering osteochondral tissue grafts with hierarchical
   structures
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE anatomical shape; biomimetics; osteochondral grafts; tissue engineering
ID EMBRYONIC STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE
   MULTILAYERED BIOMATERIAL; HUMAN BONE-GRAFTS; CHONDROGENIC
   DIFFERENTIATION; SCAFFOLD DESIGN; IN-VITRO; ELECTROSPUN NANOFIBERS;
   CARTILAGE REGENERATION; BIOMIMETIC SCAFFOLDS
AB Introduction: A major hurdle in treating osteochondral (OC) defects is the different healing abilities of two types of tissues involved - articular cartilage and subchondral bone. Biomimetic approaches to OC-construct engineering, based on recapitulation of biological principles of tissue development and regeneration, have potential for providing new treatments and advancing fundamental studies of OC tissue repair.
   Areas covered: This review on state of the art in hierarchical OC tissue graft engineering is focused on tissue engineering approaches designed to recapitulate the native milieu of cartilage and bone development. These biomimetic systems are discussed with relevance to bioreactor cultivation of clinically sized, anatomically shaped human cartilage/bone constructs with physiologic stratification and mechanical properties. The utility of engineered OC tissue constructs is evaluated for their use as grafts in regenerative medicine, and as high-fidelity models in biological research.
   Expert opinion: A major challenge in engineering OC tissues is to generate a functionally integrated stratified cartilage-bone structure starting from one single population of mesenchymal cells, while incorporating perfusable vasculature into the bone, and in bone-cartilage interface. To this end, new generations of advanced scaffolds and bioreactors, implementation of mechanical loading regimens and harnessing of inflammatory responses of the host will likely drive the further progress.
C1 Columbia Univ, Lab Stem Cells & Tissue Engn, New York, NY USA.
   [Gadjanski, Ivana] Belgrade Metropolitan Univ, Ctr Bioengn BioIRC, Kragujevac 34000, Serbia.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Lab Stem Cells & Tissue Engn, Biomed Engn & Med Sci, New York, NY USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Lab Stem Cells & Tissue Engn, New York, NY USA.
EM gv2131@columbia.edu
RI Gadjanski, Ivana/I-2162-2016
OI Gadjanski, Ivana/0000-0003-0713-7897; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
FU Ministry of Education and Science of Serbia [ON174028, III41007];
   National Institutes of Health [DE016525, EB002520, AR061988]
FX I Gadjanski has received research funding from The Ministry of Education
   and Science of Serbia (grants ON174028 and III41007) and G
   Vunjak-Novakovic has received research funding from the National
   Institutes of Health (grants DE016525, EB002520, and AR061988). In
   addition, G Vunjak-Novakovic is a co-founder of epiBone, a Columbia
   University spin out focused on growing human bones for craniofacial
   repair. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript. This includes employment, consultancies, honoraria,
   stock ownership or options, expert testimony, grants or patents received
   or pending, or royalties.
CR Alexander PG, 2014, EXP BIOL MED, V239, P1080, DOI 10.1177/1535370214539232
   Amler E, 2014, NANOMEDICINE-UK, V9, P1083, DOI [10.2217/NNM.14.57, 10.2217/nnm.14.57]
   Athanasiou K. A., 2009, SYNTHESIS LEC TISSUE, P1
   Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bhumiratana S, 2015, METHODS
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114
   Bitton Ryan, 2009, Am J Manag Care, V15, pS230
   Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112
   Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Buda R, 2015, INT ORTHOP, V39, P893, DOI 10.1007/s00264-015-2685-y
   Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016
   Chen GB, 2015, CURR PHARM DESIGN, V21, P1967, DOI 10.2174/1381612821666150302152704
   Cheng AX, 2014, TISSUE ENG PART B-RE, V20, P257, DOI [10.1089/ten.teb.2012.0757, 10.1089/ten.TEB.2012.0757]
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Christensen BB, 2015, KNEE SURG SPORTS TRA
   Correia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028352
   Cosson S, 2015, STEM CELL TRANSL MED, V4, P156, DOI 10.5966/sctm.2014-0203
   Cui X., 2014, J VIS EXP, V88
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   De Caro F, 2015, ARTHROSCOPY, V31, P757, DOI 10.1016/j.arthro.2014.11.025
   de Peppo GM, 2014, METHODS MOL BIOL, V1202, P173, DOI 10.1007/7651_2013_52
   Di Luca A, 2015, BIRTH DEFECTS RES C, V105, P34, DOI 10.1002/bdrc.21092
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2167, DOI 10.1007/s10439-010-0028-0
   Dunkin BS, 2013, OPER TECHN SPORT MED, V21, P100, DOI 10.1053/j.otsm.2013.03.003
   Falah M, 2010, INT ORTHOP, V34, P621, DOI 10.1007/s00264-010-0959-y
   Feinberg SE, 2001, CELLS TISSUES ORGANS, V169, P309, DOI 10.1159/000047896
   Foster NC, 2015, BIRTH DEFECTS RES C, V105, P19, DOI 10.1002/bdrc.21088
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Gadjanski I, 2012, STEM CELL REV REP, V8, P863, DOI 10.1007/s12015-011-9328-5
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014
   GLYN-JONES S, 2015, LANCET
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008
   Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grigolo B, 2015, J MATER SCI-MATER M, V26, P5500
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Hoemann CD, 2012, J KNEE SURG, V25, P85, DOI 10.1055/s-0032-1319782
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2008, TRENDS BIOTECHNOL, V26, P166, DOI 10.1016/j.tibtech.2007.11.012
   Jacobs JC, 2015, ORTHOP CLIN N AM, V46, P133, DOI 10.1016/j.ocl.2014.09.009
   Jeon JE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0184
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim YS, 2015, AM J SPORT MED, V43, P399, DOI 10.1177/0363546514559822
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Kon E, 2015, ARTHROSCOPY, V31, P767, DOI 10.1016/j.arthro.2014.11.017
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Lacroix D, 2009, PHILOS T R SOC A, V367, P1993, DOI 10.1098/rsta.2009.0024
   Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003
   Lee TJ, 2014, TISSUE ENG PT A, V20, P1306, DOI [10.1089/ten.tea.2013.0265, 10.1089/ten.TEA.2013.0265]
   Lee WD, 2015, OSTEOARTHRITIS CARTI
   Lima EG, 2004, BIORHEOLOGY, V41, P577
   Lin H, 2014, MOL PHARMACEUT, V11, P2203, DOI 10.1021/mp500136b
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lopa S, 2014, TISSUE ENG PT A, V20, P2052, DOI 10.1089/ten.tea.2013.0356
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lozito TP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt367
   Lynch TS, 2015, ARTHROSCOPY, V31, P746, DOI 10.1016/j.arthro.2014.11.018
   Madry H, 2015, TISSUE REGENERATION, P219
   Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mallick Kajal K, 2013, Front Biosci (Elite Ed), V5, P341
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Matta Csaba, 2013, Front Biosci (Schol Ed), V5, P305
   Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15
   Mikos A G, 2000, ELECTRON J BIOTECHN, V3, P23
   Millikan PD, 2015, CURR REV MUSCULOSKEL
   Mohan N, 2008, J BIOMED MATER RES B, V84B, P584, DOI 10.1002/jbm.b.30906
   Mohan N, 2014, BIOTECHNOL BIOENG, V111, P829, DOI 10.1002/bit.25145
   Mosher TJ, 2009, ARTHRITIS COLOR ADV, P23
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nejadnik H, 2015, STEM CELL REV REP, V11, P242, DOI 10.1007/s12015-014-9581-5
   Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004
   Obradovic B, 1999, J ORTHOP RES, V17, P130
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Preitschopf A, 2012, STEM CELL REV REP, V8, P1267, DOI 10.1007/s12015-012-9405-4
   Qu D, 2015, ANN BIOMED ENG, V43, P697, DOI 10.1007/s10439-014-1190-6
   Ren KX, 2015, BIOMATERIALS, V51, P238, DOI 10.1016/j.biomaterials.2015.02.026
   Roach BL, 2015, METHODS
   Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007
   Saw KY, 2013, ARTHROSCOPY, V29, P684, DOI 10.1016/j.arthro.2012.12.008
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Seo S.-J., 2014, J TISSUE ENG, V5, DOI DOI 10.1177/2041731414541850
   Shafiee A, 2011, BIOMED MAT RES A, V99, P467
   Sherman SL, 2014, J AM ACAD ORTHOP SUR, V22, P121, DOI 10.5435/JAAOS-22-02-121
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022
   Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869
   Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Temple JP, 2014, METHODS MOL BIOL, V1202, P57, DOI 10.1007/7651_2013_33
   Vaquette C, 2013, ACTA BIOMATER, V9, P4599, DOI 10.1016/j.actbio.2012.08.015
   Verhaegen J, 2015, CARTILAGE, V6, P12, DOI 10.1177/1947603514548890
   Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896
   Vunjak-Novakovic Gordana, 2012, HSS J, V8, P57, DOI 10.1007/s11420-011-9245-9
   Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Weng L, 2015, CURR PHARM DESIGN, V21, P1944, DOI 10.2174/1381612821666150302151959
   Xia Z, 2014, J MATER CHEM B, V2, P1998, DOI 10.1039/c3tb21595d
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yan L, 2015, ACS BIOMATER SCI ENG
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Yodmuang S, 2015, STEM CELL REV REP, V11, P228, DOI 10.1007/s12015-015-9584-x
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yousefi AM, 2015, J BIOMED MATER RES A, V103, P2460, DOI 10.1002/jbm.a.35356
   Yu LL, 2015, J ARTHROPLASTY, V30, P1273, DOI 10.1016/j.arth.2015.01.037
   Zhang X, 2015, CELL BIOCH BIOPHY
NR 120
TC 12
Z9 12
U1 1
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PY 2015
VL 15
IS 11
BP 1583
EP 1599
DI 10.1517/14712598.2015.1070825
PG 17
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DD4SH
UT WOS:000369912400004
PM 26195329
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kabra, H
   Hwang, YS
   Lim, HL
   Kar, M
   Arya, G
   Varghese, S
AF Kabra, Harsha
   Hwang, Yongsung
   Lim, Han Liang
   Kar, Mrityunjoy
   Arya, Gaurav
   Varghese, Shyni
TI Biomimetic Material-Assisted Delivery of Human Embryonic Stem Cell
   Derivatives for Enhanced In Vivo Survival and Engraftment
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE human embryonic stem cells; myogenesis; biomaterials; hyaluronic acid;
   stem cell transplantation
ID FUNCTIONAL SKELETAL-MUSCLE; FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID;
   EXTRACELLULAR-MATRIX; MYOGENIC-DIFFERENTIATION; ANTITUMOR BIOCONJUGATE;
   SATELLITE CELLS; BONE-MARROW; PROGENITORS; HYDROGELS
AB The ability of human embryonic stem cells (hESCs) and their derivatives to differentiate and contribute to tissue repair has enormous potential to treat various debilitating diseases. However, improving the in vivo viability and function of the transplanted cells, a key determinant of translating cell-based therapies to the clinic, remains a daunting task. Here, we develop a hybrid biomaterial consisting of hyaluronic acid (HA) grafted with 6-aminocaproic acid moieties (HA-6ACA) to improve cell delivery and their subsequent in vivo function using skeletal muscle as a model system. Our findings show that the biomimetic material-assisted delivery of hESC-derived myogenic progenitor cells into cardiotoxin-injured skeletal muscles of NOD/SCID mice significantly promotes survival and engraftment of transplanted cells in a dose-dependent manner. The donor cells were found to contribute to the regeneration of damaged muscle fibers and to the satellite cell (muscle specific stem cells) compartment. Such biomimetic cell delivery vehicles that are cost-effective and easy-to-synthesize could play a key role in improving the outcomes of other stem cell-based therapies.
C1 [Kabra, Harsha; Hwang, Yongsung; Lim, Han Liang; Kar, Mrityunjoy; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Arya, Gaurav] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
OI Kar, Mrityunjoy/0000-0002-7910-9580
FU California Institute of Regenerative Medicine [RN2-00945]
FX This work was funded by the California Institute of Regenerative
   Medicine (RN2-00945).
CR Ahrens T, 2001, J INVEST DERMATOL, V116, P93, DOI 10.1046/j.1523-1747.2001.00236.x
   ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   Bentzinger CF, 2013, BIOESSAYS, V35, P231, DOI 10.1002/bies.201200063
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012
   Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Peppo GM, 2010, TISSUE ENG PT A, V16, P2161, DOI [10.1089/ten.tea.2009.0629, 10.1089/ten.TEA.2009.0629]
   Ekblad T, 2008, BIOMACROMOLECULES, V9, P2775, DOI 10.1021/bm800547m
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188
   Hunt LC, 2013, J BIOL CHEM, V288, P13006, DOI 10.1074/jbc.M113.453209
   Hwang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05916
   Hwang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072023
   Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420
   Luo Y, 2002, PHARMACEUT RES, V19, P396, DOI 10.1023/A:1015170907274
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34
   Malkowski A, 2007, ACTA BIOCHIM POL, V54, P357
   Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2012, P NATL ACAD SCI USA, V109, P4383, DOI 10.1073/pnas.1201122109
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Sangaj N, 2010, BIOMACROMOLECULES, V11, P3294, DOI 10.1021/bm101041f
   Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
   Zieris A, 2010, J MATER SCI-MATER M, V21, P915, DOI 10.1007/s10856-009-3913-z
NR 44
TC 8
Z9 8
U1 3
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JAN
PY 2015
VL 1
IS 1
BP 7
EP 12
DI 10.1021/ab500021a
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DC4KP
UT WOS:000369189900003
PM 26280019
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Eddhahak, A
   Zidi, M
AF Eddhahak, Anissa
   Zidi, Mustapha
TI Influence of viscoelastic properties of an hyaluronic acid-based
   hydrogel on viability of mesenchymal stem cells
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Mesenchymal stem cells (MSCs); hydrogel based on hyaluronic acid;
   rheology; cellular viability
ID ANEURYSMS; THERAPY; MODEL
AB BACKGROUND: The present research is involved in the framework of the biotherapy using mesenchymal stem cells (MSCs). Here, MSC encapsulation in a hydrogel based on hyaluronic acid (HA) is investigated to optimize the composition of the biomaterial.
   METHODS: Several formulations candidates of the hydrogel (9 in total) are postulated as a scaffold for the 3D MSC culture in order to investigate their potential to mimic the in vivo cellular environment. Rheological measurements in oscillation mode of complex modulus and complex viscosity are performed on the different hydrogels. Biological tests are carried out for the measurement of the cell viability of MSC encapsulated in the hydrogels.
   RESULTS: Rheological and biological findings are correlated together in order to establish relationships between the viscoelastic properties of the hydrogel and the cellular viability of MSC.
   CONCLUSIONS: In the light of the viability results, the composition of the hydrogel was related to the MSC proliferation. Thus, such relations are useful tools for scientists offering them more flexibility in the design of their hydrogels while ensuring an acceptable level of MSC viability.
C1 [Eddhahak, Anissa] Arts & Metiers ParisTech, CNRS UMR 8006, Lab PIMM, 151 Blvd Hop, F-75013 Paris, France.
   [Zidi, Mustapha] Univ Paris Est Creteil, Fac Med, Lab BIOTN, Ctr Rech Chirurg, 8 Rue Gen Sarrail, F-94010 Creteil, France.
RP Zidi, M (reprint author), Univ Paris Est Creteil, Fac Med, Lab BIOTN, Ctr Rech Chirurg, 8 Rue Gen Sarrail, F-94010 Creteil, France.
EM zidi@u-pec.fr
FU University Paris-Est Creteil; European Union [FP7-Health-200647]; CNRS
FX This work is supported by CNRS, University Paris-Est Creteil and the
   European Union Grant (FP7-Health-200647, Fighting Aneurysmal Diseases).
   The authors acknowledge gratefully Dr. Faiza Mohand-Kaci and Professor
   Eric Allaire (University Paris-Est Creteil, France) for their help in
   the experimental protocols and their useful discussions.
CR Allaire E, 2004, ANN SURG, V239, P417, DOI 10.1097/01.sla.0000114131.79899.82
   ALLAIRE E, 1994, J VASC SURG, V19, P446, DOI 10.1016/S0741-5214(94)70071-0
   Clark A.H., 1987, ADV POLYM SCI, V83, P157, DOI DOI 10.1007/BFB0023330
   CLARK AH, 1992, IFT BAS SYM, V7, P263
   Deligkaris K., 2010, SENSOR ACTUAT B-CHEM, V47, P765
   DJABOUROV M, 1988, J PHYS-PARIS, V49, P333, DOI 10.1051/jphys:01988004902033300
   Gloria A, 2012, J BIOMATER APPL, V26, P745, DOI 10.1177/0885328210387174
   Haraguchi Y, 2012, STEM CELL TRANSL MED, V1, P136, DOI [10.5966/sctm.2011-0030, 10.5966/sctm.2012-0030]
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1
   Lam J, 2014, ACTA BIOMATER, V10, P1571, DOI 10.1016/j.actbio.2013.07.025
   Mohand-Kaci F., 2012, THESIS U PARIS EST C
   Mohand-Kaci F., 2012, TISSUE ENG PART C-ME, V19, P288
   Mohand-Kaci F, 2012, COMPUT METHOD BIOMEC, V15, P435, DOI 10.1080/10255842.2010.540759
   Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Rammal H, 2014, STEM CELLS DEV, V23, P2931, DOI 10.1089/scd.2014.0132
   Schneider F, 2013, EUR J VASC ENDOVASC, V45, P666, DOI 10.1016/j.ejvs.2013.03.007
   Willerth S. M., 2008, STEMBOOK, DOI [10.3824/stembook.1.1.1, DOI 10.3824/STEMBOOK.1.1.1]
NR 18
TC 3
Z9 3
U1 1
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 26
IS 3-4
BP 103
EP 114
DI 10.3233/BME-151557
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD2QO
UT WOS:000369767500002
PM 26684883
DA 2018-10-20
ER

PT J
AU Bedouin, Y
   Mussi, PP
   Tricot-Doleux, S
   Chauvel-Lebret, D
   Auroy, P
   Ravalec, X
   Oudadesse, H
   Perez, F
AF Bedouin, Y.
   Mussi, P. Pellen
   Tricot-Doleux, S.
   Chauvel-Lebret, D.
   Auroy, P.
   Ravalec, X.
   Oudadesse, H.
   Perez, F.
TI 3D cell culture to determine in vitro biocompatibility of bioactive
   glass in association with chitosan
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Spheroids; biocompatibility; bioactive glass; chitosan
ID HUMAN OSTEOBLASTS; IONIC PRODUCTS; DISSOLUTION PRODUCTS; COLLAGEN
   PRODUCTION; 45S5 BIOGLASS(R); PROLIFERATION; DIFFERENTIATION;
   EXPRESSION; COMPOSITE; GROWTH
AB This study reports the in vitro biocompatibility of a composite biomaterial composed of 46S6 bioactive glass in association with chitosan (CH) by using 3D osteoblast culture of SaOS(2). The 46S6 and CH composite (46S6-CH) forms small hydroxyapatite crystals on its surface after only three days immersion in the simulated body fluid. For 2D osteoblast culture, a significant increase in cell proliferation was observed after three days of contact with 46S6 or 46S6-CH-immersed media. After six days, 46S6-CH led to a significant increase in cell proliferation (128%) compared with pure 46S6 (113%) and pure CH (122%). For 3D osteoblast culture, after six days of culture, there was an increase in gene expression of markers of the early osteoblastic differentiation (RUNX2, ALP, COL1A1). Geometric structures corresponding to small apatite clusters were observed by SEM on the surface of the spheroids cultivated with 46S6 or 46S6-CH-immersed media.
   We showed different cellular responses depending on the 2D and 3D cell culture model. The induction of osteoblast differentiation in the 3D cell culture explained the differences of cell proliferation in contact with 46S6, CH or 46S6-CH-immersed media. This study confirmed that the 3D cell culture model is a very promising tool for in vitro biological evaluation of bone substitutes' properties.
C1 [Bedouin, Y.; Mussi, P. Pellen; Tricot-Doleux, S.; Chauvel-Lebret, D.; Oudadesse, H.; Perez, F.] Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6226, Equipe Chim Solide & Mat,Sci Chim Rennes, Campus Beaulieu,263 Ave Gen Leclerc,2 Ave Prof Le, F-35042 Rennes, France.
   [Bedouin, Y.; Chauvel-Lebret, D.; Ravalec, X.] CHU Rennes, Pole Odontol & Chirurg Buccale, 2 Pl Pasteur, F-35000 Rennes, France.
   [Auroy, P.] Univ Auvergne, Fac Chirurg Dent, 11 Blvd Charles de Gaulle, F-63000 Clermont Ferrand, France.
   [Auroy, P.] CHU Clermont Ferrand, Serv Odontol, 11 Rue Leon Malfreyt, F-63000 Clermont Ferrand, France.
   [Perez, F.] CHU Nantes, Serv Odontol, 1 Pl Alexis Ricordeau, F-44000 Nantes, France.
RP Bedouin, Y (reprint author), Univ Europeenne Bretagne, Univ Rennes 1, UMR CNRS 6226, Equipe Chim Solide & Mat,Sci Chim Rennes, Campus Beaulieu,263 Ave Gen Leclerc,2 Ave Prof Le, F-35042 Rennes, France.
EM yvan.bedouin@univ-rennes1.fr
FU Fondation Langlois
FX The authors would like to thank Jean Lecerf, Joseph Le Lannic, Helene
   Solhi and Celine Allaire for their valuable assistance. This work was
   supported by the Fondation Langlois.
CR Alno N, 2010, J BIOMED MATER RES A, V95A, P137, DOI 10.1002/jbm.a.32818
   Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955
   Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Chesnutt B.M., 2008, J BIOMED MATER RES A, V88A, P491, DOI [10.1002/jbm.a.31878, DOI 10.1002/JBM.A.31878]
   Couto DS, 2009, ACTA BIOMATER, V5, P115, DOI 10.1016/j.actbio.2008.08.006
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dietrich E, 2009, J BIOMED MATER RES A, V88A, P1087, DOI 10.1002/jbm.a.31901
   Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kang YM, 2009, ACTA BIOMATER, V5, P462, DOI 10.1016/j.actbio.2008.07.004
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Luz GM, 2012, LANGMUIR, V28, P6970, DOI 10.1021/la300667g
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Oudadesse H, 2013, KOREAN J CHEM ENG, V30, P1775, DOI 10.1007/s11814-013-0104-x
   Qiu Z, 2009, J INT MED RES, V37, P737, DOI 10.1177/147323000903700317
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sitarz M, 1999, J MOL STRUCT, V511, P281, DOI 10.1016/S0022-2860(99)00169-6
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   Wang J, 2007, BIOMED MATER, V2, P32, DOI 10.1088/1748-6041/2/1/006
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0
NR 41
TC 0
Z9 0
U1 2
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2015
VL 26
IS 3-4
BP 169
EP 181
DI 10.3233/BME-151555
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD2QO
UT WOS:000369767500008
PM 26684889
DA 2018-10-20
ER

PT J
AU Daskalopoulos, EP
   Vilaeti, AD
   Barka, E
   Mantzouratou, P
   Kouroupis, D
   Kontonika, M
   Tourmousoglou, C
   Papalois, A
   Pantos, C
   Blankesteijn, WM
   Agathopoulos, S
   Kolettis, TM
AF Daskalopoulos, Evangelos P.
   Vilaeti, Agapi D.
   Barka, Eleonora
   Mantzouratou, Polixeni
   Kouroupis, Dimitrios
   Kontonika, Marianthi
   Tourmousoglou, Christos
   Papalois, Apostolos
   Pantos, Constantinos
   Blankesteijn, W. Matthijs
   Agathopoulos, Simeon
   Kolettis, Theofilos M.
TI Attenuation of post-infarction remodeling in rats by sustained
   myocardial growth hormone administration
SO GROWTH FACTORS
LA English
DT Article
DE Alginate; angiogenesis; growth hormone; myofibroblasts; myocardial
   infarction; ventricular remodeling
ID REDUCES INFARCT EXPANSION; IMPROVES CARDIAC-FUNCTION; MESENCHYMAL
   STEM-CELLS; POSTMYOCARDIAL INFARCTION; FACTOR-I; ALGINATE HYDROGELS;
   HEART-FAILURE; INFLAMMATORY RESPONSE; GENE-EXPRESSION; PORCINE MODEL
AB Prevention of left ventricular remodeling is an important therapeutic target post-myocardial infarction. Experimentally, treatment with growth hormone (GH) is beneficial, but sustained local administration has not been thoroughly investigated. We studied 58 rats (322 +/- 4 g). GH was administered via a biomaterial-scaffold, following in vitro and in vivo evaluation of degradation and drug-release curves. Treatment consisted of intra-myocardial injection of saline or alginate-hydrogel, with or without GH, 10 min after permanent coronary artery ligation. Echocardiographic and histologic remodeling-indices were examined 3 weeks post-ligation, followed by immunohistochemical evaluation of angiogenesis, collagen, macrophages and myofibroblasts. GH-release completed at 3 days and alginate-degradation at similar to 7 days. Alginate + GH consistently improved left ventricular end-diastolic and end-systolic diameters, ventricular sphericity, wall tension index and infarct-thickness. Microvascular-density and myofibroblast-count in the infarct and peri-infarct areas were higher after alginate + GH. Macrophage-count and collagen-content did not differ between groups. Early, sustained GH-administration enhances angiogenesis and myofibroblast-activation and ameliorates post-infarction remodeling.
C1 [Daskalopoulos, Evangelos P.; Blankesteijn, W. Matthijs] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands.
   [Daskalopoulos, Evangelos P.; Vilaeti, Agapi D.; Barka, Eleonora; Kontonika, Marianthi; Tourmousoglou, Christos; Papalois, Apostolos; Kolettis, Theofilos M.] Cardiovasc Res Inst, Athens, Greece.
   [Barka, Eleonora; Agathopoulos, Simeon] Univ Ioannina, Dept Mat Sci & Engn, Ceram & Composites Lab, GR-45110 Ioannina, Greece.
   [Mantzouratou, Polixeni; Pantos, Constantinos] Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece.
   [Kouroupis, Dimitrios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Ioannina, Greece.
   [Papalois, Apostolos] Expt Res Ctr ELPEN, Athens, Greece.
RP Kolettis, TM (reprint author), Univ Ioannina, Cardiol, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM theofilos.m.kolettis@gmail.com
CR Agathopoulos S, 2014, CURR PHARM DESIGN, V20, P1925, DOI 10.2174/138161282012140401153832
   Aikawa Y, 2001, AM HEART J, V141, P234, DOI 10.1067/mhj.2001.112237
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Baltogiannis GG, 2005, CARDIOVASC RES, V67, P647, DOI 10.1016/j.cardiores.2005.04.020
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Bruel A, 1999, GROWTH HORM IGF RES, V9, P123, DOI 10.1054/ghir.1999.0097
   Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3
   Cittadini A, 1996, CIRCULATION, V93, P800
   Cittadini A, 1997, J AM COLL CARDIOL, V29, P1109, DOI 10.1016/S0735-1097(97)00010-7
   Cittadini A, 2003, J AM COLL CARDIOL, V41, P2154, DOI 10.1016/S0735-1097(03)00483-2
   Cochain C, 2013, ANTIOXID REDOX SIGN, V18, P1100, DOI 10.1089/ars.2012.4849
   COOK JJ, 1988, J CLIN INVEST, V81, P206, DOI 10.1172/JCI113296
   Daskalopoulos EP, 2014, CURR PHARM DESIGN, V20, P1987, DOI 10.2174/13816128113199990452
   de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P673, DOI 10.1161/CIRCINTERVENTIONS.114.001580
   Elaiopoulos DA, 2007, CLIN SCI, V112, P385, DOI 10.1042/CS20060193
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28
   Friberg L, 2000, EUR HEART J, V21, P1547, DOI 10.1053/euhj.2000.2125
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hatzistergos KE, 2008, GROWTH HORM IGF RES, V18, P157, DOI 10.1016/j.ghir.2007.08.002
   Jayasankar V, 2004, J MOL CELL CARDIOL, V36, P531, DOI 10.1016/j.yjmcc.2004.01.010
   Jin HK, 2002, GROWTH HORM IGF RES, V12, P208, DOI 10.1016/S1096-6374(02)00042-4
   Khan AS, 2001, J GERONTOL A-BIOL, V56, pB364, DOI 10.1093/gerona/56.8.B364
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Kolettis TM, 2007, EUROPACE, V9, P1099, DOI 10.1093/europace/eum196
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Kontonika M, 2014, TRENDS BIOMATER ARTI, V28, P79
   Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee SW, 2010, J PLAST RECONSTR AES, V63, pE364, DOI 10.1016/j.bjps.2009.10.027
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Mitsi AC, 2005, MED HYPOTHESES, V64, P582, DOI 10.1016/j.mehy.2004.07.028
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Omerovic E, 2000, ENDOCRINOLOGY, V141, P4592, DOI 10.1210/en.141.12.4592
   Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0
   Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tanaka N, 1998, AM J PHYSIOL-HEART C, V275, pH393, DOI 10.1152/ajpheart.1998.275.2.H393
   van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207
   Vilaeti AD, 2013, INT J CARDIOL, V165, P278, DOI 10.1016/j.ijcard.2011.08.036
   Wright EJ, 2012, STEM CELL TRANSL MED, V1, P759, DOI 10.5966/sctm.2012-0064
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
NR 49
TC 3
Z9 3
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0897-7194
EI 1029-2292
J9 GROWTH FACTORS
JI Growth Factors
PY 2015
VL 33
IS 4
BP 250
EP 258
DI 10.3109/08977194.2015.1072527
PG 9
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA DD3IN
UT WOS:000369815600002
PM 26290214
DA 2018-10-20
ER

PT J
AU Liu, GL
   Xu, GQ
   Gao, ZH
   Liu, ZH
   Xu, JJ
   Wang, JS
   Zhang, CM
   Wang, SL
AF Liu, Guolin
   Xu, Guoquan
   Gao, Zhenhua
   Liu, Zhenhai
   Xu, Junji
   Wang, Jinsong
   Zhang, Chunmei
   Wang, Songlin
TI Demineralized Dentin Matrix Induces Odontoblastic Differentiation of
   Dental Pulp Stem Cells
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Demineralized dentin matrix; Dental pulp stem cell; Biomaterial;
   Osteogenesis; Dentinogenesis
ID GROWTH-FACTORS; IN-VITRO; SCAFFOLD MATERIAL; MESSENGER-RNA; TGF-BETA;
   REGENERATION; TISSUE; EXPRESSION; PROPERTY; MODEL
AB The aim of this study was to investigate the effect of demineralized dentin matrix (DDM) on dental pulp stem cells (DPSCs) and the potential of complexes with DPSCs and DDM for mineralized tissue formation. Stem cells derived from the dental pulp of healthy pigs aged 18 months were isolated and cultured. DPSCs were incubated with alpha minimum essential medium treated with DDM extract at 1 mg/ml (DDM1) or 10 mg/ml (DDM10). The concentrations of 3 growth factors in DDM extract was measured by enzyme-linked immunosorbent assay. Adhesion of DPSCs on DDM and hydroxyapatite-tricalcium phosphate (HA-TCP) surfaces was observed using scanning electron microscopy. Cell proliferation was evaluated with cell counting kit-8 and migration by Transwell migration assays. Odontoblastic differentiation was assessed by alkaline phosphatase (ALP) and alizarin red staining, ALP activity and real-time polymerase chain reaction analysis of markers of ALP, runt-related transcription factor 2, type I collagen, dentin matrix acidic phosphoprotein-1, osteonectin and dentin sialophosphoprotein (DSPP). Finally, DPSCs were combined with DDM and placed subcutaneously in nude mice for 12 weeks; DPSCs combined with HA-TCP and DDM alone served as controls. DDM could promote DPSC adhesion, migration and odontoblastic differentiation. Mineralized tissue formation was observed with the DPSC and DDM combination and the DPSC and HATCP combination. The mineralized tissue of the DPSC + DDM combination stained positive for DSPP, similar to the dentin tissue. These results indicate that DDM induces DPSC odontoblastic differentiation, suggesting applications for dentin regeneration. (C) 2015 S. Karger AG, Basel
C1 [Liu, Guolin; Xu, Guoquan; Gao, Zhenhua; Liu, Zhenhai; Xu, Junji; Wang, Jinsong; Zhang, Chunmei; Wang, Songlin] Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Wang, Songlin] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Liu, Guolin] Cangzhou Cent Hosp, Cangzhou, Peoples R China.
   [Xu, Guoquan] North China Univ Sci & Technol, Affiliated Hosp, Tangshan, Peoples R China.
RP Wang, SL (reprint author), Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
EM slwang@ccmu.edu.cn
FU Beijing Municipality Government grants (Beijing Scholar Program)
   [PXM2014_014226_000180, PXM2014_014226_000048, PXM2014_014226_000013,
   PXM2014_014226_000053, Z121100005212004, PXM2013_014226_000021,
   PXM2013_014226_07_000080, TJSHG201310025005]; National Basic Research
   Program of China [2010CB944801]
FX This work was supported by Beijing Municipality Government grants
   (Beijing Scholar Program: PXM2014_014226_000180, PXM2014_014226_000048,
   PXM2014_014226_000013, PXM2014_014226_000053, Z121100005212004,
   PXM2013_014226_000021, PXM2013_014226_07_000080, and TJSHG201310025005
   to S.W.) and the National Basic Research Program of China (2010CB944801
   to S.W.).
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bakhshalian N, 2013, INT J ORAL MAX IMPL, V28, P1655, DOI 10.11607/jomi .2833
   Cassidy N, 1997, ARCH ORAL BIOL, V42, P219, DOI 10.1016/S0003-9969(96)00115-X
   Chun SY, 2011, TISSUE ENG PT A, V17, P181, DOI [10.1089/ten.tea.2010.0121, 10.1089/ten.TEA.2010.0121]
   de Oliveira GS, 2013, AUST DENT J, V58, P326, DOI 10.1111/adj.12088
   Dechichi P, 2007, MICRON, V38, P486, DOI 10.1016/j.micron.2006.08.001
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   FINKELMAN RD, 1990, J BONE MINER RES, V5, P717
   Gomes MF, 2002, INT J ORAL MAX IMPL, V17, P488
   Gomes MF, 2001, INT J ORAL MAX IMPL, V16, P563
   Gomes MF, 2007, INT J ORAL MAX IMPL, V22, P939
   Gomes Mônica Fernandes, 2006, Braz. oral res., V20, P324, DOI 10.1590/S1806-83242006000400008
   Gomes Mônica Fernandes, 2008, Braz. oral res., V22, P275, DOI 10.1590/S1806-83242008000300015
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034
   HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Jensen J, 2015, TISSUE ENG PT A, V21, P729, DOI [10.1089/ten.tea.2014.0177, 10.1089/ten.TEA.2014.0177]
   Jiao L, 2014, BIOMATERIALS, V35, P4929, DOI 10.1016/j.biomaterials.2014.03.016
   Khorsand A, 2013, J ORAL IMPLANTOL, V39, P433, DOI 10.1563/AAID-JOI-D-12-00027
   Kim D, 2014, ARCH ORAL BIOL, V59, P765, DOI 10.1016/j.archoralbio.2014.04.014
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Martens W, 2014, FASEB J, V28, P1634, DOI 10.1096/fj.13-243980
   Mathieu S, 2013, J ENDODONT, V39, P228, DOI 10.1016/j.joen.2012.11.007
   Mead B, 2014, NEURAL REGEN RES, V9, P577, DOI 10.4103/1673-5374.130089
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nemeth CL, 2014, TISSUE ENG PT A, V20, P2817, DOI [10.1089/ten.tea.2013.0614, 10.1089/ten.TEA.2013.0614]
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Press T, 2015, INT ENDOD J, V48, P185, DOI 10.1111/iej.12299
   Qu TJ, 2014, TISSUE ENG PT A, V20, P2422, DOI [10.1089/ten.TEA.2013.0741, 10.1089/ten.tea.2013.0741]
   Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3
   Roozafzoon R, 2015, BIOCHEM BIOPH RES CO, V457, P154, DOI 10.1016/j.bbrc.2014.12.069
   Saghiri MA, 2015, J ENDODONT, V41, P797, DOI 10.1016/j.joen.2014.12.019
   Schaffer E.M., 1957, J PERIODONTOL, V28, P125
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Tran H.L., 2015, CELL TISSUE BANK
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Woloszyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111010
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yamamoto A, 2014, NEUROSCI RES, V78, P16, DOI 10.1016/j.neures.2013.10.010
   Yao S, 2008, J DENT RES, V87, P767, DOI 10.1177/154405910808700801
   Zhao S, 2000, HISTOCHEM J, V32, P489, DOI 10.1023/A:1004100518245
   Zheng Y, 2012, J DENT RES, V91, P676, DOI 10.1177/0022034512449834
NR 46
TC 7
Z9 7
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2015
VL 201
IS 1
BP 65
EP 76
DI 10.1159/000440952
PG 12
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA DC1JR
UT WOS:000368973100006
PM 26569105
DA 2018-10-20
ER

PT J
AU Saxena, AK
   Misra, RK
   Dixit, A
AF Saxena, Arjit Kumar
   Misra, Raghvendra Kumar
   Dixit, Anurag
TI Numerical Analysis of Hip Joint Implant
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Conference on Materials Processing and Characterzation
   (ICMPC)
CY MAR 14, 2015
CL Gokaraju Rangaraju Inst Engin & Technol, Hyderabad, INDIA
HO Gokaraju Rangaraju Inst Engin & Technol
DE Biomaterial; Hip Implant; Femur; Prosthesis; ANSYS
ID BONE
AB Bones form the rigid skeletal framework of the body which deftly protect the internal vital organs along with allowing various movements and tasks at the different kinds of joints formed by these bones. It is a well - known fact that there are 206 bones in the adult body. However, this skeleton over which our entire body is structured is highly prone to get affected by trauma. Any trauma to any bone in the body can be mighty painful for the patient. These situations are dealt with by Orthopaedic surgeons. When trauma is suffered by Femur, the longest and strongest bone of the body, forming the length of the thigh, it becomes an emergency as often the patient is an elderly with weak bones and, if not attended to on time, this fracture can lead to massive blood loss. In elderly patients, a mere repair of the fracture of femur doesn't work. It is required to make their bone strong enough to bear the weight of the body again. For this, surgeons often use implants made of biomaterials like Titanium. A comparative study has been performed between Titanium, Stainless Steel and Aluminium made implant. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Saxena, Arjit Kumar; Misra, Raghvendra Kumar; Dixit, Anurag] Gautam Buddha Univ, Sch Engn, Dept Mech Engn, Greater Noida 201312, India.
RP Saxena, AK (reprint author), Gautam Buddha Univ, Sch Engn, Dept Mech Engn, Greater Noida 201312, India.
EM author@institute.xxx
CR Abdullah Abdul H., 2010, P INT MULTICONFERENC, VIII
   Chen TH, 2009, J MED BIOL ENG, V29, P108
   Das Sandeep, 2014, INT J BASIC APPL BIO, V1, P1
   Grecu D, 2010, ROM J MORPHOL EMBRYO, V51, P151
   Huang BW, 2012, LIFE SCI J, V9, P723
   Jade Sameer, 1896, THESIS
   Keaveny Tony M., STANDARD HDB BIOMEDI
   LI CD, 2003, FAILURE ANAL COMPOSI, V40, P131
   Monostori R., 2011, HUNGARIAN J IND CHEM, V39, P225
   O'Neill MC, 2004, J HUM EVOL, V47, P221, DOI 10.1016/j.jhevol.2004.07.002
   Pierre MA, 2010, J BIOMECH, V43, P2228, DOI 10.1016/j.jbiomech.2010.02.032
   RoyiFedida Zohar Yosibash, 2005, 2 INT C COMP BIOENG
   Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253
   Shinge AR, 2011, INT J ADV BIOTECHNOL, V2, P278
   Vahdat SeyedEbrahim, 2013, ADV MAT MANUFACTURIN, V3
   Voo Liming, 2004, J HOPKINS APL TECHNI, V25
   Weaver Timothy D., 2003, SHAPE NEANDERTAL FEM, V100
   Yousif A. E., 2012, IOSR J ENG IOSRJEN, V2, P13
   Ziylan T, 2002, TURK J MED SCI, V32, p231 
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2015
VL 2
IS 4-5
BP 1649
EP 1656
DI 10.1016/j.matpr.2015.07.092
PG 8
GA CU4AF
UT WOS:000363467600075
DA 2018-10-20
ER

PT J
AU Banoriya, D
   Purohit, R
   Dwivedi, RK
AF Banoriya, Deepen
   Purohit, Rajesh
   Dwivedi, R. K.
TI Modern Trends in Rapid Prototyping for Biomedical Applications
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th International Conference on Materials Processing and Characterzation
   (ICMPC)
CY MAR 14, 2015
CL Gokaraju Rangaraju Inst Engin & Technol, Hyderabad, INDIA
HO Gokaraju Rangaraju Inst Engin & Technol
DE Rapidprototyping; Stereo lithography; Biomaterials; Surgery; Dentresty;
   Orthopaedics
ID SCAFFOLDS; TECHNOLOGY; STEREOLITHOGRAPHY; FABRICATION; DENTISTRY
AB Rapid prototyping is known by many terms as per the technologies involved, like SFF or solid freeform fabrication, FF or freeform fabrication, digital fabrication, AFF or automated freeform fabrication, 3D printing, solid imaging, layer based manufacturing, laser prototyping and additive manufacturing. Rapid prototyping is a revolutionary and powerful technology with wide range of applications. The importance of rapid prototyping is to quickly fabricate complex-shaped, 3D parts directly from computer aided design models, which is based upon decomposition of 3D computer models data into thin cross-sectional layers, followed by physically forming the layers and stacking them up; "layer by layer technique". The process of prototyping involves quick building up of a prototype or working models for the purpose of testing the various design features, ideas, concepts, functionality, output and performance. This paper covers possibilities of using RP technologies based on biomaterial. Using RP in biomedical is a quite complex task which implies a multidisciplinary approach and very good knowledge of engineering as well as medicine. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Banoriya, Deepen; Purohit, Rajesh; Dwivedi, R. K.] MANIT, Dept Mech Engn, Bhopal 462003, India.
RP Purohit, R (reprint author), MANIT, Dept Mech Engn, Bhopal 462003, India.
EM deepenbanoriya007@gmail.com; rpurohit73@gmail.com; nitb.ravi@gmail.com
OI Purohit, Rajesh/0000-0001-6702-4662
CR Azari A, 2009, RAPID PROTOTYPING J, V15, P216, DOI 10.1108/13552540910961946
   Chan Daniel C N, 2004, J Dent Educ, V68, P64
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Clair JJ, 1996, J MATER PROCESS TECH, V57, P393, DOI 10.1016/0924-0136(95)02072-1
   Garrett R, 2006, BIOMATERIALS, V27, P2651
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Hammel EC, 2014, CERAM INT, V40, P15351, DOI 10.1016/j.ceramint.2014.06.095
   Jelena M, 2007, MECH ENG, V5, P79
   Karthicka R., 2014, PROCEDIA MAT SCI, V6, P1989
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Liu QB, 2006, INT J ADV MANUF TECH, V29, P317, DOI 10.1007/s00170-005-2523-2
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Madhav VNV, 2013, J DENT ALLIED SCI, V2, P57
   Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068
   Melchels Ferry PW, 2010, BIOMATERIALS, V31, p6 121, DOI DOI 10.1016/J.BIOMATERIALS.2010.04.050
   Mota Carlos, 2014, J TISSUE ENG REGEN M, V1, P245
   Nizam A, 2006, ARCH OROFAC SCI, V1, P60
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6603, DOI 10.1016/j.apsusc.2007.01.062
   Petzold R, 1999, COMPUT MED IMAG GRAP, V23, P277, DOI 10.1016/S0895-6111(99)00025-7
   Purohit Rajesh, 2007, FUTURE TRENDS COMPOS, V1, P12
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Seol YJ, 2014, EUR J CARDIO-THORAC, V46, P342, DOI 10.1093/ejcts/ezu148
   van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014
   Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427
   Wu M, 2001, DENT MATER, V17, P102, DOI 10.1016/S0109-5641(00)00037-3
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
NR 28
TC 4
Z9 4
U1 5
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2015
VL 2
IS 4-5
BP 3409
EP 3418
DI 10.1016/j.matpr.2015.07.316
PG 10
GA CU4AF
UT WOS:000363467600284
DA 2018-10-20
ER

PT S
AU Hotaling, NA
   Tang, L
   Irvine, DJ
   Babensee, JE
AF Hotaling, Nathan A.
   Tang, Li
   Irvine, Darrell J.
   Babensee, Julia E.
BE Yarmush, ML
TI Biomaterial Strategies for Immunomodulation
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE immunoengineering; vaccination; immunotherapy
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SECONDARY LYMPHOID ORGANS;
   ADAPTIVE IMMUNE-RESPONSES; DENDRITIC CELL MATURATION; ANTIGEN-PRESENTING
   CELL; REGULATORY T-CELLS; DRUG-DELIVERY; IN-VITRO; POLYMERIC
   NANOPARTICLES; CONTROLLED-RELEASE
AB Strategies to enhance, suppress, or qualitatively shape the immune response are of importance for diverse biomedical applications, such as the development of new vaccines, treatments for autoimmune diseases and allergies, strategies for regenerative medicine, and immunotherapies for cancer. However, the intricate cellular and molecular signals regulating the immune system are major hurdles to predictably manipulating the immune response and developing safe and effective therapies. To meet this challenge, biomaterials are being developed that control how, where, and when immune cells are stimulated in vivo, and that can finely control their differentiation in vitro. We review recent advances in the field of biomaterials for immunomodulation, focusing particularly on designing biomaterials to provide controlled immunostimulation, targeting drugs and vaccines to lymphoid organs, and serving as scaffolds to organize immune cells and emulate lymphoid tissues. These ongoing efforts highlight the many ways in which biomaterials can be brought to bear to engineer the immune system.
C1 [Hotaling, Nathan A.; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Hotaling, Nathan A.; Babensee, Julia E.] Emory Univ, Sch Med, Atlanta, GA 30332 USA.
   [Hotaling, Nathan A.; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Babensee, Julia E.] Georgia Inst Technol, Ctr Immunoengn, Atlanta, GA 30332 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Tang, Li; Irvine, Darrell J.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
   [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Hotaling, NA (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM djirvine@mit.edu; julia.babensee@bme.gatech.edu
OI Hotaling, Nathan/0000-0001-8423-6464; Tang, Li/0000-0002-6393-982X
FU NCI NIH HHS [R01 CA174795, CA172164, R01 CA172164, CA174795]; NCATS NIH
   HHS [UL1 TR000454, UL1TR000454]; NIAID NIH HHS [R01 AI095109, AI104715,
   AI095109, P01 AI104715]; NIBIB NIH HHS [1R21EB012339-01A1, R21 EB012339,
   R01 EB004633, 1R01EB004633-01A1]; Howard Hughes Medical Institute
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Al Kobiasi M, 2012, J BIOMED MATER RES A, V100A, P1859, DOI 10.1002/jbm.a.34153
   Aldinucci A, 2013, NANO LETT, V13, P6098, DOI 10.1021/nl403396e
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200
   Anderson AO, 2005, IMMUNITY, V22, P3, DOI 10.1016/j.immuni.2005.01.003
   Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039
   BAUMGARTNER HR, 1973, MICROVASC RES, V5, P167, DOI 10.1016/0026-2862(73)90069-1
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266
   Bielekova B, 2000, NAT MED, V6, P1167
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063
   Chen L, 1997, J CONTROL RELEASE, V43, P261, DOI 10.1016/S0168-3659(96)01496-4
   Chueh FY, 2012, BIOCHEM BIOPH RES CO, V426, P242, DOI 10.1016/j.bbrc.2012.08.074
   Cupedo T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00343
   Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Decuzzi P, 2005, ANN BIOMED ENG, V33, P179, DOI 10.1007/s10439-005-8976-5
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Demento S, 2009, IEEE ENG MED BIO, P1161, DOI 10.1109/IEMBS.2009.5332625
   Demento SL, 2011, TRENDS BIOTECHNOL, V29, P294, DOI 10.1016/j.tibtech.2011.02.004
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330
   Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390
   Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
   Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x
   Fadel TR, 2008, NANO LETT, V8, P2070, DOI 10.1021/nl080332i
   Fadel TR, 2013, SMALL, V9, P666, DOI 10.1002/smll.201201684
   Fahmy TM, 2007, NANOMED-NANOTECHNOL, V3, P75, DOI 10.1016/j.nano.2006.11.010
   Fernandez I, 2014, STEM CELLS, V32, P93, DOI 10.1002/stem.1512
   Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148
   Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Freedman MS, 2011, NEUROLOGY, V77, P1551, DOI 10.1212/WNL.0b013e318233b240
   Garcia-Cordero JL, 2013, INTEGR BIOL-UK, V5, P650, DOI 10.1039/c3ib20263a
   Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Giese C, 2006, ARTIF ORGANS, V30, P803, DOI 10.1111/j.1525-1594.2006.00303.x
   GOLUMBEK PT, 1993, CANCER RES, V53, P5841
   Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102
   GREF R, 1995, ADV DRUG DELIVER REV, V16, P215, DOI 10.1016/0169-409X(95)00026-4
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19
   Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748
   Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Holzapfel V, 2005, MACROMOL CHEM PHYSIC, V206, P2440, DOI 10.1002/macp.200500372
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   HORA MS, 1990, BIO-TECHNOL, V8, P755, DOI 10.1038/nbt0890-755
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Hotaling NA, 2014, BIOMATER SCI-UK, V2, P1426, DOI 10.1039/c4bm00138a
   Hotaling NA, 2014, BIOMATERIALS, V35, P5862, DOI 10.1016/j.biomaterials.2014.03.048
   Hudalla GA, 2013, ADV HEALTHC MATER, V2, P1114, DOI 10.1002/adhm.201200435
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251
   ILLUM L, 1982, INT J PHARM, V12, P135
   Irvine DJ, 2008, SEMIN IMMUNOL, V20, P137, DOI 10.1016/j.smim.2007.10.010
   Ishii KJ, 2005, J CLIN IMMUNOL, V25, P511, DOI 10.1007/s10875-005-7829-1
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2013, J LEUKOCYTE BIOL, V94, P981, DOI 10.1189/jlb.0312167
   Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Joshi VB, 2013, AAPS J, V15, P85, DOI 10.1208/s12248-012-9418-6
   JULIANO RL, 1975, BIOCHEM BIOPH RES CO, V63, P651, DOI 10.1016/S0006-291X(75)80433-5
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Kaminskas LM, 2011, FUND BIOMED TECHNOL, V5, P155, DOI 10.1007/978-94-007-1248-5_6
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kodali VK, 2007, SOFT MATTER, V3, P337, DOI 10.1039/b611022n
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   Kuo-Haller P, 2010, MOL PHARMACEUT, V7, P1585, DOI 10.1021/mp100009e
   Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x
   Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]
   Li YP, 2001, J CONTROL RELEASE, V71, P287, DOI 10.1016/S0168-3659(01)00235-8
   Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105
   Mackinnon S, 2008, BLOOD CELL MOL DIS, V40, P63, DOI 10.1016/j.bcmd.2007.07.003
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054
   Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Metcalfe SM, 2005, TRANSPLANTATION, V79, P726, DOI 10.1097/01.TP.0000149324.42994.38
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003
   Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817
   Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127
   Musyanovych A, 2011, ACTA BIOMATER, V7, P4160, DOI 10.1016/j.actbio.2011.07.033
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129
   Okamoto N, 2007, J CLIN INVEST, V117, P997, DOI 10.1172/JCI30379
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011
   Park J, 2015, J BIOMED MATER RES A, V103, P170, DOI 10.1002/jbm.a.35150
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]
   Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a
   Pescatori M, 2013, BIOMATERIALS, V34, P4395, DOI 10.1016/j.biomaterials.2013.02.052
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Pisani MJ, 2009, J INORG BIOCHEM, V103, P373, DOI 10.1016/j.jinorgbio.2008.11.014
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rehor A, 2005, LANGMUIR, V21, P411, DOI 10.1021/la0478043
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116
   Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Sanchez A, 2003, EUR J PHARM SCI, V18, P221, DOI 10.1016/S0928-0987(03)00019-8
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Schweingruber N, 2011, J IMMUNOL, V187, P4310, DOI 10.4049/jimmunol.1101604
   Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070
   Shibata Y, 2012, J IMMUNOL, V188
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Sieving A, 2003, J BIOMED MATER RES A, V64A, P457, DOI 10.1002/jbm.a.10368
   Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Steenblock ER, 2011, J BIOL CHEM, V286, P34883, DOI 10.1074/jbc.M111.276329
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Tan JKH, 2010, ADV IMMUNOL, V105, P131, DOI 10.1016/S0065-2776(10)05005-4
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Thomas TP, 2011, ARTHRITIS RHEUM-US, V63, P2671, DOI 10.1002/art.30459
   THOMPSON JA, 1987, CANCER RES, V47, P4202
   Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667
   Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wang L, 2014, MOL MED REP, V10, P473, DOI 10.3892/mmr.2014.2178
   Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499
   Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021
   Xu F, 2009, INT J PHARMACEUT, V377, P199, DOI 10.1016/j.ijpharm.2009.05.015
   Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028
   Yang ZP, 2004, J CHROMATOGR A, V1053, P79, DOI 10.1016/j.chroma.2004.08.150
   Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107
   Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109
   Yin YD, 2001, ADV MATER, V13, P267, DOI 10.1002/1521-4095(200102)13:4<267::AID-ADMA267>3.0.CO;2-9
   Yoo JW, 2011, ADV DRUG DELIVER REV, V63, P1247, DOI 10.1016/j.addr.2011.05.004
   Yoo JW, 2010, CURR PHARM DESIGN, V16, P2298, DOI 10.2174/138161210791920496
   Yoo JW, 2010, MACROMOL RAPID COMM, V31, P142, DOI 10.1002/marc.200900592
   Yuan F, 1998, SEMIN RADIAT ONCOL, V8, P164, DOI 10.1016/S1053-4296(98)80042-8
   Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b
   Zhang K, 2008, BIOCONJUGATE CHEM, V19, P1880, DOI 10.1021/bc800160b
   Zhao H, 2010, J CONTROL RELEASE, V141, P145, DOI 10.1016/j.jconrel.2009.09.002
   Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037
   Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207
NR 193
TC 37
Z9 38
U1 8
U2 74
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3517-5
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2015
VL 17
BP 317
EP 349
DI 10.1146/annurev-bioeng-071813-104814
PG 33
WC Engineering, Biomedical
SC Engineering
GA BE0XE
UT WOS:000367291800013
PM 26421896
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Konakov, VG
   Kurapova, OY
   Novik, NN
   Pivovarov, MM
   Archakov, IY
AF Konakov, V. G.
   Kurapova, O. Yu
   Novik, N. N.
   Pivovarov, M. M.
   Archakov, I. Yu
TI NANOSTRUCTURED YSZ COATINGS ON TITANIUM
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID ZIRCONIA COATINGS; HPT TITANIUM; IMPLANTS; BIOMATERIAL; CERAMICS; ALLOY
AB An approach providing yttrium-stabilized zirconia coatings deposition on titanium is suggested. High-quality YSZ coatings with 5-6 mu m thickness were studied using SEM and XRD, the mechanical properties (Brenell and Moos hardness) of covered samples were compared with pure titanium characteristics. The regimes of titanium wafer pretreatment were optimized. It was shown that both 8Y(2)O(3)-92ZrO(2) and 9Y(2)O(3)-10TiO(2)-92ZrO(2) coatings increase the material hardness.
C1 [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.; Archakov, I. Yu] Peter Great St Petersburg Polytech Univ, Res Lab Mech New Nanomat, St Petersburg 195251, Russia.
   [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.] St Petersburg State Univ, Inst Chem, St Petersburg 198504, Russia.
   [Konakov, V. G.; Kurapova, O. Yu; Novik, N. N.; Pivovarov, M. M.] Glass & Ceram Ltd, St Petersburg 199004, Russia.
   [Archakov, I. Yu] St Petersburg State Univ, Dept Mech & Math, St Petersburg 198504, Russia.
   [Archakov, I. Yu] Inst Problems Mech Engn, St Petersburg 199178, Russia.
RP Kurapova, OY (reprint author), Peter Great St Petersburg Polytech Univ, Res Lab Mech New Nanomat, Polytech Skaya 29, St Petersburg 195251, Russia.
EM glasscer@yandex.ru
OI Kurapova, Olga/0000-0002-7148-7755
FU Russian Science Foundation [14-29-00199]
FX This work was supported by the Russian Science Foundation (Project
   14-29-00199).
CR Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   de Groot K., 1998, P I MECH ENG, V2, P212
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Huang HL, 2013, THIN SOLID FILMS, V528, P151, DOI 10.1016/j.tsf.2012.07.143
   Ivanov-Pavlov D. A., 2010, B ST PETERSBURG STAT, V4, P139
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Konakov VG, 2014, MATER PHYS MECH, V21, P305
   Konakov VG, 2015, REV ADV MATER SCI, V41, P99
   Kurapova OY, 2012, REV ADV MATER SCI, V32, P112
   Lamolle S. F., 2008, J BIOMEDICAL MAT R A, V88, P581
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Schwarz M. L., 2008, J BIOMEDICAL MAT R A, V89, P667
   Wenz H. J., 2007, INT J PROSTHODONT, V21, P27
   Zhilyaev AP, 2014, REV ADV MATER SCI, V39, P15
   Zhou H, 2007, SURF COAT TECH, V201, P7360, DOI 10.1016/j.surfcoat.2007.02.010
NR 20
TC 1
Z9 1
U1 0
U2 2
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PY 2015
VL 43
IS 1-2
BP 94
EP 101
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CZ7KF
UT WOS:000367277600015
DA 2018-10-20
ER

PT J
AU Ventura, MG
   Paninho, AI
   Nunes, AVM
   Fonseca, IM
   Branco, LC
AF Ventura, Marcia G.
   Paninho, Ana I.
   Nunes, Ana V. M.
   Fonseca, Isabel M.
   Branco, Luis C.
TI Biocompatible locust bean gum mesoporous matrices prepared by ionic
   liquids and a scCO(2) sustainable system
SO RSC ADVANCES
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; CONTROLLED-RELEASE; SODIUM ALGINATE; AEROGELS;
   IBUPROFEN; POLYSACCHARIDES; CELLULOSE; SILICA; GALACTOMANNAN; SOLVENTS
AB Locust bean gum (LBG) is a natural polymer that belongs to the increasingly attractive biodegradable polymers derived from natural sources. This polymer possesses a number of appealing features such as non-toxicity that confer it a high potential for the use in fields such as pharmacy and food industries. In this work, three methylimidazolium-based ionic liquids (ILs) were used as alternative media in the preparation of biocompatible LBG gel matrices. The process consists of dissolving the biomaterial in a selected IL followed by a multi-step solvent exchange using a mixture of water and ethanol. The final gel (internal surface areas ranging from 60 to 180 m(2) g(-1)) is then dried using a semi-continuous high pressure CO2 extraction process. To the best of our knowledge this is the first time that LBG mesoporous gel matrices are reported using this efficient sustainable method.
C1 [Ventura, Marcia G.; Paninho, Ana I.; Nunes, Ana V. M.; Fonseca, Isabel M.; Branco, Luis C.] Univ Nova Lisboa, Dept Quim, LAQV REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
RP Ventura, MG (reprint author), Univ Nova Lisboa, Dept Quim, LAQV REQUIMTE, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
EM mm.ventura@fct.unl.pt; l.branco@fct.unl.pt
RI Branco, Luis/C-6426-2013; Nunes, Ana/D-2045-2013; Ventura,
   Marcia/C-6702-2013; Fonseca, Isabel/D-2513-2013
OI Branco, Luis/0000-0003-2520-1151; Nunes, Ana/0000-0001-9928-1903;
   Fonseca, Isabel/0000-0001-7007-9525; Ventura, Marcia/0000-0003-2493-4900
FU FCT-MCTES (Portugal) [PTDC/CTM/103664/2008, PTDC/CTM-NAN/120658/2010,
   PTDC/EQU-EQU/104552/2008, SFRH/BPD/40008/2007, SFRH/BPD/74994/2010]
FX FCT-MCTES (Portugal) is acknowledged for financial support through the
   projects PTDC/CTM/103664/2008, PTDC/CTM-NAN/120658/2010,
   PTDC/EQU-EQU/104552/2008, and post-doc grants SFRH/BPD/40008/2007 (MGV)
   and SFRH/BPD/74994/2010 (AVMN). The authors would like to thanks to Dr
   Nuno Costa for the technical support on the porosimetry analysis.
CR Aaltonen O, 2009, CARBOHYD POLYM, V75, P125, DOI 10.1016/j.carbpol.2008.07.008
   Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Avachat AM, 2011, INDIAN J PHARM EDUC, V45, P86
   Babu VR, 2006, J APPL POLYM SCI, V99, P2671, DOI 10.1002/app.22760
   Biswas A, 2006, CARBOHYD POLYM, V66, P546, DOI 10.1016/j.carbpol.2006.04.005
   Dionisio M, 2012, J PHARM BIOALLIED SC, V4, P175, DOI 10.4103/0975-7406.99013
   Escudero RR, 2009, CARBOHYD POLYM, V75, P52, DOI 10.1016/j.carbpol.2008.06.008
   FRICKE J, 1988, SCI AM, V258, P92, DOI 10.1038/scientificamerican0588-92
   Garcia-Gonzalez CA, 2011, CARBOHYD POLYM, V86, P1425, DOI 10.1016/j.carbpol.2011.06.066
   Hirsch S, 1999, EUR J PHARM BIOPHARM, V47, P61, DOI 10.1016/S0939-6411(98)00089-7
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Kadokawa JI, 2013, J BIOBASED MATER BIO, V7, P3, DOI 10.1166/jbmb.2013.1275
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Kulkarni VS, 2012, INT J PHARM BIOMED S, V3, P1597
   Liebert T, 2008, BIORESOURCES, V3, P576
   Martins JT, 2012, FOOD HYDROCOLLOID, V29, P280, DOI 10.1016/j.foodhyd.2012.03.004
   Paninho AB, 2013, J SUPERCRIT FLUID, V83, P35, DOI 10.1016/j.supflu.2013.08.002
   Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947
   Prajapati VD, 2013, CARBOHYD POLYM, V94, P814, DOI 10.1016/j.carbpol.2013.01.086
   Quignard F, 2008, NEW J CHEM, V32, P1300, DOI 10.1039/b808218a
   Rao KSVK, 2006, J APPL POLYM SCI, V102, P5708, DOI 10.1002/app.25087
   Robitzer M, 2011, MICROPOR MESOPOR MAT, V140, P9, DOI 10.1016/j.micromeso.2010.10.006
   Santamaria E, 2014, J SOLID STATE CHEM, V210, P242, DOI 10.1016/j.jssc.2013.11.031
   Smirnova I, 2003, LANGMUIR, V19, P8521, DOI 10.1021/la0345587
   Sujja-areevath J, 1998, EUR J PHARM SCI, V6, P207, DOI 10.1016/S0928-0987(97)00072-9
   Takada A, 2015, BIOMOLECULES, V5, P244, DOI 10.3390/biom5010244
   Vendruscolo CW, 2005, INT J PHARMACEUT, V296, P1, DOI 10.1016/j.ijpharm.2005.02.007
   Vijayaraghavan C., 2008, PHARMAZIE, V5, P342
   White RJ, 2008, CHEMSUSCHEM, V1, P408, DOI 10.1002/cssc.200800012
   Williams P. A., 2000, HDB HYDROCOLLOIDS, P137
   Yamagar M., 2004, INT J RES PHARM BIOM, V2, P453
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 32
TC 4
Z9 4
U1 1
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 130
BP 107700
EP 107706
DI 10.1039/c5ra17314k
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA CZ7HY
UT WOS:000367271700060
DA 2018-10-20
ER

PT J
AU Ma, GF
   Zhang, ZG
   Sun, KJ
   Peng, H
   Yang, Q
   Ran, FT
   Lei, ZQ
AF Ma, Guofu
   Zhang, Zhiguo
   Sun, Kanjun
   Peng, Hui
   Yang, Qian
   Ran, Feitian
   Lei, Ziqiang
TI White clover based nitrogen-doped porous carbon for a high energy
   density supercapacitor electrode
SO RSC ADVANCES
LA English
DT Article
ID HIGH-PERFORMANCE SUPERCAPACITORS; STORAGE; GRAPHENE; PYROLYSIS; FLOWER
AB We have employed the biomaterial white clover as a carbon precursor and ZnCl2 as an activating agent to prepare white clover carbons (WCCs). The WCC-2 (mass ratios of white clover and ZnCl2 is 1 : 2) possesses as high as 6.9 wt% nitrogen content and 857 m(2) g(-1) BET surface area. Furthermore, it exhibits 233.1 F g(-1) specific capacitance at a current density of 1.0 A g(-1), even 82.9% capacitance retention at 20 A g(-1) in 2 mol L-1 KOH electrolyte. The specific capacitance could remain at almost about 100.0% when the cycle number is between the 200-5000 cycles. Because of the wide potential window (0-2.0 V) and high specific capacitance, the WCC-2//WCC-2 symmetric capacitor shows an energy density of 30-13.1 W h kg(-1) under the power outputs of 503.5-9991.5 W kg(-1) in 0.5 mol L-1 Na2SO4 electrolyte. The results demonstrate WCC-2 can be a promising candidate for the electrode material of high performance supercapacitors.
C1 [Ma, Guofu; Zhang, Zhiguo; Peng, Hui; Yang, Qian; Ran, Feitian; Lei, Ziqiang] Northwest Normal Univ, Key Lab Polymer Mat Gansu Prov, Key Lab Ecoenvironm Related Polymer Mat, Minist Educ,Coll Chem & Chem Engn, Lanzhou 730070, Peoples R China.
   [Sun, Kanjun] Lanzhou City Univ, Coll Chem & Environm Sci, Lanzhou 730070, Peoples R China.
RP Ma, GF (reprint author), Northwest Normal Univ, Key Lab Polymer Mat Gansu Prov, Key Lab Ecoenvironm Related Polymer Mat, Minist Educ,Coll Chem & Chem Engn, Lanzhou 730070, Peoples R China.
EM magf@nwnu.edu.cn; leizq@nwnu.edu.cn
FU National Science Foundation of China [21164009, 21174114]; program for
   Changjiang Scholars and Innovative Research Team in University
   [IRT1177]; Science and Technology Program of Gansu Province
   [1308RJZA295, 1308RJZA265]; Key Laboratory of Eco-Environment-Related
   Polymer Materials (Northwest Normal University) of Ministry of
   Education; Key Laboratory of Polymer Materials of Gansu Province
FX This research was financially supported by the National Science
   Foundation of China (No. 21164009, 21174114), the program for Changjiang
   Scholars and Innovative Research Team in University (IRT1177), the
   Science and Technology Program of Gansu Province (No. 1308RJZA295,
   1308RJZA265), Key Laboratory of Eco-Environment-Related Polymer
   Materials (Northwest Normal University) of Ministry of Education, and
   Key Laboratory of Polymer Materials of Gansu Province.
CR Casey NM, 2010, THEOR APPL GENET, V121, P567, DOI 10.1007/s00122-010-1330-9
   Chang JL, 2015, ELECTROCHIM ACTA, V157, P290, DOI 10.1016/j.electacta.2014.12.169
   Chen HC, 2013, J PHYS CHEM C, V117, P8318, DOI 10.1021/jp4017773
   Chen LF, 2012, ACS NANO, V6, P7092, DOI 10.1021/nn302147s
   Dai LM, 2012, SMALL, V8, P1130, DOI 10.1002/smll.201101594
   Denisa H. J., 2009, ADV FUNCT MATER, V19, P438
   Ding J, 2015, ENERG ENVIRON SCI, V8, P941, DOI 10.1039/c4ee02986k
   Dutta S, 2014, ENERG ENVIRON SCI, V7, P3574, DOI 10.1039/c4ee01075b
   Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4
   Gao SY, 2015, ENERG ENVIRON SCI, V8, P221, DOI 10.1039/c4ee02087a
   Hu CX, 2015, RSC ADV, V5, P14441, DOI 10.1039/c4ra12220h
   Li Z, 2013, ENERG ENVIRON SCI, V6, P871, DOI 10.1039/c2ee23599d
   Lillo-Rodenas MA, 2001, CARBON, V39, P751, DOI 10.1016/S0008-6223(00)00186-X
   Liu MX, 2015, J MATER CHEM A, V3, P11517, DOI 10.1039/c5ta02224j
   Luo W, 2014, NANO LETT, V14, P2225, DOI 10.1021/nl500859p
   Ma XM, 2013, J SOLID STATE ELECTR, V17, P2293, DOI 10.1007/s10008-013-2110-7
   Mascotto S, 2015, CARBON, V82, P425, DOI 10.1016/j.carbon.2014.10.086
   Paraknowitsch JP, 2010, ADV MATER, V22, P87, DOI 10.1002/adma.200900965
   PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6
   Pensado AS, 2014, RSC ADV, V4, P18017, DOI 10.1039/c4ra02059f
   Puthusseri D, 2014, ENERG ENVIRON SCI, V7, P728, DOI 10.1039/c3ee42551g
   Qu WH, 2015, BIORESOURCE TECHNOL, V189, P285, DOI 10.1016/j.biortech.2015.04.005
   Ramanathan R, 2015, RSC ADV, V5, P1424, DOI 10.1039/c4ra14510k
   Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018
   Sun L, 2014, CHEM-EUR J, V20, P564, DOI 10.1002/chem.201303345
   Tang J, 2015, ANGEW CHEM INT EDIT, V54, P588, DOI 10.1002/anie.201407629
   Tripathi PK, 2014, J MATER CHEM A, V2, P8534, DOI 10.1039/c4ta00578c
   Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021
   Wang H, 2013, ACS NANO, V7, P5131, DOI 10.1021/nn400731g
   Wang Q, 2014, CARBON, V67, P119, DOI 10.1016/j.carbon.2013.09.070
   Wang Q, 2013, J POWER SOURCES, V225, P101, DOI 10.1016/j.jpowsour.2012.10.022
   Wu H, 2013, J POWER SOURCES, V226, P202, DOI 10.1016/j.jpowsour.2012.11.014
   Wu XL, 2013, ACS NANO, V7, P3589, DOI 10.1021/nn400566d
   Wu XZ, 2012, J MATER CHEM, V22, P23186, DOI 10.1039/c2jm35278h
   Yan J, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400500
   Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089
   Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984
   Zhang YZ, 2015, CHEM SOC REV, V44, P5181, DOI 10.1039/c5cs00174a
   Zhao QL, 2015, ELECTROCHIM ACTA, V173, P566, DOI 10.1016/j.electacta.2015.05.096
   Zhao YH, 2015, ELECTROCHIM ACTA, V153, P448, DOI 10.1016/j.electacta.2014.11.173
   Zhong HX, 2014, J MATER CHEM A, V2, P17047, DOI 10.1039/c4ta03778b
   Zhu DZ, 2015, ELECTROCHIM ACTA, V158, P166, DOI 10.1016/j.electacta.2015.01.155
NR 42
TC 1
Z9 2
U1 2
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 130
BP 107707
EP 107715
DI 10.1039/c5ra20327a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA CZ7HY
UT WOS:000367271700061
DA 2018-10-20
ER

PT J
AU Boehm, MW
   Shewan, HM
   Steen, JA
   Stokes, JR
AF Boehm, Michael W.
   Shewan, Heather M.
   Steen, Jennifer A.
   Stokes, Jason R.
TI ILLUSTRATING ULTRA-LOW-VOLUME RHEOLOGY ON A CONVENTIONAL RHEOMETER:
   CHARTING THE DEVELOPMENT OF HYALURONAN DURING FERMENTATION
SO APPLIED RHEOLOGY
LA English
DT Article
DE Ultra-low-volume rheology; narrow gap; hyaluronan; intrinsic viscosity;
   molecular weight
ID ATOMIC-FORCE MICROSCOPY; PARALLEL-PLATE RHEOMETRY; MOLECULAR-WEIGHT;
   STREPTOCOCCUS-ZOOEPIDEMICUS; BIOMATERIAL HYDROGELATORS; VISCOELASTIC
   BEHAVIOR; KNEE OSTEOARTHRITIS; ACID PRODUCTION; SHEAR-RATE; THIN-FILM
AB We provide methodologiesto characterise the rheology of ultra-low volumes of polymer solutions and biological fluids (10-100 mu L) on a rotational rheometer. The technique utilises a parallel plate geometry with narrow gaps of 20-100 micrometers, which is an order of magnitude less than conventional methods. Despite the complications these gaps present, the use of appropriate protocols ensures reliable and accurate rheological characterisation offluids, including shear-dependent viscosity, normal stresses and linear viscoelasticity. This rheological technique's usefulness is further demonstrated by showing how the rheology of hyaluronan solutions evolve during fermentation. The intrinsic viscosity of the hyaluronan macromolecule is determined using less than loo mu L of solution extracted directly from the bioreactor, and this is used to provide a reasonable indicator of its molecular weight as it develops during the fermentation process. The ability to measure rheology of ultra-low volumes has applications in the characterisation of biological fluids and high value macromolecules, as well as generally in biotechnology and nanotechnology research fields.
C1 [Boehm, Michael W.; Shewan, Heather M.; Stokes, Jason R.] Univ Queensland, Sch Chem Engn, Rheol & Biolubricat Lab, Brisbane, Qld 4072, Australia.
   [Steen, Jennifer A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Stokes, Jason R.] Univ Queensland, ARC Ctr Excellence Plant Cell Walls, Brisbane, Qld 4072, Australia.
RP Stokes, JR (reprint author), Univ Queensland, Sch Chem Engn, Rheol & Biolubricat Lab, Brisbane, Qld 4072, Australia.
EM jason.stokes@uq.edu.au
RI Shewan, Heather/F-7488-2011; Stokes, Jason/A-1608-2009; Boehm,
   Michael/N-4770-2017
OI Shewan, Heather/0000-0002-4405-679X; Stokes, Jason/0000-0001-7784-9297;
   Boehm, Michael/0000-0002-5022-4999; Steen, Jennifer/0000-0002-4760-9492
FU Australian Postgraduate Award
FX HMS acknowledges Ph.D. funding by an Australian Postgraduate Award.
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   ARMSTRONG DC, 1995, BIOTECHNOL TECH, V9, P491, DOI 10.1007/BF00159564
   Baik SJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3571297
   Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047
   Balazs EA, 1974, PHYS PROPERTIES SYNO, P63
   Balazs Endre A, 2004, Surg Technol Int, V12, P278
   Barnes H. A., 1989, INTRO RHEOLOGY
   Bird R. B., 1977, DYNAMICS POLYM LIQUI
   BOHDANECKY M, 1983, MACROMOLECULES, V16, P1483, DOI 10.1021/ma00243a014
   Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a
   Bureau L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218302
   Chau L, 2009, LAB CHIP, V9, P1897, DOI 10.1039/b823180j
   Chen WY, 2009, J BIOL CHEM, V284, P18007, DOI 10.1074/jbc.M109.011999
   Chong BF, 2003, BIOCHEM ENG J, V16, P153, DOI 10.1016/S1369-703X(03)00031-7
   Clasen C, 2006, J RHEOL, V50, P883, DOI 10.1122/1.2357190
   Clasen C, 2010, APPL RHEOL, V20, DOI 10.3933/ApplRheol-20-45049
   CLELAND RL, 1970, BIOPOLYMERS, V9, P799, DOI 10.1002/bip.1970.360090706
   CONNELLY RW, 1985, J RHEOL, V29, P209, DOI 10.1122/1.549828
   Cubukcu D, 2005, CLIN RHEUMATOL, V24, P336, DOI 10.1007/s10067-004-1043-z
   Davies GA, 2008, J NON-NEWTON FLUID, V148, P73, DOI 10.1016/j.jnnfm.2007.04.013
   Davies GA, 2005, J RHEOL, V49, P919, DOI 10.1122/1.1942501
   Dealy J. M., 2006, STRUCTURE RHEOLOGY M
   DIFERRANTE N, 1956, J BIOL CHEM, V220, P303
   Fam H, 2007, BIORHEOLOGY, V44, P59
   Fam H, 2009, BIORHEOLOGY, V46, P31, DOI 10.3233/BIR-2009-0521
   FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036
   Fujii K, 1996, BIOPOLYMERS, V38, P583, DOI 10.1002/(SICI)1097-0282(199605)38:5<583::AID-BIP4>3.3.CO;2-T
   Fusco S, 2007, BIORHEOLOGY, V44, P403
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Garcia-Abuin A, 2011, CARBOHYD POLYM, V85, P500, DOI 10.1016/j.carbpol.2011.02.028
   HANSMA HG, 1995, BIOPHYS J, V68, P1672, DOI 10.1016/S0006-3495(95)80343-7
   Haward SJ, 2011, SOFT MATTER, V7, P9908, DOI 10.1039/c1sm05493g
   Haward SJ, 2011, RHEOL ACTA, V50, P869, DOI 10.1007/s00397-010-0494-1
   Huggins ML, 1942, J AM CHEM SOC, V64, P2716, DOI 10.1021/ja01263a056
   Hwang DS, 2010, SOFT MATTER, V6, P3232, DOI 10.1039/c002632h
   Khair AS, 2005, J RHEOL, V49, P1449, DOI 10.1122/1.2085173
   Kraemer EO, 1938, IND ENG CHEM, V30, P1200, DOI 10.1021/ie50346a023
   Kravchuk O, 2013, J RHEOL, V57, P365, DOI 10.1122/1.4774323
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LAURENT TC, 1960, BIOCHIM BIOPHYS ACTA, V42, P476, DOI 10.1016/0006-3002(60)90826-X
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Liu L, 2008, LETT APPL MICROBIOL, V46, P383, DOI 10.1111/j.1472-765X.2008.02325.x
   Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496
   Maisonneuve BGC, 2013, BIOMACROMOLECULES
   Marcellin E, 2014, APPL MICROBIOL BIOT, V98, P6947, DOI 10.1007/s00253-014-5853-x
   Meyer A, 2006, J RHEOL, V50, P77, DOI 10.1122/1.2139098
   Mo YQ, 2001, BIORHEOLOGY, V38, P379
   Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4
   MORRIS ER, 1980, J MOL BIOL, V138, P383, DOI 10.1016/0022-2836(80)90294-6
   Mukhopadhyay A, 2001, CURR OPIN COLLOID IN, V6, P423, DOI 10.1016/S1359-0294(01)00119-4
   Ozturk C, 2006, RHEUMATOL INT, V26, P314, DOI 10.1007/s00296-005-0584-z
   PEACHEY J, 1991, REV SCI INSTRUM, V62, P463, DOI 10.1063/1.1142089
   Pipe CJ, 2008, RHEOL ACTA, V47, P621, DOI 10.1007/s00397-008-0268-1
   Remminghorst Uwe, 2009, P13
   Rief M, 1999, NAT STRUCT BIOL, V6, P346
   Schultz KM, 2012, SOFT MATTER, V8, P6198, DOI 10.1039/c2sm25187f
   Schultz KM, 2011, BIOMACROMOLECULES, V12, P4178, DOI 10.1021/bm201214r
   Schultz KM, 2011, LAB CHIP, V11, P3802, DOI 10.1039/c1lc20376b
   SHIPMAN RWG, 1991, IND ENG CHEM RES, V30, P918, DOI 10.1021/ie00053a014
   Smith BA, 2005, BIOPHYS J, V88, P2994, DOI 10.1529/biophysj.104.046649
   Stokes JR, 2007, BIORHEOLOGY, V44, P141
   Stokes JR, 2011, LANGMUIR, V27, P3474, DOI 10.1021/la104040d
   Stokes JR, 2012, ORAL RHEOLOGY FOOD O, P227
   Tadmor R, 2003, MACROMOLECULES, V36, P9519, DOI 10.1021/ma030379k
   Tadmor R, 2002, J BIOMED MATER RES, V61, P514, DOI 10.1002/jbm.10215
   Vleminckx G, 2014, CURR OPIN COLLOID IN, V19, P503, DOI 10.1016/j.cocis.2014.11.002
   Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200
   Weigel PH, 2012, GLYCOBIOLOGY, V22, P1302, DOI 10.1093/glycob/cws102
   Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005
   Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o
NR 73
TC 3
Z9 3
U1 1
U2 5
PU KERSCHENSTEINER VERLAG GMBH
PI LAPPERSDORF
PA MORIKESTR 4, LAPPERSDORF, 93138, GERMANY
SN 1430-6395
EI 1617-8106
J9 APPL RHEOL
JI Appl. Rheol.
PY 2015
VL 25
IS 5
AR 55609
DI 10.3933/APPLRHEOL-25-55609
PG 8
WC Mechanics
SC Mechanics
GA CZ7KQ
UT WOS:000367278700007
DA 2018-10-20
ER

PT J
AU Lee, JW
   Wen, HB
   Battula, S
   Akella, R
   Collins, M
   Romanos, GE
AF Lee, Jin Whan
   Wen, Hai Bo
   Battula, Suneel
   Akella, Rama
   Collins, Michael
   Romanos, Georgios E.
TI Outcome After Placement of Tantalum Porous Engineered Dental Implants in
   Fresh Extraction Sockets: A Canine Study
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone ingrowth; osseoincorporation; porous tantalum; trabecular metal
   dental implant
ID RESONANCE FREQUENCY-ANALYSIS; TOTAL HIP-ARTHROPLASTY; IMMEDIATE
   IMPLANTS; BONE INGROWTH; STABILITY; INTERFACE; TITANIUM; DOG;
   BIOMATERIAL; MORPHOLOGY
AB Purpose: This study evaluated the stability and histologic proof of osseoincorporation of Trabecular Metal (TM) dental implants, which feature a tantalum-based porous midsection. Materials and Methods: A total of 48 TM implants (test group) and Tapered Screw-Vent implants (control group) were immediately placed bilaterally into mandibular extraction sockets in dogs. Resonance frequency analysis was performed at weeks 0, 2, 4, and 12 after implant placement. Histologic and histomorphometric evaluations of the implant interface were performed. Results: Changes in mean implant stability quotients (ISQ) revealed no statistical differences between the test and control groups. Histologic analysis showed bone ingrowth into the porous tantalum structure of all test group implants. Histomorphometric analysis revealed an increased percentage of bone-to-implant contact between 4 and 8 weeks in both test and control groups. The porous sections of the test group exhibited significantly more new bone inside the pores at week 12 in comparison to weeks 2 and 4. No correlation was observed between ISQ and histomorphometric parameters. Conclusion: In a canine immediate extraction socket model, both test and control implants demonstrated comparable implant stability and bone-to-implant contact. Bone ingrowth was evident within the tantalum porous section of the test implants during the early healing.
C1 [Lee, Jin Whan; Wen, Hai Bo] Zimmer Dent, Res, Carlsbad, CA USA.
   [Battula, Suneel] Zimmer Dent, Carlsbad, CA USA.
   [Akella, Rama] Zimmer Orthobiol, Austin, TX USA.
   [Collins, Michael] Zimmer Dent, Res & Dev, Carlsbad, CA USA.
   [Collins, Michael] Zimmer Dent, Zfx, Carlsbad, CA USA.
   [Romanos, Georgios E.] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
RP Romanos, GE (reprint author), SUNY Stony Brook, Sch Dent Med, 106 Rockland Hall, Stony Brook, NY 11794 USA.
EM georgios.romanos@stonybrook.edu
CR Abed Ahmad Moghareh, 2011, Dent Res J (Isfahan), V8, P132
   Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P313, DOI 10.1111/j.1600-0501.2008.01646.x
   Al-Hezaimi K, 2013, J ORAL IMPLANTOL
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Becker W, 1995, Int J Oral Maxillofac Implants, V10, P143
   Bencharit S, 2013, CLIN IMPLANT DENT RE
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Caneva M, 2012, CLIN ORAL IMPLAN RES, V23, P789, DOI 10.1111/j.1600-0501.2011.02332.x
   Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P820, DOI 10.1111/j.1600-0501.2010.02060.x
   de Sanctis M, 2009, J CLIN PERIODONTOL, V36, P705, DOI 10.1111/j.1600-051X.2009.01427.x
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   Ito Y, 2008, CLIN ORAL IMPLAN RES, V19, P9, DOI 10.1111/j.1600-0501.2007.01419.x
   Kim DG, 2013, IMPLANT DENT, V22, P399, DOI 10.1097/ID.0b013e31829b17b5
   Levine Brett, 2007, J Knee Surg, V20, P185
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Mazor Z, 2003, INT J ORAL MAX IMPL, V18, P729
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Schliephake H, 2006, INT J ORAL MAX SURG, V35, P941, DOI 10.1016/j.ijom.2006.05.002
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
NR 32
TC 4
Z9 4
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2015
VL 30
IS 1
BP 134
EP 142
DI 10.11607/jomi.3692
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ6VV
UT WOS:000367240000017
PM 25615921
OA Bronze
DA 2018-10-20
ER

PT J
AU Scarano, A
   Piattelli, A
   Murmura, G
   Iezzi, G
   Assenza, B
   Mancino, C
AF Scarano, Antonio
   Piattelli, Adriano
   Murmura, Giovanna
   Iezzi, Giovanna
   Assenza, Bartolomeo
   Mancino, Carlo
TI Delayed Expansion of the Atrophic Mandible by Ultrasonic Surgery: A
   Clinical and Histologic Case Series
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE alveolar bone loss; alveolar ridge augmentation; bone regeneration; bone
   resorption; piezosurgery
ID LIFE-TABLE ANALYSIS; IMPLANT PLACEMENT; DENTAL IMPLANTS; SPLIT-CREST;
   RIDGE
AB Purpose: Ridge expansion is used to widen narrow ridges with adequate height for implant placement. This human case series presents the clinical and histologic results of delayed expansion of mandibles by ultrasonic surgery. Materials and Methods: Patients with residual alveolar ridge width between 2.3 and 4.1 mm in the coronal area of the posterior mandible were included in the study. First, four linear corticotomies were carried out by ultrasonic surgical device. Four weeks later, adequate bone expansion with a combination of scalpels, thin chisels, and threaded osteotomes that did not compromise cortical vascularization was performed, and two implants per ridge were inserted. Any gaps were filled with corticospongious porcine biomaterial. Three months after implant placement, healing caps were inserted, and bone cores were harvested from the regenerated areas for histologic analysis. Crestal width was recorded at each surgery. Results: The postoperative course was uneventful in all 32 patients (64 implants) who took part in the study, and the implant success rate was 96.88% at 3 months. The mean increase in ridge width was 5.17 +/- 0.86 mm. The histologic specimens showed a mixture of new bone and particles of biomaterial, as well as newly formed bone. Histomorphometry demonstrated that 64% +/- 3.1% of the specimen was composed of newly formed bone, 8% +/- 0.8% was made up of marrow spaces, and 27% +/- 2.6% comprised the residual grafted biomaterial. Conclusion: This study showed that mandibular ridge expansion using a delayed splitcrest technique by means of ultrasonic surgery and association with biomaterial led to good horizontal bone gain, with no fractures of the buccal plate, and a high implant success rate. The histologic specimens showed newly formed bone and good integration of the biomaterial.
C1 [Scarano, Antonio; Murmura, Giovanna; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Oral Pathol & Med, Chieti, Italy.
   [Mancino, Carlo] Univ G dAnnunzio, Chieti, Italy.
RP Scarano, A (reprint author), Via Frentani 98-B, I-66100 Chieti, Italy.
EM ascarano@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
FU Ministry of Education, University and Research (M.I.U.R.), Rome, Italy
FX This study was supported by the Ministry of Education, University and
   Research (M.I.U.R.), Rome, Italy. The authors reported no conflicts of
   interest related to this study.
CR Basa S, 2004, INT J ORAL MAX IMPL, V19, P554
   Blus C, 2006, CLIN ORAL IMPLAN RES, V17, P700, DOI 10.1111/j.1600-0501.2006.01206.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P265, DOI 10.1111/j.1600-0501.2005.01196.x
   Demarosi F, 2009, BRIT J ORAL MAX SURG, V47, P535, DOI 10.1016/j.bjoms.2008.11.012
   Ferrigno N, 2005, CLIN ORAL IMPLAN RES, V16, P147, DOI 10.1111/j.1600-0501.2005.01125.x
   Jensen OT, 2009, J ORAL MAXIL SURG, V67, P1921, DOI 10.1016/j.joms.2009.04.017
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Pikos M A, 2000, Implant Dent, V9, P67, DOI 10.1097/00008505-200009010-00012
   Scarano A, 2011, J IMMUNOPATHOL PHARM, V24, P71
   Scarano A, 2011, CLIN ORAL IMPLAN RES, V22, P1125, DOI 10.1111/j.1600-0501.2010.02083.x
   Scipioni A, 1997, CLIN ORAL IMPLAN RES, V8, P39, DOI 10.1111/j.1600-0501.1997.tb00006.x
   Scipioni A, 1994, Int J Periodontics Restorative Dent, V14, P451
   Selcuk B, 2004, INT J ORAL MAXILLOF, V19, P554
   Sethi A, 2000, INT J ORAL MAX IMPL, V15, P491
   Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291
NR 17
TC 5
Z9 5
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JAN-FEB
PY 2015
VL 30
IS 1
BP 144
EP 149
DI 10.11607/jomi.2753
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ6VV
UT WOS:000367240000018
PM 25615922
OA Bronze
DA 2018-10-20
ER

PT J
AU Michida, SMD
   Kimpara, ET
   dos Santos, C
   Souza, ROA
   Bottino, MA
   Ozcan, M
AF de Araujo Michida, Silvia Masae
   Kimpara, Estevao Tomomitsu
   dos Santos, Claudinei
   Assuncao Souza, Rodrigo Othavio
   Bottino, Marco Antonio
   Oezcan, Mutlu
TI Effect of air-abrasion regimens and fine diamond bur grinding on
   flexural strength, Weibull modulus and phase transformation of zirconium
   dioxide
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Air abrasion; Polishing; Flexural strength; Weibull modulus; Phase
   transformation; Yttria-stabilized tetragonal zirconia
ID PARTICLE ABRASION; DENTAL CERAMICS; TETRAGONAL ZIRCONIA;
   SURFACE-TOPOGRAPHY; BOND STRENGTH; PROTOCOLS; RESTORATIONS; BIOMATERIAL;
   RELIABILITY; CEMENTS
AB Purpose: This study evaluated the effect of air abrasion and polishing regimens on the flexural strength of yttrium stabilized polycrystalline tetragonal zirconia (Y-TZP).
   Methods: From Y-TZP blocks (InCeram 2000 YZ Cubes; Vita Zahnfabrik, Bad Sackingen, Germany) 120 bars (25 mm x 4 mm x 1.2 mm) were obtained according to ISO 6872: 2008 and randomly divided into 4 groups: Group C: (control) without surface treatment (n = 30); Group APA: Air abrasion with aluminum oxide (44 mu m) (n = 30); Group SC: Silica-coating (CoJet, 30 mu m) (n = 30); Group FD: Fine diamond bur (n = 30). Subsequently, all specimens were subjected to 4-point bending test (in distilled water at 37 degrees C) in a universal testing machine (EMIC DL 1000; Sao Jose dos Pinhais, Parana, Brazil); cross-head speed: 0.5 mm/min). The characteristic strength (sigma(0)) of each specimen was obtained from the flexural strength test and evaluated using Weibull analysis. X-ray diffraction analysis was utilized to quantity the monoclinic phase. The surface topography of specimens was analyzed using 3D optical profilometer and scanning electron microscopy (SEM) after surface conditioning methods. The flexural strength data (sigma(4p)) were statistically analyzed by 1-way ANOVA, Tukey test (alpha = 0.05) and Weibull (m = modulus, sigma(0) = characteristic strength) were calculated.
   Results: The mean +/- standard deviations (MPa) of the groups were as follows: C: 1196.2 +/- 284.2(a); APA: 1369.7 +/- 272.3(a); SC: 1207.1 +/- 229.7(a) and FD: 874.4 +/- 365.4(b). The values (m) and (sigma(0)) were as follows: C: 4.5 and 1308.12; APA: 5.9 and 1477.88; SC: 6.0 and 1300.28; and FD: 2.6 and 985.901, respectively.
   Conclusions: Air particle abrasion with neither silica nor alumina showed significant difference compared to the control group but grinding with fine diamond bur impaired the flexural strength of the zirconia tested.
C1 [de Araujo Michida, Silvia Masae] Inga Univ, Sch Dent, Post Grad Program, Maringa, Parana, Brazil.
   [Kimpara, Estevao Tomomitsu; Bottino, Marco Antonio] Sao Paulo State Univ, Sao Jose dos Campos Dent Sch, Dept Dent Mat & Prosthodont, Sao Jose Dos Campos, Brazil.
   [dos Santos, Claudinei] Univ Estado Rio De Janeiro, Dept Mech & Energy, Fac Technol, Resende, Brazil.
   [Assuncao Souza, Rodrigo Othavio] Univ Fed Rio Grande do Norte, Dept Restorat Dent, Div Prosthodont, BR-59072970 Natal, RN, Brazil.
   [Oezcan, Mutlu] Univ Zurich, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Dent Mat Unit, CH-8032 Zurich, Switzerland.
RP Ozcan, M (reprint author), Univ Zurich, Ctr Dent & Oral Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Dent Mat Unit, Plattenstr 11, CH-8032 Zurich, Switzerland.
EM mutluozcan@hotmail.com
OI Bottino, Marco Antonio/0000-0003-0077-3161
FU Sao Paolo State University
FX The study was supported entirely by Sao Paolo State University.
CR Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Albert FE, 2004, INT J PROSTHODONT, V17, P529
   [Anonymous], 1999, 69 ANSIADA
   Blatz MB, 2002, QUINTESSENCE INT, V33, P415
   Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(03)52704-9
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x
   GREEN DJ, 1983, J AM CERAM SOC, V66, pC178, DOI 10.1111/j.1151-2916.1983.tb10543.x
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   GUPTA TK, 1980, J AM CERAM SOC, V63, P117, DOI 10.1111/j.1151-2916.1980.tb10671.x
   KERN M, 1994, J PROSTHET DENT, V71, P453, DOI 10.1016/0022-3913(94)90182-1
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   KOSMAC T, 1981, J AM CERAM SOC, V64, pC72
   Ozcan M, 2013, J MECH BEHAV BIOMED, V20, P19, DOI 10.1016/j.jmbbm.2013.01.005
   Ozcan M, 2003, DENT MATER, V19, P725, DOI 10.1016/S0109-5641(03)00019-8
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Raigrodski AJ., 2004, DENT CLIN N AM, V48, P531, DOI DOI 10.1016/J.CDEN.2003.12.008
   RITTER JE, 1981, AM CERAM SOC BULL, V60, P798
   Sarmento HR, 2014, ACTA ODONTOL SCAND, V72, P346, DOI 10.3109/00016357.2013.837958
   Scherrer SS, 1996, INT J PROSTHODONT, V9, P580
   Souza ROA, 2013, J MECH BEHAV BIOMED, V26, P155, DOI 10.1016/j.jmbbm.2013.04.018
   SWAIN MV, 1989, J AM CERAM SOC, V72, P1358, DOI 10.1111/j.1151-2916.1989.tb07652.x
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Xible AA, 2006, J PROSTHET DENT, V95, P224, DOI 10.1016/j.prosdent.2005.12.010
   Xu HHK, 1997, MACH SCI TECHNOL, V1, P49, DOI 10.1080/10940349708945637
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
   Zhang Y, 2006, INT J PROSTHODONT, V19, P442
NR 29
TC 5
Z9 5
U1 1
U2 8
PU WICHTIG PUBL
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2015
VL 13
IS 3
BP E266
EP E273
DI 10.5301/jabfm.5000232
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA CZ5QV
UT WOS:000367158000011
PM 26391866
DA 2018-10-20
ER

PT S
AU Li, TT
   Gong, ZQ
   Dong, HY
   Li, XY
AF Li, Tingting
   Gong, Ziqiang
   Dong, Haiying
   Li, Xiaoyun
BE Yarlagadda, P
TI Synthesis and properties of faceted hexagonal hydroxyapatite nanotubes
SO PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON MATERIAL, MECHANICAL
   AND MANUFACTURING ENGINEERING
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Material, Mechanical and Manufacturing
   Engineering (IC3ME)
CY JUN 27-28, 2015
CL Guangzhou, PEOPLES R CHINA
DE hydroxyapatite; nanorod; nanotube; one-step hydrothermal
ID TEMPLATE
AB Nanoscale hydroxyapatite (HA) is an optimal candidate biomaterial for bone tissue engineering because of its excellent bioactive and osteoconductive properties. Here we have been successfully synthesized the faceted hexagonal hydroxyapatite nanotubes by one-step hydrothermal method. The obtained product microstructure is nanotube with faceted hexagonal. The results of cell culture shows that those novel HA nanatubes are nontoxic for the proliferation of the cell, which gives a great potential for bone repairation.
C1 [Li, Tingting; Gong, Ziqiang; Li, Xiaoyun] Zhejiang Sci Tech Univ, Ctr Nanosci & Nanotechnol, Hangzhou 310018, Peoples R China.
   [Dong, Haiying] Fujian Med Univ, Ningde Hosp, Ningde 352000, Peoples R China.
RP Li, TT (reprint author), Zhejiang Sci Tech Univ, Ctr Nanosci & Nanotechnol, Hangzhou 310018, Peoples R China.
EM 15700198481@163.com; 870013447@qq.com; 359298598@qq.com;
   506598308@qq.com
CR Costa DO, 2012, ACS APPL MATER INTER, V4, P1490, DOI 10.1021/am201735k
   Guo XK, 2014, J MATER CHEM B, V2, P1760, DOI 10.1039/c3tb21652g
   Liu G, 2009, J AM CHEM SOC, V131, P9937, DOI 10.1021/ja903817z
   Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z
   Yuan Y, 2008, MATER CHEM PHYS, V112, P275, DOI 10.1016/j.matchemphys.2008.05.068
   Zhao HX, 2011, BIOMATERIALS, V32, P5837, DOI 10.1016/j.biomaterials.2011.04.083
NR 6
TC 0
Z9 0
U1 0
U2 3
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-6252-100-1
J9 AER ADV ENG RES
PY 2015
VL 27
BP 399
EP 402
PG 4
WC Engineering, Multidisciplinary; Engineering, Manufacturing; Engineering,
   Mechanical
SC Engineering
GA BE0UT
UT WOS:000367097600078
DA 2018-10-20
ER

PT J
AU Vasilescu, VG
   Stan, MS
   Patrascu, I
   Dinischiotu, A
   Vasilescu, E
AF Vasilescu, Vlad Gabriel
   Stan, Miruna Silvia
   Patrascu, Ion
   Dinischiotu, Anca
   Vasilescu, Elisabeta
TI IN VITRO TESTING OF MATERIALS BIOCOMPATIBILITY WITH CONTROLED CHEMICAL
   COMPOSITION
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE biomaterial; biocompatibility; cell adhesion; osteoblasts
ID SURFACE-ROUGHNESS; TITANIUM SURFACE; TI ALLOYS; BIOMATERIALS;
   CYTOCOMPATIBILITY; TI-6AL-4V; CORROSION; IMPLANTS; BEHAVIOR; CELLS
AB In vitro testing of materials biocompatibility provides information on cell behavior in relation to chemical composition and surface topography of materials. The studied biomaterial Is a new one proposed to be used in oral implantology and therefore requires studying its biocompatibility compared to conventional materials commonly used in oral implantology.
   The in vitro response Induced by this bioalloy with surface characteristics conferred by casting, corrosion and anodizing was evaluated on G292 human osteoblasts. The experimental obtained surface after anodizing presented a stable and consistent oxide "gel-looking" layer well highlighted in scanning electron microscopy Images. The results demonstrated the ability of the biomaterial to support attachment, growth and proliferation of human osteoblasts. As compared to the other materials tested and demonstrates the improved properties that facilitated rapid cellular adaptation to these surfaces.
C1 [Vasilescu, Vlad Gabriel; Patrascu, Ion] Carol Davila Med & Pharm Univ, Fac Dent, Bucharest 010221, Romania.
   [Stan, Miruna Silvia; Dinischiotu, Anca] Univ Bucharest, Fac Biol, Bucharest 050095, Romania.
   [Vasilescu, Elisabeta] Univ Galatzi, Fac Engn Galati, Galati 800201, Romania.
RP Vasilescu, E (reprint author), Univ Galatzi, Fac Engn Galati, Str Domneasca 111, Galati 800201, Romania.
EM elisabeta.vasilescu@yahoo.com
FU European Social Fund [POSDRU/159/1.5/S/133391]
FX M.S. Stan gratefully acknowledges the support of the European Social
   Fund through the contract POSDRU/159/1.5/S/133391.
CR Anderson J., 2004, BIOMATERIALS SCI INT
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2001, ENG MAT SER, P485
   [Anonymous], 134852012 EN ISO
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   CAREW E.O., 2004, BIOMATERIALS SCI INT, P23
   Cremasco A, 2011, MAT SCI ENG C-MATER, V31, P833, DOI 10.1016/j.msec.2010.12.013
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dima O., 2014, ANN DUNAREA JOS U GA, V1, P8
   Dragan-Raileanu L.A., 2013, ANN ROMANIAN SOC CEL, VXVIII
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Hadi SA, 2011, BIOL MED, V3, P164
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6
   Leyensand C., 2004, TITANIUM TITANIUM AL
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meng WY, 2011, J BIONIC ENG, V8, P234, DOI 10.1016/S1672-6529(11)60031-0
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   Nonami T, 1998, MAT SCI ENG C-BIO S, V6, P281, DOI 10.1016/S0928-4931(98)00063-0
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Park J. B., 1995, BIOMEDICAL ENG HDB, P537
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Stan MS, 2015, J BIOMED MATER RES A, V103, P48, DOI 10.1002/jbm.a.35148
   VASILESCU V. G., 2014, ANN DUNAREA JOS U GA, P32
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
NR 30
TC 2
Z9 2
U1 0
U2 4
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MATER
JI Rev. Rom. Mat.
PY 2015
VL 45
IS 4
BP 315
EP 323
PG 9
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA CZ3UP
UT WOS:000367029800002
DA 2018-10-20
ER

PT S
AU Sharipova, A
   Psakhie, SG
   Swain, SK
   Gutmanas, EY
   Gotman, I
AF Sharipova, Aliya
   Psakhie, Sergey G.
   Swain, Sanjaya K.
   Gutmanas, Elazar Y.
   Gotman, Irena
BE Panin, VE
   Psakhie, SG
   Fomin, VM
TI High-Strength Bioresorbable Fe-Ag Nanocomposite Scaffolds: Processing
   and Properties
SO INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS WITH HIERARCHICAL
   STRUCTURE FOR NEW TECHNOLOGIES AND RELIABLE STRUCTURES 2015
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials with Hierarchical
   Structure for New Technologies and Reliable Structures
CY SEP 21-25, 2015
CL Tomsk, RUSSIA
SP Inst Strength Phys & Mat Sci SB RAS, Inst Theorit & Appl Mech SB RAS, Lavrentyev Inst Hydrodynam SB RAS, Inst Metal Superspecial Problems RAS, Fed Agcy Sci Org, Siberian Branch RAS, Tomsk Polytechn Russia, Tomsk State Univ, Inst Continuous Media Mech UrB RAS, Inst Mech Engn Sci UrB RAS, Inst Phys Tech Problems N SB RAS, Inst Problems Chem & Energy Technol SB RAS, Inst Petr Chem SB RAS, Tech Univ Berlin, Univ Stuttgart, Techn Inst Technol, Josef Stefan Inst, Technol Platform Med Future, Technol Platform Light & Reliable Structures, Technol Platform Natl Informat Satelite Syst, Technol Platform Hydrocarbon Extract & Proc Technol, Natl Res Tomsk Polytechn Univ, Natl Res Tomsk State Univ
ID MECHANICAL-PROPERTIES; HIGH-PRESSURE; BONE; HYDROXYAPATITE; IMPLANTS;
   BIOMATERIAL; DEGRADATION; MAGNESIUM; ALLOYS
AB High strength ductile iron-silver nanocomposite scaffolds were fabricated employing high energy attrition milling of micron-submicron powders, followed by cold sintering/high pressure consolidation. Particulate leaching method with soluble Na2SO4 and K2CO3 salts as porogens was used to create scaffolds with 50, 55, 60 and 73% volume fraction of pores. Part of specimens was annealed at 600, 800 and 900 degrees C. Specimens were characterized employing X-ray diffraction, scanning electron microscopy (SEM) with electron probe microanalysis (EDS) and high resolution SEM. Mechanical properties were measured in compression and permeability was measured in permeameter based on Darcy's law. Scaffolds with 50% and 55% porosity exhibited high compressive strength (18-22 MPa), compressive strength of 8-12 MPa was observed for scaffolds with 73% porosity. Treatments at 800 and 900 degrees C result in increase of strength and ductility with some coarsening of microstructure. Best combination of compressive strength (15 MPa) and permeability (0.6(-6) cm(2)) is close to the range of trabecular bone.
C1 [Gutmanas, Elazar Y.] Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
   [Sharipova, Aliya; Swain, Sanjaya K.; Gutmanas, Elazar Y.; Gotman, Irena] Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
   [Sharipova, Aliya; Psakhie, Sergey G.] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia.
   [Psakhie, Sergey G.; Gutmanas, Elazar Y.; Gotman, Irena] Natl Res Tomsk Polytech Univ, Tomsk 634050, Russia.
   [Psakhie, Sergey G.] Inst Strength Phys & Mat Sci SB RAS, Tomsk 634055, Russia.
RP Gutmanas, EY (reprint author), Technion Israel Inst Technol, Dept Mat Sci & Technol, IL-32000 Haifa, Israel.
EM gutmanas@technion.ac.il
RI Psakhie, Sergey/F-1469-2014
CR Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bohner M, 2000, INJURY, V31, pS37
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Gotman I, 2013, ACTA BIOMATER, V9, P8440, DOI 10.1016/j.actbio.2013.05.030
   Gotman I, 2010, ADV ENG MATER, V12, pB320, DOI 10.1002/adem.201080006
   Gutmanas E. Y., 1994, Nanostructured Materials, V4, P893, DOI 10.1016/0965-9773(94)90095-7
   GUTMANAS EY, 1983, POWDER METALL INT, V15, P129
   GUTMANAS EY, 1979, SCRIPTA METALL MATER, V13, P11, DOI 10.1016/0036-9748(79)90380-6
   Haddock SM, 1999, J BIOMED MATER RES, V47, P71, DOI 10.1002/(SICI)1097-4636(199910)47:1<71::AID-JBM10>3.0.CO;2-U
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ladd A.I, 2003, OPER TECH PLAST RECO, V9, P151, DOI DOI 10.1053/J.OTPR.2003.09.003
   Liao JA, 2010, INT J NANOMED, V5, P261
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Nair LS, 2008, J BONE JOINT SURG AM, V90A, P128, DOI 10.2106/JBJS.G.01520
   Nirmala R., 2010, J NANOPART RES
   Rakovsky A, 2013, J MECH BEHAV BIOMED, V18, P37, DOI 10.1016/j.jmbbm.2012.11.004
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Vaccaro AR, 2002, CLIN ORTHOP RELAT R, P19
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 28
TC 4
Z9 4
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1330-6
J9 AIP CONF PROC
PY 2015
VL 1683
AR UNSP 020244
DI 10.1063/1.4932934
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA BE0NI
UT WOS:000366393300244
DA 2018-10-20
ER

PT S
AU Nikityuk, DB
   Urakov, AL
   Reshetnikov, AP
   Kopylov, MV
   Baimurzin, DY
AF Nikityuk, D. B.
   Urakov, A. L.
   Reshetnikov, A. P.
   Kopylov, M. V.
   Baimurzin, D. Yu
BE Sadovoy, MA
   Orlov, SN
   Kistenev, YV
   Sharkeev, YP
TI New Operational Techniques of Implantation of Biomaterials and Titanium
   Implants in the Jaw with the Atrophy of the Bone and Soft Tissues
SO NEW OPERATIONAL TECHNOLOGIES (NEWOT'2015)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 5th International Scientific Conference on New Operational Technologies
   (NEWOT)
CY SEP 29-30, 2015
CL Tomsk, RUSSIA
SP Natl Res Tomsk State Univ, Peoples Friendship Univ Russia, Dept Hlth Adm Tomsk Region, Sci Res Inst Microsurgery, Med Future, Russian Acad Sci, Siberian Branch, Inst Strength Phys & Mat Sci, Res Inst Traumatol & Orthoped n a Ya L Tsivyan, Tomsk Canc Res Inst, Tomsk Cardiol Res Inst
AB The research into dynamics of quality of clinical use in 2003 2012 of autologous and xenogeneic biomaterials at dental transplantation and implantation among 1,100 of adult patients was made. The analysis results show that at autologous bone transplantation implant survival is observed only in 72% of cases, and the "necessary" result of bone repair occurred only in 6 9 months. Transplantation of biomaterials of OsteoBiol (R) (materials "mp3", "Genus" and "Evolution") provided engratIment and bone regeneration in 100 % of cases and allowed the use of dental implantation immediately after transplantation even in case of reduction in the patient's alveolar crest down to 2.0 ram Replace Select implants of Nobel Biocare (R) were used at plantation. In order to exclude Schneiderian membrane's perforation lighting of Highmore's sinus with the cold blue-violet light from inside at sinus elevation is recommended as well as deepening of dental instruments into the bone only until the blue-violet light appears under them. To exclude deficiency of soft tissue under the cervical part of the ceramic crown application of special anti-tissure technology involving biomaterial flap dissection and its laying around the implant is suggested.
C1 [Nikityuk, D. B.; Urakov, A. L.; Reshetnikov, A. P.; Kopylov, M. V.; Baimurzin, D. Yu] Izhevsk State Med Acad, Dept Gen & Clin Pharmacol, Russian Minist Hlth, Izhevsk, Russia.
RP Urakov, AL (reprint author), Izhevsk State Med Acad, Dept Gen & Clin Pharmacol, Russian Minist Hlth, Izhevsk, Russia.
EM urakoval@live.ru; areshetnikov@list.ru
RI Urakov, Aleksandr/F-7037-2013; Nikitjuk, Dmitry/G-2079-2017
OI Urakov, Aleksandr/0000-0002-9829-9463; Nikitjuk,
   Dmitry/0000-0002-4968-4517
CR [Anonymous], 2013, OSTEOBIOL TECNOSS BO, P111
   Fabbro M. D., 2004, INT J PERIODONT REST, V24, P565
   Martegani P., 2014, MAXILLARY SINUS AUGM, P71
   Nikityuk D. B., 2015, MODERN PROBLEMS SCI, V4, P1
   Rcshctmkov A. P., 2014, Application for invention RUS No, Patent No. 2563090
   Reshetnikov A.P., 2009, Russian Federation patent, Patent No. [RU 2360640, 2360640]
   Reshetnikov A.P., 2015, Russian Federation patent RU, Patent No. 2558996
   Schold J., 2014, AM J TRANSPLANT, V14, P1251
   Soiher M. G., 2014, THERMOLOGY INT, V2, P60
   Urakov A L, 2014, Invention RU Patent, Patent No. [2533840 C2, 2533840]
   Urakov A.L., 2012, Russian Federation patent, Patent No. [RU 2469640, 2469640]
   Urakov A. L., 2014, INT J APPL FUNDAMENT, V10, P22
   Urban IA, 2010, INT J ORAL MAX IMPL, V25, P1203
NR 13
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1335-1
J9 AIP CONF PROC
PY 2015
VL 1688
AR UNSP 080001
DI 10.1063/1.4936064
PG 6
WC Physics, Applied
SC Physics
GA BE0PQ
UT WOS:000366562700073
DA 2018-10-20
ER

PT S
AU Fara, ANKA
   Abdullah, HZ
AF Fara, A. N. K. A.
   Abdullah, H. Z.
BE BinHussain, P
   Bhat, AH
   Chowdhury, S
   Mohamed, NMB
   Othman, F
   BinMamat, O
TI Characterization of Derived Natural Hydroxyapatite (HAp) Obtained From
   Different Types of Tilapia Fish Bones and Scales
SO PROCEEDINGS OF THE 23RD SCIENTIFIC CONFERENCE OF MICROSCOPY SOCIETY
   MALAYSIA (SCMSM 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 23rd Scientific Conference of Microscopy-Society-Malaysia (SCMSM)
CY DEC 10-12, 2014
CL Univ Teknologi Petronas, Tronoh, MALAYSIA
SP Microscopy Soc Malaysia
HO Univ Teknologi Petronas
ID HEAT-TREATMENT; PHOSPHATE; APATITES
AB Hydroxyapatite, (HAp), Ca-10(PO4)(6)(OH)(2), is recognised as a biomaterial that is widely used for bone implant due to its chemical and structural similarity to the mineral components in human bone and enamel. The elements of HAp are primarily composed of calcium and phosphorus molar ratio of calcium to phosphorous is 1.67 capable to promote bone in-growth into prosthetic implant. Enormous amounts of by-product waste produced from fish factories generated an undesirable environmental impact. Thus, this study was conducted to obtain natural biological HAp from different types of tilapia fish bones and scales from fishery waste. Therefore, fish bones and scales can be as cheap source to produce biological HAp for medical applications. For this purpose, fish bones and scales of tilapia fish were boiled at 100 degrees C to remove adhering meat and other impurities. Later, fish bones and scales were separated into several groups and subjected to different calcination temperatures of 800 degrees C and 900 degrees C for 3h respectively. Afterward, all calcined samples were crushed to form a fine powder. The XRD result revealed the presence of derived HAp from the samples powder and were identical with standard HAp. Thermo Gravimetric Analysis was carried out to show the thermal stability of the HAp powder from different types of fish bones and scales. SEM results show porous structure appeared in calcined samples compared to raw samples. The findings are the promising alternative to produce calcium and phosphorus from fishery wastes that beneficial to medical applications.
C1 [Fara, A. N. K. A.; Abdullah, H. Z.] Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batupahat 86400, Johor, Malaysia.
RP Fara, ANKA (reprint author), Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batupahat 86400, Johor, Malaysia.
EM normankhaleez@gmail.com; hasan@uthm.edu.my
CR Akram M, 2014, J MATER SCI, V49, P1461, DOI 10.1007/s10853-013-7864-x
   [Anonymous], 2010, ANN FISHERIES STAT
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Fang Z, 2014, MAT SCI ENG C-MATER, V43, P145, DOI 10.1016/j.msec.2014.07.015
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Herliansyah M. K., 2012, P AS PAC INDUSTENG M, P1137
   Huang YC, 2011, CERAM INT, V37, P1825, DOI 10.1016/j.ceramint.2011.01.018
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Mondal S., 2012, J MINERALS MAT CHARA, V11, P55
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Orlovskii VP, 2002, INORG MATER+, V38, P973, DOI 10.1023/A:1020585800572
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   Rustad T., 2003, J ENV AGR FOOD CHEM, V2, P458
NR 17
TC 0
Z9 0
U1 4
U2 11
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1316-0
J9 AIP CONF PROC
PY 2015
VL 1669
AR 020077
DI 10.1063/1.4919215
PG 6
WC Microscopy; Physics, Applied
SC Microscopy; Physics
GA BE0NN
UT WOS:000366404900077
DA 2018-10-20
ER

PT S
AU Te Chuan, L
   Rathi, MFM
   Abidin, MYZ
   Abdullah, HZ
   Idris, MI
AF Te Chuan, Lee
   Rathi, Muhammad Fareez Mohamad
   Abidin, Muhamad Yusuf Zainal
   Abdullah, Hasan Zuhudi
   Idris, Maizlinda Izwana
BE BinHussain, P
   Bhat, AH
   Chowdhury, S
   Mohamed, NMB
   Othman, F
   BinMamat, O
TI Effect of Applied Voltage on Surface Properties of Anodised Titanium in
   Mixture of beta-Glycerophosphate (beta-GP) and Calcium Acetate (CA)
SO PROCEEDINGS OF THE 23RD SCIENTIFIC CONFERENCE OF MICROSCOPY SOCIETY
   MALAYSIA (SCMSM 2014)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 23rd Scientific Conference of Microscopy-Society-Malaysia (SCMSM)
CY DEC 10-12, 2014
CL Univ Teknologi Petronas, Tronoh, MALAYSIA
SP Microscopy Soc Malaysia
HO Univ Teknologi Petronas
ID OXIDATION; FILMS
AB Anodic oxidation is a surface modification method which combines electric field driven metal and oxygen ion diffusion for formation of oxide layer on the anode surface. This method has been widely used to modify the surface morphology of biomaterial especially titanium. This study aimed to investigate the effect of applied voltage on titanium. Specifically, the titanium foil was anodised in mixture of beta-glycerophosphate disodium salt pentahydrate (beta-GP) and calcium acetate monohydrate (CA) with different applied voltage (50-350 V), electrolyte concentration (0.04 M beta-GP + 0.4 M CA), anodising time (10minutes) and current density (50 and 70 mA.cm(-2)) at room temperature. Surface oxide properties of anodised titanium were characterised by digital single-lens reflex camera (DSLR camera), field emission scanning electron microscope (FESEM) and atomic force microscopy (AFM). At lower applied voltage (<= 150 V), surface of titanium foils were relatively smooth. With increasing applied voltage (>= 250 V), the oxide layer became more porous and donut-shaped pores were formed on the surface of titanium foils. The AFM results indicated that the surface roughness of anodised titanium increases with increasing of applied voltage. The porous and rough surface is able to promote the osseointegration and reduce the suffering time of patient.
C1 [Te Chuan, Lee; Rathi, Muhammad Fareez Mohamad; Abidin, Muhamad Yusuf Zainal; Abdullah, Hasan Zuhudi; Idris, Maizlinda Izwana] Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batu Pahat 86400, Johor, Malaysia.
RP Te Chuan, L (reprint author), Univ Tun Hussein Onn Malaysia, Fac Mech & Mfg Engn, Batu Pahat 86400, Johor, Malaysia.
EM gd130079@siswa.uthm.edu.my; cd110238@siswa.uthm.edu.my;
   cd110221@siswa.uthm.edu.my; hasan@uthm.edu.my; izwana@uthm.edu.my
CR Abdullah HZ, 2007, MATER SCI FORUM, V561-565, P2159, DOI 10.4028/www.scientific.net/MSF.561-565.2159
   Abdullah HZ, 2014, KEY ENG MATER, V594-595, P275, DOI 10.4028/www.scientific.net/KEM.594-595.275
   Abdullah H. Z., 2015, ADV MAT RES, V212-217, P1087
   Abdullah H. Z., 2010, THESIS
   Abdullah H. Z., 2012, ADV MAT RES, V223-228, P545
   Abdullah H. Z., 2007, J AUST CERAM SOC, V125-130, P43
   Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Lane W. A., 1895, BRIT MED J, V861, P1
   Lee T. C., 2015, J ADV MAT RES, V116-120, P1087
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Patel N. R., 2012, INT J EMERG TECH ADV, V91-101, P4
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Yao C., 2006, J NANOSCI NANOTECHNO, V2682-2692, P9
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 18
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1316-0
J9 AIP CONF PROC
PY 2015
VL 1669
AR 020054
DI 10.1063/1.4919192
PG 7
WC Microscopy; Physics, Applied
SC Microscopy; Physics
GA BE0NN
UT WOS:000366404900054
DA 2018-10-20
ER

PT J
AU Steffens, D
   Mathor, MB
   Santi, BTS
   Luco, DP
   Pranke, P
AF Steffens, Daniela
   Mathor, Monica B.
   Santi, Bruna T. S.
   Luco, Dayane P.
   Pranke, Patricia
TI Development of a biomaterial associated with mesenchymal stem cells and
   keratinocytes for use as a skin substitute
SO REGENERATIVE MEDICINE
LA English
DT Article
DE electrospinning; keratinocytes; laminin; scaffolds; skin substitute;
   stem cells; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; EXFOLIATED DECIDUOUS TEETH; IN-VITRO
   CHARACTERIZATION; BIOTIC DEGRADATION; POLYLACTIDE FOAMS; NANOFIBERS;
   DIFFERENTIATION; REGENERATION; BIOGLASS(R); COLLAGEN
AB Aim: The present study has aimed to produce a cutaneous substitute, bringing together stem cells (mesenchymal stem cells) and keratinocytes, and an electrospun biomaterial. Materials & methods: Three groups of scaffolds were studied: group 1,poly-DL-lactic acid (PDLLA); group 2, hydrolyzed PDLLA (PDLLA/NaOH) and group 3, PDLLA/Lam - a PDLLA/NaOH scaffold linked to laminin protein. They were characterized by physicochemical and biological parameters. Results: As a result, the scaffolds presented well-formed and randomly distributed fibers. Group 3 showed the greatest hydrophilic characteristics. Group 1 showed a greater degradation rate after 14 days. Groups 2 and 3 presented molecular weight of about 40-50 Da. In general, group 3 showed the best results concerning cell adhesion and viability. Conclusion: This study associated two revolutionary fields, stem cells and nanotechnology, for use in regenerative medicine.
C1 [Steffens, Daniela; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-91501970 Porto Alegre, RS, Brazil.
   [Steffens, Daniela; Santi, Bruna T. S.; Pranke, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Physiol, BR-90050170 Porto Alegre, RS, Brazil.
   [Mathor, Monica B.] Inst Pesquisas Energet & Nucl, BR-05508000 Sao Paulo, Brazil.
   [Luco, Dayane P.; Pranke, Patricia] Inst Pesquisa Celulas Tronco, Stem Cell Res Inst, BR-90020010 Porto Alegre, RS, Brazil.
RP Steffens, D (reprint author), Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-91501970 Porto Alegre, RS, Brazil.
EM dani_ste@hotmail.com
RI Mathor, Monica/C-3975-2012
OI Mathor, Monica/0000-0002-7294-9106
FU National Council of Technological and Scientific Development (CNPq);
   CAPES; FAPERGS; Stem Cell Research Institute; International Atomic
   Energy Agency
FX This work was supported by the National Council of Technological and
   Scientific Development (CNPq), CAPES, FAPERGS, Stem Cell Research
   Institute and International Atomic Energy Agency. The authors have no
   other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccafoschi F, 2012, J BIOMED MATER RES A, V100A, P2373, DOI 10.1002/jbm.a.34180
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750
   Fujimori Y, 2006, ANN PLAS SURG, V57, P408, DOI 10.1097/01.sap.0000237057.49772.4f
   Fukushima K, 2013, EUR POLYM J, V49, P706, DOI 10.1016/j.eurpolymj.2012.12.011
   Herson MR, 2001, ARTIF ORGANS, V25, P901, DOI 10.1046/j.1525-1594.2001.06896.x
   Hilmi ABM, 2015, WORLD J STEM CELLS, V7, P428, DOI 10.4252/wjsc.v7.i2.428
   Hussain D, 2010, POLYMER, V51, P3989, DOI 10.1016/j.polymer.2010.06.036
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Karlsson S, 1998, MACROMOL SYMP, V127, P219, DOI 10.1002/masy.19981270129
   Kim J-E, 2010, ADV ENG MATER, V12, P94
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lu W, 2012, CELLS TISSUES ORGANS, V195, P197, DOI 10.1159/000324921
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Nourbakhsh N, 2011, INT J DEV BIOL, V55, P189, DOI 10.1387/ijdb.103090nn
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Tanikawa DYS, 2010, ACTA CIR BRAS, V25, P541, DOI 10.1590/S0102-86502010000600015
   Silva FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098050
   Steffens D, 2013, J BIOMED NANOTECHNOL, V9, P710, DOI 10.1166/jbn.2013.1571
   Steffens D, 2014, BURNS, V40, P1650, DOI 10.1016/j.burns.2014.03.008
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tsuji H, 2001, BIOMACROMOLECULES, V2, P597, DOI 10.1021/bm010048k
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P330, DOI 10.2174/1574888X09666140228123911
   Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X..2006.00189.x
   Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382
   Zander NE, 2012, ACS APPL MATER INTER, V4, P2074, DOI 10.1021/am300045y
NR 39
TC 4
Z9 5
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PY 2015
VL 10
IS 8
BP 975
EP 987
DI 10.2217/rme.15.58
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA CY7TN
UT WOS:000366612100008
PM 26542841
DA 2018-10-20
ER

PT J
AU Chen, XH
   Zhang, Y
   Yuan, L
   Zhang, H
   Dai, WB
   He, B
   Wang, XQ
   Zhang, Q
AF Chen, Xianhui
   Zhang, Yang
   Yuan, Lan
   Zhang, Hua
   Dai, Wenbing
   He, Bing
   Wang, Xueqing
   Zhang, Qiang
TI The P-glycoprotein inhibitory effect and related mechanisms of thiolated
   chitosan and its S-protected derivative
SO RSC ADVANCES
LA English
DT Article
ID CACO-2 CELL MONOLAYERS; EFFLUX PUMP INHIBITION; IN-VIVO EVALUATION;
   DRUG-DELIVERY; ORAL DELIVERY; MEDIATED EFFLUX; ATPASE ACTIVITY;
   MOLECULAR-MASS; GP; TRANSPORTERS
AB Thiolated polymers have attracted more and more attention for their prominent efflux pump inhibitory properties. The aim of this study was to unravel the P-glycoprotein (P-gp) inhibitory mechanisms mediated by new synthetic thiolated chitosan, chitosan-thioglycolic acid (CS-TGA) and its S-protected derivative (CS-TGA-6MNA). P-gp inhibitory activity was first assessed by determining rhodamine-123 (Rho-123) accumulation in Caco-2 cells, transportation across Caco-2 cell monolayers and across freshly excised rat intestine after exposure to CS-TGA or CS-TGA-6MNA. The results showed that after incubation with CS-TGA or CS-TGA-6MNA, a significant increase in intracellular Rho-123 level was observed in Caco-2 cells, more transportation in the absorptive (AP -> BL) direction and less transportation in the secretory (BL -> AP) direction of Rho-123 was observed in Caco-2 cell monolayers compared with DMEM solution control. In freshly excised rat intestine transportation, more Rho-123 was transported in a concentration-dependent manner. Then the P-gp inhibitory mechanisms were evaluated from four aspects: P-gp expression level, P-gp ATPase activity, intracellular ATP level and plasma membrane fluidity. No obvious changes in P-gp expression or intracellular ATP level were detected after exposure. However, the plasma membrane fluidization decreased and the P-gp ATPase activity reduced, which might contribute to the P-gp inhibitory effect. These features suggested this novel biomaterial might contribute to enhance the oral bioavailability of P-gp substrate drugs, such as cyclosporine A and paclitaxel.
C1 [Chen, Xianhui; Zhang, Yang; Zhang, Hua; Dai, Wenbing; He, Bing; Wang, Xueqing; Zhang, Qiang] Peking Univ, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.
   [Yuan, Lan] Peking Univ, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China.
   [Zhang, Qiang] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
RP Wang, XQ (reprint author), Peking Univ, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.
EM wangxq@bjmu.edu.cn
FU National Natural Science Foundation of China [81273456, 81473159];
   National Basic Research Program of China [2015CB932100]
FX Andreas Bernkop-Schnurch (Institute of Pharmacy, University of
   Innsbruck) is acknowledged for his leading me to the research field of
   thiomers. This study was supported by the National Natural Science
   Foundation of China (No. 81273456, 81473159) and the National Basic
   Research Program of China (No. 2015CB932100).
CR Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e
   Barthelmes J, 2013, NANOMEDICINE-UK, V8, P65, DOI [10.2217/NNM.12.76, 10.2217/nnm.12.76]
   Batrakova EV, 2004, PHARM RES, V21, P2226, DOI 10.1007/s11095-004-7675-5
   Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483
   Baumert C, 2009, ANTI-CANCER AGENT ME, V9, P415, DOI 10.2174/1871520610909040415
   Bernkop-Schnurch A., 2006, AM J DRUG DELIV, V4, P263
   Chuan XX, 2014, MOL PHARMACEUT, V11, P3656, DOI 10.1021/mp500399j
   Colabufo NA, 2010, J MED CHEM, V53, P1883, DOI 10.1021/jm900743c
   Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r
   Constantinides PP, 2007, J PHARM SCI-US, V96, P235, DOI 10.1002/jps.20780
   Dunnhaupt S, 2012, CARBOHYD POLYM, V90, P765, DOI 10.1016/j.carbpol.2012.05.028
   Dunnhaupt S, 2012, MOL PHARMACEUT, V9, P1331, DOI 10.1021/mp200598j
   Foger F, 2006, BIOMATERIALS, V27, P5855, DOI 10.1016/j.biomaterials.2006.08.004
   Foger F, 2006, BIOMATERIALS, V27, P4250, DOI 10.1016/j.biomaterials.2006.03.033
   Grabovac V, 2015, INT J PHARMACEUT, V493, P374, DOI 10.1016/j.ijpharm.2015.05.079
   Greindl M, 2009, EUR J PHARM BIOPHARM, V72, P561, DOI 10.1016/j.ejpb.2009.03.008
   HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100
   Hugger ED, 2002, J PHARM SCI, V91, P1980, DOI 10.1002/jps.10175
   Ijaz M, 2015, EXPERT OPIN DRUG DEL, V12, P1269, DOI 10.1517/17425247.2015.1005598
   Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7
   Lin D. J. H., 2003, CLIN PHARMACOKINET, V42, P59
   Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012
   Palmberger TF, 2015, INT J PHARMACEUT, V491, P318, DOI 10.1016/j.ijpharm.2015.06.023
   Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6
   Risovic V, 2004, DRUG DEV IND PHARM, V30, P767, DOI 10.1081/DDC-120039793
   Sakloetsakun D, 2011, DRUG DEV IND PHARM, V37, P648, DOI 10.3109/03639045.2010.534484
   Schmitz T, 2008, DRUG DELIV, V15, P245, DOI 10.1080/10717540802006708 
   Shaik N, 2008, J PHARM SCI-US, V97, P5421, DOI 10.1002/jps.21372
   Shukla S, 2009, DRUG METAB DISPOS, V37, P359, DOI 10.1124/dmd.108.024612
   Summers MA, 2004, ANN PHARMACOTHER, V38, P1631, DOI 10.1345/aph.1E068
   Trapani A, 2014, BIOMACROMOLECULES, V15, P882, DOI 10.1021/bm401733p
   Werle M, 2006, J CONTROL RELEASE, V111, P41, DOI 10.1016/j.cornel.2005.11.011
   Werle M, 2008, PHARM RES, V25, P500, DOI 10.1007/s11095-007-9347-8
   Werle M, 2009, J PHARM SCI-US, V98, P1643, DOI 10.1002/jps.21550
   Yang Jian-sheng, 2014, Yaoxue Xuebao, V49, P942
   Zhao B, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-47
   Zhu X, 2012, MOL VIS, V18, P1973
NR 38
TC 0
Z9 0
U1 3
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2015
VL 5
IS 126
BP 104228
EP 104238
DI 10.1039/c5ra19418k
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA CY5FO
UT WOS:000366433700057
DA 2018-10-20
ER

PT J
AU Parazzi, V
   Lavazza, C
   Boldrin, V
   Montelatici, E
   Pallotti, F
   Marconi, M
   Lazzari, L
AF Parazzi, Valentina
   Lavazza, Cristiana
   Boldrin, Valentina
   Montelatici, Elisa
   Pallotti, Francesco
   Marconi, Maurizio
   Lazzari, Lorenza
TI Extensive Characterization of Platelet Gel Releasate From Cord Blood in
   Regenerative Medicine
SO CELL TRANSPLANTATION
LA English
DT Article
DE Adipose mesenchymal stem cells; Human cord blood; Human peripheral
   blood; Platelet gel; Proteome array
ID MESENCHYMAL STEM-CELLS; RICH PLASMA PRP; IN-VITRO; CHEMOKINE RECEPTORS;
   ANGIOGENESIS; DIFFERENTIATION; GROWTH; ERYTHROPOIETIN; PROLIFERATION;
   INFLAMMATION
AB Platelet gel derived from peripheral blood is widely applied in many clinical fields of surgery as biomaterial containing growth factors with high proliferative properties. In 2010, we studied and patented a platelet gel derived from cord blood. In this study, due to the crucial role of the factors released by the platelet gel, we first extended the characterization of its releasate. Using a wide proteomic array and splitting the two components of the releasate, that is, platelets and plasma, we have been able to study their growth factor content. Interestingly, we discovered high levels of hormones and molecules able to support tissue growth in the cord blood platelet gel releasate and, in addition, higher concentrations of several angiogenic factors if compared with the peripheral blood counterpart. On the contrary, the latter was much richer in inflammatory factors. The second aim of our work was to study the effects on cell culture, immunophenotype, and function of mesenchymal stem cells exposed to these two platelet gel releasates as substitute for the animal serum. Since our findings nicely show that the use of the peripheral versus the cord blood platelet gel releasate can differently influence the mesenchymal stem cell commitment, we can suggest that in addition to its peculiar angiogenic properties cord blood platelet gel releasate shows excellent proliferative properties as cell culture supplement.
C1 [Parazzi, Valentina; Lavazza, Cristiana; Boldrin, Valentina; Montelatici, Elisa; Lazzari, Lorenza] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Cellular Therapy & Cryobiol, Cell Factory, I-20122 Milan, Italy.
   [Pallotti, Francesco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Anat Pathol Unit, I-20122 Milan, Italy.
   [Marconi, Maurizio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Blood Transfus, I-20122 Milan, Italy.
RP Lazzari, L (reprint author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Cellular Therapy & Cryobiol, Cell Factory, Via F Sforza 35, I-20122 Milan, Italy.
EM lorenza.lazzari@policlinico.mi.it
RI Lazzari, Lorenza/J-4279-2015; Montelatici, Elisa/O-1404-2015
OI Lazzari, Lorenza/0000-0002-9434-4538; Montelatici,
   Elisa/0000-0002-0717-2695; Lavazza, Cristiana/0000-0002-1167-6167;
   BOLDRIN, VALENTINA/0000-0003-1802-1603
FU Regione Lombardia [PB 0098]; Ministero della Salute Italiano [R.F.G.R.
   2010-2318448, R.F.G.R. 2010-2312573]; European Union [241879]
FX The authors would like to thank Paolo Rebulla for his scientific support
   in developing the Cord Blood Platelet Gel project. We are also grateful
   to the Milano Cord Blood group for their help in providing cord blood
   units. This work was partially supported by funds from Regione Lombardia
   (PB 0098), from Ministero della Salute Italiano ("Young Researchers"
   grants: R.F.G.R. 2010-2318448, R.F.G.R. 2010-2312573), and from European
   Union's Seventh Programme (Grant Agreement No. 241879). All these funds
   cooperated to support this study mainly covering the salaries of the
   authors involved in this research. Valentina Parazzi and Lorenza Lazzari
   declare their role as inventors in patent No. PCT WO/2010/007502
   "Platelet fraction deriving from placental blood." The other authors
   declare no conflicts of interest.
CR Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23
   Bernuzzi G, 2013, BLOOD TRANSFUS, V3, P1
   Boswell SG, 2012, ARTHROSCOPY, V28, P429, DOI 10.1016/j.arthro.2011.10.018
   Brand A, 2008, VOX SANG, V95, P335, DOI 10.1111/j.1423-0410.2008.01106.x
   Burnouf T, 2009, ISBT SCI SER, V4, P136, DOI 10.1111/j.1751-2824.2009.01222.x
   Caimi PF, 2010, CURR OPIN HEMATOL, V17, P505, DOI 10.1097/MOH.0b013e32833e5b18
   Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200
   Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219
   Creeper F, 2009, J PERIODONTAL RES, V44, P258, DOI 10.1111/j.1600-0765.2008.01125.x
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Di Renzo GC, 2005, CURR OPIN OBSTET GYN, V17, P598, DOI 10.1097/01.gco.0000191899.84567.4d
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Folman CC, 2000, THROMB HAEMOSTASIS, V83, P923
   Frith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082931
   Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198
   GEORGE JN, 1988, BLOOD, V72, P362
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Iudicone P, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-28
   Jo CH, 2011, ACTA ORTHOP BELG, V77, P676
   Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025
   Kilan K. A., 2010, P NATL ACAD SCI USA, V107, P4872
   Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4
   Li Yon-hong, 2008, Zhonghua Xinxueguanbing Zazhi, V36, P266
   Liurba E., 2013, EUR HEART J, V35, P701
   Lo Cicero V, 2008, CELL PROLIFERAT, V41, P460, DOI 10.1111/j.1365-2184.2008.00533.x
   Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839
   Madla W, 2012, VOX SANG, V102, P116, DOI 10.1111/j.1423-0410.2011.01518.x
   Mark P, 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013.698076
   Mazzucco L, 2008, VOX SANG, V94, P202, DOI 10.1111/j.1423-0410.2007.01027.x
   Middleton Kellie K, 2012, Iowa Orthop J, V32, P150
   Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293
   Moroz A, 2013, CYTOTHERAPY, V15, P1436, DOI 10.1016/j.jcyt.2013.05.019
   Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015
   Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007
   Nagaishi VS, 2014, NEUROSCIENCE, V259, P71, DOI 10.1016/j.neuroscience.2013.11.050
   Ojala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048659
   Parazzi V, 2010, PLATELETS, V21, P549, DOI 10.3109/09537104.2010.514626
   Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x
   Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com
   Rosso L., 2013, BLOOD TRANSFUS, V14, P1
   Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002
   Schieving JH, 2014, EUR J PAEDIATR NEURO, V18, P243, DOI 10.1016/j.ejpn.2013.09.003
   Sirchia G, 1998, BONE MARROW TRANSPL, V21, P843
   Smalley DM, 2007, THROMB HAEMOSTASIS, V97, P67, DOI 10.1160/TH06-02-0066
   Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x
   Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385
   Ullah M., 2013, STEM CELL RES THER, V4, P99
   van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016
   White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074
   Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhang YZ, 2014, METHODS MOL BIOL, V1105, P43, DOI 10.1007/978-1-62703-739-6_4
NR 52
TC 6
Z9 7
U1 0
U2 4
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2015
VL 24
IS 12
BP 2573
EP 2584
DI 10.3727/096368915X687471
PG 12
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA CY1UR
UT WOS:000366193900012
PM 25695232
OA Bronze
DA 2018-10-20
ER

PT J
AU Fernandez-Lacruz, R
   Di Fulvio, F
   Athanassiadis, D
   Bergstrom, D
   Nordfjell, T
AF Fernandez-Lacruz, Raul
   Di Fulvio, Fulvio
   Athanassiadis, Dimitris
   Bergstrom, Dan
   Nordfjell, Tomas
TI Distribution, characteristics and potential of biomass-dense thinning
   forests in Sweden
SO SILVA FENNICA
LA English
DT Article
DE early thinning; small-tree harvesting; unthinned stand; GIS; wood fuel;
   bioenergy; biomaterial
ID LAND ABANDONMENT; YOUNG FORESTS; BIRCH STANDS; ENERGY-WOOD; SYSTEMS;
   COST; FINLAND; SIMULATION; CHIPS; FUEL
AB Understanding the characteristics of unutilized biomass resources, such as small-diameter trees from biomass-dense thinning forests (BDTF) (non-commercially-thinned forests), can provide important information for developing a bio-based economy. The aim of this study was to describe the areal distribution, characteristics (biomass of growing stock, tree height, etc.) and harvesting potential of BDTF in Sweden. A national forest inventory plot dataset was imported into a geographical information system and plots containing BDTF were selected by applying increasingly stringent constraints. Results show that, depending on the constraints applied, BDTF covers 9-44% (2.1-9.8 M ha) of the productive forest land area, and contains 7-34% of the total growing stock (119-564 M OD t), with an average biomass density of 57 OD t ha-1. Of the total BDTF area, 65% is located in northern Sweden and 2% corresponds to set-aside farmlands. Comparisons with a study from 2008 indicate that BDTF area has increased by at least 4% (about 102 000 ha), in line with general trends for Sweden and Europe. Analyses revealed that the technical harvesting potential of delimbed stemwood (over bark, including tops) from BDTF ranges from 3.0 to 6.1 M OD t yr(-1) (7.5 to 15.1 M m(3) yr(-1)), while the potential of whole-tree harvesting ranges from 4.3 to 8.7 M OD t yr(-1) (10.2 to 20.6 M m(3) yr(-1)) depending on the scenario considered. However, further technological developments of the harvest and supply systems are needed to utilize the full potential of BDTF.
C1 [Fernandez-Lacruz, Raul; Di Fulvio, Fulvio; Athanassiadis, Dimitris; Bergstrom, Dan; Nordfjell, Tomas] Swedish Univ Agr Sci SLU, Dept Forest Biomat & Technol SBT, SE-90183 Umea, Sweden.
   [Di Fulvio, Fulvio] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program ESM, A-2361 Laxenburg, Austria.
RP Fernandez-Lacruz, R (reprint author), Swedish Univ Agr Sci SLU, Dept Forest Biomat & Technol SBT, SE-90183 Umea, Sweden.
EM raul.fernandez@slu.se
RI Fernandez-Lacruz, Raul/E-4472-2015
OI Fernandez-Lacruz, Raul/0000-0001-9284-8911
FU Swedish national research programme Efficient Forest Fuel Systems (ESS);
   European Union Seventh Framework Programme (FP7) [311881]; project
   INFRES (Innovative and Effective Technology and Logistics for Forest
   Residual Biomass Supply in the EU); project Forest Refine (part of the
   Botnia-Atlantica Programme)
FX We gratefully acknowledge the financial support from the Swedish
   national research programme Efficient Forest Fuel Systems (ESS), the
   European Union Seventh Framework Programme (FP7/2012-2015) under grant
   agreement no 311881 financing the research project INFRES (Innovative
   and Effective Technology and Logistics for Forest Residual Biomass
   Supply in the EU) and the project Forest Refine (part of the
   Botnia-Atlantica Programme).
CR Anttila P, 2013, WORK PAP FINN FOR RE, V267, P24
   Axelsson AL, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P541, DOI 10.1007/978-90-481-3233-1_35
   Belbo H, 2014, FORESTS, V5, P2084, DOI 10.3390/f5092084
   Berg S, 1992, TERRAIN CLASSIFICATI
   Bergstrom D., 2009, ACTA U AGR SUECIAE, V87
   Bergstrom D., 2015, SKOG KLIMAT MILJO PR
   Bergstrom D., 2014, INT J FOREST ENG, V25, P156, DOI [http://dx.doi.org/10.1080/14942119.2014.945697, DOI 10.1080/14942119.2014.945697]
   Bergstrom D, 2007, SILVA FENN, V41, P137, DOI 10.14214/sf.311
   Bergstrom D, 2014, SCAND J FOREST RES, V29, P793, DOI 10.1080/02827581.2014.976590
   Claesson S., 1999, FOREST RES B, V210
   Di Fulvio F., 2013, INT J FOREST ENG, V24, P2, DOI DOI 10.1080/14942119.2013.798935
   Di Fulvio F., 2011, 3432011 SWED U AGR S
   Di Fulvio F, 2011, SCAND J FOREST RES, V26, P339, DOI 10.1080/02827581.2011.568951
   Direct Knowledge (Kunskap Direkt), 2012, ROJ NAR BOR ROJN GOR
   Emanuelsson U., 2014, FOR CLIM ENV SKM FIN
   Enstrom J., 2013, 8132013 FOR RES I SW
   Fernandez-Lacruz R, 2013, SILVA FENN, V47, DOI 10.14214/sf.904
   Food and Agriculture Organization (FAO), 2014, GLOB FOR RES ASS FRA
   Fridman J., 2011, MORKNAR BYGDERNA SKO, P4
   Gellrich M, 2007, AGR ECOSYST ENVIRON, V118, P93, DOI 10.1016/j.agee.2006.05.001
   Heikkila J, 2009, SILVA FENN, V43, P129, DOI 10.14214/sf.220
   Junden L., 2013, INT J FOREST ENG, V24, P16, DOI DOI 10.1080/14942119.2013.798131
   Jylha P., 2011, THESIS, V133, DOI [http://dx.doi.org/10.14214/df.133, DOI 10.14214/DF.133]
   Jylha P, 2015, BIOMASS BIOENERG, V75, P272, DOI 10.1016/j.biombioe.2015.02.027
   Karha K., 2005, International Journal of Forest Engineering, V16, P15
   Karlsson L., 2013, THESIS
   Karttunen K., 2015, THESIS, DOI [http://dx.doi.org/10.14214/df.186, DOI 10.14214/DF.186]
   Kons K., 2014, INT J FOREST ENG, V25, P238, DOI [http://dx.doi.org/10.1080/14942119.2014.980494, DOI 10.1080/14942119.2014.980494]
   Laitila J, 2008, SILVA FENN, V42, P267, DOI 10.14214/sf.256
   Laitila J, 2010, SILVA FENN, V44, P465, DOI 10.14214/sf.143
   Larsson F., 2013, WECALC WOOD ENERGY C
   Lundstrom A., 2009, DEFINITIONER TILLGAN
   MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335
   Marklund L. G., 1988, 45 SWED U AGR SCI DE
   Matisons M., 2014, 182014 SWED U AGR SC
   Melin Y., 2014, THESIS
   Nilsson P., 2011, SKOGSDATA AKTUELLA U
   Nordfjell T., 2008, Proceedings of the World Bioenergy Conference and Exhibition on Biomass for Energy, Jonkoping, Sweden, 27-29 May 2008, P323
   Oikari M, 2010, SILVA FENN, V44, P481, DOI 10.14214/sf.144
   Pasanen K., 2014, INT J FOREST ENG, V25, P51, DOI DOI 10.1080/14942119.2014.903614
   Petty A., 2014, DISSERTATIONES FORES, V173, DOI [http://dx.doi.org/10.14214/df.175, DOI 10.14214/DF.175]
   Raisanen T., 2013, POTENTIAL DISTRIBUTI
   Ranta T, 2005, BIOMASS BIOENERG, V28, P171, DOI 10.1016/j.biombioe.2004.08.010
   Ranta T, 2011, BIOMASS BIOENERG, V35, P1841, DOI 10.1016/j.biombioe.2011.01.029
   Ringman M., 1996, 250 SWED U AGR SCI D
   Romero-Calcerrada R, 2004, LANDSCAPE URBAN PLAN, V66, P217, DOI 10.1016/S0169-2046(03)00112-9
   Roser D., 2012, DISSERTATIONES FORES, V146, DOI [http://dx.doi.org/10.14214/df.146, DOI 10.14214/DF.146]
   Routa J., 2013, ENERGY ENV, V2, P602, DOI DOI 10.1002/WENE.24
   Sangstuvall L, 2012, SCAND J FOREST RES, V27, P56, DOI 10.1080/02827581.2011.628335
   Statistics Sweden (Statistika Centralbyran SCB), 2014, 201409 SCB ES
   Swedish Bioenergy Association (Svebio), 2013, SWED EN SUPPL NOW 50
   Swedish Bioenergy Association (Svebio), 2014, BIOEN SWED COUNTR RE
   Swedish Board of Agriculture (Jordbruksverket), 2015, US AGR LAND 2014 FIN
   Swedish Energy Agency, 2015, EN SIFFR 2015
   Swedish Energy Agency (Energymyndigheten), 2012, ER201209 SWED EN AG
   Swedish Energy Agency (Energymyndigheten), 2013, ET201316 SWED EN AG
   Swedish Forest Agency (Skogsstyrelsen), 2014, DEF LAND US
   Swedish Forest Agency (Skogsstyrelsen), 2014, SWED STAT YB FISH SI
   Thornqvist T., 1986, 180 SWED U AGR SCI D
   Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P185, DOI 10.1007/978-90-481-3233-1_11
   Tucker G., 2010, FARMLAND ABANDONMENT
   Ulvcrona K.A., 2011, THESIS
   Varmola M, 2004, SCAND J FOREST RES, V19, P142, DOI 10.1080/02827580310019545
   VMF Qbera, 2012, MATNING AV MASSAVED
   Windisch J., 2015, DISSERTATIONES FORES, V189, DOI [http://dx.doi.org/10.14214/df.189, DOI 10.14214/DF.189]
NR 65
TC 5
Z9 6
U1 1
U2 13
PU FINNISH SOC FOREST SCIENCE-NATURAL RESOURCES INST FINLAND
PI VANTAA
PA PO BOX 18, FI-01301 VANTAA, FINLAND
SN 0037-5330
EI 2242-4075
J9 SILVA FENN
JI Silva. Fenn.
PY 2015
VL 49
IS 5
AR 1377
DI 10.14214/sf.1377
PG 17
WC Forestry
SC Forestry
GA CX5YQ
UT WOS:000365778800009
DA 2018-10-20
ER

PT J
AU Gonsior, M
   Kustosz, R
   Koscielniak-Ziemniak, M
   Wierzchon, T
AF Gonsior, M.
   Kustosz, R.
   Koscielniak-Ziemniak, M.
   Wierzchon, T.
TI BIOCOMPATIBLE EVALUATION OF BIOMATERIALS USED IN THE NEW POLISH
   EXTRACORPOREAL PULSATILE HEART ASSIST DEVICE RELIGAHEART EXT
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial biocompatybility evaluation; ventricular assist device;
   polyurethanes; diffusive layers; titanium nitride
AB The innovative extracorporeal heart support device ReligaHeart (RH EXT) has been developed, based on POLVAD ventricular assist device clinical experience, collected in more than 300 patient applications. The innovative surface engineering technologies are applied in ReligaHeart EXT device. The pump is manufactured of new generation, modified surface structure, biocompatible polyurethanes, and equipped with original tilting disc valves, Moll type. The valve ring is made of titanium alloy, TiN+Ti2N+alpha Ti(N) diffusive layer modified, produced with glow discharge at plasma potential, in order to obtain the lowest thrombogenicity. The valve disc is made of polyether ether ketone. The complex in vitro and in vivo biological evaluations were performed, confirming both biomaterials biocompatible properties and device biocompatibility, proved in 30 days animal heart support.
C1 [Gonsior, M.; Kustosz, R.; Koscielniak-Ziemniak, M.] Prof Zbigniew Religa Fdn Cardiac Surg Dev, Artificial Heart Lab, PL-41800 Zabrze, Poland.
   [Wierzchon, T.] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
RP Gonsior, M (reprint author), Prof Zbigniew Religa Fdn Cardiac Surg Dev, Artificial Heart Lab, 345A Wolnosci Str, PL-41800 Zabrze, Poland.
EM gosiag@frk.pl
CR Gawlikowski M., 2013, POSTEPY INZYNIERII B
   Gonsior M., 2009, INZYNIERIA BIOMATERI, VXII
   Gonsior M., 2011, INZYNIERIA BIOMATERI, V14, P102
   Gonsior M., 2013, POLSKIE PROTEZY SERC
   Gonsior M., 2010, KOMPOZYTY, V3, P175
   Gonsior M., 2009, P BIOM AFR PRET S AF
   Kapis A., 2013, POLSKIE PROTEZY SERC
   Religa G., 2013, POLSKIE PROTEZY SERC
   Szuber A., 2013, POSTEPY INZYNIERII B
   Szuber A., 2013, POLSKIE PROTEZY SERC
NR 10
TC 1
Z9 1
U1 1
U2 6
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 3
BP 2271
EP 2278
DI 10.1515/amm-2015-0374
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CW9YL
UT WOS:000365354000101
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Major, R
AF Major, R.
TI BIO-INSPIERED BLOOD-CONTACTING MATERIALS ELABORATED FOR THE HEART ASSIST
   SYSTEM
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE Surface modification; cell-material interaction; tissue precursors;
   materials for regenerative medicine
ID POLYELECTROLYTE MULTILAYER FILMS; SURFACE-ROUGHNESS; TITANIUM IMPLANT;
   NANOMETER-SCALE; CELL-ADHESION; THIN-FILMS; COATINGS; DEPOSITION;
   GROWTH; DISCHARGES
AB The paper presents the main achievements of the author on the development of blood contacting materials. The main objective of the work is to elaborate materials dedicated for the heart support systems. Appropriately designed biomaterial surfaces enable fully controlled cellular differentiation, proliferation, and even restoration of the tissue structure on solids. The paper presents two approaches to modify the surface, which can control the life processes of tissue. The first solution considers the topography in the form of cell niches. The main objective of the study is a modified surface of thin films deposited on the polymer substrate constituting the microenvironment for the cells caused by residual stress and optimized stiffness of the surface using the plasma methods. The research hypothesis was the plasma surface modification method generating a controlled contribution of residual stress in the coating affect the surface topography in the form of nano- wrinkles similar to the niches in the tissue environment. Topography and stiffness of the surface coating allows the targeted cellular differentiation. The properly formed surface topography effectively inhibits blood clotting processes. The second solution considers implementation of self-organizing feature of extracellular matrix like coatings and selective cell mobilization. The multiscale analysis and phenomenologic description were performed to experimental research. For this purpose, the deposition method was based on electrostatic interactions in polyelectrolytes. This type of cell-polymer structure imitate the native structures.
C1 [Major, R.] Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
RP Major, R (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta Str, PL-30059 Krakow, Poland.
EM r.major@imim.pl
FU project CardioBioMat MNT Era-Net under the National Centre of Research
   and Development [MNT/15/2009]; Polish National Center of Science
   [2011/03/D/ST8/04103]; Polish-Austrian exchange project [PL 023/2012]
FX The research associated with inner surface modification of tubes was
   supported financially by the project CardioBioMat MNT Era-Net
   MNT/15/2009 "Nonstructural materials for implants and cardiovascular
   biomedical devices" under the National Centre of Research and
   Development. The research work connected with porous coatings was
   financially supported by the project 2011/03/D/ST8/04103
   "Self-assembling, biomimetic porous scaffolds in terms of inhibiting the
   activation of the coagulation system" of the Polish National Center of
   Science and Polish-Austrian exchange project PL 023/2012. The coatings
   were deposited in JOANNEUM RESEARCH Forschungs-GmbH,
   MATERIALS-Functional Surfaces, Leoben, Austria. The experiments were
   executed with the cooperation of Jagiellonian University Medical College
   and Department of Medicine Cracow, Poland, Grenoble Institute National
   Polytechnique Minatec Phelma LMGP
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chehroudi B, 2002, BIOMATERIALS, V23, P229, DOI 10.1016/S0142-9612(01)00100-4
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Kapis A., 2013, POLISH ARTIFICIAL HE, P2013
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Lackner J. M., 2005, IND SCALED HYBRID PU
   Lackner JM, 2005, VACUUM, V78, P73, DOI [10.1016/j.vacuum.2004.12.017, 10.1016/j/vacuum.2004.12.017]
   Lackner JM, 2014, PLASMA CHEM PLASMA P, V34, P259, DOI 10.1007/s11090-013-9519-8
   Lackner JM, 2011, VACUUM, V86, P144, DOI 10.1016/j.vacuum.2011.05.005
   Lackner JM, 2010, BIOMED TECH, V55, P57, DOI 10.1515/BMT.2010.001
   Laha A, 2004, MAT SCI ENG B-SOLID, V106, P111, DOI 10.1016/j.mseb.2003.08.001
   Lange M., 2012, ANATOMY PHYSL UNITY
   Major R., J MAT SCI M IN PRESS
   Major R, 2014, RSC ADV, V4, P9491, DOI 10.1039/c3ra43794a
   Major R, 2013, J MATER SCI-MATER M, V24, P725, DOI 10.1007/s10856-012-4824-y
   Mirhosseini N, 2007, APPL SURF SCI, V253, P7738, DOI 10.1016/j.apsusc.2007.02.168
   Mylvaganam K, 2003, THIN SOLID FILMS, V425, P145, DOI 10.1016/S0040-6090(02)01287-7
   Mzyk A, 2015, RSC ADV, V5, P13906, DOI 10.1039/c4ra14474k
   Mzyk A, 2014, RSC ADV, V4, P31948, DOI 10.1039/c4ra03914a
   Mzyk A, 2014, ARCH CIV MECH ENG, V14, P262, DOI 10.1016/j.acme.2013.09.006
   Naduvinamania NB, 2005, TRIBOL INT, V38, P451, DOI 10.1016/j.triboint.2004.09.001
   Ohta Yuji, 2003, J Artif Organs, V6, P101
   Picart C, 2007, COLLOID SURFACE A, V303, P30, DOI 10.1016/j.colsurfa.2007.02.015
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Sanak M, 2010, B POL ACAD SCI-TECH, V58, P317, DOI 10.2478/v10175-010-0029-z
   Sefton M.V., 2004, NONTHROMBOGENIC TREA
   THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323
   Trembecka-Wojciga K, 2015, ARCH CIV MECH ENG, V15, P621, DOI 10.1016/j.acme.2014.12.005
   Trtica M, 2006, APPL SURF SCI, V253, P2551, DOI 10.1016/j.apsusc.2006.05.024
   Tsyganov T.I., 2005, SURF COAT TECH, V200, P1041
   Wagner W.R., 2004, BIOMATERIALS SCI
   Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328
NR 37
TC 0
Z9 0
U1 0
U2 8
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PY 2015
VL 60
IS 3
BP 2279
EP 2287
DI 10.1515/amm-2015-0375
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CW9YL
UT WOS:000365354000102
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wu, H
   Liu, GH
   Wu, Q
   Yu, B
AF Wu, H.
   Liu, G. H.
   Wu, Q.
   Yu, B.
TI Repairing rabbit radial defects by combining bone marrow stroma stem
   cells with bone scaffold material comprising a core-cladding structure
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Core-cladding structure; Osteogenic capability; Bone defect; Bone tissue
   engineering
ID TISSUE; BIOMATERIAL; VASCULARIZATION
AB We prepared a bone scaffold material comprising a PLGA/beta-TCP core and a Type I collagen cladding, and recombined it with bone marrow stroma stem cells (BMSCs) to evaluate its potential for use in bone tissue engineering by in vivo and in vitro experiments. PLGA/beta-TCP without a cladding was used for comparison. The adherence rate of the BMSCs to the scaffold was determined by cell counting. Cell proliferation rate was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. The osteogenic capability was evaluated by alkaline phosphatase activity. The scaffold materials were recombined with the BMSCs and implanted into a large segmental rabbit radial defect model to evaluate defect repair. Osteogenesis was assessed in the scaffold materials by histological and double immunofluorescence labeling, etc. The adherence number, proliferation number, and alkaline phosphatase expression of the cells on the bone scaffold material with core-cladding structure were significantly higher than the corresponding values in the PLGA/beta-TCP composite scaffold material (P < 0.05). An in vivo test indicated that the bone scaffold material with core-cladding structure completely degraded at the bone defect site and bone formation was completed. The rabbit large sentimental radial defect was successfully repaired. The degradation and osteogenesis rates matched well. The bone scaffold with core-cladding structure exhibited better osteogenic activity and capacity to repair a large segmental bone defect compared to the PLGA/beta-TCP composite scaffold. The bone scaffold with core-cladding structure has excellent physical properties and biocompatibility. It is an ideal scaffold material for bone tissue engineering.
C1 [Wu, H.; Wu, Q.; Yu, B.] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Wu, H.; Liu, G. H.] Inner Mongolia Med Univ, Affiliated Hosp 2, Hohhot, Peoples R China.
RP Yu, B (reprint author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
EM yubinsmu@163.com
CR Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097
   Asaoka T, 2013, J BIOMED MATER RES A, V101, P3295, DOI 10.1002/jbm.a.34517
   Bellucci D, 2012, J MATER SCI-MATER M, V23, P1397, DOI 10.1007/s10856-012-4622-6
   Cai YZ, 2012, J BIOMED MATER RES A, V100A, P1187, DOI 10.1002/jbm.a.34063
   Delabarde C, 2012, J MATER SCI-MATER M, V23, P1371, DOI 10.1007/s10856-012-4619-1
   Dias MR, 2012, J BIOMECH, V45, P938, DOI 10.1016/j.jbiomech.2012.01.019
   Fassina L, 2010, IEEE ENG MED BIO, P247, DOI 10.1109/IEMBS.2010.5627475
   Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082945
   He NY, 2012, J NANOSCI NANOTECHNO, V12, P2858, DOI 10.1166/jnn.2012.5756
   Jakob M, 2012, EUR SURG RES, V49, P1, DOI 10.1159/000338362
   Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]
   Liu M, 2013, ORTHOPEDICS, V36, P868, DOI 10.3928/01477447-20131021-10
   Liundup A V, 2013, Vestn Ross Akad Med Nauk, P10
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Moshaverinia A, 2013, J BIOMED MATER RES A, V101, P3285, DOI 10.1002/jbm.a.34546
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005
   Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Shahini A, 2014, INT J NANOMED, V9, P167, DOI 10.2147/IJN.S54668
   Sreejit P, 2013, STEM CELL REV REP, V9, P158, DOI 10.1007/s12015-013-9427-6
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   Tsai WB, 2014, J BIOMATER APPL, V28, P837, DOI 10.1177/0885328213483842
   Varoni E, 2012, CONNECT TISSUE RES, V53, P548, DOI 10.3109/03008207.2012.712583
   Vishnoi T, 2013, J MATER SCI-MATER M, V24, P447, DOI 10.1007/s10856-012-4795-z
   Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16
   Wen Y, 2013, OR SURG OR MED OR PA, V116, pE324, DOI 10.1016/j.oooo.2012.02.024
   Zou J, 2014, MOL MED REP, V9, P185, DOI 10.3892/mmr.2013.1758
NR 30
TC 2
Z9 3
U1 0
U2 5
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 11933
EP 11943
DI 10.4238/2015.October.5.7
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CX7ZZ
UT WOS:000365922800027
PM 26505341
OA Bronze
DA 2018-10-20
ER

PT J
AU Gregoric, M
   Blackledge, TA
   Agnarsson, I
   Kuntner, M
AF Gregoric, Matjaz
   Blackledge, Todd A.
   Agnarsson, Ingi
   Kuntner, Matjaz
TI A molecular phylogeny of bark spiders reveals new species from Africa
   and Madagascar (Araneae: Araneidae: Caerostris)
SO JOURNAL OF ARACHNOLOGY
LA English
DT Article
DE Biomaterial; spider silk; web gigantism; sexual size dimorphism;
   emasculation
ID DNA BARCODES; ORB WEBS; ADAPTIVE RADIATION; SEXUAL SELECTION; MALE
   ADAPTATION; THERAPHOSIDAE; EVOLUTION; SIZE; MYGALOMORPHAE; APHONOPELMA
AB Bark spiders (genus Caerostris Thorell 1868) are important models in biomaterial research due to the remarkable biomechanical properties of the silk of C. darwini Kuntner & Agnarsson 2010 and its gigantic web. They also exhibit female gigantism and are promising candidates for coevolutionary research on sexual dimorphism. However, Caerostris spiders are taxonomically understudied and the lack of a phylogeny impedes evolutionary research. Using a combination of one mitochondrial and one nuclear marker, we provide the first species-level phylogeny of Caerostris including half of its species diversity but dense terminal sampling focusing on new lineages. Our phylogenetic and morphological results provide the evidence for six previously undescribed species: C. almae n. sp., C. bojani n. sp., C. pero n. sp. and C. wallacei n. sp., all from Madagascar, C. linnaeus n. sp. from Mozambique and C. tinamaze n. sp. from the Republic of South Africa.
C1 [Gregoric, Matjaz; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, SI-1001 Ljubljana, Slovenia.
   [Gregoric, Matjaz; Blackledge, Todd A.] Univ Akron, Dept Biol, Integrated Biosci Program, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Univ Vermont, Dept Biol, Burlington, VT USA.
   [Agnarsson, Ingi; Kuntner, Matjaz] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.
   [Kuntner, Matjaz] Hubei Univ, Coll Life Sci, Ctr Behav Ecol & Evolut, Wuhan, Hubei, Peoples R China.
RP Gregoric, M (reprint author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Novi Trg 2,POB 306, SI-1001 Ljubljana, Slovenia.
EM matjaz.gregoric@gmail.com
FU Slovenian Research Agency [P1-0236, J1-2063]; United States National
   Science Foundation [IOS-0745379]; National Geographic Society [8655-09]
FX We thank Ren-Chung Cheng, Shakira G. Qinones Lebron, Heine C. Kiesbuy,
   Tjasa Lokovsek, Laura May-Collado, Yadira Ortiz and Joel Duff for their
   laboratory and logistic help. We thank Jonathan Coddington (USNM), Jason
   Dunlop (ZMB), Charles Griswold (CAS), Peter Jager, Rudy Jocque, Daiqin
   Li, Wenjin Gan, Liu Shengjie, Honore Rabarison, Sahondra Lalao
   Rahanitriniaina, and MICET and ICTE crews for museum loans, fresh
   material and help in the field. We thank Jason Bond and an anonymous
   reviewer for useful comments. This contribution was funded by the
   Slovenian Research Agency (grants P1-0236, J1-2063), the United States
   National Science Foundation (IOS-0745379) and the National Geographic
   Society (grant 8655-09).
CR Agnarsson I., 2013, SPIDER RES 21 CENTUR, P58
   Agnarsson I, 2015, ZOOKEYS, P13, DOI 10.3897/zookeys.509.8897
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70
   Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2
   Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024
   Barth F. G, 2002, SPIDERS WORLD SENSES
   Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00833
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Blagoev G, 2009, ZOOKEYS, V16, P27, DOI DOI 10.3897/ZOOKEYS.16.239
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304
   Cheng RC, 2015, EVOL BIOL, V42, P223, DOI 10.1007/s11692-015-9313-z
   Cheng RC, 2014, EVOLUTION, V68, P2861, DOI 10.1111/evo.12504
   CODDINGTON JA, 1994, PHYLOGENETICS ECOLOG, P53
   Danielson-Francois A, 2012, ANIM BEHAV, V84, P937, DOI 10.1016/j.anbehav.2012.07.018
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Foelix RF, 2011, BIOL SPIDERS
   Foellmer MW, 2008, EVOL ECOL RES, V10, P449
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875
   GRASSHOFF M, 1984, Revue de Zoologie Africaine, V98, P725
   Gregoric M., 2015, ZOOLOGICAL J LINNEAN, DOI [10.1111/zoj.1.12281, DOI 10.1111/Z0J.1.12281]
   Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1
   Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847
   Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103
   Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007
   Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883
   Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004
   Herberstein Marie E., 2011, P1
   Jaeger Peter, 2007, Acta Arachnologica, V56, P29, DOI 10.2476/asjaa.56.29
   Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kralj-Fiser S, 2011, ANIM BEHAV, V81, P933, DOI 10.1016/j.anbehav.2011.02.010
   Kuntner M., 2014, FRONT ECOL EVOL, V2, P26, DOI [10.3389/fevo.2014.00026, DOI 10.3389/FEVO.2014.00026]
   Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x
   Kuntner M, 2015, BIOL REV, V90, P279, DOI 10.1111/brv.12109
   Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008
   Kuntner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040939
   Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002
   Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1
   Li DQ, 2012, BIOL LETTERS, V8, P512, DOI 10.1098/rsbl.2011.1202
   Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1
   Maddison W. P., 2013, MESQUITE MODULAR SYS
   Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129
   Modanu M, 2013, EVOL DEV, V15, P205, DOI 10.1111/ede.12034
   Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074
   Scharff N, 1997, ZOOL J LINN SOC-LOND, V120, P355, DOI 10.1111/j.1096-3642.1997.tb01281.x
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Smit J, 2013, ZOOKEYS, P279, DOI 10.3897/zookeys.365.5819
   Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x
   Vidergar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113030
   Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1
   World Spider Catalog, 2015, NAT HIST MUS BERN
   Yin CM, 1997, FAUNA SINICA ARACHNI
   Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010
NR 61
TC 3
Z9 3
U1 0
U2 15
PU AMER ARACHNOLOGICAL SOC
PI COLLEGE PARK
PA UNIV MARYLAND, DEPT ENTOMOLOGY, 4112 PLANT SCIENCES BLDG, COLLEGE PARK,
   MD 20742-4454 USA
SN 0161-8202
EI 1937-2396
J9 J ARACHNOL
JI J. Arachnol.
PY 2015
VL 43
IS 3
BP 293
EP 312
DI 10.1636/0161-8202-43.3.293
PG 20
WC Entomology
SC Entomology
GA CX2WS
UT WOS:000365558100002
OA Bronze
DA 2018-10-20
ER

PT J
AU Sun, BB
   Shen, H
AF Sun, Bingbing
   Shen, Hong
TI Controlling Surface-Induced Nanocomposites by Lipoplexes for Enhanced
   Gene Transfer
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID DNA DELIVERY; IN-VITRO; PLASMID DNA; LIPOFECTION EFFICIENCY;
   ELECTRON-MICROSCOPY; MAMMALIAN-CELLS; COMPLEXES; CALCIUM; SCAFFOLDS;
   SERUM
AB Surface-induced biomineralization represents a flexible approach to immobilizing DNA onto biomaterial surfaces for surface-mediated DNA delivery. Immobilized naked DNA is uniformly embedded in thin films of nanocomposites, which limits the internalization of DNA to some cell types, such as neuronal cells. In this study, DNA molecules were initially complexed with liposomes to form lipoplexes. Subsequently, these lipoplexes were immobilized onto a cell culture compatible surface through surface-induced biomineralization. Under all the conditions we examined, lipoplexes were efficiently immobilized onto the surface and formed lipoplex-nanocomposites. We have shown that the size of liposomes and the composition of mineralizing solutions have significant effects on the morphology and topology of nanocomposites and thus the organization and the intracellular levels of DNA. The transgene expression mediated by lipoplex-nanocomposites was greatly enhanced in neuronal cells compared to the immobilized naked DNA.
C1 [Sun, Bingbing] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Shen, Hong] Elsa Biol LLC, Seattle, WA 98165 USA.
RP Shen, H (reprint author), Elsa Biol LLC, POB 25725, Seattle, WA 98165 USA.
EM hong.shen@elsa-biologics.com
RI Sun, Bingbing/I-8197-2012
OI Sun, Bingbing/0000-0002-5444-5078
FU National Institutes of Health [EB007494]; National Science Foundation
   CAREER Award
FX This work was supported by the Grant EB007494 from the National
   Institutes of Health and by the National Science Foundation CAREER Award
   given to H. Shen. AFM was provided by NanoTech User Facility at
   University of Washington.
CR Almofti MR, 2003, MOL MEMBR BIOL, V20, P35, DOI 10.1080/0968768021000035104
   ARCHIBALD DD, 1993, NATURE, V364, P430, DOI 10.1038/364430a0
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Chatzinikolaidou M, 2014, J TISSUE ENG REGEN M, V8, P417
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Ewe A, 2014, ACTA BIOMATER, V10, P2663, DOI 10.1016/j.actbio.2014.02.037
   Garcia-Castellano J M, 2000, Iowa Orthop J, V20, P49
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78
   Lakshminarayanan A, 2013, BIOCONJUGATE CHEM, V24, P1612, DOI 10.1021/bc400247w
   Lee ER, 1996, HUM GENE THER, V7, P1701, DOI 10.1089/hum.1996.7.14-1701
   Letellier SR, 1998, BBA-GEN SUBJECTS, V1380, P31, DOI 10.1016/S0304-4165(97)00121-9
   Levine RM, 2013, LANGMUIR, V29, P9208, DOI 10.1021/la400859e
   Liu Y, 1997, NAT BIOTECHNOL, V15, P167, DOI 10.1038/nbt0297-167
   Luong LN, 2009, BIOMATERIALS, V30, P6996, DOI 10.1016/j.biomaterials.2009.09.001
   Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017
   MORIN LG, 1974, AM J CLIN PATHOL, V61, P114
   Oyane A, 2007, GENE THER, V14, P1750, DOI 10.1038/sj.gt.3303041
   Pereira-Rodrigues N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009667
   Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810
   Reimer DL, 1997, J BIOL CHEM, V272, P19480, DOI 10.1074/jbc.272.31.19480
   Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Slamenova D, 1996, CELL BIOL TOXICOL, V12, P11, DOI 10.1007/BF00143390
   STERNBERG B, 1994, FEBS LETT, V356, P361, DOI 10.1016/0014-5793(94)01315-2
   Sun B, 2012, ACTA BIOMATER, V8, P1109, DOI 10.1016/j.actbio.2011.12.005
   Sun BB, 2009, BIOMATERIALS, V30, P6386, DOI 10.1016/j.biomaterials.2009.08.006
   Tabatt K, 2004, J CONTROL RELEASE, V97, P321, DOI 10.1016/j.jconrel.2004.02.029
   Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077
   Wang L, 2007, MOL PHARM, V4, P615, DOI 10.1021/mp0601291
   Wong PT, 2014, BIOMACROMOLECULES, V15, P4134, DOI 10.1021/bm501169s
   Xu YH, 1999, BIOPHYS J, V77, P341, DOI 10.1016/S0006-3495(99)76894-3
   Zhang Y, 2008, J PHARM SCI-US, V97, P237, DOI 10.1002/jps.21076
NR 40
TC 0
Z9 0
U1 0
U2 8
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2015
AR 784836
DI 10.1155/2015/784836
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA CX7YV
UT WOS:000365919800001
OA DOAJ Gold
DA 2018-10-20
ER

EF